PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Booth, BW; Boulanger, CA; Anderson, LH; Smith, GH				Booth, B. W.; Boulanger, C. A.; Anderson, L. H.; Smith, G. H.			The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells	ONCOGENE			English	Article						erbB2/HER2; mammary; microenvironment; regeneration; suppression of tumorigenesis	ESTROGEN-RECEPTOR-ALPHA; HUMAN-BREAST-CANCER; TRANSGENIC MICE; GLAND DEVELOPMENT; TERATOCARCINOMA CELLS; METASTATIC-DISEASE; EPITHELIAL-CELLS; STEM-CELLS; IN-VIVO; ONCOGENE	The microenvironment of the mammary gland has been shown to exert a deterministic control over cells from different normal organs during murine mammary gland regeneration in transplantation studies. When mouse mammary tumor virus (MMTV)-neu-induced tumor cells were mixed with normal mammary epithelial cells (MECs) in a dilution series and inoculated into epithelium-free mammary fat pads, they were redirected to noncarcinogenic cell fates by interaction with untransformed MECs during regenerative growth. In the presence of non-transformed MECs (50:1), tumor cells interacted with MECs to generate functional chimeric outgrowths. When injected alone, tumor cells invariably produced tumors. Here, the normal microenvironment redirects MMTV-neu-transformed tumorigenic cells to participate in the regeneration of a normal, functional mammary gland. In addition, the redirected tumor cells show the capacity to differentiate into normal mammary cell types, including luminal, myoepithelial and secretory. The results indicate that signals emanating from a normal mammary microenvironment, comprised of stromal, epithelial and host-mediated signals, combine to suppress the cancer phenotype during glandular regeneration. Clarification of these signals offers improved therapeutic possibilities for the control of mammary cancer growth. Oncogene (2011) 30, 679-689; doi:10.1038/onc.2010.439; published online 4 October 2010	[Booth, B. W.; Boulanger, C. A.; Anderson, L. H.; Smith, G. H.] NCI, Mammary Biol & Tumorigenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smith, GH (corresponding author), NCI, Mammary Biol & Tumorigenesis Lab, Ctr Canc Res, NIH, Bldg 10,Room 5B56,9000 Rockville Pike, Bethesda, MD 20892 USA.	gs4d@nih.gov			Center for Cancer Research, NCI; NIH; Institute for Biological Interfaces of Engineering of Clemson University; NATIONAL CANCER INSTITUTE [ZIABC010021] Funding Source: NIH RePORTER	Center for Cancer Research, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Biological Interfaces of Engineering of Clemson University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank KU Wagner for the gift of the triple transgenic WAP-Cre/Rosa26/MMTV-neu cell lines and for providing paraffin blocks from WAP-Cre/Rosa26R/MMTV-neu mouse mammary tissues. BK Vonderhaar, DS Salomon, R Callahan and GW Robinson for critical evaluation of the manuscript. The intramural research program of the Center for Cancer Research, NCI, NIH and the Institute for Biological Interfaces of Engineering of Clemson University contributed support to this work.	Bissell MJ, 2008, P NATL ACAD SCI USA, V105, P15637, DOI 10.1073/pnas.0808457105; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Choong LY, 2007, MOL CANCER THER, V6, P2828, DOI 10.1158/1535-7163.MCT-06-0809; DEOME KB, 1959, CANCER RES, V19, P515; DOLBERG DS, 1984, NATURE, V309, P552, DOI 10.1038/309552a0; GERSCHENSON M, 1986, P NATL ACAD SCI USA, V83, P7307, DOI 10.1073/pnas.83.19.7307; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Guy CT, 1996, J BIOL CHEM, V271, P7673, DOI 10.1074/jbc.271.13.7673; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; McCullough KD, 1998, P NATL ACAD SCI USA, V95, P15333, DOI 10.1073/pnas.95.26.15333; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Mueller SO, 2002, ENDOCRINOLOGY, V143, P2357, DOI 10.1210/en.143.6.2357; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith GH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1856; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323	32	59	59	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	6					679	689		10.1038/onc.2010.439	http://dx.doi.org/10.1038/onc.2010.439			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	719GY	20890308	Green Accepted			2022-12-25	WOS:000287192000005
J	Takayama, K; Tsutsumi, S; Katayama, S; Okayama, T; Horie-Inoue, K; Ikeda, K; Urano, T; Kawazu, C; Hasegawa, A; Ikeo, K; Gojyobori, T; Ouchi, Y; Hayashizaki, Y; Aburatani, H; Inoue, S				Takayama, K.; Tsutsumi, S.; Katayama, S.; Okayama, T.; Horie-Inoue, K.; Ikeda, K.; Urano, T.; Kawazu, C.; Hasegawa, A.; Ikeo, K.; Gojyobori, T.; Ouchi, Y.; Hayashizaki, Y.; Aburatani, H.; Inoue, S.			Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells	ONCOGENE			English	Article						androgen receptor; prostate cancer; CAGE; Chip-chip	TRANSCRIPTION FACTOR; GROWTH; IDENTIFICATION; NETWORK; PROTEIN; BIOINFORMATICS; PROGRESSION; REGION; ETV1	The androgen receptor (AR) is a critical transcriptional factor that contributes to the development and the progression of prostate cancer (PCa) by regulating the transcription of various target genes. Genome-wide screening of androgen target genes provides useful information to understand a global view of AR-mediated gene network in PCa. In this study, we performed 50-cap analysis of gene expression (CAGE) to determine androgen-regulated transcription start sites (TSSs) and chromatin immunoprecipitation (ChIP) on array (ChIP-chip) analysis to identify AR binding sites (ARBSs) and histone H3 acetylated (AcH3) sites in the human genome. CAGE determined 13 110 distinct, androgen-regulated TSSs (P<0.01), and ChIP-chip analysis identified 2872 androgen-dependent ARBSs (P<1e-5) and 25 945 AcH3 sites (P<1e-4). Both androgen-regulated coding genes and noncoding RNAs, including microRNAs (miRNAs) were determined as androgen target genes. Besides prototypic androgen-regulated TSSs in annotated gene promoter regions, there are many androgen-dependent TSSs that are widely distributed throughout the genome, including those in antisense (AS) direction of RefSeq genes. Several pairs of sense/antisense promoters were newly identified within single RefSeq gene regions. The integration of CAGE and ChIP-chip analyses successfully identified a cluster of androgen-inducible miRNAs, as exemplified by the miR-125b-2 cluster on chromosome 21. Notably, the number of androgen-upregulated genes was larger in LNCaP cells treated with R1881 for 24 h than for 6 h, and the percentage of androgen-upregulated genes accompanied with adjacent ARBSs was also much higher in cells treated with R1881 for 24 h than 6 h. On the basis of the Oncomine database, the majority of androgen-upregulated genes containing adjacent ARBSs and CAGE tag clusters in our study were previously confirmed as androgen target genes in PCa. The integrated high-throughput genome analyses of CAGE and ChIP-chip provide useful information for elucidating the AR-mediated transcriptional network that contributes to the development and progression of PCa. Oncogene (2011) 30, 619-630; doi: 10.1038/onc.2010.436; published online 4 October 2010	[Takayama, K.; Urano, T.; Inoue, S.] Univ Tokyo, Dept Antiaging Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130032, Japan; [Takayama, K.; Urano, T.; Ouchi, Y.; Inoue, S.] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130032, Japan; [Takayama, K.; Horie-Inoue, K.; Ikeda, K.; Urano, T.; Inoue, S.] Saitama Med Univ, Div Gene Regulat & Signal Transduct, Res Ctr Genom Med, Hidaka, Saitama, Japan; [Tsutsumi, S.; Aburatani, H.] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & technol, Meguro Ku, Tokyo 1130032, Japan; [Katayama, S.; Kawazu, C.; Hasegawa, A.; Hayashizaki, Y.] RIKEN Yokohama Inst, Riken Om Sci Ctr, Kanagawa, Japan; [Okayama, T.; Ikeo, K.; Gojyobori, T.] Natl Inst Genet, Shizuoka, Japan	University of Tokyo; University of Tokyo; Saitama Medical University; University of Tokyo; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Inoue, S (corresponding author), Univ Tokyo, Dept Antiaging Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130032, Japan.	INOUE-GER@h.u-tokyo.ac.jp	Takayama, Kenichi/AAK-9238-2020; Urano, Tomohiko/AFS-9574-2022; Katayama, Shintaro/F-2958-2010	Katayama, Shintaro/0000-0001-7581-5157	MEXT; Japan Society for the Promotion of Science; MHLW; NIBIO; Grants-in-Aid for Scientific Research [22591016] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MHLW(Ministry of Health, Labour and Welfare, Japan); NIBIO(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Genome Network Project, Cell Innovation Program and Support Project of Strategic Research Center in Private Universities from the MEXT, grants from the Japan Society for the Promotion of Science, grants-in-aid from the MHLW and the Program for Promotion of Fundamental Studies in Health Sciences of the NIBIO. We are grateful to T Murata for helpful discussion and Hiromi Sano and Kazumi Yamaguchi for their assistance.	Attard G, 2008, BRIT J CANCER, V99, P314, DOI 10.1038/sj.bjc.6604472; Balint I, 2004, GENE, V332, P45, DOI 10.1016/j.gene.2004.02.045; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Ho LL, 2008, PROSTATE, V68, P1421, DOI 10.1002/pros.20809; Horie-Inoue K, 2006, BIOCHEM BIOPH RES CO, V339, P99, DOI 10.1016/j.bbrc.2005.10.188; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Katayama S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r42; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LEITE KR, 2009, UROL ONCOL; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Louro R, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-4; Luo J, 2002, CANCER RES, V62, P2220; Maeda N, 2008, BIOTECHNIQUES, V45, P95, DOI 10.2144/000112814; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Pandini G, 2009, ANN NY ACAD SCI, V1155, P263, DOI 10.1111/j.1749-6632.2009.04361.x; Pflueger D, 2009, NEOPLASIA, V11, P804, DOI 10.1593/neo.09572; Prescott JL, 1998, PROSTATE, V35, P71, DOI 10.1002/(SICI)1097-0045(19980401)35:1<71::AID-PROS10>3.0.CO;2-H; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Suzuki H, 2003, ENDOCR-RELAT CANCER, V10, P209, DOI 10.1677/erc.0.0100209; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Takayama K, 2007, ONCOGENE, V26, P4453, DOI 10.1038/sj.onc.1210229; Takayama KI, 2009, CANCER RES, V69, P137, DOI 10.1158/0008-5472.CAN-08-3633; Takayama K, 2008, BIOCHEM BIOPH RES CO, V374, P388, DOI 10.1016/j.bbrc.2008.07.056; Velasco AM, 2004, ENDOCRINOLOGY, V145, P3913, DOI 10.1210/en.2004-0311; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wilson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-419; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yu SYM, 2009, TUMOR BIOL, V30, P80, DOI 10.1159/000216843	46	81	82	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	5					619	630		10.1038/onc.2010.436	http://dx.doi.org/10.1038/onc.2010.436			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	715WG	20890304				2022-12-25	WOS:000286922300010
J	Titushin, MS; Feng, YG; Stepanyuk, GA; Li, Y; Markova, SV; Golz, S; Wang, BC; Lee, J; Wang, JF; Vysotski, ES; Liu, ZJ				Titushin, Maxim S.; Feng, Yingang; Stepanyuk, Galina A.; Li, Yang; Markova, Svetlana V.; Golz, Stefan; Wang, Bi-Cheng; Lee, John; Wang, Jinfeng; Vysotski, Eugene S.; Liu, Zhi-Jie			NMR-derived Topology of a GFP-photoprotein Energy Transfer Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-FLUORESCENT PROTEIN; STRUCTURAL DETERMINANTS; CRYSTAL-STRUCTURE; IN-VITRO; BIOLUMINESCENCE; PROGRAM; ELECTROSTATICS; SOFTWARE; DOCKING; HADDOCK	Forster resonance energy transfer within a protein-protein complex has previously been invoked to explain emission spectral modulation observed in several bioluminescence systems. Here we present a spatial structure of a complex of the Ca2+ regulated photoprotein clytin with its green-fluorescent protein (cgGFP) from the jellyfish Clytia gregaria, and show that it accounts for the bioluminescence properties of this system in vitro. We adopted an indirect approach of combining x-ray crystallography determined structures of the separate proteins, NMR spectroscopy, computational docking, and mutagenesis. Heteronuclear NMR spectroscopy using variously N-15, C-13, H-2-enriched proteins enabled assignment of backbone resonances of more than 94% of the residues of both proteins. In a mixture of the two proteins at millimolar concentrations, complexation was inferred from perturbations of certain H-1-N-15 HSQC-resonances, which could be mapped to those residues involved at the interaction site. A docking computation using HADDOCK was employed constrained by the sites of interaction, to deduce an overall spatial structure of the complex. Contacts within the clytin-cgGFP complex and electrostatic complementarity of interaction surfaces argued for a weak protein-protein complex. A weak affinity was also observed by isothermal titration calorimetry (K-D = 0.9 mM). Mutation of clytin residues located at the interaction site reduced the degree of protein-protein association concomitant with a loss of effectiveness of cgGFP in color-shifting the bioluminescence. It is suggested that this clytin-cgGFP structure corresponds to the transient complex previously postulated to account for the energy transfer effect of GFP in the bioluminescence of aequorin or Renilla luciferase.	[Wang, Jinfeng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Titushin, Maxim S.; Stepanyuk, Galina A.; Markova, Svetlana V.; Vysotski, Eugene S.] Russian Acad Sci, Inst Biophys, Siberian Branch, Lab Photobiol, Krasnoyarsk 660036, Russia; [Golz, Stefan] Bayer Schering Pharma AG, BSP GDD GTR TD GT, D-42096 Wuppertal, Germany; [Stepanyuk, Galina A.; Wang, Bi-Cheng; Lee, John] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences; Bayer AG; Bayer Healthcare Pharmaceuticals; University System of Georgia; University of Georgia	Liu, ZJ (corresponding author), Datun Rd 15, Beijing 100101, Peoples R China.	zjliu@ibp.ac.cn	Markova, Svetlana V./AAT-7574-2020; Vysotski, Eugene/I-1761-2013; Liu, Zhi-Jie/A-3946-2012; Li, Yang/G-3685-2011; Li, Yang/M-1246-2013; Feng, Yingang/B-6304-2008	Markova, Svetlana V./0000-0001-5702-1193; Vysotski, Eugene/0000-0002-5884-3081; Liu, Zhi-Jie/0000-0001-7279-2893; Feng, Yingang/0000-0002-0879-1316	National Natural Science Foundation of China; Ministry of Science and Technology of China; Russian Foundation for Basic Research [08-09-92209]; University of Georgia Research Foundation; Georgia Research Alliance; RAS; Bayer AG (Germany); CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); University of Georgia Research Foundation; Georgia Research Alliance; RAS(Russian Academy of SciencesRegione Sardegna); Bayer AG (Germany)(Bayer AG); CAS(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China, Ministry of Science and Technology of China, CAS Research Grant, CAS Fellowship for Young International Scientists Grant, Russian Foundation for Basic Research (08-09-92209 RFBR-China joint grant), SB RAS Grant 2, "Molecular and Cell Biology" program of RAS, Bayer AG (Germany), and by the University of Georgia Research Foundation and the Georgia Research Alliance.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSON JM, 1973, J BIOL CHEM, V248, P2937; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banci L, 2006, P NATL ACAD SCI USA, V103, P8320, DOI 10.1073/pnas.0600142103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Cutler M. W., 1995, THESIS RUTGERS U NEW; Cutler MW, 1997, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P403; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; LEVINE LD, 1982, COMP BIOCHEM PHYS B, V72, P77, DOI 10.1016/0305-0491(82)90013-X; Liu ZJ, 2003, BIOCHEM BIOPH RES CO, V311, P433, DOI 10.1016/j.bbrc.2003.09.231; Liu ZJ, 2000, PROTEIN SCI, V9, P2085, DOI 10.1110/ps.9.11.2085; LO CL, 1999, J MOL BIOL, V285, P2177; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Markova SV, 2010, PHOTOCH PHOTOBIO SCI, V9, P757, DOI 10.1039/c0pp00023j; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MORIN JG, 1971, J CELL PHYSIOL, V77, P313, DOI 10.1002/jcp.1040770305; MORISE H, 1974, BIOCHEMISTRY-US, V13, P2656, DOI 10.1021/bi00709a028; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; NICOLAS MT, 1987, J CELL BIOL, V105, P723, DOI 10.1083/jcb.105.2.723; Ohashi W, 2005, J BIOMOL NMR, V31, P375, DOI 10.1007/s10858-005-1609-3; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vysotski ES, 2004, ACCOUNTS CHEM RES, V37, P405, DOI 10.1021/ar0400037; Wachter RM, 2006, PHOTOCHEM PHOTOBIOL, V82, P339, DOI 10.1562/2005-10-02-IR-708; WAMPLER JE, 1973, BIOCHIM BIOPHYS ACTA, V314, P104, DOI 10.1016/0005-2728(73)90068-6; WAMPLER JE, 1971, BIOCHEMISTRY-US, V10, P2903; Ward W.W., 1978, Methods in Enzymology, V57, P257; WARD WW, 1978, PHOTOCHEM PHOTOBIOL, V27, P389, DOI 10.1111/j.1751-1097.1978.tb07621.x; WARD WW, 1979, J BIOL CHEM, V254, P781; Ward WW, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P45; WARD WW, 1976, J PHYS CHEM-US, V80, P2289, DOI 10.1021/j100561a030; Xu YQ, 2006, NAT METHODS, V3, P931, DOI 10.1038/NMETH938; Yuan XM, 2004, EMBO J, V23, P1463, DOI 10.1038/sj.emboj.7600152; Zhang NX, 2006, J MOL BIOL, V363, P188, DOI 10.1016/j.jmb.2006.08.026	54	43	43	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40891	40900		10.1074/jbc.M110.133843	http://dx.doi.org/10.1074/jbc.M110.133843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20926380	hybrid, Green Published			2022-12-25	WOS:000285414400053
J	Ishikawa, S; Taira, T; Takahashi-Niki, K; Niki, T; Ariga, H; Iguchi-Ariga, SMM				Ishikawa, Shizuma; Taira, Takahiro; Takahashi-Niki, Kazuko; Niki, Takeshi; Ariga, Hiroyoshi; Iguchi-Ariga, Sanae M. M.			Human DJ-1-specific Transcriptional Activation of Tyrosine Hydroxylase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DJ-1 MUTANTS; PARKIN-DEFICIENT MICE; OXIDATIVE STRESS; ANDROGEN RECEPTOR; PROTEIN; MUTATIONS; INACTIVATION; DEGENERATION; INHIBITION; EXPRESSION	Loss-of-function mutation in the DJ-1 gene causes a subset of familial Parkinson disease. The mechanism underlying DJ-1-related selective vulnerability in the dopaminergic pathway is, however, not known. DJ-1 has multiple functions, including transcriptional regulation, and one of transcriptional target genes for DJ-1 is the tyrosine hydroxylase (TH) gene, the product of which is a key enzyme for dopamine biosynthesis. It has been reported that DJ-1 is a neuroprotective transcriptional co-activator that sequesters a transcriptional co-repressor polypyrimidine tract-binding protein-associated splicing factor (PSF) from the TH gene promoter. In this study, we found that knockdown of human DJ-1 by small interference RNA in human dopaminergic cell lines attenuated TH gene expression and 4-dihydroxy-L-phenylalanine production but that knockdown or knock-out of mouse DJ-1 in mouse cell lines or in mice did not affect such expression and TH activity. In reporter assays using the human TH gene promoter linked to the luciferase gene, stimulation of TH promoter activity was observed in human cells, but not mouse cells, that had been transfected with DJ-1. Although human DJ-1 and mouse DJ-1 were associated either with human or with mouse PSF, TH promoter activity inhibited by PSF was restored by human DJ-1 but not by mouse DJ-1. Chromatin immunoprecipitation assays revealed that the complex of PSF with DJ-1 bound to the human but not the mouse TH gene promoter. These results suggest a novel species-specific transcriptional regulation of the TH promoter by DJ-1 and one of the mechanisms for no reduction of TH in DJ-1-knock-out mice.	[Takahashi-Niki, Kazuko; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Ishikawa, Shizuma; Niki, Takeshi; Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Ishikawa, Shizuma] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Taira, Takahiro] Yamanashi Univ, Interdisciplinary Grad Sch Med & Engn, Chuoh 4093898, Japan	Hokkaido University; Hokkaido University; Hokkaido University; University of Yamanashi	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp; myan@res.agr.hokudai.ac.jp	Ariga, Hiroyoshi/B-5895-2013; Ariga, Sanae/H-9647-2013	Ariga, Hiroyoshi/0000-0001-7384-2143; 	Ministry of Education, Science, Culture, and Sports; National Institute of Biomedical Innovation in Japan; Grants-in-Aid for Scientific Research [22790809, 21390014] Funding Source: KAKEN	Ministry of Education, Science, Culture, and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation in Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture, and Sports and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation in Japan.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Aron L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000349; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hedrich K, 2004, NEUROLOGY, V62, P389, DOI 10.1212/01.WNL.0000113022.51739.88; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Niki T, 2003, MOL CANCER RES, V1, P247; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Sawada H, 2004, J BIOL CHEM, V279, P10710, DOI 10.1074/jbc.M308434200; Shinbo YM, 2005, INT J ONCOL, V26, P641; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	42	63	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39718	39731		10.1074/jbc.M110.137034	http://dx.doi.org/10.1074/jbc.M110.137034			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20938049	Green Published, hybrid			2022-12-25	WOS:000285185500016
J	Ma, L; Xu, MX; Oberhauser, AF				Ma, Liang; Xu, Meixiang; Oberhauser, Andres F.			Naturally Occurring Osmolytes Modulate the Nanomechanical Properties of Polycystic Kidney Disease Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; RAT RENAL INNER; ORGANIC OSMOLYTES; ALPHA-CHYMOTRYPSIN; MOLECULAR-MECHANISM; PROTEIN-STRUCTURE; WATER-STRESS; UREA; DENATURATION; DYNAMICS	Polycystin-1 (PC1) is a large membrane protein that is expressed along the renal tubule and exposed to a wide range of concentrations of urea. Urea is known as a common denaturing osmolyte that affects protein function by destabilizing their structure. However, it is known that the native conformation of proteins can be stabilized by protecting osmolytes that are found in the mammalian kidney. PC1 has an unusually long ectodomain with a multimodular structure including 16 Ig-like polycystic kidney disease (PKD) domains. Here, we used single-molecule force spectroscopy to study directly the effects of several naturally occurring osmolytes on the mechanical properties of PKD domains. This experimental approach more closely mimics the conditions found in vivo. We show that upon increasing the concentration of urea there is a remarkable decrease in the mechanical stability of human PKD domains. We found that protecting osmolytes such as sorbitol and trimethylamine N-oxide can counteract the denaturing effect of urea. Moreover, we found that the refolding rate of a structurally homologous archaeal PKD domain is significantly slowed down in urea, and this effect was counteracted by sorbitol. Our results demonstrate that naturally occurring osmolytes can have profound effects on the mechanical unfolding and refolding pathways of PKD domains. Based on these findings, we hypothesize that osmolytes such as urea or sorbitol may modulate PC1 mechanical properties and may lead to changes in the activation of the associated polycystin-2 channel or other intracellular events mediated by PC1.	[Ma, Liang; Xu, Meixiang; Oberhauser, Andres F.] Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Oberhauser, Andres F.] Univ Texas Galveston, Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Oberhauser, AF (corresponding author), Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	afoberha@utmb.edu			National Institutes of Health [R01DK073394]; John Sealy Memorial Endowment Fund for Biomedical Research; Polycystic Kidney Foundation [116a2r]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Sealy Memorial Endowment Fund for Biomedical Research; Polycystic Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK073394. This work was also supported by the John Sealy Memorial Endowment Fund for Biomedical Research and by the Polycystic Kidney Foundation Grant 116a2r.	Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; BAGNASCO S, 1986, J BIOL CHEM, V261, P5872; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; Beck DAC, 2007, METHOD ENZYMOL, V428, P373, DOI 10.1016/S0076-6879(07)28022-X; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Bolen D W, 2001, Methods Mol Biol, V168, P17; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Caballero-Herrera A, 2005, BIOPHYS J, V89, P842, DOI 10.1529/biophysj.105.061978; Cao Y, 2008, J MOL BIOL, V375, P316, DOI 10.1016/j.jmb.2007.10.024; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Daggett V, 2006, CHEM REV, V106, P1898, DOI 10.1021/cr0404242; Fischer H, 2001, AM J PHYSIOL-LUNG C, V281, pL52, DOI 10.1152/ajplung.2001.281.1.L52; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; Forman JR, 2009, STRUCTURE, V17, P1582, DOI 10.1016/j.str.2009.09.013; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10540, DOI 10.1073/pnas.0902090106; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; Goyton A. C., 1997, HUMAN PHYSL MECH DIS; GREENE RF, 1974, J BIOL CHEM, V249, P5388; GUDER WG, 1990, KLIN WOCHENSCHR, V68, P1091, DOI 10.1007/BF01798058; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Holthauzen LMF, 2007, PROTEIN SCI, V16, P293, DOI 10.1110/ps.062610407; Holthauzen LMF, 2010, BIOCHEMISTRY-US, V49, P1310, DOI 10.1021/bi9015499; Howard Marybeth, 2002, Methods Mol Med, V70, P267; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Ibraghimov-Beskrovnaya O, 2008, CELL MOL LIFE SCI, V65, P605, DOI 10.1007/s00018-007-7362-x; Idrissi A, 2005, SPECTROCHIM ACTA A, V61, P1, DOI 10.1016/j.saa.2004.02.039; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021; Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361; Ma L, 2009, J BIOL CHEM, V284, P32942, DOI 10.1074/jbc.M109.021832; MACMILLEN RE, 1967, SCIENCE, V158, P383, DOI 10.1126/science.158.3799.383; MARKO JF, 1995, PHYS REV E, V52, P2912, DOI 10.1103/PhysRevE.52.2912; Mountain RD, 2003, J AM CHEM SOC, V125, P1950, DOI 10.1021/ja020496f; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; Qian F, 2005, J BIOL CHEM, V280, P40723, DOI 10.1074/jbc.M509650200; Ratnaparkhi GS, 2001, J BIOL CHEM, V276, P28789, DOI 10.1074/jbc.M101906200; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Sandford R, 1997, HUM MOL GENET, V6, P1483, DOI 10.1093/hmg/6.9.1483; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schellman JA, 2002, BIOPHYS CHEM, V96, P91, DOI 10.1016/S0301-4622(02)00009-1; SCHMIDTNIELSEN B, 1979, YALE J BIOL MED, V52, P545; SCHMOLKE M, 1989, RENAL PHYSIOL BIOCH, V12, P347; Schmolke M, 1996, EUR J CLIN CHEM CLIN, V34, P499; Schmolke M, 1996, AM J PHYSIOL-RENAL, V271, pF645, DOI 10.1152/ajprenal.1996.271.3.F645; SIZELAND PCB, 1993, KIDNEY INT, V43, P448, DOI 10.1038/ki.1993.66; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Venkatesu P, 2009, J PHYS CHEM B, V113, P5327, DOI 10.1021/jp8113013; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; WIRTHENSOHN G, 1989, AM J PHYSIOL, V256, pF128, DOI 10.1152/ajprenal.1989.256.1.F128; Wu JW, 1999, PROTEIN SCI, V8, P2090, DOI 10.1110/ps.8.10.2090; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yancey PH, 2001, AM ZOOL, V41, P699, DOI 10.1668/0003-1569(2001)041[0699:WSOAP]2.0.CO;2; YANCEY PH, 1979, BIOCHEM J, V183, P317, DOI 10.1042/bj1830317; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	72	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38438	38443		10.1074/jbc.M110.183913	http://dx.doi.org/10.1074/jbc.M110.183913			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20937836	hybrid, Green Published			2022-12-25	WOS:000284625600049
J	Sich, NM; O'Donnell, TJ; Coulter, SA; John, OA; Carter, MS; Cremo, CR; Baker, JE				Sich, Nicholas M.; O'Donnell, Timothy J.; Coulter, Sarah A.; John, Olivia A.; Carter, Michael S.; Cremo, Christine R.; Baker, Josh E.			Effects of Actin-Myosin Kinetics on the Calcium Sensitivity of Regulated Thin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-TROPOMYOSIN; SKELETAL-MUSCLE; COOPERATIVE BINDING; ACTIVATION; SUBFRAGMENT-1; FORCE; HEART; BLEBBISTATIN; CROSSBRIDGE; LENGTH	Activation of thin filaments in striated muscle occurs when tropomyosin exposes myosin binding sites on actin either through calcium-troponin (Ca-Tn) binding or by actin-myosin (A-M) strong binding. However, the extent to which these binding events contributes to thin filament activation remains unclear. Here we propose a simple analytical model in which strong A-M binding and Ca-Tn binding independently activates the rate of A-M weak-to-strong binding. The model predicts how the level of activation varies with pCa as well as A-M attachment, N center dot k(att), and detachment, k(det), kinetics. To test the model, we use an in vitro motility assay to measure the myosin-based sliding velocities of thin filaments at different pCa, N center dot k(att), and kdet values. We observe that the combined effects of varying pCa, N center dot k(att), and kdet are accurately fit by the analytical model. The model and supporting data imply that changes in attachment and detachment kinetics predictably affect the calcium sensitivity of striated muscle mechanics, providing a novel A-M kinetic-based interpretation for perturbations (e.g. disease-related mutations) that alter calcium sensitivity.	[Sich, Nicholas M.; O'Donnell, Timothy J.; Coulter, Sarah A.; John, Olivia A.; Carter, Michael S.; Cremo, Christine R.; Baker, Josh E.] Univ Nevada, Sch Med, Dept Biochem, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Baker, JE (corresponding author), Univ Nevada, Sch Med, Dept Biochem, Rm 163,Mail Stop 330,1664 N Virginia St, Reno, NV 89557 USA.	jebaker@unr.edu			National Institutes of Health [5P20RR018751-06, 1R21AR055749-01, 1R01HL090938-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by Grants 5P20RR018751-06, 1R21AR055749-01, 1R01HL090938-01 from the National Institutes of Health.	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Baker JE, 2002, BIOPHYS J, V82, p374A; Baker JE, 1999, BIOPHYS J, V77, P2657, DOI 10.1016/S0006-3495(99)77100-6; BRANDT PW, 1987, J MOL BIOL, V195, P885, DOI 10.1016/0022-2836(87)90492-X; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; Butters CA, 1997, J BIOL CHEM, V272, P13196, DOI 10.1074/jbc.272.20.13196; Campbell KB, 2004, AM J PHYSIOL-HEART C, V286, pH1535, DOI 10.1152/ajpheart.01029.2003; Craig R, 2001, J MOL BIOL, V311, P1027, DOI 10.1006/jmbi.2001.4897; Debold EP, 2010, J MOL CELL CARDIOL, V48, P286, DOI 10.1016/j.yjmcc.2009.09.014; EBASHI S, 1984, J MOL CELL CARDIOL, V16, P129, DOI 10.1016/S0022-2828(84)80701-4; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Farmna G. P., 2007, PFLUG ARCH EUR J PHY, V455, P995; Fitzsimons DP, 2007, ADV EXP MED BIOL, V592, P177; Fitzsimons DP, 2001, J PHYSIOL-LONDON, V530, P263, DOI 10.1111/j.1469-7793.2001.0263l.x; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Gordon AM, 2001, NEWS PHYSIOL SCI, V16, P49; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gorga JA, 2003, BIOPHYS J, V85, P2484, DOI 10.1016/S0006-3495(03)74671-2; Greenberg MJ, 2010, AM J PHYSIOL-REG I, V298, pR989, DOI 10.1152/ajpregu.00566.2009; Greenberg MJ, 2010, J MOL CELL CARDIOL, V48, P277, DOI 10.1016/j.yjmcc.2009.10.015; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; Guilford WH, 1997, BIOPHYS J, V72, pTU250; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; HASELGROVE JC, 1973, COLD SPRING HARB SYM, V37, P341, DOI 10.1101/SQB.1973.037.01.044; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; Hinken AC, 2007, PHYSIOLOGY, V22, P73, DOI 10.1152/physiol.00043.2006; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; Hooft AM, 2007, BIOCHEMISTRY-US, V46, P3513, DOI 10.1021/bi0614840; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; Kad NM, 2005, P NATL ACAD SCI USA, V102, P16990, DOI 10.1073/pnas.0506326102; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Lehman W, 2001, J MOL BIOL, V307, P739, DOI 10.1006/jmbi.2001.4514; Lehman W., 2008, TROPOMYOSIN; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Margossian S. S., 1982, METHODS ENZYMOLOGY; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Pardee J. D., 1982, METHODS ENZYMOLOGY; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; Potters J. D., 1982, METHODS ENZYMOLOGY; Prochniewicz E, 2008, AM J PHYSIOL-CELL PH, V294, pC613, DOI 10.1152/ajpcell.00232.2007; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; REID RE, 1980, J THEOR BIOL, V84, P401, DOI 10.1016/S0022-5193(80)80013-0; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; ROSENFELD SS, 1985, J BIOL CHEM, V260, P252; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Shimamoto Y, 2007, BIOPHYS J, V93, P4330, DOI 10.1529/biophysj.107.110650; Smillie L. B., 1982, METHODS ENZYMOLOGY; Sun YB, 2010, J MOL CELL CARDIOL, V48, P859, DOI 10.1016/j.yjmcc.2009.11.019; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; SWEITZER NK, 1990, J GEN PHYSIOL, V96, P1221, DOI 10.1085/jgp.96.6.1221; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800	58	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39150	39159		10.1074/jbc.M110.142232	http://dx.doi.org/10.1074/jbc.M110.142232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889979	Green Published, hybrid			2022-12-25	WOS:000284941300045
J	Dothager, RS; Goiffon, RJ; Jackson, E; Harpstrite, S; Piwnica-Worms, D				Dothager, Robin S.; Goiffon, Reece J.; Jackson, Erin; Harpstrite, Scott; Piwnica-Worms, David			Cerenkov Radiation Energy Transfer (CRET) Imaging: A Novel Method for Optical Imaging of PET Isotopes in Biological Systems	PLOS ONE			English	Article							POSITRON-EMITTING RADIOTRACERS; IN-VIVO	Background: Positron emission tomography (PET) allows sensitive, non-invasive analysis of the distribution of radiopharmaceutical tracers labeled with positron (beta(+))-emitting radionuclides in small animals and humans. Upon beta(+) decay, the initial velocity of high-energy beta(+) particles can momentarily exceed the speed of light in tissue, producing Cerenkov radiation that is detectable by optical imaging, but is highly absorbed in living organisms. Principal Findings: To improve optical imaging of Cerenkov radiation in biological systems, we demonstrate that Cerenkov radiation from decay of the PET isotopes (64)Cu and (18)F can be spectrally coupled by energy transfer to high Stokes-shift quantum nanoparticles (Qtracker705) to produce highly red-shifted photonic emissions. Efficient energy transfer was not detected with (99m)Tc, a predominantly gamma-emitting isotope. Similar to bioluminescence resonance energy transfer (BRET) and fluorescence resonance energy transfer (FRET), herein we define the Cerenkov radiation energy transfer (CRET) ratio as the normalized quotient of light detected within a spectral window centered on the fluorophore emission divided by light detected within a spectral window of the Cerenkov radiation emission to quantify imaging signals. Optical images of solutions containing Qtracker705 nanoparticles and [(18)F]FDG showed CRET ratios in vitro as high as 8.8 +/- 1.1, while images of mice with subcutaneous pseudotumors impregnated with Qtracker705 following intravenous injection of [(18)F] FDG showed CRET ratios in vivo as high as 3.5 +/- 0.3. Conclusions: Quantitative CRET imaging may afford a variety of novel optical imaging applications and activation strategies for PET radiopharmaceuticals and other isotopes in biomaterials, tissues and live animals.	[Dothager, Robin S.; Goiffon, Reece J.; Jackson, Erin; Harpstrite, Scott; Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63130 USA; [Dothager, Robin S.; Goiffon, Reece J.; Jackson, Erin; Harpstrite, Scott; Piwnica-Worms, David] Mallinckrodt Inst Radiol, Mol Imaging Ctr, St Louis, MO USA; [Dothager, Robin S.; Goiffon, Reece J.; Jackson, Erin; Harpstrite, Scott; Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dothager, RS (corresponding author), Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63130 USA.	piwnica-wormsd@mir.wustl.edu	Goiffon, Reece J/C-9686-2013	Goiffon, Reece J/0000-0003-1622-7253	U.S. National Institutes of Health [P50 CA94056]; National Institutes of Health [5T90 DA022781]; American Cancer Society; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R41DA022781] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was funded by U.S. National Institutes of Health grant P50 CA94056. This work also was supported by a National Institutes of Health Imaging Sciences Pathway Award 5T90 DA022781 (RJG), and an American Cancer Society Post-doctoral Fellowship Award (RSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Cho JS, 2009, PHYS MED BIOL, V54, P6757, DOI 10.1088/0031-9155/54/22/001; Gammon ST, 2009, BIOTECHNOL PROGR, V25, P559, DOI 10.1002/btpr.144; Gammon STM, 2006, ANAL CHEM, V78, P1520, DOI 10.1021/ac051999h; Glantz SA., 1987, PRIMER BIOSTATISTICS; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; JELLEY JV, 1955, BRIT J APPL PHYS, V6, P227, DOI 10.1088/0508-3443/6/7/301; Lambert J, 2009, APPL OPTICS, V48, P3362, DOI 10.1364/AO.48.003362; Li CQ, 2010, OPT LETT, V35, P1109, DOI 10.1364/OL.35.001109; Liu HG, 2010, SMALL, V6, P1087, DOI 10.1002/smll.200902408; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; ROSS HH, 1969, ANAL CHEM, V41, P1260, DOI 10.1021/ac60279a011; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; Spinelli AE, 2010, PHYS MED BIOL, V55, P483, DOI 10.1088/0031-9155/55/2/010; Tai YC, 2005, ANNU REV BIOMED ENG, V7, P255, DOI 10.1146/annurev.bioeng.6.040803.140021; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151	18	139	148	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13300	10.1371/journal.pone.0013300	http://dx.doi.org/10.1371/journal.pone.0013300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949021	Green Published, Green Submitted, gold			2022-12-25	WOS:000282748100026
J	Friberg, J; Tonnesen, MF; Heller, S; Pociot, F; Bodvarsdottir, TB; Karlsen, AE				Friberg, Josefine; Tonnesen, Morten F.; Heller, Schott; Pociot, Flemming; Bodvarsdottir, Thora B.; Karlsen, Allan E.			Inhibition of the Nuclear Factor-kappa B Pathway Prevents Beta Cell Failure and Diet Induced Diabetes in Psammomys obesus	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; ENZYME GENE-EXPRESSION; IKK-BETA; PANCREATIC-ISLETS; INFLAMMATION; OBESITY; MECHANISMS; APOPTOSIS; ACTIVATION; SALICYLATE	Background: High doses of anti-inflammatory drugs, such as aspirin and salicylates, improve glucose metabolism in insulin resistant and type 2 diabetic patients. It has also been shown that the glucose lowering effect is related to the unspecific ability of these drugs to inhibit inhibitor kinase beta (IKK beta). In this study we have investigated the effect of a selective IKK beta-inhibitor on beta cell survival and the prevention of diet induced type 2 diabetes in the gerbil Psammomys obesus (P. obesus). Methodology/Principal Findings: P. obesus were fed a diabetes inducing high energy diet for one month in the absence or presence of the IKK beta-inhibitor. Body mass, blood glucose, HbA(1C), insulin production and pancreatic insulin stores were measured. The effects on beta cell survival were also studied in INS-1 cells and primary islets. The cells were exposed to IL-1 beta and subsequently reactive oxygen species, insulin release and cell death were measured in the absence or presence of the IKKb-inhibitor. In primary islets and beta cells, IL-1 beta induced the production of reactive oxygen species, reduced insulin production and increased beta cell death, which were all reversed by pre-treatment with the IKKb-inhibitor. In P. obesus the IKKb-inhibitor prevented the development of hyperglycaemia and hyperinsulinaemia, and maintained pancreatic insulin stores with no effect on body weight. Conclusions/Significance: Inhibition of IKK beta activity prevents diet-induced diabetes in P. obesus and inhibits IL-1b induced reactive oxygen species, loss of insulin production and beta cell death in vitro.	[Friberg, Josefine; Tonnesen, Morten F.; Heller, Schott; Pociot, Flemming; Karlsen, Allan E.] Hagedorn Res Inst, Gentofte, Denmark; [Pociot, Flemming; Karlsen, Allan E.] Lund Univ, Dept Clin Sci, Univ Hosp MAS, CRC, Malmo, Sweden; [Bodvarsdottir, Thora B.] Diabet & Obes Pharmacol Novo Nordisk AS, Malov, Denmark	Novo Nordisk; Hagedorn Research Institute; Lund University; Skane University Hospital; Novo Nordisk	Friberg, J (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	frib@novonordisk.com		Pociot, Flemming/0000-0003-3274-5448	Danish Agency for Science, Technology and Innovation	Danish Agency for Science, Technology and Innovation	This work was supported by PhD grants from Novo Nordisk A/S and the Danish Agency for Science, Technology and Innovation under the Danish Ministry of Science, Technology and Innovation. The funders Danish Agency for Science, Technology and Innovation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novo Nordisk A/S employed one co-author so had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*APPL BIOS, 1997, US B APPL BIOS, V2; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; BRUNSTEDT J, 1980, DIABETES METAB, V6, P87; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eizirik DL, 2001, DIABETES, V50, pS64, DOI 10.2337/diabetes.50.2007.S64; Engstrom G, 2003, DIABETES, V52, P2097, DOI 10.2337/diabetes.52.8.2097; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; GADOT M, 1994, ENDOCRINOLOGY, V135, P610, DOI 10.1210/en.135.2.610; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gundersen HJG, 2002, J MICROSC-OXFORD, V207, P191, DOI 10.1046/j.1365-2818.2002.01054.x; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Kaiser N, 2005, DIABETES, V54, pS137, DOI 10.2337/diabetes.54.suppl_2.S137; Kaiser N, 2005, DIABETES, V54, P138, DOI 10.2337/diabetes.54.1.138; KALDERON B, 1986, DIABETES, V35, P717, DOI 10.2337/diabetes.35.6.717; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	39	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13341	10.1371/journal.pone.0013341	http://dx.doi.org/10.1371/journal.pone.0013341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948968	Green Published, Green Submitted, gold			2022-12-25	WOS:000282748100035
J	Bruneel, F; Tubach, F; Corne, P; Megarbane, B; Mira, JP; Peytel, E; Camus, C; Schortgen, F; Azoulay, E; Cohen, Y; Georges, H; Meybeck, A; Hyvernat, H; Trouillet, JL; Frenoy, E; Nicolet, L; Roy, C; Durand, R; Le Bras, J; Wolff, M				Bruneel, Fabrice; Tubach, Florence; Corne, Philippe; Megarbane, Bruno; Mira, Jean-Paul; Peytel, Eric; Camus, Christophe; Schortgen, Frederique; Azoulay, Elie; Cohen, Yves; Georges, Hugues; Meybeck, Agnes; Hyvernat, Herve; Trouillet, Jean-Louis; Frenoy, Eric; Nicolet, Laurent; Roy, Carine; Durand, Remy; Le Bras, Jacques; Wolff, Michel		SIMA Study Grp	Severe Imported Falciparum Malaria: A Cohort Study in 400 Critically Ill Adults	PLOS ONE			English	Article							SEVERE SEPSIS; RISK-FACTORS; SCORE; SURVEILLANCE; MANAGEMENT	Background: Large studies on severe imported malaria in non-endemic industrialized countries are lacking. We sought to describe the clinical spectrum of severe imported malaria in French adults and to identify risk factors for mortality at admission to the intensive care unit. Methodology and Principal Findings: Retrospective review of severe Plasmodium falciparum malaria episodes according to the 2000 World Health Organization definition and requiring admission to the intensive care unit. Data were collected from medical charts using standardised case-report forms, in 45 French intensive care units in 2000-2006. Risk factors for in-hospital mortality were identified by univariate and multivariate analyses. Data from 400 adults admitted to the intensive care unit were analysed, representing the largest series of severe imported malaria to date. Median age was 45 years; 60% of patients were white, 96% acquired the disease in sub-Saharan Africa, and 65% had not taken antimalarial chemoprophylaxis. Curative quinine treatment was used in 97% of patients. Intensive care unit mortality was 10.5% (42 deaths). By multivariate analysis, three variables at intensive care unit admission were independently associated with hospital death: older age (per 10-year increment, odds ratio [OR], 1.72; 95% confidence interval [95% CI], 1.28-2.32; P = 0.0004), Glasgow Coma Scale score (per 1-point decrease, OR, 1.32; 95% CI, 1.20-1.45; P<0.0001), and higher parasitemia (per 5% increment, OR, 1.41; 95% CI, 1.22-1.62; P<0.0001). Conclusions and Significance: In a large population of adults treated in a non-endemic industrialized country, severe malaria still carried a high mortality rate. Our data, including predictors of death, can probably be generalized to other non-endemic countries where high-quality healthcare is available.	[Bruneel, Fabrice] Ctr Hosp Versailles, Serv Reanimat, Le Chesnay, France; [Tubach, Florence; Roy, Carine] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris 18, France; [Tubach, Florence; Roy, Carine] INSERM, CIE 801, Paris, France; [Corne, Philippe] Ctr Hosp Univ Gui de Chauillac, Serv Reanimat, Montpellier, France; [Megarbane, Bruno] Ctr Hosp Univ Lariboisiere, AP HP, Serv Reanimat Med & Toxicol, Paris, France; [Mira, Jean-Paul] Ctr Hosp Univ Cochin St Vincent de Paul, AP HP, Serv Reanimat, Paris, France; [Peytel, Eric] Hop Instruct Armees Laveran, Serv Reanimat, Marseille, France; [Camus, Christophe] Ctr Hosp Univ Pontchaillou, Serv Reanimat, Rennes, France; [Schortgen, Frederique] Ctr Hosp Univ Henri Mondor, AP HP, Serv Reanimat, Creteil, France; [Azoulay, Elie] Ctr Hosp Univ St Louis, AP HP, Serv Reanimat, Paris, France; [Cohen, Yves] Ctr Hosp Univ Avicenne, AP HP, Serv Reanimat, Bobigny, France; [Georges, Hugues] Ctr Hosp Tourcoing, Serv Reanimat, Tourcoing, France; [Meybeck, Agnes] Ctr Hosp Univ Louis Mourier, AP HP, Serv Reanimat, Colombes, France; [Hyvernat, Herve] Ctr Hosp Univ Nice, Serv Reanimat, Nice, France; [Trouillet, Jean-Louis] CHU Pitie Salpetriere, AP HP, Serv Reanimat, Paris, France; [Frenoy, Eric] CHU Angers, Serv Reanimat, Angers, France; [Nicolet, Laurent] CHU Nantes, Serv Reanimat, F-44035 Nantes 01, France; [Durand, Remy] Ctr Hosp Univ Avicenne, AP HP, Serv Parasitol, Bobigny, France; [Le Bras, Jacques] Ctr Hosp Univ Bichat Claude Bernard, AP HP, Serv Parasitol, Paris, France; [Wolff, Michel] Ctr Hosp Univ Bichat Claude Bernard, AP HP, Serv Reanimat, Paris, France	Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Bruneel, F (corresponding author), Ctr Hosp Versailles, Serv Reanimat, Le Chesnay, France.	fbruneel@ch-versailles.fr	BRETAGNE, Stephane/H-6655-2019; Guery, Benoit/D-8089-2017; Benoit-Vical, Francoise/E-3938-2016; Grenouillet, Frédéric/R-5176-2016; picot, stephane/F-5973-2014; sandrine, houze/M-3260-2017	BRETAGNE, Stephane/0000-0001-6870-3800; Guery, Benoit/0000-0002-6526-0714; Benoit-Vical, Francoise/0000-0002-9468-4823; Grenouillet, Frédéric/0000-0001-6001-3135; picot, stephane/0000-0002-5735-6759; Ajzenberg, Daniel/0000-0002-5357-3318; Thellier, Marc/0000-0003-4867-2423; Schortgen, Frederique/0000-0003-1756-7508; sandrine, houze/0000-0001-9016-3847; Megarbane, Bruno/0000-0002-2522-2764				Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287; Faiz MA, 2005, LANCET, V366, P717; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Heymans MW, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-33; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Legros F, 2007, EMERG INFECT DIS, V13, P883, DOI 10.3201/eid1305.060955; Mali Sonja, 2010, Morbidity and Mortality Weekly Report, V59, P1; Morch K, 2008, EMERG INFECT DIS, V14, P1816, DOI 10.3201/eid1411.080636; Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012; Phillips A, 2009, CLIN INFECT DIS, V48, P871, DOI 10.1086/597258; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120; Societe de Pathologie Infectieuse de Langue Francaise, 2008, Med Mal Infect, V38, P68, DOI 10.1016/j.medmal.2007.11.009; TEASDALE G, 1974, LANCET, V2, P81; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; White NJ, 2003, AM J RESP CRIT CARE, V167, P673, DOI 10.1164/rccm.2212001; WHO, 2006, GUID TREATM MAL; World Health Organization, 2006, MAL CONTR EL WHO EUR; [No title captured]; 1990, MED MAL INFECT S2, V29, pS115	26	106	108	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13236	10.1371/journal.pone.0013236	http://dx.doi.org/10.1371/journal.pone.0013236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949045	Green Published, gold, Green Submitted			2022-12-25	WOS:000282676700011
J	Stroeymeyt, N; Giurfa, M; Franks, NR				Stroeymeyt, Nathalie; Giurfa, Martin; Franks, Nigel R.			Improving Decision Speed, Accuracy and Group Cohesion through Early Information Gathering in House-Hunting Ants	PLOS ONE			English	Article							NEST-SITE SELECTION; HABITAT SELECTION; PUBLIC INFORMATION; COLONIES; EXPERIENCE; CHOICE; SIZE; PERFORMANCE; EMIGRATION; STRATEGIES	Background: Successful collective decision-making depends on groups of animals being able to make accurate choices while maintaining group cohesion. However, increasing accuracy and/or cohesion usually decreases decision speed and vice-versa. Such trade-offs are widespread in animal decision-making and result in various decision-making strategies that emphasize either speed or accuracy, depending on the context. Speed-accuracy trade-offs have been the object of many theoretical investigations, but these studies did not consider the possible effects of previous experience and/or knowledge of individuals on such trade-offs. In this study, we investigated how previous knowledge of their environment may affect emigration speed, nest choice and colony cohesion in emigrations of the house-hunting ant Temnothorax albipennis, a collective decision-making process subject to a classical speed-accuracy trade-off. Methodology/Principal Findings: Colonies allowed to explore a high quality nest site for one week before they were forced to emigrate found that nest and accepted it faster than emigrating naive colonies. This resulted in increased speed in single choice emigrations and higher colony cohesion in binary choice emigrations. Additionally, colonies allowed to explore both high and low quality nest sites for one week prior to emigration remained more cohesive, made more accurate decisions and emigrated faster than emigrating naive colonies. Conclusions/Significance: These results show that colonies gather and store information about available nest sites while their nest is still intact, and later retrieve and use this information when they need to emigrate. This improves colony performance. Early gathering of information for later use is therefore an effective strategy allowing T. albipennis colonies to improve simultaneously all aspects of the decision-making process - i.e. speed, accuracy and cohesion - and partly circumvent the speed-accuracy trade-off classically observed during emigrations. These findings should be taken into account in future studies on speed-accuracy trade-offs.	[Stroeymeyt, Nathalie; Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Stroeymeyt, Nathalie; Giurfa, Martin] Univ Toulouse, UPS, Ctr Rech Cognit Anim, Toulouse, France; [Stroeymeyt, Nathalie; Giurfa, Martin] CNRS, Ctr Rech Cognit Anim, Toulouse, France	University of Bristol; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Stroeymeyt, N (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Nathalie.Stroeymeyt@bristol.ac.uk	Giurfa, Martin MG/A-7322-2008; Franks, Nigel/AAG-8207-2019; Stroeymeyt, Nathalie/H-2371-2013; Giurfa, Martin/AAS-4945-2020; Giurfa, Martin/H-5140-2016	Franks, Nigel/0000-0001-8139-9604; Stroeymeyt, Nathalie/0000-0001-8047-449X; Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X	Pole de Recherche et d'Enseignement Superieur (PRES) "Universite de Toulouse"; "programme Lavoisier 'Cotutelle de these' du Ministere des Affaires Etrangeres et Europeennes"; Centre National de la Recherche Scientifique (CNRS); University Paul Sabatier; Engineering and Physical Sciences Research Council (EPSRC) [EP/D076226/1]; EPSRC [EP/D076226/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D076226/1] Funding Source: researchfish	Pole de Recherche et d'Enseignement Superieur (PRES) "Universite de Toulouse"; "programme Lavoisier 'Cotutelle de these' du Ministere des Affaires Etrangeres et Europeennes"; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	NS acknowledges Pole de Recherche et d'Enseignement Superieur (PRES) "Universite de Toulouse" and the "programme Lavoisier 'Cotutelle de these' du Ministere des Affaires Etrangeres et Europeennes" for funding. MG acknowledges the support of the Centre National de la Recherche Scientifique (CNRS) and of the University Paul Sabatier. NRF acknowledges Engineering and Physical Sciences Research Council (EPSRC) grant EP/D076226/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, INT J COMP PSYCHOL; Blanchard GB, 2000, ANIM BEHAV, V59, P723, DOI 10.1006/anbe.1999.1374; Burns JG, 2008, CURR BIOL, V18, pR953, DOI 10.1016/j.cub.2008.08.028; Burns JG, 2008, ANIM BEHAV, V76, P911, DOI 10.1016/j.anbehav.2008.02.017; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Collett TS, 2008, CURR BIOL, V18, pR131, DOI 10.1016/j.cub.2007.11.052; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Danchin Etienne, 2001, P243; Doligez B, 2004, ANIM BEHAV, V67, P457, DOI 10.1016/j.anbehav.2003.03.010; Dornhaus A, 2006, BEHAV ECOL SOCIOBIOL, V61, P151, DOI 10.1007/s00265-006-0246-5; Dornhaus A, 2009, BEHAV ECOL, V20, P922, DOI 10.1093/beheco/arp070; Franks Nigel R., 2007, Swarm Intelligence, V1, P81, DOI 10.1007/s11721-007-0007-8; Franks NR, 2007, ANIM BEHAV, V73, P525, DOI 10.1016/j.anbehav.2006.05.020; Franks NR, 2006, ANIM BEHAV, V72, P611, DOI 10.1016/j.anbehav.2005.11.019; Franks NR, 2008, ANIM BEHAV, V76, P323, DOI 10.1016/j.anbehav.2008.02.009; Franks NR, 2007, P R SOC B, V274, P1505, DOI 10.1098/rspb.2007.0138; Franks NR, 2009, PHILOS T R SOC B, V364, P845, DOI 10.1098/rstb.2008.0224; Franks NR, 2006, P ROY SOC B-BIOL SCI, V273, P165, DOI 10.1098/rspb.2005.3312; Franks NR, 2003, ANIM BEHAV, V65, P215, DOI 10.1006/anbe.2002.2032; Franks NR, 2000, BEHAV ECOL, V11, P315, DOI 10.1093/beheco/11.3.315; Franks NR, 2005, BIOL LETTERS, V1, P190, DOI 10.1098/rsbl.2005.0302; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Healey CIM, 2008, ANIM BEHAV, V76, P893, DOI 10.1016/j.anbehav.2008.02.016; Holldobler B., 1990, pi; Langridge EA, 2004, BEHAV ECOL SOCIOBIOL, V56, P523, DOI 10.1007/s00265-004-0824-3; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; Marshall JAR, 2006, J R SOC INTERFACE, V3, P243, DOI 10.1098/rsif.2005.0075; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; MOGLICH M, 1978, INSECT SOC, V25, P205, DOI 10.1007/BF02224742; Muller H, 2008, CURR BIOL, V18, pR961, DOI 10.1016/j.cub.2008.09.001; Part T, 2003, P ROY SOC B-BIOL SCI, V270, P1809, DOI 10.1098/rspb.2003.2419; Passino KM, 2006, BEHAV ECOL SOCIOBIOL, V59, P427, DOI 10.1007/s00265-005-0067-y; Planque R, 2007, BEHAV ECOL SOCIOBIOL, V61, P347, DOI 10.1007/s00265-006-0263-4; Pratt SC, 2005, ANIM BEHAV, V70, P1023, DOI 10.1016/j.anbehav.2005.01.022; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P2635, DOI 10.1098/rspb.2009.0350; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; Scholes DR, 2009, INSECT SOC, V56, P413, DOI 10.1007/s00040-009-0039-8; Skorupski P, 2010, J NEUROSCI, V30, P3896, DOI 10.1523/JNEUROSCI.5700-09.2010; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Stamps JA, 2005, ECOLOGY, V86, P510, DOI 10.1890/04-0516; STROEYMEYT N, ROLES PRIVATE UNPUB; SULLIVAN MS, 1994, ANIM BEHAV, V47, P141, DOI 10.1006/anbe.1994.1016; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Trimmer PC, 2008, P ROY SOC B-BIOL SCI, V275, P2353, DOI 10.1098/rspb.2008.0417; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Ward MP, 2005, OECOLOGIA, V145, P650, DOI 10.1007/s00442-005-0179-0	50	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13059	10.1371/journal.pone.0013059	http://dx.doi.org/10.1371/journal.pone.0013059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927374	Green Published, gold, Green Submitted			2022-12-25	WOS:000282269400014
J	Sandfort, V; Eke, I; Cordes, N				Sandfort, Veit; Eke, Iris; Cordes, Nils			The Role of the Focal Adhesion Protein PINCH1 for the Radiosensitivity of Adhesion and Suspension Cell Cultures	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; MEDIATED DRUG-RESISTANCE; IN-VITRO; EXTRACELLULAR-MATRIX; IONIZING-RADIATION; ADAPTER PROTEIN; CANCER-CELLS; TYROSINE PHOSPHORYLATION; CARCINOMA-CELLS; TUMOR-CELLS	Focal adhesion (FA) signaling mediated by adhesion to extracellular matrix and growth factor receptors contributes to the regulation of the cellular stress response to external stimuli. Critical to focal adhesion assembly and signaling is the adapter protein PINCH1. To evaluate whether the prosurvival function of PINCH1 in radiation cell survival depends on cell adhesion, we examined PINCH1(fl/fl) and PINCH1(-/-) mouse embryonic fibroblasts and human cancer cell lines. Here, we found that the enhanced cellular radiosensitivity mediated by PINCH1 depletion observed under adhesion conditions is conserved when cells are irradiated under suspension conditions. This unsuspected finding could not be explained by the observed modification of adhesion and growth factor associated signaling involving FAK, Paxillin, p130(CAS), Src, AKT, GSK3 beta and ERK1/2 under suspension and serum withdrawal relative to adhesion conditions with serum. Our data suggest that the adapter protein PINCH1 critically participates in the regulation of the cellular radiosensitivity of normal and malignant cells similarly under adhesion and suspension conditions.	[Sandfort, Veit; Eke, Iris; Cordes, Nils] Tech Univ Dresden, OncoRay Ctr Radiat Res Oncol, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany; [Eke, Iris; Cordes, Nils] Tech Univ Dresden, Univ Hosp, Dept Radiat Oncol, D-8027 Dresden, Germany; [Sandfort, Veit] Tech Univ Dresden, Dept Med & Cardiol, Heart Ctr Dresden Univ Hosp, D-8027 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Sandfort, V (corresponding author), Tech Univ Dresden, OncoRay Ctr Radiat Res Oncol, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany.	Nils.Cordes@Oncoray.de	Eke, Iris/B-9251-2016	Eke, Iris/0000-0002-3591-019X; Cordes, Nils/0000-0001-5684-629X	Bundesministerium Bildung und Forschung [BMBF-03ZIK041]; Bundesministerium Verteidigung	Bundesministerium Bildung und Forschung; Bundesministerium Verteidigung	This work was supported in part by the Bundesministerium Bildung und Forschung (BMBF-03ZIK041 to N.C.) and the Bundesministerium Verteidigung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Aronsohn MS, 2003, LARYNGOSCOPE, V113, P1944, DOI 10.1097/00005537-200311000-00017; Beinke C, 2003, INT J RADIAT BIOL, V79, P721, DOI 10.1080/09553000310001610231; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Chen H, 2005, LAB INVEST, V85, P1342, DOI 10.1038/labinvest.3700345; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Cordes N, 2006, ONCOGENE, V25, P1378, DOI 10.1038/sj.onc.1209164; Cordes N, 2004, STRAHLENTHER ONKOL, V180, P157, DOI 10.1007/s00066-004-1144-2; Cordes N, 2003, STRAHLENTHER ONKOL, V179, P337, DOI 10.1007/s00066-003-1074-4; Damiano JS, 2002, CURR CANCER DRUG TAR, V2, P37, DOI 10.2174/1568009023334033; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Dougherty GW, 2005, EXP CELL RES, V306, P168, DOI 10.1016/j.yexcr.2005.01.025; EKE I, 2010, J CLIN INVEST    JUN; Eke I, 2007, INT J RADIAT BIOL, V83, P793, DOI 10.1080/09553000701727549; Eke I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006434; Estrugo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000269; FUKS Z, 1992, EUR J CANCER, V28A, P725, DOI 10.1016/0959-8049(92)90104-A; Golding SE, 2009, CANCER BIOL THER, V8, P730, DOI 10.4161/cbt.8.8.7927; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kasahara T, 2002, ANTIOXID REDOX SIGN, V4, P491, DOI 10.1089/15230860260196290; Kim IA, 2005, CANCER RES, V65, P7902, DOI 10.1158/0008-5472.CAN-05-0513; Klein S, 2009, CURR OPIN CELL BIOL, V21, P185, DOI 10.1016/j.ceb.2008.12.006; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; Kornberg LJ, 1998, HEAD NECK-J SCI SPEC, V20, P745, DOI 10.1002/(SICI)1097-0347(199812)20:8<745::AID-HED14>3.0.CO;2-Z; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martinsen BJ, 2006, DEV DYNAM, V235, P152, DOI 10.1002/dvdy.20616; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Sandfort V, 2007, INT J RADIAT BIOL, V83, P727, DOI 10.1080/09553000701694335; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Stanchi F, 2005, J CELL SCI, V118, P5899, DOI 10.1242/jcs.02686; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Storch K, 2010, CANCER RES, V70, P3925, DOI 10.1158/0008-5472.CAN-09-3848; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Wang-Rodriguez J, 2002, CANCER-AM CANCER SOC, V95, P1387, DOI 10.1002/cncr.10878; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Zhang YJ, 2002, J BIOL CHEM, V277, P318, DOI 10.1074/jbc.M108257200	51	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13056	10.1371/journal.pone.0013056	http://dx.doi.org/10.1371/journal.pone.0013056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927395	Green Submitted, Green Published, gold			2022-12-25	WOS:000282210700023
J	Jang, MS; Lee, SJ; Kim, CJ; Lee, CW; Kim, E				Jang, M-S; Lee, S-J; Kim, C-J; Lee, C-W; Kim, E.			Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD	ONCOGENE			English	Article						FADD; Plk1; phosphorylation; tumor suppressor; negative feedback	FAS-ASSOCIATED PROTEIN; NECROTIC CELL-DEATH; INDUCED APOPTOSIS; CANCER-CELLS; SIGNALING PATHWAY; FACTOR-I; DOMAIN; PLK1; INHIBITOR; EXPRESSION	Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD. Oncogene (2011) 30, 471-481; doi: 10.1038/onc.2010.423; published online 4 October 2010	[Jang, M-S; Lee, S-J; Kim, E.] Chungnam Natl Univ, Coll Biol Sci & Biotechnol, Taejon 305764, South Korea; [Kim, C-J] Chungnam Natl Univ, Coll Vet Med, Taejon 305764, South Korea; [Lee, C-W] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon, South Korea; [Kim, E.] Chungnam Natl Univ, Daedeok R&D Innopolis Bio Brain Ctr BK21, Taejon 305764, South Korea	Chungnam National University; Chungnam National University; Sungkyunkwan University (SKKU); Chungnam National University	Kim, E (corresponding author), Chungnam Natl Univ, Coll Biol Sci & Biotechnol, 220 Gung Dong, Taejon 305764, South Korea.	eunhee@cnu.ac.kr	ê, ìí/F-5894-2013	Kim, Chul-Joong/0000-0001-8827-6332	21C Frontier Functional Human Genome Project [FG09-21-02]; Center for Biological Modulators [CMB34-A2300-01-00-00]; National Research foundation at the Ministry of Education, Science and Technology in Korea [2009-0093957]	21C Frontier Functional Human Genome Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); Center for Biological Modulators(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research foundation at the Ministry of Education, Science and Technology in Korea	This work was supported by a grant (FG09-21-02) from the 21C Frontier Functional Human Genome Project, by a grant (CMB34-A2300-01-00-00) from the Center for Biological Modulators of the 21st Century Frontier R&D Program and by the National Research foundation (2009-0093957) at the Ministry of Education, Science and Technology in Korea. We thank Dr Soojin Lee (Department of Microbiology, Chungnam National University, Daejeon, Korea) for assistance with the colony formation studies, and Byung-Jung Choi (Medical Genomics Research Center, KRIBB, Daejeon, Korea) for assistance with the FPLC.	Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Arnt CR, 2002, J BIOL CHEM, V277, P44236, DOI 10.1074/jbc.M207578200; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Eckerdt F, 2006, CANCER RES, V66, P6895, DOI 10.1158/0008-5472.CAN-06-0358; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gilmartin AG, 2009, CANCER RES, V69, P6969, DOI 10.1158/0008-5472.CAN-09-0945; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Jang MS, 2008, J BIOL CHEM, V283, P32344, DOI 10.1074/jbc.M804199200; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Khwaja A, 1999, J BIOL CHEM, V274, P36817, DOI 10.1074/jbc.274.51.36817; Krelin Y, 2008, CELL DEATH DIFFER, V15, P1350, DOI 10.1038/cdd.2008.88; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Luschen S, 2005, EXP CELL RES, V310, P33, DOI 10.1016/j.yexcr.2005.07.022; Matsuyoshi S, 2006, BRIT J CANCER, V94, P532, DOI 10.1038/sj.bjc.6602955; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Park MY, 2005, INT J CANCER, V115, P412, DOI 10.1002/ijc.20857; Peter M E, 1999, Results Probl Cell Differ, V23, P25; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Shimada K, 2005, J PATHOL, V206, P423, DOI 10.1002/path.1791; Shimada K, 2004, CARCINOGENESIS, V25, P1089, DOI 10.1093/carcin/bgh130; Shimada K, 2002, JPN J CANCER RES, V93, P1164, DOI 10.1111/j.1349-7006.2002.tb01219.x; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Xu H, 2009, CANCER INVEST, V27, P836, DOI 10.1080/07357900902849681; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yang Qin, 2005, Ai Zheng, V24, P321; Yoo NJ, 2007, PATHOL RES PRACT, V203, P73, DOI 10.1016/j.prp.2006.11.002; Zhande R, 2007, MOL CELL BIOL, V27, P7394, DOI 10.1128/MCB.00600-07; Zhang J, 2009, CANCER BIOL THER, V8, P2374, DOI 10.4161/cbt.8.24.10182; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	50	29	29	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	4					471	481		10.1038/onc.2010.423	http://dx.doi.org/10.1038/onc.2010.423			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	711WH	20890306				2022-12-25	WOS:000286621600009
J	Moreno-Cermeno, A; Obis, E; Belli, G; Cabiscol, E; Ros, J; Tamarit, J				Moreno-Cermeno, Armando; Obis, Elia; Belli, Gemma; Cabiscol, Elisa; Ros, Joaquim; Tamarit, Jordi			Frataxin Depletion in Yeast Triggers Up-regulation of Iron Transport Systems before Affecting Iron-Sulfur Enzyme Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FRIEDREICH ATAXIA; GENE-EXPRESSION; CLUSTER FORMATION; OXIDATIVE STRESS; DEFICIENT STRAIN; SUPEROXIDE-DISMUTASE; DROSOPHILA MODEL; PROMOTER SYSTEM; HOMOLOG	The primary function of frataxin, a mitochondrial protein involved in iron homeostasis, remains controversial. Using a yeast model of conditional expression of the frataxin homologue YFH1, we analyzed the primary effects of YFH1 depletion. The main conclusion unambiguously points to the up-regulation of iron transport systems as a primary effect of YFH1 down-regulation. We observed that inactivation of aconitase, an iron-sulfur enzyme, occurs long after the iron uptake system has been activated. Decreased aconitase activity should be considered part of a group of secondary events promoted by iron overloading, which includes decreased superoxide dismutase activity and increased protein carbonyl formation. Impaired manganese uptake, which contributes to superoxide dismutase deficiency, has also been observed in YFH1-deficient cells. This low manganese content can be attributed to the down-regulation of the metal ion transporter Smf2. Low Smf2 levels were not observed in AFT1/YFH1 double mutants, indicating that high iron levels could be responsible for the Smf2 decline. In summary, the results presented here indicate that decreased iron-sulfur enzyme activities in YFH1-deficient cells are the consequence of the oxidative stress conditions suffered by these cells.	[Moreno-Cermeno, Armando; Obis, Elia; Belli, Gemma; Cabiscol, Elisa; Ros, Joaquim; Tamarit, Jordi] Univ Lleida, Dept Ciencies Med Basiques, Fac Med, Inst Recerca Biomed Lleida, Lleida 25008, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Ros, J (corresponding author), Univ Lleida, Dept Ciencies Med Basiques, Fac Med, Inst Recerca Biomed Lleida, Montserrat Roig 2, Lleida 25008, Spain.	joaquim.ros@cmb.udl.es	ROS, Joaquim/ABG-7487-2020; Cabiscol, Elisa/A-4584-2009; Obis, Elia/J-4705-2016; belli, gemma/A-7424-2011; Ros, Joaquim/A-7507-2010; Tamarit, Jordi/C-6316-2008; Bellí, Gemma/AAD-5325-2019; Obis, Elia/ACM-1208-2022	ROS, Joaquim/0000-0003-0901-8648; Cabiscol, Elisa/0000-0003-2795-7999; Obis, Elia/0000-0002-6838-1634; belli, gemma/0000-0002-4161-3204; Tamarit, Jordi/0000-0003-3227-6928; Bellí, Gemma/0000-0002-4161-3204; Obis, Elia/0000-0002-6838-1634	Ministerio de Ciencia e Innovacion [BFU2007-66249/BMC, CSD2007-00020]; Generalitat de Catalunya (Spain) [SGR0677]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya (Spain)(Generalitat de Catalunya)	This study was supported by Grants BFU2007-66249/BMC and CSD2007-00020 from the Ministerio de Ciencia e Innovacion and SGR0677 from the Generalitat de Catalunya (Spain).	Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Condo I, 2010, HUM MOL GENET, V19, P1221, DOI 10.1093/hmg/ddp592; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Irazusta V, 2006, J BIOL CHEM, V281, P12227, DOI 10.1074/jbc.M511649200; Irazusta V., 2009, FREE RADIC BIOL MED; Irazusta V, 2008, FREE RADICAL BIO MED, V44, P1712, DOI 10.1016/j.freeradbiomed.2008.01.014; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kaplan J, 1999, P NATL ACAD SCI USA, V96, P10948, DOI 10.1073/pnas.96.20.10948; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Lu CY, 2007, ARCH BIOCHEM BIOPHYS, V457, P111, DOI 10.1016/j.abb.2006.09.010; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Manchenko G. P., 1994, HDB DETECTION ENZYME, P98; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Pandolfo M, 2009, J NEUROL, V256, P9, DOI 10.1007/s00415-009-1003-2; Pfaffl MW., 2006, REAL TIME PCR, P63; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; Reverter-Branchat G, 2007, MICROBIOL-SGM, V153, P3667, DOI 10.1099/mic.0.2007/009340-0; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Schagerlof U., 2008, S BIOCH DOWNLOADED, V47, P4948; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; SWANSON WH, 1948, J BACTERIOL, V56, P115, DOI 10.1128/JB.56.1.115-124.1948; Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Wishart JA, 2005, YEAST, V22, P565, DOI 10.1002/yea.1225	56	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41653	41664		10.1074/jbc.M110.149443	http://dx.doi.org/10.1074/jbc.M110.149443			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20956517	Green Published, hybrid			2022-12-25	WOS:000285622600053
J	Meitzler, JL; Brandman, R; de Montellano, PRO				Meitzler, Jennifer L.; Brandman, Relly; de Montellano, Paul R. Ortiz			Perturbed Heme Binding Is Responsible for the Blistering Phenotype Associated with Mutations in the Caenorhabditis elegans Dual Oxidase 1 (DUOX1) Peroxidase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY NADPH OXIDASES; HORSERADISH-PEROXIDASE; MAMMALIAN PEROXIDASES; HUMAN MYELOPEROXIDASE; CATALYZED OXIDATION; POTENTIAL FUNCTIONS; HYDROGEN-PEROXIDE; DROSOPHILA GUT; LACTOPEROXIDASE; MODEL	Dual oxidase (DUOX) enzymes support a wide variety of essential reactions, from cellular signaling to thyroid hormone biosynthesis. In Caenorhabditis elegans, the DUOX system (CeDUOX1/2) plays a crucial role in innate immunity and in stabilizing the cuticle by forming tyrosine cross-links. The current model suggests that superoxide generated by CeDUOX1 at the C-terminal NADPH oxidase domain is rapidly converted to H2O2. The H2O2 is then utilized by the N-terminal peroxidase- like domain to cross-link tyrosines. We have now created a series of mutations in the isolated peroxidase domain, CeDUOX1(1-589). One set of mutations investigate the roles of a putative distal tyrosine (Tyr(105)) and Glu(238), a proposed covalent heme-binding residue. The results confirm that Glu(238) covalently binds to the heme group. A second set of mutations (G246D and D392N) responsible for a C. elegans blistering cuticle phenotype was also investigated. Surprisingly, although not among the catalytic residues, both mutations affected heme co-factor binding. The G246D mutant bound less total heme than the wild type, but a higher fraction of it was covalently bound. In contrast, the D392N mutant appears to fold normally but does not bind heme. Molecular dynamics simulations of a CeDUOX1(1-589) homology model implicate displacements of the proximal histidine residue as the likely cause. Both enzymes are structurally stable and through altered heme interactions exhibit partial or complete loss of tyrosine crosslinking activity, explaining the blistering phenotype. This result argues that the CeDUOX peroxidase domain is primarily responsible for tyrosine cross-linking.	[Meitzler, Jennifer L.; Brandman, Relly; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94518 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu		Meitzler, Jennifer/0000-0001-9798-2124				Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P10747, DOI 10.1021/bi010478v; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAYSE GS, 1972, BIOCHIM BIOPHYS ACTA, V284, P34; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boscolo B, 2007, BBA-PROTEINS PROTEOM, V1774, P1164, DOI 10.1016/j.bbapap.2007.07.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Colas C, 2002, J BIOL CHEM, V277, P7191, DOI 10.1074/jbc.M109523200; Cover TM, 1991, ELEMENTS INFORM THEO, P12, DOI [10.1002/0471200611.ch2, DOI 10.1002/0471200611.CH2]; DARDEN T, 1993, J CHEM PHYS, V98, P10092; DE D, 2000, F J Biol Chem, V275, P23227; DePillis GD, 1997, J BIOL CHEM, V272, P8857; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Eswar N., 2006, COMP PROTEIN STRUCTU; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Goedken M, 2007, J BIOL CHEM, V282, P27994, DOI 10.1074/jbc.M701984200; Gogonea V, 2006, J PHYS CHEM B, V110, P22861, DOI 10.1021/jp061653q; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hildebrandt A G, 1978, Methods Enzymol, V52, P342; Huang LS, 2006, J BIOL CHEM, V281, P18983, DOI 10.1074/jbc.M602307200; JACQUET A, 1994, BIOCHEM BIOPH RES CO, V202, P73, DOI 10.1006/bbrc.1994.1895; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; MODI S, 1991, BIOCHIM BIOPHYS ACTA, V1080, P45, DOI 10.1016/0167-4838(91)90110-L; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Pacquelet S, 2008, J BIOL CHEM, V283, P24649, DOI 10.1074/jbc.M709108200; SALMASO BLN, 1994, BIOPHYS J, V67, P436, DOI 10.1016/S0006-3495(94)80499-0; Shin K, 2000, BIOCHEM BIOPH RES CO, V271, P831, DOI 10.1006/bbrc.2000.2713; STUGARD CE, 1989, INFECT IMMUN, V57, P3534, DOI 10.1128/IAI.57.11.3534-3539.1989; Suriano G, 2001, BIOORG MED CHEM LETT, V11, P2827, DOI 10.1016/S0960-894X(01)00533-9; Tanaka T, 2003, BIOSCI BIOTECH BIOCH, V67, P2254, DOI 10.1271/bbb.67.2254; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014	50	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40991	41000		10.1074/jbc.M110.170902	http://dx.doi.org/10.1074/jbc.M110.170902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20947510	hybrid, Green Published			2022-12-25	WOS:000285414400062
J	Wang, GY				Wang, Guangyu			State-dependent Regulation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gating by a High Affinity Fe3+ Bridge between the Regulatory Domain and Cytoplasmic Loop 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							R-DOMAIN; NUCLEOTIDE-BINDING; ABC TRANSPORTER; ATP BINDING; PHOSPHORYLATION SITES; CHLORIDE CHANNEL; PROTEIN; ACTIVATION; MUTATIONS; MECHANISM	The unique regulatory (R) domain differentiates the human CFTR channel from other ATP-binding cassette transporters and exerts multiple effects on channel function. However, the underlying mechanisms are unclear. Here, an intracellular high affinity (2.3 x 10(-19) M) Fe3+ bridge is reported as a novel approach to regulating channel gating. It inhibited CFTR activity by primarily reducing an open probability and an opening rate, and inhibition was reversed by EDTA and phenanthroline. His-950, His-954, Cys-832, His-775, and Asp-836 were found essential for inhibition and phosphorylated Ser-768 may enhance Fe3+ binding. More importantly, inhibition by Fe3+ was state-dependent. Sensitivity to Fe3+ was reduced when the channel was locked in an open state by AMP-PNP. Similarly, a K978C mutation from cytoplasmic loop 3 (CL3), which promotes ATP-independent channel opening, greatly weakened inhibition by Fe3+ no matter whether NBD2 was present or not. Therefore, although ATP binding-induced dimerization of NBD1-NBD2 is required for channel gating, regulation of CFTR activity by Fe3+ may involve an interaction between the R domain and CL3. These findings may support proximity of the R domain to the cytoplasmic loops. They also suggest that Fe3+ homeostasis may play a critical role in regulating pathophysiological CFTR activity because dysregulation of this protein causes cystic fibrosis, secretary diarrhea, and infertility.	[Wang, Guangyu] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA; [Wang, Guangyu] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Wang, Guangyu] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, GY (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, 1664 N Virginia St MS 318,Manville Med Bldg,Rm 9, Reno, NV 89557 USA.	wangg@medicine.nevada.edu		Wang, Guangyu/0000-0002-5581-6926	National Institutes of Health [2R56DK056796-10]; American Heart Association [10SDG4120011]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R56DK056796-10. This work was also supported by American Heart Association Grant 10SDG4120011 (to G. W.).	Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Bruns CM, 2001, BIOCHEMISTRY-US, V40, P15631, DOI 10.1021/bi0156759; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Cotten JF, 1997, J BIOL CHEM, V272, P25617, DOI 10.1074/jbc.272.41.25617; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dhungana S, 2003, P NATL ACAD SCI USA, V100, P3659, DOI 10.1073/pnas.0536897100; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; RIORDAN JR, 1989, SCIENCE, V245, P1066; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith JJ, 2005, PROTEIN SCI, V14, P64, DOI 10.1110/ps.04965405; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Vais H, 2004, AM J PHYSIOL-CELL PH, V287, pC737, DOI 10.1152/ajpcell.00504.2003; Vankeerberghen A, 1999, BIOCHEMISTRY-US, V38, P14988, DOI 10.1021/bi991520d; Wang GY, 2007, J BIOL CHEM, V282, P13637, DOI 10.1074/jbc.M609182200; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Xie JX, 2002, J BIOL CHEM, V277, P23019, DOI 10.1074/jbc.M201661200; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004	37	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40438	40447		10.1074/jbc.M110.161497	http://dx.doi.org/10.1074/jbc.M110.161497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952391	hybrid, Green Published			2022-12-25	WOS:000285414400006
J	Kumano, T; Tomita, T; Nishiyama, M; Kuzuyama, T				Kumano, Takuto; Tomita, Takeo; Nishiyama, Makoto; Kuzuyama, Tomohisa			Functional Characterization of the Promiscuous Prenyltransferase Responsible for Furaquinocin Biosynthesis IDENTIFICATION OF A PHYSIOLOGICAL POLYKETIDE SUBSTRATE AND ITS PRENYLATED REACTION PRODUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; STREPTOMYCES-CINNAMONENSIS; HETEROLOGOUS EXPRESSION; ANTIBIOTICS; SYNTHASE; FAMILY	Furaquinocin is a natural polyketide-isoprenoid hybrid (meroterpenoid) that exhibits antitumor activity and is produced by the Streptomyces sp. strain KO-3988. Bioinformatic analysis of furaquinocin biosynthesis has identified Fur7 as a possible prenyltransferase that attaches a geranyl group to an unidentified polyketide scaffold. Here, we report the identification of a physiological polyketide substrate for Fur7, as well as its reaction product and the biochemical characterization of Fur7. A Streptomyces albus transformant (S. albus/pWHM-Fur2_del7) harboring the furaquinocin biosynthetic gene cluster lacking the fur7 gene did not produce furaquinocin but synthesized the novel intermediate 2-methoxy-3-methyl-flaviolin. After expression and purification from Escherichia coli, the recombinant Fur7 enzyme catalyzed the transfer of a geranyl group to 2-methoxy-3-methyl-flaviolin to yield 6-prenyl-2-methoxy-3-methyl-flaviolin and 7-O-geranyl-2-methoxy-3-methyl- flaviolin in a 10: 1 ratio. The reaction proceeded independently of divalent cations. When 6-prenyl-2-methoxy3- methyl-flaviolin was added to the culture medium of S. albus/pWHM-Fur2_del7, furaquinocin production was restored. The promiscuous substrate specificity of Fur7 was demonstrated with respect to prenyl acceptor substrates and prenyl donor substrates. The steady-state kinetic constants of Fur7 with each prenyl acceptor substrate were also calculated.	[Kumano, Takuto; Tomita, Takeo; Nishiyama, Makoto; Kuzuyama, Tomohisa] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Kuzuyama, T (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	utkuz@mail.ecc.u-tokyo.ac.jp	Kumano, Takuto/ABC-3242-2020	Kumano, Takuto/0000-0002-9240-4074; Kuzuyama, Tomohisa/0000-0002-7221-5858; Nishiyama, Makoto/0000-0001-8143-8052	Ministry of Economy, Trade, and Industry; Naito Foundation	Ministry of Economy, Trade, and Industry; Naito Foundation(Naito Memorial Foundation)	This work was supported in part by the "Development of Fundamental Technologies for Production of High Value Materials using Transgenic Plants" R&D project funded by the Ministry of Economy, Trade, and Industry and by a grant from the Naito Foundation.	Botta B, 2005, TRENDS PHARMACOL SCI, V26, P606, DOI 10.1016/j.tips.2005.09.012; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; Funa N, 2005, J BIOL CHEM, V280, P14514, DOI 10.1074/jbc.M500190200; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Haagen Y, 2006, CHEMBIOCHEM, V7, P2016, DOI 10.1002/cbic.200600338; ISHIBASHI M, 1991, J ANTIBIOT, V44, P390, DOI 10.7164/antibiotics.44.390; Izumikawa M, 2003, J IND MICROBIOL BIOT, V30, P510, DOI 10.1007/s10295-003-0075-8; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kawasaki T, 2006, J BACTERIOL, V188, P1236, DOI 10.1128/JB.188.4.1236-1244.2006; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KOMIYAMA K, 1990, J ANTIBIOT, V43, P247, DOI 10.7164/antibiotics.43.247; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; SEDMERA P, 1991, J NAT PROD, V54, P870, DOI 10.1021/np50075a022; SHIN-YA K, 1990, Tetrahedron Letters, V31, P6025, DOI 10.1016/S0040-4039(00)98019-5; SHINYA K, 1990, J ANTIBIOT, V43, P444, DOI 10.7164/antibiotics.43.444; SHIOMI K, 1986, J ANTIBIOT, V39, P494, DOI 10.7164/antibiotics.39.494; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Winter JM, 2007, J BIOL CHEM, V282, P16362, DOI 10.1074/jbc.M611046200	22	30	31	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39663	39671		10.1074/jbc.M110.153957	http://dx.doi.org/10.1074/jbc.M110.153957			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937800	Green Published, hybrid			2022-12-25	WOS:000285185500010
J	Song, XM; Wang, XF; Zhuo, W; Shi, HB; Feng, D; Sun, Y; Liang, Y; Fu, Y; Zhou, DF; Luo, YZ				Song, Xiaomin; Wang, Xiaofeng; Zhuo, Wei; Shi, Hubing; Feng, Dan; Sun, Yi; Liang, Yun; Fu, Yan; Zhou, Daifu; Luo, Yongzhang			The Regulatory Mechanism of Extracellular Hsp90 alpha on Matrix Metalloproteinase-2 Processing and Tumor Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; ENDOTHELIAL-CELLS; CANCER PROGRESSION; INHIBITOR; PROTEIN; HEAT-SHOCK-PROTEIN-90; INVASION; BINDING; METASTASIS; GROWTH	Heat shock protein 90 alpha (Hsp90 alpha) is a ubiquitously expressed molecular chaperone that is essential for eukaryotic homeostasis. Hsp90 alpha can also be secreted extracellularly, where it has been shown to be involved in tumor metastasis. Extracellular Hsp90 alpha interacts with and promotes the proteolytic activity of matrix metalloproteinase-2 (MMP-2). However, the regulatory mechanism of Hsp90 alpha on MMP-2 activity is still unknown. Here we show that Hsp90 alpha stabilizes MMP-2 and protects it from degradation in tumor cells. Further investigation reveals that this stabilization effect is isoform-specific, ATP-independent, and mediated by the interaction between the Hsp90 alpha middle domain and the MMP-2 C-terminal hemopexin domain. Moreover, this mechanism also applies to endothelial cells that secrete more Hsp90 alpha in their proliferating status. Furthermore, endothelial cell transmigration, Matrigel plug, and tumor angiogenesis assays demonstrate that extracellular Hsp90 alpha promotes angiogenesis in an MMP-2-dependent manner. In sum, this study provides new insights into the molecular mechanism of how Hsp90 alpha regulates its extracellular client proteins and also reveals for the first time the function of extracellular Hsp90 alpha in promoting tumor angiogenesis.	[Song, Xiaomin; Wang, Xiaofeng; Zhuo, Wei; Shi, Hubing; Feng, Dan; Sun, Yi; Liang, Yun; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Canc Biol Lab, Beijing 100084, Peoples R China; [Song, Xiaomin; Wang, Xiaofeng; Zhuo, Wei; Shi, Hubing; Feng, Dan; Sun, Yi; Liang, Yun; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China; [Zhou, Daifu; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Natl Engn Lab Antitumor Prot Therapeut, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Luo, YZ (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China.	yluo@tsinghua.edu.cn	Feng, Dan/F-7205-2013; Shi, Hubing/B-8445-2014; Liang, Yun/K-5639-2013	Feng, Dan/0000-0001-5926-8894; Song, Xiaomin/0000-0002-2586-9285	National Natural Science Foundation of China [30670419, 30771083, 30490171]; National High Technology Research and Development Program of China [2007AA02Z155]; State Key Development Program for Basic Research of China [2006CB91030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This work was supported in part by General Programs of the National Natural Science Foundation of China Grants 30670419 and 30771083, Major Program of National Natural Science Foundation of China Grant 30490171, the National High Technology Research and Development Program of China Grant 2007AA02Z155, and the State Key Development Program for Basic Research of China Grant 2006CB91030.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; BERGMANN U, 1995, BIOCHEMISTRY-US, V34, P2819, DOI 10.1021/bi00009a011; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Diaz N, 2008, J AM CHEM SOC, V130, P14070, DOI 10.1021/ja806090v; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Futagami S, 2008, J GASTROEN HEPATOL, V23, pS222, DOI 10.1111/j.1440-1746.2008.05442.x; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; HOWARD EW, 1991, J BIOL CHEM, V266, P13064; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kaur G, 2004, CLIN CANCER RES, V10, P4813, DOI 10.1158/1078-0432.CCR-03-0795; Kern J, 2009, BLOOD, V114, P3960, DOI 10.1182/blood-2009-03-209668; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Minami Y, 2000, J BIOL CHEM, V275, P9055, DOI 10.1074/jbc.275.12.9055; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Osenkowski P, 2005, J BIOL CHEM, V280, P26160, DOI 10.1074/jbc.M414379200; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Stetler-Stevenson WG, 2005, TRENDS MOL MED, V11, P97, DOI 10.1016/j.molmed.2005.01.007; Tramentozzi E, 2008, MOL IMMUNOL, V45, P3639, DOI 10.1016/j.molimm.2008.04.020; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641	48	87	90	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40039	40049		10.1074/jbc.M110.181941	http://dx.doi.org/10.1074/jbc.M110.181941			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937816	Green Published, hybrid			2022-12-25	WOS:000285185500049
J	Yang, JY; Cai, J; Zhang, Y; Wang, XM; Li, W; Xu, JY; Li, F; Guo, XP; Deng, K; Zhong, M; Chen, YL; Lai, LX; Pei, DQ; Esteban, MA				Yang, Jiayin; Cai, Jie; Zhang, Ya; Wang, Xianming; Li, Wen; Xu, Jianyong; Li, Feng; Guo, Xiangpeng; Deng, Kang; Zhong, Mei; Chen, Yonglong; Lai, Liangxue; Pei, Duanqing; Esteban, Miguel A.			Induced Pluripotent Stem Cells Can Be Used to Model the Genomic Imprinting Disorder Prader-Willi Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROBLASTS; METHYLATION; GENES; EXPRESSION; INDUCTION; CULTURE; OCT4	The recent discovery of induced pluripotent stem cell (iPSC) technology provides an invaluable tool for creating in vitro representations of human genetic conditions. This is particularly relevant for those diseases that lack adequate animal models or where the species comparison is difficult, e.g. imprinting diseases such as the neurogenetic disorder Prader-Willi syndrome (PWS). However, recent reports have unveiled transcriptional and functional differences between iPSCs and embryonic stem cells that in cases are attributable to imprinting errors. This has suggested that human iPSCs may not be useful to model genetic imprinting diseases. Here, we describe the generation of iPSCs from a patient with PWS bearing a partial translocation of the paternally expressed chromosome 15q11-q13 region to chromosome 4. The resulting iPSCs match all standard criteria of bona fide reprogramming and could be readily differentiated into tissues derived from the three germ layers, including neurons. Moreover, these iPSCs retain a high level of DNA methylation in the imprinting center of the maternal allele and show concomitant reduced expression of the disease-associated small nucleolar RNA HBII85/SNORD116. These results indicate that iPSCs may be a useful tool to study PWS and perhaps other genetic imprinting diseases as well.	[Yang, Jiayin; Cai, Jie; Zhang, Ya; Wang, Xianming; Li, Wen; Xu, Jianyong; Li, Feng; Guo, Xiangpeng; Chen, Yonglong; Lai, Liangxue; Pei, Duanqing; Esteban, Miguel A.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Wang, Xianming] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China; [Deng, Kang; Zhong, Mei] Nanfang Hosp, Ctr Prenatal & Hereditary Dis Diag, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Southern Medical University - China	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn; maestebanb@gmail.com	Lai, Liangxue/H-4545-2011	Yang, Jiayin/0000-0001-9134-1959	Guangzhou Institutes of Biomedicine and Health; Chinese Academy of Sciences [KSCX2-YW-R244]; Bureau of Science and Technology of Guangzhou Municipality [2008A1-E4011]; National Natural Science Foundation of China [90813033]; Ministry of Science and Technology of China [2007CB948002, 2009CB941102, 2006AA02A103]; Ministry of Science and Technology [2010DFB30430]	Guangzhou Institutes of Biomedicine and Health; Chinese Academy of Sciences(Chinese Academy of Sciences); Bureau of Science and Technology of Guangzhou Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by startup funding from the Guangzhou Institutes of Biomedicine and Health and Grant KSCX2-YW-R244 from the Chinese Academy of Sciences (to M.A.E.); Grant 2008A1-E4011 from the Bureau of Science and Technology of Guangzhou Municipality, Grant 90813033 from the National Natural Science Foundation of China, Grants 2007CB948002 and 2009CB941102 from the 973 Program of the Ministry of Science and Technology of China, and Grant 2010DFB30430 from the Ministry of Science and Technology International Technology Cooperation Program (to D.P.); and Grant 2006AA02A103 from the 863 Program of the Ministry of Science and Technology of China (to L.L.).	Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Chamberlain SJ, 2010, NEUROBIOL DIS, V39, P13, DOI 10.1016/j.nbd.2010.03.011; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Koerner MV, 2010, CURR OPIN GENET DEV, V20, P164, DOI 10.1016/j.gde.2010.01.009; Lako M, 2010, STEM CELLS, V28, P845, DOI 10.1002/stem.411; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Leung KN, 2009, HUM MOL GENET, V18, P4227, DOI 10.1093/hmg/ddp373; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Santos-Reboucas CB, 2007, EUR J HUM GENET, V15, P10, DOI 10.1038/sj.ejhg.5201727; SZABO P, 1994, DEVELOPMENT, V120, P1651; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Weksberg R, 2003, HUM MOL GENET, V12, pR61, DOI 10.1093/hmg/ddg067; Wilmut I, 2007, CELL STEM CELL, V1, P593, DOI 10.1016/j.stem.2007.11.013; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	46	84	86	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40303	40311		10.1074/jbc.M110.183392	http://dx.doi.org/10.1074/jbc.M110.183392			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956530	Green Published, hybrid			2022-12-25	WOS:000285185500073
J	Li, W; Johnson, DJD; Adams, TE; Pozzi, N; De Filippis, V; Huntington, JA				Li, Wei; Johnson, Daniel J. D.; Adams, Ty E.; Pozzi, Nicola; De Filippis, Vincenzo; Huntington, James A.			Thrombin Inhibition by Serpins Disrupts Exosite II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALPHA(1)-PROTEINASE INHIBITOR; PROTEINASE INHIBITION; COVALENT COMPLEX; BINDING EXOSITE; ALPHA-THROMBIN; MECHANISM; PROTHROMBIN; TRYPSIN; ACTIVATION	Thrombin uses three principal sites, the active site, exosite I, and exosite II, for recognition of its many cofactors and substrates. It is synthesized in the zymogen form, prothrombin, and its activation at the end of the blood coagulation cascade results in the formation of the active site and exosite I and the exposure of exosite II. The physiological inhibitors of thrombin are all serpins, whose mechanism involves significant conformational change in both serpin and protease. It has been shown that the formation of the thrombin-serpin final complex disorders the active site and exosite I of thrombin, but exosite II is thought to remain functional. It has also been hypothesized that thrombin contains a receptor-binding site that is exposed upon final complex formation. The position of this cryptic site may depend on the regions of thrombin unfolded by serpin complexation. Here we investigate the conformation of thrombin in its final complex with serpins and find that in addition to exosite I, exosite II is also disordered, as reflected by a loss of affinity for the gamma`-peptide of fibrinogen and for heparin and by susceptibility to limited proteolysis. This disordering of exosite II occurs for all tested natural thrombin-inhibiting serpins. Our data suggest a novel framework for understanding serpin function, especially with respect to thrombin inhibition, where serpins functionally "rezymogenize" proteases to ensure complete loss of activity and cofactor binding.	[Li, Wei; Johnson, Daniel J. D.; Adams, Ty E.; Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Pozzi, Nicola; De Filippis, Vincenzo] Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy	University of Cambridge; University of Padua	Huntington, JA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England.	jah52@cam.ac.uk	Pozzi, Nicola/AAV-4876-2021; Pozzi, Nicola/AAE-4910-2020	Pozzi, Nicola/0000-0003-2309-7100; 	National Institutes of Health [HL68629]; British Heart Foundation; Medical Research Council; Medical Research Council [G117/444, G0601596] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068629] Funding Source: NIH RePORTER; MRC [G117/444, G0601596] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant HL68629 (J. A. H.) and by grants from the British Heart Foundation (to J. A. H.) and the Medical Research Council (J. A. H.).	ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Calugaru SV, 2001, J BIOL CHEM, V276, P32446, DOI 10.1074/jbc.M104731200; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Egelund R, 2001, EUR J BIOCHEM, V268, P673, DOI 10.1046/j.1432-1327.2001.01921.x; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fredenburgh JC, 2001, J BIOL CHEM, V276, P44828, DOI 10.1074/jbc.M108710200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; He XH, 1997, BIOCHEMISTRY-US, V36, P8969, DOI 10.1021/bi9704717; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217; KASLIK G, 1995, FEBS LETT, V370, P179, DOI 10.1016/0014-5793(95)00816-R; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LIU LW, 1991, J BIOL CHEM, V266, P23632; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6284, DOI 10.1021/bi010100x; Pineda AO, 2007, BIOPHYS CHEM, V125, P556, DOI 10.1016/j.bpc.2006.08.005; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; Stavridi ES, 1996, BIOCHEMISTRY-US, V35, P10608, DOI 10.1021/bi9605806; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; WU QY, 1994, J BIOL CHEM, V269, P3725; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	32	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38621	38629		10.1074/jbc.M110.144964	http://dx.doi.org/10.1074/jbc.M110.144964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889971	Green Published, hybrid			2022-12-25	WOS:000284625600066
J	Yang, F; Xia, XA; Lei, HY; Wang, ED				Yang, Fang; Xia, Xian; Lei, Hui-Yan; Wang, En-Duo			Hemin Binds to Human Cytoplasmic Arginyl-tRNA Synthetase and Inhibits Its Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; END RULE PATHWAY; RIBONUCLEIC-ACID SYNTHETASE; REV-ERB-ALPHA; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; REGULATORY MOTIF; 2 FORMS; DEGRADATION; ACTIVATION	The free form of human cytoplasmic arginyl-tRNA synthetase (hcArgRS) is hypothesized to participate in ubiquitin-dependent protein degradation by offering arginyl-tRNA(Arg) to arginyl-tRNA transferase (ATE1). We investigated the effect of hemin on hcArgRS based on the fact that hemin regulates several critical proteins in the "N-end rule" protein degradation pathway. Extensive biochemical evidence has established that hemin could bind to both forms of hcArgRS in vitro. Based on the spectral changes of the Soret band on site-directed protein mutants, we identified Cys-115 as a specific axial ligand of hemin binding that is located in the Add1 domain. Hemin inhibited the catalytic activity of full-length and N-terminal 72-amino acid-truncated hcArgRSs by blocking amino acid activation. Kinetic analysis demonstrated that the K-m values for tRNA(Arg), arginine, and ATP in the presence of hemin were not altered, but k(cat) values dramatically decreased compared with those in the absence of hemin. By comparison, the activity of prokaryotic ArgRS was not affected obviously by hemin. Gel filtration chromatography suggested that hemin induced oligomerization of both the isolated Add1 domain and the wild type enzyme, which could account for the inhibition of catalytic activity. However, the catalytic activity of an hcArgRS mutant with Cys-115 replaced by alanine (hcArgRS-C115A) was also inhibited by hemin, suggesting that hemin binding to Cys-115 is not responsible for the inhibition of enzymatic activity and that the specific binding may participate in other biological functions.	[Yang, Fang; Xia, Xian; Lei, Hui-Yan; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	edwang@sibs.ac.cn	Milton, Ross D/J-7164-2012		National Key Basic Research Foundation of China [2006CB910301]; Natural Science Foundation of China [30930022]; Postdoctoral Science Foundation of China; Postdoctoral Foundation of Shanghai; Postdoctoral Foundation of Shanghai Institutes for Biological Sciences (SIBS); Chinese Academy of Science; Sanofi-Aventis-SIBS	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Foundation of Shanghai; Postdoctoral Foundation of Shanghai Institutes for Biological Sciences (SIBS); Chinese Academy of Science(Chinese Academy of Sciences); Sanofi-Aventis-SIBS	This work was supported by National Key Basic Research Foundation of China Grant 2006CB910301, Natural Science Foundation of China Grant 30930022, the Postdoctoral Science Foundation of China, the Postdoctoral Foundation of Shanghai, the Postdoctoral Foundation of Shanghai Institutes for Biological Sciences (SIBS), a K. C. Wong postdoctoral fellowship of the Chinese Academy of Science, and a Sanofi-Aventis-SIBS postdoctoral fellowship.	BIRDSALL WJ, 1989, BIOCHIM BIOPHYS ACTA, V1007, P176, DOI 10.1016/0167-4781(89)90036-5; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen JF, 1999, PROTEIN EXPRES PURIF, V15, P115, DOI 10.1006/prep.1998.0999; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; DEUTSCHER MP, 1982, J BIOL CHEM, V257, P6003; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ETLINGER JD, 1980, J BIOL CHEM, V255, P4563; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; FERBER S, 1987, NATURE, V326, P808, DOI 10.1038/326808a0; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Guigou L, 2005, BIOCHEMISTRY-US, V44, P16540, DOI 10.1021/bi051575h; Guigou L, 2004, BIOCHEMISTRY-US, V43, P4592, DOI 10.1021/bi036150e; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; Hori Y, 2005, BBA-GENE STRUCT EXPR, V1730, P47, DOI 10.1016/j.bbaexp.2005.06.003; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; Konno M, 2009, FEBS J, V276, P4763, DOI 10.1111/j.1742-4658.2009.07178.x; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Lazard M, 2000, J MOL BIOL, V302, P991, DOI 10.1006/jmbi.2000.4102; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Levican G, 2007, P NATL ACAD SCI USA, V104, P3135, DOI 10.1073/pnas.0611611104; Li J, 2003, BIOCHEM J, V376, P773, DOI 10.1042/BJ20030957; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Liu MF, 1999, BIOCHEMISTRY-US, V38, P11006, DOI 10.1021/bi990392q; Liu X, 2009, ELECTROPHORESIS, V30, P3034, DOI 10.1002/elps.200900151; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; PAPAS TS, 1972, BIOCHEMISTRY-US, V11, P4602, DOI 10.1021/bi00774a029; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Scolaro LM, 2004, J AM CHEM SOC, V126, P7178, DOI 10.1021/ja049669m; Shimada A, 2001, P NATL ACAD SCI USA, V98, P13537, DOI 10.1073/pnas.231267998; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; VELLEKAMP G, 1985, J BIOL CHEM, V260, P9843; Wakasugi K, 2007, BIOCHEMISTRY-US, V46, P11291, DOI 10.1021/bi7012068; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zheng YG, 2006, BIOCHEMISTRY-US, V45, P1338, DOI 10.1021/bi051675n	49	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39437	39446		10.1074/jbc.M110.159913	http://dx.doi.org/10.1074/jbc.M110.159913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923763	hybrid, Green Published			2022-12-25	WOS:000284941300070
J	Mencarelli, A; Cipriani, S; Renga, B; Francisci, D; Palladino, G; Distrutti, E; Baldelli, F; Fiorucci, S				Mencarelli, Andrea; Cipriani, Sabrina; Renga, Barbara; Francisci, Daniela; Palladino, Giuseppe; Distrutti, Eleonora; Baldelli, Franco; Fiorucci, Stefano			The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; ATHEROSCLEROTIC LESION FORMATION; ELEMENT-BINDING PROTEINS; NUCLEAR RECEPTOR; CHENODEOXYCHOLIC ACID; SCAVENGER RECEPTORS; OXIDIZED LDL; FATTY-ACID; ACTIVATION; HYPERLIPIDEMIA	Background: Although human immunodeficiency virus (HIV)-related morbidity and mortality rates in patients treated with a combination of high active antiretroviral therapy (HAART) have declined, significant metabolic/vascular adverse effects associated with the long term use of HIV protease inhibitors (PIs) have emerged as a significant side effect. Here we illustrate that targeting the bile acid sensor farnesoid X receptor (FXR) protects against dyslipidemia and vascular injury induced HIV-PIs in rodents. Methodology/Principal Findings: Administration of the HIV PI ritonavir to wild type mice increased plasma triacylglycerols and cholesterol levels and this effect was exacerbated by dosing ritonavir to mice harbouring a disrupted FXR. Dyslipidemia induced by ritonavir associated with a shift in the liver expression of signature genes, Sterol Regulatory Element-Binding Protein (SREBP)1 and fatty acid synthase. Treating wild type mice with the FXR agonist (chenodeoxycholic acid, CDCA) protected against development of dyslipidemia induced by ritonavir. Administration of ritonavir to ApoE(-/-) mice, a strain that develop spontaneously atherosclerosis, increased the extent of aortic plaques without worsening the dyslipidemia. Treating these mice with CDCA reduced the extent of aortic plaques by 70% without changing plasma lipoproteins or the liver expression of signature genes. A beneficial effect on aortic plaques was also obtained by treating ApoE(-/-) mice with gemfibrozil, a PPAR alpha agonist. FXR activation counter-regulated induction of expression/activity of CD36 caused by HIV-PIs in circulating monocytes and aortic plaques. In macrophages cell lines, CDCA attenuated CD36 induction and uptake of acetylated LDL caused by ritonavir. Natural and synthetic FXR ligands reduced the nuclear translocation of SREBP1c caused by ritonavir. Conclusions/Significance: Activation of the bile acid sensor FXR protects against dyslipidemia and atherosclerotic caused by ritonavir, a widely used HIV PI. From a mechanistic stand point it appears that besides reducing the liver expression of genes involved in fatty acid synthesis, FXR activation counter-regulates the expression/activity of CD36 on monocytes. FXR ligands might hold promise in the treatment dyslipidemia induced by ritonavir.	[Mencarelli, Andrea; Cipriani, Sabrina; Renga, Barbara; Palladino, Giuseppe; Fiorucci, Stefano] Univ Perugia, Fac Med & Chirurg, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy; [Francisci, Daniela; Baldelli, Franco] Univ Perugia, Fac Med & Chirurg, Dipartimento Med Sperimentale & Sci Biochim, I-06100 Perugia, Italy; [Distrutti, Eleonora] Osped S Maria Misericordia, Azienda Osped Perugia, Perugia, Italy	University of Perugia; University of Perugia; Hospital Santa Maria della Misericordia; University of Perugia; Azienda Ospedaliera di Perugia	Mencarelli, A (corresponding author), Univ Perugia, Fac Med & Chirurg, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy.	fiorucci@unipg.it	Fiorucci, Stefano/I-1251-2012					Barbaro G., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P337, DOI 10.2174/1568006054553444; BATESON MC, 1978, BRIT J CLIN PHARMACO, V5, P249, DOI 10.1111/j.1365-2125.1978.tb01632.x; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Calkin AC, 2006, DIABETOLOGIA, V49, P766, DOI 10.1007/s00125-005-0102-6; Calkin AC, 2007, ATHEROSCLEROSIS, V195, P17, DOI 10.1016/j.atherosclerosis.2006.11.021; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Distler O, 2001, CURR OPIN CLIN NUTR, V4, P99, DOI 10.1097/00075197-200103000-00003; Dressman J, 2003, J CLIN INVEST, V111, P389, DOI 10.1172/JCI200316261; Fiorucci S, 2010, PROG LIPID RES, V49, P171, DOI 10.1016/j.plipres.2009.11.001; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Graham NM, 2000, J ACQ IMMUN DEF SYND, V25, pS4, DOI 10.1097/00126334-200010001-00002; Hanniman EA, 2005, J LIPID RES, V46, P2595, DOI 10.1194/jlr.M500390-JLR200; Hartman HB, 2009, J LIPID RES, V50, P1090, DOI 10.1194/jlr.M800619-JLR200; Huang XP, 2007, APPL OPTICS, V46, P147, DOI 10.1364/AO.46.000147; Jung D, 2006, J BIOL CHEM, V281, P19081, DOI 10.1074/jbc.M600116200; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Lenhard JM, 2000, ARTERIOSCL THROM VAS, V20, P2625, DOI 10.1161/01.ATV.20.12.2625; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Linton MF, 2001, CURR OPIN LIPIDOL, V12, P489, DOI 10.1097/00041433-200110000-00003; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; MILLER NE, 1974, LANCET, V2, P929; Mooser V, 2003, AIDS, V17, pS65, DOI 10.1097/00002030-200304001-00009; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; Riddle TM, 2001, J BIOL CHEM, V276, P37514, DOI 10.1074/jbc.M104557200; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stein JH, 2007, NEW ENGL J MED, V356, P1773, DOI 10.1056/NEJMe078037; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yeni P, 2006, J HEPATOL, V44, pS100, DOI 10.1016/j.jhep.2005.11.021; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	45	23	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13238	10.1371/journal.pone.0013238	http://dx.doi.org/10.1371/journal.pone.0013238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949026	gold, Green Submitted, Green Published			2022-12-25	WOS:000282676700012
J	Du, QS; Wang, CH; Liao, SM; Huang, RB				Du, Qi-Shi; Wang, Cheng-Hua; Liao, Si-Ming; Huang, Ri-Bo			Correlation Analysis for Protein Evolutionary Family Based on Amino Acid Position Mutations and Application in PDZ Domain	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRESS-RESPONSE; INFORMATION; DETERMINANTS; RECOGNITION; ACTIVATION; CATALYSIS; PATHWAYS; RESIDUES; RECEPTOR	Background: It has been widely recognized that the mutations at specific directions are caused by the functional constraints in protein family and the directional mutations at certain positions control the evolutionary direction of the protein family. The mutations at different positions, even distantly separated, are mutually coupled and form an evolutionary network. Finding the controlling mutative positions and the mutative network among residues are firstly important for protein rational design and enzyme engineering. Methodology: A computational approach, namely amino acid position conservation-mutation correlation analysis (CMCA), is developed to predict mutually mutative positions and find the evolutionary network in protein family. The amino acid position mutative function, which is the foundational equation of CMCA measuring the mutation of a residue at a position, is derived from the MSA (multiple structure alignment) database of protein evolutionary family. Then the position conservation correlation matrix and position mutation correlation matrix is constructed from the amino acid position mutative equation. Unlike traditional SCA (statistical coupling analysis) approach, which is based on the statistical analysis of position conservations, the CMCA focuses on the correlation analysis of position mutations. Conclusions: As an example the CMCA approach is used to study the PDZ domain of protein family, and the results well illustrate the distantly allosteric mechanism in PDZ protein family, and find the functional mutative network among residues. We expect that the CMCA approach may find applications in protein engineering study, and suggest new strategy to improve bioactivities and physicochemical properties of enzymes.	[Du, Qi-Shi; Wang, Cheng-Hua; Liao, Si-Ming; Huang, Ri-Bo] Guangxi Acad Sci, State Key Lab Bioenergy Enzyme Technol, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Guangxi, Peoples R China; [Du, Qi-Shi; Liao, Si-Ming; Huang, Ri-Bo] Guangxi Univ, Life Sci & Biotechnol Coll, Nanning 530004, Guangxi, Peoples R China; [Wang, Cheng-Hua; Huang, Ri-Bo] Nanjing Univ Technol, Nanjing 210009, Jiangsu, Peoples R China; [Du, Qi-Shi] Gordon Life Sci Inst, San Diego, CA USA	Guangxi University; Nanjing Tech University	Du, QS (corresponding author), Guangxi Acad Sci, State Key Lab Bioenergy Enzyme Technol, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Guangxi, Peoples R China.	qishi_du@yahoo.com.cn			National Program on Key Basic Research Project (973 Program) of China [2009CB724703]; Guangxi key laboratory of Biorefinery [07-109-001A]; National Science Foundation of China (NSFC) [30970562]	National Program on Key Basic Research Project (973 Program) of China(National Basic Research Program of China); Guangxi key laboratory of Biorefinery; National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Program on Key Basic Research Project (973 Program) of China under the project 2009CB724703, by the Guangxi key laboratory of Biorefinery under the project 07-109-001A, and by the National Science Foundation of China (NSFC) under the project 30970562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Bauler TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004014; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Carmena A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000066; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Coleman SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008715; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Di Cera E, 2004, CR BIOL, V327, P1065, DOI 10.1016/j.crvi.2004.07.011; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-242; Galtier N., 2007, V3, P1, DOI 10.1159/000107599; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; Kurakin A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000953; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Ponting CP, 1997, PROTEIN SCI, V6, P464; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Schlieker C, 2004, CELL, V117, P417, DOI 10.1016/S0092-8674(04)00453-2; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Thomas MC, 2006, ELEMENTS INFORM THEO; Velthuis AJWT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000189; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4	46	7	7	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13207	10.1371/journal.pone.0013207	http://dx.doi.org/10.1371/journal.pone.0013207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949088	gold, Green Submitted, Green Published			2022-12-25	WOS:000282568400016
J	Jettestuen, E; Nermoen, A; Hestmark, G; Timdal, E; Mathiesen, J				Jettestuen, Espen; Nermoen, Anders; Hestmark, Geir; Timdal, Einar; Mathiesen, Joachim			Competition on the Rocks: Community Growth and Tessellation	PLOS ONE			English	Article							DYNAMICS	Crustose lichen communities on rocks exhibit fascinating spatial mosaics resembling political maps of nations or municipalities. Although the establishment and development of biological populations are important themes in ecology, our understanding of the formation of such patterns on the rocks is still in its infancy. Here, we present a novel model of the concurrent growth, establishment and interaction of lichens. We introduce an inverse technique based on Monte Carlo simulations to test our model on field samples of lichen communities. We derive an expression for the time needed for a community to cover a surface and predict the historical spatial dynamics of field samples. Lichens are frequently used for dating the time of exposure of rocks in glacial deposits, lake retreats or rock falls. We suggest our method as a way to improve the dating.	[Jettestuen, Espen; Hestmark, Geir] Univ Oslo, Dept Biol, Oslo, Norway; [Jettestuen, Espen] Int Res Inst Stavanger, Stavanger, Norway; [Timdal, Einar] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Mathiesen, Joachim] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark	University of Oslo; University of Oslo; University of Copenhagen; Niels Bohr Institute	Jettestuen, E (corresponding author), Univ Oslo, Dept Biol, Oslo, Norway.	mathies@nbi.dk		Mathiesen, Joachim/0000-0002-5621-5487	Center of Excellence grant; Danish National Research Foundation through the Center for Models of Life	Center of Excellence grant; Danish National Research Foundation through the Center for Models of Life	This study was supported by a Center of Excellence grant to the Physics of Geological Processes Center at the University of Oslo and by the Danish National Research Foundation through the Center for Models of Life. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong R, 2010, GEOGR ANN A, V92A, P3, DOI 10.1111/j.1468-0459.2010.00374.x; Benedict JB, 2008, ARCT ANTARCT ALP RES, V40, P15, DOI 10.1657/1523-0430(06-030)[BENEDICT]2.0.CO;2; BOWLER PA, 1975, BOT J LINN SOC, V70, P325, DOI 10.1111/j.1095-8339.1975.tb01653.x; Bradwell T, 2009, GEOGR ANN A, V91A, P61, DOI 10.1111/j.1468-0459.2009.00354.x; Ferkinghoff-Borg J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.266103; FLYVBJERG H, 1994, PHYS REV LETT, V73, P2372, DOI 10.1103/PhysRevLett.73.2372; Grube M, 2009, ISME J, V3, P1105, DOI 10.1038/ismej.2009.63; Jomelli V, 2007, GEOMORPHOLOGY, V86, P131, DOI 10.1016/j.geomorph.2006.08.010; KUENNEN E, 2008, J STAT MECH-THEORY E, V5, P5014; Mathiesen J, 2004, J GLACIOL, V50, P325, DOI 10.3189/172756504781829873; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478; Ramstad S, 2000, MYCOL RES, V104, P198, DOI 10.1017/S0953756299001975; Sletvold N, 1999, CAN J BOT, V77, P1655; van Saarloos W, 2003, PHYS REP, V386, P29, DOI 10.1016/j.physrep.2003.08.001; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	16	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12820	10.1371/journal.pone.0012820	http://dx.doi.org/10.1371/journal.pone.0012820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941362	Green Published, gold			2022-12-25	WOS:000282312600005
J	Ignacio, BL; Julio, LM; Junqueira, AOR; Ferreira-Silva, MAG				Ignacio, Barbara L.; Julio, Luciana M.; Junqueira, Andrea O. R.; Ferreira-Silva, Maria A. G.			Bioinvasion in a Brazilian Bay: Filling Gaps in the Knowledge of Southwestern Atlantic Biota	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; ARTIFICIAL SUBSTRATA; SUBTIDAL EPIBIOTA; URBAN STRUCTURES; MYTILUS-GALLOPROVINCIALIS; INTERTIDAL ASSEMBLAGES; SPECIES-DIVERSITY; NATURAL HABITATS; PARANAGUA BAY; NORTH-AMERICA	Background: Biological invasions are a major cause of global species change. Nevertheless, knowledge about the distribution and ecology of introduced species is regionally biased, and many gaps in knowledge exist for most developing countries. Methodology/Principal Findings: To study the zoobenthos on the hard substratum of the Ilha Grande Bay, a survey was conducted on both natural and artificial substrata at three depths and seven sites. The species recorded were classified as native, cryptogenic or introduced. Multivariate analyses were conducted to assess the prevalence of introduced species in these communities and to compare the distribution of species on natural and artificial substrata of this bay to identify possible discrepancies in habitat use. Of the 61 species, 25 were cryptogenic, 10 were introduced and 26 were native. Similar numbers of introduced species were found on both natural and artificial substrata, though the community composition was significantly different between them. We also compared the species composition of the Ilha Grande Bay survey to other inventories taken around the world. The highest similarities were found between the Ilha Grande Bay inventory and the Atlantic coastal region (Tampa Bay, USA and the Gulf of Mexico), American Samoa and Pearl Harbor (USA) inventories. Conclusions/Significance: This study presents the first published comprehensive list of hard substratum sessile marine invertebrate species in a Brazilian bay. The high percentage of cryptogenic species reveals gaps in both zoological records and information on introduced species for the Brazilian coast. The introduced species successfully colonized different sites in the Ilha Grande Bay, including both natural and artificial substrata. In addition, we find that artificial structures may not be good surrogates for natural rocky shores and may represent an ecological threat. Comparisons with other inventories suggest a history of broad-scale invasion, though more evidence is needed to support this conclusion.	[Ignacio, Barbara L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Julio, Luciana M.; Junqueira, Andrea O. R.; Ferreira-Silva, Maria A. G.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Ignacio, BL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	lagebarbara@yahoo.com.br	JUNQUEIRA, ANDREA/G-4705-2014; Ignacio, Barbara Lage/I-5204-2012	OLIVEIRA RIBEIRO JUNQUEIRA, ANDREA/0000-0002-3386-2454; Ignacio, Barbara/0000-0001-6943-7348	CNPq (Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico - Brazil); Ignacio's PhD scholarship	CNPq (Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico - Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ignacio's PhD scholarship	Financial support came from CNPq (Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico - Brazil) and Ignacio's PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AQ PTY LTD, 2001, EX MAR PESTS SURV PO; Ashton Gail, 2006, Aquatic Invasions, V1, P214, DOI 10.3391/ai.2006.1.4.4; Audzijonyte A, 2008, DIVERS DISTRIB, V14, P179, DOI 10.1111/j.1472-4642.2007.00434.x; Bacchiocchi F, 2003, ESTUAR COAST SHELF S, V56, P1157, DOI 10.1016/S0272-7714(02)00322-0; BAKER P, 2004, NONINDIGENOUS MARINE; Breves-Ramos A, 2010, J MAR BIOL ASSOC UK, V90, P453, DOI 10.1017/S0025315409990919; Bulleri F, 2005, AUSTRAL ECOL, V30, P655, DOI 10.1111/j.1442-9993.2005.01507.x; Bulleri F, 2004, MAR BIOL, V145, P381, DOI 10.1007/s00227-004-1316-8; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Butler AJ, 1996, BIOFOULING, V9, P187, DOI 10.1080/08927019609378303; Cardigos F, 2006, HELGOLAND MAR RES, V60, P160, DOI 10.1007/s10152-006-0034-7; Carlton JT, 1996, ECOLOGY, V77, P1653, DOI 10.2307/2265767; CARLTON JT, 1989, CONSERV BIOL, V3, P265, DOI 10.1111/j.1523-1739.1989.tb00086.x; Castilla JC, 2005, BIOL INVASIONS, V7, P213, DOI 10.1007/s10530-004-0198-5; CHAPMAN JW, 1991, J CRUSTACEAN BIOL, V11, P386, DOI 10.2307/1548465; Clark GF, 2005, MAR ECOL PROG SER, V298, P9, DOI 10.3354/meps298009; Cohen AN, 2005, BIOL INVASIONS, V7, P995, DOI 10.1007/s10530-004-3121-1; Coles SL, 1999, MAR BIOL, V135, P147, DOI 10.1007/s002270050612; COLES SL, 2006, LANAI NONINDIGENOUS; COLES SL, 2003, PACIFIC BIOL SURVEY; Connell SD, 2001, MAR ENVIRON RES, V52, P115, DOI 10.1016/S0141-1136(00)00266-X; Connell SD, 1999, MAR ENVIRON RES, V47, P373, DOI 10.1016/S0141-1136(98)00126-3; CREED J.C., 2007, BIODIVERSIDADE MARIN, P19; Creed JC, 2007, MAR ECOL PROG SER, V330, P101, DOI 10.3354/meps330101; CRISP DJ, 1960, NATURE, V185, P119, DOI 10.1038/185119a0; Elton C. S., 1958, ECOLOGY INVASIONS AN; Farrapeira Cristiane Maria Rocha, 2008, Biota Neotropica, V8, P31; Fletcher RL, 1998, HELGOLANDER MEERESUN, V52, P259, DOI 10.1007/BF02908901; Floerl O, 2005, BIOL INVASIONS, V7, P459, DOI 10.1007/s10530-004-4863-5; Floerl O, 2003, AUSTRAL ECOL, V28, P116, DOI 10.1046/j.1442-9993.2003.01254.x; Floerl O, 2004, ECOL APPL, V14, P1724, DOI 10.1890/03-5399; Galil BS, 2007, MAR POLLUT BULL, V55, P314, DOI 10.1016/j.marpolbul.2006.11.008; Galil BS, 2009, BIOL INVASIONS, V11, P359, DOI 10.1007/s10530-008-9253-y; Galil Bella S., 2007, Aquatic Invasions, V2, P281, DOI 10.3391/ai.2007.2.4.2; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Glasby TM, 1999, AMBIO, V28, P595; Glasby TM, 1999, ESTUAR COAST SHELF S, V48, P281, DOI 10.1006/ecss.1998.0417; Godwin LS, 2003, BIOFOULING, V19, P123, DOI 10.1080/0892701031000061750; Hanekom N, 2008, BIOL INVASIONS, V10, P233, DOI 10.1007/s10530-007-9125-x; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Hufbauer RA, 2008, DIVERS DISTRIB, V14, P252, DOI 10.1111/j.1472-4642.2007.00424.x; Hutchings P. A., 2002, Pacific Science, V56, P223, DOI 10.1353/psc.2002.0017; *INV SPEC FOC TEAM, 2000, INV NON AQ SPEC OCC; Karpinsky MG, 2005, HANDB ENVIRON CHEM, V5, P175, DOI 10.1007/698_5_009; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; Kremer LP, 2010, BIOL INVASIONS, V12, P1581, DOI 10.1007/s10530-009-9571-8; Lacombe D., 1977, Publicacoes Inst Pesq Mar Rio de J, VNo. 109, P1; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Leite Ferreira Carlos Eduardo, 2009, V204, P459; Mayer-Pinto M, 2003, MAR POLLUT BULL, V46, P1495, DOI 10.1016/S0025-326X(03)00249-2; MCGUINNESS KA, 1989, MAR ECOL PROG SER, V52, P201, DOI 10.3354/meps052201; Neves CS, 2008, BRAZ ARCH BIOL TECHN, V51, P623, DOI 10.1590/S1516-89132008000300025; Neves CS, 2007, BIOFOULING, V23, P319, DOI 10.1080/08927010701399174; Nicastro KR, 2007, MAR ECOL PROG SER, V336, P169, DOI 10.3354/meps336169; Nunez MA, 2010, BIOL INVASIONS, V12, P707, DOI 10.1007/s10530-009-9517-1; Orensanz Jose Maria (Lobo), 2002, Biological Invasions, V4, P115; Provan J, 2008, DIVERS DISTRIB, V14, P343, DOI 10.1111/j.1472-4642.2007.00420.x; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; RAMALHO LV, 2006, TAXONOMIA DISTRIBUIC; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ruiz GM, 1997, AM ZOOL, V37, P621; RUSS GR, 1982, OECOLOGIA, V53, P12, DOI 10.1007/BF00377130; RUSSELL B. C., 2000, BASELINE SURVEY PORT; Simberloff Daniel, 1997, P3; Simone Luiz Ricardo L., 2006, Pap. Avulsos Zool. (São Paulo), V46, P57, DOI 10.1590/S0031-10492006000600001; Smith SDA, 2002, J EXP MAR BIOL ECOL, V277, P25, DOI 10.1016/S0022-0981(02)00242-3; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Stachowicz JJ, 2006, MAR ECOL PROG SER, V311, P251, DOI 10.3354/meps311251; Streftaris N, 2005, OCEANOGR MAR BIOL, V43, P419; SUTHERLAND JP, 1977, ECOL MONOGR, V47, P425, DOI 10.2307/1942176; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; Vaselli S, 2008, MAR ENVIRON RES, V66, P395, DOI 10.1016/j.marenvres.2008.06.002; Vieira LM, 2008, ZOOTAXA, P1; Walters LJ, 1996, MAR ECOL PROG SER, V137, P161, DOI 10.3354/meps137161; Wasson K, 2001, BIOL CONSERV, V102, P143, DOI 10.1016/S0006-3207(01)00098-2; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Wyatt ASJ, 2005, DIVERS DISTRIB, V11, P33, DOI 10.1111/j.1366-9516.2005.00109.x; Zardi GI, 2008, MAR BIOL, V153, P853, DOI 10.1007/s00227-007-0857-z	82	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13065	10.1371/journal.pone.0013065	http://dx.doi.org/10.1371/journal.pone.0013065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927375	Green Submitted, Green Published, gold			2022-12-25	WOS:000282269400017
J	Rajala, AZ; Reininger, KR; Lancaster, KM; Populin, LC				Rajala, Abigail Z.; Reininger, Katharine R.; Lancaster, Kimberly M.; Populin, Luis C.			Rhesus Monkeys (Macaca mulatta) Do Recognize Themselves in the Mirror: Implications for the Evolution of Self-Recognition	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; PRIMATES; AWARENESS; EMERGENCE; RESPONSES; MIND	Self-recognition in front of a mirror is used as an indicator of self-awareness. Along with humans, some chimpanzees and orangutans have been shown to be self-aware using the mark test. Monkeys are conspicuously absent from this list because they fail the mark test and show persistent signs of social responses to mirrors despite prolonged exposure, which has been interpreted as evidence of a cognitive divide between hominoids and other species. In stark contrast with those reports, the rhesus monkeys in this study, who had been prepared for electrophysiological recordings with a head implant, showed consistent self-directed behaviors in front of the mirror and showed social responses that subsided quickly during the first experimental session. The self-directed behaviors, which were performed in front of the mirror and did not take place in its absence, included extensive observation of the implant and genital areas that cannot be observed directly without a mirror. We hypothesize that the head implant, a most salient mark, prompted the monkeys to overcome gaze aversion inhibition or lack of interest in order to look and examine themselves in front of the mirror. The results of this study demonstrate that rhesus monkeys do recognize themselves in the mirror and, therefore, have some form of self-awareness. Accordingly, instead of a cognitive divide, they support the notion of an evolutionary continuity of mental functions.	[Rajala, Abigail Z.; Populin, Luis C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Reininger, Katharine R.; Lancaster, Kimberly M.; Populin, Luis C.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; [Populin, Luis C.] Univ Wisconsin, Eye Res Inst, Madison, WI 53706 USA; [Populin, Luis C.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rajala, AZ (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.	Lpopulin@wisc.edu		Lauwereyns, Jan/0000-0003-0551-2550	National Science Foundation (NSF) [IOB-0517458]; National Institutes of Health (NIH) [DC003693]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003693] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Science Foundation (NSF) (IOB-0517458) and National Institutes of Health (NIH) (DC003693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Anderson James R., 1994, P315, DOI 10.1017/CBO9780511565526.023; ANDERSON JR, 1983, Q J EXP PSYCHOL-B, V35, P201, DOI 10.1080/14640748308400905; Bard KA, 2006, INFANCY, V9, P191, DOI 10.1207/s15327078in0902_6; Boccia M.L., 1994, SELF AWARENESS ANIMA, P350, DOI [10.1017/CBO9780511565526.025, DOI 10.1017/CBO9780511565526.025]; EGLASH AR, 1983, AM J PRIMATOL, V5, P211, DOI 10.1002/ajp.1350050305; FRYREAR JL, 1981, J PSYCHOL, V104, P123; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; GALLUP GG, 1977, DEV PSYCHOBIOL, V10, P281, DOI 10.1002/dev.420100312; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; GALLUP GG, 1979, AM SCI, V67, P417; GALLUP GG, 1977, AM PSYCHOL, V32, P329, DOI 10.1037/0003-066X.32.5.329; GALLUP GG, 1987, COMP PRIMATE BIOL B, V2, P3; Griffin Donald R., 1976, QUESTION ANIMAL AWAR; HAUSER MD, 1995, P NATL ACAD SCI USA, V92, P10811, DOI 10.1073/pnas.92.23.10811; Hauser MD, 2001, AM J PRIMATOL, V53, P131; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KELLER H, 2004, DEV CONSEQUENCES EAR; LETHMATE J, 1973, Zeitschrift fuer Tierpsychologie, V33, P248; MACPHAIL E, 1987, MINDWAVES THOUGHTS I, P177; MACPHAIL EM, 1987, BEHAV BRAIN SCI, V10, P645, DOI 10.1017/S0140525X00054984; MITCHELL RW, 1993, NEW IDEAS PSYCHOL, V11, P295, DOI 10.1016/0732-118X(93)90002-U; PATTERSON FGP, 1994, SELF AWARENESS ANIMA, P373; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Populin LC, 2006, J NEUROSCI, V26, P9820, DOI 10.1523/JNEUROSCI.3061-06.2006; POVINELLI DJ, 1993, J COMP PSYCHOL, V107, P347, DOI 10.1037/0735-7036.107.4.347; POVINELLI DJ, 1993, AM PSYCHOL, V48, P493, DOI 10.1037/0003-066X.48.5.493; Prior H, 2008, PLOS BIOL, V6, P1642, DOI 10.1371/journal.pbio.0060202; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; SUAREZ SD, 1981, J HUM EVOL, V10, P175, DOI 10.1016/S0047-2484(81)80016-4; Swartz Karyl B., 1994, P189, DOI 10.1017/CBO9780511565526.013; SWARTZ KB, 1991, PRIMATES, V32, P483, DOI 10.1007/BF02381939	33	50	52	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12865	10.1371/journal.pone.0012865	http://dx.doi.org/10.1371/journal.pone.0012865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927365	Green Submitted, Green Published, gold			2022-12-25	WOS:000282269400004
J	Moncho-Amor, V; Ibanez de Caceres, I; Bandres, E; Martinez-Poveda, B; Orgaz, JL; Sanchez-Perez, I; Zazo, S; Rovira, A; Albanell, J; Jimenez, B; Rojo, F; Belda-Iniesta, C; Garcia-Foncillas, J; Perona, R				Moncho-Amor, V.; Ibanez de Caceres, I.; Bandres, E.; Martinez-Poveda, B.; Orgaz, J. L.; Sanchez-Perez, I.; Zazo, S.; Rovira, A.; Albanell, J.; Jimenez, B.; Rojo, F.; Belda-Iniesta, C.; Garcia-Foncillas, J.; Perona, R.			DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer	ONCOGENE			English	Article						non-small-cell lung cancer; DUSP1/MKP1; VEGFC; angiogenesis; metastasis; DUSP6/MKP3	PROTEIN-KINASE PHOSPHATASE-1; LYMPH-NODE METASTASIS; BREAST-CANCER; TUMOR-GROWTH; MAP KINASE; ACTIVATION; PROGNOSIS; CARCINOMAS; EXPRESSION; PATHWAYS	DUSP1/MKP1 is a dual-specific phosphatase that regulates MAPKs activity, with an increasingly recognized role in tumor biology. To understand more about the involvement of DUSP1 in lung cancer, we performed gene expression analyses of parental and DUSP1-interfered H460 non-small-cell lung cancer (NSCLC) cells. Downregulation of DUSP1 induced changes in the expression levels of genes involved in specific biological pathways, including angiogenesis, MAP kinase phosphatase activity, cell-cell signaling, growth factor and tyrosine-kinase receptor activity. Changes in the expression of some of these genes were due to modulation of c-Jun-N-terminal kinase and/or p38 activity by DUSP1. Complementary functional assays were performed to focus on the implication of DUSP1 in angiogenesis and metastasis. In H460 cells, interference of DUSP1 resulted in a diminished capacity to invade through Matrigel, to grow tumors in nude mice and also to induce metastasis through tail-vein injection. Furthermore, the angiogenic potential of H460 cells was also impaired, correlating with a decrease in VEGFC production and indicating that DUSP1 could be required to induce angiogenesis. Finally, we studied whether a similar relationship occurred in patients. In human NSCLC specimens, DUSP1 was mainly expressed in those tumor cells close to CD31 vascular structures and a statistically significant correlation was found between VEGFC and DUSP1 expression. Overall, these results provide evidence for a role of DUSP1 in angiogenesis, invasion and metastasis in NSCLC. Oncogene (2011) 30, 668-678; doi:10.1038/onc.2010.449; published online 4 October 2010	[Moncho-Amor, V.; Sanchez-Perez, I.; Perona, R.] CSIC UAM, Inst Invest Biomed, CIBER Enfermedades Raras CIBERER, IdiPAZ, Madrid 28029, Spain; [Ibanez de Caceres, I.] FIB La Paz Univ Hosp, IdiPAZ, Oncol Res Lab, Res Unit, Madrid, Spain; [Bandres, E.; Garcia-Foncillas, J.] Univ Navarra, Ctr Appl Med Res CIMA, Div Oncol, Lab Pharmacogenom, Navarra, Spain; [Martinez-Poveda, B.; Orgaz, J. L.; Jimenez, B.] CSIC UAM, Inst Invest Biomed, Dept Mol & Cellular Biol Canc, Madrid 28029, Spain; [Zazo, S.; Rojo, F.] Capio Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain; [Rovira, A.; Albanell, J.; Rojo, F.] Autonomous Univ Barcelona, Hosp Mar IMAS, Dept Med Oncol, Barcelona, Spain; [Rovira, A.; Albanell, J.; Rojo, F.] Autonomous Univ Barcelona, Canc Res Program, IMIM Hosp Mar, Barcelona, Spain; [Belda-Iniesta, C.] La Paz Univ Hosp, Dept Med Oncol, IdiPAZ, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitario La Paz	Perona, R (corresponding author), CSIC UAM, Inst Invest Biomed, CIBER Enfermedades Raras CIBERER, IdiPAZ, C Arturo Duperier 4, Madrid 28029, Spain.	RPerona@iib.uam.es	Rojo, Federico/S-6551-2016; Moncho, Veronica/AAB-5931-2019; Martinez-Poveda, Beatriz/T-6973-2017; Orgaz, Jose L./ABH-1835-2020; Sánchez-Pérez, Isabel/R-4107-2016; Albanell, Joan/R-9470-2019; Cuenca, Benilde Jimenez/K-9959-2014; Rovira, Ana/ABH-5661-2020	Moncho, Veronica/0000-0001-7914-6683; Martinez-Poveda, Beatriz/0000-0003-3927-3877; Orgaz, Jose L./0000-0002-9776-7544; Sánchez-Pérez, Isabel/0000-0002-4829-201X; Rovira, Ana/0000-0003-1301-2599; Jimenez Cuenca, Benilde/0000-0002-1806-6636; Belda Iniesta, Cristobal/0000-0003-3254-7492; Rojo, Federico/0000-0001-9989-0290; J, Garcia-Foncillas/0000-0002-7591-8006; BANDRES, EVA/0000-0002-9497-5356	Fondo de Investigacion Sanitaria (ISCIII) [CP 08/000689]; Spanish Ministerio de Educacion y Ciencia; Spanish Health Ministry grant 'Fondo de Investigacion Sanitaria' [PI05/2019, PI05/1305, PI06/1513, PI081485, PI09/1296, PS09/01285, PS09/00472]; Ministerio de Educacion y Ciencia [SAF2007-62292]; Comunidad Autonoma de Madrid [SAL-0311-2006];  [RTICC 06/0020/19]	Fondo de Investigacion Sanitaria (ISCIII)(Instituto de Salud Carlos III); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Spanish Health Ministry grant 'Fondo de Investigacion Sanitaria'; Ministerio de Educacion y Ciencia(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); 	Ibanez de Caceres was partially supported by the Fondo de Investigacion Sanitaria (ISCIII) through the 'Miguel Servet' program (CP 08/000689); VM-A is a recipient of FIS fellowship. IS-P is in receipt of career development awards from the Ramon y Cajal program funded by the Spanish Ministerio de Educacion y Ciencia. We acknowledge Leandro Sastre for helping with cTAP constructs and helpful discussions. We thank Silvia Menendez (Hospital del Mar-IMAS) and Nuria Perez-Gonzalez (Fundacion Jimenez Diaz) for the technical support. We also thank Javier Perez and Fernando Nunez (IIB) for the artwork and animal facility, respectively. This work was supported by PI05/2019, PI05/1305, PI06/1513, PI081485, PI09/1296, PS09/01285 and PS09/00472 (Spanish Health Ministry grant 'Fondo de Investigacion Sanitaria'), SAF2007-62292 (Ministerio de Educacion y Ciencia grant), SAL-0311-2006 (Comunidad Autonoma de Madrid) and RTICC 06/0020/19 grant. We especially thank Fundacio Privada Cellex (Barcelona) and Fundacion Medical Mutua Madrilena for a generous grant to the Medical Oncology Service, Hospital del Mar-IMAS and to Instituto de Investigaciones Biomedicas (IIB), respectively.	Chattopadhyay S, 2006, ONCOGENE, V25, P3335, DOI 10.1038/sj.onc.1209364; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Denkert C, 2002, INT J CANCER, V102, P507, DOI 10.1002/ijc.10746; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Downward J, 2008, NAT MED, V14, P1315, DOI 10.1038/nm1208-1315; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Espina C, 2008, AM J PATHOL, V172, P156, DOI 10.2353/ajpath.2008.070561; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; LING L, 1995, MOL CELL BIOL, V15, P6582; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Loda M, 1996, AM J PATHOL, V149, P1553; Lu X, 2010, CANCER RES, V70, P3905, DOI 10.1158/0008-5472.CAN-09-3739; Marinov M, 2009, CLIN CANCER RES, V15, P1277, DOI 10.1158/1078-0432.CCR-08-2166; Morrison DJ, 2008, MOL CANCER RES, V6, P1225, DOI 10.1158/1541-7786.MCR-08-0078; Nutt JE, 2007, BRIT J CANCER, V96, P762, DOI 10.1038/sj.bjc.6603620; Offersen BV, 2007, LUNG CANCER, V56, P43, DOI 10.1016/j.lungcan.2006.11.018; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Renyi-Vamos F, 2005, CLIN CANCER RES, V11, P7344, DOI 10.1158/1078-0432.CCR-05-1077; Rojo F, 2009, CLIN CANCER RES, V15, P3530, DOI 10.1158/1078-0432.CCR-08-2070; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Zhang SC, 2006, CLIN CANCER RES, V12, P1735, DOI 10.1158/1078-0432.CCR-05-1982	34	64	67	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	6					668	678		10.1038/onc.2010.449	http://dx.doi.org/10.1038/onc.2010.449			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	719GY	20890299				2022-12-25	WOS:000287192000004
J	Cheung, HH; Beug, ST; Jean, MS; Brewster, A; Kelly, NL; Wang, SM; Korneluk, RG				Cheung, Herman H.; Beug, Shawn T.; Jean, Martine St.; Brewster, Audrey; Kelly, N. Lynn; Wang, Shaomeng; Korneluk, Robert G.			Smac Mimetic Compounds Potentiate Interleukin-1 beta-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; TNF-ALPHA; IAP ANTAGONISTS; C-FLIP; CANCER; TUMOR; ACTIVATION; INHIBITOR; CIAP1	Smac mimetic compounds (SMCs) potentiate TNF beta-mediated cancer cell death by targeting the inhibitor of apoptosis (IAP) proteins. In addition to TNF alpha, the tumor microenvironment is exposed to a number of pro-inflammatory cytokines, including IL-1 beta. Here, we investigated the potential impact of IL-1 beta on SMC-mediated death of cancer cells. Synergy was seen in a subset of a diverse panel of 21 cancer cell lines to the combination of SMC and IL-1 beta treatment, which required IL1 beta-induced activation of the NF-kappa B pathway. Elevated NF-kappa B activity resulted in the production of TNF alpha, which led to apoptosis dependent on caspase-8 and RIP1. In addition, concurrent silencing of cIAP1, cIAP2, and X-linked IAP by siRNA was most effective for triggering IL-1 beta-mediated cell death. Importantly, SMC-resistant cells that produced TNF in response to IL-1 beta treatment were converted to an SMC-sensitive phenotype by c-FLIP knockdown. Reciprocally, ectopic expression of c-FLIP blocked cell death caused by combined SMC and IL-1 beta treatment in sensitive cancer cells. Together, our study indicates that a positive feed-forward loop by pro-inflammatory cytokines can be exploited by SMCs to induce apoptosis in cancer cells.	[Cheung, Herman H.; Beug, Shawn T.; Jean, Martine St.; Brewster, Audrey; Kelly, N. Lynn; Korneluk, Robert G.] Childrens Hosp Eastern Ontario, Res Inst, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Korneluk, Robert G.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Korneluk, Robert G.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Wang, Shaomeng] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Korneluk, RG (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Apoptosis Res Ctr, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	bob@arc.cheo.ca		Wang, Shaomeng/0000-0002-8782-6950	Canadian Institutes of Health Research; Ottawa Neuroblastoma Fund; Ottawa Regional Cancer Foundation; James Birrell Neuroblastoma Research Fund; Ontario Institute for Cancer Research (OICR); Terry Fox Research Institute; Ministry of Research and Innovation from the province of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ottawa Neuroblastoma Fund; Ottawa Regional Cancer Foundation; James Birrell Neuroblastoma Research Fund; Ontario Institute for Cancer Research (OICR); Terry Fox Research Institute; Ministry of Research and Innovation from the province of Ontario	This work was supported by Canadian Institutes of Health Research, Ottawa Neuroblastoma Fund, Ottawa Regional Cancer Foundation, James Birrell Neuroblastoma Research Fund, and joint funding from Ontario Institute for Cancer Research (OICR) and Terry Fox Research Institute. Funding for OICR is provided by the Ministry of Research and Innovation from the province of Ontario. R. G. K. is a founder and shareholder of Aegera Therapeutics Inc., which designed SMC-AEG40730. S. W. is a shareholder and consultant for Ascenta Therapeutics Inc., which has licensed technologies related to Smac mimetic compounds.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Casciano I, 2004, CELL DEATH DIFFER, V11, P131, DOI 10.1038/sj.cdd.4401327; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; Cheung HH, 2006, EXP CELL RES, V312, P2347, DOI 10.1016/j.yexcr.2006.03.027; Cheung HH, 2009, CANCER RES, V69, P7729, DOI 10.1158/0008-5472.CAN-09-1794; Cheung HH, 2001, J NEUROCHEM, V78, P524, DOI 10.1046/j.1471-4159.2001.00433.x; Dai Y, 2009, AM J TRANSL RES, V1, P1; Dai Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-392; Dineen SP, 2010, CANCER RES, V70, P2852, DOI 10.1158/0008-5472.CAN-09-3892; Flygare JA, 2010, EXPERT OPIN THER PAT, V20, P251, DOI 10.1517/13543770903567077; Foster FM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2328; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Huerta S, 2010, SURGERY, V148, P346, DOI 10.1016/j.surg.2010.05.006; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kim S, 2004, J PEDIATR SURG, V39, P509, DOI 10.1016/j.jpedsurg.2003.12.009; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lecis D, 2010, BRIT J CANCER, V102, P1707, DOI 10.1038/sj.bjc.6605687; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Ndubaku C, 2009, ACS CHEM BIOL, V4, P557, DOI 10.1021/cb900083m; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Petersen SL, 2010, P NATL ACAD SCI USA, V107, P11936, DOI 10.1073/pnas.1005667107; Probst BL, 2010, CELL DEATH DIFFER, V17, P1645, DOI 10.1038/cdd.2010.44; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; Sayers TJ, 2003, BLOOD, V102, P303, DOI 10.1182/blood-2002-09-2975; Servida F., 2010, INVEST NEW IN PRESS; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; SIZIOPIKOU KP, 1991, CANCER, V68, P1035, DOI 10.1002/1097-0142(19910901)68:5<1035::AID-CNCR2820680522>3.0.CO;2-D; Sun HY, 2007, J AM CHEM SOC, V129, P15279, DOI 10.1021/ja074725f; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2009, J BIOL CHEM, V284, P34553, DOI 10.1074/jbc.M109.040139; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	51	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40612	40623		10.1074/jbc.M110.183616	http://dx.doi.org/10.1074/jbc.M110.183616			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956527	Green Published, hybrid			2022-12-25	WOS:000285414400024
J	Hanschmann, EM; Lonn, ME; Schutte, LD; Funke, M; Godoy, JR; Eitner, S; Hudemann, C; Lillig, CH				Hanschmann, Eva-Maria; Loenn, Maria Elisabet; Schuette, Lena Dorothee; Funke, Maria; Godoy, Jose R.; Eitner, Susanne; Hudemann, Christoph; Lillig, Christopher Horst			Both Thioredoxin 2 and Glutaredoxin 2 Contribute to the Reduction of the Mitochondrial 2-Cys Peroxiredoxin Prx3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN PEROXIREDOXIN; ANTIOXIDANT DEFENSE; EXPRESSION PATTERN; IDENTIFICATION; GLUTATHIONE; THIOLTRANSFERASE; ACCUMULATION; DISULFIDE; PROTEINS; PROTECTS	The proteins from the thioredoxin family are crucial actors in redox signaling and the cellular response to oxidative stress. The major intracellular source for oxygen radicals are the components of the respiratory chain in mitochondria. Here, we show that the mitochondrial 2-Cys peroxiredoxin (Prx3) is not only substrate for thioredoxin 2 (Trx2), but can also be reduced by glutaredoxin 2 (Grx2) via the dithiol reaction mechanism. Grx2 reduces Prx3 exhibiting catalytic constants (K-m, 23.8 mu mol.liter(-1); V-max, 1.2 mu mol.(mg.min)(-1)) similar to Trx2 (K-m, 11.2 mu mol.liter(-1); V-max, 1.1 mu mol.(mg.min)(-1)). The reduction of the catalytic disulfide of the atypical 2-Cys Prx5 is limited to the Trx system. Silencing the expression of either Trx2 or Grx2 in HeLa cells using specific siRNAs did not change the monomer: dimer ratio of Prx3 detected by a specific 2-Cys Prx redox blot. Only combined silencing of the expression of both proteins led to an accumulation of oxidized protein. We further demonstrate that the distribution of Prx3 in different mouse tissues is either linked to the distribution of Trx2 or Grx2. These results introduce Grx2 as a novel electron donor for Prx3, providing further insights into pivotal cellular redox signaling mechanisms.	[Lillig, Christopher Horst] Univ Marburg, Dept Clin Cytobiol & Cytopathol, Inst Klin Zytobiol & Zytopathol, Fachbereich Med, DE-35037 Marburg, Germany	Philipps University Marburg	Lillig, CH (corresponding author), Univ Marburg, Dept Clin Cytobiol & Cytopathol, Inst Klin Zytobiol & Zytopathol, Fachbereich Med, Robert Koch Str 6, DE-35037 Marburg, Germany.	horst@lillig.de	Hanschmann, Eva-Maria/AAS-9261-2021; Godoy, Jose/ABF-3804-2020; Hudemann, Christoph/ABF-4275-2020; Lillig, Christopher Horst/AAD-7098-2019	Hudemann, Christoph/0000-0001-5807-6882; Lillig, Christopher Horst/0000-0003-2509-5117	Deutsche Forschungsgemeinschaft [SFB593-N01]; von Behring-Rontgen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); von Behring-Rontgen Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB593-N01 and by a grant from the von Behring-Rontgen Foundation.	AONBERTOLINO ML, 2010, BIOCH BIOPH IN PRESS; Araki M, 1999, J BIOL CHEM, V274, P2271, DOI 10.1074/jbc.274.4.2271; Banmeyer I, 2005, FEBS LETT, V579, P2327, DOI 10.1016/j.febslet.2005.03.027; Brehelin C, 2003, PLANT PHYSIOL, V132, P2045, DOI 10.1104/pp.103.022533; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Cox AG, 2008, FREE RADICAL BIO MED, V44, P1001, DOI 10.1016/j.freeradbiomed.2007.11.017; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; DAMMEYER P, 2010, BIOCH BIOPH IN PRESS; Essler S, 2009, FEBS LETT, V583, P3531, DOI 10.1016/j.febslet.2009.10.017; Finkemeier I, 2005, J BIOL CHEM, V280, P12168, DOI 10.1074/jbc.M413189200; Flohe L, 2010, METHOD ENZYMOL, V473, P1, DOI 10.1016/S0076-6879(10)73001-9; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Gama F, 2008, PHYSIOL PLANTARUM, V133, P599, DOI 10.1111/j.1399-3054.2008.01097.x; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; GODOY JR, 2010, BIOCH BIOPH IN PRESS; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1978, J BIOL CHEM, V253, P7424; Hudemann C, 2009, ANTIOXID REDOX SIGN, V11, P1, DOI 10.1089/ars.2008.2068; Joensson Thomas J., 2007, V44, P115; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Li LQ, 2007, BIOCHEM BIOPH RES CO, V355, P715, DOI 10.1016/j.bbrc.2007.02.022; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lonn ME, 2008, ANTIOXID REDOX SIGN, V10, P547, DOI 10.1089/ars.2007.1821; Lundberg M, 2004, BIOCHEM BIOPH RES CO, V319, P801, DOI 10.1016/j.bbrc.2004.04.199; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Park JW, 2009, J BIOL CHEM, V284, P23364, DOI 10.1074/jbc.M109.021394; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009	42	81	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40699	40705		10.1074/jbc.M110.185827	http://dx.doi.org/10.1074/jbc.M110.185827			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20929858	hybrid, Green Published			2022-12-25	WOS:000285414400033
J	Saha, PK; Reddy, VT; Konopleva, M; Andreeff, M; Chan, L				Saha, Pradip K.; Reddy, Vasumathi T.; Konopleva, Marina; Andreeff, Michael; Chan, Lawrence			The Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic-acid Methyl Ester Has Potent Anti-diabetic Effects in Diet-induced Diabetic Mice and Lepr(db/db) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; JEGHERS CANCER SYNDROME; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; INSULIN-RESISTANCE; RECEPTOR-GAMMA; 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID; SYNTHETIC TRITERPENOIDS; GLUCOSE-TRANSPORT; ENDOTHELIAL-CELLS	The triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic-acid (CDDO) and its methyl ester (CDDO-Me) are undergoing clinical trials in cancer and leukemia therapy. Here we report that CDDO-Me ameliorates diabetes in high fat diet-fed type 2 diabetic mice and in Leprdb/db mice. CDDO-Me reduces proinflammatory cytokine expression in these animals. Oral CDDO-Me administration reduces total body fat, plasma triglyceride, and free fatty acid levels. It also improves glucose tolerance and insulin tolerance tests. Its potent glucose-lowering activity results from enhanced insulin action. Hyperinsulinemic-euglycemic clamp reveals an increased glucose infusion rate required to maintain euglycemia and showed a significant increase in muscle-specific insulin-stimulated glucose uptake (71% soleus, 58% gastrocnemius) and peripheral glucose clearance as documented by a 48% increase in glucose disposal rate. CDDO-Me activates AMP-activated protein kinase (AMPK) and via LKB1 activation in muscle and liver in vivo. Treatment of isolated hepatocytes with CDDO-Me directly stimulates AMPK activity and LKB1 phosphorylation and decreases acetyl-coA carboxylase activity; it also down-regulates lipogenic gene expression, suppresses gluconeogenesis, and increases glucose uptake. Inhibition of AMPK phosphorylation using compound C and lentiviral-mediated knockdown of AMPK completely blocks the CDDO-Me-induced effect on hepatocytes as well as C2C12 cells. We conclude that the triterpenoid CDDO-Me has potent anti-diabetic action in diabetic mouse models that is mediated at least in part through AMPK activation. The in vivo anti-diabetogenic effects occur at a dose substantially lower than that used for anti-leukemia therapy. We suggest that CDDO-Me holds promise as a potential anti-diabetic agent.	[Saha, Pradip K.; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Reddy, Vasumathi T.; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Chan, Lawrence] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA; [Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chan, L (corresponding author), Baylor Coll Med, Dept Med & Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	lchan@bcm.edu	Li-Mei, Cheng/L-2214-2013		National Institutes of Health [HL51586, P30-DK079638]; Betty Rutherford Chair in Diabetes Research; St. Luke's Episcopal Hospital; T. T. & W. F. Chao Global Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Betty Rutherford Chair in Diabetes Research; St. Luke's Episcopal Hospital; T. T. & W. F. Chao Global Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL51586 (to L. C.) and P30-DK079638. This work was also supported by the Betty Rutherford Chair in Diabetes Research, St. Luke's Episcopal Hospital, and the T. T. & W. F. Chao Global Foundation. M. A. and M. K. have stocks and consulting agreements with Reata Pharmaceuticals, Inc.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; DEZUBE BJ, 2007, ANN M AACR NCI EORTC; Fujii N, 2004, P NUTR SOC, V63, P205, DOI 10.1079/PNS2004340; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Hayashi T, 1998, DIABETES, V47, pA3; HONG DS, 2008, AM SOC CLIN ONC ASCO; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HUANG MT, 1994, CANCER RES, V54, P701; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Hyer ML, 2008, CANCER RES, V68, P2927, DOI 10.1158/0008-5472.CAN-07-5759; Ikeda T, 2004, MOL CANCER THER, V3, P39, DOI 10.2463/mrms.3.39; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Koschmieder S, 2007, BLOOD, V110, P3695, DOI 10.1182/blood-2006-11-058941; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Liby K, 2008, CANCER RES, V68, P6727, DOI 10.1158/0008-5472.CAN-08-1123; Ling XY, 2007, CANCER RES, V67, P4210, DOI 10.1158/0008-5472.CAN-06-3629; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Melichar B, 2004, GYNECOL ONCOL, V93, P149, DOI 10.1016/j.ygyno.2004.01.008; NISHINO H, 1988, CANCER RES, V48, P5210; Saha PK, 2004, J BIOL CHEM, V279, P35150, DOI 10.1074/jbc.M405499200; Sakamoto K, 2005, ARTERIOSCL THROM VAS, V25, P327, DOI 10.1161/01.ATV.0000152611.50953.e2; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; SORIANO HE, 1992, TRANSPLANTATION, V54, P717, DOI 10.1097/00007890-199210000-00029; Sporn MB, 2000, CARCINOGENESIS, V21, P525, DOI 10.1093/carcin/21.3.525; Stadheim TA, 2001, CANCER RES, V61, P1533; Suh N, 1998, CANCER RES, V58, P717; Suh NJ, 1999, CANCER RES, V59, P336; Tabe Y, 2007, CANCER BIOL THER, V6, P1967, DOI 10.4161/cbt.6.12.4982; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008; YASWEN P, 1984, CANCER RES, V44, P324; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou H, 2005, BIOCHEM BIOPH RES CO, V338, P793, DOI 10.1016/j.bbrc.2005.10.007; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	62	86	103	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40581	40592		10.1074/jbc.M110.176545	http://dx.doi.org/10.1074/jbc.M110.176545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956520	Green Published, hybrid			2022-12-25	WOS:000285414400021
J	Bai, YJ; Dergham, P; Nedev, H; Xu, J; Galan, A; Rivera, JC; Shi, ZH; Mehta, HM; Woo, SB; Sarunic, MV; Neet, KE; Saragovi, HU				Bai, Yujing; Dergham, Pauline; Nedev, Hinyu; Xu, Jing; Galan, Alba; Rivera, Jose Carlos; Shi ZhiHua; Mehta, Hrishikesh M.; Woo, Sang B.; Sarunic, Marinko V.; Neet, Kenneth E.; Saragovi, H. Uri			Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective whereas p75(NTR) Activity Is Neurotoxic through a Paracrine Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; GANGLION-CELL DEATH; EXPERIMENTAL GLAUCOMA; INTRAOCULAR-PRESSURE; MOUSE MODEL; IN-VIVO; DEGENERATION; EXPRESSION; SURVIVAL; LIGANDS	In normal adult retinas, NGF receptor TrkA is expressed in retinal ganglion cells (RGC), whereas glia express p75(NTR). During retinal injury, endogenous NGF, TrkA, and p75(NTR) are up-regulated. Paradoxically, neither endogenous NGF nor exogenous administration of wild type NGF can protect degenerating RGCs, even when administered at high frequency. Here we elucidate the relative contribution of NGF and each of its receptors to RGC degeneration in vivo. During retinal degeneration due to glaucoma or optic nerve transection, treatment with a mutant NGF that only activates TrkA, or with a biological response modifier that prevents endogenous NGF and proNGF from binding to p75(NTR) affords significant neuroprotection. Treatment of normal eyes with an NGF mutant-selective p75(NTR) agonist causes progressive RGC death, and in injured eyes it accelerates RGC death. The mechanism of p75(NTR) action during retinal degeneration due to glaucoma is paracrine, by increasing production of neurotoxic proteins TNF-alpha and alpha(2)-macroglobulin. Antagonists of p75(NTR) inhibit TNF-alpha and alpha(2)-macroglobulin up-regulation during disease, and afford neuroprotection. These data reveal a balance of neuroprotective and neurotoxic mechanisms in normal and diseased retinas, and validate each neurotrophin receptor as a pharmacological target for neuroprotection.	[Bai, Yujing; Dergham, Pauline; Nedev, Hinyu; Galan, Alba; Shi ZhiHua; Saragovi, H. Uri] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Xu, Jing; Sarunic, Marinko V.] Simon Fraser Univ, Dept Engn Sci, Burnaby, BC V5A 1S6, Canada; [Rivera, Jose Carlos] Hosp St Justine, Dept Pediat & Pharmacol, Montreal, PQ H3T 1C5, Canada; [Mehta, Hrishikesh M.; Woo, Sang B.; Neet, Kenneth E.] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Chicago, IL 60064 USA; [Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3T 1E2, Canada; [Saragovi, H. Uri] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Saragovi, H. Uri] McGill Univ, Ctr Canc, Montreal, PQ H3T 1E2, Canada; [Saragovi, H. Uri] McGill Univ, Bloomfield Ctr Res Ageing, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; Simon Fraser University; Universite de Montreal; Chicago Medical School; Rosalind Franklin University Medical & Science; McGill University; McGill University; McGill University; McGill University	Saragovi, HU (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca	Mehta, Hrishikesh/K-1108-2016	Mehta, Hrishikesh/0000-0001-9140-9765; Sarunic, Marinko/0000-0002-5636-9056	United States Public Health Service, National Institutes of Health [NS24380]; Canadian Institutes of Health Research [MOP 192060]; Canadian Institutes of Health Research/Natural Sciences and Engineering Research of Canada; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024380] Funding Source: NIH RePORTER	United States Public Health Service, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research/Natural Sciences and Engineering Research of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS24380 from the United States Public Health Service (to K. E. N.), Canadian Institutes of Health Research Grant MOP 192060 (to H. U. S.), and a grant from the Canadian Institutes of Health Research/Natural Sciences and Engineering Research of Canada Collaborative Health Research Projects (to M. V. S.).	BAI Y, 2010, INVEST OPHT IN PRESS; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P4722, DOI 10.1167/iovs.09-5032; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Cui Q, 2002, INVEST OPHTH VIS SCI, V43, P1954; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P1138, DOI 10.1167/iovs.02-0553; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Hu B, 1998, GLIA, V24, P187, DOI 10.1002/(SICI)1098-1136(199810)24:2<187::AID-GLIA4>3.3.CO;2-Z; Hughes AL, 2001, J NEUROSCI RES, V63, P10, DOI 10.1002/1097-4547(20010101)63:1<10::AID-JNR2>3.0.CO;2-R; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Laquis S, 1998, BRAIN RES, V784, P100, DOI 10.1016/S0006-8993(97)01189-X; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Lebrun-Julien F, 2009, MOL CELL NEUROSCI, V40, P410, DOI 10.1016/j.mcn.2008.12.005; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Mahapatra S, 2009, J BIOL CHEM, V284, P33600, DOI 10.1074/jbc.M109.058420; Maliartchouk S, 2000, J BIOL CHEM, V275, P9946, DOI 10.1074/jbc.275.14.9946; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Quigley HA, 2005, EYE, V19, P1241, DOI 10.1038/sj.eye.6701746; Rudzinski M, 2004, J NEUROBIOL, V58, P341, DOI 10.1002/neu.10293; Ryden M., 1997, J BIOL CHEM, V272, P16322; Saragovi HU, 2009, CURR ALZHEIMER RES, V6, P419, DOI 10.2174/156720509789207912; Saragovi HU, 1998, J BIOL CHEM, V273, P34933, DOI 10.1074/jbc.273.52.34933; Scotter EL, 2008, J NEUROSCI METH, V171, P174, DOI 10.1016/j.jneumeth.2008.02.007; Shi ZH, 2008, J BIOL CHEM, V283, P29156, DOI 10.1074/jbc.M802365200; Shi Z, 2007, DEV NEUROBIOL, V67, P884, DOI 10.1002/dneu.20360; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Srinivasan B, 2004, J BIOL CHEM, V279, P41839, DOI 10.1074/jbc.M402872200; Tezel Gulgun, 2004, Curr Opin Ophthalmol, V15, P80, DOI 10.1097/00055735-200404000-00003; THANOS S, 1991, NEUROSCI LETT, V127, P108, DOI 10.1016/0304-3940(91)90906-A; Urcola JH, 2006, EXP EYE RES, V83, P429, DOI 10.1016/j.exer.2006.01.025; Wax MB, 2002, MOL NEUROBIOL, V26, P45, DOI 10.1385/MN:26:1:045	36	79	85	5	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39392	39400		10.1074/jbc.M110.147801	http://dx.doi.org/10.1074/jbc.M110.147801			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20943663	Green Published, hybrid			2022-12-25	WOS:000284941300066
J	Serpa, J; Caiado, F; Carvalho, T; Torre, C; Goncalves, LG; Casalou, C; Lamosa, P; Rodrigues, M; Zhu, ZP; Lam, EWF; Dias, S				Serpa, Jacinta; Caiado, Francisco; Carvalho, Tania; Torre, Cheila; Goncalves, Luis G.; Casalou, Cristina; Lamosa, Pedro; Rodrigues, Margarida; Zhu, Zhenping; Lam, Eric W. F.; Dias, Sergio			Butyrate-rich Colonic Microenvironment Is a Relevant Selection Factor for Metabolically Adapted Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; ENDOTHELIAL GROWTH-FACTOR; CANCER CELLS; SIGNALING PATHWAYS; COLORECTAL-CANCER; SODIUM-BUTYRATE; GENE-EXPRESSION; CARCINOMA CELLS; RAT COLON; IN-VIVO	The short chain fatty acid (SCFA) buyrate is a product of colonic fermentation of dietary fibers. It is the main source of energy for normal colonocytes, but cannot be metabolized by most tumor cells. Butyrate also functions as a histone deacetylase (HDAC) inhibitor to control cell proliferation and apoptosis. In consequence, butyrate and its derived drugs are used in cancer therapy. Here we show that aggressive tumor cells that retain the capacity of metabolizing butyrate are positively selected in their microenvironment. In the mouse xenograft model, butyrate-preselected human colon cancer cells gave rise to subcutaneous tumors that grew faster and were more angiogenic than those derived from untreated cells. Similarly, butyrate-preselected cells demonstrated a significant increase in rates of homing to the lung after intravenous injection. Our data showed that butyrate regulates the expression of VEGF and its receptor KDR at the transcriptional level potentially through FoxM1, resulting in the generation of a functional VEGF: KDR autocrine growth loop. Cells selected by chronic exposure to butyrate express higher levels of MMP2, MMP9, alpha 2 and alpha 3 integrins, and lower levels of E-cadherin, a marker for epithelial to mesenchymal transition. The orthotopic model of colon cancer showed that cells preselected by butyrate are able to colonize the animals locally and at distant organs, whereas control cells can only generate a local tumor in the cecum. Together our data shows that a butyrate-rich microenvironment may select for tumor cells that are able to metabolize butyrate, which are also phenotypically more aggressive.	[Dias, Sergio] CIPM IPOLFG, EPE, Inst Portugues Oncol Francisco Gentil, Angiogenesis Grp,Ctr Lisboa, P-1099023 Lisbon, Portugal; [Serpa, Jacinta; Caiado, Francisco; Carvalho, Tania; Torre, Cheila; Casalou, Cristina; Dias, Sergio] Inst Gulbenkian Ciencias, P-2780157 Oeiras, Portugal; [Serpa, Jacinta; Caiado, Francisco; Carvalho, Tania; Torre, Cheila; Casalou, Cristina; Dias, Sergio] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1169056 Lisbon, Portugal; [Goncalves, Luis G.; Lamosa, Pedro] Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Rodrigues, Margarida] CIPM IPOLFG, EPE, Inst Portugues Oncol Francisco Gentil, Serv Anat Patol,Ctr Lisboa, P-1099023 Lisbon, Portugal; [Zhu, Zhenping] ImClone Syst, New York, NY 10014 USA; [Lam, Eric W. F.] Canc Res UK Labs, London W12 ONN, England; [Lam, Eric W. F.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, London W12 ONN, England	Portuguese Institute of Oncology; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa; Portuguese Institute of Oncology; Eli Lilly; Cancer Research UK; Imperial College London	Dias, S (corresponding author), CIPM IPOLFG, EPE, Inst Portugues Oncol Francisco Gentil, Angiogenesis Grp,Ctr Lisboa, Rua Prof Lima Basto, P-1099023 Lisbon, Portugal.	sergidias@ipolisboa.min-saude.pt	Lam, Eric W-F/AAW-8566-2020; Serpa, Jacinta/GLV-1532-2022; /AAD-5368-2019; Serpa, Jacinta/A-4772-2013; Serpa, Jacinta/AAD-1861-2020; Carvalho, Tânia/GNM-6203-2022; Casalou, Cristina/AAU-6804-2021; Dias, Sergio/L-1250-2014; Gonçalves, Luís Gafeira/D-3683-2011; Carvalho, Tânia/X-2873-2019	Lam, Eric W-F/0000-0003-1274-3576; Serpa, Jacinta/0000-0002-1548-5907; Casalou, Cristina/0000-0003-3198-2783; Dias, Sergio/0000-0002-7603-4616; Gonçalves, Luís Gafeira/0000-0001-5683-3552; Carvalho, Tânia/0000-0002-5283-5013; Lamosa, Pedro/0000-0002-3003-1516; Cheila, Torre/0000-0001-5518-6082; Caiado, Francisco/0000-0003-4096-4448	Fundacao Luso Americana para o Desenvolvimento (FLAD); Liga Portuguesa Contra o Cancro (LPCC), Nucleo Regional Sul; Fundacao Para a Ciencia e a Tecnologia (Portuguese Government); FCT; FEDER	Fundacao Luso Americana para o Desenvolvimento (FLAD); Liga Portuguesa Contra o Cancro (LPCC), Nucleo Regional Sul; Fundacao Para a Ciencia e a Tecnologia (Portuguese Government)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission)	This work was supported in part by grants from the Fundacao Luso Americana para o Desenvolvimento (FLAD) and Liga Portuguesa Contra o Cancro (LPCC), Nucleo Regional Sul.; Supported by Fundacao Para a Ciencia e a Tecnologia (Portuguese Government) Fellowships.; We acknowledge the Servico de Anatomia Patologica, Instituto Portugues de Oncologia de Francisco Gentil, Centro de Lisboa, EPE (CIPM/IPOLFG) for the support in histological analysis. We thank Prof. Helena Santos (ITQB) for the scientific support in NMR experiments. We acknowledge the use of the NMR spectrometers at CERMAX, which are part of the National NMR Network and were acquired with funds from FCT and FEDER.	Barnett DK, 1996, DEV DYNAM, V205, P64, DOI 10.1002/(SICI)1097-0177(199601)205:1<64::AID-AJA6>3.0.CO;2-3; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Calvani M, 2008, CANCER RES, V68, P285, DOI 10.1158/0008-5472.CAN-07-5564; Chai F, 2000, CARCINOGENESIS, V21, P7, DOI 10.1093/carcin/21.1.7; Contreras HR, 2010, UROL ONCOL-SEMIN ORI, V28, P534, DOI 10.1016/j.urolonc.2009.03.018; de Silanes IL, 2004, CANCER RES, V64, P4593, DOI 10.1158/0008-5472.CAN-04-0711; Di Simone N, 2009, J CELL MOL MED, V13, P388, DOI 10.1111/j.1582-4934.2008.00337.x; Dias S, 2001, P NATL ACAD SCI USA, V98, P10857, DOI 10.1073/pnas.191117498; Dormond O, 2007, J BIOL CHEM, V282, P23679, DOI 10.1074/jbc.M700563200; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gentner B, 2009, ANTICANCER RES, V29, P67; HEERDT BG, 1994, CANCER RES, V54, P3288; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Izumi T, 2007, AM J SURG PATHOL, V31, P85, DOI 10.1097/01.pas.0000213413.33558.85; Krimi RB, 2009, DIABETES, V58, P2032, DOI 10.2337/db08-1786; Lee TK, 2007, CANCER LETT, V254, P308, DOI 10.1016/j.canlet.2007.03.017; Leng SL, 2001, CARCINOGENESIS, V22, P1625, DOI 10.1093/carcin/22.10.1625; Mariadason JM, 2001, GASTROENTEROLOGY, V120, P889, DOI 10.1053/gast.2001.22472; Medina V, 1998, JPEN-PARENTER ENTER, V22, P14, DOI 10.1177/014860719802200114; Miranda E, 2006, BRIT J CANCER, V95, P1101, DOI 10.1038/sj.bjc.6603337; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Park S, 2008, ENDOCRINOLOGY, V149, P445, DOI 10.1210/en.2007-0754; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Santos SCR, 2004, BLOOD, V103, P3883, DOI 10.1182/BLOOD-2003-05-1634; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Shi SL, 2006, WORLD J GASTROENTERO, V12, P1694, DOI 10.3748/wjg.v12.i11.1694; Struckmann K, 2008, J PATHOL, V214, P464, DOI 10.1002/path.2310; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Weigand Melanie, 2005, Angiogenesis, V8, P197, DOI 10.1007/s10456-005-9010-0; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968	33	50	50	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39211	39223		10.1074/jbc.M110.156026	http://dx.doi.org/10.1074/jbc.M110.156026			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926374	Green Published, hybrid			2022-12-25	WOS:000284941300051
J	Zucconi, BE; Ballin, JD; Brewer, BY; Ross, CR; Huang, J; Toth, EA; Wilson, GM				Zucconi, Beth E.; Ballin, Jeff D.; Brewer, Brandy Y.; Ross, Christina R.; Huang, Jun; Toth, Eric A.; Wilson, Gerald M.			Alternatively Expressed Domains of AU-rich Element RNA-binding Protein 1 (AUF1) Regulate RNA-binding Affinity, RNA-induced Protein Oligomerization, and the Local Conformation of Bound RNA Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; 3'-UNTRANSLATED REGION; FLUORESCENCE ANISOTROPY; STRANDED-DNA; STEM-LOOP; HUR; STABILITY; ISOFORMS; DESTABILIZATION; PHOSPHORYLATION	AU-rich element RNA-binding protein 1 (AUF1) binding to AU-rich elements (AREs) in the 3'-untranslated regions of mRNAs encoding many cytokines and other regulatory proteins modulates mRNA stability, thereby influencing protein expression. AUF1-mRNA association is a dynamic paradigm directed by various cellular signals, but many features of its function remain poorly described. There are four isoforms of AUF1 that result from alternative splicing of exons 2 and 7 from a common pre-mRNA. Preliminary evidence suggests that the different isoforms have varied functional characteristics, but no detailed quantitative analysis of the properties of each isoform has been reported despite their differential expression and regulation. Using purified recombinant forms of each AUF1 protein variant, we used chemical cross-linking and gel filtration chromatography to show that each exists as a dimer in solution. We then defined the association mechanisms of each AUF1 isoform for ARE-containing RNA substrates and quantified relevant binding affinities using electrophoretic mobility shift and fluorescence anisotropy assays. Although all AUF1 isoforms generated oligomeric complexes on ARE substrates by sequential dimer association, sequences encoded by exon 2 inhibited RNA-binding affinity. By contrast, the exon 7-encoded domain enhanced RNA-dependent protein oligomerization, even permitting cooperative RNA-binding activity in some contexts. Finally, fluorescence resonance energy transfer-based assays showed that the different AUF1 isoforms remodel bound RNA substrates into divergent structures as a function of protein: RNA stoichiometry. Together, these data describe isoform-specific characteristics among AUF1 ribonucleoprotein complexes, which likely constitute a mechanistic basis for differential functions and regulation among members of this protein family.	[Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wilson, GM (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	gwils001@umaryland.edu	Wilson, Gerald/AAF-3874-2019; Ballin, Jeff D/AAC-3869-2022; Ballin, Jeff/D-3752-2011	Ballin, Jeff D/0000-0002-2712-130X; Ballin, Jeff/0000-0002-2712-130X; Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health, NCI [R01 CA102428]; National Institutes of Health, NIGMS [T32 GM066706]; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA102428 from NCI (to G. M. W.).; Supported in part by National Institutes of Health Grant T32 GM066706 from NIGMS.	Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; Arao Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P228, DOI 10.1006/abbi.2000.1938; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bhattacharyya SN, 2006, COLD SPRING HARB SYM, V71, P513, DOI 10.1101/sqb.2006.71.038; Blum JL, 2005, AM J PHYSIOL-HEART C, V289, pH2543, DOI 10.1152/ajpheart.00545.2005; Bouvet P, 2001, J MOL BIOL, V309, P763, DOI 10.1006/jmbi.2001.4691; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; Brewer G, 2003, J INTERF CYTOK RES, V23, P553, DOI 10.1089/107999003322485053; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Bujalowski W., 2000, SPECTROPHOTOMETRY SP, P141; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chang N, 2010, MOL CELL BIOL, V30, P3875, DOI 10.1128/MCB.00169-10; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1994, MOL CELL BIOL, V14, P416, DOI 10.1128/MCB.14.1.416; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; DeMaria CT, 1997, J BIOL CHEM, V272, P27635, DOI 10.1074/jbc.272.44.27635; Eversole A, 2000, MOL CELL BIOL, V20, P5425, DOI 10.1128/MCB.20.15.5425-5432.2000; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fawal M, 2006, BLOOD, V108, P2780, DOI 10.1182/blood-2006-04-014902; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Glaser ND, 2006, AM J PHYSIOL-HEART C, V291, pH1183, DOI 10.1152/ajpheart.01162.2005; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Ing NH, 2008, J BIOL CHEM, V283, P1764, DOI 10.1074/jbc.M704745200; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Jezewska MJ, 1998, J MOL BIOL, V284, P1113, DOI 10.1006/jmbi.1998.2252; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Levi R, 2006, J AM SOC NEPHROL, V17, P107, DOI 10.1681/ASN.2005070679; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; LOHMAN TM, 1991, METHOD ENZYMOL, V208, P258; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Mawji IA, 2004, J BIOL CHEM, V279, P8655, DOI 10.1074/jbc.M312190200; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; Norman DG, 2000, BIOCHEMISTRY-US, V39, P6317, DOI 10.1021/bi992944a; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Pautz A, 2009, J BIOL CHEM, V284, P2755, DOI 10.1074/jbc.M809314200; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sarkar B, 2003, J BIOL CHEM, V278, P20700, DOI 10.1074/jbc.M301176200; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; WEBER G, 1952, BIOCHEM J, V51, P145, DOI 10.1042/bj0510145; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2001, J BIOL CHEM, V276, P38400, DOI 10.1074/jbc.M106509200; Wilson GM, 2005, REV FLUORESCENCE, V2, P223; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wilson GM, 1999, METHODS, V17, P74, DOI 10.1006/meth.1998.0709; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	66	51	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39127	39139		10.1074/jbc.M110.180182	http://dx.doi.org/10.1074/jbc.M110.180182			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926381	hybrid, Green Published			2022-12-25	WOS:000284941300043
J	Hu, LJ; Lind, T; Sundqvist, A; Jacobson, A; Melhus, K				Hu, Lijuan; Lind, Thomas; Sundqvist, Anders; Jacobson, Annica; Melhus, Hakan			Retinoic Acid Increases Proliferation of Human Osteoclast Progenitors and Inhibits RANKL-Stimulated Osteoclast Differentiation by Suppressing RANK	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; BONE-MINERAL DENSITY; KAPPA-B LIGAND; VITAMIN-A; ALL-TRANS; RECEPTOR ACTIVATOR; IN-VITRO; REGULATES RANKL; PRECURSOR CELLS; RESORPTION	It has been shown that high vitamin A intake is associated with bone fragility and fractures in both animals and humans. However, the mechanism by which vitamin A affects bones is unclear. In the present study, the direct effects of retinoic acid (RA) on human and murine osteoclastogenesis were evaluated using cultured peripheral blood CD14(+) monocytes and RAW264.7 cells. Both the activity of the osteoclast marker tartrate resistant acid phosphatase (TRAP) in culture supernatant and the expression of the genes involved in osteoclast differentiation together with bone resorption were measured. To our knowledge, this is the first time that the effects of RA on human osteoclast progenitors and mature osteoclasts have been studied in vitro. RA stimulated proliferation of osteoclast progenitors both from humans and mice. In contrast, RA inhibited differentiation of the receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclastogenesis of human and murine osteoclast progenitors via retinoic acid receptors (RARs). We also show that the mRNA levels of receptor activator of nuclear factor kappa B (RANK), the key initiating factor and osteoclast associated receptor for RANKL, were potently suppressed by RA in osteoclast progenitors. More importantly, RA abolished the RANK protein in osteoclast progenitors. This inhibition could be partially reversed by a RAR pan-antagonist. Furthermore, RA treatment suppressed the expression of the transcription factor nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) and increased the expression of interferon regulatory factor-8 (IRF-8) in osteoclast progenitors via RARs. Also, RA demonstrated differential effects depending on the material supporting the cell culture. RA did not affect TRAP activity in the culture supernatant in the bone slice culture system, but inhibited the release of TRAP activity if cells were cultured on plastic. In conclusion, our results suggest that retinoic acid increases proliferation of human osteoclast progenitors and that it inhibits RANK-stimulated osteoclast differentiation by suppressing RANK.	[Hu, Lijuan; Lind, Thomas; Sundqvist, Anders; Jacobson, Annica; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University	Hu, LJ (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.			Rasmusson, Annica/0000-0002-7228-7755; Lind, Thomas/0000-0003-2791-688X	Swedish Research Council; Swedish Society of Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine	This work was supported by The Swedish Research Council (HM and GA) and The Swedish Society of Medicine (TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Barnicot N, 1956, BIOCHEMISTRY PHYSIOL, P507; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Colucci S, 1996, BIOCHEM BIOPH RES CO, V227, P47, DOI 10.1006/bbrc.1996.1465; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; Conaway HH, 1997, J ENDOCRINOL, V155, P513, DOI 10.1677/joe.0.1550513; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Day CJ, 2004, J CELL BIOCHEM, V91, P303, DOI 10.1002/jcb.10780; DELVA L, 1993, BLOOD, V82, P2175; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; Ishimi Y, 1999, J CLIN BIOCHEM NUTR, V27, P113; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; KAJI H, 1995, LIFE SCI, V56, P1903, DOI 10.1016/0024-3205(95)00165-3; Karsdal MA, 2003, J BIOL CHEM, V278, P44975, DOI 10.1074/jbc.M303905200; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; KINDMARK A, 1995, CALCIFIED TISSUE INT, V57, P242, DOI 10.1007/BF00310266; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Kneissel M, 2005, BONE, V36, P202, DOI 10.1016/j.bone.2004.11.006; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lerner UH, 2004, CRIT REV ORAL BIOL M, V15, P64, DOI 10.1177/154411130401500202; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Melhus H, 2003, NUTR ASPECTS BONE HL, P369; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; MUINDI J, 1992, BLOOD, V79, P299; NAKAJIMA H, 1994, BLOOD, V84, P4107, DOI 10.1182/blood.V84.12.4107.bloodjournal84124107; Nakashima T, 2008, ARCH BIOCHEM BIOPHYS, V473, P166, DOI 10.1016/j.abb.2008.04.004; ONEILL RPJ, 1992, BONE, V13, P23, DOI 10.1016/8756-3282(92)90357-3; OREFFO ROC, 1988, J BONE MINER RES, V3, P203; Promislow JHE, 2002, J BONE MINER RES, V17, P1349, DOI 10.1359/jbmr.2002.17.8.1349; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; SANESHIGE S, 1995, BIOCHEM J, V309, P721, DOI 10.1042/bj3090721; SCHEVEN BAA, 1990, BONE, V11, P53, DOI 10.1016/8756-3282(90)90072-7; Sorensen MG, 2007, J BONE MINER METAB, V25, P36, DOI 10.1007/s00774-006-0725-9; SPORN MB, 1975, NATURE, V253, P47, DOI 10.1038/253047a0; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; WALSH CA, 1991, J BONE MINER RES, V6, P661; Wang XX, 2002, J BONE MINER RES, V17, P91, DOI 10.1359/jbmr.2002.17.1.91; WOODS C, 1995, ENDOCRINOLOGY, V136, P85, DOI 10.1210/en.136.1.85; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yonezawa T, 2007, BIOCHEM BIOPH RES CO, V355, P10, DOI 10.1016/j.bbrc.2006.12.237; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zhou DC, 2002, BLOOD, V99, P1356, DOI 10.1182/blood.V99.4.1356	50	43	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13305	10.1371/journal.pone.0013305	http://dx.doi.org/10.1371/journal.pone.0013305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949013	Green Published, Green Submitted, gold			2022-12-25	WOS:000282748100029
J	Jain, A; Fuller, S; Backus, BT				Jain, Anshul; Fuller, Stuart; Backus, Benjamin T.			Absence of Cue-Recruitment for Extrinsic Signals: Sounds, Spots, and Swirling Dots Fail to Influence Perceived 3D Rotation Direction after Training	PLOS ONE			English	Article							MOTION; INTEGRATION; PERCEPTION; STIMULI; DRIVEN; FIELD; AREA	The visual system can learn to use information in new ways to construct appearance. Thus, signals such as the location or translation direction of an ambiguously rotating wire frame cube, which are normally uninformative, can be learned as cues to determine the rotation direction [1]. This perceptual learning occurs when the formerly uninformative signal is statistically associated with long-trusted visual cues (such as binocular disparity) that disambiguate appearance during training. In previous demonstrations, the newly learned cue was intrinsic to the perceived object, in that the signal was conveyed by the same image elements as the object itself. Here we used extrinsic new signals and observed no learning. We correlated three new signals with long-trusted cues in the rotating cube paradigm: one crossmodal (an auditory signal) and two within modality (visual). Cue recruitment did not occur in any of these conditions, either in single sessions or in ten sessions across as many days. These results suggest that the intrinsic/extrinsic distinction is important for the perceptual system in determining whether it can learn and use new information from the environment to construct appearance. Extrinsic cues do have perceptual effects (e.g. the "bounce-pass'' illusion [2] and McGurk effect [3]), so we speculate that extrinsic signals must be recruited for perception, but only if certain conditions are met. These conditions might specify the age of the observer, the strength of the long-trusted cues, or the amount of exposure to the correlation.	[Jain, Anshul; Fuller, Stuart; Backus, Benjamin T.] SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10010 USA	State University of New York (SUNY) System; SUNY Optometry	Jain, A (corresponding author), SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10010 USA.	ajain@sunyopt.edu			Human Frontier Science Program [RPG 2006/3]; National Science Foundation [BCS-0617422]; National Institutes of Health [EY-013988]; NATIONAL EYE INSTITUTE [R01EY013988] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by Human Frontier Science Program grant RPG 2006/3, National Science Foundation grant BCS-0617422 and National Institutes of Health grant EY-013988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus BT, 2007, VISION RES, V47, P919, DOI 10.1016/j.visres.2006.12.008; Backus BT, 2009, J VISION, V9, DOI 10.1167/9.1.6; BRUNSWIK E, 1956, PERCEPTION REPRESENT, P92; DOSHER BA, 1986, VISION RES, V26, P973, DOI 10.1016/0042-6989(86)90154-9; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; EBY DW, 1989, PERCEPTION, V18, P427, DOI 10.1068/p180427; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; Freeman ED, 2006, VISION RES, V46, P4007, DOI 10.1016/j.visres.2006.07.008; Garcia J, 1966, PSYCHON SCI, V4, P123, DOI [10.3758/BF03342209, DOI 10.3758/BF03342209]; Geisler WS, 2002, PHILOS T R SOC B, V357, P419, DOI 10.1098/rstb.2001.1055; Georgeson MA, 2009, VISION RES, V49, P84, DOI 10.1016/j.visres.2008.09.030; Gilroy LA, 2004, NAT NEUROSCI, V7, P921, DOI 10.1038/nn1297; Harrison S, 2010, J ADVENTURE EDUC OUT, V10, P3, DOI 10.1080/14729671003669321; HARRISON SJ, 2010, VISION RES; Hebb Donald O., 1949, ORG BEHAV; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; Klink PC, 2009, J VISION, V9, DOI 10.1167/9.10.20; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; Long GM, 2007, PERCEPTION, V36, P431, DOI 10.1068/p5630; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Meyer GF, 2005, EXP BRAIN RES, V166, P538, DOI 10.1007/s00221-005-2394-7; Michel MM, 2007, J VISION, V7, DOI 10.1167/7.1.4; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Pastukhov A, 2008, J VISION, V8, DOI 10.1167/8.13.7; Pavlov I. P., 1928, LECT CONDITIONED REF; PICK HL, 1969, PERCEPT PSYCHOPHYS, V6, P203, DOI 10.3758/BF03207017; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Qi HJ, 2006, P NATL ACAD SCI USA, V103, P483, DOI 10.1073/pnas.0506728103; SAITO H, 1986, J NEUROSCI, V6, P145; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Sereno ME, 1999, J EXP PSYCHOL HUMAN, V25, P1834; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Sinha P, 1996, NATURE, V384, P460, DOI 10.1038/384460a0; Spillmann L, 1996, TRENDS NEUROSCI, V19, P428; Sundareswara R, 2008, J VISION, V8, DOI 10.1167/8.5.12; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; van der Burg E, 2008, J VISION, V8, DOI 10.1167/8.5.2; VONHELMHOLTZ H, 1910, TREATISE PHYSIOLOGIC, V3; WATANABE T, 1995, VISION RES, V35, P2853, DOI 10.1016/0042-6989(95)00064-7	43	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13295	10.1371/journal.pone.0013295	http://dx.doi.org/10.1371/journal.pone.0013295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949047	Green Submitted, gold, Green Published			2022-12-25	WOS:000282676700022
J	Konar, B; Iken, K; Cruz-Motta, JJ; Benedetti-Cecchi, L; Knowlton, A; Pohle, G; Miloslavich, P; Edwards, M; Trott, T; Kimani, E; Riosmena-Rodriguez, R; Wong, M; Jenkins, S; Silva, A; Pinto, IS; Shirayama, Y				Konar, Brenda; Iken, Katrin; Cruz-Motta, Juan Jose; Benedetti-Cecchi, Lisandro; Knowlton, Ann; Pohle, Gerhard; Miloslavich, Patricia; Edwards, Matt; Trott, Thomas; Kimani, Edward; Riosmena-Rodriguez, Rafael; Wong, Melisa; Jenkins, Stuart; Silva, Angelica; Pinto, Isabel Sousa; Shirayama, Yoshihisa			Current Patterns of Macroalgal Diversity and Biomass in Northern Hemisphere Rocky Shores	PLOS ONE			English	Article							SPECIES-DIVERSITY; ZONATION PATTERNS; PHYTOGEOGRAPHIC CHARACTERIZATION; LATITUDINAL GRADIENT; MARINE; RICHNESS; BIODIVERSITY; COMMUNITIES; ASSEMBLAGES; VARIABILITY	Latitudinal gradients in species abundance and diversity have been postulated for nearshore taxa but few analyses have been done over sufficiently broad geographic scales incorporating various nearshore depth strata to empirically test these gradients. Typically, gradients are based on literature reviews and species lists and have focused on alpha diversity across the entire nearshore zone. No studies have used a standardized protocol in the field to examine species density among sites across a large spatial scale while also focusing on particular depth strata. The present research used field collected samples in the northern hemisphere to explore the relationships between macroalgal species density and biomass along intertidal heights and subtidal depths and latitude. Results indicated no overall correlations between either estimates of species density or biomass with latitude, although the highest numbers of both were found at mid-latitudes. However, when strata were examined separately, significant positive correlations were found for both species numbers and biomass at particular strata, namely the intertidal ones. While the data presented in this paper have some limitations, we show that latitudinal macroalgal trends in species density and biomass do exist for some strata in the northern hemisphere with more taxa and biomass at higher latitudes.	[Konar, Brenda; Iken, Katrin; Knowlton, Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA; [Cruz-Motta, Juan Jose] Univ Simon Bolivar, Ctr Biodiversidad Marina, Dept Estudios Ambientales, Caracas, Venezuela; [Benedetti-Cecchi, Lisandro; Miloslavich, Patricia] Univ Pisa, Dept Biol, CoNISMa, Pisa, Italy; [Pohle, Gerhard] Huntsman Marine Sci Ctr, Atlantic Reference Ctr, St Andrews, NB, Canada; [Edwards, Matt] San Diego State Univ, Coll Sci, Dept Biol, San Diego, CA 92182 USA; [Trott, Thomas] Suffolk Univ, Dept Biol, Boston, MA 02114 USA; [Kimani, Edward] Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Riosmena-Rodriguez, Rafael] Univ Autonoma Baja California Sur, Dept Biol Marina, Programa Invest Bot Marina, La Paz, Baja California, Mexico; [Wong, Melisa; Silva, Angelica] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [Jenkins, Stuart] Bangor Univ, Sch Ocean Sci, Anglesey, Wales; [Pinto, Isabel Sousa] Univ Porto, Ctr Marine & Environm Res, CIIMAR CIMAR, P-4100 Oporto, Portugal; [Shirayama, Yoshihisa] Kyoto Univ, Seto Marine Biol Lab, Wakayama, Japan	University of Alaska System; University of Alaska Fairbanks; Simon Bolivar University; CoNISMa; University of Pisa; California State University System; San Diego State University; Suffolk University; Universidad Autonoma de Baja California; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Bangor University; Universidade do Porto; Kyoto University	Konar, B (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA.	bkonar@guru.uaf.edu	Pinto, Isabel Sousa/W-1591-2019; Trott, Thomas J/N-4660-2018; Benedetti-Cecchi, Lisandro/J-8225-2019; Silva, Angelica J/GRO-4906-2022; Jenkins, Stuart/D-2032-2010	Pinto, Isabel Sousa/0000-0002-9231-0553; Trott, Thomas J/0000-0002-1851-5243; Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Miloslavich, Patricia/0000-0001-5409-1401; Jenkins, Stuart/0000-0002-2299-6318; Cruz Motta, Juan Jose/0000-0001-6117-9014	Alfred P. Sloan Foundation; Exxon Valdez Oil Spill Gulf Ecosystem Monitoring Program; Alaska Sea Grant; South African Environmental Observation Network (SAEON); University of Pisa; Italian Ministry of Education and Research; History of Marine Populations (HMAP); Nippon Foundation; Marine Biodiversity and Ecosystem Functioning Program (MarBEF); Coastal Biodiversity Lab (Cimar); West Indian Ocean Marine Science Association (WIOMSA); Department of Fisheries and Oceans Canada; Suffolk University; History of the Near Shore (HNS) program; Gulf of Maine (GoMA) project	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Exxon Valdez Oil Spill Gulf Ecosystem Monitoring Program(Exxon Mobil Corporation); Alaska Sea Grant; South African Environmental Observation Network (SAEON)(National Research Foundation - South Africa); University of Pisa; Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR)); History of Marine Populations (HMAP); Nippon Foundation(Nippon Foundation); Marine Biodiversity and Ecosystem Functioning Program (MarBEF); Coastal Biodiversity Lab (Cimar); West Indian Ocean Marine Science Association (WIOMSA); Department of Fisheries and Oceans Canada; Suffolk University; History of the Near Shore (HNS) program; Gulf of Maine (GoMA) project	Funding was provided by multiple sources, including the Alfred P. Sloan Foundation, the Exxon Valdez Oil Spill Gulf Ecosystem Monitoring Program, Alaska Sea Grant, the South African Environmental Observation Network (SAEON), the University of Pisa, the Italian Ministry of Education and Research, the History of Marine Populations (HMAP), the Nippon Foundation, the Marine Biodiversity and Ecosystem Functioning Program (MarBEF), the Coastal Biodiversity Lab (Cimar), the West Indian Ocean Marine Science Association (WIOMSA), the Department of Fisheries and Oceans Canada, Suffolk University, the History of the Near Shore (HNS) program, and the Gulf of Maine (GoMA) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEEM AA, 1973, BOT MAR, V16, P83, DOI 10.1515/botm.1973.16.2.83; [Anonymous], 2001, PLANT STRATEGIES VEG; Arenas F, 2009, MAR ECOL PROG SER, V381, P99, DOI 10.3354/meps07950; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; BOLTON JJ, 1994, BOT MAR, V37, P241, DOI 10.1515/botm.1994.37.3.241; Bustamante RH, 1997, S AFR J MARINE SCI, V18, P119; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.1890/0012-9658(2001)082[1799:ALGIRO]2.0.CO;2; Crain CM, 2006, BIOSCIENCE, V56, P211; Engelhardt KAM, 2001, NATURE, V411, P687, DOI 10.1038/35079573; GAINES SD, 1982, ANNU REV ECOL SYST, V13, P111, DOI 10.1146/annurev.es.13.110182.000551; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GOUGH L, 1994, OIKOS, V70, P271, DOI 10.2307/3545638; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston M. A., 1994, BIOL DIVERSITY; Huston MA, 2004, DIVERS DISTRIB, V10, P167, DOI 10.1111/j.1366-9516.2004.00083.x; Ingolfsson A, 2005, J BIOGEOGR, V32, P169, DOI 10.1111/j.1365-2699.2004.01150.x; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; MARKAGER S, 1992, MAR ECOL PROG SER, V88, P83, DOI 10.3354/meps088083; Norton TA, 1996, PHYCOLOGIA, V35, P308, DOI 10.2216/i0031-8884-35-4-308.1; Okuda T, 2004, POPUL ECOL, V46, P159, DOI 10.1007/s10144-004-0185-9; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; PIELOU EC, 1977, J BIOGEOGR, V4, P299, DOI 10.2307/3038189; Price ARG, 2006, MAR ECOL PROG SER, V319, P85, DOI 10.3354/meps319085; RIGBY PR, 2007, SAMPLING DIVERSITY C; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Sanford Eric, 2009, P357; SANTELICES B, 1980, PHYCOLOGIA, V19, P1, DOI 10.2216/i0031-8884-19-1-1.1; Santelices B, 2000, REV CHIL HIST NAT, V73, P605; Santelices B, 2009, MARINE MACROECOLOGY, P153, DOI DOI 10.7208/CHICAGO/9780226904146.003.0006; SANTELICES B, 1991, ECOSYSTEMS WORLD, V24, P347; Santelices Bernabe, 1998, Diversity and Distributions, V4, P71, DOI 10.1046/j.1472-4642.1998.00005.x; Scrosati R, 2007, MAR ECOL PROG SER, V342, P1, DOI 10.3354/meps342001; Silva Paul C., 1992, Pacific Science, V46, P429; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; STEHLI FG, 1967, GEOL SOC AM BULL, V78, P455, DOI 10.1130/0016-7606(1967)78[455:TDORBA]2.0.CO;2; Thorson G., 1957, TREATISE MARINE ECOL, V67, P461, DOI DOI 10.1130/MEM67V1-P461; Valentine James W., 2009, P3; VANDENHOEK C, 1982, BIOL J LINN SOC, V18, P81; WHEELER BD, 1982, J ECOL, V70, P179, DOI 10.2307/2259872; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; Witman JD, MARINE MACROECOLOGY	52	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13195	10.1371/journal.pone.0013195	http://dx.doi.org/10.1371/journal.pone.0013195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V32LH	20949030	Green Published, gold			2022-12-25	WOS:000208952200004
J	Chuck, CP; Chong, LT; Chen, C; Chow, HF; Wan, DCC; Wong, KB				Chuck, Chi-Pang; Chong, Lin-Tat; Chen, Chao; Chow, Hak-Fun; Wan, David Chi-Cheong; Wong, Kam-Bo			Profiling of Substrate Specificity of SARS-CoV 3CL(pro)	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; CORONAVIRUS 3C-LIKE PROTEASE; MAIN PROTEASE; 3CL PROTEASE; IDENTIFICATION; INHIBITORS; PROTEINASE; SEQUENCE; MECHANISM; BINDING	Background: The 3C-like protease (3CL(pro)) of severe acute respiratory syndrome-coronavirus is required for autoprocessing of the polyprotein, and is a potential target for treating coronaviral infection. Methodology/Principal Findings: To obtain a thorough understanding of substrate specificity of the protease, a substrate library of 19 x 8 variants was created by performing saturation mutagenesis on the autocleavage sequence at P5 to P3' positions. The substrate sequences were inserted between cyan and yellow fluorescent proteins so that the cleavage rates were monitored by in vitro fluorescence resonance energy transfer. The relative cleavage rate for different substrate sequences was correlated with various structural properties. P5 and P3 positions prefer residues with high beta-sheet propensity; P4 prefers small hydrophobic residues; P2 prefers hydrophobic residues without beta-branch. Gln is the best residue at P1 position, but observable cleavage can be detected with His and Met substitutions. P1' position prefers small residues, while P2' and P3' positions have no strong preference on residue substitutions. Noteworthy, solvent exposed sites such as P5, P3 and P3' positions favour positively charged residues over negatively charged one, suggesting that electrostatic interactions may play a role in catalysis. A super-active substrate, which combined the preferred residues at P5 to P1 positions, was found to have 2.8 fold higher activity than the wild-type sequence. Conclusions/Significance: Our results demonstrated a strong structure-activity relationship between the 3CL(pro) pro and its substrate. The substrate specificity profiled in this study may provide insights into a rational design of peptidomimetic inhibitors.	[Chuck, Chi-Pang; Wan, David Chi-Cheong] Chinese Univ Hong Kong, Sch Biochem Sci, Sha Tin, Hong Kong, Peoples R China; [Chong, Lin-Tat; Wong, Kam-Bo] Chinese Univ Hong Kong, Dept Biochem, Sha Tin, Hong Kong, Peoples R China; [Chong, Lin-Tat; Wong, Kam-Bo] Chinese Univ Hong Kong, Mol Biotechnol Programme, Sha Tin, Hong Kong, Peoples R China; [Chen, Chao; Chow, Hak-Fun] Chinese Univ Hong Kong, Dept Chem, Sha Tin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chuck, CP (corresponding author), Chinese Univ Hong Kong, Sch Biochem Sci, Sha Tin, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Chow, Hak-Fun/A-9925-2008; Wong, Kam-Bo/AAU-9364-2021; Wan, David C/H-3335-2014	Wong, Kam-Bo/0000-0002-6984-5373; Chow, Hak-Fun/0000-0002-7621-0851; Wong, Kam-Bo/0000-0002-6984-5373; 	Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government [06060432]	Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government	This work was supported by the Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government (project number: 06060432) (http://www.fhb.gov.hk/grants/english/funds/funds_rfcid/funds_rfcid_abt/funds_rfcid_abt.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaji K, 2008, BIOORGAN MED CHEM, V16, P9400, DOI 10.1016/j.bmc.2008.09.057; Bacha U, 2004, BIOCHEMISTRY-US, V43, P4906, DOI 10.1021/bi0361766; Chen LL, 2005, J VIROL, V79, P7095, DOI 10.1128/JVI.79.11.7095-7103.2005; Chen S, 2005, ACTA PHARMACOL SIN, V26, P99, DOI 10.1111/j.1745-7254.2005.00010.x; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Chu LHM, 2006, PROTEIN SCI, V15, P699, DOI 10.1110/ps.052007306; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fan KQ, 2005, BIOCHEM BIOPH RES CO, V329, P934, DOI 10.1016/j.bbrc.2005.02.061; Goetz DH, 2007, BIOCHEMISTRY-US, V46, P8744, DOI 10.1021/bi0621415; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hegyi A, 2002, J GEN VIROL, V83, P595, DOI 10.1099/0022-1317-83-3-595; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Kao RY, 2004, FEBS LETT, V576, P325, DOI 10.1016/j.febslet.2004.09.026; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee S, 2008, BIOPHYS CHEM, V134, P185, DOI 10.1016/j.bpc.2008.02.009; Li SY, 2005, ANTIVIR RES, V67, P18, DOI 10.1016/j.antiviral.2005.02.007; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Phakthanakanok K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S48; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tsui SKW, 2003, NEW ENGL J MED, V349, P187, DOI 10.1056/NEJM200307103490216; Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100	26	51	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13197	10.1371/journal.pone.0013197	http://dx.doi.org/10.1371/journal.pone.0013197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949131	Green Published, gold, Green Submitted			2022-12-25	WOS:000282568400012
J	Proctor, CJ; Tangeman, PJ; Ardley, HC				Proctor, Carole J.; Tangeman, Paul J.; Ardley, Helen C.			Modelling the Role of UCH-L1 on Protein Aggregation in Age-Related Neurodegeneration	PLOS ONE			English	Article							TERMINAL HYDROLASE L1; UBIQUITIN-PROTEASOME SYSTEM; MUTANT ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; DEGRADATION; BRAIN; IMPAIRMENT; BIOLOGY; SBML	Overexpression of the de-ubiquitinating enzyme UCH-L1 leads to inclusion formation in response to proteasome impairment. These inclusions contain components of the ubiquitin-proteasome system and alpha-synuclein confirming that the ubiquitin-proteasome system plays an important role in protein aggregation. The processes involved are very complex and so we have chosen to take a systems biology approach to examine the system whereby we combine mathematical modelling with experiments in an iterative process. The experiments show that cells are very heterogeneous with respect to inclusion formation and so we use stochastic simulation. The model shows that the variability is partly due to stochastic effects but also depends on protein expression levels of UCH-L1 within cells. The model also indicates that the aggregation process can start even before any proteasome inhibition is present, but that proteasome inhibition greatly accelerates aggregation progression. This leads to less efficient protein degradation and hence more aggregation suggesting that there is a vicious cycle. However, proteasome inhibition may not necessarily be the initiating event. Our combined modelling and experimental approach show that stochastic effects play an important role in the aggregation process and could explain the variability in the age of disease onset. Furthermore, our model provides a valuable tool, as it can be easily modified and extended to incorporate new experimental data, test hypotheses and make testable predictions.	[Proctor, Carole J.] Newcastle Univ, Ctr Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tangeman, Paul J.; Ardley, Helen C.] St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds, W Yorkshire, England	Newcastle University - UK; Saint James's University Hospital; University of Leeds	Proctor, CJ (corresponding author), Newcastle Univ, Ctr Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	c.j.proctor@ncl.ac.uk		Proctor, Carole/0000-0002-1366-1399	Alzheimer Scotland; Alzheimer's Research Trust (UK) [ART/RF2008/3]; Research Councils (UK); Alzheimers Research UK [ART-RF2008-3] Funding Source: researchfish	Alzheimer Scotland; Alzheimer's Research Trust (UK); Research Councils (UK)(UK Research & Innovation (UKRI)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	CJP is currently funded by a Research Fellowship from Alzheimer Scotland (http://www.alzscot.org/) and the Alzheimer's Research Trust (UK) (http://www.alzheimers-research.org.uk/) (Grant Ref: ART/RF2008/3). HCA is currently funded by a Research Councils (UK) Academic Fellowship (http://www.rcuk.ac.uk/acfellow/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOMODELS; Ardley HC, 2004, J NEUROCHEM, V90, P379, DOI 10.1111/j.1471-4159.2004.02485.x; Ardley HC, 2005, FEBS LETT, V579, P571, DOI 10.1016/j.febslet.2004.12.058; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Cook C, 2009, BBA-MOL BASIS DIS, V1792, P664, DOI 10.1016/j.bbadis.2009.01.012; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9; DAY INM, 2001, PROGR NEURO IN PRESS; ERIKO OT, 2006, INT J CANCER, V119, P1338; Galvin JE, 2006, ACTA NEUROPATHOL, V112, P115, DOI 10.1007/s00401-006-0096-2; Gillespie CS, 2006, BIOINFORMATICS, V22, P628, DOI 10.1093/bioinformatics/btk042; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gray Douglas A, 2005, Sci Aging Knowledge Environ, V2005, pre1, DOI 10.1126/sageke.2005.5.re1; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Kirkwood TBL, 2003, NAT REV MOL CELL BIO, V4, P243, DOI 10.1038/nrm1051; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Mukaetova-Ladinska EB, 2006, MECH AGEING DEV, V127, P188, DOI 10.1016/j.mad.2005.09.014; Nishikawa K, 2003, BIOCHEM BIOPH RES CO, V304, P176, DOI 10.1016/S0006-291X(03)00555-2; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Proctor CJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-17; Ragland M, 2009, AM J EPIDEMIOL, V170, P1344, DOI 10.1093/aje/kwp288; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shoghi-Jadid K, 2005, NUCL MED BIOL, V32, P337, DOI 10.1016/j.nucmedbio.2005.02.003; Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Terman A, 1998, APMIS, V106, P265, DOI 10.1111/j.1699-0463.1998.tb01346.x; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Van Laar VS, 2009, EXP NEUROL, V218, P247, DOI 10.1016/j.expneurol.2009.03.019; Wikstrom JD, 2009, INT J BIOCHEM CELL B, V41, P1914, DOI 10.1016/j.biocel.2009.06.006; Wilkinso D.J., 2006, STOCHASTIC MODELLING; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yu J, 2008, HEPATOLOGY, V48, P508, DOI 10.1002/hep.22343	52	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13175	10.1371/journal.pone.0013175	http://dx.doi.org/10.1371/journal.pone.0013175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949132	Green Published, gold, Green Submitted			2022-12-25	WOS:000282568400007
J	Chisholm, RH; Hughes, BD; Landman, KA				Chisholm, Rebecca H.; Hughes, Barry D.; Landman, Kerry A.			Building a Morphogen Gradient without Diffusion in a Growing Tissue	PLOS ONE			English	Article							DEVELOPMENTAL BIOLOGY; PATTERN-FORMATION; DOMAIN GROWTH; CHICK-EMBRYO; SEGMENTATION; LIMB; FGF8; MECHANISM; MESODERM; DPP	In many developmental systems, spatial pattern arises from morphogen gradients, which provide positional information for cells to determine their fate. Typically, diffusion is thought to be the mechanism responsible for building a morphogen gradient. An alternative mechanism is investigated here. Using mathematical modeling, we demonstrate how a non-diffusive morphogen concentration gradient can develop in axially growing tissue systems, where growth is due to cell proliferation only. Two distinct cases are considered: in the first, all cell proliferation occurs in a localized zone where active transcription of a morphogen-producing gene occurs, and in the second, cell proliferation is uniformly distributed throughout the tissue, occurring in both the active transcription zone and beyond. A cell containing morphogen mRNA produces the morphogen protein, hence any gradient in mRNA transcripts translates into a corresponding morphogen protein gradient. Proliferation-driven growth gives rise to both advection (the transport term) and dilution (a reaction term). These two key mechanisms determine the resultant mRNA transcript distribution. Using the full range of uniform initial conditions, we show that advection and dilution due to cell proliferation are, in general, sufficient for morphogen gradient formation for both types of axially growing systems. In particular, mRNA transcript degradation is not necessary for gradient formation; it is only necessary with localized proliferation for one special value of the initial concentration. Furthermore, the morphogen concentration decreases with distance away from the transcription zone, except in the case of localized proliferation with the initial concentration sufficiently large, when the concentration can either increase with distance from the transcription zone or sustain a local minimum. In both localized and uniformly distributed proliferation, in order for a concentration gradient to form across the whole domain, transcription must occur in a zone equal to the initial domain size; otherwise, it will only form across part of the tissue.	[Chisholm, Rebecca H.; Hughes, Barry D.; Landman, Kerry A.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia	University of Melbourne	Chisholm, RH (corresponding author), Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia.	kerryl@unimelb.edu.au	Hughes, Barry Douglas/AAB-9382-2020	Hughes, Barry Douglas/0000-0003-3594-4303; Chisholm, Rebecca/0000-0002-7830-793X	Australian Research Council [DP 0878200]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (DP 0878200), http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Baker RE, 2007, J MATH BIOL, V54, P597, DOI 10.1007/s00285-006-0060-8; Baker RE, 2007, MATH BIOSCI, V209, P30, DOI 10.1016/j.mbs.2007.01.006; Bolognesi R, 2008, CURR BIOL, V18, P1624, DOI 10.1016/j.cub.2008.09.057; CHISHOLM RH, 2010, ARE CELLULAR O UNPUB; Crampin EJ, 2002, B MATH BIOL, V64, P747, DOI 10.1006/bulm.2002.0295; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dillon R, 2003, P NATL ACAD SCI USA, V100, P10152, DOI 10.1073/pnas.1830500100; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; MAYER G, 2010, LACK LOCALISE UNPUB; McDowell N, 1999, SEMIN CELL DEV BIOL, V10, P311, DOI 10.1006/scdb.1999.0307; Meinhardt H., 1982, MODELS BIOL PATTERN; Oates AC, 2009, NAT REV GENET, V10, P517, DOI 10.1038/nrg2548; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Seaver EC, 2005, EVOL DEV, V7, P312, DOI 10.1111/j.1525-142X.2005.05037.x; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; TAM PPL, 1986, NATO ASI SER, V118, P17; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Tiedemann HB, 2007, J THEOR BIOL, V248, P120, DOI 10.1016/j.jtbi.2007.05.014; Vogel A, 1996, DEVELOPMENT, V122, P1737; VOGEL A, 1993, DEVELOPMENT, V119, P199; Whitham G.B., 1974, LINEAR NONLINEAR WAV; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	33	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12857	10.1371/journal.pone.0012857	http://dx.doi.org/10.1371/journal.pone.0012857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927336	Green Published, Green Submitted, gold			2022-12-25	WOS:000282312600006
J	Ang, SF; Zhao, ZS; Lim, L; Manser, E				Ang, Su-Fen; Zhao, Zhuo-shen; Lim, Louis; Manser, Ed			DAAM1 Is a Formin Required for Centrosome Re-Orientation during Cell Migration	PLOS ONE			English	Article							GOLGI-APPARATUS; MYOSIN IIB; ACTIN CYTOSKELETON; VERTEBRATE GASTRULATION; PROTEIN DAAM1; RHO; POLARITY; CDC42; MICROTUBULES; ACTIVATION	Background: Disheveled-associated activator of morphogenesis 1 (DAAM1) is a formin acting downstream of Wnt signaling that is important for planar cell polarity. It has been shown to promote proper cell polarization during embryonic development in both Xenopus and Drosophila. Importantly, DAAM1 binds to Disheveled (Dvl) and thus functions downstream of the Frizzled receptors. Little is known of how DAAM1 is localized and functions in mammalian cells. We investigate here how DAAM1 affects migration and polarization of cultured cells and conclude that it plays a key role in centrosome polarity. Methodology/Principal Findings: Using a specific antibody to DAAM1, we find that the protein localizes to the acto-myosin system and co-localizes with ventral myosin IIB-containing actin stress fibers. These fibers are particularly evident in the sub-nuclear region. An N-terminal region of DAAM1 is responsible for this targeting and the DAAM1(1-440) protein can interact with myosin IIB fibers independently of either F-actin or RhoA binding. We also demonstrate that DAAM1 depletion inhibits Golgi reorientation in wound healing assays. Wound-edge cells exhibit multiple protrusions characteristic of unpolarized cell migration. Finally, in U2OS cells lines stably expressing DAAM1, we observe an enhanced myosin IIB stress fiber network which opposes cell migration. Conclusions/Significance: This work highlights the importance of DAAM1 in processes underlying cell polarity and suggests that it acts in part by affecting the function of acto-myosin IIB system. It also emphasizes the importance of the N-terminal half of DAAM1. DAAM1 depletion strongly blocks centrosomal re-polarization, supporting the concept that DAAM1 signaling cooperates with the established Cdc42 associated polarity complex. These findings are also consistent with the observation that ablation of myosin IIB but not myosin IIA results in polarity defects downstream of Wnt signaling. The structure-function analysis of DAAM1 in cultured cells parallels more complex morphological events in the developing embryo.	[Zhao, Zhuo-shen; Manser, Ed] ASTAR, sGSK NRP Grp, Singapore, Singapore; [Ang, Su-Fen; Manser, Ed] ASTAR, Rho GTPases Stem Cells RGS Grp, Inst Med Biol, Singapore, Singapore; [Lim, Louis] UCL, Inst Neurol, London, England	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of London; University College London	Ang, SF (corresponding author), ASTAR, Rho GTPases Stem Cells RGS Grp, Inst Med Biol, Singapore, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020	Ang, Su Fen/0000-0003-4055-3374	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Ju R, 2010, P NATL ACAD SCI USA, V107, P6906, DOI 10.1073/pnas.1001075107; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Mellor H, 2004, CURR BIOL, V14, pR434, DOI 10.1016/j.cub.2004.05.038; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rolo A, 2009, DEV BIOL, V327, P327, DOI 10.1016/j.ydbio.2008.12.009; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; SANDOVAL IV, 1984, J CELL BIOL, V99, pS113, DOI 10.1083/jcb.99.1.113s; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Skoglund P, 2008, DEVELOPMENT, V135, P2435, DOI 10.1242/dev.014704; SKOUFIAS DA, 1990, J CELL BIOL, V111, P1929, DOI 10.1083/jcb.111.5.1929; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x	50	45	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13064	10.1371/journal.pone.0013064	http://dx.doi.org/10.1371/journal.pone.0013064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927366	Green Published, Green Submitted, gold			2022-12-25	WOS:000282269400016
J	Wiltgen, BJ; Royle, GA; Gray, EE; Abdipranoto, A; Thangthaeng, N; Jacobs, N; Saab, F; Tonegawa, S; Heinemann, SF; O'Dell, TJ; Fanselow, MS; Vissel, B				Wiltgen, Brian J.; Royle, Gordon A.; Gray, Erin E.; Abdipranoto, Andrea; Thangthaeng, Nopporn; Jacobs, Nate; Saab, Faysal; Tonegawa, Susumu; Heinemann, Stephen F.; O'Dell, Thomas J.; Fanselow, Michael S.; Vissel, Bryce			A Role for Calcium-Permeable AMPA Receptors in Synaptic Plasticity and Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ANTERIOR CINGULATE CORTEX; REMOTE SPATIAL MEMORY; IN-VIVO EXPERIENCE; NMDA RECEPTOR; CONTEXTUAL FEAR; MUTANT MICE; DORSAL HIPPOCAMPUS; DIFFERENTIAL CONTRIBUTION; POSTSYNAPTIC DENSITY-95	A central concept in the field of learning and memory is that NMDARs are essential for synaptic plasticity and memory formation. Surprisingly then, multiple studies have found that behavioral experience can reduce or eliminate the contribution of these receptors to learning. The cellular mechanisms that mediate learning in the absence of NMDAR activation are currently unknown. To address this issue, we examined the contribution of Ca(2+)-permeable AMPARs to learning and plasticity in the hippocampus. Mutant mice were engineered with a conditional genetic deletion of GluR2 in the CA1 region of the hippocampus (GluR2-cKO mice). Electrophysiology experiments in these animals revealed a novel form of long-term potentiation (LTP) that was independent of NMDARs and mediated by GluR2-lacking Ca(2+)-permeable AMPARs. Behavioral analyses found that GluR2-cKO mice were impaired on multiple hippocampus-dependent learning tasks that required NMDAR activation. This suggests that AMPAR-mediated LTP interferes with NMDAR-dependent plasticity. In contrast, NMDAR-independent learning was normal in knockout mice and required the activation of Ca(2+)-permeable AMPARs. These results suggest that GluR2-lacking AMPARs play a functional and previously unidentified role in learning; they appear to mediate changes in synaptic strength that occur after plasticity has been established by NMDARs.	[Wiltgen, Brian J.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Wiltgen, Brian J.; Jacobs, Nate; Saab, Faysal; Fanselow, Michael S.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Wiltgen, Brian J.; Jacobs, Nate; Saab, Faysal; Fanselow, Michael S.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Royle, Gordon A.; Abdipranoto, Andrea; Thangthaeng, Nopporn; Vissel, Bryce] Garvan Inst Med Res, Neural Plast & Regenerat Res Grp, Neurosci Res Program, Sydney, NSW, Australia; [Gray, Erin E.] Univ Calif Los Angeles, Interdept Phd Program Neurosci, Los Angeles, CA 90024 USA; [Tonegawa, Susumu] MIT, Picower Inst Learning & Memory, Boston, MA USA; [O'Dell, Thomas J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90024 USA; [Heinemann, Stephen F.] Salk Inst Biol Studies, Dept Mol Neurobiol, La Jolla, CA USA	University of Virginia; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Garvan Institute of Medical Research; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Northwell Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Salk Institute	Wiltgen, BJ (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	brycevissel@gmail.com	Saab, Faysal/AAT-8312-2020; Wiltgen, Brian/D-2947-2013	Saab, Faysal/0000-0002-4568-3613; Jacobs, Nathan S/0000-0003-2175-6627; Vissel, Bryce/0000-0001-8860-8050	National Health and Medical Research Council Australia [188819]; NSW State Government Office of Science and Medical Research; Amadeus Energy Ltd. Western Australia; Bill and Laura Gruy; Walter and Edith Sheldon; Tony and Vivian Howland-Rose; Silvio O. Conte Center; National Institute of Mental Health [P50-MH58880, MH609197, MH62122]; National Science Foundation [0543651]; Jeffress Memorial Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062122, P50MH058880] Funding Source: NIH RePORTER	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); NSW State Government Office of Science and Medical Research; Amadeus Energy Ltd. Western Australia; Bill and Laura Gruy; Walter and Edith Sheldon; Tony and Vivian Howland-Rose; Silvio O. Conte Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); Jeffress Memorial Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by National Health and Medical Research Council Australia Grant number 188819 to B. V., NSW State Government's BioFirst Award and a NSW Spinal Cord Injury and Related Neurological Conditions Research Grant to B. V. (from the NSW State Government Office of Science and Medical Research), Amadeus Energy Ltd. Western Australia, Bill and Laura Gruy, Walter and Edith Sheldon, Tony and Vivian Howland-Rose, the Silvio O. Conte Center, National Institute of Mental Health Grant P50-MH58880 to S. T. and S. H., the National Science Foundation grant number 0543651 to T.J.O., National Institute of Mental Health grant number MH609197 to T.J.O., National Institute of Mental Health grant number MH62122 to M. S. F., the Jeffress Memorial Trust to B.J.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdipranoto-Cowley A, 2009, STEM CELLS, V27, P1330, DOI 10.1002/stem.80; Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Asrar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004339; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BILLA SK, 2010, MOL PHARM; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Buldakova SL, 2007, NEUROSCIENCE, V144, P88, DOI 10.1016/j.neuroscience.2006.09.005; Cho YH, 1999, BEHAV BRAIN RES, V98, P77; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; FANSELOW MS, 1984, BEHAV NEUROSCI, V98, P269, DOI 10.1037/0735-7044.98.2.269; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Gerlai R, 1998, BEHAV BRAIN RES, V95, P37, DOI 10.1016/S0166-4328(98)00002-3; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hardt O, 2009, LEARN MEMORY, V16, P224, DOI 10.1101/lm.1267409; Iihara K, 2001, J NEUROSCI, V21, P2224, DOI 10.1523/JNEUROSCI.21-07-02224.2001; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; JARRARD LE, 1983, BEHAV NEUROSCI, V97, P873, DOI 10.1037/0735-7044.97.6.873; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kaczmarek Leszek, 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P187; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Kullmann DM, 2008, J PHYSIOL-LONDON, V586, P1481, DOI 10.1113/jphysiol.2007.148064; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lee H, 1998, J NEUROSCI, V18, P8444; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Magazanik LG, 1997, J PHYSIOL-LONDON, V505, P655, DOI 10.1111/j.1469-7793.1997.655ba.x; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Murphy GG, 2006, AM J GERIAT PSYCHIAT, V14, P1004, DOI 10.1097/01.JGP.0000209405.27548.7b; NADEL L, 1980, BEHAV NEURAL BIOL, V29, P405, DOI 10.1016/S0163-1047(80)90430-6; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Panicker S, 2008, P NATL ACAD SCI USA, V105, P1032, DOI 10.1073/pnas.0711313105; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rudy JW, 2004, NEUROSCI BIOBEHAV R, V28, P675, DOI 10.1016/j.neubiorev.2004.09.004; Sage JR, 2000, BEHAV NEUROSCI, V114, P295, DOI 10.1037/0735-7044.114.2.295; Samoilova MV, 1999, NEUROSCIENCE, V94, P261, DOI 10.1016/S0306-4522(99)00326-7; Sanders MJ, 2003, NEUROBIOL LEARN MEM, V80, P123, DOI 10.1016/S1074-7427(03)00040-6; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Sepehrizadeh Z, 2008, CLIN EXP PHARMACOL P, V35, P1321, DOI 10.1111/j.1440-1681.2008.05004.x; Shimshek DR, 2006, J NEUROSCI, V26, P8428, DOI 10.1523/JNEUROSCI.5410-05.2006; Stote DL, 2004, BEHAV NEUROSCI, V118, P253, DOI 10.1037/0735-7044.118.1.253; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Vissel B, 2001, NEURON, V29, P217, DOI 10.1016/S0896-6273(01)00192-1; Wiltgen BJ, 2001, BEHAV NEUROSCI, V115, P26, DOI 10.1037/0735-7044.115.1.26; Yan J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0002.2002; YOUNG SL, 1994, BEHAV NEUROSCI, V108, P19, DOI 10.1037/0735-7044.108.1.19	72	78	80	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12818	10.1371/journal.pone.0012818	http://dx.doi.org/10.1371/journal.pone.0012818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927382	Green Published, Green Submitted, gold			2022-12-25	WOS:000282269400003
J	Tonino, SH; van Laar, J; van Oers, MH; Wang, JY; Eldering, E; Kater, AP				Tonino, S. H.; van Laar, J.; van Oers, M. H.; Wang, J. Y.; Eldering, E.; Kater, A. P.			ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia	ONCOGENE			English	Article						CLL; chemoresistance; p53; ROS; platinum-based compounds; Noxa	NUCLEOTIDE EXCISION-REPAIR; DNA-DAMAGE; INDUCE APOPTOSIS; PROTEASOME INHIBITOR; PROGNOSTIC MARKERS; OXIDATIVE STRESS; IN-VITRO; B-CELLS; FLUDARABINE; EXPRESSION	In recent years considerable progress has been made in treatment strategies for chronic lymphocytic leukemia (CLL). However, the disease remains incurable because of the development of chemoresistance. Strategies to overcome resistance mechanisms are therefore highly needed. At least two mechanisms contribute to the development of resistance to drugs; acquired mutations resulting in a dysfunctional p53 response and shifts in the balance between apoptosis-regulating proteins. Platinum-based compounds have been successfully applied in relapsed lymphoma and recently also in high-risk CLL. In this study we investigated the efficacy and mechanism of action of cisplatinum (CDDP) in chemorefractory CLL. Independent of p53-functional status, CDDP acted synergistically with fludarabine (F-ara-A). The response involved generation of reactive oxygen species (ROS), which led to specific upregulation of the proapoptotic BH3-only protein Noxa. Induction of Noxa resulted in cell death by apoptosis as inhibition of caspase activation completely abrogated cell death. Furthermore, drug-resistance upon CD40-ligand stimulation, a model for the protective stimuli provided in lymph nodes, could also be overcome by CDDP/F-ara-A. ROS accumulation resulted in Noxa upregulation mainly at the transcriptional level and this was, at least in part, mediated by the mitogen-activated protein kinase p38. Finally, Noxa RNA-interference markedly decreased sensitivity to CDDP/F-ara-A, supporting a key role for Noxa as mediator between ROS signaling and apoptosis induction. Our data indicate that interference in the cellular redox balance can be exploited to overcome chemoresistance in CLL. Oncogene (2011) 30, 701-713; doi:10.1038/onc.2010.441; published online 11 October 2010	[Tonino, S. H.; van Oers, M. H.; Kater, A. P.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands; [van Laar, J.; Eldering, E.] Univ Amsterdam, Acad Med Ctr, Expt Immunol Lab, NL-1105 AZ Amsterdam, Netherlands; [Wang, J. Y.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Wang, J. Y.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California San Diego; University of California System; University of California San Diego	Kater, AP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Hematol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.p.kater@amc.nl			Netherlands Organization for Health Research and Development; NATIONAL CANCER INSTITUTE [R01CA043054] Funding Source: NIH RePORTER	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M Baou and GM Cohen of the MRC Toxicology Unit, University of Leicester, United Kingdom for sharing their experience with nucleofection-procedures. APK is personally supported by a 'Veni' grant from the Netherlands Organization for Health Research and Development.	AKABOSHI M, 1994, JPN J CANCER RES, V85, P106, DOI 10.1111/j.1349-7006.1994.tb02893.x; Ali MS, 2005, J INORG BIOCHEM, V99, P795, DOI 10.1016/j.jinorgbio.2004.12.015; Baou M, 2010, HAEMATOL-HEMATOL J, V95, P1510, DOI 10.3324/haematol.2010.022368; Bhalla S, 2009, CLIN CANCER RES, V15, P3354, DOI 10.1158/1078-0432.CCR-08-2365; Bouzar AB, 2009, BRIT J HAEMATOL, V144, P41, DOI 10.1111/j.1365-2141.2008.07426.x; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; Deriano L, 2005, BLOOD, V105, P4776, DOI 10.1182/blood-2004-07-2888; Dicker F, 2006, BLOOD, V108, P3450, DOI 10.1182/blood-2006-04-017749; Flinterman M, 2005, J BIOL CHEM, V280, P5945, DOI 10.1074/jbc.M406661200; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Garrido N, 2008, BIOCHEM J, V414, P93, DOI 10.1042/BJ20071615; GELEZIUNAS R, 1991, J NATL CANCER I, V83, P557, DOI 10.1093/jnci/83.8.557; Gong JG, 1999, NATURE, V399, P806; Hagrman D, 2004, J PHARMACOL EXP THER, V308, P658, DOI 10.1124/jpet.103.059410; Hallaert DYH, 2008, BLOOD, V112, P5141, DOI 10.1182/blood-2008-03-146704; Husain K, 1998, MOL CELL BIOCHEM, V178, P127, DOI 10.1023/A:1006889427520; Kater AP, 2004, BRIT J HAEMATOL, V127, P404, DOI 10.1111/j.1365-2141.2004.05225.x; Kater AP, 2010, CL LYMPH MYELOM LEUK, V10, pS34, DOI 10.3816/CLML.2010.s.005; Li L, 1997, CANCER RES, V57, P1487; Mackus WJM, 2005, LEUKEMIA, V19, P427, DOI 10.1038/sj.leu.2403623; Maggio SC, 2004, CANCER RES, V64, P2590, DOI 10.1158/0008-5472.CAN-03-2631; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Miller CP, 2009, BLOOD, V113, P4289, DOI 10.1182/blood-2008-08-174797; Monjanel-Mouterde S, 2003, J CLIN PHARM THER, V28, P109, DOI 10.1046/j.1365-2710.2003.00468.x; Morales AA, 2005, INT J CANCER, V113, P730, DOI 10.1002/ijc.20614; Moufarij MA, 2006, BLOOD, V108, P4187, DOI 10.1182/blood-2006-05-023259; Mous R, 2009, LEUKEMIA, V23, P1352, DOI 10.1038/leu.2009.71; Nys K, 2010, J INVEST DERMATOL, V130, P2269, DOI 10.1038/jid.2010.93; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oltra AM, 2001, FREE RADICAL BIO MED, V30, P1286, DOI 10.1016/S0891-5849(01)00521-4; Pedersen IM, 2004, LEUKEMIA LYMPHOMA, V45, P2365, DOI 10.1080/10428190412331272703; Pepper C, 2008, BLOOD, V112, P3807, DOI 10.1182/blood-2008-05-157131; Pettitt AR, 2003, BRIT J HAEMATOL, V121, P692, DOI 10.1046/j.1365-2141.2003.04336.x; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rosato RR, 2008, MOL CANCER THER, V7, P3285, DOI 10.1158/1535-7163.MCT-08-0385; Rosenwald A, 2004, BLOOD, V104, P1428, DOI 10.1182/blood-2003-09-3236; Roue G, 2008, CLIN CANCER RES, V14, P6907, DOI 10.1158/1078-0432.CCR-08-0388; SEYMOUR JF, 1995, LEUKEMIA LYMPHOMA, V18, P493, DOI 10.3109/10428199509059650; Smit LA, 2007, BLOOD, V109, P1660, DOI 10.1182/blood-2006-05-021683; SPITZ DR, 1993, J CELL PHYSIOL, V156, P72, DOI 10.1002/jcp.1041560111; Tonino SH, 2010, LEUKEMIA, V24, P652, DOI 10.1038/leu.2009.240; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Tsimberidou AM, 2008, J CLIN ONCOL, V26, P196, DOI 10.1200/JCO.2007.11.8513; Van Bockstaele F, 2009, BLOOD REV, V23, P25, DOI 10.1016/j.blre.2008.05.003; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Witte AB, 2005, FREE RADICAL BIO MED, V39, P696, DOI 10.1016/j.freeradbiomed.2005.04.025; Zenz T, 2008, BLOOD, V112, P3322, DOI 10.1182/blood-2008-04-154070; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512	51	39	39	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2011	30	6					701	713		10.1038/onc.2010.441	http://dx.doi.org/10.1038/onc.2010.441			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	719GY	20935673	Green Accepted			2022-12-25	WOS:000287192000007
J	Yoshioka, M; Nakayama, Y; Yoshida, M; Ohashi, K; Morita, N; Kobayashi, H; Yamamoto, Y				Yoshioka, Miho; Nakayama, Yosuke; Yoshida, Mari; Ohashi, Kensuke; Morita, Noriko; Kobayashi, Hideki; Yamamoto, Yasusi			Quality Control of Photosystem II FtsH HEXAMERS ARE LOCALIZED NEAR PHOTOSYSTEM II AT GRANA FOR THE SWIFT REPAIR OF DAMAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; DEPENDENT PROTEASE FTSH; THYLAKOID MEMBRANES; METALLOPROTEASE FTSH; CHLOROPLASTIC FTSH; CRYSTAL-STRUCTURE; LEAF VARIEGATION; OXYGEN EVOLUTION; HIGHER-PLANTS; SPINACH	The reaction center-binding D1 protein of Photosystem II is oxidatively damaged by excessive visible light or moderate heat stress. The metalloprotease FtsH has been suggested as responsible for the degradation of the D1 protein. We have analyzed the distribution and subunit structures of FtsH in spinach thylakoids and various membrane fractions derived from the thylakoids using clear native polyacrylamide gel electrophoresis and Western blot analysis. FtsH was found not only in the stroma thylakoids but also in the Photosystem II-enriched grana membranes. Monomeric, dimeric, and hexameric FtsH proteases were present as major subunit structures in thylakoids, whereas only hexameric FtsH proteases were detected in Triton X-100-solubilized Photosystem II membranes. Importantly, among the membrane fractions examined, hexameric FtsH proteases were most abundant in the Photosystem II membranes. In accordance with this finding, D1 degradation took place in the Photosystem II membranes under light stress. Sucrose density gradient centrifugation analysis of thylakoids and the Photosystem II membranes solubilized with n-dodecyl-beta-D-maltoside and a chemical cross-linking study of thylakoids showed localization of FtsH near the Photosystem II light-harvesting chlorophyll-protein super-complexes in the grana. These results suggest that part of the FtsH hexamers are juxtapositioned to PSII complexes in the grana in darkness, carrying out immediate degradation of the photodamaged D1 protein under light stress.	[Yamamoto, Yasusi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Kobayashi, Hideki] Okayama Univ, Ctr Fac Dev, Okayama 7008530, Japan	Okayama University; Okayama University	Yamamoto, Y (corresponding author), 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	yasusiya@cc.okayama-u.ac.jp	Yamamoto, Yasusi/B-2637-2011; Yoshioka-Nishimura, Miho/C-2745-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan [20570039]; Wesco Science Promotion Foundation; Ryobi Foundation; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Wesco Science Promotion Foundation; Ryobi Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research Number 20570039 from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Wesco Science Promotion Foundation, and the Ryobi Foundation (to Y.Y.). Support also comes from Japan Society for the Promotion of Science Research Fellowships for Young Scientists (to Miho Yoshioka).	Adam Z, 2002, TRENDS PLANT SCI, V7, P451, DOI 10.1016/S1360-1385(02)02326-9; Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Albertsson PA, 2001, TRENDS PLANT SCI, V6, P349, DOI 10.1016/S1360-1385(01)02021-0; Andersson B, 1997, PHYSIOL PLANTARUM, V100, P780, DOI 10.1034/j.1399-3054.1997.1000405.x; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Arvidsson PO, 1999, AUST J PLANT PHYSIOL, V26, P687, DOI 10.1071/PP99072; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; DUNAHAY TG, 1984, BIOCHIM BIOPHYS ACTA, V764, P179, DOI 10.1016/0005-2728(84)90027-6; ENAMI I, 1989, BIOCHIM BIOPHYS ACTA, V977, P33, DOI 10.1016/S0005-2728(89)80006-4; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Khatoon M, 2009, J BIOL CHEM, V284, P25343, DOI 10.1074/jbc.M109.007740; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; KUWABARA T, 1982, PLANT CELL PHYSIOL, V23, P533, DOI 10.1093/oxfordjournals.pcp.a076378; LETO KJ, 1985, EMBO J, V4, P1645, DOI 10.1002/j.1460-2075.1985.tb03832.x; Lindahl M, 1996, J BIOL CHEM, V271, P29329, DOI 10.1074/jbc.271.46.29329; Mullineaux CW, 2008, PHOTOCHEM PHOTOBIOL, V84, P1310, DOI 10.1111/j.1751-1097.2008.00420.x; Mustardy L, 2003, TRENDS PLANT SCI, V8, P117, DOI 10.1016/S1360-1385(03)00015-3; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Packer L, 1972, Methods Enzymol, V24, P181; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Sakamoto W, 2002, GENES CELLS, V7, P769, DOI 10.1046/j.1365-2443.2002.00558.x; SALTER AH, 1992, BIOCHEMISTRY-US, V31, P3990, DOI 10.1021/bi00131a014; Shimoni E, 2005, PLANT CELL, V17, P2580, DOI 10.1105/tpc.105.035030; SHIPTON CA, 1991, P NATL ACAD SCI USA, V88, P6691, DOI 10.1073/pnas.88.15.6691; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Sinvany-Villalobo G, 2004, PLANT PHYSIOL, V135, P1336, DOI 10.1104/pp.104.043299; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Yamamoto Y, 2004, METH MOL B, V274, P29; Yamamoto Y, 2004, METH MOL B, V274, P217; YAMAMOTO Y, 1982, BIOCHIM BIOPHYS ACTA, V679, P347, DOI 10.1016/0005-2728(82)90306-1; YAMAMOTO Y, 1981, FEBS LETT, V133, P265, DOI 10.1016/0014-5793(81)80520-0; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071	45	37	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41972	41981		10.1074/jbc.M110.117432	http://dx.doi.org/10.1074/jbc.M110.117432			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20921219	Green Published, hybrid			2022-12-25	WOS:000285622600083
J	Altun, M; Besche, HC; Overkleeft, HS; Piccirillo, R; Edelmann, MJ; Kessler, BM; Goldberg, AL; Ulfhake, B				Altun, Mikael; Besche, Henrike C.; Overkleeft, Herman S.; Piccirillo, Rosanna; Edelmann, Mariola J.; Kessler, Benedikt M.; Goldberg, Alfred L.; Ulfhake, Brun			Muscle Wasting in Aged, Sarcopenic Rats Is Associated with Enhanced Activity of the Ubiquitin Proteasome Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S-PROTEASOME; SKELETAL-MUSCLE; PROTEIN-DEGRADATION; HEAT-SHOCK; ATROPHY INVOLVE; GENE-EXPRESSION; DISEASE; LIGASE; PROTEOLYSIS; RESTRICTION	Among the hallmarks of aged organisms are an accumulation of misfolded proteins and a reduction in skeletal muscle mass ("sarcopenia"). We have examined the effects of aging and dietary restriction (which retards many age-related changes) on components of the ubiquitin proteasome system (UPS) in muscle. The hindlimb muscles of aged (30 months old) rats showed a marked loss of muscle mass and contained 2-3-fold higher levels of 26S proteasomes than those of adult (4 months old) controls. 26S proteasomes purified from muscles of aged and adult rats showed a similar capacity to degrade peptides, proteins, and an ubiquitylated substrate, but differed in levels of proteasome-associated proteins (e. g. the ubiquitin ligase E6AP and deubiquitylating enzyme USP14). Also, the activities of many other deubiquitylating enzymes were greatly enhanced in the aged muscles. Nevertheless, their content of polyubiquitylated proteins was higher than in adult animals. The aged muscles contained higher levels of the ubiquitin ligase CHIP, involved in eliminating misfolded proteins, and MuRF1, which ubiquitylates myofibrillar proteins. These muscles differed from ones rapidly atrophying due to disease, fasting, or disuse in that Atrogin-1/MAFbx expression was low and not inducible by glucocorticoids. Thus, the muscles of aged rats showed many adaptations indicating enhanced proteolysis by the UPS, which may enhance their capacity to eliminate misfolded proteins and seems to contribute to the sarcopenia. Accordingly, dietary restriction decreased or prevented the aging-associated increases in proteasomes and other UPS components and reduced muscle wasting.	[Altun, Mikael; Ulfhake, Brun] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Altun, Mikael; Edelmann, Mariola J.; Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Med, Oxford OX3 7BN, England; [Besche, Henrike C.; Piccirillo, Rosanna; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Overkleeft, Herman S.] Leiden Univ, Leiden Inst Chem, Gorlaeaus Labs, NL-2333 CC Leiden, Netherlands	Karolinska Institutet; University of Oxford; Harvard University; Harvard Medical School; Leiden University; Leiden University - Excl LUMC	Altun, M (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	mikael.altun@ki.se	Ulfhake, Brun/AAG-8969-2020; Piccirillo, Rosanna/K-6619-2016; Altun, Mikael/AAF-5496-2020; Piccirillo, Rosanna/AAQ-3653-2020; Altun, Mikael/AAI-9527-2020; Kessler, Benedikt/AAY-8614-2021	Piccirillo, Rosanna/0000-0002-1613-9352; Piccirillo, Rosanna/0000-0002-1613-9352; Altun, Mikael/0000-0002-6937-6124; Kessler, Benedikt/0000-0002-8160-2446; Ulfhake, Brun/0000-0001-5037-7461; Besche, Henrike/0000-0002-9841-9218; Edelmann, Mariola/0000-0003-0459-7716; Overkleeft, Herman/0000-0001-6976-7005	NIGMS [GM51923]; NIA [AR055255]; Ellison Foundation; Swedish MRC [10800]; M & M Wallenbergs Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER; Medical Research Council [G0501068] Funding Source: researchfish; MRC [G0501068] Funding Source: UKRI	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Foundation(Lawrence Ellison Foundation); Swedish MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); M & M Wallenbergs Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51923 from the NIGMS and AR055255 from the NIA (to H. C. B. and A. L. G.), grants from the Ellison Foundation (to H. C. B. and A. L. G.), the Swedish MRC Project 10800 and the M & M Wallenbergs Foundation (to B. U.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Altun M, 2007, PHYSIOL BEHAV, V92, P911, DOI 10.1016/j.physbeh.2007.06.017; Altun M, 2007, MUSCLE NERVE, V36, P223, DOI 10.1002/mus.20808; Attaix D, 2005, INT J BIOCHEM CELL B, V37, P1962, DOI 10.1016/j.biocel.2005.04.009; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Bardag-Gorce F, 1999, MOL BIOL REP, V26, P89, DOI 10.1023/A:1006968208077; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663; Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4; Cai DQ, 2004, ARCH BIOCHEM BIOPHYS, V425, P42, DOI 10.1016/j.abb.2004.02.027; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Clavel S, 2006, MECH AGEING DEV, V127, P794, DOI 10.1016/j.mad.2006.07.005; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; DARDEVET D, 1995, J CLIN INVEST, V96, P2113, DOI 10.1172/JCI118264; Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003; Edstrom E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x; Edstrom E, 2006, J GERONTOL A-BIOL, V61, P663, DOI 10.1093/gerona/61.7.663; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; GOFF SA, 1985, CELL, V41, P587, DOI 10.1016/S0092-8674(85)80031-3; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Goto S, 2001, ANN NY ACAD SCI, V928, P54; Grune T, 2001, J GERONTOL A-BIOL, V56, pB459, DOI 10.1093/gerona/56.11.B459; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6; Hepple RT, 2008, AM J PHYSIOL-REG I, V295, pR1231, DOI 10.1152/ajpregu.90478.2008; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Husom AD, 2004, ARCH BIOCHEM BIOPHYS, V421, P67, DOI 10.1016/j.abb.2003.10.010; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Kessler BM, 2001, CHEM BIOL, V8, P913, DOI 10.1016/S1074-5521(01)00069-2; Kim JY, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/5/055027; Kimura Y, 2009, CELL, V137, P549, DOI 10.1016/j.cell.2009.02.028; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Lam YA, 2005, METHOD ENZYMOL, V398, P379, DOI 10.1016/S0076-6879(05)98031-2; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Pattison JS, 2003, PHYSIOL GENOMICS, V15, P34, DOI 10.1152/physiolgenomics.00040.2003; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Selsby JT, 2005, EXP GERONTOL, V40, P37, DOI 10.1016/j.exger.2004.08.012; Solomon V, 1998, P NATL ACAD SCI USA, V95, P12602, DOI 10.1073/pnas.95.21.12602; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; WELLE S, 1993, AM J PHYSIOL, V264, pE693, DOI 10.1152/ajpendo.1993.264.5.E693; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Zeng BY, 2005, MECH AGEING DEV, V126, P760, DOI 10.1016/j.mad.2005.01.008; Zhang L, 2007, FEBS LETT, V581, P5543, DOI 10.1016/j.febslet.2007.10.054; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	85	153	161	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39597	39608		10.1074/jbc.M110.129718	http://dx.doi.org/10.1074/jbc.M110.129718			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940294	Green Published, hybrid			2022-12-25	WOS:000285185500004
J	Azimi, I; Matthias, LJ; Center, RJ; Wong, JWH; Hogg, PJ				Azimi, Iman; Matthias, Lisa J.; Center, Rob J.; Wong, Jason W. H.; Hogg, Philip J.			Disulfide Bond That Constrains the HIV-1 gp120 V3 Domain Is Cleaved by Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE GLYCOPROTEIN; CD4 RECEPTOR; REDUCTION; ISOMERASE; CORECEPTOR; BINDING; REDOX; ASSOCIATION; INHIBITION; PROTEINS	A functional disulfide bond in both the HIV envelope glycoprotein, gp120, and its immune cell receptor, CD4, is involved in viral entry, and compounds that block cleavage of the disulfide bond in these proteins inhibit HIV entry and infection. The disulfide bonds in both proteins are cleaved at the cell surface by the small redox protein, thioredoxin. The target gp120 disulfide and its mechanism of cleavage were determined using a thioredoxin kinetic trapping mutant and mass spectrometry. A single disulfide bond was cleaved in isolated and cell surface gp120, but not the gp160 precursor, and the extent of the reaction was enhanced when gp120 was bound to CD4. The Cys(32) sulfur ion of thioredoxin attacks the Cys(296) sulfur ion of the gp120 V3 domain Cys(296)-Cys(331) disulfide bond, cleaving the bond. Considering that V3 sequences largely determine the chemokine receptor preference of HIV, we propose that cleavage of the V3 domain disulfide, which is facilitated by CD4 binding, regulates chemokine receptor binding. There are 20 possible disulfide bond configurations, and, notably, the V3 domain disulfide has the same unusual -RHStaple configuration as the functional disulfide bond cleaved in CD4.	[Azimi, Iman; Matthias, Lisa J.; Wong, Jason W. H.; Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Azimi, Iman; Matthias, Lisa J.; Wong, Jason W. H.; Hogg, Philip J.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [Center, Rob J.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Melbourne	Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Level 2, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Azimi, Iman/E-2043-2011; Wong, Jason/A-9466-2008	Azimi, Iman/0000-0001-9477-9999; Wong, Jason/0000-0003-2953-7728; Hogg, Philip/0000-0001-6486-2863	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia and the Australian Research Council.	Auwerx J, 2009, INT J BIOCHEM CELL B, V41, P1269, DOI 10.1016/j.biocel.2008.10.031; AZIMI I, 2010, ANTIOX REDO IN PRESS; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Billington J, 2007, J VIROL, V81, P4604, DOI 10.1128/JVI.02138-06; Bourgeois R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-31; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Einfeld D, 1996, CURR TOP MICROBIOL, V214, P133; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gopalan G, 2004, P NATL ACAD SCI USA, V101, P13945, DOI 10.1073/pnas.0405240101; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Sanejouand YH, 2004, PROTEINS, V57, P205, DOI 10.1002/prot.20197; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwertassek U., 2007, SCI STKE, pl8; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Stathakis P, 1999, J BIOL CHEM, V274, P8910, DOI 10.1074/jbc.274.13.8910; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wouters MA, 2004, BIOESSAYS, V26, P73, DOI 10.1002/bies.10413	37	29	30	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40072	40080		10.1074/jbc.M110.185371	http://dx.doi.org/10.1074/jbc.M110.185371			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20943653	hybrid, Green Published			2022-12-25	WOS:000285185500052
J	Finkelstein, M; Etkovitz, N; Breitbart, H				Finkelstein, Maya; Etkovitz, Nir; Breitbart, Haim			Role and Regulation of Sperm Gelsolin Prior to Fertilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN; PHOSPHOLIPASE-C; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TYROSINE PHOSPHORYLATION; CYTOSKELETAL CALYX; MOUSE SPERM; CAPACITATION; SRC; FILAMENTS; IDENTIFICATION	To acquire fertilization competence, spermatozoa should undergo several biochemical changes in the female reproductive tract, known as capacitation. The capacitated spermatozoon can interact with the egg zona pellucida resulting in the occurrence of the acrosome reaction, a process that allowed its penetration into the egg and fertilization. Sperm capacitation requires actin polymerization, whereas F-actin must disperse prior to the acrosome reaction. Here, we suggest that the actin-severing protein, gelsolin, is inactive during capacitation and is activated prior to the acrosome reaction. The release of bound gelsolin from phosphatidylinositol 4,5-bisphosphate (PIP2) by PBP10, a peptide containing the PIP2-binding domain of gelsolin, or by activation of phospholipase C, which hydrolyzes PIP2, caused rapid Ca2+-dependent F-actin depolymerization as well as enhanced acrosome reaction. Using immunoprecipitation assays, we showed that the tyrosine kinase SRC and gelsolin coimmunoprecipitate, and activating SRC by adding 8-bromo-cAMP (8-Br-cAMP) enhanced the amount of gelsolin in this precipitate. Moreover, 8-Br-cAMP enhanced tyrosine phosphorylation of gelsolin and its binding to PIP2(4,5), both of which inactivated gelsolin, allowing actin polymerization during capacitation. This actin polymerization was blocked by inhibiting the Src family kinases, suggesting that gelsolin is activated under these conditions. These results are further supported by our finding that PBP10 was unable to cause complete F-actin breakdown in the presence of 8-Br-cAMP or vanadate. In conclusion, inactivation of gelsolin during capacitation occurs by its binding to PIP2 and tyrosine phosphorylation by SRC. The release of gelsolin from PIP2 together with its dephosphorylation enables gelsolin activation, resulting in the acrosome reaction.	[Finkelstein, Maya; Etkovitz, Nir; Breitbart, Haim] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel	Bar Ilan University	Breitbart, H (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	breith@mail.biu.ac.il						Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Baldi E, 2002, J REPROD IMMUNOL, V53, P121, DOI 10.1016/S0165-0378(01)00089-4; BANNO Y, 1992, J BIOL CHEM, V267, P6488; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitbart H, 2005, REPRODUCTION, V129, P263, DOI 10.1530/rep.1.00269; Breitbart H, 2003, CELL MOL BIOL, V49, P321; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; Cabello-Agueros JF, 2003, CELL MOTIL CYTOSKEL, V56, P94, DOI 10.1002/cm.10135; Cheng J, 1997, J BIOL CHEM, V272, P17312, DOI 10.1074/jbc.272.28.17312; Cohen G, 2004, DEV BIOL, V267, P230, DOI 10.1016/j.ydbio.2003.10.034; Cunningham CC, 2001, J BIOL CHEM, V276, P43390, DOI 10.1074/jbc.M105289200; De Corte V, 1999, PROTEIN SCI, V8, P234; DeCorte V, 1997, FEBS LETT, V401, P191, DOI 10.1016/S0014-5793(96)01471-8; delasHeras MA, 1997, TISSUE CELL, V29, P47, DOI 10.1016/S0040-8166(97)80071-7; Etkovitz N, 2007, BIOL REPROD, V77, P263, DOI 10.1095/biolreprod.106.056705; Etkovitz N, 2009, DEV BIOL, V334, P447, DOI 10.1016/j.ydbio.2009.08.002; Gremm D, 2000, EUR J BIOCHEM, V267, P4339, DOI 10.1046/j.1432-1327.2000.01463.x; Guttman JA, 2002, J CELL SCI, V115, P499; Heid HW, 2002, EXP CELL RES, V279, P177, DOI 10.1006/excr.2002.5603; Howes EA, 2001, J ANDROL, V22, P62; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Kinosian HJ, 1998, BIOPHYS J, V75, P3101, DOI 10.1016/S0006-3495(98)77751-3; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; Lawson C, 2008, BIOL REPROD, V79, P657, DOI 10.1095/biolreprod.108.070367; LAX Y, 1994, FEBS LETT, V339, P234, DOI 10.1016/0014-5793(94)80422-2; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; Mitchell LA, 2008, MOL HUM REPROD, V14, P235, DOI 10.1093/molehr/gan007; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Pelletier RM, 1999, BIOL REPROD, V60, P1128, DOI 10.1095/biolreprod60.5.1128; SPUNGIN B, 1995, J CELL SCI, V108, P2525; Steed PM, 1996, BIOCHEMISTRY-US, V35, P5229, DOI 10.1021/bi952370j; Sun HQ, 1997, J CELL BIOL, V138, P811, DOI 10.1083/jcb.138.4.811; TANAKA H, 1994, FEBS LETT, V355, P4, DOI 10.1016/0014-5793(94)01155-9; Varano G, 2008, HUM REPROD, V23, P2652, DOI 10.1093/humrep/den314; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VONBULOW M, 1995, EXP CELL RES, V219, P407, DOI 10.1006/excr.1995.1246; vonBulow M, 1997, EXP CELL RES, V233, P216, DOI 10.1006/excr.1997.3564; YIN HL, 1980, J BIOL CHEM, V255, P9494; YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409	42	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39702	39709		10.1074/jbc.M110.170951	http://dx.doi.org/10.1074/jbc.M110.170951			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937821	Green Published, hybrid			2022-12-25	WOS:000285185500014
J	Katsoulidis, E; Mavrommatis, E; Woodard, J; Shields, MA; Sassano, A; Carayol, N; Sawicki, KT; Munshi, HG; Platanias, LC				Katsoulidis, Efstratios; Mavrommatis, Evangelos; Woodard, Jennifer; Shields, Mario A.; Sassano, Antonella; Carayol, Nathalie; Sawicki, Konrad T.; Munshi, Hidayatullah G.; Platanias, Leonidas C.			Role of Interferon alpha (IFN alpha)-inducible Schlafen-5 in Regulation of Anchorage-independent Growth and Invasion of Malignant Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HISTONE DEACETYLASE ACTIVITY; STIMULATED GENE-EXPRESSION; MESSENGER-RNA TRANSLATION; HIGH-RISK MELANOMA; DELTA PKC-DELTA; P70 S6 KINASE; I INTERFERONS; IFN-ALPHA; T-CELLS	IFN alpha exerts potent inhibitory activities against malignant melanoma cells in vitro and in vivo, but the mechanisms by which it generates its antitumor effects remain unknown. We examined the effects of interferon alpha(IFN alpha) on the expression of human members of the Schlafen (SLFN) family of genes, a group of cell cycle regulators that mediate growth-inhibitory responses. Using quantitative RT-real time PCR, we found detectable basal expression of all the different human SLFN genes examined (SLFN5, SLFN11, SLFN12, SLFN13, and SLFN14), in malignant melanoma cells and primary normal human melanocytes, but SLFN5 basal expression was suppressed in all analyzed melanoma cell lines. Treatment of melanoma cells with IFN alpha resulted in induction of expression of SLFN5 in malignant cells, suggesting a potential involvement of this gene in the antitumor effects of IFN alpha. Importantly, stable knockdown of SLFN5 in malignant melanoma cells resulted in increased anchorage-independent growth, as evidenced by enhanced colony formation in soft agar assays. Moreover, SLFN5 knockdown also resulted in increased invasion in three-dimensional collagen, suggesting a dual role for SLFN5 in the regulation of invasion and anchorage-independent growth of melanoma cells. Altogether, our findings suggest an important role for the SLFN family of proteins in the generation of the anti-melanoma effects of IFN alpha and for the first time directly implicate a member of the human SLFN family in the regulation of cell invasion.	[Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; Jesse Brown Veteran Affairs Med Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super,Lurie 3-125, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Sawicki, Konrad T/AAY-4083-2021	Sawicki, Konrad T/0000-0003-2124-0081	National Institutes of Health [CA77816, CA121192, C100579, CA126888]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA077816, R01CA121192, R01CA126888, P30CA060553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, CA121192, C100579, and CA126888. This work was also supported by a merit review grant from the Department of Veterans Affairs.	Bell TA, 2006, GENETICS, V172, P411, DOI 10.1534/genetics.105.047118; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Certa U, 2001, BRIT J CANCER, V85, P107, DOI 10.1054/bjoc.2001.1865; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hancock BW, 2004, J CLIN ONCOL, V22, P53, DOI 10.1200/JCO.2004.03.185; Horton MR, 2010, NAT IMMUNOL, V11, P281, DOI 10.1038/ni0410-281; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kaur S, 2005, EXP HEMATOL, V33, P550, DOI 10.1016/j.exphem.2005.01.014; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kirkwood JM, 2000, J CLIN ONCOL, V18, P2444, DOI 10.1200/JCO.2000.18.12.2444; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Klampfer L, 2004, J BIOL CHEM, V279, P30358, DOI 10.1074/jbc.M401359200; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Lesinski GB, 2007, CLIN CANCER RES, V13, P5010, DOI 10.1158/1078-0432.CCR-06-3092; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Patel VB, 2009, BIOCHEM BIOPH RES CO, V388, P752, DOI 10.1016/j.bbrc.2009.08.094; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; RALPH SJ, 1995, J IMMUNOL, V154, P2248; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1997, J IMMUNOL, V158, P2390; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Vlasakova J, 2007, BLOOD, V109, P1373, DOI 10.1182/blood-2006-02-003418; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; Zhang YF, 2008, BIOCHEM J, V413, P239, DOI 10.1042/BJ20071510	60	64	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40333	40341		10.1074/jbc.M110.151076	http://dx.doi.org/10.1074/jbc.M110.151076			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956525	Green Published, hybrid			2022-12-25	WOS:000285185500076
J	Touchberry, CD; Bales, IK; Stone, JK; Rohrberg, TJ; Parelkar, NK; Nguyen, T; Fuentes, O; Liu, X; Qu, CK; Andresen, JJ; Valdivia, HH; Brotto, M; Wacker, MJ				Touchberry, Chad D.; Bales, Ian K.; Stone, Jessica K.; Rohrberg, Travis J.; Parelkar, Nikhil K.; Nguyen, Tien; Fuentes, Oscar; Liu, Xia; Qu, Cheng-Kui; Andresen, Jon J.; Valdivia, Hector H.; Brotto, Marco; Wacker, Michael J.			Phosphatidylinositol 3,5-Bisphosphate (PI(3,5)P2) Potentiates Cardiac Contractility via Activation of the Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; PIP2	Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) is the most recently identified phosphoinositide, and its functions have yet to be fully elucidated. Recently, members of our muscle group have shown that PI(3,5)P2 plays an important role in skeletal muscle function by altering Ca2+ homeostasis. Therefore, we hypothesized that PI(3,5)P2 may also modulate cardiac muscle contractility by altering intracellular Ca2+ ([Ca2+](i)) in cardiac myocytes. We first confirmed that PI(3,5)P2 was present and increased by insulin treatment of cardiomyocytes via immunohistochemistry. To examine the acute effects of PI(3,5)P2 treatment, electrically paced left ventricular muscle strips were incubated with PI(3,5)P2. Treatment with PI(3,5)P2 increased the magnitude of isometric force, the rate of force development, and the area associated with the contractile waveforms. These enhanced contractile responses were also observed in MIP/Mtmr14(-/-) mouse hearts, which we found to have elevated levels of PI(3,5)P2. In cardiac myocytes loaded with fura-2, PI(3,5)P2 produced a robust elevation in [Ca2+](i). The PI(3,5)P2-induced elevation of [Ca2+](i) was not present in conditions free of extracellular Ca2+ and was completely blocked by ryanodine. We investigated whether the phosphoinositide acted directly with the Ca2+ release channels of the sarcoplasmic reticulum (ryanodine receptors; RyR2). PI(3,5)P2 increased [H-3] ryanodine binding and increased the open probability (P-o) of single RyR2 channels reconstituted in lipid bilayers. This strongly suggests that the phosphoinositide binds directly to the RyR2 channel. Thus, we provide inaugural evidence that PI(3,5)P2 is a powerful activator of sarcoplasmic reticulum Ca2+ release and thereby modulates cardiac contractility.	[Touchberry, Chad D.; Bales, Ian K.; Stone, Jessica K.; Rohrberg, Travis J.; Parelkar, Nikhil K.; Nguyen, Tien; Andresen, Jon J.; Brotto, Marco; Wacker, Michael J.] Univ Missouri, Muscle Biol Res Grp, Sch Med, Kansas City, MO 64108 USA; [Andresen, Jon J.; Brotto, Marco; Wacker, Michael J.] Univ Missouri, Muscle Biol Res Grp, Sch Nursing, Kansas City, MO 64108 USA; [Fuentes, Oscar] Univ Bio Bio, Dept Ciencias Basicas, Chillan 3780000, Chile; [Liu, Xia; Qu, Cheng-Kui] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Valdivia, Hector H.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53711 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Universidad del Bio-Bio; Case Western Reserve University; University of Wisconsin System; University of Wisconsin Madison	Wacker, MJ (corresponding author), 2464 Charlotte St, Kansas City, MO 64108 USA.	wackerm@umkc.edu	Touchberry, Chad D/L-8469-2013; Touchberry, Chad/GPX-8299-2022	Touchberry, Chad/0000-0002-6569-6921; Wacker, Michael/0000-0002-1768-562X	National Institutes of Health, NIAMS [1RC2AR058962-0110]; Missouri Life Sciences Research Board [09-1101]; American Heart Association; DIPRODE-UBB; National Institutes of Health, H. L. B. I. [ROI-HL055438]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR058962] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Missouri Life Sciences Research Board; American Heart Association(American Heart Association); DIPRODE-UBB; National Institutes of Health, H. L. B. I.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RC2AR058962-0110 from the NIAMS (to M. B., J. J. A., and M. J. W.) and ROI-HL055438 (to H. H. V.) from the H. L. B. I. This work was also supported by Missouri Life Sciences Research Board Grant 09-1101 (to M. B., J. J. A., and M. J. W.), an American Heart Association grant (to M. B. and J. J. A.), and a DIPRODE-UBB grant (to O. F.).	BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Bidlingmaier S, 2007, MOL CELL PROTEOMICS, V6, P2012, DOI 10.1074/mcp.M700223-MCP200; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Hama Hiroko, 2004, Methods Mol Biol, V284, P243; HOKIN LE, 1985, ANNU REV BIOCHEM, V54, P205, DOI 10.1146/annurev.biochem.54.1.205; Jones DR, 1999, J BIOL CHEM, V274, P18407, DOI 10.1074/jbc.274.26.18407; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; MULIERI LA, 1989, CIRC RES, V65, P1441, DOI 10.1161/01.RES.65.5.1441; Shen CC, 2007, J PHYSIOL-LONDON, V582, P1011, DOI 10.1113/jphysiol.2007.132720; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tanaka H, 1998, COMP BIOCHEM PHYS A, V120, P431, DOI 10.1016/S1095-6433(98)10043-0; Wacker MJ, 2009, J PHARMACOL EXP THER, V331, P917, DOI 10.1124/jpet.109.157677; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Zhu XS, 2004, J BIOL CHEM, V279, P26588, DOI 10.1074/jbc.M403284200; Zhu XS, 2004, CELL CALCIUM, V35, P165, DOI 10.1016/j.ceca.2003.09.002	19	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40312	40321		10.1074/jbc.M110.179689	http://dx.doi.org/10.1074/jbc.M110.179689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947503	hybrid, Green Published			2022-12-25	WOS:000285185500074
J	Loveridge, C; Tonelli, F; Leclercq, T; Lim, KG; Long, JS; Berdyshev, E; Tate, RJ; Natarajan, V; Pitson, SM; Pyne, NJ; Pyne, S				Loveridge, Carolyn; Tonelli, Francesca; Leclercq, Tamara; Lim, Keng Gat; Long, Jaclyn S.; Berdyshev, Evgeny; Tate, Rothwelle J.; Natarajan, Viswanathan; Pitson, Stuart M.; Pyne, Nigel J.; Pyne, Susan			The Sphingosine Kinase 1 Inhibitor 2-(p-Hydroxyanilino)-4-(p-chlorophenyl)thiazole Induces Proteasomal Degradation of Sphingosine Kinase 1 in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; PLASMA-MEMBRANE; 1-PHOSPHATE; EXPRESSION; RECEPTOR; PHOSPHORYLATION; CERAMIDE; PROLIFERATION	Sphingosine kinase 1 (SK1) is an enzyme that catalyzes the phosphorylation of sphingosine to produce the bioactive lipid sphingosine 1-phosphate (S1P). We demonstrate here that the SK1 inhibitor, SKi (2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole) induces the proteasomal degradation of SK1 in human pulmonary artery smooth muscle cells, androgen-sensitive LNCaP prostate cancer cells, MCF-7 and MCF-7 HER2 breast cancer cells and that this is likely mediated by ceramide as a consequence of catalytic inhibition of SK1 by SKi. Moreover, SK1 is polyubiquitinated under basal conditions, and SKi appears to increase the degradation of SK1 by activating the proteasome. In addition, the proteasomal degradation of SK1a and SK1b in androgen-sensitive LNCaP cells is associated with the induction of apoptosis. However, SK1b in LNCaP-AI cells (androgen-independent) is less sensitive to SKi-induced proteasomal degradation and these cells are resistant to SKi-induced apoptosis, thereby implicating the ubiquitin-proteasomal degradation of SK1 as an important mechanism controlling cell survival.	[Loveridge, Carolyn; Tonelli, Francesca; Lim, Keng Gat; Long, Jaclyn S.; Tate, Rothwelle J.; Pyne, Nigel J.; Pyne, Susan] Univ Strathclyde, Cell Biol Grp, Glasgow G4 0RE, Lanark, Scotland; [Berdyshev, Evgeny; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Leclercq, Tamara; Pitson, Stuart M.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Leclercq, Tamara; Pitson, Stuart M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	University of Strathclyde; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centre for Cancer Biology; SA Pathology; University of Adelaide	Pyne, S (corresponding author), Univ Strathclyde, Cell Biol Grp, Glasgow G4 0RE, Lanark, Scotland.	susan.pyne@strath.ac.uk	Pitson, Stuart/B-9342-2009; Pyne, Susan/AAF-5001-2019	Pitson, Stuart/0000-0002-9527-2740; Pyne, Susan/0000-0002-6608-9584; Tonelli, Francesca/0000-0002-4600-6630; Pyne, Nigel/0000-0002-5657-4578; Tate, Rothwelle/0000-0001-5857-4267; Loveridge, Carolyn/0000-0002-6237-8661	National Institutes of Health [R01 HL079396]; CRUK [23158/A7536]; British Heart Foundation [PG/06/137/21825]; Fay Fuller Foundation; Institute for Personalized Respiratory Medicine, The University of Illinois, Chicago; National Health and Medical Research Council of Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRUK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Fay Fuller Foundation; Institute for Personalized Respiratory Medicine, The University of Illinois, Chicago; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL079396 (to V. N.). This work was also supported by Grants 23158/A7536 from CRUK, PG/06/137/21825 from the British Heart Foundation (to S. P. and N. J. P.), and by the Fay Fuller Foundation (to S. M. P. and T. L.).; Supported by The Institute for Personalized Respiratory Medicine, The University of Illinois, Chicago.; Recipient of a Senior Research Fellowship from National Health and Medical Research Council of Australia.	Ahmad M, 2006, PROSTAG OTH LIPID M, V79, P278, DOI 10.1016/j.prostaglandins.2006.03.001; Akao Y, 2006, BIOCHEM BIOPH RES CO, V342, P1284, DOI 10.1016/j.bbrc.2006.02.070; Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Calatayud CA, 2005, DEV NEUROSCI-BASEL, V27, P397, DOI 10.1159/000088454; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Dayon A., 2008, PLOS ONE, V4, pe8408; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; Garzotto M, 1999, CANCER RES, V59, P5194; Goetzl EJ, 1999, CANCER RES, V59, P4732; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Huwiler A, 2006, BBA-MOL CELL BIOL L, V1761, P367, DOI 10.1016/j.bbalip.2006.02.007; Illuzzi G, 2010, J BIOL CHEM, V285, P18594, DOI 10.1074/jbc.M109.072801; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kono K, 2000, J ANTIBIOT, V53, P459, DOI 10.7164/antibiotics.53.459; Kono K, 2000, J ANTIBIOT, V53, P759, DOI 10.7164/antibiotics.53.759; Long JS, 2010, MOL CELL BIOL, V30, P3827, DOI 10.1128/MCB.01133-09; Merrill AH, 2000, METHOD ENZYMOL, V312, P3; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Nava VE, 2000, CANCER RES, V60, P4468; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pham DH, 2008, BIOTECHNIQUES, V45, P155, DOI 10.2144/000112896; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Pyne S, 2009, CELL SIGNAL, V21, P14, DOI 10.1016/j.cellsig.2008.08.008; Ren SY, 2010, CELL PHYSIOL BIOCHEM, V26, P97, DOI 10.1159/000315110; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4	38	94	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38841	38852		10.1074/jbc.M110.127993	http://dx.doi.org/10.1074/jbc.M110.127993			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926375	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000284941300013
J	Maxson, JE; Chen, JX; Enns, CA; Zhang, AS				Maxson, Julia E.; Chen, Juxing; Enns, Caroline A.; Zhang, An-Sheng			Matriptase-2-and Proprotein Convertase-cleaved Forms of Hemojuvelin Have Different Roles in the Down-regulation of Hepcidin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE HEMOCHROMATOSIS; IRON-METABOLISM; SOLUBLE HEMOJUVELIN; PROTEIN; MEMBRANE; NEOGENIN; OVERLOAD; LIVER; BMP6; ACTIVATION	Hemojuvelin (HJV) is an important regulator of iron metabolism. Membrane-anchored HJV up-regulates expression of the iron regulatory hormone, hepcidin, through the bone morphogenic protein (BMP) signaling pathway by acting as a BMP co-receptor. HJV can be cleaved by the furin family of proprotein convertases, which releases a soluble form of HJV that suppresses BMP signaling and hepcidin expression by acting as a decoy that competes with membrane HJV for BMP ligands. Recent studies indicate that matriptase-2 binds and degrades HJV, leading to a decrease in cell surface HJV. In the present work, we show that matriptase-2 cleaves HJV at Arg(288), which produces one major soluble form of HJV. This shed form of HJV has decreased ability to bind BMP6 and does not suppress BMP6-induced hepcidin expression. These results suggest that the matriptase-2 and proprotein convertase-cleavage products have different roles in the regulation of hepcidin expression.	[Maxson, Julia E.; Chen, Juxing; Enns, Caroline A.; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University	Enns, CA (corresponding author), Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ennsca@ohsu.edu; zhanga@ohsu.edu			National Institutes of Health [DK080765, DK72166, T32 HD049309]; Vertex Pharmaceuticals; American Heart Association [10PRE3530017]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD049309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080765, R01DK072166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vertex Pharmaceuticals(Vertex Pharmaceuticals); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080765 (to A.-S. Z.) and DK72166 (to C. A. E.).; Supported in part by National Institutes of Health Grant T32 HD049309, by a scholarship from Vertex Pharmaceuticals, and by American Heart Association predoctoral fellowship 10PRE3530017.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Camaschella C, 1998, BAILLIERE CLIN GASTR, V12, P227, DOI 10.1016/S0950-3528(98)90132-4; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kuninger D, 2006, J CELL SCI, V119, P3273, DOI 10.1242/jcs.03074; Kuninger David, 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-9; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zhang AS, 2008, J BIOL CHEM, V283, P17494, DOI 10.1074/jbc.M710527200; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200	30	55	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39021	39028		10.1074/jbc.M110.183160	http://dx.doi.org/10.1074/jbc.M110.183160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937842	hybrid, Green Published			2022-12-25	WOS:000284941300032
J	Sinclair, J; Hamza, I				Sinclair, Jason; Hamza, Iqbal			A Novel Heme-responsive Element Mediates Transcriptional Regulation in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; GATA-FACTOR; ERYTHROID-CELLS; FACTOR BACH1; BETA-GLOBIN; C-ELEGANS; GENE; EXPRESSION; INTESTINE; PROTEINS	Hemes are prosthetic groups that participate in diverse biochemical pathways across phylogeny. Although heme can also regulate broad physiological processes by directly modulating gene expression in Metazoa, the regulatory pathways for sensing and responding to heme are not well defined. Caenorhabditis elegans is a heme auxotroph and relies solely on environmental heme for sustenance. Worms respond to heme availability by regulating heme-responsive genes such as hrg-1, an intestinal heme transporter that is up-regulated by >60-fold during heme depletion. To identify the mechanism for the heme-dependent regulation of hrg-1, we interrogated the hrg-1 promoter. Deletion and mutagenesis studies of the hrg-1 promoter revealed a 23-bp heme-responsive element that is both necessary and sufficient for heme-dependent regulation of hrg-1. Furthermore, our studies show that the heme regulation of hrg-1 is mediated by both activation and repression in conjunction with ELT-2 and ELT-4, transcription factors that specify intestinal expression.	Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Hamza, I (corresponding author), Univ Maryland, Anim Sci Ctr 2413, Dept Avian & Anim Sci, College Pk, MD 20742 USA.	hamza@umd.edu		Hamza, Iqbal/0000-0003-0045-0610	National Institutes of Health [R01 DK74797]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK74797 (to I. H.).	Aiyar A, 1996, Methods Mol Biol, V57, P177; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Blumenthal Thomas, 2005, WormBook, P1, DOI 10.1895/wormbook.1.5.1; BRENNER S, 1974, GENETICS, V77, P71; Fukushige T, 2003, GENETICS, V165, P575; Fukushige T, 2005, DEV BIOL, V279, P446, DOI 10.1016/j.ydbio.2004.12.012; Gilles-Gonzalez MA, 2004, J APPL PHYSIOL, V96, P774, DOI 10.1152/japplphysiol.00941.2003; HAWKINS MG, 1995, J BIOL CHEM, V270, P14666, DOI 10.1074/jbc.270.24.14666; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Ishii TM, 1998, METHOD ENZYMOL, V293, P53; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Koh K, 2001, DEVELOPMENT, V128, P2867; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee James D, 2007, WormBook, P1; METZ R, 1991, ONCOGENE, V6, P2165; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; Nass R., 2007, CURR PROTOC TOXICOL; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rees EM, 2004, CURR OPIN MICROBIOL, V7, P175, DOI 10.1016/j.mib.2004.02.004; Rodgers KR, 1999, CURR OPIN CHEM BIOL, V3, P158, DOI 10.1016/S1367-5931(99)80028-3; Romney SJ, 2008, J BIOL CHEM, V283, P716, DOI 10.1074/jbc.M707043200; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; SPIETH J, 1991, MOL CELL BIOL, V11, P4651, DOI 10.1128/MCB.11.9.4651; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Tahara T, 2004, BIOCHEM BIOPH RES CO, V324, P77, DOI 10.1016/j.bbrc.2004.09.022; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Wenger RH, 2000, J EXP BIOL, V203, P1253; Williams C, 1999, MOL CELL BIOL, V19, P376; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	37	18	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39536	39543		10.1074/jbc.M110.167619	http://dx.doi.org/10.1074/jbc.M110.167619			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20938051	hybrid, Green Published			2022-12-25	WOS:000284941300079
J	Sorci, L; Blaby, I; De Ingeniis, J; Gerdes, S; Raffaelli, N; Lagard, VD; Osterman, A				Sorci, Leonardo; Blaby, Ian; De Ingeniis, Jessica; Gerdes, Svetlana; Raffaelli, Nadia; Lagard, Valerie de Crecy; Osterman, Andrei			Genomics-driven Reconstruction of Acinetobacter NAD Metabolism INSIGHTS FOR ANTIBACTERIAL TARGET SELECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; TRANSCRIPTIONAL REGULATION; SP ADP1; BIOSYNTHESIS; SYNTHETASE; INHIBITORS; ENZYME; PHOSPHORIBOSYLTRANSFERASE; FERMENTATION; REGENERATION	Enzymes involved in the last steps of NAD biogenesis, nicotinate mononucleotide adenylyltransferase (NadD) and NAD synthetase (NadE), are conserved and essential in most bacterial species and are established targets for antibacterial drug development. Our genomics-based reconstruction of NAD metabolism in the emerging pathogen Acinetobacter baumannii revealed unique features suggesting an alternative targeting strategy. Indeed, genomes of all analyzed Acinetobacter species do not encode NadD, which is functionally replaced by its distant homolog NadM. We combined bioinformatics with genetic and biochemical techniques to elucidate this and other important features of Acinetobacter NAD metabolism using a model (nonpathogenic) strain Acinetobacter baylyi sp. ADP1. Thus, a comparative kinetic characterization of PncA, PncB, and NadV enzymes allowed us to suggest distinct physiological roles for the two alternative, deamidating and nondeamidating, routes of nicotinamide salvage/recycling. The role of the NiaP transporter in both nicotinate and nicotinamide salvage was confirmed. The nondeamidating route was shown to be transcriptionally regulated by an ADP-ribose-responsive repressor NrtR. The NadM enzyme was shown to possess dual substrate specificity toward both nicotinate and nicotinamide mononucleotide substrates, which is consistent with its essential role in all three routes of NAD biogenesis, de novo synthesis as well as the two salvage pathways. The experimentally confirmed unconditional essentiality of nadM provided support for the choice of the respective enzyme as a drug target. In contrast, nadE, encoding a glutamine-dependent NAD synthetase, proved to be dispensable when the nondeamidating salvage pathway functioned as the only route of NAD biogenesis.	[Blaby, Ian; Lagard, Valerie de Crecy] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Sorci, Leonardo; De Ingeniis, Jessica; Osterman, Andrei] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Gerdes, Svetlana] Fellowship Interpretat Genomes, Burr Ridge, IL 60527 USA; [Raffaelli, Nadia] Univ Politecn Marche, Biochem Sect, Dept Mol Pathol & Innovat Therapies, I-60131 Ancona, Italy	State University System of Florida; University of Florida; Sanford Burnham Prebys Medical Discovery Institute; Marche Polytechnic University	Lagard, VD (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	vcrecy@ufl.edu; osterman@sanfordburnham.org	SORCI, LEONARDO/AAD-7395-2019; Blaby, Ian/C-3292-2014; de Crecy-Lagard, Valerie/AAN-8995-2020	SORCI, LEONARDO/0000-0002-4356-8873; 	National Institutes of Health (NIAID) [R01 AI066244]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066244] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI066244 (NIAID; to A. O. and V. d. C. L.).	Aravind L, 2002, PROTEINS, V48, P1, DOI 10.1002/prot.10064; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Boshoff HIM, 1998, J BACTERIOL, V180, P5809, DOI 10.1128/JB.180.22.5809-5814.1998; Burgos ES, 2008, BIOCHEMISTRY-US, V47, P11086, DOI 10.1021/bi801198m; Copeland RA., 2000, ENZYMES PRACTICAL IN, P137; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; de Berardinis V, 2009, CURR OPIN MICROBIOL, V12, P568, DOI 10.1016/j.mib.2009.07.005; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gerdes SY, 2006, J BACTERIOL, V188, P3012, DOI 10.1128/JB.188.8.3012-3023.2006; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Gerlach G, 2006, J BACTERIOL, V188, P6719, DOI 10.1128/JB.00432-06; Gross JW, 1998, BIOCHEMISTRY-US, V37, P4189, DOI 10.1021/bi972014w; Gutnick David L., 2008, P231; Huang N, 2008, STRUCTURE, V16, P196, DOI 10.1016/j.str.2007.11.017; Huang NA, 2010, J MED CHEM, V53, P5229, DOI 10.1021/jm100377f; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; LaRonde-LeBlanc N, 2009, NAT STRUCT MOL BIOL, V16, P421, DOI 10.1038/nsmb.1567; Magni G, 2009, CURR MED CHEM, V16, P1372, DOI 10.2174/092986709787846505; Maicas S, 2002, MICROBIOL-SGM, V148, P325, DOI 10.1099/00221287-148-1-325; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Moro WB, 2009, J COMB CHEM, V11, P617, DOI 10.1021/cc9000357; Moro WB, 2009, BIOORG MED CHEM LETT, V19, P2001, DOI 10.1016/j.bmcl.2009.02.034; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; Osterman AL, 2007, PROG DRUG RES, V64, p[131, 133], DOI DOI 10.1007/978-3-7643-7567-6_; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60; Raffaelli N, 1997, J BACTERIOL, V179, P7718, DOI 10.1128/jb.179.24.7718-7723.1997; RAFFAELLI N, 1994, FEBS LETT, V355, P233, DOI 10.1016/0014-5793(94)01195-8; Raffaelli N, 1999, FEBS LETT, V444, P222, DOI 10.1016/S0014-5793(99)00068-X; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2032, DOI 10.1093/nar/gkn046; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Sambrook J, 2001, MOL CLONING LAB MANU; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Sorci L, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P213; Sorci L, 2009, CHEM BIOL, V16, P849, DOI 10.1016/j.chembiol.2009.07.006; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Teramoto H, 2010, APPL ENVIRON MICROB, V76, P5488, DOI 10.1128/AEM.00906-10; Velu SE, 2007, J MED CHEM, V50, P2612, DOI 10.1021/jm061349l; Verho R, 2003, APPL ENVIRON MICROB, V69, P5892, DOI 10.1128/AEM.69.10.5892-5897.2003; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Vilcheze C, 2010, MOL MICROBIOL, V76, P365, DOI 10.1111/j.1365-2958.2010.07099.x	51	32	32	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39490	39499		10.1074/jbc.M110.185629	http://dx.doi.org/10.1074/jbc.M110.185629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926389	Green Published, hybrid			2022-12-25	WOS:000284941300075
J	Rzehak, P; Thijs, C; Standl, M; Mommers, M; Glaser, C; Jansen, E; Klopp, N; Koppelman, GH; Singmann, P; Postma, DS; Sausenthaler, S; Dagnelie, PC; van den Brandt, PA; Koletzko, B; Heinrich, J				Rzehak, Peter; Thijs, Carel; Standl, Marie; Mommers, Monique; Glaser, Claudia; Jansen, Eugene; Klopp, Norman; Koppelman, Gerard H.; Singmann, Paula; Postma, Dirkje S.; Sausenthaler, Stefanie; Dagnelie, Pieter C.; van den Brandt, Piet A.; Koletzko, Berthold; Heinrich, Joachim		KOALA & LISA Study Grp	Variants of the FADS1 FADS2 Gene Cluster, Blood Levels of Polyunsaturated Fatty Acids and Eczema in Children within the First 2 Years of Life	PLOS ONE			English	Article							TOTAL IMMUNOGLOBULIN-E; KOALA BIRTH COHORT; FADS2; PHOSPHOLIPIDS; ASSOCIATION; DISEASES; MILK; IGE; INFLAMMATION; INFECTIONS	Background: Association of genetic-variants in the FADS1-FADS2-gene-cluster with fatty-acid-composition in blood of adult-populations is well established. We analyze this genetic-association in two children-cohort-studies. In addition, the association between variants in the FADS-gene-cluster and blood-fatty-acid-composition with eczema was studied. Methods and Principal Findings: Data of two population-based-birth-cohorts in the Netherlands and Germany (KOALA, LISA) were pooled (n = 879) and analyzed by (logistic) regression regarding the mutual influence of single-nucleotide-polymorphisms (SNPs) in the FADS-gene-cluster (rs174545, rs174546, rs174556, rs174561, rs3834458), on polyunsaturated fatty acids (PUFA) in blood and parent-reported eczema until the age of 2 years. All SNPs were highly significantly associated with all PUFAs except for alpha-linolenic-acid and eicosapentaenoic-acid, also after correction for multiple-testing. All tested SNPs showed associations with eczema in the LISA-study, but not in the KOALA-study. None of the PUFAs was significantly associated with eczema neither in the pooled nor in the analyses stratified by study-cohort. Conclusions and Significance: PUFA-composition in young children's blood is under strong control of the FADS-gene-cluster. Inconsistent results were found for a link between these genetic-variants with eczema. PUFA in blood was not associated with eczema. Thus the hypothesis of an inflammatory-link between PUFA and eczema by the metabolic-pathway of LC-PUFAs as precursors for inflammatory prostaglandins and leukotrienes could not be confirmed by these data.	[Rzehak, Peter; Standl, Marie; Klopp, Norman; Singmann, Paula; Sausenthaler, Stefanie; Heinrich, Joachim] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany; [Rzehak, Peter] Univ Munich, Chair Epidemiol, Inst Med Informat Biometr & Epidemiol, Oberschleissheim, Germany; [Thijs, Carel; Mommers, Monique; Dagnelie, Pieter C.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [Glaser, Claudia; Koletzko, Berthold] Univ Munich, Dr von Hauner Childrens Hosp, Div Metab Dis & Nutr Med, Munich, Germany; [Jansen, Eugene] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [van den Brandt, Piet A.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Maastricht University; University of Munich; Netherlands National Institute for Public Health & the Environment; University of Groningen; University of Groningen; Maastricht University	Rzehak, P (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany.	peter.rzehak@helmholtz-muenchen.de	Koppelman, Gerard/AAG-9187-2020; Singmann, Paula/B-3624-2014; Heinrich, Joachim/N-1720-2013; Sack, Ulrich/J-6301-2015; Thijs, Carel/H-8340-2019	Heinrich, Joachim/0000-0002-9620-1629; Sack, Ulrich/0000-0002-7813-0492; Thijs, Carel/0000-0001-6646-5458; Koppelman, Gerard/0000-0001-8567-3252; Standl, Marie/0000-0002-5345-2049; Singmann, Paula/0000-0003-2109-9970; van den Brandt, Piet/0000-0001-8781-8099	Netherlands Organisation for Health Research and Development [2100.0090, 912-03-031]; Netherlands Asthma Foundation [3.2.03.48]; Royal Friesland Foods, Triodos Foundation; Phoenix Foundation; Raphae Foundation; Iona Foundation; Foundation for the Advancement of Heilpedagogie; Netherlands Ministry of Public Health, Welfare and Sport; Netherlands and the Netherlands Organisation for Scientific Research; Federal Ministry for Education, Science, Research and Technology [01 EG 9705/2, 01EG9732]; Federal Ministry of Education and Research [01GI0826, 01GI0823, 01GS0820]; Munich Center of Health Sciences (MCHEALTH), Ludwig-Maximilians University Munich LMU; Netherlands Organisation for Scientific Research; Bristol-Myers-Squibb Foundation, New York, NY, USA	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Asthma Foundation; Royal Friesland Foods, Triodos Foundation; Phoenix Foundation; Raphae Foundation; Iona Foundation; Foundation for the Advancement of Heilpedagogie; Netherlands Ministry of Public Health, Welfare and Sport; Netherlands and the Netherlands Organisation for Scientific Research; Federal Ministry for Education, Science, Research and Technology; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences (MCHEALTH), Ludwig-Maximilians University Munich LMU; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Bristol-Myers-Squibb Foundation, New York, NY, USA(Bristol-Myers Squibb)	KOALA study with follow-up until age 2 years was co-sponsored by the Netherlands Organisation for Health Research and Development (ZonMW grants no. 2100.0090 and 912-03-031), the Netherlands Asthma Foundation (grant no. 3.2.03.48), Royal Friesland Foods, Triodos Foundation, Phoenix Foundation, Raphae Foundation, Iona Foundation, Foundation for the Advancement of Heilpedagogie, and the Netherlands Ministry of Public Health, Welfare and Sport, the Netherlands and the Netherlands Organisation for Scientific Research (NWO Spinoza award of Prof. D.S. Postma). The LISA study was funded by grants of the Federal Ministry for Education, Science, Research and Technology (Grant No. 01 EG 9705/2 and 01EG9732). This work was partly supported by the "Kompetenznetz Adipositas (Competence Network Obesity)" and NGFNplus funded by the Federal Ministry of Education and Research (FKZ: 01GI0826, 01GI0823, 01GS0820). Personal and financial support by the Munich Center of Health Sciences (MCHEALTH) as part of the Ludwig-Maximilians University Munich LMU innovative is gratefully acknowledged. Dirkje S. Postma received the NWO Spinoza award from the Netherlands Organisation for Scientific Research. Berthold Koletzko is the recipient of a Freedom to Discover Award of the Bristol-Myers-Squibb Foundation, New York, NY, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; AGREN JJ, 1992, J LIPID RES, V33, P1871; Akkerdaas JH, 2005, INT ARCH ALLERGY IMM, V138, P203, DOI 10.1159/000088720; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Chen CM, 2010, CLIN EXP DERMATOL, V35, P238, DOI 10.1111/j.1365-2230.2009.03460.x; Chen CM, 2007, J ALLERGY CLIN IMMUN, V119, P1148, DOI 10.1016/j.jaci.2007.02.017; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Duchen K, 2001, LIPIDS, V36, P1033, DOI 10.1007/s11745-001-0814-5; Filipiak B, 2007, J PEDIATR-US, V151, P352, DOI 10.1016/j.jpeds.2007.05.018; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Glaser C, 2010, J LIPID RES, V51, P216, DOI 10.1194/jlr.D000547; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Institute Inc SAS, 2005, SAS GEN 9 1 3 US GUI; Kompauer I, 2005, BRIT J NUTR, V93, P529, DOI 10.1079/BJN20041387; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lattka E, 2009, J NUTRIGENET NUTRIGE, V2, P119, DOI 10.1159/000235559; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Nwankwo JO, 2003, J LIPID RES, V44, P2311, DOI 10.1194/jlr.M300273-JLR200; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Reimerink J, 2009, CLIN EXP ALLERGY, V39, P254, DOI 10.1111/j.1365-2222.2008.03128.x; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; SAS Institute, 2008, SAS STAT US GUID; Sausenthaler S, 2007, AM J CLIN NUTR, V85, P530; Sausenthaler S, 2006, CURR NUTR FOOD SCI, V2, P351, DOI 10.2174/157340106778699395; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Snijders BEP, 2008, PEDIATRICS, V122, pE115, DOI 10.1542/peds.2007-1651; STALLMAN PJ, 1977, INT ARCH ALLER A IMM, V54, P9, DOI 10.1159/000231803; Stapel SO, 2004, PEDIATR ALLERGY IMMU, V15, P230, DOI 10.1111/j.1399-3038.2004.00142.x; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	40	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13261	10.1371/journal.pone.0013261	http://dx.doi.org/10.1371/journal.pone.0013261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948998	Green Published, Green Submitted, gold			2022-12-25	WOS:000282748100011
J	Monzon-Casanova, E; Steiniger, B; Schweigle, S; Clemen, H; Zdzieblo, D; Starick, L; Muller, I; Wang, CR; Rhost, S; Cardell, S; Pyz, E; Herrmann, T				Monzon-Casanova, Elisa; Steiniger, Birte; Schweigle, Stefanie; Clemen, Holger; Zdzieblo, Daniela; Starick, Lisa; Mueller, Ingrid; Wang, Chyung-Ru; Rhost, Sara; Cardell, Susanna; Pyz, Elwira; Herrmann, Thomas			CD1d Expression in Paneth Cells and Rat Exocrine Pancreas Revealed by Novel Monoclonal Antibodies Which Differentially Affect NKT Cell Activation	PLOS ONE			English	Article							CD1D-RESTRICTED T-CELLS; MOUSE CD1; ANTIGEN PRESENTATION; MARGINAL ZONE; MURINE CD1; B-CELLS; MICE; LOCALIZATION; RECOGNITION; MOLECULES	Background: CD1d is a nonpolymorphic MHC class I-like molecule which presents nonpeptide ligands, e.g. glycolipids, to NKT cells. These cells are known to have multiple effects on innate and adaptive immune responses and on the development of pathological conditions. In order to analyze CD1d expression and function in the rat, the first rat CD1d-specific monoclonal antibodies (mAbs) were generated. Methodology/Principal Findings: Two mAbs, WTH-1 and WTH-2, were generated which bound equally well to cell surface-expressed rat and mouse CD1d. Their non-overlapping epitopes were mapped to the CD1d heavy chain. Flow cytometry and immunohistological analyses revealed a nearly identical degree and pattern of CD1d expression for hematopoieitic cells of both species. Notable is also the detection of CD1d protein in mouse and rat Paneth cells as well as the extremely high CD1d expression in acinar exocrine cells of the rat pancreas and the expression of CD4 on rat marginal zone B cells. Both mAbs blocked alpha-galactosylceramide recognition by primary rat and mouse NKT cells. Interestingly, the two mAbs differed in their impact on the activation of various autoreactive T cell hybridomas, including the XV19.2 hybridoma whose activation was enhanced by the WTH-1 mAb. Conclusions/Significance: The two novel monoclonal antibodies described in this study, allowed the analysis of CD1d expression and CD1d-restricted T cell responses in the rat for the first time. Moreover, they provided new insights into mechanisms of CD1d-restricted antigen recognition. While CD1d expression by hematopoietic cells of mice and rats was extremely similar, CD1d protein was detected at not yet described sites of non-lymphatic tissues such as the rat exocrine pancreas and Paneth cells. The latter is of special relevance given the recently reported defects of Paneth cells in CD1d(-/-) mice, which resulted in an altered composition of the gut flora.	[Monzon-Casanova, Elisa; Schweigle, Stefanie; Clemen, Holger; Zdzieblo, Daniela; Starick, Lisa; Mueller, Ingrid; Pyz, Elwira; Herrmann, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany; [Steiniger, Birte] Univ Marburg, Dept Anat & Cell Biol, D-3550 Marburg, Germany; [Wang, Chyung-Ru] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Rhost, Sara; Cardell, Susanna] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden	University of Wurzburg; Philipps University Marburg; Northwestern University; Feinberg School of Medicine; University of Gothenburg	Monzon-Casanova, E (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, D-8700 Wurzburg, Germany.	herrmann-t@vim.uni-wuerzburg.de	Cardell, Susanna/ABC-4944-2021; Herrmann, Thomas/J-4943-2012	Herrmann, Thomas/0000-0002-1093-0194; Monzon-Casanova, Elisa/0000-0001-6617-6138; Steiniger, Birte/0000-0002-3602-7331	Deutsche Forschungsgemeinschaft Graduate College; Deutsche Akademische Auslandsdienst; Swedish Research Council [K2010-57X14063-10-3]; Swedish Cancer Foundation [09 0532]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043407] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft Graduate College(German Research Foundation (DFG)); Deutsche Akademische Auslandsdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Deutsche Forschungsgemeinschaft Graduate College 520 Immunomodulation (http://www.dfg.de/), and E.M.C. was also supported by a STIBET Doktoranden grant of the Deutsche Akademische Auslandsdienst (http://www.daad.de/hochschulen/betreuung/stibet/05096.de.html). S.C. was supported by the Swedish Research Council K2010-57X14063-10-3 and the Swedish Cancer Foundation 09 0532. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenieux C, 2000, J BIOL CHEM, V275, P37757, DOI 10.1074/jbc.M007082200; Behar SM, 2000, SEMIN IMMUNOL, V12, P551, DOI 10.1006/smim.2000.0273; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BLEICHER PA, 1990, SCIENCE, V250, P679, DOI 10.1126/science.1700477; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Bonish B, 2000, J IMMUNOL, V165, P4076, DOI 10.4049/jimmunol.165.7.4076; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; BRADBURY A, 1988, EMBO J, V7, P3081, DOI 10.1002/j.1460-2075.1988.tb03173.x; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; BROEREN CPM, 1995, IMMUNOLOGY, V84, P193; Brossay L, 1997, J IMMUNOL, V159, P1216; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; BURKE S, 1994, GASTROENTEROLOGY, V106, P1143, DOI 10.1016/0016-5085(94)90003-5; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chen YH, 1999, J IMMUNOL, V162, P4560; CROCKER PR, 1987, J EXP MED, V166, P613, DOI 10.1084/jem.166.2.613; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Higuchi R., 1990, PCR PROTOCOLS GUIDE; ICHIMIYA S, 1994, J IMMUNOL, V153, P1112; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kasai K, 1997, CLIN EXP IMMUNOL, V109, P317, DOI 10.1046/j.1365-2249.1997.3661267.x; Kasmar A, 2009, CURR OPIN IMMUNOL, V21, P397, DOI 10.1016/j.coi.2009.05.022; Katabami S, 1998, IMMUNOGENETICS, V48, P22, DOI 10.1007/s002510050396; Kenny E, 2004, EUR J IMMUNOL, V34, P1262, DOI 10.1002/eji.200324363; Knodel M, 1999, EUR J IMMUNOL, V29, P2988; KROESE FGM, 1990, EUR J IMMUNOL, V20, P1527, DOI 10.1002/eji.1830200718; KUMARARATNE DS, 1981, EUR J IMMUNOL, V11, P858, DOI 10.1002/eji.1830111103; LACASSE J, 1992, J HISTOCHEM CYTOCHEM, V40, P1527, DOI 10.1177/40.10.1382091; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Mandal M, 1998, MOL IMMUNOL, V35, P525, DOI 10.1016/S0161-5890(98)00055-8; Matsuura A, 2000, J IMMUNOL, V164, P3140, DOI 10.4049/jimmunol.164.6.3140; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; MOSSER DD, 1991, IMMUNOLOGY, V73, P298; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Park SH, 1998, J IMMUNOL, V160, P3128; Pyz E, 2006, J IMMUNOL, V176, P7447, DOI 10.4049/jimmunol.176.12.7447; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Roark JH, 1998, J IMMUNOL, V160, P3121; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Steiniger B, 2006, HISTOCHEM CELL BIOL, V126, P641, DOI 10.1007/s00418-006-0210-5; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; van den Berg TK, 2001, IMMUNOL REV, V184, P109, DOI 10.1034/j.1600-065x.2001.1840110.x; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Zimmer MI, 2006, J IMMUNOL, V176, P1421, DOI 10.4049/jimmunol.176.3.1421; Zimmer MI, 2009, P NATL ACAD SCI USA, V106, P1909, DOI 10.1073/pnas.0808476106	52	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13089	10.1371/journal.pone.0013089	http://dx.doi.org/10.1371/journal.pone.0013089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927351	Green Submitted, Green Published, gold			2022-12-25	WOS:000282312600022
J	Bi, JM; Deng, GC; Dong, J; Kong, FL; Li, XZ; Xu, QA; Zhang, MJ; Zhao, LH; Qiao, JA				Bi, Jianmin; Deng, Guangcun; Dong, Jun; Kong, Fuli; Li, Xuezhu; Xu, Qiang; Zhang, Miaojie; Zhao, Lihong; Qiao, Jian			Phylogenetic and Molecular Characterization of H9N2 Influenza Isolates from Chickens in Northern China from 2007-2009	PLOS ONE			English	Article							A H5N1 VIRUS; AVIAN INFLUENZA; HUMAN INFECTION; HONG-KONG; EVOLUTION; PATHOGENICITY; HEMAGGLUTININ; POULTRY; GENES; DUCKS	The repeated transmission to pigs and humans, and the long-term endemicity in terrestrial poultry of H9N2 viruses in China lend urgency to the study of their ecology and pathogenicity. In the present paper, we reported an H9N2 virus sublineage isolated from chickens in northern China from 2007 to 2009 has high lethality for mice. Phylogenetic analysis of the full genome indicated that six representative H9N2 isolates shared high homology to each other, and they clustered in the same sublineage with other H9N2 viruses isolated recently in northern China. The isolates were double-reassortant viruses containing M genes similar to A/Quail/Hong Kong/G1/97 (H9N2) and the other seven gene segments from A/Chicken/Shanghai/F/98 (H9N2). These six isolates were capable of replicating in the lungs of infected chickens without producing observable clinical signs of disease or death. However, they were highly lethal to mice with mortality rates as high as 100% (14/14) without prior adaptation. The affected mice exhibited severe respiratory syndromes and diffuse lung injury. The H9N2 viruses could be detected in multiple organs of the infected mice, including hearts, livers, spleens, lungs and kidneys. Our findings demonstrated that H9N2 viruses isolated from the chickens in northern China have established a stable sublineage with enhanced pathogenicity to mice, suggesting that urgent attention will need to be paid to the transmission of H9N2 viruses from chickens to mammals.	[Bi, Jianmin; Deng, Guangcun; Dong, Jun; Kong, Fuli; Li, Xuezhu; Xu, Qiang; Zhang, Miaojie; Zhao, Lihong; Qiao, Jian] China Agr Univ, Dept Pathophysiol, Coll Vet Med, Beijing 100094, Peoples R China	China Agricultural University	Bi, JM (corresponding author), China Agr Univ, Dept Pathophysiol, Coll Vet Med, Beijing 100094, Peoples R China.	zhlhong@cau.edu.cn; qiaojian@cau.edu.cn		Deng, Guangcun/0000-0002-9079-9084	National Natural Science Foundation of China [30972163, 30571398]; Program for Cheung Kong Scholars and Innovative Research Team in University of China [IRT0866]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Cheung Kong Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (Grant number: 30972163 and 30571398) and by the Program for Cheung Kong Scholars and Innovative Research Team in University of China (No. IRT0866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen B, 1994, CHIN J VET MED, V22, P3; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Cong YL, 2008, VIRUS GENES, V36, P461, DOI 10.1007/s11262-008-0227-z; Deng GC, 2010, ARCH VIROL, V155, P187, DOI 10.1007/s00705-009-0560-0; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guan Y, 2001, INT CONGR SER, V1219, P187, DOI 10.1016/S0531-5131(01)00660-4; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Huang YY, 2009, VIRUS GENES, V38, P398, DOI 10.1007/s11262-009-0339-0; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; Kendal AP, 1982, CONCEPTS PROCEDURES; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Liu JH, 2003, VIRUS GENES, V27, P197, DOI 10.1023/A:1025736829103; Lu JH, 2005, VIRUS GENES, V31, P163, DOI 10.1007/s11262-005-1790-1; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Nishimura H, 2000, J GEN VIROL, V81, P2503, DOI 10.1099/0022-1317-81-10-2503; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Peiris M, 1999, J CLIN MICROBIOL, V37, P3426, DOI 10.1128/JCM.37.10.3426-3427.1999; Perez DR, 2003, AVIAN DIS, V47, P1114, DOI 10.1637/0005-2086-47.s3.1114; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu T, 2006, AM J RESP CRIT CARE, V174, P1011, DOI 10.1164/rccm.200511-1751OC; Zhang PH, 2008, J GEN VIROL, V89, P3102, DOI 10.1099/vir.0.2008/005652-0	51	47	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13063	10.1371/journal.pone.0013063	http://dx.doi.org/10.1371/journal.pone.0013063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927364	gold, Green Published, Green Submitted			2022-12-25	WOS:000282269400015
J	Anderson, RV; McGill, J; Legge, KL				Anderson, Rebecca VanOosten; McGill, Jodi; Legge, Kevin L.			Quantification of the Frequency and Multiplicity of Infection of Respiratory- and Lymph Node-Resident Dendritic Cells During Influenza Virus Infection	PLOS ONE			English	Article							CD8(+) T-CELLS; ANTIGEN PRESENTATION; RESPONSES; PROLIFERATION; ACTIVATION; SUBSETS; LUNG; MICE; MIGRATION; HYBRIDS	Background: Previous studies have demonstrated that DC differentially regulate influenza A virus (IAV)-specific CD8 T cell responses in vivo during high and low dose IAV infections. Furthermore, in vitro infection of DC with IAV at low versus high multiplicities of infection (MOI) results in altered cytokine production and a reduced ability to prime naive CD8 T cell responses. Flow cytometric detection of IAV proteins within DC, a commonly used method for detection of cellular IAV infection, does not distinguish between the direct infection of these cells or their uptake of viral proteins from dying epithelial cells. Methods/Principal Findings: We have developed a novel, sensitive, single-cell RT-PCR-based approach to assess the infection of respiratory DC (rDC) and lymph node (LN)-resident DC (LNDC) following high and low dose IAV infections. Our results show that, while a fraction of both rDC and LNDC contain viral mRNA following IAV infection, there is little correlation between the percentage of rDC containing viral mRNA and the initial IAV inoculum dose. Instead, increasing IAV inoculums correlate with augmented rDC MOI. Conclusion/Significance: Together, our results demonstrate a novel and sensitive method for the detection of direct IAV infection at the single-cell level and suggest that the previously described ability of DC to differentially regulate IAV-specific T cell responses during high and low dose IAV infections could relate to the MOI of rDC within the LN rather than the percentage of rDC infected.	[Anderson, Rebecca VanOosten; McGill, Jodi; Legge, Kevin L.] Univ Iowa, Dept Pathol, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa	Anderson, RV (corresponding author), NIAID, Rocky Mt Labs, Intracellular Parasites Lab, NIH, Hamilton, MT 59840 USA.	kevin-legge@uiowa.edu		Legge, Kevin/0000-0001-9800-6854	National Institutes of Health (NIH) [AI-071085]; Department of Pathology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071085] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant AI-071085 and Department of Pathology Start-Up Funds to KLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj N, 1995, ADV EXP MED BIOL, V378, P375; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; EICHELBERGER MC, 1991, J GEN VIROL, V72, P1695, DOI 10.1099/0022-1317-72-7-1695; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; HAMILTONEASTON A, 1995, J VIROL, V69, P6359, DOI 10.1128/JVI.69.10.6359-6366.1995; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Jenkins MR, 2008, J IMMUNOL, V181, P3818, DOI 10.4049/jimmunol.181.6.3818; Kelso A, 2002, INT IMMUNOL, V14, P605, DOI 10.1093/intimm/dxf028; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Kusuhara M, 2002, EUR J IMMUNOL, V32, P1035, DOI 10.1002/1521-4141(200204)32:4<1035::AID-IMMU1035>3.0.CO;2-7; Lamb R.A., 2001, FIELDS VIROLOGY; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Matsue H, 2001, BLOOD, V98, P3465, DOI 10.1182/blood.V98.12.3465; Mizumoto N, 2005, J INVEST DERMATOL, V124, P718, DOI 10.1111/j.0022-202X.2005.23616.x; Oh S, 2000, J VIROL, V74, P5460, DOI 10.1128/JVI.74.12.5460-5469.2000; Oh S, 2001, VIROLOGY, V286, P403, DOI 10.1006/viro.2001.0992; Oh S, 1999, VIROLOGY, V264, P427, DOI 10.1006/viro.1999.0019; Oh S, 2000, J VIROL, V74, P7738, DOI 10.1128/JVI.74.17.7738-7744.2000; Valenzuela JO, 2005, J IMMUNOL, V174, P600, DOI 10.4049/jimmunol.174.2.600; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	21	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12902	10.1371/journal.pone.0012902	http://dx.doi.org/10.1371/journal.pone.0012902			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886117	gold, Green Published, Green Submitted			2022-12-25	WOS:000282091100012
J	Duan, L; Raja, SM; Chen, GS; Virmani, S; Williams, SH; Clubb, RJ; Mukhopadhyay, C; Rainey, MA; Ying, GG; Dimri, M; Chen, J; Reddi, AL; Naramura, M; Band, V; Band, H				Duan, Lei; Raja, Srikumar M.; Chen, Gengsheng; Virmani, Sumeet; Williams, Stetson H.; Clubb, Robert J.; Mukhopadhyay, Chandrani; Rainey, Mark A.; Ying, Guoguang; Dimri, Manjari; Chen, Jing; Reddi, Alagarsamy L.; Naramura, Mayumi; Band, Vimla; Band, Hamid			Negative Regulation of EGFR-Vav2 Signaling Axis by Cbl Ubiquitin Ligase Controls EGF Receptor-mediated Epithelial Cell Adherens Junction Dynamics and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; NUCLEOTIDE-EXCHANGE FACTORS; RHO-FAMILY GTPASES; C-CBL; TUMOR PROGRESSION; TYROSINE KINASES; DOWN-REGULATION; E-CADHERIN; BREAST-CANCER; VAV PROTEINS	The E3 ubiquitin ligase Casitas B lymphoma protein (Cbl) controls the ubiquitin-dependent degradation of EGF receptor (EGFR), but its role in regulating downstream signaling elements with which it associates and its impact on biological outcomes of EGFR signaling are less clear. Here, we demonstrate that stimulation of EGFR on human mammary epithelial cells disrupts adherens junctions (AJs) through Vav2 and Rac1/Cdc42 activation. In EGF-stimulated cells, Cbl regulates the levels of phosphorylated Vav2 thereby attenuating Rac1/Cdc42 activity. Knockdown of Cbl and Cbl-b enhanced the EGF-induced disruption of AJs and cell motility. Overexpression of constitutively active Vav2 activated Rac1/Cdc42 and reorganized junctional actin cytoskeleton; these effects were suppressed by WT Cbl and enhanced by a ubiquitin ligase-deficient Cbl mutant. Cbl forms a complex with phospho-EGFR and phospho-Vav2 and facilitates phospho-Vav2 ubiquitinylation. Cbl can also interact with Vav2 directly in a Cbl Tyr-700-dependent manner. A ubiquitin ligase-deficient Cbl mutant enhanced the morphological transformation of mammary epithelial cells induced by constitutively active Vav2; this effect requires an intact Cbl Tyr-700. These results indicate that Cbl ubiquitin ligase plays a critical role in the maintenance of AJs and suppression of cell migration through down-regulation of EGFR-Vav2 signaling.	[Band, Hamid] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Duan, Lei; Raja, Srikumar M.; Williams, Stetson H.; Clubb, Robert J.; Mukhopadhyay, Chandrani; Rainey, Mark A.; Naramura, Mayumi; Band, Vimla; Band, Hamid] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Dept Pharmacol & Neurosci, Omaha, NE 68198 USA; [Band, Vimla] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Coll Med, Omaha, NE 68198 USA; [Duan, Lei; Raja, Srikumar M.; Chen, Gengsheng; Virmani, Sumeet; Rainey, Mark A.; Ying, Guoguang; Dimri, Manjari; Chen, Jing; Reddi, Alagarsamy L.; Naramura, Mayumi; Band, Vimla; Band, Hamid] Northwestern Univ, Dept Med, N Shore Univ Hlth Syst, Evanston, IL 60201 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Northwestern University	Duan, L (corresponding author), Rush Univ, Dept Radiat Oncol, Med Ctr, 1750 W Harrison St, Chicago, IL 60612 USA.	lei_duan@rush.edu; sraja@unmc.edu; hband@unmc.edu	Band, Hamid/AAF-4701-2020	Naramura, Mayumi/0000-0003-3658-0767	National Institutes of Health [CA87986, CA99163, CA105489, CA116552, CA94143, CA96844]; Department of Defense Breast Cancer [W81XWH-05-1-0231, DAMD17-02-1-0508, W81XWH-07-1-0351]; Nebraska Department of Health and Human Services [LB-506]; Nebraska Center for Nanomedicine [NCN-COBRE]; NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA105489, R01CA087986, R01CA096844, R01CA116552, R01CA099163, R01CA094143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer(United States Department of Defense); Nebraska Department of Health and Human Services; Nebraska Center for Nanomedicine; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA87986, CA99163, CA105489, and CA116552 (to H. B.) and CA94143 and CA96844 (to V. B.). This work was also supported by Department of Defense Breast Cancer Research Grants W81XWH-05-1-0231, DAMD17-02-1-0508, and W81XWH-07-1-0351 (to V. B.), Nebraska Department of Health and Human Services Grant LB-506 (to S. M. R.), and Nebraska Center for Nanomedicine-Center for Biomedical Research Excellence Grant NCN-COBRE (seed grant to S. M. R.).; We thank Drs. Senthil Muthuswamy (MCF10A cells), Jonathan Higgins and Michael Brenner (anti-E-cadherin hybridoma), Martin Schwartz (GST-RBD), John G. Collard (GST-PBD), and Brian Druker (4G10 antibody) for gifts of critical reagents. We thank Dr. Aharon Solomon for help with statistical analyses and other members of the Band laboratories for helpful suggestions and discussion. We thank Janice Taylor and James Talaska for providing assistance with confocal microscopy. The confocal laser scanning microscope and other core facilities used in this study were supported by Nebraska Research Initiative and University of Nebraska Medical Center-Eppley Cancer Center Core Support Grant from the NCI, National Institutes of Health.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00185-4; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Bacher U, 2010, ANN HEMATOL, V89, P643, DOI 10.1007/s00277-010-0920-6; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; BEHRENS J, 1993, BREAST CANCER RES TR, V24, P175, DOI 10.1007/BF01833258; BIRCHMEIER W, 1995, CIBA F SYMP, V189, P124; Birchmeier W, 1995, CIBA FOUND S, V189, P174; Birchmeier W, 1995, CIBA FOUND S, V189, P136; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Bustelo XR, 1996, CRIT REV ONCOGENESIS, V7, P65, DOI 10.1615/CritRevOncog.v7.i1-2.50; CHRYSOGELOS SA, 1994, BREAST CANCER RES TR, V29, P29, DOI 10.1007/BF00666179; Crowley MR, 2005, DEV BIOL, V279, P58, DOI 10.1016/j.ydbio.2004.11.034; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Duan L, 2010, J BIOL CHEM, V285, P1555, DOI 10.1074/jbc.M109.057976; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fournier TM, 2000, MOL BIOL CELL, V11, P3397, DOI 10.1091/mbc.11.10.3397; Fujita Y., 2005, NOVART FDN SYMP, V269; Fujita Y., 2005, NOVART FDN SYMP, V269, P223; Fujita Yasuyuki, 2005, Novartis Found Symp, V269, P144; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jost M, 2000, EUR J DERMATOL, V10, P505; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Lee H, 2008, INT J BIOCHEM CELL B, V40, P1930, DOI 10.1016/j.biocel.2008.02.013; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Magkou C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2103; Marengere LEM, 1997, J IMMUNOL, V159, P70; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; RAJKUMAR T, 1994, BREAST CANCER RES TR, V29, P3, DOI 10.1007/BF00666177; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Rodahl LM, 2009, BIOCHEM SOC T, V37, P137, DOI 10.1042/BST0370137; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rubin C, 2005, CELL RES, V15, P66, DOI 10.1038/sj.cr.7290268; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Scaife RM, 2003, J CELL SCI, V116, P463, DOI 10.1242/jcs.00244; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Shao Y, 2003, EMBO REP, V4, P425, DOI 10.1038/sj.embor.embor813; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; SOULE HD, 1990, CANCER RES, V50, P6075; STAMPFER MR, 1993, EXP CELL RES, V208, P175, DOI 10.1006/excr.1993.1236; TAKAISHI K, 1994, ONCOGENE, V9, P273; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Teckchandani AM, 2001, ONCOGENE, V20, P1739, DOI 10.1038/sj.onc.1204246; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Turner M, 2002, ADV EXP MED BIOL, V512, P29; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang J, 2002, J IMMUNOL, V169, P2236, DOI 10.4049/jimmunol.169.5.2236; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	85	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					620	633		10.1074/jbc.M110.188086	http://dx.doi.org/10.1074/jbc.M110.188086			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20940296	Green Published, hybrid			2022-12-25	WOS:000285782800064
J	Avila, RL; D'Antonio, M; Bachi, A; Inouye, H; Feltri, ML; Wrabetz, L; Kirschner, DA				Avila, Robin L.; D'Antonio, Maurizio; Bachi, Angela; Inouye, Hideyo; Feltri, M. Laura; Wrabetz, Lawrence; Kirschner, Daniel A.			P0 (Protein Zero) Mutation S34C Underlies Instability of Internodal Myelin in S63C Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOW AXONAL-TRANSPORT; DEMYELINATING PERIPHERAL NEUROPATHIES; EXPERIMENTAL DIABETIC-NEUROPATHY; EXTRACELLULAR DOMAIN; MEMBRANE-STRUCTURE; HEREDITARY MOTOR; DEJERINE-SOTTAS; SCHWANN-CELLS; NERVE MYELIN; NEUROFILAMENT PHOSPHORYLATION	P0 constitutes 50-60% of protein in peripheral nerve myelin and is essential for its structure and stability. Mutations within the P0 gene (MPZ) underlie a variety of hereditary neuropathies. MpzS63C transgenic mice encode a P0 with a serine to cysteine substitution at position 34 in the extracellular domain of mature P0 (P0S34C), associated with the hypomyelinating Dejerine-Sottas syndrome in human. S63C mice develop a dysmyelinating neuropathy, with packing defects in peripheral myelin. Here, we used x-ray diffraction to examine time-dependent packing defects in unfixed myelin. At similar to 7 h post-dissection, WT and S63C(+/+) myelin showed native periods (175 angstrom) with the latter developing at most a few percent swollen myelin, whereas up to similar to 50% of S63C(+/-) (mutant P0 on heterozygous P0 null background) or P0(+/+) myelin swelled to periods of similar to 205 angstrom. In the same time frame, S63C(-/-) myelin was stable, remaining swollen at similar to 210 angstrom. Surprisingly, treatment of whole S63C(-/-) nerves with a reducing agent completely reverted swollen arrays to native spacing and also normalized the swollen arrays that had formed in S63C(+/-) myelin, the genotype most closely related to the human disorder. Western blot revealed P0-positive bands at similar to 27 and similar to 50 kDa, and MALDI-TOF mass spectrometry showed these bands consisted of Ser(34)-containing peptides or P0 dimers having oxidized Cys(34) residues. We propose that P0S34C forms ectopic disulfide bonds in trans between apposed Cys(34) side chains that retard wrapping during myelin formation causing hypomyelination. Moreover, the new bonds create a packing defect by stabilizing swollen membrane arrays that leads to demyelination.	[Kirschner, Daniel A.] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [D'Antonio, Maurizio; Bachi, Angela; Feltri, M. Laura; Wrabetz, Lawrence] DIBIT, Div Genet & Cell Biol, San Raffaele Sci Inst, I-20132 Milan, Italy	Boston College; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Kirschner, DA (corresponding author), Boston Coll, Dept Biol, 140 Commonwealth Ave, Chestnut Hill, MA 02467 USA.	kirschnd@bc.edu	bachi, angela/B-3527-2015; D'Antonio, Maurizio/AHI-1781-2022; Feltri, Maria Laura/J-5286-2018	bachi, angela/0000-0003-4842-6556; D'Antonio, Maurizio/0000-0003-0637-8971; Kirschner, Daniel/0000-0003-3498-1452	NINDS [NS55256, NS45630]; Boston College, Telethon, Italy [GGP07100, GGP08021]; European Community [NGIDD-HEALTH-F2-2008-201535]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045630, R01NS055256] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Boston College, Telethon, Italy; European Community(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS55256 and NS45630 from NINDS. This work was also supported by institutional funds from Boston College (to D. A. K.), Telethon, Italy, Grants GGP07100 and GGP08021, and European Community Grants NGIDD-HEALTH-F2-2008-201535 (to L.W. and M. L. F.).	Agrawal D, 2009, J STRUCT BIOL, V168, P521, DOI 10.1016/j.jsb.2009.06.019; AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; Alexander L.E., 1979, XRAY DIFFRACTION MET; Avila RL, 2005, J NEUROPATH EXP NEUR, V64, P976, DOI 10.1097/01.jnen.0000186925.95957.dc; Bjartmar C, 1999, J NEUROCYTOL, V28, P383, DOI 10.1023/A:1007010205037; BLAUROCK AE, 1991, NEUROPATH APPL NEURO, V17, P309, DOI 10.1111/j.1365-2990.1991.tb00728.x; DEWAEGH S, 1990, J NEUROSCI, V10, P1855; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HAN JC, 1994, ANAL BIOCHEM, V220, P5, DOI 10.1006/abio.1994.1290; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; INOUYE H, 1989, BIOPHYS J, V56, P129, DOI 10.1016/S0006-3495(89)82658-X; INOUYE H, 1988, BIOPHYS J, V53, P235, DOI 10.1016/S0006-3495(88)83085-6; Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200; Kirschner D. A., 2004, MYELIN BIOL DISORDER, V1, P523; Kirschner DA, 1996, J NEUROSCI RES, V46, P502, DOI 10.1002/(SICI)1097-4547(19961115)46:4<502::AID-JNR12>3.0.CO;2-#; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; KIRSCHNER DA, 1975, P NATL ACAD SCI USA, V72, P3513, DOI 10.1073/pnas.72.9.3513; KIRSCHNER DA, 1989, J NEUROCHEM, V53, P1599, DOI 10.1111/j.1471-4159.1989.tb08558.x; KIRSCHNER DA, 1980, J ULTRA MOL STRUCT R, V73, P211, DOI 10.1016/S0022-5320(80)90125-2; KIRSCHNER DA, 1994, J NEUROSCI RES, V39, P63, DOI 10.1002/jnr.490390109; Kirschner Daniel A., 1992, P3; LEVISON ME, 1969, EXPERIENTIA, V25, P126, DOI 10.1007/BF01899076; LEWIS SD, 1976, BIOCHEMISTRY-US, V15, P5009, DOI 10.1021/bi00668a010; LEWIS SD, 1981, BIOCHEMISTRY-US, V20, P48, DOI 10.1021/bi00504a009; Li H, 2005, ACTA CRYSTALLOGR E, V61, pM761, DOI 10.1107/S1600536805009098; Martini R, 2001, MUSCLE NERVE, V24, P456, DOI 10.1002/mus.1027; MARTINI R, 1995, J NEUROSCI, V15, P4488; MEDORI R, 1988, J NEUROSCI, V8, P1814; MEDORI R, 1988, NEUROLOGY, V38, P597, DOI 10.1212/WNL.38.4.597; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; OUVRIER RA, 1987, BRAIN, V110, P121, DOI 10.1093/brain/110.1.121; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Peters A., 1991, FINE STRUCTURE NERVO; Pinitglang S, 1997, BIOCHEMISTRY-US, V36, P9968, DOI 10.1021/bi9705974; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shy ME, 2002, LANCET NEUROL, V1, P110, DOI 10.1016/S1474-4422(02)00042-X; Shy ME, 2004, BRAIN, V127, P371, DOI 10.1093/brain/awh048; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; WATSON DF, 1994, NEUROLOGY, V44, P2383, DOI 10.1212/WNL.44.12.2383; WELLS CA, 1993, J NEUROCHEM, V61, P1987, DOI 10.1111/j.1471-4159.1993.tb07434.x; WHITAKER JR, 1965, J AM CHEM SOC, V87, P2728, DOI 10.1021/ja01090a034; Wrabetz L, 2006, J NEUROSCI, V26, P2358, DOI 10.1523/JNEUROSCI.3819-05.2006; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; Yin X, 2000, J CELL BIOL, V148, P1009, DOI 10.1083/jcb.148.5.1009; Yin XH, 2006, J CELL BIOL, V172, P469, DOI 10.1083/jcb.200509174	50	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42001	42012		10.1074/jbc.M110.166967	http://dx.doi.org/10.1074/jbc.M110.166967			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20937820	Green Published, hybrid			2022-12-25	WOS:000285622600086
J	Komatsu, H; Feingold-Link, E; Sharp, KA; Rastogi, T; Axelsen, PH				Komatsu, Hiroaki; Feingold-Link, Elana; Sharp, Kim A.; Rastogi, Tanvi; Axelsen, Paul H.			Intrinsic Linear Heterogeneity of Amyloid beta Protein Fibrils Revealed by Higher Resolution Mass-per-length Determinations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; TRANSMISSION ELECTRON-MICROSCOPE; ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; QUATERNARY STRUCTURE; CONGO RED; A-BETA(1-40); PEPTIDE; OXIDATION; FIBRILLOGENESIS	Amyloid beta proteins spontaneously form fibrils in vitro that vary in their thermodynamic stability and in morphological characteristics such as length, width, shape, longitudinal twist, and the number of component filaments. It is vitally important to determine which variant best represents the type of fibril that accumulates in Alzheimer disease. In the present study, the nature of morphological variation was examined by dark-field and transmission electron microscopy in a preparation of seeded amyloid beta protein fibrils that formed at relatively low protein concentrations and exhibited remarkably high thermodynamic stability. The number of filaments comprising these fibrils changed frequently from two to six along their length, and these changes only became apparent when mass-per-length (MPL) determinations are made with sufficient resolution. The MPL results could be reproduced by a simple stochastic model with a single adjustable parameter. The presence of more than two primary filaments could not be discerned by transmission electron microscopy, and they had no apparent relationship to the longitudinal twist of the fibrils. However, the pitch of the twist was strongly affected by the pH of the negative stain. We conclude that highly stable amyloid fibrils may form in which a surprising amount of intrinsic linear heterogeneity may be obscured by MPL measurements of insufficient resolution, and by the negative stains used for imaging fibrils by electron microscopy.	[Komatsu, Hiroaki; Feingold-Link, Elana; Axelsen, Paul H.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Sharp, Kim A.; Rastogi, Tanvi; Axelsen, Paul H.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Axelsen, Paul H.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Axelsen, PH (corresponding author), Univ Penn, Dept Pharmacol, 105 Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	axe@upenn.edu		Tal, Elana/0000-0001-7065-8121	National Institute on Aging; American Health Assistance Foundation; Alzheimer Association	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Health Assistance Foundation; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation)	This work was supported in part by grants from the National Institute on Aging, the American Health Assistance Foundation, and the Alzheimer Association.	Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; Arimon M, 2005, FASEB J, V19, P1344, DOI 10.1096/fj.04-3137fje; Benzinger TLS, 2000, BIOCHEMISTRY-US, V39, P3491, DOI 10.1021/bi991527v; Bose PP, 2010, ACS CHEM NEUROSCI, V1, P315, DOI 10.1021/cn900041x; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Carter DB, 1998, NEUROBIOL AGING, V19, P37, DOI 10.1016/S0197-4580(97)00164-4; Chaney MO, 1998, PROTEIN ENG, V11, P761, DOI 10.1093/protein/11.9.761; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Feja B, 1997, J STRUCT BIOL, V119, P72, DOI 10.1006/jsbi.1997.3861; Feja B, 1999, MICRON, V30, P299, DOI 10.1016/S0968-4328(99)00032-3; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; JACKSON M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P231, DOI 10.1016/0167-4838(91)90563-F; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Karsai A, 2006, J STRUCT BIOL, V155, P316, DOI 10.1016/j.jsb.2005.12.015; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Liu L, 2008, J MOL BIOL, V377, P1236, DOI 10.1016/j.jmb.2008.01.057; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; MORI H, 1992, J BIOL CHEM, V267, P17082; NAMBA K, 1986, SCIENCE, V231, P1401, DOI 10.1126/science.3952490; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Rubin N, 2008, J AM CHEM SOC, V130, P4602, DOI 10.1021/ja800328y; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Sachse C, 2006, J MOL BIOL, V362, P347, DOI 10.1016/j.jmb.2006.07.011; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; SELKOE DJ, 1986, METHOD ENZYMOL, V134, P388; Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; SHECHTER Y, 1986, J BIOL CHEM, V261, P66; Shivaprasad S, 2004, BIOCHEMISTRY-US, V43, P15310, DOI 10.1021/bi048019s; Sousa AA, 2007, J MICROSC-OXFORD, V228, P25, DOI 10.1111/j.1365-2818.2007.01819.x; Usui K, 2009, P NATL ACAD SCI USA, V106, P18563, DOI 10.1073/pnas.0804758106; WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355; Wang ZG, 2003, ULTRAMICROSCOPY, V97, P73, DOI 10.1016/S0304-3991(03)00031-7; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; ZEITLER E, 1962, J APPL PHYS, V33, P847, DOI 10.1063/1.1777179; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106	56	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41843	41851		10.1074/jbc.M110.165068	http://dx.doi.org/10.1074/jbc.M110.165068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20940298	Green Published, hybrid			2022-12-25	WOS:000285622600072
J	Fukuda, T; Sugita, S; Inatome, R; Yanagi, S				Fukuda, Toshifumi; Sugita, Satoko; Inatome, Ryoko; Yanagi, Shigeru			CAMDI, a Novel Disrupted in Schizophrenia 1 (DISC1)-binding Protein, Is Required for Radial Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY LIGHT-CHAIN; NEURONAL MIGRATION; BEHAVIORAL PHENOTYPES; DISC1; CENTROSOME; DYNEIN; BRAIN; MICE; LIS1; DISRUPTED-IN-SCHIZOPHRENIA-1	Centrosomes play a crucial role in the directed migration of developing neurons. However, the underlying mechanism is poorly understood. This study has identified a novel disrupted in schizophrenia 1 (DISC1)-interacting protein, named CAMDI after coiled-coil protein associated with myosin II and DISC1, which translocates to the centrosome in a DISC1-dependent manner. Knockdown of CAMDI by shRNA revealed severely impaired radial migration with disoriented centrosomes. A yeast two-hybrid screen identified myosin II as a binding protein of CAMDI. CAMDI interacts preferentially with phosphomyosin II and induces an accumulation of phosphomyosin II at the centrosome in a DISC1-dependent manner. Interestingly, one single nucleotide polymorphism of the CAMDI gene (R828W) is identified, and its gene product was found to reduce the binding ability to phosphomyosin II. Furthermore, mice with overexpression of R828W in neurons exhibit an impaired radial migration. Our findings indicate that CAMDI is required for radial migration probably through DISC1 and myosin II-mediated centrosome positioning during neuronal development.	[Fukuda, Toshifumi; Sugita, Satoko; Inatome, Ryoko; Yanagi, Shigeru] Tokyo Univ Pharm & Life Sci, Lab Mol Biochem, Sch Life Sci, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences	Fukuda, T (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Mol Biochem, Sch Life Sci, Tokyo 1920392, Japan.	tfukuda@ls.toyaku.ac.jp; syanagi@ls.toyaku.ac.jp	Yanagi, Shigeru/AAU-9513-2020	Yanagi, Shigeru/0000-0002-1392-8663	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology and the Japan Society for the Promotion of Science (to T. F., R. I., and S. Y.).	Asada N, 2007, J NEUROSCI, V27, P11769, DOI 10.1523/JNEUROSCI.1938-07.2007; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Conroy J, 2009, AM J MED GENET B, V150B, P535, DOI 10.1002/ajmg.b.30854; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Goulding MB, 2007, J CELL BIOL, V178, P1177, DOI 10.1083/jcb.200703159; Gressens P, 2006, CURR OPIN NEUROL, V19, P135, DOI 10.1097/01.wco.0000218228.73678.e1; Hatten ME, 2005, J CELL BIOL, V170, P867, DOI 10.1083/jcb.200506140; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; KAMISOYAMA H, 1994, BIOCHEMISTRY-US, V33, P840, DOI 10.1021/bi00169a027; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; Korth C, 2009, REV NEUROSCIENCE, V20, P321; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Mencarelli MA, 2007, AM J MED GENET A, V143A, P858, DOI 10.1002/ajmg.a.31602; Metin C, 2008, J NEUROSCI, V28, P11746, DOI 10.1523/JNEUROSCI.3860-08.2008; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; SWEENEY HL, 1994, P NATL ACAD SCI USA, V91, P1490, DOI 10.1073/pnas.91.4.1490; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Williams T, 2008, TRENDS CELL BIOL, V18, P193, DOI 10.1016/j.tcb.2008.01.008; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	45	40	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40554	40561		10.1074/jbc.M110.179481	http://dx.doi.org/10.1074/jbc.M110.179481			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956536	hybrid, Green Published			2022-12-25	WOS:000285414400018
J	Park, H; Boyington, JC				Park, HaJeung; Boyington, Jeffrey C.			The 1.5 angstrom Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-PRODUCTS RAGE; CELL-SURFACE RECEPTOR; PATTERN-RECOGNITION; SCAVENGER RECEPTORS; ALZHEIMERS-DISEASE; NMR SYSTEM; PROTEINS; ACTIVATION; S100B; CRYSTALLOGRAPHY	Interaction of the pattern recognition receptor, RAGE with key ligands such as advanced glycation end products (AGE), S100 proteins, amyloid beta, and HMGB1 has been linked to diabetic complications, inflammatory and neurodegenerative disorders, and cancer. To help answer the question of how a single receptor can recognize and respond to a diverse set of ligands we have investigated the structure and binding properties of the first two extracellular domains of human RAGE, which are implicated in various ligand binding and subsequent signaling events. The 1.5-angstrom crystal structure reveals an elongated molecule with a large basic patch and a large hydrophobic patch, both highly conserved. Isothermal titration calorimetry (ITC) and deletion experiments indicate S100B recognition by RAGE is an entropically driven process involving hydrophobic interaction that is dependent on Ca2+ and on residues in the C'D loop (residues 54-67) of domain 1. In contrast, competition experiments using gel shift assays suggest that RAGE interaction with AGE is driven by the recognition of negative charges on AGE-proteins. We also demonstrate that RAGE can bind to dsDNA and dsRNA. These findings reveal versatile structural features of RAGE that help explain its ability to recognize of multiple ligands.	[Park, HaJeung; Boyington, Jeffrey C.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Park, H (corresponding author), Scripps Res Inst, Jupiter, FL 33458 USA.	hajpark@scripps.edu; boyingtonj@niaid.nih.gov		ADSIT, FLOYD/0000-0002-1971-3604; Park, HaJeung/0000-0003-4898-7919	National Institutes of Health, NIEHS	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIEHS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAUDIER J, 1982, FEBS LETT, V148, P231, DOI 10.1016/0014-5793(82)80813-2; Bhattacharya S, 2003, BIOCHEMISTRY-US, V42, P14416, DOI 10.1021/bi035089a; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; BRETT J, 1993, AM J PATHOL, V143, P1699; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YL, 2004, J IMMUNOL, V173, P1399, DOI 10.4049/jimmunol.173.2.1399; Drohat AC, 1999, PROTEIN SCI, V8, P800; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Horner AA, 2004, CURR OPIN ALLERGY CL, V4, P555, DOI 10.1097/00130832-200412000-00014; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; IVANENKOV VV, 1995, J BIOL CHEM, V270, P14651, DOI 10.1074/jbc.270.24.14651; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LO TWC, 1994, J BIOL CHEM, V269, P32299; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; Park H, 2005, J BIOL CHEM, V280, P13593, DOI 10.1074/jbc.M500768200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Ramasamy R, 2005, TRENDS CARDIOVAS MED, V15, P237, DOI 10.1016/j.tcm.2005.08.003; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Sasahira T, 2007, HISTOPATHOLOGY, V51, P166, DOI 10.1111/j.1365-2559.2007.02739.x; SCHMIDT AM, 1994, P NATL ACAD SCI USA, V91, P8807, DOI 10.1073/pnas.91.19.8807; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Smith SP, 1998, STRUCTURE, V6, P211, DOI 10.1016/S0969-2126(98)00022-7; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	49	101	106	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40762	40770		10.1074/jbc.M110.169276	http://dx.doi.org/10.1074/jbc.M110.169276			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943659	hybrid, Green Published			2022-12-25	WOS:000285414400040
J	Wu, SH; Arevalo, JC; Neubrand, VE; Zhang, H; Arancio, O; Chao, MV				Wu, Synphen H.; Arevalo, Juan Carlos; Neubrand, Veronika E.; Zhang, Hong; Arancio, Ottavio; Chao, Moses V.			The Ankyrin Repeat-rich Membrane Spanning (ARMS)/Kidins220 Scaffold Protein Is Regulated by Activity-dependent Calpain Proteolysis and Modulates Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; MEDIATED TRUNCATION; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; GENE-EXPRESSION; AMPA RECEPTORS; MAP KINASE; PHOSPHORYLATION; ACTIVATION; DEPOLARIZATION	The expression of forms of synaptic plasticity, such as the phenomenon of long-term potentiation, requires the activity-dependent regulation of synaptic proteins and synapse composition. Here we show that ARMS (ankyrin repeat-rich membrane spanning protein)/Kidins220, a transmembrane scaffold molecule and BDNF TrkB substrate, is significantly reduced in hippocampal neurons after potassium chloride depolarization. The activity-dependent proteolysis of ARMS/Kidins220 was found to occur through calpain, a calcium-activated protease. Moreover, hippocampal long-term potentiation in ARMS/ Kidins220(+/-) mice was enhanced, and inhibition of calpain in these mice reversed these effects. These results provide an explanation for a role for the ARMS/Kidins220 protein in synaptic plasticity events and suggest that the levels of ARMS/ Kidins220 can be regulated by neuronal activity and calpain action to influence synaptic function.	[Wu, Synphen H.; Arevalo, Juan Carlos; Chao, Moses V.] NYU, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; [Wu, Synphen H.; Arevalo, Juan Carlos; Chao, Moses V.] NYU, Dept Physiol & Neurosci, New York, NY 10016 USA; [Chao, Moses V.] NYU, Dept Cell Biol, New York, NY 10016 USA; [Neubrand, Veronika E.] London Res Inst, Mol Neuropathobiol Lab, Canc Res UK, London WC2A 3PX, England; [Zhang, Hong; Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, Taub Inst, New York, NY 10032 USA	New York University; New York University; New York University; Cancer Research UK; Columbia University	Wu, SH (corresponding author), 540 1st Ave,SK 5-15, New York, NY 10016 USA.	synphen.wu@nyumc.org	IBSAL, Secretaría/H-3719-2011; Neubrand, Veronika Elisabeth/AAA-3195-2019; Arévalo, Juan Carlos/J-8154-2014; arancio, ottavio/AAB-7959-2019	Neubrand, Veronika Elisabeth/0000-0002-3793-8487; Arévalo, Juan Carlos/0000-0003-1994-3095; Chao, Moses/0000-0002-6969-3744; arancio, ottavio/0000-0001-6335-164X	National Institutes of Health [NS21072, HD23315, NS049442]; Medical Scientist Training Program; Marie Curie International Reintegration Grant within the 7th European Community; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072, R56NS021072, R01NS049442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie International Reintegration Grant within the 7th European Community; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS21072 and HD23315 (to M. V. C.) and NS049442 (to O. A.). This work was also supported by the Medical Scientist Training Program (to S. H. W.), and a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme (to J. C. A.).	Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; Battaglia F, 2003, J MOL NEUROSCI, V20, P357, DOI 10.1385/JMN:20:3:357; Bi RF, 1998, BRAIN RES, V797, P154, DOI 10.1016/S0006-8993(98)00433-8; Bi XN, 1997, J NEUROCHEM, V68, P1484; Bi XN, 1998, BRAIN RES, V790, P245, DOI 10.1016/S0006-8993(98)00067-5; Arevalo JC, 2010, MOL CELL NEUROSCI, V45, P92, DOI 10.1016/j.mcn.2010.06.002; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; Cortes RY, 2007, DEV NEUROBIOL, V67, P1687, DOI 10.1002/dneu.20542; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Jia JM, 2008, J BIOL CHEM, V283, P21242, DOI 10.1074/jbc.M800282200; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Li XR, 2007, MOL BIOCHEM PARASIT, V155, P26, DOI 10.1016/j.molbiopara.2007.05.004; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Lopez-Menendez C, 2009, J CELL SCI, V122, P3554, DOI 10.1242/jcs.056473; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Lu XY, 2000, BRAIN RES, V863, P143, DOI 10.1016/S0006-8993(00)02112-0; Lu XY, 2001, J NEUROCHEM, V77, P1553, DOI 10.1046/j.1471-4159.2001.00359.x; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; Park HJ, 2010, MOL CELLS, V30, P143, DOI 10.1007/s10059-010-0099-7; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sutachan JJ, 2010, J NEUROSCI RES, V88, P3447, DOI 10.1002/jnr.22513; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Wu SH, 2009, DEV NEUROBIOL, V69, P547, DOI 10.1002/dneu.20723; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Yuen EY, 2007, J BIOL CHEM, V282, P16434, DOI 10.1074/jbc.M701283200; Yuen EY, 2007, J PHYSIOL-LONDON, V580, P241, DOI 10.1113/jphysiol.2006.122754; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010	42	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40472	40478		10.1074/jbc.M110.171371	http://dx.doi.org/10.1074/jbc.M110.171371			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943655	Green Published, hybrid			2022-12-25	WOS:000285414400009
J	Hammes, UZ; Meier, S; Dietrich, D; Ward, JM; Rentsch, D				Hammes, Ulrich Z.; Meier, Stefan; Dietrich, Daniela; Ward, John M.; Rentsch, Doris			Functional Properties of the Arabidopsis Peptide Transporters AtPTR1 and AtPTR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; OLIGOPEPTIDE TRANSPORTER; SEED DEVELOPMENT; AFFINITY; GERMINATION; EXPRESSION; NITRATE; PLANTS; IDENTIFICATION; MECHANISMS	The Arabidopsis di- and tripeptide transporters AtPTR1 and AtPTR5 were expressed in Xenopus laevis oocytes, and their selectivity and kinetic properties were determined by voltage clamping and by radioactive uptake. Dipeptide transport by AtPTR1 and AtPTR5 was found to be electrogenic and dependent on protons but not sodium. In the absence of dipeptides, both transporters showed proton-dependent leak currents that were inhibited by Phe-Ala (AtPTR5) and Phe-Ala, Trp-Ala, and Phe-Phe (AtPTR1). Phe-Ala was shown to reduce leak currents by binding to the substrate-binding site with a high apparent affinity. Inhibition of leak currents was only observed when the aromatic amino acids were present at the N-terminal position. AtPTR1 and AtPTR5 transport activity was voltage-dependent, and currents increased supralinearly with more negative membrane potentials and did not saturate. The voltage dependence of the apparent affinities differed between Ala-Ala, Ala-Lys, and Ala-Asp and was not conserved between the two transporters. The apparent affinity of AtPTR1 for these dipeptides was pH-dependent and decreased with decreasing proton concentration. In contrast to most proton-coupled transporters characterized so far, -I-max increased at high pH, indicating that regulation of the transporter by pH overrides the importance of protons as co-substrate.	[Hammes, Ulrich Z.; Meier, Stefan; Dietrich, Daniela; Rentsch, Doris] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [Ward, John M.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA	University of Bern; University of Minnesota System; University of Minnesota Twin Cities	Rentsch, D (corresponding author), Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland.	doris.rentsch@ips.unibe.ch	Dietrich, Daniela/AAC-2755-2020	Dietrich, Daniela/0000-0001-7241-4585; Ward, John/0000-0001-8185-0434; Rentsch, Doris/0000-0003-4313-7683	Swiss National Science Foundation [31003A_127340, 3100A0-107507]; United States Department of Energy [DE-FG02-07ER15886]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Swiss National Science Foundation Grants 31003A_127340 and 3100A0-107507 (to D. R.) and United States Department of Energy Grant DE-FG02-07ER15886 (to J. M. W.).	Baukrowitz T, 1999, EMBO J, V18, P847, DOI 10.1093/emboj/18.4.847; Biegel A, 2006, AMINO ACIDS, V31, P137, DOI 10.1007/s00726-006-0331-0; Chen XZ, 2000, BIOCHEM BIOPH RES CO, V272, P726, DOI 10.1006/bbrc.2000.2851; Chen XZ, 1999, J BIOL CHEM, V274, P2773, DOI 10.1074/jbc.274.5.2773; Chiang CS, 2004, J BIOL CHEM, V279, P30150, DOI 10.1074/jbc.M405192200; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; DANIEL H, 1992, J BIOL CHEM, V267, P9565; Detmers FJM, 2001, RES MICROBIOL, V152, P245, DOI 10.1016/S0923-2508(01)01196-2; Dietrich D, 2004, PLANT J, V40, P488, DOI 10.1111/j.1365-313X.2004.02224.x; Fang G, 2000, J BACTERIOL, V182, P2530, DOI 10.1128/JB.182.9.2530-2535.2000; Fei YJ, 1997, BIOCHEMISTRY-US, V36, P452, DOI 10.1021/bi962058p; Jeong JY, 2004, PLANT PHYSIOL, V134, P969, DOI 10.1104/pp.103.032102; Komarova NY, 2008, PLANT PHYSIOL, V148, P856, DOI 10.1104/pp.108.123844; Kottra G, 2002, J BIOL CHEM, V277, P32683, DOI 10.1074/jbc.M204192200; Mackenzie B, 1996, J BIOL CHEM, V271, P5430, DOI 10.1074/jbc.271.10.5430; MEHARG AA, 1995, J MEMBRANE BIOL, V145, P49; Miranda M, 2003, PLANT PHYSIOL, V132, P1950, DOI 10.1104/pp.103.024422; Paungfoo-Lonhienne C, 2009, J EXP BOT, V60, P2665, DOI 10.1093/jxb/erp111; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rentsch D, 2007, FEBS LETT, V581, P2281, DOI 10.1016/j.febslet.2007.04.013; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Segonzac C, 2007, PLANT CELL, V19, P3760, DOI 10.1105/tpc.106.048173; Sivitz AB, 2007, PLANT PHYSIOL, V143, P188, DOI 10.1104/pp.106.089003; Song W, 1997, PLANT PHYSIOL, V114, P927, DOI 10.1104/pp.114.3.927; Sugiura M, 2007, PLANT CELL PHYSIOL, V48, P1022, DOI 10.1093/pcp/pcm073; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Ward JM, 1997, PLANT PHYSIOL, V114, P1151, DOI 10.1104/pp.114.4.1151; Waterworth WM, 2006, ANN BOT-LONDON, V98, P1, DOI 10.1093/aob/mcl099; West CE, 1998, PLANT J, V15, P221, DOI 10.1046/j.1365-313X.1998.00199.x; Zhou JJ, 1998, J BIOL CHEM, V273, P12017, DOI 10.1074/jbc.273.20.12017	32	23	25	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39710	39717		10.1074/jbc.M110.141457	http://dx.doi.org/10.1074/jbc.M110.141457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937801	Green Published, hybrid			2022-12-25	WOS:000285185500015
J	Screen, M; Britton, M; Downey, SL; Verdoes, M; Voges, MJ; Blom, AEM; Geurink, PP; Risseeuw, MDP; Florea, BI; van der Linden, WA; Pletnev, AA; Overkleeft, HS; Kisselev, AF				Screen, Michael; Britton, Matthew; Downey, Sondra L.; Verdoes, Martijn; Voges, Mathias J.; Blom, Annet E. M.; Geurink, Paul P.; Risseeuw, Martijn D. P.; Florea, Bogdan I.; van der Linden, Wouter A.; Pletnev, Alexandre A.; Overkleeft, Herman S.; Kisselev, Alexei F.			Nature of Pharmacophore Influences Active Site Specificity of Proteasome Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; SELECTIVE INHIBITOR; PEPTIDE; YEAST; BORTEZOMIB; MECHANISM; SUBSTRATE; PROTEIN; CELLS	Proteasomes degrade most proteins in mammalian cells and are established targets of anti-cancer drugs. The majority of proteasome inhibitors are composed of short peptides with an electrophilic functionality (pharmacophore) at the C terminus. All eukaryotic proteasomes have three types of active sites as follows: chymotrypsin-like, trypsin-like, and caspase-like. It is widely believed that active site specificity of inhibitors is determined primarily by the peptide sequence and not the pharmacophore. Here, we report that active site specificity of inhibitors can also be tuned by the chemical nature of the pharmacophore. Specifically, replacement of the epoxyketone by vinyl sulfone moieties further improves the selectivity of beta 5-specific inhibitors NC-005, YU-101, and PR-171 (carfilzomib). This increase in specificity is likely the basis of the decreased cytotoxicity of vinyl sulfone-based inhibitors to HeLa cells as compared with that of epoxyketone-based inhibitors.	[Screen, Michael; Britton, Matthew; Downey, Sondra L.; Kisselev, Alexei F.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Screen, Michael; Britton, Matthew; Downey, Sondra L.; Pletnev, Alexandre A.; Kisselev, Alexei F.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Pletnev, Alexandre A.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Verdoes, Martijn; Voges, Mathias J.; Blom, Annet E. M.; Geurink, Paul P.; Risseeuw, Martijn D. P.; Florea, Bogdan I.; van der Linden, Wouter A.; Overkleeft, Herman S.] Leiden Inst Chem, NL-2333 CC Leiden, Netherlands; [Verdoes, Martijn; Voges, Mathias J.; Blom, Annet E. M.; Geurink, Paul P.; Risseeuw, Martijn D. P.; Florea, Bogdan I.; van der Linden, Wouter A.; Overkleeft, Herman S.] Netherlands Prote Ctr, NL-2333 CC Leiden, Netherlands; [Screen, Michael; Britton, Matthew] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Leiden University; University of Bath	Kisselev, AF (corresponding author), 1 Med Ctr Dr,HB7936, Lebanon, NH 03756 USA.	Alexei.F.Kisselev@Dartmouth.edu	Blom, Annet/S-8615-2019; Florea, Bogdan I./AAM-9975-2020; Verdoes, Martijn/A-4911-2015; Verdoes, Martijn/AAD-5239-2022	Verdoes, Martijn/0000-0001-8753-3528; Verdoes, Martijn/0000-0001-8753-3528; Overkleeft, Herman/0000-0001-6976-7005; Geurink, Paul/0000-0003-1849-1111	National Institutes of Health, NCI [RO1]; Netherlands Organization for Scientific Research; Netherlands Genomics Initiative; NATIONAL CANCER INSTITUTE [R01CA124634] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 Grant from NCI (to A.F.K.).; Supported by The Netherlands Organization for Scientific Research and The Netherlands Genomics Initiative. To whom correspondence may be addressed: Gorlaeus Laboratories, Einsteinweg 55, 2300 CC Leiden, The Netherlands. Tel.: 31715274342; Fax: 317-527-4307; h.s.overkleeft@chem.leidenuniv.nl.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Britton M, 2009, CHEM BIOL, V16, P1278, DOI 10.1016/j.chembiol.2009.11.015; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; Elofsson M, 1999, CHEM BIOL, V6, P811, DOI 10.1016/S1074-5521(99)80128-8; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Groll M, 2002, CHEM BIOL, V9, P655, DOI 10.1016/S1074-5521(02)00144-8; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; KIRSCHKE H, 1994, METHOD ENZYMOL, V244, P500; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; Marastoni M, 2005, J MED CHEM, V48, P5038, DOI 10.1021/JM040905D; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Parlati F, 2009, BLOOD, V114, P3439, DOI 10.1182/blood-2009-05-223677; Piva R, 2008, BLOOD, V111, P2765, DOI 10.1182/blood-2007-07-100651; van Swieten PF, 2007, BIOORG MED CHEM LETT, V17, P3402, DOI 10.1016/j.bmcl.2007.03.092; Verdoes M, 2007, ORG BIOMOL CHEM, V5, P1416, DOI 10.1039/b702268a; Verdoes M, 2006, CHEM BIOL, V13, P1217, DOI 10.1016/j.chembiol.2006.09.013; Verdoes M, 2010, ORG BIOMOL CHEM, V8, P2719, DOI 10.1039/c001036g	29	50	56	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40125	40134		10.1074/jbc.M110.160606	http://dx.doi.org/10.1074/jbc.M110.160606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937826	Green Published, hybrid			2022-12-25	WOS:000285185500058
J	Sengupta, D; Linstedt, AD				Sengupta, Debrup; Linstedt, Adam D.			Mitotic Inhibition of GRASP65 Organelle Tethering Involves Polo-like Kinase 1 (PLK1) Phosphorylation Proximate to an Internal PDZ Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI CISTERNAL STACKING; REGULATES GOLGI; HELA-CELLS; PROTEIN; MITOSIS; COMPLEX; FRAGMENTATION; DOMAIN; CHECKPOINT; SECRETION	GRASP65 links cis-Golgi cisternae via a homotypic, N-terminal PDZ interaction, and its mitotic phosphorylation disrupts this activity. Neither the identity of the PDZ ligand involved in the GRASP65 self-interaction nor the mechanism by which phosphorylation inhibits its interaction is known. Phospho-mimetic mutation of known cyclin-dependent kinase 1/cyclin B sites, all of which are in the C-terminal "regulatory domain" of the molecule, failed to block organelle tethering. However, we identified a site phosphorylated by Polo-like kinase 1 (PLK1) in the GRASP65 N-terminal domain for which mutation to aspartic acid blocked tethering and alanine substitution prevented mitotic Golgi unlinking. Further, using interaction assays, we discovered an internal PDZ ligand adjacent to the PLK phosphorylation site that was required for tethering. These results reveal the mechanism of phosphoinhibition as direct inhibition by PLK1 of the PDZ ligand underlying the GRASP65 self-interaction.	[Sengupta, Debrup; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Linstedt, AD (corresponding author), 4400 5th Ave, Pittsburgh, PA 15213 USA.	linstedt@cmu.edu			National Institutes of Health [GM-56779]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-56779 (to A. D. L.).	Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Carcedo CH, 2004, SCIENCE, V305, P93, DOI 10.1126/science.1097775; Chen BS, 2006, J BIOL CHEM, V281, P16583, DOI 10.1074/jbc.M513029200; Colanzi A, 2007, EMBO J, V26, P2465, DOI 10.1038/sj.emboj.7601686; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; Duran JM, 2008, MOL BIOL CELL, V19, P2579, DOI 10.1091/mbc.E07-10-0998; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Feinstein TN, 2007, MOL BIOL CELL, V18, P594, DOI 10.1091/mbc.E06-06-0530; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; Jesch SA, 2001, TRAFFIC, V2, P873, DOI 10.1034/j.1600-0854.2001.21203.x; Kano F, 2000, J CELL BIOL, V149, P357, DOI 10.1083/jcb.149.2.357; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; LUCOCQ JM, 1987, J CELL BIOL, V104, P865, DOI 10.1083/jcb.104.4.865; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; MISTELI T, 1995, J CELL SCI, V108, P2715; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rabouille C, 2007, CELL CYCLE, V6, P2723, DOI 10.4161/cc.6.22.4896; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Shaul YD, 2006, J CELL BIOL, V172, P885, DOI 10.1083/jcb.200509063; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Sutterlin C, 2001, P NATL ACAD SCI USA, V98, P9128, DOI 10.1073/pnas.161283998; Tang DM, 2010, TRAFFIC, V11, P827, DOI 10.1111/j.1600-0854.2010.01055.x; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132; Yoshimura S, 2005, J BIOL CHEM, V280, P23048, DOI 10.1074/jbc.M502442200; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	53	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39994	40003		10.1074/jbc.M110.189449	http://dx.doi.org/10.1074/jbc.M110.189449			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937827	hybrid, Green Published			2022-12-25	WOS:000285185500044
J	Thakur, S; Du, JJ; Hourani, S; Ledent, C; Li, JM				Thakur, Sapna; Du, Junjie; Hourani, Susanna; Ledent, Catherine; Li, Jian-Mei			Inactivation of Adenosine A(2A) Receptor Attenuates Basal and Angiotensin II-induced ROS Production by Nox2 in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE; MICE; RELAXATION; PATHOPHYSIOLOGY; PHARMACOLOGY; ACTIVATION; P47(PHOX); PATHWAY; MEDIATE	Endothelial cells (ECs) express a Nox2 enzyme, which, by generating reactive oxygen species (ROS), contributes to EC redox signaling and angiotensin II (AngII)-induced endothelial dysfunction. ECs also express abundantly an adenosine A(2A) receptor (A(2A)R), but its role in EC ROS production remains unknown. In this study, we investigated the role of A(2A)R in the regulation of Nox2 activity and signaling in ECs with or without acute AngII stimulation. In cultured ECs (SVEC4-10), AngII (100 nM, 30 min) significantly increased Nox2 membrane translocation and association with A(2A)R. These were accompanied by p47(phox), ERK1/2, p38 MAPK, and Akt phosphorylation and an increased ROS production (169 +/- 0.04%). These AngII effects were inhibited back to the control levels by a specific A(2A)R antagonist (SCH58261), or adenosine deaminase, or by knockdown of A(2A)R or Nox2 using specific siRNAs. Knockdown of A(2A)R, as determined by Western blotting, decreased Nox2 and p47(phox) expression. In wild-type mouse aorta, SCH58261 significantly reduced acute AngII-induced ROS production and preserved endothelium-dependent vessel relaxation to acetylcholine. These results were further confirmed by using aortas from A(2A)R knock-out mice. In conclusion, A(2A)R is involved in the regulation of EC ROS production by Nox2. Inhibition or blockade of A(2A)R protects ECs from acute AngII-induced oxidative stress, MAPK activation, and endothelium dysfunction.	[Thakur, Sapna; Du, Junjie; Hourani, Susanna; Li, Jian-Mei] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Ledent, Catherine] Univ Libre Bruxelles, Inst Rech Interdisplinaire Biol Humane & Mol, B-1070 Brussels, Belgium	University of Surrey; Universite Libre de Bruxelles	Li, JM (corresponding author), Univ Surrey, Fac Hlth & Med Sci, AY Bldg, Guildford GU2 7XH, Surrey, England.	j.li@surrey.ac.uk			British Heart Foundation [PG/06/073/21118]; Wellcome Trust [078637/Z/05/Z]	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the British Heart Foundation Grant PG/06/073/21118 and the Wellcome Trust Grant 078637/Z/05/Z.	Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927; Bengtsson SH, 2003, CLIN EXP PHARMACOL P, V30, P849, DOI 10.1046/j.1440-1681.2003.03929.x; Cheng KT, 2008, ARTERIOSCL THROM VAS, V28, P913, DOI 10.1161/ATVBAHA.107.148338; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Fan LM, 2009, ARTERIOSCL THROM VAS, V29, P1651, DOI 10.1161/ATVBAHA.109.191502; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hingtgen SD, 2006, PHYSIOL GENOMICS, V26, P180, DOI 10.1152/physiolgenomics.00029.2005; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Li JM, 2007, FREE RADICAL BIO MED, V43, P976, DOI 10.1016/j.freeradbiomed.2007.06.001; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Nadeem A, 2009, J PHARMACOL EXP THER, V330, P99, DOI 10.1124/jpet.109.151613; Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005; Ponnoth DS, 2009, AM J PHYSIOL-HEART C, V297, pH1655, DOI 10.1152/ajpheart.00192.2009; Prentice D, 2001, EUR J PHARMACOL, V415, P251, DOI 10.1016/S0014-2999(01)00841-X; Ribe D, 2008, FREE RADICAL BIO MED, V44, P1433, DOI 10.1016/j.freeradbiomed.2007.12.035; Sands WA, 2005, IMMUNOL LETT, V101, P1, DOI 10.1016/j.imlet.2005.04.005; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Tabrizchi R, 2001, PHARMACOL THERAPEUT, V91, P133, DOI 10.1016/S0163-7258(01)00152-8; Wang H, 2009, ARTERIOSCL THROM VAS, V29, P1046, DOI 10.1161/ATVBAHA.109.188839; Zezula J, 2008, BRIT J PHARMACOL, V153, pS184, DOI 10.1038/sj.bjp.0707674	23	57	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40104	40113		10.1074/jbc.M110.184606	http://dx.doi.org/10.1074/jbc.M110.184606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940302	hybrid, Green Published			2022-12-25	WOS:000285185500056
J	Wang, Z; Collighan, RJ; Gross, SR; Danen, EHJ; Orend, G; Telci, D; Griffin, M				Wang, Zhuo; Collighan, Russell J.; Gross, Stephane R.; Danen, Erik H. J.; Orend, Gertraud; Telci, Dilek; Griffin, Martin			RGD-independent Cell Adhesion via a Tissue Transglutaminase-Fibronectin Matrix Promotes Fibronectin Fibril Deposition and Requires Syndecan-4/2 and alpha 5 beta 1 Integrin Co-signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; SWISS 3T3 FIBROBLASTS; EXTRACELLULAR-MATRIX; BINDING SITE; TUMOR PROGRESSION; GROWTH; IDENTIFICATION; EXPRESSION; APOPTOSIS; PROTEIN	Fibronectin (FN) deposition mediated by fibroblasts is an important process in matrix remodeling and wound healing. By monitoring the deposition of soluble biotinylated FN, we show that the stress-induced TG-FN matrix, a matrix complex of tissue transglutaminase (TG2) with its high affinity binding partner FN, can increase both exogenous and cellular FN deposition and also restore it when cell adhesion is interrupted via the presence of RGD-containing peptides. This mechanism does not require the transamidase activity of TG2 but is activated through an RGD-independent adhesion process requiring a heterocomplex of TG2 and FN and is mediated by a syndecan-4 and beta 1 integrin co-signaling pathway. By using alpha 5 null cells, beta 1 integrin functional blocking antibody, and a alpha 5 beta 1 integrin targeting peptide A5-1, we demonstrate that the alpha 5 and beta 1 integrins are essential for TG-FN to compensate RGD-induced loss of cell adhesion and FN deposition. The importance of syndecan-2 in this process was shown using targeting siRNAs, which abolished the compensation effect of TG-FN on the RGD-induced loss of cell adhesion, resulting in disruption of actin skeleton formation and FN deposition. Unlike syndecan-4, syndecan-2 does not interact directly with TG2 but acts as a downstream effector in regulating actin cytoskeleton organization through the ROCK pathway. We demonstrate that PKC alpha is likely to be the important link between syndecan-4 and syndecan-2 signaling and that TG2 is the functional component of the TG-FN heterocomplex in mediating cell adhesion via its direct interaction with heparan sulfate chains.	[Wang, Zhuo; Collighan, Russell J.; Gross, Stephane R.; Telci, Dilek; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Danen, Erik H. J.] Leiden Univ, Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Toxicol, NL-2300 RA Leiden, Netherlands; [Orend, Gertraud] INSERM, Strasbourg, France	Aston University; Leiden University; Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Griffin, M (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	M.Griffin@aston.ac.uk	Telci, Dilek/N-5053-2019; Telci, Dilek/B-5880-2017; Orend, Gertraud/E-8446-2015	Telci, Dilek/0000-0002-2793-6533; Telci, Dilek/0000-0002-2793-6533; Orend, Gertraud/0000-0003-2522-1195; danen, erik/0000-0002-0491-6345; Griffin, Martin/0000-0003-3824-306X; gross, stephane/0000-0002-0867-8866; WANG, ZHUO/0000-0002-2212-8318	Marie Curie TRACKS RTN [MRTN-CT-2006-036032]; INSERM; Agence National de la Recherche; Association pour la Recherche sur le Cancer; Institut National du Cancer; University Hospital Hautepierre; University Strasbourg	Marie Curie TRACKS RTN; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); University Hospital Hautepierre; University Strasbourg	This work was supported in part by Marie Curie TRACKS RTN Grant MRTN-CT-2006-036032. The laboratory of G.O. is supported by INSERM, the Agence National de la Recherche, the Association pour la Recherche sur le Cancer, the Institut National du Cancer, the University Hospital Hautepierre, and the University Strasbourg.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Echtermeyer F, 1999, J CELL SCI, V112, P3433; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; FREUND KF, 1994, BIOCHEMISTRY-US, V33, P10109, DOI 10.1021/bi00199a039; Gambetti S, 2005, BIOCHIMIE, V87, P551, DOI 10.1016/j.biochi.2005.01.012; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Hsiao HL, 2005, MOL CELL BIOCHEM, V272, P75, DOI 10.1007/s11010-005-7638-0; Huang WT, 2001, CANCER RES, V61, P8586; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Isobe T, 1999, EUR J CELL BIOL, V78, P876, DOI 10.1016/S0171-9335(99)80089-2; Kim EY, 2008, BIOCHEM BIOPH RES CO, V377, P1288, DOI 10.1016/j.bbrc.2008.10.166; Klass CM, 2000, J CELL SCI, V113, P493; Kotsakis P, 2007, AMINO ACIDS, V33, P373, DOI 10.1007/s00726-007-0516-1; Kramer KL, 2002, CELL, V111, P981, DOI 10.1016/S0092-8674(02)01200-X; Kusano Y, 2004, J BIOCHEM, V135, P129, DOI 10.1093/jb/mvh015; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; Liaw L, 1999, BRAZ J MED BIOL RES, V32, P805, DOI 10.1590/S0100-879X1999000700002; Madden HL, 2000, AM J RESP CRIT CARE, V162, P1553, DOI 10.1164/ajrccm.162.4.2001015; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; Mostafavi-Pour Z, 2001, MATRIX BIOL, V20, P63, DOI 10.1016/S0945-053X(00)00131-1; NOTO K, 1995, INT IMMUNOL, V7, P835, DOI 10.1093/intimm/7.5.835; Orosco A, 2006, J CELL BIOCHEM, V98, P838, DOI 10.1002/jcb.20826; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Rudolph P, 1999, AM J DERMATOPATH, V21, P414, DOI 10.1097/00000372-199910000-00002; Scardigli R, 1996, EXP CELL RES, V227, P223, DOI 10.1006/excr.1996.0271; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Small K, 1999, J BIOL CHEM, V274, P21291, DOI 10.1074/jbc.274.30.21291; Sottile J, 2000, J CELL SCI, V113, P4287; Switala-Jelen K, 2004, FOLIA BIOL-PRAGUE, V50, P143; Tchilian EZ, 1997, IMMUNOLOGY, V92, P321, DOI 10.1046/j.1365-2567.1997.00351.x; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; Verderio E, 1999, J HISTOCHEM CYTOCHEM, V47, P1417, DOI 10.1177/002215549904701108; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; WOODS A, 1984, J CELL BIOL, V99, P1743, DOI 10.1083/jcb.99.5.1743; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	53	66	67	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40212	40229		10.1074/jbc.M110.123703	http://dx.doi.org/10.1074/jbc.M110.123703			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20929862	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000285185500066
J	Cheng, GM; Takahashi, M; Shunmugavel, A; Wallenborn, JG; DePaoli-Roach, AA; Gergs, U; Neumann, J; Kuppuswamy, D; Menick, DR; Cooper, G				Cheng, Guangmao; Takahashi, Masaru; Shunmugavel, Anandakumar; Wallenborn, J. Grace; DePaoli-Roach, Anna A.; Gergs, Ulrich; Neumann, Joachim; Kuppuswamy, Dhandapani; Menick, Donald R.; Cooper, George			Basis for MAP4 Dephosphorylation-related Microtubule Network Densification in Pressure Overload Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; CONTRACTILE DYSFUNCTION; NEUROFIBRILLARY DEGENERATION; P21-ACTIVATED KINASE; NEGATIVE REGULATOR; CATALYTIC SUBUNIT; CYTOSKELETAL ROLE; MESSENGER-RNA; PHOSPHORYLATION; TAU	Increased activity of Ser/Thr protein phosphatases types 1 (PP1) and 2A (PP2A) during maladaptive cardiac hypertrophy contributes to cardiac dysfunction and eventual failure, partly through effects on calcium metabolism. A second maladaptive feature of pressure overload cardiac hypertrophy that instead leads to heart failure by interfering with cardiac contraction and intracellular transport is a dense microtubule network stabilized by decoration with microtubule-associated protein 4 (MAP4). In an earlier study we showed that the major determinant of MAP4-microtubule affinity, and thus microtubule network density and stability, is site-specific MAP4 dephosphorylation at Ser-924 and to a lesser extent at Ser-1056; this was found to be prominent in hypertrophied myocardium. Therefore, in seeking the etiology of this MAP4 dephosphorylation, we looked here at PP2A and PP1, as well as the upstream p21-activated kinase 1, in maladaptive pressure overload cardiac hypertrophy. The activity of each was increased persistently during maladaptive hypertrophy, and overexpression of PP2A or PP1 in normal hearts reproduced both the microtubule network phenotype and the dephosphorylation of MAP4 Ser-924 and Ser-1056 seen in hypertrophy. Given the major microtubule-based abnormalities of contractile and transport function in maladaptive hypertrophy, these findings constitute a second important mechanism for phosphatase-dependent pathology in the hypertrophied and failing heart.	[Cheng, Guangmao; Takahashi, Masaru; Shunmugavel, Anandakumar; Wallenborn, J. Grace; Kuppuswamy, Dhandapani; Menick, Donald R.; Cooper, George] Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, Charleston, SC 29403 USA; [DePaoli-Roach, Anna A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Gergs, Ulrich; Neumann, Joachim] Univ Halle Wittenberg, Fak Med, Inst Pharmakol & Toxikol, D-06112 Halle, Germany; [Cooper, George] Dept Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Indiana University System; Indiana University-Purdue University Indianapolis; Martin Luther University Halle Wittenberg	Cooper, G (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, POB 250773,114 Doughty St, Charleston, SC 29403 USA.	cooperge@musc.edu		Gergs, Ulrich/0000-0001-6986-485X	National Institutes of Health [HL48788, HL094545, HL104287]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048788, R01HL094545, R21HL104287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL48788 (to G.C., D.K., and D.R.M.) and HL094545 and HL104287 (to G.C.). This work was also supported by a Department of Veterans Affairs Merit Review Grant (to G.C.).	Boknik P, 2000, N-S ARCH PHARMACOL, V362, P222, DOI 10.1007/s002100000283; BURNS RG, 1992, FEBS LETT, V297, P205, DOI 10.1016/0014-5793(92)80538-R; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; CHIDSEY CA, 1966, PHARMACOL REV, V18, P685; Chinnakkannu P, 2010, J BIOL CHEM, V285, P21837, DOI 10.1074/jbc.M110.120709; COOPER G, 1973, CIRC RES, V33, P213, DOI 10.1161/01.RES.33.2.213; Cooper G, 2006, AM J PHYSIOL-HEART C, V291, pH1003, DOI 10.1152/ajpheart.00132.2006; Drewes G, 2004, TRENDS BIOCHEM SCI, V29, P548, DOI 10.1016/j.tibs.2004.08.001; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Echeverria V, 2008, NEUROSCI LETT, V444, P92, DOI 10.1016/j.neulet.2008.07.092; El-Armouche A, 2006, BIOCHEM BIOPH RES CO, V346, P700, DOI 10.1016/j.bbrc.2006.05.182; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hein S, 2008, AM J PHYSIOL-HEART C, V294, pH1130, DOI 10.1152/ajpheart.91528.2007; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Iqbal K, 2008, J CELL MOL MED, V12, P38, DOI 10.1111/j.1582-4934.2008.00225.x; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kostin S, 2000, Heart Fail Rev, V5, P271; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470; Liu R, 2008, J CELL MOL MED, V12, P241, DOI 10.1111/j.1582-4934.2008.00249.x; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; OSTLUND RE, 1979, ANAL BIOCHEM, V96, P155, DOI 10.1016/0003-2697(79)90568-2; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Rodriguez P, 2006, J BIOL CHEM, V281, P38599, DOI 10.1074/jbc.M604139200; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Scholz D, 2008, AM J PHYSIOL-HEART C, V294, pH1135, DOI 10.1152/ajpheart.01275.2007; SCHULZE E, 1986, J CELL BIOL, V102, P1020, DOI 10.1083/jcb.102.3.1020; Sheehan KA, 2007, AM J PHYSIOL-REG I, V293, pR963, DOI 10.1152/ajpregu.00253.2007; Sheehan KA, 2009, AM J PHYSIOL-CELL PH, V296, pC47, DOI 10.1152/ajpcell.00012.2008; Tagawa H, 1996, P ASSOC AM PHYSICIAN, V108, P218; Tagawa H, 1996, CIRCULATION, V93, P1230, DOI 10.1161/01.CIR.93.6.1230; Takahashi M, 2003, AM J PHYSIOL-HEART C, V285, pH2072, DOI 10.1152/ajpheart.00396.2003; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; Yoon SY, 2008, NEUROSCI LETT, V437, P111, DOI 10.1016/j.neulet.2008.03.083; Zile MR, 2001, J AM COLL CARDIOL, V37, P1080, DOI 10.1016/S0735-1097(00)01207-9	48	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38125	38140		10.1074/jbc.M110.148650	http://dx.doi.org/10.1074/jbc.M110.148650			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889984	Green Published, hybrid			2022-12-25	WOS:000284625600020
J	Esposito, AM; Kinzy, TG				Esposito, Anthony M.; Kinzy, Terri Goss			The Eukaryotic Translation Elongation Factor 1B gamma Has a Non-guanine Nucleotide Exchange Factor Role in Protein Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; DEGRADATION; REQUIREMENT; MUTATIONS; NETWORK	The turnover of damaged proteins is critical to cell survival during stressful conditions such as heat shock or oxidative stress. The accumulation of misfolded proteins in the endoplasmic reticulum (ER) is toxic to cells. Therefore these proteins must be efficiently exported from the ER and degraded by the proteasome or the vacuole. Previously it was shown that the loss of eukaryotic elongation factor 1B gamma (eEF1B gamma) from the yeast Saccharomyces cerevisiae results in resistance to oxidative stress. Strains lacking eEF1B gamma show severe defects in protein turnover during conditions of oxidative stress. Furthermore, these strains accumulate a greater amount of oxidized proteins, which correlates with changes in heat shock chaperones. These strains show severe defects in vacuole morphology and defects related to the maturation of carboxypeptidase Y that is not dependent on the catalytic subunit of the eEF1B complex as a guanine nucleotide exchange factor. Finally, eEF1B gamma co-immunoprecipitates with an essential component of ER-Golgi transport vesicles. Taken together, these results support a broader protein metabolism role for eEF1B gamma.	[Esposito, Anthony M.; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes La, Piscataway, NJ 08854 USA.	kinzytg@umdnj.edu		Kinzy, Terri/0000-0003-1394-9226	National Institutes of Health [GM57483]; National Science Foundation [MCB0516688]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57483 ( to T.G.K.). This work was also supported by National Science Foundation Grant MCB0516688 ( to T.G.K.).	Amshoff C, 1999, BIOL CHEM, V380, P669, DOI 10.1515/BC.1999.083; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; CREUTZ CE, 1991, YEAST, V7, P229, DOI 10.1002/yea.320070305; DUDEN R, 1994, J BIOL CHEM, V269, P24486; Esposito A. M., 2010, JOVE            0615, DOI [10. 3791/ 1948, DOI 10.3791/1948]; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldberg A. L., 2003, V Microbiology, V426, P895; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Kim SS, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2722291; KINZY TG, 1994, NUCLEIC ACIDS RES, V22, P2703, DOI 10.1093/nar/22.13.2703; LAWRENCE BP, 1993, J CELL SCI, V105, P473; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Ozturk SB, 2006, GENETICS, V174, P651, DOI 10.1534/genetics.106.059899; Pimpl P, 2006, PLANT CELL, V18, P198, DOI 10.1105/tpc.105.036665; RIPMASTER TL, 1993, MOL CELL BIOL, V13, P7901, DOI 10.1128/MCB.13.12.7901; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; WIEMKEN A, 1970, Archiv fuer Mikrobiologie, V70, P89, DOI 10.1007/BF00412200	29	13	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37995	38004		10.1074/jbc.M110.160887	http://dx.doi.org/10.1074/jbc.M110.160887			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926387	Green Published, hybrid			2022-12-25	WOS:000284625600007
J	Fei, EK; Ma, XC; Zhu, CQ; Xue, T; Yan, J; Xu, YX; Zhou, JN; Wang, GH				Fei, Erkang; Ma, Xiaochuan; Zhu, Cuiqing; Xue, Ting; Yan, Jie; Xu, Yuxia; Zhou, Jiangning; Wang, Guanghui			Nucleocytoplasmic Shuttling of Dysbindin-1, a Schizophrenia-related Protein, Regulates Synapsin I Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROBREVIN-BINDING-PROTEIN; HIGH-RISK HAPLOTYPE; SUSCEPTIBILITY GENE; PREFRONTAL CORTEX; DTNBP1 GENE; NEUROTRANSMITTER RELEASE; HIPPOCAMPAL-FORMATION; ORGANELLES COMPLEX-1; NEURITE OUTGROWTH; NUCLEAR EXPORT	Dysbindin-1 is a 50-kDa coiled-coil-containing protein encoded by the gene DTNBP1 (dystrobrevin-binding protein 1), a candidate genetic factor for schizophrenia. Genetic variations in this gene confer a susceptibility to schizophrenia through a decreased expression of dysbindin-1. It was reported that dysbindin-1 regulates the expression of presynaptic proteins and the release of neurotransmitters. However, the precise functions of dysbindin-1 are largely unknown. Here, we show that dysbindin-1 is a novel nucleocytoplasmic shuttling protein and translocated to the nucleus upon treatment with leptomycin B, an inhibitor of exportin-1/CRM1-mediated nuclear export. Dysbindin-1 harbors a functional nuclear export signal necessary for its nuclear export, and the nucleocytoplasmic shuttling of dysbindin-1 affects its regulation of synapsin I expression. In brains of sandy mice, a dysbindin-1-null strain that displays abnormal behaviors related to schizophrenia, the protein and mRNA levels of synapsin I are decreased. These findings demonstrate that the nucleocytoplasmic shuttling of dysbindin-1 regulates synapsin I expression and thus may be involved in the pathogenesis of schizophrenia.	[Fei, Erkang; Ma, Xiaochuan; Xue, Ting; Zhou, Jiangning; Wang, Guanghui] Univ Sci & Technol China, Lab Mol Neuropathol, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Zhu, Cuiqing; Yan, Jie; Xu, Yuxia] Fudan Univ, State Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Fudan University	Wang, GH (corresponding author), Univ Sci & Technol China, Lab Mol Neuropathol, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	wghui@ustc.edu.cn	FEI, Erkang/AAI-9825-2021; Wang, Guanghui/U-3979-2017; Zhou, JiangNing/N-3374-2013; 薛, 挺/D-4799-2011	Wang, Guanghui/0000-0001-8551-6468; 薛, 挺/0000-0002-5644-6613; FEI, Erkang/0000-0002-3581-9521	National Natural Sciences Foundation of China [30770664, 30970921, 30900412]; Chinese Academy of Sciences [KSCX2-YW-R-138]; Anhui Educational Committee [ZD2008008-2]; K.C. Wong Education Foundation (Hong Kong); China Postdoctoral Science Foundation [20090450808]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Anhui Educational Committee; K.C. Wong Education Foundation (Hong Kong); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by National Natural Sciences Foundation of China Grants 30770664 and 30970921, Chinese Academy of Sciences Knowledge Innovation Project Grant KSCX2-YW-R-138, and Anhui Educational Committee Grant ZD2008008-2.; Supported by the K.C. Wong Education Foundation (Hong Kong), China Postdoctoral Science Foundation-funded Project 20090450808, and National Natural Sciences Foundation of China Grant 30900412.	BAHLER M, 1990, BIOESSAYS, V12, P259, DOI 10.1002/bies.950120603; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bhardwaj SK, 2009, BEHAV BRAIN RES, V197, P435, DOI 10.1016/j.bbr.2008.10.011; Bray NJ, 2008, HUM MOL GENET, V17, P1169, DOI 10.1093/hmg/ddn006; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; BROWNING MD, 1993, BIOL PSYCHIAT, V34, P529, DOI 10.1016/0006-3223(93)90195-J; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Duan JB, 2007, HUM HERED, V64, P97, DOI 10.1159/000101961; EASTWOOD SL, 1995, NEUROSCIENCE, V66, P309, DOI 10.1016/0306-4522(94)00586-T; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Feng YQ, 2008, SCHIZOPHR RES, V106, P218, DOI 10.1016/j.schres.2008.07.018; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Godenschwege TA, 2004, EUR J NEUROSCI, V20, P611, DOI 10.1111/j.1460-9568.2004.03527.x; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Li T, 1996, PSYCHIAT GENET, V6, P131, DOI 10.1097/00041444-199623000-00005; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Okuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008773; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Owen MJ, 2004, J CLIN INVEST, V113, P1255, DOI 10.1172/JCI200421470; Oyama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004199; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Pae CU, 2009, EUR ARCH PSY CLIN N, V259, P137, DOI 10.1007/s00406-008-0830-y; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Porton B, 2007, SCHIZOPHR RES, V94, P366, DOI 10.1016/j.schres.2007.04.016; Rethelyi JM, 2010, AM J MED GENET B, V153B, P792, DOI 10.1002/ajmg.b.31049; Riley B, 2009, SCHIZOPHR RES, V115, P245, DOI 10.1016/j.schres.2009.09.008; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Ryder PV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293pe66; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Tang JX, 2009, HUM MOL GENET, V18, P3851, DOI 10.1093/hmg/ddp329; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tosato S, 2007, AM J MED GENET B, V144B, P647, DOI 10.1002/ajmg.b.30484; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Wessman J, 2009, BIOL PSYCHIAT, V66, P990, DOI 10.1016/j.biopsych.2009.05.034; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yang YH, 2004, J BIOL CHEM, V279, P38820, DOI 10.1074/jbc.M401663200; Young CE, 1998, CEREB CORTEX, V8, P261, DOI 10.1093/cercor/8.3.261; Zuo LJ, 2009, PSYCHIAT GENET, V19, P292, DOI 10.1097/YPG.0b013e32832a50bc	73	20	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38630	38640		10.1074/jbc.M110.107912	http://dx.doi.org/10.1074/jbc.M110.107912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20921223	Green Published, hybrid			2022-12-25	WOS:000284625600067
J	Horvath, P; Hunziker, A; Erdossy, J; Krishna, S; Semsey, S				Horvath, Peter; Hunziker, Alexander; Erdossy, Janos; Krishna, Sandeep; Semsey, Szabolcs			Timing of Gene Transcription in the Galactose Utilization System of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE REPRESSION; STATIONARY-PHASE; EXPRESSION; GROWTH; POLARITY; PROTEIN; PROMOTERS	In the natural environment, bacterial cells have to adjust their metabolism to alterations in the availability of food sources. The order and timing of gene expression are crucial in these situations to produce an appropriate response. We used the galactose regulation in Escherichia coli as a model system for understanding how cells integrate information about food availability and cAMP levels to adjust the timing and intensity of gene expression. We simulated the feast-famine cycle of bacterial growth by diluting stationary phase cells in fresh medium containing galactose as the sole carbon source. We followed the activities of six promoters of the galactose system as cells grew on and ran out of galactose. We found that the cell responds to a decreasing external galactose level by increasing the internal galactose level, which is achieved by limiting galactose metabolism and increasing the expression of transporters. We show that the cell alters gene expression based primarily on the current state of the cell and not on monitoring the level of extracellular galactose in real time. Some decisions have longer term effects; therefore, the current state does subtly encode the history of food availability. In summary, our measurements of timing of gene expression in the galactose system suggest that the system has evolved to respond to environments where future galactose levels are unpredictable rather than regular feast and famine cycles.	[Hunziker, Alexander; Krishna, Sandeep; Semsey, Szabolcs] Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen O, Denmark; Eotvos Lorand Univ, Dept Genet, H-1117 Budapest, Hungary	University of Copenhagen; Niels Bohr Institute; Eotvos Lorand University	Semsey, S (corresponding author), Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen O, Denmark.	semsey@nbi.dk	Semsey, Szabolcs/L-6329-2013; Erdőssy, János/ABB-2741-2021	Semsey, Szabolcs/0000-0002-4522-5495; krishna, sandeep/0000-0002-0581-173X	Hungarian Scientific Research Fund (OTKA) [PD75496]; Danish National Research Foundation	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the Hungarian Scientific Research Fund (OTKA) Grant PD75496 (to S.S.) and by the Danish National Research Foundation.	ADHYA S, 2003, SCI STKE, pPE22; Amir A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100113; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEATH A, 1994, J BACTERIOL, V176, P5101, DOI 10.1128/jb.176.16.5101-5107.1994; EPSTEIN W, 1975, P NATL ACAD SCI USA, V72, P2300, DOI 10.1073/pnas.72.6.2300; Gaudet J, 2004, PLOS BIOL, V2, P1828, DOI 10.1371/journal.pbio.0020352; Geanacopoulos M, 1997, J BACTERIOL, V179, P228, DOI 10.1128/jb.179.1.228-234.1997; GUIDIRONTANI C, 1984, MOL GEN GENET, V195, P96, DOI 10.1007/BF00332730; Hogema BM, 1997, MOL MICROBIOL, V24, P857, DOI 10.1046/j.1365-2958.1997.3991761.x; Hunziker A, 2010, P NATL ACAD SCI USA, V107, P12998, DOI 10.1073/pnas.0915003107; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Johnson CH, 2004, CURR ISSUES MOL BIOL, V6, P103; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; KOLB A, 1995, NUCLEIC ACIDS RES, V23, P819, DOI 10.1093/nar/23.5.819; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Krishna S, 2007, P NATL ACAD SCI USA, V104, P20815, DOI 10.1073/pnas.0706231105; Krishna S, 2009, J MOL BIOL, V391, P671, DOI 10.1016/j.jmb.2009.06.043; Lee HJ, 2008, J MOL BIOL, V378, P318, DOI 10.1016/j.jmb.2008.02.067; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Otten R.H.J.M., 1989, ANNEALING ALGORITHM; Park YH, 2006, J BIOL CHEM, V281, P6448, DOI 10.1074/jbc.M512672200; Reddy P, 1998, J BACTERIOL, V180, P732, DOI 10.1128/JB.180.3.732-736.1998; RYU S, 1993, P NATL ACAD SCI USA, V90, P75, DOI 10.1073/pnas.90.1.75; SCHUPP JM, 1995, BIOTECHNIQUES, V19, P18; Semsey S, 2006, J MOL BIOL, V358, P355, DOI 10.1016/j.jmb.2006.02.022; Semsey S, 2007, MOL MICROBIOL, V65, P465, DOI 10.1111/j.1365-2958.2007.05798.x; Semsey S, 2009, J BACTERIOL, V191, P4487, DOI 10.1128/JB.00056-09; Shin M, 2005, GENE DEV, V19, P2388, DOI 10.1101/gad.1316305; Sneppen K, 2010, ANNU REV BIOPHYS, V39, P43, DOI 10.1146/annurev.biophys.093008.131241; ULLMANN A, 1979, P NATL ACAD SCI USA, V76, P3194, DOI 10.1073/pnas.76.7.3194; WEICKERT MJ, 1993, J BACTERIOL, V175, P251, DOI 10.1128/JB.175.1.251-258.1993; WEICKERT MJ, 1993, MOL MICROBIOL, V10, P245, DOI 10.1111/j.1365-2958.1993.tb01950.x	38	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38062	38068		10.1074/jbc.M110.152264	http://dx.doi.org/10.1074/jbc.M110.152264			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923764	Green Published, hybrid			2022-12-25	WOS:000284625600014
J	Zhang, L; Jin, M; Margariti, A; Wang, G; Luo, ZL; Zampetaki, A; Zeng, LF; Ye, S; Zhu, JH; Xiao, QH				Zhang, Li; Jin, Min; Margariti, Andriana; Wang, Gang; Luo, Zhenling; Zampetaki, Anna; Zeng, Lingfang; Ye, Shu; Zhu, Jianhua; Xiao, Qingzhong			Sp1-dependent Activation of HDAC7 Is Required for Platelet-derived Growth Factor-BB-induced Smooth Muscle Cell Differentiation from Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTONE DEACETYLASES; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; INTIMAL HYPERPLASIA; FAMILY; SP1; EXPRESSION; COMPLEX; COREPRESSORS; HYPERTROPHY	We have previously demonstrated that histone deacetylase 7 (HDAC7) expression and splicing play an important role in smooth muscle cell (SMC) differentiation from embryonic stem (ES) cells, but the molecular mechanisms of increased HDAC7 expression during SMC differentiation are currently unknown. In this study, we found that platelet-derived growth factor-BB (PDGF-BB) induced a 3-fold increase in the transcripts of HDAC7 in differentiating ES cells. Importantly, our data also revealed that PDGF-BB regulated HDAC7 expression not through phosphorylation of HDAC7 but through transcriptional activation. By dissecting its promoters with progressive deletion analysis, we identified the sequence between -343 and -292 bp in the 5`-flanking region of the Hdac7 gene promoter as the minimal PDGF-BB-responsive element, which contains one binding site for the transcription factor, specificity protein 1 (Sp1). Mutation of the Sp1 site within this PDGF-BB-responsive element abolished PDGF-BB-induced HDAC7 activity. PDGF-BB treatment enhanced Sp1 binding to the Hdac7 promoter in differentiated SMCs in vivo as demonstrated by the chromatin immunoprecipitation assay. Moreover, we also demonstrated that knockdown of Sp1 abrogated PDGF-BB-induced HDAC7 up-regulation and SMC differentiation gene expression in differentiating ES cells, although enforced expression of Sp1 alone was sufficient to increase the activity of the Hdac7 promoter and expression levels of SMC differentiation genes. Importantly, we further demonstrated that HDAC7 was required for Sp1-induced SMC differentiation of gene expression. Our data suggest that Sp1 plays an important role in the regulation of Hdac7 gene expression in SMC differentiation from ES cells. These findings provide novel molecular insights into the regulation of HDAC7 and enhance our knowledge in SMC differentiation and vessel formation during embryonic development.	[Zhang, Li; Zhu, Jianhua] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Min] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310000, Zhejiang, Peoples R China; [Margariti, Andriana; Wang, Gang; Luo, Zhenling; Zampetaki, Anna; Zeng, Lingfang] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, London SE5 9NU, England; [Ye, Shu; Xiao, Qingzhong] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Clin Pharmacol, London EC1M 6BQ, England	Zhejiang University; Zhejiang University; University of London; King's College London; University of London; Queen Mary University London	Zhu, JH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China.	zjh_john@medmail.com; q.xiao@qmul.ac.uk	Ye, Shu/R-6384-2017; Ye, Shu/C-4067-2009; Margariti, Andriana/AAH-5318-2019	Ye, Shu/0000-0002-4126-4278; Zampetaki, Anna/0000-0002-7257-8624; Zeng, Lingfang/0000-0002-0390-4561	British Heart Foundation; National Natural Science Foundation of China [30900571]; Qiangjiang Talent Project of Science and Technology Department of Zhejiang Province [2010R1066]; Natural Science Foundation of Zhejiang Province [Y2090411]; National Institute of Health Research; British Heart Foundation [FS/09/044/28007] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qiangjiang Talent Project of Science and Technology Department of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Institute of Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This work was supported in part by the British Heart Foundation, National Natural Science Foundation of China Grant 30900571, Qiangjiang Talent Project of Science and Technology Department of Zhejiang Province (2010R1066), and Natural Science Foundation of Zhejiang Province Grant Y2090411. This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; BLANK RS, 1990, J CELL PHYSIOL, V142, P635, DOI 10.1002/jcp.1041420325; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; FISCHER KD, 1993, J BIOL CHEM, V268, P23915; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, BIOCHEM CELL BIOL, V79, P337, DOI 10.1139/bcb-79-3-337; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Karamboulas C, 2006, J CELL SCI, V119, P4305, DOI 10.1242/jcs.03185; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Miyata T, 2005, J CELL PHYSIOL, V204, P948, DOI 10.1002/jcp.20362; Nishishita T, 2004, J CELL BIOCHEM, V91, P584, DOI 10.1002/jcb.10718; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang CH, 2008, ARTERIOSCL THROM VAS, V28, P54, DOI 10.1161/ATVBAHA.107.147256; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Yin XK, 2006, PROTEOMICS, V6, P6437, DOI 10.1002/pmic.200600351; Zampetaki A, 2005, AM J PHYSIOL-HEART C, V288, pH2946, DOI 10.1152/ajpheart.00919.2004; Zampetaki A, 2007, AM J PHYSIOL-CELL PH, V293, pC1226, DOI 10.1152/ajpcell.00152.2007; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	49	33	34	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38463	38472		10.1074/jbc.M110.153999	http://dx.doi.org/10.1074/jbc.M110.153999			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889501	Green Published, hybrid			2022-12-25	WOS:000284625600052
J	Alzhanov, DT; McInerney, SF; Rotwein, P				Alzhanov, Damir T.; McInerney, Stephanie F.; Rotwein, Peter			Long Range Interactions Regulate Igf2 Gene Transcription during Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-II; SIGNALING PATHWAYS; MYOD BINDING; LIFE-SPAN; H19 GENE; INSULIN; EXPRESSION; METHYLATION; HYPERTROPHY; ACTIVATION	The differentiation, maintenance, and repair of skeletal muscle is controlled by interactions between genetically determined transcriptional programs regulated by myogenic transcription factors and environmental cues activated by growth factors and hormones. Signaling through the insulin-like growth factor 1 (IGF1) receptor by locally produced IGF2 defines one such pathway that is critical for normal muscle growth and for regeneration after injury. IGF2 gene and protein expression are induced as early events in muscle differentiation, but the responsible molecular mechanisms are unknown. Here we characterize a distal DNA element within the imprinted mouse Igf2-H19 locus with properties of a muscle transcriptional enhancer. We find that this region undergoes a transition to open chromatin during differentiation, whereas adjacent chromatin remains closed, and that it interacts in differentiating muscle nuclei but not in mesenchymal precursor cells with the Igf2 gene found more than 100 kb away, suggesting that chromatin looping or sliding to bring the enhancer in proximity to Igf2 promoters is also an early event in muscle differentiation. Because this element directly stimulates the transcriptional activity of an Igf2 promoter-reporter gene in differentiating myoblasts, our results indicate that we have identified a bona fide distal transcriptional enhancer that supports Igf2 gene activation in skeletal muscle cells. Because this DNA element is conserved in the human IGF2-H19 locus, our results further suggest that its muscle enhancer function also is conserved among different mammalian species.	[Alzhanov, Damir T.; McInerney, Stephanie F.; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Hudon, Stephanie/0000-0001-5255-9381; Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [R01 DK42748-21, T32 DK007680, T32 DK007674]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007674, R01DK042748, T32DK007680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK42748-21 (to P. R.) and Training Grants T32 DK007680 and T32 DK007674 (to D. T. A.). This work was also supported by a predoctoral fellowship from the American Heart Association (to S. F. M.).	Ainscough JFX, 2000, DEVELOPMENT, V127, P3923; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DEVOL DL, 1990, AM J PHYSIOL, V259, pE89, DOI 10.1152/ajpendo.1990.259.1.E89; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Ishihara K, 2000, GENOME RES, V10, P664, DOI 10.1101/gr.10.5.664; Kaffer CR, 2000, GENE DEV, V14, P1908; Kaffer CR, 2001, MOL CELL BIOL, V21, P8189, DOI 10.1128/MCB.21.23.8189-8196.2001; KOU K, 1993, MOL ENDOCRINOL, V7, P291, DOI 10.1210/me.7.2.291; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; LASSAR A, 1994, CURR OPIN CELL BIOL, V6, P432, DOI 10.1016/0955-0674(94)90037-X; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Palacios D, 2006, J CELL PHYSIOL, V207, P1, DOI 10.1002/jcp.20489; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Pfeifer K, 1996, P NATL ACAD SCI USA, V93, P13876, DOI 10.1073/pnas.93.24.13876; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rotwein P, 1999, CONT ENDOCRINOL, V17, P19; Rotwein P, 2003, GROWTH HORM IGF RES, V13, P303, DOI 10.1016/j.ghir.2003.09.001; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Stewart CEH, 1996, J CELL PHYSIOL, V169, P23, DOI 10.1002/(SICI)1097-4652(199610)169:1<23::AID-JCP3>3.0.CO;2-G; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Yoon YS, 2007, MOL CELL BIOL, V27, P3499, DOI 10.1128/MCB.02170-06	53	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38969	38977		10.1074/jbc.M110.160986	http://dx.doi.org/10.1074/jbc.M110.160986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937833	Green Published, hybrid			2022-12-25	WOS:000284941300027
J	Assumpcao, TCF; Alvarenga, PH; Ribeiro, JMC; Andersen, JF; Francischetti, IMB				Assumpcao, Teresa C. F.; Alvarenga, Patricia H.; Ribeiro, Jose M. C.; Andersen, John F.; Francischetti, Ivo M. B.			Inhibits Platelet Aggregation, Vasoconstriction, and Angiogenesis through Unique Binding Specificity for TXA(2), PGF(2 alpha), and 15(S)-HETE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AORTIC ENDOTHELIAL-CELLS; BLOODSUCKING BUG; TRIATOMA-INFESTANS; RHODNIUS-PROLIXUS; GLYCOPROTEIN-VI; GENE DISRUPTION; SALIVARY-GLANDS; PROTEIN FAMILY; TICK SALIVA; COLLAGEN	Dipetalodipin (DPTL) is an 18 kDa protein cloned from salivary glands of the triatomine Dipetalogaster maxima. DPTL belongs to the lipocalin superfamily and has strong sequence similarity to pallidipin, a salivary inhibitor of collagen-induced platelet aggregation. DPTL expressed in Escherichia coli was found to inhibit platelet aggregation by collagen, U-46619, or arachidonic acid without affecting aggregation induced by ADP, convulxin, PMA, and ristocetin. An assay based on incubation of DPTL with small molecules (e. g. prostanoids, leukotrienes, lipids, biogenic amines) followed by chromatography, mass spectrometry, and isothermal titration calorimetry showed that DPTL binds with high affinity to carbocyclic TXA(2), TXA(2) mimetic (U-46619), TXB2, PGH(2) mimetic (U-51605), PGD(2), PGJ(2), and PGF(2 alpha). It also interacts with 15(S)-HETE, being the first lipocalin described to date to bind to a derivative of 15-lipoxygenase. Binding was not observed to other prostaglandins (e.g. PGE(1), PGE(2), 8-iso-PGF(2 alpha), prostacyclin), leukotrienes (e.g,. LTB4, LTC4, LTD4, LTE4), HETEs (e.g. 5(S)-HETE, 12(S)-HETE, 20-HETE), lipids (e.g. arachidonic acid, PAF), and biogenic amines (e.g. ADP, serotonin, epinephrine, norepinephrine, histamine). Consistent with its binding specificity, DPTL prevents contraction of rat uterus stimulated by PGF(2 alpha) and induces relaxation of aorta previously contracted with U-46619. Moreover, it inhibits angiogenesis mediated by 15(S)-HETE and did not enhance inhibition of collagen-induced platelet aggregation by SQ29548 (TXA(2) antagonist) and indomethacin. A3-D model for DPTL and pallidipin is presented that indicates the presence of a conserved Arg(39) and Gln(135) in the binding pocket of both lipocalins. Results suggest that DPTL blocks platelet aggregation, vasoconstriction, and angiogenesis through binding to distinct eicosanoids involved in inflammation.	[Assumpcao, Teresa C. F.; Alvarenga, Patricia H.; Ribeiro, Jose M. C.; Andersen, John F.; Francischetti, Ivo M. B.] NIAID, Vector Biol Sect, LMVR, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Francischetti, IMB (corresponding author), NIAID, Vector Biol Sect, LMVR, NIH, 12735 Twinbrook Pkwy,Rm 2E-28, Bethesda, MD 20892 USA.	ifrancischetti@niaid.nih.gov	Alvarenga, Patricia Hessab/I-2272-2012	Hessab Alvarenga, Patricia/0000-0002-2236-6308; Ribeiro, Jose/0000-0002-9107-0818	Division of Intramural Research, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012, ZIAAI000810] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Division of Intramural Research, NIAID, National Institutes of Health.	Andersen JF, 1997, BIOCHEMISTRY-US, V36, P4423, DOI 10.1021/bi9628883; Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Assumpcao TCF, 2008, INSECT BIOCHEM MOLEC, V38, P213, DOI 10.1016/j.ibmb.2007.11.001; Boyce JA, 2005, CHEM IMMUNOL ALLERGY, V87, P59, DOI 10.1159/000087571; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138; Charkoudian N, 2003, MAYO CLIN PROC, V78, P603, DOI 10.4065/78.5.603; Cosemans JMEM, 2005, ATHEROSCLEROSIS, V181, P19, DOI 10.1016/j.atherosclerosis.2004.12.037; Feletou M, 2010, J CARDIOVASC PHARM, V55, P317, DOI 10.1097/FJC.0b013e3181d8bc8a; Firuzi O, 2008, FASEB J, V22, P1169, DOI 10.1096/fj.07-9131.com; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Francischetti IMB, 2000, J BIOL CHEM, V275, P12639, DOI 10.1074/jbc.275.17.12639; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Francischetti IMB, 2005, THROMB HAEMOSTASIS, V94, P167, DOI 10.1160/TH04-09-0566; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; Jackson SP, 2003, NAT REV DRUG DISCOV, V2, P775, DOI 10.1038/nrd1198; Jin RC, 2005, MICROCIRCULATION, V12, P247, DOI 10.1080/10739680590925493; Jung SM, 1998, J BIOL CHEM, V273, P14827, DOI 10.1074/jbc.273.24.14827; Jung SM, 2000, TRENDS CARDIOVAS MED, V10, P285, DOI 10.1016/S1050-1738(01)00064-0; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; KELLER PM, 1992, J BIOL CHEM, V267, P6899; Legler DF, 2010, INT J BIOCHEM CELL B, V42, P198, DOI 10.1016/j.biocel.2009.09.015; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P22, DOI 10.1016/j.ibmb.2007.09.002; Moers A, 2004, J BIOL CHEM, V279, P45354, DOI 10.1074/jbc.M408962200; Morita A, 2006, FEBS J, V273, P2955, DOI 10.1111/j.1742-4658.2006.05306.x; Mumford AD, 2010, BLOOD, V115, P363, DOI 10.1182/blood-2009-08-236976; Nakamura T, 1998, J BIOL CHEM, V273, P4338, DOI 10.1074/jbc.273.8.4338; NOESKEJUNGBLUT C, 1994, J BIOL CHEM, V269, P5050; Paddock CD, 2001, J IMMUNOL, V167, P2694, DOI 10.4049/jimmunol.167.5.2694; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Patricia MK, 1999, ARTERIOSCL THROM VAS, V19, P2615, DOI 10.1161/01.ATV.19.11.2615; Pratico D, 2008, ATHEROSCLEROSIS, V201, P8, DOI 10.1016/j.atherosclerosis.2008.04.037; Reddy VB, 2006, J BIOL CHEM, V281, P16197, DOI 10.1074/jbc.M509429200; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; Shimura C, 2010, AM J PATHOL, V176, P227, DOI 10.2353/ajpath.2010.090111; Sordillo LM, 2008, FREE RADICAL BIO MED, V44, P34, DOI 10.1016/j.freeradbiomed.2007.09.002; Tang EHC, 2009, PHARMACOL THERAPEUT, V122, P140, DOI 10.1016/j.pharmthera.2009.02.006; Tang L, 2008, ATHEROSCLEROSIS, V199, P265, DOI 10.1016/j.atherosclerosis.2007.11.038; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Zhang BL, 2005, CANCER RES, V65, P7283, DOI 10.1158/0008-5472.CAN-05-0633	50	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39001	39012		10.1074/jbc.M110.152835	http://dx.doi.org/10.1074/jbc.M110.152835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889972	Green Published, hybrid			2022-12-25	WOS:000284941300030
J	Husain, A; Sato, D; Jeelani, G; Mi-ichi, F; Ali, V; Suematsu, M; Soga, T; Nozaki, T				Husain, Afzal; Sato, Dan; Jeelani, Ghulam; Mi-ichi, Fumika; Ali, Vahab; Suematsu, Makoto; Soga, Tomoyoshi; Nozaki, Tomoyoshi			Metabolome Analysis Revealed Increase in S-Methylcysteine and Phosphatidylisopropanolamine Synthesis upon L-Cysteine Deprivation in the Anaerobic Protozoan Parasite Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-METABOLISM; MASS-SPECTROMETRY; GIARDIA-LAMBLIA; CHINESE CABBAGE; BIOSYNTHESIS; SYNTHASE; PROTIST; ENZYME; PHOSPHATIDYLCHOLINE; ACETYLTRANSFERASE	L-Cysteine is ubiquitous in all living organisms and is involved in a variety of functions, including the synthesis of iron-sulfur clusters and glutathione and the regulation of the structure, stability, and catalysis of proteins. In the protozoan parasite Entamoeba histolytica, the causative agent of amebiasis, L-cysteine plays an essential role in proliferation, adherence, and defense against oxidative stress; however, the essentiality of this amino acid in the pathways it regulates is not well understood. In the present study, we applied capillary electrophoresis time-of-flight mass spectrometry to quantitate charged metabolites modulated in response to L-cysteine deprivation in E. histolytica, which was selected as a model for examining the biological roles of L-cysteine. L-Cysteine deprivation had profound effects on glycolysis, amino acid, and phospholipid metabolism, with sharp decreases in the levels of L-cysteine, L-cystine, and S-adenosylmethionine and a dramatic accumulation of O-acetylserine and S-methylcysteine. We further demonstrated that S-methylcysteine is synthesized from methanethiol and O-acetylserine by cysteine synthase, which was previously considered to be involved in sulfur-assimilatory L-cysteine biosynthesis. In addition, L-cysteine depletion repressed glycolysis and energy generation, as it reduced acetylCoA, ethanol, and the major nucleotide di- and triphosphates, and led to the accumulation of glycolytic intermediates. Interestingly, L-cysteine depletion increased the synthesis of isopropanolamine and phosphatidylisopropanolamine, and it was confirmed that their increment was not a result of oxidative stress but was a specific response to L-cysteine depletion. We also identified a pathway in which isopropanolamine is synthesized from methylglyoxal via aminoacetone. To date, this study represents the first case where L-cysteine deprivation leads to drastic changes in core metabolic pathways, including energy, amino acid, and phospholipid metabolism.	[Husain, Afzal; Jeelani, Ghulam; Mi-ichi, Fumika; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Husain, Afzal; Ali, Vahab] Gunma Univ, Grad Sch Med, Dept Parasitol, Maebashi, Gunma 3718511, Japan; [Sato, Dan; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Jeelani, Ghulam; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, Tokyo 1608582, Japan	National Institute of Infectious Diseases (NIID); Gunma University; Keio University; Keio University	Nozaki, T (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	nozaki@nih.go.jp	Suematsu, Makoto/I-8135-2013; Soga, Tomoyoshi/B-8105-2014; Mi-ichi, Fumika/O-9668-2015; Suematsu, Makoto/O-5762-2018; HUSAIN, AFZAL/GRO-1733-2022	Suematsu, Makoto/0000-0002-7165-6336; Soga, Tomoyoshi/0000-0001-9502-2509; Suematsu, Makoto/0000-0002-7165-6336; HUSAIN, AFZAL/0000-0002-6627-5520; Mi-ichi, Fumika/0000-0001-7042-2266	Ministry of Education, Culture, Sports, Science and Technology of Japan [18GS0314, 18050006, 18073001, 20590429]; Ministry of Health, Labour and Welfare of Japan [H20-Shinkosaiko-016]; Japan Health Sciences Foundation; Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research 18GS0314, 18050006, and 18073001 (to T. N.) and 20590429 (to D. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant H20-Shinkosaiko-016 for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labour and Welfare of Japan, and a grant for research to promote the development of anti-AIDS pharmaceuticals from the Japan Health Sciences Foundation (to T. N.).; Supported by the Monbukagakusho Scholarship from the Ministry of Education, Culture, Sports, Science and Technology.	ACETI DJ, 1988, J BIOL CHEM, V263, P15444; Ali V, 2007, CLIN MICROBIOL REV, V20, P164, DOI 10.1128/CMR.00019-06; Anderson IJ, 2005, EXP PARASITOL, V110, P173, DOI 10.1016/j.exppara.2005.03.010; Ariyanayagam MR, 1999, MOL BIOCHEM PARASIT, V103, P61, DOI 10.1016/S0166-6851(99)00118-8; Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choi JY, 2004, J BIOL CHEM, V279, P42321, DOI 10.1074/jbc.M405074200; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; Cullis P.R., 1996, NEW COMPREHENSIVE BI, V31, P1; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; GILLIN FD, 1981, EXP PARASITOL, V51, P382, DOI 10.1016/0014-4894(81)90125-9; GILLIN FD, 1981, EXP PARASITOL, V52, P9, DOI 10.1016/0014-4894(81)90055-2; GILLIN FD, 1980, J PROTOZOOL, V27, P474, DOI 10.1111/j.1550-7408.1980.tb05402.x; Giovanelli J., 1980, BIOCH PLANTS, VVolume 5, P453, DOI [DOI 10.1016/B978-0-12-675405-6.50018-8, 10.1016/b978-0-12-675405-6.50018-8]; GORDON LI, 1991, FREE RADICAL RES COM, V15, P65, DOI 10.3109/10715769109049126; GREEN ML, 1964, BIOCHEM J, V92, P537, DOI 10.1042/bj0920537; Heikinheimo L, 2002, TRAFFIC, V3, P367, DOI 10.1034/j.1600-0854.2002.30506.x; HORNER WH, 1959, J BIOL CHEM, V234, P2935; Husain A, 2010, MOL BIOCHEM PARASIT, V170, P100, DOI 10.1016/j.molbiopara.2009.11.004; Hussain S, 2009, MOL BIOCHEM PARASIT, V163, P39, DOI 10.1016/j.molbiopara.2008.09.006; Inoue Y, 1995, Adv Microb Physiol, V37, P177, DOI 10.1016/S0065-2911(08)60146-0; Jeelani G, 2010, J BIOL CHEM, V285, P26889, DOI 10.1074/jbc.M110.106310; KELLEY JJ, 1984, J BIOL CHEM, V259, P2124; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; KUHLMANN MK, 1991, J BIOL CHEM, V266, P15042; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; MAE T, 1976, PLANT CELL PHYSIOL, V17, P459; MAE T, 1971, PLANT CELL PHYSIOL, V12, P881, DOI 10.1093/oxfordjournals.pcp.a074692; Mehlotra RK, 1996, CRIT REV MICROBIOL, V22, P295, DOI 10.3109/10408419609105484; MEYER W, 1979, BIOCHIM BIOPHYS ACTA, V575, P463, DOI 10.1016/0005-2760(79)90116-4; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Nozaki T, 2005, ADV PARASIT, V60, P1, DOI 10.1016/S0065-308X(05)60001-2; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Perez-Mato I, 1999, J BIOL CHEM, V274, P17075, DOI 10.1074/jbc.274.24.17075; Ramos E, 2007, EXP PARASITOL, V116, P257, DOI 10.1016/j.exppara.2007.01.011; Ramos-Martinez E, 2009, INT J PARASITOL, V39, P693, DOI 10.1016/j.ijpara.2008.11.004; RAY M, 1987, J BIOL CHEM, V262, P5974; Rebeille F, 2006, P NATL ACAD SCI USA, V103, P15687, DOI 10.1073/pnas.0606195103; Ronald C. D., 1971, PHYTOCHEMISTRY, V10, P1745; Sato D, 2008, FEBS J, V275, P548, DOI 10.1111/j.1742-4658.2007.06221.x; Sato D, 2010, INT J ANTIMICROB AG, V35, P56, DOI 10.1016/j.ijantimicag.2009.08.016; Sato S, 2004, PLANT J, V40, P151, DOI 10.1111/j.1365-313X.2004.02187.x; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SMITH JD, 1988, BIOCHEM J, V254, P301, DOI 10.1042/bj2540301; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Tokoro M, 2003, J BIOL CHEM, V278, P42717, DOI 10.1074/jbc.M212414200; WEINBACH EC, 1974, EXP PARASITOL, V35, P232, DOI 10.1016/0014-4894(74)90027-7; Westrop GD, 2006, J BIOL CHEM, V281, P25062, DOI 10.1074/jbc.M600688200; WIEBERS JL, 1964, J BACTERIOL, V88, P1798, DOI 10.1128/JB.88.6.1798-1804.1964; Wirtz M, 2010, J BIOL CHEM, V285, P32810, DOI 10.1074/jbc.M110.157446; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; ZHOU X, 1992, J LIPID RES, V33, P1233; ZUO X, 1995, FEMS MICROBIOL LETT, V130, P253	65	37	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39160	39170		10.1074/jbc.M110.167304	http://dx.doi.org/10.1074/jbc.M110.167304			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923776	Green Published, hybrid			2022-12-25	WOS:000284941300046
J	Xu, DZ; Yao, YX; Lu, L; Costa, M; Dai, W				Xu, Dazhong; Yao, Yixin; Lu, Luo; Costa, Max; Dai, Wei			Plk3 Functions as an Essential Component of the Hypoxia Regulatory Pathway by Direct Phosphorylation of HIF-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-3; CELL-CYCLE ARREST; INDUCIBLE FACTOR; GROWTH-FACTOR; CANCER CELLS; LUNG-CANCER; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; EXPRESSION; POLO-LIKE-KINASE-3; FACTOR-1-ALPHA	Polo-like kinase 3 (Plk3) plays an important role in the regulation of cell cycle progression and stress responses. Plk3 also has a tumor-suppressing activity as aging PLK3-null mice develop tumors in multiple organs. The growth of highly vascularized tumors in PLK3-null mice suggests a role for Plk3 in angiogenesis and cellular responses to hypoxia. By studying primary isogenic murine embryonic fibroblasts, we tested the hypothesis that Plk3 functions as a component in the hypoxia signaling pathway. PLK3(-/-) murine embryonic fibroblasts contained an enhanced level of HIF-1 alpha under hypoxic conditions. Immunoprecipitation and pulldown analyses revealed that Plk3 physically interacted with HIF-1 alpha under hypoxia. Purified recombinant Plk3, but not a kinase-defective mutant, phosphorylated HIF-1 alpha in vitro, resulting in a major mobility shift. Mass spectrometry identified two unique serine residues that were phosphorylated by Plk3. Moreover, ectopic expression followed by cycloheximide or pulse-chase treatment demonstrated that phospho-mutants exhibited a much longer half-life than the wild-type counterpart, strongly suggesting that Plk3 directly regulates HIF-1 alpha stability in vivo. Combined, our study identifies Plk3 as a new and essential player in the regulation of the hypoxia signaling pathway.	[Dai, Wei] NYU, Dept Environm Med & Pharmacol, Langone Med Ctr, Sch Med, Tuxedo Pk, NY 10987 USA; [Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA	New York University; NYU Langone Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dai, W (corresponding author), NYU, Dept Environm Med & Pharmacol, Langone Med Ctr, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@nyumc.org	costa, max/H-1754-2012	Dai, Wei/0000-0003-0169-8327; Xu, Dazhong/0000-0001-9264-3342; Yao, Yixin/0000-0003-1891-7186	United States Public Service Awards [CA090658, CA113349, AG029953]; NATIONAL CANCER INSTITUTE [R01CA090658, R01CA113349] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015281, R01EY018343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG029953] Funding Source: NIH RePORTER	United States Public Service Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Service Awards CA090658 and CA113349 (to W. D.) and AG029953 (to D. X.).	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Chizhikov V, 2001, MOL CARCINOGEN, V30, P151, DOI 10.1002/mc.1023; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Gong RJ, 2005, BIOCHEM BIOPH RES CO, V330, P27, DOI 10.1016/j.bbrc.2005.02.122; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Liu YS, 2005, CHEM BIOL, V12, P99, DOI 10.1016/j.chembiol.2004.11.009; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Mylonis I, 2008, J BIOL CHEM, V283, P27620, DOI 10.1074/jbc.M803081200; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Perotti D, 1999, HAEMATOLOGICA, V84, P110; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Schnitzer SE, 2005, FEBS LETT, V579, P529, DOI 10.1016/j.febslet.2004.12.023; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Zhong H, 2000, CANCER RES, V60, P1541; Zimmerman WC, 2007, CELL CYCLE, V6, P1314, DOI 10.4161/cc.6.11.4275; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	27	61	66	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38944	38950		10.1074/jbc.M110.160325	http://dx.doi.org/10.1074/jbc.M110.160325			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889502	Green Published, hybrid			2022-12-25	WOS:000284941300024
J	Yuan, ZG; Peng, LR; Radhakrishnan, R; Seto, E				Yuan, Zhigang; Peng, Lirong; Radhakrishnan, Rangasudhagar; Seto, Edward			Histone Deacetylase 9 (HDAC9) Regulates the Functions of the ATDC (TRIM29) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEF2 TRANSCRIPTION FACTOR; MYOCYTE ENHANCER FACTOR-2; GENE-EXPRESSION; MUSCLE DIFFERENTIATION; ACTIVATION; BINDING; FAMILY; ASSOCIATION; REPRESSION; COMPLEX	Histone deacetylase 9 (HDAC9), like most Class II HDACs, catalyzes the removal of acetyl moieties from the epsilon-amino groups of conserved lysine residues in the N-terminal tail of histones. Biologically, HDAC9 regulates a wide variety of normal and abnormal physiological functions, including cardiac growth, T-regulatory cell function, neuronal disorders, muscle differentiation, development, and cancer. In a biochemical approach to identify non-histone substrates of HDAC9, we found that HDAC9 co-purifies specifically with the ataxia telangiectasia group D-complementing (ATDC; also called TRIM29) protein. HDAC9 deacetylates ATDC, alters the ability of ATDC to associate with p53, and consequently inhibits the cell proliferation-promoting activity of ATDC. These results implicate the importance of non-histone deacetylation by HDAC9 and confirm and further extend the multifunctions of this Class II deacetylase.	[Yuan, Zhigang; Peng, Lirong; Radhakrishnan, Rangasudhagar; Seto, Edward] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Seto, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, SRB 23011,12902 Magnolia Dr, Tampa, FL 33612 USA.	ed.seto@moffitt.org	radhakrishnan, rangasudhagar/B-8557-2016	radhakrishnan, rangasudhagar/0000-0001-6616-8525	National Institutes of Health [GM081650]; American Heart Association [0755298]; Kaul Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Kaul Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081650 (to E. S.). This work was also supported by American Heart Association Grant 0755298 and a grant from the Kaul Foundation (to E. S.).	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Glozak MA, 2009, J BIOL CHEM, V284, P11446, DOI 10.1074/jbc.M809394200; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; LEONHARDT EA, 1994, GENOMICS, V19, P130, DOI 10.1006/geno.1994.1022; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mahlknecht U, 2002, BIOCHEM BIOPH RES CO, V293, P182, DOI 10.1016/S0006-291X(02)00193-6; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Morrison BE, 2008, EXP BIOL MED, V233, P980, DOI 10.3181/0802-RM-48; Peng YH, 2003, ONCOGENE, V22, P4478, DOI 10.1038/sj.onc.1206777; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rezai-Zadeh N, 2004, METHOD ENZYMOL, V377, P167; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang AH, 2005, J BIOL CHEM, V280, P29117, DOI 10.1074/jbc.M500295200; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; Yuan ZG, 2010, MOL CELL BIOL, V30, P3004, DOI 10.1128/MCB.01023-09; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang CL, 2001, P NATL ACAD SCI USA, V98, P7354, DOI 10.1073/pnas.131198498; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	50	57	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39329	39338		10.1074/jbc.M110.179333	http://dx.doi.org/10.1074/jbc.M110.179333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20947501	Green Published, hybrid			2022-12-25	WOS:000284941300060
J	Zhang, WQ; Wu, WW; Lin, WC; Zhou, PF; Dai, L; Zhang, Y; Huang, JF; Zhang, DL				Zhang, Wenqian; Wu, Wenwu; Lin, Wenchao; Zhou, Pengfang; Dai, Li; Zhang, Yang; Huang, Jingfei; Zhang, Deli			Deciphering Heterogeneity in Pig Genome Assembly Sscrofa9 by Isochore and Isochore-Like Region Analyses	PLOS ONE			English	Article							BIASED GENE CONVERSION; GC-CONTENT EVOLUTION; EUKARYOTIC GENOMES; VERTEBRATE GENOMES; DNA-SEQUENCES; ARABIDOPSIS-THALIANA; MAMMALIAN GENOMES; CHROMOSOME MAPS; TRANSCRIPTION; RECOMBINATION	Background: The isochore, a large DNA sequence with relatively small GC variance, is one of the most important structures in eukaryotic genomes. Although the isochore has been widely studied in humans and other species, little is known about its distribution in pigs. Principal Findings: In this paper, we construct a map of long homogeneous genome regions (LHGRs), i.e., isochores and isochore-like regions, in pigs to provide an intuitive version of GC heterogeneity in each chromosome. The LHGR pattern study not only quantifies heterogeneities, but also reveals some primary characteristics of the chromatin organization, including the followings: (1) the majority of LHGRs belong to GC-poor families and are in long length; (2) a high gene density tends to occur with the appearance of GC-rich LHGRs; and (3) the density of LINE repeats decreases with an increase in the GC content of LHGRs. Furthermore, a portion of LHGRs with particular GC ranges (50%-51% and 54%-55%) tend to have abnormally high gene densities, suggesting that biased gene conversion (BGC), as well as time-and energy-saving principles, could be of importance to the formation of genome organization. Conclusion: This study significantly improves our knowledge of chromatin organization in the pig genome. Correlations between the different biological features (e.g., gene density and repeat density) and GC content of LHGRs provide a unique glimpse of in silico gene and repeats prediction.	[Zhang, Wenqian; Lin, Wenchao; Zhou, Pengfang; Dai, Li] NW A&F Univ, Bioinformat Ctr, Coll Life Sci, Xianyang, Shaanxi, Peoples R China; [Zhang, Yang; Zhang, Deli] NW A&F Univ, Coll Vet Med, Invest Grp Mol Virol Immunol Oncol & Syst Biol, Xianyang, Shaanxi, Peoples R China; [Zhang, Yang; Zhang, Deli] NW A&F Univ, Coll Vet Med, Bioinformat Ctr, Xianyang, Shaanxi, Peoples R China; [Huang, Jingfei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, WQ (corresponding author), NW A&F Univ, Bioinformat Ctr, Coll Life Sci, Xianyang, Shaanxi, Peoples R China.	huangjf@mail.kiz.ac.cn; zhangdeli@tsinghua.org.cn	Wu, Wenwu/AAP-1966-2021; Wu, Wenwu/HDO-7873-2022	Wu, Wenwu/0000-0003-2996-8675; Wu, Wenwu/0000-0003-2996-8675	Open Foundation of the State Key Laboratory of Genetic Resources; Evolution of Kunming Institute of Zoology, Chinese Academy of Sciences [GREKF09-05]	Open Foundation of the State Key Laboratory of Genetic Resources; Evolution of Kunming Institute of Zoology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Open Foundation of the State Key Laboratory of Genetic Resources and Evolution of Kunming Institute of Zoology, Chinese Academy of Sciences (grant GREKF09-05 to J.H. and D.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benecke A, 2006, EUR PHYS J E, V19, P353, DOI 10.1140/epje/i2005-10068-8; BERNARDI G, 1988, J MOL EVOL, V28, P7, DOI 10.1007/BF02143493; Bernardi G., 2004, STRUCTURAL EVOLUTION; BROWN TC, 1988, CELL, V54, P705, DOI 10.1016/S0092-8674(88)80015-1; Carpena P, 2002, GENE, V300, P97, DOI 10.1016/S0378-1119(02)01041-7; Chen LL, 2005, FEBS J, V272, P3328, DOI 10.1111/j.1742-4658.2005.04748.x; Chojnowski JL, 2008, INTEGR COMP BIOL, V48, P454, DOI 10.1093/icb/icn062; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Costantini M, 2008, P NATL ACAD SCI USA, V105, P13971, DOI 10.1073/pnas.0803916105; Costantini M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-146; Duret L, 2006, GENE, V385, P71, DOI 10.1016/j.gene.2006.04.030; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Elhaik E, 2009, MOL BIOL EVOL, V26, P1829, DOI 10.1093/molbev/msp100; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Fearnhead P, 2009, J AM STAT ASSOC, V104, P132, DOI 10.1198/jasa.2009.0009; Federico C, 2004, GENE, V343, P245, DOI 10.1016/j.gene.2004.09.011; Galtier N, 2003, TRENDS GENET, V19, P65, DOI 10.1016/S0168-9525(02)00002-1; Galtier N, 2001, GENETICS, V159, P907; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Gautier C, 2000, CURR OPIN GENET DEV, V10, P656, DOI 10.1016/S0959-437X(00)00144-1; Gonzalez-Barrera S, 2002, GENETICS, V162, P603; Gottipati P, 2009, MUTAGENESIS, V24, P203, DOI 10.1093/mutage/gen072; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; Haiminen N, 2007, GENE, V394, P53, DOI 10.1016/j.gene.2007.01.028; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lercher MJ, 2003, HUM MOL GENET, V12, P2411, DOI 10.1093/hmg/ddg251; Li WT, 2002, COMPUT CHEM, V26, P491, DOI 10.1016/S0097-8485(02)00010-4; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Melodelima C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-632; Nekrutenko A, 2000, GENOME RES, V10, P1986, DOI 10.1101/gr.10.12.1986; NICKOLOFF JA, 1992, MOL CELL BIOL, V12, P5311, DOI 10.1128/MCB.12.12.5311; Oliver JL, 2002, GENE, V300, P117, DOI 10.1016/S0378-1119(02)01034-X; Oliver JL, 2001, GENE, V276, P47, DOI 10.1016/S0378-1119(01)00641-2; Ou HY, 2004, INT J BIOCHEM CELL B, V36, P535, DOI 10.1016/j.biocel.2003.08.013; SABEUR G, 1993, J MOL EVOL, V37, P93, DOI 10.1007/BF02407344; Schmidt T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r104; Semon M, 2005, HUM MOL GENET, V14, P421, DOI 10.1093/hmg/ddi038; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sofronov GY, 2009, ENVIRON MODEL ASSESS, V14, P577, DOI 10.1007/s10666-008-9160-8; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; THIERY JP, 1976, J MOL BIOL, V108, P219, DOI 10.1016/S0022-2836(76)80104-0; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; YUNIS JJ, 1977, MOL STRUCTURE HUMAN, P20; ZHANG CT, 1991, NUCLEIC ACIDS RES, V19, P6313, DOI 10.1093/nar/19.22.6313; Zhang CT, 2001, J BIOMOL STRUCT DYN, V19, P333, DOI 10.1080/07391102.2001.10506743; ZHANG R, 1994, J BIOMOL STRUCT DYN, V11, P767, DOI 10.1080/07391102.1994.10508031; Zhang R, 2004, J MOL EVOL, V59, P227, DOI 10.1007/s00239-004-2617-8	49	1	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13303	10.1371/journal.pone.0013303	http://dx.doi.org/10.1371/journal.pone.0013303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948965	gold, Green Published, Green Submitted			2022-12-25	WOS:000282748100028
J	Zhou, ZK; Sheng, XH; Zhang, ZW; Zhao, KY; Zhu, L; Guo, G; Friedenberg, SG; Hunter, LS; Vandenberg-Foels, WS; Hornbuckle, WE; Krotscheck, U; Corey, E; Moise, NS; Dykes, NL; Li, JY; Xu, SZ; Du, LX; Wang, YC; Sandler, J; Acland, GM; Lust, G; Todhunter, RJ				Zhou, Zhengkui; Sheng, Xihui; Zhang, Zhiwu; Zhao, Keyan; Zhu, Lan; Guo, Gang; Friedenberg, Steve G.; Hunter, Linda S.; Vandenberg-Foels, Wendy S.; Hornbuckle, William E.; Krotscheck, Ursula; Corey, Elizabeth; Moise, Nancy S.; Dykes, Nathan L.; Li, Junya; Xu, Shangzhong; Du, Lixin; Wang, Yachun; Sandler, Jody; Acland, Gregory M.; Lust, George; Todhunter, Rory J.			Differential Genetic Regulation of Canine Hip Dysplasia and Osteoarthritis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; LIMITED FOOD-CONSUMPTION; GERMAN-SHEPHERD DOGS; LABRADOR-RETRIEVERS; DOMESTIC DOGS; COAT COLOR; CANDIDATE GENES; PROTEIN; JOINT	Background: Canine hip dysplasia (HD) is a common polygenic trait characterized by hip malformation that results in osteoarthritis (OA). The condition in dogs is very similar to developmental dysplasia of the human hip which also leads to OA. Methodology/Principal Findings: A total of 721 dogs, including both an association and linkage population, were genotyped. The association population included 8 pure breeds (Labrador retriever, Greyhounds, German Shepherd, Newfoundland, Golden retriever, Rottweiler, Border Collie and Bernese Mountain Dog). The linkage population included Labrador retrievers, Greyhounds, and their crosses. Of these, 366 dogs were genotyped at similar to 22,000 single nucleotide polymorphism (SNP) loci and a targeted screen across 8 chromosomes with similar to 3,300 SNPs was performed on 551 dogs (196 dogs were common to both sets). A mixed linear model approach was used to perform an association study on this combined association and linkage population. The study identified 4 susceptibility SNPs associated with HD and 2 SNPs associated with hip OA. Conclusion/Significance: The identified SNPs included those near known genes (PTPRD, PARD3B, and COL15A1) reported to be associated with, or expressed in, OA in humans. This suggested that the canine model could provide a unique opportunity to identify genes underlying natural HD and hip OA, which are common and debilitating conditions in both dogs and humans.	[Zhou, Zhengkui] NW A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Zhou, Zhengkui; Sheng, Xihui; Li, Junya; Xu, Shangzhong; Du, Lixin] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Zhou, Zhengkui; Sheng, Xihui; Friedenberg, Steve G.; Hunter, Linda S.; Vandenberg-Foels, Wendy S.; Hornbuckle, William E.; Krotscheck, Ursula; Corey, Elizabeth; Moise, Nancy S.; Dykes, Nathan L.; Todhunter, Rory J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Sheng, Xihui] Beijing Agr Univ, Dept Anim Sci & Technol, Beijing 100094, Peoples R China; [Zhang, Zhiwu] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Zhao, Keyan] Cornell Univ, Dept Computat Biol & Stat, Ithaca, NY USA; [Zhu, Lan] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; [Guo, Gang; Wang, Yachun] China Agr Univ, Dept Anim Sci, Beijing 100094, Peoples R China; [Sandler, Jody] Guiding Eyes Blind, Yorktown Hts, NY USA; [Acland, Gregory M.; Lust, George] Cornell Univ, James A Baker Inst Anim Hlth, Ithaca, NY USA	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Cornell University; Beijing University of Agriculture; Cornell University; Cornell University; Oklahoma State University System; Oklahoma State University - Stillwater; China Agricultural University; Cornell University	Zhou, ZK (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China.	zz19@cornell.edu	Friedenberg, Steven/L-2681-2019; Zhang, Zhiwu/P-6156-2016; Zhang, zs/GXN-3521-2022	Friedenberg, Steven/0000-0002-7510-2322; Zhang, Zhiwu/0000-0002-5784-9684; Zhou, Zhengkui/0000-0002-5192-2465; Vanden Berg-Foels, Wendy/0000-0002-1557-3317	National Institutes of Health [1R21AR055228-01A1]; National Science Foundation [0606461]; Chinese National Key Technologies RD Program [2006BAD04A01, 2006BAD01A10, 2008BADB2B03, 2008AA101010]; National Department Public Benefit Research Foundation of China [nyhyzx07-035]; National Natural Science Foundation of China [30871774]; Waltham Center for Pet Nutrition; Cornell Advanced Technology in Biotechnology; Department of Clinical Sciences; Baker Institute for Animal Health in the College of Veterinary Medicine, Cornell University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Chinese National Key Technologies RD Program(National Key Technology R&D Program); National Department Public Benefit Research Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Waltham Center for Pet Nutrition; Cornell Advanced Technology in Biotechnology; Department of Clinical Sciences; Baker Institute for Animal Health in the College of Veterinary Medicine, Cornell University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by National Institutes of Health (1R21AR055228-01A1), National Science Foundation (#0606461), Chinese National Key Technologies R&D Program (No. 2006BAD04A01, No. 2006BAD01A10, No. 2008BADB2B03, No. 2008AA101010), National Department Public Benefit Research Foundation of China (No. nyhyzx07-035), National Natural Science Foundation of China (No. 30871774), Waltham Center for Pet Nutrition, Cornell Advanced Technology in Biotechnology, and the Collaborative Research Grant Program, Department of Clinical Sciences, and the Baker Institute for Animal Health in the College of Veterinary Medicine, Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bliss S, 2002, AM J VET RES, V63, P1029, DOI 10.2460/ajvr.2002.63.1029; BOYKO AR, PLOS BIOL, V8; Breur G. J., 2001, The genetics of the dog, P267, DOI 10.1079/9780851995205.0267; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Chase K, 2005, AM J MED GENET A, V135A, P334, DOI 10.1002/ajmg.a.30719; Chase K, 2004, AM J MED GENET A, V124A, P239, DOI 10.1002/ajmg.a.20363; Choi B, 2007, EXP MOL MED, V39, P796, DOI 10.1038/emm.2007.86; CILLIERS HJ, 1990, AM J MED GENET, V36, P386, DOI 10.1002/ajmg.1320360403; Clements DN, 2006, AM J VET RES, V67, P909, DOI 10.2460/ajvr.67.5.909; Feldman G, 2010, CLIN ORTHOP RELAT R, V468, P337, DOI 10.1007/s11999-009-1073-6; FRIEDENBERG SG, 2010, AM J VET RE IN PRESS; FUERST PA, 1977, GENETICS, V86, P455; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Higashino A, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-24; Ikegawa S, 2007, CURR OPIN RHEUMATOL, V19, P429, DOI 10.1097/BOR.0b013e32825b079d; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jacobsen S, 2005, RHEUMATOLOGY, V44, P211, DOI 10.1093/rheumtology/keh436; Jacobsen S, 2006, ACTA ORTHOP, V77, P8; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; KEALY RD, 1993, AM J VET RES, V54, P555; Kealy RD, 2000, J AM VET MED ASSOC, V217, P1678, DOI 10.2460/javma.2000.217.1678; Kealy RD, 1997, J AM VET MED ASSOC, V210, P222; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Lark KG, 2006, TRENDS GENET, V22, P537, DOI 10.1016/j.tig.2006.08.009; Lee JW, 2000, J ANIM SCI, V78, P2108; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu WG, 1997, HUM GENET, V99, P578, DOI 10.1007/s004390050409; Lou XY, 2003, MAMM GENOME, V14, P555, DOI 10.1007/s00335-003-2272-1; Lust G, 1997, J AM VET MED ASSOC, V210, P1443; Lust G, 2001, J AM VET MED ASSOC, V219, P1242, DOI 10.2460/javma.2001.219.1242; Lust G, 2001, AM J VET RES, V62, P1711, DOI 10.2460/ajvr.2001.62.1711; MADSEN JS, 1994, ACTA VET SCAND, V35, P115; MAFFIA M, 1996, AM J PHYSIOL-REG I, V271, pR1576; Makarieva AM, 2001, HEREDITY, V87, P41, DOI 10.1046/j.1365-2540.2001.00899.x; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marschall Y, 2007, MAMM GENOME, V18, P861, DOI 10.1007/s00335-007-9071-z; Mateescu RG, 2008, AM J VET RES, V69, P1294, DOI 10.2460/ajvr.69.10.1294; Meulenbelt I, 2006, EUR J HUM GENET, V14, P1280, DOI 10.1038/sj.ejhg.5201704; Moonesinghe R, 2007, PLOS MED, V4, P218, DOI 10.1371/journal.pmed.0040028; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; NAKAMURA S, 1989, CLIN ORTHOP RELAT R, P190; Ortiz EM, 1998, GASTROENTEROLOGY, V114, P808, DOI 10.1016/S0016-5085(98)70595-5; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Parentin F, 2001, GRAEF ARCH CLIN EXP, V239, P316, DOI 10.1007/s004170100286; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Phavaphutanon J, 2009, AM J VET RES, V70, P1094, DOI 10.2460/ajvr.70.9.1094; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Schmutz SM, 2002, MAMM GENOME, V13, P380, DOI 10.1007/s00335-001-2147-2; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Smith GK, 2001, J AM VET MED ASSOC, V219, P1719, DOI 10.2460/javma.2001.219.1719; Stevenson DA, 2009, J PEDIATR ORTHOPED, V29, P463, DOI 10.1097/BPO.0b013e3181aa586b; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Todhunter RJ, 1997, J AM VET MED ASSOC, V210, P1458; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Todhunter RJ, 2003, AM J VET RES, V64, P1472, DOI 10.2460/ajvr.2003.64.1472; Tompson SWJ, 2007, HUM GENET, V120, P663, DOI 10.1007/s00439-006-0237-7; Tsuritani K, 2010, CALCIFIED TISSUE INT, V86, P47, DOI 10.1007/s00223-009-9311-1; Uetani N, 2006, J NEUROSCI, V26, P5872, DOI 10.1523/JNEUROSCI.0386-06.2006; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; WEINSTEIN SL, 1987, CLIN ORTHOP RELAT R, P62; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; YEH H, 1994, GENOMICS, V23, P443, DOI 10.1006/geno.1994.1521; Yoshimura N, 1998, BRIT J RHEUMATOL, V37, P1193; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhu L, 2008, ANIM GENET, V39, P141, DOI 10.1111/j.1365-2052.2007.01691.x	72	41	41	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13219	10.1371/journal.pone.0013219	http://dx.doi.org/10.1371/journal.pone.0013219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949002	Green Submitted, Green Published, gold			2022-12-25	WOS:000282748100003
J	Blasco, H; Corcia, P; Moreau, C; Veau, S; Fournier, C; Vourc'h, P; Emond, P; Gordon, P; Pradat, PF; Praline, J; Devos, D; Nadal-Desbarats, L; Andres, CR				Blasco, Helene; Corcia, Philippe; Moreau, Caroline; Veau, Segolene; Fournier, Clementine; Vourc'h, Patrick; Emond, Patrick; Gordon, Paul; Pradat, Pierre-Francois; Praline, Julien; Devos, David; Nadal-Desbarats, Lydie; Andres, Christian R.			H-1-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; CEREBROSPINAL-FLUID; ASCORBIC-ACID; BRAIN GLUCOSE; BIOMARKERS; TRANSPORT; ALS; NEURODEGENERATION; ASTROCYTES; DIAGNOSIS	Background: Pathophysiological mechanisms involved in amyotrophic lateral sclerosis (ALS) are complex and none has identified reliable markers useful in routine patient evaluation. The aim of this study was to analyze the CSF of patients with ALS by H-1 NMR (Nuclear Magnetic Resonance) spectroscopy in order to identify biomarkers in the early stages of the disease, and to evaluate the biochemical factors involved in ALS. Methodology: CSF samples were collected from patients with ALS at the time of diagnosis and from patients without neurodegenerative diseases. One and two-dimensional H-1 NMR analyses were performed and metabolites were quantified by the ERETIC method. We compared the concentrations of CSF metabolites between both groups. Finally, we performed principal component (PCA) and discriminant analyses. Principal Findings: Fifty CSF samples from ALS patients and 44 from controls were analyzed. We quantified 17 metabolites including amino-acids, organic acids, and ketone bodies. Quantitative analysis revealed significantly lower acetate concentrations (p = 0.0002) in ALS patients compared to controls. Concentration of acetone trended higher (p = 0.015), and those of pyruvate (p = 0.002) and ascorbate (p = 0.003) were higher in the ALS group. PCA demonstrated that the pattern of analyzed metabolites discriminated between groups. Discriminant analysis using an algorithm of 17 metabolites revealed that patients were accurately classified 81.6% of the time. Conclusion/Significance: CSF screening by NMR spectroscopy could be a useful, simple and low cost tool to improve the early diagnosis of ALS. The results indicate a perturbation of glucose metabolism, and the need to further explore cerebral energetic metabolism.	[Blasco, Helene; Corcia, Philippe; Vourc'h, Patrick; Emond, Patrick; Praline, Julien; Nadal-Desbarats, Lydie; Andres, Christian R.] CNRS 2448, INSERM, U930, Tours, France; [Vourc'h, Patrick; Emond, Patrick; Nadal-Desbarats, Lydie] Univ Tours, Lab RMN PPF Anal Syst Biol, Tours, France; [Blasco, Helene; Veau, Segolene; Fournier, Clementine; Vourc'h, Patrick; Emond, Patrick; Andres, Christian R.] CHRU Tours, Lab Biochim & Biol Mol, Tours, France; [Corcia, Philippe; Praline, Julien] CHRU Tours, Serv Neurol, Tours, France; [Moreau, Caroline; Devos, David] CHRU Lille, Serv Neurol, Lille, France; [Gordon, Paul] No Navajo Med Ctr, Shiprock, NM USA; [Pradat, Pierre-Francois] Hop La Pitie Salpetriere, APHP, Ctr Referent Malad Rare SLA, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; CHU Tours; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Blasco, H (corresponding author), CNRS 2448, INSERM, U930, Tours, France.	helene.blasco@univ-tours.fr	Devos, David/E-4059-2013; Emond, Patrick/P-6994-2016	Devos, David/0000-0002-2417-799X; Emond, Patrick/0000-0002-5324-2164; blasco, helene/0000-0001-6107-0035; Andres, Christian/0000-0002-5062-3156; Gordon, Paul/0000-0001-5714-9875				Ala-Korpela M, 2007, EXPERT REV MOL DIAGN, V7, P761, DOI 10.1586/14737159.7.6.761; Barantin L, 1997, MAGN RESON MED, V38, P179, DOI 10.1002/mrm.1910380203; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Castro MA, 2007, J NEUROCHEM, V102, P773, DOI 10.1111/j.1471-4159.2007.04631.x; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Deelchand DK, 2009, J NEUROCHEM, V109, P46, DOI 10.1111/j.1471-4159.2009.05895.x; Desport JC, 2005, NEURODEGENER DIS, V2, P202, DOI 10.1159/000089626; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Fiszman ML, 2010, ACTA NEUROL SCAND, V121, P120, DOI 10.1111/j.1600-0404.2009.01200.x; Ihara Y, 2005, NEUROL RES, V27, P105, DOI 10.1179/016164105X18430; Kalapos MP, 2003, BBA-GEN SUBJECTS, V1621, P122, DOI 10.1016/S0304-4165(03)00051-5; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Kraemer M, 2010, CLIN NEUROL NEUROSUR, V112, P103, DOI 10.1016/j.clineuro.2009.10.014; Kumar A, 2010, CLIN CHIM ACTA; Lavi R, 2010, EUR NEUROL, V64, P108, DOI 10.1159/000316774; Maillet S, 1998, BRAIN RES PROTOC, V3, P123, DOI 10.1016/S1385-299X(98)00033-6; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Paraskevas GP, 1997, ACTA NEUROL SCAND, V96, P88; Pawlosky RJ, 2010, ALCOHOL CLIN EXP RES, V34, P375, DOI 10.1111/j.1530-0277.2009.01099.x; Pradat PF, 2009, MOL DIAGN THER, V13, P115, DOI 10.2165/01250444-200913020-00005; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; SPENCER PS, 1987, CAN J NEUROL SCI, V14, P347, DOI 10.1017/S0317167100037732; Sussmuth SD, 2008, CURR MED CHEM, V15, P1788, DOI 10.2174/092986708785133031; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302; Tumani H, 2008, EXPERT REV MOL DIAGN, V8, P479, DOI 10.1586/14737159.8.4.479; Wilson JX, 2000, BRAIN RES, V858, P61, DOI 10.1016/S0006-8993(99)02433-6; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wuolikainen A, 2009, AMYOTROPH LATERAL SC, V10, P229, DOI 10.1080/17482960902871009	32	95	96	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13223	10.1371/journal.pone.0013223	http://dx.doi.org/10.1371/journal.pone.0013223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949041	Green Published, gold, Green Submitted			2022-12-25	WOS:000282676700010
J	Ghanta, S; Mitchell, ME; Ames, M; Hidestrand, M; Simpson, P; Goetsch, M; Thilly, WG; Struble, CA; Tomita-Mitchell, A				Ghanta, Sujana; Mitchell, Michael E.; Ames, Mary; Hidestrand, Mats; Simpson, Pippa; Goetsch, Mary; Thilly, William G.; Struble, Craig A.; Tomita-Mitchell, Aoy			Non-Invasive Prenatal Detection of Trisomy 21 Using Tandem Single Nucleotide Polymorphisms	PLOS ONE			English	Article							TEMPERATURE CAPILLARY-ELECTROPHORESIS; WHOLE GENOME AMPLIFICATION; POLYMERASE-CHAIN-REACTION; MATERNAL BLOOD; LARGE POPULATIONS; FETAL DNA; ANEUPLOIDY; DIAGNOSIS; IDENTIFICATION; PLASMA	Background: Screening tests for Trisomy 21 (T21), also known as Down syndrome, are routinely performed for the majority of pregnant women. However, current tests rely on either evaluating non-specific markers, which lead to false negative and false positive results, or on invasive tests, which while highly accurate, are expensive and carry a risk of fetal loss. We outline a novel, rapid, highly sensitive, and targeted approach to non-invasively detect fetal T21 using maternal plasma DNA. Methods and Findings: Highly heterozygous tandem Single Nucleotide Polymorphism (SNP) sequences on chromosome 21 were analyzed using High-Fidelity PCR and Cycling Temperature Capillary Electrophoresis (CTCE). This approach was used to blindly analyze plasma DNA obtained from peripheral blood from 40 high risk pregnant women, in adherence to a Medical College of Wisconsin Institutional Review Board approved protocol. Tandem SNP sequences were informative when the mother was heterozygous and a third paternal haplotype was present, permitting a quantitative comparison between the maternally inherited haplotype and the paternally inherited haplotype to infer fetal chromosomal dosage by calculating a Haplotype Ratio (HR). 27 subjects were assessable; 13 subjects were not informative due to either low DNA yield or were not informative at the tandem SNP sequences examined. All results were confirmed by a procedure (amniocentesis/CVS) or at postnatal follow-up. Twenty subjects were identified as carrying a disomy 21 fetus (with two copies of chromosome 21) and seven subjects were identified as carrying a T21 fetus. The sensitivity and the specificity of the assay was 100% when HR values lying between 3/5 and 5/3 were used as a threshold for normal subjects. Conclusions: In summary, a targeted approach, based on calculation of Haplotype Ratios from tandem SNP sequences combined with a sensitive and quantitative DNA measurement technology can be used to accurately detect fetal T21 in maternal plasma when sufficient fetal DNA is present in maternal plasma.	[Ghanta, Sujana; Mitchell, Michael E.; Hidestrand, Mats; Goetsch, Mary; Tomita-Mitchell, Aoy] Med Coll Wisconsin, Dept Surg, Div Cardiothorac Surg, Milwaukee, WI 53226 USA; [Ghanta, Sujana] Univ Louisville, Dept Comp Sci & Engn, Louisville, KY 40292 USA; [Ames, Mary] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Simpson, Pippa] Med Coll Wisconsin, Dept Pediat, Div Quantitat Hlth Sci, Milwaukee, WI 53226 USA; [Thilly, William G.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Struble, Craig A.] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA	Medical College of Wisconsin; University of Louisville; Medical College of Wisconsin; Medical College of Wisconsin; Massachusetts Institute of Technology (MIT); Marquette University	Ghanta, S (corresponding author), Med Coll Wisconsin, Dept Surg, Div Cardiothorac Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	amitchell@mcw.edu	simpson, pippa/AAI-8172-2020	simpson, pippa/0000-0003-1458-3748	Wallace Coulter Foundation; Medical College of Wisconsin Biotechnology and Bioengineering Center; Medical College of Wisconsin Department of Surgery; National Science Foundation PFI [0438604]; Tandem Diagnostics	Wallace Coulter Foundation; Medical College of Wisconsin Biotechnology and Bioengineering Center; Medical College of Wisconsin Department of Surgery; National Science Foundation PFI; Tandem Diagnostics	This work was supported in part by the Wallace Coulter Foundation (ATM and MEM), the Medical College of Wisconsin Biotechnology and Bioengineering Center Inducement Grant Fund, the Medical College of Wisconsin Department of Surgery, and through the National Science Foundation PFI grant NSF#0438604 (SG). The Reconstruction experiments described in Supporting Information were funded in part by Tandem Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or scientific preparation of the manuscript.	[Anonymous], 2003, NATURE, V426, P789; Birch L, 2005, CLIN CHEM, V51, P312, DOI 10.1373/clinchem.2004.042713; Bjorheim J, 2005, ELECTROPHORESIS, V26, P2520, DOI 10.1002/elps.200410403; Bjorheim J, 2003, ELECTROPHORESIS, V24, P63, DOI 10.1002/elps.200390032; Boys C, 2008, LANCET, V372, P1789, DOI 10.1016/S0140-6736(08)61742-0; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dhallan R, 2007, LANCET, V369, P474, DOI 10.1016/S0140-6736(07)60115-9; Dietmaier W, 1999, AM J PATHOL, V154, P83, DOI 10.1016/S0002-9440(10)65254-6; Ekstrom PO, 2006, ELECTROPHORESIS, V27, P1878, DOI 10.1002/elps.200500642; Evans MI, 2008, CURR OPIN OBSTET GYN, V20, P164, DOI 10.1097/GCO.0b013e3282f7321f; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2007, ANAL CHEM, V79, P7576, DOI 10.1021/ac0709394; Granelli AD, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3037; Hinselwood DC, 2005, ELECTROPHORESIS, V26, P2553, DOI 10.1002/elps.200410427; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Li-Sucholeiki XC, 2005, ELECTROPHORESIS, V26, P2531, DOI 10.1002/elps.200410431; Li-Sucholeiki XC, 2005, MUTAT RES-FUND MOL M, V570, P267, DOI 10.1016/j.mrfmmm.2004.11.004; Lim EL, 2001, APPL ENVIRON MICROB, V67, P3897, DOI 10.1128/AEM.67.9.3897-3903.2001; Liu CJ, 2004, GLOBAL ECOL BIOGEOGR, V13, P105, DOI 10.1111/j.1466-882X.2004.00072.x; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Marshall AC, 2008, PRENATAL DIAG, V28, P1023, DOI 10.1002/pd.2114; Simpson JL, 2004, JAMA-J AM MED ASSOC, V291, P1135, DOI 10.1001/jama.291.9.1135; Stoecklein NH, 2002, AM J PATHOL, V161, P43, DOI 10.1016/S0002-9440(10)64155-7; Wang VW, 2001, CANCER RES, V61, P4169	25	17	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13184	10.1371/journal.pone.0013184	http://dx.doi.org/10.1371/journal.pone.0013184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949031	gold, Green Published, Green Submitted			2022-12-25	WOS:000282676700004
J	Liu, JY; Hutchison, K; Perrone-Bizzozero, N; Morgan, M; Sui, J; Calhoun, V				Liu, Jingyu; Hutchison, Kent; Perrone-Bizzozero, Nora; Morgan, Marilee; Sui, Jing; Calhoun, Vince			Identification of Genetic and Epigenetic Marks Involved in Population Structure	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-N-CATENIN; DNA METHYLATION; EYE COLOR; HERC2; PHENOTYPE; HUMANS; WOMEN; OCA2	Population structure is well known as a prevalent and important factor in genetic studies, but its relevance in epigenetics is unclear. Very little is known about the affected epigenetic markers and their connections with genetics. In this study we assessed the impact of population diversity on genome wide single nucleotide polymorphisms (SNPs) and DNA methylation levels in 196 participants from five ethnic groups, using principle and independent component analyses. Three population stratification factors (PSFs) were identified in the genomic SNP dataset, accounting for a relatively large portion of total variance (6%). In contrast, only one PSF was identified in genomic methylation dataset accounting for 0.2% of total variance. This methylation PSF, however, was significantly correlated with the largest SNP PSF (r = 0.72, p<1E-23). We then investigated the top contributing markers in these two linked PSFs. The SNP PSF predominantly consists of 8 SNPs from three genes, SLC45A2, HERC2 and CTNNA2, known to encode skin/hair/eye color. The methylation PSF includes 48 methylated sites in 44 genes coding for basic molecular functions, including transcription regulation, DNA binding, cytokine, and transferase activity. Among them, 8 sites are either hypo- or hyper-methylated correlating to minor alleles of SNPs in the SNP PSF. We found that the genes in SNP and methylation PSFs share common biological processes including sexual/multicellular organism reproduction, cell-cell signaling and cytoskeleton organization. We further investigated the transcription regulatory network operating at these genes and identified that most of genes closely interact with ID2, which encodes for a helix-loop-helix inhibitor of DNA binding. Overall, our results show a significant correlation between genetic and epigenetic population stratification, and suggest that the interrelationship between genetic and epigenetic population structure is mediated via complex multiple gene interactions in shared biological processes, through possibly, SNP-dependent modulation and ID2 repressor function.	[Liu, Jingyu; Hutchison, Kent; Morgan, Marilee; Sui, Jing; Calhoun, Vince] Mind Res Network, Albuquerque, NM USA; [Liu, Jingyu; Calhoun, Vince] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Hutchison, Kent] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Perrone-Bizzozero, Nora; Calhoun, Vince] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University of New Mexico	Liu, JY (corresponding author), Mind Res Network, Albuquerque, NM USA.	jliu@mrn.org	Sui, Jing/B-3455-2018; Calhoun, Vince D./ACN-9399-2022	Sui, Jing/0000-0001-6837-5966; Calhoun, Vince D./0000-0001-9058-0747; Liu, Jingyu/0000-0002-1724-7523	National Institutes of Health [NIH R01EB005846, NIH R01AA012238, NIH R21DA027626]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Health (NIH R01EB005846 to V. Calhoun and NIH R01AA012238 to K. Hutchison, NIH R21DA027626 to J. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Babor TF, 2006, AUDIT ALCOHOL USE DI; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; BRAIT M, 2009, CANC EPIDEMIOL BIOMA; Branicki W, 2009, ANN HUM GENET, V73, P160, DOI 10.1111/j.1469-1809.2009.00504.x; Branicki W, 2008, J HUM GENET, V53, P966, DOI 10.1007/s10038-008-0338-3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardoso JF, 1997, IEEE SIGNAL PROC LET, V4, P112, DOI 10.1109/97.566704; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Chang HSW, 2004, CANCER-AM CANCER SOC, V101, P125, DOI 10.1002/cncr.20323; Das PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-28; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edenberg HJ, 2006, ADDICT BIOL, V11, P386, DOI 10.1111/j.1369-1600.2006.00035.x; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kayser M, 2008, AM J HUM GENET, V82, P411, DOI 10.1016/j.ajhg.2007.10.003; LIU J, 2010, PLOS ONE IN PRESS; Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004; NIELSEN DA, HUM GENET; Park C, 2002, NAT GENET, V31, P279, DOI 10.1038/ng908; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shukla SD, 2008, ALCOHOL CLIN EXP RES, V32, P1525, DOI 10.1111/j.1530-0277.2008.00729.x; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Tost J, 2008, DNA METHYLATION METH, P3; WANG K, 2009, GENET EPIDEMIOL; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	36	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13209	10.1371/journal.pone.0013209	http://dx.doi.org/10.1371/journal.pone.0013209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949057	Green Published, gold, Green Submitted			2022-12-25	WOS:000282633700010
J	Muller-Anstett, MA; Muller, P; Albrecht, T; Nega, M; Wagener, J; Gao, Q; Kaesler, S; Schaller, M; Biedermann, T; Gotz, F				Mueller-Anstett, Maria Anna; Mueller, Patrick; Albrecht, Till; Nega, Mulugeta; Wagener, Jeanette; Gao, Qiang; Kaesler, Susanne; Schaller, Martin; Biedermann, Tilo; Goetz, Friedrich			Staphylococcal Peptidoglycan Co-Localizes with Nod2 and TLR2 and Activates Innate Immune Response via Both Receptors in Primary Murine Keratinocytes	PLOS ONE			English	Article								In mammalian host cells staphylococcal peptidoglycan (PGN) is recognized by Nod2. Whether PGN is also recognized by TLR2 is disputed. Here we carried out PGN co-localization and stimulation studies with TLR2 and Nod2 in wild type and mutant host cells. To exclude contamination with lipoproteins, polymeric staphylococcal PGN (PGN(pol)) was isolated from Staphylococcus aureus Delta lgt (lacking lipidated prelipoproteins). PGN(pol) was biotinylated (PGN-Bio) for fluorescence monitoring with specific antibodies. Keratinocytes from murine oral epithelium (MK) readily internalized PGN-Bio in an endocytosis-like process. In wt MK, PGN(pol) induced intracellular accumulation of Nod2 and TLR2 and co-localized with Nod2 and TLR2, but not with TLR4. In TLR2-deficient MK Nod2 and in Nod2-deficient MK TLR2 was induced, indicating that PGN(pol) recognition by Nod2 is independent of TLR2 and vice versa. In both mutants IL-6 and IL-1B release was decreased by approximately 50% compared to wt MK, suggesting that the immune responses induced by Nod2 and TLR2 are comparable and that the two receptors act additively in MK. In TLR2-tranfected HEK293 cells PGN(pol) induced NFkB-promoter fused luciferase expression. To support the data, co-localization and signaling studies were carried out with SHL-PGN, a lipase protein covalently tethered to PGN-fragments of varying sizes at its C-terminus. SHL-PGN also co-localized with Nod2 or TLR2 and induced their accumulation, while SHL without PGN did not. The results show that staphylococcal PGN not only co-localizes with Nod2 but also with TLR2. PGN is able to stimulate the immune system via both receptors.	[Mueller-Anstett, Maria Anna; Mueller, Patrick; Albrecht, Till; Nega, Mulugeta; Gao, Qiang; Goetz, Friedrich] Univ Tubingen, Tubingen, Germany; [Wagener, Jeanette; Kaesler, Susanne; Schaller, Martin; Biedermann, Tilo] Univ Tubingen, Dept Dermatol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Gotz, F (corresponding author), Univ Tubingen, Tubingen, Germany.	friedrich.goetz@uni-tuebingen.de		Biedermann, Tilo/0000-0002-5352-5105; Wagener, Jeanette/0000-0002-7227-4348	DFG [SFB 766]; Graduate College "Infection biology'' [GKI 685]	DFG(German Research Foundation (DFG)); Graduate College "Infection biology''	This work was supported by the DFG: SFB 766 and Graduate College "Infection biology'' (GKI 685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-8; Ali RS, 2001, J INVEST DERMATOL, V117, P106; Asong J, 2009, J BIOL CHEM, V284, P8634, DOI 10.1074/jbc.M806633200; AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V66, P203, DOI 10.1016/0378-1097(90)90283-V; Begon E, 2007, EUR J DERMATOL, V17, P497; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2004, EUR J IMMUNOL, V34, P1777, DOI 10.1002/eji.200425095; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GOTZ F, 1990, J APPL BACTERIOL, V69, pS49, DOI 10.1111/j.1365-2672.1990.tb01797.x; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 1997, J BIOCHEM-TOKYO, V121, P779; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Herbert S, 2010, INFECT IMMUN; Hermanson GT, 1996, BIOCONJUGATE TECHNIQ, P116; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; Hussain T, 2008, AM J PHYSIOL-LUNG C, V295, pL461, DOI 10.1152/ajplung.00276.2007; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kobayashi M, 2009, BRIT J DERMATOL, V160, P297, DOI 10.1111/j.1365-2133.2008.08897.x; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Krismer BA, STAPHYLOCOCCUS CARNO, VVI; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Mempel M, 2002, BRIT J DERMATOL, V146, P943, DOI 10.1046/j.1365-2133.2002.04752.x; Natsuka M, 2008, INNATE IMMUN-LONDON, V14, P298, DOI 10.1177/1753425908096518; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Sieradzki K, 1997, J BACTERIOL, V179, P2557, DOI 10.1128/jb.179.8.2557-2566.1997; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Strauss A, 1996, MOL MICROBIOL, V21, P491, DOI 10.1111/j.1365-2958.1996.tb02558.x; Sugita K, 2007, CLIN EXP IMMUNOL, V147, P176, DOI 10.1111/j.1365-2249.2006.03258.x; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Uehara A, 2006, J IMMUNOL, V177, P1796, DOI 10.4049/jimmunol.177.3.1796; Underhill DM, 1999, NATURE, V402, P39, DOI DOI 10.1038/35005543; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; WONG W, 1974, J BACTERIOL, V120, P837, DOI 10.1128/JB.120.2.837-843.1974; Xuan N, 2009, CELL PHYSIOL BIOCHEM, V24, P167, DOI 10.1159/000233243; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	66	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13153	10.1371/journal.pone.0013153	http://dx.doi.org/10.1371/journal.pone.0013153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V32LH	20949035	Green Submitted, Green Published, gold			2022-12-25	WOS:000208952200002
J	Bromenshenk, JJ; Henderson, CB; Wick, CH; Stanford, MF; Zulich, AW; Jabbour, RE; Deshpande, SV; McCubbin, PE; Seccomb, RA; Welch, PM; Williams, T; Firth, DR; Skowronski, E; Lehmann, MM; Bilimoria, SL; Gress, J; Wanner, KW; Cramer, RA				Bromenshenk, Jerry J.; Henderson, Colin B.; Wick, Charles H.; Stanford, Michael F.; Zulich, Alan W.; Jabbour, Rabih E.; Deshpande, Samir V.; McCubbin, Patrick E.; Seccomb, Robert A.; Welch, Phillip M.; Williams, Trevor; Firth, David R.; Skowronski, Evan; Lehmann, Margaret M.; Bilimoria, Shan L.; Gress, Joanna; Wanner, Kevin W.; Cramer, Robert A., Jr.			Iridovirus and Microsporidian Linked to Honey Bee Colony Decline	PLOS ONE			English	Article							CHILO IRIDESCENT VIRUS; APIS-MELLIFERA L.; COLLAPSE DISORDER; NOSEMA-CERANAE; KAKUGO-VIRUS; TRANSMISSION; INDUCTION; INFECTION; APOPTOSIS; DISEASE	Background: In 2010 Colony Collapse Disorder (CCD), again devastated honey bee colonies in the USA, indicating that the problem is neither diminishing nor has it been resolved. Many CCD investigations, using sensitive genome-based methods, have found small RNA bee viruses and the microsporidia, Nosema apis and N. ceranae in healthy and collapsing colonies alike with no single pathogen firmly linked to honey bee losses. Methodology/Principal Findings: We used Mass spectrometry-based proteomics (MSP) to identify and quantify thousands of proteins from healthy and collapsing bee colonies. MSP revealed two unreported RNA viruses in North American honey bees, Varroa destructor-1 virus and Kakugo virus, and identified an invertebrate iridescent virus (IIV) (Iridoviridae) associated with CCD colonies. Prevalence of IIV significantly discriminated among strong, failing, and collapsed colonies. In addition, bees in failing colonies contained not only IIV, but also Nosema. Co-occurrence of these microbes consistently marked CCD in (1) bees from commercial apiaries sampled across the U. S. in 2006-2007, (2) bees sequentially sampled as the disorder progressed in an observation hive colony in 2008, and (3) bees from a recurrence of CCD in Florida in 2009. The pathogen pairing was not observed in samples from colonies with no history of CCD, namely bees from Australia and a large, non-migratory beekeeping business in Montana. Laboratory cage trials with a strain of IIV type 6 and Nosema ceranae confirmed that co-infection with these two pathogens was more lethal to bees than either pathogen alone. Conclusions/Significance: These findings implicate co-infection by IIV and Nosema with honey bee colony decline, giving credence to older research pointing to IIV, interacting with Nosema and mites, as probable cause of bee losses in the USA, Europe, and Asia. We next need to characterize the IIV and Nosema that we detected and develop management practices to reduce honey bee losses.	[Bromenshenk, Jerry J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Henderson, Colin B.] Univ Montana, Coll Technol, Missoula, MT USA; [Wick, Charles H.; Stanford, Michael F.; Zulich, Alan W.; Skowronski, Evan] USA, Edgewood Chem Biol Ctr, Edgewood Area, MD USA; [Jabbour, Rabih E.] Sci Applicat Int Corp, Abingdon, MD USA; [Deshpande, Samir V.] Sci Technol Corp, Edgewood, MD USA; [McCubbin, Patrick E.] OptiMetrics Inc, Abingdon, MD USA; [Bromenshenk, Jerry J.; Henderson, Colin B.; Seccomb, Robert A.; Welch, Phillip M.] Bee Alert Technol Inc, Missoula, MT USA; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Firth, David R.] Univ Montana, Dept Informat Syst & Technol, Missoula, MT 59812 USA; [Lehmann, Margaret M.; Cramer, Robert A., Jr.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; [Bilimoria, Shan L.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Gress, Joanna; Wanner, Kevin W.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Deshpande, Samir V.] Towson Univ, Dept Comp & Informat Sci, Towson, MD USA; [Bilimoria, Shan L.] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); Science Applications International Corporation (SAIC); Instituto de Ecologia - Mexico; University of Montana System; University of Montana; Montana State University System; Montana State University Bozeman; Texas Tech University System; Texas Tech University; Montana State University System; Montana State University Bozeman; University System of Maryland; Towson University; Texas Tech University System; Texas Tech University	Bromenshenk, JJ (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	beeresearch@aol.com	Williams, Trevor/F-1447-2011; Williams, Trevor/J-4239-2013; Williams, Trevor/ABG-3961-2020	Williams, Trevor/0000-0003-3414-3440; Williams, Trevor/0000-0003-3414-3440; 	Point Detection Branch of ECBC, Defense Threat Reduction Agency (DTRA); National Honey Board, California Almond Board [06-POLL8-Bromenshenk, 09-POLL10-Bromenshenk]; Foundation for the Preservation of the Honey Bee; US Army Medical Research and Material Command [W81XWH-04-C-0013]; California Beekeepers Association; Montana Agricultural Experiment Station in the laboratory of RAC	Point Detection Branch of ECBC, Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); National Honey Board, California Almond Board; Foundation for the Preservation of the Honey Bee; US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); California Beekeepers Association; Montana Agricultural Experiment Station in the laboratory of RAC	Proteomics analysis was provided by the Point Detection Branch of ECBC under the auspices of the basic science program of the Defense Threat Reduction Agency (DTRA). Sampling and analysis was supported by the National Honey Board, California Almond Board (06-POLL8-Bromenshenk, 09-POLL10-Bromenshenk), The Foundation for the Preservation of the Honey Bee, and the US Army Medical Research and Material Command (W81XWH-04-C-0013), with data processing and statistical analysis by the US Army Night Vision Laboratory (W909MY-06-C-0037). Project Apis m. is funding confirmatory inoculation studies. Work related to these studies was supported by the California Beekeepers Association and the Montana Agricultural Experiment Station in the laboratory of RAC. These companies and the other listed funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Anderson D, 2008, SCIENCE, V319, P724, DOI 10.1126/science.319.5864.724c; BAILEY L, 1976, J GEN VIROL, V31, P459, DOI 10.1099/0022-1317-31-3-459; BAILEY L, 1978, J INVERTEBR PATHOL, V31, P368, DOI 10.1016/0022-2011(78)90231-8; Baker AC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-10; Becnel JJ, 2007, J AM MOSQUITO CONTR, V23, P36, DOI 10.2987/8756-971X(2007)23[36:MPVLY]2.0.CO;2; Bilimoria SL, 2001, US patent, Patent No. 6200561; BROMENSHENK JJ, 2010, BEE CULTURE, V138, P51; BRUCE WA, 1995, AM BEE J, V135, P352; Camazine S, 1998, J INVERTEBR PATHOL, V71, P177, DOI 10.1006/jipa.1997.4713; *CCD WORK GROUP, 2006, COL COLL DIS CCD; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chitnis NS, 2008, VIROLOGY, V370, P333, DOI 10.1016/j.virol.2007.09.010; COLE A, 1980, INTERVIROLOGY, V14, P21, DOI 10.1159/000149158; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; D'Costa SM, 2004, ARCH VIROL, V149, P723, DOI 10.1007/s00705-003-0232-4; DE MIRANDA, 2004, J GEN VIROL 8, V85, P2263; Debnam S WD, 2008, BEE CULTURE, V137, P30; Delhon G, 2006, J VIROL, V80, P8439, DOI 10.1128/JVI.00464-06; Dworzanski JP, 2006, J PROTEOME RES, V5, P76, DOI 10.1021/pr050294t; *EDG CHEM BIOL CTR, 2007, SCI ID PATH THAT MAY; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Fujiyuki T, 2006, J VIROL, V80, P11528, DOI 10.1128/JVI.00754-06; Henderson CW, 2001, ARCH VIROL, V146, P767, DOI 10.1007/s007050170145; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; HUKUHARA T, 1964, J INSECT PATHOL, V6, P246; Jabbour RE, 2010, APPL ENVIRON MICROB, V76, P3637, DOI 10.1128/AEM.00055-10; Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Lopez M, 2002, J INVERTEBR PATHOL, V80, P160, DOI 10.1016/S0022-2011(02)00106-4; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Marina CF, 2005, ECOL ENTOMOL, V30, P376, DOI 10.1111/j.0307-6946.2005.00711.x; Marina CF, 2003, ENTOMOL EXP APPL, V106, P53, DOI 10.1046/j.1570-7458.2003.00010.x; Marina CF, 1999, OECOLOGIA, V119, P383, DOI 10.1007/s004420050799; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Ongus JR, 2006, J GEN VIROL, V87, P3397, DOI 10.1099/vir.0.82122-0; Paul ER, 2007, ARCH VIROL, V152, P1353, DOI 10.1007/s00705-007-0945-x; Suter II G.W., 2007, ECOLOGICAL RISK ASSE; Terio V, 2008, NEW MICROBIOL, V31, P439; TINSLEY T W, 1970, Journal of Invertebrate Pathology, V16, P470, DOI 10.1016/0022-2011(70)90170-9; Tonka T, 2000, J INVERTEBR PATHOL, V76, P229, DOI 10.1006/jipa.2000.4971; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Verma S., 1983, Indian Bee Journal, V44, P36; Webby R, 1998, ARCH VIROL, V143, P1949, DOI 10.1007/s007050050432; WICK CH, 2010, TR814 EDG CHEM BIOL; Williams T, 1998, VIRUSES, P31; WILLIAMS T, 1994, J GEN VIROL, V75, P1291, DOI 10.1099/0022-1317-75-6-1291; Williams T, 2008, NEOTROP ENTOMOL, V37, P615, DOI 10.1590/S1519-566X2008000600001; WILSON WT, 1979, AM BEE J, V119, P184; 2000, ANAL INFORM LAB ANAL	54	158	173	0	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13181	10.1371/journal.pone.0013181	http://dx.doi.org/10.1371/journal.pone.0013181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949138	Green Published, gold, Green Submitted			2022-12-25	WOS:000282568400008
J	Mann, AP; Somasunderam, A; Nieves-Alicea, R; Li, X; Hu, A; Sood, AK; Ferrari, M; Gorenstein, DG; Tanaka, T				Mann, Aman P.; Somasunderam, Anoma; Nieves-Alicea, Rene; Li, Xin; Hu, Austin; Sood, Anil K.; Ferrari, Mauro; Gorenstein, David G.; Tanaka, Takemi			Identification of Thioaptamer Ligand against E-Selectin: Potential Application for Inflamed Vasculature Targeting	PLOS ONE			English	Article							COLON-CANCER CELLS; RADIOLABELED MONOCLONAL-ANTIBODY; LEUKOCYTE ADHESION MOLECULE; COMBINATORIAL SELECTION; IN-VIVO; RHEUMATOID-ARTHRITIS; THERAPEUTIC AGENTS; BREAST-CANCER; NUCLEIC-ACIDS; APTAMERS	Active targeting of a drug carrier to a specific target site is crucial to provide a safe and efficient delivery of therapeutics and imaging contrast agents. E-selectin expression is induced on the endothelial cell surface of vessels in response to inflammatory stimuli but is absent in the normal vessels. Thus, E-selectin is an attractive molecular target, and high affinity ligands for E-selectin could be powerful tools for the delivery of therapeutics and/or imaging agents to inflamed vessels. In this study, we identified a thiophosphate modified aptamer (thioaptamer, TA) against E-selectin (ESTA-1) by employing a two-step selection strategy: a recombinant protein-based TA binding selection from a combinatorial library followed by a cell-based TA binding selection using E-selectin expressing human microvascular endothelial cells. ESTA-1 selectively bound to E-selectin with nanomolar binding affinity (K(D) = 47 nM) while exhibiting minimal cross reactivity to P- and L-selectin. Furthermore, ESTA-1 binding to E-selectin on the endothelial cells markedly antagonized the adhesion (over 75% inhibition) of sLe(x) positive HL-60 cells at nanomolar concentration. ESTA-1 also bound specifically to the inflamed tumor-associated vasculature of human carcinomas derived from breast, ovarian, and skin but not to normal organs, and this binding was highly associated with the E-selectin expression level. Similarly, intravenously injected ESTA-1 demonstrated distinct binding to the tumor vasculature in a breast cancer xenograft model. Together, our data substantiates the discovery of a thioaptamer (ESTA-1) that binds to E-selectin with high affinity and specificity, thereby highlighting the potential application of ESTA-1 for E-selectin targeted delivery.	[Mann, Aman P.; Somasunderam, Anoma; Nieves-Alicea, Rene; Ferrari, Mauro; Tanaka, Takemi] Univ Texas Hlth Sci Ctr Houston, Dept Nanomed & Biomed Engn, Houston, TX USA; [Li, Xin; Gorenstein, David G.] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX USA; [Hu, Austin; Ferrari, Mauro; Tanaka, Takemi] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Ferrari, Mauro] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Ferrari, Mauro] Rice Univ, Dept Bioengn, Houston, TX USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Tanaka, Takemi] Thomas Jefferson Univ, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; Rice University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Jefferson University	Mann, AP (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Nanomed & Biomed Engn, Houston, TX USA.	Takemi.Tanaka@jefferson.edu			Department of Defense [BC096250, W81XWH-07-2-0101, W81XWH-09-1-0212]; National Institutes of Health [U54CA151668, R01CA128797, N01-HV-28184]; Welch Foundation [H-1296]; NASA [NNX08AW91G]; USAMRMC [10117004]; AM Biotechnologies; AptaMed Inc.; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA128797, U54CA151668] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NASA(National Aeronautics & Space Administration (NASA)); USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); AM Biotechnologies; AptaMed Inc.; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense (BC096250 to T.T., W81XWH-07-2-0101 to M.F., W81XWH-09-1-0212 to M.F.); the National Institutes of Health (U54CA151668, R01CA128797 to M.F., N01-HV-28184 to D.G.); the Welch Foundation (H-1296 to D. G.); and Alliance for NanoHealth supported by NASA (NNX08AW91G to A.M.) and USAMRMC (10117004 to A.S., D.G., T.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D.G. has financial interest in AM Biotechnologies and AptaMed Inc. A.M, A.S., D.G, and T.T are inventors on a patent on ESTA-1 in preparation. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; BECKERANDRE M, 1992, EUR J BIOCHEM, V206, P401, DOI 10.1111/j.1432-1033.1992.tb16940.x; BERG EL, 1991, J BIOL CHEM, V266, P14869; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Bhushan M, 2002, BRIT J DERMATOL, V146, P824, DOI 10.1046/j.1365-2133.2002.04743.x; Chapman PT, 1996, ARTHRITIS RHEUM, V39, P1371, DOI 10.1002/art.1780390815; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Ehrhardt C, 2004, ADV DRUG DELIVER REV, V56, P527, DOI 10.1016/j.addr.2003.10.029; Eichbaum MHR, 2004, ONCOL RES, V14, P603, DOI 10.3727/0965040042707916; ELLINGTON AD, 1992, NATURE, V355, P850, DOI 10.1038/355850a0; Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Funovics M, 2005, NEOPLASIA, V7, P904, DOI 10.1593/neo.05352; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Gryaznov SM, 1999, BBA-GENE STRUCT EXPR, V1489, P131, DOI 10.1016/S0167-4781(99)00151-7; Guo KT, 2008, INT J MOL SCI, V9, P668, DOI 10.3390/ijms9040668; Hicke BJ, 1996, J CLIN INVEST, V98, P2688, DOI 10.1172/JCI119092; Jamar F, 1997, BRIT J RADIOL, V70, P473, DOI 10.1259/bjr.70.833.9227228; JAMAR F, 1995, RADIOLOGY, V194, P843, DOI 10.1148/radiology.194.3.7532314; Jenison RD, 1998, ANTISENSE NUCLEIC A, V8, P265, DOI 10.1089/oli.1.1998.8.265; Jhaveri S, 1998, BIOORG MED CHEM LETT, V8, P2285, DOI 10.1016/S0960-894X(98)00414-4; JOYCE GF, 1994, CURR OPIN STRUC BIOL, V4, P331, DOI 10.1016/S0959-440X(94)90100-7; KEELAN ETM, 1994, AM J PHYSIOL, V266, pH279, DOI 10.1152/ajpheart.1994.266.1.H279; King DJ, 1998, BIOCHEMISTRY-US, V37, P16489, DOI 10.1021/bi981780f; King DJ, 2002, BIOCHEMISTRY-US, V41, P9696, DOI 10.1021/bi020220k; Kneuer C, 2006, DRUG DISCOV TODAY, V11, P1034, DOI 10.1016/j.drudis.2006.09.004; KUIJPERS TW, 1994, J IMMUNOL, V152, P5060; Magnani John L, 2009, Discov Med, V8, P247; Marcucci F, 2004, DRUG DISCOV TODAY, V9, P219, DOI 10.1016/S1359-6446(03)02988-X; MARTENS CL, 1995, J BIOL CHEM, V270, P21129, DOI 10.1074/jbc.270.36.21129; Micklefield J, 2001, CURR MED CHEM, V8, P1157, DOI 10.2174/0929867013372391; Monteith DK, 1998, TOXICOL SCI, V46, P365, DOI 10.1093/toxsci/46.2.365; Monteith DK, 1997, ANTI-CANCER DRUG DES, V12, P421; Nawrot B, 1998, NUCLEIC ACIDS RES, V26, P2650, DOI 10.1093/nar/26.11.2650; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Somasunderam A, 2005, BIOCHEMISTRY-US, V44, P10388, DOI 10.1021/bi0507074; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TOZEREN A, 1995, INT J CANCER, V60, P426; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Tremblay PL, 2008, CANCER RES, V68, P5167, DOI 10.1158/0008-5472.CAN-08-1229; Volk DE, 2002, TETRAHEDRON LETT, V43, P4443, DOI 10.1016/S0040-4039(02)00850-X; WELPLY JK, 1994, BBA-REV BIOMEMBRANES, V1197, P215, DOI 10.1016/0304-4157(94)90006-X; Yang XB, 2004, CURR DRUG TARGETS, V5, P705, DOI 10.2174/1389450043345074; Yang XB, 2006, ANN NY ACAD SCI, V1082, P116, DOI 10.1196/annals.1348.065; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219	51	67	73	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13050	10.1371/journal.pone.0013050	http://dx.doi.org/10.1371/journal.pone.0013050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927342	gold, Green Published, Green Submitted			2022-12-25	WOS:000282312600014
J	Jiang, L; Saetre, P; Radomska, KJ; Jazin, E; Carlstrom, EL				Jiang, Lin; Saetre, Peter; Radomska, Katarzyna J.; Jazin, Elena; Carlstrom, Eva Lindholm			QKI-7 Regulates Expression of Interferon-Related Genes in Human Astrocyte Glioma Cells	PLOS ONE			English	Article							GUANYLATE BINDING PROTEIN-1; MYELINATION-RELATED GENES; MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNITY; SCHIZOPHRENIA; QUAKING; INFECTION; DYSMYELINATION; PATHOGENESIS	Background: The human QKI gene, called quaking homolog, KH domain RNA binding (mouse), is a candidate gene for schizophrenia encoding an RNA-binding protein. This gene was shown to be essential for myelination in oligodendrocytes. QKI is also highly expressed in astrocytes, but its function in these cells is not known. Methods/Principal Findings: We studied the effect of small interference RNA (siRNA)-mediated QKI depletion on global gene expression in human astrocyte glioma cells. Microarray measurements were confirmed with real-time quantitative polymerase chain reaction (qPCR). The presence of QKI binding sites (QRE) was assessed by a bioinformatic approach. Viability and cell morphology were also studied. The most significant alteration after QKI silencing was the decreased expression of genes involved in interferon (IFN) induction (P = 6.3E-10), including IFIT1, IFIT2, MX1, MX2, G1P2, G1P3, GBP1 and IFIH1. All eight genes were down-regulated after silencing of the splice variant QKI-7, but were not affected by QKI-5 silencing. Interestingly, four of them were up-regulated after treatment with the antipsychotic agent haloperidol that also resulted in increased QKI-7 mRNA levels. Conclusions/Significance: The coordinated expression of QKI-7 splice variant and IFN-related genes supports the idea that this particular splice variant has specific functions in astrocytes. Furthermore, a role of QKI-7 as a regulator of an inflammatory gene pathway in astrocytes is suggested. This hypothesis is well in line with growing experimental evidence on the role of inflammatory components in schizophrenia.	[Jiang, Lin; Saetre, Peter; Radomska, Katarzyna J.; Jazin, Elena; Carlstrom, Eva Lindholm] Uppsala Univ, Dept Genet & Dev, Uppsala, Sweden; [Saetre, Peter] Karolinska Hosp & Inst, HUBIN Project, Dept Clin Neurosci, Stockholm, Sweden	Uppsala University; Karolinska Institutet; Karolinska University Hospital	Jiang, L (corresponding author), Uppsala Univ, Dept Genet & Dev, Uppsala, Sweden.	eva.lindholm@ebc.uu.se		Radomska, Katarzyna/0000-0001-8243-0669; Jiang, Lin/0000-0001-9123-5988; Jazin, Elena/0000-0002-0363-3466	Brain Foundation in Sweden; Marcus Borgstrom's Foundation, Uppsala University, Sweden	Brain Foundation in Sweden; Marcus Borgstrom's Foundation, Uppsala University, Sweden	The research was supported by a grant from the Brain Foundation in Sweden and Eva Lindholm Carlstrom is funded by Marcus Borgstrom's Foundation, Uppsala University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Barley K, 2009, SCHIZOPHR RES, V112, P54, DOI 10.1016/j.schres.2009.04.019; Bernstein HG, 2009, EXPERT REV NEUROTHER, V9, P1059, DOI [10.1586/ern.09.59, 10.1586/ERN.09.59]; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Buka SL, 2008, BIOL PSYCHIAT, V63, P809, DOI 10.1016/j.biopsych.2007.09.022; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Chen YT, 2007, J BIOL CHEM, V282, P23553, DOI 10.1074/jbc.M702045200; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Foster R, 2006, EUR J NEUROSCI, V24, P3561, DOI 10.1111/j.1460-9568.2006.05219.x; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hanson DR, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-7; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Haroutunian V, 2006, AM J PSYCHIAT, V163, P1834, DOI 10.1176/appi.ajp.163.10.1834; Herberts CA, 2003, HUM IMMUNOL, V64, P44, DOI 10.1016/S0198-8859(02)00707-3; Jiang Lin, 2009, BMC Pharmacology, V9, P6, DOI 10.1186/1471-2210-9-6; Karoutzou G, 2008, MOL PSYCHIATR, V13, P245, DOI 10.1038/sj.mp.4002096; KOLOMEETS NS, 2009, WORLD J BIOL PSYCHIA, P1; Larocque Daniel, 2005, RNA Biol, V2, P37, DOI 10.4161/rna.2.2.1603; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; McCullumsmith RE, 2007, SCHIZOPHR RES, V90, P15, DOI 10.1016/j.schres.2006.11.017; McInnes LA, 2006, NEUROSCI BIOBEHAV R, V30, P551, DOI 10.1016/j.neubiorev.2005.10.003; Monji A, 2009, PSYCHIAT CLIN NEUROS, V63, P257, DOI 10.1111/j.1440-1819.2009.01945.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller Norbert, 2009, Dialogues Clin Neurosci, V11, P319; Naschberger E, 2006, AM J PATHOL, V169, P1088, DOI 10.2353/ajpath.2006.060244; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Saetre P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-46; Segal D, 2007, INT J NEUROPSYCHOPH, V10, P503, DOI 10.1017/S146114570600722X; Sugai T, 2004, ANN NY ACAD SCI, V1025, P84, DOI 10.1196/annals.1316.011; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Walterfang M, 2006, NEUROSCI BIOBEHAV R, V30, P918, DOI 10.1016/j.neubiorev.2006.02.001; WESTERMARK B, 1973, ACTA PATH MICRO IM A, VA 81, P791; Wolf F, 2008, SCIENCE, V320, P1597, DOI 10.1126/science.1160122; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399	46	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13079	10.1371/journal.pone.0013079	http://dx.doi.org/10.1371/journal.pone.0013079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927331	Green Submitted, Green Published, gold			2022-12-25	WOS:000282269400026
J	Mallau, S; Vaugoyeau, M; Assaiante, C				Mallau, Sophie; Vaugoyeau, Marianne; Assaiante, Christine			Postural Strategies and Sensory Integration: No Turning Point between Childhood and Adolescence	PLOS ONE			English	Article							VOLUNTARY HEAD STABILIZATION; OSCILLATORY TRUNK MOVEMENTS; DEVELOPMENTAL PERSPECTIVE; STANDING BALANCE; EYE-MOVEMENTS; YOUNG-ADULTS; VISUAL CUES; CHILDREN; SWAY; ORIENTATION	In this study, we investigated the sensory integration to postural control in children and adolescents from 5 to 15 years of age. We adopted the working hypothesis that considerable body changes occurring during these periods may lead subjects to under-use the information provided by the proprioceptive pathway and over-use other sensory systems such as vision to control their orientation and stabilize their body. It was proposed to determine which maturational differences may exist between the sensory integration used by children and adolescents in order to test the hypothesis that adolescence may constitute a specific phase in the development of postural control. This hypothesis was tested by applying an original protocol of slow oscillations below the detection threshold of the vestibular canal system, which mainly serves to mediate proprioceptive information, to the platform on which the subjects were standing. We highlighted the process of acquiring an accurate sensory and anatomical reference frame for functional movement. We asked children and adolescents to maintain a vertical stance while slow sinusoidal oscillations in the frontal plane were applied to the support at 0.01 Hz (below the detection threshold of the semicircular canal system) and at 0.06 Hz (above the detection threshold of the semicircular canal system) with their eyes either open or closed. This developmental study provided evidence that there are mild differences in the quality of sensory integration relative to postural control in children and adolescents. The results reported here confirmed the predominance of vision and the gradual mastery of somatosensory integration in postural control during a large period of ontogenesis including childhood and adolescence. The youngest as well as the oldest subjects adopted similar qualitative damping and segmental stabilization strategies that gradually improved with age without reaching an adult's level. Lastly, sensory reweighting for postural strategies as assessed by very slow support oscillations presents a linear development without any qualitative turning point between childhood and adolescence.	[Mallau, Sophie] Univ Aix Marseille 1, Grp DPA, UMR 6149, Marseille, France; CNRS, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Mallau, S (corresponding author), Univ Aix Marseille 1, Grp DPA, UMR 6149, Pole 3C, Marseille, France.	marianne.vaugoyeau@univ-provence.fr						Amblard B, 1997, EXP BRAIN RES, V114, P214, DOI 10.1007/PL00005630; Amblard B, 2001, EXP BRAIN RES, V137, P170, DOI 10.1007/s002210000621; Anoh-Tanon MJ, 2000, PEDIATR NEUROL, V23, P49, DOI 10.1016/S0887-8994(00)00140-5; ASSAIANTE C, 1993, NEUROREPORT, V4, P875, DOI 10.1097/00001756-199307000-00009; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; ASSAIANTE C, 1992, HUM MOVEMENT SCI, V11, P533, DOI 10.1016/0167-9457(92)90014-3; ASSAIANTE C, 1993, EXP BRAIN RES, V93, P499; Assaiante C, 2005, NEURAL PLAST, V12, P33; Bacsi AM, 2005, EXP BRAIN RES, V160, P22, DOI 10.1007/s00221-004-1982-2; Bair WN, 2007, EXP BRAIN RES, V183, P435, DOI 10.1007/s00221-007-1057-2; Borel L, 2002, BRAIN, V125, P880, DOI 10.1093/brain/awf085; Bringoux L, 2000, J VESTIBUL RES-EQUIL, V10, P251; BUTTERWORTH G, 1977, PERCEPTION, V6, P255, DOI 10.1068/p060255; Cherng RJ, 2001, PERCEPT MOTOR SKILL, V92, P1167, DOI 10.2466/pms.2001.92.3c.1167; Diamond A, 2008, CURR DIR PSYCHOL SCI, V17, P136, DOI 10.1111/j.1467-8721.2008.00563.x; Ferber-Viart C, 2007, INT J PEDIATR OTORHI, V71, P1041, DOI 10.1016/j.ijporl.2007.03.012; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Franchignoni F P, 1985, Minerva Med, V76, P835; HENN V, 1980, NEUROSCI RES PROG B, V18, P459; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; HYTONEN M, 1993, ACTA OTO-LARYNGOL, V113, P119, DOI 10.3109/00016489309135778; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Isableu B, 2003, EXP BRAIN RES, V150, P208, DOI 10.1007/s00221-003-1446-0; Jahn K, 2002, BRAIN, V125, P2005, DOI 10.1093/brain/awf204; JOUEN F, 1985, BEHAV BRAIN RES, V15, P241, DOI 10.1016/0166-4328(85)90178-0; KIKUKAWA M, 1985, 7 INT S INT SOC POST; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; Mallau S, 2007, SPINE, V32, pE14, DOI 10.1097/01.brs.0000251069.58498.eb; Nadeau S, 2003, GAIT POSTURE, V18, P134, DOI 10.1016/S0966-6362(02)00070-X; OBLACK B, 1985, 7 INT S INT SOC POST; ODENRICK P, 1984, HUM NEUROBIOL, V3, P241; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Peterka R J, 1990, J Vestib Res, V1, P73; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; SAKAGUCHI M, 1994, INT J PEDIATR OTORHI, V29, P101, DOI 10.1016/0165-5876(94)90089-2; Schmitz C, 2002, EXP BRAIN RES, V142, P354, DOI 10.1007/s00221-001-0910-y; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Sparto PJ, 2006, EXP BRAIN RES, V168, P505, DOI 10.1007/s00221-005-0109-8; STOFFREGEN TA, 1987, PERCEPTION, V16, P113, DOI 10.1068/p160113; Strupp M, 2003, ANN NY ACAD SCI, V1004, P352, DOI 10.1196/annals.1303.033; Sveistrup H, 2008, EXP BRAIN RES, V188, P237, DOI 10.1007/s00221-008-1357-1; UCHIDA T, 1979, NEUROSCI LETT, V13, P253, DOI 10.1016/0304-3940(79)91503-9; Vacherot F, 2007, CLIN NEUROPHYSIOL, V118, P1019, DOI 10.1016/j.clinph.2007.01.013; VAUGHT GM, 1975, B PSYCHONOMIC SOC, V5, P151; Vaugoyeau M, 2008, GAIT POSTURE, V27, P294, DOI 10.1016/j.gaitpost.2007.04.003; Vaugoyeau M, 2007, NEUROSCIENCE, V146, P852, DOI 10.1016/j.neuroscience.2007.01.052; VAUGOYEAU M, 2005, GAIT POSTURE, V21, pS31; WITKIN HA, 1967, J PERS SOC PSYCHOL, V7, P291, DOI 10.1037/h0025070; Wolff DR, 1998, J ORTHOPAED RES, V16, P271, DOI 10.1002/jor.1100160215	51	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13078	10.1371/journal.pone.0013078	http://dx.doi.org/10.1371/journal.pone.0013078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927328	Green Submitted, Green Published, gold			2022-12-25	WOS:000282269400025
J	Honarmand, M; Goymann, W; Naguib, M				Honarmand, Mariam; Goymann, Wolfgang; Naguib, Marc			Stressful Dieting: Nutritional Conditions but Not Compensatory Growth Elevate Corticosterone Levels in Zebra Finch Nestlings and Fledglings	PLOS ONE			English	Article							CATCH-UP GROWTH; TAENIOPYGIA-GUTTATA; BROOD SIZE; DEVELOPMENTAL STRESS; REARING ENVIRONMENT; NEONATAL NUTRITION; AMERICAN KESTRELS; POEPHILA-GUTTATA; METABOLIC-RATE; CLIMATE-CHANGE	Unfavourable conditions throughout the period of parental care can severely affect growth, reproductive performance, and survival. Yet, individuals may be affected differently, depending on the developmental period during which constraints are experienced. Here we tested whether the nestling phase compared to the fledgling phase is more susceptible to nutritional stress by considering biometry, physiology, sexually selected male ornaments and survival using zebra finches (Taeniopygia guttata) as a model species. As nestlings (day 0-17) or fledglings (day 17-35), subjects were raised either on low or high quality food. A low quality diet resulted in significantly elevated baseline corticosterone titres in both nestlings and fledglings. Subjects showed substantial compensatory growth after they had experienced low quality food as nestlings but catch-up growth did neither lead to elevated baseline corticosterone titres nor did we detect long term effects on biometry, male cheek patch, or survival. The compensation for temporally unfavourable environmental conditions reflects substantial phenotypic plasticity and the results show that costs of catch-up growth were not mediated via corticosterone as a physiological correlate of allostatic load. These findings provide new insights into the mechanisms and plasticity with which animals respond to periods of constraints during development as they may occur in a mistiming of breeding.	[Honarmand, Mariam; Naguib, Marc] Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany; [Honarmand, Mariam] Free Univ Berlin, Dept Anim Behav, D-1000 Berlin, Germany; [Goymann, Wolfgang] Max Planck Inst Ornithol, Abt Verhaltensneurobiol, Evolutionary & Environm Physiol Lab, Seewiesen, Germany; [Naguib, Marc] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Heteren, Netherlands	University of Bielefeld; Free University of Berlin; Max Planck Society; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Honarmand, M (corresponding author), Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany.	m.honarmand@fu-berlin.de	Naguib, Marc/C-2650-2009; Goymann, Wolfgang/E-4854-2010	Goymann, Wolfgang/0000-0002-7553-5910; Naguib, Marc/0000-0003-0494-4888	German Research Foundation (DFG) [Na335/6]	German Research Foundation (DFG)(German Research Foundation (DFG))	The research and MH were funded by a grant of the German Research Foundation (DFG) to MN (Na335/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apanius V., 1998, AVIAN GROWTH DEV EVO; Arnold KE, 2007, J AVIAN BIOL, V38, P356, DOI 10.1111/j.2007.0908-8857.03818.x; Barber I, 2001, P ROY SOC B-BIOL SCI, V268, P71, DOI 10.1098/rspb.2000.1331; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; Blas J, 2006, GEN COMP ENDOCR, V148, P172, DOI 10.1016/j.ygcen.2006.02.011; Blount JD, 2003, P ROY SOC B-BIOL SCI, V270, P1691, DOI 10.1098/rspb.2003.2411; BOAG PT, 1987, AUK, V104, P155, DOI 10.1093/auk/104.2.155; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bradbury RR, 1998, P ROY SOC B-BIOL SCI, V265, P895, DOI 10.1098/rspb.1998.0375; Brinkhof MWG, 1999, P ROY SOC B-BIOL SCI, V266, P2315, DOI 10.1098/rspb.1999.0925; Criscuolo F, 2008, P ROY SOC B-BIOL SCI, V275, P1565, DOI 10.1098/rspb.2008.0148; DeKogel CH, 1997, J ANIM ECOL, V66, P167; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Gil D, 2008, HORM BEHAV, V54, P238, DOI 10.1016/j.yhbeh.2007.11.013; Glennemeier KA, 2002, GEN COMP ENDOCR, V127, P16, DOI 10.1016/S0016-6480(02)00015-1; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Goymann W, 2006, HORM BEHAV, V49, P644, DOI 10.1016/j.yhbeh.2005.12.006; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Haase E., 1980, Avian endocrinology., P549; Hales CN, 2003, J PHYSIOL-LONDON, V547, P5, DOI 10.1113/jphysiol.2002.024406; Harper E J, 1998, J Nutr, V128, p2684S, DOI 10.1093/jn/128.12.2684S; Harper EJ, 1998, SEMIN AVIAN EXOT PET, V7, P116, DOI 10.1016/S1055-937X(98)80002-9; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; HAYWOOD S, 1992, P ROY SOC B-BIOL SCI, V249, P195, DOI 10.1098/rspb.1992.0103; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Kilner R, 1998, ANIM BEHAV, V56, P155, DOI 10.1006/anbe.1998.0775; Kitaysky AS, 1999, J COMP PHYSIOL B, V169, P303, DOI 10.1007/s003600050225; Krause ET, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005015; Leader N, 2006, ANIM BEHAV, V72, P113, DOI 10.1016/j.anbehav.2005.09.013; Love OP, 2003, PHYSIOL BIOCHEM ZOOL, V76, P753, DOI 10.1086/376431; MARTIN JT, 1978, AM ZOOL, V18, P489; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McGraw KJ, 2007, BEHAV ECOL, V18, P137, DOI 10.1093/beheco/arl059; Mcgraw KJ, 2004, CONDOR, V106, P686, DOI 10.1650/7418.1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Morici LA, 1997, J EXP ZOOL, V279, P156, DOI 10.1002/(SICI)1097-010X(19971001)279:2&lt;156::AID-JEZ6&gt;3.0.CO;2-N; Naguib M, 2004, P ROY SOC B-BIOL SCI, V271, P833, DOI 10.1098/rspb.2003.2673; Naguib M, 2005, BIOL LETT-UK, V1, P95, DOI 10.1098/rsbl.2004.0277; Naguib M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000901; Pinheiro JC, 2006, NLME LINEAR NONLINEA, P31; Pravosudov VV, 2006, GEN COMP ENDOCR, V145, P25, DOI 10.1016/j.ygcen.2005.06.011; Pravosudov VV, 2001, P ROY SOC B-BIOL SCI, V268, P363, DOI 10.1098/rspb.2000.1401; Quillfeldt P, 2007, NATURWISSENSCHAFTEN, V94, P919, DOI 10.1007/s00114-007-0275-6; Riebel K, 2009, ANIM BEHAV, V78, P1397, DOI 10.1016/j.anbehav.2009.09.011; Romero LM, 2009, HORM BEHAV, V55, P375, DOI 10.1016/j.yhbeh.2008.12.009; SAPOLSKY R M, 1992, P287; Sims CG, 2000, GEN COMP ENDOCR, V119, P193, DOI 10.1006/gcen.2000.7506; Sockman KW, 2001, GEN COMP ENDOCR, V122, P205, DOI 10.1006/gcen.2001.7626; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; Verhulst S, 1997, FUNCT ECOL, V11, P714, DOI 10.1046/j.1365-2435.1997.00145.x; Verhulst S, 2006, BIOL LETTERS, V2, P478, DOI 10.1098/rsbl.2006.0496; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Wada H, 2008, J EXP BIOL, V211, P1696, DOI 10.1242/jeb.009191; Wada H, 2008, GEN COMP ENDOCR, V156, P441, DOI 10.1016/j.ygcen.2008.02.004; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x; Zann RA., 1996, ZEBRA FINCH SYNTHESI	60	48	48	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e12930	10.1371/journal.pone.0012930	http://dx.doi.org/10.1371/journal.pone.0012930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927394	Green Published, gold, Green Submitted			2022-12-25	WOS:000282210700005
J	Hamad, OA; Nilsson, PH; Lasaosa, M; Ricklin, D; Lambris, JD; Nilsson, B; Ekdahl, KN				Hamad, Osama A.; Nilsson, Per H.; Lasaosa, Maria; Ricklin, Daniel; Lambris, John D.; Nilsson, Bo; Ekdahl, Kristina Nilsson			Contribution of Chondroitin Sulfate A to the Binding of Complement Proteins to Activated Platelets	PLOS ONE			English	Article							GLOBULAR HEAD REGION; FACTOR-H BINDS; HUMAN SERUM; DERMATAN SULFATE; IMMUNE-COMPLEXES; B-CHAIN; C1Q; BLOOD; THROMBIN; GLYCOSAMINOGLYCANS	Background: Exposure of chondroitin sulfate A (CS-A) on the surface of activated platelets is well established. The aim of the present study was to investigate to what extent CS-A contributes to the binding of the complement recognition molecule C1q and the complement regulators C1 inhibitor (C1INH), C4b-binding protein (C4BP), and factor H to platelets. Principal Findings: Human blood serum was passed over Sepharose conjugated with CS-A, and CS-A-specific binding proteins were identified by Western blotting and mass spectrometric analysis. C1q was shown to be the main protein that specifically bound to CS-A, but C4BP and factor H were also shown to interact. Binding of C1INH was dependent of the presence of C1q and then not bound to CS-A from C1q-depleted serum. The specific interactions observed of these proteins with CS-A were subsequently confirmed by surface plasmon resonance analysis using purified proteins. Importantly, C1q, C4BP, and factor H were also shown to bind to activated platelets and this interaction was inhibited by a CS-A-specific monoclonal antibody, thereby linking the binding of C1q, C4BP, and factor H to exposure of CS-A on activated platelets. CS-A-bound C1q was also shown to amplify the binding of model immune complexes to both microtiter plate-bound CS-A and to activated platelets. Conclusions: This study supports the concept that CS-A contributes to the binding of C1q, C4BP, and factor H to platelets, thereby adding CS-A to the previously reported binding sites for these proteins on the platelet surface. CS-A-bound C1q also seems to amplify the binding of immune complexes to activated platelets, suggesting a role for this molecule in immune complex diseases.	[Hamad, Osama A.; Nilsson, Bo; Ekdahl, Kristina Nilsson] Uppsala Univ, Div Clin Immunol, Rudbeck Lab C5, Uppsala, Sweden; [Nilsson, Per H.; Ekdahl, Kristina Nilsson] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden; [Lasaosa, Maria; Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Uppsala University; Linnaeus University; University of Pennsylvania	Hamad, OA (corresponding author), Uppsala Univ, Div Clin Immunol, Rudbeck Lab C5, Uppsala, Sweden.	bo.nilsson@klinimm.uu.se	Nilsson, Bo/B-3102-2012; Ekdahl, Kristina Nilsson/B-5301-2012; Lambris, John/Q-5633-2018; Ricklin, Daniel/F-5104-2011	Nilsson, Bo/0000-0003-0057-2730; Lambris, John/0000-0002-9370-5776; Ricklin, Daniel/0000-0001-6140-0233; Nilsson, Per/0000-0002-7192-5794	National Institutes of Health [AI068730, EB003968, GM62134, GM069736]; Swedish Research Council [2009-4462, 2009-4675, 15244]; Natural Sciences Faculty, Linneaus University, Kalmar and Vaxjo, Sweden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062134, R24GM069736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Sciences Faculty, Linneaus University, Kalmar and Vaxjo, Sweden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants AI068730, EB003968, GM62134, and GM069736, Swedish Research Council grants 2009-4462, 2009-4675 and 15244, and grants from the Natural Sciences Faculty, Linneaus University, Kalmar and Vaxjo, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderluh M, 2002, CURR MED CHEM, V9, P1229, DOI 10.2174/0929867023369934; DAHLBACK B, 1990, J BIOL CHEM, V265, P16082; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; DEVINE DV, 1987, P NATL ACAD SCI USA, V84, P5873, DOI 10.1073/pnas.84.16.5873; DONATO JL, 1994, BRAZ J MED BIOL RES, V27, P2163; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x; HAMAD OA, J IMMUNOL, V184, P2686; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; Henningsson AJ, 2007, J NEUROIMMUNOL, V183, P200, DOI 10.1016/j.jneuroim.2006.10.022; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Kishore U, 1998, BIOCHEM J, V333, P27, DOI 10.1042/bj3330027; Lamari FN, 2006, ADV PHARMACOL, V53, P33, DOI 10.1016/S1054-3589(05)53003-5; Lamari FN, 2006, BIOMED CHROMATOGR, V20, P539, DOI 10.1002/bmc.669; LINDAHL TL, 1993, PLATELETS, V4, P73, DOI 10.3109/09537109309013199; MACPHERSON GG, 1972, J CELL SCI, V10, P705; MALMSTROM A, 1982, BIOCHEM J, V201, P489, DOI 10.1042/bj2010489; McGrath FDG, 2006, J IMMUNOL, V176, P2950, DOI 10.4049/jimmunol.176.5.2950; Mnjoyan Z, 2008, PLATELETS, V19, P512, DOI 10.1080/09537100802238494; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; NILSSON UR, 1965, J EXP MED, V122, P277, DOI 10.1084/jem.122.2.277; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; OKAYAMA M, 1986, BIOCHEM J, V233, P73, DOI 10.1042/bj2330073; PEERSCHKE EIB, 1994, SEMIN HEMATOL, V31, P320; PEERSCHKE EIB, 1988, J IMMUNOL, V141, P3505; Peerschke EIB, 1997, J IMMUNOL, V159, P5594; PEERSCHKE EIB, 1987, J IMMUNOL, V138, P1537; PEERSCHKE EIB, 1992, CLIN IMMUNOL IMMUNOP, V63, P45, DOI 10.1016/0090-1229(92)90092-3; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; SJOHOLM AG, 1991, APMIS, V99, P1120; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; SUZUKI H, 1995, EXP MOL PATHOL, V62, P63, DOI 10.1006/exmp.1995.1007; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; TENNER AJ, 1981, J IMMUNOL, V127, P648; Tissot B, 2005, BIOCHEMISTRY-US, V44, P2602, DOI 10.1021/bi047802h; Vaziri-Sani F, 2005, J THROMB HAEMOST, V3, P154, DOI 10.1111/j.1538-7836.2004.01010.x; WARD JV, 1979, BIOCHIM BIOPHYS ACTA, V583, P196, DOI 10.1016/0304-4165(79)90427-6; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703	40	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12889	10.1371/journal.pone.0012889	http://dx.doi.org/10.1371/journal.pone.0012889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886107	Green Published, gold			2022-12-25	WOS:000282091100006
J	Hayes, KR; Beatty, M; Meng, X; Simmons, CR; Habben, JE; Danilevskaya, ON				Hayes, Kevin R.; Beatty, Mary; Meng, Xin; Simmons, Carl R.; Habben, Jeffrey E.; Danilevskaya, Olga N.			Maize Global Transcriptomics Reveals Pervasive Leaf Diurnal Rhythms but Rhythms in Developing Ears Are Largely Limited to the Core Oscillator	PLOS ONE			English	Article							PSEUDO-RESPONSE REGULATORS; CIRCADIAN CLOCK; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; KEY PATHWAYS; GROWTH; TIME; PHOTOSYNTHESIS; NETWORK; BIOLOGY	Background: Plant diurnal rhythms are vital environmental adaptations to coordinate internal physiological responses to alternating day-night cycles. A comprehensive view of diurnal biology has been lacking for maize (Zea mays), a major world crop. Methodology: A photosynthetic tissue, the leaf, and a non-photosynthetic tissue, the developing ear, were sampled under natural field conditions. Genome-wide transcript profiling was conducted on a high-density 105 K Agilent microarray to investigate diurnal rhythms. Conclusions: In both leaves and ears, the core oscillators were intact and diurnally cycling. Maize core oscillator genes are found to be largely conserved with their Arabidopsis counterparts. Diurnal gene regulation occurs in leaves, with some 23% of expressed transcripts exhibiting a diurnal cycling pattern. These transcripts can be assigned to over 1700 gene ontology functional terms, underscoring the pervasive impact of diurnal rhythms on plant biology. Considering the peak expression time for each diurnally regulated gene, and its corresponding functional assignment, most gene functions display temporal enrichment in the day, often with distinct patterns, such as dawn or midday preferred, indicating that there is a staged procession of biological events undulating with the diurnal cycle. Notably, many gene functions display a bimodal enrichment flanking the midday photosynthetic maximum, with an initial peak in mid-morning followed by another peak during the afternoon/evening. In contrast to leaves, in developing ears as few as 47 gene transcripts are diurnally regulated, and this set of transcripts includes primarily the core oscillators. In developing ears, which are largely shielded from light, the core oscillator therefore is intact with little outward effect on transcription.	[Hayes, Kevin R.; Beatty, Mary; Meng, Xin; Simmons, Carl R.; Habben, Jeffrey E.; Danilevskaya, Olga N.] Pioneer HiBred Int Inc, Johnston, IA 50131 USA	DuPont	Hayes, KR (corresponding author), Pioneer HiBred Int Inc, Johnston, IA 50131 USA.	olga.danilevskaya@pioneer.com			Pioneer Hi-Bred International, Inc., a DuPont Company	Pioneer Hi-Bred International, Inc., a DuPont Company	This work was supported by Pioneer Hi-Bred International, Inc., a DuPont Company. Investigators from Pioneer were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Barak S, 2000, TRENDS PLANT SCI, V5, P517, DOI 10.1016/S1360-1385(00)01785-4; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bruggmann R, 2006, GENOME RES, V16, P1241, DOI 10.1101/gr.5338906; Ciceri P, 1999, PLANT PHYSIOL, V121, P1321, DOI 10.1104/pp.121.4.1321; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Facella P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002798; Fukushima A, 2009, P NATL ACAD SCI USA, V106, P7251, DOI 10.1073/pnas.0900952106; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Hudson KA, 2010, PLANT GENOME-US, V3, P3, DOI 10.3835/plantgenome2009.08.0025; Hughes M, 2007, COLD SPRING HARB SYM, V72, P381, DOI 10.1101/sqb.2007.72.011; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; JAHN D, 1992, TRENDS BIOCHEM SCI, V17, P215, DOI 10.1016/0968-0004(92)90380-R; James AB, 2008, SCIENCE, V322, P1832, DOI 10.1126/science.1161403; KALTTORRES W, 1987, PLANT PHYSIOL, V83, P283, DOI 10.1104/pp.83.2.283; KALTTORRES W, 1987, PLANT PHYSIOL, V83, P294, DOI 10.1104/pp.83.2.294; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Miller TA, 2008, PLANTA, V227, P1377, DOI 10.1007/s00425-008-0709-1; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Murakami M, 2007, BIOSCI BIOTECH BIOCH, V71, P1107, DOI 10.1271/bbb.70048; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Nernhauser JL, 2008, CURR OPIN PLANT BIOL, V11, P4, DOI 10.1016/j.pbi.2007.10.005; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Nozue K, 2006, PLANT CELL ENVIRON, V29, P396, DOI 10.1111/j.1365-3040.2005.01489.x; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Ptitsyn A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S18; Rawat R, 2009, P NATL ACAD SCI USA, V106, P16883, DOI 10.1073/pnas.0813035106; REDINBAUGH MG, 1990, P NATL ACAD SCI USA, V87, P6853, DOI 10.1073/pnas.87.17.6853; Ritchie SW, 1997, CORN PLANT DEV; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun N, 2003, PLANT MOL BIOL, V53, P467, DOI 10.1023/B:PLAN.0000019071.12878.9e; Tsuji H, 2008, RICE, V1, P25, DOI 10.1007/s12284-008-9005-8; Ueda HR, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100105; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364	58	52	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12887	10.1371/journal.pone.0012887	http://dx.doi.org/10.1371/journal.pone.0012887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886102	gold, Green Published, Green Submitted			2022-12-25	WOS:000282091100005
J	Ochanuna, Z; Geiger-Maor, A; Dembinsky-Vaknin, A; Karussis, D; Tykocinski, ML; Rachmilewitz, J				Ochanuna, Zohar; Geiger-Maor, Anat; Dembinsky-Vaknin, Adi; Karussis, Dimitrios; Tykocinski, Mark L.; Rachmilewitz, Jacob			Inhibition of Effector Function but Not T Cell Activation and Increase in FoxP3 Expression in T Cells Differentiated in the Presence of PP14	PLOS ONE			English	Article							PLACENTAL PROTEIN-14; MULTIPLE-SCLEROSIS; RETINOIC-ACID; ENDOMETRIAL PROTEIN; REGULATORY ACTIVITY; BETA RECEPTOR; GLYCODELIN-A; IN-VITRO; PREGNANCY; LINEAGE	Background: T-helper polarization of naive T cells is determined by a complex mechanism that involves many factors, eventually leading to activation of Th1, Th2, or Th17 responses or alternatively the generation of regulatory T cells. Placental Protein 14 (PP14) is a 28 kDa glycoprotein highly secreted in early pregnancy that is able to desensitize T cell receptor (TCR) signaling and modulate T cell activation. Methodology/Principal Findings: Prolonged antigen-specific stimulation of T cells in the presence of PP14 resulted in an impaired secretion of IFN-gamma, IL-5 and IL-17 upon restimulation, although the cells proliferated and expressed activation markers. Furthermore, the generation of regulatory CD4(+)CD25(high)Foxp3(+) T cells was induced in the presence of PP14, in both antigen-specific as well as polyclonal stimulation. In accordance with previous reports, we found that the induction of FoxP3 expression by PP14 is accompanied by down regulation of the PI3K-mTOR signaling pathway. Conclusions/Significance: These data suggest that PP14 arrests T cells in a unique activated state that is not accompanied with the acquisition of effector function, together with promoting the generation of regulatory T cells. Taken together, our results may elucidate the role of PP14 in supporting immune tolerance in pregnancy by reducing T cell effector functions along with augmenting Treg differentiation.	[Ochanuna, Zohar; Geiger-Maor, Anat; Rachmilewitz, Jacob] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Dembinsky-Vaknin, Adi; Karussis, Dimitrios] Hadassah Hebrew Univ Med Ctr, Dept Neurol, Jerusalem, Israel; [Tykocinski, Mark L.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Jefferson University	Ochanuna, Z (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	rjacob@cc.huji.ac.il			Horowitz foundation; National Multiple Sclerosis Society	Horowitz foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by grants from the Horowitz foundation and the National Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2004, CLIN IMMUNOL, V113, P155, DOI 10.1016/j.clim.2004.06.004; Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Amsalem H, 2008, INT IMMUNOL, V20, P1147, DOI 10.1093/intimm/dxn072; BELL SC, 1989, BAILLIERE CLIN OB GY, V3, P271, DOI 10.1016/S0950-3552(89)80022-7; Borovsky Z, 2002, J BIOL CHEM, V277, P21529, DOI 10.1074/jbc.M201613200; Buyon JP, 1996, CLIN IMMUNOL IMMUNOP, V78, P99, DOI 10.1006/clin.1996.0018; Cho TH, 2000, MOL CELLS, V10, P695; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; CULOUSCOU JM, 1986, J REPROD IMMUNOL, V9, P33, DOI 10.1016/0165-0378(86)90023-9; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Hamalainen H, 2001, GENOME BIOL, V2; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ish-Shalom E, 2006, GLYCOBIOLOGY, V16, P173, DOI 10.1093/glycob/cwj053; Jayachandran R, 2006, GLYCOBIOLOGY, V16, P1052, DOI 10.1093/glycob/cwl024; JULKUNEN M, 1986, HUM REPROD, V1, P7, DOI 10.1093/oxfordjournals.humrep.a136349; Karande Anjali A., 2005, Indian Journal of Physiology and Pharmacology, V49, P271; Koistinen H, 1996, MOL HUM REPROD, V2, P759, DOI 10.1093/molehr/2.10.759; Kontopidis G, 2004, J DAIRY SCI, V87, P785, DOI 10.3168/jds.S0022-0302(04)73222-1; Lapid K, 2006, GLYCOBIOLOGY, V16, p39R, DOI 10.1093/glycob/cwj059; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; McClain MA, 2007, J IMMUNOL, V179, P8146, DOI 10.4049/jimmunol.179.12.8146; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; MINCHEVANILSSON L, 1992, J IMMUNOL, V149, P2203; Mishan-Eisenberg G, 2004, J IMMUNOL, V173, P5524, DOI 10.4049/jimmunol.173.9.5524; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P8577, DOI 10.1074/jbc.M306673200; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; NEWCOMER ME, 1995, FASEB J, V9, P229, DOI 10.1096/fasebj.9.2.7781925; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; POCKLEY AG, 1989, CLIN EXP IMMUNOL, V77, P252; POCKLEY AG, 1989, BIOLOGY, V69, P277; Rachmilewitz J, 2003, J BIOL CHEM, V278, P14059, DOI 10.1074/jbc.M211716200; Rachmilewitz J, 2002, TRENDS IMMUNOL, V23, P592, DOI 10.1016/S1471-4906(02)02342-6; Rachmilewitz J, 2002, J IMMUNOL, V168, P2745, DOI 10.4049/jimmunol.168.6.2745; Rachmilewitz J, 2001, BLOOD, V98, P3727, DOI 10.1182/blood.V98.13.3727; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; SEPPALA M, 1990, EUR J OBSTET GYN R B, V36, P250, DOI 10.1016/0028-2243(90)90206-G; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Song MQ, 2001, P NATL ACAD SCI USA, V98, P9265, DOI 10.1073/pnas.151151198; SWAIN SL, 1990, J IMMUNOL, V144, P1788; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tejada-Simon MV, 2001, EUR J IMMUNOL, V31, P907, DOI 10.1002/1521-4141(200103)31:3<907::AID-IMMU907>3.0.CO;2-1; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Van den Nieuwenhof IM, 2000, EUR J BIOCHEM, V267, P4753, DOI 10.1046/j.1432-1327.2000.01528.x; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Weetman AP, 1999, THYROID, V9, P643, DOI 10.1089/thy.1999.9.643; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; ZHANG JW, 1992, CELL IMMUNOL, V139, P118	57	16	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12868	10.1371/journal.pone.0012868	http://dx.doi.org/10.1371/journal.pone.0012868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886106	Green Submitted, Green Published, gold			2022-12-25	WOS:000282091100003
J	Placencio, VR; Li, XH; Sherrill, TP; Fritz, G; Bhowmick, NA				Placencio, Veronica R.; Li, Xiaohong; Sherrill, Taylor P.; Fritz, Gloria; Bhowmick, Neil A.			Bone Marrow Derived Mesenchymal Stem Cells Incorporate into the Prostate during Regrowth	PLOS ONE			English	Article							CANCER METASTASIS; BETA-CATENIN; DIFFERENTIATION; ANDROGEN; FUSION; GROWTH; MODEL; TUMOR; LIVER; TRANSPLANTATION	Background: Prostate cancer recurrence involves increased growth of cancer epithelial cells, as androgen dependent prostate cancer progresses to castrate resistant prostate cancer (CRPC) following initial therapy. Understanding CRPC prostate regrowth will provide opportunities for new cancer therapies to treat advanced disease. Methodology/Principal Findings: Elevated chemokine expression in the prostate stroma of a castrate resistant mouse model, Tgfbr2(fspKO), prompted us to look at the involvement of bone marrow derived cells (BMDCs) in prostate regrowth. We identified bone marrow cells recruited to the prostate in GFP-chimeric mice. A dramatic increase in BMDC recruitment for prostate regrowth occurred three days after exogenous testosterone implantation. Recruitment led to incorporation of BMDCs within the prostate epithelia. Immunofluorescence staining suggested BMDCs in the prostate coexpressed androgen receptor; p63, a basal epithelial marker; and cytokeratin 8, a luminal epithelial marker. A subset of the BMDC population, mesenchymal stem cells (MSCs), were specifically found to be incorporated in the prostate at its greatest time of remodeling. Rosa26 expressing MSCs injected into GFP mice supported MSC fusion with resident prostate epithelial cells through co-localization of beta-galactosidase and GFP during regrowth. In a human C4-2B xenograft model of CRPC, MSCs were specifically recruited. Injection of GFP-labeled MSCs supported C4-2B tumor progression by potentiating canonical Wnt signaling. The use of MSCs as a targeted delivery vector for the exogenously expressed Wnt antagonist, secreted frizzled related protein-2 (SFRP2), reduced tumor growth, increased apoptosis and potentiated tumor necrosis. Conclusions/Significance: Mesenchymal stem cells fuse with prostate epithelia during the process of prostate regrowth. MSCs recruited to the regrowing prostate can be used as a vehicle for transporting genetic information with potential therapeutic effects on castrate resistant prostate cancer, for instance by antagonizing Wnt signaling through SFRP2.	[Placencio, Veronica R.; Li, Xiaohong; Bhowmick, Neil A.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Li, Xiaohong; Fritz, Gloria; Bhowmick, Neil A.] Vanderbilt Univ, Dept Urol Surg, Nashville, TN USA; [Sherrill, Taylor P.] Vanderbilt Univ, Dept Pulm & Crit Care Med, Nashville, TN USA; [Bhowmick, Neil A.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Cedars Sinai Medical Center	Placencio, VR (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA.	bhowmickn@cshs.org	Bhowmick, Neil/AAA-7302-2019	Bhowmick, Neil/0000-0001-8747-5989; , Xiaohong/0000-0001-5074-193X	National Institute of Health/National Cancer Institute [CA108646, CA126505]; Department of Defense Prostate Cancer Research [PC081246]; National Institute of Health/NRSA [GM079879]; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009592, P30CA068485, R01CA108646, U54CA126505] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P60DK020593, P30DK058404, U24DK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM079879] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Research(United States Department of Defense); National Institute of Health/NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Institute of Health/National Cancer Institute (CA108646 and CA126505 to NAB), the Department of Defense Prostate Cancer Research Program (PC081246 to NAB), and National Institute of Health/NRSA (GM079879 to VRP). Immunofluorescence and confocal images were taken in part through the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637, and EY08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Alison MR, 2009, CURR OPIN ONCOL, V21, P77, DOI 10.1097/CCO.0b013e32831de4cf; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Anumanthan G, 2008, J UROLOGY, V180, P1778, DOI 10.1016/j.juro.2008.04.076; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Boomershine CS, 2009, GUT, V58, P1267, DOI 10.1136/gut.2008.170779; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Dan YY, 2008, J GASTROEN HEPATOL, V23, P687, DOI 10.1111/j.1440-1746.2008.05383.x; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Dittmar T, 2009, MED HYPOTHESES, V73, P542, DOI 10.1016/j.mehy.2009.05.044; Everhart MB, 2005, J LEUKOCYTE BIOL, V77, P173, DOI 10.1189/jlb.1203647; Fritz V, 2008, CURR STEM CELL RES T, V3, P32, DOI 10.2174/157488808783489462; Fritz V, 2008, STEM CELLS, V26, P2981, DOI 10.1634/stemcells.2008-0139; Li HC, 2006, WORLD J GASTROENTERO, V12, P363, DOI 10.3748/wjg.v12.i3.363; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Houghton J, 2007, SEMIN CANCER BIOL, V17, P191, DOI 10.1016/j.semcancer.2006.04.003; Ichim TE, 2010, CELL IMMUNOL, V260, P75, DOI 10.1016/j.cellimm.2009.10.006; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kasper S, 1998, LAB INVEST, V78, P319; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; LI X, 2008, PROSTATE TUMOR PROGR; Liu CF, 2006, NEOPLASIA, V8, P716, DOI 10.1593/neo.06253; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Palapattu GS, 2006, J UROLOGY, V176, P813, DOI 10.1016/j.juro.2006.03.077; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Reinders MEJ, 2010, NEPHROL DIAL TRANSPL, V25, P17, DOI 10.1093/ndt/gfp552; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Song H, 2010, EXPERT OPIN BIOL TH, V10, P309, DOI 10.1517/14712590903455997; Spagnoli A, 2005, ENDOCRIN DEV, V9, P17, DOI 10.1159/000085719; Terry S, 2006, J CELL BIOCHEM, V99, P402, DOI 10.1002/jcb.20983; THALMANN GN, 1994, CANCER RES, V54, P2577; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Vaday GG, 2006, PROSTATE, V66, P124, DOI 10.1002/pros.20306; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877	46	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12920	10.1371/journal.pone.0012920	http://dx.doi.org/10.1371/journal.pone.0012920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886110	Green Submitted, gold, Green Published			2022-12-25	WOS:000282091100024
J	Tapia, M; Wandosell, F; Garrido, JJ				Tapia, Monica; Wandosell, Francisco; Jose Garrido, Juan			Impaired Function of HDAC6 Slows Down Axonal Growth and Interferes with Axon Initial Segment Development	PLOS ONE			English	Article							KINESIN-1 MOTOR DOMAIN; HISTONE DEACETYLASE-6; MICROTUBULE STABILIZATION; TUBULIN; PROTEIN; ACETYLATION; SIRT2; TRANSPORT; DYNAMICS; BINDING	The development of morphological neuronal polarity starts by the formation and elongation of an axon. At the same time the axon initial segment (AIS) is generated and creates a diffusion barrier which differentiate axon and somatodendritic compartment. Different structural and functional proteins that contribute to the generation of neuronal action potential are concentrated at the axon initial segment. While axonal elongation is controlled by signalling pathways that regulate cytoskeleton through microtubule associated proteins and tubulin modifications, the microtubule cytoskeleton under the AIS is mostly unknown. Thus, understanding which proteins modify tubulin, where in the neuron and at which developmental stage is crucial to understanding how morphological and functional neuronal polarity is achieved. In this study performed in mice and using a well established model of murine cultured hippocampal neurons, we report that the tubulin deacetylase HDAC6 is localized at the distal region of the axon, and its inhibition with TSA or tubacin slows down axonal growth. Suppression of HDAC6 expression with HDAC6 shRNAs or expression of a non-active mutant of HDAC6 also reduces axonal length. Furthermore, HDAC6 inhibition or suppression avoids the concentration of ankyrinG and sodium channels at the axon initial segment (AIS). Moreover, treatment of mouse cultured hippocampal neurons with detergents to eliminate the soluble pool of microtubules identified a pool of detergent resistant acetylated microtubules at the AIS, not present at the rest of the axon. Inhibition or suppression of HDAC6 increases acetylation all along the axon and disrupts the specificity of AIS cytoskeleton, modifying the axonal distal gradient localization of KIF5C to a somatodendritic and axonal localization. In conclusion, our results reveal a new role of HDAC6 tubulin deacetylase as a regulator of microtubule characteristics in the axon distal region where axonal elongation takes place, and allowing the development of acetylated microtubules microdomains where HDAC6 is not concentrated, such as the axon initial segment.	[Tapia, Monica; Jose Garrido, Juan] CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain; [Tapia, Monica; Wandosell, Francisco; Jose Garrido, Juan] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Tapia, Monica; Wandosell, Francisco; Jose Garrido, Juan] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED	Tapia, M (corresponding author), CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain.	jjgarrido@cajal.csic.es	Wandosell, Francisco/AAV-6391-2020; Garrido, Juan Jose/E-6782-2012; Tapia, Monica/J-3664-2018; Wandosell, Francisco/G-6105-2015	Garrido, Juan Jose/0000-0002-4499-4487; Wandosell, Francisco/0000-0001-6537-2321	Ministerio de Educacion y Ciencia e Innovacion [SAF2006-00906, SAF2009-12249-C02-02, SAF2006-12782-C03-C01, SAF2009-12249-C02-01, EU-FP7-2009-CT222887]; Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED); CSIC	Ministerio de Educacion y Ciencia e Innovacion(Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED); CSIC	This work was supported by grants from the Ministerio de Educacion y Ciencia e Innovacion (SAF2006-00906, SAF2009-12249-C02-02 to J.J.G. and SAF2006-12782-C03-C01 and SAF2009-12249-C02-01 to F. W.) and EU-FP7-2009-CT222887; and by the Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED). M. T. is supported by a JAE fellowship from CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD FJ, 1993, J NEUROSCI, V13, P856; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; BAAS PW, 1993, J NEUROSCI, V13, P2177; BROWN A, 1993, J CELL SCI, V104, P339; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Cabrero JR, 2006, MOL BIOL CELL, V17, P3435, DOI 10.1091/mbc.E06-01-0008; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; HOBARA T, 2009, J PSYCHIAT RES; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jiang Q, 2008, J NEUROSCI, V28, P12993, DOI 10.1523/JNEUROSCI.2860-08.2008; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Liao H, 1998, J BIOL CHEM, V273, P21901, DOI 10.1074/jbc.273.34.21901; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; PEREZ M, 2009, J NEUROCHEM; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Sanchez-Ponce D, 2008, MOL CELL NEUROSCI, V37, P832, DOI 10.1016/j.mcn.2008.01.010; Shea TB, 1999, BRAIN RES BULL, V48, P255, DOI 10.1016/S0361-9230(98)00019-7; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yan JZ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000047; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	49	79	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12908	10.1371/journal.pone.0012908	http://dx.doi.org/10.1371/journal.pone.0012908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886111	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100016
J	Wen, L; Wang, HX; Tanimoto, S; Egawa, R; Matsuzaka, Y; Mushiake, H; Ishizuka, T; Yawo, H				Wen, Lei; Wang, Hongxia; Tanimoto, Saki; Egawa, Ryo; Matsuzaka, Yoshiya; Mushiake, Hajime; Ishizuka, Toru; Yawo, Hiromu			Opto-Current-Clamp Actuation of Cortical Neurons Using a Strategically Designed Channelrhodopsin	PLOS ONE			English	Article							IMMEDIATE-EARLY GENES; MILLISECOND-TIMESCALE; OPTICAL CONTROL; C-FOS; LIGHT; NETWORK; ACTIVATION; CELLS; CHLAMYDOMONAS; HIPPOCAMPUS	Background: Optogenetic manipulation of a neuronal network enables one to reveal how high-order functions emerge in the central nervous system. One of the Chlamydomonas rhodopsins, channelrhodopsin-1 (ChR1), has several advantages over channelrhodopsin-2 (ChR2) in terms of the photocurrent kinetics. Improved temporal resolution would be expected by the optogenetics using the ChR1 variants with enhanced photocurrents. Methodology/Principal Findings: The photocurrent retardation of ChR1 was overcome by exchanging the sixth helix domain with its counterpart in ChR2 producing Channelrhodopsin-green receiver (ChRGR) with further reform of the molecule. When the ChRGR photocurrent was measured from the expressing HEK293 cells under whole-cell patch clamp, it was preferentially activated by green light and has fast kinetics with minimal desensitization. With its kinetic advantages the use of ChRGR would enable one to inject a current into a neuron by the time course as predicted by the intensity of the shedding light (opto-current clamp). The ChRGR was also expressed in the motor cortical neurons of a mouse using Sindbis pseudovirion vectors. When an oscillatory LED light signal was applied sweeping through frequencies, it robustly evoked action potentials synchronized to the oscillatory light at 5-10 Hz in layer 5 pyramidal cells in the cortical slice. The ChRGR-expressing neurons were also driven in vivo with monitoring local field potentials (LFPs) and the time-frequency energy distribution of the light-evoked response was investigated using wavelet analysis. The oscillatory light enhanced both the in-phase and out-phase responses of LFP at the preferential frequencies of 5-10 Hz. The spread of activity was evidenced by the fact that there were many c-Fos-immunoreactive neurons that were negative for ChRGR in a region of the motor cortex. Conclusions/Significance: The opto-current-clamp study suggests that the depolarization of a small number of neurons wakes up the motor cortical network over some critical point to the activated state.	[Wen, Lei; Wang, Hongxia; Tanimoto, Saki; Egawa, Ryo; Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Wen, Lei; Wang, Hongxia; Tanimoto, Saki; Egawa, Ryo; Matsuzaka, Yoshiya; Mushiake, Hajime; Ishizuka, Toru; Yawo, Hiromu] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Wen, Lei; Wang, Hongxia; Tanimoto, Saki; Egawa, Ryo; Mushiake, Hajime; Yawo, Hiromu] Tohoku Univ, Basic & Translat Res Ctr Global Brain Sci, Sendai, Miyagi 980, Japan; [Matsuzaka, Yoshiya; Mushiake, Hajime] Tohoku Univ, Dept Physiol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Mushiake, Hajime; Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Ctr Neurosci, Sendai, Miyagi 980, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; Tohoku University; Tohoku University	Wen, L (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan.	yawo-hiromu@m.tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Yawo, Hiromu/I-4871-2015	Ishizuka, Toru/0000-0003-4405-8792; Yawo, Hiromu/0000-0002-4299-3288; Mushiake, Hajime/0000-0002-5130-4720	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21026002]; MEXT [08030013]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST): http://www.jst.go.jp/kisoken/crest/en/index.html. Grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, #21026002: http://www.nips.ac.jp/cellsensor/index.html. Global COE Program (Basic & Translational Research Centre for Global Brain Science), MEXT: http://sendaibrain.org/. Strategic Research Program for Brain Sciences (SRPBS), MEXT, #08030013: http://brainprogram.mext.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Callaway EM, 2002, CURR OPIN NEUROBIOL, V12, P587, DOI 10.1016/S0959-4388(02)00364-1; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; KALIL K, 1984, TRENDS NEUROSCI, V7, P394, DOI 10.1016/S0166-2236(84)80064-8; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; PUIL E, 1986, J NEUROPHYSIOL, V55, P995, DOI 10.1152/jn.1986.55.5.995; Rolls ET, 2008, EUR J NEUROSCI, V28, P782, DOI 10.1111/j.1460-9568.2008.06379.x; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Sutoh T, 2000, CLIN NEUROPHYSIOL, V111, P858, DOI 10.1016/S1388-2457(99)00321-1; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; TERASHIMA T, 1995, NEUROSCI RES, V22, P139, DOI 10.1016/0168-0102(95)00895-9; Tohidi V, 2009, J NEUROSCI, V29, P6427, DOI 10.1523/JNEUROSCI.0545-09.2009; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Van der Zee EA, 1999, PROG NEUROBIOL, V58, P409, DOI 10.1016/S0301-0082(98)00092-6; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	49	56	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12893	10.1371/journal.pone.0012893	http://dx.doi.org/10.1371/journal.pone.0012893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886118	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100009
J	Zhong, XM; Li, N; Liang, S; Huang, QH; Coukos, G; Zhang, L				Zhong, Xiaomin; Li, Ning; Liang, Shun; Huang, Qihong; Coukos, George; Zhang, Lin			Identification of MicroRNAs Regulating Reprogramming Factor LIN28 in Embryonic Stem Cells and Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; LET-7 MICRORNA; NUCLEAR EXPORT; PROMOTES TRANSFORMATION; RNA-INTERFERENCE; BINDING PROTEIN; GENE-EXPRESSION; MESSENGER-RNA; SELF-RENEWAL; C-ELEGANS	LIN28 (a homologue of the Caenorhabditis elegans lin-28 gene) is an evolutionarily conserved RNA-binding protein and a master regulator controlling the pluripotency of embryonic stem cells. Together with OCT4, SOX2, and NANOG, LIN28 can reprogram somatic cells, producing induced pluripotent stem cells. Expression of LIN28 is highly restricted to embryonic stem cells and developing tissues. In human tumors, LIN28 is up-regulated and functions as an oncogene promoting malignant transformation and tumor progression. However, the mechanisms of transcriptional and post-transcriptional regulation of LIN28 are still largely unknown. To examine microRNAs (miRNAs) that repress LIN28 expression, a combined in silico prediction and miRNA library screening approach was used in the present study. Four miRNAs directly regulating LIN28 (let-7, mir-125, mir-9, and mir-30) were initially identified by this approach and further validated by quantitative RT-PCR, Western blot analysis, and a LIN28 3 ' UTR reporter assay. We found that expression levels of these four miRNAs were clustered together and inversely correlated with LIN28 expression during embryonic stem cell differentiation. In addition, the expression of these miRNAs was remarkably lower in LIN28-positive tumor cells compared with LIN28-negative tumor cells. Importantly, we demonstrated that these miRNAs were able to regulate the expression and activity of let-7, mediated by LIN28. Taken together, our studies demonstrate that miRNAs let-7, mir-125, mir-9, and mir-30 directly repress LIN28 expression in embryonic stem and cancer cells. Global down-regulation of these miRNAs may be one of the mechanisms of LIN28 reactivation in human cancers.	[Zhang, Lin] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Huang, Qihong] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute	Zhang, L (corresponding author), Univ Penn, Sch Med, Dept Obstet & Gynecol, Rm 1209 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Coukos, George/ABG-7389-2020; Zhang, Lin/K-8478-2012	Coukos, George/0000-0001-8813-7367	National Institutes of Health, NCI [R01CA142776]; Ovarian Cancer SPORE [P50-CA83638-7951]; Breast Cancer Alliance; Mary Kay Ash Charitable Foundation; United States Department of Defense [W81XWH-10-1-0082]; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA142776, P50CA083638] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer SPORE; Breast Cancer Alliance; Mary Kay Ash Charitable Foundation; United States Department of Defense(United States Department of Defense); Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01CA142776 and Ovarian Cancer SPORE P50-CA83638-7951 Project 3. This work was also supported in part by grants from the Breast Cancer Alliance, the Ovarian Cancer Research Fund (Liz Tilberis Scholar), and the Mary Kay Ash Charitable Foundation and by United States Department of Defense Grant W81XWH-10-1-0082.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Darr H, 2009, STEM CELLS, V27, P352, DOI 10.1634/stemcells.2008-0720; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yokoyama S, 2008, GENE EXPR PATTERNS, V8, P155, DOI 10.1016/j.gep.2007.11.001; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	84	131	147	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41961	41971		10.1074/jbc.M110.169607	http://dx.doi.org/10.1074/jbc.M110.169607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20947512	Green Published, hybrid			2022-12-25	WOS:000285622600082
J	Su, V; Nakagawa, R; Koval, M; Lau, AF				Su, Vivian; Nakagawa, Reid; Koval, Michael; Lau, Alan F.			Ubiquitin-independent Proteasomal Degradation of Endoplasmic Reticulum-localized Connexin43 Mediated by CIP75	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; DAMAGE-INDUCIBLE PROTEINS; CARDIAC MYOCYTES; ORNITHINE DECARBOXYLASE; POLYUBIQUITIN CHAINS; UBA DOMAINS; INTERCELLULAR COMMUNICATION; DEPENDENT DEGRADATION; P53 DEGRADATION; 26S PROTEASOME	Connexin43 (Cx43) is a transmembrane protein that forms gap junction channels. Regulation of Cx43 turnover is one mechanism to control the level of intercellular communication that occurs through gap junction channels. Proteasomal degradation of Cx43 is regulated in part through CIP75, a ubiquitin-like and ubiquitin-associated domain containing protein. CIP75 interacts with endoplasmic reticulum-localized Cx43, as demonstrated through co-immunoprecipitation and immunofluorescence microscopy experiments. CIP75 also binds to free monoubiquitin and lysine 48-linked tetraubiquitin chains in vitro and binds to ubiquitinated proteins in cellular lysates. However, analysis of Cx43 that immunoprecipitated with CIP75 demonstrated that the Cx43 associated with CIP75 was not ubiquitinated, and a mutant form of Cx43 that lacked lysines capable of ubiquitination retained the capacity to interact with CIP75. These results suggest that although CIP75 can interact with ubiquitinated cellular proteins, its interaction with Cx43 and stimulation of Cx43 proteasomal degradation does not require the ubiquitination of Cx43.	[Su, Vivian; Nakagawa, Reid; Lau, Alan F.] Canc Res Ctr Hawaii, Nat Prod & Canc Biol Program, Honolulu, HI 96813 USA; [Koval, Michael] Emory Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Koval, Michael] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Lau, Alan F.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; Emory University; Emory University; University of Hawaii System; University of Hawaii Manoa	Lau, AF (corresponding author), Canc Res Ctr Hawaii, Nat Prod & Canc Biol Program, 651 Ilalo St,BSB 222L, Honolulu, HI 96813 USA.	aflau@crch.hawaii.edu	Koval, Michael/C-6366-2015	Koval, Michael/0000-0002-5422-5614	National Institutes of shuttle, NCI [CA052098]; NATIONAL CANCER INSTITUTE [R01CA052098] Funding Source: NIH RePORTER	National Institutes of shuttle, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of shuttle or an adaptor protein to bring target substrates to the Health, NCI, Grant CA052098 (to A. F. L.).	Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Brignone C, 2004, ONCOGENE, V23, P4121, DOI 10.1038/sj.onc.1207540; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; DARROW BJ, 1995, CIRC RES, V76, P381, DOI 10.1161/01.RES.76.3.381; Das Sarma J, 2002, J BIOL CHEM, V277, P20911, DOI 10.1074/jbc.M111498200; Das S, 2009, MOL BIOL CELL, V20, P2593, DOI 10.1091/mbc.E08-07-0790; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Girao H, 2003, MOL VIS, V9, P24; GLASS JR, 1987, J CELL PHYSIOL, V130, P133, DOI 10.1002/jcp.1041300119; Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003; Goh Amanda M., 2008, BMC Biochemistry, V9, P4, DOI 10.1186/1471-2091-9-4; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kieken F, 2010, J BIOMOL NMR, V46, P245, DOI 10.1007/s10858-010-9397-9; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laing JG, 1998, CARDIOVASC RES, V38, P711, DOI 10.1016/S0008-6363(98)00060-1; Laird DW, 2008, J BIOL CHEM, V283, P2997, DOI 10.1074/jbc.R700041200; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lan Z, 2005, BIOCHEMISTRY-US, V44, P2385, DOI 10.1021/bi048306w; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Li XL, 2008, J BIOL CHEM, V283, P5748, DOI 10.1074/jbc.M709288200; Martin PEM, 2004, CARDIOVASC RES, V62, P378, DOI 10.1016/j.cardiores.2004.01.016; Maza J, 2005, J BIOL CHEM, V280, P21115, DOI 10.1074/jbc.M412612200; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Rutz ML, 2001, EUR J CELL BIOL, V80, P20, DOI 10.1078/0171-9335-00140; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Su V, 2009, HYBRIDOMA, V28, P79, DOI 10.1089/hyb.2008.0082; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; van Veen TAB, 2001, CARDIOVASC RES, V51, P217, DOI 10.1016/S0008-6363(01)00324-8; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029	76	42	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40979	40990		10.1074/jbc.M110.170753	http://dx.doi.org/10.1074/jbc.M110.170753			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20940304	Green Published, hybrid			2022-12-25	WOS:000285414400061
J	Evankovich, J; Cho, SW; Zhang, RL; Cardinal, J; Dhupar, R; Zhang, LM; Klune, JR; Zlotnicki, J; Billiar, T; Tsung, A				Evankovich, John; Cho, Sung W.; Zhang, Ruilin; Cardinal, Jon; Dhupar, Rajeev; Zhang, Lemeng; Klune, John R.; Zlotnicki, Jason; Billiar, Timothy; Tsung, Allan			High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN PROTEIN HMGB1; INHIBITOR TRICHOSTATIN-A; GLYCATION END-PRODUCTS; LIVER ISCHEMIA; RAT HEPATOCYTES; CELL-ACTIVATION; HEPATOMA-CELLS; NUCLEAR IMPORT; ACIDIC TAIL; IN-VITRO	The mobilization and extracellular release of nuclear high mobility group box-1 (HMGB1) by ischemic cells activates inflammatory pathways following liver ischemia/reperfusion (I/R) injury. In immune cells such as macrophages, post-translational modification by acetylation appears to be critical for active HMGB1 release. Hyperacetylation shifts its equilibrium from a predominant nuclear location toward cytosolic accumulation and subsequent release. However, mechanisms governing its release by parenchymal cells such as hepatocytes are unknown. In this study, we found that serum HMGB1 released following liver I/R in vivo is acetylated, and that hepatocytes exposed to oxidative stress in vitro also released acetylated HMGB1. Histone deacetylases (HDACs) are a family of enzymes that remove acetyl groups and control the acetylation status of histones and various intracellular proteins. Levels of acetylated HMGB1 increased with a concomitant decrease in total nuclear HDAC activity, suggesting that suppression in HDAC activity contributes to the increase in acetylated HMGB1 release after oxidative stress in hepatocytes. We identified the isoforms HDAC1 and HDAC4 as critical in regulating acetylated HMGB1 release. Activation of HDAC1 was decreased in the nucleus of hepatocytes undergoing oxidative stress. In addition, HDAC1 knockdown with siRNA promoted HMGB1 translocation and release. Furthermore, we demonstrate that HDAC4 is shuttled from the nucleus to cytoplasm in response to oxidative stress, resulting in decreased HDAC activity in the nucleus. Together, these findings suggest that decreased nuclear HDAC1 and HDAC4 activities in hepatocytes following liver I/R is a mechanism that promotes the hyperacetylation and subsequent release of HMGB1.	[Evankovich, John; Cho, Sung W.; Zhang, Ruilin; Cardinal, Jon; Dhupar, Rajeev; Zhang, Lemeng; Klune, John R.; Zlotnicki, Jason; Billiar, Timothy; Tsung, Allan] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tsung, A (corresponding author), Univ Pittsburgh, Dept Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA.	tsunga@upmc.edu			National Institutes of Health [R01-GM50441]; Howard Hughes Medical Institute; American College of Surgeons; Association for Academic Surgery Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American College of Surgeons; Association for Academic Surgery Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM50441 (to T. B.), Howard Hughes Medical Institute Physician-Scientist Award (to A. T.), American College of Surgeons Research Fellowship (to A. T.), Association for Academic Surgery Foundation Research Fellowship (to S. W. C.), and Howard Hughes Medical Institute Research Training for Medical Student Fellowship (to J. E.).	Armeanu S, 2005, J HEPATOL, V42, P210, DOI 10.1016/j.jhep.2004.10.020; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Brandl A, 2009, BIOL CELL, V101, P193, DOI 10.1042/BC20080158; BUSTIN M, 1978, J BIOL CHEM, V253, P1694; Carlisi D, 2008, INT J ONCOL, V32, P177; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dhupar R, 2011, SHOCK, V35, P293, DOI 10.1097/SHK.0b013e3181f6aab0; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; FUJII K, 2009, CELL PROLIF; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Henkens T, 2007, TOXICOL APPL PHARM, V218, P64, DOI 10.1016/j.taap.2006.10.012; Herold C, 2002, J HEPATOL, V36, P233, DOI 10.1016/S0168-8278(01)00257-4; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Papeleu P, 2003, J HEPATOL, V39, P374, DOI 10.1016/S0168-8278(03)00288-5; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; STERNER R, 1979, J BIOL CHEM, V254, P1577; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Topalova D, 2008, INT J BIOCHEM CELL B, V40, P1536, DOI 10.1016/j.biocel.2007.11.014; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Tsung A, 2006, AM J PHYSIOL-GASTR L, V290, pG1261, DOI 10.1152/ajpgi.00460.2005; Urbonaviciute V, 2007, J LEUKOCYTE BIOL, V81, P67, DOI 10.1189/jlb.0306196; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Vanhaecke T, 2004, BIOCHEM PHARMACOL, V68, P753, DOI 10.1016/j.bcp.2004.05.022; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; WEST MA, 1989, GASTROENTEROLOGY, V96, P1572, DOI 10.1016/0016-5085(89)90529-5; Xu H, 2010, J IMMUNOL, V184, P1492, DOI 10.4049/jimmunol.0902660; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015	45	189	197	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39888	39897		10.1074/jbc.M110.128348	http://dx.doi.org/10.1074/jbc.M110.128348			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937823	hybrid, Green Published			2022-12-25	WOS:000285185500033
J	van der Velden, LM; Wichers, CGK; van Breevoort, AED; Coleman, JA; Molday, RS; Berger, R; Klomp, LWJ; van de Graaf, SFJ				van der Velden, Lieke M.; Wichers, Catharina G. K.; van Breevoort, Adriana E. D.; Coleman, Jonathan A.; Molday, Robert S.; Berger, Ruud; Klomp, Leo W. J.; van de Graaf, Stan F. J.			Heteromeric Interactions Required for Abundance and Subcellular Localization of Human CDC50 Proteins and Class 1 P-4-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; INTRAHEPATIC CHOLESTASIS TYPE-1; YEAST PLASMA-MEMBRANE; PHOSPHOLIPID TRANSLOCATION; SACCHAROMYCES-CEREVISIAE; AMINOPHOSPHOLIPID TRANSPORT; HEREDITARY CHOLESTASIS; BETA-SUBUNITS; EXPRESSION; DRS2P	Members of the P-4 family of P-type ATPases (P-4-ATPases) are believed to function as phospholipid flippases in complex with CDC50 proteins. Mutations in the human class 1 P-4-ATPase gene ATP8B1 cause a severe syndrome characterized by impaired bile flow (intrahepatic cholestasis), often leading to end-stage liver failure in childhood. In this study, we determined the specificity of human class 1 P-4-ATPase interactions with CDC50 proteins and the functional consequences of these interactions on protein abundance and localization of both protein classes. ATP8B1 and ATP8B2 co-immunoprecipitated with CDC50A and CDC50B, whereas ATP8B4, ATP8A1, and ATP8A2 associated only with CDC50A. ATP8B1 shifted from the endoplasmic reticulum (ER) to the plasma membrane upon coexpression of CDC50A or CDC50B. ATP8A1 and ATP8A2 translocated from the ER to the Golgi complex and plasma membrane upon coexpression of CDC50A, but not CDC50B. ATP8B2 and ATP8B4 already displayed partial plasma membrane localization in the absence of CDC50 coexpression but displayed a large increase in plasma membrane abundance upon coexpression of CDC50A. ATP8B3 did not bind CDC50A and CDC50B and was invariably present in the ER. Our data show that interactions between CDC50 proteins and class 1 P-4-ATPases are essential for ER exit and stability of both subunits. Furthermore, the subcellular localization of the complex is determined by the P-4-ATPase, not the CDC50 protein. The interactions of CDC50A and CDC50B with multiple members of the human P-4-ATPase family suggest that these proteins perform broader functions in human physiology than thus far assumed.	[van der Velden, Lieke M.; Wichers, Catharina G. K.; van Breevoort, Adriana E. D.; Berger, Ruud; Klomp, Leo W. J.; van de Graaf, Stan F. J.] UMC Utrecht, Dept Metab & Endocrine Dis, NL-3508 AB Utrecht, Netherlands; [van der Velden, Lieke M.; Wichers, Catharina G. K.; van Breevoort, Adriana E. D.; Berger, Ruud; Klomp, Leo W. J.; van de Graaf, Stan F. J.] Netherlands Metabol Ctr, NL-3508 AB Utrecht, Netherlands; [Coleman, Jonathan A.; Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Dept Ophthalmol & Visual Sci, Vancouver, BC V6T IZ3, Canada; [Coleman, Jonathan A.; Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Dept Biochem & Mol Biol, Vancouver, BC V6T IZ3, Canada	Utrecht University; Utrecht University Medical Center; University of British Columbia; University of British Columbia	van de Graaf, SFJ (corresponding author), UMC Utrecht, Dept Metab & Endocrine Dis, KC 02-069-1,POB 85090, NL-3508 AB Utrecht, Netherlands.	s.vandegraaf-4@umcutrecht.nl		Coleman, Jonathan/0000-0003-0001-6195; van de Graaf, Stan/0000-0003-4238-4359	Netherlands Organization for Scientific Research (NWO) [016.096.108]; Wilhelmina Children's Foundation; Utrecht University; Dutch Digestive Disease Foundation	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Wilhelmina Children's Foundation; Utrecht University; Dutch Digestive Disease Foundation	This work was supported by Netherlands Organization for Scientific Research (NWO) SFJvdG Project 016.096.108 and by the Wilhelmina Children's Foundation, the Utrecht University High Potential Program, and the Dutch Digestive Disease Foundation (to L.W.J.K.).	ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Gong EY, 2009, REPRODUCTION, V137, P345, DOI 10.1530/REP-08-0048; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Halleck MS, 1998, GENOME RES, V8, P354, DOI 10.1101/gr.8.4.354; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Katoh Y, 2004, ONCOL REP, V12, P939; Knisely AS, 1997, ARCH DIS CHILD, V77, P276, DOI 10.1136/adc.77.3.276; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Lykavieris P, 2003, J HEPATOL, V39, P447, DOI 10.1016/S0168-8278(03)00286-1; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Noji T, 2006, BIOCHEM BIOPH RES CO, V344, P323, DOI 10.1016/j.bbrc.2006.03.095; Osada N, 2007, GENE, V392, P151, DOI 10.1016/j.gene.2006.11.021; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Radji M, 2001, YEAST, V18, P195, DOI 10.1002/1097-0061(200102)18:3<195::AID-YEA660>3.0.CO;2-L; Ruaud AF, 2009, TRAFFIC, V10, P88, DOI 10.1111/j.1600-0854.2008.00844.x; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, HEPATOLOGY, V51, P286, DOI 10.1002/hep.23268; Verhulst PM, 2010, HEPATOLOGY, V51, P2049, DOI 10.1002/hep.23586; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	37	83	91	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40088	40096		10.1074/jbc.M110.139006	http://dx.doi.org/10.1074/jbc.M110.139006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947505	Green Published, hybrid			2022-12-25	WOS:000285185500054
J	Diebold, ML; Loeliger, E; Koch, M; Winston, F; Cavarelli, J; Romier, C				Diebold, Marie-Laure; Loeliger, Erin; Koch, Michael; Winston, Fred; Cavarelli, Jean; Romier, Christophe			Noncanonical Tandem SH2 Enables Interaction of Elongation Factor Spt6 with RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; CHROMATIN-STRUCTURE; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; DOMAIN; YEAST; GENE; BINDING	Src homology 2 (SH2) domains are mostly found in multicellular organisms where they recognize phosphotyrosine-containing signaling proteins. Spt6, a conserved transcription factor and putative histone chaperone, contains a C-terminal SH2 domain conserved from yeast to human. In mammals, this SH2 domain recognizes phosphoserines rather than phosphotyrosines and is essential for the recruitment of Spt6 by elongating RNA polymerase II (RNAPII), enabling Spt6 to participate in the coupling of transcription elongation, chromatin modulation, and mRNA export. We have determined the structure of the entire Spt6 C-terminal region from Antonospora locustae, revealing the presence of two highly conserved tandem SH2 domains rather than a single SH2 domain. Although the first SH2 domain has a canonical organization, the second SH2 domain is highly noncanonical and appears to be unique in the SH2 family. However, both SH2 domains have phosphate-binding determinants. Our biochemical and genetic data demonstrate that the complete tandem, but not the individual SH2 domains, are necessary and sufficient for the interaction of Spt6 with RNAPII and are important for Spt6 function in vivo. Furthermore, our data suggest that binding of RNAPII to the Spt6 tandem SH2 is more extensive than the mere recognition of a doubly phosphorylated C-terminal domain peptide by the tandem SH2. Taken together, our results show that Spt6 interaction with RNAPII via a novel arrangement of canonical and noncanonical SH2 domains is crucial for Spt6 function in vivo.	Univ Strasbourg, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire,Dept Biol & Ge, F-67404 Illkirch Graffenstaden, France; [Loeliger, Erin; Winston, Fred] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Harvard Medical School		romier@igbmc.fr	Cavarelli, Jean/P-3566-2016	Cavarelli, Jean/0000-0001-8620-8723; Romier, Christophe/0000-0002-3680-935X; Diebold-Durand, Marie-Laure/0000-0002-2061-9260	National Institutes of Health [GM32967]; CNRS; INSERM; Universite de Strasbourg; European Commission [LSHG-CT-2006-031220]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032967, T32GM007753, R01GM032967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32967. This work was also supported by the CNRS, INSERM, the Universite de Strasbourg, and the European Commission SPINE2-Complexes Contract LSHG-CT-2006-031220.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Besse Sylvie, 1995, Gene Expression, V4, P143; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; CLARKADAMS CD, 1987, MOL CELL BIOL, V7, P679, DOI 10.1128/MCB.7.2.679; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endoh M, 2004, MOL CELL BIOL, V24, P3324, DOI 10.1128/MCB.24.8.3324-3336.2004; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Fischbeck JA, 2002, GENETICS, V162, P1605; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Johnson SJ, 2008, J MOL BIOL, V377, P1460, DOI 10.1016/j.jmb.2008.01.096; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu ZG, 2007, BIOCHEM BIOPH RES CO, V353, P47, DOI 10.1016/j.bbrc.2006.11.133; MACLENNAN AJ, 1993, TRENDS BIOCHEM SCI, V18, P464; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; NEIGEBORN L, 1987, MOL CELL BIOL, V7, P672, DOI 10.1128/MCB.7.2.672; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Romier C, 2007, J MOL BIOL, V368, P1292, DOI 10.1016/j.jmb.2007.02.039; Romier C, 2006, ACTA CRYSTALLOGR D, V62, P1232, DOI 10.1107/S0907444906031003; Rose M, 1990, LAB COURSE MANUAL ME; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WINSTON F, 1984, GENETICS, V107, P179; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	55	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38389	38398		10.1074/jbc.M110.146696	http://dx.doi.org/10.1074/jbc.M110.146696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926373	hybrid, Green Published			2022-12-25	WOS:000284625600045
J	Ikeda, H; Miyatake, M; Koshikawa, N; Ochiai, K; Yamada, K; Kiss, A; Donlin, MJ; Panneton, WM; Churchill, JD; Green, M; Siddiqui, AM; Leinweber, AL; Crews, NR; Ezerskiy, LA; Rendell, VR; Belcheva, MM; Coscia, CJ				Ikeda, Hiroko; Miyatake, Mayumi; Koshikawa, Noriaki; Ochiai, Kuniyasu; Yamada, Kiyoshi; Kiss, Alexi; Donlin, Maureen J.; Panneton, W. Michael; Churchill, James D.; Green, Michael; Siddiqui, Akbar M.; Leinweber, Andrew L.; Crews, Nicholas R.; Ezerskiy, Lubov A.; Rendell, Victoria R.; Belcheva, Mariana M.; Coscia, Carmine J.			Morphine Modulation of Thrombospondin Levels in Astrocytes and Its Implications for Neurite Outgrowth and Synapse Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; MU-OPIOID-RECEPTORS; C6 GLIOMA-CELLS; PRIMARY ASTROGLIAL CULTURES; NUCLEUS-ACCUMBENS SHELL; DENDRITIC SPINES; GENE-EXPRESSION; GLIAL-CELLS	Opioid receptor signaling via EGF receptor (EGFR) transactivation and ERK/MAPK phosphorylation initiates diverse cellular responses that are cell type-dependent. In astrocytes, multiple mu opioid receptor-mediated mechanisms of ERK activation exist that are temporally distinctive and feature different outcomes. Upon discovering that chronic opiate treatment of rats down-regulates thrombospondin 1 (TSP1) expression in the nucleus accumbens and cortex, we investigated the mechanism of action of this modulation in astrocytes. TSP1 is synthesized in astrocytes and is released into the extracellular matrix where it is known to play a role in synapse formation and neurite outgrowth. Acute morphine (hours) reduced TSP1 levels in astrocytes. Chronic (days) opioids repressed TSP1 gene expression and reduced its protein levels by mu opioid receptor and ERK-dependent mechanisms in astrocytes. Morphine also depleted TSP1 levels stimulated by TGF beta 1 and abolished ERK activation induced by this factor. Chronic morphine treatment of astrocyte-neuron co-cultures reduced neurite outgrowth and synapse formation. Therefore, inhibitory actions of morphine were detected after both acute and chronic treatments. An acute mechanism of morphine signaling to ERK that entails depletion of TSP1 levels was suggested by inhibition of morphine activation of ERK by a function-blocking TSP1 antibody. This raises the novel possibility that acute morphine uses TSP1 as a source of EGF-like ligands to activate EGFR. Chronic morphine inhibition of TSP1 is reminiscent of the negative effect of mu opioids on EGFR-induced astrocyte proliferation via a phospho-ERK feedback inhibition mechanism. Both of these variations of classical EGFR transactivation may enable opiates to diminish neurite outgrowth and synapse formation.	[Ikeda, Hiroko; Miyatake, Mayumi; Kiss, Alexi; Donlin, Maureen J.; Leinweber, Andrew L.; Crews, Nicholas R.; Ezerskiy, Lubov A.; Rendell, Victoria R.; Belcheva, Mariana M.; Coscia, Carmine J.] St Louis Univ, EA Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Ikeda, Hiroko; Koshikawa, Noriaki] Nihon Univ, Sch Dent, Dept Pharmacol, Tokyo 1018310, Japan; [Ochiai, Kuniyasu; Yamada, Kiyoshi] Nihon Univ, Sch Dent, Dept Microbiol, Tokyo 1018310, Japan	Saint Louis University; Nihon University; Nihon University	Coscia, CJ (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	cosciacc@slu.edu	Kiss, Alexi/AAH-6830-2021; Donlin, Maureen J./M-4709-2019	Ezerskiy, Lubov/0000-0002-1869-0658; Kiss, Alexi/0000-0003-2330-6929; Donlin, Maureen/0000-0001-7312-079X	National Institutes of Health [DA-005412]; Nihon University; Ministry of Education, Culture, Sports, Science and Technology; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005412, F32DA005412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nihon University; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA-005412 (to C. J. C.). This work was also supported by individual research grant from Nihon University and a grant for promotion of multidisciplinary research projects from the Ministry of Education, Culture, Sports, Science and Technology (to H. I.).	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Ammon-Treiber S, 2005, ADDICT BIOL, V10, P81, DOI 10.1080/13556210412331308994; BARG J, 1991, PEPTIDES, V12, P845, DOI 10.1016/0196-9781(91)90144-E; BARG J, 1994, J NEUROSCI, V14, P5858; Barker AJ, 2008, J NEUROSCI, V28, P8150, DOI 10.1523/JNEUROSCI.1744-08.2008; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Belcheva MM, 2002, J PHARMACOL EXP THER, V303, P909, DOI 10.1124/jpet.102.038554; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; Blondel O, 2000, J NEUROSCI, V20, P8012; Bohn LM, 2000, J NEUROCHEM, V74, P564, DOI 10.1046/j.1471-4159.2000.740564.x; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Dibrov A, 2006, GROWTH FACTORS, V24, P1, DOI 10.1080/08977190500365995; ERIKSSON PS, 1991, NEUROPHARMACOLOGY, V30, P1233, DOI 10.1016/0028-3908(91)90170-G; ERIKSSON PS, 1990, NEUROCHEM RES, V15, P1123, DOI 10.1007/BF01101714; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Fuchshofer R, 2005, INVEST OPHTH VIS SCI, V46, P568, DOI 10.1167/iovs.04-0649; Gurwell JA, 1996, BRAIN RES, V737, P175, DOI 10.1016/0006-8993(96)00728-7; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; Hauser KF, 1998, PERSPECT DEV NEUROBI, V5, P437; HAUSER KF, 1987, BRAIN RES, V416, P157, DOI 10.1016/0006-8993(87)91509-5; Hauser KF, 2000, EUR J NEUROSCI, V12, P1281, DOI 10.1046/j.1460-9568.2000.01015.x; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hemby SE, 2004, NEUROSCIENCE, V126, P689, DOI 10.1016/j.neuroscience.2004.01.056; Hou YN, 2006, NEUROSCI LETT, V395, P244, DOI 10.1016/j.neulet.2005.10.086; Hou YN, 2004, DEV BRAIN RES, V151, P149, DOI 10.1016/j.devbrainres.2004.05.002; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Jacobs EH, 2002, FASEB J, V16, P1961, DOI 10.1096/fj.02-0272fje; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Joo CK, 2008, ONCOGENE, V27, P614, DOI 10.1038/sj.onc.1210649; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kim E, 2006, J BIOL CHEM, V281, P33749, DOI 10.1074/jbc.M603862200; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Liao D, 2005, P NATL ACAD SCI USA, V102, P1725, DOI 10.1073/pnas.0406797102; Liao D, 2007, MOL CELL NEUROSCI, V35, P456, DOI 10.1016/j.mcn.2007.04.007; Liao DZ, 2007, J NEUROPHYSIOL, V97, P1485, DOI 10.1152/jn.00790.2006; Lin H, 2009, NEUROPSYCHOPHARMACOL, V34, P2097, DOI 10.1038/npp.2009.34; LISKA DJ, 1994, J CELL PHYSIOL, V158, P495, DOI 10.1002/jcp.1041580314; Liu A, 2009, MICROVASC RES, V77, P13, DOI 10.1016/j.mvr.2008.08.008; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; Miljkovic-Licina M, 2004, BIOSYSTEMS, V76, P75, DOI 10.1016/j.biosystems.2004.05.030; Miyatake M, 2009, J NEUROCHEM, V110, P662, DOI 10.1111/j.1471-4159.2009.06156.x; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nakagawa T, 2005, J AM SOC NEPHROL, V16, P899, DOI 10.1681/ASN.2004080689; Narita M, 2006, J NEUROCHEM, V97, P1494, DOI 10.1111/j.1471-4159.2006.03849.x; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSHEA KS, 1991, NEURON, V7, P231, DOI 10.1016/0896-6273(91)90261-W; OSTERHOUT DJ, 1992, DEV BIOL, V150, P256, DOI 10.1016/0012-1606(92)90240-H; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RADANY EH, 1992, P NATL ACAD SCI USA, V89, P6467, DOI 10.1073/pnas.89.14.6467; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Ruzicka BB, 1995, MOL BRAIN RES, V34, P209, DOI 10.1016/0169-328X(95)00165-O; ScottDrew S, 1997, J NEUROSCI RES, V50, P202, DOI 10.1002/(SICI)1097-4547(19971015)50:2<202::AID-JNR9>3.0.CO;2-J; Semiali A, 2008, AM J RESP CELL MOL, V38, P202, DOI 10.1165/rcmb.2007-0031OC; Spijker S, 2004, FASEB J, V18, P848, DOI 10.1096/fj.03-0612fje; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stiene-Martin A, 2001, GLIA, V36, P78, DOI 10.1002/glia.1097; STIENEMARTIN A, 1991, DEV BRAIN RES, V60, P1, DOI 10.1016/0165-3806(91)90149-D; Suzuki M, 2006, EUR J PHARMACOL, V535, P166, DOI 10.1016/j.ejphar.2006.01.033; Tikhonenko AT, 1996, J BIOL CHEM, V271, P30741, DOI 10.1074/jbc.271.48.30741; Ueda H, 2009, FRONT BIOSCI, V14, P5260, DOI 10.2741/3596; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Van den Pol AN, 2000, NEUROSCIENCE, V95, P603; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yu KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002470; Ziolkowska B, 2005, J NEUROSCI, V25, P4996, DOI 10.1523/JNEUROSCI.4376-04.2005	87	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38415	38427		10.1074/jbc.M110.109827	http://dx.doi.org/10.1074/jbc.M110.109827			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889977	Green Published, hybrid			2022-12-25	WOS:000284625600047
J	Madge, LA; May, MJ				Madge, Lisa A.; May, Michael J.			Classical NF-kappa B Activation Negatively Regulates Noncanonical NF-kappa B-dependent CXCL12 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; SIGNALING SYSTEM; GENE-EXPRESSION; PATHWAYS; TRANSCRIPTION; NF-KAPPA-B2; CHEMOKINES; INFLAMMATION; RECEPTORS	Ligation of the lymphotoxin-beta receptor (LT beta R) by LIGHT (lymphotoxin-related inducible ligand that competes for glycoprotein D binding to herpes virus entry mediator on T cells (TNFSF14)) activates the noncanonical (NC) NF-kappa B (nuclear factor-kappa B) pathway and up-regulates CXCL12 gene expression by human umbilical vein endothelial cells (HUVEC). In contrast, TNF only activates classical NF-kappa B signaling and does not up-regulate CXCL12. To determine whether cross-talk between the classical and NC pathways affects CXCL12 expression, we investigated the effects of TNF on LIGHT signaling in HUVEC. We show here that TNF inhibits both basal and LIGHT-induced CXCL12 expression. Negative regulation by TNF requires the classical NF-kappa B pathway as inhibition of basal and induced CXCL12 was reversed in HUVEC-expressing dominant negative I kappa B (inhibitor of NF-kappa B) kinase (IKK)beta (IKK beta(K44M)). TNF did not inhibit the NC NF-kappa B pathway activation as LIGHT-induced p100 processing to p52 was intact; however, TNF either alone or together with LIGHT up-regulated p100 and RelB expression and induced the nuclear localization of p100-RelB complexes. Enhanced p100 and RelB expression was inhibited by IKK beta(K44M), which led us to question whether the I kappa B function of elevated p100 mediates the inhibition of CXCL12 expression by TNF. We retrovirally transduced HUVEC to express p100 at a level similar to that up-regulated by TNF; however, basal and LIGHT-induced CXCL12 expression was normal in the transduced cells. In contrast, ectopic RelB expression recapitulated the effects of TNF on NC signaling and inhibited basal and LIGHT-induced CXCL12 expression by HUVEC. Our findings therefore demonstrate that TNF-induced classical NF-kappa B signaling up-regulates RelB expression that inhibits both basal and NC NF-kappa B-dependent CXCL12 expression.	[May, Michael J.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [May, Michael J.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	May, MJ (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St,OVH 200E, Philadelphia, PA 19104 USA.	maym@vet.upenn.edu		May, Michael/0000-0002-2485-3716	National Institutes of Health [RO1HL080612, RO1HL080612-04S1]; W.W. Smith Charitable Trust [H0703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.W. Smith Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL080612 and RO1HL080612-04S1. This work was also supported by W.W. Smith Charitable Trust Grant H0703.	Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Croxton R, 2006, CANCER RES, V66, P9026, DOI 10.1158/0008-5472.CAN-06-1047; Dejardin E, 1999, ONCOGENE, V18, P2567, DOI 10.1038/sj.onc.1202599; DEJARDIN E, 1995, ONCOGENE, V11, P1835; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Fedyk ER, 2001, J IMMUNOL, V166, P5749, DOI 10.4049/jimmunol.166.9.5749; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Legarda-Addison D, 2007, J IMMUNOL, V178, P7767, DOI 10.4049/jimmunol.178.12.7767; Liu KKY, 2009, J NEUROIMMUNOL, V215, P49, DOI 10.1016/j.jneuroim.2009.08.003; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Loh SA, 2009, PLAST RECONSTR SURG, V123, p65S, DOI 10.1097/PRS.0b013e318191bdf4; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Speirs K, 2004, J IMMUNOL, V172, P752, DOI 10.4049/jimmunol.172.2.752; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Sung ML, 2009, CIRC RES, V105, P755, DOI 10.1161/CIRCRESAHA.109.206524; Suto H, 2009, INT IMMUNOL, V21, P467, DOI 10.1093/intimm/dxp014; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Xia YY, 1997, AM J PATHOL, V151, P375; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zhang Q, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2391	45	34	35	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38069	38077		10.1074/jbc.M110.147207	http://dx.doi.org/10.1074/jbc.M110.147207			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923761	Green Published, hybrid			2022-12-25	WOS:000284625600015
J	Ito, S; Osaka, M; Higuchi, Y; Nishijima, F; Ishii, H; Yoshida, M				Ito, Shunsuke; Osaka, Mizuko; Higuchi, Yusuke; Nishijima, Fuyuhiko; Ishii, Hideto; Yoshida, Masayuki			Indoxyl Sulfate Induces Leukocyte-Endothelial Interactions through Up-regulation of E-selectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC-RENAL-FAILURE; CHRONIC KIDNEY-DISEASE; E-DEFICIENT MICE; ADHESION MOLECULES; OXIDATIVE STRESS; ORAL ADSORBENT; KAPPA-B; GLOMERULAR SCLEROSIS; FEMORAL-ARTERY; IN-VITRO	Despite a positive correlation between chronic kidney disease and atherosclerosis, the causative role of uremic toxins in leukocyte-endothelial interactions has not been reported. We thus examined the effects of indoxyl sulfate, a uremic toxin, on leukocyte adhesion to activated endothelial cells and the underlying mechanisms. Pretreatment of human umbilical vein endothelial cells (HUVEC) with indoxyl sulfate significantly enhanced the adhesion of human monocytic cells (THP-1 cell line) to TNF-alpha-activated HUVEC under physiological flow conditions. Treatment with indoxyl sulfate enhanced the expression level of E-selectin, but not that of ICAM-1 or VCAM-1, in HUVEC. Indoxyl sulfate treatment enhanced the activation of JNK, p38 MAPK, and NF-kappa B in TNF-alpha-activated HUVEC. Inhibitors of JNK and NF-kappa B attenuated indoxyl sulfate-induced E-selectin expression in HUVEC and subsequent THP-1 adhesion. Furthermore, treatment with the NAD(P)H oxidase inhibitor apocynin and the glutathione donor N-acetylcysteine inhibited indoxyl sulfate-induced enhancement of THP-1 adhesion to HUVEC. Next, we examined the in vivo effect of indoxyl sulfate in nephrectomized chronic kidney disease model mice. Indoxyl sulfate-induced leukocyte adhesion to the femoral artery was significantly reduced by anti-E-selectin antibody treatment. These findings suggest that indoxyl sulfate enhances leukocyte-endothelial interactions through up-regulation of E-selectin, presumably via the JNK- and NF-kappa B-dependent pathway.	Tokyo Med & Dent Univ, Dept Life Sci & Med Eth, Grad Sch Med, Bunkyo Ku, Tokyo 1138510, Japan; [Ito, Shunsuke; Higuchi, Yusuke; Nishijima, Fuyuhiko] Kureha Corp, Biomed Res Labs, Tokyo 1698503, Japan	Tokyo Medical & Dental University (TMDU)		masa.vasc@tmd.ac.jp			Ministry of Education, Science, and Technology [10178102]; Ministry of Culture of Japan; Ministry of Health, Labor, and Welfare of Japan; Ono Medical Research Foundation	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Culture of Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ono Medical Research Foundation	This work was supported in part by Ministry of Education, Science, and Technology Grant-in-aid for Scientific Research 10178102 and special coordination funds, a grant-in-aid from the Ministry of Culture of Japan, a grant from the Ministry of Health, Labor, and Welfare of Japan, and a grant-in-aid from the Ono Medical Research Foundation.	Amann K, 2004, J AM SOC NEPHROL, V15, P1664, DOI 10.1097/01.ASN.0000128365.76153.5B; Asgeirsdottir S. A., 2007, MOL PHARM, V72, P121; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; BOLTON WK, 1987, KIDNEY INT, V32, P869, DOI 10.1038/ki.1987.288; Bro S, 2004, J AM SOC NEPHROL, V15, P1495, DOI 10.1097/01.ASN.0000128371.33195.7B; Bro S, 2007, ARTERIOSCL THROM VAS, V27, P1080, DOI 10.1161/ATVBAHA.107.139634; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Faure V, 2006, J THROMB HAEMOST, V4, P566, DOI 10.1111/j.1538-7836.2005.01780.x; Fujii H, 2009, NEPHROL DIAL TRANSPL, V24, P2089, DOI 10.1093/ndt/gfp007; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gotoh R, 2004, ARTERIOSCL THROM VAS, V24, P2063, DOI 10.1161/01.ATV.0000145942.31404.20; Hagita S, 2008, HYPERTENSION, V51, P797, DOI 10.1161/HYPERTENSIONAHA.107.098855; Kobayashi N, 2002, NEPHRON, V91, P480, DOI 10.1159/000064291; Kren S, 1999, KIDNEY INT, V56, P333, DOI 10.1046/j.1523-1755.1999.00527.x; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; Lin CW, 2007, BIOMATERIALS, V28, P1355, DOI 10.1016/j.biomaterials.2006.11.006; Malaponte G, 2007, INT J MOL MED, V20, P471; Malatino LS, 2007, J INTERN MED, V262, P479, DOI 10.1111/j.1365-2796.2007.01841.x; Murakami S, 2001, MICROVASC RES, V62, P383, DOI 10.1006/mvre.2001.2356; Nakamura T., 2011, METABOLISM IN PRESS; Nakatani K, 2004, KIDNEY INT, V65, P1290, DOI 10.1111/j.1523-1755.2004.00537.x; Namikoshi T, 2009, HYPERTENS RES, V32, P194, DOI 10.1038/hr.2008.29; Nishiwaki Y, 2003, BIOCHEM BIOPH RES CO, V310, P1062, DOI 10.1016/j.bbrc.2003.09.125; NIWA T, 1994, J LAB CLIN MED, V124, P96; NIWA T, 1994, AM J NEPHROL, V14, P207, DOI 10.1159/000168716; Osaka M, 2007, AM J PHYSIOL-HEART C, V292, pH1876, DOI 10.1152/ajpheart.00708.2006; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shimoishi K, 2007, PHARM RES-DORDR, V24, P1283, DOI 10.1007/s11095-007-9248-x; Testa A, 2006, NEPHROL DIAL TRANSPL, V21, P1921, DOI 10.1093/ndt/gfl115; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Wheeler DC, 1996, LANCET, V348, P1673, DOI 10.1016/S0140-6736(05)65816-3; Wolf D, 2001, J IMMUNOL, V166, P1300, DOI 10.4049/jimmunol.166.2.1300; Yamamoto H, 2006, KIDNEY INT, V69, P1780, DOI 10.1038/sj.ki.5000340; Yoshida M, 1998, J IMMUNOL, V161, P933; Yoshida M, 2001, ARTERIOSCL THROM VAS, V21, P1165, DOI 10.1161/hq0701.092143	39	125	128	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38869	38875		10.1074/jbc.M110.166686	http://dx.doi.org/10.1074/jbc.M110.166686			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937831	Green Published, hybrid			2022-12-25	WOS:000284941300016
J	You, R; Zheng, MZ; McKeown-Longo, PJ				You, Ran; Zheng, Mingzhe; McKeown-Longo, Paula J.			The First Type III Repeat in Fibronectin Activates an Inflammatory Pathway in Dermal Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOGNITION; ANASTELLIN; PEPTIDE; INJURY; SITES; FORM	Remodeling of the fibronectin matrix occurs during a variety of pathological and regenerative processes. Cellular generated tensional forces can alter the secondary and tertiary structure of the fibronectin matrix and regulate the exposure of cryptic activities that directly impact cell behavior. In the present study, we evaluated the effect of the partially unfolded Type III fibronectin module, FnIII-1c, on gene expression in dermal fibroblasts. Microarray and PCR analysis indicated that the addition of FnIII-1c to human dermal fibroblasts induced the expression of several inflammatory genes including the cytokines, IL-8 and TNF-alpha. ELISA analysis indicated that the increased gene expression was accompanied by the secretion of IL-8 and TNF-alpha protein. FnIII-1c-induced gene expression was preceded by increased phosphorylation of I kappa B kinase (IKK) and I kappa B alpha as well as the nuclear translocation of NF kappa B. PCR and ELISA analysis showed that inhibition of the NF kappa B signaling pathway completely blocked the induction of IL-8 and TNF-alpha. Blocking antibodies to Toll-like receptor 4 inhibited both the activation of the NF kappa B signaling pathway as well as cytokine expression in response to FnIII-1c. These data suggest that fibronectin matrix remodeling can induce the expression of cytokines by stromal cells present in the tissue microenvironment.	[You, Ran; Zheng, Mingzhe; McKeown-Longo, Paula J.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	McKeown-Longo, PJ (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MC-165,47 New Scotland Ave, Albany, NY 12208 USA.	mckeowp@mail.amc.edu			National Institutes of Health [CA-69612]; NATIONAL CANCER INSTITUTE [R01CA069612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by, in whole or in part, by National Institutes of Health Grant CA-69612 (to P.J.M.-L.).	Ambesi A, 2005, CANCER RES, V65, P148; Ambesi A, 2009, MOL CANCER RES, V7, P255, DOI 10.1158/1541-7786.MCR-08-0195; Antia M, 2008, FARADAY DISCUSS, V139, P229, DOI 10.1039/b718714a; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gee EPS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002373; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hocking DC, 2008, CIRC RES, V102, P372, DOI 10.1161/CIRCRESAHA.107.158501; Klein RM, 2003, J CELL SCI, V116, P4663, DOI 10.1242/jcs.00778; Kubow KE, 2009, INTEGR BIOL-UK, V1, P635, DOI 10.1039/b914996a; Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566; Meighan CM, 2008, CURR OPIN CELL BIOL, V20, P520, DOI 10.1016/j.ceb.2008.05.010; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200; Miura S, 2007, BIOL PHARM BULL, V30, P891, DOI 10.1248/bpb.30.891; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Pasqualini R, 1996, NAT MED, V2, P1197, DOI 10.1038/nm1196-1197; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Suki Bela, 2007, Drug Discov Today Dis Models, V4, P139, DOI 10.1016/j.ddmod.2007.10.002; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Yi M, 2003, P NATL ACAD SCI USA, V100, P11435, DOI 10.1073/pnas.1635112100; You R, 2009, MATRIX BIOL, V28, P101, DOI 10.1016/j.matbio.2009.01.003; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	31	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36255	36259		10.1074/jbc.C110.176990	http://dx.doi.org/10.1074/jbc.C110.176990			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20923762	Green Published, hybrid			2022-12-25	WOS:000284146100001
J	Otomo, T; Tomchick, DR; Otomo, C; Machius, M; Rosen, MK				Otomo, Takanori; Tomchick, Diana R.; Otomo, Chinatsu; Machius, Mischa; Rosen, Michael K.			Crystal Structure of the Formin mDia1 in Autoinhibited Conformation	PLOS ONE			English	Article							DIAPHANOUS-RELATED FORMINS; ACTIN-FILAMENT ELONGATION; ARP2/3 COMPLEX; AUTOREGULATORY DOMAIN; HOMOLOGY-2 DOMAIN; FH2 DOMAIN; PROTEIN; RHO; ACTIVATION; NUCLEATION	Background: Formin proteins utilize a conserved formin homology 2 (FH2) domain to nucleate new actin filaments. In mammalian diaphanous-related formins (DRFs) the FH2 domain is inhibited through an unknown mechanism by intramolecular binding of the diaphanous autoinhibitory domain (DAD) and the diaphanous inhibitory domain (DID). Methodology/Principal Findings: Here we report the crystal structure of a complex between DID and FH2-DAD fragments of the mammalian DRF, mDia1 (mammalian diaphanous 1 also called Drf1 or p140mDia). The structure shows a tetrameric configuration (4 FH2 + 4 DID) in which the actin-binding sites on the FH2 domain are sterically occluded. However biochemical data suggest the full-length mDia1 is a dimer in solution (2 FH2 + 2 DID). Based on the crystal structure, we have generated possible dimer models and found that architectures of all of these models are incompatible with binding to actin filament but not to actin monomer. Furthermore, we show that the minimal functional monomeric unit in the FH2 domain, termed the bridge element, can be inhibited by isolated monomeric DID. NMR data on the bridge-DID system revealed that at least one of the two actin-binding sites on the bridge element is accessible to actin monomer in the inhibited state. Conclusions/Significance: Our findings suggest that autoinhibition in the native DRF dimer involves steric hindrance with the actin filament. Although the structure of a full-length DRF would be required for clarification of the presented models, our work here provides the first structural insights into the mechanism of the DRF autoinhibition.	[Otomo, Takanori; Tomchick, Diana R.; Otomo, Chinatsu; Machius, Mischa; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Otomo, T (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Michael.Rosen@UTSouthwestern.edu	Tomchick, Diana/HGV-2018-2022; , PEP-MX Core/AGV-4051-2022	Tomchick, Diana/0000-0002-7529-4643; Otomo, Takanori/0000-0003-3589-238X	National Institutes of Health (NIH) [R01 GM056322]; Howard Hughes Medical Institute; Human Frontier Science Program; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant R01 GM056322 and the Howard Hughes Medical Institute. T.O. was supported by the Human Frontier Science Program fellowship. The structure shown in this report is derived from work performed on beamline 19-ID at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carlier MF, 2003, CR BIOL, V326, P161, DOI 10.1016/S1631-0691(03)00067-2; Chang F, 2003, CURR BIOL, V13, pR692, DOI 10.1016/j.cub.2003.08.038; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zigmond S, 2004, NAT CELL BIOL, V6, P12, DOI 10.1038/ncb0104-12	57	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12896	10.1371/journal.pone.0012896	http://dx.doi.org/10.1371/journal.pone.0012896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927343	gold, Green Published, Green Submitted			2022-12-25	WOS:000282312600008
J	Callenberg, KM; Choudhary, OP; de Forest, GL; Gohara, DW; Baker, NA; Grabe, M				Callenberg, Keith M.; Choudhary, Om P.; de Forest, Gabriel L.; Gohara, David W.; Baker, Nathan A.; Grabe, Michael			APBSmem: A Graphical Interface for Electrostatic Calculations at the Membrane	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GENERALIZED BORN THEORY; ION CHANNELS; K+ CHANNEL; DIELECTRIC ENVIRONMENTS; POTASSIUM CHANNELS; FREE-ENERGIES; PROTEIN; ASSOCIATION; MODEL	Electrostatic forces are one of the primary determinants of molecular interactions. They help guide the folding of proteins, increase the binding of one protein to another and facilitate protein-DNA and protein-ligand binding. A popular method for computing the electrostatic properties of biological systems is to numerically solve the Poisson-Boltzmann (PB) equation, and there are several easy-to-use software packages available that solve the PB equation for soluble proteins. Here we present a freely available program, called APBSmem, for carrying out these calculations in the presence of a membrane. The Adaptive Poisson-Boltzmann Solver (APBS) is used as a back-end for solving the PB equation, and a Java-based graphical user interface (GUI) coordinates a set of routines that introduce the influence of the membrane, determine its placement relative to the protein, and set the membrane potential. The software Jmol is embedded in the GUI to visualize the protein inserted in the membrane before the calculation and the electrostatic potential after completing the computation. We expect that the ease with which the GUI allows one to carry out these calculations will make this software a useful resource for experimenters and computational researchers alike. Three examples of membrane protein electrostatic calculations are carried out to illustrate how to use APBSmem and to highlight the different quantities of interest that can be calculated.	[Callenberg, Keith M.; Choudhary, Om P.] Univ Pittsburgh, Carnegie Mellon Univ Pittsburgh Program Computat, Pittsburgh, PA 15260 USA; [de Forest, Gabriel L.; Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Gohara, David W.] St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO USA; [Baker, Nathan A.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Grabe, Michael] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint Louis University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Callenberg, KM (corresponding author), Univ Pittsburgh, Carnegie Mellon Univ Pittsburgh Program Computat, Pittsburgh, PA 15260 USA.	mdgrabe@pitt.edu	Callenberg, Keith/C-4838-2011; Baker, Nathan A/A-8605-2010	Baker, Nathan A/0000-0002-5892-6506; Gohara, David/0000-0001-8799-9125	National Science Foundation [MCB0845286]; Direct For Biological Sciences [0845286] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069702] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation CAREER Grant MCB0845286. M. G. is a Research Fellow of the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TW, 1999, BIOPHYS J, V77, P2502, DOI 10.1016/S0006-3495(99)77086-4; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beckstein O, 2004, J AM CHEM SOC, V126, P14694, DOI 10.1021/ja045271e; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bond PJ, 2006, P NATL ACAD SCI USA, V103, P9518, DOI 10.1073/pnas.0600398103; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Choe S, 2008, J GEN PHYSIOL, V131, P563, DOI 10.1085/jgp.200809959; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Cohen BE, 2002, SCIENCE, V296, P1700, DOI 10.1126/science.1069346; Denning EJ, 2008, BIOPHYS J, V95, P3161, DOI 10.1529/biophysj.108.134049; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Faraldo-Gomez JD, 2004, J MOL BIOL, V339, P981, DOI 10.1016/j.jmb.2004.04.023; Feig M, 2004, J CHEM PHYS, V120, P903, DOI 10.1063/1.1631258; Feig M, 2010, ANN REP COMP CHEM, V4, P107, DOI 10.1016/S1574-1400(08)00006-6; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Grabe M, 2004, P NATL ACAD SCI USA, V101, P17640, DOI 10.1073/pnas.0408116101; Grant JA, 2001, J COMPUT CHEM, V22, P608, DOI 10.1002/jcc.1032; Green DF, 2003, J PHYS CHEM B, V107, P10261, DOI 10.1021/jp0350971; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; HILLE B, 1984, IONIC CHANNELS EXCIT, V174, P289; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Jackson J., 1975, CLASSICAL ELECTRODYN; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jmol, JMOL OP SOURC JAV VI; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Jogini V, 2005, J MOL BIOL, V354, P272, DOI 10.1016/j.jmb.2005.09.031; Khelashvili G, 2008, BIOPHYS J, V94, P2580, DOI 10.1529/biophysj.107.120667; Khelashvili G, 2009, BIOPHYS J, V97, P1626, DOI 10.1016/j.bpj.2009.07.006; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; MacCallum JL, 2007, P NATL ACAD SCI USA, V104, P6206, DOI 10.1073/pnas.0605859104; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Murray D, 2001, J BIOL CHEM, V276, P45153, DOI 10.1074/jbc.M101784200; Nina M, 2000, EUR BIOPHYS J BIOPHY, V29, P439, DOI 10.1007/PL00006649; PARSEGIAN A, 1969, NATURE, V221, P844, DOI 10.1038/221844a0; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Petrache HI, 2002, LANGMUIR, V18, P1340, DOI 10.1021/la011338p; Philippsen A, 2002, BIOPHYS J, V82, P1667, DOI 10.1016/S0006-3495(02)75517-3; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Roux B, 1997, BIOPHYS J, V73, P2980, DOI 10.1016/S0006-3495(97)78327-9; Roux B, 2000, BIOCHEMISTRY-US, V39, P13295, DOI 10.1021/bi001567v; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Swanson JMJ, 2007, J CHEM THEORY COMPUT, V3, P170, DOI 10.1021/ct600216k; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tanizaki S, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1865992; Tanizaki S, 2006, J PHYS CHEM B, V110, P548, DOI 10.1021/jp054694f; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Ulmschneider MB, 2007, BIOPHYS J, V92, P2338, DOI 10.1529/biophysj.106.081810; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; WARWICKER J, 1986, J THEOR BIOL, V121, P199, DOI 10.1016/S0022-5193(86)80093-5; ZAUHAR RJ, 1985, J MOL BIOL, V186, P815, DOI 10.1016/0022-2836(85)90399-7; Zhang JM, 2006, BIOPHYS J, V91, P1710, DOI 10.1529/biophysj.106.081224; Zhou YC, 2008, J COMPUT CHEM, V29, P87, DOI 10.1002/jcc.20769	63	72	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12722	10.1371/journal.pone.0012722	http://dx.doi.org/10.1371/journal.pone.0012722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20949122	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000282269400001
J	Liang, WG; Ouyang, SY; Shaw, N; Joachimiak, A; Zhang, RG; Liu, ZJ				Liang, Wenguang; Ouyang, Songying; Shaw, Neil; Joachimiak, Andrzej; Zhang, Rongguang; Liu, Zhi-Jie			Conversion of D-ribulose 5-phosphate to D-xylulose 5-phosphate: new insights from structural and biochemical studies on human RPE	FASEB JOURNAL			English	Article						oxidative stress; pentose phospate pathway; metalloenzyme	PENTOSE-PHOSPHATE PATHWAY; ENZYME D-RIBULOSE-5-PHOSPHATE 3-EPIMERASE; SITE-DIRECTED MUTAGENESIS; OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; MECHANISM; CHLOROPLASTS; REFINEMENT; PROTECTION	The pentose phosphate pathway (PPP) confers protection against oxidative stress by supplying NADPH necessary for the regeneration of glutathione, which detoxifies H2O2 into H2O and O-2. RPE functions in the PPP, catalyzing the reversible conversion of D-ribulose 5-phosphate to D-xylulose 5-phosphate and is an important enzyme for cellular response against oxidative stress. Here, using structural, biochemical, and functional studies, we show that human D-ribulose 5-phosphate 3-epimerase (hRPE) uses Fe2+ for catalysis. Structures of the binary complexes of hRPE with D-ribulose 5-phosphate and D-xylulose 5-phosphate provide the first detailed molecular insights into the binding mode of physiological ligands and reveal an octahedrally coordinated Fe2+ ion buried deep inside the active site. Human RPE folds into a typical (beta/alpha)(8) triosephosphate isomerase (TIM) barrel with a loop regulating access to the active site. Two aspartic acids are well positioned to carry out the proton transfers in an acid-base type of reaction mechanism. Interestingly, mutating Ser-10 to alanine almost abolished the enzymatic activity, while L12A and M72A mutations resulted in an almost 50% decrease in the activity. The binary complexes of hRPE reported here will aid in the design of small molecules for modulating the activity of the enzyme and altering flux through the PPP. -Liang, W., Ouyang, S., Shaw, N., Joachimiak, A., Zhang, R., Liu, Z-J. Conversion of D-ribulose 5-phosphate to D-xylulose 5-phosphate: new insights from structural and biochemical studies on human RPE. FASEB J. 25, 497-504 (2011). www.fasebj.org	[Liang, Wenguang; Ouyang, Songying; Shaw, Neil; Zhang, Rongguang; Liu, Zhi-Jie] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Liang, Wenguang] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China; [Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; United States Department of Energy (DOE); Argonne National Laboratory	Liu, ZJ (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China.	zjliu@ibp.ac.cn	Liu, Zhi-Jie/A-3946-2012	Liu, Zhi-Jie/0000-0001-7279-2893; Shaw, Neil/0000-0003-2722-9967	Ministry of Science and Technology of China [2006AA02A316, 2009DFB30310, 2006CB910901]; National Natural Science Foundation of China [30670427, 30721003]; Ministry of Health of China [2008ZX10404]; Chinese Academy of Sciences (CAS) [KSCX2-YW-R-127, INFO-115-D01-2009]; CAS [2010Y1SA1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of China; Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); CAS(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Keming Tan (Structural Biology Center, Argonne National Laboratory) for the help in collecting anomalous data at the edge of Fe. This work was funded by the Ministry of Science and Technology of China (grants 2006AA02A316, 2009DFB30310, and 2006CB910901), the National Natural Science Foundation of China (grants 30670427 and 30721003), the Ministry of Health of China (grant 2008ZX10404), a Chinese Academy of Sciences (CAS) research grant (KSCX2-YW-R-127 and INFO-115-D01-2009), and a CAS fellowship for young international scientists (grant 2010Y1SA1). Crystallographic data were collected at beamline 19-ID of APS (Argonne National Laboratory).	Akana J, 2006, BIOCHEMISTRY-US, V45, P2493, DOI 10.1021/bi052474m; Caruthers J, 2006, PROTEINS, V62, P338, DOI 10.1002/prot.20764; Chen YR, 1999, J BIOL CHEM, V274, P2132, DOI 10.1074/jbc.274.4.2132; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAVIS L, 1972, J BIOL CHEM, V247, P5862; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; He Y, 2007, ACTA CRYSTALLOGR D, V63, P793, DOI 10.1107/S0907444907023451; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jelakovic S, 2003, J MOL BIOL, V326, P127, DOI 10.1016/S0022-2836(02)01374-8; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Kopp J, 1999, J MOL BIOL, V287, P761, DOI 10.1006/jmbi.1999.2643; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng CH, 2008, FREE RADICAL BIO MED, V44, P1131, DOI 10.1016/j.freeradbiomed.2007.12.008; Nowitzki U, 1995, PLANT MOL BIOL, V29, P1279, DOI 10.1007/BF00020468; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; WILLIAMSON WT, 1966, METHODS ENZYMOLOGY, V9; Wise EL, 2004, ACTA CRYSTALLOGR D, V60, P1687, DOI 10.1107/S0907444904015896; WOOD T, 1986, CELL BIOCHEM FUNCT, V4, P241, DOI 10.1002/cbf.290040403	26	16	18	5	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					497	504		10.1096/fj.10-171207	http://dx.doi.org/10.1096/fj.10-171207			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20923965	Green Published			2022-12-25	WOS:000286724800008
J	Praper, T; Sonnen, A; Viero, G; Kladnik, A; Froelich, CJ; Anderluh, G; Dalla Serra, M; Gilbert, RJC				Praper, Tilen; Sonnen, Andreas; Viero, Gabriella; Kladnik, Ales; Froelich, Christopher J.; Anderluh, Gregor; Dalla Serra, Mauro; Gilbert, Robert J. C.			Human Perforin Employs Different Avenues to Damage Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING PROTEIN; CHOLESTEROL-DEPENDENT CYTOLYSINS; T-CELL GRANULES; BACTERIAL TOXINS; DIVALENT-CATIONS; PREPORE COMPLEX; GRANZYME-B; C2 DOMAIN; MECHANISM; PNEUMOLYSIN	Perforin (PFN) is a pore-forming protein produced by cytotoxic lymphocytes that aids in the clearance of tumor or virus-infected cells by a mechanism that involves the formation of transmembrane pores. The properties of PFN pores and the mechanism of their assembly remain unclear. Here, we studied pore characteristics by functional and structural methods to show that perforin forms pores more heterogeneous than anticipated. Planar lipid bilayer experiments indicate that perforin pores exhibit a broad range of conductances, from 0.15 to 21 nanosiemens. In comparison with large pores that possessed low noise and remained stably open, small pores exhibited high noise and were very unstable. Furthermore, the opening step and the pore size were dependent on the lipid composition of the membrane. The heterogeneity in pore sizes was confirmed with cryo-electron microscopy and showed a range of sizes matching that observed in the conductance measurements. Furthermore, two different membrane-bound PFN conformations were observed, interpreted as pre-pore and pore states of the protein. The results collectively indicate that PFN forms heterogeneous pores through a multistep mechanism and provide a new paradigm for understanding the range of different effects of PFN and related membrane attack complex/perforin domain proteins observed in vivo and in vitro.	[Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia; [Sonnen, Andreas; Gilbert, Robert J. C.] Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Viero, Gabriella; Dalla Serra, Mauro] Bruno Kessler Fdn, I-38123 Trento, Povo, Italy; [Viero, Gabriella; Dalla Serra, Mauro] Inst Biophys, Natl Res Council, I-38123 Trento, Povo, Italy; [Froelich, Christopher J.] NorthShore Univ HealthSyt Res Inst, Dept Med, Evanston, IL 60201 USA	University of Ljubljana; University of Oxford; Wellcome Centre for Human Genetics; Fondazione Bruno Kessler; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); NorthShore University Health System	Anderluh, G (corresponding author), Univ Ljubljana, Biotech Fac, Dept Biol, Vecna Pot 111, Ljubljana 1000, Slovenia.	gregor.anderluh@bf.uni-lj.si; mauro.dallaserra@cnr.it; gilbert@strubi.ox.ac.uk	Serra, Mauro Dalla/AAK-9299-2021; Viero, Gabriella/G-2096-2012; Anderluh, Gregor/C-6905-2014; Kladnik, Aleš/B-6045-2008; Serra, Mauro Dalla/A-6218-2010	Serra, Mauro Dalla/0000-0003-1048-2739; Viero, Gabriella/0000-0002-6755-285X; Anderluh, Gregor/0000-0002-9916-8465; Kladnik, Aleš/0000-0002-3466-0088; Serra, Mauro Dalla/0000-0003-1048-2739; Gilbert, Robert/0000-0001-9336-5604	National Institutes of Health [5RO1AI04494-03]; Slovenian-Italian collaborative grant; FEBS; Slovene Human Resources Development and Scholarship fund; Slovenian Research Agency; Wellcome Trust; Royal Society International Joint Project; EMBO	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Slovenian-Italian collaborative grant; FEBS; Slovene Human Resources Development and Scholarship fund; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society International Joint Project(Royal Society of London); EMBO(European Molecular Biology Organization (EMBO))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1AI04494-03. This work was also supported in part by a Slovenian-Italian collaborative grant.; Supported by the FEBS Collaborative Experimental Scholarship for Central and Eastern Europe and by the Slovene Human Resources Development and Scholarship fund.; Supported by Slovenian Research Agency.; Recipient of a Wellcome Trust 4-year Ph.D. Studentship in Structural Biology.; Supported in part by the award of a Royal Society International Joint Project grant and EMBO short term fellowship.	Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Baran K, 2009, IMMUNITY, V30, P684, DOI 10.1016/j.immuni.2009.03.016; BASHFORD CL, 1988, J IMMUNOL, V141, P3965; BASHFORD CL, 1988, J MEMBRANE BIOL, V103, P79, DOI 10.1007/BF01871934; Bayley H, 1997, CURR BIOL, V7, pR763, DOI 10.1016/S0960-9822(06)00399-X; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BHAKDI S, 1985, INFECT IMMUN, V47, P47; BLUMENTHAL R, 1984, P NATL ACAD SCI-BIOL, V81, P5551, DOI 10.1073/pnas.81.17.5551; Browne KA, 1999, MOL CELL BIOL, V19, P8604; Chattopadhyay K, 2002, EUR J BIOCHEM, V269, P4351, DOI 10.1046/j.1432-1033.2002.03137.x; Dalla Serra M, 2000, METH MOL B, V145, P171; Ecker A, 2008, MOL MICROBIOL, V70, P209, DOI 10.1111/j.1365-2958.2008.06407.x; Ecker A, 2007, EXP PARASITOL, V116, P504, DOI 10.1016/j.exppara.2007.01.015; El-Rachkidy RG, 2008, BIOCHEM BIOPH RES CO, V368, P786, DOI 10.1016/j.bbrc.2008.01.151; Findlay HE, 2006, J PHYS-CONDENS MAT, V18, pS1281, DOI 10.1088/0953-8984/18/28/S11; Froelich CJ, 1996, BIOCHEM BIOPH RES CO, V229, P44, DOI 10.1006/bbrc.1996.1755; From C, 2008, FEMS MICROBIOL LETT, V286, P85, DOI 10.1111/j.1574-6968.2008.01256.x; Gilbert RJC, 2005, STRUCTURE, V13, P1097, DOI 10.1016/j.str.2005.04.019; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Heller WT, 1997, BIOPHYS J, V73, P239, DOI 10.1016/S0006-3495(97)78064-0; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KORCHEV YE, 1992, J MEMBRANE BIOL, V127, P195; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MASSON D, 1985, J BIOL CHEM, V260, P9069; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Palmer M, 2004, FEMS MICROBIOL LETT, V238, P281, DOI 10.1016/j.femsle.2004.07.059; Peterlin P, 2008, COLLOID SURFACE B, V64, P77, DOI 10.1016/j.colsurfb.2008.01.004; PETERS R, 1990, EMBO J, V9, P2447, DOI 10.1002/j.1460-2075.1990.tb07421.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Poklar N, 1999, BIOCHEMISTRY-US, V38, P14999, DOI 10.1021/bi9916022; Praper T, 2010, MOL IMMUNOL, V47, P2492, DOI 10.1016/j.molimm.2010.06.001; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; SAUER H, 1991, BIOCHIM BIOPHYS ACTA, V1063, P137, DOI 10.1016/0005-2736(91)90363-D; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; YOUNG JDE, 1986, P NATL ACAD SCI USA, V83, P150, DOI 10.1073/pnas.83.1.150; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3; YOUNG JDE, 1986, P NATL ACAD SCI USA, V83, P5668, DOI 10.1073/pnas.83.15.5668; YOUNG JDE, 1986, J EXP MED, V164, P144, DOI 10.1084/jem.164.1.144; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429; YOUNG LHY, 1990, LANCET, V336, P1019, DOI 10.1016/0140-6736(90)92486-2	59	68	69	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2946	2955		10.1074/jbc.M110.169417	http://dx.doi.org/10.1074/jbc.M110.169417			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	20889983	hybrid, Green Published			2022-12-25	WOS:000286464300058
J	Kohli, RM; Maul, RW; Guminski, AF; McClure, RL; Gajula, KS; Saribasak, H; McMahon, MA; Siliciano, RF; Gearhart, PJ; Stivers, JT				Kohli, Rahul M.; Maul, Robert W.; Guminski, Amy F.; McClure, Rhonda L.; Gajula, Kiran S.; Saribasak, Huseyin; McMahon, Moira A.; Siliciano, Robert F.; Gearhart, Patricia J.; Stivers, James T.			Local Sequence Targeting in the AID/APOBEC Family Differentially Impacts Retroviral Restriction and Antibody Diversification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INDUCED CYTIDINE DEAMINASE; CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; HUMAN APOBEC3G; HIV-1 INFECTION; DNA INTEGRATION; IN-VIVO; AID; CELLS	Nucleic acid cytidine deaminases of the activation-induced deaminase (AID)/APOBEC family are critical players in active and innate immune responses, playing roles as target-directed, purposeful mutators. AID specifically deaminates the host immunoglobulin (Ig) locus to evolve antibody specificity, whereas its close relative, APOBEC3G (A3G), lethally mutates the genomes of retroviral pathogens such as HIV. Understanding the basis for the target-specific action of these enzymes is essential, as mistargeting poses significant risks, potentially promoting oncogenesis (AID) or fostering drug resistance (A3G). AID prefers to deaminate cytosine in WRC (W = A/T, R = A/G) motifs, whereas A3G favors deamination of CCC motifs. This specificity is largely dictated by a single, divergent protein loop in the enzyme family that recognizes the DNA sequence. Through grafting of this substrate-recognition loop, we have created enzyme variants of A3G and AID with altered local targeting to directly evaluate the role of sequence specificity on immune function. We find that grafted loops placed in the A3G scaffold all produced efficient restriction of HIV but that foreign loops in the AID scaffold compromised hypermutation and class switch recombination. Local targeting, therefore, appears alterable for innate defense against retroviruses by A3G but important for adaptive antibody maturation catalyzed by AID. Notably, AID targeting within the Ig locus is proportionally correlated to its in vitro ability to target WRC sequences rather than non-WRC sequences. Although other mechanisms may also contribute, our results suggest that local sequence targeting by AID/APOBEC3 enzymes represents an elegant example of co-evolution of enzyme specificity with its target DNA sequence.	[Maul, Robert W.; McClure, Rhonda L.; Saribasak, Huseyin; Gearhart, Patricia J.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Kohli, Rahul M.; Gajula, Kiran S.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Guminski, Amy F.; McMahon, Moira A.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University	Gearhart, PJ (corresponding author), NIA, Lab Mol Gerontol, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	gearhartp@mail.nih.gov; jstivers@jhmi.edu	Gajula, Kiran/I-1115-2019; Gearhart, Patricia/Y-7227-2019; Maul, Robert W./Y-6818-2019; Saribasak, Huseyin/C-9331-2012	Gajula, Kiran/0000-0002-2047-2457; Saribasak, Huseyin/0000-0003-0055-062X; Kohli, Rahul/0000-0002-7689-5678; Maul, Robert/0000-0002-6958-8514; McMahon, Moira/0000-0001-9810-8623	NIA; National Institutes of Health;  [GM06669];  [GM056834];  [KAI089242A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000715] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NIA, National Institutes of Health (Intramural Research Program), T32 Grant GM06669, and Grants GM056834 (to J. T. S.) and KAI089242A (to R. M. K.).	Armitage AE, 2008, J VIROL, V82, P8743, DOI 10.1128/JVI.00584-08; Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello SG, 2007, NAT STRUCT MOL BIOL, V14, P7, DOI 10.1038/nsmb0107-7; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Fugmann SD, 2004, EUR J IMMUNOL, V34, P844, DOI 10.1002/eji.200324418; Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Hackney JA, 2009, ADV IMMUNOL, V101, P163, DOI 10.1016/S0065-2776(08)01005-5; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Langlois MA, 2008, J VIROL, V82, P4660, DOI 10.1128/JVI.02469-07; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Mbisa JL, 2010, J VIROL, V84, P5250, DOI 10.1128/JVI.02358-09; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Opi S, 2007, J VIROL, V81, P8236, DOI 10.1128/JVI.02694-06; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Rausch JW, 2009, J BIOL CHEM, V284, P7047, DOI 10.1074/jbc.M807258200; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roy D, 2008, MOL CELL BIOL, V28, P50, DOI 10.1128/MCB.01251-07; Russell RA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-16; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Saribasak H, 2006, J IMMUNOL, V176, P365, DOI 10.4049/jimmunol.176.1.365; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1997, J VIROL, V71, P5259, DOI 10.1128/JVI.71.7.5259-5267.1997; Smith RA, 2005, VIRUS RES, V107, P215, DOI 10.1016/j.virusres.2004.11.011; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Wang M, 2009, NAT STRUCT MOL BIOL, V16, P769, DOI 10.1038/nsmb.1623; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	53	59	68	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40956	40964		10.1074/jbc.M110.177402	http://dx.doi.org/10.1074/jbc.M110.177402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20929867	hybrid, Green Published			2022-12-25	WOS:000285414400059
J	Lakshminarayanan, R; Bromley, KM; Lei, YP; Snead, ML; Moradian-Oldak, J				Lakshminarayanan, Rajamani; Bromley, Keith M.; Lei, Ya-Ping; Snead, Malcolm L.; Moradian-Oldak, Janet			Perturbed Amelogenin Secondary Structure Leads to Uncontrolled Aggregation in Amelogenesis Imperfecta Mutant Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; IN-VITRO; CONFORMATIONAL STABILITY; DISORDERED PROTEINS; PORCINE AMELOGENIN; CALCIUM-BINDING; DENTAL ENAMEL; TOOTH ENAMEL; IDENTIFICATION; PHENOTYPE	Mutations in amelogenin sequence result in defective enamel, and the diverse group of genetically altered conditions is collectively known as amelogenesis imperfecta (AI). Despite numerous studies, the detailed molecular mechanism of defective enamel formation is still unknown. In this study, we have examined the biophysical properties of a recombinant murine amelogenin (rM180) and two point mutations identified from human DNA sequences in two cases of AI (T21I and P41T). At pH 5.8 and 25 degrees C, wild type (WT) rM180 and mutant P41T existed as monomers, and mutant T21I formed lower order oligomers. CD, dynamic light scattering, and fluorescence studies indicated that rM180 and P41T can be classified as a premolten globule-like subclass protein at 25 degrees C. Thermal denaturation and refolding monitored by CD ellipticity at 224 nm indicated the presence of a strong hysteresis in mutants compared with WT. Variable temperature tryptophan fluorescence and dynamic light scattering studies showed that WT transformed to a partially folded conformation upon heating and remained stable. The partially folded conformation formed by P41T, however, readily converted into a heterogeneous population of aggregates. T21I existed in an oligomeric state at room temperature and, upon heating, rapidly formed large aggregates over a very narrow temperature range. Thermal denaturation and refolding studies indicated that the mutants are less stable and exhibit poor refolding ability compared with WT rM180. Our results suggest that alterations in self-assembly of amelogenin are a consequence of destabilization of the intrinsic disorder. Therefore, we propose that, like a number of other human diseases, AI appears to be due to the destabilization of the secondary structure as a result of amelogenin mutations.	[Lakshminarayanan, Rajamani; Bromley, Keith M.; Lei, Ya-Ping; Snead, Malcolm L.; Moradian-Oldak, Janet] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA	University of Southern California	Moradian-Oldak, J (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	joldak@usc.edu	Rajamani, Lakshminarayanan/AAG-5541-2019	Rajamani, Lakshminarayanan/0000-0001-8214-5315; Bromley, Keith/0000-0002-8001-3818	National Institutes of Health [DE-013414, DE-02009, DE-15644]; NIDCR [DE-13045, DE-06988]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013045, R01DE006988, R01DE013414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015644, R37DE013045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE-013414, DE-02009, and DE-15644 (to J. M. O.) and DE-13045 and DE-06988 (to M. L. S.) from NIDCR.	Almstedt K, 2008, BIOCHEMISTRY-US, V47, P1288, DOI 10.1021/bi701720p; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bulaj G, 2001, J MOL BIOL, V313, P639, DOI 10.1006/jmbi.2001.5046; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chai H, 2009, P NATL ACAD SCI USA, V106, P7289, DOI 10.1073/pnas.0902466106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Danielsson J, 2005, FEBS J, V272, P3938, DOI 10.1111/j.1742-4658.2005.04812.x; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Fan DM, 2009, J STRUCT BIOL, V166, P88, DOI 10.1016/j.jsb.2009.01.003; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; FINCHAM AG, 1994, CALCIFIED TISSUE INT, V55, P398, DOI 10.1007/BF00299322; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Harada A, 2007, BIOSCI BIOTECH BIOCH, V71, P2952, DOI 10.1271/bbb.70354; Hart PS, 2002, ARCH ORAL BIOL, V47, P261, DOI 10.1016/S0003-9969(02)00003-1; Hill RB, 2000, STRUCT FOLD DES, V8, P471, DOI 10.1016/S0969-2126(00)00130-1; Huq NL, 2005, ARCH ORAL BIOL, V50, P599, DOI 10.1016/j.archoralbio.2004.12.009; Ishijima J, 2007, J BIOCHEM, V142, P201, DOI 10.1093/jb/mvm130; Lai ZH, 1997, BIOCHEMISTRY-US, V36, P10230, DOI 10.1021/bi963195p; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lakshminarayanan R, 2009, PROTEINS, V76, P560, DOI 10.1002/prot.22369; Lam SL, 2003, BIOPOLYMERS, V69, P270, DOI 10.1002/bip.10354; Le TQ, 2006, EUR J ORAL SCI, V114, P320, DOI 10.1111/j.1600-0722.2006.00313.x; LENCH NJ, 1995, HUM MUTAT, V5, P251, DOI 10.1002/humu.1380050310; Lim KH, 2007, BIOCHEM BIOPH RES CO, V353, P443, DOI 10.1016/j.bbrc.2006.12.043; Mahoney EK, 2004, BIOMATERIALS, V25, P5091, DOI 10.1016/j.biomaterials.2004.02.044; MATTHEWS BW, 1995, ADV PROTEIN CHEM, V46, P249, DOI 10.1016/S0065-3233(08)60337-X; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; Moradian-Oldak J., 2010, AMELOGENINS MULTIFAC, P106; Myers JK, 1996, BIOPHYS J, V71, P2033, DOI 10.1016/S0006-3495(96)79401-8; Nicolini C, 2004, BIOPHYS J, V86, P1385, DOI 10.1016/S0006-3495(04)74209-5; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; PAIN RH, 2004, CURRENT PROTOCOLS PR; Paine ML, 2002, J BIOL CHEM, V277, P17112, DOI 10.1074/jbc.M110473200; Prajapati RS, 2007, PROTEINS, V66, P480, DOI 10.1002/prot.21215; Ramirez-Alvarado M, 2002, J MOL BIOL, V323, P17, DOI 10.1016/S0022-2836(02)00840-9; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Robinson C, 2004, J MATER CHEM, V14, P2242, DOI 10.1039/b401154f; Schartl W, 2007, SPRINGER LAB MAN POL, P1; Shen C, 2008, PROTEINS, V71, P1744, DOI 10.1002/prot.21857; SHORTLE D, 1992, Q REV BIOPHYS, V25, P205, DOI 10.1017/S0033583500004674; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; SINCLAIR JF, 1994, NAT STRUCT BIOL, V1, P320, DOI 10.1038/nsb0594-320; SNEAD ML, 1983, P NATL ACAD SCI-BIOL, V80, P7254, DOI 10.1073/pnas.80.23.7254; Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Tanimoto K, 2008, J DENT RES, V87, P451, DOI 10.1177/154405910808700516; Toyosawa S, 1998, P NATL ACAD SCI USA, V95, P13056, DOI 10.1073/pnas.95.22.13056; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007; Wright JT, 2006, AM J MED GENET A, V140A, P2547, DOI 10.1002/ajmg.a.31358; Wright JT, 2003, CONNECT TISSUE RES, V44, P72, DOI 10.1080/03008200390152124; Xie ZH, 2007, ACTA BIOMATER, V3, P865, DOI 10.1016/j.actbio.2007.05.007; Xie ZH, 2008, BIOMATERIALS, V29, P2697, DOI 10.1016/j.biomaterials.2008.02.022	66	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40593	40603		10.1074/jbc.M110.131136	http://dx.doi.org/10.1074/jbc.M110.131136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20929860	Green Published, hybrid			2022-12-25	WOS:000285414400022
J	Liu, H; Tian, N; Arany, I; Bigler, SA; Waxman, DJ; Shah, SV; Baliga, R				Liu, Hua; Tian, Niu; Arany, Istvan; Bigler, Steven A.; Waxman, David J.; Shah, Sudhir V.; Baliga, Radhakrishna			Cytochrome P450 2B1 Mediates Complement-dependent Sublytic Injury in a Model of Membranous Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASSIVE HEYMANN NEPHRITIS; AMINONUCLEOSIDE-INDUCED CYTOTOXICITY; CATALYTIC IRON; HYDROGEN-PEROXIDE; LIPID-PEROXIDATION; HYDROXYL RADICALS; ATTACK COMPLEX; EXPRESSION; GENERATION; PROTEINS	Membranous nephropathy is a disease that affects the filtering units of the kidney, the glomeruli, and results in proteinuria accompanied by loss of kidney function. Passive Heymann nephritis is an experimental model that mimics membranous nephropathy in humans, wherein the glomerular epithelial cell (GEC) injury induced by complement C5b-9 leads to proteinuria. We examined the role of cytochrome P450 2B1 (CYP2B1) in this complement-mediated sublytic injury. Overexpression of CYP2B1 in GECs significantly increased the formation of reactive oxygen species, cytotoxicity, and collapse of the actin cytoskeleton following treatment with anti-tubular brush-border antiserum (anti-Fx1A). In contrast, silencing of CYP2B1 markedly attenuated anti-Fx1A-induced reactive oxygen species generation and cytotoxicity with preservation of the actin cytoskeleton. Gelsolin, which maintains an organized actin cytoskeleton, was significantly decreased by complement C5b-9-mediated injury but was preserved in CYP2B1-silenced cells. In rats injected with anti-Fx1A, the cytochrome P450 inhibitor cimetidine blocked an increase in catalytic iron and ROS generation, reduced the formation of malondialdehyde adducts, maintained a normal distribution of nephrin in the glomeruli, and provided significant protection at the onset of proteinuria. Thus, GEC CYP2B1 contributes to complement C5b-9-mediated injury and plays an important role in the pathogenesis of passive Heymann nephritis.	[Baliga, Radhakrishna] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Bigler, Steven A.] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Waxman, David J.] Boston Univ, Dept Biol, Div Cell & Mol Biol, Boston, MA 02215 USA; [Shah, Sudhir V.] Univ Arkansas Med Sci, Dept Internal Med, Div Nephrol, Little Rock, AR 72205 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Boston University; University of Arkansas System; University of Arkansas Medical Sciences	Baliga, R (corresponding author), Univ Mississippi, Med Ctr, Dept Pediat, Res Wing R116A,2500 N State St, Jackson, MS 39216 USA.	rbaliga@umc.edu	Baliga, Radhakrishna/G-2871-2015	Waxman, David/0000-0001-7982-9206	National Institutes of Health [5 P42 ES07381]; University of Mississippi Medical Center; American Heart Association [0655716Z]; Boston University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Mississippi Medical Center; American Heart Association(American Heart Association); Boston University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grant 5 P42 ES07381 (to D. J. W.). This work was also supported by the Intramural Research Support Program through the University of Mississippi Medical Center (to R. B.), by American Heart Association Grant-in-aid 0655716Z (to I. A.) and by the Superfund Research Program at Boston University (to D. J. W.).	Baliga R, 1996, KIDNEY INT, V49, P362, DOI 10.1038/ki.1996.53; Baliga R, 1998, KIDNEY INT, V54, P1562, DOI 10.1046/j.1523-1755.1998.00161.x; Baliga R, 1998, KIDNEY INT, V53, P394, DOI 10.1046/j.1523-1755.1998.00767.x; Baliga R, 1996, KIDNEY INT, V50, P1118, DOI 10.1038/ki.1996.418; Baliga R, 1996, J AM SOC NEPHROL, V7, P1183; BALIGA R, 1992, AM J PHYSIOL, V263, pF56, DOI 10.1152/ajprenal.1992.263.1.F56; BALIGA R, 1997, CURRENT NEPHROLOGY, P135; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941; BONDY SC, 1994, BIOCHEM PHARMACOL, V48, P155, DOI 10.1016/0006-2952(94)90235-6; Bradd S J, 1993, Methods Mol Biol, V19, P211; BRIGGS RT, 1975, J CELL BIOL, V67, P566, DOI 10.1083/jcb.67.3.566; BYSANI GK, 1990, J CLIN INVEST, V86, P1434, DOI 10.1172/JCI114859; COUSER WG, 1993, KIDNEY INT, V44, pS19; COUSER WG, 1988, ANNU REV MED, V39, P517; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; CYBULSKY AV, 1986, J CLIN INVEST, V77, P1096, DOI 10.1172/JCI112408; Cybulsky AV, 2002, J BIOL CHEM, V277, P41342, DOI 10.1074/jbc.M204694200; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; GUTTERIDGE JMC, 1982, BIOCHEM J, V206, P605, DOI 10.1042/bj2060605; GUTTERIDGE JMC, 1986, FEBS LETT, V201, P291, DOI 10.1016/0014-5793(86)80626-3; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; JOHNSON RJ, 1987, J CLIN INVEST, V79, P1379, DOI 10.1172/JCI112965; Kappus H., 1993, HDB EXP PHARM, V105, P145; KARUZINA II, 1994, FREE RADICAL BIO MED, V16, P73, DOI 10.1016/0891-5849(94)90245-3; KUTHAN H, 1978, FEBS LETT, V91, P343, DOI 10.1016/0014-5793(78)81206-X; Liu H, 2003, NEPHRON EXP NEPHROL, V94, pE17, DOI 10.1159/000070815; Liu H, 2002, KIDNEY INT, V62, P868, DOI 10.1046/j.1523-1755.2002.00515.x; Liu H, 2001, AM J PHYSIOL-RENAL, V280, pF88, DOI 10.1152/ajprenal.2001.280.1.F88; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lueck A, 1998, J CELL SCI, V111, P3633; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; NEALE TJ, 1993, P NATL ACAD SCI USA, V90, P3645, DOI 10.1073/pnas.90.8.3645; NEALE TJ, 1994, J CLIN INVEST, V94, P1577, DOI 10.1172/JCI117499; Ni XG, 2008, MOL MED, V14, P582, DOI 10.2119/2008-00020.Ni; NORDBLOM GD, 1977, ARCH BIOCHEM BIOPHYS, V180, P343, DOI 10.1016/0003-9861(77)90047-9; PALLER MS, 1994, P NATL ACAD SCI USA, V91, P7002, DOI 10.1073/pnas.91.15.7002; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; QUIGG RJ, 1988, KIDNEY INT, V34, P43, DOI 10.1038/ki.1988.143; RASHBASTEP J, 1994, MOL PHARMACOL, V45, P150; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; ROSREMEDIOS CG, 2003, PHYSIOL REV, V83, P433; SALANT DJ, 1989, KIDNEY INT, V35, P976, DOI 10.1038/ki.1989.81; SHAH SV, 1988, AM J PHYSIOL, V254, pF337, DOI 10.1152/ajprenal.1988.254.3.F337; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Tian N, 2010, KIDNEY INT, V78, P182, DOI 10.1038/ki.2010.100; Topham PS, 1999, KIDNEY INT, V55, P1763, DOI 10.1046/j.1523-1755.1999.00407.x; Tzanakakis ES, 2002, CELL BIOL TOXICOL, V18, P13, DOI 10.1023/A:1014415128392; Ueda N, 1996, KIDNEY INT, V49, P370, DOI 10.1038/ki.1996.54; United States Renal Data System, 2009, ATL END STAG REN DIS; Yuan HP, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134946	53	6	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40901	40910		10.1074/jbc.M110.165498	http://dx.doi.org/10.1074/jbc.M110.165498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20947506	hybrid, Green Published			2022-12-25	WOS:000285414400054
J	Soleimanpour, SA; Crutchlow, MF; Ferrari, AM; Raum, JC; Groff, DN; Rankin, MM; Liu, CY; De Leon, DD; Naji, A; Kushner, JA; Stoffers, DA				Soleimanpour, Scott A.; Crutchlow, Michael F.; Ferrari, Alana M.; Raum, Jeffrey C.; Groff, David N.; Rankin, Matthew M.; Liu, Chengyang; De Leon, Diva D.; Naji, Ali; Kushner, Jake A.; Stoffers, Doris A.			Calcineurin Signaling Regulates Human Islet beta-Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; PROTEIN-KINASE-B; DIABETES-MELLITUS; CYCLIN D1; GLUCOSE-HOMEOSTASIS; KIDNEY-TRANSPLANTATION; COACTIVATOR TORC2; PRIMARY MECHANISM; IRS-2 EXPRESSION; GENE-EXPRESSION	The calcium-regulated phosphatase calcineurin intersects with both calcium and cAMP-mediated signaling pathways in the pancreatic beta-cell. Pharmacologic calcineurin inhibition, necessary to prevent rejection in the setting of organ transplantation, is associated with post-transplant beta-cell failure. We sought to determine the effect of calcineurin inhibition on beta-cell replication and survival in rodents and in isolated human islets. Further, we assessed whether the GLP-1 receptor agonist and cAMP stimulus, exendin-4 (Ex-4), could rescue beta-cell replication and survival following calcineurin inhibition. Following treatment with the calcineurin inhibitor tacrolimus, human beta-cell apoptosis was significantly increased. Although we detected no human beta-cell replication, tacrolimus significantly decreased rodent beta-cell replication. Ex-4 nearly normalized both human beta-cell survival and rodent beta-cell replication when co-administered with tacrolimus. We found that tacrolimus decreased Akt phosphorylation, suggesting that calcineurin could regulate replication and survival via the PI3K/Akt pathway. We identify insulin receptor substrate-2 (Irs2), a known cAMP-responsive element-binding protein target and upstream regulator of the PI3K/Akt pathway, as a novel calcineurin target in beta-cells. Irs2 mRNA and protein are decreased by calcineurin inhibition in both rodent and human islets. The effect of calcineurin on Irs2 expression is mediated at least in part through the nuclear factor of activated T-cells (NFAT), as NFAT occupied the Irs2 promoter in a calcineurin-sensitive manner. Ex-4 restored Irs2 expression in tacrolimustreated rodent and human islets nearly to baseline. These findings reveal calcineurin as a regulator of human beta-cell survival in part through regulation of Irs2, with implications for the pathogenesis and treatment of diabetes following organ transplantation.	[Soleimanpour, Scott A.; Crutchlow, Michael F.; Ferrari, Alana M.; Raum, Jeffrey C.; Groff, David N.; Stoffers, Doris A.] Univ Penn, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; [Soleimanpour, Scott A.; Crutchlow, Michael F.; Ferrari, Alana M.; Raum, Jeffrey C.; Groff, David N.; Stoffers, Doris A.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Rankin, Matthew M.; De Leon, Diva D.; Kushner, Jake A.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA; [Rankin, Matthew M.; De Leon, Diva D.; Kushner, Jake A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Liu, Chengyang; Naji, Ali] Univ Penn, Dept Surg, Div Transplant Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Stoffers, DA (corresponding author), 415 Curie Blvd,726 CRB, Philadelphia, PA 19104 USA.	stoffers@mail.med.upenn.edu	De Leon, Diva D./V-8626-2019; Ferrari, Alana/S-4566-2019; Kushner, Jake A/AFJ-8198-2022; Kushner, Jake A/AAF-5049-2022; Stoffers, Doris/H-6157-2012	De Leon, Diva D./0000-0003-1225-8087; Ferrari, Alana/0000-0002-9058-8041; Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744; Soleimanpour, Scott/0000-0001-6777-4498	National Institutes of Health [DK49210, DK062965, U42 (RR016600), K12 (RR017625)]; American Diabetes Association [7-01-CD-15]; Commonwealth of Pennsylvania Center for Excellence in Regenerative Medicine [4100043362]; Iacocca Foundation; Benjamin and Mary Siddons Measey Foundation; University of Pennsylvania Center for Molecular Studies in Digestive and Liver Disease Center [P30 DK50306]; Kirschstein NRSA [DK007314-27]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016600, K12RR017625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, R01DK062965, P30DK050306, T32DK007314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Commonwealth of Pennsylvania Center for Excellence in Regenerative Medicine; Iacocca Foundation; Benjamin and Mary Siddons Measey Foundation; University of Pennsylvania Center for Molecular Studies in Digestive and Liver Disease Center; Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK49210 and DK062965 (to D. A. S.), U42 (RR016600) (to A. N.), and National Institutes of Health Career Development Award K12 (RR017625) (to M. F. C.). This work was also supported by American Diabetes Association Career Development Award 7-01-CD-15 (to D. A. S.), Commonwealth of Pennsylvania Center for Excellence in Regenerative Medicine Grant 4100043362 (to D. A. S., A. N., and J. A. K.), a research grant from The Iacocca Foundation (to D. A. S. and A. N.), Kirschstein NRSA-T32 Award DK007314-27 (to S. A. S.), a grant from the Benjamin and Mary Siddons Measey Foundation (to S. A. S.), and Morphology Core of the University of Pennsylvania Center for Molecular Studies in Digestive and Liver Disease Center Grant P30 DK50306.	Baid S, 2001, TRANSPLANTATION, V72, P1066, DOI 10.1097/00007890-200109270-00015; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Buzzi F, 2010, MOL CELL BIOL, V30, P601, DOI 10.1128/MCB.00719-09; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cosio FG, 2005, KIDNEY INT, V67, P2415, DOI 10.1111/j.1523-1755.2005.00349.x; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Crutchlow MF, 2007, CURR OPIN ORGAN TRAN, V12, P55, DOI 10.1097/MOT.0b013e328012b281; Davidson J, 2003, TRANSPLANTATION, V75, pSS3, DOI 10.1097/01.TP.0000069952.49242.3E; De Leon DD, 2006, PHYSIOL GENOMICS, V24, P133, DOI 10.1152/physiolgenomics.00156.2005; De Leon DD, 2006, INT J BIOCHEM CELL B, V38, P845, DOI 10.1016/j.biocel.2005.07.011; Deramaudt TB, 2006, J BIOL CHEM, V281, P38385, DOI 10.1074/jbc.M605891200; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Dickson LM, 2001, J BIOL CHEM, V276, P21110, DOI 10.1074/jbc.M101257200; Drachenberg CB, 1999, TRANSPLANTATION, V68, P396, DOI 10.1097/00007890-199908150-00012; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Fiaschi-Taesch N, 2009, DIABETES, V58, P882, DOI 10.2337/db08-0631; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Holst LS, 1998, BIOCHEM BIOPH RES CO, V250, P181, DOI 10.1006/bbrc.1998.9166; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Kahl CR, 2004, MOL BIOL CELL, V15, P1833, DOI 10.1091/mbc.e03-10-0730; Kang JH, 2006, DIABETOLOGIA, V49, P969, DOI 10.1007/s00125-006-0179-6; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kim MJ, 2006, J ENDOCRINOL, V188, P623, DOI 10.1677/joe.1.06480; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lawrence MC, 2002, DIABETES, V51, P691, DOI 10.2337/diabetes.51.3.691; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V209, P17, DOI 10.1016/j.mce.2003.08.003; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Rao P, 2005, DIABETES, V54, P1664, DOI 10.2337/diabetes.54.6.1664; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; SCHARP DW, 1973, TRANSPLANTATION, V16, P686, DOI 10.1097/00007890-197312000-00028; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Stoffers DA, 1998, J CLIN INVEST, V102, P232, DOI 10.1172/JCI2242; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	67	101	107	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40050	40059		10.1074/jbc.M110.154955	http://dx.doi.org/10.1074/jbc.M110.154955			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20943662	hybrid, Green Published			2022-12-25	WOS:000285185500050
J	Yamasaki, K; Daiho, T; Danko, S; Suzuki, H				Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi			Ca2+ Release to Lumen from ADP-sensitive Phosphoenzyme E1PCa(2) without Bound K+ of Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLED ATP HYDROLYSIS; STABLE STRUCTURAL ANALOG; CALCIUM-PUMP; INSENSITIVE PHOSPHOENZYME; ADENOSINE-TRIPHOSPHATASE; PHOSPHORYLATED INTERMEDIATE; CA-2+-TRANSPORT ATPASE; CRYSTAL-STRUCTURE; TRANSPORT SITES; HEAT-PRODUCTION	During Ca2+ transport by sarcoplasmic reticulum Ca2+-ATPase, the conformation change of ADP-sensitive phosphoenzyme (E1PCa(2)) to ADP-insensitive phosphoenzyme (E2PCa(2)) is followed by rapid Ca2+ release into the lumen. Here, we find that in the absence of K+, Ca2+ release occurs considerably faster than E1PCa(2) to E2PCa(2) conformation change. Therefore, the lumenal Ca2+ release pathway is open to some extent in the K+-free E1PCa(2) structure. The Ca2+ affinity of this E1P is as high as that of the unphosphorylated ATPase (E1), indicating the Ca2+ binding sites are not disrupted. Thus, bound K+ stabilizes the E1PCa(2) structure with occluded Ca2+, keeping the Ca2+ pathway to the lumen closed. We found previously (Yamasaki, K., Wang, G., Daiho, T., Danko, S., and Suzuki, H. (2008) J. Biol. Chem. 283, 29144-29155) that the K+ bound in E2P reduces the Ca2+ affinity essential for achieving the high physiological Ca2+ gradient and to fully open the lumenal Ca2+ gate for rapid Ca2+ release (E2PCa(2)-> E2P + 2Ca(2+)). These findings show that bound K+ is critical for stabilizing both E1PCa(2) and E2P structures, thereby contributing to the structural changes that efficiently couple phosphoenzyme processing and Ca2+ handling.	[Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Yamasaki, K (corresponding author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	kyamasak@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21570127] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research C (to K. Y.) and B (to H. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Barata H, 2002, J BIOL CHEM, V277, P16868, DOI 10.1074/jbc.M200648200; BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; Champeil P, 1997, BIOCHEMISTRY-US, V36, P12383, DOI 10.1021/bi9709699; Chen L, 1996, J BIOL CHEM, V271, P10745, DOI 10.1074/jbc.271.18.10745; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; DUGGAN PF, 1970, J GEN PHYSIOL, V56, P147, DOI 10.1085/jgp.56.2.147; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; HANEL AM, 1991, BIOCHEMISTRY-US, V30, P11320, DOI 10.1021/bi00111a019; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1987, J BIOL CHEM, V262, P16338; KANAZAWA T, 1970, J BIOCHEM-TOKYO, V67, P693, DOI 10.1093/oxfordjournals.jbchem.a129297; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; Lee AG, 2002, BBA-BIOMEMBRANES, V1565, P246, DOI 10.1016/S0005-2736(02)00573-4; LEE AG, 1995, BIOCHEM J, V305, P225, DOI 10.1042/bj3050225; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MALAN NT, 1975, FEBS LETT, V60, P122, DOI 10.1016/0014-5793(75)80432-7; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; MEDDA P, 1987, EUR J BIOCHEM, V165, P251, DOI 10.1111/j.1432-1033.1987.tb11435.x; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; NAKAMURA J, 1989, J BIOL CHEM, V264, P17029; NAKAMURA S, 1994, J BIOL CHEM, V269, P16015; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P11331, DOI 10.1021/bi00111a020; PETITHORY JR, 1988, BIOCHEMISTRY-US, V27, P8626, DOI 10.1021/bi00423a018; Reis M, 2001, J BIOL CHEM, V276, P42793, DOI 10.1074/jbc.M107625200; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361; Zhang ZS, 2001, J BIOL CHEM, V276, P15232, DOI 10.1074/jbc.M010813200	58	2	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38674	38683		10.1074/jbc.M110.183343	http://dx.doi.org/10.1074/jbc.M110.183343			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20937807	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000284625600072
J	Guo, Y; Au, WC; Shakoury-Elizeh, M; Protchenko, O; Basrai, M; Prinz, WA; Philpott, CC				Guo, Yan; Au, Wei-Chun; Shakoury-Elizeh, Minoo; Protchenko, Olga; Basrai, Munira; Prinz, William A.; Philpott, Caroline C.			Phosphatidylserine Is Involved in the Ferrichrome-induced Plasma Membrane Trafficking of Arn1 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; UBIQUITIN-DEPENDENT TRAFFICKING; CROSS-PATHWAY REGULATION; PHOSPHOLIPID METHYLATION; PROTEIN LOCALIZATION; INOSITOL SYNTHESIS; GENETIC-ANALYSIS; BUDDING YEAST; PKH-KINASES; IRON UPTAKE	Arn1 is an integral membrane protein that mediates the uptake of ferrichrome, an important nutritional source of iron, in Saccharomyces cerevisiae. In the absence of ferrichrome, Arn1p is sorted directly from the trans-Golgi network to the vacuolar lumen for degradation. In the presence of low levels of ferrichrome, the siderophore binds to a receptor domain on Arn1, triggering the redistribution of Arn1 to the plasma membrane. When extracellular ferrichrome levels are high, Arn1 cycles between the plasma membrane and intracellular vesicles. To further understand the mechanisms of trafficking of Arn1p, we screened 4580 viable yeast deletion mutants for mislocalization of Arn1-GFP using synthetic genetic array technology. We identified over 100 genes required for trans-Golgi network-to-vacuole trafficking of Arn1-GFP and only two genes, SER1 and SER2, required for the ferrichrome-induced plasma membrane trafficking of Arn1-GFP. SER1 and SER2 encode two enzymes of the major serine biosynthetic pathway, and the Arn1 trafficking defect in the ser1 Delta strain was corrected with supplemental serine or glycine. Plasma membrane trafficking of Hxt3, a structurally related glucose transporter, was unaffected by SER1 deletion. Serine is required for the synthesis of multiple cellular components, including purines, sphingolipids, and phospholipids, but of these only phosphatidylserine corrected the Arn1 trafficking defects of the ser1 Delta strain. Strains with defects in phospholipid synthesis also exhibited alterations in Arn1p trafficking, indicating that the intracellular trafficking of some transporters is dependent on the phospholipid composition of the cellular membranes.	[Guo, Yan; Shakoury-Elizeh, Minoo; Protchenko, Olga; Philpott, Caroline C.] NIDDK, Liver Dis Branch, Bethesda, MD 20892 USA; [Prinz, William A.] NIDDK, Lab Cell Biol & Biochem, Bethesda, MD 20892 USA; [Au, Wei-Chun; Basrai, Munira] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Philpott, CC (corresponding author), Bldg 10 Rm 9B-16,10 Ctr Dr, Bethesda, MD 20892 USA.	carolinep@intra.niddk.nih.gov	Protchenko, Olga/AAU-9237-2021; Basrai, Munira/AAV-4422-2020	Protchenko, Olga/0000-0002-4688-4214	National Institutes of Health (NIH), NIDDK, Intramural Research Program; NCI, NIH; NATIONAL CANCER INSTITUTE [ZIABC010822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054512] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIDDK, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health (NIH), NIDDK, Intramural Research Program (to Y. G., M. S.-E., O. P., W. A. P., and C. C. P.) and by NCI, NIH (to W.-C. A. and M. B.).	Barfield RM, 2009, MOL BIOL CELL, V20, P4985, DOI 10.1091/mbc.E09-04-0324; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Brohee S, 2010, BBA-BIOMEMBRANES, V1798, P1908, DOI 10.1016/j.bbamem.2010.06.008; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Ferguson-Yankey SR, 2002, YEAST, V19, P573, DOI 10.1002/yea.861; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Kim Y, 2005, EMBO J, V24, P952, DOI 10.1038/sj.emboj.7600579; Kim Y, 2002, EMBO J, V21, P3632, DOI 10.1093/emboj/cdf382; Kim Y, 2007, MOL BIOL CELL, V18, P1790, DOI 10.1091/mbc.E06-09-0861; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; MCGRAW P, 1989, GENETICS, V122, P317; MELCHER K, 1992, CURR GENET, V21, P295, DOI 10.1007/BF00351686; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Nakamura H, 2000, BIOSCI BIOTECH BIOCH, V64, P167, DOI 10.1271/bbb.64.167; Opekarova M, 2002, BBA-BIOMEMBRANES, V1564, P9, DOI 10.1016/S0005-2736(02)00455-8; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; Philpott CC, 1998, EMBO J, V17, P5026, DOI 10.1093/emboj/17.17.5026; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Raychaudhuri S, 2008, P NATL ACAD SCI USA, V105, P15785, DOI 10.1073/pnas.0808321105; Schuiki I, 2010, BBA-MOL CELL BIOL L, V1801, P480, DOI 10.1016/j.bbalip.2009.12.008; SHERMAN F, 1991, P3; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; SUMMERS EF, 1988, GENETICS, V120, P909; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Walther TC, 2007, EMBO J, V26, P4946, DOI 10.1038/sj.emboj.7601933; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yun CW, 2000, J BIOL CHEM, V275, P16354, DOI 10.1074/jbc.M001456200	42	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39564	39573		10.1074/jbc.M110.177055	http://dx.doi.org/10.1074/jbc.M110.177055			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923770	hybrid, Green Published			2022-12-25	WOS:000284941300082
J	Kowlessur, D; Tobacman, LS				Kowlessur, Devanand; Tobacman, Larry S.			Low Temperature Dynamic Mapping Reveals Unexpected Order and Disorder in Troponin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIN FILAMENT PROTEINS; HUMAN CARDIAC TROPONIN; PHOTO-CROSS-LINKING; C-TERMINAL REGION; HYDROGEN-EXCHANGE; MUSCLE-CONTRACTION; SKELETAL-MUSCLE; INHIBITORY REGION; MASS-SPECTROMETRY; STRIATED-MUSCLE	Troponin is a pivotal regulatory protein that binds Ca2+ reversibly to act as the muscle contraction on-off switch. To understand troponin function, the dynamic behavior of the Ca2+-saturated cardiac troponin core domain was mapped in detail at 10 degrees C, using H/D exchange-mass spectrometry. The low temperature conditions of the present study greatly enhanced the dynamic map compared with previous work. Approximately 70% of assessable peptide bond hydrogens were protected from exchange sufficiently for dynamic measurement. This allowed the first characterization by this method of many regions of regulatory importance. Most of the TnI COOH terminus was protected from H/D exchange, implying an intrinsically folded structure. This region is critical to the troponin inhibitory function and has been implicated in thin filament activation. Other new findings include unprotected behavior, suggesting high mobility, for the residues linking the two domains of TnC, as well as for the inhibitory peptide residues preceding the TnI switch helix. These data indicate that, in solution, the regulatory subdomain of cardiac troponin is mobile relative to the remainder of troponin. Relatively dynamic properties were observed for the interacting TnI switch helix and TnC NH2-domain, contrasting with stable, highly protected properties for the interacting TnI helix 1 and TnC COOH-domain. Overall, exchange protection via protein folding was relatively weak or for a majority of peptide bond hydrogens. Several regions of TnT and TnI were unfolded even at low temperature, suggesting intrinsic disorder. Finally, change in temperature prominently altered local folding stability, suggesting that troponin is an unusually mobile protein under physiological conditions.	Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Tobacman, Larry S.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tobacman, LS (corresponding author), 1853 W Polk St,MC 784, Chicago, IL 60612 USA.	LST@uic.edu			National Institutes of Health [HL063774, HL038834]; Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063774, R29HL038834, R01HL038834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL063774 and HL038834, and also by the CBC/UIC Proteomics and Informatics Facility, established by a grant from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium.	Arrington CB, 2000, METHOD ENZYMOL, V323, P104; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Foster DB, 2003, CIRC RES, V93, P917, DOI 10.1161/01.RES.0000099889.35340.6F; Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Heeley DH, 2002, P NATL ACAD SCI USA, V99, P16731, DOI 10.1073/pnas.252236399; Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9600, DOI 10.1021/bi00088a012; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kowlessur D, 2010, J BIOL CHEM, V285, P2686, DOI 10.1074/jbc.M109.062349; Kronert WA, 1999, J CELL BIOL, V144, P989, DOI 10.1083/jcb.144.5.989; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Luo Y, 2000, J MOL BIOL, V296, P899, DOI 10.1006/jmbi.1999.3495; Mathur MC, 2008, BIOPHYS J, V94, P542, DOI 10.1529/biophysj.107.113944; Mathur MC, 2009, BIOPHYS J, V96, P2237, DOI 10.1016/j.bpj.2008.12.3909; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Milne JS, 1999, J MOL BIOL, V290, P811, DOI 10.1006/jmbi.1999.2924; Mudalige WAKA, 2009, J MOL BIOL, V389, P575, DOI 10.1016/j.jmb.2009.04.027; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TALBOT JA, 1981, J BIOL CHEM, V256, P2374; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; VANEYK JE, 1988, J BIOL CHEM, V263, P1726; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	47	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38978	38986		10.1074/jbc.M110.181305	http://dx.doi.org/10.1074/jbc.M110.181305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889975	Green Published, hybrid			2022-12-25	WOS:000284941300028
J	Raistrick, CA; Day, INM; Gaunt, TR				Raistrick, Christopher A.; Day, Ian N. M.; Gaunt, Tom R.			Genome-Wide Data-Mining of Candidate Human Splice Translational Efficiency Polymorphisms (STEPs) and an Online Database	PLOS ONE			English	Article							PRE-MESSENGER-RNA; HUMAN-DISEASE GENES; NUCLEOTIDE STRUCTURE; COMPUTATIONAL TOOLS; ALZHEIMERS-DISEASE; MUTATION PATTERN; 5'-SPLICE SITES; INSULIN GENE; ASSOCIATION; INTRON	Background: Variation in pre-mRNA splicing is common and in some cases caused by genetic variants in intronic splicing motifs. Recent studies into the insulin gene (INS) discovered a polymorphism in a 59 non-coding intron that influences the likelihood of intron retention in the final mRNA, extending the 59 untranslated region andmaintaining protein quality. Retention was also associated with increased insulin levels, suggesting that such variants-splice translational efficiency polymorphisms (STEPs)-may relate to disease phenotypes through differential protein expression. We set out to explore the prevalence of STEPs in the human genome and validate this new category of protein quantitative trait loci (pQTL) using publicly available data. Methodology/Principal Findings: Gene transcript and variant data were collected and mined for candidate STEPs in motif regions. Sequences from transcripts containing potential STEPs were analysed for evidence of splice site recognition and an effect in expressed sequence tags (ESTs). 16 publicly released genome-wide association data sets of common diseases were searched for association to candidate polymorphisms with HapMap frequency data. Our study found 3324 candidate STEPs lying in motif sequences of 59 non-coding introns and further mining revealed 170 with transcript evidence of intron retention. 21 potential STEPs had EST evidence of intron retention or exon extension, as well as population frequency data for comparison. Conclusions/Significance: Results suggest that the insulin STEP was not a unique example and that many STEPs may occur genome-wide with potentially causal effects in complex disease. An online database of STEPs is freely accessible at http://dbstep. genes.org.uk/.	[Raistrick, Christopher A.; Day, Ian N. M.; Gaunt, Tom R.] Univ Bristol, Bristol Genet Epidemiol Labs, Sch Social & Community Med, Bristol, Avon, England; [Day, Ian N. M.; Gaunt, Tom R.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Bristol, Avon, England	University of Bristol; University of Bristol	Raistrick, CA (corresponding author), Univ Bristol, Bristol Genet Epidemiol Labs, Sch Social & Community Med, Bristol, Avon, England.	ian.day@bristol.ac.uk	Gaunt, Tom R/O-3918-2014	Gaunt, Tom R/0000-0003-0924-3247	UK Medical Research Council; MRC; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (MRC Capacity Building Studentship in Bioinformatics to author CR). CR is a member of the MRC funded Bristol Centre for Systems Biomedicine (BCSBmed) doctoral training centre (director INMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; BERNARDI G, 1988, J MOL EVOL, V28, P7, DOI 10.1007/BF02143493; Bian L, 2005, BIOL PSYCHIAT, V58, P731, DOI 10.1016/j.biopsych.2005.05.013; Birzele F, 2008, NUCLEIC ACIDS RES, V36, pD63, DOI 10.1093/nar/gkm793; BODMER WF, 1995, CANCER SURV, V22, P5; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bonnal S, 2003, NUCLEIC ACIDS RES, V31, P427, DOI 10.1093/nar/gkg003; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4250, DOI 10.1093/nar/gkm402; Day INM, 2006, PHYSIOL GENOMICS, V28, P113, DOI 10.1152/physiolgenomics.00126.2006; DESMET F, 2009, NUCLEIC ACIDS RES; Dodel RC, 2000, NEUROLOGY, V54, P438, DOI 10.1212/WNL.54.2.438; Eden E, 2004, NUCLEIC ACIDS RES, V32, P1131, DOI 10.1093/nar/gkh273; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fernandez-Capetillo O, 2010, EMBO REP, V11, P32, DOI 10.1038/embor.2009.262; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jones MH, 1997, GENOMICS, V45, P529, DOI 10.1006/geno.1997.5000; Kogan S, 2005, GENE, V352, P57, DOI 10.1016/j.gene.2005.03.004; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Kralovicova J, 2006, DIABETES, V55, P260, DOI 10.2337/diabetes.55.01.06.db05-0773; Lin CL, 2004, BIOCHEM BIOPH RES CO, V321, P638, DOI 10.1016/j.bbrc.2004.07.013; Liu G, 2006, BIOCHEM BIOPH RES CO, V349, P360, DOI 10.1016/j.bbrc.2006.08.049; Marchand L, 2007, DIABETES, V56, P709, DOI 10.2337/db06-0402; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; McClelland S, 2009, PPAR RES, V2009, DOI 10.1155/2009/193413; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Mount SM, 2000, AM J HUM GENET, V67, P788, DOI 10.1086/303098; Myllykangas L, 1999, ANN NEUROL, V46, P382; Nestel FP, 1996, GENE, V180, P151, DOI 10.1016/S0378-1119(96)00436-2; Rao KS, 2007, NAT CLIN PRACT NEURO, V3, P162, DOI 10.1038/ncpneuro0448; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roca X, 2008, GENOME RES, V18, P77, DOI 10.1101/gr.6859308; RODRIGUEZ S, 2007, DIABETES, V56, pE17; Rodriguez Santiago, 2007, Diabetes, V56, pe17, DOI 10.2337/db07-0805; Sakashita E, 2004, MOL CELL BIOL, V24, P1174, DOI 10.1128/MCB.24.3.1174-1187.2004; SEDMAN SA, 1990, J VIROL, V64, P453, DOI 10.1128/JVI.64.1.453-457.1990; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vorechovsky I, 2007, DIABETES, V56, P709; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Zappia M, 2004, ARCH NEUROL-CHICAGO, V61, P341, DOI 10.1001/archneur.61.3.341; ZHANG J, 1995, GENOMICS, V29, P179, DOI 10.1006/geno.1995.1229; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	55	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13340	10.1371/journal.pone.0013340	http://dx.doi.org/10.1371/journal.pone.0013340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948966	Green Submitted, gold, Green Published			2022-12-25	WOS:000282748100034
J	Warrilow, D; Warren, K; Harrich, D				Warrilow, David; Warren, Kylie; Harrich, David			Strand Transfer and Elongation of HIV-1 Reverse Transcription Is Facilitated by Cell Factors In Vitro	PLOS ONE			English	Article							AVIAN RETROVIRUS PARTICLES; PREINTEGRATION COMPLEXES; VIRUS; DNA; REPLICATION; CDNA; INTEGRASE; INFECTION; PROTEINS; IDENTIFICATION	Recent work suggests a role for multiple host factors in facilitating HIV-1 reverse transcription. Previously, we identified a cellular activity which increases the efficiency of HIV-1 reverse transcription in vitro. Here, we describe aspects of the activity which shed light on its function. The cellular factor did not affect synthesis of strong-stop DNA but did improve downstream DNA synthesis. The stimulatory activity was isolated by gel filtration in a single fraction of the exclusion volume. Velocity-gradient purified HIV-1, which was free of detectable RNase activity, showed poor reverse transcription efficiency but was strongly stimulated by partially purified cell proteins. Hence, the cell factor(s) did not inactivate an RNase activity that might degrade the viral genomic RNA and block completion of reverse transcription. Instead, the cell factor(s) enhanced first strand transfer and synthesis of late reverse transcription suggesting it stabilized the reverse transcription complex. The factor did not affect lysis of HIV-1 by Triton X-100 in the endogenous reverse transcription (ERT) system, and ERT reactions with HIV-1 containing capsid mutations, which varied the biochemical stability of viral core structures and impeded reverse transcription in cells, showed no difference in the ability to be stimulated by the cell factor(s) suggesting a lack of involvement of the capsid in the in vitro assay. In addition, reverse transcription products were found to be resistant to exogenous DNase I activity when the active fraction was present in the ERT assay. These results indicate that the cell factor(s) may improve reverse transcription by facilitating DNA strand transfer and DNA synthesis. It also had a protective function for the reverse transcription products, but it is unclear if this is related to improved DNA synthesis.	[Warrilow, David; Warren, Kylie; Harrich, David] Queensland Inst Med Res, Div Immunol & Infect Dis, Brisbane, Qld 4006, Australia; [Warrilow, David; Harrich, David] Griffith Med Res Coll, Herston, Qld, Australia; [Warren, Kylie] Univ Western Sydney, Sch Nat Sci, Hawkesbury, Australia	QIMR Berghofer Medical Research Institute; Griffith University; Western Sydney University	Warrilow, D (corresponding author), Queensland Inst Med Res, Div Immunol & Infect Dis, Brisbane, Qld 4006, Australia.	David.Harrich@qimr.edu.au	Harrich, David/H-6668-2016	Harrich, David/0000-0003-3690-0150	Australian National Health and Medical Research Council [496663]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian National Health and Medical Research Council project grant number 496663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; BOONE LR, 1981, J VIROL, V37, P109, DOI 10.1128/JVI.37.1.109-116.1981; BOONE LR, 1980, P NATL ACAD SCI-BIOL, V77, P847, DOI 10.1073/pnas.77.2.847; BORROTOESODA K, 1994, ANTIVIR RES, V23, P235, DOI 10.1016/0166-3542(94)90021-3; BORROTOESODA K, 1991, J VIROL, V65, P1952, DOI 10.1128/JVI.65.4.1952-1959.1991; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Choi SJ, 2000, ANAL BIOCHEM, V281, P95, DOI 10.1006/abio.2000.4529; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Fassati A, 1999, J VIROL, V73, P8919, DOI 10.1128/JVI.73.11.8919-8925.1999; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Hamamoto S, 2006, J VIROL, V80, P5670, DOI 10.1128/JVI.02471-05; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Khiytani DK, 2002, J GEN VIROL, V83, P2523, DOI 10.1099/0022-1317-83-10-2523; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lemay J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-47; Lemay J, 2008, J MOL BIOL, V383, P783, DOI 10.1016/j.jmb.2008.08.055; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Narayan S, 2004, P NATL ACAD SCI USA, V101, P7721, DOI 10.1073/pnas.0401312101; Nermut MV, 2003, J VIROL, V77, P8196, DOI 10.1128/JVI.77.15.8196-8206.2003; Sambook J, 1989, MOL CLONING LAB MANU; Sorin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000463; Warren K, 2009, VIRUSES-BASEL, V1, P873, DOI 10.3390/v1030873; Warrilow D, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-77; Warrilow D, 2008, J VIROL, V82, P1425, DOI 10.1128/JVI.01808-07; Warrilow D, 2009, REV MED VIROL, V19, P324, DOI 10.1002/rmv.627; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Ye Y, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-63; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; YONG WH, 1990, AIDS, V4, P199, DOI 10.1097/00002030-199003000-00004; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	35	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13229	10.1371/journal.pone.0013229	http://dx.doi.org/10.1371/journal.pone.0013229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949087	Green Published, gold			2022-12-25	WOS:000282568400018
J	Blum, R; Gupta, R; Burger, PE; Ontiveros, CS; Salm, SN; Xiong, XZ; Kamb, A; Wesche, H; Marshall, L; Cutler, G; Wang, XY; Zavadil, J; Moscatelli, D; Wilson, EL				Blum, Roy; Gupta, Rashmi; Burger, Patricia E.; Ontiveros, Christopher S.; Salm, Sarah N.; Xiong, Xiaozhong; Kamb, Alexander; Wesche, Holger; Marshall, Lisa; Cutler, Gene; Wang, Xiangyun; Zavadil, Jiri; Moscatelli, David; Wilson, E. Lynette			Molecular Signatures of the Primitive Prostate Stem Cell Niche Reveal Novel Mesenchymal-Epithelial Signaling Pathways	PLOS ONE			English	Article							HUMAN EMBRYONIC STEM; DIFFERENTIAL GENE-EXPRESSION; ELEMENT-BINDING PROTEINS; CANCER CELLS; SELF-RENEWAL; PROXIMAL REGION; IN-VIVO; TFII-I; TRANSCRIPTION FACTORS; ANDROGEN RECEPTOR	Background: Signals between stem cells and stroma are important in establishing the stem cell niche. However, very little is known about the regulation of any mammalian stem cell niche as pure isolates of stem cells and their adjacent mesenchyme are not readily available. The prostate offers a unique model to study signals between stem cells and their adjacent stroma as in the embryonic prostate stem cell niche, the urogenital sinus mesenchyme is easily separated from the epithelial stem cells. Here we investigate the distinctive molecular signals of these two stem cell compartments in a mammalian system. Methodology/Principal Findings: We isolated fetal murine urogenital sinus epithelium and urogenital sinus mesenchyme and determined their differentially expressed genes. To distinguish transcripts that are shared by other developing epithelial/mesenchymal compartments from those that pertain to the prostate stem cell niche, we also determined the global gene expression of epidermis and dermis of the same embryos. Our analysis indicates that several of the key transcriptional components that are predicted to be active in the embryonic prostate stem cell niche regulate processes such as self-renewal (e.g., E2f and Ap2), lipid metabolism (e.g., Srebp1) and cell migration (e.g., Areb6 and Rreb1). Several of the enriched promoter binding motifs are shared between the prostate epithelial/mesenchymal compartments and their epidermis/dermis counterparts, indicating their likely relevance in epithelial/mesenchymal signaling in primitive cellular compartments. Based on differential gene expression we also defined ligand-receptor interactions that may be part of the molecular interplay of the embryonic prostate stem cell niche. Conclusions/Significance: We provide a comprehensive description of the transcriptional program of the major regulators that are likely to control the cellular interactions in the embryonic prostatic stem cell niche, many of which may be common to mammalian niches in general. This study provides a comprehensive source for further studies of mesenchymal/epithelial interactions in the prostate stem cell niche. The elucidation of pathways in the normal primitive niche may provide greater insight into mechanisms subverted during abnormal proliferative and oncogenic processes. Understanding these events may result in the development of specific targeted therapies for prostatic diseases such as benign prostatic hypertrophy and carcinomas.	[Blum, Roy; Gupta, Rashmi; Ontiveros, Christopher S.; Salm, Sarah N.; Xiong, Xiaozhong; Moscatelli, David; Wilson, E. Lynette] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Blum, Roy; Zavadil, Jiri] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Burger, Patricia E.; Wilson, E. Lynette] Univ Cape Town, Div Immunol, ZA-7925 Cape Town, South Africa; [Salm, Sarah N.] CUNY, Borough Manhattan Community Coll, Dept Sci, New York, NY USA; [Wilson, E. Lynette] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Kamb, Alexander; Wesche, Holger; Marshall, Lisa; Cutler, Gene] Amgen Inc, San Francisco, CA USA; [Wang, Xiangyun] Pfizer Inc, Groton, CT 06340 USA; [Zavadil, Jiri; Moscatelli, David; Wilson, E. Lynette] NYU, Sch Med, NYU Canc Inst, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA	New York University; New York University; University of Cape Town; City University of New York (CUNY) System; New York University; Amgen; Pfizer; New York University; New York University	Blum, R (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	Elaine.Wilson@nyumc.org	Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Blum, Roy/0000-0002-3987-7198; Moscatelli, David/0000-0002-4627-4213	National Institutes of Health [CA132641, CA 90593]; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [5F32DK071468]; Amgen Inc.; Helen L and Martin S Kimmel Center for Stem Cell Biology at NYU School of Medicine; NATIONAL CANCER INSTITUTE [R01CA132641, R01CA090593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK071468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Amgen Inc.(Amgen); Helen L and Martin S Kimmel Center for Stem Cell Biology at NYU School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, CA132641 (ELW) CA 90593 (DM), National Research Service Award (NRSA) from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 5F32DK071468 (CSO), Amgen Inc. and the Helen L and Martin S Kimmel Center for Stem Cell Biology at NYU School of Medicine. Amgen scientists had a role in this study by participating in the analysis of data and in the preparation of the RNA used in the microarray experiments. No other funders had a role in this study.	Abate-Shen C, 2007, CANCER CELL, V12, P495, DOI 10.1016/j.ccr.2007.11.021; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Annes JP, 2002, FEBS LETT, V511, P65, DOI 10.1016/S0014-5793(01)03280-X; Aparicio LMA, 2007, CLIN TRANSL ONCOL, V9, P66, DOI 10.1007/s12094-007-0015-6; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005722; BREUSS JM, 1995, J CELL SCI, V108, P2241; Brusselmans K, 2003, INT J CANCER, V106, P856, DOI 10.1002/ijc.11317; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Caine GJ, 2003, EUR J CLIN INVEST, V33, P883, DOI 10.1046/j.1365-2362.2003.01243.x; Charpentier E, 2000, J CELL BIOL, V149, P503, DOI 10.1083/jcb.149.2.503; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Crusselle-Davis VJ, 2006, MOL CELL BIOL, V26, P6832, DOI 10.1128/MCB.01770-05; Cunha G R, 1987, Prog Clin Biol Res, V239, P273; D'Souza SJA, 2002, J BIOL CHEM, V277, P10626, DOI 10.1074/jbc.M111956200; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Fox BP, 2006, BIOCHEM BIOPH RES CO, V342, P1263, DOI 10.1016/j.bbrc.2006.02.099; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Gipp J, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-19; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gratzinger D, 2009, AM J CLIN PATHOL, V131, P264, DOI 10.1309/AJCP5FP3NAXAXRJE; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hoei-Hansen CE, 2006, J PATHOL, V209, P25, DOI 10.1002/path.1948; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Hughes-Fulford M, 2001, CARCINOGENESIS, V22, P701, DOI 10.1093/carcin/22.5.701; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kaneko KJ, 2004, MOL CELL BIOL, V24, P1968, DOI 10.1128/MCB.24.5.1968-1982.2004; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Ku MC, 2005, MOL CELL BIOL, V25, P7144, DOI 10.1128/MCB.25.16.7144-7157.2005; Kubo M, 2007, ACTA ORTHOP, V78, P845, DOI 10.1080/17453670710014653; Kurata S, 2004, J BIOL CHEM, V279, P50069, DOI 10.1074/jbc.M406322200; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Lickliter JD, 1996, P NATL ACAD SCI USA, V93, P145, DOI 10.1073/pnas.93.1.145; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; Lind AJ, 2005, PROSTATE, V62, P394, DOI 10.1002/pros.20163; Lorz C, 2010, STEM CELL REV REP, V6, P162, DOI 10.1007/s12015-010-9139-0; Ma JJ, 2009, J BIOL CHEM, V284, P34600, DOI 10.1074/jbc.M109.016246; Ma S, 2007, J PATHOL, V211, P278, DOI 10.1002/path.2109; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; Melani M, 2008, CURR BIOL, V18, P532, DOI 10.1016/j.cub.2008.03.024; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Miura Y, 2006, STEM CELLS, V24, P2428, DOI 10.1634/stemcells.2006-0089; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mukhopadhyay NK, 2007, MOL ENDOCRINOL, V21, P2056, DOI 10.1210/me.2006-0503; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Parra E, 2009, ONCOL REP, V22, P1513, DOI 10.3892/or_00000595; Pinto L, 2009, NAT NEUROSCI, V12, P1229, DOI 10.1038/nn.2399; Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Risbridger GP, 2008, ENDOCRINOLOGY, V149, P4303, DOI 10.1210/en.2008-0465; Salah Z, 2007, CANCER RES, V67, P9835, DOI 10.1158/0008-5472.CAN-07-1886; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Schmid T, 2007, J NEUROCHEM, V102, P2061, DOI 10.1111/j.1471-4159.2007.04694.x; Seo J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-395; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shetty RS, 2005, MOL CELL NEUROSCI, V30, P583, DOI 10.1016/j.mcn.2005.06.003; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Sperandio S, 2009, MOL CARCINOGEN, V48, P38, DOI 10.1002/mc.20454; Staack A, 2003, DIFFERENTIATION, V71, P402, DOI 10.1046/j.1432-0436.2003.7107004.x; Stasyk T, 2005, MOL BIOL CELL, V16, P4765, DOI 10.1091/mbc.E05-03-0257; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; WANG SP, 2008, CLIN EXP PHARM PHYSL; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Wang XD, 2004, J BIOL CHEM, V279, P24733, DOI 10.1074/jbc.M401602200; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Weissman AM, 2008, CANCER CELL, V13, P381, DOI 10.1016/j.ccr.2008.04.011; Wenzel PL, 2007, GENE DEV, V21, P85, DOI 10.1101/gad.1485307; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WOLOSIN JM, 1995, INVEST OPHTH VIS SCI, V36, pS217; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yang SZ, 2006, J CELL BIOCHEM, V97, P1292, DOI 10.1002/jcb.20736; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zandstra PW, 2000, BLOOD, V96, P1215, DOI 10.1182/blood.V96.4.1215.h8001215_1215_1222; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zheng CG, 2009, CANCER RES, V69, P2324, DOI 10.1158/0008-5472.CAN-08-4113; Zhou ZX, 2007, CANCER RES, V67, P5683, DOI 10.1158/0008-5472.CAN-07-0768	100	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13024	10.1371/journal.pone.0013024	http://dx.doi.org/10.1371/journal.pone.0013024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941365	Green Published, gold			2022-12-25	WOS:000282312600011
J	Bui, T; Stevenson, J; Hoekman, J; Zhang, SR; Maravilla, K; Ho, RJY				Bui, Tot; Stevenson, Jeff; Hoekman, John; Zhang, Shanrong; Maravilla, Kenneth; Ho, Rodney J. Y.			Novel Gd Nanoparticles Enhance Vascular Contrast for High-Resolution Magnetic Resonance Imaging	PLOS ONE			English	Article							MR-ANGIOGRAPHY; IN-VIVO; LIPOSOMES; ALBUMIN; AGENT	Background: Gadolinium (Gd), with its 7 unpaired electrons in 4f orbitals that provide a very large magnetic moment, is proven to be among the best agents for contrast enhanced MRI. Unfortunately, the most potent MR contrast agent based on Gd requires relatively high doses of Gd. The Gd-chelated to diethylene-triamine-penta-acetic acid (DTPA), or other derivatives (at 0.1 mmole/kg recommended dose), distribute broadly into tissues and clear through the kidney. These contrast agents carry the risk of Nephrogenic Systemic Fibrosis (NSF), particularly in kidney impaired subjects. Thus, Gd contrast agents that produce higher resolution images using a much lower Gd dose could address both imaging sensitivity and Gd safety. Methodology/Principal Findings: To determine whether a biocompatible lipid nanoparticle with surface bound Gd can improve MRI contrast sensitivity, we constructed Gd-lipid nanoparticles (Gd-LNP) containing lipid bound DTPA and Gd. The Gd-LNP were intravenously administered to rats and MR images collected. We found that Gd in Gd-LNP produced a greater than 33-fold higher longitudinal (T(1)) relaxivity, r(1), constant than the current FDA approved Gd-chelated contrast agents. Intravenous administration of these Gd-LNP at only 3% of the recommended clinical Gd dose produced MRI signal-to-noise ratios of greater than 300 in all vasculatures. Unlike current Gd contrast agents, these Gd-LNP stably retained Gd in normal vasculature, and are eliminated predominately through the biliary, instead of the renal system. Gd-LNP did not appear to accumulate in the liver or kidney, and was eliminated completely within 24 hrs. Conclusions/Significance: The novel Gd-nanoparticles provide high quality contrast enhanced vascular MRI at 97% reduced dose of Gd and do not rely on renal clearance. This new agent is likely to be suitable for patients exhibiting varying degrees of renal impairment. The simple and adaptive nanoparticle design could accommodate ligand or receptor coating for drug delivery optimization and in vivo drug-target definition in system biology profiling, increasing the margin of safety in treatment of cancers and other diseases.	[Bui, Tot; Hoekman, John; Ho, Rodney J. Y.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Stevenson, Jeff; Zhang, Shanrong; Maravilla, Kenneth] Univ Washington, Dept Radiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bui, T (corresponding author), Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA.	rodneyho@uw.edu			National Institutes of Health (NIH) [AI 077390, NS 39178]; University of Washington; Milo Gibaldi Endowment fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039178] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); Milo Gibaldi Endowment fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by National Institutes of Health (NIH) grants AI 077390, NS 39178 and the University of Washington Technology Gap Innovation Fund (TGIF) program. RJYH is also supported by Milo Gibaldi Endowment fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballmer PE, 2001, CLIN NUTR, V20, P271, DOI 10.1054/clnu.2001.0439; FDA, 2007, INF HEALTHC PROF GAD; HAK S, 2008, EUR J PHARM BIOPHARM; HUANG SK, 1992, CANCER RES, V52, P5135; Lauffer RB, 1998, RADIOLOGY, V207, P529, DOI 10.1148/radiology.207.2.9577506; Meaney JFM, 2007, EUR RADIOL, V17, pB1, DOI 10.1007/s10406-007-0199-4; Neubauer AM, 2008, MAGN RESON MED, V60, P1353, DOI 10.1002/mrm.21795; PETERS T, 1972, J BIOL CHEM, V247, P3858; Rofsky NM, 2008, RADIOLOGY, V247, P608, DOI 10.1148/radiol.2473071975; Sitharaman B, 2005, CHEM COMMUN, P3915, DOI 10.1039/b504435a; SOLOMON I, 1956, J CHEM PHYS, V25, P261, DOI 10.1063/1.1742867; TRUBETSKOY VS, 1995, MAGN RESON IMAGING, V13, P31, DOI 10.1016/0730-725X(94)00083-F; Woods Mark, 2004, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V4, P349, DOI 10.2174/1568013043357338	13	40	42	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13082	10.1371/journal.pone.0013082	http://dx.doi.org/10.1371/journal.pone.0013082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927340	gold, Green Published, Green Submitted			2022-12-25	WOS:000282312600017
J	Li, S; Ou, XH; Wang, ZB; Xiong, B; Tong, JS; Wei, LA; Li, M; Yuan, J; Ouyang, YC; Hou, Y; Schatten, H; Sun, QY				Li, Sen; Ou, Xiang-Hong; Wang, Zhen-Bo; Xiong, Bo; Tong, Jing-Shan; Wei, Liang; Li, Mo; Yuan, Ju; Ouyang, Ying-Chun; Hou, Yi; Schatten, Heide; Sun, Qing-Yuan			ERK3 Is Required for Metaphase-Anaphase Transition in Mouse Oocyte Meiosis	PLOS ONE			English	Article							KINETOCHORE-MICROTUBULE INTERFACE; SPINDLE-ASSEMBLY CHECKPOINT; ACTIVATED PROTEIN-KINASE; MAP KINASE; DYNAMIC INSTABILITY; MEIOTIC RESUMPTION; FEMALE MEIOSIS; MATURATION; CELLS; CDC20	ERK3 (extracellular signal-regulated kinase 3) is an atypical member of the mitogen-activated protein (MAP) kinase family of serine/threonine kinases. Little is known about its function in mitosis, and even less about its roles in mammalian oocyte meiosis. In the present study, we examined the localization, expression and functions of ERK3 during mouse oocyte meiotic maturation. Immunofluorescent analysis showed that ERK3 localized to the spindles from the pre-MI stage to the MII stage. ERK3 co-localized with alpha-tubulin on the spindle fibers and asters in oocytes after taxol treatment. Deletion of ERK3 by microinjection of ERK3 morpholino (ERK3 MO) resulted in oocyte arrest at the MI stage with severely impaired spindles and misaligned chromosomes. Most importantly, the spindle assembly checkpoint protein BubR1 could be detected on kinetochores even in oocytes cultured for 10 h. Low temperature treatment experiments indicated that ERK3 deletion disrupted kinetochore-microtubule (K-MT) attachments. Chromosome spreading experiments showed that knock-down of ERK3 prevented the segregation of homologous chromosomes. Our data suggest that ERK3 is crucial for spindle stability and required for the metaphase-anaphase transition in mouse oocyte maturation.	[Li, Sen; Ou, Xiang-Hong; Wang, Zhen-Bo; Xiong, Bo; Tong, Jing-Shan; Wei, Liang; Li, Mo; Yuan, Ju; Ouyang, Ying-Chun; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Li, Sen; Wang, Zhen-Bo; Wei, Liang; Li, Mo; Yuan, Ju] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Li, S (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	Wei, Liang/U-4349-2017	Tong, Jingshan/0000-0003-1640-5769	National Natural Science Foundation of China [30930065]; National Basic Research Program of China [2006CB504004, 2006CB944001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (30930065) and National Basic Research Program of China (2006CB504004, 2006CB944001) to QYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Doubilet S, 2007, CHROMOSOME RES, V15, P681, DOI 10.1007/s10577-007-1148-8; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Fukagawa T, 2008, FRONT BIOSCI-LANDMRK, V13, P2705, DOI 10.2741/2877; Gerton JL, 2007, GENE DEV, V21, P238, DOI 10.1101/gad.1523107; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Hoeflich KP, 2006, INT J ONCOL, V29, P839; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; JONES KT, CELL CYCLE, V9; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Li M, 2008, BIOL REPROD, V79, P897, DOI 10.1095/biolreprod.108.069245; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Liang CG, 2007, MOL ENDOCRINOL, V21, P2037, DOI 10.1210/me.2006-0408; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Schindler K, 2009, CELL CYCLE, V8, P1090, DOI 10.4161/cc.8.7.8144; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Sirard MA, 2001, THERIOGENOLOGY, V55, P1241, DOI 10.1016/S0093-691X(01)00480-0; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Swan A, 2005, CELL CYCLE, V4, P1332, DOI 10.4161/cc.4.10.2088; TANGUAY PL, BIOCH J, V428, P103; Turgeon B, 2000, BIOCHEM J, V346, P169, DOI 10.1042/0264-6021:3460169; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; WEI L, CELL CYCLE, V9; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Yin S, 2008, CELL CYCLE, V7, P2997, DOI 10.4161/cc.7.19.6809; Yin S, 2007, CELL CYCLE, V6, P2990, DOI 10.4161/cc.6.23.4993	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13074	10.1371/journal.pone.0013074	http://dx.doi.org/10.1371/journal.pone.0013074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927325	Green Published, Green Submitted, gold			2022-12-25	WOS:000282269400023
J	Camm, EJ; Martin-Gronert, MS; Wright, NL; Hansell, JA; Ozanne, SE; Giussani, DA				Camm, E. J.; Martin-Gronert, M. S.; Wright, N. L.; Hansell, J. A.; Ozanne, S. E.; Giussani, D. A.			Prenatal hypoxia independent of undernutrition promotes molecular markers of insulin resistance in adult offspring	FASEB JOURNAL			English	Article						IUGR; insulin-signaling proteins; type 2 diabetes	PROTEIN-KINASE-C; LOW-BIRTH-WEIGHT; FREE FATTY-ACIDS; NUTRIENT RESTRICTION; GROWTH-RETARDATION; GLUCOSE-TRANSPORT; 3-KINASE ACTIVITY; SKELETAL-MUSCLE; DIABETIC OB/OB; HIGH-ALTITUDE	Molecular mechanisms predisposing people to insulin resistance are starting to emerge. Altered insulin signaling for hepatic gluconeogenesis and muscle glucose uptake is thought to play a central role. Development under suboptimal conditions is also known to increase the risk of insulin resistance in adulthood. However, the partial contributions of reduced oxygen vs. nutrient delivery to the fetus, two common adverse conditions in utero, to developmental programming of insulin resistance remain unknown. The aim of this study was to determine the effects of developmental hypoxia or undernutrition on the expression of insulin-signaling proteins in liver and skeletal muscle in adult rat offspring. We show that the expression of hepatic phospho-Akt and muscle Akt2 were significantly reduced in offspring of hypoxic, relative to offspring from normoxic or undernourished, pregnancies. Hepatic Akt-1, Akt-2, and PKC zeta protein expression was reduced in offspring from both hypoxic and undernourished pregnancies. Muscle GLUT4 expression was decreased in undernourished, and further decreased in hypoxic, offspring. These findings link prenatal hypoxia to down-regulation of components of hepatic and muscle Akt expression in adult offspring. Akt may represent a pharmaceutical target for clinical intervention against the developmental programming of metabolic disease resulting from prenatal hypoxia.-Camm, E. J., Martin-Gronert, M. S., Wright, N. L., Hansell, J. A., Ozanne, S. E., Giussani, D. A. Prenatal hypoxia independent of undernutrition promotes molecular markers of insulin resistance in adult offspring. FASEB J. 25, 420-427 (2011). www.fasebj.org	[Camm, E. J.; Wright, N. L.; Hansell, J. A.; Giussani, D. A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Martin-Gronert, M. S.; Ozanne, S. E.] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 3EG, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	dag26@cam.ac.uk		Ozanne, Susan/0000-0001-8753-5144; Giussani, Dino/0000-0002-1308-1204	British Heart Foundation; Medical Research Council Centre for Obesity and Related Metabolic Disorders (MRC-CORD); Royal Society; British Heart Foundation [FS/09/029/27902] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council Centre for Obesity and Related Metabolic Disorders (MRC-CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation and the Medical Research Council Centre for Obesity and Related Metabolic Disorders (MRC-CORD). S.E.O. is a British Heart Foundation Senior Fellow. D. A. G. is a Royal Society Wolfson Research Merit Award Holder.	Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Barker DJP, 2009, ANN HUM BIOL, V36, P445, DOI 10.1080/03014460902980295; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; Baschat AA, 2004, SEMIN PERINATOL, V28, P67, DOI 10.1053/j.semperi.2003.10.014; Boden G, 2001, Endocr Pract, V7, P44; Byrne CD, 2000, J CLIN PATHOL, V53, P822, DOI 10.1136/jcp.53.11.822; Camm EJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.046; Campbell ME, 2005, PEDIATR RES, V58, P840, DOI 10.1203/01.PDR.0000181376.83137.ED; CHANG JHT, 1984, BIOL NEONATE, V46, P10; Cheema KK, 2005, BRIT J NUTR, V93, P471, DOI 10.1079/BJN20041392; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cianfarani S, 1999, ARCH DIS CHILD-FETAL, V81, pF71, DOI 10.1136/fn.81.1.F71; DEGRAUW TJ, 1986, BIOL NEONATE, V49, P85, DOI 10.1159/000242515; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Farese RV, 2005, EXP BIOL MED, V230, P593; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Giussani DA, 2007, J PHYSIOL-LONDON, V585, P911, DOI 10.1113/jphysiol.2007.141572; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; HASS JD, 1980, HUM BIOL, V52, P459; Jensen CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003738; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kim YB, 2003, DIABETES, V52, pA281; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; LICHTY JA, 1957, AMA J DIS CHILD, V93, P666, DOI 10.1001/archpedi.1957.02060040668009; Martin-Gronert MS, 2007, J INTERN MED, V261, P437, DOI 10.1111/j.1365-2796.2007.01800.x; McClung J., 1969, EFFECTS HIGH ALTITUD; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; Neerhof MG, 2008, SEMIN PERINATOL, V32, P201, DOI 10.1053/j.semperi.2007.11.002; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Ozanne SE, 2006, DIABETOLOGIA, V49, P2993, DOI 10.1007/s00125-006-0466-2; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Park E, 2007, J ENDOCRINOL, V195, P323, DOI 10.1677/JOE-07-0005; Peyronnet J, 2002, PFLUG ARCH EUR J PHY, V443, P858, DOI 10.1007/s00424-001-0766-9; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; Salinas CE, 2010, J DEV ORIG HLTH DIS, V1, P60, DOI 10.1017/S2040174409990043; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Williams SJ, 2005, AM J PHYSIOL-REG I, V288, pR360, DOI 10.1152/ajpregu.00178.2004; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zamudio S, 2007, FRONT BIOSCI-LANDMRK, V12, P2967, DOI 10.2741/2286; Zick Y, 2004, BIOCHEM SOC T, V32, P812, DOI 10.1042/BST0320812	52	57	58	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					420	427		10.1096/fj.10-158188	http://dx.doi.org/10.1096/fj.10-158188			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20923964				2022-12-25	WOS:000285869500038
J	Yang, LM; Blount, P				Yang, Li-Min; Blount, Paul			Manipulating the permeation of charged compounds through the MscL nanovalve	FASEB JOURNAL			English	Article						osmoregulation; drug-release device; ionic preference; ionic selectivity	MECHANOSENSITIVE CHANNEL MSCL; ESCHERICHIA-COLI-CELLS; ION-CHANNEL; MYCOBACTERIUM-TUBERCULOSIS; OSMOTIC DOWNSHOCK; STEALTH LIPOSOMES; SINGLE RESIDUE; SENSORY VALVE; PROTEIN; MEMBRANE	MscL is a bacterial mechanosensor that serves as a biological emergency release valve, releasing cytoplasmic solutes to the environment on osmotic downshock. Previous studies have recognized that this channel has properties that make it ideal for use as a triggered nanovalve for vesicular-based targeted drug-release devices. One can even change the modality of the sensor. Briefly, the introduction of charges into the MscL pore lumen gates the channel in the absence of membrane tension; thus, by inserting compounds that acquire a charge on exposure to an alternative stimulus, such as light or pH, into the pore of the channel, controllable nanoswitches that detect these alternative modalities have been engineered. However, a charge in the pore lumen could not only encourage actuation of the nanopore but also have a significant influence on the permeation of large charged compounds, which would thus have important implications for the efficiency of drug-release devices. In this study, we used in vivo and electrophysiological approaches to demonstrate that the introduction of a charge into pore lumen of MscL does indeed influence the permeation of charged molecules. These effects were more drastic for larger compounds and, surprisingly, were related to the orientation of the MscL channel in the membrane.-Yang, L-M, Blount, P. Manipulating the permeation of charged compounds through the MscL nanovalve. FASEB J. 25, 428-434 (2011). www.fasebj.org	[Yang, Li-Min; Blount, Paul] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Blount, P (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	paul.blount@utsouthwestern.edu			Cancer Prevention and Research Institute of Texas (CPRIT) [RP100146]; Welch Foundation [I-1420]; U.S. National Aeronautics and Space Administration [NNH08ZTT003N NRA]; U.S. National Institutes of Health [GM61028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061028] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); Welch Foundation(The Welch Foundation); U.S. National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Zoltan Kovacs, Irene Iscla, and Yuezhou Li for many helpful discussions and critical reading of the manuscript. This work was supported by grant RP100146 from the Cancer Prevention and Research Institute of Texas (CPRIT; http://www.cprit.state.tx.us), grant I-1420 of the Welch Foundation, grant NNH08ZTT003N NRA from the U.S. National Aeronautics and Space Administration, and grant GM61028 and its supplement from the U.S. National Institutes of Health.	Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670; Ajouz B, 1998, BIOPHYS J, V74, pA238; Bartlett JL, 2006, BIOPHYS J, V91, P3684, DOI 10.1529/biophysj.106.088062; Bartlett JL, 2004, P NATL ACAD SCI USA, V101, P10161, DOI 10.1073/pnas.0402040101; Berrier C, 2004, BIOCHEMISTRY-US, V43, P12585, DOI 10.1021/bi049049y; Berrier C, 2000, J BACTERIOL, V182, P248, DOI 10.1128/JB.182.1.248-251.2000; Betanzos M, 2002, NAT STRUCT BIOL, V9, P704, DOI 10.1038/nsb828; Blount P, 1999, Methods Enzymol, V294, P458; Blount P, 1996, BIOL CELL, V87, P1, DOI 10.1016/S0248-4900(97)89832-2; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Clayton D, 2004, P NATL ACAD SCI USA, V101, P4764, DOI 10.1073/pnas.0305693101; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; EPSTEIN W, 1965, J GEN PHYSIOL, V49, P221, DOI 10.1085/jgp.49.2.221; Ewis HE, 2005, FEMS MICROBIOL LETT, V253, P295, DOI 10.1016/j.femsle.2005.09.046; Gabizon AA, 2001, CLIN CANCER RES, V7, P223; Immordino ML, 2006, INT J NANOMED, V1, P297; Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760; Kocer A, 2007, NAT PROTOC, V2, P1426, DOI 10.1038/nprot.2007.196; Kocer A, 2006, ANGEW CHEM INT EDIT, V45, P3126, DOI 10.1002/anie.200503403; Kocer-Sagiroglu A, 2005, J CONTROL RELEASE, V101, P374; Kumanovics A, 2002, FASEB J, V16, P1623, DOI 10.1096/fj.02-0238hyp; Levin G, 2004, BIOPHYS J, V86, P2862, DOI 10.1016/S0006-3495(04)74338-6; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Moe PC, 2000, J BIOL CHEM, V275, P31121, DOI 10.1074/jbc.M002971200; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; NAKAJIMA H, 1979, J BIOCHEM-TOKYO, V85, P303, DOI 10.1093/oxfordjournals.jbchem.a132325; Nakatani K, 2007, LANGMUIR, V23, P7170, DOI 10.1021/la7002723; OGAHARA T, 1995, J BACTERIOL, V177, P5987, DOI 10.1128/jb.177.20.5987-5990.1995; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Powl AM, 2008, BIOCHEMISTRY-US, V47, P4317, DOI 10.1021/bi702409t; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9	38	11	12	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					428	434		10.1096/fj.10-170076	http://dx.doi.org/10.1096/fj.10-170076			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20930114	Green Published			2022-12-25	WOS:000285869500039
J	Abramian, AM; Comenencia-Ortiz, E; Vithlani, M; Tretter, EV; Sieghart, W; Davies, PA; Moss, SJ				Abramian, Armen M.; Comenencia-Ortiz, Eydith; Vithlani, Mansi; Tretter, Eva Verena; Sieghart, Werner; Davies, Paul A.; Moss, Stephen J.			Protein Kinase C Phosphorylation Regulates Membrane Insertion of GABA(A) Receptor Subtypes That Mediate Tonic Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE STABILITY; HIPPOCAMPAL PYRAMIDAL NEURONS; GRANULE CELLS; ALPHA-BUNGAROTOXIN; A RECEPTORS; SYNAPTIC INHIBITION; DELTA-SUBUNITS; DENTATE GYRUS; HIGH-AFFINITY; BINDING-SITE	Tonic inhibition in the brain is mediated largely by specialized populations of extrasynaptic receptors, gamma-aminobutyric acid receptors (GABA(A)Rs). In the dentate gyrus region of the hippocampus, tonic inhibition is mediated primarily by GABA(A)R subtypes assembled from alpha 4 beta 2/3 with or without the delta subunit. Although the gating of these receptors is subject to dynamic modulation by agents such as anesthetics, barbiturates, and neurosteroids, the cellular mechanisms neurons use to regulate their accumulation on the neuronal plasma membrane remain to be determined. Using immunoprecipitation coupled with metabolic labeling, we demonstrate that the alpha 4 subunit is phosphorylated at Ser(443) by protein kinase C (PKC) in expression systems and hippocampal slices. In addition, the beta 3 subunit is phosphorylated on serine residues 408/409 by PKC activity, whereas the delta subunit did not appear to be a PKC substrate. We further demonstrate that the PKC-dependent increase of the cell surface expression of alpha 4 subunit-containing GABA(A)Rs is dependent on Ser(443). Mechanistically, phosphorylation of Ser(443) acts to increase the stability of the alpha 4 subunit within the endoplasmic reticulum, thereby increasing the rate of receptor insertion into the plasma membrane. Finally, we show that phosphorylation of Ser(443) increases the activity of alpha 4 subunit-containing GABA(A)Rs by preventing current run-down. These results suggest that PKC-dependent phosphorylation of the alpha 4 subunit plays a significant role in enhancing the cell surface stability and activity of GABA(A)R subtypes that mediate tonic inhibition.	[Abramian, Armen M.; Comenencia-Ortiz, Eydith; Vithlani, Mansi; Davies, Paul A.; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA; [Abramian, Armen M.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Sieghart, Werner] Med Univ Vienna, Brain Res Ctr, Dept Biochem & Mol Biol, A-1090 Vienna, Austria; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Tufts University; University of Pennsylvania; Medical University of Vienna; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	stephen.moss@tufts.edu	Sieghart, Werner/A-4877-2013; Davies, Paul A/P-4595-2017	Sieghart, Werner/0000-0002-0443-0302; Davies, Paul A/0000-0002-3973-3143	National Institutes of Health/NINDS [NS048045, NS051195, NS056359, NS054900]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081986, T32NS061764, R01NS056359, R01NS051195, R21NS080064, P01NS054900, R01NS048045] Funding Source: NIH RePORTER	National Institutes of Health/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health/NINDS Grants NS048045, NS051195, NS056359, and NS054900 (to S. J. M.). S. J. M. serves as a consultant for Pfizer Pharmaceuticals, a relationship that is regulated by Tufts University and does not impact on this work.	Behr J, 1998, J NEUROPHYSIOL, V79, P1726, DOI 10.1152/jn.1998.79.4.1726; Bencsits E, 1999, J BIOL CHEM, V274, P19613, DOI 10.1074/jbc.274.28.19613; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brandon NJ, 1999, J NEUROSCI, V19, P9228; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Bright DP, 2007, J NEUROSCI, V27, P2560, DOI 10.1523/JNEUROSCI.5100-06.2007; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Caraiscos VB, 2004, J NEUROSCI, V24, P8454, DOI 10.1523/JNEUROSCI.2063-04.2004; Carlson GC, 2008, NAT PROTOC, V3, P249, DOI 10.1038/nprot.2007.539; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Cheng VY, 2006, ANESTHESIOLOGY, V105, P325, DOI 10.1097/00000542-200608000-00015; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2006, J NEUROSCI, V26, P1499, DOI 10.1523/JNEUROSCI.2913-05.2006; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HEINEMANN U, 1992, EPILEPSY RES, P273; Jacob TC, 2009, P NATL ACAD SCI USA, V106, P12500, DOI 10.1073/pnas.0903943106; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Katchalski-Katzir E, 2003, BIOPHYS CHEM, V100, P293, DOI 10.1016/S0301-4622(02)00287-9; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; Liang J, 2008, ALCOHOL CLIN EXP RES, V32, P19, DOI 10.1111/j.1530-0277.2007.00564.x; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Maldonado-Aviles JG, 2009, AM J PSYCHIAT, V166, P450, DOI 10.1176/appi.ajp.2008.08101484; MCDONALD BJ, 1994, J BIOL CHEM, V269, P18111; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mody I, 2005, J PHYSIOL-LONDON, V562, P37, DOI 10.1113/jphysiol.2004.077362; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Park JB, 2006, ENDOCRINOLOGY, V147, P3746, DOI 10.1210/en.2006-0218; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Rothman JS, 2009, NATURE, V457, P1015, DOI 10.1038/nature07604; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Scherf T, 2001, P NATL ACAD SCI USA, V98, P6629, DOI 10.1073/pnas.111164298; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Senawongse P, 2005, J CHEM INF MODEL, V45, P1147, DOI 10.1021/ci050047+; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sun CS, 2004, BRAIN RES, V1029, P207, DOI 10.1016/j.brainres.2004.09.056; Tang X, 2010, J NEUROPHYSIOL, V103, P1007, DOI 10.1152/jn.00801.2009; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Tretter V, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.007.2008; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007	55	74	77	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41795	41805		10.1074/jbc.M110.149229	http://dx.doi.org/10.1074/jbc.M110.149229			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20940303	Green Published, hybrid			2022-12-25	WOS:000285622600067
J	Chen, SR; Chen, H; Yuan, WX; Wess, J; Pan, HL				Chen, Shao-Rui; Chen, Hong; Yuan, Wei-Xiu; Wess, Juergen; Pan, Hui-Lin			Dynamic Control of Glutamatergic Synaptic Input in the Spinal Cord by Muscarinic Receptor Subtypes Defined Using Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL-HORN NEURONS; ACETYLCHOLINE-RECEPTOR; CHOLINERGIC RECEPTORS; AUTORADIOGRAPHIC LOCALIZATION; PROJECTION NEURONS; GABA(B) RECEPTORS; GLYCINERGIC INPUT; NEUROPATHIC PAIN; GABAERGIC INPUTS; TRANSMISSION	Activation of muscarinic acetylcholine receptors (mAChRs) in the spinal cord inhibits pain transmission. At least three mAChR subtypes (M-2, M-3, andM(4)) are present in the spinal dorsal horn. However, it is not clear how each mAChR subtype contributes to the regulation of glutamatergic input to dorsal horn neurons. We recorded spontaneous excitatory postsynaptic currents (sEPSCs) from lamina II neurons in spinal cord slices from wild-type (WT) and mAChR subtype knock-out (KO) mice. The mAChR agonist oxotremorine-M increased the frequency of glutamatergic sEPSCs in 68.2% neurons from WT mice and decreased the sEPSC frequency in 21.2% neurons. Oxotremorine-M also increased the sEPSC frequency in similar to 50% neurons fromM(3)-single KO andM(1)/M-3 double-KO mice. In addition, the M-3 antagonist J104129 did not block the stimulatory effect of oxotremorine-M in the majority of neurons from WT mice. Strikingly, in M-5-single KO mice, oxotremorine-M increased sEPSCs in only 26.3% neurons, and J104129 abolished this effect. InM2/M-4 double-KO mice, but not M-2-or M-4-single KO mice, oxotremorine-M inhibited sEPSCs in significantly fewer neurons compared with WT mice, and blocking group II/III metabotropic glutamate receptors abolished this effect. The M-2/M-4 antagonist himbacine either attenuated the inhibitory effect of oxotremorine-M or potentiated the stimulatory effect of oxotremorine-M in WT mice. Our study demonstrates that activation of the M-2 and M-4 receptor subtypes inhibits synaptic glutamate release to dorsal horn neurons. M-5 is the predominant receptor subtype that potentiates glutamatergic synaptic transmission in the spinal cord.	[Chen, Shao-Rui] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, Houston, TX 77030 USA; [Wess, Juergen] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chen, SR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	schen@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM64830, NS45602]; N.G. and Helen T. Hawkins endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N.G. and Helen T. Hawkins endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grants GM64830 and NS45602 from the National Institutes of Health and by the N.G. and Helen T. Hawkins endowment (to H.-L. P.).	ALLEN TGJ, 1993, J PHYSIOL-LONDON, V466, P173; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Chen SR, 2005, J PHARMACOL EXP THER, V313, P765, DOI 10.1124/jpet.104.082537; Chen SR, 2004, NEUROSCIENCE, V125, P141, DOI 10.1016/j.neuroscience.2004.01.015; Chen SR, 2003, J PHARMACOL EXP THER, V307, P676, DOI 10.1124/jpet.103.055905; Chen YP, 2005, J PHARMACOL EXP THER, V315, P696, DOI 10.1124/jpet.105.091314; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Doller D, 1999, BIOORG MED CHEM LETT, V9, P901, DOI 10.1016/S0960-894X(99)00101-8; Duttaroy A, 2002, MOL PHARMACOL, V62, P1084, DOI 10.1124/mol.62.5.1084; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Gautam D, 2004, MOL PHARMACOL, V66, P260, DOI 10.1124/mol.66.2.260; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; Hoglund AU, 1997, J PHARMACOL EXP THER, V281, P470; Hood DD, 1997, J PHARMACOL EXP THER, V282, P86; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; MCKINNEY M, 1993, PROG BRAIN RES, V98, P333; MILLER JH, 1992, J PHARMACOL EXP THER, V263, P663; Mitsuya M, 1999, BIOORGAN MED CHEM, V7, P2555, DOI 10.1016/S0968-0896(99)00177-7; Nakayama M, 2001, J CLIN ANESTH, V13, P86, DOI 10.1016/S0952-8180(01)00218-5; Oki T, 2005, MOL BRAIN RES, V133, P6, DOI 10.1016/j.molbrainres.2004.09.012; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; RIBEIRODASILVA A, 1990, J COMP NEUROL, V295, P370, DOI 10.1002/cne.902950303; SCATTON B, 1984, NEUROSCI LETT, V49, P239, DOI 10.1016/0304-3940(84)90296-9; Schoppa NE, 1997, J NEUROPHYSIOL, V78, P1468, DOI 10.1152/jn.1997.78.3.1468; VILLIGER JW, 1985, BRAIN RES, V345, P196, DOI 10.1016/0006-8993(85)90854-6; Wang XL, 2006, J PHYSIOL-LONDON, V571, P403, DOI 10.1113/jphysiol.2005.102905; WANKE E, 1994, EUR J NEUROSCI, V6, P381, DOI 10.1111/j.1460-9568.1994.tb00281.x; WEI J, 1994, J NEUROCHEM, V63, P815; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; WETTS R, 1994, NEUROSCIENCE, V63, P1117, DOI 10.1016/0306-4522(94)90577-0; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; YAMAMURA HI, 1983, EUR J PHARMACOL, V91, P147, DOI 10.1016/0014-2999(83)90379-5; Yung KKL, 1997, NEUROSCI LETT, V229, P81, DOI 10.1016/S0304-3940(97)00426-6; Zhang HM, 2009, NEUROSCIENCE, V158, P875, DOI 10.1016/j.neuroscience.2008.10.042; Zhang HM, 2006, MOL PHARMACOL, V69, P1048, DOI 10.1124/mol.105.018069; Zhang HM, 2005, J PHARMACOL EXP THER, V313, P697, DOI 10.1124/jpet.104.079939; Zhang HM, 2007, J PHARMACOL EXP THER, V323, P963, DOI 10.1124/jpet.107.127795; Zhang HM, 2007, J NEUROPHYSIOL, V97, P102, DOI 10.1152/jn.00586.2006; Zhou HY, 2008, J PHARMACOL EXP THER, V324, P1000, DOI 10.1124/jpet.107.133470; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; ZHUO M, 1991, PAIN, V46, P211, DOI 10.1016/0304-3959(91)90078-C	44	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40427	40437		10.1074/jbc.M110.176966	http://dx.doi.org/10.1074/jbc.M110.176966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20940295	Green Published, hybrid			2022-12-25	WOS:000285414400005
J	Yang, Y; Koo, S; Lin, CS; Neu, B				Yang, Yang; Koo, Stephanie; Lin, Cheryl Shuyi; Neu, Bjoern			Specific Binding of Red Blood Cells to Endothelial Cells Is Regulated by Nonadsorbing Macromolecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLSERINE-POSITIVE ERYTHROCYTES; MEMBRANE PHOSPHOLIPID ASYMMETRY; VASCULAR ENDOTHELIUM; DEPLETION FLOCCULATION; ADHESION; ADHERENCE; DEXTRAN; DISEASE; ELECTROPHORESIS; AGGREGATION	Abnormal adhesion of red blood cells to the endothelium has been linked to the pathophysiology of several diseases associated with vascular disorders. Various biochemical changes, including phosphatidylserine exposure on the outer membrane of red blood cells as well as plasma protein levels, have been identified as being likely to play a key role, but the detailed interplay between plasma factors and cellular factors remains unknown. It has been proposed that the adhesion-promoting effect of plasma proteins originates from ligand interaction, but evidence substantiating this assumption is often missing. In this work, we identified an alternative pathway by demonstrating that nonadsorbing macromolecules can also have a marked impact on the adhesion efficiency of red blood cells with enhanced phosphatidylserine exposure to endothelial cells. It is concluded that this adhesion-promoting effect originates from macromolecular depletion interaction and thereby presents an alternative mechanism by which plasma proteins could regulate cell-cell interactions. These findings should thus be of potential value for a detailed understanding of the pathophysiology of diseases associated with vascular complications and might be applicable to a wide range of cell-cell interactions in plasma or plasma-like media.	[Yang, Yang; Koo, Stephanie; Lin, Cheryl Shuyi; Neu, Bjoern] Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Neu, B (corresponding author), Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, 70 Nanyang Dr, Singapore 639798, Singapore.	neu@ntu.edu.sg	Neu, Bjoern/G-6213-2010		Ministry of Education (Singapore); Biomedical Research Council A*Star (Singapore)	Ministry of Education (Singapore)(Ministry of Education, Singapore); Biomedical Research Council A*Star (Singapore)(Agency for Science Technology & Research (A*STAR))	This work was supported by grants from the Ministry of Education (Singapore) and from the Biomedical Research Council A*Star (Singapore).	Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baumler H, 1996, BIORHEOLOGY, V33, P333, DOI 10.1016/0006-355X(96)00026-1; BAUMLER H, 1987, STUD BIOPHYS, V120, P113; BELL GI, 1984, BIOPHYS J, V45, pA24; Betal SG, 2008, TRANSL RES, V152, P165, DOI 10.1016/j.trsl.2008.07.007; Bonomini M, 2002, KIDNEY INT, V62, P1358, DOI 10.1046/j.1523-1755.2002.00560.x; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; BUXBAUM K, 1982, BIOCHEMISTRY-US, V21, P3235, DOI 10.1021/bi00256a032; Closse C, 1999, BRIT J HAEMATOL, V107, P300, DOI 10.1046/j.1365-2141.1999.01718.x; FEIGIN RI, 1980, J COLLOID INTERF SCI, V75, P525, DOI 10.1016/0021-9797(80)90475-0; Frenette PS, 2007, J CLIN INVEST, V117, P850, DOI 10.1172/JCI30920; Gallagher PG, 2003, BLOOD, V101, P4625, DOI 10.1182/blood-2001-12-0329; Guchhait P, 2007, HAEMATOLOGICA, V92, P1266, DOI 10.3324/haematol.11379; Hebbel RP, 2008, TRANSFUS CLIN BIOL, V15, P14, DOI 10.1016/j.tracli.2008.03.011; Hebbel RP, 2004, MICROCIRCULATION, V11, P129, DOI 10.1080/10739680490278402; HEBBEL RP, 1981, BLOOD, V58, P947; HEBBEL RP, 1980, J CLIN INVEST, V65, P154, DOI 10.1172/JCI109646; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; Jenkins P, 1996, LANGMUIR, V12, P3107, DOI 10.1021/la940901j; Kuypers FA, 1996, BLOOD, V87, P1179, DOI 10.1182/blood.V87.3.1179.bloodjournal8731179; Kuypers FA, 1996, AM J HEMATOL, V51, P45, DOI 10.1002/(SICI)1096-8652(199601)51:1<45::AID-AJH8>3.0.CO;2-7; Neu B, 2003, BIOPHYS J, V85, P75, DOI 10.1016/S0006-3495(03)74456-7; Neu B, 2002, BIOPHYS J, V83, P2482, DOI 10.1016/S0006-3495(02)75259-4; Neu B, 2001, BIORHEOLOGY, V38, P53; Rad S, 2009, ELECTROPHORESIS, V30, P450, DOI 10.1002/elps.200800318; RICHARDSON SGN, 1979, BRIT J HAEMATOL, V41, P95, DOI 10.1111/j.1365-2141.1979.tb03685.x; Setty BNY, 2008, BLOOD, V111, P905, DOI 10.1182/blood-2007-07-099465; Setty BNY, 2002, BLOOD, V99, P1564, DOI 10.1182/blood.V99.5.1564; Shiu YT, 2003, ANN BIOMED ENG, V31, P1299, DOI 10.1114/1.1630320; VINCENT B, 1990, COLLOID SURFACE, V50, P241, DOI 10.1016/0166-6622(90)80267-8; VINCENT B, 1986, COLLOID SURFACE, V18, P261, DOI 10.1016/0166-6622(86)80317-1; Wandersee NJ, 2005, BRIT J HAEMATOL, V131, P366, DOI 10.1111/j.1365-2141.2005.05767.x; Wautier JL, 2004, CIRC RES, V95, P233, DOI 10.1161/01.RES.0000137876.28454.64; WAUTIER JL, 1983, J LAB CLIN MED, V101, P911; WAUTIER JL, 1981, NEW ENGL J MED, V305, P237, DOI 10.1056/NEJM198107303050501; Wood BL, 1996, BLOOD, V88, P1873; Yang Y, 2010, LANGMUIR, V26, P2680, DOI 10.1021/la902977y; Zhang ZWW, 2009, BIOPHYS J, V97, P1031, DOI 10.1016/j.bpj.2009.06.006	39	23	24	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40489	40495		10.1074/jbc.M110.116608	http://dx.doi.org/10.1074/jbc.M110.116608			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952392	Green Published, hybrid			2022-12-25	WOS:000285414400011
J	Murphy, BA; Bunda, S; Mitts, T; Hinek, A				Murphy, Brooke A.; Bunda, Severa; Mitts, Thomas; Hinek, Aleksander			The Hyperthermia-enhanced Association between Tropoelastin and Its 67-kDa Chaperone Results in Better Deposition of Elastic Fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROVIRALLY MEDIATED OVEREXPRESSION; FORMATION IN-VITRO; BINDING-PROTEIN; EXTRACELLULAR-MATRIX; COSTELLO-SYNDROME; BETA-GALACTOSIDASE; SPLICED VARIANT; IMPAIRED ELASTOGENESIS; INFRARED RADIATION; HURLER-DISEASE	The results of our in vitro experiments indicate that exposing cultured human aortic smooth muscle cells and dermal fibroblasts to 39 to 41 degrees C induces a significant up-regulation in the net deposition of elastic fibers, but not of collagen I or fibronectin, and also decreases the deposition of chondroitin sulfate-containing moieties. We further demonstrate that mild hyperthermia also rectifies the insufficient elastogenesis notable in cultures of fibroblasts derived from the stretch-marked skin of adult patients and in cultures of dermal fibroblasts from children with Costello syndrome, which is characterized by the accumulation of chondroitin 6-sulfate glycosaminoglycans that induce shedding and inactivation of the 67-kDa elastin-binding protein. We have previously established that this protein serves as a reusable chaperone for tropoelastin and that its recycling is essential for the normal deposition of elastic fibers. We now report that hyperthermia not only inhibits deposition of chondroitin 6-sulfate moieties and the consequent preservation of elastin-binding protein molecules but also induces their faster recycling. This, in turn, triggers a more efficient preservation of tropoelastin, enhancement of its secretion and extracellular assembly into elastic fibers. The presented results encourage using mild hyperthermia to restore elastic fiber production in damaged adult skin and to enhance elastogenesis in children with genetic elastinopathies.	[Murphy, Brooke A.; Bunda, Severa; Hinek, Aleksander] Univ Toronto, Hosp Sick Children, Cardiovasc Res Program, Toronto, ON M5G 1X8, Canada; [Hinek, Aleksander] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada; [Mitts, Thomas] Human Matrix Sci LLC, Visalia, CA 93291 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Hinek, A (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	alek.hinek@sickkids.on.ca	Hinek, Aleksander/V-8790-2019		Canadian Institute of Health Research [PG 13920]; Heart and Stroke Foundation of Ontario [NA 4381]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by Canadian Institute of Health Research Grant PG 13920 and Heart and Stroke Foundation of Ontario Grant NA 4381 (to A.H.).	Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Arribas SM, 2006, PHARMACOL THERAPEUT, V111, P771, DOI 10.1016/j.pharmthera.2005.12.003; Bunda S, 2009, J BIOL CHEM, V284, P16633, DOI 10.1074/jbc.M109.008748; Chen Z, 2005, J INVEST DERMATOL, V124, P70, DOI 10.1111/j.0022-202X.2004.23550.x; Chen Z, 2009, PHOTODERMATOL PHOTO, V25, P310, DOI 10.1111/j.1600-0781.2009.00465.x; Cho S, 2009, J INVEST DERM SYMP P, V14, P15, DOI 10.1038/jidsymp.2009.7; Costello JM, 1996, AM J MED GENET, V62, P199, DOI 10.1002/ajmg.1320620203; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; Hendershot LM, 2000, CURR BIOL, V10, pR912, DOI 10.1016/S0960-9822(00)00850-2; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hinek A, 2000, AM J HUM GENET, V66, P859, DOI 10.1086/302829; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; Hinek A, 2000, AM J HUM GENET, V67, P23, DOI 10.1086/302968; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; Hinek A, 1995, CIBA F SYMP, V192, P185; Huang R, 2006, CIRC RES, V98, P370, DOI 10.1161/01.RES.0000202051.28319.c8; Hwang JY, 2008, AM J PATHOL, V173, P1919, DOI 10.2353/ajpath.2008.070875; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kielty CM, 2002, J CELL SCI, V115, P2817; LEE KS, 1994, CLIN EXP DERMATOL, V19, P285, DOI 10.1111/j.1365-2230.1994.tb01196.x; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; Merrilees MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-41; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Mitts TF, 2010, J INVEST DERMATOL, V130, P2396, DOI 10.1038/jid.2010.155; Mitts Thomas F, 2005, Aesthet Surg J, V25, P593, DOI 10.1016/j.asj.2005.09.004; Morrone A, 2000, HUM MUTAT, V15, P354, DOI 10.1002/(SICI)1098-1004(200004)15:4<354::AID-HUMU8>3.3.CO;2-C; MUSTO L, 1996, J HISTOTECHNOL, V9, P173; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Nollen EAA, 2002, J CELL SCI, V115, P2809; O'Brien KD, 2004, ATHEROSCLEROSIS, V177, P29, DOI 10.1016/j.atherosclerosis.2004.07.007; Park HG, 2005, CELL MOL LIFE SCI, V62, P10, DOI 10.1007/s00018-004-4208-7; Patterson CE, 2000, MOL BIOL CELL, V11, P3925, DOI 10.1091/mbc.11.11.3925; PIERAGGI MT, 1982, VIRCHOWS ARCH A, V396, P279, DOI 10.1007/BF00431387; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; Rissmann A, 2002, KLIN PADIATR, V214, P132, DOI 10.1055/s-2002-30149; Ritz-Timme S, 2003, BRIT J DERMATOL, V149, P951, DOI 10.1111/j.1365-2133.2003.05618.x; Starcher B, 1999, CONNECT TISSUE RES, V40, P273, DOI 10.3109/03008209909000705; Trautinger F, 2001, J PHOTOCH PHOTOBIO B, V63, P70, DOI 10.1016/S1011-1344(01)00203-2; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; WEGROWSKI Y, 1993, FEBS LETT, V334, P121, DOI 10.1016/0014-5793(93)81695-V; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052; Wight TN, 1997, AM J PATHOL, V151, P963; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Wust P, 2007, HEALTH PHYS, V92, P565, DOI 10.1097/01.HP.0000258918.36430.a3; Zouboulis CC, 2003, HAUTARZT, V54, P825, DOI 10.1007/s00105-003-0581-7	52	2	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40282	40293		10.1074/jbc.M110.169656	http://dx.doi.org/10.1074/jbc.M110.169656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947500	hybrid, Green Published			2022-12-25	WOS:000285185500071
J	Petrusca, DN; Gu, YA; Adamowicz, JJ; Rush, NI; Hubbard, WC; Smith, PA; Berdyshev, EV; Birukov, KG; Lee, CH; Tuder, RM; Twigg, HL; Vandivier, RW; Petrache, I				Petrusca, Daniela N.; Gu, Yuan; Adamowicz, Jeremy J.; Rush, Natalia I.; Hubbard, Walter C.; Smith, Patricia A.; Berdyshev, Evgeni V.; Birukov, Konstantin G.; Lee, Chao-Hung; Tuder, Rubin M.; Twigg, Homer L., III; Vandivier, R. William; Petrache, Irina			Sphingolipid-mediated Inhibition of Apoptotic Cell Clearance by Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ENDOTHELIAL GROWTH-FACTOR; RHO FAMILY PROTEINS; CIGARETTE-SMOKE; PHOSPHATIDYLSERINE RECEPTOR; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; CERAMIDE; PHAGOCYTOSIS; ENGULFMENT	A decreased clearance of apoptotic cells (efferocytosis) by alveolar macrophages (AM) may contribute to inflammation in emphysema. The up-regulation of ceramides in response to cigarette smoking (CS) has been linked to AM accumulation and increased detection of apoptotic alveolar epithelial and endothelial cells in lung parenchyma. We hypothesized that ceramides inhibit the AM phagocytosis of apoptotic cells. Release of endogenous ceramides via sphingomyelinase or exogenous ceramide treatments dose-dependently impaired apoptotic Jurkat cell phagocytosis by primary rat or human AM, irrespective of the molecular species of ceramide. Similarly, in vivo augmentation of lung ceramides via intratracheal instillation in rats significantly decreased the engulfment of instilled target apoptotic thymocytes by resident AM. The mechanism of ceramide-induced efferocytosis impairment was dependent on generation of sphingosine via ceramidase. Sphingosine treatment recapitulated the effects of ceramide, dose-dependently inhibiting apoptotic cell clearance. The effect of ceramide on efferocytosis was associated with decreased membrane ruffle formation and attenuated Rac1 plasma membrane recruitment. Constitutively active Rac1 overexpression rescued AM efferocytosis against the effects of ceramide. CS exposure significantly increased AM ceramides and recapitulated the effect of ceramides on Rac1 membrane recruitment in a sphingosine-dependent manner. Importantly, CS profoundly inhibited AM efferocytosis via ceramide-dependent sphingosine production. These results suggest that excessive lung ceramides may amplify lung injury in emphysema by causing both apoptosis of structural cells and inhibition of their clearance by AM.	[Petrusca, Daniela N.] Indiana Univ, Div Pulm Allergy Crit Care & Occupat Med, Dept Med, Indianapolis, IN 46202 USA; [Hubbard, Walter C.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21287 USA; [Berdyshev, Evgeni V.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Lee, Chao-Hung] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Petrache, Irina] RL Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Tuder, Rubin M.; Vandivier, R. William] Univ Colorado, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Johns Hopkins University; University of Chicago; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Petrusca, DN (corresponding author), Indiana Univ, Div Pulm Allergy Crit Care & Occupat Med, Dept Med, Walther Hall R3 C400,980 W Walnut St, Indianapolis, IN 46202 USA.	ipetrach@iupui.edu	Birukov, Konstantin/FJB-5755-2022; Petrache, Irina/AAZ-9648-2020		National Institutes of Health [1 S10 RR16798]; American Heart Association [0826103G, RO1HL077328]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016798] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 S10 RR16798 ( to W. C. H. for funding the API4000 LCMS/MS system). This work was also supported by American Heart Association Grants 0826103G ( to D. N. P.) and RO1HL077328 ( to I. P.).	Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; CARP H, 1980, EXP LUNG RES, V1, P225, DOI 10.3109/01902148009065462; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Deigner HP, 2001, FASEB J, V15, P807, DOI 10.1096/fj.15.3.807; Demedts IK, 2005, CURR OPIN PHARMACOL, V5, P257, DOI 10.1016/j.coph.2004.12.005; Dobrowsky RT, 2001, METHOD CELL BIOL, V66, P135; ELLIS RE, 1991, GENETICS, V129, P79; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Gomez-Munoz A, 2004, FEBS LETT, V562, P5, DOI 10.1016/S0014-5793(04)00211-X; Hanna AN, 2001, MOL BIOL CELL, V12, P3618, DOI 10.1091/mbc.12.11.3618; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HED J, 1987, J IMMUNOL METHODS, V101, P119, DOI 10.1016/0022-1759(87)90224-9; Henson PM, 2008, AM J PHYSIOL-LUNG C, V294, pL601, DOI 10.1152/ajplung.00320.2007; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; Hinkovska-Galcheva V, 2005, J BIOL CHEM, V280, P26612, DOI 10.1074/jbc.M501359200; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Lee CK, 2006, PROTEOMICS, V6, P6455, DOI 10.1002/pmic.200600124; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Medler TR, 2008, AM J RESP CELL MOL, V38, P639, DOI 10.1165/rcmb.2007-0274OC; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Monick MM, 1998, AM J PHYSIOL-LUNG C, V275, pL389, DOI 10.1152/ajplung.1998.275.2.L389; Monick MM, 2001, J IMMUNOL, V167, P5977, DOI 10.4049/jimmunol.167.10.5977; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; OLIVERA A, 1992, J BIOL CHEM, V267, P26121; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2003, FASEB J, V17, P407, DOI 10.1096/fj.02-0672com; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rosen H, 2003, CURR OPIN CHEM BIOL, V7, P461, DOI 10.1016/S1367-5931(03)00085-1; Sakai M, 2000, BIOCHEM BIOPH RES CO, V278, P79, DOI 10.1006/bbrc.2000.3767; Schramm M, 2008, CELL MICROBIOL, V10, P1839, DOI 10.1111/j.1462-5822.2008.01169.x; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; Thompson CR, 2005, J IMMUNOL, V174, P3551, DOI 10.4049/jimmunol.174.6.3551; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Tuder RM, 2003, AM J RESP CELL MOL, V28, P551, DOI 10.1165/rcmb.F269; Twigg HL, 1999, AM J RESP CRIT CARE, V159, P1439, DOI 10.1164/ajrccm.159.5.9808031; Uller L, 2006, TRENDS PHARMACOL SCI, V27, P461, DOI 10.1016/j.tips.2006.07.006; Utermohlen O, 2003, J IMMUNOL, V170, P2621, DOI 10.4049/jimmunol.170.5.2621; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; Weigert A, 2006, BLOOD, V108, P1635, DOI 10.1182/blood-2006-04-014852; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006	56	59	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40322	40332		10.1074/jbc.M110.137604	http://dx.doi.org/10.1074/jbc.M110.137604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956540	hybrid, Green Published			2022-12-25	WOS:000285185500075
J	Tanaka, T; Yokoyama, M; Matsumoto, S; Fukatsu, R; You, ZY; Masai, H				Tanaka, Taku; Yokoyama, Mika; Matsumoto, Seiji; Fukatsu, Rino; You, Zhiying; Masai, Hisao			Fission Yeast Swi1-Swi3 Complex Facilitates DNA Binding of Mrc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; S-PHASE; CHECKPOINT RESPONSE; PRIA PROTEIN; DAMAGE; PROGRESSION; TIPIN; ACTIVATION; HELICASE; CLASPIN	Replication fork protection complex Swi1-Swi3 and replication checkpoint mediator Mrc1 are required for maintenance of replication fork integrity during the course of DNA replication in the fission yeast Schizosaccharomyces pombe. These proteins play crucial roles in stabilizing stalled forks and activating replication checkpoint signaling pathways. Although they are conserved replication fork components, precise biochemical roles of these proteins are not known. Here we purified Mrc1 and Swi1-Swi3 proteins and show that these proteins bind to DNA independently but synergistically in vitro. Mrc1 binds preferentially to arrested fork or D-loop-like structures, although the affinity is relatively low, whereas the Swi1-Swi3 complex binds to double-stranded DNA with higher affinity. In the presence of a low concentration of Swi1-Swi3, Mrc1 generates a novel ternary complex and binds to various types of DNA with higher affinity. Moreover, purified Mrc1 and Swi1-Swi3 physically interact with each other, and this interaction is lost by mutations in the known DNA binding domain of Mrc1 (K235E, K236E). The interaction is also lost in a mutant form of Swi1 (E662K) that is specifically defective in polar fork arrest at a site called RTS1 and causes sensitivity to genotoxic agents, although the DNA binding affinity of Swi1-Swi3 is not affected by this mutation. As expected, the synergistic effect of the Swi1-Swi3 on DNA binding of Mrc1 is also lost by these mutations affecting the interaction between Mrc1 and Swi1-Swi3. Our results reveal an aspect of molecular interactions that may play an important role in replication pausing and fork stabilization.	[Tanaka, Taku; Yokoyama, Mika; Matsumoto, Seiji; Fukatsu, Rino; You, Zhiying; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	masai-hs@igakuken.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by a grant-in-aid for scientific research on priority area "Chromosome Cycle" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Takeda Science Foundation; and the Astellas Foundation for Research on Metabolic Disorders (to H. M.).	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Cobb JA, 2004, CURR OPIN GENET DEV, V14, P292, DOI 10.1016/j.gde.2004.04.001; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Foss EJ, 2001, GENETICS, V157, P567; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Komata M, 2009, MOL CELL BIOL, V29, P5008, DOI 10.1128/MCB.01934-08; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumar S, 2009, MOL CELL BIOL, V29, P602, DOI 10.1128/MCB.01319-08; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Masai H, 2010, BIOESSAYS, V32, P687, DOI 10.1002/bies.200900196; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; Mizukoshi T, 2003, J BIOL CHEM, V278, P42234, DOI 10.1074/jbc.C300285200; Nitani N, 2006, GENETICS, V174, P155, DOI 10.1534/genetics.106.060053; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka T, 2002, J BIOL CHEM, V277, P38062, DOI 10.1074/jbc.M204397200; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; Yin L, 2008, MOL BIOL CELL, V19, P4374, DOI 10.1091/mbc.E08-01-0020; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhao H, 2004, J BIOL CHEM, V279, P53023, DOI 10.1074/jbc.M410449200	41	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39609	39622		10.1074/jbc.M110.173344	http://dx.doi.org/10.1074/jbc.M110.173344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20924116	hybrid, Green Published			2022-12-25	WOS:000285185500005
J	Velayos-Baeza, A; Levecque, C; Kobayashi, K; Holloway, ZG; Monaco, AP				Velayos-Baeza, Antonio; Levecque, Clotilde; Kobayashi, Kazuhiro; Holloway, Zoe G.; Monaco, Anthony P.			The Dyslexia-associated KIAA0319 Protein Undergoes Proteolytic Processing with gamma-Secretase-independent Intramembrane Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR INHIBITOR TYPE-1; END RULE PATHWAY; ALZHEIMERS-DISEASE; NEURONAL MIGRATION; RECEPTOR LIGANDS; GENE KIAA0319; MEMBRANE; METALLOPROTEINASES; PRESENILIN; ADAMS	The KIAA0319 gene has been associated with reading disability in several studies. It encodes a plasma membrane protein with a large, highly glycosylated, extracellular domain. This protein is proposed to function in adhesion and attachment and thought to play an important role during neuronal migration in the developing brain. We have previously proposed that endocytosis of this protein could constitute an important mechanism to regulate its function. Here we show that KIAA0319 undergoes ectodomain shedding and intramembrane cleavage. At least five different cleavage events occur, four in the extracellular domain and one within the transmembrane domain. The ectodomain shedding processing cleaves the extracellular domain, generating several small fragments, including the N-terminal region with the Cys-rich MANEC domain. It is possible that these fragments are released to the extracellular medium and trigger cellular responses. The intramembrane cleavage releases the intracellular domain from its membrane attachment. Our results suggest that this cleavage event is not carried out by gamma-secretase, the enzyme complex involved in similar processing in many other type I proteins. The soluble cytoplasmic domain of KIAA0319 is able to translocate to the nucleus, accumulating in nucleoli after overexpression. This fragment has an unknown role, although it could be involved in regulation of gene expression. The absence of DNA-interacting motifs indicates that such a function would most probably be mediated through interaction with other proteins, not by direct DNA binding. These results suggest that KIAA0319 not only has a direct role in neuronal migration but may also have additional signaling functions.	[Velayos-Baeza, Antonio; Levecque, Clotilde; Kobayashi, Kazuhiro; Holloway, Zoe G.; Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anthony.monaco@well.ox.ac.uk	Monaco, Anthony P/A-4495-2010; Kobayashi, Kazuhiro/AAH-8638-2021; Velayos-Baeza, Antonio/K-6310-2019	Monaco, Anthony P/0000-0001-7480-3197; Kobayashi, Kazuhiro/0000-0001-7801-147X; Velayos-Baeza, Antonio/0000-0002-7717-4477; Levecque, Clotilde/0000-0002-0519-337X	Wellcome Trust [076566/Z/05/Z, 075491/Z/04]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (076566/Z/05/Z; 075491/Z/04).	Andrews W, 2008, DEV BIOL, V313, P648, DOI 10.1016/j.ydbio.2007.10.052; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; Dennis MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000436; Fisher SE, 2006, TRENDS COGN SCI, V10, P250, DOI 10.1016/j.tics.2006.04.003; Gabel LA, 2010, NEUROBIOL DIS, V38, P173, DOI 10.1016/j.nbd.2009.06.019; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Guo JH, 2004, TRENDS BIOCHEM SCI, V29, P172, DOI 10.1016/j.tibs.2004.02.007; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Levecque C, 2009, AM J PHYSIOL-CELL PH, V297, pC160, DOI 10.1152/ajpcell.00630.2008; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McGrath LM, 2006, TRENDS MOL MED, V12, P333, DOI 10.1016/j.molmed.2006.05.007; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; Peschansky VJ, 2010, CEREB CORTEX, V20, P884, DOI 10.1093/cercor/bhp154; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Stockley JH, 2008, CELL MOL LIFE SCI, V65, P3265, DOI 10.1007/s00018-008-8271-3; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Velayos-Baeza A, 2008, HUM MOL GENET, V17, P859, DOI 10.1093/hmg/ddm358; Velayos-Baeza A, 2007, MAMM GENOME, V18, P627, DOI 10.1007/s00335-007-9051-3; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005	51	30	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40148	40162		10.1074/jbc.M110.145961	http://dx.doi.org/10.1074/jbc.M110.145961			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20943657	Green Published, hybrid			2022-12-25	WOS:000285185500060
J	Kramara, J; Willcox, S; Gunisova, S; Kinsky, S; Nosek, J; Griffith, JD; Tomaska, L				Kramara, Juraj; Willcox, Smaranda; Gunisova, Stanislava; Kinsky, Slavomir; Nosek, Jozef; Griffith, Jack D.; Tomaska, Lubomir			Tay1 Protein, a Novel Telomere Binding Factor from Yarrowia lipolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; MAMMALIAN TELOMERES; SEQUENCE; TRANSCRIPTION; CONSERVATION; COMPLEX; DOMAIN; TRF1; END; IDENTIFICATION	Inspection of the complete genome of the yeast Yarrowia lipolytica for the presence of genes encoding homologues of known telomere-binding proteins surprisingly revealed no counterparts of typical yeast Myb domain-containing telomeric factors including Rap1 or Taz1. Instead, we identified a gene, YALIOD10923g, encoding a protein containing two Myb domains, exhibiting a high degree of similarity to the Myb domain of human telomeric proteins TRF1 and TRF2 and homologous to an essential fission yeast protein Mug152 whose expression is elevated during meiosis. The protein, which we named Tay1p (telomere-associated in Yarrowia lipolytica 1), was purified for biochemical studies. Using a model Y. lipolytica telomere, we demonstrate that the protein preferentially binds to Y. lipolytica telomeric tracts. Tay1p binds along the telomeric tract as dimers and larger oligomers, and it is able to remodel the telomeric DNA into both looped structures and synaptic complexes of two model telomere DNAs. The ability of Tay1p to induce dimerization of telomeres in vitro goes in line with its oligomeric nature, where each oligomer can employ several Myb domains to form intermolecular telomere clusters. We also provide experimental evidence that Tay1p may be associated with Y. lipolytica telomeres in vivo. Together with its homologues from Schizosaccharomyces pombe and several basidiomycetous fungi (Sanchez-Alonso, P., and Guzman, P. (2008) Fungal Genet. Biol. 45, S54-S62), Tay1p constitutes a novel family of putative telomeric factors whose analysis may be instrumental in understanding the function and evolution of double-stranded DNA telomeric proteins.	[Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Comenius Univ, Fac Nat Sci, Dept Genet, Bratislava 84215, Slovakia; Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Comenius University Bratislava; Comenius University Bratislava	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Mason Farm Rd,CB7095, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu; tomaska@fns.uniba.sk	Nosek, Jozef/A-7581-2008; Gunišová, Stanislava/I-1765-2014; Kinsky, Slavomir/G-6312-2014; Tomaska, Lubomir/I-3071-2014	Nosek, Jozef/0000-0002-1020-5451; Tomaska, Lubomir/0000-0003-4886-1910	National Institutes of Health [GM31819, ES013773, TW005654]; Howard Hughes Medical Institute [55005622]; Agentura na podporu vyskumu a vyvoja [20-001604, 0024-07]; Vedecta grantova agentura [1/0132/09, 1/0219/08]; SAIA (Slovak Academy Information Agency); Europsky fond regionalneho rozvoja; Slovak Academy Information Agency; FOGARTY INTERNATIONAL CENTER [R03TW005654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agentura na podporu vyskumu a vyvoja; Vedecta grantova agentura; SAIA (Slovak Academy Information Agency); Europsky fond regionalneho rozvoja; Slovak Academy Information Agency; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31819, ES013773, and TW005654 (to J.D.G.). This work was also supported by Howard Hughes Medical Institute Grant 55005622 (to J.N.) and Slovak grant agencies Agentura na podporu vyskumu a vyvoja (20-001604 (to L. T.) and 0024-07 (J.N.)) and Vedecta grantova agentura 1/0132/09 (to L. T.) and 1/0219/08 (to J.N.). J. K. was supported by a travel fellowship from SAIA (Slovak Academy Information Agency). This contribution/publication is the result of the project implementation: "Centre of excellence for exploitation of informational biomacromolecules in the disease prevention and improvement of quality of life" supported by the Research and Development Operational Programme funded by the Europsky fond regionalneho rozvoja.; Supported by a travel fellowship from the Slovak Academy Information Agency.	ARNDT KT, 1987, SCIENCE, V237, P874, DOI 10.1126/science.3303332; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Brandt U, 2005, BIOCHEM SOC T, V33, P840, DOI 10.1042/BST0330840; Casaregola S, 2000, FEBS LETT, V487, P95, DOI 10.1016/S0014-5793(00)02288-2; Chen DC, 1997, APPL MICROBIOL BIOT, V48, P232, DOI 10.1007/s002530051043; Cockell MM, 2009, EUKARYOT CELL, V8, P207, DOI 10.1128/EC.00174-08; Cohn M, 1998, CURR GENET, V33, P83, DOI 10.1007/s002940050312; Cohn M, 2006, TOP CURR GENET, V15, P101, DOI 10.1007/4735_106; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAIGNANFORNIER B, 1992, P NATL ACAD SCI USA, V89, P6746, DOI 10.1073/pnas.89.15.6746; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Denis V, 1998, MOL GEN GENET, V259, P246, DOI 10.1007/s004380050810; Denis V, 1998, MOL MICROBIOL, V30, P557, DOI 10.1046/j.1365-2958.1998.01087.x; Drummond AJ, 2009, GENEIOUS VERSION 4 8; Edso JR, 2008, FEMS YEAST RES, V8, P1289, DOI 10.1111/j.1567-1364.2008.00431.x; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Gunisova S, 2009, RNA, V15, P546, DOI 10.1261/rna.1194009; Hogues H, 2008, MOL CELL, V29, P552, DOI 10.1016/j.molcel.2008.02.006; Kanoh J, 2003, CELL MOL LIFE SCI, V60, P2295, DOI 10.1007/s00018-003-3245-y; Kinsky S, 2010, CURR GENET, V56, P413, DOI 10.1007/s00294-010-0310-6; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; KOVAC L, 1968, BIOCHIM BIOPHYS ACTA, V153, P32, DOI 10.1016/0005-2728(68)90143-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Lue NF, 2010, TRENDS BIOCHEM SCI, V35, P8, DOI 10.1016/j.tibs.2009.08.006; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nicholas K. B., 1997, EMBNET NEWS, V4, P14; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; NUTTLEY WM, 1994, J BIOL CHEM, V269, P556; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; PERTUISET B, 1995, CURR GENET, V27, P123, DOI 10.1007/BF00313425; Pitt CW, 2008, J BIOL CHEM, V283, P2693, DOI 10.1074/jbc.M708784200; Rhodin J, 2006, J MOL BIOL, V355, P335, DOI 10.1016/j.jmb.2005.10.078; RHODINEDSO J, 2009, THESIS LUND U; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-Alonso P, 2008, FUNGAL GENET BIOL, V45, pS54, DOI 10.1016/j.fgb.2008.04.009; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Springer C, 1996, J BIOL CHEM, V271, P29637, DOI 10.1074/jbc.271.47.29637; Stansel RM, 2001, EMBO J, V20, P5532; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Szabo R, 1999, FOLIA MICROBIOL, V44, P19, DOI 10.1007/BF02816215; SZABO R, 2001, THESIS COMENIUS U BR; Teixeira MT, 2005, CHROMOSOME RES, V13, P535, DOI 10.1007/s10577-005-0999-0; Tomaska L, 2004, J BIOL CHEM, V279, P50764, DOI 10.1074/jbc.M409790200; Tomita K, 2007, CELL, V130, P113, DOI 10.1016/j.cell.2007.05.024; VANATTIKUM H, 2010, EPIGENOMICS; Vassetzky NS, 1999, NUCLEIC ACIDS RES, V27, P4687, DOI 10.1093/nar/27.24.4687; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	63	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38078	38092		10.1074/jbc.M110.127605	http://dx.doi.org/10.1074/jbc.M110.127605			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923774	Green Published, hybrid			2022-12-25	WOS:000284625600016
J	Nakano, N; Itoh, S; Watanabe, Y; Maeyama, K; Itoh, F; Kato, M				Nakano, Naoko; Itoh, Susumu; Watanabe, Yukihide; Maeyama, Kota; Itoh, Fumiko; Kato, Mitsuyasu			Requirement of TCF7L2 for TGF-beta-dependent Transcriptional Activation of the TMEPAI Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; NEDD4-BINDING PROTEIN; SIGNALING PATHWAYS; WNT; PROMOTER; CANCER; EXPRESSION; SMAD4; BINDING; PMEPA1	The TGF-beta and Wnt pathways are involved in cell fate and tumorigenicity. A recent report indicated that a TGF-beta target gene, TMEPAI (transmembrane prostate androgen-induced RNA), is possibly also a downstream target of Wnt signaling. Although TMEPAI was believed to be involved in tumorigenicity because of its blockage of TGF-beta signaling, how TGF-beta and Wnt signals affect the activation of the TMEPAI gene is not well understood. Herein, we show that the TMEPAI promoter is regulated synergistically by TGF-beta/Smad and Wnt/beta-catenin/T cell factor (TCF) 7L2. The critical cis-element for dual signals, termed TGF-beta-responsive TCF7L2-binding element (TTE), is located in intron 1 of the TMEPAI gene. TCF7L2, but not Smad proteins, bound to TTE, whereas the disruption of TTE by mutagenesis remarkably counteracted both TGF-beta and TCF7L2 responses. The introduction of mutations in critical Smad-binding elements blocked the activation of the TMEPAI promoter by TCF7L2. Furthermore, our DNA-protein interaction experiments revealed the indirect binding of TCF7L2 to Smad-binding elements via Smad3 upon TGF-beta stimulation as well as its TGF-beta-dependent association with TTE. We demonstrate that the Wnt/beta-catenin/TCF7L2 pathway is preferentially able to alter the transcriptional regulation of the TGF-beta-target gene, TMEPAI.	[Nakano, Naoko; Itoh, Susumu] Showa Pharmaceut Univ, Biochem Lab, Tokyo 1948543, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Expt Pathol, Tsukuba, Ibaraki 3058575, Japan; [Nakano, Naoko; Itoh, Susumu] Showa Pharmaceut Univ, High Technol Res Ctr, Tokyo 1948543, Japan	Showa Pharmaceutical University; University of Tsukuba; Showa Pharmaceutical University	Itoh, S (corresponding author), Showa Pharmaceut Univ, Biochem Lab, 3-3165 Higashi Tamagawa Gakuen, Tokyo 1948543, Japan.	sitoh@ac.shoyaku.ac.jp		Itoh, Fumiko/0000-0002-6134-5331; Itoh, Susumu/0000-0002-7967-0730	Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Japan Chemical Industry Association;  [17390073];  [20012007];  [21590328]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Chemical Industry Association; ; ; 	This work was supported by Grants-in-aid for Scientific Research 17390073, 20012007, and 21590328 (to M.K. and S.I.), the Takeda Science Foundation (to S.I.), a Genome Network Project grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M.K.), a grant-in-aid for Japan Society for the Promotion of Science Fellows (to Y.W. and F.I.), and a long range research initiative grant from the Japan Chemical Industry Association (to M.K.).	Anazawa Y, 2004, ONCOGENE, V23, P7621, DOI 10.1038/sj.onc.1207270; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brunschwig EB, 2003, CANCER RES, V63, P1568; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Giannini G, 2003, MOL CARCINOGEN, V38, P188, DOI 10.1002/mc.10162; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hirota M, 2008, CELL SIGNAL, V20, P1632, DOI 10.1016/j.cellsig.2008.05.003; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Noda D, 2006, ONCOGENE, V25, P5591, DOI 10.1038/sj.onc.1209571; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Rae FK, 2001, MOL CARCINOGEN, V32, P44, DOI 10.1002/mc.1063; Reichling T, 2005, CANCER RES, V65, P166; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sasaki T, 2003, CANCER RES, V63, P801; Szeto DR, 2004, DEVELOPMENT, V131, P3751, DOI 10.1242/dev.01236; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Weerkamp F, 2006, TRENDS IMMUNOL, V27, P125, DOI 10.1016/j.it.2006.01.006; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Xu LL, 2003, CANCER RES, V63, P4299; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280	44	38	38	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38023	38033		10.1074/jbc.M110.132209	http://dx.doi.org/10.1074/jbc.M110.132209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889500	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000284625600010
J	Yang, Y; Shi, WW; Cui, NR; Wu, ZY; Jiang, C				Yang, Yang; Shi, Weiwei; Cui, Ningren; Wu, Zhongying; Jiang, Chun			Oxidative Stress Inhibits Vascular K-ATP Channels by S-Glutathionylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNEL; PROTEIN-KINASE-C; SMOOTH-MUSCLE; KIR6.1/SUR2B CHANNEL; REDOX REGULATION; NITRIC-OXIDE; KAPPA-B; ACTIVATION; NITROSYLATION; EXPRESSION	The K-ATP channel is an important player in vascular tone regulation. Its opening and closure lead to vasodilation and vasoconstriction, respectively. Such functions may be disrupted in oxidative stress seen in a variety of cardiovascular diseases, while the underlying mechanism remains unclear. Here, we demonstrated that S-glutathionylation was a modulation mechanism underlying oxidant-mediated vascular K-ATP channel regulation. An exposure of isolated mesenteric rings to hydrogen peroxide (H2O2) impaired the K-ATP channel-mediated vascular dilation. In whole-cell recordings and inside-out patches, H2O2 or diamide caused a strong inhibition of the vascular K-ATP channel (Kir6.1/SUR2B) in the presence, but not in the absence, of glutathione (GSH). Similar channel inhibition was seen with oxidized glutathione (GSSG) and thiol-modulating reagents. The oxidant-mediated channel inhibition was reversed by the reducing agent dithiothreitol (DTT) and the specific deglutathionylation reagent glutaredoxin-1 (Grx1). Consistent with S-glutathionylation, streptavidin pull-down assays with biotinylated glutathione ethyl ester (BioGEE) showed incorporation of GSH to the Kir6.1 subunit in the presence of H2O2. These results suggest that S-glutathionylation is an important mechanism for the vascular K-ATP channel modulation in oxidative stress.	[Yang, Yang; Shi, Weiwei; Cui, Ningren; Wu, Zhongying; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30302 USA.	cjiang@gsu.edu	Yang, Yang/B-3440-2008; SHI, WEIWEI/B-3477-2008	Yang, Yang/0000-0003-4275-0515; SHI, WEIWEI/0000-0001-6216-712X; Yang, Yang/0000-0001-6417-3654	National Institutes of Health [HD060959]; American Heart Association [09GRNT2010037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060959] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant HD060959 and the American Heart Association (09GRNT2010037).	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Ardanaz N, 2006, EXP BIOL MED, V231, P237; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Brown LAS, 2007, AM J PHYSIOL-LUNG C, V292, pL824, DOI 10.1152/ajplung.00346.2006; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cao K, 2002, BIOCHEM BIOPH RES CO, V296, P463, DOI 10.1016/S0006-291X(02)00892-6; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Erdos B, 2004, STROKE, V35, P964, DOI 10.1161/01.STR.0000119753.05670.F1; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Gutterman DD, 2005, ARTERIOSCL THROM VAS, V25, P671, DOI 10.1161/01.ATV.0000158497.09626.3b; Ichinari K, 1996, J MOL CELL CARDIOL, V28, P1867, DOI 10.1006/jmcc.1996.0179; Kil IS, 2008, BIOCHEM BIOPH RES CO, V373, P169, DOI 10.1016/j.bbrc.2008.06.007; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Miki T, 2005, J MOL CELL CARDIOL, V38, P917, DOI 10.1016/j.yjmcc.2004.11.019; Miura H, 2003, CIRC RES, V92, P151, DOI 10.1161/01.RES.0000052671.53256.49; Moran LK, 2001, CURR MED CHEM, V8, P763, DOI 10.2174/0929867013372904; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Shi WW, 2007, AM J PHYSIOL-REG I, V293, pR191, DOI 10.1152/ajpregu.00047.2007; Shi WW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.058313; Shi Y, 2008, J BIOL CHEM, V283, P7523, DOI 10.1074/jbc.M709941200; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; Sun XF, 2004, BIOCHEM PHARMACOL, V67, P147, DOI 10.1016/j.bcp.2003.08.041; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; Tricarico D, 2006, P NATL ACAD SCI USA, V103, P1118, DOI 10.1073/pnas.0505974103; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Waypa GB, 2006, CIRC RES, V99, P970, DOI 10.1161/01.RES.0000247068.75808.3f; Weintraub NL, 2003, CIRC RES, V92, P127, DOI 10.1161/01.RES.0000056965.71699.02; Yang Y, 2008, BBA-BIOMEMBRANES, V1778, P88, DOI 10.1016/j.bbamem.2007.08.030; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902	42	53	58	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38641	38648		10.1074/jbc.M110.162578	http://dx.doi.org/10.1074/jbc.M110.162578			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926382	Green Published, hybrid			2022-12-25	WOS:000284625600068
J	Kawano, T; Shimoda, M; Matsumoto, H; Ryuda, M; Tsuzuki, S; Hayakawa, Y				Kawano, Takeshi; Shimoda, Masami; Matsumoto, Hitoshi; Ryuda, Masasuke; Tsuzuki, Seiji; Hayakawa, Yoichi			Identification of a Gene, Desiccate, Contributing to Desiccation Resistance in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; GROWTH-BLOCKING PEPTIDE; STRESS; MECHANISMS; TRANSCRIPTION; RECEPTORS; TOLERANCE; EVOLUTION; RECOVERY; BINDING	Suitable alterations in gene expression are believed to allow animals to survive drastic changes in environmental conditions. Drosophila melanogaster larvae cease eating and exit moist food to search for dry pupation sites after the foraging stage in what is known as the wandering stage. Although the behavioral change from foraging to wandering causes desiccation stress, the mechanism by which Drosophila larvae protect themselves from desiccation remains obscure. Here, we identified a gene, CG14686 (designated as Desiccate (Desi)), whose expression was elevated during the wandering stage. The Desi expression level was reversibly decreased by transferring wandering larvae to wet conditions and increased again by transferring them to dry conditions. Elevation of Desi expression was also observed in foraging larvae when they were placed in dry conditions. Desi encoded a 261-amino acid single-pass transmembrane protein with notable motifs, such as SH2 and PDZ domain-binding motifs and a cAMP-dependent protein kinase phosphorylation motif, in the cytoplasmic region, and its expression was observed mainly in the epidermal cells of the larval integuments. Overexpression of Desi slightly increased the larval resistance to desiccation stress during the second instar. Furthermore, Desi RNAi larvae lost more weight under dry conditions, and subsequently, their mortalities significantly increased compared with control larvae. Under dry conditions, consumption of carbohydrate was much higher in Desi RNAi larvae than control larvae. Based on these results, it is reasonable to conclude that Desi contributes to the resistance of Drosophila larvae to desiccation stress.	[Hayakawa, Yoichi] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900065, Japan; [Shimoda, Masami] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Matsumoto, Hitoshi; Ryuda, Masasuke; Tsuzuki, Seiji; Hayakawa, Yoichi] Saga Univ, Dept Appl Biol Sci, Saga 8408502, Japan	Kagoshima University; National Institute of Agrobiological Sciences - Japan; Saga University	Hayakawa, Y (corresponding author), Honjo 1, Saga 8408502, Japan.	hayakayo@cc.saga-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y. H.).	Ainsley JA, 2008, DEV BIOL, V322, P46, DOI 10.1016/j.ydbio.2008.07.003; Beisenherz-Huss C, 2001, MOL CELL ENDOCRINOL, V183, P101, DOI 10.1016/S0303-7207(01)00588-3; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Folk DG, 2004, J EXP BIOL, V207, P2671, DOI 10.1242/jeb.01048; Folk DG, 2001, J EXP BIOL, V204, P3323; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; HAYAKAWA Y, 1982, INSECT BIOCHEM, V12, P361, DOI 10.1016/0020-1790(82)90032-4; Hayakawa Y, 2000, CELL TISSUE RES, V300, P459, DOI 10.1007/s004419900152; Marican C, 2004, INSECT BIOCHEM MOLEC, V34, P823, DOI 10.1016/j.ibmb.2004.05.002; Marron MT, 2003, J INSECT PHYSIOL, V49, P261, DOI 10.1016/S0022-1910(02)00287-1; Matsumoto Y, 2003, J BIOL CHEM, V278, P38579, DOI 10.1074/jbc.M305986200; Nishizaki T, 1998, BRAIN RES, V812, P242, DOI 10.1016/S0006-8993(98)00836-1; Oda Y, 2010, P NATL ACAD SCI USA, V107, P15862, DOI 10.1073/pnas.1003785107; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riddiford Lynn M., 1993, P899; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryuda M, 2008, APPL ENTOMOL ZOOL, V43, P563, DOI 10.1303/aez.2008.563; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Sorensen JG, 2007, J EVOLUTION BIOL, V20, P1624, DOI 10.1111/j.1420-9101.2007.01326.x; STANLEY PE, 1969, ANAL BIOCHEM, V29, P381, DOI 10.1016/0003-2697(69)90323-6; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Tammariello SP, 1999, J INSECT PHYSIOL, V45, P933, DOI 10.1016/S0022-1910(99)00073-6; Telonis-Scott M, 2003, J INSECT PHYSIOL, V49, P1013, DOI 10.1016/S0022-1910(03)00184-7; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0	29	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38889	38897		10.1074/jbc.M110.168864	http://dx.doi.org/10.1074/jbc.M110.168864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937803	hybrid, Green Published			2022-12-25	WOS:000284941300018
J	Pain, J; Balamurali, MM; Dancis, A; Pain, D				Pain, Jayashree; Balamurali, M. M.; Dancis, Andrew; Pain, Debkumar			Mitochondrial NADH Kinase, Pos5p, Is Required for Efficient Iron-Sulfur Cluster Biogenesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCTASE HOMOLOG ARH1P; YEAST FRATAXIN; PROTEIN TRANSLOCATION; GENE; IDENTIFICATION; GTP; MATURATION; SCAFFOLD; HOMEOSTASIS; COMPONENT	In Saccharomyces cerevisiae, the mitochondrial inner membrane readily allows transport of cytosolic NAD(+), but not NADPH, to the matrix. Pos5p is the only known NADH kinase in the mitochondrial matrix. The enzyme phosphorylates NADH to NADPH and is the major source of NADPH in the matrix. The importance of mitochondrial NADPH for cellular physiology is underscored by the phenotypes of the Delta pos5 mutant, characterized by oxidative stress sensitivity and iron-sulfur (Fe-S) cluster deficiency. Fe-S clusters are essential cofactors of proteins such as aconitase [4Fe-4S] and ferredoxin [2Fe-2S] in mitochondria. Intact mitochondria isolated from wild-type yeast can synthesize these clusters and insert them into the corresponding apoproteins. Here, we show that this process of Fe-S cluster biogenesis in wild-type mitochondria is greatly stimulated and kinetically favored by the addition of NAD(+) or NADH in a dose-dependent manner, probably via transport into mitochondria and subsequent conversion into NADPH. Unlike wild-type mitochondria, Delta pos5 mitochondria cannot efficiently synthesize Fe-S clusters on endogenous aconitase or imported ferredoxin, although cluster biogenesis in isolated Delta pos5 mitochondria is restored to a significant extent by a small amount of imported Pos5p. Interestingly, Fe-S cluster biogenesis in wild-type mitochondria is further enhanced by overexpression of Pos5p. The effects of Pos5p on Fe-S cluster generation in mitochondria indicate that one or more steps in the biosynthetic process require NADPH. The role of mitochondrial NADPH in Fe-S cluster biogenesis appears to be distinct from its function in anti-oxidant defense.	[Pain, Debkumar] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07101 USA; [Dancis, Andrew] Univ Penn, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania	Pain, D (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave,MSB I-669, Newark, NJ 07101 USA.	painde@umdnj.edu	MM, Balamurali/ABG-9767-2020	MM, Balamurali/0000-0001-7948-9950	National Institutes of Health, NIA [AG030504]; American Heart Association [09GRNT2260364];  [R37DK053953]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030504] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG030504 from NIA (to D. P.) and Grant R37DK053953 (to A. D.). This work was also supported by American Heart Association Grant 09GRNT2260364 (to D. P.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Amutha B, 2009, METHOD ENZYMOL, V456, P247, DOI 10.1016/S0076-6879(08)04414-5; Atkinson A, 2009, CHEM REV, V109, P4708, DOI 10.1021/cr900006y; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Gordon DM, 2001, HUM MOL GENET, V10, P259, DOI 10.1093/hmg/10.3.259; Gordon DM, 2006, BIOCHEM J, V400, P163, DOI 10.1042/BJ20060904; Gu YJ, 2005, J BIOL CHEM, V280, P18604, DOI 10.1074/jbc.M500847200; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Kawai S, 2001, FEMS MICROBIOL LETT, V200, P181, DOI 10.1111/j.1574-6968.2001.tb10712.x; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Kim R, 2001, J BIOL CHEM, V276, P17524, DOI 10.1074/jbc.M010695200; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; KREMS B, 1995, CURR GENET, V27, P427, DOI 10.1007/BF00311211; Labbe-Bois Rosine, 1994, V11, P413; Lacour T, 1998, J BIOL CHEM, V273, P23984, DOI 10.1074/jbc.273.37.23984; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Luttik MAH, 1998, J BIOL CHEM, V273, P24529, DOI 10.1074/jbc.273.38.24529; MCGUINNESS ET, 1985, INT J BIOCHEM, V17, P1, DOI 10.1016/0020-711X(85)90079-5; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Pedrajas JR, 2002, BIOCHEM J, V364, P617, DOI 10.1042/BJ20020570; Pedrajas JR, 1999, J BIOL CHEM, V274, P6366, DOI 10.1074/jbc.274.10.6366; Sepuri NBV, 1998, J BIOL CHEM, V273, P20941, DOI 10.1074/jbc.273.33.20941; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Shianna KV, 2006, MITOCHONDRION, V6, P94, DOI 10.1016/j.mito.2006.02.003; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Stuart GR, 2009, MITOCHONDRION, V9, P211, DOI 10.1016/j.mito.2009.02.004; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; TZAGOLOFF A, 1982, MITOCHONDRIA, P199; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; YING W, 2008, YEAST, V10, P1511; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	53	26	27	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39409	39424		10.1074/jbc.M110.178947	http://dx.doi.org/10.1074/jbc.M110.178947			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889970	Green Published, hybrid			2022-12-25	WOS:000284941300068
J	Tokhtaeva, E; Sachs, G; Vagin, O				Tokhtaeva, Elmira; Sachs, George; Vagin, Olga			Diverse Pathways for Maturation of the Na,K-ATPase beta(1) and beta(2) Subunits in the Endoplasmic Reticulum of Madin-Darby Canine Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; ACTIVATED ADENOSINE-TRIPHOSPHATASE; UNFOLDED PROTEIN RESPONSE; N-GLYCOSYLATION SITES; XENOPUS-OOCYTES; QUALITY-CONTROL; INTRACELLULAR-TRANSPORT; FUNCTIONAL EXPRESSION; MOLECULAR-WEIGHT; ALPHA-SUBUNITS	Proper folding of the Na,K-ATPase beta subunits followed by assembly with the alpha subunits is necessary for their export from the endoplasmic reticulum (ER). Here we examine roles of the ER lectin chaperone, calnexin, and non-lectin chaperone, BiP, in folding and quality control of the beta(1) and beta(2) subunits in Madin-Darby canine kidney cells. Short term prevention of glycan-calnexin interactions by castanospermine slightly increases ER retention of beta(1), suggesting minor involvement of calnexin in subunit folding. However, both prolonged incubation with castanospermine and removal of N-glycosylation sites do not affect the alpha(1)-assembly or trafficking of beta(1) but increase the amount of the beta(1)-bound BiP, showing that BiP can compensate for calnexin in assisting beta(1) folding. In contrast to beta(1), prevention of either N-glycosylation or glycan-calnexin interactions abolishes the alpha(1)-assembly and export of beta(2) from the ER despite increased beta(2)-BiP binding. Mutations in the alpha(1)-interacting regions of beta(1) and beta(2) subunits impair alpha(1) assembly but do not affect folding of the beta subunits tested by their sensitivity to trypsin. At the same time, these mutations increase the amount of beta-bound BiP but not of beta-bound calnexin and increase ER retention of both beta-isoforms. BiP, therefore, prevents the ER export of folded but alpha(1)-unassembled beta subunits. These alpha(1)-unassembled beta subunits are degraded faster than alpha(1)-bound beta subunits, preventing ER overload. In conclusion, folding of the beta(1) and beta(2) subunits is assisted predominantly by BiP and calnexin, respectively. Folded beta(1) and beta(2) either assemble with alpha(1) or bind BiP. The alpha(1)-bound beta subunits traffic to the Golgi, whereas BiP-bound beta subunits are retained and degraded in the ER.	Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA; Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Vagin, O (corresponding author), 11301 Wilshire Blvd,VAGLAHS W LA,Bldg 113,Rm 324, Los Angeles, CA 90073 USA.	olgav@ucla.edu			National Institutes of Health [DK077149, DK058333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK058333, R01DK058333, R01DK077149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077149 and DK058333.	ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; Bae EH, 2008, AM J PHYSIOL-RENAL, V294, pF272, DOI 10.1152/ajprenal.00352.2007; Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Beggah AT, 1997, ANN NY ACAD SCI, V834, P537, DOI 10.1111/j.1749-6632.1997.tb52311.x; Beggah AT, 1997, J BIOL CHEM, V272, P10318; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BROTHERUS JR, 1983, BIOCHIM BIOPHYS ACTA, V731, P290, DOI 10.1016/0005-2736(83)90021-4; CAMERON R, 1994, MOL BRAIN RES, V21, P333, DOI 10.1016/0169-328X(94)90264-X; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Caramelo JJ, 2007, SEMIN CELL DEV BIOL, V18, P732, DOI 10.1016/j.semcdb.2007.09.006; Cougnon MH, 2002, PFLUG ARCH EUR J PHY, V445, P123, DOI 10.1007/s00424-002-0898-6; CRAIG WS, 1980, J BIOL CHEM, V255, P6262; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Eriyamremu GE, 2005, BIOMETALS, V18, P1, DOI 10.1007/s10534-004-1202-3; FORSAYETH JR, 1992, J CELL BIOL, V117, P841, DOI 10.1083/jcb.117.4.841; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; HAMADA T, 1991, TOXICOL PATHOL, V19, P138, DOI 10.1177/019262339101900208; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; JAUNIN P, 1992, J BIOL CHEM, V267, P577; JORGENSEN PL, 1980, PHYSIOL REV, V60, P864; Karthikeyan J, 2009, J ENVIRON BIOL, V30, P895; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Kitamura M, 2010, BIOMETALS, V23, P941, DOI 10.1007/s10534-010-9296-2; Kroepfl JF, 2001, J NEUROCHEM, V77, P1301, DOI 10.1046/j.1471-4159.2001.00343.x; KYTE J, 1971, J BIOL CHEM, V246, P4157; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Liu LJ, 2006, AM J PHYSIOL-CELL PH, V291, pC569, DOI 10.1152/ajpcell.00002.2006; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MILLER RP, 1988, BIOCHIM BIOPHYS ACTA, V954, P50, DOI 10.1016/0167-4838(88)90054-4; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Peng L, 1997, J NEUROSCI, V17, P3488; PETERSON GL, 1981, J BIOL CHEM, V256, P3751; Rajasekaran SA, 2007, AM J PHYSIOL-GASTR L, V292, pG124, DOI 10.1152/ajpgi.00297.2006; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; SHANBAKY NM, 1995, BIOCHEM CELL BIOL, V73, P261, DOI 10.1139/o95-032; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SUN Y, 1992, AM J PHYSIOL, V262, pC1491, DOI 10.1152/ajpcell.1992.262.6.C1491; TAKEDA K, 1988, FEBS LETT, V238, P201, DOI 10.1016/0014-5793(88)80256-4; Tamura T., 2010, MOL MEMBR B IN PRESS; Therien AG, 1996, J BIOL CHEM, V271, P7104, DOI 10.1074/jbc.271.12.7104; Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008; Tokbtaeva E, 2010, BIOCHEMISTRY-US, V49, P3116, DOI 10.1021/bi100115a; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x; Yokouchi M, 2007, CELL DEATH DIFFER, V14, P1467, DOI 10.1038/sj.cdd.4402154; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	64	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39289	39302		10.1074/jbc.M110.172858	http://dx.doi.org/10.1074/jbc.M110.172858			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937802	hybrid, Green Published			2022-12-25	WOS:000284941300057
J	Xu, H; Wickner, W				Xu, Hao; Wickner, William			Phosphoinositides Function Asymmetrically for Membrane Fusion, Promoting Tethering and 3Q-SNARE Subcomplex Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOTYPIC VACUOLE FUSION; TRANS-SNARE COMPLEXES; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; YEAST VACUOLE; REGULATORY LIPIDS; PLASMA-MEMBRANE; T-SNARE; VAM7P; DOCKING; PHOSPHOLIPIDS	Phosphatidylinositol 3-phosphate (PI(3)P) and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) are essential for rapid SNARE-dependent fusion of yeast vacuoles and other organelles. These phosphoinositides also regulate the fusion of reconstituted proteoliposomes. The reconstituted reaction allows separate analysis of phosphoinositide-responsive subreactions: fusion with SNAREs alone, with the addition of the HOPS tethering factor, and with the further addition of the SNARE complex disassembly chaperones Sec17p and Sec18p. Using assays of membrane tethering, trans-SNARE pairing, and lipid mixing, we found that PI(3)P and PI(4,5)P-2 have distinct functions that are asymmetric with respect to R-SNARE (Nyv1p) and the 3Q-SNAREs (Vam3p, Vti1p, and Vam7p). Fusion reactions with the Q-SNAREs and R-SNARE on separate membranes showed that PI(3)P has two distinct functions. PI(3)P on Q-SNARE proteoliposomes promoted Vam7p binding and association with the other two Q-SNAREs. PI(3)P on R-SNARE proteoliposomes was recognized by the PX domain of Vam7p on Q-SNARE proteoliposomes to promote tethering, although this function could be supplanted by the tethering activity of HOPS. PI(4,5)P-2 stimulated fusion when it was on R-SNARE proteoliposomes, apposed to Q-SNARE proteoliposomes bearing PI(3)P. These functions are essential for the phosphoinositide-dependent synergy between HOPS and Sec17p/Sec18p in promoting rapid fusion.	[Xu, Hao; Wickner, William] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wickner, W (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg,Remsen 425, Hanover, NH 03755 USA.	bill.wickner@dartmouth.edu	Xu, Hao/B-3194-2011	Xu, Hao/0000-0002-5776-0276	National Institutes of Health [GM23377-35]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023377, R37GM023377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM23377-35.	Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Hickey CM, 2009, J BIOL CHEM, V284, P16118, DOI 10.1074/jbc.M109.000737; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jun Y, 2007, EMBO J, V26, P4935, DOI 10.1038/sj.emboj.7601915; Lorente-Rodriguez A., 2010, THESIS DARTMOUTH COL; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128	35	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39359	39365		10.1074/jbc.M110.183111	http://dx.doi.org/10.1074/jbc.M110.183111			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937838	Green Published, hybrid			2022-12-25	WOS:000284941300063
J	Zepeda-Lopez, HM; Perea-Araujo, L; Miliar-Garcia, A; Dominguez-Lopez, A; Xoconostle-Cazarez, B; Lara-Padilla, E; Hernandez, JAR; Sevilla-Reyes, E; Orozco, ME; Ahued-Ortega, A; Villasenor-Ruiz, I; Garcia-Cavazos, RJ; Teran, LM				Zepeda-Lopez, Hector M.; Perea-Araujo, Lizbeth; Miliar-Garcia, Angel; Dominguez-Lopez, Aaron; Xoconostle-Cazarez, Beatriz; Lara-Padilla, Eleazar; Ramirez Hernandez, Jorge A.; Sevilla-Reyes, Edgar; Esther Orozco, Maria; Ahued-Ortega, Armando; Villasenor-Ruiz, Ignacio; Garcia-Cavazos, Ricardo J.; Teran, Luis M.			Inside the Outbreak of the 2009 Influenza A (H1N1) v Virus in Mexico	PLOS ONE			English	Article							TRANSMISSION; A(H1N1)	Background: Influenza viruses pose a threat to human health because of their potential to cause global disease. Between mid March and mid April a pandemic influenza A virus emerged in Mexico. This report details 202 cases of infection of humans with the 2009 influenza A virus (H1N1) v which occurred in Mexico City as well as the spread of the virus throughout the entire country. Methodology and Findings: From May 1st to May 5th nasopharyngeal swabs, derived from 751 patients, were collected at 220 outpatient clinics and 28 hospitals distributed throughout Mexico City. Analysis of samples using real time RT-PCR revealed that 202 patients out of the 751 subjects (26.9%) were confirmed to be infected with the new virus. All confirmed cases of human infection with the strain influenza (H1N1) v suffered respiratory symptoms. The greatest number of confirmed cases during the outbreak of the 2009 influenza A (H1N1) v were seen in neighbourhoods on the northeast side of Mexico City including Iztapalapa, Gustavo A. Madero, Iztacalco, and Tlahuac which are the most populated areas in Mexico City. Using these data, together with data reported by the Mexican Secretariat of Health (MSH) to date, we plot the course of influenza (H1N1) v activity throughout Mexico. Conclusions: Our data, which is backed up by MSH data, show that the greatest numbers of the 2009 influenza A (H1N1) cases were seen in the most populated areas. We speculate on conditions in Mexico which may have sparked this flu pandemic, the first in 41 years. We accept the hypothesis that high population density and a mass gathering which took in Iztapalapa contributed to the rapid spread of the disease which developed in three peaks of activity throughout the Country.	[Zepeda-Lopez, Hector M.; Perea-Araujo, Lizbeth; Miliar-Garcia, Angel; Dominguez-Lopez, Aaron; Lara-Padilla, Eleazar; Garcia-Cavazos, Ricardo J.] Inst Politecn Nacl, Escuela Super Med, Lab Med Conservac, Mexico City 07738, DF, Mexico; [Xoconostle-Cazarez, Beatriz] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biotecnol & Bioingn, Mexico City 07738, DF, Mexico; [Ramirez Hernandez, Jorge A.; Sevilla-Reyes, Edgar; Teran, Luis M.] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Esther Orozco, Maria] Inst Ciencia & Tecnol, Direcc Gen, Mexico City, DF, Mexico; [Ahued-Ortega, Armando] Secretaria Salud Mexico, Direcc Gen, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Zepeda-Lopez, HM (corresponding author), Inst Politecn Nacl, Escuela Super Med, Lab Med Conservac, Mexico City 07738, DF, Mexico.	lmteran@iner.gob.mx	Sevilla, Edgar/AAS-3300-2021; Teran, Luis/AAI-9815-2021	Sevilla, Edgar/0000-0002-7047-0222; Teran, Luis Manuel/0000-0003-1806-1779	Federal District government	Federal District government	The Federal District government provided a grant to support the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Bi YH, 2010, EMERG INFECT DIS, V16, P1162, DOI 10.3201/eid1607.091881; Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; *DEIS, 2009, GOOD FRID IZT MEX; DELACRUZ JPL, 2009, B TUR CANCUN, V2, P9; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Ebrahim SH, 2009, SCIENCE, V326, P938, DOI 10.1126/science.1183210; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Haworth E, 2010, J ROY SOC MED, V103, P79, DOI 10.1258/jrsm.2010.090463; *INEGI, 2009, 12 CENS POBL VIV 200; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KINGSFORD C, 2009, PLOS            0728, DOI DOI 10.1371/JOURNAL.PONE.0006402; Lipsitch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006895; Memish ZA, 2009, LANCET, V374, P1786, DOI 10.1016/S0140-6736(09)61927-9; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; *SECR SAL, 2009, INFL MEX TEMP OT INV; *SECR SAL, 2009, SIT ACT PAND; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Tsouros AD, 2004, MASS GATHERINGS PUBL; van Hal SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006620; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Ward HH, 2004, GENOMICS, V84, P991, DOI 10.1016/j.ygeno.2004.08.002; World Health Organization, 2009, PAND H1N1 2009 UPD 8	29	30	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13256	10.1371/journal.pone.0013256	http://dx.doi.org/10.1371/journal.pone.0013256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949040	Green Published, gold, Green Submitted			2022-12-25	WOS:000282676700019
J	Qiu, XN; Hother, C; Ralfkiaer, UM; Sogaard, A; Lu, QJ; Workman, CT; Liang, GN; Jones, PA; Gronbaek, K				Qiu, Xiangning; Hother, Christoffer; Ralfkiaer, Ulrik M.; Sogaard, Alexandra; Lu, Qianjin; Workman, Christopher T.; Liang, Gangning; Jones, Peter A.; Gronbaek, Kirsten			Equitoxic Doses of 5-Azacytidine and 5-Aza-2 ' Deoxycytidine Induce Diverse Immediate and Overlapping Heritable Changes in the Transcriptome	PLOS ONE			English	Article							CONVENTIONAL CARE REGIMENS; CANCER-TESTIS GENE; MYELODYSPLASTIC SYNDROME; DNA METHYLATION; EPIGENETIC CHANGES; PHASE-II; AZACITIDINE; DECITABINE; EXPRESSION; CTCF	Background: The hypomethylating agent 5-Azacytidine (5-Aza-CR) is the first drug to prolong overall survival in patients with myelodysplastic syndrome (MDS). Surprisingly, the deoxyribonucleoside analog 5-Aza-2'deoxycytidine (5-Aza-CdR) did not have a similar effect on survival in a large clinical trial. Both drugs are thought to exert their effects after incorporation into DNA by covalent binding of DNA methyltransferase (DNMT). While 5-Aza-CdR is incorporated into only DNA, 5-Aza-CR is also incorporated into RNA. Here, we have analyzed whether this difference in nucleic acid incorporation may influence the capacities of these drugs to regulate the expression of mRNA and microRNAs (miRNA), which may potentially affect the activities of the drugs in patients. Methodology/Principal Findings: A hematopoietic (HL-60; acute myeloid leukemia) and a solid (T24; transitional cell carcinoma) cancer cell line were treated with equitoxic doses of 5-Aza-CR and 5-Aza-CdR for 24 hrs, and the immediate (day 2) and lasting (day 8) effects on RNA expression examined. There was considerable overlap between the RNAs heritably upregulated by both drugs on day 8 but more RNAs were stably induced by the deoxy analog. Both drugs strongly induced expression of cancer testis antigens. On day 2 more RNAs were downregulated by 5-Aza-CR, particularly at higher doses. A remarkable downregulation of miRNAs and a significant upregulation of tRNA synthetases and other genes involved in amino acid metabolism was observed in T24 cells. Conclusions/Significance: Overall, this suggests that significant differences exist in the immediate action of the two drugs, however the dominant pattern of the lasting, and possible heritable changes, is overlapping.	[Qiu, Xiangning; Liang, Gangning; Jones, Peter A.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Hother, Christoffer; Ralfkiaer, Ulrik M.; Sogaard, Alexandra; Gronbaek, Kirsten] Rigshosp, Dept Hematol, DK-2100 Copenhagen, Denmark; [Workman, Christopher T.] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Qiu, Xiangning; Lu, Qianjin] Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha, Hunan, Peoples R China	University of Southern California; Rigshospitalet; University of Copenhagen; Technical University of Denmark; Central South University	Qiu, XN (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	kirsten.groenbaek@rh.regionh.dk	Ralfkiaer, Ulrik/N-2836-2016; Workman, Christopher T/K-1066-2015	Ralfkiaer, Ulrik/0000-0003-2647-2148; Workman, Christopher T/0000-0002-2210-3743; Liang, Gangning/0000-0001-8664-922X; Gronbaek, Kirsten/0000-0002-1535-9601	Rigshospitalets Research Foundation; Danish Cancer Society; Novo Nordisk Foundation; Lundbeck Foundation; NIH [R37 CA82422, R01 CA1378794]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA138794, R37CA082422] Funding Source: NIH RePORTER	Rigshospitalets Research Foundation; Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from Rigshospitalets Research Foundation (CH, KG), The Danish Cancer Society (CH, KG), The Novo Nordisk Foundation (KG), The Lundbeck Foundation (KG), NIH (R37 CA82422, PAJ), (R01 CA1378794, GL). Xiangning Qiu is supported by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Borthakur G, 2008, LEUKEMIA LYMPHOMA, V49, P690, DOI 10.1080/10428190701882146; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; CONSTANTINIDES PG, 1978, DEV BIOL, V66, P57, DOI 10.1016/0012-1606(78)90273-7; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; DALTON WT, 1988, BLOOD, V71, P242; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fandy TE, 2009, BLOOD, V114, P2764, DOI 10.1182/blood-2009-02-203547; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Gonzalgo ML, 1997, NUCLEIC ACIDS RES, V25, P2529, DOI 10.1093/nar/25.12.2529; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Guldberg P, 2002, METHODS, V27, P121, DOI 10.1016/S1046-2023(02)00063-4; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kantarjian H, 2007, BLOOD, V109, P52, DOI 10.1182/blood-2006-05-021162; Khan R, 2006, EXP HEMATOL, V34, P35, DOI 10.1016/j.exphem.2005.09.007; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; MOMPARLER RL, 1976, BIOCHEM PHARMACOL, V25, P389, DOI 10.1016/0006-2952(76)90338-5; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Schaefer M, 2009, CANCER RES, V69, P8127, DOI 10.1158/0008-5472.CAN-09-0458; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; WEBER J, 1994, CANCER RES, V54, P1766; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wijermans P, 2000, J CLIN ONCOL, V18, P956, DOI 10.1200/JCO.2000.18.5.956; WIJERMANS P, 2008, BLOOD, V112; WORKMAN C, 2002, GENOME BIOL, V0003; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z	43	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12994	10.1371/journal.pone.0012994	http://dx.doi.org/10.1371/journal.pone.0012994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927380	gold, Green Published, Green Submitted			2022-12-25	WOS:000282269400008
J	van der Werf-Eldering, MJ; Burger, H; Holthausen, EAE; Aleman, A; Nolen, WA				van der Werf-Eldering, Marieke J.; Burger, Huibert; Holthausen, Esther A. E.; Aleman, Andre; Nolen, Willem A.			Cognitive Functioning in Patients with Bipolar Disorder: Association with Depressive Symptoms and Alcohol Use	PLOS ONE			English	Article							REPORT QIDS-SR; NEUROCOGNITIVE IMPAIRMENT; EUTHYMIC PATIENTS; NEUROPSYCHOLOGICAL DEFICITS; CLINICAL PREDICTORS; NATURAL-HISTORY; QUICK INVENTORY; SYMPTOMATOLOGY; ILLNESS; METAANALYSIS	Background: Cognitive dysfunction is clearly recognized in bipolar patients, but the degree of impairment varies due to methodological factors as well as heterogeneity in patient populations. The goal of this study was to evaluate cognitive functioning in bipolar patients and to assess its association with depressive symptoms. Post hoc the relationship with lifetime alcohol use disorder was explored. Methodology/Principal Findings: The study included 110 bipolar patients and 75 healthy controls. Patients with severe depressive symptoms, (hypo) manic symptoms and current severe alcohol use disorder were excluded. Diagnoses were evaluated via the Mini-International Neuropsychiatric Interview. Cognitive functioning was measured in domains of psychomotor speed, speed of information processing, attentional switching, verbal memory, visual memory, executive functioning and an overall mean score. Severity of depression was assessed by the Inventory of Depressive Symptomatology-self rating. Patients were euthymic (n=46) or with current mild (n=38) or moderate (n=26) depressive symptoms. Cognitive impairment was found in 26% (z-score 2 or more above reference control group for at least one domain) of patients, most prominent in executive functioning (effect size; ES 0.49) and speed of information processing (ES 0.47). Depressive symptoms were associated with dysfunction in psychomotor speed (adjusted beta 0.43; R-2 7%), speed of information processing (adjusted beta 0.36; R-2 20%), attentional switching (adjusted beta 0.24; R-2 16%) and the mean score (adjusted beta 0.23; R-2 24%), but not with verbal and visual memory and executive functioning. Depressive symptoms explained 24% of the variance in the mean z-score of all 6 cognitive domains. Comorbid lifetime alcohol use (n=21) was not associated with cognitive dysfunction. Conclusions/Significance: Cognitive dysfunction in bipolar disorder is more severe in patients with depressive symptoms, especially regarding speed and attention. Therefore, interpretation of cognitive functioning in patients with depressive symptoms should be cautious. No association was found between cognitive functioning and lifetime comorbid alcohol use disorder.	[van der Werf-Eldering, Marieke J.; Burger, Huibert; Holthausen, Esther A. E.; Nolen, Willem A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van der Werf-Eldering, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands.	m.j.van.der.werf@psy.umcg.nl	Aleman, Andre/E-1341-2012; Nolen, Willem A/E-9006-2014	Eldering, Marieke/0000-0002-7715-5946	AstraZeneca, The Netherlands; The Netherlands Organisation for Health Research and Development; European Union; Stanley Medical Research Institute; Astra Zeneca; Eli Lilly; GlaxoSmithKline; Wyeth; Pfizer; Servier	AstraZeneca, The Netherlands(Netherlands GovernmentAstraZeneca); The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); European Union(European Commission); Stanley Medical Research Institute; Astra Zeneca(AstraZeneca); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Wyeth(Wyeth); Pfizer(Pfizer); Servier(Servier)	M.J. van der Werf-Eldering received an unrestricted Young Investigators award from AstraZeneca, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M.J. van der Werf-Eldering received an unrestricted Young Investigator's award from AstraZeneca, The Netherlands. W. A. Nolen has received grants from The Netherlands Organisation for Health Research and Development, the European Union, the Stanley Medical Research Institute, Astra Zeneca, Eli Lilly, GlaxoSmithKline and Wyeth; has received honoraria/speaker's fees from Astra Zeneca, Eli Lilly, Pfizer, Servier and Wyeth; and has served in advisory boards for Astra Zeneca, Cyberonics, Pfizer and Servier. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors deny any conflicts of interest or commercial associations in connection with the submitted manuscript.	Arts B, 2008, PSYCHOL MED, V38, P771, DOI 10.1017/S0033291707001675; Balanza-Martinez V, 2010, EUR J PHARMACOL, V626, P87, DOI 10.1016/j.ejphar.2009.10.018; Bonnin CM, 2010, J AFFECT DISORDERS, V121, P156, DOI 10.1016/j.jad.2009.05.014; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; BRANDT J, 1983, ARCH GEN PSYCHIAT, V40, P435; Carey KB, 2003, J NERV MENT DIS, V191, P300; Castaneda AE, 2010, PSYCHOL MED, V40, P29, DOI 10.1017/S0033291709005959; DALES LG, 1978, INT J EPIDEMIOL, V7, P373, DOI 10.1093/ije/7.4.373; Dean BB, 2004, CURR MED RES OPIN, V20, P139, DOI 10.1185/030079903125002801; Delis DC., 2000, CALIFORNIA VERBAL LE; Dickerson F, 2010, BIPOLAR DISORD, V12, P10, DOI 10.1111/j.1399-5618.2009.00784.x; Ferrier IN, 2002, BRIT J PSYCHIAT, V180, P293, DOI 10.1192/bjp.180.4.293; Frangou S, 2002, BIPOLAR DISORD, V4, P41, DOI 10.1034/j.1399-5618.4.s1.13.x; Frasch K, 2009, PSYCHOPATHOLOGY, V42, P59, DOI 10.1159/000187635; Frye MA, 2006, BIPOLAR DISORD, V8, P677, DOI 10.1111/j.1399-5618.2006.00370.x; Goldberg JF, 2008, COGNITIVE DYSFUNCTION IN BIPOLAR DISORDER: A GUIDE FOR CLINICIANS, P1; Goldberg JF, 2009, BIPOLAR DISORD, V11, P123, DOI 10.1111/j.1399-5618.2009.00716.x; Golden, 1978, STROOP COLOUR WORD T; GOODWIN FK, 2007, MANICDEPRESSIVE ILLN, P273; Gualtieri CT, 2008, J CLIN PSYCHIAT, V69, P1122, DOI 10.4088/JCP.v69n0712; Hedges L. V., 1985, STAT METHODS META AN, DOI [DOI 10.1016/B978-0-08-057065-5.50005-1, 10.2307/1164953, DOI 10.2307/1164953]; Huxley N, 2007, BIPOLAR DISORD, V9, P183, DOI 10.1111/j.1399-5618.2007.00430.x; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P207, DOI 10.1080/09084280903098778; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; KEEFE RSE, 1995, AM J PSYCHIAT, V152, P6; Kennedy N, 2007, BIPOLAR DISORD, V9, P25, DOI 10.1111/j.1399-5618.2007.00326.x; Kupka RW, 2007, BIPOLAR DISORD, V9, P531, DOI 10.1111/j.1399-5618.2007.00467.x; Kurtz MM, 2009, NEUROPSYCHOLOGY, V23, P551, DOI 10.1037/a0016277; Leverich GS, 2001, J AFFECT DISORDERS, V67, P33, DOI 10.1016/S0165-0327(01)00430-X; Levin FR, 2004, BIOL PSYCHIAT, V56, P738, DOI 10.1016/j.biopsych.2004.05.008; Levy B, 2008, PSYCHIAT RES, V161, P28, DOI 10.1016/j.psychres.2007.09.009; Levy B, 2009, HARVARD REV PSYCHIAT, V17, P226, DOI 10.1080/10673220902979870; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, V4th, P1016; Malhi GS, 2007, BIPOLAR DISORD, V9, P114, DOI 10.1111/j.1399-5618.2007.00324.x; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; Martino DJ, 2008, J AFFECT DISORDERS, V109, P149, DOI 10.1016/j.jad.2007.12.232; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Mur M, 2009, PSYCHOPATHOLOGY, V42, P148, DOI 10.1159/000207456; Nelson HE., 1982, NATL ADULT READING T; Olley A, 2005, J NERV MENT DIS, V193, P323, DOI 10.1097/01.nmd.0000161684.35904.f4; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; Pavuluri MN, 2006, AM J PSYCHIAT, V163, P286, DOI 10.1176/appi.ajp.163.2.286; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Rosa AR, 2009, BIPOLAR DISORD, V11, P401, DOI 10.1111/j.1399-5618.2009.00698.x; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sanchez-Moreno J, 2009, J CLIN PSYCHIAT, V70, P1120, DOI 10.4088/JCP.08m04302; Savitz J, 2005, BIPOLAR DISORD, V7, P216, DOI 10.1111/j.1399-5618.2005.00203.x; Savitz JB, 2005, NEUROMOL MED, V7, P275, DOI 10.1385/NMM:7:4:275; Savitz JB, 2008, BIPOLAR DISORD, V10, P479, DOI 10.1111/j.1399-5618.2008.00591.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smid HGOM, 2006, J CLIN EXP NEUROPSYC, V28, P859, DOI 10.1080/13803390591001025; SPSS Inc, 2008, STAT PACK SOC SCI SP; Suppes T, 2001, J AFFECT DISORDERS, V67, P45, DOI 10.1016/S0165-0327(01)00432-3; Tabares-Seisdedos R, 2008, J AFFECT DISORDERS, V109, P286, DOI 10.1016/j.jad.2007.12.234; Tamam L, 2008, EUR ARCH PSY CLIN N, V258, P385, DOI 10.1007/s00406-008-0807-x; Thompson JM, 2005, BRIT J PSYCHIAT, V186, P32, DOI 10.1192/bjp.186.1.32; Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; van Gorp WG, 1998, ARCH GEN PSYCHIAT, V55, P41, DOI 10.1001/archpsyc.55.1.41; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; Wingo AP, 2009, J CLIN PSYCHIAT, V70, P1588, DOI 10.4088/JCP.08r04972; Wingo AP, 2009, BIPOLAR DISORD, V11, P113, DOI 10.1111/j.1399-5618.2009.00665.x; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	68	27	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13032	10.1371/journal.pone.0013032	http://dx.doi.org/10.1371/journal.pone.0013032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	654ZQ	20927392	Green Submitted, Green Published, gold			2022-12-25	WOS:000282210700013
J	Wei, JW; Heeley, EL; Jan, S; Huang, YN; Huang, QF; Wang, JG; Cheng, Y; Xu, E; Yang, QD; Anderson, CS				Wei, Jade W.; Heeley, Emma L.; Jan, Stephen; Huang, Yining; Huang, Qifang; Wang, Ji-Guang; Cheng, Yan; Xu, En; Yang, Qidong; Anderson, Craig S.		ChinaQUEST Investigators	Variations and Determinants of Hospital Costs for Acute Stroke in China	PLOS ONE			English	Article							HEALTH-INSURANCE REFORM; LONG-TERM COST; ISCHEMIC-STROKE; CARE; REHABILITATION; CHARGES; LENGTH; STAY; SERVICES; SUBTYPES	Background: The burden of stroke is high and increasing in China. We modelled variations in, and predictors of, the costs of hospital care for patients with acute stroke in China. Methods and Findings: Baseline characteristics and hospital costs for 5,255 patients were collected using the prospective register-based ChinaQUEST study, conducted in 48 Level 3 and 14 Level 2 hospitals in China during 2006-2007. Ordinary least squares estimation was used to determine factors associated with hospital costs. Overall mean cost of hospitalisation was 11,216 Chinese Yuan Renminbi (CNY) (approximate to US$1,602) per patient, which equates to more than half the average annual wage in China. Variations in cost were largely attributable to stroke severity and length of hospital stay (LOS). Model forecasts showed that reducing LOS from the mean of 20 days for Level 3 and 18 days for Level 2 hospitals to a duration of 1 week, which is common among Western countries, afforded cost reductions of 49% and 19%, respectively. Other lesser determinants varied by hospital level: in Level 3 hospitals, health insurance and the occurrence of in-hospital complications were each associated with 10% and 18% increases in cost, respectively, whilst treatment in a teaching hospital was associated with approximately 39% decrease in cost on average. For Level 2 hospitals, stroke due to intracerebral haemorrhage was associated with a 19% greater cost than for ischaemic stroke. Conclusions: Changes to hospital policies to standardise resource use and reduce the variation in LOS could attenuate costs and improve efficiencies for acute stroke management in China. The success of these strategies will be enhanced by broader policy initiatives currently underway to reform hospital reimbursement systems.	[Wei, Jade W.; Heeley, Emma L.; Jan, Stephen; Anderson, Craig S.] Royal Prince Alfred Hosp, George Inst Global Hlth, Sydney, NSW, Australia; [Wei, Jade W.; Heeley, Emma L.; Jan, Stephen; Anderson, Craig S.] Univ Sydney, Sydney, NSW 2006, Australia; [Huang, Yining] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China; [Huang, Qifang; Wang, Ji-Guang] Shanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Ruijin Hosp, Shanghai 200030, Peoples R China; [Cheng, Yan] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Xu, En] Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Yang, Qidong] Ctr S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China	George Institute for Global Health; University of Sydney; University of Sydney; Peking University; Shanghai Jiao Tong University; Tianjin Medical University; Guangzhou Medical University; Central South University	Wei, JW (corresponding author), Royal Prince Alfred Hosp, George Inst Global Hlth, Sydney, NSW, Australia.	jwei@george.org.au	Wang, Ji Guang/AAP-4045-2021; Jan, Stephen/AAG-3333-2021; Demchuk, Andrew M/E-1103-2012	Wang, Ji Guang/0000-0001-8511-1524; Demchuk, Andrew M/0000-0002-4930-7789; Jan, Stephen/0000-0003-2839-1405; Heeley, Emma/0000-0001-9190-2832; Anderson, Craig/0000-0002-7248-4863	Macquarie Bank Foundation; The George Foundation; AstraZeneca Pharmaceutical China; The George Institute for International Health; National Health and Medical Research Council of Australia (NHMRC); Australian Postgraduate Award	Macquarie Bank Foundation; The George Foundation; AstraZeneca Pharmaceutical China(AstraZeneca); The George Institute for International Health; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	The ChinaQUEST study was supported by grants from the Macquarie Bank Foundation, The George Foundation, and AstraZeneca Pharmaceutical China. CSA received salary support from The George Institute for International Health and as a Senior Principal Research Fellow of the National Health and Medical Research Council of Australia (NHMRC). JWW was a recipient of an Australian Postgraduate Award. SJ is a recipient of a Career Development Award from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The ChinaQUEST study was an academic initiated and conducted study. Commercial sources of funding including AstraZeneca Pharmaceutical China had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors exercise complete right to make freely available any materials and information described in their publication that are reasonably requested by others for the purpose of academic, non-commercial research.	Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; BURNS LR, 1991, MED CARE, V29, P251, DOI 10.1097/00005650-199103000-00007; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; *CHIN CDC CHIN MED, 2007, CHIN GUID CER DIS PR; Dewey HM, 2003, STROKE, V34, P2502, DOI 10.1161/01.STR.0000091395.85357.09; DOBKIN B, 1995, NEUROLOGY, V45, pS6; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Evers S, 2002, HEALTH POLICY, V61, P21, DOI 10.1016/S0168-8510(01)00219-6; Fjaertoft Hild, 2007, Tidsskr Nor Laegeforen, V127, P744; Galán Iñaki, 2004, Gac Sanit, V18, P440, DOI 10.1157/13069762; Gao WM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-110; Gioldasis G, 2008, ACTA NEUROL SCAND, V118, P268, DOI 10.1111/j.1600-0404.2008.01014.x; Harvey RL, 1998, ARCH PHYS MED REHAB, V79, P1349, DOI 10.1016/S0003-9993(98)90226-X; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Heeley E, 2009, STROKE, V40, P2149, DOI 10.1161/STROKEAHA.108.540054; Jorgensen HS, 1997, STROKE, V28, P1138, DOI 10.1161/01.STR.28.6.1138; Joshi R, 2008, J AM COLL CARDIOL, V52, P1817, DOI 10.1016/j.jacc.2008.08.049; Khealani B. A., 2003, JPMA Journal of the Pakistan Medical Association, V53, P552; Kwan J, 2007, J CLIN NEUROSCI, V14, P189, DOI 10.1016/j.jocn.2006.01.026; Langhorne P, 2005, LANCET, V365, P501; Lee WC, 2007, CEREBROVASC DIS, V23, P57, DOI 10.1159/000096542; LI L, 2008, CHINESE J HLTH EC, V27; Lim Seung-Ji, 2009, J Prev Med Public Health, V42, P251, DOI 10.3961/jpmph.2009.42.4.251; Liu GG, 2002, SOC SCI MED, V55, P1779, DOI 10.1016/S0277-9536(01)00306-9; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Liu YL, 2002, HEALTH POLICY, V60, P133, DOI 10.1016/S0168-8510(01)00207-X; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; McGowan B, 2003, Ir Med J, V96, P234; MENG Q, 2008, HLTH PROVIDER PAYMEN; Meng QY, 2004, HEALTH POLICY, V68, P197, DOI 10.1016/j.healthpol.2003.09.010; *MIN HLTH PEOPL RE, 2007, CHIN HLTH STAT YB; Payne KA, 2002, PHARMACOECONOMICS, V20, P813, DOI 10.2165/00019053-200220120-00002; Petersen MA, 2009, REV FINANC STUD, V22, P435, DOI 10.1093/rfs/hhn053; Qureshi AI, 2007, STROKE, V38, P2180, DOI 10.1161/STROKEAHA.106.467506; SHI LY, 2006, CHINESE J PUBLIC HLT, V22, P1022; Tu F, 2003, HEALTH POLICY, V66, P239, DOI 10.1016/S0168-8510(03)00080-0; Tu F, 2002, HEALTH POLICY, V59, P243, DOI 10.1016/S0168-8510(01)00182-8; Tukey JW, 1977, EXPLORATORY DATA ANA; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; WADE DT, 1985, J EPIDEMIOL COMMUN H, V39, P347, DOI 10.1136/jech.39.4.347; Wang H, 2009, HEALTH ECON, V18, pS65, DOI 10.1002/hec.1465; Xu L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-37; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Yoneda Y, 2005, HEALTH POLICY, V73, P202, DOI 10.1016/j.healthpol.2004.11.016; Zizza C, 2004, AM J PUBLIC HEALTH, V94, P1587, DOI 10.2105/AJPH.94.9.1587	46	77	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13041	10.1371/journal.pone.0013041	http://dx.doi.org/10.1371/journal.pone.0013041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	654ZQ	20927384	Green Published, gold, Green Submitted			2022-12-25	WOS:000282210700017
J	Ramon, HE; Cejas, PJ; LaRosa, D; Rahman, A; Harris, JE; Zhang, JD; Hunter, C; Choi, Y; Turka, LA				Ramon, Hilda E.; Cejas, Pedro J.; LaRosa, David; Rahman, Adeeb; Harris, John E.; Zhang, Jidong; Hunter, Christopher; Choi, Yongwon; Turka, Laurence A.			EGR-2 Is Not Required for In Vivo CD4 T Cell Mediated Immune Responses	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; FAS LIGAND; GROWTH; PROTEINS	Background: The zinc finger transcription factor EGR-2 has been shown to play an important role in the induction of T cell anergy and the regulation of peripheral T cell tolerance. In vitro, a prior study has show that T cells deficient in EGR-2 are hyperproliferative to IL-2 and produce elevated levels of the effector cytokine IFN-gamma. EGR-2 deficient mice have increased levels of CD44(high) T cells in peripheral lymphoid organs, and with age, develop autoimmune-like features. Principal Findings: Here we show that despite increased numbers of cells bearing an activated CD44(high) CD62L(low) phenotype, T cells from young healthy EGR-2 deficient mice have normal proliferative and cytokine responses, and the mice themselves mount normal immune responses against minor histocompatibility antigens, and the pathogens Toxoplasma gondii and lymphocytic choriomeningitis virus. Conclusions: Our results indicate that EGR-2 is not required to mount normal acute in vivo immune responses against foreign antigens, and suggest instead that it may serve to regulate the response to chronic antigenic exposure, such as that which occurs to autoantigens.	[Ramon, Hilda E.; LaRosa, David; Rahman, Adeeb; Zhang, Jidong; Turka, Laurence A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Cejas, Pedro J.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Harris, John E.] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Hunter, Christopher] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Ramon, HE (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	lturka@bidmc.harvard.edu	Hunter, Christopher/H-1970-2011	Rahman, Adeeb/0000-0002-8620-3161	National Institutes of Health [AI-43620]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI-43620 to Christopher Hunter, Yongwon Choi and Laurence A. Turka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Cron RQ, 2006, J IMMUNOL, V176, P811, DOI 10.4049/jimmunol.176.2.811; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dzierszinski FS, 2008, PARASITE IMMUNOL, V30, P235, DOI 10.1111/j.1365-3024.2007.01016.x; GAMPER CJ, 2010, IMMUNOL RES; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gomez-Martin D, 2009, AUTOIMMUN REV, V9, P34, DOI 10.1016/j.autrev.2009.02.035; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Khanolkar A, 2002, IMMUNOL RES, V26, P309, DOI 10.1385/IR:26:1-3:309; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Mittelstadt PR, 1999, J BIOL CHEM, V274, P3222, DOI 10.1074/jbc.274.5.3222; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Skerka C, 1997, IMMUNOBIOLOGY, V198, P179, DOI 10.1016/S0171-2985(97)80039-3; Taillebourg E, 2002, GENESIS, V32, P112, DOI 10.1002/gene.10062; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Yang SZ, 2006, J CELL BIOCHEM, V97, P1292, DOI 10.1002/jcb.20736; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12904	10.1371/journal.pone.0012904	http://dx.doi.org/10.1371/journal.pone.0012904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886122	gold, Green Submitted, Green Published			2022-12-25	WOS:000282091100013
J	Dunn, EF; Iida, M; Myers, RA; Campbell, DA; Hintz, KA; Armstrong, EA; Li, C; Wheeler, DL				Dunn, E. F.; Iida, M.; Myers, R. A.; Campbell, D. A.; Hintz, K. A.; Armstrong, E. A.; Li, C.; Wheeler, D. L.			Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab	ONCOGENE			English	Article						colorectal cancer; KRAS mutation; cetuximab resistance; Src family kinases; dasatinib	GROWTH-FACTOR RECEPTOR; SRC-FAMILY KINASES; COLON-CANCER CELLS; CARCINOMA-ASSOCIATED ANTIGEN; PP60C-SRC PROTEIN-KINASE; FOCAL-ADHESION KINASE; C-SRC; ACQUIRED-RESISTANCE; TYROSINE KINASES; SIGNAL-TRANSDUCTION	KRAS mutation is a predictive biomarker for resistance to cetuximab (Erbitux) in metastatic colorectal cancer (mCRC). This study sought to determine if KRAS mutant CRC lines could be sensitized to cetuximab using dasatinib (BMS-354825, Sprycel), a potent, orally bioavailable inhibitor of several tyrosine kinases, including the Src family kinases (SFKs). We analyzed 16 CRC lines for: (1) KRAS mutation status, (2) dependence on mutant KRAS signaling and (3) expression level of epidermal growth factor receptor (EGFR) and SFKs. From these analyses, we selected three KRAS mutant (LS180, LoVo and HCT116) cell lines and two KRAS wild-type cell lines (SW48 and CaCo2). In vitro, using poly-D-lysine/laminin plates, KRAS mutant cell lines were resistant to cetuximab, whereas KRAS wild-type lines showed sensitivity to cetuximab. Treatment with cetuximab and dasatinib showed a greater antiproliferative effect on KRAS mutant lines when compared with either agent alone in vitro and in vivo. To investigate potential mechanisms for this antiproliferative response in the combinatorial therapy, we performed Human Phospho-Kinase Antibody Array analysis, measuring the relative phosphorylation levels of 39 intracellular proteins in untreated, cetuximab, dasatinib or the combinatorial treatment in the KRAS mutant lines LS180, LoVo and HCT116 cells. The results of this experiment showed a decrease in a broad spectrum of kinases centered on the beta-catenin pathway, the mitogen-activated protein kinase (MAPK) pathway, AKT/mammalian target of rapamycin (mTOR) pathway and the family of signal transducers and activators of transcription (STATs) when compared with the untreated control or monotherapy treatments. Next, we analyzed tumor growth with cetuximab, dasatinib or their combination in vivo. KRAS mutant xenografts showed resistance to cetuximab therapy, whereas KRAS wild type demonstrated an antitumor response when treated with cetuximab. KRAS mutant tumors exhibited minimal response to dasatinib monotherapy. However, as in vitro, KRAS mutant lines exhibited a response to the combination of cetuximab and dasatinib. Combinatorial treatment of KRAS mutant xenografts resulted in decreased cell proliferation, as measured by Ki67, and higher rates of apoptosis, as measured by TUNEL terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling). The data presented in this study indicate that dasatinib can sensitize KRAS mutant CRC tumors to cetuximab and may do so by altering the activity of several key signaling pathways. Furthermore, these results suggest that signaling via EGFR and SFKs may be necessary for cell proliferation and survival of KRAS mutant CRC tumors. These data strengthen the rationale for clinical trials combining cetuximab and dasatinib in the KRAS mutant CRC genetic setting. Oncogene (2011) 30, 561-574; doi: 10.1038/onc.2010.430; published online 18 October 2010	[Wheeler, D. L.] Univ Wisconsin, Dept Human Oncol, Ctr Comprehens Canc, Sch Med & Publ Hlth, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Wheeler, DL (corresponding author), Univ Wisconsin, Dept Human Oncol, Ctr Comprehens Canc, Sch Med & Publ Hlth, 1111 Highland Ave,WIMR 3159, Madison, WI 53705 USA.	dlwheeler@wisc.edu	Li, Chunrong/F-6955-2011; Wheeler, Deric/B-7175-2013	Wheeler, Deric/0000-0001-5915-3675	Bristol-Myers Squibb; National Cancer Institute [P30CA014520]; National Center for Research Resources, National Institutes of Health [1UL1RR025011]; American Cancer Society [RSG-10-193-01TBG]; National Institutes of Health [CA009614-17]; NATIONAL CANCER INSTITUTE [P30CA014520, T32CA009614] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	DLW has held a sponsored research agreement with Bristol-Myers Squibb.; This project was supported, in part, by grant P30CA014520 from the National Cancer Institute, grant 1UL1RR025011 from the Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health (to DLW), by grant RSG-10-193-01TBG from the American Cancer Society (to DLW) and T32 grant CA009614-17 Physician Scientist Training in Cancer Medicine from the National Institutes of Health (to EFD).	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Belsches A P, 1997, Front Biosci, V2, pd501; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Blake RA, 1999, CELL GROWTH DIFFER, V10, P231; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Cappuzzo F, 2008, ANN ONCOL, V19, P717, DOI 10.1093/annonc/mdm492; CARTWRIGHT CA, 1994, J CLIN INVEST, V93, P509, DOI 10.1172/JCI117000; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; DeMali KA, 1999, EXP CELL RES, V253, P271, DOI 10.1006/excr.1999.4669; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Emaduddin M, 2008, P NATL ACAD SCI USA, V105, P2358, DOI 10.1073/pnas.0712176105; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fu YN, 2008, ONCOGENE, V27, P957, DOI 10.1038/sj.onc.1210684; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Irby R, 1997, CELL GROWTH DIFFER, V8, P1287; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Kantarjian H, 2006, NAT REV DRUG DISCOV, V5, P717, DOI 10.1038/nrd2135; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Koppikar P, 2008, CLIN CANCER RES, V14, P4284, DOI 10.1158/1078-0432.CCR-07-5226; Kronfeld I, 2000, J BIOL CHEM, V275, P35491, DOI 10.1074/jbc.M005991200; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; LI WQ, 1994, MOL CELL BIOL, V14, P6727, DOI 10.1128/MCB.14.10.6727; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, BIOCHEM BIOPH RES CO, V281, P440, DOI 10.1006/bbrc.2001.4383; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; MUTHUSWAMY SK, 1994, MOL CELL BIOL, V14, P735, DOI 10.1128/MCB.14.1.735; MUTHUSWAMY SK, 1995, ONCOGENE, V11, P271; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Rini BI, 2008, CLIN CANCER RES, V14, P1286, DOI 10.1158/1078-0432.CCR-07-4719; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; TERMUHLEN PM, 1993, J SURG RES, V54, P293, DOI 10.1006/jsre.1993.1046; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Viloria-Petit A, 2001, CANCER RES, V61, P5090; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Wheeler DL, 2009, CANCER BIOL THER, V8, P696, DOI 10.4161/cbt.8.8.7903; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706	78	102	107	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	5					561	574		10.1038/onc.2010.430	http://dx.doi.org/10.1038/onc.2010.430			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	715WG	20956938	Green Accepted			2022-12-25	WOS:000286922300005
J	Lahav, T; Sivam, D; Volpin, H; Ronen, M; Tsigankov, P; Green, A; Holland, N; Kuzyk, M; Borchers, C; Zilberstein, D; Myler, PJ				Lahav, T.; Sivam, D.; Volpin, H.; Ronen, M.; Tsigankov, P.; Green, A.; Holland, N.; Kuzyk, M.; Borchers, C.; Zilberstein, D.; Myler, P. J.			Multiple levels of gene regulation mediate differentiation of the intracellular pathogen Leishmania	FASEB JOURNAL			English	Article						gene expression; development; microarray; proteomics	INFECTED MACROPHAGES; AXENIC AMASTIGOTES; GLOBAL ANALYSIS; LIFE-CYCLE; EXPRESSION; DONOVANI; PARASITE; TRANSCRIPTOME; INHIBITION; VACUOLES	For many years, mRNA abundance has been used as the surrogate measure of gene expression in biological systems. However, recent genome-scale analyses in both bacteria and eukaryotes have revealed that mRNA levels correlate with steady-state protein abundance for only 50-70% of genes, indicating that translation and post-translation processes also play important roles in determining gene expression. What is not yet clear is whether dynamic processes such as cell cycle progression, differentiation, or response to environmental changes change the relationship between mRNA and protein abundance. Here, we describe a systems approach to interrogate promastigote-to-amastigote differentiation in the obligatory intracellular parasitic protozoan Leishmania donovani. Our results indicate that regulation of mRNA levels plays a major role early in the differentiation process, while translation and post-translational regulation are more important in the latter part. In addition, it appears that the differentiation signal causes a transient global increase in the rate of protein synthesis, which is subsequently down-regulated by phosphorylation of alpha-subunit of translation initiation factor 2. Thus, Leishmania dynamically changes the relationship between mRNA and protein abundance as it adapts to new environmental circumstances. It is likely that similar mechanisms play a more important role than previously recognized in regulation of gene expression in other organisms.-Lahav, T., Sivam, D., Volpin, H., Ronen, M., Tsigankov, P., Green, A., Holland, N., Kuzyk, M., Borchers, C., Zilberstein, D., Myler, P. J. Multiple levels of gene regulation mediate differentiation of the intracellular pathogen Leishmania. FASEB J. 25, 515-525 (2011). www.fasebj.org	[Lahav, T.; Ronen, M.; Tsigankov, P.; Holland, N.; Zilberstein, D.] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Sivam, D.; Green, A.; Myler, P. J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Sivam, D.; Myler, P. J.] Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA; [Myler, P. J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Volpin, H.] Keygene NV, Wageningen, Netherlands; [Kuzyk, M.; Borchers, C.] Univ Victoria, Prote Ctr, Victoria, BC, Canada	Technion Israel Institute of Technology; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Keygene N.V.; University of Victoria	Zilberstein, D (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	danz@tx.technion.ac.il	BORCHERS, Christoph/U-5964-2019; Myler, Peter John/AAR-9535-2021	Myler, Peter/0000-0002-0056-0513	U.S.-Israel Binational Foundation [2003237]; Israel Ministry of Health Chief Scientist Foundation [33928]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI047234] Funding Source: NIH RePORTER	U.S.-Israel Binational Foundation(US-Israel Binational Science Foundation); Israel Ministry of Health Chief Scientist Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Dr. Roni Koren, Adele Goldman, and Gur Sevillya for experimental aid, Drs. Dan Cassel and Marilyn Parsons for critical discussions, and Dr. Yoav Arava for his help with polysome analyses. This work was supported by U.S.-Israel Binational Foundation grant 2003237 and by Israel Ministry of Health Chief Scientist Foundation grant 33928.	Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; ALEXANDER J, 1992, ADV PARASIT, V31, P175, DOI 10.1016/S0065-308X(08)60022-6; Almeida R, 2004, MOL BIOCHEM PARASIT, V136, P87, DOI 10.1016/j.molbiopara.2004.03.004; ANTOINE JC, 1990, INFECT IMMUN, V58, P779, DOI 10.1128/IAI.58.3.779-787.1990; Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; BATES PA, 1994, EXP PARASITOL, V79, P215, DOI 10.1006/expr.1994.1084; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Burchmore RJS, 2001, INT J PARASITOL, V31, P1311, DOI 10.1016/S0020-7519(01)00259-4; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Chaussee MA, 2008, ARCH MICROBIOL, V189, P27, DOI 10.1007/s00203-007-0290-1; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; DESCOTEAUX A, 1992, J IMMUNOL, V149, P3008; Desjardins M, 1997, J EXP MED, V185, P2061, DOI 10.1084/jem.185.12.2061; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Garcia-Martinez J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r222; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; LANG T, 1994, J CELL SCI, V107, P2137; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Melamed D, 2008, RNA, V14, P1337, DOI 10.1261/rna.864908; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saxena A, 2007, MOL BIOCHEM PARASIT, V152, P53, DOI 10.1016/j.molbiopara.2006.11.011; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Soukas A, 2000, GENE DEV, V14, P963; Swanson MS, 2002, TRAFFIC, V3, P170, DOI 10.1034/j.1600-0854.2002.030302.x; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; Turco SJ, 2001, TRENDS PARASITOL, V17, P223, DOI 10.1016/S1471-4922(01)01895-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469; Zilberstein Dan, 2008, P107	43	111	112	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					515	525		10.1096/fj.10-157529	http://dx.doi.org/10.1096/fj.10-157529			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20952481	Green Published			2022-12-25	WOS:000286724800010
J	Bhatia, B; Hsieh, M; Kenney, AM; Nahle, Z				Bhatia, B.; Hsieh, M.; Kenney, A. M.; Nahle, Z.			Mitogenic Sonic hedgehog signaling drives E2F1-dependent lipogenesis in progenitor cells and medulloblastoma	ONCOGENE			English	Article						sonic hedgehog; medulloblastoma; E2F1; Rb; lipogenesis; metabolism	FATTY-ACID SYNTHASE; ACTIVATED PROTEIN-KINASE; REDUCES FOOD-INTAKE; N-MYC; CYCLE PROGRESSION; E2F1 EXPRESSION; HUMAN HOMOLOG; MICE LACKING; PROLIFERATION; INHIBITION	Deregulation of the Rb/E2F tumor suppressor complex and aberrantion of Sonic hedgehog (Shh) signaling are documented across the spectrum of human malignancies. Exaggerated de novo lipid synthesis is also found in certain highly proliferative, aggressive tumors. Here, we show that in Shh-driven medulloblastomas, Rb is inactivated and E2F1 is upregulated, promoting lipogenesis. Extensive lipid accumulation and elevated levels of the lipogenic enzyme fatty acid synthase (FASN) mark those tumors. In primary cerebellar granule neuron precursors (CGNPs), proposed Shh-associated medulloblastoma cells-of-origin, Shh signaling triggers E2F1 and FASN expression, whereas suppressing fatty acid oxidation (FAO), in a smoothened-dependent manner. In the developing cerebellum, E2F1 and FASN co-localize in proliferating CGNPs. in vivo and in vitro, E2F1 is required for FASN expression and CGNP proliferation, and E2F1 knockdown impairs Shh-mediated FAO inhibition. Pharmacological blockade of Rb inactivation and/or lipogenesis inhibits CGNP proliferation, drives medulloblastoma cell death and extends survival of medulloblastoma-bearing animals In vivo. These findings identify a novel mechanism through which Shh signaling links cell cycle progression to lipid synthesis, through E2F1-dependent regulation of lipogenic enzymes. These findings pertinent to the etiology of tumor metabolism also underscore the key role of the Shh-->E2F1-->FASN axis in regulating de novo lipid synthesis in cancers, and as such its value as a global therapeutic target in hedgehog-dependent and/or Rb-inactivated tumors. Oncogene (2011) 30, 410-422; doi: 10.1038/onc.2010.454; published online 4 October 2010	[Bhatia, B.; Kenney, A. M.] Weill Cornell Med Coll, Dept Cardiothorac Surg, New York, NY 10021 USA; [Hsieh, M.; Nahle, Z.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Nahle, Z (corresponding author), Weill Cornell Med Coll, Dept Cardiothorac Surg, 1300 York Ave, New York, NY 10021 USA.	zan2003@med.cornell.edu			Lung Cancer Center and the division of thoracic surgery at Weill Cornell Medical College; NIH [NINDS R01NS061070]; Memorial Sloan-Kettering Brain Tumor Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061070] Funding Source: NIH RePORTER	Lung Cancer Center and the division of thoracic surgery at Weill Cornell Medical College; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan-Kettering Brain Tumor Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Michael J Klein and the Pathology and Laboratory Medicine group at the Hospital for Special Surgery and MSKCC microcyteometry facility. We also thank Lori A Mainwaring, Cedric Dray, Cemille Guldal, Elisa DeStanchina and Fajun Yang for helpful discussions. These studies were funded by the Lung Cancer Center and the division of thoracic surgery at Weill Cornell Medical College (ZN), the NIH (NINDS R01NS061070) (AMK) and the Memorial Sloan-Kettering Brain Tumor Center (BB).	Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Bhatia B, 2009, CANCER RES, V69, P7224, DOI 10.1158/0008-5472.CAN-09-1299; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cooper-Kuhn CM, 2002, MOL CELL NEUROSCI, V21, P312, DOI 10.1006/mcne.2002.1176; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Dahmane N, 1999, DEVELOPMENT, V126, P3089; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Dowell P, 2005, ANNU REV BIOCHEM, V74, P515, DOI 10.1146/annurev.biochem.73.011303.074027; Dynlacht BD, 1997, MOL CELL BIOL, V17, P3867, DOI 10.1128/MCB.17.7.3867; Eberhart CG, 2008, CANCER CELL, V14, P105, DOI 10.1016/j.ccr.2008.07.011; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Ferretti E, 2006, ONCOGENE, V25, P7267, DOI 10.1038/sj.onc.1209716; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Hepker J, 1997, DEVELOPMENT, V124, P549; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Ho KS, 2002, CURR OPIN NEUROBIOL, V12, P57, DOI 10.1016/S0959-4388(02)00290-8; Hsieh MCF, 2008, J BIOL CHEM, V283, P27410, DOI 10.1074/jbc.M802418200; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Karpen HE, 2001, J BIOL CHEM, V276, P19503, DOI 10.1074/jbc.M010832200; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kimura H, 2008, CANCER CELL, V13, P249, DOI 10.1016/j.ccr.2008.01.027; KolfClauw M, 1996, TERATOLOGY, V54, P115, DOI 10.1002/(SICI)1096-9926(199609)54:3<115::AID-TERA1>3.0.CO;2-2; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Marino S, 2000, GENE DEV, V14, P994; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; MENENDEZ JA, 2009, BIOCH BIOPHYS ACTA; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Olson MV, 2007, CANCER RES, V67, P4005, DOI 10.1158/0008-5472.CAN-06-2973; Orita H, 2008, CLIN CANCER RES, V14, P2458, DOI 10.1158/1078-0432.CCR-07-4177; Orita H, 2007, CLIN CANCER RES, V13, P7139, DOI 10.1158/1078-0432.CCR-07-1186; Parathath SR, 2008, DEVELOPMENT, V135, P3291, DOI 10.1242/dev.022871; Platt KA, 1997, MECH DEVELOP, V62, P121, DOI 10.1016/S0925-4773(96)00648-X; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Thupari JN, 2004, AM J PHYSIOL-ENDOC M, V287, pE97, DOI 10.1152/ajpendo.00261.2003; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wetmore C, 2003, CURR OPIN GENET DEV, V13, P34, DOI 10.1016/S0959-437X(03)00002-9; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; ZHU L, 1995, EMBO J, V14, P1904, DOI 10.1002/j.1460-2075.1995.tb07182.x	67	51	54	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	4					410	422		10.1038/onc.2010.454	http://dx.doi.org/10.1038/onc.2010.454			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	711WH	20890301	Green Accepted			2022-12-25	WOS:000286621600004
J	Dong, CH; Jang, M; Scharein, B; Malach, A; Rivarola, M; Liesch, J; Groth, G; Hwang, I; Chang, C				Dong, Chun-Hai; Jang, Mihue; Scharein, Benjamin; Malach, Anuschka; Rivarola, Maximo; Liesch, Jeff; Groth, Georg; Hwang, Inhwan; Chang, Caren			Molecular Association of the Arabidopsis ETR1 Ethylene Receptor and a Regulator of Ethylene Signaling, RTE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; PROTEIN-PROTEIN INTERACTIONS; HISTIDINE KINASE-ACTIVITY; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; FAMILY-MEMBERS; GENE FAMILY; THALIANA; BINDING	The plant hormone ethylene plays important roles in growth and development. Ethylene is perceived by a family of membrane-bound receptors that actively repress ethylene responses. When the receptors bind ethylene, their signaling is shut off, activating responses. REVERSION-TO-ETHYLENE SENSITIVITY (RTE1) encodes a novel membrane protein conserved in plants and metazoans. Genetic analyses in Arabidopsis thaliana suggest that RTE1 promotes the signaling state of the ethylene receptor ETR1 through the ETR1 N-terminal domain. RTE1 and ETR1 have been shown to co-localize to the endoplasmic reticulum (ER) and Golgi apparatus in Arabidopsis. Here, we demonstrate a physical association of RTE1 and ETR1 using in vivo and in vitro methods. Interaction of RTE1 and ETR1 was revealed in vivo by bimolecular fluorescence complementation (BiFC) in a tobacco cell transient assay and in stably transformed Arabidopsis. The association was also observed using a truncated version of ETR1 comprising the N terminus (amino acids 1-349). Interaction of RTE1 and ETR1 was confirmed by co-immunoprecipitation from Arabidopsis. The interaction occurs with high affinity (K-d, 117 nM) based on tryptophan fluorescence spectroscopy using purified recombinant RTE1 and a tryptophan-less version of purified recombinant ETR1. An amino acid substitution (C161Y) in RTE1 that is known to confer an ETR1 loss-of-function phenotype correspondingly gives a nearly 12-fold increase in the dissociation constant (K-d, 1.38 mu M). These findings indicate that a high affinity association of RTE1 and ETR1 is important in the regulation of ETR1.	[Chang, Caren] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Jang, Mihue; Hwang, Inhwan] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Jang, Mihue; Hwang, Inhwan] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; [Scharein, Benjamin; Malach, Anuschka; Groth, Georg] Univ Dusseldorf, Dept Plant Biochem, D-40225 Dusseldorf, Germany	University System of Maryland; University of Maryland College Park; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Heinrich Heine University Dusseldorf	Chang, C (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, Biosci Res Bldg, College Pk, MD 20742 USA.	carenc@umd.edu	Rivarola, Maximo L/C-1261-2014	Rivarola, Maximo/0000-0003-2818-1037; Jang, Mihue/0000-0002-2135-2983	National Institutes of Health [1R01GM071855]; Ministry of Education, Science and Technology, Korea; Deutsche Forschungsgemeinschaft, Heinrich-Heine-Universitat Dusseldorf [SFB 590]; University of Maryland Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071855] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Deutsche Forschungsgemeinschaft, Heinrich-Heine-Universitat Dusseldorf(German Research Foundation (DFG)); University of Maryland Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant 1R01GM071855 from the National Institutes of Health (to C.C.), a grant from the World Class University project of the Ministry of Education, Science and Technology, Korea (to I.H.), and a grant of the Deutsche Forschungsgemeinschaft (to G.G.) within the SFB 590 "Inharente und adaptive Differenzierungsprozesse" at the Heinrich-Heine-Universitat Dusseldorf. .; Supported in part by the University of Maryland Agricultural Experiment Station.	Abeles F, 1992, ETHYLENE PLANT BIOL; Barry CS, 2006, P NATL ACAD SCI USA, V103, P7923, DOI 10.1073/pnas.0602319103; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Citovsky V, 2008, METHODS, V45, P196, DOI 10.1016/j.ymeth.2008.06.007; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conceicao ADS, 1997, PLANT CELL, V9, P571, DOI 10.2307/3870508; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Hall AE, 2003, PLANT CELL, V15, P2032, DOI 10.1105/tpc.013060; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIN B, 2007, CELLS, P73; Liang F, 1997, P NATL ACAD SCI USA, V94, P8579, DOI 10.1073/pnas.94.16.8579; Ma B, 2006, PLANT PHYSIOL, V141, P587, DOI 10.1104/pp.106.080523; MASON SW, 1992, J MOL BIOL, V223, P55, DOI 10.1016/0022-2836(92)90715-V; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; O'Malley RC, 2005, PLANT J, V41, P651, DOI 10.1111/j.1365-313X.2004.02331.X; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Resnick JS, 2008, PLANT J, V56, P423, DOI 10.1111/j.1365-313X.2008.03615.x; Resnick JS, 2006, P NATL ACAD SCI USA, V103, P7917, DOI 10.1073/pnas.0602239103; Rivarola M, 2009, PLANT PHYSIOL, V150, P547, DOI 10.1104/pp.109.138461; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Sanderfoot AA, 2001, MOL BIOL CELL, V12, P3733, DOI 10.1091/mbc.12.12.3733; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Scharein B, 2008, ANAL BIOCHEM, V377, P72, DOI 10.1016/j.ab.2008.03.015; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Voet-van-Vormizeele J, 2008, MOL PLANT, V1, P380, DOI 10.1093/mp/ssn004; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang WY, 2006, PLANT CELL, V18, P3429, DOI 10.1105/tpc.106.044537; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; ZHOU M, 1993, BIOCHEMISTRY-US, V32, P8193, DOI 10.1021/bi00083a020; Zhou X, 2007, PLANT PHYSIOL, V145, P75, DOI 10.1104/pp.107.104299	49	70	78	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40706	40713		10.1074/jbc.M110.146605	http://dx.doi.org/10.1074/jbc.M110.146605			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952388	hybrid, Green Published			2022-12-25	WOS:000285414400034
J	Sirinupong, N; Brunzelle, J; Ye, J; Pirzada, A; Nico, L; Yang, Z				Sirinupong, Nualpun; Brunzelle, Joseph; Ye, Jun; Pirzada, Ali; Nico, Lindsey; Yang, Zhe			Crystal Structure of Cardiac-specific Histone Methyltransferase SmyD1 Reveals Unusual Active Site Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; MYND DOMAIN; PROTEIN; METHYLATION; MECHANISM; SOFTWARE; ENCODES; TARGET; MODEL; BOP	SmyD1 is a cardiac-and muscle-specific histone methyltransferase that methylates histone H3 at lysine 4 and regulates gene transcription in early heart development. The unique domain structure characterized by a "split" SET domain, a conserved MYND zinc finger, and a novel C-terminal domain (CTD) distinguishes SmyD1 from other SET domain containing methyltransferases. Here we report the crystal structure of full-length SmyD1 in complex with the cofactor analog sinefungin at 2.3 angstrom. The structure reveals that SmyD1 folds into a wrench-shaped structure with two thick "grips" separated by a large, deep concave opening. Importantly, our structural and functional analysis suggests that SmyD1 appears to be regulated by an autoinhibition mechanism, and that unusually spacious target lysine-access channel and the presence of the CTD domain both negatively contribute to the regulation of this cardiovascularly relevant methyltransferase. Furthermore, our structure also provides a structural basis for the interaction between SmyD1 and cardiac transcription factor skNAC, and suggests that the MYND domain may primarily serve as a protein interaction module and cooperate SmyD1 with skNAC to regulate cardiomyocyte growth and maturation. Overall, our data provide novel insights into the mechanism of SmyD1 regulation, which would be helpful in further understanding the role of this protein in heart development and cardiovascular diseases.	[Sirinupong, Nualpun; Ye, Jun; Pirzada, Ali; Nico, Lindsey; Yang, Zhe] Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI USA; [Brunzelle, Joseph] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Wayne State University; United States Department of Energy (DOE); Argonne National Laboratory	Yang, Z (corresponding author), 540 E Canfield St, Detroit, MI 48201 USA.	zyang@med.wayne.edu	Ye, Jun/J-8823-2012; Sirinupong, Nualpun/AAX-4886-2020	Sirinupong, Nualpun/0000-0002-9986-3011	American Heart Association	American Heart Association(American Heart Association)	This work was supported by the American Heart Association.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Kunizaki M, 2007, CANCER RES, V67, P10759, DOI 10.1158/0008-5472.CAN-07-1132; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ruden DM, 2005, HUM MOL GENET, V14, pR149, DOI 10.1093/hmg/ddi103; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Silva FP, 2008, ONCOGENE, V27, P2686, DOI 10.1038/sj.onc.1210929; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	31	59	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40635	40644		10.1074/jbc.M110.168187	http://dx.doi.org/10.1074/jbc.M110.168187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943667	Green Published, hybrid			2022-12-25	WOS:000285414400026
J	Yuan, J; Sterckx, Y; Mitchenall, LA; Maxwell, A; Loris, R; Waldor, MK				Yuan, Jie; Sterckx, Yann; Mitchenall, Lesley A.; Maxwell, Anthony; Loris, Remy; Waldor, Matthew K.			Vibrio cholerae ParE2 Poisons DNA Gyrase via a Mechanism Distinct from Other Gyrase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RANGE PLASMID RK2; TOXIN-ANTITOXIN SYSTEMS; P-BAD PROMOTER; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BACTERIAL TOXIN; F-PLASMID; STRUCTURAL BASIS; STRAND-PASSAGE; NALIDIXIC-ACID	DNA gyrase is an essential bacterial enzyme required for the maintenance of chromosomal DNA topology. This enzyme is the target of several protein toxins encoded in toxin-antitoxin ( TA) loci as well as of man-made antibiotics such as quinolones. The genome of Vibrio cholerae, the cause of cholera, contains three putative TA loci that exhibit modest similarity to the RK2 plasmid-borne parDE TA locus, which is thought to target gyrase although its mechanism of action is uncharacterized. Here we investigated the V. cholerae parDE2 locus. We found that this locus encodes a functional proteic TA pair that is active in Escherichia coli as well as V. cholerae. ParD2 co-purified with ParE2 and interacted with it directly. Unlike many other antitoxins, ParD2 could prevent but not reverse ParE2 toxicity. ParE2, like the unrelated F-encoded toxin CcdB and quinolones, targeted the GyrA subunit and stalled the DNA-gyrase cleavage complex. However, in contrast to other gyrase poisons, ParE2 toxicity required ATP, and it interfered with gyrase-dependent DNA supercoiling but not DNA relaxation. ParE2 did not bind GyrA fragments bound by CcdB and quinolones, and a set of strains resistant to a variety of known gyrase inhibitors all exhibited sensitivity to ParE2. Together, our findings suggest that ParE2 and presumably its many plasmid-and chromosome-encoded homologues inhibit gyrase in a different manner than previously described agents.	[Waldor, Matthew K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Yuan, Jie; Waldor, Matthew K.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Yuan, Jie; Waldor, Matthew K.] Tufts Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; [Sterckx, Yann; Loris, Remy] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Sterckx, Yann; Loris, Remy] Vlaams Inst Biotechnol, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Tufts University; Tufts University; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Waldor, MK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	mwaldor@rics.bwh.harvard.edu	Loris, Remy/GPG-0894-2022; Sterckx, Yann G.-J./F-2269-2017	Sterckx, Yann G.-J./0000-0002-7420-0983; Waldor, Matthew/0000-0003-1843-7000; Loris, Remy/0000-0002-8862-3338; Mitchenall, Lesley/0000-0002-0063-1991; Maxwell, Anthony/0000-0002-5756-6430	National Institutes of Health [R37 AI-42347]; Howard Hughes Medical Institute; Vlaams Instituut voor Biotechnologie, Vrije Universiteit Brussel and FWO-Vlaanderen; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Vlaams Instituut voor Biotechnologie, Vrije Universiteit Brussel and FWO-Vlaanderen; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 AI-42347. This work was also supported by the Howard Hughes Medical Institute (to M. K. W.). Part of this work was supported by grants from Vlaams Instituut voor Biotechnologie, Vrije Universiteit Brussel and FWO-Vlaanderen. This work was also supported by the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (to A.M.).	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; Bocs S, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-5; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dao-Thi MH, 2004, ACTA CRYSTALLOGR D, V60, P1132, DOI 10.1107/S0907444904007814; De Jonge N, 2007, ACTA CRYSTALLOGR F, V63, P356, DOI 10.1107/S1744309107012092; De Jonge N, 2010, J BIOL CHEM, V285, P5606, DOI 10.1074/jbc.M109.068429; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Easter CL, 1997, J BACTERIOL, V179, P6472, DOI 10.1128/jb.179.20.6472-6479.1997; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hallez R, 2010, MOL MICROBIOL, V76, P719, DOI 10.1111/j.1365-2958.2010.07129.x; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; LESSL M, 1992, J BACTERIOL, V174, P2493, DOI 10.1128/jb.174.8.2493-2500.1992; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; Nollmann M, 2007, NAT STRUCT MOL BIOL, V14, P264, DOI 10.1038/nsmb1213; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; ROBERTS RC, 1994, J MOL BIOL, V237, P35, DOI 10.1006/jmbi.1994.1207; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Simic M, 2009, J BIOL CHEM, V284, P20002, DOI 10.1074/jbc.M109.014035; Smith AB, 2006, NUCLEIC ACIDS RES, V34, P4667, DOI 10.1093/nar/gkl636; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Yamaichi Y, 2007, P NATL ACAD SCI USA, V104, P630, DOI 10.1073/pnas.0608341104	55	51	54	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40397	40408		10.1074/jbc.M110.138776	http://dx.doi.org/10.1074/jbc.M110.138776			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20952390	hybrid, Green Published			2022-12-25	WOS:000285185500082
J	Gravel, S; Malouf, C; Boulais, PE; Berchiche, YA; Oishi, S; Fujii, N; Leduc, R; Sinnett, D; Heveker, N				Gravel, Stephanie; Malouf, Camille; Boulais, Philip E.; Berchiche, Yamina A.; Oishi, Shinya; Fujii, Nobutaka; Leduc, Richard; Sinnett, Daniel; Heveker, Nikolaus			The Peptidomimetic CXCR4 Antagonist TC14012 Recruits beta-Arrestin to CXCR7 ROLES OF RECEPTOR DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; WEAK PARTIAL AGONISTS; HIV PEPTIDE T140; CHEMOKINE RECEPTOR; T-LYMPHOCYTES; AMD3100; PHOSPHORYLATION; INHIBITION; ACTIVATION; MIGRATION	CXCR7 is an atypical chemokine receptor that signals through beta-arrestin in response to agonists without detectable activation of heterotrimeric G-proteins. Its cognate chemokine ligand CXCL12 also binds CXCR4, a chemokine receptor of considerable clinical interest. Here we report that TC14012, a peptidomimetic inverse agonist of CXCR4, is an agonist on CXCR7. The potency of beta-arrestin recruitment to CXCR7 by TC14012 is much higher than that of the previously reported CXCR4 antagonist AMD3100 and differs only by one log from that of the natural ligand CXCL12 (EC50 350 nM for TC14012, as compared with 30 nM for CXCL12 and 140 mu M for AMD3100). Moreover, like CXCL12, TC14012 leads to Erk 1/2 activation in U373 glioma cells that express only CXCR7, but not CXCR4. Given that with TC14012 and AMD3100 two structurally unrelated CXCR4 antagonists turn out to be agonists on CXCR7, this likely reflects differences in the activation mechanism of the arrestin pathway by both receptors. To identify the receptor domain responsible for these opposed effects, we investigated CXCR4 and CXCR7 C terminus-swapping chimeras. Using quantitative bioluminescence resonance energy transfer, we find that the CXCR7 receptor core formed by the seven-transmembrane domains and the connecting loops determines the agonistic activity of both TC14012 and AMD3100. Moreover, we find that the CXCR7 chimera bearing the CXCR4 C-terminal constitutively associates with arrestin in the absence of ligands. Our data suggest that the CXCR4 and CXCR7 cores share ligand-binding surfaces for the binding of the synthetic ligands, indicating that CXCR4 inhibitors should be tested also on CXCR7.	[Gravel, Stephanie; Malouf, Camille; Berchiche, Yamina A.; Heveker, Nikolaus] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Gravel, Stephanie; Malouf, Camille; Berchiche, Yamina A.; Sinnett, Daniel; Heveker, Nikolaus] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Boulais, Philip E.; Leduc, Richard] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Sinnett, Daniel] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; University of Sherbrooke; Kyoto University; Universite de Montreal	Heveker, N (corresponding author), 6737 Hop St Justine, Ctr Rech, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nikolaus.heveker@recherche-ste-justine.qc.ca	Oishi, Shinya/C-1350-2011; sinnett, daniel/S-4589-2017; Heveker, Nikolaus/G-5306-2012	Oishi, Shinya/0000-0002-2833-2539; sinnett, daniel/0000-0003-3625-6676; Malouf, Camille/0000-0002-1066-8376; Berchiche, Yamina/0000-0002-9559-9209	Canadian Institutes of Health Research (CIHR); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Fondation de l'Hopital Sainte-Justine; Groupe de Recherche Universitaire sur le Medicament; "Fonds de la recherche en sante du Quebec" (FRSQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fondation de l'Hopital Sainte-Justine; Groupe de Recherche Universitaire sur le Medicament; "Fonds de la recherche en sante du Quebec" (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, scholarships from the "Fondation de l'Hopital Sainte-Justine" and the "Groupe de Recherche Universitaire sur le Medicament" (to S.G.), a grant from the "Fonds de la recherche en sante du Quebec" (FRSQ) (to C.M.), and CIHR fellowships (to P.E.B. and Y.A.B.).	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Boulais PE, 2009, BIOCHEM PHARMACOL, V78, P1382, DOI 10.1016/j.bcp.2009.07.007; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Narumi T, 2010, ORG BIOMOL CHEM, V8, P616, DOI 10.1039/b917236j; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Oishi S, 2008, CHEMBIOCHEM, V9, P1154, DOI 10.1002/cbic.200700761; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Schiller PW, 2010, LIFE SCI, V86, P598, DOI 10.1016/j.lfs.2009.02.025; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tamamura H, 2001, BIOORG MED CHEM LETT, V11, P1897, DOI 10.1016/S0960-894X(01)00323-7; Tamamura H, 1998, BIOCHEM BIOPH RES CO, V253, P877, DOI 10.1006/bbrc.1998.9871; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Trent JO, 2003, J BIOL CHEM, V278, P47136, DOI 10.1074/jbc.M307850200; Wu B., 2010, SCIENCE IN PRESS; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	30	72	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37939	37943		10.1074/jbc.C110.147470	http://dx.doi.org/10.1074/jbc.C110.147470			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20956518	Green Published, hybrid			2022-12-25	WOS:000284625600001
J	Ikeda, O; Sekine, Y; Mizushima, A; Nakasuji, M; Miyasaka, Y; Yamamoto, C; Muromoto, R; Nanbo, A; Oritani, K; Yoshimura, A; Matsuda, T				Ikeda, Osamu; Sekine, Yuichi; Mizushima, Akihiro; Nakasuji, Misa; Miyasaka, Yuto; Yamamoto, Chikako; Muromoto, Ryuta; Nanbo, Asuka; Oritani, Kenji; Yoshimura, Akihiko; Matsuda, Tadashi			Interactions of STAP-2 with Brk and STAT3 Participate in Cell Growth of Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRECEPTOR TYROSINE KINASE; MAMMARY EPITHELIAL-CELLS; TUMOR KINASE; EXPRESSION; ACTIVATION; PROTEIN; SUBSTRATE; MIGRATION; INVASION; BRK/SIK	STAP-2 (signal transducing adaptor protein-2) is a recently identified adaptor protein that contains pleckstrin homology (PH) and Src homology 2-like domains, as well as a STAT3-binding motif in its C-terminal region. STAP-2 is also a substrate of breast tumor kinase (Brk). In breast cancers, Brk expression is deregulated and promotes STAT3-dependent cell proliferation. In the present study, manipulated STAP-2 expression demonstrated essential roles of STAP-2 in Brk-mediated STAT3 activation. STAP-2 interacts with both Brk and STAT3. In addition, small interfering RNA-mediated reduction of endogenous STAP-2 expression strongly decreased Brk-mediated STAT3 activation in T47D breast cancer cells. The PH domain of STAP-2 is involved in multiple steps: the binding between Brk and STAP-2, the activation and tyrosine phosphorylation of STAT3, and the activation of Brk. Notably, a STAP-2 PH-Brk fusion protein exhibited robust kinase activity and increased activation and tyrosine phosphorylation of STAT3. Finally, STAP-2 knockdown in T47D cells induced a significant decrease of proliferation, as strong as that of Brk or STAT3 knockdown. Taken together, our findings are likely to inform the development of a novel therapeutic strategy, as well as the determination of novel prognostic values, in breast carcinomas.	[Matsuda, Tadashi] Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Oritani, Kenji] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka 5650871, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan	Hokkaido University; Osaka University; Keio University	Matsuda, T (corresponding author), Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Muromoto, Ryuta/E-4203-2012; Nanbo, Asuka/C-6630-2012; Yoshimura, Akihiko/K-5515-2013; Nanbo, Asuka/P-2478-2019; Sekine, Yuichi/S-8813-2019	Matsuda, Tadashi/0000-0002-3089-3757; Muromoto, Ryuta/0000-0002-7474-493X; Nanbo, Asuka/0000-0001-8764-1350; Nanbo, Asuka/0000-0001-8764-1350; Sekine, Yuichi/0000-0002-2861-603X; Misa, Togi/0000-0002-7424-4548	Suhara Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Suhara Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Suhara Memorial Foundation and Grant-in-Aid for scientific research from Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aubele M, 2008, BRIT J CANCER, V99, P1089, DOI 10.1038/sj.bjc.6604660; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, BREAST CANCER RES, V2, P86, DOI 10.1186/bcr38; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Harvey AJ, 2003, ONCOGENE, V22, P5006, DOI 10.1038/sj.onc.1206577; Ikeda O, 2008, MOL CELL BIOL, V28, P5027, DOI 10.1128/MCB.00194-08; Ikeda O, 2009, BIOCHEM BIOPH RES CO, V384, P71, DOI 10.1016/j.bbrc.2009.04.076; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; LEE ST, 1993, ONCOGENE, V8, P3403; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Llor X, 1999, CLIN CANCER RES, V5, P1767; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; Matsuda T, 2004, BIOCHEM BIOPH RES CO, V325, P586, DOI 10.1016/j.bbrc.2004.10.071; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Mitchell PJ, 2000, ONCOGENE, V19, P4273, DOI 10.1038/sj.onc.1203775; Mitchell PJ, 1997, ONCOGENE, V15, P1497, DOI 10.1038/sj.onc.1201292; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Sekine Y, 2007, ONCOGENE, V26, P6038, DOI 10.1038/sj.onc.1210426; Sekine Y, 2005, J BIOL CHEM, V280, P8188, DOI 10.1074/jbc.M411692200; Sekine Y, 2009, J IMMUNOL, V183, P7966, DOI 10.4049/jimmunol.0902096; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794	30	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38093	38103		10.1074/jbc.M110.162388	http://dx.doi.org/10.1074/jbc.M110.162388			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20929863	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000284625600017
J	El-Kasaby, A; Just, H; Malle, E; Stolt-Bergner, PC; Sitte, HH; Freissmuth, M; Kudlacek, O				El-Kasaby, Ali; Just, Herwig; Malle, Elisabeth; Stolt-Bergner, Peggy C.; Sitte, Harald H.; Freissmuth, Michael; Kudlacek, Oliver			Mutations in the Carboxyl-terminal SEC24 Binding Motif of the Serotonin Transporter Impair Folding of the Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; DOPAMINE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; GABA TRANSPORTER-1; C-TERMINUS; OLIGOMER FORMATION; IN-VIVO; PROTEIN; EXPORT; TRAFFICKING	The serotonin transporter (SERT) is a member of the SLC6 family of solute carriers. SERT plays a crucial role in synaptic neurotransmission by retrieving released serotonin. The intracellular carboxyl terminus of various neurotransmitter transporters has been shown to be important for the correct delivery of SLC6 family members to the cell surface. Here we studied the importance of the C terminus in trafficking and folding of human SERT. Serial truncations followed by mutagenesis identified sequence spots (PG(601,602), RII607-609) within the C terminus relevant for export of SERT from the endoplasmic reticulum (ER). RI607,608 is homologous to the RL-motif that in other SLC6 family members provides a docking site for the COPII component Sec24D. The primary defect resulting from mutation at PG(601,602) and RI607,608 was impaired folding, because mutated transporters failed to bind the inhibitor [H-3] imipramine. In contrast, when retained in the ER (e. g. by dominant negative Sar1) the wild type transporter bound [3H] imipramine with an affinity comparable to that of the surface-expressed transporter. SERT-RI(607,608)AA and SERT-RII(607-609)AAA were partially rescued by treatment of cells with the nonspecific chemical chaperone DMSO or the specific pharmacochaperone ibogaine (which binds to the inward facing conformation of SERT) but not by other classes of ligands (inhibitors, substrates, amphetamines). These observations (i) demonstrate an hitherto unappreciated role of the C terminus in the folding of SERT, (ii) indicates that the folding trajectory proceeds via an inward facing intermediate, and (iii) suggest a model where the RI-motif plays a crucial role in preventing premature Sec24-recruitment and export of incorrectly folded transporters.	[El-Kasaby, Ali; Just, Herwig; Sitte, Harald H.; Freissmuth, Michael; Kudlacek, Oliver] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Malle, Elisabeth; Stolt-Bergner, Peggy C.] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Medical University of Vienna; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Kudlacek, O (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Wahringer Str 13A, A-1090 Vienna, Austria.	oliver.kudlacek@meduniwien.ac.at	Sitte, Harald/N-2681-2013; Sitte, Harald/O-7025-2019	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Stolt-Bergner, Peggy/0000-0002-5887-2915; Freissmuth, Michael/0000-0001-9398-1765; Kudlacek, Oliver/0000-0002-3086-8551	Austrian Science Fund/FWF [SFB3506, SFB3507, SFB3510]; Egyptian Ministry of Higher Education and State for Scientific Research; Austrian Science Fund (FWF) [F 3507, F 3506] Funding Source: researchfish	Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Egyptian Ministry of Higher Education and State for Scientific Research(Ministry of Higher Education & Scientific Research (MHESR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund/FWF (SFB3506, to H. H. S.; SFB3507, to P. C. S.-B., and SFB3510, to M. F.) and a stipend from the Egyptian Ministry of Higher Education and State for Scientific Research (to A. E.).	Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001; Bauman PA, 2002, ARCH BIOCHEM BIOPHYS, V404, P80, DOI 10.1016/S0003-9861(02)00232-1; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2008, J CELL SCI, V121, P753, DOI 10.1242/jcs.017681; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Korkhov VM, 2008, J MOL BIOL, V378, P337, DOI 10.1016/j.jmb.2008.02.056; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Masson J, 1999, PHARMACOL REV, V51, P439; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Moss FJ, 2009, J GEN PHYSIOL, V134, P489, DOI 10.1085/jgp.200910314; Nelson N, 1998, J NEUROCHEM, V71, P1785; Nezu A, 2009, J BIOL CHEM, V284, P6869, DOI 10.1074/jbc.M804302200; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Singh SK, 2008, CHANNELS, V2, P380, DOI 10.4161/chan.2.5.6904; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 2001, MOL PHARMACOL, V59, P1129, DOI 10.1124/mol.59.5.1129; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2	39	47	47	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39201	39210		10.1074/jbc.M110.118000	http://dx.doi.org/10.1074/jbc.M110.118000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889976	hybrid, Green Published			2022-12-25	WOS:000284941300050
J	Kennedy, EM; Gavegnano, C; Nguyen, L; Slater, R; Lucas, A; Fromentin, E; Schinazi, RF; Kim, B				Kennedy, Edward M.; Gavegnano, Christina; Nguyen, Laura; Slater, Rebecca; Lucas, Amanda; Fromentin, Emilie; Schinazi, Raymond F.; Kim, Baek			Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEADY-STATE KINETICS; DNA-POLYMERASE-BETA; NUCLEOSIDE ANALOGS; HIV-1 INFECTION; DNTP BINDING; IN-VIVO; FIDELITY; CELLS; INHIBITION; SEQUENCE	We biochemically simulated HIV-1 DNA polymerization in physiological nucleotide pools found in two HIV-1 target cell types: terminally differentiated/non-dividing macrophages and activated/dividing CD4(+) T cells. Quantitative tandem mass spectrometry shows that macrophages harbor 22-320-fold lower dNTP concentrations and a greater disparity between ribonucleoside triphosphate (rNTP) and dNTP concentrations than dividing target cells. A biochemical simulation of HIV-1 reverse transcription revealed that rNTPs are efficiently incorporated into DNA in the macrophage but not in the T cell environment. This implies that HIV-1 incorporates rNTPs during viral replication in macrophages and also predicts that rNTP chain terminators lacking a 3'-OH should inhibit HIV-1 reverse transcription in macrophages. Indeed, 3'-deoxyadenosine inhibits HIV-1 proviral DNA synthesis in human macrophages more efficiently than in CD4(+) T cells. This study reveals that the biochemical landscape of HIV-1 replication in macrophages is unique and that ribonucleoside chain terminators may be a new class of anti-HIV-1 agents specifically targeting viral macrophage infection.	[Kennedy, Edward M.; Nguyen, Laura; Slater, Rebecca; Lucas, Amanda; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Gavegnano, Christina; Fromentin, Emilie; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, Decatur, GA 30033 USA; [Gavegnano, Christina; Fromentin, Emilie; Schinazi, Raymond F.] Vet Affairs Med Ctr, Decatur, GA 30033 USA	University of Rochester; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu	Schinazi, Raymond F/B-6777-2017	Kennedy, Edward/0000-0002-2817-4809	National Institutes of Health [AI049781, T32 AI007362, TL1 RR024135, 2P30-AI-050409, R01-AI-076535, 5R37-AI-041980, 5R37-AI-025899]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R37AI025899, R01AI076535, R37AI041980, T32AI007362, P30AI050409, R56AI049781] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AI049781 (to B. K.), T32 AI007362 (to E. M. K.), TL1 RR024135 (to A. L.), 2P30-AI-050409, R01-AI-076535, 5R37-AI-041980, and 5R37-AI-025899. This work was also supported by the Department of Veterans Affairs (to R. F. S.).	Aggarwal S., PLOS ONE, V5, pe10372; Arts EJ, 1996, J VIROL, V70, P712, DOI 10.1128/JVI.70.2.712-720.1996; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; Bergoglio V, 2003, J MOL BIOL, V331, P1017, DOI 10.1016/S0022-2836(03)00837-4; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Boule JB, 2001, J BIOL CHEM, V276, P31388, DOI 10.1074/jbc.M105272200; Boyer JC, 1996, METHOD ENZYMOL, V275, P523; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; Fernandes PA, 2003, CHEM-EUR J, V9, P5916, DOI 10.1002/chem.200304948; Fromentin E, 2010, ANAL CHEM, V82, P1982, DOI 10.1021/ac902737j; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gardner AF, 1999, NUCLEIC ACIDS RES, V27, P2545, DOI 10.1093/nar/27.12.2545; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kennedy EM, 2009, BIOCHEMISTRY-US, V48, P11161, DOI 10.1021/bi9010122; KOPP EB, 1991, NUCLEIC ACIDS RES, V19, P3035, DOI 10.1093/nar/19.11.3035; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; LETVIN NL, 1983, P NATL ACAD SCI-BIOL, V80, P2718, DOI 10.1073/pnas.80.9.2718; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; Perez-Bercoff D, 2007, J VIROL, V81, P4540, DOI 10.1128/JVI.01620-06; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; SCHUITEMAKER H, 1994, EMBO J, V13, P5929, DOI 10.1002/j.1460-2075.1994.tb06938.x; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Skasko M, 2008, J VIROL, V82, P7716, DOI 10.1128/JVI.00120-08; Skasko M, 2009, BIOCHEMISTRY-US, V48, P5389, DOI 10.1021/bi900346m; STRIDH S, 1983, ARCH VIROL, V77, P223, DOI 10.1007/BF01309269; Sun GL, 2001, J VIROL, V75, P11902, DOI 10.1128/JVI.75.23.11902-11906.2001; Traut T., 1994, MOL CELL BIOCHEM, V140, P1573; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; Weiss KK, 2000, BIOCHEMISTRY-US, V39, P10684, DOI 10.1021/bi000788y; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200; WESTERVELT P, 1992, J VIROL, V66, P2577, DOI 10.1128/JVI.66.4.2577-2582.1992; Wilkinson DA, 1998, J INFECT DIS, V178, P1163, DOI 10.1086/515675; Willey S, 2005, ANTIVIR RES, V68, P96, DOI 10.1016/j.antiviral.2005.07.006; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	55	77	77	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39380	39391		10.1074/jbc.M110.178582	http://dx.doi.org/10.1074/jbc.M110.178582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20924117	Green Published, hybrid			2022-12-25	WOS:000284941300065
J	Pessa, HKJ; Greco, D; Kvist, J; Wahlstrom, G; Heino, TI; Auvinen, P; Frilander, MJ				Pessa, Heli K. J.; Greco, Dario; Kvist, Jouni; Wahlstrom, Gudrun; Heino, Tapio I.; Auvinen, Petri; Frilander, Mikko J.			Gene Expression Profiling of U12-Type Spliceosome Mutant Drosophila Reveals Widespread Changes in Metabolic Pathways	PLOS ONE			English	Article							U12-DEPENDENT INTRONS; MINOR-CLASS; PROHIBITIN FAMILY; IN-VIVO; U11; PROTEIN; SITE; U6ATAC; SNRNPS; ACTIVATION	Background: The U12-type spliceosome is responsible for the removal of a subset of introns from eukaryotic mRNAs. U12-type introns are spliced less efficiently than normal U2-type introns, which suggests a rate-limiting role in gene expression. The Drosophila genome contains about 20 U12-type introns, many of them in essential genes, and the U12-type spliceosome has previously been shown to be essential in the fly. Methodology/Principal Findings: We have used a Drosophila line with a P-element insertion in U6atac snRNA, an essential component of the U12-type spliceosome, to investigate the impact of U12-type introns on gene expression at the organismal level during fly development. This line exhibits progressive accumulation of unspliced U12-type introns during larval development and the death of larvae at the third instar stage. Surprisingly, microarray and RT-PCR analyses revealed that most genes containing U12-type introns showed only mild perturbations in the splicing of U12-type introns. In contrast, we detected widespread downstream effects on genes that do not contain U12-type introns, with genes related to various metabolic pathways constituting the largest group. Conclusions/Significance: U12-type intron-containing genes exhibited variable gene-specific responses to the splicing defect, with some genes showing up-or downregulation, while most did not change significantly. The observed residual U12-type splicing activity could be explained with the mutant U6atac allele having a low level of catalytic activity. Detailed analysis of all genes suggested that a defect in the splicing of the U12-type intron of the mitochondrial prohibitin gene may be the primary cause of the various downstream effects detected in the microarray analysis.	[Pessa, Heli K. J.; Greco, Dario; Kvist, Jouni; Wahlstrom, Gudrun; Auvinen, Petri; Frilander, Mikko J.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Wahlstrom, Gudrun; Heino, Tapio I.] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki; University of Helsinki	Pessa, HKJ (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	Mikko.Frilander@Helsinki.fi	Frilander, Mikko J/B-6660-2009; Auvinen, Petri/AAP-8117-2021; Greco, Dario/T-7113-2019; Auvinen, Petri/D-5044-2009	Frilander, Mikko J/0000-0002-1732-4808; Greco, Dario/0000-0001-9195-9003; Auvinen, Petri/0000-0002-3947-4778; Wahlstrom, Gudrun/0000-0003-1177-1137; Kvist, Jouni/0000-0002-4089-8877	Academy of Finland [110245, 117968]; Viikki Graduate School in Biosciences; Alfred Kordelin Foundation	Academy of Finland(Academy of Finland); Viikki Graduate School in Biosciences; Alfred Kordelin Foundation	This work was supported by the Academy of Finland (Grant 110245 to MJF and Grant 117968 to PA; www.aka.fi), Viikki Graduate School in Biosciences (HP; www.biocenter.helsinki.fi/viikkigs), and Alfred Kordelin Foundation (HP; www.kordelin.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Basu MK, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-19; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EVELETH DD, 1986, NUCLEIC ACIDS RES, V14, P6169, DOI 10.1093/nar/14.15.6169; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Friend K, 2008, RNA, V14, P1459, DOI 10.1261/rna.1119708; Frilander MJ, 1999, GENE DEV, V13, P851, DOI 10.1101/gad.13.7.851; Frilander MJ, 2001, MOL CELL, V7, P217, DOI 10.1016/S1097-2765(01)00169-1; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Incorvaia R, 1998, RNA, V4, P709, DOI 10.1017/S1355838298980207; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Kolossova I, 1997, RNA, V3, P227; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Lin CF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-47; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Patel AA, 2002, EMBO J, V21, P3804, DOI 10.1093/emboj/cdf297; Pessa HKJ, 2008, P NATL ACAD SCI USA, V105, P8655, DOI 10.1073/pnas.0803646105; Pessa HKJ, 2006, RNA, V12, P1883, DOI 10.1261/rna.213906; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Russell AG, 2006, NATURE, V443, P863, DOI 10.1038/nature05228; Schneider C, 2004, P NATL ACAD SCI USA, V101, P9584, DOI 10.1073/pnas.0403400101; Schneider C, 2002, MOL CELL BIOL, V22, P3219, DOI 10.1128/MCB.22.10.3219-3229.2002; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Shukla GC, 1999, RNA, V5, P525, DOI 10.1017/S1355838299982213; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spradling AC, 1999, GENETICS, V153, P135; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Turunen JJ, 2008, MOL CELL BIOL, V28, P3548, DOI 10.1128/MCB.01928-07; Valadkhan S, 2005, CURR OPIN CHEM BIOL, V9, P603, DOI 10.1016/j.cbpa.2005.10.008; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Van Aken O, 2007, PLANT J, V52, P850, DOI 10.1111/j.1365-313X.2007.03276.x; Verbeeren J, 2010, MOL CELL, V37, P821, DOI 10.1016/j.molcel.2010.02.014; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yu YT, 1997, P NATL ACAD SCI USA, V94, P6030, DOI 10.1073/pnas.94.12.6030; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142	54	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13215	10.1371/journal.pone.0013215	http://dx.doi.org/10.1371/journal.pone.0013215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949011	Green Published, gold, Green Submitted			2022-12-25	WOS:000282748100002
J	Pongratz, C; Yazdanpanah, B; Kashkar, H; Lehmann, MJ; Krausslich, HG; Kronke, M				Pongratz, Carola; Yazdanpanah, Benjamin; Kashkar, Hamid; Lehmann, Maik J.; Kraeusslich, Hans-Georg; Kroenke, Martin			Selection of Potent Non-Toxic Inhibitory Sequences from a Randomized HIV-1 Specific Lentiviral Short Hairpin RNA Library	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL INTERFERING RNAS; MAMMALIAN-CELLS; PHAGE POLYMERASE; GENE-THERAPY; SIRNA; EXPRESSION; INFECTION; SHRNA; ESCAPE	RNA interference (RNAi) has been considered as an efficient therapeutic approach against the human immunodeficiency virus type 1 (HIV-1). However, to establish a durable inhibition of HIV-1, multiple effective short hairpin RNAs (shRNAs) need to be stably expressed to prevent the emergence of viral escape variants. In this study, we engineered a randomized lentiviral H1-promoter driven shRNA-library against the viral genome. Potent HIV-1 specific shRNAs were selected by ganciclovir treatment of cell lines stably expressing the cDNA of Herpes Simplex Virus thymidine kinase (HSV-TK) fused to HIV-1 nucleotide sequences. More than 50% of 200 selected shRNAs inhibited an HIV-1 based luciferase reporter assay by more than 70%. Stable expression of some of those shRNAs in an HIV-1 permissive HeLa cell line inhibited infection of wildtype HIV-1 by more than 90%. The combination of a randomized shRNA-library directed against HIV-1 with a live cell selection procedure yielded non-toxic and highly efficient HIV-1 specific inhibitory sequences that could serve as valuable candidates for gene therapy studies.	[Pongratz, Carola; Yazdanpanah, Benjamin; Kashkar, Hamid; Kroenke, Martin] Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Pongratz, Carola; Kashkar, Hamid; Kroenke, Martin] Univ Cologne, Inst Genet, D-5000 Cologne, Germany; [Yazdanpanah, Benjamin; Kashkar, Hamid; Kroenke, Martin] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Lehmann, Maik J.; Kraeusslich, Hans-Georg] Univ Heidelberg Hosp, Dept Virol, Heidelberg, Germany	University of Cologne; University of Cologne; University of Cologne; Ruprecht Karls University Heidelberg	Pongratz, C (corresponding author), Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany.	benjamin.yazdanpanah@uk-koeln.de			Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; ANDERSON S, 1981, NUCLEIC ACIDS RES, V9, P3015, DOI 10.1093/nar/9.13.3015; Berkhout B, 2004, CURR OPIN MOL THER, V6, P141; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang LJ, 2005, GENE THER, V12, P1133, DOI 10.1038/sj.gt.3302509; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Coburn GA, 2002, J VIROL, V76, P9225, DOI 10.1128/JVI.76.18.9225-9231.2002; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; EHRLICH SD, 1973, EUR J BIOCHEM, V40, P143, DOI 10.1111/j.1432-1033.1973.tb03178.x; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fuchs U, 2007, ADV CANCER RES, V96, P75, DOI 10.1016/S0065-230X(06)96004-7; Gondai T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1043; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Ill CR, 2005, GENE THER, V12, P795, DOI 10.1038/sj.gt.3302524; Jabs DA, 2002, AM J OPHTHALMOL, V133, P552, DOI 10.1016/S0002-9394(02)01325-9; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Jakobsen MR, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh064; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kaiser J, 2003, SCIENCE, V299, P495, DOI 10.1126/science.299.5606.495; Kasim Vivi, 2003, Nucleic Acids Res Suppl, P255; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kittler R, 2005, CELL CYCLE, V4, P564; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Li W, 2007, CELL MOL LIFE SCI, V64, P1785, DOI 10.1007/s00018-007-7057-3; Liu YP, 2008, NUCLEIC ACIDS RES, V36, P2811, DOI 10.1093/nar/gkn109; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Scherer LJ, 2004, MOL THER, V10, P597, DOI 10.1016/j.ymthe.2004.05.003; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Van Rij RP, 2006, TRENDS BIOTECHNOL, V24, P186, DOI 10.1016/j.tibtech.2006.02.006; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Wu RH, 2007, J GENE MED, V9, P620, DOI 10.1002/jgm.1048; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206; Zhao HF, 2005, NAT METHODS, V2, P967, DOI 10.1038/NMETH812; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100; Zhou DM, 2008, CHEMBIOCHEM, V9, P1365, DOI 10.1002/cbic.200800049; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13172	10.1371/journal.pone.0013172	http://dx.doi.org/10.1371/journal.pone.0013172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949027	Green Published, gold, Green Submitted			2022-12-25	WOS:000282676700003
J	Thorner, AR; Parker, JS; Hoadley, KA; Perou, CM				Thorner, Aaron R.; Parker, Joel S.; Hoadley, Katherine A.; Perou, Charles M.			Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer	PLOS ONE			English	Article							ANTISENSE OLIGODEOXYNUCLEOTIDES; PREOPERATIVE CHEMOTHERAPY; EXPRESSION SIGNATURE; MOLECULAR PORTRAITS; CELL-LINES; IN-VITRO; B-MYB; GENE; LEUKEMIA; SENSITIVITY	Background: The transcription factor c-Myb has been well characterized as an oncogene in several human tumor types, and its expression in the hematopoietic stem/progenitor cell population is essential for proper hematopoiesis. However, the role of c-Myb in mammopoeisis and breast tumorigenesis is poorly understood, despite its high expression in the majority of breast cancer cases (60-80%). Methodology/Principal Findings: We find that c-Myb high expression in human breast tumors correlates with the luminal/ER+ phenotype and a good prognosis. Stable RNAi knock-down of endogenous c-Myb in the MCF7 luminal breast tumor cell line increased tumorigenesis both in vitro and in vivo, suggesting a possible tumor suppressor role in luminal breast cancer. We created a mammary-derived c-Myb expression signature, comprised of both direct and indirect c-Myb target genes, and found it to be highly correlated with a published mature luminal mammary cell signature and least correlated with a mammary stem/progenitor lineage gene signature. Conclusions/Significance: These data describe, for the first time, a possible tumor suppressor role for the c-Myb protooncogene in breast cancer that has implications for the understanding of luminal tumorigenesis and for guiding treatment.	[Thorner, Aaron R.; Parker, Joel S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA; [Thorner, Aaron R.; Parker, Joel S.; Hoadley, Katherine A.; Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Thorner, Aaron R.; Parker, Joel S.; Hoadley, Katherine A.; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Thorner, AR (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.	cperou@med.unc.edu	Perou, Charles M/H-9934-2014; Parker, Joel/AAG-1108-2019	Perou, Charles M/0000-0001-9827-2247; Hoadley, Katherine/0000-0002-1216-477X	National Cancer Institute (NCI) [P50-CA58223-09A1, RO1-CA138255]; Breast Cancer Research Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA138255, P50CA058223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	5This work was supported by funds from the National Cancer Institute (NCI) Breast SPORE program to University of North Carolina-Chapel Hill (UNC-CH) (P50-CA58223-09A1), by the NCI (RO1-CA138255), the Breast Cancer Research Foundation, and by the V Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Biroccio A, 2001, AM J PATHOL, V158, P1289, DOI 10.1016/S0002-9440(10)64080-1; CALABRETTA B, 1991, P NATL ACAD SCI USA, V88, P2351, DOI 10.1073/pnas.88.6.2351; DEISENROTH C, 2010, MOL CELL BIOL; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Ess KC, 1999, ONCOGENE, V18, P1103, DOI 10.1038/sj.onc.1202387; Fu SL, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-54; GUDAS JM, 1995, CLIN CANCER RES, V1, P235; GUERIN M, 1990, ONCOGENE, V5, P131; Harrell JC, 2006, CANCER RES, V66, P9308, DOI 10.1158/0008-5472.CAN-06-1769; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hogg A, 1997, ONCOGENE, V15, P2885, DOI 10.1038/sj.onc.1201472; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Kauraniemi P, 2000, CANCER RES, V60, P5323; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Kopecki Z, 2007, J PATHOL, V211, P351, DOI 10.1002/path.2113; Lei WL, 2004, J BIOL CHEM, V279, P29519, DOI 10.1074/jbc.M403133200; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Malaterre J, 2008, STEM CELLS, V26, P173, DOI 10.1634/stemcells.2007-0293; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; RATAJCZAK MZ, 1992, P NATL ACAD SCI USA, V89, P11823, DOI 10.1073/pnas.89.24.11823; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thorner AR, 2009, ONCOGENE, V28, P742, DOI 10.1038/onc.2008.430; Troester MA, 2004, CANCER RES, V64, P4218, DOI 10.1158/0008-5472.CAN-04-0107; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	42	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13073	10.1371/journal.pone.0013073	http://dx.doi.org/10.1371/journal.pone.0013073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949095	Green Published, Green Submitted, gold			2022-12-25	WOS:000282633700003
J	Nezami, A; Poy, F; Toms, A; Zheng, W; Eck, MJ				Nezami, Azin; Poy, Florence; Toms, Angela; Zheng, Wei; Eck, Michael J.			Crystal Structure of a Complex between Amino and Carboxy Terminal Fragments of mDia1: Insights into Autoinhibition of Diaphanous-Related Formins	PLOS ONE			English	Article							ACTIN-FILAMENT ELONGATION; HOMOLOGY-2 DOMAIN; FH2 DOMAIN; AUTOREGULATORY DOMAIN; BINDING PROTEIN; ARP2/3 COMPLEX; RHO; NUCLEATION; PROFILIN; MECHANISM	Formin proteins direct the nucleation and assembly of linear actin filaments in a variety of cellular processes using their conserved formin homology 2 (FH2) domain. Diaphanous-related formins (DRFs) are effectors of Rho-family GTPases, and in the absence of Rho activation they are maintained in an inactive state by intramolecular interactions between their regulatory N-terminal region and a C-terminal segment referred to as the DAD domain. Although structures are available for the isolated DAD segment in complex with the interacting region in the N-terminus, it remains unclear how this leads to inhibition of actin assembly by the FH2 domain. Here we describe the crystal structure of the N-terminal regulatory region of formin mDia1 in complex with a C-terminal fragment containing both the FH2 and DAD domains. In the crystal structure and in solution, these fragments form a tetrameric complex composed of two interlocking N+C dimers. Formation of the tetramer is likely a consequence of the particular N-terminal construct employed, as we show that a nearly full-length mDia1 protein is dimeric, as are other autoinhibited N+C complexes containing longer N-terminal fragments. The structure provides the first view of the intact C-terminus of a DRF, revealing the relationship of the DAD to the FH2 domain. Delineation of alternative dimeric N+C interactions within the tetramer provides two general models for autoinhibition in intact formins. In both models, engagement of the DAD by the N-terminus is incompatible with actin filament formation on the FH2, and in one model the actin binding surfaces of the FH2 domain are directly blocked by the N-terminus.	[Nezami, Azin; Poy, Florence; Toms, Angela; Zheng, Wei; Eck, Michael J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Nezami, Azin; Toms, Angela; Zheng, Wei; Eck, Michael J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Nezami, A (corresponding author), Vertex Pharmaceut, Cambridge, MA USA.	eck@red.dfci.harvard.edu			National Institutes of Health (NIH) [R01GM071834]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071834] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R01GM071834 (MJE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x	42	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12992	10.1371/journal.pone.0012992	http://dx.doi.org/10.1371/journal.pone.0012992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927338	gold, Green Published, Green Submitted			2022-12-25	WOS:000282312600010
J	Ge, F; Xiao, CL; Bi, LJ; Tao, SC; Xiong, S; Yin, XF; Li, LP; Lu, CH; Jia, HT; He, QY				Ge, Feng; Xiao, Chuan-Le; Bi, Li-Jun; Tao, Sheng-Ce; Xiong, Sheng; Yin, Xin-Feng; Li, Li-Ping; Lu, Chun-Hua; Jia, Hai-Tao; He, Qing-Yu			Quantitative Phosphoproteomics of Proteasome Inhibition in Multiple Myeloma Cells	PLOS ONE			English	Article							AMINO-ACIDS; PROTEIN; PHOSPHORYLATION; AUTOPHAGY; PS-341; APOPTOSIS; STATHMIN; SURVIVAL; CULTURE; DEATH	Background: The proteasome inhibitor bortezomib represents an important advance in the treatment of multiple myeloma (MM). Bortezomib inhibits the activity of the 26S proteasome and induces cell death in a variety of tumor cells; however, the mechanism of cytotoxicity is not well understood. Methodology/Principal Findings: We investigated the differential phosphoproteome upon proteasome inhibition by using stable isotope labeling by amino acids in cell culture (SILAC) in combination with phosphoprotein enrichment and LC-MS/MS analysis. In total 233 phosphoproteins were identified and 72 phosphoproteins showed a 1.5-fold or greater change upon bortezomib treatment. The phosphoproteins with expression alterations encompass all major protein classes, including a large number of nucleic acid binding proteins. Site-specific phosphopeptide quantitation revealed that Ser38 phosphorylation on stathmin increased upon bortezomib treatment, suggesting new mechanisms associated to bortezomib-induced apoptosis in MM cells. Further studies demonstrated that stathmin phosphorylation profile was modified in response to bortezomib treatment and the regulation of stathmin by phosphorylation at specific Ser/Thr residues participated in the cellular response induced by bortezomib. Conclusions/Significance: Our systematic profiling of phosphorylation changes in response to bortezomib treatment not only advanced the global mechanistic understanding of the action of bortezomib on myeloma cells but also identified previously uncharacterized signaling proteins in myeloma cells.	[Ge, Feng; Xiao, Chuan-Le; Xiong, Sheng; Yin, Xin-Feng; Li, Li-Ping; Lu, Chun-Hua; Jia, Hai-Tao; He, Qing-Yu] Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China; [Ge, Feng; Xiao, Chuan-Le; Xiong, Sheng; Yin, Xin-Feng; Li, Li-Ping; Lu, Chun-Hua; Jia, Hai-Tao; He, Qing-Yu] Jinan Univ, Natl Engn Res Ctr Genet Med, Guangzhou, Guangdong, Peoples R China; [Ge, Feng] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Tao, Sheng-Ce] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China	Jinan University; Jinan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Shanghai Jiao Tong University	Ge, F (corresponding author), Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China.	tqyhe@jnu.edu.cn	Tao, Sheng-ce/A-5833-2012; He, Qing-Yu/H-7078-2014; ge, feng/E-9158-2011; ge, feng/AGA-6334-2022	Tao, Sheng-ce/0000-0002-9210-1823; He, Qing-Yu/0000-0003-0503-9492; ge, feng/0000-0002-1032-280X; ge, feng/0000-0002-1032-280X	Chang-Jiang Scholars Program; "211'' Projects; Chinese Academy of Sciences; National Protein Research Fund [2009CB825400, 2006CB910902]; Ministry of Health of China [2008ZX10003-005]; State Key Development Program for Basic Research of China [2010CB529205]; Fundamental Research Funds for the Central Universities	Chang-Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); "211'' Projects; Chinese Academy of Sciences(Chinese Academy of Sciences); National Protein Research Fund; Ministry of Health of China; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially supported by the 2007 Chang-Jiang Scholars Program, "211'' Projects, the Hundred Talents Program of The Chinese Academy of Sciences, the National Protein Research Fund (Grant No: 2009CB825400 and 2006CB910902) and the Major Special Program on Infectious Diseases from Ministry of Health of China (2008ZX10003-005), the State Key Development Program for Basic Research of China (Grant No. 2010CB529205) and the Fundamental Research Funds for the Central Universities (to Q.-Y.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Chauhan D, 2003, CANCER RES, V63, P6174; Chauhan D, 2003, J BIOL CHEM, V278, P17593, DOI 10.1074/jbc.C300076200; Chauhan D, 2003, APOPTOSIS, V8, P337, DOI 10.1023/A:1024164700094; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; DiPaolo G, 1997, FEBS LETT, V416, P149, DOI 10.1016/S0014-5793(97)01188-5; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Ge F, 2009, J PROTEOME RES, V8, P3006, DOI 10.1021/pr9001004; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hamilton AL, 2005, J CLIN ONCOL, V23, P6107, DOI 10.1200/JCO.2005.01.136; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Holmfeldt P, 2001, MOL BIOL CELL, V12, P73, DOI 10.1091/mbc.12.1.73; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kassis JN, 2006, EXP CELL RES, V312, P2962, DOI 10.1016/j.yexcr.2006.05.023; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lawler S, 1998, CURR BIOL, V8, pR212, DOI 10.1016/S0960-9822(98)70128-9; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Mitsiades N, 2003, BLOOD, V101, P2377, DOI 10.1182/blood-2002-06-1768; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moreno FJ, 1998, MOL CELL BIOCHEM, V183, P201, DOI 10.1023/A:1006807814580; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pan C, 2008, PROTEOMICS, V8, P4534, DOI 10.1002/pmic.200800105; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Poruchynsky MS, 2008, CELL CYCLE, V7, P940, DOI 10.4161/cc.7.7.5625; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Santamaria E, 2009, PROTEOMICS, V9, P4495, DOI 10.1002/pmic.200900110; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; SUN X, 2009, J PROTEOME RES; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Tedford NC, 2009, PROTEOMICS, V9, P1469, DOI 10.1002/pmic.200800468; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Zada AAP, 2006, PROTEOMICS, V6, P5705, DOI 10.1002/pmic.200600307; Zhang GA, 2006, J PROTEOME RES, V5, P581, DOI 10.1021/pr050362b; Zhang L, 2010, J VIROL, V84, P6050, DOI 10.1128/JVI.00213-10; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	54	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13095	10.1371/journal.pone.0013095	http://dx.doi.org/10.1371/journal.pone.0013095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927383	Green Published, gold, Green Submitted			2022-12-25	WOS:000282269400031
J	Engel, LA; Jing, Z; O'Brien, DE; Sun, MY; Kotzbauer, PT				Engel, Laura A.; Jing, Zheng; O'Brien, Daniel E.; Sun, Mengyang; Kotzbauer, Paul T.			Catalytic Function of PLA2G6 Is Impaired by Mutations Associated with Infantile Neuroaxonal Dystrophy but Not Dystonia-Parkinsonism	PLOS ONE			English	Article							PHOSPHOLIPASE A(2); ALPHA-SYNUCLEIN; SEITELBERGERS-DISEASE; FATTY-ACIDS; GENE; HOMEOSTASIS; MODEL; MICE	Background: Mutations in the PLA2G6 gene have been identified in autosomal recessive neurodegenerative diseases classified as infantile neuroaxonal dystrophy (INAD), neurodegeneration with brain iron accumulation (NBIA), and dystonia-parkinsonism. These clinical syndromes display two significantly different disease phenotypes. NBIA and INAD are very similar, involving widespread neurodegeneration that begins within the first 1-2 years of life. In contrast, patients with dystonia-parkinsonism present with a parkinsonian movement disorder beginning at 15 to 30 years of age. The PLA2G6 gene encodes the PLA2G6 enzyme, also known as group VIA calcium-independent phospholipase A(2), which has previously been shown to hydrolyze the sn-2 acyl chain of phospholipids, generating free fatty acids and lysophospholipids. Methodology/Principal Findings: We produced purified recombinant wildtype (WT) and mutant human PLA2G6 proteins and examined their catalytic function using in vitro assays with radiolabeled lipid substrates. We find that human PLA2G6 enzyme hydrolyzes both phospholipids and lysophospholipids, releasing free fatty acids. Mutations associated with different disease phenotypes have different effects on catalytic activity. Mutations associated with INAD/NBIA cause loss of enzyme activity, with mutant proteins exhibiting less than 20% of the specific activity of WT protein in both lysophospholipase and phospholipase assays. In contrast, mutations associated with dystonia-parkinsonism do not impair catalytic activity, and two mutations produce a significant increase in specific activity for phospholipid but not lysophospholipid substrates. Conclusions/Significance: These results indicate that different alterations in PLA2G6 function produce the different disease phenotypes of NBIA/INAD and dystonia-parkinsonism. INAD/NBIA is caused by loss of the ability of PLA2G6 to catalyze fatty acid release from phospholipids, which predicts accumulation of PLA2G6 phospholipid substrates and provides a mechanistic explanation for the accumulation of membranes in neuroaxonal spheroids previously observed in histopathological studies of INAD/NBIA. In contrast, dystonia-parkinsonism mutations do not appear to directly impair catalytic function, but may modify substrate preferences or regulatory mechanisms for PLA2G6.	[Engel, Laura A.] Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Dev Biol, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Engel, LA (corresponding author), Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA.	kotzbauerp@neuro.wustl.edu	Sun, Mengyang/AAP-5033-2020	Sun, Mengyang/0000-0002-3998-8744	NINDS [NS48924-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048924] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS grant NS48924-01 (PTK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICARDI J, 1979, BRAIN, V102, P727, DOI 10.1093/brain/102.4.727; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Barbour SE, 1999, BBA-MOL CELL BIOL L, V1439, P77, DOI 10.1016/S1388-1981(99)00078-5; Broersen K, 2006, BIOCHEMISTRY-US, V45, P15610, DOI 10.1021/bi061743l; DELEON GA, 1985, ACTA NEUROPATHOL, V66, P89, DOI 10.1007/BF00688682; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Golovko MY, 2007, J NEUROCHEM, V101, P201, DOI 10.1111/j.1471-4159.2006.04357.x; Golovko MY, 2006, BIOCHEMISTRY-US, V45, P6956, DOI 10.1021/bi0600289; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Jenkins CM, 2006, J BIOL CHEM, V281, P15615, DOI 10.1074/jbc.M511623200; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; KIMURA S, 1991, PEDIATR NEUROL, V7, P116, DOI 10.1016/0887-8994(91)90007-8; Kurian MA, 2008, NEUROLOGY, V70, P1623, DOI 10.1212/01.wnl.0000310986.48286.8e; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; LIU HM, 1974, ACTA NEUROPATHOL, V27, P201; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Paisan-Ruiz C, 2008, ANN NEUROL, V64, pS36; RAMAEKERS VT, 1987, NEUROPEDIATRICS, V18, P170, DOI 10.1055/s-2008-1052474; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sina F, 2009, EUR J NEUROL, V16, P101, DOI 10.1111/j.1468-1331.2008.02356.x; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Wada H, 2009, AM J PATHOL, V175, P2257, DOI 10.2353/ajpath.2009.090343; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; Wolf MJ, 1996, J BIOL CHEM, V271, P30879, DOI 10.1074/jbc.271.48.30879; Wu Y, 2009, EUR J NEUROL, V16, P240, DOI 10.1111/j.1468-1331.2008.02397.x; YAGISHITA S, 1974, ACTA NEUROPATHOL, V29, P115, DOI 10.1007/BF00684770; YAGISHITA S, 1975, ACTA NEUROPATHOL, V31, P191, DOI 10.1007/BF00684558	31	73	82	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12897	10.1371/journal.pone.0012897	http://dx.doi.org/10.1371/journal.pone.0012897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886109	Green Published, gold, Green Submitted			2022-12-25	WOS:000282091100010
J	Zhang, XT; Kang, LG; Ding, L; Vranic, S; Gatalica, Z; Wang, ZY				Zhang, X. T.; Kang, L. G.; Ding, L.; Vranic, S.; Gatalica, Z.; Wang, Z-Y			A positive feedback loop of ER-alpha 36/EGFR promotes malignant growth of ER-negative breast cancer cells	ONCOGENE			English	Article						EGFR; ER-alpha 36; estrogen signaling; ER-negative breast cancer	ESTROGEN-RECEPTOR-ALPHA; VARIANT; EXPRESSION; PROLIFERATION; ESTRADIOL	It is prevailingly thought that estrogen signaling is not involved in development of estrogen receptor (ER)negative breast cancer. However, there is evidence indicating that ovariectomy prevents the development of both ER-positive and -negative breast cancer, suggesting that estrogen signaling is involved in the development of ER-negative breast cancer. Previously, our laboratory cloned a variant of ER-alpha, ER-alpha 36, and found that ER-alpha 36 mediated nongenomic estrogen signaling and is highly expressed in ER-negative breast cancer cells. In this study, we found that ER-alpha 36 was highly expressed in 10/12 cases of triple-negative breast cancer. We investigated the role of mitogenic estrogen signaling mediated by ER-alpha 36 in malignant growth of triple-negative breast cancer MDA-MB-231 and MDA-MB-436 cells that express high levels of ER-alpha 36 and found that these cells strongly responded to mitogenic estrogen signaling both in vitro and in vivo. Knockdown of ER-alpha 36 expression in these cells using the small hairpin RNA method diminished their responsiveness to estrogen. ER-alpha 36 physically interacted with the EGFR/Src/Shc complex and mediated estrogen-induced phosphorylation of epidermal growth factor receptor (EGFR) and Src. EGFR signaling activated ER-alpha 36 transcription through an AP1 site in the ER-alpha 36 promoter, and ER-alpha 36 expression was able to stabilize EGFR protein. Our results, thus demonstrated that ER-alpha 36 mediates nongenomic estrogen signaling through the EGFR/Src/ERK signaling pathway in ER-negative breast cancer cells and suggested that a subset of ER-negative breast tumors that expresses ER-alpha 36, retains responsiveness to mitogenic estrogen signaling. Oncogene (2011) 30, 770-780; doi:10.1038/onc.2010.458; published online 11 October 2010	[Zhang, X. T.; Kang, L. G.; Wang, Z-Y] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Ding, L.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Vranic, S.; Gatalica, Z.; Wang, Z-Y] Creighton Univ, Sch Med, Dept Pathol, Omaha, NE 68178 USA; [Vranic, S.] Univ Sarajevo, Ctr Clin, Dept Pathol, Sarajevo 71000, Bosnia & Herceg	Creighton University; Zhejiang University; Creighton University; University of Sarajevo	Wang, ZY (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Criss 3,Room 355,2500 Calif Plaza, Omaha, NE 68178 USA.	zywang@creighton.edu	Vranic, Semir/J-4113-2012; Kang, Lianguo/D-7780-2012; Vranic, Semir/I-6823-2019	Vranic, Semir/0000-0001-9743-7265	National Institute of Health [DK84328]; Nebraska Tobacco Settlement Biomedical Research Program Award [LB-595, LB692]; American Cancer Society [ACS/08/004]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070016] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program Award; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health Grant DK84328 and by the Nebraska Tobacco Settlement Biomedical Research Program Award (LB-595 and LB692) to ZY Wang. Dr Semir Vranic was a research fellow at Creighton University Medical School, Omaha, NE, USA and had been supported by a UICC American Cancer Society Beginning Investigators Fellowship (ACSBI) (ACS/08/004) funded by the American Cancer Society.	[Anonymous], 1992, Lancet, V339, P1; Behrens D, 2007, MOL CELL ENDOCRINOL, V274, P19, DOI 10.1016/j.mce.2007.05.012; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; FRIEDL A, 1994, EUR J CANCER, V30A, P1559, DOI 10.1016/0959-8049(94)00293-E; FRIEDL A, 1989, CANCER RES, V49, P4758; Geisler J, 2002, J CLIN ONCOL, V20, P751, DOI 10.1200/JCO.2002.20.3.751; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Lacroix M, 2004, ENDOCR-RELAT CANCER, V11, P497, DOI 10.1677/erc.1.00758; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; MAHFOUDI A, 1995, P NATL ACAD SCI USA, V92, P4206, DOI 10.1073/pnas.92.10.4206; Narod SA, 2001, ANN NY ACAD SCI, V952, P36, DOI 10.1111/j.1749-6632.2001.tb02726.x; NISSENMEYER R, 1964, ACTA UNION INT CONTR, V20, P527; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Rai D, 2005, MOL ENDOCRINOL, V19, P1606, DOI 10.1210/me.2004-0468; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Simpson PT, 2005, J PATHOL, V205, P248, DOI 10.1002/path.1691; Tong D, 2002, BREAST CANCER RES TR, V71, P249, DOI 10.1023/A:1014465916473; Tsai EM, 2001, CANCER RES, V61, P8390; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	26	124	133	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	7					770	780		10.1038/onc.2010.458	http://dx.doi.org/10.1038/onc.2010.458			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	722OT	20935677	Green Accepted			2022-12-25	WOS:000287444600002
J	Ahn, J; Ko, M; Lee, C; Kim, J; Yoon, H; Seong, RH				Ahn, J.; Ko, M.; Lee, C.; Kim, J.; Yoon, H.; Seong, R. H.			Srg3, a mouse homolog of BAF155, is a novel p53 target and acts as a tumor suppressor by modulating p21(WAF1/CIP1) expression	ONCOGENE			English	Article						SWI/SNF chromatin remodeling complex; tumor suppressor; Srg3; DNA damage signal; p53; p21	CHROMATIN REMODELING COMPLEX; STRAND BREAK REPAIR; CELL-CYCLE ARREST; MAMMALIAN SWI/SNF COMPLEXES; PROTEASOMAL DEGRADATION; RHABDOID TUMORS; DNA-DAMAGE; IN-VIVO; APOPTOSIS; CANCER	Some subunits of the SWI/SNF complex function as tumor suppressors. However, underlying mechanisms are still incompletely defined. Here, we show that Srg3, a mouse homolog of BAF155 that function as a core subunit of this complex, suppresses tumorigenesis in vivo. DNA damage signals promoted Srg3 degradation by inducing p53. Deficiency of Srg3 promoted G1 cell-cycle arrest, but antagonized apoptotic response to DNA damage by robustly inducing p53 and p21 proteins. Srg3 heterozygous mice were prone to sarcoma formation, which was further enhanced by haploinsufficiency of p53. These tumors highly expressed p53 and p21 but lacked Srg3 expression. Our results establish a novel function of Srg3 in tumor suppression and provide insights into genetic pathways dictating tumor suppression by the SWI/SNF complex. Oncogene (2011) 30, 445-456; doi: 10.1038/onc.2010.424; published online 11 October 2010	[Seong, R. H.] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea; Seoul Natl Univ, Inst Mol Biol & Genet, Res Ctr Funct Cellul, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Seong, RH (corresponding author), Seoul Natl Univ, Dept Biol Sci, Gwanak Ro 599,Bldg 105, Seoul 151742, South Korea.	rhseong@snu.ac.kr		Ko, Myunggon/0000-0002-6007-2570; Seong, Rho/0000-0001-5699-0718	Ministry of Education, Science and Technology [20090094022]; MEST	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the National Research Foundation of Korea (NRF), funded by Ministry of Education, Science and Technology, in part through the Research Center for Functional Cellulomics and in part through the Priority Research Centers Program (20090094022). JA, MK, JK, HY and CL were supported by the BK21 program from MEST.	Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Biegel JA, 1999, CANCER RES, V59, P74; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chan TA, 2000, GENE DEV, V14, P1584; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; De la Cueva E, 2006, ONCOGENE, V25, P4128, DOI 10.1038/sj.onc.1209432; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Gartel AL, 2002, MOL CANCER THER, V1, P639; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Han D, 2008, DEV BIOL, V315, P136, DOI 10.1016/j.ydbio.2007.12.024; Han SM, 2001, J IMMUNOL, V167, P805, DOI 10.4049/jimmunol.167.2.805; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hu G, 1999, MOL CELL BIOL, V19, P724; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Kaneuchi M, 1999, MOL CARCINOGEN, V26, P44, DOI 10.1002/(SICI)1098-2744(199909)26:1<44::AID-MC6>3.3.CO;2-V; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Martin-Caballero J, 2001, CANCER RES, V61, P6234; McKenna ES, 2008, MOL CELL BIOL, V28, P6223, DOI 10.1128/MCB.00658-08; Moshkin YM, 2007, MOL CELL BIOL, V27, P651, DOI 10.1128/MCB.01257-06; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Ring HZ, 1998, GENOMICS, V51, P140, DOI 10.1006/geno.1998.5343; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Sohn DH, 2007, J BIOL CHEM, V282, P10614, DOI 10.1074/jbc.M610563200; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vries RGJ, 2005, GENE DEV, V19, P665, DOI 10.1101/gad.335805; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590; Wong AKC, 2000, CANCER RES, V60, P6171; Yang XF, 2007, NAT STRUCT MOL BIOL, V14, P540, DOI 10.1038/nsmb1238; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002	55	14	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2011	30	4					445	456		10.1038/onc.2010.424	http://dx.doi.org/10.1038/onc.2010.424			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	711WH	20935679				2022-12-25	WOS:000286621600007
J	Pierce, E; Becker, DF; Ragsdale, SW				Pierce, Elizabeth; Becker, Donald F.; Ragsdale, Stephen W.			Identification and Characterization of Oxalate Oxidoreductase, a Novel Thiamine Pyrophosphate-dependent 2-Oxoacid Oxidoreductase That Enables Anaerobic Growth on Oxalate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-FERREDOXIN OXIDOREDUCTASE; 2 2-OXOACID-FERREDOXIN OXIDOREDUCTASES; SULFOLOBUS SP STRAIN-7; CLOSTRIDIUM-THERMOACETICUM; OXALOBACTER-FORMIGENES; MOORELLA-THERMOACETICA; RADICAL INTERMEDIATE; HYPERTHERMOPHILIC ARCHAEON; HALOBACTERIUM-HALOBIUM; CARBON ASSIMILATION	Moorella thermoacetica is an anaerobic acetogen, a class of bacteria that is found in the soil, the animal gastrointestinal tract, and the rumen. This organism engages the Wood-Ljungdahl pathway of anaerobic CO2 fixation for heterotrophic or autotrophic growth. This paper describes a novel enzyme, oxalate oxidoreductase (OOR), that enables M. thermoacetica to grow on oxalate, which is produced in soil and is a common component of kidney stones. Exposure to oxalate leads to the induction of three proteins that are subunits of OOR, which oxidizes oxalate coupled to the production of two electrons and CO2 or bicarbonate. Like other members of the 2-oxoacid: ferredoxin oxidoreductase family, OOR contains thiamine pyrophosphate and three [Fe4S4] clusters. However, unlike previously characterized members of this family, OOR does not use coenzyme A as a substrate. Oxalate is oxidized with a kcat of 0.09 s(-1) and a K-m of 58 mu M at pH 8. OOR also oxidizes a few other 2-oxoacids (which do not induce OOR) also without any requirement for CoA. The enzyme transfers its reducing equivalents to a broad range of electron acceptors, including ferredoxin and the nickel-dependent carbon monoxide dehydrogenase. In conjunction with the well characterized Wood-Ljungdahl pathway, OOR should be sufficient for oxalate metabolism by M. thermoacetica, and it constitutes a novel pathway for oxalate metabolism.	[Ragsdale, Stephen W.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu		Pierce, Elizabeth/0000-0003-4693-5883	National Institutes of Health (NIH) [GM39451]; NIH, NCRR [P20 RR-017675]; National Science Foundation [DBI-0619764]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039451, R01GM039451, R29GM039451] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant GM39451 (to S. W. R.) and NIH, NCRR, Grant P20 RR-017675 (to D. F. B.) (for the ultracentrifugation studies). This work was also supported by National Science Foundation Grant DBI-0619764.	Abe K, 1996, J BIOL CHEM, V271, P6789, DOI 10.1074/jbc.271.12.6789; ALLISON MJ, 1985, ARCH MICROBIOL, V141, P1, DOI 10.1007/BF00446731; ANANTHARAM V, 1989, J BIOL CHEM, V264, P7244; Arendsen AF, 1999, J BACTERIOL, V181, P1489, DOI 10.1128/JB.181.5.1489-1495.1999; Astashkin AV, 2006, J AM CHEM SOC, V128, P3888, DOI 10.1021/ja0585275; BAETZ AL, 1989, J BACTERIOL, V171, P2605, DOI 10.1128/jb.171.5.2605-2608.1989; Barent RL, 1992, PLANT MOL BIOL REP, V10, P338, DOI 10.1007/BF02668910; CAMMACK R, 1980, FEBS LETT, V118, P271, DOI 10.1016/0014-5793(80)80236-5; Chabriere E, 1999, NAT STRUCT BIOL, V6, P182; Cornick NA, 1996, CAN J MICROBIOL, V42, P1219, DOI 10.1139/m96-157; Cornick NA, 1996, APPL ENVIRON MICROB, V62, P3011, DOI 10.1128/AEM.62.8.3011-3013.1996; Costelloe SJ, 2008, J MOL EVOL, V66, P36, DOI 10.1007/s00239-007-9056-2; Daniel SL, 2004, FEMS MICROBIOL LETT, V231, P39, DOI 10.1016/S0378-1097(03)00924-8; DANIEL SL, 1993, APPL ENVIRON MICROB, V59, P3062, DOI 10.1128/AEM.59.9.3062-3069.1993; Dorner E, 2002, J BACTERIOL, V184, P3975, DOI 10.1128/JB.184.14.3975-3983.2002; Doukov TI, 2008, BIOCHEMISTRY-US, V47, P3474, DOI 10.1021/bi702386t; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V190, P351, DOI 10.1016/0003-9861(78)90285-0; Frostl JM, 1996, J BACTERIOL, V178, P4597; Fukuda E, 2002, BBA-PROTEIN STRUCT M, V1597, P74, DOI 10.1016/S0167-4838(02)00280-7; Fukuda E, 2001, EUR J BIOCHEM, V268, P5639, DOI 10.1046/j.1432-1033.2001.02504.x; Furdui C, 2002, BIOCHEMISTRY-US, V41, P9921, DOI 10.1021/bi0257641; Guo FS, 1998, BIOCHEMISTRY-US, V37, P13379, DOI 10.1021/bi9807097; KERSCHER L, 1981, EUR J BIOCHEM, V116, P587, DOI 10.1111/j.1432-1033.1981.tb05376.x; LUNDIE LL, 1984, J BACTERIOL, V159, P700, DOI 10.1128/JB.159.2.700-703.1984; Ma K, 1997, P NATL ACAD SCI USA, V94, P9608, DOI 10.1073/pnas.94.18.9608; MATHEWS R, 1974, J BIOL CHEM, V249, P4326; MEINECKE B, 1989, ARCH MICROBIOL, V152, P244, DOI 10.1007/BF00409658; Menon S, 1997, BIOCHEMISTRY-US, V36, P8484, DOI 10.1021/bi970403k; Nishizawa Y, 2005, FEBS LETT, V579, P2319, DOI 10.1016/j.febslet.2004.11.117; ORMEJOHN.WH, 1969, BIOCHEM BIOPH RES CO, V36, P337, DOI 10.1016/0006-291X(69)90569-5; Park YJ, 2006, J BIOCHEM MOL BIOL, V39, P46; Penttinen H K, 1979, Methods Enzymol, V62, P58, DOI 10.1016/0076-6879(79)62190-0; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; PIEULLE L, 1995, BBA-PROTEIN STRUCT M, V1250, P49, DOI 10.1016/0167-4838(95)00029-T; QUAYLE JR, 1963, BIOCHEM J, V89, P492, DOI 10.1042/bj0890492; QUAYLE JR, 1959, BIOCHEM J, V72, P623, DOI 10.1042/bj0720623; Ragsdale SW, 2003, CHEM REV, V103, P2333, DOI 10.1021/cr020423e; Seifritz C, 1999, FEMS MICROBIOL LETT, V170, P399, DOI 10.1111/j.1574-6968.1999.tb13400.x; Seifritz C, 2002, ARCH MICROBIOL, V178, P457, DOI 10.1007/s00203-002-0475-6; Seravalli J, 2000, BIOCHEMISTRY-US, V39, P1274, DOI 10.1021/bi991812e; Strobel BW, 2001, GEODERMA, V99, P169, DOI 10.1016/S0016-7061(00)00102-6; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; Tittmann K, 2005, BIOCHEMISTRY-US, V44, P13291, DOI 10.1021/bi051058z; WEAST RC, 1981, CRC HDB CHEM PHYSICS, pD166; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Yamamoto M, 2003, BIOCHEM BIOPH RES CO, V312, P1297, DOI 10.1016/j.bbrc.2003.11.078; Zhang Q, 1996, J BIOCHEM-TOKYO, V120, P587; [No title captured]	48	16	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40515	40524		10.1074/jbc.M110.155739	http://dx.doi.org/10.1074/jbc.M110.155739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956531	Green Published, hybrid			2022-12-25	WOS:000285414400014
J	Furrer, M; Balbi, M; Albarca-Aguilera, M; Gallant, M; Herr, W; Gallant, P				Furrer, Michael; Balbi, Mirjam; Albarca-Aguilera, Monica; Gallant, Maria; Herr, Winship; Gallant, Peter			Drosophila Myc Interacts with Host Cell Factor (dHCF) to Activate Transcription and Control Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE COMPLEX; C-MYC; INDEPENDENT FUNCTIONS; PROTEIN; DMYC; MAX; METHYLTRANSFERASE; PROLIFERATION; ASSOCIATION; APOPTOSIS	The Myc proto-oncoproteins are transcription factors that recognize numerous target genes through hexameric DNA sequences called E-boxes. The mechanism by which they then activate the expression of these targets is still under debate. Here, we use an RNAi screen in Drosophila S2 cells to identify Drosophila host cell factor (dHCF) as a novel co-factor for Myc that is functionally required for the activation of a Myc-dependent reporter construct. dHCF is also essential for the full activation of endogenous Myc target genes in S2 cells, and for the ability of Myc to promote growth in vivo. Myc and dHCF physically interact, and they colocalize on common target genes. Furthermore, down-regulation of dHCF-associated histone acetyltransferase and histone methyltransferase complexes in vivo interferes with the Myc biological activities. We therefore propose that dHCF recruits such chromatin-modifying complexes and thereby contributes to the expression of Myc targets and hence to the execution of Myc biological activities.	[Furrer, Michael; Balbi, Mirjam; Gallant, Maria; Gallant, Peter] Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; [Albarca-Aguilera, Monica; Herr, Winship] Univ Lausanne, CIG, CH-1015 Lausanne, Switzerland	University of Zurich; University of Lausanne	Gallant, P (corresponding author), Univ Wurzburg, Inst Physiol Chem 2, D-97074 Wurzburg, Germany.	peter.gallant@biozentrum.uni-wuerzburg.de	Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546	Swiss National Science Foundation; DFG; University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DFG(German Research Foundation (DFG)); University of Lausanne	These studies were supported by grants from the Swiss National Science Foundation (to P. G. and W. H.), from the DFG (to P. G.), and by the University of Lausanne (W. H.).	Bellosta P, 2005, P NATL ACAD SCI USA, V102, P11799, DOI 10.1073/pnas.0408945102; Beltran S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r67; Benassayag C, 2005, MOL CELL BIOL, V25, P9897, DOI 10.1128/MCB.25.22.9897-9909.2005; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Gallant P, 2009, ADV CANCER RES, V103, P111, DOI 10.1016/S0065-230X(09)03005-X; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Hulf T, 2005, MOL CELL BIOL, V25, P3401, DOI 10.1128/MCB.25.9.3401-3410.2005; Izeta A, 2003, GENE, V305, P175, DOI 10.1016/S0378-1119(03)00380-9; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Mahajan SS, 2003, J CELL PHYSIOL, V194, P117, DOI 10.1002/jcp.10193; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Montero L, 2008, GENESIS, V46, P104, DOI 10.1002/dvg.20373; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Pirity M, 2006, CURR TOP MICROBIOL, V302, P205; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Schwinkendorf D, 2009, GENE, V436, P90, DOI 10.1016/j.gene.2009.02.009; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Steiger D, 2008, NAT GENET, V40, P1084, DOI 10.1038/ng.178; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410	45	11	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39623	39636		10.1074/jbc.M110.140467	http://dx.doi.org/10.1074/jbc.M110.140467			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937797	Green Published, hybrid			2022-12-25	WOS:000285185500006
J	Muiznieks, LD; Keeley, FW				Muiznieks, Lisa D.; Keeley, Fred W.			Proline Periodicity Modulates the Self-assembly Properties of Elastin-like Polypeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPROLINE-II STRUCTURE; HUMAN TROPOELASTIN; HYDROPHOBIC DOMAINS; IN-VITRO; PROTEIN; AGGREGATION; SEQUENCE; C-13; MOBILITY; DETERMINANTS	Elastin is a self-assembling protein of the extracellular matrix that provides tissues with elastic extensibility and recoil. The monomeric precursor, tropoelastin, is highly hydrophobic yet remains substantially disordered and flexible in solution, due in large part to a high combined threshold of proline and glycine residues within hydrophobic sequences. In fact, proline-poor elastin-like sequences are known to form amyloid-like fibrils, rich in beta-structure, from solution. On this basis, it is clear that hydrophobic elastin sequences are in general optimized to avoid an amyloid fate. However, a small number of hydrophobic domains near the C terminus of tropoelastin are substantially depleted of proline residues. Here we investigated the specific contribution of proline number and spacing to the structure and self-assembly propensities of elastin-like polypeptides. Increasing the spacing between proline residues significantly decreased the ability of polypeptides to reversibly self-associate. Real-time imaging of the assembly process revealed the presence of smaller colloidal droplets that displayed enhanced propensity to cluster into dense networks. Structural characterization showed that these aggregates were enriched in beta-structure but unable to bind thioflavin-T. These data strongly support a model where proline-poor regions of the elastin monomer provide a unique contribution to assembly and suggest a role for localized beta-sheet in mediating self-assembly interactions.	[Muiznieks, Lisa D.; Keeley, Fred W.] Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Keeley, Fred W.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Keeley, FW (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	fwk@sickkids.ca			Heart and Stroke Foundation of Ontario [T6725]; Canadian Institutes of Health Research [MOP84496]; Heart and Stroke/Richard Lewar Centre	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke/Richard Lewar Centre	This project was supported by grants from the Heart and Stroke Foundation of Ontario (Operating Grant T6725) and the Canadian Institutes of Health Research (Operating Grant MOP84496) (to F. W. K.). and a Heart and Stroke/Richard Lewar Centre of Excellence Fellowship (to L. D. M.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X; Bochicchio B, 2004, BIOPOLYMERS, V73, P484, DOI 10.1002/bip.10552; Bochicchio B, 2007, BIOMACROMOLECULES, V8, P3478, DOI 10.1021/bm700636a; Cheung MS, 2002, P NATL ACAD SCI USA, V99, P685, DOI 10.1073/pnas.022387699; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; Cirulis JT, 2010, BIOCHEMISTRY-US, V49, P5726, DOI 10.1021/bi100468v; Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092; Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d; DEBELLE L, 1995, J MOL STRUCT, V348, P321, DOI 10.1016/0022-2860(95)08653-D; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dyksterhuis LB, 2009, ARCH BIOCHEM BIOPHYS, V487, P79, DOI 10.1016/j.abb.2009.06.001; Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Hall D, 2005, J MOL BIOL, V351, P195, DOI 10.1016/j.jmb.2005.05.013; INDIK Z, 1987, P NATL ACAD SCI USA, V84, P5680, DOI 10.1073/pnas.84.16.5680; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; Jensen SA, 2000, J BIOL CHEM, V275, P28449, DOI 10.1074/jbc.M004265200; Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Kumashiro KK, 2001, BIOPOLYMERS, V59, P266, DOI 10.1002/1097-0282(20011005)59:4<266::AID-BIP1023>3.0.CO;2-2; Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g; LYERLA JR, 1975, BIOCHEMISTRY-US, V14, P5175, DOI 10.1021/bi00694a024; Martino M, 2000, J MOL STRUCT, V519, P173, DOI 10.1016/S0022-2860(99)00299-9; Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173; Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; Mithieux SM, 2009, BIOMATERIALS, V30, P431, DOI 10.1016/j.biomaterials.2008.10.018; Monsellier E, 2007, BIOPHYS J, V93, P4382, DOI 10.1529/biophysj.107.111336; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1; Muiznieks LD, 2007, BIOCHEMISTRY-US, V46, P8196, DOI 10.1021/bi700139k; Muiznieks LD, 2010, BIOCHEM CELL BIOL, V88, P239, DOI [10.1139/O09-161, 10.1139/o09-161]; Nikolic A, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.22854; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Pedersen JS, 2004, J MOL BIOL, V341, P575, DOI 10.1016/j.jmb.2004.06.020; Pepe A, 2007, NANOMEDICINE-UK, V2, P203, DOI 10.2217/17435889.2.2.203; Perry A, 2002, J AM CHEM SOC, V124, P6832, DOI 10.1021/ja017711x; Perry A, 2002, BIOPHYS J, V82, P1086, DOI 10.1016/S0006-3495(02)75468-4; Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Renault A, 2009, LANGMUIR, V25, P8170, DOI 10.1021/la900475q; Reumers J, 2009, HUM MUTAT, V30, P431, DOI 10.1002/humu.20905; ROBSON P, 1993, J BIOL CHEM, V268, P1440; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217; Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225; Tamburro AM, 2005, PATHOL BIOL, V53, P383, DOI 10.1016/j.patbio.2004.12.014; Tamburro AM, 2005, J BIOL CHEM, V280, P2682, DOI 10.1074/jbc.M411617200; TAMBURRO AM, 1990, BIOPOLYMERS, V29, P855, DOI 10.1002/bip.360290419; Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t; Toonkool P, 2001, J BIOL CHEM, V276, P28042, DOI 10.1074/jbc.M103391200; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; Torchia D A, 1977, Adv Exp Med Biol, V79, P655; TORCHIA DA, 1973, J MOL BIOL, V76, P419, DOI 10.1016/0022-2836(73)90514-7; Tu YD, 2010, MICRON, V41, P268, DOI 10.1016/j.micron.2009.11.003; URRY D W, 1976, Critical Reviews in Biochemistry, V4, P1, DOI 10.3109/10409237609102557; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000	61	58	60	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39779	39789		10.1074/jbc.M110.164467	http://dx.doi.org/10.1074/jbc.M110.164467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947499	hybrid, Green Published			2022-12-25	WOS:000285185500022
J	Radnai, L; Rapali, P; Hodi, Z; Suveges, D; Molnar, T; Kiss, B; Becsi, B; Erdodi, F; Buday, L; Kardos, J; Kovacs, M; Nyitray, L				Radnai, Laszlo; Rapali, Peter; Hodi, Zsuzsa; Sueveges, Daniel; Molnar, Tamas; Kiss, Bence; Becsi, Balint; Erdoedi, Ferenc; Buday, Laszlo; Kardos, Jozsef; Kovacs, Mihaly; Nyitray, Laszlo			Affinity, Avidity, and Kinetics of Target Sequence Binding to LC8 Dynein Light Chain Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; COILED-COIL DOMAIN; SPLICED EXON-B; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; MOTOR COMPLEX; MYOSIN-VA; PROTEIN INHIBITOR; BCL-2 FAMILY; PHOSPHORYLATION	LC8 dynein light chain (DYNLL) is a highly conserved eukaryotic hub protein with dozens of binding partners and various functions beyond being a subunit of dynein and myosin Va motor proteins. Here, we compared the kinetic and thermodynamic parameters of binding of both mammalian isoforms, DYNLL1 and DYNLL2, to two putative consensus binding motifs (KXTQTX and XG(I/V)QVD) and report only subtle differences. Peptides containing either of the above motifs bind to DYNLL2 with micromolar affinity, whereas a myosin Va peptide (lacking the conserved Gln) and the noncanonical Pak1 peptide bind with K-d values of 9 and 40 mu M, respectively. Binding of the KXTQTX motif is enthalpy-driven, although that of all other peptides is both enthalpy- and entropy-driven. Moreover, the KXTQTX motif shows strikingly slower off-rate constant than the other motifs. As most DYNLL partners are homodimeric, we also assessed the binding of bivalent ligands to DYNLL2. Compared with monovalent ligands, a significant avidity effect was found as follows: K-d values of 37 and 3.5 nM for a dimeric myosin Va fragment and a Leu zipper dimerized KXTQTX motif, respectively. Ligand binding kinetics of DYNLL can best be described by a conformational selection model consisting of a slow isomerization and a rapid binding step. We also studied the binding of the phosphomimetic S88E mutant of DYNLL2 to the dimeric myosin Va fragment, and we found a significantly lower apparent K-d value (3 mu M). We conclude that the thermodynamic and kinetic fine-tuning of binding of various ligands to DYNLL could have physiological relevance in its interaction network.	[Kardos, Jozsef; Kovacs, Mihaly; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Becsi, Balint; Erdoedi, Ferenc] Univ Debrecen, Dept Med Chem, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary; [Buday, Laszlo] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1113 Budapest, Hungary; [Buday, Laszlo] Semmelweis Univ Med Sch, Dept Med Chem, H-1094 Budapest, Hungary	Eotvos Lorand University; University of Debrecen; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Semmelweis University	Nyitray, L (corresponding author), Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.	nyitray@elte.hu	Kardos, József/J-1035-2017; Kiss, Bence/AAF-1808-2020; Kovacs, Mihaly/A-6841-2011; Nyitray, László/AAE-5910-2020; Erdődi, Ferenc/B-3383-2011	Kardos, József/0000-0002-2135-2932; Nyitray, László/0000-0003-4717-5994; Kiss, Bence/0000-0001-5810-5858; Radnai, Laszlo/0000-0001-6843-3740; Rapali, Peter/0000-0003-1422-6660; Kovacs, Mihaly/0000-0002-1200-4741; Suveges, Daniel/0000-0003-4133-0447	Hungarian Scientific Research Fund OTKA [K61784, NI68466, NK81950, K71915, NNF78783]; National Development Agency [TAMOP-4.2.1.B-09/1/KMR]	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency	This work was supported by Hungarian Scientific Research Fund OTKA K61784, NI68466, and NK81950 (L. N.), K71915, NNF78783 (M. K.), and National Development Agency Grant TAMOP-4.2.1.B-09/1/KMR. M. K. is a Bolyai Fellow of the Hungarian Academy of Sciences.	Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2009, BIOCHEMISTRY-US, V48, P11381, DOI 10.1021/bi901589w; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Benison G, 2009, METHOD ENZYMOL, V455, P237, DOI 10.1016/S0076-6879(08)04209-2; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fan JS, 2002, J BIOMOL NMR, V23, P103, DOI 10.1023/A:1016332918178; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hall J, 2008, BIOCHEMISTRY-US, V47, P11940, DOI 10.1021/bi801093k; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; HODI Z, 2007, FEBS J S1, V274, P106; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Lajoix AD, 2004, MOL DIVERS, V8, P281, DOI 10.1023/B:MODI.0000036242.01129.27; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lightcap CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006025; Lo KWH, 2007, J BIOL CHEM, V282, P36871, DOI 10.1074/jbc.M705991200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Lu JQ, 2005, BIOCHEM BIOPH RES CO, V331, P153, DOI 10.1016/j.bbrc.2005.03.128; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pabbisetty KB, 2007, PROTEIN SCI, V16, P355, DOI 10.1110/ps.062608807; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rodriguez-Crespo I, 1998, ARCH BIOCHEM BIOPHYS, V359, P297, DOI 10.1006/abbi.1998.0928; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Su Y, 2010, CELL MICROBIOL, V12, P1098, DOI 10.1111/j.1462-5822.2010.01453.x; Tochio H, 1998, NAT STRUCT BIOL, V5, P965, DOI 10.1038/2940; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Yang PF, 2009, J BIOL CHEM, V284, P31412, DOI 10.1074/jbc.M109.050666; Yang ZB, 2005, J BIOL CHEM, V280, P654, DOI 10.1074/jbc.M408486200; Zhou HX, 2006, BIOPHYS J, V91, P3170, DOI 10.1529/biophysj.106.090258; Zhou HX, 2003, J MOL BIOL, V329, P1, DOI 10.1016/S0022-2836(03)00372-3	59	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38649	38657		10.1074/jbc.M110.165894	http://dx.doi.org/10.1074/jbc.M110.165894			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889982	hybrid, Green Published			2022-12-25	WOS:000284625600069
J	Chen, YH; Wendt-Pienkowski, E; Ju, JH; Lin, SJ; Rajski, SR; Shen, B				Chen, Yihua; Wendt-Pienkowski, Evelyn; Ju, Jianhua; Lin, Shuangjun; Rajski, Scott R.; Shen, Ben			Characterization of FdmV as an Amide Synthetase for Fredericamycin A Biosynthesis in Streptomyces griseus ATCC 43944	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYTETRACYCLINE POLYKETIDE SYNTHASE; GENE-CLUSTER; PHYSICOCHEMICAL PROPERTIES; FUNCTIONAL-ANALYSIS; SKELETAL TYPE; CLONING; IDENTIFICATION; ASPARAGINE; ANTIBIOTICS; PURIFICATION	Fredericamycin (FDM) A is a pentadecaketide natural product that features an amide linkage. Analysis of the fdm cluster from Streptomyces griseus ATCC 43944, however, failed to reveal genes encoding the types of amide synthetases commonly seen in natural product biosynthesis. Here, we report in vivo and in vitro characterizations of FdmV, an asparagine synthetase (AS) B-like protein, as an amide synthetase that catalyzes the amide bond formation in FDM A biosynthesis. This is supported by the findings that (i) inactivation of fdmV in vivo afforded the Delta fdmV mutant strain SB4027 that abolished FDM A and FDM E production but accumulated FDM C, a biosynthetic intermediate devoid of the characteristic amide linkage; (ii) FdmV in vitro catalyzes conversion of FDM C to FDM B, a known intermediate for FDM A biosynthesis (apparent K-m = 162 +/- 67 mu M and k(cat) = 0.11 +/- 0.02 min(-1)); and (iii) FdmV also catalyzes the amidation of FDM M-3, a structural analog of FDM C, to afford amide FDM M-6 in vitro, albeit at significantly reduced efficiency. Preliminary enzymatic studies revealed that, in addition to the common nitrogen sources (L-Gln and free amine) of class II glutamine amidotransferases (to which AS B belongs), FdmV can also utilize L-Asn as a nitrogen donor. The amide bond formation in FDM A biosynthesis is proposed to occur after C-8 hydroxylation but before the carbaspirocycle formation.	[Shen, Ben] Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, B (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu	Chen, Yihua/B-3550-2012		National Institutes of Health [CA113297]; NATIONAL CANCER INSTITUTE [U19CA113297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113297.	Anderle C, 2007, CHEM BIOL, V14, P955, DOI 10.1016/j.chembiol.2007.07.014; BYRNE KM, 1985, BIOCHEMISTRY-US, V24, P478, DOI 10.1021/bi00323a035; Chen Y, 2008, J BACTERIOL, V190, P5587, DOI 10.1128/JB.00592-08; Chen YH, 2008, J NAT PROD, V71, P431, DOI 10.1021/np070664n; Chen YH, 2009, J BIOL CHEM, V284, P24735, DOI 10.1074/jbc.M109.014191; Doumith M, 2000, MOL GEN GENET, V264, P477, DOI 10.1007/s004380000329; Fortin PD, 2007, NATURE, V448, P824, DOI 10.1038/nature06068; Hornung A, 2007, CHEMBIOCHEM, V8, P757, DOI 10.1002/cbic.200600375; Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim BC, 2007, J MICROBIOL BIOTECHN, V17, P830; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Li AY, 2002, CHEM BIOL, V9, P1017, DOI 10.1016/S1074-5521(02)00223-5; Lopez P, 2010, GENE, V461, P5, DOI 10.1016/j.gene.2010.03.016; Luft T, 2005, ARCH MICROBIOL, V183, P277, DOI 10.1007/s00203-005-0770-0; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Madduri K, 1998, NAT BIOTECHNOL, V16, P69, DOI 10.1038/nbt0198-69; Magarvey NA, 2008, ACS CHEM BIOL, V3, P542, DOI 10.1021/cb800085g; Martin R, 2001, J ANTIBIOT, V54, P239, DOI 10.7164/antibiotics.54.239; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Miller MT, 2003, J BIOL CHEM, V278, P40996, DOI 10.1074/jbc.M307901200; Miller MT, 2001, NAT STRUCT BIOL, V8, P684, DOI 10.1038/90394; MISRA R, 1982, J AM CHEM SOC, V104, P4478, DOI 10.1021/ja00380a025; MISRA R, 1987, J ANTIBIOT, V40, P786; Nakano T, 2004, BIOSCI BIOTECH BIOCH, V68, P1345, DOI 10.1271/bbb.68.1345; Ogasawara Y, 2004, CHEM BIOL, V11, P79, DOI 10.1016/j.chembiol.2003.12.010; PANDEY RC, 1981, J ANTIBIOT, V34, P1389, DOI 10.7164/antibiotics.34.1389; Pompeo F, 2002, PROTEIN EXPRES PURIF, V24, P138, DOI 10.1006/prep.2001.1550; Richards NGJ, 1998, ADV ENZYMOL RAMB, V72, P145; Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sontag B, 2004, J ANTIBIOT, V57, P823, DOI 10.7164/antibiotics.57.823; TOMITA K, 1990, J ANTIBIOT, V43, P755, DOI 10.7164/antibiotics.43.755; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Yunt Z, 2009, J AM CHEM SOC, V131, P2297, DOI 10.1021/ja807827k; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203; Zhang WJ, 2006, J NAT PROD, V69, P1633, DOI 10.1021/np060290i; Zhang WJ, 2006, APPL ENVIRON MICROB, V72, P2573, DOI 10.1128/AEM.72.4.2573-2580.2006; Zhang X, 2008, ANTIMICROB AGENTS CH, V52, P574, DOI 10.1128/AAC.00717-07; Ziermann R, 1999, BIOTECHNIQUES, V26, P106, DOI 10.2144/99261st05	40	16	17	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38853	38860		10.1074/jbc.M110.147744	http://dx.doi.org/10.1074/jbc.M110.147744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926388	hybrid, Green Published			2022-12-25	WOS:000284941300014
J	Luanpitpong, S; Talbott, SJ; Rojanasakul, Y; Nimmannit, U; Pongrakhananon, V; Wang, LY; Chanvorachote, P				Luanpitpong, Sudjit; Talbott, Siera Jo; Rojanasakul, Yon; Nimmannit, Ubonthip; Pongrakhananon, Varisa; Wang, Liying; Chanvorachote, Pithi			Regulation of Lung Cancer Cell Migration and Invasion by Reactive Oxygen Species and Caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED P53 ACTIVATION; OXIDATIVE STRESS; PROSTATE-CANCER; HYDROGEN-PEROXIDE; BREAST-CANCER; TUMOR PROGRESSION; POOR-PROGNOSIS; EXPRESSION; GROWTH; METASTASIS	The acquired capability of tumor cells to migrate and invade neighboring tissues is associated with high metastatic potential and advanced stage of cancers. Recently, signaling molecules such as reactive oxygen species (ROS) and caveolin-1 (Cav-1) have been implicated in the aggressive behavior of cancer cells. However, the roles of specific ROS in cancer cell migration and Cav-1 regulation are unclear. We demonstrate here that Cav-1 plays an important role in the migration and invasion of human lung carcinoma H460 cells and that these effects are differentially regulated by cellular ROS. Using various known inhibitors and donors of ROS, we found that different ROS have different effects on Cav-1 expression and cell migration and invasion. Superoxide anion and hydrogen peroxide down-regulated Cav-1 expression and inhibited cell migration and invasion, whereas hydroxyl radical up-regulated the Cav-1 expression and promoted cell migration and invasion. The down-regulating effect of superoxide anion and hydrogen peroxide on Cav-1 is mediated through a transcription-independent mechanism that involves protein degradation via the ubiquitin-proteasome pathway. These results indicate the essential role of different ROS in cancer cell motility and through Cav-1 expression, which may provide a key mechanism controlling tumor progression and metastasis. The upregulation of Cav-1 and cell motility by hydroxyl free radical suggests an important role of this ROS as a positive regulator of tumor progression.	[Rojanasakul, Yon] W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA; Chulalongkorn Univ, Pharmaceut Technol Int Program, Bangkok 10330, Thailand; [Chanvorachote, Pithi] Chulalongkorn Univ, Dept Physiol & Pharmacol, Bangkok 10330, Thailand; [Talbott, Siera Jo] W Virginia Univ, Canc Cell Biol Program, Morgantown, WV 26506 USA; [Nimmannit, Ubonthip] Natl Nanotechnol Ctr, Pathum Thani 12120, Thailand; [Wang, Liying] NIOSH, Morgantown, WV 26505 USA	West Virginia University; Chulalongkorn University; Chulalongkorn University; West Virginia University; National Science & Technology Development Agency - Thailand; National Nanotechnology Center (NANOTEC); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Rojanasakul, Y (corresponding author), W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA.	yrojan@hsc.wvu.edu; pithi_chan@yahoo.com	Luanpitpong, Sudjit/ABF-1962-2021	chanvorachote, pithi/0000-0002-3103-3249; Rojanasakul, Yon/0000-0002-8839-6462; Luanpitpong, Sudjit/0000-0002-1639-4935	National Institutes of Health [R01-HL076340]; Thailand Research Fund [5.Q.CU/49/A.1]; Ratchadaphiseksomphot Endowment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund(Thailand Research Fund (TRF)); Ratchadaphiseksomphot Endowment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL076340. This work was also supported by Thailand Research Fund Grant 5.Q.CU/49/A.1 and Ratchadaphiseksomphot Endowment Fund.	Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Ben Mahdi MH, 2000, IUBMB LIFE, V50, P291, DOI 10.1080/15216540051081038; Brenneisen P, 1998, J BIOL CHEM, V273, P5279, DOI 10.1074/jbc.273.9.5279; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Cassoni P, 2009, HISTOPATHOLOGY, V55, P20, DOI 10.1111/j.1365-2559.2009.03326.x; Chanvorachote P, 2009, J BIOL CHEM, V284, P28476, DOI 10.1074/jbc.M109.050864; Chen DB, 2005, BIOL REPROD, V73, P761, DOI 10.1095/biolreprod.105.040881; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; CHUNGMAN HJ, 2001, CANCER RES, V61, P8578; Dokka S, 2001, AM J PHYSIOL-LUNG C, V280, pL1196, DOI 10.1152/ajplung.2001.280.6.L1196; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Esme H, 2008, RESPIROLOGY, V13, P112, DOI 10.1111/j.1440-1843.2007.01212.x; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Han F, 2010, J SURG RES, V159, P443, DOI 10.1016/j.jss.2009.03.079; Herr B, 2007, CELL MOL LIFE SCI, V64, P3295, DOI 10.1007/s00018-007-7371-9; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Ishihara Y, 2006, TOXICOL APPL PHARM, V214, P109, DOI 10.1016/j.taap.2005.12.003; Jiang M, 2007, BIOCHEM PHARMACOL, V73, P1499, DOI 10.1016/j.bcp.2007.01.010; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kato T, 2004, CANCER LETT, V214, P121, DOI 10.1016/j.canlet.2004.04.017; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Laurent A, 2005, CANCER RES, V65, P948; Lee KJ, 2008, CANCER LETT, V268, P233, DOI 10.1016/j.canlet.2008.03.058; Li LK, 2009, MOL CANCER RES, V7, P1781, DOI 10.1158/1541-7786.MCR-09-0255; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Misthos P, 2005, EUR J CARDIO-THORAC, V27, P379, DOI 10.1016/j.ejcts.2004.12.023; Moon KC, 2005, ANTICANCER RES, V25, P4631; Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008; Novo E, 2006, GUT, V55, P90, DOI 10.1136/gut.2005.069633; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; OToole EA, 1996, DERMATOL SURG, V22, P525, DOI 10.1111/j.1524-4725.1996.tb00368.x; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Ravid D, 2005, ONCOGENE, V24, P1338, DOI 10.1038/sj.onc.1208337; Shatz M, 2008, INT J RADIAT BIOL, V84, P177, DOI 10.1080/09553000701745293; Shim E, 2007, BIOTECHNOL LETT, V29, P141, DOI 10.1007/s10529-006-9213-5; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; Steiling H, 1999, EXP CELL RES, V247, P484, DOI 10.1006/excr.1998.4366; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Svensk AM, 2004, AM J CLIN PATHOL, V122, P395, DOI 10.1309/A45QHB0QRRX6CT9A; Svineng G, 2008, CONNECT TISSUE RES, V49, P197, DOI 10.1080/03008200802143166; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tobar N, 2008, CANCER LETT, V267, P125, DOI 10.1016/j.canlet.2008.03.011; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Wang SW, 2004, MOL CELL BIOCHEM, V255, P119, DOI 10.1023/B:MCBI.0000007268.42733.53; Williams TM, 2005, J BIOL CHEM, V280, P25134, DOI 10.1074/jbc.M501186200; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yoo SH, 2003, LUNG CANCER, V42, P195, DOI 10.1016/S0169-5002(03)00287-3; Zhang W, 2000, J BIOL CHEM, V275, P20717, DOI 10.1074/jbc.M909895199	59	143	145	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38832	38840		10.1074/jbc.M110.124958	http://dx.doi.org/10.1074/jbc.M110.124958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923773	Green Published, hybrid			2022-12-25	WOS:000284941300012
J	Shannon, LA; Calloway, PA; Welch, TP; Vines, CM				Shannon, Laura A.; Calloway, Psachal A.; Welch, T. Paul; Vines, Charlotte M.			CCR7/CCL21 Migration on Fibronectin Is Mediated by Phospholipase C gamma 1 and ERK1/2 in Primary T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; LYMPH-NODE; INTEGRIN; CHEMOTAXIS; ADHESION; ACTIVATION; RECEPTORS; PLC-GAMMA-1; PATHWAYS; PROMOTES	CCR7 binds to its cognate ligand, CCL21, to mediate the migration of circulating naive T lymphocytes to the lymph nodes. T lymphocytes can bind to fibronectin, a constituent of lymph nodes, via their beta 1 integrins, which is a primary mechanism of T lymphocyte migration; however, the signaling pathways involved are unclear. We report that rapid (within 2 min) and transient phosphorylation of ERK1/2 is required for T cell migration on fibronectin in response to CCL21. Conversely, prevention of ERK1/2 phosphorylation by inhibition of its kinase, MAPK/MEK, prevented T lymphocyte migration. Previous studies have suggested that phospholipase C gamma 1 (PLC gamma 1) can mediate phosphorylation of ERK1/2, which is required for beta 1 integrin activation. Paradoxically, we found that inhibition of PLC gamma 1 phosphorylation by the general PLC inhibitor U73122 was associated with a delayed and reduced phosphorylation of ERK1/2 and reduced migration of T lymphocytes on fibronectin. To further characterize the relationship between ERK1/2 and PLC gamma 1, we reduced PLC gamma 1 levels by 85% using shRNA and observed a reduced phosphorylation of ERK1/2 and a significant loss of CCR7-mediated migration of T lymphocytes on fibronectin. In addition, we found that inhibition of ERK1/2 phosphorylation by U0126 resulted in a decreased phosphorylation of PLC gamma 1, suggesting a feedback loop between ERK1/2 and PLC gamma 1. Overall, these results suggest that the CCR7 signaling pathway leading to T lymphocyte migration on fibronectin is a beta 1 integrin-dependent pathway involving transient ERK1/2 phosphorylation, which is modulated by PLC gamma 1.	[Shannon, Laura A.; Calloway, Psachal A.; Welch, T. Paul; Vines, Charlotte M.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Vines, CM (corresponding author), 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	cvines@kumc.edu			National Institutes of Health, National Center for Research Resources [P20 RO16443]; National Institutes of Health, NIAID [K22AIP60815]; University of Kansas Medical Center Research Institute; Hall Foundation; National Institutes of Health [P20 RR016443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI060815] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Kansas Medical Center Research Institute; Hall Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported, in whole or in part, by National Institutes of Health Grant P20 RO16443 from the National Center for Research Resources and National Institutes of Health Grant K22AIP60815 from NIAID (to C. M. V.). This work was also supported by a University of Kansas Medical Center Research Institute bridging award and biomedical research training award (to L. A. S.). Flow cytometry was carried out at the University of Kansas Medical Center flow cytometry core laboratory, which is supported by a generous endowment from the Hall Foundation and by National Institutes of Health Grant P20 RR016443.	Bach TL, 2007, J IMMUNOL, V179, P2223, DOI 10.4049/jimmunol.179.4.2223; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Cheung R, 2009, J LEUKOCYTE BIOL, V86, P833, DOI 10.1189/jlb.0908551; Faull RJ, 1996, J AM SOC NEPHROL, V7, P1091; Gerthoffer William T, 2008, Proc Am Thorac Soc, V5, P97, DOI 10.1513/pats.200704-051VS; Gollmer K, 2009, BLOOD, V114, P580, DOI 10.1182/blood-2009-01-200923; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; GUTKIND JS, 2000, SCI STKE, V40, pRE1; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Kaiser A, 2005, J IMMUNOL, V175, P2349, DOI 10.4049/jimmunol.175.4.2349; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Kranenburg O, 2001, ONCOGENE, V20, P1540, DOI 10.1038/sj.onc.1204187; Liu E, 2005, MOL CELL BIOL, V25, P11145, DOI 10.1128/MCB.25.24.11145-11155.2005; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Mu H, 2009, AM J PHYSIOL-HEART C, V297, pH400, DOI 10.1152/ajpheart.01254.2008; Otero C, 2008, J CELL SCI, V121, P2759, DOI 10.1242/jcs.029074; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Rong R, 2003, J BIOL CHEM, V278, P52497, DOI 10.1074/jbc.M306744200; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; SZEKANECZ Z, 1992, J CELL SCI, V101, P885; Szekeres CK, 2000, J BIOL CHEM, V275, P38831, DOI 10.1074/jbc.M002673200; Tvorogov D, 2005, J CELL SCI, V118, P601, DOI 10.1242/jcs.01643; Vossmeyer D, 2002, J BIOL CHEM, V277, P4636, DOI 10.1074/jbc.M105415200; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Yang JM, 2001, MOL PHARMACOL, V60, P674; Yopp AC, 2005, J IMMUNOL, V175, P2913, DOI 10.4049/jimmunol.175.5.2913	31	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38781	38787		10.1074/jbc.M110.152173	http://dx.doi.org/10.1074/jbc.M110.152173			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889506	Green Published, hybrid			2022-12-25	WOS:000284941300007
J	Shimura, K; Nameki, D; Kajiwara, K; Watanabe, K; Sakagami, Y; Oishi, S; Fujii, N; Matsuoka, M; Sarafianos, SG; Kodama, EN				Shimura, Kazuya; Nameki, Daisuke; Kajiwara, Keiko; Watanabe, Kentaro; Sakagami, Yasuko; Oishi, Shinya; Fujii, Nobutaka; Matsuoka, Masao; Sarafianos, Stefan G.; Kodama, Eiichi N.			Resistance Profiles of Novel Electrostatically Constrained HIV-1 Fusion Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENV-MEDIATED FUSION; ANTIRETROVIRAL ACTIVITY; ENFUVIRTIDE RESISTANCE; BASE-LINE; HIV-1-INFECTED PATIENTS; PHENOTYPIC RESISTANCE; ENVELOPE GLYCOPROTEIN; HEPTAD REPEAT; GP41 GENOTYPE	Human immunodeficiency virus (HIV) gp41 plays a key role in viral fusion; the N- and C-terminal heptad repeats (N-HR and C-HR) of gp41 form a stable 6-helical conformation for fusion. Therefore, HR-derived peptides, such as enfuvirtide (T-20), inhibit HIV-1 fusion by acting as decoys, and have been used for the treatment of HIV-1 infection. However, the efficacy of T-20 is attenuated by resistance mutations in gp41, including V38A and N43D. To suppress the resistant variants, we previously developed electrostatically constrained peptides, SC34 and SC34EK, and showed that both exhibited potent anti-HIV-1 activity against wild-type and T-20-resistant variants. In this study, to clarify the resistance mechanism to this next generation of fusion inhibitors, we selected variants with resistance to SC34 and SC34EK in vitro. The resistant variants had multiple mutations in gp41. All of these mutations individually caused less than 6-fold resistance to SC34 and SC34EK, indicating that there is a significant genetic barrier for high-level resistance. Cross-resistance to SC34 and SC34EK was reduced by a simple difference in the polarity of two intramolecular electrostatic pairs. Furthermore, the selected mutations enhanced the physicochemical interactions with N-HR variants and restored activities of the parental peptide, C34, even to resistant variants. These results demonstrate that our approach of designing gp41-binding inhibitors using electrostatic constraints and information derived from resistance studies produces inhibitors with enhanced activity, high genetic barrier, and distinct resistance profile from T-20 and other inhibitors. Hence, this is a promising approach for the design of future generation peptide fusion inhibitors.	[Matsuoka, Masao; Kodama, Eiichi N.] Kyoto Univ, Inst Virus Res, Lab Virus Control, Kyoto 6068507, Japan; [Watanabe, Kentaro; Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068507, Japan; [Kodama, Eiichi N.] Tohoku Univ, Sch Med, Div Emerging Infect Dis, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Sarafianos, Stefan G.] Univ Missouri, Sch Med, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	Kyoto University; Kyoto University; Tohoku University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Shimura, K (corresponding author), 53 Shogoin Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	kshimura@virus.kyoto-u.ac.jp; kodama515@med.tohoku.ac.jp	Kodama, Eiichi N/C-4032-2009; Oishi, Shinya/C-1350-2011	Kodama, Eiichi N/0000-0002-6622-2752; Oishi, Shinya/0000-0002-2833-2539; Matsuoka, Masao/0000-0002-0473-754X; Sarafianos, Stefan G/0000-0002-5840-154X; SHIMURA, Kazuya/0000-0001-7819-5184	National Institutes of Health [AI076119, AI074389, AI079801]; Ministry of Health and Welfare of Japan; Japan Health Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076119, R33AI079801, R01AI074389, R21AI079801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI076119, AI074389, and AI079801 (to S. G. S.), in part by a grant for Promotion of AIDS Research from the Ministry of Health and Welfare of Japan (to E. N. K. and M. M.), a grant for Research on Health Science Focusing on Drug Innovation from the Japan Health Science Foundation (to E. N. K. and M. M.), and a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E. N. K.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aquaro S, 2006, J ANTIMICROB CHEMOTH, V58, P714, DOI 10.1093/jac/dkl306; Bai XF, 2008, BIOCHEMISTRY-US, V47, P6662, DOI 10.1021/bi702509d; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Cabrera C, 2006, AIDS, V20, P2075, DOI 10.1097/QAD.0b013e3280102377; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chibo D, 2007, AIDS, V21, P1974, DOI 10.1097/QAD.0b013e3282ef1bc8; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Izumi K, 2009, J BIOL CHEM, V284, P4914, DOI 10.1074/jbc.M807169200; Kuiken C, 2008, HIV SEQUENCE COMPEND; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Lu J, 2006, JAIDS-J ACQ IMM DEF, V43, P60, DOI 10.1097/01.qai.0000234083.34161.55; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; Melby T, 2007, AIDS RES HUM RETROV, V23, P1366, DOI 10.1089/aid.2006.0277; Melby T, 2006, AIDS RES HUM RETROV, V22, P375, DOI 10.1089/aid.2006.22.375; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; Oishi S, 2008, J MED CHEM, V51, P388, DOI 10.1021/jm701109d; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Pan C, 2009, AIDS, V23, P639, DOI 10.1097/QAD.0b013e328325a4cd; Qi Z, 2008, J BIOL CHEM, V283, P30376, DOI 10.1074/jbc.M804672200; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Ryser HJP, 2005, DRUG DISCOV TODAY, V10, P1085, DOI 10.1016/S1359-6446(05)03550-6; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; Sista PR, 2004, AIDS, V18, P1787, DOI 10.1097/00002030-200409030-00007; Tolstrup M, 2007, AIDS, V21, P519, DOI 10.1097/QAD.0b013e3280187558; Watabe T, 2009, J MOL BIOL, V392, P657, DOI 10.1016/j.jmb.2009.07.027; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005	49	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39471	39480		10.1074/jbc.M110.145789	http://dx.doi.org/10.1074/jbc.M110.145789			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937812	Green Published, hybrid			2022-12-25	WOS:000284941300073
J	Laeyendecker, O; Church, JD; Oliver, AE; Mwatha, A; Owen, SM; Donnell, D; Brookmeyer, R; Musoke, P; Jackson, JB; Guay, L; Nakabiito, C; Quinn, TC; Eshleman, SH				Laeyendecker, Oliver; Church, Jessica D.; Oliver, Amy E.; Mwatha, Anthony; Owen, S. Michele; Donnell, Deborah; Brookmeyer, Ron; Musoke, Philippa; Jackson, J. Brooks; Guay, Laura; Nakabiito, Clemesia; Quinn, Thomas C.; Eshleman, Susan H.			Pregnancy Does Not Affect HIV Incidence Test Results Obtained Using the BED Capture Enzyme Immunoassay or an Antibody Avidity Assay	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; UNITED-STATES; WOMEN; SEROCONVERSION; INFECTIONS; ALGORITHM	Background: Accurate incidence estimates are needed for surveillance of the HIV epidemic. HIV surveillance occurs at maternal-child health clinics, but it is not known if pregnancy affects HIV incidence testing. Methods: We used the BED capture immunoassay (BED) and an antibody avidity assay to test longitudinal samples from 51 HIV-infected Ugandan women infected with subtype A, C, D and intersubtype recombinant HIV who were enrolled in the HIVNET 012 trial (37 baseline samples collected near the time of delivery and 135 follow-up samples collected 3, 4 or 5 years later). Nineteen of 51 women were also pregnant at the time of one or more of the follow-up visits. The BED assay was performed according to the manufacturer's instructions. The avidity assay was performed using a Genetic Systems HIV-1/HIV-2 + O EIA using 0.1M diethylamine as the chaotropic agent. Results: During the HIVNET 012 follow-up study, there was no difference in normalized optical density values (OD-n) obtained with the BED assay or in the avidity test results (%) when women were pregnant (n = 20 results) compared to those obtained when women were not pregnant (n = 115; for BED: p = 0.9, generalized estimating equations model; for avidity: p = 0.7, Wilcoxon rank sum). In addition, BED and avidity results were almost exactly the same in longitudinal samples from the 18 women who were pregnant at only one study visit during the follow-up study (p = 0.6, paired t-test). Conclusions: These results from 51 Ugandan women suggest that any changes in the antibody response to HIV infection that occur during pregnancy are not sufficient to alter results obtained with the BED and avidity assays. Confirmation with larger studies and with other HIV subtypes is needed.	[Laeyendecker, Oliver; Church, Jessica D.; Oliver, Amy E.; Jackson, J. Brooks; Guay, Laura; Quinn, Thomas C.; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Mwatha, Anthony; Donnell, Deborah] Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA; [Owen, S. Michele] Ctr Dis Control & Prevent, Atlanta, GA USA; [Brookmeyer, Ron] Univ Calif Los Angeles, Los Angeles, CA USA; [Musoke, Philippa; Nakabiito, Clemesia] MUJHU Res Collaborat, Kampala, Uganda; [Musoke, Philippa; Nakabiito, Clemesia] Makerere Univ, Sch Med, Kampala, Uganda; [Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Fred Hutchinson Cancer Center; Centers for Disease Control & Prevention - USA; University of California System; University of California Los Angeles; Makerere University; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Laeyendecker, O (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	olaeyen1@jhmi.edu	Laeyendecker, Oliver B/B-9331-2009	Laeyendecker, Oliver/0000-0002-6429-4760; Donnell, Deborah/0000-0002-0587-7480; jackson, brooks/0000-0001-9458-135X	U.S. National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Dept. of Health and Human Services (DHHS) through Family Health International [N01-AI-35173]; Fred Hutchinson Cancer Research Center [N01-AI-45200]; Johns Hopkins Univ. [NOI-AI-35173-417]; NIAID; National Institutes of Child Health and Human Development (NICH/HD); National Institute on Drug Abuse; National Institute of Mental Health; Office of AIDS Research of NIH, DHHS [U01-AI-46745, U01-AI-48054, U01-AI-068613]; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group Network Laboratory [U01 AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613, N01AI045200, ZIAAI001040, U01AI048054, N01AI035173, ZIAAI000361, U01AI046745, U01AI068632] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Health and Human Services (DHHS) through Family Health International; Fred Hutchinson Cancer Research Center; Johns Hopkins Univ.; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Child Health and Human Development (NICH/HD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research of NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group Network Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by (1) the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS), through contracts with Family Health International (N01-AI-35173), Fred Hutchinson Cancer Research Center (N01-AI-45200), and Johns Hopkins Univ. (NOI-AI-35173-417), (2) the HIV Prevention Trials Network (HPTN) sponsored by the NIAID, National Institutes of Child Health and Human Development (NICH/HD), National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, DHHS (U01-AI-46745, U01-AI-48054, and U01-AI-068613), and (3) the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group Network Laboratory (U01 AI068632). Additional support was provided by the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Eshleman SH, 2004, JAIDS-J ACQ IMM DEF, V35, P126, DOI 10.1097/00126334-200402010-00004; Flys TS, 2007, AIDS, V21, P2077, DOI 10.1097/QAD.0b013e3282703847; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; LAEYENDECKER O, 2009, DECREASING HIV INCID; LAEYENDECKER O, 2009, 2 GLOB HIV ADIS SURV; Laeyendecker O., 2009, 16 C RETR OPP INF MO; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; MARINDA ET, 2004, J ACQ IMMUN DEF SYND, V53, P496; Martro E, 2005, J CLIN MICROBIOL, V43, P6197, DOI 10.1128/JCM.43.12.6197-6199.2005; Masciotra S, 2010, 17 C RETR OPP INF SA; Murphy G, 2008, EURO SURVEILL, V13; Patel D, 2009, INT J INFECT DIS, V13, P266, DOI 10.1016/j.ijid.2008.07.004; Piccinni MP, 2010, J REPROD IMMUNOL, V85, P71, DOI 10.1016/j.jri.2010.01.006; Robertson SA, 2010, J REPROD IMMUNOL, V85, P51, DOI 10.1016/j.jri.2010.01.008; *UNAIDS, 2006, WKLY EPIDEMIOL REC, V81, P40; WELTE A, EURO SURVEILL, V15; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13259	10.1371/journal.pone.0013259	http://dx.doi.org/10.1371/journal.pone.0013259			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949006	Green Submitted, gold, Green Published			2022-12-25	WOS:000282748100009
J	Shanab, SMM; Shalaby, EA; Lightfoot, DA; El-Shemy, HA				Shanab, Sanaa M. M.; Shalaby, Emad A.; Lightfoot, David A.; El-Shemy, Hany A.			Allelopathic Effects of Water Hyacinth [Eichhornia crassipes]	PLOS ONE			English	Article							BLUE-GREEN-ALGAE; DIBUTYL PHTHALATE; GROWTH; SUBSTANCES; MACROPHYTE; COMPOUND; PLANTS	Eichhornia crassipes (Mart) Solms is an invasive weed known to out-compete native plants and negatively affect microbes including phytoplankton. The spread and population density of E. crassipes will be favored by global warming. The aim here was to identify compounds that underlie the effects on microbes. The entire plant of E. crassipes was collected from El Zomor canal, River Nile (Egypt), washed clean, then air dried. Plant tissue was extracted three times with methanol and fractionated by thin layer chromatography (TLC). The crude methanolic extract and five fractions from TLC (A-E) were tested for antimicrobial (bacteria and fungal) and anti-algal activities (green microalgae and cyanobacteria) using paper disc diffusion bioassay. The crude extract as well as all five TLC fractions exhibited antibacterial activities against both the Gram positive bacteria; Bacillus subtilis and Streptococcus faecalis; and the Gram negative bacteria; Escherichia coli and Staphylococcus aureus. Growth of Aspergillus flavus and Aspergillus niger were not inhibited by either E. crassipes crude extract nor its five fractions. In contrast, Candida albicans (yeast) was inhibited by all. Some antialgal activity of the crude extract and its fractions was manifest against the green microalgae; Chlorella vulgaris and Dictyochloropsis splendida as well as the cyanobacteria; Spirulina platensis and Nostoc piscinale. High antialgal activity was only recorded against Chlorella vulgaris. Identifications of the active antimicrobial and antialgal compounds of the crude extract as well as the five TLC fractions were carried out using gas chromatography combined with mass spectroscopy. The analyses showed the presence of an alkaloid (fraction A) and four phthalate derivatives (Fractions B-E) that exhibited the antimicrobial and antialgal activities.	[Shanab, Sanaa M. M.] Cairo Univ, Fac Sci, Dept Bot, Giza, Egypt; [Shalaby, Emad A.; El-Shemy, Hany A.] Cairo Univ, Fac Agr, Dept Biochem, Giza, Egypt; [Lightfoot, David A.] So Illinois Univ Carbondale, Genom Core Facil, Carbondale, IL USA	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Southern Illinois University System; Southern Illinois University	Shanab, SMM (corresponding author), Cairo Univ, Fac Sci, Dept Bot, Giza, Egypt.	helshemy@hotmail.com	Shanab, Sanaa/AAR-2613-2020; Shalaby, Emad A./AAB-6935-2021; El-Shemy, Hany A./A-6367-2008	Shanab, Sanaa/0000-0002-3254-9618; Lightfoot, David/0000-0002-5725-4381; Shalaby, Emad/0000-0003-2900-4833				Alim Al-Bari M. A., 2006, RES J MED SCI, V1, P77; ALLER RTV, 1985, CHEM ALLELOPATHY BIO, P387; ALLIOTTA G, 1991, J CHEM ECOL, V17, P2223; ALLIOTTA G, 1990, J CHEM ECOL, V16, P2637; Awad HEA, 2008, THESIS CAIRO U; BOURRELLY P, 1970, INITIATION SYSTEMATI, V3; BOURRELLY P., 1972, INITIATION SYSTEMATI, VI; Chattopadhyay D, 1998, FITOTERAPIA, V69, P365; Dandelot S, 2008, AQUAT BOT, V88, P311, DOI 10.1016/j.aquabot.2007.12.004; DELLAGRECA M, 1989, PHYTOCHEMISTRY, V28, P2319; El-Mehalawy A. A., 2008, Journal of Applied Sciences Research, P425; ElNaggar MYM, 1997, BIOMED LETT, V55, P125; ELSHOUBARY MEE, 2010, THESIS TANTA U TANTA; GAOLEI, 2004, ACTA PHYTOECOLOGICA, V28, P735; GONZALEZ S, 2004, J ATAWAPASKAT RES, V2, P7; GRAYER RJ, 1994, PHYTOCHEMISTRY, V37, P19, DOI 10.1016/0031-9422(94)85005-4; Gross E. M., 1994, Acta Horticulturae, P710; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; HASLER AD, 1949, ECOLOGY, V30, P359, DOI 10.2307/1932616; Ignacimuthu S., 1997, Proceedings of the Indian National Science Academy Part B Biological Sciences, V63, P537; Jawetz E, 1974, REV MED MICROBIOLOGY, V11th; Jin ZH, 2003, B ENVIRON CONTAM TOX, V71, P1048, DOI 10.1007/s00128-003-0226-7; Khattab A.F., 1988, INT WORKSH WAT HYAC, P303; KHATTAB AF, 2007, THESIS CAIRO U EGYPT; Mahalwal V. S., 2001, Journal of Essential Oil-Bearing Plants, V4, P45; MOGESTU K, 1960, JAP J LIMNOL, V21, P124; Muanza D. N., 1994, International Journal of Pharmacognosy, V32, P337; Nakai S, 1996, WATER SCI TECHNOL, V34, P227, DOI 10.1016/S0273-1223(96)00749-4; Nakai S, 1999, WATER SCI TECHNOL, V39, P47, DOI 10.1016/S0273-1223(99)00185-7; Prescott GW., 1982, ALGAE W GREAT LAKES, P1; Prescott GW., 1978, KNOW FRESH WATER ALG, P12; Rice EL, 1974, ALLELOPATHY; RICE EL, 1979, BOT REV, P45; Rossenthaler L., 1930, CHEM INVESTIGATION P; Roy RN, 2006, MICROBIOL RES, V161, P121, DOI 10.1016/j.micres.2005.06.007; SAITO K, 1989, J NAT PROD, V52, P1221, DOI 10.1021/np50066a004; SASTRY VMVS, 1994, BOT MAR, V37, P357, DOI 10.1515/botm.1994.37.4.357; SASTRY VMVS, 1995, J APPL PHYCOL, V7, P185, DOI 10.1007/BF00693066; Sharma A, 1996, WATER RES, V30, P2281, DOI 10.1016/0043-1354(96)00113-3; SHARMA KP, 1985, AQUAT BOT, V22, P71, DOI 10.1016/0304-3770(85)90030-0; Subhasini Sharma, 2005, Aquatic weeds: problems, control and management, P95; SUN W-H, 1990, Acta Phytophysiologica Sinica, V16, P301; SWAIN T, 1977, ANNU REV PLANT PHYS, V28, P479, DOI 10.1146/annurev.pp.28.060177.002403; Yu S, 1991, BIOINDICATORS ENV MA, P255; ZHILAN C, 2005, ACTA HYDROBIOL, V29, P313	45	77	83	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13200	10.1371/journal.pone.0013200	http://dx.doi.org/10.1371/journal.pone.0013200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949048	Green Published, Green Submitted, gold			2022-12-25	WOS:000282676700007
J	Sreekumar, PG; Kannan, R; Kitamura, M; Spee, C; Barron, E; Ryan, SJ; Hinton, DR				Sreekumar, Parameswaran G.; Kannan, Ram; Kitamura, Mizuki; Spee, Christine; Barron, Ernesto; Ryan, Stephen J.; Hinton, David R.			alpha B Crystallin Is Apically Secreted within Exosomes by Polarized Human Retinal Pigment Epithelium and Provides Neuroprotection to Adjacent Cells	PLOS ONE			English	Article							GROWTH-FACTOR; PROTEINS; HSP70; DEGENERATION; PATHOGENESIS; EXPRESSION; LOCALIZATION; TRAFFICKING; RELEVANCE; PROTEOME	alpha B Crystallin is a chaperone protein with anti-apoptotic and anti-inflammatory functions and has been identified as a biomarker in age-related macular degeneration. The purpose of this study was to determine whether alpha B crystallin is secreted from retinal pigment epithelial (RPE) cells, the mechanism of this secretory pathway and to determine whether extracellular alpha B crystallin can be taken up by adjacent retinal cells and provide protection from oxidant stress. We used human RPE cells to establish that alpha B crystallin is secreted by a non-classical pathway that involves exosomes. Evidence for the release of exosomes by RPE and localization of alpha B crystallin within the exosomes was achieved by immunoblot, immunofluorescence, and electron microscopic analyses. Inhibition of lipid rafts or exosomes significantly reduced alpha B crystallin secretion, while inhibitors of classic secretory pathways had no effect. In highly polarized RPE monolayers, alpha B crystallin was selectively secreted towards the apical, photoreceptor-facing side. In support, confocal microscopy established that alpha B crystallin was localized predominantly in the apical compartment of RPE monolayers, where it colocalized in part with exosomal marker CD63. Severe oxidative stress resulted in barrier breakdown and release of alpha B crystallin to the basolateral side. In normal mouse retinal sections, alpha B crystallin was identified in the interphotoreceptor matrix. An increased uptake of exogenous alpha B crystallin and protection from apoptosis by inhibition of caspase 3 and PARP activation were observed in stressed RPE cultures. alpha B Crystallin was taken up by photoreceptors in mouse retinal explants exposed to oxidative stress. These results demonstrate an important role for alpha B crystallin in maintaining and facilitating a neuroprotective outer retinal environment and may also explain the accumulation of alpha B crystallin in extracellular sub-RPE deposits in the stressed microenvironment in age-related macular degeneration. Thus evidence from our studies supports a neuroprotective role for alpha B crystallin in ocular diseases.	[Sreekumar, Parameswaran G.; Kannan, Ram; Kitamura, Mizuki; Spee, Christine; Barron, Ernesto; Ryan, Stephen J.; Hinton, David R.] Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Kannan, Ram; Ryan, Stephen J.; Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	Doheny Eye Institute; University of Southern California; University of Southern California	Sreekumar, PG (corresponding author), Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, 1355 San Pablo St, Los Angeles, CA 90033 USA.	dhinton@usc.edu	kannan, ram/ABB-7154-2020	kannan, ram/0000-0002-1583-3414; /0000-0002-9425-3986	Arnold and Mabel Beckman Foundation; National Institutes of Health [EY01545, EY03040]; Department of Ophthalmology by Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [P30EY003040, R01EY001545] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Ophthalmology by Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The Arnold and Mabel Beckman Foundation, National Institutes of Health Grants (EY01545, EY03040), and a grant to the Department of Ophthalmology by Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER AJ, 1989, EXP EYE RES, V49, P1067, DOI 10.1016/S0014-4835(89)80027-2; Alcazar O, 2009, MOL CELL PROTEOMICS, V8, P2201, DOI 10.1074/mcp.M900203-MCP200; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Asea A, 2000, CELL STRESS CHAPERON, V5, P425, DOI 10.1379/1466-1268(2000)005<0425:HPBAPN>2.0.CO;2; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Bryantsev AL, 2007, EXP CELL RES, V313, P195, DOI 10.1016/j.yexcr.2006.10.004; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Danysh BP, 2010, MATRIX BIOL, V29, P228, DOI 10.1016/j.matbio.2009.12.004; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Ethen CM, 2006, INVEST OPHTH VIS SCI, V47, P2280, DOI 10.1167/iovs.05-1395; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Hauck SM, 2005, PROTEOMICS, V5, P3623, DOI 10.1002/pmic.200401223; HIGHTOWER LE, 1989, J CELL PHYSIOL, V138, P257, DOI 10.1002/jcp.1041380206; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Jin JK, 2008, AM J PHYSIOL-HEART C, V294, pH337, DOI 10.1152/ajpheart.00881.2007; Johnson PT, 2005, INVEST OPHTH VIS SCI, V46, P4788, DOI 10.1167/iovs.05-0767; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Karakousis PC, 2001, MOL VIS, V7, P154; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; MIGNATTI P, 1992, J CELL PHYSIOL, V151, P81, DOI 10.1002/jcp.1041510113; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; ROHLICH P, 1970, EXP EYE RES, V10, P80, DOI 10.1016/S0014-4835(70)80013-6; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sreekumar PG, 2008, INVEST OPHTH VIS SCI, V49, P1210, DOI 10.1167/iovs.07-0667; Steiner-Champliaud MF, 2006, MOL VIS, V12, P892; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van Rijk AF, 2003, EUR J CELL BIOL, V82, P361, DOI 10.1078/0171-9335-00321; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Whiston EA, 2008, INFECT IMMUN, V76, P1781, DOI 10.1128/IAI.01285-07; Yaung J, 2008, EXP EYE RES, V86, P355, DOI 10.1016/j.exer.2007.11.007; Yaung J, 2007, MOL VIS, V13, P566; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	45	146	152	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e12578	10.1371/journal.pone.0012578	http://dx.doi.org/10.1371/journal.pone.0012578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949024	Green Published, Green Submitted, gold			2022-12-25	WOS:000282676700001
J	Bartmeyer, B; Kuecherer, C; Houareau, C; Werning, J; Keeren, K; Somogyi, S; Kollan, C; Jessen, H; Dupke, S; Hamouda, O				Bartmeyer, Barbara; Kuecherer, Claudia; Houareau, Claudia; Werning, Johanna; Keeren, Kathrin; Somogyi, Sybille; Kollan, Christian; Jessen, Heiko; Dupke, Stephan; Hamouda, Osamah		German HIV-1 Seroconverter Study G	Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; ACTIVE ANTIRETROVIRAL THERAPY; GENOTYPIC RESISTANCE; INFECTED PATIENTS; MUTATIONS; TRANSMISSION; EPIDEMIOLOGY; SURVEILLANCE; DECLINE; INDIVIDUALS	Background: The aim of this study is to analyse the prevalence of transmitted drug resistance, TDR, and the impact of TDR on treatment success in the German HIV-1 Seroconverter Cohort. Methods: Genotypic resistance analysis was performed in treatment-naive study patients whose sample was available 1,312/1,564 (83.9% October 2008). A genotypic resistance result was obtained for 1,276/1,312 (97.3%). The resistance associated mutations were identified according to the surveillance drug resistance mutations list recommended for drug-naive patients. Treatment success was determined as viral suppression below 500 copies/ml. Results: Prevalence of TDR was stable at a high level between 1996 and 2007 in the German HIV-1 Seroconverter Cohort (N = 158/1,276; 12.4%; CI(wilson) 10.7-14.3; p (for trend) = 0.25). NRTI resistance was predominant (7.5%) but decreased significantly over time (CI(Wilson): 6.2-9.1, p (for trend) = 0.02). NNRTI resistance tended to increase over time (NNRTI: 3.5%; CI(Wilson): 2.6-4.6; p for trend = 0.07), whereas PI resistance remained stable (PI: 3.0%; CI(Wilson): 2.1-4.0; p (for trend) = 0.24). Resistance to all drug classes was frequently caused by singleton resistance mutations (NRTI 55.6%, PI 68.4%, NNRTI 99.1%). The majority of NRTI-resistant strains (79.8%) carried resistance-associated mutations selected by the thymidine analogues zidovudine and stavudine. Preferably 2NRTI/1PIr combinations were prescribed as first line regimen in patients with resistant HIV as well as in patients with susceptible strains (susceptible 45.3%; 173/382 vs. resistant 65.5%; 40/61). The majority of patients in both groups were treated successfully within the first year after ART-initiation (susceptible: 89.9%; 62/69; resistant: 7/9; 77.8%). Conclusion: Overall prevalence of TDR remained stable at a high level but trends of resistance against drug classes differed over time. The significant decrease of NRTI-resistance in patients newly infected with HIV might be related to the introduction of novel antiretroviral drugs and a wider use of genotypic resistance analysis prior to treatment initiation.	[Bartmeyer, Barbara; Houareau, Claudia; Werning, Johanna; Kollan, Christian; Hamouda, Osamah] Robert Koch Inst, HIV AIDS STD Unit, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany; [Kuecherer, Claudia; Keeren, Kathrin; Somogyi, Sybille] Robert Koch Inst, Project HIV Variabil & Mol Epidemiol, D-1000 Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Bartmeyer, B (corresponding author), Robert Koch Inst, HIV AIDS STD Unit, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany.	Gunsenheimer-BartmeyerB@rki.de	Jessen, Heiko/P-2192-2019	Keeren, Kathrin/0000-0001-5230-2199	German Ministry of Health	German Ministry of Health	The German HIV-1 Seroconerverter Study was funded by the German Ministry of Health (http://www.bmg.bund.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bezemer D, 2004, AIDS, V18, P1571, DOI 10.1097/01.aids.0000131357.52457.33; Bogart LM, 2000, J ACQ IMMUN DEF SYND, V23, P396; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Brenner BG, 2002, EXPERT OPIN BIOL TH, V2, P751, DOI 10.1517/14712598.2.7.751; CUEVAS MT, 2009, J ACQUIR IMMUNE DEFI; de Mendoza C, 2002, AIDS, V16, P1830, DOI 10.1097/00002030-200209060-00019; De Mendoza C, 2007, AIDS RES HUM RETROV, V23, P879, DOI 10.1089/aid.2005.0072; Duwe S, 2001, J ACQ IMMUN DEF SYND, V26, P266, DOI 10.1097/00126334-200103010-00010; FAUCI AS, 1995, NATURE, V378, P561, DOI 10.1038/378561a0; Garcia-Lerma JG, 2005, J ANTIMICROB CHEMOTH, V56, P265, DOI 10.1093/jac/dki194; Garcia-Lerma JG, 2004, J VIROL, V78, P7545, DOI 10.1128/JVI.78.14.7545-7552.2004; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Geretti AM, 2006, AIDS REV, V8, P210; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Johnson Victoria A, 2008, Top HIV Med, V16, P62; Johnson Victoria A, 2007, Top HIV Med, V15, P119; Little SJ, 2005, CLIN INFECT DIS, V41, P233, DOI 10.1086/431215; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Neifer S, 2006, AIDS, V20, P2231, DOI 10.1097/QAD.0b013e328010ac6f; Oette M, 2007, DEUT MED WOCHENSCHR, V132, P977, DOI 10.1055/s-2007-979365; Oette M, 2006, JAIDS-J ACQ IMM DEF, V41, P573, DOI 10.1097/01.qai.0000214805.52723.c1; Pao D, 2004, JAIDS-J ACQ IMM DEF, V37, P1570, DOI 10.1097/00126334-200412150-00006; Parruti G, 2006, AIDS PATIENT CARE ST, V20, P48, DOI 10.1089/apc.2006.20.48; Poggensee G, 2007, HIV MED, V8, P511, DOI 10.1111/j.1468-1293.2007.00504.x; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Sagir A, 2007, J ANTIMICROB CHEMOTH, V60, P843, DOI 10.1093/jac/dkm274; Shafer RW, 2008, AIDS REV, V10, P67; Shafer RW, 2008, ANTIVIR THER, V13, P59; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Simon V, 2002, AIDS, V16, P1511, DOI 10.1097/00002030-200207260-00008; Tozzi V, 2008, AIDS RES HUM RETROV, V24, P787, DOI 10.1089/aid.2007.0236; Turner D, 2004, JAIDS-J ACQ IMM DEF, V37, P1627, DOI 10.1097/00126334-200412150-00017; VERCAUTEREN J, 2009, J INFECT DIS; Vercauteren J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-12; Violin M, 2004, AIDS, V18, P227, DOI 10.1097/00002030-200401230-00012; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; Waters L, 2007, INT J CLIN PRACT, V61, P105, DOI 10.1111/j.1742-1241.2006.01146.x; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; 2007, AIDS, V21, P1035	44	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e12718	10.1371/journal.pone.0012718	http://dx.doi.org/10.1371/journal.pone.0012718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949104	gold, Green Published			2022-12-25	WOS:000282633700001
J	Chen, B; Mi, SL; Wright, B; Connon, CJ				Chen, Bo; Mi, Shengli; Wright, Bernice; Connon, Che John			Investigation of K14/K5 as a Stem Cell Marker in the Limbal Region of the Bovine Cornea	PLOS ONE			English	Article							OCULAR SURFACE; EPITHELIAL-CELLS; AMNIOTIC MEMBRANE; DIFFERENTIATION; EXPRESSION; LOCATION; KERATINS; P63	Background: Identification of stem cells from a corneal epithelial cell population by specific molecular markers has been investigated previously. Expressions of P63, ABCG2 and K14/K5 have all been linked to mammalian corneal epithelial stem cells. Here we report on the limitations of K14/K5 as a limbal stem cell marker. Methodology/Principal Findings: K14/K5 expression was measured by immunohistochemistry, Western blotting and Real time PCR and compared between bovine epithelial cells in the limbus and central cornea. A functional study was also included to investigate changes in K5/14 expression within cultured limbal epithelial cells undergoing forced differentiation. K14 expression (or its partner K5) was detected in quiescent epithelial cells from both the limbal area and central cornea. K14 was localized predominantly to basal epithelial cells in the limbus and suprabasal epithelial cells in the central cornea. Western blotting revealed K14 expression in both limbus and central cornea (higher levels in the limbus). Similarly, quantitative real time PCR found K5, partner to K14, to be expressed in both the central cornea and limbus. Following forced differentiation in culture the limbal epithelial cells revealed an increase in K5/14 gene/protein expression levels in concert with a predictable rise in a known differentiation marker. Conclusions/Significance: K14 and its partner K5 are limited not only to the limbus but also to the central bovine cornea epithelial cells suggesting K14/K5 is not limbal specific in situ. Furthermore K14/K5 expression levels were not lowered (in fact they increased) within a limbal epithelial cell culture undergoing forced differentiation suggesting K14/K5 is an unreliable maker for undifferentiated cells ex vivo.	[Chen, Bo; Mi, Shengli; Wright, Bernice; Connon, Che John] Univ Reading, Sch Pharm, Reading, Berks, England	University of Reading	Chen, B (corresponding author), Univ Reading, Sch Pharm, Reading, Berks, England.	c.j.connon@reading.ac.uk	Connon, Che/B-3128-2012; Chen, Bo/A-3351-2015	Connon, Che/0000-0001-8264-6531; 	Biotechnology and Biological Sciences Research Council of United Kingdom [BB/F019742/1]; Cardiff University; University of Reading; Biotechnology and Biological Sciences Research Council [BB/F019742/1] Funding Source: researchfish; BBSRC [BB/F019742/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cardiff University; University of Reading; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was financially supported by the Biotechnology and Biological Sciences Research Council of United Kingdom (Grant Ref: BB/F019742/1), Cardiff University and University of Reading. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard Z, 2001, CLIN EXP OPHTHALMOL, V29, P138, DOI 10.1046/j.1442-9071.2001.00394.x; Bickenbach Jr, 2004, METH MOL B, V289, P97; CHALOINDUFAU C, 1990, CELL DIFFER DEV, V32, P97, DOI 10.1016/0922-3371(90)90103-4; Chen B, 2010, TISSUE ENG PT A, V16, P2721, DOI 10.1089/ten.tea.2009.0711; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Djalilian AR, 2008, MOL VIS, V14, P1041; Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664; Hsueh YJ, 2004, J BIOMED SCI, V11, P641, DOI 10.1159/000079677; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; KURPAKUS MA, 1994, CURR EYE RES, V13, P805, DOI 10.3109/02713689409025135; KURPAKUS MA, 1990, INVEST OPHTH VIS SCI, V31, P448; Lavker RM, 2003, EYE, V17, P937, DOI 10.1038/sj.eye.6700575; LAVKER RM, 1991, INVEST OPHTH VIS SCI, V32, P1864; Lehrer MS, 1998, J CELL SCI, V111, P2867; Ma A, 2007, INVEST OPHTH VIS SCI, V48, P3576, DOI 10.1167/iovs.06-1373; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Matic M, 1997, DIFFERENTIATION, V61, P251, DOI 10.1046/j.1432-0436.1997.6140251.x; Metallo CM, 2010, METHODS MOL BIOL, V585, P83, DOI 10.1007/978-1-60761-380-0_7; Mi SL, 2010, TISSUE ENG PT A, V16, P2091, DOI 10.1089/ten.TEA.2009.0748; Mimura T, 2008, MOL VIS, V14, P1819; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; PRUNIERAS M, 1983, J INVEST DERMATOL, V81, pS28, DOI 10.1111/1523-1747.ep12540324; Romano AC, 2003, INVEST OPHTH VIS SCI, V44, P5125, DOI 10.1167/iovs.03-0628; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Secker GA, 2008, STEM CELL REV, V4, P159, DOI 10.1007/s12015-008-9029-x; Wang DY, 2003, INVEST OPHTH VIS SCI, V44, P4698, DOI 10.1167/iovs.03-0272; Watanabe K, 2004, FEBS LETT, V565, P6, DOI 10.1016/j.febslet.2004.03.064; WILLIAMS ML, 1988, J CELL PHYSIOL, V136, P103, DOI 10.1002/jcp.1041360113; Yoshida S, 2006, INVEST OPHTH VIS SCI, V47, P4780, DOI 10.1167/iovs.06-0574; Zhao B, 2008, INVEST OPHTH VIS SCI, V49, P3395, DOI 10.1167/iovs.07-1263	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13192	10.1371/journal.pone.0013192	http://dx.doi.org/10.1371/journal.pone.0013192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949137	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000282568400010
J	Amini-Nik, S; Kraemer, D; Cowan, ML; Gunaratne, K; Nadesan, P; Alman, BA; Miller, RJD				Amini-Nik, Saeid; Kraemer, Darren; Cowan, Michael L.; Gunaratne, Keith; Nadesan, Puviindran; Alman, Benjamin A.; Miller, R. J. Dwayne			Ultrafast Mid-IR Laser Scalpel: Protein Signals of the Fundamental Limits to Minimally Invasive Surgery	PLOS ONE			English	Article							HYPERPLASTIC CUTANEOUS WOUNDS; BETA-CATENIN STABILIZATION; SKIN; REGENERATION; TISSUES	Lasers have in principle the capability to cut at the level of a single cell, the fundamental limit to minimally invasive procedures and restructuring biological tissues. To date, this limit has not been achieved due to collateral damage on the macroscale that arises from thermal and shock wave induced collateral damage of surrounding tissue. Here, we report on a novel concept using a specifically designed Picosecond IR Laser (PIRL) that selectively energizes water molecules in the tissue to drive ablation or cutting process faster than thermal exchange of energy and shock wave propagation, without plasma formation or ionizing radiation effects. The targeted laser process imparts the least amount of energy in the remaining tissue without any of the deleterious photochemical or photothermal effects that accompanies other laser wavelengths and pulse parameters. Full thickness incisional and excisional wounds were generated in CD1 mice using the Picosecond IR Laser, a conventional surgical laser (DELight Er:YAG) or mechanical surgical tools. Transmission and scanning electron microscopy showed that the PIRL laser produced minimal tissue ablation with less damage of surrounding tissues than wounds formed using the other modalities. The width of scars formed by wounds made by the PIRL laser were half that of the scars produced using either a conventional surgical laser or a scalpel. Aniline blue staining showed higher levels of collagen in the early stage of the wounds produced using the PIRL laser, suggesting that these wounds mature faster. There were more viable cells extracted from skin using the PIRL laser, suggesting less cellular damage. beta-catenin and TGF-beta signalling, which are activated during the proliferative phase of wound healing, and whose level of activation correlates with the size of wounds was lower in wounds generated by the PIRL system. Wounds created with the PIRL systsem also showed a lower rate of cell proliferation. Direct comparison of wound healing responses to a conventional surgical laser, and standard mechanical instruments shows far less damage and near absence of scar formation by using PIRL laser. This new laser source appears to have achieved the long held promise of lasers in minimally invasive surgery.	[Amini-Nik, Saeid; Gunaratne, Keith; Nadesan, Puviindran; Alman, Benjamin A.] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Kraemer, Darren; Cowan, Michael L.; Miller, R. J. Dwayne] Univ Toronto, Dept Chem, Toronto, ON M5G 1X8, Canada; [Kraemer, Darren; Cowan, Michael L.; Miller, R. J. Dwayne] Univ Toronto, Dept Phys, Toronto, ON M5G 1X8, Canada; [Kraemer, Darren; Cowan, Michael L.; Miller, R. J. Dwayne] Univ Toronto, Inst Opt Sci, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Amini-Nik, S (corresponding author), Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada.	dmiller@lphys.chem.utoronto.ca	Nik, Saeid Amini/B-6640-2014	Nik, Saeid Amini/0000-0002-9185-9456	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC) are funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Cheon S, 2005, LAB INVEST, V85, P416, DOI 10.1038/labinvest.3700237; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; FitzGibbon G M, 1968, Br J Plast Surg, V21, P226, DOI 10.1016/S0007-1226(68)80028-1; Flanders KC, 2003, AM J PATHOL, V163, P2247, DOI 10.1016/S0002-9440(10)63582-1; FRANJIC K, 2010, DESORPTION IMP UNPUB; Franjic K, 2009, OPT EXPRESS, V17, P22937, DOI 10.1364/OE.17.022937; Girard B, 2007, LASER SURG MED, V39, P273, DOI 10.1002/lsm.20466; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Paltauf G, 2003, CHEM REV, V103, P487, DOI 10.1021/cr010436c; Sakimoto T, 2006, LANCET, V367, P1432, DOI 10.1016/S0140-6736(06)68275-5; Sanders DL, 2000, LASER SURG MED, V26, P22, DOI 10.1002/(SICI)1096-9101(2000)26:1<22::AID-LSM5>3.0.CO;2-R; SOLON LR, 1961, SCIENCE, V134, P1506, DOI 10.1126/science.134.3489.1506; Wadman M, 2005, NATURE, V436, P1079, DOI 10.1038/4361079a	17	130	135	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13053	10.1371/journal.pone.0013053	http://dx.doi.org/10.1371/journal.pone.0013053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927391	gold, Green Submitted, Green Published			2022-12-25	WOS:000282210700022
J	Onnis, A; De Falco, G; Antonicelli, G; Onorati, M; Bellan, C; Sherman, O; Sayed, S; Leoncini, L				Onnis, Anna; De Falco, Giulia; Antonicelli, Giuseppina; Onorati, Monica; Bellan, Cristiana; Sherman, Omar; Sayed, Shasheen; Leoncini, Lorenzo			Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma	PLOS ONE			English	Article							ORGAN SIZE; GENE; EXPRESSION; TRANSLOCATION; MECHANISM; CELLS	Background: Burkitt lymphoma (BL) is an aggressive B-cell lymphoma, with a characteristic clinical presentation, morphology and immunophenotype. Over the past years, the typical translocation t(8;14) and its variants have been considered the molecular hallmark of this tumor. However, BL cases with no detectable MYC rearrangement have been identified. Intriguingly, these cases express MYC at levels comparable with cases carrying the translocation. In normal cells c-Myc expression is tightly regulated through a complex feedback loop mechanism. In cancer, MYC is often dysregulated, commonly due to genomic abnormalities. It has recently emerged that this phenomenon may rely on an alteration of post-transcriptional regulation mediated by microRNAs (miRNAs), whose functional alterations are associated with neoplastic transformation. It is also emerging that c-Myc modulates miRNA expression, revealing an intriguing crosstalk between c-Myc and miRNAs. Principal Findings: Here, we investigated the expression of miRNAs possibly regulated by c-Myc in BL cases positive or negative for the translocation. A common trend of miRNA expression, with the exception of hsa-miR-9*, was observed in all of the cases. Intriguingly, down-regulation of this miRNA seems to specifically identify a particular subset of BL cases, lacking MYC translocation. Here, we provided evidence that hsa-miR-9-1 gene is heavily methylated in those cases. Finally, we showed that hsa-miR-9* is able to modulate E2F1 and c-Myc expression. Conclusions: Particularly, this study identifies hsa-miR-9* as potentially relevant for malignant transformation in BL cases with no detectable MYC translocation. Deregulation of hsa-miR-9* may therefore be useful as a diagnostic tool, suggesting it as a promising novel candidate for tumor cell marker.	[Onnis, Anna; De Falco, Giulia; Antonicelli, Giuseppina; Onorati, Monica; Bellan, Cristiana; Leoncini, Lorenzo] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy; [Sherman, Omar; Sayed, Shasheen] Aga Khan Hosp, Nairobi, Kenya	University of Siena	Onnis, A (corresponding author), Univ Siena, Dept Human Pathol & Oncol, Via Laterina 8, I-53100 Siena, Italy.	leoncinil@unisi.it	leoncini, lorenzo/P-8361-2018; BELLAN, CRISTIANA/ABG-4750-2021; BELLAN, CRISTIANA/L-3903-2013; LEONCINI, Lorenzo/U-4413-2019	leoncini, lorenzo/0000-0002-7457-300X; BELLAN, CRISTIANA/0000-0001-6119-9007; BELLAN, CRISTIANA/0000-0001-6119-9007; LEONCINI, Lorenzo/0000-0002-7457-300X; Onnis, Anna/0000-0003-3199-9868	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Monte dei Paschi (MPS) foundation	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Monte dei Paschi (MPS) foundation	This work has been supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) and Monte dei Paschi (MPS) foundation grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baudino TA, 2003, MOL CELL, V11, P905, DOI 10.1016/S1097-2765(03)00102-3; Bellan C, 2005, BLOOD, V106, P1031, DOI 10.1182/blood-2005-01-0168; Chung HJ, 2005, MOL CELLS, V20, P157; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; De Falco G, 2007, BLOOD, V110, P1301, DOI 10.1182/blood-2006-12-064865; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Lazzi S, 2009, HUM PATHOL, V40, P1252, DOI 10.1016/j.humpath.2009.01.007; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Leone G, 1997, NATURE, V387, P932, DOI 10.1038/43230; Leucci E, 2008, J PATHOL, V216, P440, DOI 10.1002/path.2410; Leucci E, 2010, INT J CANCER, V126, P1316, DOI 10.1002/ijc.24655; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Scaria V, 2007, CELL MICROBIOL, V9, P2784, DOI 10.1111/j.1462-5822.2007.01050.x; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Sevilla DW, 2007, AM J CLIN PATHOL, V128, P981, DOI 10.1309/C1PP15P7CDB8UY39; Sun Y, 2009, BREAST CANCER RES TR, V118, P185, DOI 10.1007/s10549-008-0171-6; Swerdlow SH, 2008, WHO CLASSIFICATION T; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837	36	52	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12960	10.1371/journal.pone.0012960	http://dx.doi.org/10.1371/journal.pone.0012960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20930934	Green Published, Green Submitted, gold			2022-12-25	WOS:000282122600004
J	Sakwe, AM; Koumangoye, R; Goodwin, SJ; Ochieng, J				Sakwe, Amos M.; Koumangoye, Rainelli; Goodwin, Shawn J.; Ochieng, Josiah			Fetuin-A (alpha 2HS-Glycoprotein) Is a Major Serum Adhesive Protein That Mediates Growth Signaling in Breast Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; CARCINOMA CELLS; CYSTATIN SUPERFAMILY; MUSCLE-CELLS; CALCIFICATION; FIBRONECTIN; PROLIFERATION; GLYCOPROTEIN; MODULATION; MECHANISMS	The identity of the cell adhesive factors in fetal bovine serum, commonly used to supplement growth media, remains a mystery due to the plethora of serum proteins. In the present analyses, we showed that fetuin-A, whose function in cellular attachment in tissue culture has been debated for many years, is indeed a major serum cell attachment factor particularly for tumor cells. We are able to report this because of a new purification strategy that has for the first time given us a homogeneous protein band in colloidal Coomassie-stained gels that retains biological activity. The tumor cells adhered to immobilized fetuin-A and not alpha(2)-macroglobulin, its major contaminant. The interaction of cells with fetuin-A was driven mainly by Ca2+ ions, and cells growing in regular medium supplemented with fetal bovine serum were just as sensitive to loss of extracellular Ca2+ ions as cells growing in fetuin-A. Fractionation of human serum revealed that cell attachment was confined to the fractions that had fetuin-A. Interestingly, the tumor cells also took up fetuin-A and secreted it back to the medium using an unknown mechanism that can be observed in live cells. The attachment of tumor cells to fetuin-A was accompanied by phosphatidylinositol 3-kinase/Akt activation that was down-regulated in cells that lack annexin-A6, one of the cell surface receptors for fetuin-A. Taken together, our data show the significance of fetuin-A in tumor cell growth mechanisms in vitro and open new research vistas for this protein.	[Sakwe, Amos M.; Koumangoye, Rainelli; Goodwin, Shawn J.; Ochieng, Josiah] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Ochieng, Josiah] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA	Meharry Medical College; Vanderbilt University	Ochieng, J (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, 1005 DB Todd Blvd, Nashville, TN 37208 USA.	jochieng@mmc.edu	Sakwe, Amos/AAU-7639-2020	Sakwe, Amos/0000-0002-2283-794X	National Institutes of Health [1SC1CA134018-01, G12RR03032-19, 5U54NS041071]; Department of Defense [W81XWH-07-1-0254]; NATIONAL CANCER INSTITUTE [SC1CA134018] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140, S10RR025497, G12RR003032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1SC1CA134018-01 (to J. O.), G12RR03032-19 (to J. O.), and 5U54NS041071 (to S. J. G.). This work was also supported by Department of Defense Grant W81XWH-07-1-0254 (to J. O.).	Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; BROWN WM, 1992, EUR J BIOCHEM, V205, P321, DOI 10.1111/j.1432-1033.1992.tb16783.x; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; BURRILL PH, 1981, J SUPRAMOL STR CELL, V16, P385, DOI 10.1002/jsscb.1981.380160409; Cartellieri S, 2002, BIOTECHNOL APPL BIOC, V35, P83, DOI 10.1042/BA20010067; Chen NX, 2007, AM J PHYSIOL-RENAL, V292, pF599, DOI 10.1152/ajprenal.00303.2006; Chiang YP, 1999, MOL CELL BIOCHEM, V199, P139, DOI 10.1023/A:1006942128672; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Dy Grace K, 2009, Proc Am Thorac Soc, V6, P218, DOI 10.1513/pats.200808-099LC; Dziegielewska KM, 2001, HISTOCHEM J, V33, P443, DOI 10.1023/A:1014412013445; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; FIDLER IJ, 1995, J NATL CANCER I, V87, P1588, DOI 10.1093/jnci/87.21.1588; FISHER HW, 1958, P NATL ACAD SCI USA, V44, P4, DOI 10.1073/pnas.44.1.4; HAM RG, 1988, IN VITRO CELL DEV B, V24, P833; HAYMAN EG, 1985, J CELL BIOL, V100, P1948, DOI 10.1083/jcb.100.6.1948; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Ivaska J., CELL TISSUE RES, V339, P111; KOHN EC, 1995, CANCER RES, V55, P1856; Kojima K, 1996, J BIOL CHEM, V271, P7679, DOI 10.1074/jbc.271.13.7679; Kundranda MN, 2005, CANCER RES, V65, P499; Kundranda MN, 2004, BBA-MOL CELL RES, V1693, P111, DOI 10.1016/j.bbamcr.2004.06.005; MCINNES C, 1987, J CELL SCI, V88, P623; Mellgren RL, 2007, J BIOL CHEM, V282, P35868, DOI 10.1074/jbc.M706929200; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Mould AP, 1996, J CELL SCI, V109, P2613; NIE Z, 1991, BIOCHEM BIOPH RES CO, V178, P959, DOI 10.1016/0006-291X(91)90985-G; NIE ZT, 1992, AM J PHYSIOL, V263, pC551, DOI 10.1152/ajpcell.1992.263.3.C551; Ochieng J, 1999, J CELL BIOCHEM, V75, P505, DOI 10.1002/(SICI)1097-4644(19991201)75:3<505::AID-JCB14>3.0.CO;2-I; Ochieng J, 2010, J HEALTH CARE POOR U, V21, P51, DOI 10.1353/hpu.0.0257; Ochieng J, 2009, EXP CELL RES, V315, P1875, DOI 10.1016/j.yexcr.2009.03.010; Padmasekar M, 2007, CARDIOVASC RES, V75, P118, DOI 10.1016/j.cardiores.2007.03.003; Ray S, 2003, BBA-PROTEINS PROTEOM, V1652, P91, DOI 10.1016/j.bbapap.2003.08.004; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; RIZZINO A, 1978, P NATL ACAD SCI USA, V75, P1844, DOI 10.1073/pnas.75.4.1844; Rodan SB, 1997, J ENDOCRINOL, V154, pS47; SALOMON DS, 1982, J BIOL CHEM, V257, P4093; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; SPIRO RG, 1960, J BIOL CHEM, V235, P2860; Suva LJ, 2009, ENDOCR-RELAT CANCER, V16, P703, DOI 10.1677/ERC-09-0012; Takagi H, 2002, J CELL SCI, V115, P3309; Wang HC, 1998, P NATL ACAD SCI USA, V95, P14429, DOI 10.1073/pnas.95.24.14429; Yu CH, 2008, CANCER SCI, V99, P2467, DOI 10.1111/j.1349-7006.2008.00966.x; Yu CL, 2001, CANCER LETT, V166, P173, DOI 10.1016/S0304-3835(01)00417-7	45	49	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41827	41835		10.1074/jbc.M110.128926	http://dx.doi.org/10.1074/jbc.M110.128926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20956534	hybrid, Green Published			2022-12-25	WOS:000285622600070
J	Briffotaux, J; Kobryn, K				Briffotaux, Julien; Kobryn, Kerri			Preventing Broken Borrelia Telomeres ResT COUPLES DUAL HAIRPIN TELOMERE FORMATION WITH PRODUCT RELEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; BIDIRECTIONAL REPLICATION; STRAND EXCHANGE; RESOLVASE REST; LINEAR DNA; BURGDORFERI; PROTELOMERASE; RESOLUTION; MECHANISMS; SYNAPSIS	Spirochetes of the genus Borrelia include the tick-transmitted causative agents of Lyme disease and relapsing fever. They possess unusual genomes composed mainly of linear replicons terminated by closed DNA hairpins. Hairpin telomeres are formed from inverted repeat replicated telomere junctions (rTels) by the telomere resolvase ResT. ResT uses a reaction mechanism similar to that of the type IB topoisomerases and tyrosine recombinases. ResT can catalyze three distinct reactions: telomere resolution, telomere fusion, and Holliday junction (HJ) formation. HJ formation is known to occur only in the context of a synapsed pair of rTels. To test whether telomere resolution was synapsis-dependent, we performed experiments with rTel substrates immobilized on streptavidin-coated beads. We report that telomere resolution by ResT is synapsis-independent, indicating that alternative complexes are formed for telomere resolution and HJ formation. We also present evidence that dual hairpin telomere formation precedes product release. This mechanism of telomere resolution prevents the appearance of broken telomeres. We compare and contrast this mechanism with that proposed for TelK, the telomere resolvase of phi KO2.	[Briffotaux, Julien; Kobryn, Kerri] Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Kobryn, K (corresponding author), Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada.	kerri.kobryn@usask.ca	Briffotaux, Julien/AAG-2189-2021	Briffotaux, Julien/0000-0002-0084-5818	Canadian Institutes for Health Research [MOP 79344]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grant MOP 79344.	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; Allingham JS, 2001, EMBO J, V20, P2931, DOI 10.1093/emboj/20.11.2931; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; Barbour AG, 2001, EMERGING INFECTIONS 5, P153; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; BARIL C, 1989, RES MICROBIOL, V140, P507, DOI 10.1016/0923-2508(89)90083-1; Barre F.-X., 2002, MOBILE DNA, P149; Beaurepaire C, 2005, MOL MICROBIOL, V57, P132, DOI 10.1111/j.1365-2958.2005.04688.x; Byram R, 2004, J BACTERIOL, V186, P3561, DOI 10.1128/JB.186.11.3561-3569.2004; Casjens S, 1999, CURR OPIN MICROBIOL, V2, P529, DOI 10.1016/S1369-5274(99)00012-0; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Deneke J, 2004, J BIOL CHEM, V279, P53699, DOI 10.1074/jbc.M409001200; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; Dworkin MS, 2002, MED CLIN N AM, V86, P417, DOI 10.1016/S0025-7125(03)00095-6; FERDOWS MS, 1989, P NATL ACAD SCI USA, V86, P5969, DOI 10.1073/pnas.86.15.5969; Grindley NDF, 1997, CURR BIOL, V7, pR608, DOI 10.1016/S0960-9822(06)00314-9; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; HAASNOOT CAG, 1983, J BIOMOL STRUCT DYN, V1, P115, DOI 10.1080/07391102.1983.10507429; HANIFORD DB, 2002, MOBILE DNA, V2, P457; Huang WM, 2004, J MOL BIOL, V337, P77, DOI 10.1016/j.jmb.2004.01.012; Kobryn K, 2005, J BIOL CHEM, V280, P26788, DOI 10.1074/jbc.M504530200; Kobryn K, 2005, MOL CELL, V17, P783, DOI 10.1016/j.molcel.2005.02.025; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Kobryn K, 2009, MOL MICROBIOL, V71, P1117, DOI 10.1111/j.1365-2958.2008.06584.x; Kobryn Kerri, 2007, V7, P117, DOI 10.1007/7171_2007_093; Marshall JJT, 2007, J MOL BIOL, V367, P419, DOI 10.1016/j.jmb.2006.12.070; Moriarty TJ, 2009, J BIOL CHEM, V284, P23293, DOI 10.1074/jbc.M109.023549; NASH HA, 1989, EMBO J, V8, P3523, DOI 10.1002/j.1460-2075.1989.tb08518.x; NunesDuby SE, 1997, J MOL BIOL, V272, P493, DOI 10.1006/jmbi.1997.1260; Picardeau M, 2000, GENOME RES, V10, P1594, DOI 10.1101/gr.124000; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; Picardeau M, 2000, MICROBIOL-UK, V146, P305, DOI 10.1099/00221287-146-2-305; Ravin NV, 2003, NUCLEIC ACIDS RES, V31, P6552, DOI 10.1093/nar/gkg856; Ravin NV, 2003, FEMS MICROBIOL LETT, V221, P1, DOI 10.1016/S0378-1097(03)00125-3; SCHWAN TG, 1999, MANUAL CLIN MICROBIO, P746; Stanek G, 2003, LANCET, V362, P1639, DOI 10.1016/S0140-6736(03)14798-8; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; Tourand Y, 2006, J BACTERIOL, V188, P7378, DOI 10.1128/JB.00760-06; Tourand Y, 2009, J BIOL CHEM, V284, P7264, DOI 10.1074/jbc.M808918200; Yu KF, 2000, MOL CELL BIOL, V20, P7914, DOI 10.1128/MCB.20.21.7914-7921.2000; ZHU XD, 1995, J BIOL CHEM, V270, P11646, DOI 10.1074/jbc.270.19.11646	44	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41010	41018		10.1074/jbc.M110.150060	http://dx.doi.org/10.1074/jbc.M110.150060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952394	Green Published, hybrid			2022-12-25	WOS:000285414400064
J	Hirakawa, J; Tsuboi, K; Sato, K; Kobayashi, M; Watanabe, S; Takakura, A; Imai, Y; Ito, Y; Fukuda, M; Kawashima, H				Hirakawa, Jotaro; Tsuboi, Koichiro; Sato, Kaori; Kobayashi, Motohiro; Watanabe, Sota; Takakura, Atsushi; Imai, Yasuyuki; Ito, Yuki; Fukuda, Minoru; Kawashima, Hiroto			Novel Anti-carbohydrate Antibodies Reveal the Cooperative Function of Sulfated N- and O-Glycans in Lymphocyte Homing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-ENDOTHELIAL VENULES; L-SELECTIN LIGANDS; VASCULAR ADDRESSIN; NODE ADDRESSIN; FUC-TVII; EXPRESSION; RECRUITMENT; ANTIGEN; INFLAMMATION; MECA-79	Cell surface glycans play pivotal roles in immune cell trafficking and immunity. Here we present an efficient method for generating anti-carbohydrate monoclonal antibodies (mAbs) using gene-targeted mice and describe critical glycans in lymphocyte homing. We immunized sulfotransferase GlcNAc6ST-1 and GlcNAc6ST-2 doubly deficient mice with sulfotransferase-overexpressing Chinese hamster ovary cells and generated two mAbs, termed S1 and S2. Both S1 and S2 bound high endothelial venules (HEVs) in the lymphoid organs of humans and wild-type mice, but not in those of doubly deficient mice. Glycan array analysis indicated that both S1 and S2 specifically bound 6-sulfo sialyl Lewis X and its defuco-sylated structure. Interestingly, S2 inhibited lymphocyte homing to peripheral lymph nodes by 95%, whereas S1 inhibited it by only 25%. S2 also significantly inhibited contact hypersensitivity responses and L-selectin-dependent leukocyte adhesion to HEVs. Immunohistochemical and Western blot analyses indicated that S1 preferentially bound sulfated O-glycans, whereas S2 bound both sulfated N- and O-glycans in HEVs. Furthermore, S2 strongly inhibited the N-glycan-dependent residual lymphocyte homing in mutant mice lacking sulfated O-glycans, indicating the importance of both sulfated N- and O-glycans in lymphocyte homing. Thus, the two mAbs generated by a novel method revealed the cooperative function of sulfated N- and O-glycans in lymphocyte homing and immune surveillance.	[Hirakawa, Jotaro; Tsuboi, Koichiro; Sato, Kaori; Watanabe, Sota; Takakura, Atsushi; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka 4228526, Japan; [Hirakawa, Jotaro; Tsuboi, Koichiro; Sato, Kaori; Watanabe, Sota; Takakura, Atsushi; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Sch Pharmaceut Sci, Global Ctr Excellence Program, Shizuoka 4228526, Japan; [Kobayashi, Motohiro] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 3908621, Japan; [Ito, Yuki; Fukuda, Minoru] Sanford Burnham Med Res Inst, Glycobiol Unit, La Jolla, CA 92037 USA; [Kawashima, Hiroto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Shizuoka; University of Shizuoka; Shinshu University; Sanford Burnham Prebys Medical Discovery Institute; Japan Science & Technology Agency (JST)	Kawashima, H (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, 52-1 Yada, Shizuoka 4228526, Japan.	kawashih@u-shizuoka-ken.ac.jp	Imai, Yasuyuki/E-8701-2010	Imai, Yasuyuki/0000-0002-8937-0221	National Institutes of Health [PO1CA71932, U54GM62116]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21390023, 20057022]; Takeda Science Foundation; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant PO1CA71932 (to M. F.). This work was also supported by Grant-in-Aid for Scientific Research, Category (B) 21390023 and Grant-in-Aid for Scientific Research on Priority Areas, Dynamics of Extracellular Environments 20057022 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to H. K.), by the Takeda Science Foundation (to H. K.), and by a research fellowship from the Japan Society for the Promotion of Science (to J. H.).; We thank Drs. John B. Lowe (Genentech) for providing the FucT-IV and FucT-VII DKO mice, Eugene Butcher (Stanford University, School of Medicine) for providing the MECA-79 hybridomas, and Pamela Stanley (Albert Einstein College of Medicine) for providing the Lec1 and Lec2 cells. We also thank Dr. Yuki Tobisawa and Ryuji Matsumura (University of Shizuoka, School of Pharmaceutical Sciences) for technical support and Core H of the Consortium for Functional Glycomics (funded by National Institutes of Health Grant U54GM62116) for the glycan array analysis.	ARATAKAWAI H, 2010, AM J PATHOL IN PRESS; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Bruehl RE, 2000, J BIOL CHEM, V275, P32642, DOI 10.1074/jbc.M001703200; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; HOKE D, 1995, CURR BIOL, V5, P670, DOI 10.1016/S0960-9822(95)00132-1; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; IMAI Y, 1993, NATURE, V361, P555; Kannagi R, 2009, GLYCOCONJUGATE J, V26, P923, DOI 10.1007/s10719-008-9122-z; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kawashima H, 2006, BIOL PHARM BULL, V29, P2343, DOI 10.1248/bpb.29.2343; Kawashima H, 2009, J IMMUNOL, V182, P5461, DOI 10.4049/jimmunol.0802327; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; Lee J, 2002, GLYCOCONJUGATE J, V19, P211, DOI 10.1023/A:1024205925263; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Mitoma J, 2009, GLYCOCONJUGATE J, V26, P511, DOI 10.1007/s10719-008-9207-8; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; ROSEN SD, 1985, SCIENCE, V228, P1005, DOI 10.1126/science.4001928; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Suzawa K, 2007, AM J GASTROENTEROL, V102, P1499, DOI 10.1111/j.1572-0241.2007.01189.x; Tahara H, 2010, J IMMUNOL, V184, P3269, DOI 10.4049/jimmunol.0902857; Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935; Tobisawa Y, 2010, J BIOL CHEM, V285, P6750, DOI 10.1074/jbc.M109.067082; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Varki A., 2009, ESSENTIALS GLYCOBIOL; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	44	41	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40864	40878		10.1074/jbc.M110.167296	http://dx.doi.org/10.1074/jbc.M110.167296			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20929857	Green Published, hybrid			2022-12-25	WOS:000285414400051
J	Vazquez-Novelle, MD; Mailand, N; Ovejero, S; Bueno, A; Sacristan, MP				Vazquez-Novelle, Maria D.; Mailand, Niels; Ovejero, Sara; Bueno, Avelino; Sacristan, Maria P.			Human Cdc14A Phosphatase Modulates the G2/M Transition through Cdc25A and Cdc25B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; FISSION YEAST; MITOTIC EXIT; CHROMOSOME SEGREGATION; PROTEIN PHOSPHATASE; DNA-DAMAGE; MITOSIS; PHOSPHORYLATION; ACTIVATION; CENTROSOME	The Cdc14 family of serine-threonine phosphatases antagonizes CDK activity by reversing CDK-dependent phosphorylation events. It is well established that the yeast members of this family bring about the M/G1 transition. Budding yeast Cdc14 is essential for CDK inactivation at the end of mitosis and fission yeast Cdc14 homologue Flp1/Clp1 down-regulates Cdc25 to ensure the inactivation of mitotic CDK complexes to trigger cell division. However, the functions of human Cdc14 homologues remain poorly understood. Here we have tested the hypothesis that Cdc14A might regulate Cdc25 mitotic inducers in human cells. We found that increasing levels of Cdc14A delay entry into mitosis by inhibiting Cdk1-cyclin B1 activity. By contrast, lowering the levels of Cdc14A accelerates mitotic entry. Biochemical analyses revealed that Cdc14A acts through key Cdk1-cyclin B1 regulators. We observed that Cdc14A directly bound to and dephosphorylated Cdc25B, inhibiting its catalytic activity. Cdc14A also regulated the activity of Cdc25A at the G2/M transition. Our results indicate that Cdc14A phosphatase prevents premature activation of Cdk1 regulating Cdc25A and Cdc25B at the entry into mitosis.	[Vazquez-Novelle, Maria D.; Ovejero, Sara; Bueno, Avelino; Sacristan, Maria P.] Univ Salamanca, CSIC, Ctr Invest Canc, Salamanca 37007, Spain; [Mailand, Niels] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Danish Cancer Society	Sacristan, MP (corresponding author), Campus Miguel de Unamuno, Salamanca 37007, Spain.	msacristan@usal.es	Bueno, Avelino/A-9505-2016; Sacristan, Maria/Y-4923-2019; Sacristán, María P/A-9587-2016	Bueno, Avelino/0000-0002-0362-4391; Sacristan, Maria/0000-0003-2314-8430; Sacristán, María P/0000-0003-2314-8430; Ovejero, Sara/0000-0002-8354-856X	Spanish Ministerio de Educacion y Ciencia (MEC) [BFU2006-05878/BFU2008-04293]; Junta Castilla y Leon [SAN196/SA32/07]; MEC	Spanish Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Junta Castilla y Leon(Junta de Castilla y Leon); MEC(European Commission)	This work was supported by Grants BFU2006-05878/BFU2008-04293 from Spanish Ministerio de Educacion y Ciencia (MEC) and SAN196/SA32/07 from Junta Castilla y Leon.; Supported by a FPU fellowship from MEC. Present address: Cancer Research UK London Research Institute, Clare Hall Laboratories, South Mimms, Herts EN6 3LD, UK.	Andersen SSL, 1999, BIOESSAYS, V21, P53, DOI 10.1002/(SICI)1521-1878(199901)21:1<53::AID-BIES7>3.0.CO;2-L; ATHERTONFESSLER S, 1993, MOL CELL BIOL, V13, P1675, DOI 10.1128/MCB.13.3.1675; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Esteban V, 2004, J CELL SCI, V117, P2461, DOI 10.1242/jcs.01107; Esteban V, 2008, CELL CYCLE, V7, P1269, DOI 10.4161/cc.7.9.5947; Esteban V, 2006, CELL CYCLE, V5, P2894, DOI 10.4161/cc.5.24.3566; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gabrielli BG, 1997, J BIOL CHEM, V272, P28607, DOI 10.1074/jbc.272.45.28607; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jensen S, 2002, CURR BIOL, V12, pR221, DOI 10.1016/S0960-9822(02)00756-X; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Lammer C, 1998, J CELL SCI, V111, P2445; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Lukas J, 1999, ONCOGENE, V18, P3930, DOI 10.1038/sj.onc.1202777; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; MILLAR JBA, 1991, P NATL ACAD SCI USA, V88, P10500, DOI 10.1073/pnas.88.23.10500; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Neely KE, 2003, CELL CYCLE, V2, P455, DOI 10.4161/cc.2.5.488; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Nurse P, 1998, NAT MED, V4, P1103, DOI 10.1038/2594; Saito RM, 2004, NAT CELL BIOL, V6, P777, DOI 10.1038/ncb1154; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Theis-Febvre N, 2003, ONCOGENE, V22, P220, DOI 10.1038/sj.onc.1206107; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Vazquez-Novelle MD, 2005, J BIOL CHEM, V280, P29144, DOI 10.1074/jbc.M413328200; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wolfe BA, 2004, EMBO J, V23, P919, DOI 10.1038/sj.emboj.7600103; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	52	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40544	40553		10.1074/jbc.M110.133009	http://dx.doi.org/10.1074/jbc.M110.133009			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956543	Green Published, hybrid			2022-12-25	WOS:000285414400017
J	Lee, HJ; Joo, M; Abdolrasulnia, R; Young, DG; Choi, I; Ware, LB; Blackwell, TS; Christman, BW				Lee, Hye Jeong; Joo, Myungsoo; Abdolrasulnia, Rasul; Young, David G.; Choi, Inyeong; Ware, Lorraine B.; Blackwell, Timothy S.; Christman, Brian W.			Peptidylarginine Deiminase 2 Suppresses Inhibitory kappa B Kinase Activity in Lipopolysaccharide-stimulated RAW 264.7 Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEIMINATION; POSTTRANSLATIONAL MODIFICATION; DEVELOPMENTALLY IMMATURE; ARGININE METHYLATION; TISSUE INFLAMMATION; MULTIPLE-SCLEROSIS; PROSTAGLANDIN D-2; STRUCTURAL BASIS; KERATIN K1; HUMAN PAD4	Peptidylarginine deiminases (PADs) are enzymes that convert arginine to citrulline in proteins. In this study, we examined PAD-mediated citrullination and its effect on pro-inflammatory activity in the macrophage cell line RAW 264.7. Citrullination of 45-65-kDa proteins was induced when cells were treated with lipopolysaccharide (LPS; 1 mu g/ml). Protein citrullination was suppressed by the intracellular calcium chelator BAPTA/AM (30 mu M). LPS treatment up-regulated COX-2 levels in cells. Interestingly, overexpressing PAD2 reduced LPS-mediated COX-2 up-regulation by 50%. PAD2 overexpression also reduced NF-kappa B activity, determined by NF-kappa B-driven luciferase activity. The effect of PAD2 on NF-kappa B activity was further examined by using HEK 293 cells transfected with NF-kappa B luciferase, I kappa B beta/gamma kinase (IKK beta/gamma) subunits, and PAD2. IKK beta increased NF-kappa B activity, but this increase was markedly suppressed when PAD2 was present in cells. IKK kappa-mediated NF-kappa B activation was further enhanced by IKK beta in the presence of calcium ionophore A23187. However, this stimulatory effect of IKK beta/gamma was abolished by PAD2. Coimmunoprecipitation of cell lysates showed that IKK gamma and PAD2 can coimmunoprecipitate in the presence of the Ca2+ ionophore. IKK gamma coimmunoprecipitated truncation mutants, PAD2(1-385) and PAD2(355-672). The substitution of Gln-358 (a putative ligand for Ca2+ binding) with an Ala abolished coimmunoprecipitation. Conversely, PAD2 coimmunoprecipitated truncation mutants IKK gamma(1-196) and IKK gamma(197419). In other experiments, treating RAW 264.7 cells with LPS induced citrullination in the immunoprecipitates of IKK gamma. In vitro citrullination assay showed that incubation of purified PAD2 and IKK gamma proteins in the presence of Ca2+ citrullinated IKK gamma. These results demonstrate that PAD2 interacts with IKK gamma and suppresses NF-kappa B activity.	[Lee, Hye Jeong; Joo, Myungsoo; Abdolrasulnia, Rasul; Young, David G.; Ware, Lorraine B.; Blackwell, Timothy S.; Christman, Brian W.] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.; Christman, Brian W.] Dept Vet Affairs, Nashville, TN 37232 USA; [Choi, Inyeong] Emory Univ, Dept Physiol, Atlanta, GA 30033 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University	Lee, HJ (corresponding author), Dept Radiol & Radiol Sci, 1161 21st Ave S,CCC 1121 MCN, Nashville, TN 37232 USA.	hye-jeong.lee@vanderbilt.edu	Ware, Lorraine/AAJ-9307-2021; choi, inyeong/AAM-4826-2021	Ware, Lorraine/0000-0002-9429-4702; 	National Institutes of Health [PO1 HL66196, R01-GM078502, HL81332, HL088263]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL081332, K24HL103836, P01HL066196, R01HL088263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL66196 (to B. W. C., M. J., and T. S. B.), R01-GM078502 (to I. C.), and HL81332 (to L. B. W.) and HL088263 (to L. B. W.). This work was also supported by an American Heart Association Established Investigator Award (L. B. W.).	Arita K, 2006, P NATL ACAD SCI USA, V103, P5291, DOI 10.1073/pnas.0509639103; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Asaga H, 2001, J LEUKOCYTE BIOL, V70, P46; BENBARUCH A, 1995, J BIOL CHEM, V270, P11703, DOI 10.1074/jbc.270.20.11703; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2002, CURR TOP MICROBIOL, V270, P109; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Ishida-Yamamoto A, 2000, J INVEST DERMATOL, V114, P701, DOI 10.1046/j.1523-1747.2000.00936.x; Joo M, 2007, J IMMUNOL, V179, P2565, DOI 10.4049/jimmunol.179.4.2565; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim Y, 2004, BIOCHEM BIOPH RES CO, V314, P695, DOI 10.1016/j.bbrc.2003.12.153; LEE HJ, 2006, P AM THRAC SOC, V3, pA232; Liu GY, 2006, APOPTOSIS, V11, P183, DOI 10.1007/s10495-006-3715-4; Loos T, 2008, BLOOD, V112, P2648, DOI 10.1182/blood-2008-04-149039; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Nakashima K, 1999, J BIOL CHEM, V274, P27786, DOI 10.1074/jbc.274.39.27786; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; ROGERS GE, 1962, NATURE, V194, P1149, DOI 10.1038/1941149a0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Senshu T, 1999, J DERMATOL SCI, V21, P113, DOI 10.1016/S0923-1811(99)00026-2; Shifera AS, 2010, BIOCHEM BIOPH RES CO, V396, P585, DOI 10.1016/j.bbrc.2010.05.012; Shifera AS, 2010, J CELL PHYSIOL, V223, P558, DOI 10.1002/jcp.22105; Shirai H, 2001, TRENDS BIOCHEM SCI, V26, P465, DOI 10.1016/S0968-0004(01)01906-5; Struyf S, 2009, J IMMUNOL, V182, P666, DOI 10.4049/jimmunol.182.1.666; Tanaka Y, 2004, BIOL PHARM BULL, V27, P985, DOI 10.1248/bpb.27.985; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; WATANABE K, 1988, BIOCHIM BIOPHYS ACTA, V966, P375, DOI 10.1016/0304-4165(88)90088-8; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106	42	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39655	39662		10.1074/jbc.M110.170290	http://dx.doi.org/10.1074/jbc.M110.170290			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937835	hybrid, Green Published			2022-12-25	WOS:000285185500009
J	Mendes, AI; Matos, P; Moniz, S; Jordan, P				Mendes, Ana Isabel; Matos, Paulo; Moniz, Sonia; Jordan, Peter			Protein Kinase WNK1 Promotes Cell Surface Expression of Glucose Transporter GLUT1 by Regulating a Tre-2/USP6-BUB2-Cdc16 Domain Family Member 4 (TBC1D4)-Rab8A Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; EPITHELIAL SODIUM-CHANNEL; SIGNALING PATHWAY; CL-COTRANSPORTER; MOLECULAR-BASIS; BLOOD-PRESSURE; AKT SUBSTRATE; MUSCLE-CELLS; RAB-GAP; TRANSLOCATION	One mechanism by which mammalian cells regulate the uptake of glucose is the number of glucose transporter proteins (GLUT) present at the plasma membrane. In insulin-responsive cells types, GLUT4 is released from intracellular stores through inactivation of the Rab GTPase activating protein Tre-2/USP6-BUB2-Cdc16 domain family member 4 (TBC1D4) (also known as AS160). Here we describe that TBC1D4 forms a protein complex with protein kinase WNK1 in human embryonic kidney (HEK293) cells. We show that WNK1 phosphorylates TBC1D4 in vitro and that the expression levels of WNK1 in these cells regulate surface expression of the constitutive glucose transporter GLUT1. WNK1 was found to increase the binding of TBC1D4 to regulatory 14-3-3 proteins while reducing its interaction with the exocytic small GTPase Rab8A. These effects were dependent on the catalytic activity because expression of a kinase-dead WNK1 mutant had no effect on binding of 14-3-3 and Rab8A, or on surface GLUT1 levels. Together, the data describe a pathway regulating constitutive glucose uptake via GLUT1, the expression level of which is related to several human diseases.	[Mendes, Ana Isabel; Matos, Paulo; Moniz, Sonia; Jordan, Peter] Natl Inst Hlth, Dept Genet, P-1649016 Lisbon, Portugal		Jordan, P (corresponding author), Ave Padre Cruz, P-1649016 Lisbon, Portugal.	peter.jordan@insa.min-saude.pt	Matos, Paulo/P-3012-2019; Jordan, Peter/G-9335-2012; Matos, Paulo/F-5245-2012	Matos, Paulo/0000-0002-9379-9696; Jordan, Peter/0000-0002-1425-9211; Matos, Paulo/0000-0002-9379-9696	Portuguese Fundacao para a Ciencia e Tecnologia [POCI_PPCDT/SAU-MMO/56439/04]; Programa de Financiamento Plurianual do CIGMH;  [BD 23001/05]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa de Financiamento Plurianual do CIGMH; 	This work was supported by Portuguese Fundacao para a Ciencia e Tecnologia through Grant POCI_PPCDT/SAU-MMO/56439/04, Programa de Financiamento Plurianual do CIGMH, and Fellowship BD 23001/05 (to A. I. M.).	Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Cope G, 2006, J AM SOC NEPHROL, V17, P1867, DOI 10.1681/ASN.2005111224; Delaloy C, 2008, HYPERTENSION, V52, P1149, DOI 10.1161/HYPERTENSIONAHA.108.120899; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Gamba G, 2005, AM J PHYSIOL-RENAL, V288, pF245, DOI 10.1152/ajprenal.00311.2004; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Gnudi L, 2003, HYPERTENSION, V42, P19, DOI 10.1161/01.HYP.0000075949.19968.EF; Hadchouel J, 2006, J AM SOC NEPHROL, V17, P208, DOI 10.1681/ASN.2005030314; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Klepper J, 2007, DEV MED CHILD NEUROL, V49, P707, DOI 10.1111/j.1469-8749.2007.00707.x; Koumanov Francoise, 2007, Biochem J, V403, pe9; Lee BH, 2004, MOL CELL, V15, P741, DOI 10.1016/j.molcel.2004.07.018; Lee BH, 2007, J BIOL CHEM, V282, P17985, DOI 10.1074/jbc.M702664200; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Liang XB, 2010, MOL BIOL CELL, V21, P2024, DOI 10.1091/mbc.E10-01-0042; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Moniz S, 2007, ONCOGENE, V26, P6071, DOI 10.1038/sj.onc.1210706; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Ngo S, 2009, MOL CELL ENDOCRINOL, V302, P33, DOI 10.1016/j.mce.2008.10.020; Oh E, 2007, J BIOL CHEM, V282, P32613, DOI 10.1074/jbc.M706591200; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2006, PEDIATR NEPHROL, V21, P1231, DOI 10.1007/s00467-006-0106-6; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; ZHAO FQ, 1993, INT J BIOCHEM, V25, P1897, DOI 10.1016/0020-711X(88)90322-9	62	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39117	39126		10.1074/jbc.M110.159418	http://dx.doi.org/10.1074/jbc.M110.159418			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937822	hybrid, Green Published			2022-12-25	WOS:000284941300042
J	Ger, MF; Rendon, G; Tilson, JL; Jakobsson, E				Ger, Mao-Feng; Rendon, Gloria; Tilson, Jeffrey L.; Jakobsson, Eric			Domain-Based Identification and Analysis of Glutamate Receptor Ion Channels and Their Relatives in Prokaryotes	PLOS ONE			English	Article							PREDICTION; MECHANISMS	Voltage-gated and ligand-gated ion channels are used in eukaryotic organisms for the purpose of electrochemical signaling. There are prokaryotic homologues to major eukaryotic channels of these sorts, including voltage-gated sodium, potassium, and calcium channels, Ach-receptor and glutamate-receptor channels. The prokaryotic homologues have been less well characterized functionally than their eukaryotic counterparts. In this study we identify likely prokaryotic functional counterparts of eukaryotic glutamate receptor channels by comprehensive analysis of the prokaryotic sequences in the context of known functional domains present in the eukaryotic members of this family. In particular, we searched the nonredundant protein database for all proteins containing the following motif: the two sections of the extracellular glutamate binding domain flanking two transmembrane helices. We discovered 100 prokaryotic sequences containing this motif, with a wide variety of functional annotations. Two groups within this family have the same topology as eukaryotic glutamate receptor channels. Group 1 has a potassium-like selectivity filter. Group 2 is most closely related to eukaryotic glutamate receptor channels. We present analysis of the functional domain architecture for the group of 100, a putative phylogenetic tree, comparison of the protein phylogeny with the corresponding species phylogeny, consideration of the distribution of these proteins among classes of prokaryotes, and orthologous relationships between prokaryotic and human glutamate receptor channels. We introduce a construct called the Evolutionary Domain Network, which represents a putative pathway of domain rearrangements underlying the domain composition of present channels. We believe that scientists interested in ion channels in general, and ligand-gated ion channels in particular, will be interested in this work. The work should also be of interest to bioinformatics researchers who are interested in the use of functional domain-based analysis in evolutionary and functional discovery.	[Ger, Mao-Feng; Jakobsson, Eric] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Rendon, Gloria; Jakobsson, Eric] Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA; [Tilson, Jeffrey L.] Renaissance Comp Inst, Raleigh, NC USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ger, MF (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	jake@illinois.edu			National Science Foundation (NSF) [0835718]	National Science Foundation (NSF)(National Science Foundation (NSF))	The authors gratefully acknowledge support from National Science Foundation (NSF) grant 0835718, "Hierarchical Modularity in Structure and Function'' to EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Booth IR, 2003, BIOCHEMISTRY-US, V42, P10045, DOI 10.1021/bi034953w; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FELSENSTEIN J, 1993, PHYIP PHYLOGENY INFE; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hu ZJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-1; Kalsbeek A, 2007, ENDOCRINOLOGY, V148, P5635, DOI 10.1210/en.2007-0776; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Kung C, 2004, MOL MICROBIOL, V53, P373, DOI 10.1111/j.1365-2958.2004.04180.x; Mackey SR, 2007, TRENDS MICROBIOL, V15, P381, DOI 10.1016/j.tim.2007.08.005; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Pohorille A, 2005, ASTROBIOLOGY, V5, P1, DOI 10.1089/ast.2005.5.1; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Tasneem A, 2005, GENOME BIOL, V6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tilson JL, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P620; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	25	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e12827	10.1371/journal.pone.0012827	http://dx.doi.org/10.1371/journal.pone.0012827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949136	Green Published, gold, Green Submitted			2022-12-25	WOS:000282568400001
J	Aronsson, L; Huang, Y; Parini, P; Korach-Andre, M; Hakansson, J; Gustafsson, JA; Pettersson, S; Arulampalam, V; Rafter, J				Aronsson, Linda; Huang, Ying; Parini, Paolo; Korach-Andre, Marion; Hakansson, Janet; Gustafsson, Jan-Ake; Pettersson, Sven; Arulampalam, Velmurugesan; Rafter, Joseph			Decreased Fat Storage by Lactobacillus Paracasei Is Associated with Increased Levels of Angiopoietin-Like 4 Protein (ANGPTL4)	PLOS ONE			English	Article							CHOLESTEROL ACYLTRANSFERASE-2; LIPOPROTEIN-LIPASE; GASSERI SBT2055; GUT MICROBIOME; TARGET GENE; MICE; MODULATION; PROBIOTICS; OBESITY; PLASMA	Background: Intervention strategies for obesity are global issues that require immediate attention. One approach is to exploit the growing consensus that beneficial gut microbiota could be of use in intervention regimes. Our objective was to determine the mechanism by which the probiotic bacteria Lactobacillus paracasei ssp paracasei F19 (F19) could alter fat storage. Angiopoietin-like 4 (ANGPTL4) is a circulating lipoprotein lipase (LPL) inhibitor that controls triglyceride deposition into adipocytes and has been reported to be regulated by gut microbes. Methodology/Principal Findings: A diet intervention study of mice fed high-fat chow supplemented with F19 was carried out to study potential mechanistic effects on fat storage. Mice given F19 displayed significantly less body fat, as assessed by magnetic resonance imaging, and a changed lipoprotein profile. Given that previous studies on fat storage have identified ANGPTL4 as an effector, we also investigated circulating levels of ANGPTL4, which proved to be higher in the F19-treated group. This increase, together with total body fat and triglyceride levels told a story of inhibited LPL action through ANGPTL4 leading to decreased fat storage. Co-culture experiments of colonic cell lines and F19 were set up in order to monitor any ensuing alterations in ANGPTL4 expression by qPCR. We observed that potentially secreted factors from F19 can induce ANGPTL4 gene expression, acting in part through the peroxisome proliferator activated receptors alpha and gamma. To prove validity of in vitro findings, germ-free mice were monocolonized with F19. Here we again found changes in serum triglycerides as well as ANGPTL4 in response to F19. Conclusions/Significance: Our results provide an interesting mechanism whereby modifying ANGPTL4, a central player in fat storage regulation, through manipulating gut flora could be an important gateway upon which intervention trials of weight management can be based.	[Aronsson, Linda; Huang, Ying; Pettersson, Sven; Arulampalam, Velmurugesan] Karolinska Inst, Dept Microbiol Cell & Tumor Biol, Stockholm, Sweden; [Huang, Ying; Parini, Paolo; Korach-Andre, Marion; Gustafsson, Jan-Ake; Rafter, Joseph] Karolinska Inst, Dept Biosci & Nutr NOVUM, Huddinge, Sweden; [Parini, Paolo] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Hakansson, Janet] Arla Foods Nord Innovat, Stockholm, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Houston System; University of Houston	Aronsson, L (corresponding author), Karolinska Inst, Dept Microbiol Cell & Tumor Biol, Stockholm, Sweden.	velmurugesan.arulampalam@ki.se; joseph.rafter@ki.se	Korach-André, Marion/AAC-3545-2022; Korach-André, Marion/A-8920-2017; Pettersson, Sven/F-9511-2015	Korach-André, Marion/0000-0003-3292-9124; 	Vinnova Sweden; Swedish Research Council; Soderberg Foundation; Heart-Lung Foundation; EU [222720-2]	Vinnova Sweden(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg Foundation; Heart-Lung Foundation(Swedish Heart-Lung Foundation); EU(European Commission)	This work was supported by Vinnova Sweden, the Swedish Research Council, the Soderberg Foundation, the Heart-Lung Foundation, and the EU project TORNADO (Framework 7, grant no. 222720-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2007, J INTERN MED, V262, P184, DOI 10.1111/j.1365-2796.2007.01825.x; Ali AA, 2005, J NUTR BIOCHEM, V16, P693, DOI 10.1016/j.jnutbio.2005.03.011; Are A, 2008, P NATL ACAD SCI USA, V105, P1943, DOI 10.1073/pnas.0711734105; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Fernandez ML, 2007, NUTR REV, V65, pS30, DOI [10.1111/j.1753-4887.2007.tb00325.x, 10.1301/nr.2007.jun.S30-S34]; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	23	199	213	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13087	10.1371/journal.pone.0013087	http://dx.doi.org/10.1371/journal.pone.0013087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927337	Green Submitted, Green Published, gold			2022-12-25	WOS:000282312600020
J	Melnychuk, MC; Welch, DW; Walters, CJ				Melnychuk, Michael C.; Welch, David W.; Walters, Carl J.			Spatio-Temporal Migration Patterns of Pacific Salmon Smolts in Rivers and Coastal Marine Waters	PLOS ONE			English	Article							JUVENILE COHO SALMON; STOCK-SPECIFIC MIGRATIONS; WIRE TAG RECOVERIES; SOCKEYE-SALMON; ONCORHYNCHUS-KISUTCH; ATLANTIC SALMON; CONTINENTAL-SHELF; VANCOUVER-ISLAND; WEST-COAST; SURVIVAL	Background: Migrations allow animals to find food resources, rearing habitats, or mates, but often impose considerable predation risk. Several behavioural strategies may reduce this risk, including faster travel speed and taking routes with shorter total distance. Descriptions of the natural range of variation in migration strategies among individuals and populations is necessary before the ecological consequences of such variation can be established. Methodology/Principal Findings: Movements of tagged juvenile coho, steelhead, sockeye, and Chinook salmon were quantified using a large-scale acoustic tracking array in southern British Columbia, Canada. Smolts from 13 watersheds (49 watershed/species/year combinations) were tagged between 2004-2008 and combined into a mixed-effects model analysis of travel speed. During the downstream migration, steelhead were slower on average than other species, possibly related to freshwater residualization. During the migration through the Strait of Georgia, coho were slower than steelhead and sockeye, likely related to some degree of inshore summer residency. Hatchery-reared smolts were slower than wild smolts during the downstream migration, but after ocean entry, average speeds were similar. In small rivers, downstream travel speed increased with body length, but in the larger Fraser River and during the coastal migration, average speed was independent of body length. Smolts leaving rivers located towards the northern end of the Strait of Georgia ecosystem migrated strictly northwards after ocean entry, but those from rivers towards the southern end displayed split-route migration patterns within populations, with some moving southward. Conclusions/Significance: Our results reveal a tremendous diversity of behavioural migration strategies used by juvenile salmon, across species, rearing histories, and habitats, as well as within individual populations. During the downstream migration, factors that had strong effects on travel speeds included species, wild or hatchery-rearing history, watershed size and, in smaller rivers, body length. During the coastal migration, travel speeds were only strongly affected by species differences.	[Melnychuk, Michael C.; Walters, Carl J.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Melnychuk, Michael C.; Walters, Carl J.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Welch, David W.] Kintama Res Corp, Nanaimo, BC, Canada	University of British Columbia; University of British Columbia	Melnychuk, MC (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	mmel@u.washington.edu	Walters, Carl/D-5714-2012; Melnychuk, Michael/A-4680-2013	Melnychuk, Michael/0000-0002-6088-7657	Alfred P. Sloan Foundation; Gordon and Betty Moore Foundation; Pacific Salmon Foundation [07350-35/FSWP 07 I D1]; Pacific Salmon Commission; CN Railway through the Cheakamus Ecosystem Restoration Technical Committee [17R32878]; B.C. Pacific Salmon Forum; Natural Sciences and Engineering Research Council of Canada	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Salmon Foundation; Pacific Salmon Commission; CN Railway through the Cheakamus Ecosystem Restoration Technical Committee; B.C. Pacific Salmon Forum; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Sources of funding were: Alfred P. Sloan Foundation (www.sloan.org), Gordon and Betty Moore Foundation (www.moore.org), Pacific Salmon Foundation (Grant number 07350-35/FSWP 07 I D1; www.psf.ca), Pacific Salmon Commission (www.psc.org), CN Railway through the Cheakamus Ecosystem Restoration Technical Committee (Grant numbers 17R32878, and Monitor2-ProjectF; www.cn.ca/en/ and www.certc.ca), B.C. Pacific Salmon Forum (www.pacificsalmonforum.ca). M. M. was supported by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JJ, 2005, ECOL MODEL, V186, P196, DOI 10.1016/j.ecolmodel.2005.01.014; [Anonymous], 1981, CAN SPEC PUBL FISH A; Bauer S, 2009, BIOL LETTERS, V5, P433, DOI 10.1098/rsbl.2009.0324; BEAMISH RJ, 1992, T AM FISH SOC, V121, P444, DOI 10.1577/1548-8659(1992)121<0444:SDPOCA>2.3.CO;2; Brodeur RD, 2007, AM FISH S S, V57, P183; Brodeur Richard D., 2003, North Pacific Anadromous Fish Commission Bulletin, V3, P89; Chittenden CM, 2009, T AM FISH SOC, V138, P1220, DOI 10.1577/T09-037.1; Collis K, 2001, T AM FISH SOC, V130, P385, DOI 10.1577/1548-8659(2001)130<0385:CWPOJS>2.0.CO;2; Giorgi A. E., 1997, North American Journal of Fisheries Management, V17, P268, DOI 10.1577/1548-8675(1997)017<0268:FTITDM>2.3.CO;2; Godfrey H., 1975, Bulletin Int N Pacif Fish Commn, VNo. 31, P1; GROOT C, 1987, FISH B-NOAA, V85, P455; Groot C., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P53; Healey MC, 1980, SALMONID ECOSYSTEMS, P203; Hedger RD, 2008, MAR ECOL PROG SER, V355, P235, DOI 10.3354/meps07239; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Kallio-Nyberg I, 1999, CAN J FISH AQUAT SCI, V56, P853, DOI 10.1139/cjfas-56-5-853; Laake JL, 2002, FISH B-NOAA, V100, P434; Labelle M, 1997, CAN J FISH AQUAT SCI, V54, P1433, DOI 10.1139/cjfas-54-7-1433; McKinnell S, 1999, FISH OCEANOGR, V8, P104, DOI 10.1046/j.1365-2419.1999.00098.x; Melnychuk M.C., 2009, THESIS U BRIT COLUMB; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Melnychuk MC, 2010, CAN J FISH AQUAT SCI, V67, P641, DOI 10.1139/F09-199; Miller BA, 2003, T AM FISH SOC, V132, P546, DOI 10.1577/1548-8659(2003)132<0546:RTASMO>2.0.CO;2; MOORE A, 1990, J FISH BIOL, V37, P713, DOI 10.1111/j.1095-8649.1990.tb02535.x; Moore ME, 2010, T AM FISH SOC, V139, P49, DOI 10.1577/T09-012.1; Morris JFT, 2007, AM FISH S S, V57, P81; MOSER ML, 1991, CAN J FISH AQUAT SCI, V48, P1670, DOI 10.1139/f91-198; Olesiuk PF, 1996, S9510 PSARC; PEARCY WG, 1988, FISH B-NOAA, V86, P173; Pinheiro J, 2001, MIXED EFFECTS MODELS; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; RICKER W. E., 1938, JOUR FISH RES BD CANADA, V4, P192; ROSE GA, 1993, NATURE, V366, P458, DOI 10.1038/366458a0; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Secor DH, 1999, FISH RES, V43, P13, DOI 10.1016/S0165-7836(99)00064-8; SKALSKI JR, 2006, DESIGN ANAL SALMONID, V20; Trudel M, 2009, T AM FISH SOC, V138, P1369, DOI 10.1577/T08-181.1; Tucker S, 2009, T AM FISH SOC, V138, P1458, DOI 10.1577/T08-211.1; Welch DW, 2007, HYDROBIOLOGIA, V582, P289, DOI 10.1007/s10750-006-0553-x; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; WOOD CC, 1993, CAN J FISH AQUAT SCI, V50, P1329, DOI 10.1139/f93-151; WOOD CC, 1987, CAN J FISH AQUAT SCI, V44, P941, DOI 10.1139/f87-112; WOOD CC, AM FISH SOC IN PRESS; Zimmerman CE, 2000, CAN J FISH AQUAT SCI, V57, P2152, DOI 10.1139/cjfas-57-10-2152; Zuur Alain F., 2009, P1; [No title captured]	48	51	51	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12916	10.1371/journal.pone.0012916	http://dx.doi.org/10.1371/journal.pone.0012916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886121	Green Submitted, gold, Green Published			2022-12-25	WOS:000282091100021
J	Grassian, AR; Schafer, ZT; Brugge, JS				Grassian, Alexandra R.; Schafer, Zachary T.; Brugge, Joan S.			ErbB2 Stabilizes Epidermal Growth Factor Receptor (EGFR) Expression via Erk and Sprouty2 in Extracellular Matrix-detached Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL ACINI; DOWN-REGULATION; TISSUE ARCHITECTURE; ANOIKIS RESISTANCE; TUMOR PROGRESSION; KINASE PATHWAY; CANCER CELLS; MECHANISMS; PHOSPHORYLATION; INHIBITION	Epithelial cells are dependent on extracellular matrix (ECM) attachment for maintenance of metabolic activity and suppression of apoptosis. Here we show that loss of ECM attachment causes down-regulation of epidermal growth factor receptor (EGFR) and beta 1 integrin protein and mRNA expression and that ErbB2, which is amplified in 25% of breast tumors, reverses these effects of ECM deprivation. ErbB2 rescue of beta 1 integrin mRNA and protein in suspended cells is dependent on EGFR, however, the rescue of EGFR expression does not require beta 1 integrin. We show that there is a significant decrease in the stability of EGFR in ECM-detached cells that is reversed by ErbB2 overexpression. Rescue of both EGFR and beta 1 integrin protein by ErbB2 is dependent on Erk activity and induction of its downstream target Sprouty2, a protein known to regulate EGFR protein stability. Interestingly, expression of EGFR and beta 1 integrin protein is more dependent on Erk/Sprouty2 in ECM-detached ErbB2-overexpressing cells when compared with ECM-attached cells. These results provide further insight into the ErbB2-driven anchorage independence of tumor cells and provide a new mechanism for regulation of EGFR and beta 1 integrin expression in ECM-detached cells.	[Grassian, Alexandra R.; Schafer, Zachary T.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu			NCI; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA105134] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant from the NCI (to J. S. B.). This work was also supported by a National Science Foundation Graduate Research Fellowship (to A. R. G.).	Barbachano A, 2010, ONCOGENE, V29, P4800, DOI 10.1038/onc.2010.225; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Brandt B, 2006, CLIN CANCER RES, V12, P7252, DOI 10.1158/1078-0432.CCR-06-0626; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Carraway KL, 2009, FUTURE ONCOL, V5, P1631, DOI 10.2217/FON.09.125; Carraway KL, 2006, CANCER CELL, V10, P93, DOI 10.1016/j.ccr.2006.07.015; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Feng YH, 2010, CANCER SCI, V101, P2033, DOI 10.1111/j.1349-7006.2010.01637.x; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris J, 1999, DIS BREAST; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kim LT, 1997, P SOC EXP BIOL MED, V214, P123; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lito P, 2008, J BIOL CHEM, V283, P2002, DOI 10.1074/jbc.M709046200; Lito P, 2009, J BIOL CHEM, V284, P848, DOI 10.1074/jbc.M808045200; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Miin Wong Esther Sook, 2006, V327, P61; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ozaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1084, DOI 10.1006/bbrc.2001.5295; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Rubin C, 2005, J BIOL CHEM, V280, P9735, DOI 10.1074/jbc.M408308200; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Spangenberg C, 2006, CANCER RES, V66, P3715, DOI 10.1158/0008-5472.CAN-05-2823; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Workman HC, 2009, CANCER RES, V69, P2845, DOI 10.1158/0008-5472.CAN-08-2089; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yu X, 2000, J CELL SCI, V113, P2139; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	69	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					79	90		10.1074/jbc.M110.169821	http://dx.doi.org/10.1074/jbc.M110.169821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20956544	hybrid, Green Published			2022-12-25	WOS:000285782800009
J	Noh, OJ; Park, YH; Chung, YW; Kim, IY				Noh, Ok Jeong; Park, Yong Hwan; Chung, Youn Wook; Kim, Ick Young			Transcriptional Regulation of Selenoprotein W by MyoD during Early Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOGENIC DIFFERENTIATION; OXIDATIVE STRESS; BINDING PROTEIN; MYOBLAST CELLS; DNA-BINDING; STEM-CELLS; EXPRESSION; GENE; THIOREDOXIN; ACTIVATION	Selenoprotein W (SelW) is expressed in various tissues, but it is especially high in the skeletal muscle of mammals. Such tissue-specific protein expression implies regulation by a tissue-specific factor. In this study, we investigated SelW expression during myogenic C2C12 cell differentiation using RTPCR, quantitative PCR, and Western blot analysis. Both the protein and mRNA levels of SelW were increased during C2C12 cell differentiation, particularly during the early stage. Sequence analysis of the SelW promoter revealed four putative E-boxes, E1, E2, E3, and E4, which are known binding sites for MyoD, a myogenic transcriptional factor. Luciferase reporter assay showed that E1 and E4 were crucial for MyoD-dependent promoter activity. Using EMSA analysis, we observed that MyoD bound directly to E1 but not to E4, even though E4 mutation reduced SelW promoter activity in the luciferase reporter assay. Binding of MyoD to E1 was further investigated by ChIP assay. These results suggest that the SelW gene was activated by the binding of MyoD to a specific E-box during early skeletal muscle differentiation.	[Noh, Ok Jeong; Park, Yong Hwan; Kim, Ick Young] Korea Univ, Lab Cellular & Mol Biochem, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Chung, Youn Wook] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	Korea University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, IY (corresponding author), Korea Univ, Lab Cellular & Mol Biochem, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	ickkim@korea.ac.kr		Chung, Youn Wook/0000-0002-4382-1410	Korean Government (MOEHRD) [KRF-2005-070-C00086]; Korea University	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Korea University	This work was authored, in whole or in part, by National Institutes of Health staff. This work was funded by Korea Research Foundation Grant from the Korean Government (MOEHRD) KRF-2005-070-C00086 (to I. Y. K.) and in part by a Korea University grant.	Aachmann FL, 2007, J BIOL CHEM, V282, P37036, DOI 10.1074/jbc.M705410200; Amantana A, 2004, J INORG BIOCHEM, V98, P1513, DOI 10.1016/j.jinorgbio.2004.06.003; Amantana A, 2002, J INORG BIOCHEM, V91, P356, DOI 10.1016/S0162-0134(02)00453-1; ASAKURA A, 1993, MOL CELL BIOL, V13, P7153, DOI 10.1128/MCB.13.11.7153; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Castets P, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-46; Catani MV, 2004, FREE RADICAL BIO MED, V37, P1024, DOI 10.1016/j.freeradbiomed.2004.06.021; Chung YW, 2009, MOL CELLS, V27, P609, DOI 10.1007/s10059-009-0074-3; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Flohe L, 2009, BBA-GEN SUBJECTS, V1790, P1389, DOI 10.1016/j.bbagen.2009.03.031; Fujita H, 2010, BIOTECHNOL BIOENG, V107, P894, DOI 10.1002/bit.22865; Gao Y, 2006, CYTOKINE, V33, P246, DOI 10.1016/j.cyto.2006.02.005; Gu QP, 2002, BIOMETALS, V15, P411, DOI 10.1023/A:1020241032336; Huang J, 1996, MOL CELL BIOL, V16, P3893; Jeong DW, 2002, FEBS LETT, V517, P225, DOI 10.1016/S0014-5793(02)02628-5; Jeong DW, 2004, MOL CELLS, V17, P156; Kaspar P, 2005, EXP CELL RES, V309, P419, DOI 10.1016/j.yexcr.2005.06.016; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Lawson MA, 2000, CELLS TISSUES ORGANS, V167, P130, DOI 10.1159/000016776; Loflin J, 2006, J INORG BIOCHEM, V100, P1679, DOI 10.1016/j.jinorgbio.2006.05.018; Parker MH, 2006, MOL CELL BIOL, V26, P5771, DOI 10.1128/MCB.02404-05; Petit N, 2003, HUM MOL GENET, V12, P1045, DOI 10.1093/hmg/ddg115; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Sengupta A, 2009, BIOCHEM CELL BIOL, V87, P953, DOI [10.1139/O09-064, 10.1139/o09-064]; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Stoytcheva ZR, 2010, BBA-GEN SUBJECTS, V1800, P416, DOI 10.1016/j.bbagen.2009.11.003; Stoytcheva ZR, 2009, BBA-GEN SUBJECTS, V1790, P1429, DOI 10.1016/j.bbagen.2009.05.012; Tajbakhsh S, 2003, CURR OPIN GENET DEV, V13, P413, DOI 10.1016/S0959-437X(03)00090-X; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Thisse C, 2003, GENE EXPR PATTERNS, V3, P525, DOI 10.1016/S1567-133X(03)00054-1; Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171; Whanger PD, 2000, CELL MOL LIFE SCI, V57, P1846, DOI 10.1007/PL00000666; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; YEH JY, 1995, FASEB J, V9, P392, DOI 10.1096/fasebj.9.5.7896009	41	24	24	5	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40496	40507		10.1074/jbc.M110.152934	http://dx.doi.org/10.1074/jbc.M110.152934			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956524	hybrid, Green Published			2022-12-25	WOS:000285414400012
J	Chen, HJ; Anagnostou, G; Chai, A; Withers, J; Morris, A; Adhikaree, J; Pennetta, G; de Belleroche, JS				Chen, Han-Jou; Anagnostou, Georgia; Chai, Andrea; Withers, James; Morris, Alex; Adhikaree, Jason; Pennetta, Giuseppa; de Belleroche, Jackie S.			Characterization of the Properties of a Novel Mutation in VAPB in Familial Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; SUPEROXIDE-DISMUTASE PROTEINS; ENDOPLASMIC-RETICULUM STRESS; OXYSTEROL-BINDING PROTEIN; MEMBRANE-PROTEIN; FFAT MOTIF; HAPLOTYPE RECONSTRUCTION; DROSOPHILA-MELANOGASTER; NEUROMUSCULAR-JUNCTIONS; DEPENDENT MANNER	Following the mutation screening of genes known to cause amyotrophic lateral sclerosis (ALS) in index cases from 107 familial ALS (FALS) kindred, a point mutation was identified in vesicle-associated membrane protein-associated protein B (VAPB), or VAMP-associated protein B, causing an amino acid change from threonine to isoleucine at codon 46 (T46I) in one FALS case but not in 257 controls. This is an important finding because it is only the second mutation identified in this gene that causes ALS. In order to investigate the pathogenic effects of this mutation, we have used a motor neuron cell line and tissue-specific expression of the mutant protein in Drosophila. We provide substantial evidence for the pathogenic effects of this mutation in abolishing the effect of wild type VAPB in the unfolded protein response, promoting ubiquitin aggregate formation, and activating neuronal cell death. We also report that expression of the mutant protein in the Drosophila motor system induces aggregate deposition, endoplasmic reticulum disorganization, and chaperone up-regulation both in neurons and in muscles. Our integrated analysis of the pathogenic effect of the T46I mutation and the previously identified P56S mutation indicate extensive commonalities in the disease mechanism for these two mutations. In summary, we show that this newly identified mutation in human FALS has a pathogenic effect, supporting and reinforcing the role of VAPB as a causative gene of ALS.	[Chen, Han-Jou; Anagnostou, Georgia; Morris, Alex; Adhikaree, Jason; de Belleroche, Jackie S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Div Expt Med,Ctr Neurosci, London W12 0NN, England; [Chai, Andrea; Withers, James; Pennetta, Giuseppa] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh EH8 9XD, Midlothian, Scotland	Imperial College London; University of Edinburgh	de Belleroche, JS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Div Expt Med,Ctr Neurosci, London W12 0NN, England.	j.belleroche@imperial.ac.uk		Withers, James/0000-0002-5974-3728	ALS Association; Motor Neurone Disease Association; Wellcome Trust	ALS Association; Motor Neurone Disease Association; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the ALS Association, Motor Neurone Disease Association and Wellcome Trust.	Acharya U, 2005, CELL MOL LIFE SCI, V62, P128, DOI 10.1007/s00018-004-4254-1; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Anagnostou G, 2010, NEUROBIOL AGING, V31, P969, DOI 10.1016/j.neurobiolaging.2008.07.005; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bradley M, 2005, NEUROLOGY, V64, P1628, DOI 10.1212/01.WNL.0000160395.43761.AC; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chai A, 2008, HUM MOL GENET, V17, P266, DOI 10.1093/hmg/ddm303; Conforti FL, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-7; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fasana E, 2010, FASEB J, V24, P1419, DOI 10.1096/fj.09-147850; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fleiss JL, 2013, STAT METHODS RATES P; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gifondorwa DJ, 2007, J NEUROSCI, V27, P13173, DOI 10.1523/JNEUROSCI.4057-07.2007; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HARALICK R, 1992, COMPUTER ROBOT VISIO, V1, P168; Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kim S, 2010, J BIOL CHEM, V285, P13839, DOI 10.1074/jbc.M109.097345; KONG TY, 1996, TOPOLOGICAL ALGORITH, P99; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Landers JE, 2008, NEUROLOGY, V70, P1179, DOI 10.1212/01.wnl.0000289760.85237.4e; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Millecamps S, 2010, J MED GENET, V47, P554, DOI 10.1136/jmg.2010.077180; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Oyanagi K, 2008, NEUROPATH APPL NEURO, V34, P650, DOI 10.1111/j.1365-2990.2008.00941.x; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; PRATT WK, 2007, DIGITAL IMAGE PROCES, P431; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Sanyal S, 2005, GENETICS, V169, P737, DOI 10.1534/genetics.104.031930; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strong MJ, 2008, AMYOTROPH LATERAL SC, V9, P323, DOI 10.1080/17482960802372371; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Watson MR, 2008, J BIOL CHEM, V283, P24972, DOI 10.1074/jbc.M804817200; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; YAO KM, 1994, J NEUROCHEM, V63, P41; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	77	121	127	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40266	40281		10.1074/jbc.M110.161398	http://dx.doi.org/10.1074/jbc.M110.161398			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940299	hybrid, Green Published			2022-12-25	WOS:000285185500070
J	Driscoll, MD; McLean, KJ; Levy, C; Mast, N; Pikuleva, IA; Lafite, P; Rigby, SEJ; Leys, D; Munro, AW				Driscoll, Max D.; McLean, Kirsty J.; Levy, Colin; Mast, Natalia; Pikuleva, Irina A.; Lafite, Pierre; Rigby, Stephen E. J.; Leys, David; Munro, Andrew W.			Structural and Biochemical Characterization of Mycobacterium tuberculosis CYP142	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANT TUBERCULOSIS; HEME IRON; CHOLESTEROL DEGRADATION; CYTOCHROME-P450; P450; REDUCTION; PROTEINS; SITE; IDENTIFICATION; REVEALS	The Mycobacterium tuberculosis cytochrome P450 enzyme CYP142 is encoded in a large gene cluster involved in metabolism of host cholesterol. CYP142 was expressed and purified as a soluble, low spin P450 hemoprotein. CYP142 binds tightly to cholesterol and its oxidized derivative cholest-4-en-3-one, with extensive shift of the heme iron to the high spin state. High affinity for azole antibiotics was demonstrated, highlighting their therapeutic potential. CYP142 catalyzes either 27- hydroxylation of cholesterol/cholest-4-en-3-one or generates 5-cholestenoic acid/cholest-4-en-3-one-27-oic acid from these substrates by successive sterol oxidations, with the catalytic outcome dependent on the redox partner system used. The CYP142 crystal structure was solved to 1.6A angstrom, revealing a similar active site organization to the cholesterol-metabolizing M. tuberculosis CYP125, but having a near-identical organization of distal pocket residues to the branched fatty acid oxidizing M. tuberculosis CYP124. The cholesterol oxidizing activity of CYP142 provides an explanation for previous findings that del CYP125 strains of Mycobacterium bovis and M. bovis BCG cannot grow on cholesterol, because these strains have a defective CYP142 gene. CYP142 is revealed as a cholesterol 27-oxidase with likely roles in host response modulation and cholesterol metabolism.	[Driscoll, Max D.; McLean, Kirsty J.; Levy, Colin; Rigby, Stephen E. J.; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs M1 7DN, England; [Mast, Natalia; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Lafite, Pierre] Univ Orleans, CNRS, ICOA, UMR 6005, F-45067 Orleans, France; [Leys, David] Royal Soc Univ, London, England	University of Manchester; Case Western Reserve University; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester, Lancs M1 7DN, England.	Andrew.Munro@Manchester.ac.uk	Lafite, Pierre/F-6806-2011; Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Lafite, Pierre/0000-0003-1637-4966; Munro, Andrew/0000-0002-4642-180X; Pikuleva, Irina/0000-0001-9742-6232; McLean, Kirsty/0000-0002-7193-5044	National Institutes of Health [GM062882]; European Union [NM4TB]; BBSRC [BB/E013007/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E013007/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062882 (to I. A. P.). This work was also supported by European Union FPVI Project NM4TB.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Aoyama Y, 1998, J BIOCHEM-TOKYO, V124, P694; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; BATIE CJ, 1981, J BIOL CHEM, V256, P7756; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Campbell IA, 2006, BRIT MED J, V332, P1194, DOI 10.1136/bmj.332.7551.1194; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DRISCOLL MD, 2010, BIOCHIM BIO IN PRESS; Dunford AJ, 2007, J BIOL CHEM, V282, P24816, DOI 10.1074/jbc.M702958200; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; Dutton P L, 1978, Methods Enzymol, V54, P411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Girvan HM, 2010, BIOCHEM J, V427, P455, DOI 10.1042/BJ20091603; Girvan HM, 2004, J BIOL CHEM, V279, P23274, DOI 10.1074/jbc.M401716200; Hansson M, 2003, BBA-MOL CELL RES, V1593, P283, DOI 10.1016/S0167-4889(02)00398-1; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Javitt NB, 2002, J LIPID RES, V43, P665; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lafite P, 2007, BIOCHEMISTRY-US, V46, P10237, DOI 10.1021/bi700876a; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2010, FUTURE MED CHEM, V2, P1339, DOI [10.4155/fmc.10.216, 10.4155/FMC.10.216]; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2006, TRENDS MICROBIOL, V14, P220, DOI 10.1016/j.tim.2006.03.002; McLean KJ, 2003, BIOCHEM J, V372, P317, DOI 10.1042/BJ20021692; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Riccardi G, 2009, FUTURE MICROBIOL, V4, P597, DOI [10.2217/fmb.09.20, 10.2217/FMB.09.20]; Rivers EC, 2008, DRUG DISCOV TODAY, V13, P1090, DOI 10.1016/j.drudis.2008.09.004; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; STOMBAUGH NA, 1976, BIOCHEMISTRY-US, V15, P2633, DOI 10.1021/bi00657a024; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104	60	78	83	4	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38270	38282		10.1074/jbc.M110.164293	http://dx.doi.org/10.1074/jbc.M110.164293			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889498	hybrid, Green Published			2022-12-25	WOS:000284625600085
J	Kulkarni, MV; Tettamanzi, MC; Murphy, JW; Keeler, C; Myszka, DG; Chayen, NE; Lolis, EJ; Hodsdon, ME				Kulkarni, Mandar V.; Tettamanzi, M. Cristina; Murphy, James W.; Keeler, Camille; Myszka, David G.; Chayen, Naomi E.; Lolis, Elias J.; Hodsdon, Michael E.			Two Independent Histidines, One in Human Prolactin and One in Its Receptor, Are Critical for pH-dependent Receptor Recognition and Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; POSTMENOPAUSAL BREAST-CANCER; TRAFFICKING DYNAMICS; BINDING-SITE; POSTENDOCYTIC TRAFFICKING; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; CELL-SURFACE; UCSF CHIMERA; FAMILY	Human prolactin (hPRL), a member of the family of hematopoietic cytokines, functions as both an endocrine hormone and autocrine/paracrine growth factor. We have previously demonstrated that recognition of the hPRL.receptor depends strongly on solution acidity over the physiologic range from pH 6 to pH 8. The hPRL.receptor binding interface contains four histidines whose protonation is hypothesized to regulate pH-dependent receptor recognition. Here, we systematically dissect its molecular origin by characterizing the consequences of His to Ala mutations on pH-dependent receptor binding kinetics, site-specific histidine protonation, and high resolution structures of the intermolecular interface. Thermodynamic modeling of the pH dependence to receptor binding affinity reveals large changes in site-specific protonation constants for a majority of interface histidines upon complexation. Removal of individual His imidazoles reduces these perturbations in protonation constants, which is most likely explained by the introduction of solvent-filled, buried cavities in the crystallographic structures without inducing significant conformational rearrangements.	[Kulkarni, Mandar V.; Tettamanzi, M. Cristina; Keeler, Camille; Hodsdon, Michael E.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Murphy, James W.; Lolis, Elias J.; Hodsdon, Michael E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Myszka, David G.] Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA; [Chayen, Naomi E.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Fac Med, London SW7 2AZ, England	Yale University; Yale University; Utah System of Higher Education; University of Utah; Imperial College London	Hodsdon, ME (corresponding author), Yale Univ, Sch Med, Dept Lab Med, POB 208035, New Haven, CT 06520 USA.	michael.hodsdon@yale.edu		Lolis, Elias/0000-0002-7902-7868	National Institutes of Health [RO1 CA 108992, T32-HL007974-07, P41 RR-01081]; NATIONAL CANCER INSTITUTE [R01CA108992] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082295, R01AI065029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA 108992 (to M. E. H.).; Supported by National Institutes of Health Training Grant T32-HL007974-07.; We are thankful to Dr. B. R. Smith for insight and critical comments on the manuscript. The UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, used for creating the molecular graphics images, was supported by National Institutes of Health Grant P41 RR-01081 grant.	Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Balbis A, 2004, J BIOL CHEM, V279, P12777, DOI 10.1074/jbc.M311493200; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; BIGNON C, 1994, J BIOL CHEM, V269, P3318; Broutin I, 2010, J BIOL CHEM, V285, P8422, DOI 10.1074/jbc.M109.089128; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clevenger Charles V, 2003, Breast Dis, V18, P75; Clevenger CV, 2009, TRENDS ENDOCRIN MET, V20, P223, DOI 10.1016/j.tem.2009.03.001; Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219; Das R, 1996, ONCOGENE, V13, P1139; Deller MC, 2000, CURR OPIN STRUC BIOL, V10, P213, DOI 10.1016/S0959-440X(00)00072-5; Eliassen AH, 2007, INT J CANCER, V120, P1536, DOI 10.1002/ijc.22482; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallon EM, 2000, BIOTECHNOL PROGR, V16, P905, DOI 10.1021/bp000097t; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; French AR, 1997, ANN BIOMED ENG, V25, P690, DOI 10.1007/BF02684846; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; GOFFIN V, 1992, MOL ENDOCRINOL, V6, P1381, DOI 10.1210/me.6.9.1381; Gutzman JH, 2007, ONCOGENE, V26, P6341, DOI 10.1038/sj.onc.1210454; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Horn JR, 2009, P NATL ACAD SCI USA, V106, P2559, DOI 10.1073/pnas.0809800106; Keeler C, 2007, BIOCHEMISTRY-US, V46, P2398, DOI 10.1021/bi061958v; Keeler C, 2009, PROTEIN SCI, V18, P909, DOI 10.1002/pro.100; Kinet S, 1996, J BIOL CHEM, V271, P14353, DOI 10.1074/jbc.271.24.14353; Kline JB, 2001, MOL ENDOCRINOL, V15, P832, DOI 10.1210/me.15.5.832; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laskowski RA, 1995, J MOL GRAPHICS, V13, P328; Lauffenburger DA, 1998, CHEM BIOL, V5, pR257, DOI 10.1016/S1074-5521(98)90110-7; LUCK DN, 1991, MOL ENDOCRINOL, V5, P1880, DOI 10.1210/mend-5-12-1880; Maus MV, 1999, ENDOCRINOLOGY, V140, P5447, DOI 10.1210/en.140.11.5447; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pezet A, 1997, J BIOL CHEM, V272, P25043, DOI 10.1074/jbc.272.40.25043; Sarkar CA, 2003, BIOTECHNOL PROGR, V19, P955, DOI 10.1021/bp020017g; STARBUCK C, 1992, BIOTECHNOL PROGR, V8, P132, DOI 10.1021/bp00014a007; Struman I, 1999, P NATL ACAD SCI USA, V96, P1246, DOI 10.1073/pnas.96.4.1246; Svensson LA, 2008, J BIOL CHEM, V283, P19085, DOI 10.1074/jbc.M801202200; Tettamanzi MC, 2008, BIOCHEMISTRY-US, V47, P8638, DOI 10.1021/bi800444t; Tworoger SS, 2008, J MAMMARY GLAND BIOL, V13, P41, DOI 10.1007/s10911-008-9063-y; Tworoger SS, 2007, J CLIN ONCOL, V25, P1482, DOI 10.1200/JCO.2006.07.6356; Tworoger SS, 2006, CANCER LETT, V243, P160, DOI 10.1016/j.canlet.2006.01.032; Tworoger SS, 2004, CANCER RES, V64, P6814, DOI 10.1158/0008-5472.CAN-04-1870; Voorhees JL, 2010, J BIOL CHEM, V285, P20022, DOI 10.1074/jbc.M109.084988; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	48	24	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38524	38533		10.1074/jbc.M110.172072	http://dx.doi.org/10.1074/jbc.M110.172072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889499	Green Published, hybrid			2022-12-25	WOS:000284625600058
J	Liu, L; Luo, Y; Chen, L; Shen, T; Xu, BS; Chen, WX; Zhou, HY; Han, XZ; Huang, SL				Liu, Lei; Luo, Yan; Chen, Long; Shen, Tao; Xu, Baoshan; Chen, Wenxing; Zhou, Hongyu; Han, Xiuzhen; Huang, Shile			Rapamycin Inhibits Cytoskeleton Reorganization and Cell Motility by Suppressing RhoA Expression and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICTOR-MTOR COMPLEX; MAMMALIAN TARGET; PROTEIN-KINASE; MOTIF PHOSPHORYLATION; BINDING PARTNER; RAPTOR; ACTIVATION; CANCER; GROWTH; MIGRATION	The mammalian target of rapamycin (mTOR) functions in cells at least as two complexes, mTORC1 and mTORC2. Intensive studies have focused on the roles of mTOR in the regulation of cell proliferation, growth, and survival. Recently we found that rapamycin inhibits type I insulin-like growth factor (IGF-1)-stimulated lamellipodia formation and cell motility, indicating involvement of mTOR in regulating cell motility. This study was set to further elucidate the underlying mechanism. Here we show that rapamycin inhibited protein synthesis and activities of small GTPases (RhoA, Cdc42, and Rac1), crucial regulatory proteins for cell migration. Disruption of mTORC1 or mTORC2 by down-regulation of raptor or rictor, respectively, inhibited the activities of these proteins. However, only disruption of mTORC1 mimicked the effect of rapamycin, inhibiting their protein expression. Ectopic expression of rapamycin-resistant and constitutively active S6K1 partially prevented rapamycin inhibition of RhoA, Rac1, and Cdc42 expression, whereas expression of constitutively hypophosphorylated 4E-BP1 (4EBP1-5A) or down-regulation of S6K1 by RNA interference suppressed expression of the GTPases, suggesting that both mTORC1-mediated S6K1 and 4E-BP1 pathways are involved in protein synthesis of the GTPases. Expression of constitutively active RhoA, but not Cdc42 and Rac1, conferred resistance to rapamycin inhibition of IGF-1-stimulated lamellipodia formation and cell migration. The results suggest that rapamycin inhibits cell motility at least in part by down-regulation of RhoA protein expression and activity through mTORC1-mediated S6K1 and 4E-BP1-signaling pathways.	[Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Huang, SL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	shuan1@lsuhsc.edu	luo, yan/I-5305-2015; Chen, Wenxing/GSI-9910-2022; Xu, Baoshan/H-6435-2011; Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072; Chen, Wenxing/0000-0003-4571-7622; Xu, Baoshan/0000-0001-8902-1243	National Institutes of Health [CA115414]; American Cancer Society [RSG-08-135-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115414 (to S. H.). This work was also supported by American Cancer Society Grant RSG-08-135-01-CNE (to S. H.).	Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fasolo A, 2008, EXPERT OPIN INV DRUG, V17, P1717, DOI [10.1517/13543784.17.11.1717, 10.1517/13543784.17.11.1717 ]; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Genda T, 1999, HEPATOLOGY, V30, P1027, DOI 10.1002/hep.510300420; Guerin P, 2005, J VASC RES, V42, P21, DOI 10.1159/000082873; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo FK, 2004, MOL CELL BIOL, V24, P1426, DOI 10.1128/MCB.24.3.1426-1438.2004; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; Sunavala-Dossabhoy G, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-1; Tsang CK, 2007, CELL CYCLE, V6, P25, DOI 10.4161/cc.6.1.3675; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	52	103	113	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38362	38373		10.1074/jbc.M110.141168	http://dx.doi.org/10.1074/jbc.M110.141168			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20937815	Green Published, hybrid			2022-12-25	WOS:000284625600042
J	Feng, XY; Tang, KH; Blankenship, RE; Tang, YJ				Feng, Xueyang; Tang, Kuo-Hsiang; Blankenship, Robert E.; Tang, Yinjie J.			Metabolic Flux Analysis of the Mixotrophic Metabolisms in the Green Sulfur Bacterium Chlorobaculum tepidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; COMPLETE GENOME SEQUENCE; CHLOROBIUM-TEPIDUM; SACCHAROMYCES-CEREVISIAE; PATHWAYS; STRAIN; ACID; MS; PURIFICATION; PYRUVATE	The photosynthetic green sulfur bacterium Chlorobaculum tepidum assimilates CO2 and organic carbon sources (acetate or pyruvate) during mixotrophic growth conditions through a unique carbon and energy metabolism. Using a C-13-labeling approach, this study examined biosynthetic pathways and flux distributions in the central metabolism of C. tepidum. The isotopomer patterns of proteinogenic amino acids revealed an alternate pathway for isoleucine synthesis (via citramalate synthase, CimA, CT0612). A C-13-assisted flux analysis indicated that carbons in biomass were mostly derived from CO2 fixation via three key routes: the reductive tricarboxylic acid (RTCA) cycle, the pyruvate synthesis pathway via pyruvate: ferredoxin oxidoreductase, and the CO2-anaplerotic pathway via phosphoenolpyruvate carboxylase. During mixotrophic growth with acetate or pyruvate as carbon sources, acetyl-CoA was mainly produced from acetate (via acetyl-CoA synthetase) or citrate (via ATP citrate lyase). Pyruvate: ferredoxin oxidoreductase converted acetyl-CoA and CO2 to pyruvate, and this growth-rate control reaction is driven by reduced ferredoxin generated during phototrophic growth. Most reactions in the RTCA cycle were reversible. The relative fluxes through the RTCA cycle were 80 similar to 100 units for mixotrophic cultures grown on acetate and 200 similar to 230 units for cultures grown on pyruvate. Under the same light conditions, the flux results suggested a trade-off between energy-demanding CO2 fixation and biomass growth rate; C. tepidum fixed more CO2 and had a higher biomass yield (Y-X/S, mole carbon in biomass/mole substrate) in pyruvate culture (Y-X/S = 9.2) than in acetate culture (Y-X/S = 6.4), but the biomass growth rate was slower in pyruvate culture than in acetate culture.	Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA; [Tang, Kuo-Hsiang; Blankenship, Robert E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)		yinjie.tang@seas.wustl.edu	Tang, Yinjie/AAI-5584-2020; Feng, Xueyang/G-1295-2015	Feng, Xueyang/0000-0003-4426-5732	National Science Foundation [MCB0954016]; NASA [NNX08AP62G]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported in part by National Science Foundation Career Grant MCB0954016 (to Y. J. T.). This work was also supported by Grant NNX08AP62G from the Exobiology program of NASA (to R. E. B.).	Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Feng XY, 2010, MICROBIOL-SGM, V156, P2566, DOI 10.1099/mic.0.038232-0; Feng XY, 2009, APPL ENVIRON MICROB, V75, P5001, DOI 10.1128/AEM.00715-09; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Fischer E, 2005, NAT GENET, V37, P636, DOI 10.1038/ng1555; Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4; Furdui C, 2000, J BIOL CHEM, V275, P28494, DOI 10.1074/jbc.M003291200; HOWELL BF, 1979, CLIN CHEM, V25, P269; Kleijn RJ, 2007, FEMS YEAST RES, V7, P216, DOI 10.1111/j.1567-1364.2006.00180.x; Pingitore F, 2007, ANAL CHEM, V79, P2483, DOI 10.1021/ac061906b; Risso C, 2008, J BACTERIOL, V190, P2266, DOI 10.1128/JB.01841-07; Sauer U, 1999, J BACTERIOL, V181, P6679, DOI 10.1128/JB.181.21.6679-6688.1999; Seo D, 2002, BBA-PROTEIN STRUCT M, V1597, P123, DOI 10.1016/S0167-4838(02)00269-8; Sonderegger M, 2004, APPL ENVIRON MICROB, V70, P2307, DOI 10.1128/AEM.70.4.2307-2317.2004; Stephanopoulos G. N., 1998, METABOLIC ENG PRINCI, P119; Tan YJ, 2009, BIOTECHNOL BIOENG, V102, P1161, DOI 10.1002/bit.22129; Tang KH, 2010, J BIOL CHEM, V285, P35848, DOI 10.1074/jbc.M110.157834; Tang KH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-150; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tang Y, 2007, J BACTERIOL, V189, P940, DOI 10.1128/JB.00948-06; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P3859, DOI 10.1128/AEM.02986-06; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P718, DOI 10.1128/AEM.01532-06; Tang YJ, 2007, J BACTERIOL, V189, P894, DOI 10.1128/JB.00926-06; Tang YJ, 2009, MASS SPECTROM REV, V28, P362, DOI 10.1002/mas.20191; Tang YJ, 2009, BIOTECHNOL BIOENG, V102, P1377, DOI 10.1002/bit.22181; Voet D., 2008, FUNDAMENTALS BIOCH, P586; Wahl SA, 2004, BIOTECHNOL BIOENG, V85, P259, DOI 10.1002/bit.10909; Wahlund TM, 1997, J BACTERIOL, V179, P4859, DOI 10.1128/jb.179.15.4859-4867.1997; Wu B, 2010, MICROBIOL-SGM, V156, P596, DOI 10.1099/mic.0.031799-0; Yang C, 2002, METAB ENG, V4, P202, DOI 10.1006/mben.2002.0226; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4	31	42	43	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39544	39550		10.1074/jbc.M110.162958	http://dx.doi.org/10.1074/jbc.M110.162958			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937805	Green Published, hybrid			2022-12-25	WOS:000284941300080
J	Lachman, ME; Agrigoroaei, S				Lachman, Margie E.; Agrigoroaei, Stefan			Promoting Functional Health in Midlife and Old Age: Long-Term Protective Effects of Control Beliefs, Social Support, and Physical Exercise	PLOS ONE			English	Article							QUALITY-OF-LIFE; ELDERLY POPULATION; PERCEIVED CONTROL; ACTIVITY PROGRAMS; ALLOSTATIC LOAD; UNITED-STATES; RISK-FACTORS; DISABILITY; PREDICTORS; MACARTHUR	Background: Previous studies have examined physical risk factors in relation to functional health, but less work has focused on the protective role of psychological and social factors. We examined the individual and joint protective contribution of control beliefs, social support and physical exercise to changes in functional health, beyond the influence of health status and physical risk factors in middle-aged and older adults. Given that functional health typically declines throughout adulthood, it is important to identify modifiable factors that can be implemented to maintain functioning, improve quality of life, and reduce disability. Methodology/Principal Findings: We conducted a national longitudinal study, Midlife in the United States (MIDUS), with assessments in 1995-1996 and 2004-2006, and 3,626 community-residing adults, aged 32 to 84, were included in the analyses. Functional health (Physical Functioning subscale of the SF-36) and protective factors were measured at both occasions. While controlling for socio-demographic, health status, and physical risk factors (large waist circumference, smoking, and alcohol or drug problems), a composite of the three protective variables (control beliefs, social support, and physical exercise) at Time 1 was significantly related to functional health change. The more of these factors at Time 1, the better the health maintenance over 10 years. Among middle-aged and older adults, declines in health were significantly reduced with an increased number of protective factors. Conclusion/Significance: Age-related declines in health were reduced among those with more protective factors up to a decade earlier in life. Modifiable psychological, social, and physical protective factors, individually and in the aggregate, are associated with maintenance of functional health, beyond the damaging effects of physical risk factors. The results are encouraging for the prospect of developing interventions to promote functional health and for reducing public health expenditures for physical disability in later life.	[Lachman, Margie E.; Agrigoroaei, Stefan] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA	Brandeis University	Lachman, ME (corresponding author), Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA.	Lachman@brandeis.edu		Lachman, Margie/0000-0003-3027-8735	National Institute on Aging [PO1 AG20166, RO1 AG17920, RO1 AG032271]; NATIONAL INSTITUTE ON AGING [R01AG017920, P01AG020166, R01AG032271] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants (PO1 AG20166, RO1 AG17920, RO1 AG032271) from the National Institute on Aging (http://www.nia.nih.gov/). The first wave of the study was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 1995, PSYCHOL AGING, V10, P578, DOI 10.1037/0882-7974.10.4.578; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Anderson RT, 1998, J GERONTOL B-PSYCHOL, V53, pS17, DOI 10.1093/geronb/53B.1.S17; Andrew MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002232; Antonucci T.C., 2001, HDB PSYCHOL AGING, P427, DOI DOI 10.1016/B0-08-043076-7/01699-5; Antonucci T.C., 2009, HDB THEORIES AGING, V2nd ed., P247; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Berkman LE, 2009, ANNU REV PUBL HEALTH, V30, P27, DOI 10.1146/annurev.publhealth.031308.100310; Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Brim O. G., 2004, HLTH ARE WE NATL STU; Britton A, 2008, J AM GERIATR SOC, V56, P1098, DOI 10.1111/j.1532-5415.2008.01740.x; Busetto L, 2009, J AM GERIATR SOC, V57, P1015, DOI 10.1111/j.1532-5415.2009.02273.x; Centers for Disease Control and Prevention National Center for Health Statistics, HLTH DAT INT; Chen HL, 2008, J AM GERIATR SOC, V56, P689, DOI 10.1111/j.1532-5415.2007.01624.x; Chipperfield JG, 2004, J AGING HEALTH, V16, P116, DOI 10.1177/0898264303260447; Cohen J, 2003, APPL MULTIPLE REGRES, V3rd, DOI DOI 10.4324/9780203774441; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Cotter KA, 2010, PSYCHOL HEALTH, V25, P805, DOI 10.1080/08870440902883212; Ferrer E, 2010, CURR DIR PSYCHOL SCI, V19, P149, DOI 10.1177/0963721410370300; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; Fiatarone MA, 1996, RES Q EXERCISE SPORT, V67, pS70; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Freedman VA, 1998, AM J PUBLIC HEALTH, V88, P1457, DOI 10.2105/AJPH.88.10.1457; Fries JF, 2002, JAMA-J AM MED ASSOC, V288, P3164, DOI 10.1001/jama.288.24.3164; Gruenewald TL, 2009, J AM GERIATR SOC, V57, P1525, DOI 10.1111/j.1532-5415.2009.02389.x; GURALNIK JM, 1989, AM J PUBLIC HEALTH, V79, P703, DOI 10.2105/AJPH.79.6.703; Hanson GR, 2003, JAMA-J AM MED ASSOC, V289, P1031, DOI 10.1001/jama.289.8.1031; He XXZ, 2004, AM J PUBLIC HEALTH, V94, P1567, DOI 10.2105/AJPH.94.9.1567; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hubbard RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006174; Jette AM, 1999, AM J PUBLIC HEALTH, V89, P66, DOI 10.2105/AJPH.89.1.66; Jette AM, 1998, GERONTOLOGIST, V38, P412, DOI 10.1093/geront/38.4.412; Johnstone B, 2009, REHABIL PSYCHOL, V54, P422, DOI 10.1037/a0017758; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kim JY, 2007, SOC SCI MED, V65, P2489, DOI 10.1016/j.socscimed.2007.07.022; King AC, 2000, J GERONTOL A-BIOL, V55, pM74; Krause N, 2003, RES AGING, V25, P559, DOI 10.1177/0164027503256695; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Lachman ME, 1986, PSYCHOL AGING, V1, P34, DOI 10.1037/0882-7974.1.1.34; Lachman ME, 2008, PSYCHOL SCI, V19, P889, DOI 10.1111/j.1467-9280.2008.02173.x; Lachman ME, 2006, CURR DIR PSYCHOL SCI, V15, P282, DOI 10.1111/j.1467-8721.2006.00453.x; Lachman ME, 2004, ANNU REV PSYCHOL, V55, P305, DOI 10.1146/annurev.psych.55.090902.141521; Lachman ME, 1998, J PERS SOC PSYCHOL, V74, P763, DOI 10.1037/0022-3514.74.3.763; LACHMAN ME, 2004, HLTH ARE WE NATL STU; LACHMAN ME, HDB PSYCHOL IN PRESS; Levy BR, 2002, J GERONTOL B-PSYCHOL, V57, pP409, DOI 10.1093/geronb/57.5.P409; Manandhar MC, 1995, P NUTR SOC, V54, P677, DOI 10.1079/PNS19950067; MARMOT MG, 2004, STATUS SYNDROME SOCI, P319; Mavandadi S, 2007, J GERONTOL B-PSYCHOL, V62, pS361, DOI 10.1093/geronb/62.6.S361; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Miller RR, 2004, J AM GERIATR SOC, V52, P217, DOI 10.1046/j.0002-8614.2004.52057.x; MIROWSKY J, 1995, SOC PSYCHOL QUART, V58, P31, DOI 10.2307/2787141; MOR V, 1994, AM J PUBLIC HEALTH, V84, P1274, DOI 10.2105/AJPH.84.8.1274; Murabito JM, 2008, AM J PUBLIC HEALTH, V98, P1256, DOI 10.2105/AJPH.2007.128132; *NAT CTR HLTH STAT, 2008, HLTH US 2008 CHARTB; Newson RS, 2006, EXP AGING RES, V32, P341, DOI 10.1080/03610730600699134; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; POPE AM, 1991, DISABILITY AM NATL A; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; Rains SA, 2009, HUM COMMUN RES, V35, P309, DOI 10.1111/j.1468-2958.2009.01353.x; Rodin J, 1985, Annu Rev Gerontol Geriatr, V5, P3; RODIN J, 1986, SCIENCE, V233, P1271, DOI 10.1126/science.3749877; Rothman AJ, 2006, J COMMUN, V56, pS202, DOI 10.1111/j.1460-2466.2006.00290.x; Rowe JW, 1998, SUCCESSFUL AGING; Ruger JP, 2010, AM J PUBLIC HEALTH, V100, P41, DOI 10.2105/AJPH.2008.143651; Sapolsky R.M., 1998, WHY ZEBRAS DONT GET; Sarna L, 2008, QUAL LIFE RES, V17, P1217, DOI 10.1007/s11136-008-9404-8; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; SEEMAN TE, 1995, J GERONTOL A-BIOL, V50, pM177, DOI 10.1093/gerona/50A.4.M177; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; SINGER BH, 2001, NEW HORIZONS HLTH IN; Spencer SM, 2008, J AM GERIATR SOC, V56, P553, DOI 10.1111/j.1532-5415.2007.01595.x; StataCorp, 2009, STAT STAT SOFTW; Stewart AL, 1992, MEASURING FUNCTIONIN, P67; Sturman MT, 2005, ARCH NEUROL-CHICAGO, V62, P1750, DOI 10.1001/archneur.62.11.1750; Syddall HE, 2009, J NUTR HEALTH AGING, V13, P57, DOI 10.1007/s12603-009-0010-4; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Walen HR, 2000, J SOC PERS RELAT, V17, P5, DOI 10.1177/0265407500171001; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; White AM, 2009, AM J PUBLIC HEALTH, V99, P1872, DOI 10.2105/AJPH.2008.146894; Willcox BJ, 2006, JAMA-J AM MED ASSOC, V296, P2343, DOI 10.1001/jama.296.19.2343; Wrosch C, 2009, PSYCHOSOM MED, V71, P996, DOI 10.1097/PSY.0b013e3181ba6cd1; Yan TJ, 2009, GERONTOLOGIST, V49, P847, DOI 10.1093/geront/gnp113	86	100	103	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13297	10.1371/journal.pone.0013297	http://dx.doi.org/10.1371/journal.pone.0013297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	661SK	20949016	Green Published, gold, Green Submitted			2022-12-25	WOS:000282748100023
J	Mulissa, Z; Jerene, D; Lindtjorn, B				Mulissa, Zewdie; Jerene, Degu; Lindtjorn, Bernt			Patients Present Earlier and Survival Has Improved, but Pre-ART Attrition Is High in a Six-Year HIV Cohort Data from Ethiopia	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; FOLLOW-UP; SOUTH-AFRICA; MORTALITY; PROGRAM; CARE; COUNTRIES; CAMBODIA; OUTCOMES; SERVICE	Background: Previous studies showed higher early mortality rates among patients treated with antiretroviral drugs in settings with limited resources. One of the reasons was late presentation of patients to care. With improved access to HIV services, we expect improvements in disease stage at presentation. Our objective was to assess the effect of improved availability of HIV services on patient presentation to care and subsequent pre-ART and on-ART outcomes. Methodology and Principal Findings: At Arba Minch Hospital in Ethiopia, we reviewed baseline characteristics and outcomes of 2191 adult HIV patients. Nearly a half were in WHO stage III at presentation. About two-thirds of the patients (1428) started ART. Patients enrolled in the early phase (OR = 4.03, 95% CI 3.07-5.27), men (OR = 1.78, 95% CI 1.47-2.16), and those aged 45 years and above (OR = 2.04, 95% CI 1.48-2.82) were at higher risk of being in advanced clinical stage at presentation. The pretreatment mortality rate was 13.1 per 100 PYO, ranging from 1.4 in the rapid scale-up phase to 25.9 per 100 PYO in the early phase. A quarter of the patients were lost to follow-up before starting treatment. Being in less advanced stage (HR = 1.9, 95% CI = 1.6, 2.2), being in the recent cohort (HR = 2.0, 95% CI = 1.6, 2.6), and rural residence (HR = 1.8, 95% CI = 1.5, 2.2) were independent predictors of pre-ART loss to follow-up. Of those who started ART, 13.4% were lost to follow-up and 15.4% died. The survival improved during the study. Patients with advanced disease, men and older people had higher death rates. Conclusions and Significance: Patients started to present at earlier stages of their illness and death has decreased among adult HIV patients visiting Arba Minch Hospital. However, many patients were lost from pre-treatment follow-up. Early treatment start contributed to improved survival. Both pre-ART and on-ART patient retention mechanisms should be strengthened.	[Mulissa, Zewdie; Lindtjorn, Bernt] Arba Minch Hosp, Arba Minch, Ethiopia; [Jerene, Degu] WHO Country Off, Addis Ababa, Ethiopia; [Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway	University of Bergen	Mulissa, Z (corresponding author), Arba Minch Hosp, Arba Minch, Ethiopia.	degujerene@yahoo.com	Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984; Mulissa, Zewdie/0000-0002-3947-9579	Centre for International Health, University of Bergen, Norway; WHO Country Office in Ethiopia	Centre for International Health, University of Bergen, Norway; WHO Country Office in Ethiopia	This study was financially supported by the Centre for International Health, University of Bergen, Norway. The WHO Country Office in Ethiopia provided additional financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2009, INT J TUBERC LUNG D, V13, P927; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; BASSETT IV, AIDS S1, V24, pS37; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Dou Zhi-hui, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1091; *FDRE, 2008, REP PROGR IMPL UN DE; *FDRE, 2002, POL ANT DRUGS SUPPL; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jerene D, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-136; Jerene Degu, 2006, AIDS Res Ther, V3, P10, DOI 10.1186/1742-6405-3-10; Jerene Degu, 2005, MedGenMed, V7, P66, DOI 10.1186/1758-2652-7-3-66; Keruly JC, 2007, CLIN INFECT DIS, V45, P1369, DOI 10.1086/522759; Kiboneka A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b201; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; LUBEGA M, 2009, HLTH POLICY; *MOH, 2005, GUID US ANT DRUGS ET; *MOH HAPCO DACA, 2003, GUID US ANT DRUGS ET; Mugavero Michael J, 2008, Top HIV Med, V16, P156; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; SANTIAGO P, 2007, J WOMENS HEALTH, V16, P1052; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; WHO, 2009, UN ACC SCAL PRIOR HI	29	77	77	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13268	10.1371/journal.pone.0013268	http://dx.doi.org/10.1371/journal.pone.0013268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949010	Green Published, gold			2022-12-25	WOS:000282748100015
J	Roman, J; McCarthy, JJ				Roman, Joe; McCarthy, James J.			The Whale Pump: Marine Mammals Enhance Primary Productivity in a Coastal Basin	PLOS ONE			English	Article							STELLER SEA LIONS; ATLANTIC RIGHT WHALE; NORTH-ATLANTIC; EUMETOPIAS-JUBATUS; VERTICAL MIGRATION; SOUTHERN-OCEAN; BALEEN WHALES; GREY SEALS; FOOD; NITROGEN	It is well known that microbes, zooplankton, and fish are important sources of recycled nitrogen in coastal waters, yet marine mammals have largely been ignored or dismissed in this cycle. Using field measurements and population data, we find that marine mammals can enhance primary productivity in their feeding areas by concentrating nitrogen near the surface through the release of flocculent fecal plumes. Whales and seals may be responsible for replenishing 2.3x10(4) metric tons of N per year in the Gulf of Maine's euphotic zone, more than the input of all rivers combined. This upward "whale pump" played a much larger role before commercial harvest, when marine mammal recycling of nitrogen was likely more than three times atmospheric N input. Even with reduced populations, marine mammals provide an important ecosystem service by sustaining productivity in regions where they occur in high densities.	[Roman, Joe] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA; [McCarthy, James J.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Vermont; Harvard University	Roman, J (corresponding author), Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA.	jroman@uvm.edu			Stellwagen Bank National Marine Sanctuary, Office of Naval Research (ONR) [N00014-08-1-0630]; National Oceanographic Partnership Program (NOPP) [N00014-07-1-1029]; Museum of Comparative Zoology, Harvard University	Stellwagen Bank National Marine Sanctuary, Office of Naval Research (ONR)(Office of Naval Research); National Oceanographic Partnership Program (NOPP); Museum of Comparative Zoology, Harvard University	Funding was supported by Stellwagen Bank National Marine Sanctuary, Office of Naval Research (ONR) grant N00014-08-1-0630, National Oceanographic Partnership Program (NOPP) grant N00014-07-1-1029, and the Museum of Comparative Zoology, Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A., 1986, Reports of the International Whaling Commission Special Issue, P191; ANTIA NJ, 1974, J FISH RES BOARD CAN, V31, P1327, DOI 10.1139/f74-157; Barlow J, 2008, MAR ECOL PROG SER, V371, P285, DOI 10.3354/meps07695; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P123, DOI 10.3354/meps264123; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Boyd Ian L., 1999, P218; Carlini AR, 2005, POLAR BIOL, V28, P769, DOI 10.1007/s00300-005-0004-6; Clapham Phil, 2003, Journal of Cetacean Research and Management, V5, P13; Corkeron PJ, 2009, BIOL LETTERS, V5, P204, DOI 10.1098/rsbl.2008.0628; Cornick LA, 2006, ECOL MODEL, V199, P107, DOI 10.1016/j.ecolmodel.2006.07.003; Croll DA, 2001, COMP BIOCHEM PHYS A, V129, P797, DOI 10.1016/S1095-6433(01)00348-8; Croll DA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P202; Daunt F, 2006, CONSERV BIOL SER, P177, DOI 10.1017/CBO9780511541964.013; Friedlaender AS, 2009, MAR ECOL PROG SER, V395, P91, DOI 10.3354/meps08003; Gaskin DE., 1982, ECOLOGY WHALES DOLPH; Gilbert JR, 2005, MAR MAMMAL SCI, V21, P519, DOI 10.1111/j.1748-7692.2005.tb01246.x; HAMNER P, 1977, SCIENCE, V195, P886, DOI 10.1126/science.841313; Hansen BJL, 2006, J SEA RES, V56, P329, DOI 10.1016/j.seares.2006.06.004; Holdo RM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000210; Holt SJ, 2003, BIOSCIENCE, V53, P204; Huettmann F, 2001, ESTIMATES ABUNDANCE; HUNTLEY ME, 1991, SCIENCE, V253, P64, DOI 10.1126/science.1905841; HUTCHINS DA, 1995, LIMNOL OCEANOGR, V40, P989, DOI 10.4319/lo.1995.40.5.0989; KANWISHER JW, 1983, SCI AM, V248, P110, DOI 10.1038/scientificamerican0683-110; KATONA S, 1988, OCEANOGR MAR BIOL, V26, P553; Kenney Robert D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P155; Kjeld M, 2003, CAN J ZOOL, V81, P606, DOI [10.1139/z03-041, 10.1139/Z03-041]; KOOYMAN GL, 1981, ANNU REV PHYSIOL, V43, P343, DOI 10.1146/annurev.ph.43.030181.002015; Lavery TJ, 2010, P ROY SOC B-BIOL SCI, V277, P3527, DOI 10.1098/rspb.2010.0863; Lockyer C., 1981, FAO FISHERIES SERIES, V5, P379; LONGHURST AR, 1989, PROG OCEANOGR, V22, P47, DOI 10.1016/0079-6611(89)90010-4; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; MAYO CA, 1990, CAN J ZOOL, V68, P2214, DOI 10.1139/z90-308; McCarthy JJ, 1999, DEEP-SEA RES PT II, V46, P1623, DOI 10.1016/S0967-0645(99)00038-7; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MICHAUD J, 2005, THESIS DALHOUSIE U; Michaud Josee, 2007, Endangered Species Research, V3, P77, DOI 10.3354/esr003077; MILLAR JS, 1990, FUNCT ECOL, V4, P5, DOI 10.2307/2389646; MORENO P, THESIS HARVARD U; Morissette L, 2010, FISH FISH, V11, P388, DOI 10.1111/j.1467-2979.2010.00366.x; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Ortiz RM, 2001, J EXP BIOL, V204, P1831; PALKA D, 2000, NOAANMFSNEFSC0007; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pershing AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012444; Pfister B, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P116; Powers K.D., 1987, P359; Prospero JM, 1996, BIOGEOCHEMISTRY, V35, P27, DOI 10.1007/BF02179824; Rabalais NN, 2002, AMBIO, V31, P102, DOI 10.1579/0044-7447-31.2.102; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; RONALD K, 1984, CAN J ZOOL, V62, P1101, DOI 10.1139/z84-160; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; SMITH FA, NATURE GEOSCIENCE, V3, P374; SOWLES J, 2001, NITROGEN GULF MAINE; Sparling CE, 2007, BIOL LETTERS, V3, P94, DOI 10.1098/rsbl.2006.0566; Sparling CE, 2006, J COMP PHYSIOL B, V176, P505, DOI 10.1007/s00360-006-0072-0; Steinberg DK, 2002, DEEP-SEA RES PT I, V49, P1445, DOI 10.1016/S0967-0637(02)00037-7; Theobald MR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024384; Townsend DW, 1998, J MARINE SYST, V16, P283, DOI 10.1016/S0924-7963(97)00024-9; Trites AW, 2002, J ZOOL, V256, P547, DOI 10.1017/S0952836902000596; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; WARING GT, 2006, NMFSNE194; Weinrich M, 1998, J MAMMAL, V79, P163, DOI 10.2307/1382851; Willis J, 2007, EVOL ECOL RES, V9, P651; Winship AJ, 2002, MAR ECOL PROG SER, V229, P291, DOI 10.3354/meps229291	68	173	174	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13255	10.1371/journal.pone.0013255	http://dx.doi.org/10.1371/journal.pone.0013255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949007	gold, Green Published			2022-12-25	WOS:000282748100008
J	Ghosh, AS; Ray, D; Dutta, S; Raha, S				Ghosh, Anupama Sardar; Ray, Doel; Dutta, Suman; Raha, Sanghamitra			EhMAPK, the Mitogen-Activated Protein Kinase from Entamoeba histolytica Is Associated with Cell Survival	PLOS ONE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; SIGNAL-REGULATED KINASES; MAP KINASES; PHOSPHORYLATION; IDENTIFICATION; EUKARYOTE; KINOME; GENES	Mitogen Activated Protein Kinases (MAPKs) are a class of serine/threonine kinases that regulate a number of different cellular activities including cell proliferation, differentiation, survival and even death. The pathogen Entamoeba histolytica possess a single homologue of a typical MAPK gene (EhMAPK) whose identification was previously reported by us but its functional implications remained unexplored. EhMAPK, the only mitogen-activated protein kinase from the parasitic protist Entamoeba histolytica with Threonine-X-Tyrosine (TXY) phosphorylation motif was cloned, expressed in E. coli and functionally characterized under different stress conditions. The expression profile of EhMAPK at the protein and mRNA level remained similar among untreated, heat shocked and hydrogen peroxide-treated samples in all cases of dose and time. But a significant difference was obtained in the phosphorylation status of the protein in response to different stresses. Heat shock at 43 degrees C or 0.5 mM H2O2 treatment enhanced the phosphorylation status of EhMAPK and augmented the kinase activity of the protein whereas 2.0 mM H2O2 treatment induced dephosphorylation of EhMAPK and loss of kinase activity. 2.0 mM H2O2 treatment reduced parasite viability significantly but heat shock and 0.5 mM H2O2 treatment failed to adversely affect E. histolytica viability. Therefore, a distinct possibility that activation of EhMAPK is associated with stress survival in E. histolytica is seen. Our study also gives a glimpse of the regulatory mechanism of the protein under in vivo conditions. Since the parasite genome lacks any typical homologue of mammalian MEK, the dual specificity kinases which are the upstream activators of MAPK, indications of the existence of some alternate regulatory mechanisms of the EhMAPK activity is perceived. These may include the autophosphorylation activity of the protein itself in combination with some upstream phosphatases which are not yet identified.	[Ghosh, Anupama Sardar; Ray, Doel; Dutta, Suman; Raha, Sanghamitra] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics	Ghosh, AS (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India.	sanghamitra.raha@saha.ac.in		Ghosh, Anupama/0000-0002-4200-5091	Department of Atomic Energy, Government Of India	Department of Atomic Energy, Government Of India(Department of Atomic Energy (DAE))	This study was funded by the Department of Atomic Energy, Government Of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Anamika K, 2008, PROTEINS, V71, P995, DOI 10.1002/prot.21790; Andreeva AV, 2008, INT J PARASITOL, V38, P1279, DOI 10.1016/j.ijpara.2008.04.003; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Chen W, 1998, MOL CELL BIOL, V18, P5178, DOI 10.1128/MCB.18.9.5178; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dorin-Semblat D, 2007, MOL MICROBIOL, V65, P1170, DOI 10.1111/j.1365-2958.2007.05859.x; Ellis JG, 2003, J BIOL CHEM, V278, P1936, DOI 10.1074/jbc.M209274200; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; Ghosh AS, 2010, PARASITOL INT, V59, P166, DOI 10.1016/j.parint.2010.01.001; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Klevernic IV, 2006, BIOCHEM J, V394, P365, DOI 10.1042/BJ20051288; Klevernic IV, 2009, FEBS LETT, V583, P680, DOI 10.1016/j.febslet.2009.01.011; Lacey MR, 2007, J MOL EVOL, V64, P4, DOI 10.1007/s00239-005-0197-x; Lee JT, 2002, LEUKEMIA, V16, P486, DOI 10.1038/sj/leu/2402460; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mishima K, 2002, ORAL ONCOL, V38, P468, DOI 10.1016/S1368-8375(01)00104-X; Morales MA, 2007, INT J PARASITOL, V37, P1187, DOI 10.1016/j.ijpara.2007.03.006; Ng DCH, 2000, J BIOL CHEM, V275, P40856, DOI 10.1074/jbc.M004639200; Pimienta G, 2007, CELL CYCLE, V6, P2628, DOI 10.4161/cc.6.21.4930; Rangarajan R, 2005, EMBO REP, V6, P464, DOI 10.1038/sj.embor.7400404; Ray D, 2005, GENE, V346, P41, DOI 10.1016/j.gene.2004.10.026; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WILSON K, 1991, J BIOL CHEM, V266, P1665	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13291	10.1371/journal.pone.0013291	http://dx.doi.org/10.1371/journal.pone.0013291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949043	gold, Green Published, Green Submitted			2022-12-25	WOS:000282676700021
J	Keenan, TM; Nelson, AD; Grinager, JR; Thelen, JC; Svendsen, CN				Keenan, Thomas M.; Nelson, Aaron D.; Grinager, Jeffrey R.; Thelen, Jarett C.; Svendsen, Clive N.			Real Time Imaging of Human Progenitor Neurogenesis	PLOS ONE			English	Article							NEURAL STEM-CELLS; CORTICAL DEVELOPMENT; PRECURSOR CELLS; NEURONS ARISE; RADIAL GLIA; IN-VITRO; SPECIFICATION; NEOCORTEX; DIFFERENTIATION; EXPRESSION	Human neural progenitors are increasingly being employed in drug screens and emerging cell therapies targeted towards neurological disorders where neurogenesis is thought to play a key role including developmental disorders, Alzheimer's disease, and depression. Key to the success of these applications is understanding the mechanisms by which neurons arise. Our understanding of development can provide some guidance but since little is known about the specifics of human neural development and the requirement that cultures be expanded in vitro prior to use, it is unclear whether neural progenitors obey the same developmental mechanisms that exist in vivo. In previous studies we have shown that progenitors derived from fetal cortex can be cultured for many weeks in vitro as undifferentiated neurospheres and then induced to undergo neurogenesis by removing mitogens and exposing them to supportive substrates. Here we use live time lapse imaging and immunocytochemical analysis to show that neural progenitors use developmental mechanisms to generate neurons. Cells with morphologies and marker profiles consistent with radial glia and recently described outer radial glia divide asymmetrically and symmetrically to generate multipolar intermediate progenitors, a portion of which express ASCL1. These multipolar intermediate progenitors subsequently divide symmetrically to produce CTIP2(+) neurons. This 3-cell neurogenic scheme echoes observations in rodents in vivo and in human fetal slice cultures in vitro, providing evidence that hNPCs represent a renewable and robust in vitro assay system to explore mechanisms of human neurogenesis without the continual need for fresh primary human fetal tissue. Knowledge provided by this and future explorations of human neural progenitor neurogenesis will help maximize the safety and efficacy of new stem cell therapies by providing an understanding of how to generate physiologically-relevant cell types that maintain their identities when placed in diagnostic or transplantation environments.	[Keenan, Thomas M.; Nelson, Aaron D.; Grinager, Jeffrey R.; Thelen, Jarett C.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Svendsen, Clive N.] Cedars Sinai Regenerat Med Inst, Los Angeles, CA USA	University of Wisconsin System; University of Wisconsin Madison; Cedars Sinai Medical Center	Keenan, TM (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.	clive.svendsen@cshs.org			National Institutes of Health [NIH T32 AG027455, NIH R21 NS060047-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institutes of Health (NIH T32 AG027455, NIH R21 NS060047-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2007, EXP NEUROL, V204, P512, DOI 10.1016/j.expneurol.2006.12.025; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Behrstock S, 2004, ANN NY ACAD SCI, V1019, P5, DOI 10.1196/annals.1297.002; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; BLINKOV SAMUIL M., 1968; Buchet D, 2009, NEUROSCI LETT, V456, P112, DOI 10.1016/j.neulet.2008.09.086; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; HANSEN DV, 2010, NATURE; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Howard B, 2006, GLIA, V53, P57, DOI 10.1002/glia.20259; Klein SM, 2005, HUM GENE THER, V16, P509, DOI 10.1089/hum.2005.16.509; Kosztowski T, 2009, EXPERT REV ANTICANC, V9, P597, DOI 10.1586/ERA.09.22; Kowalczyk T, 2009, CEREB CORTEX; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Muller F, 2004, CELLS TISSUES ORGANS, V178, P93, DOI 10.1159/000081720; Nelson AD, 2006, MOL CELL NEUROSCI, V33, P29, DOI 10.1016/j.mcn.2006.06.003; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639; Ostenfeld T, 2004, STEM CELLS, V22, P798, DOI 10.1634/stemcells.22-5-798; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Ostenfeld T, 2002, J NEUROSCI RES, V69, P955, DOI 10.1002/jnr.10396; Perez-Alvarez MJ, 2008, J NEUROSCI RES, V86, P1871, DOI 10.1002/jnr.21623; Pluchino S, 2009, NEUROSCI LETT, V456, P101, DOI 10.1016/j.neulet.2008.03.097; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Regulier Etienne, 2004, V277, P199; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tai YT, 2004, CURR OPIN PHARMACOL, V4, P98, DOI 10.1016/j.coph.2003.09.006; Tewarie RSN, 2009, J SPINAL CORD MED, V32, P105, DOI 10.1080/10790268.2009.11760761; Trounson A, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-29; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102	47	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13187	10.1371/journal.pone.0013187	http://dx.doi.org/10.1371/journal.pone.0013187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949053	Green Submitted, Green Published, gold			2022-12-25	WOS:000282633700007
J	Guerrero-Bosagna, C; Settles, M; Lucker, B; Skinner, MK				Guerrero-Bosagna, Carlos; Settles, Matthew; Lucker, Ben; Skinner, Michael K.			Epigenetic Transgenerational Actions of Vinclozolin on Promoter Regions of the Sperm Epigenome	PLOS ONE			English	Article							CTCF-BINDING-SITES; ENDOCRINE DISRUPTOR VINCLOZOLIN; DNA METHYLATION PATTERNS; BISPHENOL-A; GENE-EXPRESSION; BROAD-COMPLEX; DISEASE; MOUSE; EXPOSURE; INHERITANCE	Previous observations have demonstrated that embryonic exposure to the endocrine disruptor vinclozolin during gonadal sex determination promotes transgenerational adult onset disease such as male infertility, kidney disease, prostate disease, immune abnormalities and tumor development. The current study investigates genome-wide promoter DNA methylation alterations in the sperm of F3 generation rats whose F0 generation mother was exposed to vinclozolin. A methylated DNA immunoprecipitation with methyl-cytosine antibody followed by a promoter tilling microarray (MeDIP-Chip) procedure was used to identify 52 different regions with statistically significant altered methylation in the sperm promoter epigenome. Mass spectrometry bisulfite analysis was used to map the CpG DNA methylation and 16 differential DNA methylation regions were confirmed, while the remainder could not be analyzed due to bisulfite technical limitations. Analysis of these validated regions identified a consensus DNA sequence (motif) that associated with 75% of the promoters. Interestingly, only 16.8% of a random set of 125 promoters contained this motif. One candidate promoter (Fam111a) was found to be due to a copy number variation (CNV) and not a methylation change, suggesting initial alterations in the germline epigenome may promote genetic abnormalities such as induced CNV in later generations. This study identifies differential DNA methylation sites in promoter regions three generations after the initial exposure and identifies common genome features present in these regions. In addition to primary epimutations, a potential indirect genetic abnormality was identified, and both are postulated to be involved in the epigenetic transgenerational inheritance observed. This study confirms that an environmental agent has the ability to induce epigenetic transgenerational changes in the sperm epigenome.	[Guerrero-Bosagna, Carlos; Settles, Matthew; Lucker, Ben; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Guerrero-Bosagna, C (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Settles, Matthew L/F-2031-2011; Guerrero-Bosagna, Carlos/W-7319-2019	Settles, Matthew L/0000-0002-3424-1086; Guerrero-Bosagna, Carlos/0000-0003-1935-5875	Department of Defense; National Institutes of Health, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by a Department of Defense and a National Institutes of Health, National Institute of Environmental Health Sciences grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bertram C, 2008, J PHYSIOL-LONDON, V586, P2217, DOI 10.1113/jphysiol.2007.147967; Burghardt B, 2001, PEPTIDES, V22, P1119, DOI 10.1016/S0196-9781(01)00433-8; Chen ZX, 2005, BIOCHEM CELL BIOL, V83, P438, DOI 10.1139/O05-138; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Cheng RYS, 2004, MOL CARCINOGEN, V40, P1, DOI 10.1002/mc.20022; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; Cooney CA, 2002, J NUTR, V132, p2393S; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Edwards TM, 2007, ENVIRON HEALTH PERSP, V115, P1264, DOI 10.1289/ehp.9951; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Elzeinova F, 2008, REPROD TOXICOL, V26, P231, DOI 10.1016/j.reprotox.2008.09.007; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Fantozzi I, 2006, AM J PHYSIOL-LUNG C, V291, pL993, DOI 10.1152/ajplung.00191.2005; Feltus FA, 2006, GENOMICS, V87, P572, DOI 10.1016/j.ygeno.2005.12.016; FRANKLIN TB, 2009, NEUROBIOL DIS; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gebelein B, 1996, CANCER LETT, V105, P225, DOI 10.1016/0304-3835(96)04286-3; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Guerrero-Bosagna C, 2005, EVOL DEV, V7, P341, DOI 10.1111/j.1525-142X.2005.05033.x; Guerrero-Bosagna Carlos M., 2008, BMC Physiology, V8, P17, DOI 10.1186/1472-6793-8-17; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hakme A, 2008, DEV DYNAM, V237, P209, DOI 10.1002/dvdy.21399; Hilder TL, 2007, METHOD ENZYMOL, V428, P297, DOI 10.1016/S0076-6879(07)28017-6; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Inokuchi J, 2009, CARCINOGENESIS, V30, P1082, DOI 10.1093/carcin/bgp078; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kundu P, 2008, MOL CELL ENDOCRINOL, V292, P50, DOI 10.1016/j.mce.2008.06.003; Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441; Lamb HK, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe38; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lin CH, 2009, GENOMICS, V94, P241, DOI 10.1016/j.ygeno.2009.06.004; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; MATSUZAKI H, 2010, HUM MOL GENET; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Newbold RR, 2006, ENDOCRINOLOGY, V147, pS11, DOI 10.1210/en.2005-1164; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Novikova SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001919; Ottinger MA, 2008, BRAIN RES REV, V57, P376, DOI 10.1016/j.brainresrev.2007.08.011; Pan YL, 2007, CANCER LETT, V246, P129, DOI 10.1016/j.canlet.2006.02.010; POPP C, 2010, NATURE; Pothuluri JV, 2000, J AGR FOOD CHEM, V48, P6138, DOI 10.1021/jf0008543; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reza AMS, 2004, COMP BIOCHEM PHYS B, V139, P753, DOI 10.1016/j.cbpc.2004.09.009; Rodenhiser DI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2121; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Rompler M, 2005, J BIOL CHEM, V280, P31068, DOI 10.1074/jbc.M503586200; SALIAN S, 2009, LIFE SCI; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; SKINNER MK, 2010, TRENDS ENDOCRINOLOGY; Slattery MG, 2006, EUKARYOT CELL, V5, P313, DOI 10.1128/EC.5.2.313-320.2006; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; Tanimoto K, 2005, P NATL ACAD SCI USA, V102, P10250, DOI 10.1073/pnas.0409541102; Tomazou EM, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-19; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; WONG CI, 1995, J BIOL CHEM, V270, P19998, DOI 10.1074/jbc.270.34.19998; Xie HH, 2009, GENOMICS, V93, P434, DOI 10.1016/j.ygeno.2009.01.005; YAMASAKI H, 1992, ENVIRON HEALTH PERSP, V98, P39, DOI 10.2307/3431245; Yaoi T, 2008, BIOCHEM BIOPH RES CO, V376, P563, DOI 10.1016/j.bbrc.2008.09.028; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032	86	293	307	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13100	10.1371/journal.pone.0013100	http://dx.doi.org/10.1371/journal.pone.0013100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927350	Green Published, Green Submitted, gold			2022-12-25	WOS:000282312600026
J	Lonchamp, E; Dupont, JL; Wioland, L; Courjaret, R; Mbebi-Liegeois, C; Jover, E; Doussau, F; Popoff, MR; Bossu, JL; de Barry, J; Poulain, B				Lonchamp, Etienne; Dupont, Jean-Luc; Wioland, Laetitia; Courjaret, Raphael; Mbebi-Liegeois, Corinne; Jover, Emmanuel; Doussau, Frederic; Popoff, Michel R.; Bossu, Jean-Louis; de Barry, Jean; Poulain, Bernard			Clostridium perfringens Epsilon Toxin Targets Granule Cells in the Mouse Cerebellum and Stimulates Glutamate Release	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURONAL CELLS; MDCK CELLS; PERMEABILITY; MEMBRANES; BINDING; MICE; PORE; LOCALIZATION; PROTEINS	Epsilon toxin (ET) produced by C. perfringens types B and D is a highly potent pore-forming toxin. ET-intoxicated animals express severe neurological disorders that are thought to result from the formation of vasogenic brain edemas and indirect neuronal excitotoxicity. The cerebellum is a predilection site for ET damage. ET has been proposed to bind to glial cells such as astrocytes and oligodendrocytes. However, the possibility that ET binds and attacks the neurons remains an open question. Using specific anti-ET mouse polyclonal antibodies and mouse brain slices preincubated with ET, we found that several brain structures were labeled, the cerebellum being a prominent one. In cerebellar slices, we analyzed the costaining of ET with specific cell markers, and found that ET binds to the cell body of granule cells, oligodendrocytes, but not astrocytes or nerve endings. Identification of granule cells as neuronal ET targets was confirmed by the observation that ET induced intracellular Ca2+ rises and glutamate release in primary cultures of granule cells. In cultured cerebellar slices, whole cell patch-clamp recordings of synaptic currents in Purkinje cells revealed that ET greatly stimulates both spontaneous excitatory and inhibitory activities. However, pharmacological dissection of these effects indicated that they were only a result of an increased granule cell firing activity and did not involve a direct action of the toxin on glutamatergic nerve terminals or inhibitory interneurons. Patch-clamp recordings of granule cell somata showed that ET causes a decrease in neuronal membrane resistance associated with pore-opening and depolarization of the neuronal membrane, which subsequently lead to the firing of the neuronal network and stimulation of glutamate release. This work demonstrates that a subset of neurons can be directly targeted by ET, suggesting that part of ET-induced neuronal damage observed in neuronal tissue is due to a direct effect of ET on neurons.	[Lonchamp, Etienne; Dupont, Jean-Luc; Wioland, Laetitia; Courjaret, Raphael; Mbebi-Liegeois, Corinne; Jover, Emmanuel; Doussau, Frederic; Bossu, Jean-Louis; de Barry, Jean; Poulain, Bernard] CNRS, Inst Neurosci Cellulaires & Integrat, UPR3212, Strasbourg, France; [Popoff, Michel R.] Inst Pasteur, Unite Anaerobies & Leurs Toxines, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lonchamp, E (corresponding author), CNRS, Inst Neurosci Cellulaires & Integrat, UPR3212, Strasbourg, France.	poulain@inci-cnrs.unistra.fr	Blasi, Juan/K-7943-2014; Popoff, Michel/O-7719-2016	Blasi, Juan/0000-0002-0482-9444; Popoff, Michel/0000-0001-9305-8989; Doussau, Frederic/0000-0002-3769-1402	Mission pour la Recherche et l'Innovation Scientifique - Delegation Generale l'Armement (MRIS/DGA); Association Francaise contre les Myopathies (AFM); DGA [03 34 046]; Sanofi-Aventis France; Bayer Pharma; European Neuroscience Institutes Network, EU [LSHM-CT-2005-019063]	Mission pour la Recherche et l'Innovation Scientifique - Delegation Generale l'Armement (MRIS/DGA); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); DGA; Sanofi-Aventis France(Sanofi-Aventis); Bayer Pharma; European Neuroscience Institutes Network, EU	EL and LW are recipients of a doctoral grant from the Mission pour la Recherche et l'Innovation Scientifique - Delegation Generale l'Armement (MRIS/DGA). RC has been supported by a grant from Association Francaise contre les Myopathies (AFM). Part of the experimental work has been supported by grants from DGA (contract no. 03 34 046 to MRP and BP) and from Sanofi-Aventis France and Bayer Pharma as part of the BIOTOX multi-organism program, and the European Neuroscience Institutes Network project (ENINET, contract N<SUP>o</SUP> LSHM-CT-2005-019063 from the EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2005, INFECT IMMUN, V73, P4879, DOI 10.1128/IAI.73.8.4879-4887.2005; Barski JJ, 2003, J NEUROSCI, V23, P3469; BUXTON D, 1978, J MED MICROBIOL, V11, P299, DOI 10.1099/00222615-11-3-299; Castejon OJ, 2004, DEV BRAIN RES, V151, P25, DOI 10.1016/j.devbrainres.2004.03.019; Chapman J, 1999, ANAL CHIM ACTA, V402, P47, DOI 10.1016/S0003-2670(99)00533-4; Chassin C, 2007, AM J PHYSIOL-RENAL, V293, pF927, DOI 10.1152/ajprenal.00199.2007; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; de Barry J, 2006, J BIOL CHEM, V281, P18098, DOI 10.1074/jbc.M509842200; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Dorca-Arevalo J, 2008, VET MICROBIOL, V131, P14, DOI 10.1016/j.vetmic.2008.02.015; Dupont JL, 2006, CEREBELLUM, V5, P243, DOI 10.1080/14734220600905317; Fernandez-Miyakawa ME, 2007, INFECT IMMUN, V75, P4282, DOI 10.1128/IAI.00562-07; Finnie JW, 1999, J COMP PATHOL, V120, P415, DOI 10.1053/jcpa.1998.0289; Finnie JW, 2004, ANAEROBE, V10, P145, DOI 10.1016/j.anaerobe.2003.08.003; FINNIE JW, 1984, J COMP PATHOL, V94, P363, DOI 10.1016/0021-9975(84)90024-0; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; GILL DM, 1987, TOXINS ENZYMES, V8, P127; Goldstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007065; Greenfield RA, 2002, AM J MED SCI, V323, P326, DOI 10.1097/00000441-200206000-00005; HUBER G, 1984, J NEUROSCI, V4, P151; Imura T, 2003, J NEUROSCI, V23, P2824; KADOTA T, 1991, ARCH HISTOL CYTOL, V54, P519, DOI 10.1679/aohc.54.519; Knapp O, 2009, BBA-BIOMEMBRANES, V1788, P2584, DOI 10.1016/j.bbamem.2009.09.020; Lamanauskas N, 2008, EUR J NEUROSCI, V27, P2501, DOI 10.1111/j.1460-9568.2008.06211.x; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lonchamp E, 2009, EUR J NEUROSCI, V30, P2293, DOI 10.1111/j.1460-9568.2009.07023.x; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; MELTON JA, 2006, COMPREHENSIVE SOURCE, P623; Miyamoto O, 1998, INFECT IMMUN, V66, P2501, DOI 10.1128/IAI.66.6.2501-2508.1998; Miyamoto O, 2000, FEMS MICROBIOL LETT, V189, P109, DOI 10.1111/j.1574-6968.2000.tb09215.x; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; Munro P, 2001, BIOCHEM BIOPH RES CO, V289, P623, DOI 10.1006/bbrc.2001.6031; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; NAGAHAMA M, 1992, INFECT IMMUN, V60, P1237, DOI 10.1128/IAI.60.3.1237-1240.1992; NAGAHAMA M, 1993, TOXICON, V31, P427, DOI 10.1016/0041-0101(93)90178-L; Ottico E, 2003, J LIPID RES, V44, P2142, DOI 10.1194/jlr.M300247-JLR200; Palay S. L., 1974, CEREBELLAR CORTEX CY; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2003, CELL MICROBIOL, V5, P155, DOI 10.1046/j.1462-5822.2003.00262.x; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; POPOFF MR, 1987, INFECT IMMUN, V55, P35, DOI 10.1128/IAI.55.1.35-43.1987; Ribaut-Barassin C, 2003, NEUROSCIENCE, V120, P405, DOI 10.1016/S0306-4522(03)00332-4; Sakurai J., 1995, Reviews in Medical Microbiology, V6, P175; Shimamoto S, 2005, MICROBIOL IMMUNOL, V49, P245, DOI 10.1111/j.1348-0421.2005.tb03726.x; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Soler-Jover A, 2007, TOXICON, V50, P530, DOI 10.1016/j.toxicon.2007.04.025; THOMPSON CL, 1994, J NEUROCHEM, V62, P2037; TRAPP BD, 1988, J NEUROCHEM, V51, P859, DOI 10.1111/j.1471-4159.1988.tb01822.x; Uzal FA, 2004, J VET DIAGN INVEST, V16, P403, DOI 10.1177/104063870401600506; Uzal FA, 2004, ANAEROBE, V10, P135, DOI 10.1016/j.anaerobe.2003.08.005; WEISER M, 1995, J NEUROSCI, V15, P4298; Zhu C, 2001, EXP NEUROL, V169, P72, DOI 10.1006/exnr.2001.7652	56	51	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13046	10.1371/journal.pone.0013046	http://dx.doi.org/10.1371/journal.pone.0013046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941361	Green Published, gold			2022-12-25	WOS:000282312600013
J	Mena, AL; Lam, EWF; Chatterjee, S				Mena, Ana Lucia; Lam, Eric W. -F.; Chatterjee, Sukalyan			Sustained Spindle-Assembly Checkpoint Response Requires De Novo Transcription and Translation of Cyclin B1	PLOS ONE			English	Article							MITOTIC CHECKPOINT; HELA-CELLS; MITOSIS; DESTRUCTION; INHIBITION; ANAPHASE; SLIPPAGE; BUBR1; PROGRESSION; ATTACHMENT	Background: Microtubule-targeting drugs induce mitotic delay at pro-metaphase by preventing the spindle assembly checkpoint to be satisfied. However, especially after prolonged treatments, cells can escape this arrest in a process called mitotic slippage. The mechanisms underlying the spindle assembly checkpoint and slippage are not fully understood. It has been generally accepted that during mitosis there is a temporary shutdown of high-energy-consuming processes, such as transcription and translation. However, the synthesis of specific proteins is maintained or up-regulated since protein synthesis is necessary for entry into and progression through mitosis. Methodology/Principal Findings: In this work we investigated whether the mitotic arrest caused by the mitotic checkpoint is independent of transcription and translation. By using immunofluorescent microscopy and western blotting, we demonstrate that inhibition of either of these processes induces a shortening of the mitotic arrest caused by the nocodazole treatment, and ultimately leads to mitotic slippage. Our western blotting and RTQ-PCR results show that inhibition of transcription during mitotic arrest does not affect the expression of the spindle checkpoint proteins, whereas it induces a significant decrease in the mRNA and protein levels of Cyclin B1. The exogenous expression of Cyclin B1 substantially rescued the mitotic phenotype in nocodazole cells treated with the inhibitors of transcription and translation. Conclusions/Significance: This work emphasizes the importance of transcription and translation for the maintenance of the spindle assembly checkpoint, suggesting the existence of a mechanism dependent on cyclin B1 gene regulation during mitosis. We propose that continuous transcription of mitotic regulators is required to sustain the activation of the spindle assembly checkpoint.	[Mena, Ana Lucia; Chatterjee, Sukalyan] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Lam, Eric W. -F.] Univ London Imperial Coll Sci Technol & Med, Dept Canc & Surg, London, England	Instituto Gulbenkian de Ciencia; Imperial College London	Mena, AL (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	sukalyan@yahoo.com	Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576; Mena, Ana Lucia/0000-0003-2111-4077	Fundacao para a Ciencia e a Tecnologia (FCT) [POCTI/BCI/42249/01, CBO/47565/02, SFRH/BD/9607/2002]; Fundacao Calouste Gulbenkian; POCI; FSE	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission); POCI(European Commission); FSE(European Social Fund (ESF))	This work was funded by grants (POCTI/BCI/42249/01 and CBO/47565/02) from Fundacao para a Ciencia e a Tecnologia (FCT). A.L. Mena, as a student of Instituto Gulbenkian de Ciencia's PhD Programme in Biomedicine (sponsored by FCT and Fundacao Calouste Gulbenkian) was supported by the FCT fellowship SFRH/BD/9607/2002, financed by POCI 2010 and FSE (http://alfa.fct.mctes.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Chen JG, 2003, CANCER RES, V63, P7891; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Elhajouji A, 1998, MUTAGENESIS, V13, P193; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; GROLLMAN AP, 1966, P NATL ACAD SCI USA, V56, P1867, DOI 10.1073/pnas.56.6.1867; JORDAN MA, 1992, J CELL SCI, V102, P401; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Le Breton M, 2005, BIOCHIMIE, V87, P805, DOI 10.1016/j.biochi.2005.04.014; LEE J, CELL CYCLE, P1792; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; STEVENS FE, 2007, ONCOGENE; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Zhou J, 2002, J CELL SCI, V115, P3547, DOI 10.1242/jcs.00029	29	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13037	10.1371/journal.pone.0013037	http://dx.doi.org/10.1371/journal.pone.0013037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927403	Green Published, Green Submitted, gold			2022-12-25	WOS:000282210700016
J	Hussain, KM; Leong, KLJ; Ng, MML; Chu, JJH				Hussain, Khairunnisa' Mohamed; Leong, Kim Lian Janet; Ng, Mary Mah-Lee; Chu, Justin Jang Hann			The Essential Role of Clathrin-mediated Endocytosis in theInfectious Entry of Human Enterovirus 71	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; ACTIN-FILAMENTS; VIRUS ENTRY; CYTOPLASMIC DOMAIN; POLIOVIRUS TYPE-1; ARP2/3 COMPLEX; H+-ATPASE; RECEPTOR; MEMBRANE; CELLS	Little is currently known about the infectious entry process of human enterovirus 71 (HEV71) into host cells, which may represent potential anti-viral targeting sites. In this study a targeted small-interfering RNA (siRNA) screening platform assay was established and validated to identify and profile key cellular genes involved in processes of endocytosis, cytoskeletal dynamics, and endosomal trafficking essential for HEV71 infection. Screen evaluation was conducted via the expression of well characterized dominant-negative mutants, bioimaging studies (double-labeled immunofluorescence assays, transmission electron microscopy analysis), secondary siRNA-based dosage dependence studies, and drug inhibition assays. The infectious entry of HEV71 into rhabdomyosarcoma cells was shown to be significantly inhibited by siRNAs targeting genes associated with clathrin-mediated endocytosis (CME) that include AP2A1, ARRB1, CLTC, CLTCL1, SYNJ1, ARPC5, PAK1, ROCK1, and WASF1. The functional role of CME was verified by the observation of strong co-localization between HEV71 particles and clathrin as well as dose-dependent inhibition of HEV71 infection upon siRNA knockdown of CME-associated genes. HEV71 entry by CME was further confirmed via inhibition by dominant-negative EPS15 mutants and treatment of CME drug inhibitors, with more than 80% inhibition observed at 20 mu M chlorpromazine. Furthermore, HEV71 infection was shown to be sensitive to the disruption of human genes in regulating early to late endosomal trafficking as well as endosomal acidic pH. The identification of clathrin-mediated endocytosis as the entry pathway for HEV71 infection of susceptible host cells contributes to a better understanding of HEV71 pathogenesis and enables future development of anti-viral strategies against HEV71 infection.	[Hussain, Khairunnisa' Mohamed; Leong, Kim Lian Janet; Ng, Mary Mah-Lee; Chu, Justin Jang Hann] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore	National University of Singapore	Chu, JJH (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol, 5 Sci Dr 2, Singapore 117597, Singapore.	miccjh@nus.edu.sg	Chu, Justin Jang Hann/ABA-8297-2021; Ng, Mei Li/Q-3704-2016	Chu, Justin Jang Hann/0000-0002-1673-6819; Ng, Mei Li/0000-0001-9917-4534	Ministry of Education Academic Research Fund [R182-000-165-133]; National Medical Research Council (Singapore) [NMRC/NIG/0012/2007]; Defense Science and Technology Agency [POD0713895]; National University of Singapore	Ministry of Education Academic Research Fund; National Medical Research Council (Singapore)(National Medical Research Council, Singapore); Defense Science and Technology Agency; National University of Singapore(National University of Singapore)	This work was supported by The Ministry of Education Academic Research Fund Grant R182-000-165-133), National Medical Research Council (Singapore) Grant (Project no. NMRC/NIG/0012/2007), Defense Science and Technology Agency Grant POD0713895, and an Infectious Diseases Program grant (National University of Singapore) (to J. H. C.).	Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Bergelson JM, 2008, TRENDS MICROBIOL, V16, P44, DOI 10.1016/j.tim.2007.12.004; Buss F, 2001, FEBS LETT, V508, P295, DOI 10.1016/S0014-5793(01)03065-4; CARRASCO L, 1994, FEBS LETT, V350, P151, DOI 10.1016/0014-5793(94)00780-2; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Durrbach A, 1996, J CELL SCI, V109, P457; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; FLANAGAN MD, 1980, J BIOL CHEM, V255, P835; Gagliardi S, 1999, CURR MED CHEM, V6, P1197; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3; Grimmer S, 2006, TRAFFIC, V7, P1243, DOI 10.1111/j.1600-0854.2006.00456.x; Harrison DN, 2008, J VIROL, V82, P1465, DOI 10.1128/JVI.01374-07; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Isaacson MK, 2008, CURR TOP MICROBIOL, V325, P85; Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; MADSHUS IH, 1984, J CELL BIOL, V98, P1194, DOI 10.1083/jcb.98.4.1194; MADSHUS IH, 1984, EMBO J, V3, P1945, DOI 10.1002/j.1460-2075.1984.tb02074.x; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; MAUPIN P, 1983, J CELL BIOL, V96, P51, DOI 10.1083/jcb.96.1.51; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Nolan MA, 2003, NEUROLOGY, V60, P1651, DOI 10.1212/01.WNL.0000066810.62490.FF; Opdam FJM, 2000, J CELL SCI, V113, P2725; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; PEREZ L, 1993, J VIROL, V67, P4543; Pietiainen V, 2004, MOL BIOL CELL, V15, P4911, DOI 10.1091/mbc.E04-01-0070; Qualmann B, 2002, INT REV CYTOL, V220, P93; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SETIADI H, 1995, J BIOL CHEM, V270, P26818, DOI 10.1074/jbc.270.45.26818; Setiadi H, 2003, J CELL BIOL, V163, P1385, DOI 10.1083/jcb.200307178; Setiadi H, 1998, J CELL BIOL, V142, P859, DOI 10.1083/jcb.142.3.859; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Tung WH, 2007, CELL SIGNAL, V19, P2127, DOI 10.1016/j.cellsig.2007.06.009; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-141; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Young A, 2007, SEMIN CELL DEV BIOL, V18, P448, DOI 10.1016/j.semcdb.2007.07.006; ZEICHHARDT H, 1985, J GEN VIROL, V66, P483, DOI 10.1099/0022-1317-66-3-483; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	66	95	104	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					309	321		10.1074/jbc.M110.168468	http://dx.doi.org/10.1074/jbc.M110.168468			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20956521	Green Published, hybrid			2022-12-25	WOS:000285782800034
J	Fernandez, CA; Roy, R; Lee, S; Yang, JA; Panigrahy, D; Van Vliet, KJ; Moses, MA				Fernandez, Cecilia A.; Roy, Roopali; Lee, Sunyoung; Yang, Jiang; Panigrahy, Dipak; Van Vliet, Krystyn J.; Moses, Marsha A.			The Anti-angiogenic Peptide, Loop 6, Binds Insulin-like Growth Factor-1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; CELL-SURFACE BINDING; TISSUE INHIBITOR; CROSS-TALK; IGF-I; 1-MATRIX METALLOPROTEINASE; CATALYTIC DOMAIN; TUMOR INVASION; CANCER GROWTH; TIMP-2	Tissue inhibitors of metalloproteinases (TIMPs), the endogenous inhibitors of matrix metalloproteinases, have been shown to possess biological functions that are independent of their ability to inhibit matrix metalloproteinases. We have previously shown that the C-terminal domain of TIMP-2 and, in particular, Loop 6 inhibit capillary endothelial cell proliferation and angiogenesis both in vitro and in vivo. To elucidate the mechanism by which Loop 6 inhibits angiogenesis, we sought to determine whether its biological effects were the result of a known TIMP-2 protein-protein interaction or of a receptor-mediated event. In this study, we identify insulin-like growth factor-1 receptor as a binding partner of Loop 6/TIMP-2 and characterize this interaction on the endothelial cell surface and the consequences of this interaction on downstream receptor signaling.	[Moses, Marsha A.] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Fernandez, Cecilia A.; Roy, Roopali; Yang, Jiang; Panigrahy, Dipak; Moses, Marsha A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Lee, Sunyoung; Van Vliet, Krystyn J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Van Vliet, Krystyn J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Moses, MA (corresponding author), Childrens Hosp, Vasc Biol Program, Karp Family Res Bldg,300 Longwood Ave, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu			National Institutes of Health [1 RO1 CA118764-01, P01 CA045548]; S. Elizabeth O'Brien Trust Charitable Foundation; Nancy and Neal Foster Research Fund; Arnold and Mabel Beckman Young award; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA118764, P01CA045548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); S. Elizabeth O'Brien Trust Charitable Foundation; Nancy and Neal Foster Research Fund; Arnold and Mabel Beckman Young award; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1 RO1 CA118764-01 and P01 CA045548 (to M. A. M.). The S. Elizabeth O'Brien Trust Charitable Foundation, the Nancy and Neal Foster Research Fund (to M. A. M.), an Arnold and Mabel Beckman Young award (to K.J.V.), and a National Science Foundation career award (to K.J.V.).	Beattie J, 2010, J CELL PHYSIOL, V224, P605, DOI 10.1002/jcp.22183; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bjorndahl M, 2005, P NATL ACAD SCI USA, V102, P15593, DOI 10.1073/pnas.0507865102; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; Corcoran ML, 1996, ADV EXP MED BIOL, V389, P295; Danielpour D, 2006, CYTOKINE GROWTH F R, V17, P59, DOI 10.1016/j.cytogfr.2005.09.007; EMMERTBUCK MR, 1995, FEBS LETT, V364, P28, DOI 10.1016/0014-5793(95)00345-A; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Fernandez CA, 2006, BIOCHEM BIOPH RES CO, V345, P523, DOI 10.1016/j.bbrc.2006.04.083; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Goel HL, 2004, J CELL BIOL, V166, P407, DOI 10.1083/jcb.200403003; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; Hu YP, 2008, CANCER RES, V68, P8004, DOI 10.1158/0008-5472.CAN-08-0280; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Ko YC, 1997, BIOCHEM BIOPH RES CO, V236, P100, DOI 10.1006/bbrc.1997.6859; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; Lee S, 2007, P NATL ACAD SCI USA, V104, P9609, DOI 10.1073/pnas.0702668104; Li S, 2009, MOL ENDOCRINOL, V23, P2013, DOI 10.1210/me.2009-0197; Long L, 1998, CANCER RES, V58, P3243; Manara MC, 2007, CLIN CANCER RES, V13, P1322, DOI 10.1158/1078-0432.CCR-06-1518; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Moser C, 2008, EUR J CANCER, V44, P1577, DOI 10.1016/j.ejca.2008.04.003; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Stroh C, 2004, P NATL ACAD SCI USA, V101, P12503, DOI 10.1073/pnas.0403538101; Tai YT, 2003, CANCER RES, V63, P5850; Tuuttila A, 1998, J MOL BIOL, V284, P1133, DOI 10.1006/jmbi.1998.2223; Walton EB, 2008, BIOPHYS J, V94, P2621, DOI 10.1529/biophysj.107.114454; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yoon A, 2001, MOL CELL BIOCHEM, V223, P1, DOI 10.1023/A:1017549222677; Zhang D, 2003, HORM METAB RES, V35, P802; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	43	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41886	41895		10.1074/jbc.M110.166439	http://dx.doi.org/10.1074/jbc.M110.166439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20940305	hybrid, Green Published			2022-12-25	WOS:000285622600076
J	Simboeck, E; Sawicka, A; Zupkovitz, G; Senese, S; Winter, S; Dequiedt, F; Ogris, E; Di Croce, L; Chiocca, S; Seiser, C				Simboeck, Elisabeth; Sawicka, Anna; Zupkovitz, Gordin; Senese, Silvia; Winter, Stefan; Dequiedt, Franck; Ogris, Egon; Di Croce, Luciano; Chiocca, Susanna; Seiser, Christian			A Phosphorylation Switch Regulates the Transcriptional Activation of Cell Cycle Regulator p21 by Histone Deacetylase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Poetry							DEPENDENT KINASE INHIBITOR; WAF1/CIP1 GENE PROMOTER; H3 PHOSPHORYLATION; P21(WAF1/CIP1) EXPRESSION; CHROMATIN MODIFICATION; POTENTIAL MEDIATOR; CANCER-CELLS; MAP KINASE; ACETYLATION; PHOSPHATASE	Histone deacetylase inhibitors induce cell cycle arrest and apoptosis in tumor cells and are, therefore, promising anticancer drugs. The cyclin-dependent kinase inhibitor p21 is activated in histone deacetylase (HDAC) inhibitor-treated tumor cells, and its growth-inhibitory function contributes to the anti-tumorigenic effect of HDAC inhibitors. We show here that induction of p21 by trichostatin A involves MAP kinase signaling. Activation of the MAP kinase signaling pathway by growth factors or stress signals results in histone H3 serine 10 phosphorylation at the p21 promoter and is crucial for acetylation of the neighboring lysine 14 and recruitment of activated RNA polymerase II in response to trichostatin A treatment. In non-induced cells, the protein phosphatase PP2A is associated with the p21 gene and counteracts its activation. Induction of p21 is linked to simultaneous acetylation and phosphorylation of histone H3. The dual modification mark H3S10phK14ac at the activated p21 promoter is recognized by the phospho-binding protein 14-3-3 zeta, which protects the phosphoacetylation mark from being processed by PP2A. Taken together we have revealed a cross-talk of reversible phosphorylation and acetylation signals that controls the activation of p21 by HDAC inhibitors and identify the phosphatase PP2A as chromatin-associated transcriptional repressor in mammalian cells.	[Simboeck, Elisabeth; Sawicka, Anna; Zupkovitz, Gordin; Winter, Stefan; Ogris, Egon; Seiser, Christian] Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Med Biochem, A-1030 Vienna, Austria; [Simboeck, Elisabeth; Di Croce, Luciano] Ctr Regulacio Genom, Barcelona 08003, Spain; [Senese, Silvia; Chiocca, Susanna] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Dequiedt, Franck] FUSAGx, Cellular & Mol Biol Unit, B-5030 Gembloux, Belgium; [Dequiedt, Franck] Univ Liege, CHU Sart Tilman, Interdisciplinary Cluster Appl Genoprote GIGA R, B-4000 Liege, Belgium	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); IRCCS European Institute of Oncology (IEO); University of Liege; University of Liege	Seiser, C (corresponding author), Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Med Biochem, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	christian.seiser@univie.ac.at	Chiocca, Susanna/AAC-8863-2019; qiao, zhixin/I-3408-2012; Chiocca, Susanna/K-5233-2016; Di Croce, Luciano/E-7759-2015	Chiocca, Susanna/0000-0002-9721-0850; Di Croce, Luciano/0000-0003-3488-6228; Seiser, Christian/0000-0002-7046-9352; Zupkovitz, Gordin/0000-0001-8101-4524; Dequiedt, Franck/0000-0003-1234-7477; Ogris, Egon/0000-0001-5950-9264	Austrian Science Fund (FWF) [P18746, P22340]; Herzfelder Family Foundation; Italian Association for Cancer Research; Austrian Ministry of Science and Research; Austrian Science Fund (FWF) [P 22340] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Herzfelder Family Foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Austrian Ministry of Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF P18746 and P22340), the GEN-AU project "Epigenetic Plasticity of the Mammalian Genome" (Austrian Ministry of Science and Research), the Herzfelder Family Foundation (to C. S.), and by the Italian Association for Cancer Research (to S. C.).	Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Ballestar E, 2008, ADV GENET, V61, P247, DOI 10.1016/S0065-2660(07)00009-0; Brunmeir R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000927; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DOTTO GP, 2000, BIOCHIM BIOPHYS ACTA, V1471, P43; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Espino PS, 2006, CANCER RES, V66, P4610, DOI 10.1158/0008-5472.CAN-05-4251; Gartel AL, 2006, BIOMOL ENG, V23, P17, DOI 10.1016/j.bioeng.2006.01.002; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Gartel AL, 2000, ONCOGENE, V19, P961, DOI 10.1038/sj.onc.1203411; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hauser C, 2002, MOL CELL BIOL, V22, P7820, DOI 10.1128/MCB.22.22.7820-7830.2002; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karam CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000975; Kobayashi H, 2004, INT J CANCER, V109, P207, DOI 10.1002/ijc.11697; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; MAHADEVAN LC, 1991, NATURE, V349, P747, DOI 10.1038/349747c0; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; MICHIELI P, 1994, CANCER RES, V54, P3391; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; Mottet D, 2008, CLIN EXP METASTAS, V25, P183, DOI 10.1007/s10585-007-9131-5; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; Vaziri C, 1998, CELL GROWTH DIFFER, V9, P465; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Wang J, 2005, J BIOL CHEM, V280, P37725, DOI 10.1074/jbc.M507976200; Wharton W, 2000, J BIOL CHEM, V275, P33981, DOI 10.1074/jbc.M005600200; Winter S, 2008, CELL CYCLE, V7, P1336, DOI 10.4161/cc.7.10.5946; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	74	47	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41062	41073		10.1074/jbc.M110.184481	http://dx.doi.org/10.1074/jbc.M110.184481			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952396	hybrid, Green Published			2022-12-25	WOS:000285414400069
J	Dong, H; Fillingame, RH				Dong, Hui; Fillingame, Robert H.			Chemical Reactivities of Cysteine Substitutions in Subunit a of ATP Synthase Define Residues Gating H+ Transport from Each Side of the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS ACCESS PATHWAYS; ESCHERICHIA-COLI; PROTON TRANSLOCATION; C-RING; OXIDATIVE-PHOSPHORYLATION; MUTAGENIC ANALYSIS; ALPHA-SUBUNIT; CROSS-LINKING; ROTARY MOTOR; ROTOR RING	Subunit a plays a key role in coupling H+ transport to rotations of the subunit c-ring in F1Fo ATP synthase. In Escherichia coli, H+ binding and release occur at Asp-61 in the middle of the second transmembrane helix (TMH) of F-o subunit c. Based upon the Ag+ sensitivity of Cys substituted into subunit a, H+ are thought to reach Asp-61 via aqueous pathways mapping to surfaces of TMH 2-5. In this study we have extended characterization of the most Ag+-sensitive residues in subunit a with cysteine reactive methanethiosulfonate (MTS) reagents and Cd2+. The effect of these reagents on ATPase-coupled H+ transport was measured using inside-out membrane vesicles. Cd2+ inhibited the activity of all Ag+-sensitive Cys on the cytoplasmic side of the TMHs, and three of these substitutions were also sensitive to inhibition by MTS reagents. On the other hand, Cd2+ did not inhibit the activities of substitutions at residues 119 and 120 on the periplasmic side of TMH2, and residues 214 and 215 in TMH4 and 252 in TMH5 at the center of the membrane. When inside-out membrane vesicles from each of these substitutions were sonicated during Cd2+ treatment to expose the periplasmic surface, the ATPase-coupled H+ transport activity was strongly inhibited. The periplasmic access to N214C and Q252C, and their positioning in the protein at the a-c interface, is consistent with previous proposals that these residues may be involved in gating H+ access from the periplasmic half-channel to Asp-61 during the protonation step.	[Dong, Hui; Fillingame, Robert H.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu			National Institutes of Health [GM23105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by United States Public Health Service Grant GM23105 from the National Institutes of Health.	Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Barik S, 1996, Methods Mol Biol, V57, P203; CAIN BD, 1986, J BIOL CHEM, V261, P43; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; HARTZOG PE, 1994, J BIOL CHEM, V269, P32313; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; Hicks DB, 2010, BBA-BIOENERGETICS, V1797, P1362, DOI 10.1016/j.bbabio.2010.02.028; HOWITT SM, 1988, BIOCHIM BIOPHYS ACTA, V936, P74, DOI 10.1016/0005-2728(88)90253-8; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Krah A, 2010, J MOL BIOL, V395, P20, DOI 10.1016/j.jmb.2009.10.059; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; McMillan DGG, 2007, J BIOL CHEM, V282, P17395, DOI 10.1074/jbc.M611709200; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; Mulkidjanian AY, 2006, BBA-BIOENERGETICS, V1757, P415, DOI 10.1016/j.bbabio.2006.04.023; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; Wang ZX, 2004, J BIOL CHEM, V279, P26546, DOI 10.1074/jbc.M401206200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	43	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39811	39818		10.1074/jbc.M110.175844	http://dx.doi.org/10.1074/jbc.M110.175844			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20943664	hybrid, Green Published			2022-12-25	WOS:000285185500025
J	Tillotson, B; Slocum, K; Coco, J; Whitebread, N; Thomas, B; West, KA; MacDougall, J; Ge, J; Ali, JA; Palombella, VJ; Normant, E; Adams, J; Fritz, CC				Tillotson, Bonnie; Slocum, Kelly; Coco, John; Whitebread, Nigel; Thomas, Brian; West, Kip A.; MacDougall, John; Ge, Jie; Ali, Janid A.; Palombella, Vito J.; Normant, Emmanuel; Adams, Julian; Fritz, Christian C.			Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrest in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTROINTESTINAL STROMAL TUMOR; PHASE-I; HEAT-SHOCK-PROTEIN-90 INHIBITION; CHAPERONE MACHINERY; CANCER CHAPERONE; GELDANAMYCIN; IPI-504; ASSAY; HYDROQUINONE; KINASE	Several Hsp90 (heat shock protein 90) inhibitors are currently under clinical evaluation as anticancer agents. However, the correlation between the duration and magnitude of Hsp90 inhibition and the downstream effects on client protein degradation and cancer cell growth inhibition has not been thoroughly investigated. To investigate the relationship between Hsp90 inhibition and cellular effects, we developed a method that measures drug occupancy on Hsp90 after treatment with the Hsp90 inhibitor IPI-504 in living cells and in tumor xenografts. In cells, we find the level of Hsp90 occupancy to be directly correlated with cell growth inhibition. At the molecular level, the relationship between Hsp90 occupancy and Hsp90 client protein degradation was examined for different client proteins. For sensitive Hsp90 clients (e. g. HER2 (human epidermal growth factor receptor 2), client protein levels directly mirror Hsp90 occupancy at all time points after IPI-504 administration. For insensitive client proteins, we find that protein abundance matches Hsp90 occupancy only after prolonged incubation with drug. Additionally, we investigate the correlation between plasma pharmacokinetics (PK), tumor PK, pharmacodynamics (PD) (client protein degradation), tumor growth inhibition, and Hsp90 occupancy in a xenograft model of human cancer. Our results indicate Hsp90 occupancy to be a better predictor of PD than either plasma PK or tumor PK. In the nonsmall cell lung cancer xenograft model studied, a linear correlation between Hsp90 occupancy and tumor growth inhibition was found. This novel binding assay was evaluated both in vitro and in vivo and could be used as a pharmacodynamic readout in the clinic.	[Tillotson, Bonnie; Slocum, Kelly; Coco, John; Whitebread, Nigel; Thomas, Brian; West, Kip A.; MacDougall, John; Ge, Jie; Ali, Janid A.; Palombella, Vito J.; Normant, Emmanuel; Adams, Julian; Fritz, Christian C.] Infin Pharmaceut, Cambridge, MA 02139 USA		Tillotson, B (corresponding author), Infin Pharmaceut, 780 Mem Dr, Cambridge, MA 02139 USA.	bonnie.tillotson@infi.com						Abramson JS, 2009, BRIT J HAEMATOL, V144, P358, DOI 10.1111/j.1365-2141.2008.07484.x; Aherne Wynne, 2003, Methods Mol Med, V85, P149; Avila C, 2006, BIOORG MED CHEM LETT, V16, P3005, DOI 10.1016/j.bmcl.2006.02.063; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Carreras CW, 2003, ANAL BIOCHEM, V317, P40, DOI 10.1016/S0003-2697(03)00060-5; Chan CT, 2008, CANCER RES, V68, P216, DOI 10.1158/0008-5472.CAN-07-2268; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dewaele B, 2008, CLIN CANCER RES, V14, P5749, DOI 10.1158/1078-0432.CCR-08-0533; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Douglas M, 2009, MOL CANCER THER, V8, P3369, DOI 10.1158/1535-7163.MCT-09-0568; Galam L, 2007, BIOORGAN MED CHEM, V15, P1939, DOI 10.1016/j.bmc.2007.01.004; Ge J, 2006, J MED CHEM, V49, P4606, DOI 10.1021/jm0603116; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Howes R, 2006, ANAL BIOCHEM, V350, P202, DOI 10.1016/j.ab.2005.12.023; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; Maroney AC, 2006, BIOCHEMISTRY-US, V45, P5678, DOI 10.1021/bi0524969; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Park H, 2007, BIOORG MED CHEM LETT, V17, P6345, DOI 10.1016/j.bmcl.2007.08.069; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Ramanathan RK, 2005, CLIN CANCER RES, V11, P3385, DOI 10.1158/1078-0432.CCR-04-2322; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; SCHUMACHER RJ, 1994, J BIOL CHEM, V269, P9493; Smith-Jones PM, 2004, NAT BIOTECHNOL, V22, P701, DOI 10.1038/nbt968; Song D, 2008, MOL CANCER THER, V7, P3275, DOI 10.1158/1535-7163.MCT-08-0508; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; Sydor JR, 2006, P NATL ACAD SCI USA, V103, P17408, DOI 10.1073/pnas.0608372103; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu L, 2003, J PHARMACOKINET PHAR, V30, P185, DOI 10.1023/A:1025542026488; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200	42	38	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39835	39843		10.1074/jbc.M110.141580	http://dx.doi.org/10.1074/jbc.M110.141580			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940293	hybrid, Green Published			2022-12-25	WOS:000285185500028
J	Chakraborty, S; Li, M; Chatterjee, C; Sivaraman, J; Leung, KY; Mok, YK				Chakraborty, Smarajit; Li, Mo; Chatterjee, Chiradip; Sivaraman, J.; Leung, Ka Yin; Mok, Yu-Keung			Temperature and Mg2+ Sensing by a Novel PhoP-PhoQ Two-component System for Regulation of Virulence in Edwardsiella tarda	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; SENSOR DOMAIN; MOLECULAR CHARACTERIZATION; SECRETION SYSTEM; SIGNAL-DETECTION; GENE-EXPRESSION; SALMONELLA; IDENTIFICATION; PATHOGENESIS	The PhoP-PhoQ two-component system is commonly used by bacteria to sense environmental factors. Here we show that the PhoP-PhoQ system of Edwardsiella tarda detects changes in environmental temperature and Mg2+ concentration as well as regulates the type III and VI secretion systems through direct activation of esrB. Protein secretion is activated from 23 to 35 degrees C or at low Mg2+ concentrations, but it is suppressed at or below 20 degrees C, at or above 37 C, or at high Mg2+ concentrations. The effects of temperature and Mg2+ concentration are additive. The PhoQ sensor domain has a low T-m of 37.9 degrees C, and it detects temperatures through a conformational change of its secondary structure. Mutation of specific Pro or Thr residues increased the stability of the PhoQ sensor drastically, altering its temperature-sensing ability. The PhoQ sensor detects Mg2+ concentration through the direct binding of Mg2+ to a cluster of acidic residues (DDDSAD) and through changes that likely affect its tertiary structure. Here, we describe for the first time the use of PhoP-PhoQ as a temperature sensor for bacterial virulence control.	[Chakraborty, Smarajit; Li, Mo; Chatterjee, Chiradip; Sivaraman, J.; Mok, Yu-Keung] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore; [Leung, Ka Yin] Trinity Western Univ, Fac Nat & Appl Sci, Dept Biol, Langley, BC V2Y 1T1, Canada	National University of Singapore; Trinity Western University	Mok, YK (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore.	dbsmokh@nus.edu.sg	Mok, Yu Keung/H-8019-2012; Sivaraman, J/H-8028-2012	Mok, Yu Keung/0000-0002-2829-4878; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore [07/1/21/19/495]	Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore Grant 07/1/21/19/495 (to Y.-K.M.).	Aguirre A, 2006, J BACTERIOL, V188, P6889, DOI 10.1128/JB.00804-06; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chamnongpol S, 2002, MOL MICROBIOL, V44, P561, DOI 10.1046/j.1365-2958.2002.02917.x; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Cybulski LE, 2002, MOL MICROBIOL, V45, P1379, DOI 10.1046/j.1365-2958.2002.03103.x; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Hargreaves J. A., 2004, BIOL CULTURE CHANNEL, P42; Hunger K, 2004, FEMS MICROBIOL LETT, V230, P41, DOI 10.1016/S0378-1097(03)00852-8; JANDA JM, 1993, CLIN INFECT DIS, V17, P742, DOI 10.1093/clinids/17.4.742; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Lesley JA, 2001, J BIOL CHEM, V276, P30827, DOI 10.1074/jbc.M104262200; Li M, 2004, APPL ENVIRON MICROB, V70, P5274, DOI 10.1128/AEM.70.9.5274-5282.2004; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Minagawa S, 2003, J BACTERIOL, V185, P3696, DOI 10.1128/JB.185.13.3696-3702.2003; Mohanty BR, 2007, J BIOSCIENCES, V32, P1331, DOI 10.1007/s12038-007-0143-8; Mok YK, 1996, PROTEIN SCI, V5, P310; Mok YK, 2001, J MOL BIOL, V307, P913, DOI 10.1006/jmbi.2001.4521; Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070; NELSON DL, 1971, J BIOL CHEM, V246, P3042; Prajapati RS, 2007, PROTEINS, V66, P480, DOI 10.1002/prot.21215; Prost LR, 2008, MOL MICROBIOL, V69, P503, DOI 10.1111/j.1365-2958.2008.06303.x; Prost LR, 2008, CELL MICROBIOL, V10, P576, DOI 10.1111/j.1462-5822.2007.01111.x; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rao PSS, 2003, INFECT IMMUN, V71, P1343, DOI 10.1128/IAI.71.3.1343-1351.2003; RUIZSANZ J, 1995, BIOCHEMISTRY-US, V34, P1695, DOI 10.1021/bi00005a026; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; Vescovi EG, 1997, J BIOL CHEM, V272, P1440, DOI 10.1074/jbc.272.3.1440; Waldburger CD, 1996, J BIOL CHEM, V271, P26630, DOI 10.1074/jbc.271.43.26630; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Zheng J, 2005, INFECT IMMUN, V73, P4127, DOI 10.1128/IAI.73.7.4127-4137.2005; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	42	55	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38876	38888		10.1074/jbc.M110.179150	http://dx.doi.org/10.1074/jbc.M110.179150			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937832	Green Published, hybrid			2022-12-25	WOS:000284941300017
J	Moriyama, K; Sitkovsky, MV				Moriyama, Kengo; Sitkovsky, Michail V.			Adenosine A2A Receptor Is Involved in Cell Surface Expression of A2B Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE RECEPTOR; PROTEIN-COUPLED RECEPTORS; NEPHROGENIC DIABETES-INSIPIDUS; ENDOPLASMIC-RETICULUM; TRAFFICKING; MEMBRANE; EXPORT; UBIQUITINATION; DEGRADATION; MATURATION	The A2A and A2B adenosine receptors (A2AR and A2BR) are implicated in many physiological processes. However, the mechanisms of their intracellular maturation and trafficking are poorly understood. In comparative studies of A2AR versus A2BR expression in transfected cells, we noticed that the levels of cell surface expression of A2BR were significantly lower than those of A2AR. A large portion of the A2BR was degraded by the proteasome. Studies of cell surface expression of A2BR chimeric molecules in transfectants suggested that A2BR does not have the dominant forward transport signal for export from the endoplasmic reticulum to the cell surface. A2BR surface expression was increased in A2BR chimeras where the A2BR carboxyl terminus (CT) was replaced or fused with the A2AR CT. Co-transfection of A2AR with A2BR enhanced surface expression of A2BR though the F(X)(6)LL motif in the A2AR CT. The requirements of A2AR expression for better A2BR cell surface expression was not only established in transfectants but also confirmed by observations of much lower levels of A2BR-induced intracellular cAMP accumulation in response to A2BR-activating ligand in splenocytes from A2AR(-/-) mice than in wild type mice. The results of mechanistic studies suggested that poor A2BR expression at the cell surface might be accounted for mainly by the lack of a dominant forward transport signal from the endoplasmic reticulum to the plasma membrane; it is likely that A2BR forms a heterooligomer complex for better function.	[Sitkovsky, Michail V.] Northeastern Univ, Dept Pharmaceut Sci, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA; Northeastern Univ, Dept Biol, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA	Northeastern University; Northeastern University	Sitkovsky, MV (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, New England Inflammat & Tissue Protect Inst, 360 Huntington Ave,134 Mugar Sci Bldg, Boston, MA 02115 USA.	m.sitkovsky@neu.edu			National Institutes of Health [R01 CA111985, R01 CA112561]; NATIONAL CANCER INSTITUTE [R01CA112561, R01CA111985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA111985 and R01 CA112561 (to M. V. S.).	Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Apaja PM, 2006, MOL BIOL CELL, V17, P2243, DOI 10.1091/mbc.E05-09-0875; Apaja PM, 2005, ENDOCRINOLOGY, V146, P3224, DOI 10.1210/en.2005-0073; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Burgueno J, 2003, J BIOL CHEM, V278, P37545, DOI 10.1074/jbc.M302809200; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Fredholm BB, 2007, ACTA PHYSIOL, V190, P3, DOI 10.1111/j.1365-201X.2007.01689.x; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gelman MS, 2002, J CLIN INVEST, V110, P1591, DOI 10.1172/JCI200216786; Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HIPKIN RW, 1992, MOL ENDOCRINOL, V6, P2210, DOI 10.1210/me.6.12.2210; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Lee CM, 2009, ONCOGENE, V28, P1694, DOI 10.1038/onc.2009.12; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Milligan G, 2003, LIFE SCI, V74, P181, DOI 10.1016/j.lfs.2003.09.005; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; OMORCHOE CCC, 1984, J CELL BIOL, V98, P629, DOI 10.1083/jcb.98.2.629; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Sun CN, 2006, MOL PHARMACOL, V70, P454, DOI 10.1124/mol.105.021261; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Tan CM, 2003, J BIOL CHEM, V278, P35678, DOI 10.1074/jbc.M301888200; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Ulloa-Aguirre A, 2006, ACS CHEM BIOL, V1, P631, DOI 10.1021/cb600360h; Vannier B, 1996, BIOCHEMISTRY-US, V35, P1358, DOI 10.1021/bi952290f; VUHAILUUTHI MT, 1992, BIOCHEMISTRY-US, V31, P8377, DOI 10.1021/bi00150a035; WADA I, 1994, J BIOL CHEM, V269, P7464; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200; Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835	64	56	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39271	39288		10.1074/jbc.M109.098293	http://dx.doi.org/10.1074/jbc.M109.098293			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926384	hybrid, Green Published			2022-12-25	WOS:000284941300056
J	Zarrabi, T; Cervenka, R; Sandtner, W; Lukacs, P; Koenig, X; Hilber, K; Mille, M; Lipkind, GM; Fozzard, HA; Todt, H				Zarrabi, Touran; Cervenka, Rene; Sandtner, Walter; Lukacs, Peter; Koenig, Xaver; Hilber, Karlheinz; Mille, Markus; Lipkind, Gregory M.; Fozzard, Harry A.; Todt, Hannes			A Molecular Switch between the Outer and the Inner Vestibules of the Voltage-gated Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE-INACTIVATION; SHAKER K+ CHANNEL; ULTRA-SLOW INACTIVATION; CARDIAC SODIUM-CHANNELS; POTASSIUM CHANNELS; LOCAL-ANESTHETICS; SELECTIVITY FILTER; STRUCTURAL BASIS; CONFORMATIONAL-CHANGES; CELLULAR PLASTICITY	Voltage-gated ion channels are transmembrane proteins that undergo complex conformational changes during their gating transitions. Both functional and structural data from K+ channels suggest that extracellular and intracellular parts of the pore communicate with each other via a trajectory of interacting amino acids. No crystal structures are available for voltage-gated Na+ channels, but functional data suggest a similar intramolecular communication involving the inner and outer vestibules. However, the mechanism of such communication is unknown. Here, we report that amino acid Ile-1575 in the middle of transmembrane segment 6 of domain IV (DIV-S6) in the adult rat skeletal muscle isoform of the voltage-gated sodium channel (rNa(V)1.4) may act as molecular switch allowing for interaction between outer and inner vestibules. Cysteine scanning mutagenesis of the internal part of DIV-S6 revealed that only mutations at site 1575 rescued the channel from a unique kinetic state ("ultra-slow inactivation," I-US) produced by the mutation K1237E in the selectivity filter. A similar effect was seen with I1575A. Previously, we reported that conformational changes of both the internal and the external vestibule are involved in the generation of I-US. The fact that mutations at site 1575 modulate I-US produced by K1237E strongly suggests an interaction between these sites. Our data confirm a previously published molecular model in which Ile-1575 of DIV-S6 is in close proximity to Lys-1237 of the selectivity filter. Furthermore, these functional data define the position of the selectivity filter relative to the adjacent DIV-S6 segment within the ionic permeation pathway.	[Todt, Hannes] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Lipkind, Gregory M.; Fozzard, Harry A.] Univ Chicago, Dept Med, Cardiac Electrophysiol Labs, Chicago, IL 60637 USA	Medical University of Vienna; University of Chicago	Todt, H (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria.	hannes.todt@meduniwien.ac.at	Koenig, Xaver/Y-5588-2019	Koenig, Xaver/0000-0002-2423-4966; Hilber, Karlheinz/0000-0002-3033-0874	National Institutes of Health [1R01 HL096476-01]; Austrian Science Fund [P21006-B11, P17509-B11, P13961-B05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 HL096476-01. This work was also supported by Austrian Science Fund Grants P21006-B11, P17509-B11, and P13961-B05.	Balser JR, 1996, J PHYSIOL-LONDON, V494, P431, DOI 10.1113/jphysiol.1996.sp021503; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Bett GCL, 2004, J PHYSIOL-LONDON, V556, P109, DOI 10.1113/jphysiol.2003.055012; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Carr DB, 2003, NEURON, V39, P793, DOI 10.1016/S0896-6273(03)00531-2; Chancey JH, 2007, AM J PHYSIOL-CELL PH, V293, pC1895, DOI 10.1152/ajpcell.00377.2007; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Chen ZH, 2000, J PHYSIOL-LONDON, V524, P37, DOI 10.1111/j.1469-7793.2000.t01-1-00037.x; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Creighton T. E., 1993, PROTEINS STRUCTURES, P141; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Cuello LG, 2009, BIOPHYS J, V96, p381A, DOI 10.1016/j.bpj.2008.12.2852; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Fukuda K, 2005, J PHYSIOL-LONDON, V564, P21, DOI 10.1113/jphysiol.2004.081646; Hilber K, 2005, BIOCHEMISTRY-US, V44, P13874, DOI 10.1021/bi0511944; Hilber K, 2002, J BIOL CHEM, V277, P37105, DOI 10.1074/jbc.M205661200; Hilber K, 2001, J BIOL CHEM, V276, P27831, DOI 10.1074/jbc.M101933200; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huang CJ, 2000, J GEN PHYSIOL, V115, P435, DOI 10.1085/jgp.115.4.435; Huang CJ, 2001, BIOPHYS J, V80, P1262, DOI 10.1016/S0006-3495(01)76102-4; Jiang XJ, 2003, J PHYSIOL-LONDON, V549, P683, DOI 10.1113/jphysiol.2002.034660; Kambouris NG, 1998, J PHYSIOL-LONDON, V512, P693, DOI 10.1111/j.1469-7793.1998.693bd.x; Lee PJ, 2001, CIRC RES, V89, P1014, DOI 10.1161/hh2301.100002; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; Lipkind GM, 2008, J GEN PHYSIOL, V131, P523, DOI 10.1085/jgp.200809991; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Meyer R, 1997, EUR BIOPHYS J BIOPHY, V26, P433, DOI 10.1007/s002490050098; O'Leary ME, 2003, MOL PHARMACOL, V64, P1575, DOI 10.1124/mol.64.6.1575; O'Reilly JP, 2000, BIOPHYS J, V78, P773, DOI 10.1016/S0006-3495(00)76635-5; O'Reilly JP, 2001, BIOPHYS J, V81, P2100, DOI 10.1016/S0006-3495(01)75858-4; Ogielska EM, 1999, J GEN PHYSIOL, V113, P347, DOI 10.1085/jgp.113.2.347; Olcese R, 2001, J GEN PHYSIOL, V117, P149, DOI 10.1085/jgp.117.2.149; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; Panyi G, 2007, J GEN PHYSIOL, V129, P403, DOI 10.1085/jgp.200709758; Panyi G, 2006, J GEN PHYSIOL, V128, P547, DOI 10.1085/jgp.200609644; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Ramos E, 2004, J PHYSIOL-LONDON, V560, P37, DOI 10.1113/jphysiol.2004.065003; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Sandtner W, 2004, MOL PHARMACOL, V66, P648; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Struyk AF, 2002, J GEN PHYSIOL, V120, P509, DOI 10.1085/jgp.20028672; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Sunami A, 2001, MOL PHARMACOL, V59, P684, DOI 10.1124/mol.59.4.684; Szendroedi J, 2007, BIOPHYS J, V93, P4209, DOI 10.1529/biophysj.107.104794; Takahashi MP, 1999, BIOPHYS J, V76, P861, DOI 10.1016/S0006-3495(99)77249-8; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; TOMASELLI GF, 1995, BIOPHYS J, V68, P1814, DOI 10.1016/S0006-3495(95)80358-9; Townsend C, 1997, J GEN PHYSIOL, V110, P23, DOI 10.1085/jgp.110.1.23; Tsushima RG, 1997, J GEN PHYSIOL, V109, P463, DOI 10.1085/jgp.109.4.463; Tsushima RG, 1997, J GEN PHYSIOL, V110, P59, DOI 10.1085/jgp.110.1.59; Vedantham V, 2000, BIOPHYS J, V78, P2943, DOI 10.1016/S0006-3495(00)76834-2; Vilin YY, 2001, BIOPHYS J, V80, p21A; Wang GK, 1998, PFLUG ARCH EUR J PHY, V435, P293; Wang SY, 2005, BIOPHYS J, V88, P3991, DOI 10.1529/biophysj.105.059352; Wang SY, 1997, BIOPHYS J, V72, P1633, DOI 10.1016/S0006-3495(97)78809-X; Xiong W, 2003, J GEN PHYSIOL, V122, P323, DOI 10.1085/jgp.200308881; Xiong W, 2006, J PHYSIOL-LONDON, V576, P739, DOI 10.1113/jphysiol.2006.115105; Yamagishi T, 2009, MOL PHARMACOL, V76, P861, DOI 10.1124/mol.109.055863; Yang YC, 2009, J GEN PHYSIOL, V134, P95, DOI 10.1085/jgp.200810158; YELLEN G, 1994, BIOPHYS J, V66, pA23; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; YOOL AJ, 1995, BIOPHYS J, V68, P448, DOI 10.1016/S0006-3495(95)80206-7; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	75	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39458	39470		10.1074/jbc.M110.132886	http://dx.doi.org/10.1074/jbc.M110.132886			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926383	hybrid, Green Published			2022-12-25	WOS:000284941300072
J	Liu-Yesucevitz, L; Bilgutay, A; Zhang, YJ; Vanderwyde, T; Citro, A; Mehta, T; Zaarur, N; McKee, A; Bowser, R; Sherman, M; Petrucelli, L; Wolozin, B				Liu-Yesucevitz, Liqun; Bilgutay, Aylin; Zhang, Yong-Jie; Vanderwyde, Tara; Citro, Allison; Mehta, Tapan; Zaarur, Nava; McKee, Ann; Bowser, Robert; Sherman, Michael; Petrucelli, Leonard; Wolozin, Benjamin			Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; MOTOR-NEURON PROTEIN; RIBONUCLEOPROTEIN COMPLEXES; MESSENGER-RNA; P-BODIES; AGGREGATION; DISEASE; EXON-9	Tar DNA Binding Protein-43 (TDP-43) is a principle component of inclusions in many cases of frontotemporal lobar degeneration (FTLD-U) and amyotrophic lateral sclerosis (ALS). TDP-43 resides predominantly in the nucleus, but in affected areas of ALS and FTLD-U central nervous system, TDP-43 is aberrantly processed and forms cytoplasmic inclusions. The mechanisms governing TDP-43 inclusion formation are poorly understood. Increasing evidence indicates that TDP-43 regulates mRNA metabolism by interacting with mRNA binding proteins that are known to associate with RNA granules. Here we show that TDP-43 can be induced to form inclusions in cell culture and that most TDP-43 inclusions co-localize with SGs. SGs are cytoplasmic RNA granules that consist of mixed protein - RNA complexes. Under stressful conditions SGs are generated by the reversible aggregation of prion-like proteins, such as TIA-1, to regulate mRNA metabolism and protein translation. We also show that disease-linked mutations in TDP-43 increased TDP-43 inclusion formation in response to stressful stimuli. Biochemical studies demonstrated that the increased TDP-43 inclusion formation is associated with accumulation of TDP-43 detergent insoluble complexes. TDP-43 associates with SG by interacting with SG proteins, such as TIA-1, via direct protein-protein interactions, as well as RNA-dependent interactions. The signaling pathway that regulates SGs formation also modulates TDP-43 inclusion formation. We observed that inclusion formation mediated by WT or mutant TDP-43 can be suppressed by treatment with translational inhibitors that suppress or reverse SG formation. Finally, using Sudan black to quench endogenous autofluorescence, we also demonstrate that TDP-43 positive-inclusions in pathological CNS tissue co-localize with multiple protein markers of stress granules, including TIA-1 and eIF3. These data provide support for accumulating evidence that TDP-43 participates in the SG pathway.	[Liu-Yesucevitz, Liqun; Bilgutay, Aylin; Vanderwyde, Tara; Citro, Allison; Mehta, Tapan; Zaarur, Nava; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Zhang, Yong-Jie; Petrucelli, Leonard] Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA; [McKee, Ann; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Bowser, Robert] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Sherman, Michael] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Mayo Clinic; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Boston University	Liu-Yesucevitz, L (corresponding author), Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA.	bwolozin@bu.edu	Zhang, Yong-Jie/G-3378-2011	Bilgutay, Aylin/0000-0003-3737-8114; Sherman, Michael/0000-0003-3345-073X	NIEHS (National Institute of Environmental Health Sciences) [ES15567]; NINDS (National Institute of Neurological Disorders and Stroke) [NS41786, NS66108]; Alzheimer Association; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015567, R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073679, R01NS041786, R21NS066108] Funding Source: NIH RePORTER	NIEHS (National Institute of Environmental Health Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by NIEHS (National Institute of Environmental Health Sciences) ES15567, NINDS (National Institute of Neurological Disorders and Stroke) NS41786, NS66108, the Alzheimer Association and the Michael J. Fox Foundation (B.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Brandmeir NJ, 2008, ACTA NEUROPATHOL, V115, P123, DOI 10.1007/s00401-007-0315-5; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Chernov K. G., 2009, J BIOL CHEM; COLOMBRITA C, 2009, J NEUROCHEM; CUSTER SK, 1997, HUM MOL GENET, V19, P1741; Del Razo LM, 2001, TOXICOL APPL PHARM, V177, P132, DOI 10.1006/taap.2001.9291; Dormann D., 2009, J NEUROCHEM; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitcho MA, 2008, ANN NEUROL; Goggin K, 2008, BBA-MOL CELL RES, V1783, P479, DOI 10.1016/j.bbamcr.2007.10.008; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LI Y, 2010, P NATL ACAD SCI US; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Neumann M, 2007, ACTA NEUROPATHOL, V113, P543, DOI 10.1007/s00401-007-0221-x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Ule J, 2008, CURR OPIN NEUROBIOL, V18, P516, DOI 10.1016/j.conb.2008.09.018; VOLKENING K, 2009, BRAIN RES; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; WILS H, P NATL ACAD SCI US; WILS H, P NATL ACAD SCI US, V107; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Zerbinatti CV, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-5; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zuccato E, 2004, J BIOL CHEM, V279, P16980, DOI 10.1074/jbc.M313439200	48	425	431	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13250	10.1371/journal.pone.0013250	http://dx.doi.org/10.1371/journal.pone.0013250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948999	Green Published, gold, Green Accepted			2022-12-25	WOS:000282748100005
J	Powers, RW; Jeyabalan, A; Clifton, RG; Van Dorsten, P; Hauth, JC; Klebanoff, MA; Lindheimer, MD; Sibai, B; Landon, M; Miodovnik, M				Powers, Robert W.; Jeyabalan, Arun; Clifton, Rebecca G.; Van Dorsten, Peter; Hauth, John C.; Klebanoff, Mark A.; Lindheimer, Marshall D.; Sibai, Baha; Landon, Mark; Miodovnik, Menachem		Eunice Kennedy Shriver Natl Inst	Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies	PLOS ONE			English	Article							ANTIANGIOGENIC FACTORS; PREVENTION; WOMEN	Background: Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng) and the pro-angiogenic growth factor PlGF are reported to precede the onset of preeclampsia weeks to months in low-risk pregnant women. The objective of this study was to investigate whether similar changes can be detected in pregnant women at high-risk to develop the syndrome. Methods: This study is a secondary analysis of the NICHD MFMU trial of aspirin to prevent preeclampsia in high-risk pregnancies. Serum samples were available from 194 women with pre-existing diabetes, 313 with chronic hypertension, 234 with multifetal gestation, and 252 with a history of preeclampsia in a previous pregnancy. Samples collected across pregnancy were analyzed in a blinded fashion for sFlt1, sEng and PlGF. Results: The odds of developing preeclampsia were significantly increased among women with multiple fetuses for each 2-fold elevation in sFlt1, sEng and the ratio of angiogenic factors (e.g. OR 2.18, 95% CI 1.46-3.32), and significantly decreased for each 2-fold elevation in circulating PlGF (OR 0.50, 95% CI 0.30-0.82) between 7 and 26 weeks' gestation. Cross-sectional analysis of the angiogenic factors across gestation showed significant differences during the third trimester in women who develop preeclampsia compared with appropriate controls in all high-risk groups. However, when data were examined in relation to the gestational week when preeclampsia was diagnosed only sFlt1 was significantly higher 2 to 5 weeks before the clinical onset of preeclampsia and only in women with previous preeclampsia. Conclusions: The pattern of elevated concentrations of sFlt1 and sEng, and low PlGF in high-risk pregnant subjects who develop preeclampsia is similar to that reported in low-risk pregnant women. However, differences in these factors among high-risk women who do and do not develop preeclampsia are modest, and do not appear to be clinically useful predictors in these high-risk pregnant women.	[Powers, Robert W.; Jeyabalan, Arun] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Womens Hlth, Pittsburgh, PA 15260 USA; [Clifton, Rebecca G.] George Washington Univ, Ctr Biostat, Washington, DC USA; [Van Dorsten, Peter] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA; [Hauth, John C.] Univ Alabama Birmingham, Sch Med, Dept Obstet & Gynecol, Birmingham, AL USA; [Klebanoff, Mark A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Lindheimer, Marshall D.] Univ Chicago, Sch Med, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Sibai, Baha] Univ Tennessee, Dept Obstet & Gynecol, Sch Med, Memphis, TN 38103 USA; [Landon, Mark] Ohio State Univ, Sch Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Miodovnik, Menachem] Univ Cincinnati, Sch Med, Dept Obstet & Gynecol, Cincinnati, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; Medical University of South Carolina; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Chicago; University of Tennessee System; University of Tennessee Health Science Center; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati	Powers, RW (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Womens Hlth, Pittsburgh, PA 15260 USA.	powersrw@upmc.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD19897, HD36801, HD21410, HD21414, HD21434, HD27860, HD27861, HD27869, HD27883, HD27889, HD27905, HD27915, HD27917, NIH-2P01-HD30367]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD021410, UG1HD027915, U10HD027917, U10HD027869, P01HD030367, U10HD036801, U10HD027915, UG1HD027869] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD021434, U01HD021434, U01HD036801, U01HD021414, U10HD027861, U10HD027860, U10HD027883, U10HD027905, U10HD021414, U01HD019897, U01HD021410, U10HD027889] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD19897, HD36801, HD21410, HD21414, HD21434, HD27860, HD27861, HD27869, HD27883, HD27889, HD27905, HD27915, and HD27917) and NIH-2P01-HD30367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2006, AM J OBSTET GYNECOL, V194, P1034, DOI 10.1016/j.ajog.2005.10.192; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Levine RJ, 1996, CONTROL CLIN TRIALS, V17, P442, DOI 10.1016/S0197-2456(96)00106-7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.042; Powers RW, 2005, AM J OBSTET GYNECOL, V193, P185, DOI 10.1016/j.ajog.2004.11.038; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; ROBERTS JM, 2009, MATERNAL FETAL MED, P651; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Sibai BM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.071; Simas TAM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.030; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244	16	107	115	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13263	10.1371/journal.pone.0013263	http://dx.doi.org/10.1371/journal.pone.0013263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948996	Green Published, Green Accepted, gold			2022-12-25	WOS:000282748100012
J	Presman, DM; Alvarez, LD; Levi, V; Eduardo, S; Digman, MA; Marti, MA; Veleiro, AS; Burton, G; Pecci, A				Presman, Diego M.; Alvarez, Lautaro D.; Levi, Valeria; Eduardo, Silvina; Digman, Michelle A.; Marti, Marcelo A.; Veleiro, Adriana S.; Burton, Gerardo; Pecci, Adali			Insights on Glucocorticoid Receptor Activity Modulation through the Binding of Rigid Steroids	PLOS ONE			English	Article							RAY CRYSTAL-STRUCTURE; HUMAN BREAST-CANCER; NF-KAPPA-B; DNA-BINDING; LIVING CELLS; MOLECULAR-DYNAMICS; TRANSCRIPTION FACTORS; ANTAGONIST COMPLEXES; RESPONSE ELEMENT; IN-VIVO	Background: The glucocorticoid receptor (GR) is a transcription factor that regulates gene expression in a ligand-dependent fashion. This modular protein is one of the major pharmacological targets due to its involvement in both cause and treatment of many human diseases. Intense efforts have been made to get information about the molecular basis of GR activity. Methodology/Principal Findings: Here, the behavior of four GR-ligand complexes with different glucocorticoid and antiglucocorticoid properties were evaluated. The ability of GR-ligand complexes to oligomerize in vivo was analyzed by performing the novel Number and Brightness assay. Results showed that most of GR molecules form homodimers inside the nucleus upon ligand binding. Additionally, in vitro GR-DNA binding analyses suggest that ligand structure modulates GR-DNA interaction dynamics rather than the receptor's ability to bind DNA. On the other hand, by coimmunoprecipitation studies we evaluated the in vivo interaction between the transcriptional intermediary factor 2 (TIF2) coactivator and different GR-ligand complexes. No correlation was found between GR intranuclear distribution, cofactor recruitment and the homodimerization process. Finally, Molecular determinants that support the observed experimental GR LBD-ligand/TIF2 interaction were found by Molecular Dynamics simulation. Conclusions/Significance: The data presented here sustain the idea that in vivo GR homodimerization inside the nucleus can be achieved in a DNA-independent fashion, without ruling out a dependent pathway as well. Moreover, since at least one GR-ligand complex is able to induce homodimer formation while preventing TIF2 coactivator interaction, results suggest that these two events might be independent from each other. Finally, 21-hydroxy-6,19-epoxyprogesterone arises as a selective glucocorticoid with potential pharmacological interest. Taking into account that GR homodimerization and cofactor recruitment are considered essential steps in the receptor activation pathway, results presented here contribute to understand how specific ligands influence GR behavior.	[Presman, Diego M.; Levi, Valeria; Marti, Marcelo A.; Pecci, Adali] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Alvarez, Lautaro D.; Eduardo, Silvina; Veleiro, Adriana S.; Burton, Gerardo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, UMYMFOR CONICET, RA-1428 Buenos Aires, DF, Argentina; [Digman, Michelle A.] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA USA; [Digman, Michelle A.] Univ Calif Irvine, Ctr Dev Biol, Opt Biol Core Facil, Irvine, CA 92717 USA; [Marti, Marcelo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE CONICET, Buenos Aires, DF, Argentina; [Presman, Diego M.; Pecci, Adali] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IFIBYNE CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of California System; University of California Irvine; University of California System; University of California Irvine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Presman, DM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina.	apecci@qb.fcen.uba.ar	Presman, Diego Martín/Y-6750-2019; Burton, Gerardo/AGF-6611-2022	Presman, Diego Martín/0000-0003-4515-8058; Burton, Gerardo/0000-0002-8559-7306; Marti, Marcelo/0000-0002-7911-9340; , Michelle/0000-0003-4611-7100; Alvarez, Lautaro Damian/0000-0001-8841-2330; Levi, Valeria/0000-0002-1666-4675	Consejo Nacional de Investigaciones Cientifico y Tecnicas (CONICET); University of Buenos Aires (UBA); Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)	Consejo Nacional de Investigaciones Cientifico y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires (UBA)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)(ANPCyT)	This work was supported by Consejo Nacional de Investigaciones Cientifico y Tecnicas (CONICET), the University of Buenos Aires (UBA), and Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2003, MOL ENDOCRINOL, V17, P2583, DOI 10.1210/me.2002-0305; Alvarez LD, 2008, J MED CHEM, V51, P1352, DOI 10.1021/jm800007w; Alvarez LD, 2008, CHEMMEDCHEM, V3, P1869, DOI 10.1002/cmdc.200800256; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aumais JP, 1996, J BIOL CHEM, V271, P12568, DOI 10.1074/jbc.271.21.12568; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BHANDARE R, AM J RESP CELL MOL B, V42, P9; Biggadike K, 2008, J MED CHEM, V51, P3349, DOI 10.1021/jm800279t; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Burton G, 2006, U.S. Patent, Patent No. [7,071,328, 7071328]; CAIRNS W, 1991, J BIOL CHEM, V266, P11221; CHALEPAKIS G, 1990, DNA CELL BIOL, V9, P355, DOI 10.1089/dna.1990.9.355; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Costas MA, 2000, BBA-MOL CELL RES, V1499, P122, DOI 10.1016/S0167-4889(00)00113-0; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; DAHLMANWRIGHT K, 1990, J BIOL CHEM, V265, P14030; Dalal RB, 2008, MICROSC RES TECHNIQ, V71, P69, DOI 10.1002/jemt.20526; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; DROUIN J, 1992, MOL ENDOCRINOL, V6, P1299, DOI 10.1210/me.6.8.1299; ERIKSSON P, 1990, J BIOL CHEM, V265, P3535; Frego L, 2006, PROTEIN SCI, V15, P722, DOI 10.1110/ps.051781406; FRISCH MJ, 2004, GAUSSIAN 0O RC; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; GROYER A, 1987, NATURE, V328, P624, DOI 10.1038/328624a0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guido EC, 1996, MOL ENDOCRINOL, V10, P1178, DOI 10.1210/me.10.10.1178; Hager GL, 2006, CHROMOSOME RES, V14, P107, DOI 10.1007/s10577-006-1030-0; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HORWITZ KB, 1978, CANCER RES, V38, P2434; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iavarone C, 2003, J BIOL CHEM, V278, P50024, DOI 10.1074/jbc.M308617200; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; KIM B, 1992, SCIENCE, V255, P203, DOI 10.1126/science.1553548; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; LIPPMAN M, 1976, CANCER RES, V36, P4610; Liu WH, 1996, MOL ENDOCRINOL, V10, P1399, DOI 10.1210/me.10.11.1399; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Madauss KP, 2008, BIOORG MED CHEM LETT, V18, P6097, DOI 10.1016/j.bmcl.2008.10.021; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; McMaster A, 2007, EXP PHYSIOL, V92, P299, DOI 10.1113/expphysiol.2006.036194; Mikuni S, 2007, FEBS LETT, V581, P389, DOI 10.1016/j.febslet.2006.12.038; Molinero LL, 2004, J IMMUNOL, V173, P5583, DOI 10.4049/jimmunol.173.9.5583; Nagaich AK, 2004, ANN NY ACAD SCI, V1024, P213, DOI 10.1196/annals.1321.002; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Nojek IM, 2004, MEDICINA-BUENOS AIRE, V64, P135; Ogawa H, 2004, BIOCHEM BIOPH RES CO, V320, P218, DOI 10.1016/j.bbrc.2004.05.161; Pandit S, 2002, J BIOL CHEM, V277, P1538, DOI 10.1074/jbc.M105438200; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; ROBERSON S, 2009, J BIOL CHEM; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Schaaf MJM, 2005, MOL ENDOCRINOL, V19, P1501, DOI 10.1210/me.2005-0050; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; Schulz M, 2002, J BIOL CHEM, V277, P26238, DOI 10.1074/jbc.M203268200; SegardMaurel I, 1996, BIOCHEMISTRY-US, V35, P1634, DOI 10.1021/bi951369h; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Suino-Powell K, 2008, MOL CELL BIOL, V28, P1915, DOI 10.1128/MCB.01541-07; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; van der Laan S, 2008, EUR J PHARMACOL, V585, P483, DOI 10.1016/j.ejphar.2008.01.060; VANSTEENSEL B, 1995, J CELL SCI, V108, P3003; Veleiro AS, 2010, CHEMMEDCHEM, V5, P649, DOI 10.1002/cmdc.201000014; Veleiro AS, 2005, J MED CHEM, V48, P5675, DOI 10.1021/jm049266x; VELEIRO AS, 1995, STEROIDS, V60, P268, DOI 10.1016/0039-128X(94)00052-E; Vicent GP, 1997, MOL PHARMACOL, V52, P749, DOI 10.1124/mol.52.4.749; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; WILLMANN T, 1986, NATURE, V324, P688, DOI 10.1038/324688a0; WRANGE O, 1989, J BIOL CHEM, V264, P5253	90	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13279	10.1371/journal.pone.0013279	http://dx.doi.org/10.1371/journal.pone.0013279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949009	gold, Green Published			2022-12-25	WOS:000282748100017
J	Gunaratne, GH; Gunaratne, PH; Seemann, L; Torok, A				Gunaratne, Gemunu H.; Gunaratne, Preethi H.; Seemann, Lars; Toeroek, Andrei			Using Effective Subnetworks to Predict Selected Properties of Gene Networks	PLOS ONE			English	Article							CLUSTER-ANALYSIS; EXPRESSION; TRANSFECTION; MODELS; MOTIFS	Background: Difficulties associated with implementing gene therapy are caused by the complexity of the underlying regulatory networks. The forms of interactions between the hundreds of genes, proteins, and metabolites in these networks are not known very accurately. An alternative approach is to limit consideration to genes on the network. Steady state measurements of these influence networks can be obtained from DNA microarray experiments. However, since they contain a large number of nodes, the computation of influence networks requires a prohibitively large set of microarray experiments. Furthermore, error estimates of the network make verifiable predictions impossible. Methodology/Principal Findings: Here, we propose an alternative approach. Rather than attempting to derive an accurate model of the network, we ask what questions can be addressed using lower dimensional, highly simplified models. More importantly, is it possible to use such robust features in applications? We first identify a small group of genes that can be used to affect changes in other nodes of the network. The reduced effective empirical subnetwork (EES) can be computed using steady state measurements on a small number of genetically perturbed systems. We show that the EES can be used to make predictions on expression profiles of other mutants, and to compute how to implement pre-specified changes in the steady state of the underlying biological process. These assertions are verified in a synthetic influence network. We also use previously published experimental data to compute the EES associated with an oxygen deprivation network of E. coli, and use it to predict gene expression levels on a double mutant. The predictions are significantly different from the experimental results for less than 30% of genes. Conclusions/Significance: The constraints imposed by gene expression levels of mutants can be used to address a selected set of questions about a gene network.	[Gunaratne, Gemunu H.; Seemann, Lars] Univ Houston, Dept Phys, Houston, TX 77204 USA; [Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Gunaratne, Preethi H.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Toeroek, Andrei] Univ Houston, Dept Math, Houston, TX 77204 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston	Gunaratne, GH (corresponding author), Univ Houston, Dept Phys, Houston, TX 77204 USA.	gemunu@uh.edu			National Science Foundation [0607345]	National Science Foundation(National Science Foundation (NSF))	This work was partially funded by grant 0607345 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angeli D, 2008, NONLINEAR ANAL-REAL, V9, P128, DOI 10.1016/j.nonrwa.2006.09.006; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernard C., 1957, INTRO ETUDE MED EXPT; Bertram J, 2006, CURR PHARM BIOTECHNO, V7, P277, DOI 10.2174/138920106777950825; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Carlsson G, 2009, DISCRETE COMPUT GEOM, V42, P71, DOI 10.1007/s00454-009-9176-0; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2003, J THEOR BIOL, V221, P309, DOI 10.1006/jtbi.2003.3071; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Feinberg M, 1995, ARCH RATION MECH AN, V132, P311, DOI 10.1007/BF00375614; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gill G, 2001, ESSAYS BIOCHEM, V37, P33, DOI 10.1042/bse0370033; Hauser K, 2009, CELL CYCLE, V8, P2718, DOI 10.4161/cc.8.17.9401; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Herrgard MJ, 2003, GENOME RES, V13, P2423, DOI 10.1101/gr.1330003; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; TSUKAKOSHI M, 1984, APPL PHYS B-PHOTO, V35, P135, DOI 10.1007/BF00697702; van Someren E P, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P355; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; WADDINGTON CH, 1960, GENET RES, V1, P140, DOI 10.1017/S0016672300000136; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Yang K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.60; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	42	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13080	10.1371/journal.pone.0013080	http://dx.doi.org/10.1371/journal.pone.0013080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949025	gold, Green Published, Green Submitted			2022-12-25	WOS:000282676700002
J	Lucas, A; Kim, Y; Rivera-Pabon, O; Chae, S; Kim, DH; Kim, B				Lucas, Amanda; Kim, Yuri; Rivera-Pabon, Omayra; Chae, Sunju; Kim, Dong-Hyun; Kim, Baek			Targeting the PI3K/Akt Cell Survival Pathway to Induce Cell Death of HIV-1 Infected Macrophages with Alkylphospholipid Compounds	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MICROGLIAL CELLS; AKT INHIBITOR; TAT PROTEIN; PERIFOSINE; APOPTOSIS; ACTIVATION; DEMENTIA; TUMOR; LINES	Background: HIV-1 infected macrophages and microglia are long-lived viral reservoirs persistently producing viral progenies. HIV-1 infection extends the life span of macrophages by promoting the stress-induced activation of the PI3K/Akt cell survival pathway. Importantly, various cancers also display the PI3K/Akt activation for long-term cell survival and outgrowth, and Akt inhibitors have been extensively searched as anti-cancer agents. This led us to investigate whether Akt inhibitors could antagonize long-term survival and cytoprotective phenotype of HIV-1 infected macrophages. Principal Findings: Here, we examined the effect of one such class of drugs, alkylphospholipids (ALPs), on cell death and Akt pathway signals in human macrophages and a human microglial cell line, CHME5, infected with HIV-1 BaL or transduced with HIV-1 vector, respectively. Our findings revealed that the ALPs, perifosine and edelfosine, specifically induced the death of HIV-1 infected primary human macrophages and CHME5 cells. Furthermore, these two compounds reduced phosphorylation of both Akt and GSK3 beta, a downstream substrate of Akt, in the transduced CHME5 cells. Additionally, we observed that perifosine effectively reduced viral production in HIV-1 infected primary human macrophages. These observations demonstrate that the ALP compounds tested are able to promote cell death in both HIV-1 infected macrophages and HIV-1 expressing CHME5 cells by inhibiting the action of the PI3K/Akt pathway, ultimately restricting viral production from the infected cells. Significance: This study suggests that Akt inhibitors, such as ALP compounds, may serve as potential anti-HIV-1 agents specifically targeting long-living HIV-1 macrophages and microglia reservoirs.	[Lucas, Amanda; Rivera-Pabon, Omayra; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Kim, Yuri; Chae, Sunju; Kim, Dong-Hyun] Kyung Hee Univ, Coll Pharm, Dept Pharm, Seoul, South Korea	University of Rochester; Kyung Hee University	Lucas, A (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	dhkim@khu.ac.kr; baek_kim@urmc.rochester.edu			National Center for Research Resources [TL1 RR024135]; Korean Government [R33-2008-000-100018]; NIH [AI077401]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077401] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Korean Government(Korean Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH AI077401 (B.K.), TL1 RR024135 from the National Center for Research Resources, NIH (A.L.L.) and National Research Foundation of Korea Grant funded by the Korean Government R33-2008-000-100018 (D.H.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Cosenza MA, 2004, NEUROPATH APPL NEURO, V30, P478, DOI 10.1111/j.1365-2990.2004.00563.x; Dieterle A, 2009, INT J CANCER, V125, P932, DOI 10.1002/ijc.24374; Duijsings D, 2004, EUR J PHARMACOL, V502, P185, DOI 10.1016/j.ejphar.2004.09.015; Engel JB, 2008, EUR J OBSTET GYN R B, V141, P64, DOI 10.1016/j.ejogrb.2008.06.007; Ernst DS, 2005, INVEST NEW DRUG, V23, P569, DOI 10.1007/s10637-005-1157-4; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Grosman N, 2001, INT IMMUNOPHARMACOL, V1, P1321, DOI 10.1016/S1567-5769(01)00064-9; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Konstantinov SM, 1999, CANCER LETT, V144, P153, DOI 10.1016/S0304-3835(99)00219-0; Lee P, 2001, BRAIN RES, V892, P380, DOI 10.1016/S0006-8993(00)03257-1; Leonard R, 2001, J CLIN ONCOL, V19, P4150, DOI 10.1200/JCO.2001.19.21.4150; Liu DX, 2009, CANCER RES, V69, P7311, DOI 10.1158/0008-5472.CAN-09-1077; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; van Blitterswijk WJ, 2008, CURR PHARM DESIGN, V14, P2061, DOI 10.2174/138161208785294636; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Vink SR, 2005, INVEST NEW DRUG, V23, P279, DOI 10.1007/s10637-005-1436-0; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Zhao RY, 2005, CELL RES, V15, P143, DOI 10.1038/sj.cr.7290279	26	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13121	10.1371/journal.pone.0013121	http://dx.doi.org/10.1371/journal.pone.0013121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927348	Green Submitted, Green Published, gold			2022-12-25	WOS:000282312600034
J	Heuberger, AL; Lewis, MR; Chen, MH; Brick, MA; Leach, JE; Ryan, EP				Heuberger, Adam L.; Lewis, Matthew R.; Chen, Ming-Hsuan; Brick, Mark A.; Leach, Jan E.; Ryan, Elizabeth P.			Metabolomic and Functional Genomic Analyses Reveal Varietal Differences in Bioactive Compounds of Cooked Rice	PLOS ONE			English	Article							VITAMIN-E; OXIDATIVE STRESS; GAMMA-TOCOPHEROL; ALPHA-TOCOPHEROL; GENETICS; INHIBIT; PLANTS; GENES; DEATH	Emerging evidence supports that cooked rice (Oryza sativa L.) contains metabolites with biomedical activities, yet little is known about the genetic diversity that is responsible for metabolite variation and differences in health traits. Metabolites from ten diverse varieties of cooked rice were detected using ultra performance liquid chromatography coupled to mass spectrometry. A total of 3,097 compounds were detected, of which 25% differed among the ten varieties. Multivariate analyses of the metabolite profiles showed that the chemical diversity among the varieties cluster according to their defined subspecies classifications: indica, japonica, and aus. Metabolite-specific genetic diversity in rice was investigated by analyzing a collection of single nucleotide polymorphisms (SNPs) in genes from biochemical pathways of nutritional importance. Two classes of bioactive compounds, phenolics and vitamin E, contained nonsynonymous SNPs and SNPs in the 5' and 3' untranslated regions for genes in their biosynthesis pathways. Total phenolics and tocopherol concentrations were determined to examine the effect of the genetic diversity among the ten varieties. Per gram of cooked rice, total phenolics ranged from 113.7 to 392.6 mu g (gallic acid equivalents), and total tocopherols ranged between 7.2 and 20.9 mu g. The variation in the cooked rice metabolome and quantities of bioactive components supports that the SNP-based genetic diversity influenced nutritional components in rice, and that this approach may guide rice improvement strategies for plant and human health.	[Heuberger, Adam L.; Brick, Mark A.] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA; [Lewis, Matthew R.] Colorado State Univ, Dept Vice President Res, Prote & Metab Facil, Ft Collins, CO 80523 USA; [Chen, Ming-Hsuan] ARS, Rice Res Unit, USDA, Beaumont, TX USA; [Leach, Jan E.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Ryan, Elizabeth P.] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; United States Department of Agriculture (USDA); Colorado State University; Colorado State University	Heuberger, AL (corresponding author), Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA.	e.p.ryan@colostate.edu		Lewis, Matthew/0000-0001-5760-5359	United States Department of Agriculture-Cooperative State Research, Education, and Extension Service (USDA-CSREES) [2006-35604-16628]; National Institute of Food and Agriculture [2007-38420-17766]; National Institutes of Health [R03CA150070]; Shipley Foundation; NATIONAL CANCER INSTITUTE [R03CA150070] Funding Source: NIH RePORTER	United States Department of Agriculture-Cooperative State Research, Education, and Extension Service (USDA-CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shipley Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grants from the United States Department of Agriculture-Cooperative State Research, Education, and Extension Service (USDA-CSREES) (2006-35604-16628), USDA National Needs Graduate Fellowship Competitive Grant from the National Institute of Food and Agriculture (2007-38420-17766), National Institutes of Health (R03CA150070), and the Shipley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billman GE, 1999, CIRCULATION, V99, P2452, DOI 10.1161/01.CIR.99.18.2452; Boateng J., 2009, International Journal of Cancer Research (USA), V5, P153, DOI 10.3923/ijcr.2009.153.166; Chaudhary N, 2009, PLANT SCI, V177, P479, DOI 10.1016/j.plantsci.2009.07.014; Chen MH, 2005, J FOOD COMPOS ANAL, V18, P317, DOI 10.1016/j.jfca.2004.12.001; DellaPenna D, 2005, J PLANT PHYSIOL, V162, P729, DOI 10.1016/j.jplph.2005.04.004; Demurin Y, 1996, PLANT BREEDING, V115, P33, DOI 10.1111/j.1439-0523.1996.tb00867.x; Duthie G, 2000, CURR OPIN LIPIDOL, V11, P43, DOI 10.1097/00041433-200002000-00007; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Goffman FD, 2004, J SCI FOOD AGR, V84, P1235, DOI 10.1002/jsfa.1780; Grassmann J, 2002, PLANT PHYSIOL BIOCH, V40, P471, DOI 10.1016/S0981-9428(02)01395-5; Hudson EA, 2000, CANCER EPIDEM BIOMAR, V9, P1163; Ishikawa T, 2010, PLANT CELL PHYSIOL, V51, P9, DOI 10.1093/pcp/pcp162; Jiang Q, 2000, P NATL ACAD SCI USA, V97, P11494, DOI 10.1073/pnas.200357097; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Leonard SW, 2005, FREE RADICAL BIO MED, V38, P857, DOI 10.1016/j.freeradbiomed.2004.12.001; Lin XB, 2009, AM J PHYSIOL-GASTR L, V296, pG931, DOI 10.1152/ajpgi.00001.2009; Lisec J, 2008, PLANT J, V53, P960, DOI 10.1111/j.1365-313X.2007.03383.x; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; McNally KL, 2006, PLANT PHYSIOL, V141, P26, DOI 10.1104/pp.106.077313; MOCHIDA K, 2009, BMC GENOMICS, V10; Morris CE, 2006, NAT BIOTECHNOL, V24, P1078, DOI 10.1038/nbt0906-1078; Nes WD, 1999, CRIT REV BIOCHEM MOL, V34, P81, DOI 10.1080/10409239991209219; Oksman-Caldentey KM, 2005, CURR OPIN BIOTECH, V16, P174, DOI 10.1016/j.copbio.2005.02.007; Pryor WA, 2000, FREE RADICAL BIO MED, V28, P141, DOI 10.1016/S0891-5849(99)00224-5; Saldeen T, 1999, J AM COLL CARDIOL, V34, P1208, DOI 10.1016/S0735-1097(99)00333-2; Sands DC, 2009, PLANT SCI, V177, P377, DOI 10.1016/j.plantsci.2009.07.011; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Sierra S, 2005, EUR J NUTR, V44, P509, DOI 10.1007/s00394-005-0554-y; Simon PW., 2009, PLANT BREED REV, V31, P325, DOI DOI 10.1002/9780470593783.CH7; Singh U, 2005, ANNU REV NUTR, V25, P151, DOI 10.1146/annurev.nutr.24.012003.132446; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Skogerson K, 2010, J AGR FOOD CHEM, V58, P3600, DOI 10.1021/jf903705y; Tarpley L, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-8; *UN FAO, 2010, FAO STAT DAT AN GRAP; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Van Eenennaam AL, 2004, METAB ENG, V6, P101, DOI 10.1016/j.ymben.2003.11.001; Xia XD, 2006, J NUTR, V136, P2220, DOI 10.1093/jn/136.8.2220; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zhou JM, 2008, PHARM BIOL, V46, P26, DOI 10.1080/13880200701729745	41	61	63	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12915	10.1371/journal.pone.0012915	http://dx.doi.org/10.1371/journal.pone.0012915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886119	gold, Green Submitted, Green Published			2022-12-25	WOS:000282091100020
J	Wu, WI; Voegtli, WC; Sturgis, HL; Dizon, FP; Vigers, GPA; Brandhuber, BJ				Wu, Wen-I; Voegtli, Walter C.; Sturgis, Hillary L.; Dizon, Faith P.; Vigers, Guy P. A.; Brandhuber, Barbara J.			Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition	PLOS ONE			English	Article							PLECKSTRIN-HOMOLOGY-DOMAIN; MOLECULAR-MECHANISM; MAP KINASE; PH DOMAIN; ACTIVATION; PHOSPHORYLATION; DISCOVERY; MUTATION; BINDING; SYSTEM	AKT1 (NP_005154.2) is a member of the serine/threonine AGC protein kinase family involved in cellular metabolism, growth, proliferation and survival. The three human AKT isozymes are highly homologous multi-domain proteins with both overlapping and distinct cellular functions. Dysregulation of the AKT pathway has been identified in multiple human cancers. Several clinical trials are in progress to test the efficacy of AKT pathway inhibitors in treating cancer. Recently, a series of AKT isozyme-selective allosteric inhibitors have been reported. They require the presence of both the pleckstrin-homology (PH) and kinase domains of AKT, but their binding mode has not yet been elucidated. We present here a 2.7 angstrom resolution co-crystal structure of human AKT1 containing both the PH and kinase domains with a selective allosteric inhibitor bound in the interface. The structure reveals the interactions between the PH and kinase domains, as well as the critical amino residues that mediate binding of the inhibitor to AKT1. Our work also reveals an intricate balance in the enzymatic regulation of AKT, where the PH domain appears to lock the kinase in an inactive conformation and the kinase domain disrupts the phospholipid binding site of the PH domain. This information advances our knowledge in AKT1 structure and regulation, thereby providing a structural foundation for interpreting the effects of different classes of AKT inhibitors and designing selective ones.	[Wu, Wen-I; Voegtli, Walter C.; Sturgis, Hillary L.; Dizon, Faith P.; Vigers, Guy P. A.; Brandhuber, Barbara J.] Array BioPharma Inc, Dept Biol Struct, Boulder, CO USA	Pfizer; Array BioPharma	Wu, WI (corresponding author), Array BioPharma Inc, Dept Biol Struct, Boulder, CO USA.	bbrandhuber@arraybiopharma.com		Vigers, Guy/0000-0003-4451-8453	Array BioPharma Inc.; Genentech, Inc.	Array BioPharma Inc.; Genentech, Inc.(Roche HoldingGenentech)	Array BioPharma Inc. and Genentech, Inc. funded and approved the publication of this work. The companies had a role in this study due to employment of one or more authors of this study.	Ananthanarayanan B, 2007, J BIOL CHEM, V282, P36634, DOI 10.1074/jbc.M706227200; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja Veronique, 2009, J Chem Biol, V2, P11, DOI 10.1007/s12154-009-0016-8; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Converso A, 2009, BIOORG MED CHEM LETT, V19, P1240, DOI 10.1016/j.bmcl.2008.12.076; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Huang L, 2003, BIOORGAN MED CHEM, V11, P21, DOI 10.1016/S0968-0896(02)00427-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Lindsley CW, 2010, CURR TOP MED CHEM, V10, P458, DOI 10.2174/156802610790980602; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Lippa B, 2008, BIOORG MED CHEM LETT, V18, P3359, DOI 10.1016/j.bmcl.2008.04.034; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Tolcher AW, 2009, J CLIN ONCOL, V27; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zhao ZJ, 2005, BIOORG MED CHEM LETT, V15, P905, DOI 10.1016/j.bmcl.2004.12.062	31	184	192	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12913	10.1371/journal.pone.0012913	http://dx.doi.org/10.1371/journal.pone.0012913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886116	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100019
J	Zhang, JL; Patterson, LJ; Qiu, LY; Graziussi, D; Sebald, W; Hammerschmidt, M				Zhang, Jin-Li; Patterson, Lucy J.; Qiu, Li-Yan; Graziussi, Daria; Sebald, Walter; Hammerschmidt, Matthias			Binding between Crossveinless-2 and Chordin Von Willebrand Factor Type C Domains Promotes BMP Signaling by Blocking Chordin Activity	PLOS ONE			English	Article							TWISTED GASTRULATION; XENOPUS-EMBRYOS; ZEBRAFISH EMBRYO; EXTRACELLULAR REGULATION; SPEMANNS ORGANIZER; DROSOPHILA EMBRYO; PATTERN-FORMATION; PROTEIN; EXPRESSION; GENES	Background: Crossveinless-2 (CV2) is an extracellular BMP modulator protein of the Chordin family, which can either enhance or inhibit BMP activity. CV2 binds to BMP2 via subdomain 1 of the first of its five N-terminal von Willebrand factor type C domains (VWC1). Previous studies showed that this BMP binding is required for the anti-, but not for the pro-BMP effect of CV2. More recently, it was shown that CV2 can also bind to the BMP inhibitor Chordin. However, it remained unclear which domains mediate this binding, and whether it accounts for an anti-or pro-BMP effect. Principal Findings: Here we report that a composite interface of CV2 consisting of subdomain 2 of VWC1 and of VWC2-4, which are dispensable for BMP binding, binds to the VWC2 domain of Chordin. Functional data obtained in zebrafish embryos indicate that this binding of Chordin is required for CV2's pro-BMP effect, which actually is an anti-Chordin effect and, at least to a large extent, independent of Tolloid-mediated Chordin degradation. We further demonstrate that CV2 mutant versions that per se are incapable of BMP binding can attenuate the Chordin/BMP interaction. Conclusions: We have physically dissected the anti-and pro-BMP effects of CV2. Its anti-BMP effect is obtained by binding to BMP via subdomain1 of the VWC1 domain, a binding that occurs in competition with Chordin. In contrast, its pro-BMP effect is achieved by direct binding to Chordin via subdomain 2 of VWC1 and VWC2-4. This binding seems to induce conformational changes within the Chordin protein that weaken Chordin's affinity to BMP. We propose that in ternary Chordin-CV2-BMP complexes, both BMP and Chordin are directly associated with CV2, whereas Chordin is pushed away from BMP, ensuring that BMPs can be more easily delivered to their receptors.	[Zhang, Jin-Li; Patterson, Lucy J.; Graziussi, Daria; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, Cologne Bioctr, Cologne, Germany; [Zhang, Jin-Li; Qiu, Li-Yan; Sebald, Walter] Univ Wurzburg, Dept Physiol Chem 2, Bioctr, Wurzburg, Germany; [Hammerschmidt, Matthias] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Hammerschmidt, Matthias] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	University of Cologne; University of Wurzburg; University of Cologne; University of Cologne	Zhang, JL (corresponding author), Univ Cologne, Inst Dev Biol, Cologne Bioctr, Cologne, Germany.	zhangj1@uni-koeln.de; mhammers@uni-koeln.de	Patterson, Lucy/G-1803-2011	Patterson, Lucy/0000-0002-2578-381X	DGF [SFB 572, KFO 103]	DGF(German Research Foundation (DFG))	Work in M.H.'s laboratory was supported by SFB 572 of the DGF, work in W.S.'s laboratory by DGF Grant KFO 103, part C (www.DGF.de). The funders had no role in study design, data collection and analysis, decision to publish, or prepatation of the manuscript.	Ambrosio AL, 2008, DEV CELL, V15, P248, DOI 10.1016/j.devcel.2008.06.013; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Bier E, 2008, DEV CELL, V15, P176, DOI 10.1016/j.devcel.2008.07.012; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Coles E, 2004, DEVELOPMENT, V131, P5309, DOI 10.1242/dev.01419; Conley CA, 2000, DEVELOPMENT, V127, P3947; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Decotto E, 2001, DEVELOPMENT, V128, P3831; Fisher S, 1997, DEVELOPMENT, V124, P1301; Fujisawa T, 2009, BIOCHEM BIOPH RES CO, V385, P215, DOI 10.1016/j.bbrc.2009.05.041; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hammerschmidt M, 1999, METHOD CELL BIOL, V59, P87; HAMMERSCHMIDT M, DORSOVENTRAL PATTERN, P72; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Kamimura M, 2004, DEV DYNAM, V230, P434, DOI 10.1002/dvdy.20069; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Larrain J, 2001, DEVELOPMENT, V128, P4439; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; Matsui M, 2000, P NATL ACAD SCI USA, V97, P5291, DOI 10.1073/pnas.090020497; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Moser M, 2007, J MOL CELL CARDIOL, V43, P243, DOI 10.1016/j.yjmcc.2007.05.008; Mullins MC, 1996, DEVELOPMENT, V123, P81; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Oelgeschlager M, 2003, DEVELOPMENT, V130, P4047, DOI 10.1242/dev.00633; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Rentzsch F, 2006, DEVELOPMENT, V133, P801, DOI 10.1242/dev.02250; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SASAI Y, 1995, NATURE, V377, P757, DOI 10.1038/377757a0; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Wagner DS, 2002, DEV BIOL, V245, P109, DOI 10.1006/dbio.2002.0614; Xie J, 2005, DEVELOPMENT, V132, P383, DOI 10.1242/dev.01577; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	50	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12846	10.1371/journal.pone.0012846	http://dx.doi.org/10.1371/journal.pone.0012846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886103	Green Submitted, gold, Green Published			2022-12-25	WOS:000282091100001
J	Uniewicz, KA; Cross, MJ; Fernig, DG				Uniewicz, Katarzyna A.; Cross, Michael J.; Fernig, David G.			Exogenous Recombinant Dimeric Neuropilin-1 Is Sufficient to Drive Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-CELLS; STEM-CELLS; VEGF; RECEPTOR; EXPRESSION; VEGF(165); BINDING; ORGANIZATION; APOPTOSIS	Neuropilin-1 (NRP-1) is present on the cell surface of endothelial cells, or as a soluble truncated variant. Membrane NRP-1 is proposed to enhance angiogenesis by promoting the formation of a signaling complex between vascular endothelial growth factor-A(165) (VEGF-A(165)), VEGF receptor-2 (VEGFR-2) and heparan sulfate, whereas the soluble NRP-1 is thought to act as an antagonist of signaling complex formation. We have analyzed the angiogenic potential of a chimera comprising the entire extracellular NRP-1 region dimerized through an Fc IgG domain and a monomeric truncated NRP-1 variant. Both NRP-1 proteins stimulated tubular morphogenesis and cell migration in HDMECs and HUVECs. Fc rNRP-1 was able to induce VEGFR-2 phosphorylation and expression of the VEGFR-2 specific target, regulator of calcineurin-1 (RCAN1.4). siRNA mediated gene silencing of VEGFR-2 revealed that VEGFR-2 was required for Fc rNRP-1 mediated activation of the intracellular signaling proteins PLC-gamma, AKT, and MAPK and tubular morphogenesis. The stimulatory activity was independent of VEGF-A(165). This was evidenced by depleting the cell culture of exogenous VEGF-A(165), and using instead for routine culture VEGF-A(121), which does not interact with NRP-1, and by the inability of VEGF-A sequestering antibodies to inhibit the angiogenic activity of the NRP proteins. Analysis of angiogenesis over a period of 6 days in an in vitro fibroblast/ endothelial co-culture model revealed that Fc rNRP-1 could induce endothelial cell tubular morphogenesis. Thus, we conclude that soluble Fc rNRP-1 is a VEGF-A(165)-independent agonist of VEGFR-2 and stimulates angiogenesis in endothelial cells.	[Cross, Michael J.] Univ Liverpool, Dept Mol & Clin Pharmacol, Inst Translat Med, Liverpool L69 3GE, Merseyside, England; [Uniewicz, Katarzyna A.; Fernig, David G.] Univ Liverpool, Dept Chem & Struct Biol, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Cross, MJ (corresponding author), Univ Liverpool, Dept Mol & Clin Pharmacol, Inst Translat Med, Liverpool L69 3GE, Merseyside, England.	m.j.cross@liv.ac.uk; Dgfernig@liverpool.ac.uk	Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293	European Commission; North West Cancer Research Fund; Cancer and Polio Research Fund	European Commission(European CommissionEuropean Commission Joint Research Centre); North West Cancer Research Fund; Cancer and Polio Research Fund	This work was supported by the European Commission (Marie Curie Early Stage Training Fellowship, to K.A.U.), the North West Cancer Research Fund, and the Cancer and Polio Research Fund.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; An ZQ, 2009, MABS-AUSTIN, V1, P572, DOI 10.4161/mabs.1.6.10185; Ball SG, 2010, BIOCHEM J, V427, P29, DOI 10.1042/BJ20091512; Barr MP, 2005, BRIT J CANCER, V92, P328, DOI 10.1038/sj.bjc.6602308; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Bartsch G, 2008, J UROLOGY, V179, P326, DOI 10.1016/j.juro.2007.08.086; Bechet D, 2010, PHARM RES-DORDR, V27, P468, DOI 10.1007/s11095-009-0035-8; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Cristofaro B, 2009, CURR OPIN PHARMACOL, V9, P102, DOI 10.1016/j.coph.2008.11.006; da Silva AJ, 2002, J IMMUNOL, V168, P4462, DOI 10.4049/jimmunol.168.9.4462; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Fiocco U, 2008, AUTOIMMUN REV, V8, P76, DOI 10.1016/j.autrev.2008.07.035; Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Fukasawa M, 2007, CANCER BIOL THER, V6, P1173; Geretti E, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4490; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Gualandris A, 2009, FASEB J, V23, P68, DOI 10.1096/fj.08-112847; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Herzog Y, 2001, MECH DEVELOP, V109, P115, DOI 10.1016/S0925-4773(01)00518-4; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Holmes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011435; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Jarvis A, 2010, J MED CHEM, V53, P2215, DOI 10.1021/jm901755g; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Lambert S, 2009, BLOOD, V113, P5176, DOI 10.1182/blood-2008-04-150342; Lee TY, 2008, CLIN CANCER RES, V14, P1487, DOI 10.1158/1078-0432.CCR-07-1530; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Narazaki M, 2008, BLOOD, V111, P4126, DOI 10.1182/blood-2007-09-112474; Narazaki M, 2006, BLOOD, V107, P3892, DOI 10.1182/blood-2005-10-4113; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Roberts OL, 2010, J CELL SCI, V123, P3189, DOI 10.1242/jcs.072801; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622; SEDMAK DD, 1991, AM J PATHOL, V138, P175; Slimani H, 2006, J DRUG TARGET, V14, P694, DOI 10.1080/10611860600947607; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Sorrell JM, 2007, CELLS TISSUES ORGANS, V186, P157, DOI 10.1159/000106670; Starzec A, 2007, PEPTIDES, V28, P2397, DOI 10.1016/j.peptides.2007.09.013; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; UCHIDA K, 1994, AM J PHYSIOL, V266, pF81, DOI 10.1152/ajprenal.1994.266.1.F81; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; Uniewicz KA, 2008, FRONT BIOSCI-LANDMRK, V13, P4339, DOI 10.2741/3008; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; West DC, 2005, J BIOL CHEM, V280, P13457, DOI 10.1074/jbc.M410924200; Whittles CE, 2002, MICROCIRCULATION, V9, P513, DOI 10.1038/sj.mn.7800164; Yamada Y, 2001, BLOOD, V97, P1671, DOI 10.1182/blood.V97.6.1671; Zachary IC, 2009, BIOCHEM SOC T, V37, P1171, DOI 10.1042/BST0371171	72	18	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					12	23		10.1074/jbc.M110.190801	http://dx.doi.org/10.1074/jbc.M110.190801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20956519	Green Published, hybrid			2022-12-25	WOS:000285782800002
J	Zhang, MH; Lu, SQ; Li, GW; Mao, ZL; Yu, X; Sun, WN; Tang, ZC; Long, MA; Su, WA				Zhang, Minhua; Lue, Shouqin; Li, Guowei; Mao, Zhilei; Yu, Xin; Sun, Weining; Tang, Zhangcheng; Long, Mian; Su, Weiai			Identification of a Residue in Helix 2 of Rice Plasma Membrane Intrinsic Proteins That Influences Water Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; AQUAPORIN NTAQP1; CHANNEL ACTIVITY; STRUCTURAL BASIS; TRANSPORT; FAMILY; ARABIDOPSIS; SELECTIVITY; PERMEATION; GLYCEROL	Molecular selection, ion exclusion, and water permeation are well known regulatory mechanisms in aquaporin. Water permeability was found to be diverse in different subgroups of plasma membrane intrinsic proteins (PIPs), even though the residues surrounding the water holes remained the same across the subgroups. Upon homology modeling and structural comparison, a conserved Ala/Ile(Val) residue difference was identified in helix 2 that affected the conformation of the NPA region and consequently influenced the water permeability. The residue difference was found to be conservative within the two subgroups of PIPs in rice as well as in other plants. Functional tests further confirmed the prediction via site-directed mutagenesis where replacement of Ala(103) or Ala(102) in respective OsPIP1; 1 or OsPIP1; 3 with Val yielded 7.0- and 2.2-fold increases in water transportation, and substitution of Ile(98) or Val(95) in respective OsPIP2; 3 or OsPIP2; 7 with Ala resulted in 73 or 52% reduction of water transportation. Based on structural analyses and molecular dynamics simulations, we proposed that the difference in water permeability was attributed to the orientation variations of helix 2 that modified water-water and water-protein interactions.	[Su, Weiai] Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Lue, Shouqin; Long, Mian] Chinese Acad Sci, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100190, Peoples R China; [Lue, Shouqin; Long, Mian] Chinese Acad Sci, Ctr Biomech & Bioengn, Inst Mech, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS	Long, MA (corresponding author), 15 N 4th Ring Rd, Beijing 100190, Peoples R China.	mlong@imech.ac.cn; zstressc@online.sh.cn		Mao, Zhi-Lei/0000-0002-7071-8048	National Natural Science Foundation of China [30670172, 30730032, 10332060]; National Key Basic Research Foundation of China [2006CB910303]; Chinese Academy of Science [KSCX2-YW-N-011, KJCX2-YW-L08]; National High Technology Research and Development Program of China [2007AA100603, 2007AA02Z306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30670172, 30730032, and 10332060, National Key Basic Research Foundation of China Grant 2006CB910303, Knowledge Innovation Program of Chinese Academy of Science Grants KSCX2-YW-N-011 and KJCX2-YW-L08, and National High Technology Research and Development Program of China Grants 2007AA100603 and 2007AA02Z306.	Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Dixit R, 2001, PLANT MOL BIOL, V45, P51, DOI 10.1023/A:1006428007826; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Fujiyoshi Y, 2002, CURR OPIN STRUC BIOL, V12, P509, DOI 10.1016/S0959-440X(02)00355-X; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Han BG, 2006, J MOL BIOL, V360, P285, DOI 10.1016/j.jmb.2006.04.039; Hashido M, 2005, FEBS LETT, V579, P5549, DOI 10.1016/j.febslet.2005.09.018; Hashido M, 2007, BIOPHYS J, V93, P373, DOI 10.1529/biophysj.106.101170; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; Jensen MO, 2008, P NATL ACAD SCI USA, V105, P14430, DOI 10.1073/pnas.0802401105; Kitson David H, 2002, Brief Bioinform, V3, P32, DOI 10.1093/bib/3.1.32; Kjellbom P, 1999, TRENDS PLANT SCI, V4, P308, DOI 10.1016/S1360-1385(99)01438-7; Kong YF, 2001, P NATL ACAD SCI USA, V98, P14345, DOI 10.1073/pnas.251507998; Lee JK, 2005, P NATL ACAD SCI USA, V102, P18932, DOI 10.1073/pnas.0509469102; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nyirenda TE, 2004, INT J TUBERC LUNG D, V8, P1089; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sakurai J, 2008, PLANT CELL PHYSIOL, V49, P30, DOI 10.1093/pcp/pcm162; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smolin N, 2008, BIOPHYS J, V95, P1089, DOI 10.1529/biophysj.107.125187; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Weig A, 1997, PLANT PHYSIOL, V114, P1347, DOI 10.1104/pp.114.4.1347; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; ZHANG R, 1991, AM J PHYSIOL, V260, pC26, DOI 10.1152/ajpcell.1991.260.1.C26; Zhu FQ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.224501	41	12	15	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41982	41992		10.1074/jbc.M110.101790	http://dx.doi.org/10.1074/jbc.M110.101790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20926385	hybrid, Green Published			2022-12-25	WOS:000285622600084
J	Takata, K; Kitamura, Y; Saeki, M; Terada, M; Kagitani, S; Kitamura, R; Fujikawa, Y; Maelicke, A; Tomimoto, H; Taniguchi, T; Shimohama, S				Takata, Kazuyuki; Kitamura, Yoshihisa; Saeki, Mana; Terada, Maki; Kagitani, Sachiko; Kitamura, Risa; Fujikawa, Yasuhiro; Maelicke, Alfred; Tomimoto, Hidekazu; Taniguchi, Takashi; Shimohama, Shun			Galantamine-induced Amyloid-beta Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; ALLOSTERIC MODULATION; CHOLINERGIC NEURONS; TREATMENT STRATEGY; SELECTIVE LOSS; MOUSE MODEL; RAT-BRAIN; IN-VIVO	Reduction of brain amyloid-beta (A beta) has been proposed as a therapeutic target for Alzheimer disease (AD), and microglial A beta phagocytosis is noted as an A beta clearance system in brains. Galantamine is an acetylcholinesterase inhibitor approved for symptomatic treatment of AD. Galantamine also acts as an allosterically potentiating ligand (APL) for nicotinic acetylcholine receptors (nAChRs). APL-binding site is located close to but distinct from that for acetylcholine on nAChRs, and FK1 antibody specifically binds to the APL-binding site without interfering with the acetylcholine-binding site. We found that in human AD brain, microglia accumulated on A beta deposits and expressed alpha 7 nAChRs including the APL-binding site recognized with FK1 antibody. Treatment of rat microglia with galantamine significantly enhanced microglial A beta phagocytosis, and acetylcholine competitive antagonists as well as FK1 antibody inhibited the enhancement. Thus, the galantamine-enhanced microglial A beta phagocytosis required the combined actions of an acetylcholine competitive agonist and the APL for nAChRs. Indeed, depletion of choline, an acetylcholine-competitive alpha 7 nAChR agonist, from the culture medium impeded the enhancement. Similarly, Ca2+ depletion or inhibition of the calmodulin-dependent pathways for the actin reorganization abolished the enhancement. These results suggest that galantamine sensitizes microglial alpha 7 nAChRs to choline and induces Ca2+ influx into microglia. The Ca2+-induced intracellular signaling cascades may then stimulate A beta phagocytosis through the actin reorganization. We further demonstrated that galantamine treatment facilitated A beta clearance in brains of rodent AD models. In conclusion, we propose a further advantage of galantamine in clinical AD treatment and microglial nAChRs as a new therapeutic target.	[Takata, Kazuyuki; Kitamura, Yoshihisa; Saeki, Mana; Terada, Maki; Kagitani, Sachiko; Kitamura, Risa; Fujikawa, Yasuhiro; Taniguchi, Takashi] Kyoto Pharmaceut Univ, Dept Neurobiol, Yamashina Ku, Kyoto 6078414, Japan; [Maelicke, Alfred] Galantos Pharma GmbH, D-55131 Mainz, Germany; [Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 5148507, Japan; [Shimohama, Shun] Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Kyoto Pharmaceutical University; Mie University; Sapporo Medical University	Kitamura, Y (corresponding author), Kyoto Pharmaceut Univ, Dept Neurobiol, Yamashina Ku, Kyoto 6078414, Japan.	yo-kita@mb.kyoto-phu.ac.jp; shimoha@sapmed.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Frontier Research Program, grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for Promotion of Science.	Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; DAVIES P, 1976, LANCET, V2, P1403; Elsaraj SM, 2008, BBA-MOL CELL RES, V1783, P770, DOI 10.1016/j.bbamcr.2008.01.022; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann J, 2008, NEUROCHEM INT, V52, P972, DOI 10.1016/j.neuint.2007.10.008; Hellstrom-Lindahl E, 2004, EUR J NEUROSCI, V19, P2703, DOI 10.1111/j.1460-9568.2004.03377.x; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Kihara T, 2004, BIOCHEM BIOPH RES CO, V325, P976, DOI 10.1016/j.bbrc.2004.10.132; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kitamura Y, 2003, J PHARMACOL SCI, V92, P115; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Maelicke A, 2000, EUR J PHARMACOL, V393, P165, DOI 10.1016/S0014-2999(00)00093-5; Maelicke A, 2001, BIOL PSYCHIAT, V49, P279, DOI 10.1016/S0006-3223(00)01109-4; Maelicke A, 1997, J RECEPT SIGNAL TR R, V17, P11, DOI 10.3109/10799899709036592; MANDELZYS A, 1995, J NEUROPHYSIOL, V74, P1212, DOI 10.1152/jn.1995.74.3.1212; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nordberg A, 2002, J NEUROCHEM, V81, P655, DOI 10.1046/j.1471-4159.2002.00874.x; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Papke RL, 1996, NEUROSCI LETT, V213, P201; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; Ramsden M, 2003, J NEUROCHEM, V87, P1052, DOI 10.1046/j.1471-4159.2003.02114.x; Raskind MA, 2004, ARCH NEUROL-CHICAGO, V61, P252, DOI 10.1001/archneur.61.2.252; Raskind MA, 2003, NEUROLOGIST, V9, P235, DOI 10.1097/01.nrl.0000087722.46430.c4; Raskind MA, 2001, MED CLIN N AM, V85, P803, DOI 10.1016/S0025-7125(05)70341-2; Raskind MA, 2000, NEUROLOGY, V54, P2261, DOI 10.1212/WNL.54.12.2261; Sala C, 1996, NEUROSCI LETT, V215, P71, DOI 10.1016/0304-3940(96)12923-2; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schrattenholz A, 1996, MOL PHARMACOL, V49, P1; SCHRATTENHOLZ A, 1993, EUR J BIOCHEM, V216, P671, DOI 10.1111/j.1432-1033.1993.tb18187.x; SCHRODER B, 1994, J BIOL CHEM, V269, P10407; Shimizu E, 2008, J IMMUNOL, V181, P6503, DOI 10.4049/jimmunol.181.9.6503; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Takata K, 2004, J NEUROSCI RES, V78, P880, DOI 10.1002/jnr.20340; Takata K, 2007, EUR J NEUROSCI, V26, P2458, DOI 10.1111/j.1460-9568.2007.05852.x; Takata K, 2009, AM J PATHOL, V175, P17, DOI 10.2353/ajpath.2009.080908; Unger C, 2006, J PHARMACOL EXP THER, V317, P30, DOI 10.1124/jpet.105.098566; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; Wisniewski T, 2008, LANCET NEUROL, V7, P805, DOI 10.1016/S1474-4422(08)70170-4; Yanagida T, 2008, NEUROSCI RES, V62, P254, DOI 10.1016/j.neures.2008.09.003; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	55	122	129	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40180	40191		10.1074/jbc.M110.142356	http://dx.doi.org/10.1074/jbc.M110.142356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947502	Green Published, hybrid			2022-12-25	WOS:000285185500063
J	Todi, SV; Scaglione, KM; Blount, JR; Basrur, V; Conlon, KP; Pastore, A; Elenitoba-Johnson, K; Paulson, HL				Todi, Sokol V.; Scaglione, K. Matthew; Blount, Jessica R.; Basrur, Venkatesha; Conlon, Kevin P.; Pastore, Annalisa; Elenitoba-Johnson, Kojo; Paulson, Henry L.			Activity and Cellular Functions of the Deubiquitinating Enzyme and Polyglutamine Disease Protein Ataxin-3 Are Regulated by Ubiquitination at Lysine 117	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACHADO-JOSEPH-DISEASE; CRYSTAL-STRUCTURE; BRAZILIAN FAMILIES; STATISTICAL-MODEL; GENE-PRODUCT; MECHANISM; BINDING; CHAINS; RETROTRANSLOCATION; LOCALIZATION	Deubiquitinating enzymes (DUbs) play important roles in many ubiquitin-dependent pathways, yet how DUbs themselves are regulated is not well understood. Here, we provide insight into the mechanism by which ubiquitination directly enhances the activity of ataxin-3, a DUb implicated in protein quality control and the disease protein in the polyglutamine neurodegenerative disorder, Spinocerebellar Ataxia Type 3. We identify Lys-117, which resides near the catalytic triad, as the primary site of ubiquitination in wild type and pathogenic ataxin-3. Further studies indicate that ubiquitin-dependent activation of ataxin-3 at Lys-117 is important for its ability to reduce high molecular weight ubiquitinated species in cells. Ubiquitination at Lys-117 also facilitates the ability of ataxin-3 to induce aggresome formation in cells. Finally, structure-function studies support a model of activation whereby ubiquitination at Lys-117 enhances ataxin-3 activity independent of the known ubiquitin-binding sites in ataxin-3, most likely through a direct conformational change in or near the catalytic domain.	[Todi, Sokol V.; Scaglione, K. Matthew; Blount, Jessica R.; Paulson, Henry L.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA; [Basrur, Venkatesha; Conlon, Kevin P.; Elenitoba-Johnson, Kojo] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Pastore, Annalisa] Natl Inst Med Res, MRC, London NW7 1AA, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; MRC National Institute for Medical Research	Todi, SV (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, 540 E Canfield,Scott Hall 6374, Detroit, MI 48201 USA.	sokolt@umich.edu; henryp@umich.edu		Scaglione, Kenneth/0000-0002-3858-9418; TODI, SOKOL/0000-0003-4399-5549; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	National Institutes of Health [K99NS064097, R01 NS038712]; NRSA through the NINDS [1F32NS064596]; MRC [MC_U117584256] Funding Source: UKRI; Medical Research Council [MC_U117584256] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038712, K99NS064097, F32NS064596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants K99NS064097 (Pathway to Independence Award to S. V. T.), R01 NS038712 (to H. L. P.), and NRSA 1F32NS064596 (to K. M. S.) through the NINDS.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Costa MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011728; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; Fischer JA, 2003, INT REV CYTOL, V229, P43, DOI 10.1016/S0074-7696(03)29002-1; Fujigasaki H, 2000, EXP NEUROL, V165, P248, DOI 10.1006/exnr.2000.7479; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Marfany G, 2008, BIOCHEM SOC T, V36, P833, DOI 10.1042/BST0360833; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Nanao MH, 2004, EMBO REP, V5, P783, DOI 10.1038/sj.embor.7400201; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012430; Nicastro G, 2009, BIOPOLYMERS, V91, P1203, DOI 10.1002/bip.21210; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Seilhean D, 2004, ACTA NEUROPATHOL, V108, P81, DOI 10.1007/s00401-004-0855-x; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STEVANIN G, 1995, AM J HUM GENET, V57, P1247; STEVANIN G, 1995, J MED GENET, V32, P827, DOI 10.1136/jmg.32.10.827; Takahashi J, 2001, J NEUROPATH EXP NEUR, V60, P369, DOI 10.1093/jnen/60.4.369; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wada K, 2006, BIOCHEM BIOPH RES CO, V342, P253, DOI 10.1016/j.bbrc.2006.01.144; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	51	72	74	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39303	39313		10.1074/jbc.M110.181610	http://dx.doi.org/10.1074/jbc.M110.181610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20943656	hybrid, Green Published			2022-12-25	WOS:000284941300058
J	Balu, B; Singh, N; Maher, SP; Adams, JH				Balu, Bharath; Singh, Naresh; Maher, Steven P.; Adams, John H.			A Genetic Screen for Attenuated Growth Identifies Genes Crucial for Intraerythrocytic Development of Plasmodium falciparum	PLOS ONE			English	Article							REVEALS; LIFE; EXPRESSION; PROTEINS; DESIGN; YEAST; ART	A majority of the Plasmodium falciparum genome codes for genes with unknown functions, which presents a major challenge to understanding the parasite's biology. Large-scale functional analysis of the parasite genome is essential to pave the way for novel therapeutic intervention strategies against the disease and yet difficulties in genetic manipulation of this deadly human malaria parasite have been a major hindrance for functional analysis of its genome. Here, we used a forward functional genomic approach to study P. falciparum and identify genes important for optimal parasite development in the disease-causing, intraerythrocytic stages. We analyzed 123 piggyBac insertion mutants of P. falciparum for proliferation efficiency in the intraerythrocytic stages, in vitro. Almost 50% of the analyzed mutants showed significant reduction in proliferation efficiency, with 20% displaying severe defects. Functional categorization of genes in the severely attenuated mutants revealed significant enrichment for RNA binding proteins, suggesting the significance of post-transcriptional gene regulation in parasite development and emphasizing its importance as an antimalarial target. This study demonstrates the feasibility of much needed forward genetics approaches for P. falciparum to better characterize its genome and accelerate drug and vaccine development.	[Balu, Bharath; Singh, Naresh; Maher, Steven P.; Adams, John H.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Balu, B (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA.	jadams3@health.usf.edu	Adams, John H./ABB-8458-2020; Adams, John/G-1800-2015	Adams, John H./0000-0003-3707-7979; Adams, John/0000-0003-3707-7979; Maher, Steven/0000-0002-9560-5656	National Institutes of Health [R21 AI070888, R01 AI33656]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070888, R01AI033656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by National Institutes of Health grants R21 AI070888 and R01 AI33656. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Balu B, 2007, INT J PARASITOL, V37, P1, DOI 10.1016/j.ijpara.2006.10.001; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chu Angela M., 2008, V416, P205, DOI 10.1007/978-1-59745-321-9_14; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gavigan CS, 2003, INT J PARASITOL, V33, P987, DOI 10.1016/S0020-7519(03)00125-5; Grimm S, 2004, NAT REV GENET, V5, P179, DOI 10.1038/nrg1291; Hayes F, 2003, ANNU REV GENET, V37, P3, DOI 10.1146/annurev.genet.37.110801.142807; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Wuchty S, 2009, PROTEOMICS, V9, P1841, DOI 10.1002/pmic.200800383	26	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13282	10.1371/journal.pone.0013282	http://dx.doi.org/10.1371/journal.pone.0013282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949012	gold, Green Published, Green Submitted			2022-12-25	WOS:000282748100018
J	Jarrett, BR; Correa, C; Ma, KL; Louie, AY				Jarrett, Benjamin R.; Correa, Carlos; Ma, Kwan Liu; Louie, Angelique Y.			In Vivo Mapping of Vascular Inflammation Using Multimodal Imaging	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUE RUPTURE; VULNERABLE PLAQUE; ANIMAL-MODELS; ARTERY PLAQUE; MICROPET-II; HIGH-RISK; THROMBOSIS; PERFORMANCE; MACROPHAGE; DISEASE	Background: Plaque vulnerability to rupture has emerged as a critical correlate to risk of adverse coronary events but there is as yet no clinical method to assess plaque stability in vivo. In the search to identify biomarkers of vulnerable plaques an association has been found between macrophages and plaque stability-the density and pattern of macrophage localization in lesions is indicative of probability to rupture. In very unstable plaques, macrophages are found in high densities and concentrated in the plaque shoulders. Therefore, the ability to map macrophages in plaques could allow noninvasive assessment of plaque stability. We use a multimodality imaging approach to noninvasively map the distribution of macrophages in vivo. The use of multiple modalities allows us to combine the complementary strengths of each modality to better visualize features of interest. Our combined use of Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI) allows high sensitivity PET screening to identify putative lesions in a whole body view, and high resolution MRI for detailed mapping of biomarker expression in the lesions. Methodology/Principal Findings: Macromolecular and nanoparticle contrast agents targeted to macrophages were developed and tested in three different mouse and rat models of atherosclerosis in which inflamed vascular plaques form spontaneously and/or are induced by injury. For multimodal detection, the probes were designed to contain gadolinium (T1 MRI) or iron oxide (T2 MRI), and Cu-64 (PET). PET imaging was utilized to identify regions of macrophage accumulation; these regions were further probed by MRI to visualize macrophage distribution at high resolution. In both PET and MR images the probes enhanced contrast at sites of vascular inflammation, but not in normal vessel walls. MRI was able to identify discrete sites of inflammation that were blurred together at the low resolution of PET. Macrophage content in the lesions was confirmed by histology. Conclusions/Significance: The multimodal imaging approach allowed high-sensitivity and high-resolution mapping of biomarker distribution and may lead to a clinical method to predict plaque probability to rupture.	[Jarrett, Benjamin R.; Louie, Angelique Y.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Correa, Carlos; Ma, Kwan Liu] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Jarrett, BR (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	aylouie@ucdavis.edu			National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering [R01EB000993]; Department of Energy [DESC0002289]; NCI [U24 CA 110804]; NATIONAL CANCER INSTITUTE [U24CA110804, P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000993] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Department of Energy(United States Department of Energy (DOE)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering R01EB000993 (AYL and BRJ), and the Department of Energy DESC0002289 (AYL, CC, KM). Imaging work performed at the CMGI is supported in part by a NCI Small Animal Imaging Resource grant (U24 CA 110804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia V, 2003, SOUTH MED J, V96, P1142, DOI 10.1097/01.SMJ.0000089063.76530.04; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Calara F, 2001, J PATHOL, V195, P257, DOI 10.1002/path.915; Cherry SR, 2001, J CLIN PHARMACOL, V41, P482, DOI 10.1177/00912700122010357; Choudhury RP, 2002, ARTERIOSCL THROM VAS, V22, P1065, DOI 10.1161/01.ATV.0000019735.54479.2F; DAVIES MJ, 1993, BRIT HEART J, V69, P377; Fayad ZA, 2001, INT J CARDIAC IMAG, V17, P165, DOI 10.1023/A:1010611530845; Fayad ZA, 2001, CIRC RES, V89, P305, DOI 10.1161/hh1601.095596; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Fuster V, 2005, J AM COLL CARDIOL, V46, P1209, DOI 10.1016/j.jacc.2005.03.075; Gustafsson B, 2006, BIOCONJUGATE CHEM, V17, P538, DOI 10.1021/bc060018k; GUSTAFSSON B, 2006, BIOCONJUGATE C UNPUB; Hu WC, 2005, CARDIOVASC PATHOL, V14, P120, DOI 10.1016/j.carpath.2005.02.004; Jarrett BR, 2008, BIOCONJUGATE CHEM, V19, P1496, DOI 10.1021/bc800108v; Jarrett BR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/3/035603; Johnson JL, 2001, ATHEROSCLEROSIS, V154, P399, DOI 10.1016/S0021-9150(00)00515-3; LeFont A, 2005, HEART, V89, P1262; Lowe HC, 2003, THROMB HAEMOSTASIS, V90, P774, DOI 10.1160/TH03-06-0374; Lutgens E, 2003, ARTERIOSCL THROM VAS, V23, P2123, DOI 10.1161/01.ATV.0000097783.01596.E2; MacNeill BD, 2003, ARTERIOSCL THROM VAS, V23, P1333, DOI 10.1161/01.ATV.0000080948.08888.BF; Mitra AK, 2004, CAN J PHYSIOL PHARM, V82, P860, DOI 10.1139/Y04-095; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Nighoghossian N, 2005, STROKE, V36, P2764, DOI 10.1161/01.STR.0000190895.51934.43; PALMACCI S, 1993, SYNTHESIS POLYSACCHA, P1; Rekhter MD, 2002, CARDIOVASC RES, V54, P36, DOI 10.1016/S0008-6363(01)00537-5; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Tai YC, 2003, PHYS MED BIOL, V48, P1519, DOI 10.1088/0031-9155/48/11/303; Tiong AY, 2005, AM HEART J, V150, P11, DOI 10.1016/j.ahj.2004.12.019; Tuzcu EM, 2003, J AM COLL CARDIOL, V42, P1033, DOI 10.1016/S0735-1097(03)00904-5; Volker W, 1997, ATHEROSCLEROSIS, V130, P29, DOI 10.1016/S0021-9150(96)06039-X; von Maltzahn G, 2008, BIOCONJUGATE CHEM, V19, P1570, DOI 10.1021/bc800077y; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; Yang YF, 2004, PHYS MED BIOL, V49, P2527, DOI 10.1088/0031-9155/49/12/005; Zheng J, 2005, MAGNET RESON MED, V54, P1360, DOI 10.1002/mrm.20724; Zoldhelyi P, 2000, AM J PHYSIOL-HEART C, V279, pH3065, DOI 10.1152/ajpheart.2000.279.6.H3065	36	44	46	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13254	10.1371/journal.pone.0013254	http://dx.doi.org/10.1371/journal.pone.0013254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949008	Green Submitted, Green Published, gold			2022-12-25	WOS:000282748100007
J	Yuan, QA; Jantti, J				Yuan, Qiang; Jantti, Jussi			Functional Analysis of Phosphorylation on Saccharomyces cerevisiae Syntaxin 1 Homologues Sso1p and Sso2p	PLOS ONE			English	Article							PROSPORE MEMBRANE FORMATION; FILAMENTOUS GROWTH; PSEUDOHYPHAL DIFFERENTIATION; SECRETORY PATHWAY; SNARE COMPLEX; BUDDING YEAST; FUSION; PROTEINS; SPORULATION; EXOCYTOSIS	Background: The Saccharomyces cerevisiae syntaxin1 homologues Sso1p and Sso2p perform an essential function in membrane fusion in exocytosis. While deletion of either SSO1 or SSO2 causes no obvious phenotype in vegetatively grown cells, deletion of both genes is lethal. In sporulating diploid S. cerevisiae cells only Sso1p, but not Sso2p, is needed for membrane fusion during prospore membrane formation. Mass spectrometry and in vivo labeling data suggest that serines 23, 24, and 79 in Sso1p and serines 31 and 34 in Sso2p can be phosphorylated in vivo. Here we set out to assess the contribution of phosphorylation on Sso protein in vivo function. Principal Findings: Different mutant versions of SSO1 and SSO2 were generated to target the phosphorylation sites in Sso1p and Sso2p. Basal or overexpression of phospho-mimicking or putative non-phosphorylated Sso1p or Sso2p mutants resulted in no obvious growth phenotype. However, S79A and S79E mutations caused a mild defect in the ability of Sso1p to complement the temperature-sensitive growth phenotype of sso2-1 sso1 Delta cells. Combination of all mutations did not additionally compromise Sso1p in vivo function. When compared to the wild type SSO1 and SSO2, the phosphoamino acid mutants displayed similar genetic interactions with late acting sec mutants. Furthermore, diploid cells expressing only the mutant versions of Sso1p had no detectable sporulation defects. In addition to sporulation, also pseudohyphal and invasive growth modes are regulated by the availability of nutrients. In contrast to sporulating diploid cells, deletion of SSO1 or SSO2, or expression of the phospho-mutant versions of SSO1 or SSO2 as the sole copies of SSO genes caused no defects in haploid or diploid pseudohyphal and invasive growth. Conclusions: The identified phosphorylation sites do not significantly contribute to the in vivo functionality of Sso1p and Sso2p in S. cerevisiae.	[Yuan, Qiang; Jantti, Jussi] Univ Helsinki, Inst Biotechnol, Res Program Cell & Mol Biol, Helsinki, Finland	University of Helsinki	Yuan, QA (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Cell & Mol Biol, Helsinki, Finland.	jussi.jantti@helsinki.fi			Academy of Finland [124249, 133552]; Magnus Ehrnrooth Foundation; Institute of Biotechnology; Helsinki Graduate School in Biotechnology and Molecular Biology	Academy of Finland(Academy of Finland); Magnus Ehrnrooth Foundation; Institute of Biotechnology; Helsinki Graduate School in Biotechnology and Molecular Biology	This work was financially supported by the Academy of Finland (Grants 124249 and 133552 to JJ), Magnus Ehrnrooth Foundation (JJ), and the Institute of Biotechnology. QY was supported by the Helsinki Graduate School in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Brachmann CB, 1998, YEAST, V14, P115; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; CHOUDHARY C, 2010, NATURE REV MOL CELL, V10; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Enyenihi AH, 2003, GENETICS, V163, P47; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Jahn R, 2002, CURR OPIN CELL BIOL, V14, P488, DOI 10.1016/S0955-0674(02)00356-3; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jantti J, 1999, P NATL ACAD SCI USA, V96, P909, DOI 10.1073/pnas.96.3.909; Jantti J, 2002, J CELL SCI, V115, P409; Knop M, 2005, MOL BIOL CELL, V16, P4543, DOI 10.1091/mbc.E05-03-0243; Liu HP, 1996, GENETICS, V144, P967; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; Marash M, 2001, EMBO J, V20, P411, DOI 10.1093/emboj/20.3.411; Mendonsa R, 2009, EUKARYOT CELL, V8, P1094, DOI 10.1128/EC.00076-09; Moreno-Borchart AC, 2003, MICROBIOL RES, V158, P83, DOI 10.1078/0944-5013-00194; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Oyen M, 2004, CURR GENET, V45, P76, DOI 10.1007/s00294-003-0462-8; Pan XW, 2000, CURR OPIN MICROBIOL, V3, P567, DOI 10.1016/S1369-5274(00)00142-9; Patwardhan P, 2007, CELL SIGNAL, V19, P2218, DOI 10.1016/j.cellsig.2007.06.006; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Schweiger R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-6; SHERMAN F, 1991, P3; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Weber M, 2010, MOL BIOL CELL, V21, P1362, DOI 10.1091/mbc.E09-07-0546; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Yang HJ, 2008, J CELL BIOL, V183, P1089, DOI 10.1083/jcb.200809178	35	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13323	10.1371/journal.pone.0013323	http://dx.doi.org/10.1371/journal.pone.0013323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948969	Green Published, Green Submitted, gold			2022-12-25	WOS:000282748100031
J	Ribeiro-dos-Santos, A; Khayat, AS; Silva, A; Alencar, DO; Lobato, J; Luz, L; Pinheiro, DG; Varuzza, L; Assumpcao, M; Assumpcao, P; Santos, S; Zanette, DL; Silva, WA; Burbano, R; Darnet, S				Ribeiro-dos-Santos, Andrea; Khayat, Andre S.; Silva, Artur; Alencar, Dayse O.; Lobato, Jesse; Luz, Larissa; Pinheiro, Daniel G.; Varuzza, Leonardo; Assumpcao, Monica; Assumpcao, Paulo; Santos, Sidney; Zanette, Dalila L.; Silva, Wilson A., Jr.; Burbano, Rommel; Darnet, Sylvain			Ultra-Deep Sequencing Reveals the microRNA Expression Pattern of the Human Stomach	PLOS ONE			English	Article							CANCER-CELL-LINES; HELICOBACTER-PYLORI; TARGETS; METASTASIS; BIOGENESIS; SIGNATURES; PROFILES; GENOMICS; RNAS	Background: While microRNAs (miRNAs) play important roles in tissue differentiation and in maintaining basal physiology, little is known about the miRNA expression levels in stomach tissue. Alterations in the miRNA profile can lead to cell deregulation, which can induce neoplasia. Methodology/Principal Findings: A small RNA library of stomach tissue was sequenced using high-throughput SOLiD sequencing technology. We obtained 261,274 quality reads with perfect matches to the human miRnome, and 42% of known miRNAs were identified. Digital Gene Expression profiling (DGE) was performed based on read abundance and showed that fifteen miRNAs were highly expressed in gastric tissue. Subsequently, the expression of these miRNAs was validated in 10 healthy individuals by RT-PCR showed a significant correlation of 83.97% (P<0.05). Six miRNAs showed a low variable pattern of expression (miR-29b, miR-29c, miR-19b, miR-31, miR-148a, miR-451) and could be considered part of the expression pattern of the healthy gastric tissue. Conclusions/Significance: This study aimed to validate normal miRNA profiles of human gastric tissue to establish a reference profile for healthy individuals. Determining the regulatory processes acting in the stomach will be important in the fight against gastric cancer, which is the second-leading cause of cancer mortality worldwide.	[Ribeiro-dos-Santos, Andrea; Khayat, Andre S.; Silva, Artur; Alencar, Dayse O.; Lobato, Jesse; Luz, Larissa; Santos, Sidney; Burbano, Rommel; Darnet, Sylvain] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Pinheiro, Daniel G.; Zanette, Dalila L.; Silva, Wilson A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, Brazil; [Varuzza, Leonardo] Life Technol, Sao Paulo, Brazil; [Assumpcao, Monica; Assumpcao, Paulo] Fed Univ Para, Hosp Univ Joao Barros Barreto, BR-66059 Belem, Para, Brazil; [Zanette, Dalila L.; Silva, Wilson A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Reg Hemoterapia, Ribeirao Preto, Brazil; [Zanette, Dalila L.; Silva, Wilson A., Jr.] Inst Nacl Ciencia & Tecnol Celulas Troncos & Tera, Ribeirao Preto, Brazil	Universidade Federal do Para; Universidade de Sao Paulo; Thermo Fisher Scientific; Universidade Federal do Para; Universidade de Sao Paulo	Ribeiro-dos-Santos, A (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	akely@ufpa.br	Silva, Artur/E-1474-2014; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; DARNET, Sylvain Henri/G-4912-2012; ZANETTE, DALILA/Q-3541-2016; Burbano, Rommel R/C-4149-2012; Guariz Pinheiro, Daniel/H-4604-2012; Silva Jr, Wilson Araújo/E-9487-2011; Santos, Ândrea Ribeiro dos/B-6061-2013; Khayat, Andre/AAF-2415-2019; Luiz Silva, Artur da Costa da/AAI-3516-2021	Silva, Artur/0000-0002-4082-1132; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; DARNET, Sylvain Henri/0000-0001-6351-0903; Burbano, Rommel R/0000-0002-4872-234X; Guariz Pinheiro, Daniel/0000-0001-7062-5936; Silva Jr, Wilson Araújo/0000-0001-9364-2886; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; zanette, dalila l./0000-0001-9397-4127	Governo do Para/SEDECT/FAPESPA; PROPESP/UFPA; FADESP; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Governo do Para/SEDECT/FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PROPESP/UFPA; FADESP; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the Genoma Paraense de Genomica e Proteomica Project (Governo do Para/SEDECT/FAPESPA), PROPESP/UFPA, FADESP and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen YH, 2009, BIOINFORMATICS, V25, P2514, DOI 10.1093/bioinformatics/btp486; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Fischbach W, 2009, DTSCH ARZTEBL INT, V106, P801, DOI 10.3238/arztebl.2009.0801; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kuehn H., 2008, CURR PROTOC BIOINFOR, DOI [DOI 10.1002/0471250953.BI0712S22, 10.1002/0471250953.bi0712s22]; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langner Marini, 2009, Arq. Gastroenterol., V46, P328, DOI 10.1590/S0004-28032009000400015; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Magoha G A O, 2007, East Afr Med J, V84, pS3; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ricarte Filho Júlio C.M., 2006, Arq Bras Endocrinol Metab, V50, P1102, DOI 10.1590/S0004-27302006000600018; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0	27	52	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13205	10.1371/journal.pone.0013205	http://dx.doi.org/10.1371/journal.pone.0013205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949028	Green Submitted, gold, Green Published			2022-12-25	WOS:000282676700008
J	Coffroth, MA; Poland, DM; Petrou, EL; Brazeau, DA; Holmberg, JC				Coffroth, Mary Alice; Poland, Daniel M.; Petrou, Eleni L.; Brazeau, Daniel A.; Holmberg, Jennie C.			Environmental Symbiont Acquisition May Not Be the Solution to Warming Seas for Reef-Building Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; ALGAL ENDOSYMBIONTS; THERMAL TOLERANCE; BLEACHING EVENT; CLIMATE-CHANGE; ZOOXANTHELLAE; SYMBIODINIUM; DIVERSITY; FLEXIBILITY	Background: Coral reefs worldwide are in decline. Much of the mortality can be attributed to coral bleaching (loss of the coral's intracellular photosynthetic algal symbiont) associated with global warming. How corals will respond to increasing oceanic temperatures has been an area of extensive study and debate. Recovery after a bleaching event is dependent on regaining symbionts, but the source of repopulating symbionts is poorly understood. Possibilities include recovery from the proliferation of endogenous symbionts or recovery by uptake of exogenous stress-tolerant symbionts. Methodology/Principal Findings: To test one of these possibilities, the ability of corals to acquire exogenous symbionts, bleached colonies of Porites divaricata were exposed to symbiont types not normally found within this coral and symbiont acquisition was monitored. After three weeks exposure to exogenous symbionts, these novel symbionts were detected in some of the recovering corals, providing the first experimental evidence that scleractinian corals are capable of temporarily acquiring symbionts from the water column after bleaching. However, the acquisition was transient, indicating that the new symbioses were unstable. Only those symbiont types present before bleaching were stable upon recovery, demonstrating that recovery was from the resident in situ symbiont populations. Conclusions/Significance: These findings suggest that some corals do not have the ability to adjust to climate warming by acquiring and maintaining exogenous, more stress-tolerant symbionts. This has serious ramifications for the success of coral reefs and surrounding ecosystems and suggests that unless actions are taken to reverse it, climate change will lead to decreases in biodiversity and a loss of coral reefs.	[Coffroth, Mary Alice] SUNY Buffalo, Grad Program Evolut Ecol & Behav, Dept Geol, Buffalo, NY 14260 USA; [Poland, Daniel M.; Petrou, Eleni L.; Holmberg, Jennie C.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Brazeau, Daniel A.] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Coffroth, MA (corresponding author), SUNY Buffalo, Grad Program Evolut Ecol & Behav, Dept Geol, Buffalo, NY 14260 USA.	Coffroth@buffalo.edu		Holmberg, Jennie/0000-0002-1106-4718	National Science Foundation [0424996]; UB Honors College	National Science Foundation(National Science Foundation (NSF)); UB Honors College	This work was supported by National Science Foundation (NSF-http://www.nsf.gov/) grant 0424996 awarded to Mary Alice Coffroth and a grant from the UB Honors College Research and Creative Activities Fund (http://honors.buffalo.edu/enrolled/research.php) awarded to Eleni Petrou. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Brown BE, 1997, CORAL REEFS, V16, P129; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; COFFROTH MA, 1992, MAR BIOL, V114, P317, DOI 10.1007/BF00349534; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Deboer ML, 2007, COMP BIOCHEM PHYS D, V2, P63, DOI 10.1016/j.cbd.2006.11.003; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Glynn PW, 2001, B MAR SCI, V69, P79; GLYNN PW, 1983, ENVIRON CONSERV, V10, P149, DOI 10.1017/S0376892900012248; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Lewis CL, 2004, SCIENCE, V304, P1490, DOI 10.1126/science.1097323; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; POLNEFULLER M, 1991, J PHYCOL, V27, P552, DOI 10.1111/j.0022-3646.1991.00552.x; Rodriguez-Lanetty M, 2006, MAR BIOL, V149, P713, DOI 10.1007/s00227-006-0272-x; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x	37	72	73	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13258	10.1371/journal.pone.0013258	http://dx.doi.org/10.1371/journal.pone.0013258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949064	gold, Green Submitted, Green Published			2022-12-25	WOS:000282633700021
J	Liu, JL; Piette, BMAG; Deeks, MJ; Franklin-Tong, VE; Hussey, PJ				Liu, Junli; Piette, Bernard M. A. G.; Deeks, Michael J.; Franklin-Tong, Vernonica E.; Hussey, Patrick J.			A Compartmental Model Analysis of Integrative and Self-Regulatory Ion Dynamics in Pollen Tube Growth	PLOS ONE			English	Article							TIP GROWTH; CALCIUM; MEMBRANE; OSCILLATIONS; PLANTS; HYDRODYNAMICS; CHANNELS; GTPASE; FLUXES; CELLS	Sexual reproduction in higher plants relies upon the polarised growth of pollen tubes. The growth-site at the pollen tube tip responds to signalling processes to successfully steer the tube to an ovule. Essential features of pollen tube growth are polarisation of ion fluxes, intracellular ion gradients, and oscillating dynamics. However, little is known about how these features are generated and how they are causally related. We propose that ion dynamics in biological systems should be studied in an integrative and self-regulatory way. Here we have developed a two-compartment model by integrating major ion transporters at both the tip and shank of pollen tubes. We demonstrate that the physiological features of polarised growth in the pollen tube can be explained by the localised distribution of transporters at the tip and shank. Model analysis reveals that the tip and shank compartments integrate into a self-regulatory dynamic system, however the oscillatory dynamics at the tip do not play an important role in maintaining ion gradients. Furthermore, an electric current travelling along the pollen tube contributes to the regulation of ion dynamics. Two candidate mechanisms for growth-induced oscillations are proposed: the transition of tip membrane into shank membrane, and growth-induced changes in kinetic parameters of ion transporters. The methodology and principles developed here are applicable to the study of ion dynamics and their interactions with other functional modules in any plant cellular system.	[Liu, Junli; Deeks, Michael J.; Hussey, Patrick J.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Piette, Bernard M. A. G.] Univ Durham, Dept Math Sci, Durham, England; [Liu, Junli; Piette, Bernard M. A. G.; Deeks, Michael J.; Hussey, Patrick J.] Univ Durham, Biophys Sci Inst, Durham, England; [Franklin-Tong, Vernonica E.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	Durham University; Durham University; Durham University; University of Birmingham	Liu, JL (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	junli.liu@durham.ac.uk; p.j.hussey@durham.ac.uk	Franklin-Tong, Vernonica E/D-1287-2012	Deeks, Michael/0000-0001-5487-5732; Hussey, Patrick/0000-0002-7349-8722; Piette, Bernard/0000-0001-9777-603X; Franklin-Tong, Noni/0000-0003-1782-8413; Liu, Junli/0000-0001-8264-2450	Research Councils UK; Biotechnology and Biological Sciences Research Council (BBSRC); Science and Technology Facilities Council (STFC) [ST/H003649/1]; Science and Technology Facilities Council [ST/G000433/1] Funding Source: researchfish; STFC [ST/G000433/1] Funding Source: UKRI	Research Councils UK(UK Research & Innovation (UKRI)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	JL and PH gratefully acknowledge Research Councils UK and the Biotechnology and Biological Sciences Research Council (BBSRC) for funding in support of this work. BP was supported by the Science and Technology Facilities Council (STFC) grant ST/H003649/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JD, 2007, ANN BOT-LONDON, V100, P1117, DOI 10.1093/aob/mcm208; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Certal AC, 2008, PLANT CELL, V20, P614, DOI 10.1105/tpc.106.047423; Chebli Y., 2007, FUNCT PLANT SCI BIOT, V1, P232; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; Dutta R, 2004, PLANT PHYSIOL, V135, P1398, DOI 10.1104/pp.104.041483; Endresen LP, 2000, EUR BIOPHYS J BIOPHY, V29, P90, DOI 10.1007/s002490050254; Feijo JA, 1999, J CELL BIOL, V144, P483, DOI 10.1083/jcb.144.3.483; FELLE HH, 1994, PLANT PHYSIOL, V106, P1131, DOI 10.1104/pp.106.3.1131; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Gradmann D, 1998, J MEMBRANE BIOL, V166, P51, DOI 10.1007/s002329900446; Gradmann D, 2001, AUST J PLANT PHYSIOL, V28, P577; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; Iwano M, 2009, PLANT PHYSIOL, V150, P1322, DOI 10.1104/pp.109.139329; KLIPP E, 2008, SYSTEMS BIOL TXB; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; Lovy-Wheeler A, 2006, PLANT CELL, V18, P2182, DOI 10.1105/tpc.106.044867; MALHO R, 1994, PLANT J, V5, P331, DOI 10.1111/j.1365-313X.1994.00331.x; Messerli MA, 1999, J CELL SCI, V112, P1497; Messerli MA, 2004, PLANT J, V40, P799, DOI 10.1111/j.1365-313X.2004.02252.x; Messerli MA, 2003, PLANTA, V217, P147, DOI 10.1007/s00425-003-0972-0; Michard E, 2008, SEX PLANT REPROD, V21, P169, DOI 10.1007/s00497-008-0076-x; Michard E, 2009, INT J DEV BIOL, V53, P1609, DOI 10.1387/ijdb.072296em; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Parton RM, 2003, J CELL SCI, V116, P2707, DOI 10.1242/jcs.00468; Pierson ES, 1996, DEV BIOL, V174, P160, DOI 10.1006/dbio.1996.0060; Roberts SK, 2006, NEW PHYTOL, V169, P647, DOI 10.1111/j.1469-8137.2006.01639.x; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Shabala S, 2006, J EXP BOT, V57, P171, DOI 10.1093/jxb/erj022; Voit E., 1991, CANONICAL NONLINEAR; WEISENSEEL MH, 1975, J CELL BIOL, V66, P556, DOI 10.1083/jcb.66.3.556; Yan A, 2009, P NATL ACAD SCI USA, V106, P22002, DOI 10.1073/pnas.0910811106; Zonia L, 2002, PLANT CELL, V14, P2233, DOI 10.1105/tpc.003830; Zonia L, 2001, SEX PLANT REPROD, V14, P111, DOI 10.1007/s004970100093; Zonia L, 2006, CELL BIOCHEM BIOPHYS, V46, P209, DOI 10.1385/CBB:46:3:209; Zonia L, 2010, J EXP BOT, V61, P1939, DOI 10.1093/jxb/erq073	39	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13157	10.1371/journal.pone.0013157	http://dx.doi.org/10.1371/journal.pone.0013157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949135	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000282568400004
J	Gautier, M; Laloe, D; Moazami-Goudarzi, K				Gautier, Mathieu; Laloe, Denis; Moazami-Goudarzi, Katayoun			Insights into the Genetic History of French Cattle from Dense SNP Data on 47 Worldwide Breeds	PLOS ONE			English	Article							TAURINE BOS-TAURUS; POPULATION-STRUCTURE; EUROPEAN CATTLE; DOMESTIC CATTLE; DIVERSITY; MICROSATELLITES; EVOLUTION; ORIGINS; VARIABILITY; ADMIXTURE	Background: Modern cattle originate from populations of the wild extinct aurochs through a few domestication events which occurred about 8,000 years ago. Newly domesticated populations subsequently spread worldwide following breeder migration routes. The resulting complex historical origins associated with both natural and artificial selection have led to the differentiation of numerous different cattle breeds displaying a broad phenotypic variety over a short period of time. Methodology/Principal Findings: This study gives a detailed assessment of cattle genetic diversity based on 1,121 individuals sampled in 47 populations from different parts of the world (with a special focus on French cattle) genotyped for 44,706 autosomal SNPs. The analyzed data set consisted of new genotypes for 296 individuals representing 14 French cattle breeds which were combined to those available from three previously published studies. After characterizing SNP polymorphism in the different populations, we performed a detailed analysis of genetic structure at both the individual and population levels. We further searched for spatial patterns of genetic diversity among 23 European populations, most of them being of French origin, under the recently developed spatial Principal Component analysis framework. Conclusions/Significance: Overall, such high throughput genotyping data confirmed a clear partitioning of the cattle genetic diversity into distinct breeds. In addition, patterns of differentiation among the three main groups of populations-the African taurine, the European taurine and zebus-may provide some additional support for three distinct domestication centres. Finally, among the European cattle breeds investigated, spatial patterns of genetic diversity were found in good agreement with the two main migration routes towards France, initially postulated based on archeological evidence.	[Gautier, Mathieu] INRA, CBGP, UMR 1031, Montferrier Sur Lez, France; [Laloe, Denis; Moazami-Goudarzi, Katayoun] INRA, GABI, UMR 1313, Jouy En Josas, France	INRAE; Institut de Recherche pour le Developpement (IRD); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gautier, M (corresponding author), INRA, CBGP, UMR 1031, Montferrier Sur Lez, France.	gautierm@supagro.inra.fr	Laloe, Denis/O-7045-2019; gautier, mathieu/AAU-8789-2020; gautier, mathieu/F-7429-2010	gautier, mathieu/0000-0001-7257-5880; gautier, mathieu/0000-0001-7257-5880; Laloe, Denis/0000-0001-8359-0760	French Ministry of Education and Research; National Institute of Agronomic Research	French Ministry of Education and Research; National Institute of Agronomic Research	Genotyping was supported by the French Ministry of Education and Research and the National Institute of Agronomic Research (INRA AIP "BioRessources''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; BAKER CMA, 1980, ANIM BLOOD GROUPS BI, V11, P127; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; DENIS B., 2010, RACES BOVINES HIST A; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Freeman AR, 2006, ANIM GENET, V37, P1, DOI 10.1111/j.1365-2052.2005.01363.x; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; GROSCLAUDE F, 1990, GENET SEL EVOL, V22, P317, DOI 10.1051/gse:19900306; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hanotte O, 2000, MOL ECOL, V9, P387, DOI 10.1046/j.1365-294x.2000.00858.x; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Laloe D., 2010, Diversity, V2, P932, DOI 10.3390/d2060932; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MoazamiGoudarzi K, 1997, ANIM GENET, V28, P338, DOI 10.1111/j.1365-2052.1997.00176.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Payne W.J.A., 1997, TROPICAL CATTLE ORIG; Perez-Pardal L, 2010, HEREDITY, V105, P511, DOI 10.1038/hdy.2010.30; Perez-Pardal L, 2010, ANIM GENET, V41, P232, DOI 10.1111/j.1365-2052.2009.01988.x; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Thioulouse J, 1995, ENVIRON ECOL STAT, V2, P1, DOI 10.1007/BF00452928; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; WARTENBERG D, 1985, GEOGR ANAL, V17, P263, DOI 10.1111/j.1538-4632.1985.tb00849.x; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Wendorf Fred, 1994, Evolutionary Anthropology, V3, P118, DOI 10.1002/evan.1360030406; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zenger KR, 2007, ANIM GENET, V38, P7, DOI 10.1111/j.1365-2052.2006.01543.x	51	116	119	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13038	10.1371/journal.pone.0013038	http://dx.doi.org/10.1371/journal.pone.0013038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927341	Green Published, Green Submitted, gold			2022-12-25	WOS:000282312600012
J	Cao, KJ; Chen-Plotkin, AS; Plotkin, JB; Wang, LS				Cao, Kajia; Chen-Plotkin, Alice S.; Plotkin, Joshua B.; Wang, Li-San			Age-Correlated Gene Expression in Normal and Neurodegenerative Human Brain Tissues	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; ALZHEIMERS-DISEASE; TRANSCRIPTIONAL PROFILES; TDP-43 PROTEINOPATHY; DEMENTIA; NETWORKS; POPULATION; PREVALENCE; AUTOPHAGY	Background: Human brain aging has received special attention in part because of the elevated risks of neurodegenerative disorders such as Alzheimer's disease in seniors. Recent technological advances enable us to investigate whether similar mechanisms underlie aging and neurodegeneration, by quantifying the similarities and differences in their genome-wide gene expression profiles. Principal Findings: We have developed a computational method for assessing an individual's "physiological brain age'' by comparing global mRNA expression datasets across a range of normal human brain samples. Application of this method to brains samples from select regions in two diseases - Alzheimer's disease (AD, superior frontal gyrus), frontotemporal lobar degeneration (FTLD, in rostral aspect of frontal cortex, similar to BA10) - showed that while control cohorts exhibited no significant difference between physiological and chronological ages, FTLD and AD exhibited prematurely aged expression profiles. Conclusions: This study establishes a quantitative scale for measuring premature aging in neurodegenerative disease cohorts, and it identifies specific physiological mechanisms common to aging and some forms of neurodegeneration. In addition, accelerated expression profiles associated with AD and FTLD suggest some common mechanisms underlying the risk of developing these diseases.	[Cao, Kajia; Wang, Li-San] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.; Wang, Li-San] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.] Univ Penn, Ctr Neurodegenerat Dis, Philadelphia, PA 19104 USA; [Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Cao, Kajia; Wang, Li-San] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Cao, KJ (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	lswang@mail.med.upenn.edu	Plotkin, Joshua B/E-6947-2013		University of Pennsylvania Research Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists; NIH [K08AG033101-01]; AAN-ALS Association; James S. McDonnell Foundation; Alfred P. Sloan Foundation; David and Lucille Packard Foundation; NATIONAL INSTITUTE ON AGING [K08AG033101] Funding Source: NIH RePORTER	University of Pennsylvania Research Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAN-ALS Association; James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David and Lucille Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is funded by a University of Pennsylvania Research Foundation Pilot Grant (KC and LW). ACP is supported by a Burroughs Wellcome Fund Career Award for Medical Scientists, NIH K08AG033101-01, and an AAN-ALS Association Clinician Scientist Development Award. JBP is supported by a Burroughs Wellcome Fund Career Award at the Scientific Interface, the James S. McDonnell Foundation, and the Alfred P. Sloan Foundation, and the David and Lucille Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MS, 1988, PSYCHOL AGING, V3, P173, DOI 10.1037/0882-7974.3.2.173; ALBERT MS, 1990, PSYCHOL AGING, V5, P94, DOI 10.1037/0882-7974.5.1.94; Arenberg D, 1990, Adv Neurol, V51, P207; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Boeve BF, 2008, ARCH NEUROL-CHICAGO, V65, P460, DOI 10.1001/archneur.65.4.460; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chen-Plotkin AS, 2008, HUM MOL GENET, V17, P1349, DOI 10.1093/hmg/ddn023; Colsher Patricia L., 1991, Annals of Epidemiology, V1, P215; Cook PE, 2007, NAT PROTOC, V2, P2796, DOI 10.1038/nprot.2007.396; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; Cruts M, 2008, TRENDS GENET, V24, P186, DOI 10.1016/j.tig.2008.01.004; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Ertekin-Taner N, 2007, NEUROL CLIN, V25, P611, DOI 10.1016/j.ncl.2007.03.009; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golden TR, 2008, AGING CELL, V7, P850, DOI 10.1111/j.1474-9726.2008.00433.x; Hawse JR, 2004, EXP EYE RES, V79, P935, DOI 10.1016/j.exer.2004.04.007; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; Kumar-Singh S, 2007, BRAIN PATHOL, V17, P104, DOI 10.1111/j.1750-3639.2007.00055.x; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Rosso SM, 2003, BRAIN, V126, P2016, DOI 10.1093/brain/awg204; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wu JZ, 2007, GERMA BACKGROUND ADJ; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zelinski EM, 1997, PSYCHOL AGING, V12, P503, DOI 10.1037/0882-7974.12.3.503	47	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13098	10.1371/journal.pone.0013098	http://dx.doi.org/10.1371/journal.pone.0013098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927326	Green Submitted, gold, Green Published			2022-12-25	WOS:000282269400032
J	Accetturo, M; Creanza, TM; Santoro, C; Tria, G; Giordano, A; Battagliero, S; Vaccina, A; Scioscia, G; Leo, P				Accetturo, Matteo; Creanza, Teresa M.; Santoro, Claudia; Tria, Giancarlo; Giordano, Antonio; Battagliero, Simone; Vaccina, Antonella; Scioscia, Gaetano; Leo, Pietro			Finding New Genes for Non-Syndromic Hearing Loss through an In Silico Prioritization Study	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE DEAFNESS; HUMAN NONSYNDROMIC DEAFNESS; TRANSCRIPTION FACTOR; ALLELIC MUTATIONS; JUNCTION PROTEIN; HUMAN HOMOLOG; HAIR-CELLS; DOMINANT; COCHLEAR; SIMILARITY	At present, 51 genes are already known to be responsible for Non-Syndromic hereditary Hearing Loss (NSHL), but the knowledge of 121 NSHL-linked chromosomal regions brings to the hypothesis that a number of disease genes have still to be uncovered. To help scientists to find new NSHL genes, we built a gene-scoring system, integrating Gene Ontology, NCBI Gene and Map Viewer databases, which prioritizes the candidate genes according to their probability to cause NSHL. We defined a set of candidates and measured their functional similarity with respect to the disease gene set, computing a score (S S M-avg) that relies on the assumption that functionally related genes might contribute to the same (disease) phenotype. A Kolmogorov-Smirnov test, comparing the pair-wise S S M-avg distribution on the disease gene set with the distribution on the remaining human genes, provided a statistical assessment of this assumption. We found at a p-value<2.2.10(-16) that the former pair-wise S S M-avg is greater than the latter, justifying a prioritization strategy based on the functional similarity of candidate genes respect to the disease gene set. A cross-validation test measured to what extent the S S M-avg ranking for NSHL is different from a random ordering: adding 15% of the disease genes to the candidate gene set, the ranking of the disease genes in the first eight positions resulted statistically different from a hypergeometric distribution with a p-value=2.04.10(-5) and a power>0.99. The twenty top-scored genes were finally examined to evaluate their possible involvement in NSHL. We found that half of them are known to be expressed in human inner ear or cochlea and are mainly involved in remodeling and organization of actin formation and maintenance of the cilia and the endocochlear potential. These findings strongly indicate that our metric was able to suggest excellent NSHL candidates to be screened in patients and controls for causative mutations.	[Accetturo, Matteo] IBM Corp, GBS BAO Adv Analyt Serv, Bari, Italy; IBM Corp, MBLab, Bari, Italy	International Business Machines (IBM); International Business Machines (IBM)	Accetturo, M (corresponding author), IBM Corp, GBS BAO Adv Analyt Serv, Bari, Italy.	pietro_leo@it.ibm.com	CREANZA, TERESA MARIA/AAX-6584-2020	CREANZA, TERESA MARIA/0000-0003-4926-6451; TRIA, Giancarlo/0000-0003-4736-471X	Ministero dell'Universita e della Ricerca (MUR) [DM19410]	Ministero dell'Universita e della Ricerca (MUR)(Ministry of Education, Universities and Research (MIUR))	The authors acknowledge support of the Ministero dell'Universita e della Ricerca (MUR), under the project DM19410 "Laboratorio di Bioinformatica per la Biodiversita' Molecolare'' MBLab (www.mblabproject.it). Given the educational spirit of this work and of the entire project, this study was conducted by the authors in total autonomy, and the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are employed with IBM Italy SpA. They serve as investigators for the research and educational project DM19410 "Laboratorio di Bioinformatica per la Biodiversita' Molecolare'' MBLab. The authors confirm their adherence to all the PLoS ONE policies on sharing data and materials.	Abe S, 2003, J HUM GENET, V48, P564, DOI 10.1007/s10038-003-0079-2; Abe S, 2003, AM J HUM GENET, V72, P73, DOI 10.1086/345398; Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Ahmed ZM, 2008, NAT GENET, V40, P1335, DOI 10.1038/ng.245; Ansar M, 2003, EUR J HUM GENET, V11, P77, DOI 10.1038/sj.ejhg.5200905; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bespalova IN, 2001, HUM MOL GENET, V10, P2501, DOI 10.1093/hmg/10.22.2501; *BGEE, DATABASE GEN EXPR EV; BODENREIDER O, 2005, PAC S BIOCOMPUT, V7, P91; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; Collin RWJ, 2008, AM J HUM GENET, V82, P125, DOI 10.1016/j.ajhg.2007.09.008; Couto F.M., 2005, P 14 ACM INT C INF K, P343, DOI DOI 10.1145/1099554.1099658; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; del Pozo A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-50; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Donaudy F, 2003, AM J HUM GENET, V72, P1571, DOI 10.1086/375654; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; *IHR, TABL GEN EXPR DEV EA; Jiang J. J., 1997, P INT C RES COMP LIN, P19; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; Kalay E, 2006, HUM MUTAT, V27, P633, DOI 10.1002/humu.20368; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Khan SY, 2007, HUM MUTAT, V28, P417, DOI 10.1002/humu.20469; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; Li GC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030008; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Lin D, 1998, P INT C MACH LEARN; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Liu XZ, 2010, AM J HUM GENET, V86, P65, DOI 10.1016/j.ajhg.2009.11.015; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; LORD P, 2003, PAC S BIOCOMPUT, V8, P601; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Modamio-Hoybjor S, 2007, AM J HUM GENET, V80, P1076, DOI 10.1086/518311; *MORT LAB, MORT LAB COCHL EST D; Naz S, 2002, AM J HUM GENET, V71, P632, DOI 10.1086/342193; Naz S, 2004, J MED GENET, V41, P591, DOI 10.1136/jmg.2004.018523; *NCBI, NCBI UNIGENE ORG VIE; *NCBI, NCBI GEO GEN EXPR OM; OTHMAN R, 2007, J BIOMED INFORM, V23, P529; Ouyang XM, 2002, HUM GENET, V111, P26, DOI 10.1007/s00439-002-0736-0; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Peters LM, 2002, HUM MOL GENET, V11, P2877, DOI 10.1093/hmg/11.23.2877; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Riazuddin S, 2006, AM J HUM GENET, V78, P137, DOI 10.1086/499164; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; RIENSCHE RM, 2007, IEEE C, P99; Robertson NG, 1998, NAT GENET, V20, P299, DOI 10.1038/3118; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schrijver I, 2004, J MOL DIAGN, V6, P275, DOI 10.1016/S1525-1578(10)60522-3; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Schultz JM, 2009, AM J HUM GENET, V85, P25, DOI 10.1016/j.ajhg.2009.06.003; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Shabbir MI, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039834; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Tlili A, 2005, HUM HERED, V60, P123, DOI 10.1159/000088974; Tranebjaerg L, 1997, AM J HUM GENET, V61, pA349; Tulipano A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-329; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Van Laer L, 1998, NAT GENET, V20, P194; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Wu HW, 2005, NUCLEIC ACIDS RES, V33, P2822, DOI 10.1093/nar/gki573; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Young TL, 2001, HUM MOL GENET, V10, P2509, DOI 10.1093/hmg/10.22.2509; Yu H, 2005, GENE, V352, P75, DOI 10.1016/j.gene.2005.03.033; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999; R PACKAGE MATCHING; GENE ANALOGUE FINDER	101	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e12742	10.1371/journal.pone.0012742	http://dx.doi.org/10.1371/journal.pone.0012742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927407	Green Published, Green Submitted, gold			2022-12-25	WOS:000282210700001
J	Wickstrom, D; Wagner, S; Baars, L; Ytterberg, AJ; Klepsch, M; van Wijk, KJ; Luirink, J; de Gier, JW				Wickstrom, David; Wagner, Samuel; Baars, Louise; Ytterberg, A. Jimmy; Klepsch, Mirjam; van Wijk, Klaas J.; Luirink, Joen; de Gier, Jan-Willem			Consequences of Depletion of the Signal Recognition Particle in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYTOPIC MEMBRANE-PROTEIN; HEAT-SHOCK PROTEINS; CYTOPLASMIC MEMBRANE; TRIGGER FACTOR; 4.5S RNA; PATHWAY; INNER; INSERTION; TRANSLOCATION; TRANSLATION	Thus far, the role of the Escherichia coli signal recognition particle (SRP) has only been studied using targeted approaches. It has been shown for a handful of cytoplasmic membrane proteins that their insertion into the cytoplasmic membrane is at least partially SRP-dependent. Furthermore, it has been proposed that the SRP plays a role in preventing toxic accumulation of mistargeted cytoplasmic membrane proteins in the cytoplasm. To complement the targeted studies on SRP, we have studied the consequences of the depletion of the SRP component Fifty-four homologue (Ffh) in E. coli using a global approach. The steady-state proteomes and the proteome dynamics were evaluated using one- and two-dimensional gel analysis, followed by mass spectrometry-based protein identification and immunoblotting. Our analysis showed that depletion of Ffh led to the following: (i) impaired kinetics of the biogenesis of the cytoplasmic membrane proteome; (ii) lowered steady-state levels of the respiratory complexes NADH dehydrogenase, succinate dehydrogenase, and cytochrome bo(3) oxidase and lowered oxygen consumption rates; (iii) increased levels of the chaperones DnaK and GroEL at the cytoplasmic membrane; (iv) a sigma(32) stress response and protein aggregation in the cytoplasm; and (v) impaired protein synthesis. Our study shows that in E. coli SRP-mediated protein targeting is directly linked to maintaining protein homeostasis and the general fitness of the cell.	[Luirink, Joen] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [de Gier, Jan-Willem] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Ytterberg, A. Jimmy; van Wijk, Klaas J.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Vrije Universiteit Amsterdam; Stockholm University; Cornell University	Luirink, J (corresponding author), Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, De Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.	joen.luirink@falw.vu.nl; degier@dbb.su.se	Luirink, Joen/AAB-8658-2021; Ytterberg, Anders/E-1773-2016	Ytterberg, Anders/0000-0002-1485-2314; Luirink, J./0000-0001-8431-0804	National Institutes of Health [5R01GM081827-03]; Swedish Research Council; Carl Tryggers Stiftelse; Marianne and Marcus Wallenberg Foundation; Swedish Foundation for Strategic Research; Swedish Foundation for International Cooperation in Research and Higher Education; Wenner Foundation; Gren Foundation; NYSTAR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse; Marianne and Marcus Wallenberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Foundation for International Cooperation in Research and Higher Education; Wenner Foundation; Gren Foundation; NYSTAR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM081827-03. This work was also supported by the Swedish Research Council, Carl Tryggers Stiftelse, Marianne and Marcus Wallenberg Foundation, Swedish Foundation for Strategic Research-supported Center for Biomembrane Research (to J.-W. d. G.), grants from the Swedish Foundation for International Cooperation in Research and Higher Education (to J.-W. d. G. and K. J. v. W.), and the Wenner-Gren Foundations (to K. J. v. W.).; Proteomics infrastructure was supported by a grant from NYSTAR (to K. J. v. W.).	Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Avdeeva ON, 2002, FEBS LETT, V514, P70, DOI 10.1016/S0014-5793(02)02332-3; Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; BALZER D, 1992, NUCLEIC ACIDS RES, V20, P1851, DOI 10.1093/nar/20.8.1851; Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; Bernstein KD, 2001, J BACTERIOL, V183, P2187, DOI 10.1128/JB.183.7.2187-2197.2001; Bochkareva E, 1996, J BIOL CHEM, V271, P22256, DOI 10.1074/jbc.271.36.22256; Bochkareva ES, 1998, P NATL ACAD SCI USA, V95, P478, DOI 10.1073/pnas.95.2.478; Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Bowers CW, 2003, J BACTERIOL, V185, P5697, DOI 10.1128/JB.185.19.5697-5705.2003; Burk J, 2009, J BACTERIOL, V191, P7017, DOI 10.1128/JB.00208-09; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen Y, 2003, PROTEIN EXPRES PURIF, V32, P221, DOI 10.1016/S1046-5928(03)00233-X; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Dalbey RE, 2004, BBA-MOL CELL RES, V1694, P37, DOI 10.1016/j.bbamcr.2004.03.009; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Froderberg L, 2003, MOL MICROBIOL, V47, P1015, DOI 10.1046/j.1365-2958.2003.03346.x; Froderberg L, 2001, FEBS LETT, V498, P52, DOI 10.1016/S0014-5793(01)02494-2; Funes S, 2009, P NATL ACAD SCI USA, V106, P6656, DOI 10.1073/pnas.0809951106; Hasona A, 2005, P NATL ACAD SCI USA, V102, P17466, DOI 10.1073/pnas.0508778102; Hasona A, 2007, J BACTERIOL, V189, P1219, DOI 10.1128/JB.01146-06; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Hewitt CJ, 2004, ADV BIOCHEM ENG BIOT, V89, P197; JENSEN CG, 1994, J BACTERIOL, V176, P7148, DOI 10.1128/JB.176.23.7148-7154.1994; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Klepsch M, 2008, METHODS, V46, P48, DOI 10.1016/j.ymeth.2008.06.017; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; LUIRINK J, 1992, NATURE, V359, P741, DOI 10.1038/359741a0; MACFARLANE J, 1995, EUR J BIOCHEM, V233, P766, DOI 10.1111/j.1432-1033.1995.766_3.x; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Nakatogawa H, 2004, CURR OPIN MICROBIOL, V7, P145, DOI 10.1016/j.mib.2004.01.001; Nicchitta CV, 2002, CURR OPIN CELL BIOL, V14, P412, DOI 10.1016/S0955-0674(02)00353-8; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; PHILLIPS GJ, 1990, NATURE, V344, P882, DOI 10.1038/344882a0; PHILLIPS GJ, 1992, NATURE, V359, P744, DOI 10.1038/359744a0; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Raine A, 2003, BIOCHIMIE, V85, P659, DOI 10.1016/S0300-9084(03)00130-5; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1189, DOI 10.1046/j.1365-2958.2003.03772.x; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; RIBES V, 1990, CELL, V63, P591, DOI 10.1016/0092-8674(90)90454-M; Santos JM, 2002, MOL MICROBIOL, V45, P1729, DOI 10.1046/j.1365-2958.2002.03131.x; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; WIKSTROM PM, 1988, J BACTERIOL, V170, P3025, DOI 10.1128/jb.170.7.3025-3031.1988; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595	74	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4598	4609		10.1074/jbc.M109.081935	http://dx.doi.org/10.1074/jbc.M109.081935			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	20923772	Green Published, hybrid			2022-12-25	WOS:000286975700060
J	Wu, KM; Jiao, XM; Li, ZM; Katiyar, S; Casimiro, MC; Yang, WC; Zhang, QO; Willmarth, NE; Chepelev, I; Crosariol, M; Wei, Z; Hu, JB; Zhao, K; Pestell, RG				Wu, Kongming; Jiao, Xuanmao; Li, Zhaoming; Katiyar, Sanjay; Casimiro, Mathew C.; Yang, Wancai; Zhang, Qiong; Willmarth, Nicole E.; Chepelev, Iouri; Crosariol, Marco; Wei, Zhang; Hu, Junbo; Zhao, Keji; Pestell, Richard G.			Cell Fate Determination Factor Dachshund Reprograms Breast Cancer Stem Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERMINATION FACTOR DACH1; EPITHELIAL-MESENCHYMAL TRANSITION; CYCLIN D1; ANDROGEN RECEPTOR; EXPRESSION; GROWTH; BINDING; IDENTIFICATION; ACETYLATION; COACTIVATOR	The cell fate determination factor Dachshund was cloned as a dominant inhibitor of the hyperactive epidermal growth factor receptor ellipse. The expression of Dachshund is lost in human breast cancer associated with poor prognosis. Breast tumor-initiating cells (TIC) may contribute to tumor progression and therapy resistance. Here, endogenous DACH1 was reduced in breast cancer cell lines with high expression of TIC markers and in patient samples of the basal breast cancer phenotype. Re-expression of DACH1 reduced new tumor formation in serial transplantations in vivo, reduced mammosphere formation, and reduced the proportion of CD44(high)/CD24(low) breast tumor cells. Conversely, lentiviral shRNA to DACH1 increased the breast (B) TIC population. Genome-wide expression studies of mammary tumors demonstrated DACH1 repressed a molecular signature associated with stem cells (SOX2, Nanog, and KLF4) and genome-wide ChIP-seq analysis identified DACH1 binding to the promoter of the Nanog, KLF4, and Lin28 genes. KLF4/c-Myc and Oct4/Sox2 antagonized DACH1 repression of BTIC. Mechanistic studies demonstrated DACH1 directly repressed the Nanog and Sox2 promoters via a conserved domain. Endogenous DACH1 regulates BTIC in vitro and in vivo.	[Wu, Kongming; Zhang, Qiong; Willmarth, Nicole E.; Crosariol, Marco; Wei, Zhang; Pestell, Richard G.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Wu, Kongming; Li, Zhaoming; Hu, Junbo] Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Wuhan 430030, Peoples R China; [Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Chepelev, Iouri; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Jefferson University; Huazhong University of Science & Technology; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wu, KM (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, 233 S 10th St, Philadelphia, PA 19107 USA.	kmwu2005@gmail.com; director@kimmelcancercenter.org	Yang, Wancai/O-7655-2019; Zhang, Qiong/F-8172-2015	Yang, Wancai/0000-0001-7437-9197; Katiyar, Sanjay/0000-0003-1622-5661; Chepelev, Iouri/0000-0002-2121-8805; Li, Zhaoming/0000-0002-2876-5182	National Institutes of Health [R01CA70896, R01CA75503, R01CA86072, P30CA56036]; Dr. Ralph and Marian C. Falk Medical Research Trust; Margaret Q. Landenberger Research Foundation; Pennsylvania Department of Health; National Natural Science Foundation of China [81072169]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA075503, R01CA086072, R01CA070896] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian C. Falk Medical Research Trust; Margaret Q. Landenberger Research Foundation; Pennsylvania Department of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA70896, R01CA75503, and R01CA86072 (to R. G. P.) and Grant P30CA56036 (Kimmel Cancer Center Core grant to R. G. P.).; This work was also supported by a grant from Dr. Ralph and Marian C. Falk Medical Research Trust (to R. G. P.), Margaret Q. Landenberger Research Foundation (to K. W.), in part by a grant from the Pennsylvania Department of Health (to R. G. P.), and in part by National Natural Science Foundation of China Grant 81072169 (to K. W.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Edelman E, 2006, BIOINFORMATICS, V22, pE108, DOI 10.1093/bioinformatics/btl231; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Jiao XM, 2010, J BIOL CHEM, V285, P8218, DOI 10.1074/jbc.M110.100792; Laflamme C, 2003, CANCER RES, V63, P449; Li X, 2002, SCIENCE, V297, P1180; Li Z, 2008, J BIOL CHEM, V283, P7007, DOI 10.1074/jbc.M706992200; Lindsay J, 2008, CTS-CLIN TRANSL SCI, V1, P107, DOI 10.1111/j.1752-8062.2008.00041.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Nan FF, 2009, CANCER BIOL THER, V8, P1534, DOI 10.4161/cbt.8.16.8963; Noveen A, 2000, DEVELOPMENT, V127, P3475; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Popov VM, 2009, CANCER RES, V69, P5752, DOI 10.1158/0008-5472.CAN-08-3992; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sakamaki T, 2006, MOL CELL BIOL, V26, P5449, DOI 10.1128/MCB.02074-05; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Visvader JE, 2006, CANCER RES, V66, P9798, DOI 10.1158/0008-5472.CAN-06-2254; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Winchester C, 2000, J CLIN PATHOL, V53, P212, DOI 10.1136/jcp.53.3.212; Wu KM, 2003, J BIOL CHEM, V278, P51673, DOI 10.1074/jbc.M310021200; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Wu KM, 2007, MOL BIOL CELL, V18, P755, DOI 10.1091/mbc.E06-09-0793; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Wu KM, 2009, CANCER RES, V69, P3347, DOI 10.1158/0008-5472.CAN-08-3821; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhou J, 2010, P NATL ACAD SCI USA, V107, P6864, DOI 10.1073/pnas.1002746107	44	69	73	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2132	2142		10.1074/jbc.M110.148395	http://dx.doi.org/10.1074/jbc.M110.148395			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	20937839	hybrid, Green Published			2022-12-25	WOS:000286191500055
J	Lu, HY; Huang, DP; Saederup, N; Charo, IF; Ransohoff, RM; Zhou, L				Lu, Haiyan; Huang, Danping; Saederup, Noah; Charo, Israel F.; Ransohoff, Richard M.; Zhou, Lan			Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury	FASEB JOURNAL			English	Article						chemokine; chemokine receptor; inflammation; IGF-I; skeletal muscle regeneration	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR 2; MDX MICE; IGF-I; CELL ACTIVATION; BONE-MARROW; REGENERATION; EXPRESSION; MONOCYTES; INFLAMMATION	CC chemokine receptor 2 (CCR2) is essential to acute skeletal muscle injury repair. We studied the subpopulation of inflammatory cells recruited via CCR2 signaling and their cellular functions with respect to muscle regeneration. Mobilization of monocytes/macrophages (MOs/MPs), but not lymphocytes or neutrophils, was impaired from bone marrow to blood and from blood to injured muscle in Ccr2(-/-) mice. While the Ly-6C(+) but not the Ly-6C(-) subset of MOs/MPs was significantly reduced in blood, both subsets were drastically reduced in injured muscle of Ccr2(-/-) mice. Expression of insulin-like growth factor-1 (IGF-I) was markedly up-regulated in injured muscle of wild-type but not Ccr2(-/-) mice. IGF-I was strongly expressed by macrophages within injured muscle, more prominently by the Ly-6C(-) subset. A single injection of IGF-I, but not PBS, into injured muscle to replace IGF-I remarkably improved muscle regeneration in Ccr2(-/-) mice. CCR2 was not detected in myogenic cells or capillary endothelial cells in injured muscle to suggest its direct involvement in muscle regeneration or angiogenesis. We conclude that CCR2 is essential to acute skeletal muscle injury repair primarily by recruiting Ly-6C(+) MOs/MPs. Within injured muscle, these cells conduct phagocytosis, contribute to accumulation of intramuscular Ly-6C(-) macrophages, and produce a high level of IGF-I to promote muscle regeneration.-Lu, H., Huang, D., Saederupm, N., Charo, I. F., Ransohoff, R. M., Zhou, L. Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury. FASEB J. 25, 358-369 (2011). www.fasebj.org	[Lu, Haiyan; Huang, Danping; Ransohoff, Richard M.; Zhou, Lan] Cleveland Clin, Neuroinflammat Res Ctr, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA; [Ransohoff, Richard M.; Zhou, Lan] Cleveland Clin, Neurol Inst, Dept Neurol, Cleveland, OH 44195 USA; [Saederup, Noah; Charo, Israel F.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Saederup, Noah; Charo, Israel F.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Zhou, L (corresponding author), Cleveland Clin, Neuroinflammat Res Ctr, Dept Neurosci, Lerner Res Inst, 9500 Euclid Ave,S90, Cleveland, OH 44195 USA.	zhoul2@ccf.org			U.S. National Institutes of Health [K08 NS049346, 91682, K24 51400]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS049346] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is supported by U.S. National Institutes of Health grants K08 NS049346 (to L.Z.), MDA#91682 (to L.Z.), and K24 51400 (to R.M.R.). The authors thank Drs. Liping Liu and Georgiana Cheng and the Flow Cytometry Core of the Cleveland Clinic for superb technical support.	ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bartoli C, 2001, ACTA NEUROPATHOL, V102, P385; BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Cantini M, 2002, NEUROL SCI, V23, P189, DOI 10.1007/s100720200060; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; CARLSON BM, 1983, MED SCI SPORT EXER, V15, P187; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Dumont N, 2010, AM J PATHOL, V176, P2228, DOI 10.2353/ajpath.2010.090884; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayashi S, 2004, HISTOCHEM CELL BIOL, V122, P427, DOI 10.1007/s00418-004-0704-y; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Hill M, 2003, J PHYSIOL-LONDON, V549, P409, DOI 10.1113/jphysiol.2002.035832; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Kurek JB, 1997, MUSCLE NERVE, V20, P815; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Layland J, 2005, FASEB J, V19, P1137, DOI 10.1096/fj.04-2519fje; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Musaro A, 2005, ARCH ITAL BIOL, V143, P243; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Quinones MP, 2004, J CLIN INVEST, V113, P856, DOI 10.1172/JCI200420126; ROBERTSON TA, 1993, EXP CELL RES, V207, P321, DOI 10.1006/excr.1993.1199; Sacco A, 2005, J CELL BIOL, V171, P483, DOI 10.1083/jcb.200506123; Saederup N., 2010, PLOS ONE IN PRESS; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901; Tang G, 2004, J VASC SURG, V40, P786, DOI 10.1016/j.jvs.2004.07.012; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wagatsuma A, 2007, MOL CELL BIOCHEM, V298, P151, DOI 10.1007/s11010-006-9361-x; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Yahiaoui L, 2008, J PHYSIOL-LONDON, V586, P3991, DOI 10.1113/jphysiol.2008.152090; Zhou L, 2006, NEUROMUSCULAR DISORD, V16, P32, DOI 10.1016/j.nmd.2005.09.009; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	52	186	191	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					358	369		10.1096/fj.10-171579	http://dx.doi.org/10.1096/fj.10-171579			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20889618	Green Published			2022-12-25	WOS:000285869500032
J	Sun, M; Lariviere, L; Dengl, S; Mayer, A; Cramer, P				Sun, Mai; Lariviere, Laurent; Dengl, Stefan; Mayer, Andreas; Cramer, Patrick			A Tandem SH2 Domain in Transcription Elongation Factor Spt6 Binds the Phosphorylated RNA Polymerase II C-terminal Repeat Domain (CTD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; 3'-END FORMATION; STRUCTURAL BASIS; IN-VIVO; PROTEIN; YEAST; INHIBITION; ELEMENTS; ZAP-70	Spt6 is an essential transcription elongation factor and histone chaperone that binds the C-terminal repeat domain (CTD) of RNA polymerase II. We show here that Spt6 contains a tandem SH2 domain with a novel structure and CTD-binding mode. The tandem SH2 domain binds to a serine 2-phosphorylated CTD peptide in vitro, whereas its N-terminal SH2 subdomain, which we previously characterized, does not. CTD binding requires a positively charged crevice in the C-terminal SH2 subdomain, which lacks the canonical phospho-binding pocket of SH2 domains and had previously escaped detection. The tandem SH2 domain is apparently required for transcription elongation in vivo as its deletion in cells is lethal in the presence of 6-azauracil.	[Cramer, Patrick] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; Univ Munich, Dept Biochem, CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de	Mayer, Andreas/AAA-5173-2021; Sun, Mai/A-3837-2010	Sun, Mai/0000-0003-2824-7964; Mayer, Andreas/0000-0002-4532-9382	Deutsche Forschungsgemeinschaft [SFB646]; Transregio 5; Nanosystems Initiative Munich (NIM) the Elitenetzwerk Bayern; Fonds der Chemischen Industrie; Jung Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Transregio 5; Nanosystems Initiative Munich (NIM) the Elitenetzwerk Bayern; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Jung Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich SFB646, the Transregio 5, the Nanosystems Initiative Munich (NIM) the Elitenetzwerk Bayern, the Fonds der Chemischen Industrie, and the Jung Stiftung.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Bucheli ME, 2005, EMBO J, V24, P2150, DOI 10.1038/sj.emboj.7600687; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; CLARKADAMS CD, 1987, MOL CELL BIOL, V7, P679, DOI 10.1128/MCB.7.2.679; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Johnson SJ, 2008, J MOL BIOL, V377, P1460, DOI 10.1016/j.jmb.2008.01.096; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Labarga A, 2007, NUCLEIC ACIDS RES, V35, pW6, DOI 10.1093/nar/gkm291; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu PD, 2008, MOL BIOL EVOL, V25, P719, DOI 10.1093/molbev/msn017; Liu PD, 2010, MOL BIOL EVOL, V27, P2628, DOI 10.1093/molbev/msq151; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; MACLENNAN AJ, 1993, TRENDS BIOCHEM SCI, V18, P464; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2003, J BIOL CHEM, V278, P48267, DOI 10.1074/jbc.M307874200; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; SWANSON MS, 1990, MOL CELL BIOL, V10, P4935, DOI 10.1128/MCB.10.9.4935; SWANSON MS, 1992, GENETICS, V132, P325; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WEINER MP, 1994, PCR METH APPL, V4, pS131; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08	43	63	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41597	41603		10.1074/jbc.M110.144568	http://dx.doi.org/10.1074/jbc.M110.144568			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20926372	Green Published, hybrid			2022-12-25	WOS:000285622600047
J	Schaedler, S; Krause, J; Himmelsbach, K; Carvajal-Yepes, M; Lieder, F; Klingel, K; Nassal, M; Weiss, TS; Werner, S; Hildt, E				Schaedler, Stephanie; Krause, Janis; Himmelsbach, Kiyoshi; Carvajal-Yepes, Monica; Lieder, Franziska; Klingel, Karin; Nassal, Michael; Weiss, Thomas S.; Werner, Sabine; Hildt, Eberhard			Hepatitis B Virus Induces Expression of Antioxidant Response Element-regulated Genes by Activation of Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE SURFACE PROTEIN; TRANSGENIC MICE; HBX PROTEIN; LIVER-REGENERATION; HUMAN HEPATOCYTES; X PROTEIN; IN-VITRO; HEPATOCELLULAR-CARCINOMA; HEPATOTROPHIC FACTOR; PROTEASOME COMPLEX	The expression of a variety of cytoprotective genes is regulated by short cis-acting elements in their promoters, called antioxidant response elements (AREs). A central regulator of ARE-mediated gene expression is the NF-E2-related factor 2 (Nrf2). Human hepatitis B virus (HBV) induces a strong activation of Nrf2/ARE-regulated genes in vitro and in vivo. This is triggered by the HBV-regulatory proteins (HBx and LHBs) via c-Raf and MEK. The Nrf2/ARE-mediated induction of cytoprotective genes by HBV results in a better protection of HBV-positive cells against oxidative damage as compared with control cells. Furthermore, there is a significantly increased expression of the Nrf2/ARE-regulated proteasomal subunit PSMB5 in HBV-positive cells that is associated with a decreased level of the immunoproteasome subunit PSMB5i. In accordance with this finding, HBV-positive cells display a higher constitutive proteasome activity and a decreased activity of the immunoproteasome as compared with control cells even after interferon alpha/gamma treatment. The HBV-dependent induction of Nrf2/ARE-regulated genes might ensure survival of the infected cell, shape the immune response to HBV, and thereby promote establishment of the infection.	[Hildt, Eberhard] Univ Kiel, UKSH, Inst Infect Med Mol Med Virol, D-24105 Kiel, Germany; [Schaedler, Stephanie; Krause, Janis; Himmelsbach, Kiyoshi; Carvajal-Yepes, Monica; Nassal, Michael; Hildt, Eberhard] Univ Freiburg, Dept Internal Med 2, D-79106 Freiburg, Germany; [Schaedler, Stephanie; Carvajal-Yepes, Monica] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Klingel, Karin] Univ Tubingen, Dept Mol Pathol, D-72076 Tubingen, Germany; [Lieder, Franziska; Werner, Sabine] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Weiss, Thomas S.] Univ Regensburg, Ctr Liver Cell Res, D-93053 Regensburg, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Freiburg; University of Freiburg; Eberhard Karls University of Tubingen; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Regensburg	Hildt, E (corresponding author), Univ Kiel, UKSH, Inst Infect Med Mol Med Virol, Brunswiker Str 10, D-24105 Kiel, Germany.	hildt@infmed.uni-kiel.de	Weiss, Thomas S./G-3989-2012; Hildt, Eberhard/A-1040-2015; Nassal, Michael/U-4529-2019	Weiss, Thomas S./0000-0003-0336-0581; Nassal, Michael/0000-0003-2204-9158; Himmelsbach, Kiyoshi/0000-0002-1840-6012; Werner, Sabine/0000-0001-7397-8710	Deutsche Forschungsgemeinschaft; Studienstiftung des Deutschen Volkes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft Excellence Cluster "Inflammation at Interfaces" (to E. H.).; Supported by a fellowship from the Studienstiftung des Deutschen Volkes.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Bandi P, 2010, ANTIMICROB AGENTS CH, V54, P749, DOI 10.1128/AAC.01101-09; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bea F, 2003, CIRC RES, V92, P386, DOI 10.1161/01.RES.0000059561.65545.16; BEASLEY RP, 1981, LANCET, V2, P1129; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Brandenburg B, 2005, HEPATOLOGY, V42, P1300, DOI 10.1002/hep.20950; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; BRUSS V, 1995, J VIROL, V69, P6652, DOI 10.1128/JVI.69.11.6652-6657.1995; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chemin I, 2009, CANCER LETT, V286, P52, DOI 10.1016/j.canlet.2008.12.003; Dayoub R, 2006, BIOCHEM BIOPH RES CO, V345, P181, DOI 10.1016/j.bbrc.2006.04.040; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Durchdewald M, 2007, J INVEST DERMATOL, V127, P646, DOI 10.1038/sj.jid.5700585; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; FAVREAU LV, 1995, J BIOL CHEM, V270, P24468, DOI 10.1074/jbc.270.41.24468; Friedrich B, 2005, J HEPATOL, V43, P696, DOI 10.1016/j.jhep.2005.02.026; Hafner A, 2003, EMBO REP, V4, P767, DOI 10.1038/sj.embor.embor903; HAGEN TM, 1994, P NATL ACAD SCI USA, V91, P12808, DOI 10.1073/pnas.91.26.12808; HEERMANN KH, 1984, J VIROL, V52, P396, DOI 10.1128/JVI.52.2.396-402.1984; Higuchi A, 2004, J BIOMED MATER RES A, V71A, P470, DOI 10.1002/jbm.a.30169; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; Hildt E, 2002, EMBO J, V21, P525, DOI 10.1093/emboj/21.4.525; Hu ZY, 1999, J VIROL, V73, P7231, DOI 10.1128/JVI.73.9.7231-7240.1999; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008649; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Lupberger J, 2006, J HEPATOL, V45, P547, DOI 10.1016/j.jhep.2006.05.012; Melegari M, 2005, J VIROL, V79, P9810, DOI 10.1128/JVI.79.15.9810-9820.2005; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Robek MD, 2007, J VIROL, V81, P483, DOI 10.1128/JVI.01779-06; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Severi T, 2007, CHEM-BIOL INTERACT, V168, P128, DOI 10.1016/j.cbi.2007.03.006; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Sijts AJAM, 2000, J EXP MED, V191, P503, DOI 10.1084/jem.191.3.503; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Stockl L, 2003, ONCOGENE, V22, P2604, DOI 10.1038/sj.onc.1206320; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; TANAKA K, 1986, J BIOL CHEM, V261, P5197; Thasler WE, 2006, J PHARMACOL EXP THER, V316, P822, DOI 10.1124/jpet.105.094201; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Ying CX, 2003, BIOCHEM BIOPH RES CO, V309, P482, DOI 10.1016/j.bbrc.2003.08.021; Zhang ZS, 2000, J BIOL CHEM, V275, P15157, DOI 10.1074/jbc.M910378199; Zhang ZS, 2004, J VIROL, V78, P4566, DOI 10.1128/JVI.78.9.4566-4572.2004; Zhu HZ, 2004, EXP MOL PATHOL, V76, P44, DOI 10.1016/j.yexmp.2003.09.001	60	69	74	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41074	41086		10.1074/jbc.M110.145862	http://dx.doi.org/10.1074/jbc.M110.145862			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956535	hybrid, Green Published			2022-12-25	WOS:000285414400070
J	Mehta, M; Braberg, H; Wang, SY; Lozsa, A; Shales, M; Solache, A; Krogan, NJ; Keogh, MC				Mehta, Monika; Braberg, Hannes; Wang, Shuyi; Lozsa, Anita; Shales, Michael; Solache, Alejandra; Krogan, Nevan J.; Keogh, Michael-Christopher			Individual Lysine Acetylations on the N Terminus of Saccharomyces cerevisiae H2A.Z Are Highly but Not Differentially Regulated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL CHARGE PATCH; HISTONE H2A.Z; GENE ACTIVITY; VARIANT HTZ1; YEAST; CHROMATIN; COMPLEX; GENOME; HETEROCHROMATIN; NUCLEOSOMES	The multi-functional histone variant Htz1 (Saccharomyces cerevisiae H2A.Z) is acetylated on up to four N-terminal lysines at positions 3, 8, 10, and 14. It has thus been posited that specific acetylated forms of the histone could regulate distinct roles. Antibodies against Htz1-K8(Ac), -K10(Ac), and -K14(Ac) show that all three modifications are added by Esa1 acetyltransferase and removed by Hda1 deacetylase. Completely unacetylatable htz1 alleles exhibit widespread interactions in genome scale genetic screening. However, singly mutated (e. g. htz1-K8R) or singly acetylable (e. g. the triple mutant htz1-K3R/K10R/K14R) alleles show no significant defects in these analyses. This suggests that the N-terminal acetylations on Htz1 are internally redundant. Further supporting this proposal, each acetylation decays with similar kinetics when Htz1 transcription is repressed, and proteomic screening did not find a single condition in which one Htz1(Ac) was differentially regulated. However, whereas the individual acetylations on Htz1 may be redundant, they are not dispensable. Completely unacetylatable htz1 alleles display genetic interactions and phenotypes in common with and distinct from htz1 Delta. In addition, each Htz1 N-terminal lysine is deacetylated by Hda1 in response to benomyl and reacetylated when this agent is removed. Such active regulation suggests that acetylation plays a significant role in Htz1 function.	[Mehta, Monika; Keogh, Michael-Christopher] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Braberg, Hannes; Wang, Shuyi; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Braberg, Hannes; Wang, Shuyi; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Lozsa, Anita; Solache, Alejandra] Millipore Corp, Temecula, CA 92590 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck KGaA; MilliporeSigma	Keogh, MC (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Chanin 415A,1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.keogh@einstein.yu.edu		Mehta, Monika/0000-0003-3928-3733	National Institutes of Health; Searle Foundation; Keck Foundation; National Cancer Institute Cancer Centre [2P30CA013330]; Speaker's Fund for Biomedical Research; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Foundation; Keck Foundation(W.M. Keck Foundation); National Cancer Institute Cancer Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Speaker's Fund for Biomedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health. This work was also supported by the Searle and Keck Foundations, by National Cancer Institute Cancer Centre Grant 2P30CA013330 to Albert Einstein College of Medicine, and by the Speaker's Fund for Biomedical Research: Toward the Science of Patient Care awarded by the City of New York.	Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Caterino TL, 2007, NAT STRUCT MOL BIOL, V14, P1056, DOI 10.1038/nsmb1107-1056; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dryhurst D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-86; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Kanta H, 2006, GENETICS, V173, P435, DOI 10.1534/genetics.105.050559; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Keogh MC, 2002, MOL CELL BIOL, V22, P1288, DOI 10.1128/MCB.22.5.1288-1297.2002; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lall S, 2007, NAT STRUCT MOL BIOL, V14, P1110, DOI 10.1038/nsmb1107-1110; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Mehta Monika, 2010, J Biol, V9, P3, DOI 10.1186/jbiol214; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Raisner RM, 2006, CURR OPIN GENET DEV, V16, P119, DOI 10.1016/j.gde.2006.02.005; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ren QH, 2003, MOL CELL BIOL, V23, P2778, DOI 10.1128/MCB.23.8.2778-2789.2003; Ren QH, 2001, MOL CELL, V7, P1329, DOI 10.1016/S1097-2765(01)00269-6; Schneider J, 2004, METHOD ENZYMOL, V377, P227; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Straube K, 2010, TRAFFIC, V11, P185, DOI 10.1111/j.1600-0854.2009.01010.x; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Tanabe M, 2008, GENES CELLS, V13, P1279, DOI 10.1111/j.1365-2443.2008.01244.x; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thambirajah AA, 2009, BIOCHEM CELL BIOL, V87, P7, DOI 10.1139/O08-103; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	53	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39855	39865		10.1074/jbc.M110.185967	http://dx.doi.org/10.1074/jbc.M110.185967			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20952395	Green Published, hybrid			2022-12-25	WOS:000285185500030
J	Muradov, H; Boyd, KK; Artemyev, NO				Muradov, Hakim; Boyd, Kimberly K.; Artemyev, Nikolai O.			Rod phosphodiesterase-6 PDE6A and PDE6B Subunits Are Enzymatically Equivalent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY GAMMA-SUBUNIT; CGMP-PHOSPHODIESTERASE; PHOTORECEPTOR PHOSPHODIESTERASE; BINDING-SITES; BETA-SUBUNIT; TRANSDUCIN; PROTEIN; ALPHA; PHOTOTRANSDUCTION; ACTIVATION	Phosphodiesterase-6 (PDE6) is the key effector enzyme of the phototransduction cascade in rods and cones. The catalytic core of rod PDE6 is a unique heterodimer of PDE6A and PDE6B catalytic subunits. The functional significance of rod PDE6 heterodimerization and conserved differences between PDE6AB and cone PDE6C and the individual properties of PDE6A and PDE6B are unknown. To address these outstanding questions, we expressed chimeric homodimeric enzymes, enhanced GFP (EGFP)-PDE6C-A and EGFP-PDE6C-B, containing the PDE6A and PDE6B catalytic domains, respectively, in transgenic Xenopus laevis. Similar to EGFP-PDE6C, EGFP-PDE6C-A and EGFP-PDE6C-B were targeted to the rod outer segments and concentrated at the disc rims. PDE6C, PDE6C-A, and PDE6C-B were isolated following selective immunoprecipitation of the EGFP fusion proteins. All three enzymes, PDE6C, PDE6C-A, and PDE6C-B, hydrolyzed cGMP with similar K-m (20-23 mu M) and k(cat) (4200-5100 s(-1)) values. Likewise, the K-i values for PDE6C, PDE6C-A, and PDE6C-B inhibition by the cone-and rod-specific PDE6 gamma-subunits (P gamma) were comparable. Recombinant cone transducin-alpha (G alpha(t2)) and native rod G alpha(t1) fully and potently activated PDE6C, PDE6C-A, and PDE6C-B. In contrast, the half-maximal activation of bovine rod PDE6 required markedly higher concentrations of G alpha(t2) or G alpha(t1). Our results suggest that PDE6A and PDE6B are enzymatically equivalent. Furthermore, PDE6A and PDE6B are similar to PDE6C with respect to catalytic properties and the interaction with P gamma but differ in the interaction with transducin. This study significantly limits the range of mechanisms by which conserved differences between PDE6A, PDE6B, and PDE6C may contribute to remarkable differences in rod and cone physiology.	[Muradov, Hakim; Boyd, Kimberly K.; Artemyev, Nikolai O.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Artemyev, NO (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	nikolai-artemyev@uiowa.edu		Artemyev, Nikolai/0000-0002-5266-6854	National Institutes of Health [EY-10843, EY-12682]; NATIONAL EYE INSTITUTE [R01EY010843, R01EY012682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY-10843 and EY-12682 (to N.O.A.).	Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; Berger AL, 1999, BIOCHEMISTRY-US, V38, P1293, DOI 10.1021/bi981683m; BRUCKERT F, 1994, BIOCHEMISTRY-US, V33, P12625, DOI 10.1021/bi00208a013; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; Colville CA, 1996, J BIOL CHEM, V271, P32968, DOI 10.1074/jbc.271.51.32968; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; HAMILTON SE, 1993, FEBS LETT, V318, P157, DOI 10.1016/0014-5793(93)80012-J; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Liu YT, 2009, J BIOL CHEM, V284, P31541, DOI 10.1074/jbc.M109.018606; MALINSKI JA, 1992, BIOCHEMISTRY-US, V31, P9502, DOI 10.1021/bi00154a024; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov H, 2007, BIOCHEMISTRY-US, V46, P9992, DOI 10.1021/bi700535s; Muradov H, 2009, J BIOL CHEM, V284, P32662, DOI 10.1074/jbc.M109.049916; Muradov KG, 2003, J BIOL CHEM, V278, P10594, DOI 10.1074/jbc.M208456200; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Natochin M, 1999, J BIOL CHEM, V274, P7865, DOI 10.1074/jbc.274.12.7865; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; Pentia DC, 2006, J BIOL CHEM, V281, P5500, DOI 10.1074/jbc.M507488200; Piri N, 2003, J BIOL CHEM, V278, P36999, DOI 10.1074/jbc.M303710200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; SUGIMOTO Y, 1991, P NATL ACAD SCI USA, V88, P3116, DOI 10.1073/pnas.88.8.3116; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612	42	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39828	39834		10.1074/jbc.M110.170068	http://dx.doi.org/10.1074/jbc.M110.170068			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940301	hybrid, Green Published			2022-12-25	WOS:000285185500027
J	Franco, M; Muratori, C; Corso, S; Tenaglia, E; Bertotti, A; Capparuccia, L; Trusolino, L; Comoglio, PM; Tamagnone, L				Franco, Melanie; Muratori, Claudia; Corso, Simona; Tenaglia, Enrico; Bertotti, Andrea; Capparuccia, Lorena; Trusolino, Livio; Comoglio, Paolo M.; Tamagnone, Luca			The Tetraspanin CD151 Is Required for Met-dependent Signaling and Tumor Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; BREAST-CANCER CELLS; C-MET; FACTOR RECEPTORS; IN-VIVO; CLINICAL-SIGNIFICANCE; INTEGRIN; MOTILITY; ALPHA-6-BETA-4; TUMORIGENESIS	CD151, a transmembrane protein of the tetraspanin family, is implicated in the regulation of cell-substrate adhesion and cell migration through physical and functional interactions with integrin receptors. In contrast, little is known about the potential role of CD151 in controlling cell proliferation and survival. We have previously shown that beta 4 integrin, a major CD151 partner, not only acts as an adhesive receptor for laminins but also as an intracellular signaling platform promoting cell proliferation and invasive growth upon interaction with Met, the tyrosine kinase receptor for hepatocyte growth factor (HGF). Here we show that RNAi-mediated silencing of CD151 expression in cancer cells impairs HGF-driven proliferation, anchorage-independent growth, protection from anoikis, and tumor progression in xenograft models in vivo. Mechanistically, we found that CD151 is crucially implicated in the formation of signaling complexes between Met and beta 4 integrin, a known amplifier of HGF-induced tumor cell growth and survival. CD151 depletion hampered HGF-induced phosphorylation of beta 4 integrin and the ensuing Grb2-Gab1 association, a signaling pathway leading to MAPK stimulation and cell growth. Accordingly, CD151 knockdown reduced HGF-triggered activation of MAPK but not AKT signaling cascade. These results indicate that CD151 controls Met-dependent neoplastic growth by enhancing receptor signaling through beta 4 integrin-mediated pathways, independent of cell-substrate adhesion.	[Franco, Melanie; Muratori, Claudia; Corso, Simona; Tenaglia, Enrico; Bertotti, Andrea; Capparuccia, Lorena; Trusolino, Livio; Comoglio, Paolo M.; Tamagnone, Luca] Univ Turin, Sch Med, Inst Canc Res & Treatment IRCC, I-10060 Turin, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Tamagnone, L (corresponding author), Univ Turin, IRCC, SP 142, I-10060 Candiolo, TO, Italy.	luca.tamagnone@ircc.it	Trusolino, Livio/A-3896-2011; FRANCO, Melanie/I-1612-2015; Tamagnone, Luca/J-8948-2018	FRANCO, Melanie/0000-0001-6519-4131; Tamagnone, Luca/0000-0002-2884-7946; Trusolino, Livio/0000-0002-6379-3365; Bertotti, Andrea/0000-0001-8196-7608; Muratori, Claudia/0000-0002-3359-164X; Comoglio, Paolo/0000-0002-7056-5328; CORSO, Simona/0000-0002-5069-1503	Italian Association for Cancer Research (AIRC); Regione Piemonte	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Regione Piemonte(Regione Piemonte)	This work was supported by grants from the Italian Association for Cancer Research (AIRC) and Regione Piemonte (grants to L. Trusolino, L. Tamagnone, and P.M.C.).	Ang J, 2004, CANCER EPIDEM BIOMAR, V13, P1717; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Chometon G, 2006, EXP CELL RES, V312, P983, DOI 10.1016/j.yexcr.2005.12.034; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Garcia-Lopez MA, 2005, J INVEST DERMATOL, V125, P1001, DOI 10.1111/j.0022-202X.2005.23882.x; Geary SM, 2001, TISSUE ANTIGENS, V58, P141, DOI 10.1034/j.1399-0039.2001.580301.x; Gesierich S, 2005, CLIN CANCER RES, V11, P2840, DOI 10.1158/1078-0432.CCR-04-1935; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hashida H, 2003, BRIT J CANCER, V89, P158, DOI 10.1038/sj.bjc.6601015; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Israels SJ, 2007, THROMB HAEMOSTASIS, V98, P1081, DOI 10.1160/TH06-08-0455; Klosek SK, 2009, BIOCHEM BIOPH RES CO, V379, P1097, DOI 10.1016/j.bbrc.2009.01.023; Klosek SK, 2005, BIOCHEM BIOPH RES CO, V336, P408, DOI 10.1016/j.bbrc.2005.08.106; Lazo PA, 2007, CANCER SCI, V98, P1666, DOI 10.1111/j.1349-7006.2007.00584.x; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Murayama Y, 2008, J CELL PHYSIOL, V216, P135, DOI 10.1002/jcp.21384; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; PRAT M, 1991, MOL CELL BIOL, V11, P5954, DOI 10.1128/MCB.11.12.5954; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Sincock PM, 1999, J CELL SCI, V112, P833; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Sterk LMT, 2002, J CELL SCI, V115, P1161; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Todeschini AR, 2008, P NATL ACAD SCI USA, V105, P1925, DOI 10.1073/pnas.0709619104; Tokuhara T, 2001, CLIN CANCER RES, V7, P4109; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yamada M, 2008, FEBS J, V275, P3335, DOI 10.1111/j.1742-4658.2008.06481.x; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	46	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38756	38764		10.1074/jbc.M110.145417	http://dx.doi.org/10.1074/jbc.M110.145417			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937830	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000284941300004
J	Ma, D; Li, SM; Lucas, EK; Cowell, RM; Lin, JD				Ma, Di; Li, Siming; Lucas, Elizabeth K.; Cowell, Rita M.; Lin, Jiandie D.			Neuronal Inactivation of Peroxisome Proliferator-activated Receptor gamma Coactivator 1 alpha (PGC-1 alpha) Protects Mice from Diet-induced Obesity and Leads to Degenerative Lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; INSULIN-RESISTANCE; NUCLEAR RECEPTORS; HEPATIC GLUCONEOGENESIS; MONITORING AUTOPHAGY; LIPID-METABOLISM; NERVOUS-SYSTEM; RAT-BRAIN; PGC-1	Peroxisome proliferator-activated receptor alpha coactivator 1 alpha (PGC-1 alpha) is a transcriptional coactivator that regulates diverse aspects of energy metabolism in peripheral tissues. Mice deficient in PGC-1 alpha have elevated metabolic rate and are resistant to diet-induced obesity. However, it remains unknown whether this alteration in energy balance is due to the action of PGC-1 alpha in peripheral tissues or the central nervous system. In this study, we generated neuronal PGC-1 alpha knock-out mice (B alpha KO) using calcium/calmodulin-dependent protein kinase II alpha(CaMKII alpha)-Cre to address its role in the regulation of energy balance and neuronal function. Unlike whole body PGC-1 alpha null mice, B alpha KO mice have normal adaptive metabolic response to starvation and cold exposure in peripheral tissues. In contrast, B alpha KO mice are hypermetabolic, and similar to whole body PGC-1 alpha null mice, are also resistant to diet-induced obesity, resulting in significantly improved metabolic profiles. Neuronal inactivation of PGC-1 alpha leads to striatal lesions that are reminiscent of neurodegeneration in whole body PGC-1 alpha null brain and impairs nutritional regulation of hypothalamic expression of genes that regulate systemic energy balance. Together, these studies have demonstrated a physiological role for neuronal PGC-1 alpha in the control of energy balance. Our results also implicate CaMKII alpha-positive neurons as an important part of the neural circuitry that governs energy expenditure in vivo.	[Ma, Di; Li, Siming; Lin, Jiandie D.] Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ma, Di; Li, Siming; Lin, Jiandie D.] Univ Michigan, Med Ctr, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Lucas, Elizabeth K.; Cowell, Rita M.] Univ Alabama, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham	Lin, JD (corresponding author), Univ Michigan, Life Sci Inst 5437, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	jdlin@umich.edu	Cowell, Rita/J-5083-2013	Cowell, Rita/0000-0001-5814-9412; Lucas, Elizabeth/0000-0002-0632-4538	National Institutes of Health; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant (to J. D. L.).; Supported by a predoctoral fellowship from the American Heart Association.	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cowell RM, 2007, J COMP NEUROL, V502, P1, DOI 10.1002/cne.21211; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Draper S, 2010, BRAIN RES, V1350, P139, DOI 10.1016/j.brainres.2010.03.082; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tritos NA, 2003, BRAIN RES, V961, P255, DOI 10.1016/S0006-8993(02)03961-6; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	57	59	62	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39087	39095		10.1074/jbc.M110.151688	http://dx.doi.org/10.1074/jbc.M110.151688			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20947495	Green Published, hybrid			2022-12-25	WOS:000284941300039
J	D'Avanzo, N; Cheng, WWL; Doyle, DA; Nichols, CG				D'Avanzo, Nazzareno; Cheng, Wayland W. L.; Doyle, Declan A.; Nichols, Colin G.			Direct and Specific Activation of Human Inward Rectifier K+ Channels by Membrane Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANIONIC PHOSPHOLIPIDS; POTASSIUM CHANNELS; KIR CHANNELS; CRYSTAL-STRUCTURE; PIP2 REGULATION; ATP CHANNELS; ION CHANNELS; CHANNELOPATHIES; DETERMINANTS; SENSITIVITY	Many ion channels are modulated by phosphatidylinositol 4,5-bisphosphate (PIP2), but studies examining the PIP2 dependence of channel activity have been limited to cell expression systems, which present difficulties for controlling membrane composition. We have characterized the PIP2 dependence of purified human Kir2.1 and Kir2.2 activity using Rb-86(+) flux and patch clamp assays in liposomes of defined composition. We definitively show that these channels are directly activated by PIP2 and that PIP2 is absolutely required in the membrane for channel activity. The results provide the first quantitative description of the dependence of eukaryotic Kir channel function on PIP2 levels in the membrane; Kir2.1 shows measureable activity in as little as 0.01% PIP2, and open probability increases to similar to 0.4 at 1% PIP2. Activation of Kir2.1 by phosphatidylinositol phosphates is also highly selective for PIP2; PI, PI(4) P, and PI(5) P do not activate channels, and PI(3,4,5)P-3 causes minimal activity. The PIP2 dependence of eukaryotic Kir activity is almost exactly opposite that of KirBac1.1, which shows marked inhibition by PIP2. This raises the interesting hypothesis that PIP2 activation of eukaryotic channels reflects an evolutionary adaptation of the channel to the appearance of PIP2 in the eukaryotic cell membrane.	[D'Avanzo, Nazzareno; Cheng, Wayland W. L.; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [D'Avanzo, Nazzareno; Cheng, Wayland W. L.; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Doyle, Declan A.] Trinity Coll Dublin, Sch Biochem & Immunol, Coll Green, Dublin 2, Ireland	Washington University (WUSTL); Washington University (WUSTL); Trinity College Dublin	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	cnichols@wustl.edu	Nichols, Colin/D-6336-2012	Cheng, Wayland/0000-0002-9529-9820	National Institutes of Health [HL54171]; American Heart Association [0810196Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL54171 (to C. G. N.). This work was also supported by American Heart Association Fellowship 0810196Z (to W. W. L. C.).	Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Cukras CA, 2002, J GEN PHYSIOL, V119, P581, DOI 10.1085/jgp.20028562; D'Avanzo N, 2010, CHANNELS, V4, P139, DOI 10.4161/chan.4.3.12129; D'Avanzo N, 2010, PROTEIN EXPRES PURIF, V71, P115, DOI 10.1016/j.pep.2010.01.010; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; Dowhan W, 2008, N COMP BIOC, P1, DOI 10.1016/B978-044453219-0.50003-9; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hilgemann DW, 2007, PFLUG ARCH EUR J PHY, V455, P55, DOI 10.1007/s00424-007-0280-9; Hilgemann DW, 2004, SCIENCE, V304, P223, DOI 10.1126/science.1097439; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Liu GX, 2001, J PHYSIOL-LONDON, V532, P115, DOI 10.1111/j.1469-7793.2001.0115g.x; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; VANPHUNG L, 1995, MICROBIOL IMMUNOL, V39, P105, DOI 10.1111/j.1348-0421.1995.tb02176.x; Xie LH, 2008, J PHYSIOL-LONDON, V586, P1833, DOI 10.1113/jphysiol.2007.147868; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	37	54	55	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37129	37132		10.1074/jbc.C110.186692	http://dx.doi.org/10.1074/jbc.C110.186692			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20921230	Green Published, hybrid			2022-12-25	WOS:000284424000005
J	Siddiqua, A; Margittai, M				Siddiqua, Ayisha; Margittai, Martin			Three- and Four-repeat Tau Coassemble into Heterogeneous Filaments AN IMPLICATION FOR ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN-TAU; STRAIN VARIATION; AMYLOID FIBRILS; SPIN; AGGREGATION; PARALLEL; BRAIN; CORE; TRANSMISSION	Tau filaments are the pathological hallmark of numerous neurodegenerative diseases including Alzheimer disease, Pick disease, and progressive supranuclear palsy. In the adult human brain, six isoforms are expressed that differ by the presence or absence of the second of four semiconserved repeats. As a consequence, half of the tau isoforms have three repeats (3R tau), whereas the other half of the isoforms have four repeats (4R tau). Tauopathies can be characterized based on the isoform composition of their filaments. Alzheimer disease filamentous inclusions contain all isoforms. Pick disease filaments contain 3R tau. Progressive supranuclear palsy filaments contain 4R tau. Here, we used site-directed spin labeling of recombinant tau in conjunction with electron paramagnetic resonance spectroscopy to obtain structural insights into these filaments. We find that filaments of 4R tau and 3R tau share a highly ordered core structure in the third repeat with parallel, in-register arrangement of beta-strands. This structure is conserved regardless of whether full-length isoforms (htau40 and htau23) or truncated constructs (K18 and K19) are used. When mixed, 3R tau and 4R tau coassemble into heterogeneous filaments. These filaments share the highly ordered core in the third repeat; however, they differ in their overall composition. Our findings indicate that at least three distinct types of filaments exist: homogeneous 3R tau, homogeneous 4R tau, and heterogeneous 3R/4R tau. These results suggest that individual filaments found in Alzheimer disease are structurally distinct from those in the 3R and 4R tauopathies.	[Siddiqua, Ayisha; Margittai, Martin] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA	University of Denver	Margittai, M (corresponding author), Univ Denver, Dept Chem & Biochem, 2190 E Iliff Ave, Denver, CO 80208 USA.	martin.margittai@du.edu	Siddiqua, Ayisha/AGZ-8093-2022; Margittai, Martin/D-5039-2014	Siddiqua, Ayisha/0000-0002-9241-204X; Margittai, Martin/0000-0003-1903-5927	CurePSP - Society for Progressive Supranuclear Palsy	CurePSP - Society for Progressive Supranuclear Palsy	This work was supported by grants from CurePSP - Society for Progressive Supranuclear Palsy (to M. M.).	Adams SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010810; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bretteville A, 2008, J ALZHEIMERS DIS, V14, P431; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Gross A, 1999, BIOCHEMISTRY-US, V38, P10324, DOI 10.1021/bi990856k; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	59	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37920	37926		10.1074/jbc.M110.185728	http://dx.doi.org/10.1074/jbc.M110.185728			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20921227	Green Published, hybrid			2022-12-25	WOS:000284424000081
J	Abebe, G; Deribew, A; Apers, L; Woldemichael, K; Shiffa, J; Tesfaye, M; Abdissa, A; Deribie, F; Jira, C; Bezabih, M; Aseffa, A; Duchateau, L; Colebunders, R				Abebe, Gemeda; Deribew, Amare; Apers, Ludwig; Woldemichael, Kifle; Shiffa, Jaffer; Tesfaye, Markos; Abdissa, Alemseged; Deribie, Fetene; Jira, Chali; Bezabih, Mesele; Aseffa, Abraham; Duchateau, Luc; Colebunders, Robert			Knowledge, Health Seeking Behavior and Perceived Stigma towards Tuberculosis among Tuberculosis Suspects in a Rural Community in Southwest Ethiopia	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS; SERVICE DELAY; CARE SEEKING; GENDER; DIAGNOSIS; TB; PREVALENCE; PATIENT; WOMEN	Background: Perceived stigma and lack of awareness could contribute to the late presentation and low detection rate of tuberculosis (TB). We conducted a study in rural southwest Ethiopia among TB suspects to assess knowledge about and stigma towards TB and their health seeking behavior. Methods: A community based cross sectional survey was conducted from February to March 2009 in the Gilgel Gibe field research area. Any person 15 years and above with cough for at least 2 weeks was considered a TB suspect and included in the study. Data were collected by trained personnel using a pretested structured questionnaire. Logistic regression analysis was done using SPSS 15.0 statistical software. Results: Of the 476 pulmonary TB suspects, 395 (83.0%) had ever heard of TB; "evil eye'' (50.4%) was the commonly mentioned cause of TB. Individuals who could read and write were more likely to be aware about TB [(crude OR = 2.98, (95% CI: 1.25, 7.08)] and more likely to know that TB is caused by a microorganism [(adjusted OR = 3.16, (95% CI: 1.77, 5.65)] than non-educated individuals. Males were more likely to know the cause of TB [(adjusted OR = 1.92, (95% CI: 1.22, 3.03)] than females. 51.3% of TB suspects perceived that other people would consider them inferior if they had TB. High stigma towards TB was reported by 199(51.2%). 220 (46.2%) did not seek help for their illness. Individuals who had previous anti-TB treatment were more likely to have appropriate health seeking behavior [(adjusted OR = 3.65, (95% CI: 1.89, 7.06)] than those who had not. Conclusion: There was little knowledge about TB in the Gilgel Gibe field research area. We observed inappropriate health seeking behavior and stigma towards TB. TB control programs in Ethiopia should educate rural communities, particularly females and non-educated individuals, about the cause and the importance of early diagnosis and treatment of TB.	[Abebe, Gemeda; Abdissa, Alemseged; Deribie, Fetene; Bezabih, Mesele] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Deribew, Amare; Woldemichael, Kifle] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Apers, Ludwig; Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Shiffa, Jaffer] Jimma Univ, Dept Internal Med, Jimma, Ethiopia; [Tesfaye, Markos] Jimma Univ, Dept Psychiat, Jimma, Ethiopia; [Jira, Chali] Jimma Univ, Dept Hlth Serv Management, Jimma, Ethiopia; [Aseffa, Abraham] Armauer Hanssen Res Inst, Addis Ababa, Ethiopia; [Duchateau, Luc] Univ Ghent, Dept Comparat Physiol & Biometr, B-9000 Ghent, Belgium; [Abebe, Gemeda; Deribew, Amare; Colebunders, Robert] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium	Jimma University; Jimma University; Institute of Tropical Medicine (ITM); Jimma University; Jimma University; Jimma University; Ghent University; University of Antwerp	Abebe, G (corresponding author), Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.	gemeda.abebe@ju.edu.et	Abebe, Gemeda/AAB-8789-2019; Aseffa, Abraham/J-3248-2016; Tesfaye, Markos/H-9297-2019	Abebe, Gemeda/0000-0002-7172-9136; Aseffa, Abraham/0000-0002-8028-1150; Tesfaye, Markos/0000-0002-3351-701X; Deribew, Amare/0000-0003-2031-6080; Abdissa, Alemseged/0000-0001-6871-1958	Directorate General for Development Cooperation (DGDC) through the Flemish Interuniversity Council (VLIR-UOS)	Directorate General for Development Cooperation (DGDC) through the Flemish Interuniversity Council (VLIR-UOS)	The study was funded by the Directorate General for Development Cooperation (DGDC) through the Flemish Interuniversity Council (VLIR-UOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Rumman K, 2008, AM J TROP MED HYG, V79, P545, DOI 10.4269/ajtmh.2008.79.545; Ayuo P O, 2008, East Afr Med J, V85, P263; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Chang Ching Thon, 2007, Rural Remote Health, V7, P667; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Demissie M, 2002, INT J TUBERC LUNG D, V6, P580; Demissie M., 2000, Ethiopian Journal of Health Development, V14, P277; Dodor EA, 2009, PSYCHOL HEALTH MED, V14, P170, DOI 10.1080/13548500802199753; Dujardin B, 1997, TROP MED INT HEALTH, V2, P715, DOI 10.1046/j.1365-3156.1997.d01-388.x; Getahun H, 1999, ETHIOPIAN MED J, V37, P147; Global Initiative for Asthma, 2009, PUBL WHO, V02-3659; Hoa NP, 2003, SCAND J PUBLIC HEALT, V31, P59, DOI 10.1080/14034950310015121; Hoa NR, 2004, INT J TUBERC LUNG D, V8, P603; Huong NT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-110; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Karim F, 2007, HEALTH POLICY PLANN, V22, P329, DOI 10.1093/heapol/czm026; Kassu Afework, 2007, Journal of Microbiology Immunology and Infection, V40, P116; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Long NH, 1999, SOC SCI MED, V49, P815, DOI 10.1016/S0277-9536(99)00171-9; MADEBO T, 1999, MED GEN MED, pE6; Mangesho P E, 2007, Tanzan Health Res Bull, V9, P38; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P7; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P21; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; *MOH ETH, 2008, TUB LEPR TB HIV PREV; Muniyandi M, 2007, INT J TUBERC LUNG D, V11, P1042; Needham DM, 2001, TROP MED INT HEALTH, V6, P256, DOI 10.1046/j.1365-3156.2001.00709.x; Ouedraogo M, 2006, INT J TUBERC LUNG D, V10, P184; Shargie EB, 2006, INT J TUBERC LUNG D, V10, P87; Sharma N, 2007, ASIA-PAC J PUBLIC HE, V19, P10, DOI 10.1177/10105395070190020301; Shetty N, 2004, Commun Dis Public Health, V7, P77; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Steen TW, 1999, SOC SCI MED, V48, P163, DOI 10.1016/S0277-9536(98)00329-3; Tatek Wondimu, 2007, Ethiopian Journal of Health Development, V21, P148; Wang JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-354; Wang Y, 2008, TROP MED INT HEALTH, V13, P927, DOI 10.1111/j.1365-3156.2008.02093.x; *WHO, 2009, GLOB TUB CONTR SHORT; WHO, STOP TB STRAT; Yimer S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-454	40	97	99	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13339	10.1371/journal.pone.0013339	http://dx.doi.org/10.1371/journal.pone.0013339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	661SK	20948963	Green Published, gold, Green Submitted			2022-12-25	WOS:000282748100033
J	Laloux, G; Deghelt, M; de Barsy, M; Letesson, JJ; De Bolle, X				Laloux, Geraldine; Deghelt, Michael; de Barsy, Marie; Letesson, Jean-Jacques; De Bolle, Xavier			Identification of the Essential Brucella melitensis Porin Omp2b as a Suppressor of Bax-Induced Cell Death in Yeast in a Genome-Wide Screening	PLOS ONE			English	Article							MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; BACTERIAL PATHOGENS; BCL-2 FAMILY; IN-VITRO; APOPTOSIS; PROTEINS; MEMBRANE; SYSTEM; MITOCHONDRIA	Background: Inhibition of apoptosis is one of the mechanisms selected by numerous intracellular pathogenic bacteria to control their host cell. Brucellae, which are the causative agent of a worldwide zoonosis, prevent apoptosis of infected cells, probably to support survival of their replication niche. Methodology/Principal Findings: In order to identify Brucella melitensis anti-apoptotic effector candidates, we performed a genome-wide functional screening in yeast. The B. melitensis ORFeome was screened to identify inhibitors of Bax-induced cell death in S. cerevisiae. B. melitensis porin Omp2b, here shown to be essential, prevents Bax lethal effect in yeast, unlike its close paralog Omp2a. Our results based on Omp2b size variants characterization suggest that signal peptide processing is required for Omp2b effect in yeast. Conclusion/Significance: We report here the first application to a bacterial genome-wide library of coding sequences of this "yeast-rescue" screening strategy, previously used to highlight several new apoptosis regulators. Our work provides B. melitensis proteins that are candidates for an anti-apoptotic function, and can be tested in mammalian cells in the future. Hypotheses on possible molecular mechanisms of Bax inhibition by the B. melitensis porin Omp2b are discussed.	[Laloux, Geraldine; Deghelt, Michael; de Barsy, Marie; Letesson, Jean-Jacques; De Bolle, Xavier] Univ Namur FUNDP, Dept Biol, Res Unit Mol Biol, Namur, Belgium	University of Namur	Laloux, G (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	xavier.debolle@fundp.ac.be	Laloux, Geraldine/AAF-9009-2021; Jean-Jacques, LETESSON/AHB-6921-2022; Laloux, Geraldine/N-4373-2017	Laloux, Geraldine/0000-0003-3230-1679; Laloux, Geraldine/0000-0003-3230-1679; De Bolle, Xavier/0000-0002-3845-3043; LETESSON, Jean-Jacques/0000-0002-5838-0224	FRFC (Fonds de la Recherche Fondamentale Collective) [2.4521.04, 2.4541.08]; ARC (Actions de Recherche Concertee) [04/09-325, 08/13-015]; University of Namur; FRS-FNRS (Fonds de la Recherche Scientifique - Fonds National de la Recherche Scientifique)	FRFC (Fonds de la Recherche Fondamentale Collective)(Fonds de la Recherche Scientifique - FNRS); ARC (Actions de Recherche Concertee); University of Namur; FRS-FNRS (Fonds de la Recherche Scientifique - Fonds National de la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the FRFC (Fonds de la Recherche Fondamentale Collective, agreements 2.4521.04 and 2.4541.08), an ARC project (Actions de Recherche Concertee, agreements 04/09-325 and 08/13-015, French-Speaking Community of Belgium) and by the University of Namur. G. Laloux held a PhD fellowship from the FRS-FNRS (Fonds de la Recherche Scientifique - Fonds National de la Recherche Scientifique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Chen SR, 2004, PLANT PHYSIOL, V135, P1630, DOI 10.1104/pp.103.038091; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Clement JM, 1995, J BIOTECHNOL, V43, P169, DOI 10.1016/0168-1656(95)00127-1; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Forestier C, 1999, J IMMUNOL, V162, P6784; Greenhalf W, 1999, YEAST, V15, P1307, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1307::AID-YEA455>3.3.CO;2-V; Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000; HALL J, 1990, J BIOL CHEM, V265, P19996; He YQ, 2006, INFECT IMMUN, V74, P5035, DOI 10.1128/IAI.01998-05; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Khoury CM, 2008, BBA-MOL CELL RES, V1783, P1449, DOI 10.1016/j.bbamcr.2007.12.013; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kozjak-Pavlovic V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000629; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Lapaque N, 2006, CELL MICROBIOL, V8, P197, DOI 10.1111/j.1462-5822.2005.00609.x; Levine A, 2001, J BIOL CHEM, V276, P46284, DOI 10.1074/jbc.M107375200; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Massari P, 2003, CELL MICROBIOL, V5, P99, DOI 10.1046/j.1462-5822.2003.00257.x; Matsuyama S, 1999, CURR OPIN MICROBIOL, V2, P618, DOI 10.1016/S1369-5274(99)00031-4; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Moeller L, 2009, J EXP BOT, V60, P3337, DOI 10.1093/jxb/erp167; Muller A, 2000, EMBO J, V19, P5332, DOI 10.1093/emboj/19.20.5332; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Niu H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000774; Paquet JY, 2001, J BACTERIOL, V183, P4839, DOI 10.1128/JB.183.16.4839-4847.2001; Polcic P, 2003, BIOCHEM J, V374, P393, DOI 10.1042/BJ20030690; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Xu QL, 2000, METHOD ENZYMOL, V322, P283; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zha HB, 1996, MOL CELL BIOL, V16, P6494; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597	44	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13274	10.1371/journal.pone.0013274	http://dx.doi.org/10.1371/journal.pone.0013274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949000	Green Published, Green Submitted, gold			2022-12-25	WOS:000282748100016
J	Hoppenrath, M; Leander, BS				Hoppenrath, Mona; Leander, Brian S.			Dinoflagellate Phylogeny as Inferred from Heat Shock Protein 90 and Ribosomal Gene Sequences	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ELECTRON-MICROSCOPY; OXYRRHIS-MARINA; SP-NOV; EVOLUTIONARY HISTORY; PLANKTONIC DIATOMS; RDNA SEQUENCES; DNA-SEQUENCES; SUBUNIT RDNA; BODY SCALES	Background: Interrelationships among dinoflagellates in molecular phylogenies are largely unresolved, especially in the deepest branches. Ribosomal DNA (rDNA) sequences provide phylogenetic signals only at the tips of the dinoflagellate tree. Two reasons for the poor resolution of deep dinoflagellate relationships using rDNA sequences are (1) most sites are relatively conserved and (2) there are different evolutionary rates among sites in different lineages. Therefore, alternative molecular markers are required to address the deeper phylogenetic relationships among dinoflagellates. Preliminary evidence indicates that the heat shock protein 90 gene (Hsp90) will provide an informative marker, mainly because this gene is relatively long and appears to have relatively uniform rates of evolution in different lineages. Methodology/Principal Findings: We more than doubled the previous dataset of Hsp90 sequences from dinoflagellates by generating additional sequences from 17 different species, representing seven different orders. In order to concatenate the Hsp90 data with rDNA sequences, we supplemented the Hsp90 sequences with three new SSU rDNA sequences and five new LSU rDNA sequences. The new Hsp90 sequences were generated, in part, from four additional heterotrophic dinoflagellates and the type species for six different genera. Molecular phylogenetic analyses resulted in a paraphyletic assemblage near the base of the dinoflagellate tree consisting of only athecate species. However, Noctiluca was never part of this assemblage and branched in a position that was nested within other lineages of dinokaryotes. The phylogenetic trees inferred from Hsp90 sequences were consistent with trees inferred from rDNA sequences in that the backbone of the dinoflagellate clade was largely unresolved. Conclusions/Significance: The sequence conservation in both Hsp90 and rDNA sequences and the poor resolution of the deepest nodes suggests that dinoflagellates reflect an explosive radiation in morphological diversity in their recent evolutionary past. Nonetheless, the more comprehensive analysis of Hsp90 sequences enabled us to infer phylogenetic interrelationships of dinoflagellates more rigorously. For instance, the phylogenetic position of Noctiluca, which possesses several unusual features, was incongruent with previous phylogenetic studies. Therefore, the generation of additional dinoflagellate Hsp90 sequences is expected to refine the stem group of athecate species observed here and contribute to future multi-gene analyses of dinoflagellate interrelationships.	[Hoppenrath, Mona; Leander, Brian S.] Univ British Columbia, Dept Zool, Canadian Inst Adv Res, Program Integrated Microbial Biodivers, Vancouver, BC, Canada; [Hoppenrath, Mona] Deutsch Zentrum Marine Biodiversitatsforsch, Forschungsinst Senckenberg, Wilhelmshaven, Germany	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Senckenberg Gesellschaft fur Naturforschung (SGN)	Hoppenrath, M (corresponding author), Univ British Columbia, Dept Zool, Canadian Inst Adv Res, Program Integrated Microbial Biodivers, Vancouver, BC, Canada.	leander@zoology.ubc.ca			Deutsche Forschungsgemeinschaft [Ho3267/1-1]; National Science and Engineering Research Council of Canada (NSERC) [NSERC 283091-09]; National Science Foundation's Assembling the Tree of Life (NSF) [EF-0629624]; Canadian Institute for Advanced Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation's Assembling the Tree of Life (NSF); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by a postdoctoral scholarship from the Deutsche Forschungsgemeinschaft (Grant Ho3267/1-1), by operating grants from the National Science and Engineering Research Council of Canada (NSERC 283091-09), the National Science Foundation's Assembling the Tree of Life (NSF #EF-0629624), and by the Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Breglia SA, 2007, J EUKARYOT MICROBIOL, V54, P86, DOI 10.1111/j.1550-7408.2006.00233.x; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Clarke K.J, 1972, British phycol J, V7, P357; CLARKE KJ, 1976, BRIT PHYCOL J, V11, P345, DOI 10.1080/00071617600650391; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; de Salas MF, 2003, J PHYCOL, V39, P1233, DOI 10.1111/j.0022-3646.2003.03-019.x; Edvardsen B, 2003, J PHYCOL, V39, P395, DOI 10.1046/j.1529-8817.2003.01252.x; Fast NM, 2002, J EUKARYOT MICROBIOL, V49, P30, DOI 10.1111/j.1550-7408.2002.tb00336.x; Fensome R.A., 1993, MICROPALEONTOLOGY, V7, P1; Fukuda Y, 2008, EUR J PROTISTOL, V44, P27, DOI 10.1016/j.ejop.2007.07.001; Fukuda Y, 2006, EUR J PROTISTOL, V42, P209, DOI 10.1016/j.ejop.2006.05.003; Gomez F, 2010, PROTIST, V161, P466, DOI 10.1016/j.protis.2009.12.005; Gribble KE, 2007, PHYCOLOGIA, V46, P315, DOI 10.2216/06-68.1; Gribble KE, 2006, J PHYCOL, V42, P1081, DOI 10.1111/j.1529-8817.2006.00267.x; Grzebyk D, 1998, J PHYCOL, V34, P1055, DOI 10.1046/j.1529-8817.1998.341055.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; Handy SM, 2009, J PHYCOL, V45, P1163, DOI 10.1111/j.1529-8817.2009.00738.x; Hansen G, 2007, PHYCOL RES, V55, P25, DOI 10.1111/j.1440-1835.2006.00442.x; Hohfeld I, 1995, PHYCOLOGIA, V34, P508, DOI 10.2216/i0031-8884-34-6-508.1; Hoppenrath M, 2004, HELGOLAND MAR RES, V58, P243, DOI 10.1007/s10152-004-0190-6; Hoppenrath M., 2009, KL SENCKENBERG-REIHE, V49, P264; Hoppenrath M, 2008, J PHYCOL, V44, P451, DOI 10.1111/j.1529-8817.2008.00483.x; Hoppenrath M, 2007, PROTIST, V158, P209, DOI 10.1016/j.protis.2006.12.001; Hoppenrath M, 2007, J PHYCOL, V43, P366, DOI 10.1111/j.1529-8817.2007.00319.x; Hoppenrath M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-116; Hoppenrath M, 2010, EUR J PROTISTOL, V46, P29, DOI 10.1016/j.ejop.2009.08.003; Iwataki M, 2004, PHYCOLOGIA, V43, P394, DOI 10.2216/i0031-8884-43-4-394.1; Jensen MH, 2009, J PHYCOL, V45, P1136, DOI 10.1111/j.1529-8817.2009.00741.x; Jorgensen MF, 2004, PHYCOL RES, V52, P284; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Ki JS, 2010, EUR J PROTISTOL, V46, P111, DOI 10.1016/j.ejop.2009.11.001; Leander BS, 2004, J PHYCOL, V40, P341, DOI 10.1111/j.1529-8817.2004.03129.x; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Leander BS, 2003, INT J SYST EVOL MICR, V53, P345, DOI 10.1099/ijs.0.02284-0; Lindberg K, 2005, PHYCOLOGIA, V44, P416, DOI 10.2216/0031-8884(2005)44[416:SOWDIW]2.0.CO;2; Litaker RW, 1999, J PHYCOL, V35, P1379, DOI 10.1046/j.1529-8817.1999.3561379.x; Liu LY, 2007, P NATL ACAD SCI USA, V104, P696, DOI 10.1073/pnas.0607816103; MAROTEAUX L, 1985, BIOSYSTEMS, V18, P307, DOI 10.1016/0303-2647(85)90031-0; Mohammad-Noor N, 2007, PHYCOLOGIA, V46, P549, DOI 10.2216/06-94.1; Murray S, 2005, PROTIST, V156, P269, DOI 10.1016/j.protis.2005.05.003; Murray S, 2004, J PHYCOL, V40, P366, DOI 10.1046/j.1529-8817.2004.03132.x; Murray S, 2009, PROTIST, V160, P245, DOI 10.1016/j.protis.2008.12.004; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; SCHNEPF E, 1993, HELGOLANDER MEERESUN, V47, P265, DOI 10.1007/BF02367168; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Sekida S, 2003, PHYCOLOGIA, V42, P661, DOI 10.2216/i0031-8884-42-6-661.1; Shalchian-Tabrizi K, 2006, J EUKARYOT MICROBIOL, V53, P217, DOI 10.1111/j.1550-7408.2006.00098.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Sparmann SF, 2008, PROTIST, V159, P383, DOI 10.1016/j.protis.2007.12.002; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2003, J MOL EVOL, V57, P408, DOI 10.1007/s00239-003-2490-x; Tamura M, 2009, PHYCOL RES, V57, P304, DOI 10.1111/j.1440-1835.2009.00550.x; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; Taylor F.J.R., 1987, BOT MONOGR, VVolume 21; Taylor FJR, 2004, PHYCOL RES, V52, P308, DOI 10.1111/j.1440-1835.2004.tb00341.x; TAYLOR FJR, 1980, BIOSYSTEMS, V13, P65, DOI 10.1016/0303-2647(80)90006-4; UHLIG G, 1972, ENTWICKLUNG NOCTILUC; WATANABE MM, 1990, J PHYCOL, V26, P741, DOI 10.1111/j.0022-3646.1990.00741.x; Yamaguchi A, 2006, PHYCOL RES, V54, P317, DOI 10.1111/j.1440-1835.2006.00438.x; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang H, 2007, J MOL EVOL, V65, P463, DOI 10.1007/s00239-007-9038-4; ZINGMARK RG, 1970, J PHYCOL, V6, P122, DOI 10.1111/j.0022-3646.1970.00122.x	70	65	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13220	10.1371/journal.pone.0013220	http://dx.doi.org/10.1371/journal.pone.0013220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949037	Green Submitted, Green Published, gold			2022-12-25	WOS:000282676700009
J	Castiello, U; Becchio, C; Zoia, S; Nelini, C; Sartori, L; Blason, L; D'Ottavio, G; Bulgheroni, M; Gallese, V				Castiello, Umberto; Becchio, Cristina; Zoia, Stefania; Nelini, Cristian; Sartori, Luisa; Blason, Laura; D'Ottavio, Giuseppina; Bulgheroni, Maria; Gallese, Vittorio			Wired to Be Social: The Ontogeny of Human Interaction	PLOS ONE			English	Article							4-DIMENSIONAL SONOGRAPHY; TWIN PREGNANCIES; NEWBORN-INFANTS; FETAL BEHAVIOR; MOVEMENTS; COGNITION; INTENTION; GESTURES; FETUS	Background: Newborns come into the world wired to socially interact. Is a propensity to socially oriented action already present before birth? Twin pregnancies provide a unique opportunity to investigate the social pre-wiring hypothesis. Although various types of inter-twins contact have been demonstrated starting from the 11(th) week of gestation, no study has so far investigated the critical question whether intra-pair contact is the result of motor planning rather then the accidental outcome of spatial proximity. Methodology/Principal Findings: Kinematic profiles of movements in five pairs of twin foetuses were studied by using four-dimensional ultrasonography during two separate recording sessions carried out at the 14(th) and 18(th) week of gestation. We demonstrate that by the 14(th) week of gestation twin foetuses do not only display movements directed towards the uterine wall and self-directed movements, but also movements specifically aimed at the co-twin, the proportion of which increases between the 14(th) and 18(th) gestational week. Kinematic analysis revealed that movement duration was longer and deceleration time was prolonged for other-directed movements compared to movements directed towards the uterine wall. Similar kinematic profiles were observed for movements directed towards the co-twin and self-directed movements aimed at the eye-region, i.e. the most delicate region of the body. Conclusions/Significance: We conclude that performance of movements towards the co-twin is not accidental: already starting from the 14(th) week of gestation twin foetuses execute movements specifically aimed at the co-twin.	[Castiello, Umberto; Nelini, Cristian; Sartori, Luisa] Univ Padua, Dept Gen Psychol, Padua, Italy; [Becchio, Cristina] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Zoia, Stefania; Blason, Laura; Bulgheroni, Maria] Inst Child Hlth IRCCS, Dept Paediat, Child Neurol & Psychiat Unit, Trieste, Italy; [D'Ottavio, Giuseppina] Inst Child Hlth IRCCS, Dept Obstet & Gynaecol, Unit Prenatal Diag, Trieste, Italy; [Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gallese, Vittorio] IIT, Sect Parma, Parma, Italy	University of Padua; University of Turin; University of Parma	Castiello, U (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it	Gallese, Vittorio/ABD-5097-2021; ZOIA, STEFANIA/HCI-1235-2022	Gallese, Vittorio/0000-0003-4815-3607; Sartori, Luisa/0000-0002-3838-8958; Becchio, Cristina/0000-0002-6845-0521; Bulgheroni, Maria/0000-0001-8484-9834; Castiello, Umberto/0000-0003-0629-1286	Institute of Child Health IRCCS, Burlo Garofolo, Trieste, Italy [R.C. 44/03]; Ministero Italiano dell' Universite e della Ricerca; Regione Piemonte; Bando Scienze Umane e Sociali [L.R. n.4/2006]	Institute of Child Health IRCCS, Burlo Garofolo, Trieste, Italy; Ministero Italiano dell' Universite e della Ricerca; Regione Piemonte(Regione Piemonte); Bando Scienze Umane e Sociali	This work was supported by grant R.C. 44/03 of the Institute of Child Health IRCCS, Burlo Garofolo, Trieste, Italy and by the Ministero Italiano dell' Universite e della Ricerca. C.B. was supported by a grant from the Regione Piemonte, Bando Scienze Umane e Sociali 2008, L.R. n.4/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel-Tison C, 2004, EARLY HUM DEV, V78, P15, DOI 10.1016/j.earlhumdev.2004.03.002; Andonotopo W, 2005, J MATERN-FETAL NEO M, V17, P165, DOI 10.1080/14767050400028717; Arabin B, 1996, ULTRASOUND OBST GYN, V8, P166, DOI 10.1046/j.1469-0705.1996.08030166.x; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; Braten S, 2009, ADV CONSC RES, V76, P1; BUBER M, 1923, I THOU; D'Elia A, 2001, EARLY HUM DEV, V65, P139, DOI 10.1016/S0378-3782(01)00224-9; DEVRIES JIP, 1988, EARLY HUM DEV, V16, P85, DOI 10.1016/0378-3782(88)90089-8; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; Hata T, 1998, GYNECOL OBSTET INVES, V46, P26, DOI 10.1159/000009991; Kurjak A, 2003, J PERINAT MED, V31, P496, DOI 10.1515/JPM.2003.076; MELTZOFF AN, 1983, CHILD DEV, V54, P702, DOI 10.2307/1130058; MELTZOFF AN, 1989, DEV PSYCHOL, V25, P954, DOI 10.1037/0012-1649.25.6.954; MYOWAYAMAKOSHI M, 2006, DO HUMAN FETUSES ANT, P289; Piontelli A, 1997, EARLY HUM DEV, V50, P39, DOI 10.1016/S0378-3782(97)00091-1; REDDY V, 2007, INFANTS KNOW MINDS; Reece E A, 1989, Obstet Gynecol Surv, V44, P544, DOI 10.1097/00006254-198907000-00010; REID VM, 2007, SOCIAL COGNITION INF; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Sasaki M, 2010, INT J GYNECOL OBSTET, V108, P104, DOI 10.1016/j.ijgo.2009.09.025; SIVAL DA, 1990, EARLY HUM DEV, V23, P233, DOI 10.1016/0378-3782(90)90014-A; Sparling JW, 1999, PHYS THER, V79, P24, DOI 10.1093/ptj/79.1.24; Striano T, 2006, TRENDS COGN SCI, V10, P471, DOI 10.1016/j.tics.2006.08.006; TONGSONG T, 1992, INT J GYNECOL OBSTET, V38, P87, DOI 10.1016/0020-7292(92)90041-G; Trevarthen C., 1993, PERCEIVED SELF ECOLO, P121, DOI [10.1017/CBO9780511664007.009, DOI 10.1017/CBO9780511664007.009]; TREVARTHEN C., 1979, SPEECH BEGINNING HUM, P321; von Hofsten C, 2007, DEVELOPMENTAL SCI, V10, P54, DOI 10.1111/j.1467-7687.2007.00564.x; von Hofsten C, 2009, SCAND J PSYCHOL, V50, P617, DOI 10.1111/j.1467-9450.2009.00780.x; Yigiter AB, 2006, J MATERN-FETAL NEO M, V19, P707, DOI 10.1080/14767050600924129; Zoia S, 2007, EXP BRAIN RES, V176, P217, DOI 10.1007/s00221-006-0607-3	32	99	100	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13199	10.1371/journal.pone.0013199	http://dx.doi.org/10.1371/journal.pone.0013199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	660IN	20949058	Green Published, Green Submitted, gold			2022-12-25	WOS:000282633700008
J	Song, WW; Dou, XY; Qi, ZQ; Wang, Q; Zhang, X; Zhang, HF; Guo, M; Dong, SM; Zhang, ZG; Wang, P; Zheng, XB				Song, Wenwen; Dou, Xianying; Qi, Zhongqiang; Wang, Qi; Zhang, Xing; Zhang, Haifeng; Guo, Min; Dong, Suomeng; Zhang, Zhengguang; Wang, Ping; Zheng, Xiaobo			R-SNARE Homolog MoSec22 Is Required for Conidiogenesis, Cell Wall Integrity, and Pathogenesis of Magnaporthe oryzae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CHITIN SYNTHASE; RETROGRADE TRANSPORT; CALCOFLUOR WHITE; OXIDATIVE STRESS; GENE-EXPRESSION; NADPH OXIDASES; IDENTIFICATION; GRISEA	Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins mediate intracellular vesicle fusion, which is an essential cellular process of the eukaryotic cells. To investigate the role of SNARE proteins in the rice blast fungus Magnaporthe oryzae, MoSec22, an ortholog of Saccharomyces cerevisiae SNARE protein Sec22, was identified and the MoSEC22 gene disrupted. MoSec22 restored a S. cerevisiae sec22 mutant in resistance to cell wall perturbing agents, and the Delta Mosec22 mutant also exhibited defects in mycelial growth, conidial production, and infection of the host plant. Treatment with oxidative stress inducers indicated a breach in cell wall integrity, and staining and quantification assays suggested abnormal chitin deposition on the lateral walls of hyphae of the Delta Mosec22 mutant. Furthermore, hypersensitivity to the oxidative stress correlates with the reduced expression of the extracellular enzymes peroxidases and laccases. Our study thus provides new evidence on the conserved function of Sec22 among fungal organisms and indicates that MoSec22 has a role in maintaining cell wall integrity affecting the growth, morphogenesis, and virulence of M. oryzae.	[Song, Wenwen; Dou, Xianying; Qi, Zhongqiang; Wang, Qi; Zhang, Xing; Zhang, Haifeng; Guo, Min; Dong, Suomeng; Zhang, Zhengguang; Zheng, Xiaobo] Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Peoples R China; [Song, Wenwen; Dou, Xianying; Qi, Zhongqiang; Wang, Qi; Zhang, Xing; Zhang, Haifeng; Guo, Min; Dong, Suomeng; Zhang, Zhengguang; Zheng, Xiaobo] Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Peoples R China; [Wang, Ping] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA USA; [Wang, Ping] Louisiana State Univ, Res Inst Children, Hlth Sci Ctr, New Orleans, LA USA	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zhang, ZG (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Peoples R China.	zhgzhang@njau.edu.cn	Zhang, Zhengguang/F-3917-2014		Special Fund for Agro-scientific Research in the Public Interest [200803008]; National Basic Research Program of China [2006CB101901]; Ministry of Education of China [NCET-07-0442]; Natural Science Foundations of China [30771394, 30971890]; US NIH/NIAID [AI054958]	Special Fund for Agro-scientific Research in the Public Interest; National Basic Research Program of China(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); US NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Special Fund for Agro-scientific Research in the Public Interest (200803008 to ZG Zhang), National Basic Research Program of China (2006CB101901 to Zhengguang Zhang), the New Century Excellent Scholar Project of the Ministry of Education of China (NCET-07-0442 to ZG Zhang), and the Natural Science Foundations of China (30771394 and 30971890 to XB Zheng). Research in Ping Wang lab was partially supported by a US grant (NIH/NIAID AI054958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; APOSTOL I, 1989, PLANT PHYSIOL, V90, P109, DOI 10.1104/pp.90.1.109; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Bulik DA, 2003, EUKARYOT CELL, V2, P886, DOI 10.1128/EC.2.5.886-900.2003; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Chen HJ, 2008, NUMER MATH-THEORY ME, V1, P1; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; Choquer M, 2004, EUR J BIOCHEM, V271, P2153, DOI 10.1111/j.1432-1033.2004.04135.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Doke N, 1996, GENE, V179, P45, DOI 10.1016/S0378-1119(96)00423-4; Dufresne M, 2001, MOL PLANT MICROBE IN, V14, P300, DOI 10.1094/MPMI.2001.14.3.300; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fuchs U, 2005, PROTOPLASMA, V226, P75, DOI 10.1007/s00709-005-0109-3; Garzia A, 2009, MOL MICROBIOL, V71, P172, DOI 10.1111/j.1365-2958.2008.06520.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gilbert MJ, 2006, NATURE, V440, P535, DOI 10.1038/nature04567; Guo M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053; Gupta GD, 2002, FUNGAL GENET BIOL, V36, P1, DOI 10.1016/S1087-1845(02)00017-8; HARRIS SD, 1994, GENETICS, V136, P517; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kikuma T, 2007, AUTOPHAGY, V3, P128, DOI 10.4161/auto.3560; Kuratsu M, 2007, FUNGAL GENET BIOL, V44, P1310, DOI 10.1016/j.fgb.2007.04.012; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lussier M, 1997, GENETICS, V147, P435; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; Martin-Udiroz M, 2004, MICROBIOL-SGM, V150, P3175, DOI 10.1099/mic.0.27236-0; Molina L, 2007, PLANT CELL, V19, P2293, DOI 10.1105/tpc.107.052332; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Odenbach D, 2009, MOL PLANT PATHOL, V10, P81, DOI 10.1111/j.1364-3703.2008.00515.x; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; RAM AFJ, 1995, FEBS LETT, V358, P165, DOI 10.1016/0014-5793(94)01418-Z; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; SHIMIZU J, 1994, MOL GEN GENET, V242, P641, DOI 10.1007/BF00283417; Silue D, 1998, PHYSIOL MOL PLANT P, V53, P239, DOI 10.1006/pmpp.1998.0180; Skamnioti P, 2007, PLANT CELL, V19, P2674, DOI 10.1105/tpc.107.051219; SLACK JK, 1994, NUCLEIC ACIDS RES, V22, P1316; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timberlake WE, 1991, CURR OPIN GENET DEV, V1, P351, DOI 10.1016/S0959-437X(05)80299-0; VALENT B, 1991, GENETICS, V127, P87; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; WOOD PJ, 1983, J HISTOCHEM CYTOCHEM, V31, P823, DOI 10.1177/31.6.6841974; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988; Yukioka H, 1998, BBA-GENE STRUCT EXPR, V1442, P161, DOI 10.1016/S0167-4781(98)00159-6; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zheng W, 2007, EUKARYOT CELL, V6, P2240, DOI 10.1128/EC.00104-07; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402	70	61	69	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13193	10.1371/journal.pone.0013193	http://dx.doi.org/10.1371/journal.pone.0013193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949084	Green Submitted, Green Published, gold			2022-12-25	WOS:000282568400011
J	Kabakchiev, B; Turner, D; Hyams, J; Mack, D; Leleiko, N; Crandall, W; Markowitz, J; Otley, AR; Xu, W; Hu, PZ; Griffiths, AM; Silverberg, MS				Kabakchiev, Boyko; Turner, Dan; Hyams, Jeffrey; Mack, David; Leleiko, Neal; Crandall, Wallace; Markowitz, James; Otley, Anthony R.; Xu, Wei; Hu, Pingzhao; Griffiths, Anne M.; Silverberg, Mark S.			Gene Expression Changes Associated with Resistance to Intravenous Corticosteroid Therapy in Children with Severe Ulcerative Colitis	PLOS ONE			English	Article							ACTIVITY INDEX; IN-VITRO; GLUCOCORTICOID SENSITIVITY; INCREASING PROTEIN; MEDICAL THERAPY; MESSENGER-RNA; HAPTOGLOBIN; RECEPTOR; IL-8; PREDICTORS	Background and Aims: Microarray analysis of RNA expression allows gross examination of pathways operative in inflammation. We aimed to determine whether genes expressed in whole blood early following initiation of intravenous corticosteroid treatment can be associated with response. Methods: From a prospectively accrued cohort of 128 pediatric patients hospitalized for intravenous corticosteroid treatment of severe UC, we selected for analysis 20 corticosteroid responsive (hospital discharge or PUCAI <= 45 by day 5) and 20 corticosteroid resistant patients (need for second line medical therapy or colectomy, or PUCAI >45 by day 5). Total RNA was extracted from blood samples collected on day 3 of intravenous corticosteroid therapy. The eluted transcriptomes were quantified on Affymetrix Human Gene 1.0 ST arrays. The data was analysed by the local-pooled error method for discovery of differential gene expression and false discovery rate correction was applied to adjust for multiple comparisons. Results: A total of 41 genes differentially expressed between responders and non-responders were detected with statistical significance. Two of these genes, CEACAM1 and MMP8, possibly inhibited by methylprednisolone through IL8, were both found to be over-expressed in non-responsive patients. ABCC4 (MRP4) as a member of the multi-drug resistance superfamily was a novel candidate gene for corticosteroid resistance. The expression pattern of a cluster of 10 genes selected from the 41 significant hits were able to classify the patients with 80% sensitivity and 80% specificity. Conclusions: Elevated expression of several genes involved in inflammatory pathways was associated with resistance to intravenous corticosteroid therapy early in the course of treatment. Gene expression profiles may be useful to classify resistance to intravenous corticosteroids in children with severe UC and assist with clinical management decisions.	[Kabakchiev, Boyko; Silverberg, Mark S.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Hu, Pingzhao; Griffiths, Anne M.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Otley, Anthony R.] Izaak Walton Killam Hosp Children, Halifax, NS B3J 3G9, Canada; [Mack, David] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Hyams, Jeffrey] Connecticut Childrens Med Ctr, Hartford, CT USA; [Markowitz, James] Schneider Childrens Hosp, New Hyde Pk, NY USA; [Leleiko, Neal] Brown Univ, Providence, RI 02912 USA; [Crandall, Wallace] Columbus Childrens Hosp, Columbus, OH USA; [Turner, Dan] Shaare Zedek Med Ctr, Jerusalem, Israel; [Kabakchiev, Boyko; Silverberg, Mark S.] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Dalhousie University; University of Ottawa; Children's Hospital of Eastern Ontario; Connecticut Children's Medical Center; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Brown University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Hebrew University of Jerusalem; Shaare Zedek Medical Center; University of Toronto	Kabakchiev, B (corresponding author), Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada.	kabakchiev@lunenfeld.ca	Silverberg, Mark/B-4183-2008; LeLeiko, Neal/GRJ-6855-2022	Otley, Anthony/0000-0002-7371-9302; leleiko, neal/0000-0001-7699-1400; Hu, Pingzhao/0000-0002-9546-2245	Schering-Plough Canada Inc.; Crohn's and Colitis Foundation of Canada; National Institutes of Health; Proctor and Gamble; Centocor Ortho Biotech; Abbott; UCB; Astra Zeneca; Prometheus Laboratories; Centocor; Axcan Pharma	Schering-Plough Canada Inc.; Crohn's and Colitis Foundation of Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Proctor and Gamble(Procter & Gamble); Centocor Ortho Biotech; Abbott(Abbott Laboratories); UCB(UCB Pharma SA); Astra Zeneca(AstraZeneca); Prometheus Laboratories; Centocor; Axcan Pharma(Dexcel Pharma)	This investigator-initiated study was funded by Schering-Plough Canada Inc. (http://www.schering-plough.ca/), the Crohn's and Colitis Foundation of Canada (http://www.ccfc.ca/), and the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Study participants were aware of the following potential conflicts of interest: Dan Turner: Proctor and Gamble - consultant; Medici medical - consultant, research support; Jeffrey Hyams: Centocor Ortho Biotech - research support, consultant, speaker's bureau; Abbott - research support, consultant; UCB - research support, consultant; Astra Zeneca - research support; Anne M Griffiths: Proctor and Gamble - consultant; Centocor Ortho Biotech research support, consultant; UCB - consultant; Abbott - consultant; James Markowitz: Centocor Ortho Biotech - research support, consultant; Abbott - research support; UCB - research support, consultant; Astra Zeneca - research support; Prometheus Laboratories - research support, consultant, honorarium; Abbott Nutritionals - speaker's bureau, honoraria; Wallace Crandall: Centocor Ortho Biotech - consultant, research support; Abbott - research support; Neal LeLeiko: Centocor - research support; Astra Zeneca - research support; Proctor and Gamble - research support; Anthony Otley: Abbott - research support, consultant, speaker's bureau; UCB - research support; Schering - research support; Proctor and Gamble - research support; David Mack: Axcan Pharma - consultant; Schering-Plough - speaker's bureau, consultant; Abbott - speaker, research support; AstraZeneca - speaker; Merck-Frosst - speaker; Proctor and Gamble - research support; Novartis - consultant; Bristol-Myers Squibb - consultant, speaker; all others have nothing to declare.	Aarbiou J, 2004, AM J RESP CELL MOL, V30, P193, DOI 10.1165/rcmb.2002-0267OC; [Anonymous], 2007, J PEDIATR GASTR NUTR, V44, P653; Arredouani M, 2001, REDOX REP, V6, P369; Azuz-Lieberman N, 2005, INT IMMUNOL, V17, P837, DOI 10.1093/intimm/dxh270; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bokarewa MI, 2003, J RHEUMATOL, V30, P1719; Bray PJ, 2003, HUM MUTAT, V21, P557, DOI 10.1002/humu.10213; Celik JB, 2004, PERFUSION-UK, V19, P185, DOI 10.1191/0267659104pf733oa; Chen ZS, 2002, CANCER RES, V62, P3144; Conrotto P, 2008, INT J CANCER, V123, P2856, DOI 10.1002/ijc.23861; Dentener MA, 1997, J INFECT DIS, V175, P108, DOI 10.1093/infdis/175.1.108; Donn R, 2007, FASEB J, V21, P402, DOI 10.1096/fj.06-7236com; Farrell RJ, 2000, GASTROENTEROLOGY, V118, P279, DOI 10.1016/S0016-5085(00)70210-1; Flood L, 2001, INFLAMM BOWEL DIS, V7, P202, DOI 10.1097/00054725-200108000-00004; Gohring K, 2004, BRIT J HAEMATOL, V126, P252, DOI 10.1111/j.1365-2141.2004.05027.x; GOLD DM, 1995, AM J GASTROENTEROL, V90, P732; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Hakonarson H, 2005, P NATL ACAD SCI USA, V102, P14789, DOI 10.1073/pnas.0409904102; Hearing SD, 1999, GUT, V45, P382, DOI 10.1136/gut.45.3.382; Ho GT, 2009, AM J GASTROENTEROL, V104, P673, DOI 10.1038/ajg.2008.119; Ho GT, 2004, ALIMENT PHARM THER, V19, P1079, DOI 10.1111/j.1365-2036.2004.01945.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kelly RW, 2002, J REPROD IMMUNOL, V57, P217, DOI 10.1016/S0165-0378(02)00007-4; KUHN M, 2002, NUCLEIC ACIDS RES, V38, pD552; LEUNG DYM, 1995, J EXP MED, V181, P33, DOI 10.1084/jem.181.1.33; Lindgren SC, 1998, EUR J GASTROEN HEPAT, V10, P831, DOI 10.1097/00042737-199810000-00003; LIU W, 2004, P NATL ACAD SCI USA, V107, P11056; Liu WL, 2008, CLIN CANCER RES, V14, P1041, DOI 10.1158/1078-0432.CCR-07-4125; Liu WL, 2006, EXP CELL RES, V312, P1785, DOI 10.1016/j.yexcr.2006.02.011; Matsuda R, 2009, INFLAMM BOWEL DIS, V15, P328, DOI 10.1002/ibd.20759; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Papp M, 2007, DIGEST DIS SCI, V52, P1279, DOI 10.1007/s10620-006-9615-1; PETERSEN F, 1991, LYMPHOKINE CYTOK RES, V10, P35; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Schaaf Bernhard, 2008, BMC Pulm Med, V8, P12, DOI 10.1186/1471-2466-8-12; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sharpe-Timms KL, 2002, FERTIL STERIL, V78, pS88, DOI 10.1016/S0015-0282(02)03612-9; Shinozaki S, 2001, GUT, V48, P623, DOI 10.1136/gut.48.5.623; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; Thirumangalakudi L, 2007, J ALZHEIMERS DIS, V11, P305; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Travis SPL, 1996, GUT, V38, P905, DOI 10.1136/gut.38.6.905; Turner D, 2008, GUT, V57, DOI 10.1136/gut.2007.136481; TURNER D, 2009, INFLAMM BOWEL DIS; Turner D, 2007, GASTROENTEROLOGY, V133, P423, DOI 10.1053/j.gastro.2007.05.029; Turner D, 2007, CLIN GASTROENTEROL H, V5, P103, DOI 10.1016/j.cgh.2006.09.033; Turner D, 2010, GASTROENTEROLOGY, V138, P2282, DOI 10.1053/j.gastro.2010.02.047; Turner D, 2009, GASTROENTEROLOGY, V136, pA571; Turner D, 2009, CLIN GASTROENTEROL H, V7, P1081, DOI 10.1016/j.cgh.2009.06.024; Turner D, 2009, INFLAMM BOWEL DIS, V15, P1218, DOI 10.1002/ibd.20867; Turner D, 2009, J CLIN EPIDEMIOL, V62, P738, DOI 10.1016/j.jclinepi.2008.09.008; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zhang XW, 2004, CANCER RES, V64, P2474, DOI 10.1158/0008-5472.CAN-03-3443	60	27	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13085	10.1371/journal.pone.0013085	http://dx.doi.org/10.1371/journal.pone.0013085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941359	Green Published, gold, Green Submitted			2022-12-25	WOS:000282312600018
J	Kido, S; Kuriwaka-Kido, R; Umino-Miyatani, Y; Endo, I; Inoue, D; Taniguchi, H; Inoue, Y; Imamura, T; Matsumoto, T				Kido, Shinsuke; Kuriwaka-Kido, Rika; Umino-Miyatani, Yuka; Endo, Itsuro; Inoue, Daisuke; Taniguchi, Hisaaki; Inoue, Yasumichi; Imamura, Takeshi; Matsumoto, Toshio			Mechanical Stress Activates Smad Pathway through PKC delta to Enhance Interleukin-11 Gene Transcription in Osteoblasts	PLOS ONE			English	Article							PROTEIN-KINASE-C; MARROW STROMAL CELLS; BONE-FORMATION; FLUID SHEAR; MC3T3-E1 OSTEOBLASTS; MESSENGER-RNA; SPACE-FLIGHT; BED REST; INDUCTION; MICE	Background: Mechanical stress rapidly induces Delta FosB expression in osteoblasts, which binds to interleukin (IL)-11 gene promoter to enhance IL-11 expression, and IL-11 enhances osteoblast differentiation. Because bone morphogenetic proteins (BMPs) also stimulate IL-11 expression in osteoblasts, there is a possibility that BMP-Smad signaling is involved in the enhancement of osteoblast differentiation by mechanical stress. The present study was undertaken to clarify whether mechanical stress affects BMP-Smad signaling, and if so, to elucidate the role of Smad signaling in mechanical stress-induced enhancement of IL-11 gene transcription. Methodology/Principal Findings: Mechanical loading by fluid shear stress (FSS) induced phosphorylation of BMP-specific receptor-regulated Smads (BR-Smads), Smad1/5, in murine primary osteoblasts (mPOBs). FSS rapidly phosphorylated Y311 of protein kinase C (PKC)delta, and phosphorylated PKC delta interacted with BR-Smads to phosphorylate BR-Smads. Transfection of PKC delta siRNA or Y311F mutant PKC delta abrogated BR-Smads phosphorylation and suppressed IL-11 gene transcription enhanced by FSS. Activated BR-Smads bound to the Smad-binding element (SBE) of IL-11 gene promoter and formed complex with Delta FosB/JunD heterodimer via binding to the C-terminal region of JunD. Site-directed mutagenesis in the SBE and the AP-1 site revealed that both SBE and AP-1 sites were required for full activation of IL-11 gene promoter by FSS. Conclusions/Significance: These results demonstrate that PKC delta-BR-Smads pathway plays an important role in the intracellular signaling in response to mechanical stress, and that a cross-talk between PKC delta-BR-Smads and Delta FosB/JunD pathways synergistically stimulates IL-11 gene transcription in response to mechanical stress.	[Kido, Shinsuke; Kuriwaka-Kido, Rika; Endo, Itsuro; Inoue, Daisuke; Matsumoto, Toshio] Univ Tokushima, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Tokushima 770, Japan; [Kido, Shinsuke; Matsumoto, Toshio] Univ Tokushima, 21st Century Ctr Excellence COE Program, Grad Sch Med Sci, Tokushima 770, Japan; [Umino-Miyatani, Yuka] Univ Tokushima, Dept Obstet & Gynecol, Grad Sch Med Sci, Tokushima 770, Japan; [Taniguchi, Hisaaki] Univ Tokushima, Div Mol Enzyme Physiol, Inst Enzyme Res, Tokushima 770, Japan; [Inoue, Yasumichi; Imamura, Takeshi] JFCR, Inst Canc, Div Biochem, Tokyo, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Japanese Foundation for Cancer Research	Kido, S (corresponding author), Univ Tokushima, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Tokushima 770, Japan.	toshimat@clin.med.tokushima-u.ac.jp	Taniguchi, Hisaaki/I-9171-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was carried out as a part of "Ground Research Announcement for Space Utilization'' promoted by Japan Science Forum. The study was also supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Center-of-Excellence Program of the 21st Century from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; CARVALHO RS, 1994, J BONE MINER RES, V9, P999; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hung CT, 1996, J BIOMECH, V29, P1411, DOI 10.1016/0021-9290(96)84536-2; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; Inoue M, 2000, BONE, V26, P281, DOI 10.1016/S8756-3282(99)00282-3; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Jordan NJ, 1996, BRIT J PHARMACOL, V117, P1245, DOI 10.1111/j.1476-5381.1996.tb16722.x; Kido S, 2009, BONE, V45, P1125, DOI 10.1016/j.bone.2009.07.087; Kodama Y, 1998, J BONE MINER RES, V13, P1370, DOI 10.1359/jbmr.1998.13.9.1370; Kodama Y, 1997, J BONE MINER RES, V12, P1058, DOI 10.1359/jbmr.1997.12.7.1058; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kveiborg M, 2004, MOL CELL BIOL, V24, P2820, DOI 10.1128/MCB.24.7.2820-2830.2004; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; Rawlinson SCF, 1996, BONE, V19, P609, DOI 10.1016/S8756-3282(96)00260-8; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Sakai K, 1999, J BONE MINER RES, V14, P2089, DOI 10.1359/jbmr.1999.14.12.2089; Schneider V, 1995, ACTA ASTRONAUT, V36, P463, DOI 10.1016/0094-5765(95)00131-X; Takase M, 1998, BIOCHEM BIOPH RES CO, V244, P26, DOI 10.1006/bbrc.1998.8200; Takeuchi Y, 2002, J BIOL CHEM, V277, P49011, DOI 10.1074/jbc.M207804200; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Tohjima E, 2003, J BONE MINER RES, V18, P1461, DOI 10.1359/jbmr.2003.18.8.1461; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Walker LM, 2000, J CELL BIOCHEM, V79, P648, DOI 10.1002/1097-4644(20001215)79:4<648::AID-JCB130>3.0.CO;2-Q; Watanabe Y, 2004, J BONE MINER RES, V19, P1771, DOI 10.1359/JBMR.040811; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200	33	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13090	10.1371/journal.pone.0013090	http://dx.doi.org/10.1371/journal.pone.0013090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927330	Green Submitted, Green Published, gold			2022-12-25	WOS:000282269400030
J	Appanna, R; Ponnampalavanar, S; See, LLC; Sekaran, SD				Appanna, Ramapraba; Ponnampalavanar, Sasheela; See, Lucy Lum Chai; Sekaran, Shamala Devi			Susceptible and Protective HLA Class 1 Alleles against Dengue Fever and Dengue Hemorrhagic Fever Patients in a Malaysian Population	PLOS ONE			English	Article							T-CELL RESPONSES; CLASS-I; VIRUS-INFECTION; DISEASE SEVERITY; IDENTIFICATION; POLYMORPHISM; ASSOCIATION; EPITOPES; FREQUENCIES; CLEARANCE	The human leukocyte antigen alleles have been implicated as probable genetic markers in predicting the susceptibility and/or protection to severe manifestations of dengue virus (DENV) infection. In this present study, we aimed to investigate for the first time, the genotype variants of HLA Class 1(-A and -B) of DENV infected patients against healthy individuals in Malaysia. Methodology/Principal Findings: This study was carried out with 92 dengue disease patients and 95 healthy controls from three different ethnic groups (Malay, Chinese and Indian) in Malaysia. All patients with clinical and laboratory confirmation of DENV infection were typed for the HLA-A and B loci, using polymerase chain reaction-sequence specific primer techniques. In our total population, a significant increase for HLA-B*53 (P=0.042, Pc=1.008) allele and a significant decrease for A*03 (P=0.015, Pc=0.18, OR=5.23, 95% CI=1.19-23.02) and B*18 (P=0.017, Pc=0.408) alleles were noted in DHF patients as compared to healthy donors. We also observed that in the Malay DHF patients, allele B*13 (P=0.049, Pc=1.176, OR=0.18, 95% CI=0.03-0.90) was present at a significantly higher frequency in this population while allele HLA-B*18 (P=0.024, Pc=0.576) was seen to be negatively associated with DHF. Conclusions/Significance: These are the first findings on genetic polymorphisms in our population and we conclude that: (1) In our total population, HLA-B*53 probably involve in disease susceptibility, while the HLA-A*03 and HLA-B*18 may confer protection from progression to severe disease; (2) In the Malay population, HLA-B*13 and B*18 are probably associated in disease susceptibility and protection, respectively. These results could furnish as a valuable predictive tool to identify ethnically different individuals at risk and/or protection from severe forms of DENV infection and would provide valuable informations for the design of future dengue vaccine.	[Appanna, Ramapraba; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Ponnampalavanar, Sasheela] Univ Malaya, Med Ctr, Dept Infect Dis, Kuala Lumpur, Malaysia; [See, Lucy Lum Chai] Univ Malaya, Dept Pediat, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Appanna, R (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	Sekaran, Shamala Devi/B-8482-2008; Devi, Shamala Devi/B-9735-2010; LA SRI PONNAMPALAVANAR, SASHEELA SRI/B-9703-2010; Lum, Lucy/Q-9871-2017	Sekaran, Shamala Devi/0000-0002-0478-0425; Devi, Shamala Devi/0000-0002-0478-0425; Lum, Lucy/0000-0002-7452-4208; sri la sri ponnampalavanar, sasheela/0000-0002-4506-1304	Academy of Science Malaysia [SAGA 66-02-03-0041]; University Malaya Vote PPP [PS169/2007C]; University Malaya Vote PJP [FS245/2008B]	Academy of Science Malaysia; University Malaya Vote PPP; University Malaya Vote PJP	This study was funded by the Academy of Science Malaysia Grant [SAGA 66-02-03-0041], University Malaya Vote PPP [PS169/2007C] and University Malaya Vote PJP [FS245/2008B]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Falcon-Lezama JA, 2009, ACTA TROP, V112, P193, DOI 10.1016/j.actatropica.2009.07.025; AIKEN SR, 1978, T I BRIT GEOGR, V3, P476, DOI 10.2307/622125; Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; *BUR E AS PAC AFF, BACKGR NOT; CHAN SH, 1985, BRIT J CANCER, V51, P389, DOI 10.1038/bjc.1985.52; Chandanayingyong D, 1997, HUM IMMUNOL, V53, P174, DOI 10.1016/S0198-8859(96)00284-4; Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x; CHIEWSILP P, 1981, AM J TROP MED HYG, V30, P1100, DOI 10.4269/ajtmh.1981.30.1100; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Dawson DV, 2001, GENET EPIDEMIOL, V20, P87, DOI 10.1002/1098-2272(200101)20:1<87::AID-GEPI8>3.0.CO;2-R; Dhaliwal JS, 2007, ASIAN PAC J ALLERGY, V25, P47; Edinur HA, 2009, HUM IMMUNOL, V70, P518, DOI 10.1016/j.humimm.2009.04.003; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; FANG R, 1984, Southeast Asian Journal of Tropical Medicine and Public Health, V15, P51; Farquhar C, 2004, AIDS RES HUM RETROV, V20, P692, DOI 10.1089/0889222041524616; GOLDSBY RA, 2003, IMMUNOLOGY, P161; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Imirizaldu JJZ, 2003, J NEUROL NEUROSUR PS, V74, P1080, DOI 10.1136/jnnp.74.8.1080; Jeffery KJM, 2000, J IMMUNOL, V165, P7278, DOI 10.4049/jimmunol.165.12.7278; Kawashima Y, 2005, HUM IMMUNOL, V66, P1155, DOI 10.1016/j.humimm.2005.10.015; LAM S K, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P532; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Louie LG, 2004, J INFECT DIS, V189, P1084, DOI 10.1086/382030; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; McNeil AJ, 1996, QJM-INT J MED, V89, P177; McNicholl J, 1998, EMERG INFECT DIS, V4, P423, DOI 10.3201/eid0403.980322; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Novitsky V, 2001, HUM IMMUNOL, V62, P146, DOI 10.1016/S0198-8859(00)00236-6; PEREZ MLP, 1987, HAEMATOLOGIA, V20, P83; Rajendra S, 2005, ALIMENT PHARM THER, V21, P1377, DOI 10.1111/j.1365-2036.2005.02496.x; Rudnick A, 1986, DENGUE FEVER STUDIES, P9; SEKHAR KC, 1992, ASIA-PAC J PUBLIC HE, V6, P126; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Skae FMT, 1902, BRIT MED J, V1902, P1581, DOI 10.1136/bmj.2.2185.1581-a; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Subklewe M, 2006, TRANSPLANTATION, V82, P1093, DOI 10.1097/01.tp.0000235889.05171.12; Takedatsu H, 2004, CLIN CANCER RES, V10, P1112, DOI 10.1158/1078-0432.CCR-0797-3; Thio CL, 2003, J VIROL, V77, P12083, DOI 10.1128/JVI.77.22.12083-12087.2003; Van Epps HL, 1999, J VIROL, V73, P5301, DOI 10.1128/JVI.73.7.5301-5308.1999; Wagenaar J. F. P., 2004, Dengue Bulletin, V28, P126; WALLACE H G, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P1; WHO, 2009, DENG DENG HAEM FEV; Yong Y. K., 2007, SMJ Singapore Medical Journal, V48, P662; Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959; HIST MALAYSIA	51	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13029	10.1371/journal.pone.0013029	http://dx.doi.org/10.1371/journal.pone.0013029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927388	Green Published, Green Submitted, gold			2022-12-25	WOS:000282210700010
J	Safonov, LA; Isomura, Y; Kang, S; Struzik, ZR; Fukai, T; Cateau, H				Safonov, Leonid A.; Isomura, Yoshikazu; Kang, Siu; Struzik, Zbigniew R.; Fukai, Tomoki; Cateau, Hideyuki			Near Scale-Free Dynamics in Neural Population Activity of Waking/Sleeping Rats Revealed by Multiscale Analysis	PLOS ONE			English	Article							NEURONAL AVALANCHES; SINGLE-NEURON; CASCADES; TURBULENCE; LAYER-2/3; NETWORKS; BEHAVIOR; MODELS	A neuron embedded in an intact brain, unlike an isolated neuron, participates in network activity at various spatial resolutions. Such multiple scale spatial dynamics is potentially reflected in multiple time scales of temporal dynamics. We identify such multiple dynamical time scales of the inter-spike interval (ISI) fluctuations of neurons of waking/sleeping rats by means of multiscale analysis. The time scale of large non-Gaussianity in the ISI fluctuations, measured with the Castaing method, ranges up to several minutes, markedly escaping the low-pass filtering characteristics of neurons. A comparison between neural activity during waking and sleeping reveals that non-Gaussianity is stronger during waking than sleeping throughout the entire range of scales observed. We find a remarkable property of near scale independence of the magnitude correlations as the primary cause of persistent non-Gaussianity. Such scale-invariance of correlations is characteristic of multiplicative cascade processes and raises the possibility of the existence of a scale independent memory preserving mechanism.	[Safonov, Leonid A.; Isomura, Yoshikazu; Kang, Siu; Fukai, Tomoki; Cateau, Hideyuki] RIKEN BSI, Lab Neural Circuit Theory, Wako, Saitama, Japan; [Isomura, Yoshikazu] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Kang, Siu] Yamagata Univ, Dept Biosyst Engn, Grad Sch Sci & Engn, Yonezawa, Yamagata, Japan; [Struzik, Zbigniew R.] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo, Japan; [Fukai, Tomoki] JST, CREST, Kawaguchi, Saitama, Japan; [Fukai, Tomoki] RIKEN Computat Sci Res Program, Brain & Neural Syst Team, Wako, Saitama, Japan; [Cateau, Hideyuki] Kyushu Inst Technol, Grad Sch Life Sci & Sci Engn, Kitakyushu, Fukuoka 804, Japan	RIKEN; Yamagata University; University of Tokyo; Japan Science & Technology Agency (JST); RIKEN; Kyushu Institute of Technology	Safonov, LA (corresponding author), RIKEN BSI, Lab Neural Circuit Theory, Wako, Saitama, Japan.	cateau@brain.riken.jp	Cateau, Hideyuki/R-9446-2016; Struzik, Zbigniew/E-4295-2012; Fukai, Tomoki/A-3936-2015	Cateau, Hideyuki/0000-0002-8861-0916; Struzik, Zbigniew/0000-0002-1352-8897; Fukai, Tomoki/0000-0001-6977-5638	RIKEN; Japanese Ministry of Education, Culture, Sports, Science and Technology [18019041, 19700284]	RIKEN; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The present study was supported by the President's Discretionary Fund (2007-2009) of RIKEN. The study was also supported by Grants-in-Aid for Scientific Research on Priority Areas (No. 18019041) to Y.I., on Innovative Areas (No. 22115013) to T.F., and Wakate (B) (No. 19700284) to S.K. from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambeau C, 2007, NEURAL NETWORKS, V20, P129, DOI 10.1016/j.neunet.2006.06.009; Arneodo A, 1998, PHYS REV LETT, V80, P708, DOI 10.1103/PhysRevLett.80.708; Bacry E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026103; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bhattacharya J, 2005, NEUROSCIENCE, V131, P547, DOI 10.1016/j.neuroscience.2004.11.013; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; CASTAING B, 1990, PHYSICA D, V46, P177, DOI 10.1016/0167-2789(90)90035-N; CHABAUD B, 1994, PHYS REV LETT, V73, P3227, DOI 10.1103/PhysRevLett.73.3227; Chainais P, 2005, IEEE T INFORM THEORY, V51, P1063, DOI 10.1109/TIT.2004.842570; CHAINAIS P, 1998, PHYS REV LETT, V80, P708; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Ghashghaie S, 1996, NATURE, V381, P767, DOI 10.1038/381767a0; Ghil M., 1985, TURBULENCE PREDICTAB; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Kandel E., 2000, PRINCIPLES NEURAL SC; Kiyono K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.058101; Kiyono K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.068701; Kiyono K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178103; Kiyono K, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041113; Lungarella M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056117; Nakamura T, 2000, J NEUROSCI, V20, P8365, DOI 10.1523/JNEUROSCI.20-22-08365.2000; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Persi E, 2004, NEURAL COMPUT, V16, P2577, DOI 10.1162/0899766042321823; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; TAKEKAWA T, 2009, ETOS EFFICIENT TECHN; TAKEKAWA T, 2008, SOC NEUR 38 ANN M; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; Takekawa T, 2009, NEUROCOMPUTING, V72, P3366, DOI 10.1016/j.neucom.2009.04.003; Teramae JN, 2007, J COMPUT NEUROSCI, V22, P301, DOI 10.1007/s10827-006-0014-6; TSUBO Y, 2009, SOC NEUR 39 ANN M; Volman V, 2004, PHYSICA A, V335, P249, DOI 10.1016/j.physa.2003.11.015; Yamada WM, 1989, METHODS NEURONAL MOD, P97	40	5	5	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e12869	10.1371/journal.pone.0012869	http://dx.doi.org/10.1371/journal.pone.0012869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927400	gold, Green Published, Green Submitted			2022-12-25	WOS:000282210700004
J	Aran, A; Weiner, K; Lin, L; Finn, LA; Greco, MA; Peppard, P; Young, T; Ofran, Y; Mignot, E				Aran, Adi; Weiner, Karin; Lin, Ling; Finn, Laurel Ann; Greco, Mary Ann; Peppard, Paul; Young, Terry; Ofran, Yanay; Mignot, Emmanuel			Post-Streptococcal Auto-Antibodies Inhibit Protein Disulfide Isomerase and Are Associated with Insulin Resistance	PLOS ONE			English	Article							PLATELET-AGGREGATION; ANTISTREPTOCOCCAL ANTIBODIES; METABOLIC SYNDROME; CELL DEATH; TISSUE; DISEASE; PREVALENCE; ANTIGENS; FUSION	Post-streptococcal autoimmunity affects millions worldwide, targeting multiple organs including the heart, brain, and kidneys. To explore the post-streptococcal autoimmunity spectrum, we used western blot analyses, to screen 310 sera from healthy subjects with (33%) and without (67%) markers of recent streptococcal infections [ anti-Streptolysin O (ASLO) or anti-DNAse B (ADB)]. A 58 KDa protein, reacting strongly with post-streptococcal sera, was identified as Protein Disulfide Isomerase (PDI), an abundant protein with pleiotropic metabolic, immunologic, and thrombotic effects. Anti-PDI autoantibodies, purified from human sera, targeted similar epitopes in Streptolysin O (SLO, P51-61) and PDI (P328-338). The correlation between post-streptococcal status and anti-human PDI auto-immunity was further confirmed in a total of 2987 samples (13.6% in 530 ASLO positive versus 5.6% in 2457 ASLO negative samples, p<0.0001). Finally, anti-PDI autoantibodies inhibited PDI-mediated insulin degradation in vitro (n = 90, p<0.001), and correlated with higher serum insulin (14.1 iu/ml vs. 12.2 iu/ml, n = 1215, p = 0.039) and insulin resistance (Homeostatic Model Assessment (HOMA) 4.1 vs. 3.1, n = 1215, p = 0.004), in a population-based cohort. These results identify PDI as a major target of post-streptococcal autoimmunity, and establish a new link between infection, autoimmunity, and metabolic disturbances.	[Aran, Adi; Weiner, Karin; Lin, Ling; Mignot, Emmanuel] Stanford Univ, Stanford, CA 94305 USA; [Aran, Adi] Hebrew Univ Jerusalem, Jerusalem, Israel; [Finn, Laurel Ann; Peppard, Paul; Young, Terry] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA; [Greco, Mary Ann] SRI Int, Behav Biochem Lab, Menlo Pk, CA 94025 USA; [Ofran, Yanay] Bar Ilan Univ, Goodman Fac Life Sci, Lab Syst Biol & Funct Genom, Ramat Gan, Israel	Stanford University; Hebrew University of Jerusalem; University of Wisconsin System; University of Wisconsin Madison; SRI International; Bar Ilan University	Aran, A (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	mignot@stanford.edu		Aran, Adi/0000-0001-9460-4689	U.S. National Institutes of Health [NS23724, MH73073435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS023724, P50NS023724] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health grants NS23724, MH73073435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abromaitis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000357; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bennett TA, 2000, J IMMUNOL, V164, P4120, DOI 10.4049/jimmunol.164.8.4120; Blyth CC, 2006, PATHOLOGY, V38, P152, DOI 10.1080/00313020600557060; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; Essex DW, 1999, BRIT J HAEMATOL, V104, P448, DOI 10.1046/j.1365-2141.1999.01197.x; Essex DW, 1999, THROMB RES, V96, P445, DOI 10.1016/S0049-3848(99)00133-4; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fae KC, 2008, J AUTOIMMUN, V31, P136, DOI 10.1016/j.jaut.2008.04.023; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; Fonseca C, 2009, BLOOD, V113, P1681, DOI 10.1182/blood-2007-09-114157; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; KAPLAN EL, 1974, J PEDIATR-US, V84, P21, DOI 10.1016/S0022-3476(74)80548-2; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Maeda R, 2007, BBA-PROTEINS PROTEOM, V1774, P1619, DOI 10.1016/j.bbapap.2007.08.016; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Obeid M, 2008, J IMMUNOL, V181, P2533, DOI 10.4049/jimmunol.181.4.2533; POPESCU NI, 2010, BLOOD; Raturi A, 2008, BBA-BIOMEMBRANES, V1778, P2790, DOI 10.1016/j.bbamem.2008.07.003; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Shah CM, 2007, NITRIC OXIDE-BIOL CH, V16, P135, DOI 10.1016/j.niox.2006.08.001; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; Tian F, 2009, AM J PHYSIOL-HEART C, V297, pH1078, DOI 10.1152/ajpheart.00937.2008; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Versteeg HH, 2007, J BIOL CHEM, V282, P25416, DOI 10.1074/jbc.M702410200; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vincent A, 2004, BRAIN, V127, P2, DOI 10.1093/brain/awh063; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Yaddanapudi K, 2010, MOL PSYCHIATR, V15, P712, DOI 10.1038/mp.2009.77; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	40	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12875	10.1371/journal.pone.0012875	http://dx.doi.org/10.1371/journal.pone.0012875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886095	Green Submitted, Green Published, gold			2022-12-25	WOS:000282091100004
J	O'Driscoll, C; Bressler, JP				O'Driscoll, Cliona; Bressler, Joseph P.			Hairless Expression Attenuates Apoptosis in a Mouse Model and the COS Cell Line; Involvement of p53	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; TUMOR-SUPPRESSOR P53; DEVELOPING BRAIN; DEVELOPING CEREBELLUM; ENHANCED APOPTOSIS; CASPASE ACTIVATION; NERVOUS-SYSTEM; HR GENE; DEATH; COREPRESSOR	Background: Neurons are more likely to die through apoptosis in the immature brain after injury whereas adult neurons in the mature brain die by necrosis. Several studies have suggested that this maturational change in the mechanism of cell death is regulated, in part, by thyroid hormone. We examined the involvement of the hairless ( Hr) gene which has been suspected of having a role in cell cycle regulation and apoptosis in the hair follicle and is strongly regulated by the thyroid hormone in the brain. Methodology: Forced expression of Hr by transfection decreased the number of apoptotic nuclei, levels of caspase-3 activity, and cytosolic cytochrome C in COS cells exposed to staurosporine and tunicamycin. Similarly, capsase-3 activity was lower and the decrease in mitochondrial membrane potential was smaller in cultures of adult cerebellar granule neurons from wild type mice compared to Hr knockout mice induced to undergo apoptosis. In vivo, apoptosis as detected by positive TUNEL labeling and caspase 3 activity was lower in wild-type mice compared to Hr knockouts after exposure to trimethyltin. Hr expression lowered levels of p53, p53 mediated reporter gene activity, and lower levels of the pro-apoptotic Bcl2 family member Bax in COS cells. Finally, Hr expression did not attenuate apoptosis in mouse embryonic fibroblasts from p53 knockout mice but was effective in mouse embryonic fibroblasts from wild type mice. Conclusions/Significance: Overall, our studies demonstrate that Hr evokes an anti-apoptotic response by repressing expression of p53 and pro-apoptotic events regulated by p53.	[O'Driscoll, Cliona] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Div Toxicol, Baltimore, MD 21205 USA; Hugo Moser Res Inst Kennedy Krieger, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	O'Driscoll, C (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Div Toxicol, Baltimore, MD 21205 USA.	bressler@kennedykrieger.org			U.S. Army [W81XWH-09-0430]; ROAR foundation	U.S. Army(United States Department of DefenseUnited States Army); ROAR foundation	This work was supported by U.S. Army grant W81XWH-09-0430 (https://cdmrp.org/) and the ROAR foundation (www.roar.kennedykrieger.org/). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Blomgren K, 2003, BIOCHEM BIOPH RES CO, V304, P551, DOI 10.1016/S0006-291X(03)00628-4; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Bratton SB, 2001, TRENDS PHARMACOL SCI, V22, P306, DOI 10.1016/S0165-6147(00)01718-1; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; DeGracia DJ, 2002, J CEREBR BLOOD F MET, V22, P127, DOI 10.1097/00004647-200202000-00001; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Gunasekar P, 2001, TOXICOL SCI, V64, P83, DOI 10.1093/toxsci/64.1.83; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Howdeshell KL, 2002, ENVIRON HEALTH PERSP, V110, P337, DOI 10.1289/ehp.02110s3337; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Ikonomidou C, 2009, BRAIN DEV-JPN, V31, P488, DOI 10.1016/j.braindev.2009.02.006; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Johnson MD, 1999, J NEUROSCI, V19, P2996; Johnston MV, 2002, NEUROSCIENTIST, V8, P212, DOI 10.1177/1073858402008003007; Kumar A, 2006, ENDOCRINOLOGY, V147, P4893, DOI 10.1210/en.2006-0027; Malloy PJ, 2009, ENDOCRINOLOGY, V150, P4950, DOI 10.1210/en.2009-0358; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MIYASHITA T, 1995, CELL, V80, P293; Moraitis AN, 2002, MOL CELL BIOL, V22, P6831, DOI 10.1128/MCB.22.19.6831-6841.2002; Nakamura S, 2002, ONCOGENE, V21, P2605, DOI 10.1038/sj.onc.1205343; Olney JW, 2002, BRAIN PATHOL, V12, P488, DOI 10.1111/j.1750-3639.2002.tb00467.x; Panteleyev AA, 1999, AM J PATHOL, V155, P159, DOI 10.1016/S0002-9440(10)65110-3; Panteleyev AA, 1998, EXP DERMATOL, V7, P249, DOI 10.1111/j.1600-0625.1998.tb00295.x-i1; Potter GB, 2002, MOL ENDOCRINOL, V16, P2547, DOI 10.1210/me.2002-0115; Potter GB, 2001, GENE DEV, V15, P2687, DOI 10.1101/gad.916701; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Singh R, 2003, J ENDOCRINOL, V176, P39, DOI 10.1677/joe.0.1760039; Soane L, 2008, J NEUROSCI RES, V86, P1267, DOI 10.1002/jnr.21584; Thompson CC, 1996, J NEUROSCI, V16, P7832; Thompson CC, 1997, P NATL ACAD SCI USA, V94, P8527, DOI 10.1073/pnas.94.16.8527; Thompson TA, 1996, J PHARMACOL EXP THER, V276, P1201; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vekrellis K, 1997, DEVELOPMENT, V124, P1239; Wang J, 2007, J BIOL CHEM, V282, P25231, DOI 10.1074/jbc.M702939200; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Xiang H, 1996, J NEUROSCI, V16, P6753; Xiao Y, 1999, NEUROTOXICOLOGY, V20, P761; Xie ZJ, 2006, ENDOCRINOLOGY, V147, P314, DOI 10.1210/en.2005-1111; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303; ZHANG L, 2009, NEUROBIOL DIS	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12911	10.1371/journal.pone.0012911	http://dx.doi.org/10.1371/journal.pone.0012911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886113	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100018
J	Straschil, U; Talman, AM; Ferguson, DJP; Bunting, KA; Xu, ZY; Bailes, E; Sinden, RE; Holder, AA; Smith, EF; Coates, JC; Tewari, R				Straschil, Ursula; Talman, Arthur M.; Ferguson, David J. P.; Bunting, Karen A.; Xu, Zhengyao; Bailes, Elizabeth; Sinden, Robert E.; Holder, Anthony A.; Smith, Elizabeth F.; Coates, Juliet C.; Tewari, Rita			The Armadillo Repeat Protein PF16 Is Essential for Flagellar Structure and Function in Plasmodium Male Gametes	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; CENTRAL APPARATUS; CHLAMYDOMONAS-REINHARDTII; MOTILITY; COMPONENTS; KINASE; GENE; TRANSMISSION; MICROTUBULES; CYTOKINESIS	Malaria, caused by the apicomplexan parasite Plasmodium, threatens 40% of the world's population. Transmission between vertebrate and insect hosts depends on the sexual stages of the life-cycle. The male gamete of Plasmodium parasite is the only developmental stage that possesses a flagellum. Very little is known about the identity or function of proteins in the parasite's flagellar biology. Here, we characterise a Plasmodium PF16 homologue using reverse genetics in the mouse malaria parasite Plasmodium berghei. PF16 is a conserved Armadillo-repeat protein that regulates flagellar structure and motility in organisms as diverse as green algae and mice. We show that P. berghei PF16 is expressed in the male gamete flagellum, where it plays a crucial role maintaining the correct microtubule structure in the central apparatus of the axoneme as studied by electron microscopy. Disruption of the PF16 gene results in abnormal flagellar movement and reduced fertility, but does not lead to complete sterility, unlike pf16 mutations in other organisms. Using homology modelling, bioinformatics analysis and complementation studies in Chlamydomonas, we show that some regions of the PF16 protein are highly conserved across all eukaryotes, whereas other regions may have species-specific functions. PF16 is the first ARM-repeat protein characterised in the malaria parasite genus Plasmodium and this study opens up a novel model for analysis of Plasmodium flagellar biology that may provide unique insights into an ancient organelle and suggest novel intervention strategies to control the malaria parasite.	[Straschil, Ursula; Bunting, Karen A.; Xu, Zhengyao; Bailes, Elizabeth; Tewari, Rita] Univ Nottingham, Sch Biol, Inst Genet, Nottingham NG7 2RD, England; [Straschil, Ursula; Talman, Arthur M.; Sinden, Robert E.; Tewari, Rita] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Holder, Anthony A.] MRC Natl Inst Med Res, Div Parasitol, London, England; [Smith, Elizabeth F.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Coates, Juliet C.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Nottingham; Imperial College London; University of Oxford; MRC National Institute for Medical Research; Dartmouth College; University of Birmingham	Straschil, U (corresponding author), Univ Nottingham, Sch Biol, Inst Genet, Nottingham NG7 2RD, England.	rita.tewari@nottingham.ac.uk	Talman, Arthur/GMW-9116-2022; Holder, Anthony A/A-7554-2013; Coates, Juliet C/A-3608-2013; Tewari, Rita/M-5698-2014	Holder, Anthony A/0000-0002-8490-6058; Coates, Juliet C/0000-0002-2381-0298; Talman, Arthur/0000-0003-2584-3672; Ferguson, David/0000-0001-5045-819X; Tewari, Rita/0000-0003-3943-1847	UK Medical Research Council [G0900109, U117532067]; Wellcome Trust; Leverhulme Trust [ID20070575]; Bio Mal Par PhD studentship; Medical Research Council [G0900109, MC_U117532067] Funding Source: researchfish; MRC [MC_U117532067, G0900109] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Bio Mal Par PhD studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (G0900109 to RT; U117532067 to AH), the Wellcome Trust (equipment grant to DJPF), the Leverhulme Trust (ID20070575 to JC) and a Bio Mal Par PhD studentship to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Briggs LJ, 2004, CURR BIOL, V14, pR611, DOI 10.1016/j.cub.2004.07.041; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; COX FEG, 1983, NATURE, V304, P394, DOI 10.1038/304394b0; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; DUTCHER SK, 1984, J CELL BIOL, V98, P229, DOI 10.1083/jcb.98.1.229; Ferguson DJP, 2005, EUKARYOT CELL, V4, P814, DOI 10.1128/EC.4.4.814-826.2005; Ferguson DJP, 2002, TRENDS PARASITOL, V18, P355, DOI 10.1016/S1471-4922(02)02330-9; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Mitchell DR, 2004, BIOL CELL, V96, P691, DOI 10.1016/j.biolcel.2004.07.004; Mitchison TJ, 2010, NATURE, V463, P308, DOI 10.1038/463308a; Pearson CG, 2009, MOL BIOL CELL, V20, P904, DOI 10.1091/mbc.E08-08-0835; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; Reininger L, 2009, J BIOL CHEM, V284, P20858, DOI 10.1074/jbc.M109.017988; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RUDZINSKA MA, 1983, P NATL ACAD SCI-BIOL, V80, P2966, DOI 10.1073/pnas.80.10.2966; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; SCHOLTYSECK E, 1972, Z PARASITENK, V38, P95, DOI 10.1007/BF00329023; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Silflow CD, 2001, PLANT PHYSIOL, V127, P1500, DOI 10.1104/pp.127.4.1500; SINDEN RE, 1976, PROC R SOC SER B-BIO, V193, P55, DOI 10.1098/rspb.1976.0031; Smith EF, 2000, CELL MOTIL CYTOSKEL, V46, P157, DOI 10.1002/1097-0169(200007)46:3<157::AID-CM1>3.0.CO;2-D; Smith EF, 1997, CELL MOTIL CYTOSKEL, V38, P1; Smith EF, 1996, J CELL BIOL, V132, P359, DOI 10.1083/jcb.132.3.359; Tewari R, 2005, MOL MICROBIOL, V58, P1253, DOI 10.1111/j.1365-2958.2005.04793.x; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Woodland HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003778	48	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12901	10.1371/journal.pone.0012901	http://dx.doi.org/10.1371/journal.pone.0012901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886115	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100011
J	Deng, WH; Garrett, C; Dombert, B; Soura, V; Bank, G; Fishe, EMC; van der Brug, MP; Hafezparast, M				Deng, Wenhan; Garrett, Caroline; Dombert, Benjamin; Soura, Violetta; Bank, Gareth; Fishe, Elizabeth M. C.; van der Brug, Marcel P.; Hafezparast, Majid			Neurodegenerative Mutation in Cytoplasmic Dynein Alters Its Organization and Dynein-Dynactin and Dynein-Kinesin Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT INTERMEDIATE CHAIN; MOTOR-NEURON DISEASE; AXONAL-TRANSPORT; IN-VIVO; SUBUNIT; PROTEIN; PHOSPHORYLATION; MICROTUBULES; BINDING; LC8	A single amino acid change, F580Y (Legs at odd angles (Loa), Dync1h1(Loa)), in the highly conserved and overlapping homodimerization, intermediate chain, and light intermediate chain binding domain of the cytoplasmic dynein heavy chain can cause severe motor and sensory neuron loss in mice. The mechanism by which the Loa mutation impairs the neuron-specific functions of dynein is not understood. To elucidate the underlying molecular mechanisms of neurodegeneration arising from this mutation, we applied a cohort of biochemical methods combined with in vivo assays to systemically study the effects of the mutation on the assembly of dynein and its interaction with dynactin. We found that the Loa mutation in the heavy chain leads to increased affinity of this subunit of cytoplasmic dynein to light intermediate and a population of intermediate chains and a suppressed association of dynactin to dynein. These data suggest that the Loa mutation drives the assembly of cytoplasmic dynein toward a complex with lower affinity to dynactin and thus impairing transport of cargos that tether to the complex via dynactin. In addition, we detected up-regulation of kinesin light chain 1 (KLC1) and its increased association with dynein but reduced microtubule-associated KLC1 in the Loa samples. We provide a model describing how up-regulation of KLC1 and its interaction with cytoplasmic dynein in Loa could play a regulatory role in restoring the retrograde and anterograde transport in the Loa neurons.	[Deng, Wenhan; Garrett, Caroline; Dombert, Benjamin; Soura, Violetta; Hafezparast, Majid] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Bank, Gareth; Fishe, Elizabeth M. C.] UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [van der Brug, Marcel P.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	University of Sussex; University of London; University College London; Scripps Research Institute	Hafezparast, M (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	M.Hafezparast@sussex.ac.uk	Hafezparast, Majid/H-6728-2018; Hafezparast, Majid/N-8292-2019; Fisher, Elizabeth MC/C-2168-2008	Hafezparast, Majid/0000-0002-5262-7150; Fisher, Elizabeth MC/0000-0003-2850-9936; Banks, Gareth/0000-0002-8647-667X	European Union; University of Sussex; BBSRC [BB/D012309/1] Funding Source: UKRI; MRC [G0500288] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D012309/1] Funding Source: researchfish; Medical Research Council [G0500288] Funding Source: researchfish	European Union(European Commission); University of Sussex; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council (to M. H., W. D., and C. G.), the Wellcome Trust (to G. B.), the ENDOCYTE Research and Training Network funded by the European Union (to E. M. C. F.), and the University of Sussex (to V.S.).	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; COLLINS CA, 1989, CELL MOTIL CYTOSKEL, V14, P491, DOI 10.1002/cm.970140407; Dell KR, 2000, TRAFFIC, V1, P38, DOI 10.1034/j.1600-0854.2000.010107.x; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; DILLMAN JF, 1994, J CELL BIOL, V127, P1671, DOI 10.1083/jcb.127.6.1671; El-Kadi AM, 2010, J BIOL CHEM, V285, P18627, DOI 10.1074/jbc.M110.129320; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman Sven, 2002, Sci STKE, V2002, ppl18; GILL SR, 1994, MOL BIOL CELL, V5, P645, DOI 10.1091/mbc.5.6.645; Hackney DD, 2008, BIOCHEMISTRY-US, V47, P7770, DOI 10.1021/bi8006687; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; King SJ, 2002, PROTEIN SCI, V11, P1239, DOI 10.1110/ps.2520102; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; King SM, 2000, J CELL SCI, V113, P2521; Kuta A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011682; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Myers KR, 2007, J NEUROSCI RES, V85, P2640, DOI 10.1002/jnr.21213; NEELY MD, 1990, J BIOL CHEM, V265, P8691; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; Pfister KK, 1999, MOL NEUROBIOL, V20, P81, DOI 10.1007/BF02742435; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Susalka SJ, 2000, J NEUROCYTOL, V29, P819, DOI 10.1023/A:1010995408343; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; WOYNIAK MJ, 2006, EMBO J, V25, P5457; Yamada M, 2010, EMBO J, V29, P517, DOI 10.1038/emboj.2009.378	51	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39922	39934		10.1074/jbc.M110.178087	http://dx.doi.org/10.1074/jbc.M110.178087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20889981	Green Published, hybrid			2022-12-25	WOS:000285185500037
J	Perrotta, C; Bizzozero, L; Cazzato, D; Morlacchi, S; Assi, E; Simbari, F; Zhang, Y; Gulbins, E; Bassi, MT; Rosa, P; Clementi, E				Perrotta, Cristiana; Bizzozero, Laura; Cazzato, Denise; Morlacchi, Sara; Assi, Emma; Simbari, Fabio; Zhang, Yang; Gulbins, Erich; Bassi, Maria Teresa; Rosa, Patrizia; Clementi, Emilio			Syntaxin 4 Is Required for Acid Sphingomyelinase Activity and Apoptotic Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; DENDRITIC CELLS; T-LYMPHOCYTES; LIPID RAFTS; MOUSE MODEL; ACTIVATION; CERAMIDE; PATHWAY; INHIBITION; DEATH	Acid sphingomyelinase (A-SMase) is an important enzyme in sphingolipid metabolism and plays key roles in apoptosis, immunity, development, and cancer. In addition, it mediates cytotoxicity of cisplatin and some other chemotherapeutic drugs. The mechanism of A-SMase activation is still undefined. We now demonstrate that, upon CD95 stimulation, A-SMase is activated through translocation from intracellular compartments to the plasma membrane in an exocytic pathway requiring the t-SNARE protein syntaxin 4. Indeed, down-regulation of syntaxin 4 inhibits A-SMase translocation and activation induced by CD95 stimulation. This leads to inhibition of the CD95-triggered signaling events, including caspase 3 and 9 activation and apoptosis, activation of the survival pathway involving the protein kinase Akt, and important changes in cell cycle and proliferation. The molecular interaction between A-SMase and syntaxin 4 was not known and clarifies the mechanism of A-SMase activation. The novel actions of syntaxin 4 in sphingolipid metabolism and exocytosis we describe here define signaling mechanisms of broad relevance in cell pathophysiology.	[Perrotta, Cristiana; Bizzozero, Laura; Morlacchi, Sara; Assi, Emma; Clementi, Emilio] Univ Milan, Dept Clin Sci, Clin Pharmacol Unit, Univ Hosp Luigi Sacco, I-20157 Milan, Italy; [Cazzato, Denise; Bassi, Maria Teresa; Clementi, Emilio] E Medea Sci Inst, I-23842 Bosisio Parini, Lecco, Italy; [Simbari, Fabio] Inst Adv Chem Catalonia CSIC, Dept Biomed Chem, Barcelona, Spain; [Zhang, Yang; Gulbins, Erich] Univ Duisburg Essen, Ctr Med Biol, D-45122 Essen, Germany; [Zhang, Yang; Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, D-45122 Essen, Germany; [Rosa, Patrizia] CNR, Inst Neurosci, Dept Med Pharmacol, I-20129 Milan, Italy	University of Milan; Luigi Sacco Hospital; IRCCS Eugenio Medea; Consejo Superior de Investigaciones Cientificas (CSIC); University of Duisburg Essen; University of Duisburg Essen; Consiglio Nazionale delle Ricerche (CNR)	Clementi, E (corresponding author), Univ Milan, Dept Clin Sci L Sacco, Via GB Grassi 74, I-20157 Milan, Italy.	emilio.clementi@unimi.it	Perrotta, Cristiana/I-2835-2016; Bassi, Maria Teresa T/A-3517-2014; Gulbins, Erich/L-6989-2014; PERROTTA, CRISTIANA/A-9179-2010	Perrotta, Cristiana/0000-0001-6680-4536; Bassi, Maria Teresa T/0000-0002-8236-1197; Gulbins, Erich/0000-0002-3117-1342; Bizzozero, Laura/0000-0003-2038-7356; Rosa, Patrizia/0000-0002-2590-6955	Italian Association of Cancer Research; Italian Ministry of Research; Fondazione Cariplo; Fondazione Romeo and Enrica Invernizzi; Deutsche Forschungsgemeinschaft [GU335/21-1]; Italian Ministry of Health	Italian Association of Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); Fondazione Romeo and Enrica Invernizzi; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from the Italian Association of Cancer Research (to E.C.), the Italian Ministry of Research Programmi di Ricerca di Rilevante Interesse Nazionale 2007 (to E.C.), Fondazione Cariplo (to E.C.), Fondazione Romeo and Enrica Invernizzi (to E.C.), Deutsche Forschungsgemeinschaft Grant GU335/21-1 (to E.G.), Italian Ministry of Health Ricerca Finalizzata 2007 (to M.T.B. and E.C.), and Ricerca Corrente 2010 (to M.T.B. and E.C.).	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Band AM, 2002, FEBS LETT, V531, P513, DOI 10.1016/S0014-5793(02)03605-0; Barsacchi R, 2002, CELL DEATH DIFFER, V9, P1248, DOI 10.1038/sj.cdd.4401095; Beneteau M, 2008, MOL CANCER RES, V6, P604, DOI 10.1158/1541-7786.MCR-07-0331; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Calegari F, 1999, J BIOL CHEM, V274, P22539, DOI 10.1074/jbc.274.32.22539; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Degli Esposti M, 2009, MOL BIOL CELL, V20, P600, DOI 10.1091/mbc.E08-09-0925; Falcone S, 2004, J IMMUNOL, V173, P4452, DOI 10.4049/jimmunol.173.7.4452; Faustino RS, 2008, J LIPID RES, V49, P654, DOI 10.1194/jlr.M700464-JLR200; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Henriques-Pons A, 2009, J CARDIOVASC PHARM, V53, P94, DOI 10.1097/FJC.0b013e318198fe46; Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757; Hong WJ, 2005, TRENDS CELL BIOL, V15, P644, DOI 10.1016/j.tcb.2005.10.003; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Ng CG, 2006, J VIROL, V80, P10989, DOI 10.1128/JVI.01154-06; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Peraud A, 1999, LAB INVEST, V79, P123; Perrotta C, 2004, CANCER RES, V64, P3767, DOI 10.1158/0008-5472.CAN-04-0668; Perrotta C, 2007, CANCER RES, V67, P7559, DOI 10.1158/0008-5472.CAN-07-0309; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Poonia B, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-91; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Sciorati C, 1997, J BIOL CHEM, V272, P23211, DOI 10.1074/jbc.272.37.23211; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Utermohlen O, 2008, IMMUNOBIOLOGY, V213, P307, DOI 10.1016/j.imbio.2007.10.016; Wiegmann K, 1999, J BIOL CHEM, V274, P5267, DOI 10.1074/jbc.274.9.5267; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	40	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40240	40251		10.1074/jbc.M110.139287	http://dx.doi.org/10.1074/jbc.M110.139287			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956541	hybrid, Green Published			2022-12-25	WOS:000285185500068
J	Minagawa, H; Watanabe, A; Akatsu, H; Adachi, K; Ohtsuka, C; Terayama, Y; Hosono, T; Takahashi, S; Wakita, H; Jung, CG; Komano, H; Michikawa, M				Minagawa, Hirohisa; Watanabe, Atsushi; Akatsu, Hiroyasu; Adachi, Kayo; Ohtsuka, Chigumi; Terayama, Yasuo; Hosono, Takashi; Takahashi, Satoshi; Wakita, Hideaki; Jung, Cha-Gyun; Komano, Hiroto; Michikawa, Makoto			Homocysteine, Another Risk Factor for Alzheimer Disease, Impairs Apolipoprotein E3 Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KNOCK-IN MICE; PLASMA HOMOCYSTEINE; LIPID RELEASE; A-BETA; APOE; BRAIN; HYPERHOMOCYSTEINEMIA; ASTROCYTES; NEURONS; TRANSTHYRETIN	Apolipoprotein E (apoE) epsilon 4 and hyperhomocysteinemia are risk factors for Alzheimer disease (AD). The dimerization of apoE3 by disulfide bonds between cysteine residues enhances apoE3 function to generate HDL. Because homocysteine (Hcy) harbors a thiol group, we examined whether Hcy interferes with the dimerization of apoE3 and thereby impairs apoE3 function. We found that Hcy inhibits the dimerization of apoE3 and reduces apoE3-mediated HDL generation to a level similar to that by apoE4, whereas Hcy does not affect apoE4 function. Western blot analysis of cerebrospinal fluid showed that the ratio of apoE3 dimers was significantly lower in the samples from the patients with hyperhomocysteinemia than in those that from control subjects. Hyperhomocysteinemia induced by subcutaneous injection of Hcy to apoE3 knock-in mice decreased the level of the apoE3 dimer in the brain homogenate. Because apoE-HDL plays a role in amyloid beta-protein clearance, these results suggest that two different risk factors, apoE4 and hyperhomocysteinemia, may share a common mechanism that accelerates the pathogenesis of AD in terms of reduced HDL generation.	[Hosono, Takashi; Jung, Cha-Gyun] Natl Ctr Geriatr & Gerontol, Dept Alzheimer Dis Res, Aichi 4748511, Japan; [Watanabe, Atsushi; Adachi, Kayo; Wakita, Hideaki] Natl Ctr Geriatr & Gerontol, Dept Cognit Brain Sci, Aichi 4748511, Japan; [Akatsu, Hiroyasu] Fukushimura Hosp, Choju Med Inst, Toyohashi, Aichi 4418124, Japan; [Ohtsuka, Chigumi; Terayama, Yasuo; Takahashi, Satoshi] Iwate Med Univ, Sch Med, Dept Neurol & Gerontol, Shiwa, Iwate 0283694, Japan; [Komano, Hiroto] Iwate Med Univ, Sch Pharm, Dept Neurosci, Shiwa, Iwate 0283694, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology; Iwate Medical University; Iwate Medical University		michi@ncgg.go.jp	Watanabe, Atsushi/AAU-8018-2020	Jung, Cha-Gyun/0000-0002-0225-0658	Ministry of Health, Labor and Welfare of Japan [H20-007]; National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japan [20023040]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Health, Labor and Welfare of Japan Comprehensive Research on Aging and Health Grant H20-007, the Program for Promotion of Fundamental Studies in Health of the National Institute of Biomedical Innovation (NIBIO), and Grant-in-aid for Scientific Research on Priority Areas 20023040 (Research on Pathomechanisms of Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Altenburg M, 2007, J BIOL CHEM, V282, P7817, DOI 10.1074/jbc.M610712200; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; Gong JS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-9; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Guthikonda S, 1999, CURR OPIN CARDIOL, V14, P283, DOI 10.1097/00001573-199907000-00002; Hamanaka H, 2000, HUM MOL GENET, V9, P353, DOI 10.1093/hmg/9.3.353; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Isobe C, 2005, LIFE SCI, V77, P1836, DOI 10.1016/j.lfs.2005.02.014; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kamath AF, 2006, BLOOD, V107, P591, DOI 10.1182/blood-2005-06-2506; Kim NK, 2003, NEUROLOGY, V61, P1595, DOI 10.1212/01.WNL.0000096010.98989.49; Kolovou GD, 2007, AGEING RES REV, V6, P94, DOI 10.1016/j.arr.2006.11.001; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Lim A, 2003, J BIOL CHEM, V278, P49707, DOI 10.1074/jbc.M306748200; Luchsinger JA, 2004, NEUROLOGY, V62, P1972, DOI 10.1212/01.WNL.0000129504.60409.88; Maler JM, 2003, NEUROSCI LETT, V347, P85, DOI 10.1016/S0304-3940(03)00655-4; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; Michikawa M, 2000, J NEUROCHEM, V74, P1008, DOI 10.1046/j.1471-4159.2000.0741008.x; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; Minagawa Hirohisa, 2009, J Neurosci Res, V87, P2498, DOI 10.1002/jnr.22073; Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35; Pacheco-Quinto J, 2006, NEUROBIOL DIS, V22, P651, DOI 10.1016/j.nbd.2006.01.005; Perry IJ, 1999, J CARDIOVASC RISK, V6, P235; Ravaglia G, 2005, AM J CLIN NUTR, V82, P636, DOI 10.1093/ajcn/82.3.636; Sass JO, 2003, BIOCHEM BIOPH RES CO, V310, P242, DOI 10.1016/j.bbrc.2003.08.089; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; STARKEBAUM G, 1986, J CLIN INVEST, V77, P1370, DOI 10.1172/JCI112442; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200; Zhang CE, 2009, AM J PATHOL, V174, P1481, DOI 10.2353/ajpath.2009.081036	35	30	32	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38382	38388		10.1074/jbc.M110.146258	http://dx.doi.org/10.1074/jbc.M110.146258			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889503	hybrid, Green Published			2022-12-25	WOS:000284625600044
J	Sadakata, T; Shinoda, Y; Sekine, Y; Saruta, C; Itakura, M; Takahashi, M; Furuichi, T				Sadakata, Tetsushi; Shinoda, Yo; Sekine, Yukiko; Saruta, Chihiro; Itakura, Makoto; Takahashi, Masami; Furuichi, Teiichi			Interaction of Calcium-dependent Activator Protein for Secretion 1 (CAPS1) with the Class II ADP-ribosylation Factor Small GTPases Is Required for Dense-core Vesicle Trafficking in the trans-Golgi Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; ARF FAMILY; EXOCYTOSIS; MEMBRANE; LOCALIZATION; EXPRESSION; REGULATORS; RELEASE; DOMAINS; GROWTH	Ca2+-dependent activator protein for secretion (CAPS) regulates exocytosis of catecholamine-or neuropeptide-containing dense-core vesicles (DCVs) at secretion sites, such as nerve terminals. However, large amounts of CAPS protein are localized in the cell soma, and the role of somal CAPS protein remains unclear. The present study shows that somal CAPS1 plays an important role in DCV trafficking in the trans-Golgi network. The anti-CAPS1 antibody appeared to pull down membrane fractions, including many Golgi-associated proteins, such as ADP-ribosylation factor (ARF) small GTPases. Biochemical analyses of the protein-protein interaction showed that CAPS1 interacted specifically with the class II ARF4/ARF5, but not with other classes of ARFs, via the pleckstrin homology domain in a GDP-bound ARF form-specific manner. The pleckstrin homology domain of CAPS1 showed high affinity for the Golgi membrane, thereby recruiting ARF4/ARF5 to the Golgi complex. Knockdown of either CAPS1 or ARF4/ARF5 expression caused accumulation of chromogranin, a DCV marker protein, in the Golgi, thereby reducing its DCV secretion. In addition, the overexpression of CAPS1 binding-deficient ARF5 mutants induced aberrant chromogranin accumulation in the Golgi and consequently reduced its DCV secretion. These findings implicate a functional role for CAPS1 protein in the soma, a major subcellular localization site of CAPS1 in many cell types, in regulating DCV trafficking in the trans-Golgi network; this activity occurs via protein-protein interaction with ARF4/ARF5 in a GDP-dependent manner.	[Sadakata, Tetsushi; Shinoda, Yo; Sekine, Yukiko; Saruta, Chihiro; Furuichi, Teiichi] RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan; [Sadakata, Tetsushi; Shinoda, Yo; Itakura, Makoto; Takahashi, Masami; Furuichi, Teiichi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Itakura, Makoto; Takahashi, Masami] Kitasato Univ, Sch Med, Dept Biochem, Kanagawa 2288555, Japan	RIKEN; Japan Science & Technology Agency (JST); Kitasato University	Furuichi, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan.	tfuruichi@brain.riken.jp	Shinoda, Yo/H-3091-2019; Sadakata, Tetsushi/W-9324-2018; Furuichi, Teiichi/B-5086-2014	Shinoda, Yo/0000-0003-3253-2194; Sadakata, Tetsushi/0000-0003-0276-4162; Furuichi, Teiichi/0000-0002-9676-1888	Takeda Science Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kao Foundation for Arts and Sciences; Life Science Foundation of Japan; Japanese Ministry of Education, Culture, Sports, Science, and Technology [21700421]; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Institute of Physical and Chemical Research	Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kao Foundation for Arts and Sciences; Life Science Foundation of Japan(Life Science Foundation of Japan); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute of Physical and Chemical Research	This work was supported by grants-in-aid for Scientific Research from the Takeda Science Foundation; the Naito Foundation; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; the Kao Foundation for Arts and Sciences; the Life Science Foundation of Japan; the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Grant 21700421), the Japan Science and Technology Agency; the Japan Society for the Promotion of Science; and the Institute of Physical and Chemical Research.	Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; Brunk I, 2009, J BIOL CHEM, V284, P1050, DOI 10.1074/jbc.M805328200; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Donaldson Julie G, 2002, Methods Mol Biol, V189, P191; Fujita Y, 2007, J BIOL CHEM, V282, P21392, DOI 10.1074/jbc.M703699200; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; JOHN J, 1993, J BIOL CHEM, V268, P923; Kim SW, 2003, J BIOL CHEM, V278, P2661, DOI 10.1074/jbc.M205819200; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; Sadakata T, 2006, J COMP NEUROL, V495, P735, DOI 10.1002/cne.20947; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Speidel D, 2008, CELL METAB, V7, P57, DOI 10.1016/j.cmet.2007.11.009; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719	38	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38710	38719		10.1074/jbc.M110.137414	http://dx.doi.org/10.1074/jbc.M110.137414			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20921225	Green Published, hybrid			2022-12-25	WOS:000284625600076
J	Bhattacharyya, S; Dudeja, PK; Tobacman, JK				Bhattacharyya, Sumit; Dudeja, Pradeep K.; Tobacman, Joanne K.			Tumor Necrosis Factor alpha-induced Inflammation Is Increased but Apoptosis Is Inhibited by Common Food Additive Carrageenan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; DEATH DOMAIN; SIGNAL-TRANSDUCTION; PROTEIN; ACTIVATION; KINASE; RIP; PATHWAY; BCL10	Tumor necrosis factor (TNF)-alpha, a homotrimeric, pleiotropic cytokine, is secreted in response to inflammatory stimuli in diseases such as rheumatoid arthritis and inflammatory bowel disease. TNF-alpha mediates both apoptosis and inflammation, stimulating an inflammatory cascade through the non-canonical pathway of NF-kappa B activation, leading to increased nuclear RelB and p52. In contrast, the common food additive carrageenan (CGN) stimulates inflammation through both the canonical and non-canonical pathways of NF-kappa B activation and utilizes the adaptor molecule BCL10 (B-cell leukemia/lymphoma 10). In a series of experiments, colonic epithelial cells and mouse embryonic fibroblasts were treated with TNF-alpha and carrageenan in order to simulate the possible effects of exposure to dietary CGN in the setting of a TNF-alpha-mediated inflammatory disease process. A marked increase in secretion of IL-8 occurred, attributable to synergistic effects on phosphorylated NF-kappa B-inducing kinase (NIK) in the non-canonical pathway. TNF-alpha induced the ubiquitination of TRAF2 (TNF receptor-associated factor 2), which interacts with NIK, and CGN induced phosphorylation of BCL10, leading to increased NIK phosphorylation. These results suggest that TNF-alpha and CGN in combination act to increase NIK phosphorylation, thereby increasing activation of the non-canonical pathway of NF-kappa B activation. In contrast, the apoptotic effects of TNF-alpha, including activation of caspase-8 and PARP-1 (poly(ADP-ribose) polymerase 1) fragmentation, were markedly reduced in the presence of CGN, and CGN caused reduced expression of Fas. These findings demonstrate that exposure to CGN drives TNF-alpha-stimulated cells toward inflammation rather than toward apoptotic cell death and suggest that CGN exposure may compromise the effectiveness of anti-TNF-alpha/therapy.	[Bhattacharyya, Sumit; Dudeja, Pradeep K.; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Dudeja, Pradeep K.; Tobacman, Joanne K.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,CSN 440 M-C 718, Chicago, IL 60612 USA.	jkt@uic.edu			Veterans Affairs Merit funds	Veterans Affairs Merit funds	This work was supported by Veterans Affairs Merit funds (to J. K. T.).	[Anonymous], 1983, IARC Monogr Eval Carcinog Risk Chem Hum, V31, P79; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Behm BW, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006893; BENITZ KF, 1973, FOOD COSMET TOXICOL, V11, P565, DOI 10.1016/S0015-6264(73)80327-X; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bhattacharyya S, 2008, J NUTR, V138, P469, DOI 10.1093/jn/138.3.469; Bhattacharyya S, 2007, J IMMUNOASS IMMUNOCH, V28, P173, DOI 10.1080/15321810701454573; Bhattacharyya S, 2010, EXP CELL RES, V316, P3317, DOI 10.1016/j.yexcr.2010.05.004; Bhattacharyya S, 2010, J NUTR BIOCHEM, V21, P906, DOI 10.1016/j.jnutbio.2009.07.002; Bhattacharyya S, 2010, J BIOL CHEM, V285, P522, DOI 10.1074/jbc.M109.050815; Borthakur A, 2007, AM J PHYSIOL-GASTR L, V292, pG829, DOI 10.1152/ajpgi.00380.2006; Borthakur A, 2010, INFLAMM BOWEL DIS, V16, P593, DOI 10.1002/ibd.21092; Ceccarelli M, 2009, J CELL MOL MED, V13, P2704, DOI 10.1111/j.1582-4934.2009.00658.x; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chung JY, 2007, ADV EXP MED BIOL, V597, P93; Chung JY, 2002, J CELL SCI, V115, P679; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; FAO/WHO, 2007, SUMM CONCL 68 M UN; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Ha Hyunil, 2009, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109ds87; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kollias G, 2002, CYTOKINE GROWTH F R, V13, P315, DOI 10.1016/S1359-6101(02)00019-9; Kotova E, 2010, P NATL ACAD SCI USA, V107, P6406, DOI 10.1073/pnas.0914152107; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; MARCUS R, 1969, LANCET, V2, P489; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; McFarlane SM, 2002, FEBS LETT, V515, P119, DOI 10.1016/S0014-5793(02)02450-X; Mohamed AAA, 2002, BIOCHEM J, V366, P145, DOI 10.1042/BJ20020527; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Sfikakis PP, 2010, CURR DIR AUTOIMMUN, V11, P180, DOI 10.1159/000289205; Shah GM, 1996, BIOCHEM BIOPH RES CO, V229, P838, DOI 10.1006/bbrc.1996.1889; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Steinhilb ML, 2001, J BIOL CHEM, V276, P4476, DOI 10.1074/jbc.M008793200; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; TOBACMAN JK, 2003, REV FOOD NUTR TOXICI, V1, P204; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Weinlich R, 2010, CELL MOL LIFE SCI, V67, P1631, DOI 10.1007/s00018-010-0289-7; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; West J., 2001, AGAROPHYTES CARRAGEE, P286; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5	55	28	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39511	39522		10.1074/jbc.M110.159681	http://dx.doi.org/10.1074/jbc.M110.159681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937806	Green Published, hybrid			2022-12-25	WOS:000284941300077
J	Olafsen, T; Young, SG; Davies, BSJ; Beigneux, AP; Kenanova, VE; Voss, C; Young, G; Wong, KP; Barnes, RH; Tu, YP; Weinstein, MM; Nobumori, C; Huang, SC; Goldberg, IJ; Bensadoun, A; Wu, AM; Fong, LG				Olafsen, Tove; Young, Stephen G.; Davies, Brandon S. J.; Beigneux, Anne P.; Kenanova, Vania E.; Voss, Constance; Young, Glen; Wong, Koon-Pong; Barnes, Richard H., II; Tu, Yiping; Weinstein, Michael M.; Nobumori, Chika; Huang, Sung-Cheng; Goldberg, Ira J.; Bensadoun, Andre; Wu, Anna M.; Fong, Loren G.			Unexpected Expression Pattern for Glycosylphosphatidylinositol-anchored HDL-binding Protein 1 (GPIHBP1) in Mouse Tissues Revealed by Positron Emission Tomography Scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; LIPASE-DEFICIENT MICE; FC ANTIBODY FRAGMENTS; SEVERE HYPERTRIGLYCERIDEMIA; PHARMACOKINETICS; RELEASE; PLASMA; MUSCLE; LIVER	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1), a GPI-anchored endothelial cell protein, binds lipoprotein lipase (LPL) and transports it into the lumen of capillaries where it hydrolyzes triglycerides in lipoproteins. GPIHBP1 is assumed to be expressed mainly within the heart, skeletal muscle, and adipose tissue, the sites where most lipolysis occurs, but the tissue pattern of GPIHBP1 expression has never been evaluated systematically. Because GPIHBP1 is found on the luminal face of capillaries, we predicted that it would be possible to define GPIHBP1 expression patterns with radiolabeled GPIHBP1-specific antibodies and positron emission tomography (PET) scanning. In Gpihbp1(-/-) mice, GPIHBP1-specific antibodies were cleared slowly from the blood, and PET imaging showed retention of the antibodies in the blood pools (heart and great vessels). In Gpihbp1(+/+) mice, the antibodies were cleared extremely rapidly from the blood and, to our surprise, were taken up mainly by lung and liver. Immunofluorescence microscopy confirmed the presence of GPIHBP1 in the capillary endothelium of both lung and liver. In most tissues with high levels of Gpihbp1 expression, Lpl expression was also high, but the lung was an exception (very high Gpihbp1 expression and extremely low Lpl expression). Despite low Lpl transcript levels, however, LPL protein was readily detectable in the lung, suggesting that some of that LPL originates elsewhere and then is captured by GPIHBP1 in the lung. In support of this concept, lung LPL levels were significantly lower in Gpihbp1(-/-) mice than in Gpihbp1(+/+) mice. In addition, Lpl(-/-) mice expressing human LPL exclusively in muscle contained high levels of human LPL in the lung.	[Olafsen, Tove; Kenanova, Vania E.; Wong, Koon-Pong; Huang, Sung-Cheng; Wu, Anna M.] Calif NanoSyst Inst, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Young, Stephen G.; Davies, Brandon S. J.; Beigneux, Anne P.; Voss, Constance; Young, Glen; Barnes, Richard H., II; Tu, Yiping; Nobumori, Chika; Fong, Loren G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Young, Stephen G.; Weinstein, Michael M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Huang, Sung-Cheng] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Goldberg, Ira J.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Cornell University	Young, SG (corresponding author), 675 Charles Young Dr S, Los Angeles, CA 90095 USA.	sgyoung@mednet.ucla.edu; lfong@mednet.ucla.edu	Wong, Koon-Pong/AAI-3780-2020	Young, Stephen/0000-0001-7270-3176; Davies, Brandon/0000-0002-7168-8522; Wu, Anna/0000-0001-8487-823X; Wong, Koon-Pong/0000-0002-6095-4645	National Institutes of Health [1RC1 HL100008, R01 HL094732, P01 HL090553, RO1 HL086683, R01 HL087228, R01 EB001943, P30 CA016042, U24 CA092865, R25 CA098010]; American Heart Association, Western States Affiliate; NATIONAL CANCER INSTITUTE [P30CA016042, R25CA098010, U24CA092865] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045095, P01HL090553, RC1HL100008, R01HL094732, R01HL087228, R01HL086683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Western States Affiliate(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RC1 HL100008, R01 HL094732, P01 HL090553, RO1 HL086683, R01 HL087228, R01 EB001943, P30 CA016042, U24 CA092865, and R25 CA098010 and a grant from the American Heart Association, Western States Affiliate.	Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; BRUNZELL JD, 2001, METABOLIC MOL BASES; Cai WB, 2007, J NUCL MED, V48, P304; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; DOOLITTLE MH, 1987, J LIPID RES, V28, P1326; Ginzinger DG, 1999, EUR J CLIN INVEST, V29, P17, DOI 10.1046/j.1365-2362.1999.00435.x; Havel R.J., 2001, METABOLIC MOL BASES; Ioka RX, 2003, J BIOL CHEM, V278, P7344, DOI 10.1074/jbc.M211932200; Kenanova V, 2005, CANCER RES, V65, P622; Kenanova V, 2007, CANCER RES, V67, P718, DOI 10.1158/0008-5472.CAN-06-0454; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Olafsen T, 2005, CANCER RES, V65, P5907, DOI 10.1158/0008-5472.CAN-04-4472; Olafsen T, 2006, NAT PROTOC, V1, P2048, DOI 10.1038/nprot.2006.322; Strauss JG, 2001, J BIOL CHEM, V276, P36083, DOI 10.1074/jbc.M104430200; VILARO S, 1988, BIOCHIM BIOPHYS ACTA, V959, P106, DOI 10.1016/0005-2760(88)90021-5; WALLINDER L, 1984, BIOCHIM BIOPHYS ACTA, V795, P513, DOI 10.1016/0005-2760(84)90181-4; Weinstein MM, 2010, ARTERIOSCL THROM VAS, V30, P20, DOI 10.1161/ATVBAHA.109.196329; Weinstein MM, 2008, J BIOL CHEM, V283, P34511, DOI 10.1074/jbc.M806067200; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Zhang XH, 2008, CIRC RES, V102, P250, DOI 10.1161/CIRCRESAHA.107.156554	23	28	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39239	39248		10.1074/jbc.M110.171041	http://dx.doi.org/10.1074/jbc.M110.171041			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889497	hybrid, Green Published			2022-12-25	WOS:000284941300053
J	Richards, EL; van Oosterhout, C; Cable, J				Richards, E. Loys; van Oosterhout, Cock; Cable, Joanne			Sex-Specific Differences in Shoaling Affect Parasite Transmission in Guppies	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; FRESH-WATER FISHES; 2 WILD POPULATIONS; POECILIA-RETICULATA; GYRODACTYLUS-TURNBULLI; TRINIDADIAN GUPPY; JUVENILE STICKLEBACKS; SCHOOLING BEHAVIOR; MATING TACTICS; SELECTION	Background: Individuals have to trade-off the costs and benefits of group membership during shoaling behaviour. Shoaling can increase the risk of parasite transmission, but this cost has rarely been quantified experimentally. Guppies (Poecilia reticulata) are a model system for behavioural studies, and they are commonly infected by gyrodactylid parasites, notorious fish pathogens that are directly transmitted between guppy hosts. Methodology/Principal Findings: Parasite transmission in single sex shoals of male and female guppies were observed using an experimental infection of Gyrodactylus turnbulli. Parasite transmission was affected by sex-specific differences in host behaviour, and significantly more parasites were transmitted when fish had more frequent and more prolonged contact with each other. Females shoaled significantly more than males and had a four times higher risk to contract an infection. Conclusions/Significance: Intersexual differences in host behaviours such as shoaling are driven by differences in natural and sexual selection experienced by both sexes. Here we show that the potential benefits of an increased shoaling tendency are traded off against increased risks of contracting an infectious parasite in a group-living species.	[Richards, E. Loys; Cable, Joanne] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [van Oosterhout, Cock] Univ Hull, Evolutionary Biol Grp, Kingston Upon Hull HU6 7RX, N Humberside, England	Cardiff University; University of Hull	Richards, EL (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	cablej@cardiff.ac.uk	Cable, Joanne/A-4360-2010	Cable, Joanne/0000-0002-8510-7055; van Oosterhout, Cock/0000-0002-5653-738X	Natural Environment Research Council (NERC) [NER/S/A/2006/14328, NER/J/S/2002/00706]; Natural Environment Research Council [NER/J/S/2002/00706] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (NERC) case studentship (NER/S/A/2006/14328) in association with the Waltham Centre for Pet Nutrition to LR and an Advanced NERC Research Fellowship (NER/J/S/2002/00706) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber I, 1996, P ROY SOC B-BIOL SCI, V263, P1095, DOI 10.1098/rspb.1996.0161; Barber I, 2000, REV FISH BIOL FISHER, V10, P131, DOI 10.1023/A:1016658224470; Barber I, 1998, J FISH BIOL, V53, P1365, DOI 10.1111/j.1095-8649.1998.tb00256.x; BROWN CR, 1986, ECOLOGY, V67, P737; Cable J, 2007, INT J PARASITOL, V37, P1449, DOI 10.1016/j.ijpara.2007.04.013; Cable J, 2007, BIOL J LINN SOC, V90, P647, DOI 10.1111/j.1095-8312.2006.00755.x; Cable J, 2002, INT J PARASITOL, V32, P255, DOI 10.1016/S0020-7519(01)00330-7; Cable J, 2002, J PARASITOL, V88, P183, DOI 10.1645/0022-3395(2002)088[0183:BFTITV]2.0.CO;2; CABLE J, ECOLOGY EVO IN PRESS; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; DUGATKIN LA, 1994, ENVIRON BIOL FISH, V39, P215, DOI 10.1007/BF00004940; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Griffiths SW, 1998, ANIM BEHAV, V56, P689, DOI 10.1006/anbe.1998.0767; HARRIS PD, 1992, J PARASITOL, V78, P912, DOI 10.2307/3283329; Helfman G, 2009, DIVERSITY FISHES BIO; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; Houde AE, 1997, SEX COLOUR MATE CHOI; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; Kolluru GR, 2005, BEHAV ECOL, V16, P294, DOI 10.1093/beheco/arh161; Krause J, 1996, ETHOLOGY, V102, P40, DOI 10.1111/j.1439-0310.1996.tb01102.x; Krause J, 2002, LIVING GROUPS; Magurran A. E., 1983, BEHAV ECOL SOCIOBIOL, V12, P142; MAGURRAN AE, 1985, Z TIERPSYCHOL, V67, P167; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; PITCHER TJ, 1982, BEHAV ECOL SOCIOBIOL, V10, P149, DOI 10.1007/BF00300175; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; POULIN R, 1989, CAN J ZOOL, V67, P14, DOI 10.1139/z89-003; POULIN R, 1989, BEHAV ECOL SOCIOBIOL, V24, P251, DOI 10.1007/BF00295205; POULIN R, 1991, OECOLOGIA, V86, P390, DOI 10.1007/BF00317606; RANTA E, 1992, OECOLOGIA, V89, P150, DOI 10.1007/BF00319028; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Reznick DN, 1996, AM NAT, V147, P319, DOI 10.1086/285854; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; Schelkle B, 2009, DIS AQUAT ORGAN, V86, P65, DOI 10.3354/dao02087; SCOTT ME, 1982, PARASITOLOGY, V85, P217, DOI 10.1017/S0031182000055207; Tobler M, 2008, ENVIRON BIOL FISH, V81, P29, DOI 10.1007/s10641-006-9153-x; van Oosterhout C, 2008, INT J PARASITOL, V38, P541, DOI 10.1016/j.ijpara.2007.09.016; van Oosterhout C, 2007, INT J PARASITOL, V37, P805, DOI 10.1016/j.ijpara.2006.12.016; van Oosterhout C, 2006, HEREDITY, V97, P111, DOI 10.1038/sj.hdy.6800843; Van Oosterhout C, 2003, BIOL J LINN SOC, V79, P645, DOI 10.1046/j.1095-8312.2003.00203.x; Van Oosterhout C, 2007, CONSERV BIOL, V21, P1573, DOI 10.1111/j.1523-1739.2007.00809.x; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x	43	51	51	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13285	10.1371/journal.pone.0013285	http://dx.doi.org/10.1371/journal.pone.0013285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949014	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000282748100019
J	Rogers, RL; Van Seuningen, I; Gould, J; Hertzog, PJ; Naylor, MJ; Pritchard, MA				Rogers, Renee L.; Van Seuningen, Isabelle; Gould, Jodee; Hertzog, Paul J.; Naylor, Matthew J.; Pritchard, Melanie A.			Transcript Profiling of Elf5(+/-) Mammary Glands during Pregnancy Identifies Novel Targets of Elf5	PLOS ONE			English	Article							INTRAMEMBRANE ERBB2 LIGAND; RECEPTOR TYROSINE KINASE; PANCREATIC-CANCER CELLS; MUC4/SIALOMUCIN COMPLEX; EPITHELIAL-CELLS; BREAST-CANCER; EXPRESSION; MUC4; GENE; PHOSPHORYLATION	Background: Elf5, an epithelial specific Ets transcription factor, plays a crucial role in the pregnancy-associated development of the mouse mammary gland. Elf5(+/-) embryos do not survive, however the Elf5(+/-) mammary gland displays a severe pregnancy-associated developmental defect. While it is known that Elf5 is crucial for correct mammary development and lactation, the molecular mechanisms employed by Elf5 to exert its effects on the mammary gland are largely unknown. Principal Findings: Transcript profiling was used to investigate the transcriptional changes that occur as a result of Elf5 haploinsufficiency in the Elf5(+/-) mouse model. We show that the development of the mouse Elf5(+/-) mammary gland is delayed at a transcriptional and morphological level, due to the delayed increase in Elf5 protein in these glands. We also identify a number of potential Elf5 target genes, including Mucin 4, whose expression, is directly regulated by the binding of Elf5 to an Ets binding site within its promoter. Conclusion: We identify novel transcriptional targets of Elf5 and show that Muc4 is a direct target of Elf5, further elucidating the mechanisms through which Elf5 regulates proliferation and differentiation in the mammary gland.	[Rogers, Renee L.; Gould, Jodee; Hertzog, Paul J.; Pritchard, Melanie A.] Monash Inst Med Res, Ctr Funct Genom & Human Dis, Clayton, Vic, Australia; [Van Seuningen, Isabelle] Ctr Rech Jean Pierre Aubert, INSERM, U837, Lille, France; [Rogers, Renee L.; Naylor, Matthew J.] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Naylor, Matthew J.] Univ New S Wales, St Vincents Hosp Clin Sch, Fac Med, Sydney, NSW, Australia	Monash University; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Rogers, RL (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia.	r.rogers@garvan.org.au; melanie.pritchard@med.monash.edu.au	Hertzog, Paul J/I-7053-2013; VAN SEUNINGEN, Isabelle/N-6176-2016; Hertzog, Paul J/G-6734-2013	Hertzog, Paul J/0000-0002-1373-8472; VAN SEUNINGEN, Isabelle/0000-0002-3131-2694; Hertzog, Paul J/0000-0002-1373-8472	Australian Postgraduate Award; Women in Scientific Excellence (WISE) award; Australian Research Council; National Health and Medical Research Council; National Breast Cancer Foundation of Australia; Gardiner Foundation; Ligue Nationale contre le Cancer	Australian Postgraduate Award(Australian Government); Women in Scientific Excellence (WISE) award; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation of Australia; Gardiner Foundation; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	RLR was the recipient of an Australian Postgraduate Award and a Women in Scientific Excellence (WISE) award. The authors also wish to thank the Australian Research Council (MAP), National Health and Medical Research Council (MAP), National Breast Cancer Foundation of Australia (MN), Gardiner Foundation (RLR, MAP) and Ligue Nationale contre le Cancer (Equipe labellisee 2008, IVS) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carraway KL, 2001, J MAMMARY GLAND BIOL, V6, P323, DOI 10.1023/A:1011327708973; Carraway KL, 1999, J BIOL CHEM, V274, P5263, DOI 10.1074/jbc.274.9.5263; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Fauquette V, 2005, BIOCHEM J, V386, P35, DOI 10.1042/BJ20040706; GROENEN MAM, 1995, GENE, V158, P189, DOI 10.1016/0378-1119(95)00138-V; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Jepson S, 2002, ONCOGENE, V21, P7524, DOI 10.1038/sj.onc.1205970; Jonckheere N, 2007, J BIOL CHEM, V282, P22638, DOI 10.1074/jbc.M700905200; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Locke D, 2000, J CELL PHYSIOL, V183, P228; Naylor MJ, 2005, MOL ENDOCRINOL, V19, P1868, DOI 10.1210/me.2004-0254; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Oakes SR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1411; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Perez A, 2003, J BIOL CHEM, V278, P36942, DOI 10.1074/jbc.M300264200; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Price-Schiavi SA, 2005, J CELL PHYSIOL, V203, P44, DOI 10.1002/jcp.20200; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Ramsauer VP, 2003, J BIOL CHEM, V278, P30142, DOI 10.1074/jbc.M303220200; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Shepherd T, 2001, J MAMMARY GLAND BIOL, V6, P129, DOI 10.1023/A:1009576801226; Thomas RS, 2000, ADV EXP MED BIOL, V480, P123; YANG Y, 1994, MEMBERS FATTY ACID B; Yaniw D, 2005, CELL RES, V15, P423, DOI 10.1038/sj.cr.7290310; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004; YULEE LY, 1983, J BIOL CHEM, V258, P794; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538	32	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13150	10.1371/journal.pone.0013150	http://dx.doi.org/10.1371/journal.pone.0013150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949099	Green Published, gold			2022-12-25	WOS:000282633700006
J	Guo, XL; Harada, C; Namekata, K; Mitamura, Y; Yoshida, H; Matsumoto, Y; Harada, T				Guo, Xiaoli; Harada, Chikako; Namekata, Kazuhiko; Mitamura, Yoshinori; Yoshida, Hiroshi; Matsumoto, Yoh; Harada, Takayuki			Delayed Onset of Experimental Autoimmune Encephalomyelitis in Olig1 Deficient Mice	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; OPTIC NEURITIS; PRECURSOR CELLS; SPINAL-CORD; REMYELINATION; LESIONS; CNS; OLIGODENDROCYTES; POPULATION; MECHANISMS	Background: Olig1 is a basic helix-loop-helix (bHLH) transcription factor that is essential for oligodendrogenesis and efficient remyelination. However, its role in neurodegenerative disorders has not been well-elucidated. Methodology/Principal Findings: Here we investigated the effects of Olig1 deficiency on experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). We show that the mean disease onset of myelin oligodendrocyte glycoprotein (MOG)-induced EAE in Olig1(-/-) mice is significantly slower than wide-type (WT) mice (19.8 +/- 2.2 in Olig1(-/-) mice and 9.5 +/- 0.3 days in WT mice). In addition, 10% of Olig1(-/-) mice did not develop EAE by the end of the observation periods (60 days). The severity of EAE, the extent of demyelination, and the activation of microglial cells and astrocytes in spinal cords, were significantly milder in Olig1(-/-) mice compared with WT mice in the early stage. Moreover, the visual function, as assessed by the second-kernel of multifocal electroretinograms, was better preserved, and the number of degenerating axons in the optic nerve was significantly reduced in Olig1(-/-) mice. Interestingly, Olig1 deficiency had no effect on T cell response capability, however, it reduced the expression of myelin proteins such as MOG, myelin basic protein (MBP) and myelin-associated glycoprotein (MAG). The expression of Olig2 remained unchanged in the optic nerve and brain, and it was reduced in the spinal cord of Olig1(-/-) mice. Conclusions/Significance: Our results suggest that the Olig1 signaling pathways may be involved in the incidence rate and the severity of neurological symptoms in MS.	[Guo, Xiaoli; Harada, Chikako; Namekata, Kazuhiko; Harada, Takayuki] Tokyo Metropolitan Inst Neurosci, Dept Mol Neurobiol, Tokyo, Japan; [Mitamura, Yoshinori] Univ Tokushima, Inst Hlth Biosci, Dept Ophthalmol, Grad Sch, Tokushima 770, Japan; [Yoshida, Hiroshi] Tokyo Metropolitan Neurol Hosp, Dept Neuroophthalmol, Tokyo, Japan; [Matsumoto, Yoh] Tokyo Metropolitan Inst Neurosci, Dept Mol Neuropathol, Tokyo, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Tokushima University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Guo, XL (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Mol Neurobiol, Tokyo, Japan.	harada-tk@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists; Tokyo Metropolitan Government; Ministry of Health, Labour, and Welfare of Japan; Japan Medical Association	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Metropolitan Government(Tokyo Metropolitan Government); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Medical Association	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (X. G., K.N., T. H.); Japan Society for the Promotion of Science for Young Scientists (C. H.); the Welfare and Health Funds from Tokyo Metropolitan Government (Y.M.); the Ministry of Health, Labour, and Welfare of Japan (Y.M., T. H.); and the Japan Medical Association (T. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Burton A, 2005, LANCET NEUROL, V4, P80, DOI 10.1016/S1474-4422(05)00978-6; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Delarasse C, 2003, J CLIN INVEST, V112, P544, DOI 10.1172/JCI200315861; Goris A, 2006, J NEUROL NEUROSUR PS, V77, P1296, DOI 10.1136/jnnp.2006.090639; Guo X, 2007, NEUROSCI RES, V59, P457, DOI 10.1016/j.neures.2007.08.014; Guo XL, 2009, NEUROSCI LETT, V462, P281, DOI 10.1016/j.neulet.2009.07.028; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Hickman SJ, 2002, LANCET, V360, P1953, DOI 10.1016/S0140-6736(02)11919-2; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Korner H, 1997, J EXP MED, V186, P1585, DOI 10.1084/jem.186.9.1585; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Liu Y, 2004, GLIA, V45, P67, DOI 10.1002/glia.10303; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Magnus T, 2005, J CELL MOL MED, V9, P303, DOI 10.1111/j.1582-4934.2005.tb00357.x; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Namekata K, 2008, MOL CELL BIOL, V28, P3273, DOI 10.1128/MCB.02159-07; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Prineas J. W., 1997, GREENFIELDS NEUROPAT, P813; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; RAINE CS, 1997, TXB NEUROPATHOLOGY, P243; Wolswijk G, 1998, J NEUROSCI, V18, P601; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	29	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13083	10.1371/journal.pone.0013083	http://dx.doi.org/10.1371/journal.pone.0013083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927333	gold, Green Published, Green Submitted			2022-12-25	WOS:000282269400028
J	Pouvreau, S				Pouvreau, Sandrine			Superoxide Flashes in Mouse Skeletal Muscle Are Produced by Discrete Arrays of Active Mitochondria Operating Coherently	PLOS ONE			English	Article							PERMEABILITY TRANSITION; SINGLE MITOCHONDRIA; TRANSMITTING CABLES; CARDIAC MYOCYTES; OXIDATIVE STRESS; FREE-RADICALS; ROS RELEASE; OSCILLATIONS; FIBERS; DEPOLARIZATIONS	Reactive Oxygen Species (ROS) constitute important intracellular signaling molecules. Mitochondria are admitted sources of ROS, especially of superoxide anions through the electron transport chain. Here the mitochondria-targeted ratiometric pericam (RPmt) was used as a superoxide biosensor, by appropriate choice of the excitation wavelength. RPmt was transfected in vivo into mouse muscles. Confocal imaging of isolated muscle fibers reveals spontaneous flashes of RPmt fluorescence. Flashes correspond to increases in superoxide production, as shown by simultaneous recordings of the fluorescence from MitoSox, a mitochondrial superoxide probe. Flashes occur in all subcellular populations of mitochondria. Spatial analysis of the flashes pattern over time revealed that arrays of mitochondria work as well-defined superoxide-production-units. Increase of superoxide production at the muscle fiber level involves recruitment of supplemental units with no increase in per-unit production. Altogether, these results demonstrate that superoxide flashes in muscle fibers correspond to physiological signals linked to mitochondrial metabolism. They also suggest that superoxide, or one of its derivatives, modulates its own production at the mitochondrial level.	Univ Lyon 1, UMR CNRS 5123, F-69622 Villeurbanne, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Pouvreau, S (corresponding author), Univ Lyon 1, UMR CNRS 5123, F-69622 Villeurbanne, France.	sandrine.pouvreau@univ-lyon1.fr	Pouvreau, Sandrine/AFV-8178-2022		Universite Lyon 1; Centre National de la Recherche Scientifique	Universite Lyon 1; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Universite Lyon 1 and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Aon MA, 2004, P NATL ACAD SCI USA, V101, P4447, DOI 10.1073/pnas.0307156101; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; DiFranco M, 2006, PROTEIN EXPRES PURIF, V47, P281, DOI 10.1016/j.pep.2005.10.018; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Isaev NK, 2008, BIOCHEMISTRY-MOSCOW+, V73, P149, DOI 10.1134/S0006297908020053; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; Kudin AP, 2005, BIOMED PHARMACOTHER, V59, P163, DOI 10.1016/j.biopha.2005.03.012; Kuznetsov AV, 2006, BBA-BIOENERGETICS, V1757, P686, DOI 10.1016/j.bbabio.2006.03.014; Kuznetsov AV, 1998, J CELL BIOL, V140, P1091, DOI 10.1083/jcb.140.5.1091; LOEW LM, 1993, BIOPHYS J, V65, P2396, DOI 10.1016/S0006-3495(93)81318-3; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; O'Reilly CM, 2003, BIOPHYS J, V85, P3350, DOI 10.1016/S0006-3495(03)74754-7; OGATA T, 1985, CELL TISSUE RES, V241, P251, DOI 10.1007/BF00217168; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Reid MB, 2008, FREE RADICAL BIO MED, V44, P169, DOI 10.1016/j.freeradbiomed.2007.03.002; Romashko DN, 1998, P NATL ACAD SCI USA, V95, P1618, DOI 10.1073/pnas.95.4.1618; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	35	75	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13035	10.1371/journal.pone.0013035	http://dx.doi.org/10.1371/journal.pone.0013035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927399	Green Submitted, gold, Green Published			2022-12-25	WOS:000282210700015
J	Kitajima, S; Miki, T; Takegami, Y; Kido, Y; Noda, M; Hara, E; Shamma, A; Takahashi, C				Kitajima, S.; Miki, T.; Takegami, Y.; Kido, Y.; Noda, M.; Hara, E.; Shamma, A.; Takahashi, C.			Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling	ONCOGENE			English	Article						senescence; negative feedback; RECK; EGFR; RAS; MMP	ONCOGENE-INDUCED SENESCENCE; METASTASIS SUPPRESSOR RECK; CELL LUNG-CANCER; DNA-DAMAGE RESPONSE; MATRIX-METALLOPROTEINASE; DOWN-REGULATION; PROGNOSTIC-SIGNIFICANCE; PROMOTER METHYLATION; NEGATIVE FEEDBACK; EXPRESSION	The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) gene had been isolated as an antagonist to RAS signaling; however, the mechanism of its action is not clear. In this study, the effect of loss of RECK function was assessed in various ways and cell systems. Successive cell cultivation of mouse embryonic fibroblasts (MEFs) according to 3T3 protocol revealed that the germline knockout of RECK confers accelerated cell proliferation and early escape from cellular senescence associated with downregulation of p19(Arf), Trp53 and p21(Cdkn1a). In contrast, short hairpin RNA-mediated depletion of RECK induced irreversible growth arrest along with several features of the Arf, Trp53 and Cdkn1a-dependent cellular senescence. Within 2 days of RECK depletion, we observed a transient increase in protein kinase B (AKT) and extracellular signal-regulated kinase (ERK) phosphorylation associated with an upregulated expression of cyclin D1, p19(Arf), Trp53, p21(Cdkn1a) and Sprouty 2. On further cultivation, RAS, AKT and ERK activities were then downregulated to a level lower than control, indicating that RECK depletion leads to a negative feedback to RAS signaling and subsequent cellular senescence. In addition, we observed that epidermal growth factor receptor (EGFR) activity was transiently upregulated by RECK depletion in MEFs, and continuously downregulated by RECK overexpression in colon cancer cells. These findings indicate that RECK is a novel modulator of EGFR signaling. Oncogene (2011) 30, 737-750; doi:10.1038/onc.2010.448; published online 4 October 2010	[Kitajima, S.; Kido, Y.; Shamma, A.; Takahashi, C.] Kanazawa Univ, Canc Res Inst, Canc & Stem Cell Res Program, Div Oncol & Mol Biol, Kanazawa, Ishikawa 9201192, Japan; [Kitajima, S.; Miki, T.; Takegami, Y.; Noda, M.; Shamma, A.; Takahashi, C.] Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto, Japan; [Miki, T.; Shamma, A.; Takahashi, C.] Kyoto Univ, Grad Sch Med, 21st Century Ctr Excellence Program, Sakyo Ku, Kyoto, Japan; [Miki, T.] Univ Texas Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX USA; [Hara, E.] Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 170, Japan	Kanazawa University; Kyoto University; Kyoto University; University of Texas System; University of Texas Health Science Center Houston; Japanese Foundation for Cancer Research	Takahashi, C (corresponding author), Kanazawa Univ, Canc Res Inst, Canc & Stem Cell Res Program, Div Oncol & Mol Biol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	chtakaha@staff.kanazawa-u.ac.jp		Shamma, Awad/0000-0002-3037-616X	JASSO scholarship; Princess Takamatsu Cancer Research Fund; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [22500998] Funding Source: KAKEN	JASSO scholarship; Princess Takamatsu Cancer Research Fund; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H Sato and T Muraguchi for critical reading of the paper; T Kamijo, P Leder, N Sharpless, S Itohara, Y Okada and M Seiki for providing the mice; M Seiki, T Sakamoto and T Nakano for providing cells; S Yano and K Matsumoto and S Higashiyama for providing the reagents; C Sugita for supporting mouse transfer; W Hung, K Lee and J Oh for encouragement; H Gu and A Nishimoto for technical assistance; and A Miyazaki and M Suzuki for secretarial assistance. SK thanks the JASSO scholarship for support. This work was supported by a Research Grant from the Princess Takamatsu Cancer Research Fund, Astellas Foundation for Research on Metabolic Disorders, the Takeda Science Foundation and the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Andratschke Nicolaus H, 2004, Clin Lung Cancer, V5, P340, DOI 10.3816/CLC.2004.n.012; ANKER P, 1994, CR ACAD SCI III-VIE, V317, P869; Bardeesy N, 2006, CANCER CELL, V10, P451, DOI 10.1016/j.ccr.2006.11.015; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chang HC, 2004, CELL SIGNAL, V16, P675, DOI 10.1016/j.cellsig.2003.11.001; Chang HC, 2007, CANCER SCI, V98, P169, DOI 10.1111/j.1349-7006.2006.00367.x; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Clark JCM, 2007, CANCER METAST REV, V26, P675, DOI 10.1007/s10555-007-9093-8; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hatta M, 2009, CELL SIGNAL, V21, P1885, DOI 10.1016/j.cellsig.2009.08.005; Hsu MC, 2006, J BIOL CHEM, V281, P4718, DOI 10.1074/jbc.M510937200; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Janne PA, 2005, SEMIN ONCOL, V32, pS9, DOI 10.1053/j.seminoncol.2005.10.004; Jodele S, 2006, CANCER METAST REV, V25, P35, DOI 10.1007/s10555-006-7887-8; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Liu LT, 2003, ONCOGENE, V22, P8263, DOI 10.1038/sj.onc.1207157; Loayza-Puch F, 2010, ONCOGENE, V29, P2638, DOI 10.1038/onc.2010.23; Long NK, 2008, ORAL ONCOL, V44, P1052, DOI 10.1016/j.oraloncology.2008.02.004; LYONS JG, 1993, J BIOL CHEM, V268, P19143; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200; Miki T, 2010, MOL CANCER RES, V8, P665, DOI 10.1158/1541-7786.MCR-09-0351; Morioka Y, 2009, ONCOGENE, V28, P1454, DOI 10.1038/onc.2008.486; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Noda M, 2007, CANCER SCI, V98, P1659, DOI 10.1111/j.1349-7006.2007.00588.x; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Omura A, 2009, J BIOL CHEM, V284, P3461, DOI 10.1074/jbc.M806212200; Rabien A, 2007, EUR UROL, V51, P1259, DOI 10.1016/j.eururo.2006.05.050; RAHMAH NN, 2009, NEUROSURG REV, V173, P167; Sasahara RM, 1999, BIOCHEM BIOPH RES CO, V264, P668, DOI 10.1006/bbrc.1999.1552; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Takagi S, 2009, CANCER RES, V69, P1502, DOI 10.1158/0008-5472.CAN-08-2635; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Takemoto N, 2007, LUNG CANCER, V58, P376, DOI 10.1016/j.lungcan.2007.07.004; Takenaka K, 2005, ANN SURG ONCOL, V12, P817, DOI 10.1245/ASO.2005.09.018; Takenaka K, 2004, EUR J CANCER, V40, P1617, DOI 10.1016/j.ejca.2004.02.028; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TSUKADA T, 1993, ONCOGENE, V8, P3313; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	57	23	23	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	6					737	750		10.1038/onc.2010.448	http://dx.doi.org/10.1038/onc.2010.448			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	719GY	20890302	Green Submitted			2022-12-25	WOS:000287192000010
J	Lee, Y; Smith, RS; Jordan, W; King, BL; Won, J; Valpuesta, JM; Naggert, JK; Nishina, PM				Lee, YongSuk; Smith, Richard S.; Jordan, Wanda; King, Benjamin L.; Won, Jungyeon; Valpuesta, Jose M.; Naggert, Jurgen K.; Nishina, Patsy M.			Prefoldin 5 Is Required for Normal Sensory and Neuronal Development in a Murine Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE PREFOLDIN; POLYCYSTIC KIDNEY-DISEASE; CYTOSOLIC CHAPERONIN; EUKARYOTIC PREFOLDIN; SACCHAROMYCES-CEREVISIAE; UNFOLDED PROTEINS; GENE CAUSES; C-ELEGANS; IN-VIVO; ACTIN	Molecular chaperones and co-chaperones are crucial for cellular development and maintenance as they assist in protein folding and stabilization of unfolded or misfolded proteins. Prefoldin (PFDN), a ubiquitously expressed heterohexameric co-chaperone, is necessary for proper folding of nascent proteins, in particular, tubulin and actin. Here we show that a genetic disruption in the murine Pfdn5 gene, a subunit of prefoldin, causes a syndrome characterized by photoreceptor degeneration, central nervous system abnormalities, and male infertility. Our data indicate that a missense mutation in Pfdn5, may cause these phenotypes through a reduction in formation of microtubules and microfilaments, which are necessary for the development of cilia and cytoskeletal structures, respectively. The diversity of phenotypes demonstrated by models carrying mutations in different PFDN subunits suggests that each PFDN subunit must confer a distinct substrate specificity to the prefoldin holocomplex.	[Lee, YongSuk; Smith, Richard S.; Jordan, Wanda; King, Benjamin L.; Won, Jungyeon; Naggert, Jurgen K.; Nishina, Patsy M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Valpuesta, Jose M.] Univ Autonoma Madrid, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Jackson Laboratory; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Nishina, PM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	patsy.nishina@jax.org	Valpuesta, José M/T-1977-2017; King, Benjamin/AAI-1492-2019; Valpuesta, Jose M/AAA-6002-2019	Valpuesta, José M/0000-0001-7468-8053; King, Benjamin/0000-0001-6463-1336	Institutional Cancer Core grant [CA-24190]; NEI, National Institutes of Health [EY016501, EY11996]; NATIONAL EYE INSTITUTE [R01EY016501, R01EY011996] Funding Source: NIH RePORTER	Institutional Cancer Core grant; NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Drs. Susan Ackerman and Gregory Cox for critical review of the manuscript, Adrienne Mehalow for initiating the mapping crosses, Dr. Robert Braun for testis analysis, Jeanie Hansen for mouse colony care, and Douglas Howell for ERG measurement. Shared scientific services were supported by an Institutional Cancer Core grant (CA-24190).; This work was supported, in whole or in part, by NEI, National Institutes of Health Grants EY016501 and EY11996.	Andreu J. M., 2007, MICROTUBULE PROTOCOL; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; Buchner DA, 2004, MAMM GENOME, V15, P344, DOI 10.1007/s00335-004-2332-1; Cao S, 2008, J IMMUNOL, V181, P476, DOI 10.4049/jimmunol.181.1.476; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; Gu Y, 2008, P NATL ACAD SCI USA, V105, P18064, DOI 10.1073/pnas.0808652105; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Lacefield S, 2003, GENETICS, V165, P531; Lacefield S, 2006, GENETICS, V173, P635, DOI 10.1534/genetics.105.055160; Le Bot N, 2003, CURR BIOL, V13, P1499, DOI 10.1016/S0960-9822(03)00577-3; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Leroux MR, 1999, EMBO J, V18, P6730, DOI 10.1093/emboj/18.23.6730; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Lundin VF, 2008, DEV BIOL, V313, P320, DOI 10.1016/j.ydbio.2007.10.022; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Martin-Benito J, 2007, STRUCTURE, V15, P101, DOI 10.1016/j.str.2006.11.006; Micheva KD, 1998, EUR J NEUROSCI, V10, P3785, DOI 10.1046/j.1460-9568.1998.00391.x; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Ohtaki A, 2008, J MOL BIOL, V376, P1130, DOI 10.1016/j.jmb.2007.12.010; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Simons CT, 2004, J BIOL CHEM, V279, P4196, DOI 10.1074/jbc.M306053200; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Tsuchiya H, 1996, CANCER RES, V56, P2881; URSIC D, 1991, MOL CELL BIOL, V11, P2629, DOI 10.1128/MCB.11.5.2629; URSIC D, 1994, MOL BIOL CELL, V5, P1065, DOI 10.1091/mbc.5.10.1065; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	42	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					726	736		10.1074/jbc.M110.177352	http://dx.doi.org/10.1074/jbc.M110.177352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20956523	Green Published, hybrid			2022-12-25	WOS:000285782800072
J	Jeanguenin, L; Lara-Nunez, A; Pribat, A; Mageroy, MH; Gregory, JF; Rice, KC; de Crecy-Lagard, V; Hanson, AD				Jeanguenin, Linda; Lara-Nunez, Aurora; Pribat, Anne; Mageroy, Melissa Hamner; Gregory, Jesse F., III; Rice, Kelly C.; de Crecy-Lagard, Valerie; Hanson, Andrew D.			Moonlighting Glutamate Formiminotransferases Can Functionally Replace 5-Formyltetrahydrofolate Cycloligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; METHENYLTETRAHYDROFOLATE SYNTHETASE; METHANOSARCINA-BARKERI; STAPHYLOCOCCUS-AUREUS; METHANOGENIC ARCHAEON; MOLECULAR-CLONING; FOLIC-ACID; FOLATE; STREPTOCOCCUS; ENZYMES	5-Formyltetrahydrofolate (5-CHO-THF) is formed by a side reaction of serine hydroxymethyltransferase. Unlike other folates, it is not a one-carbon donor but a potent inhibitor of folate enzymes and must therefore be metabolized. Only 5-CHO-THF cycloligase (5-FCL) is generally considered to do this. However, comparative genomic analysis indicated (i) that certain prokaryotes lack 5-FCL, implying that they have an alternative 5-CHO-THF-metabolizing enzyme, and (ii) that the histidine breakdown enzyme glutamate formiminotransferase (FT) might moonlight in this role. A functional complementation assay for 5-CHO-THF metabolism was developed in Escherichia coli, based on deleting the gene encoding 5-FCL (ygfA). The deletion mutant accumulated 5-CHO-THF and, with glycine as sole nitrogen source, showed a growth defect; both phenotypes were complemented by bacterial or archaeal genes encoding FT. Furthermore, utilization of supplied 5-CHO-THF by Streptococcus pyogenes was shown to require expression of the native FT. Recombinant bacterial and archaeal FTs catalyzed formyl transfer from 5-CHO-THF to glutamate, with k(cat) values of 0.1-1.2 min(-1) and K-m values for 5-CHO-THF and glutamate of 0.4-5 mu M and 0.03-1 mM, respectively. Although the formyltransferase activities of these proteins were far lower than their formiminotransferase activities, the K-m values for both substrates relative to their intracellular levels in prokaryotes are consistent with significant in vivo flux through the formyltransferase reaction. Collectively, these data indicate that FTs functionally replace 5-FCL in certain prokaryotes.	[Jeanguenin, Linda; Pribat, Anne; Mageroy, Melissa Hamner; Hanson, Andrew D.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Lara-Nunez, Aurora; Gregory, Jesse F., III] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Rice, Kelly C.; de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hanson, AD (corresponding author), Univ Florida, Dept Hort Sci, POB 110690, Gainesville, FL 32611 USA.	adha@ufl.edu	de Crecy-Lagard, Valerie/AAN-8995-2020; Nunez, Aurora Lara/G-3485-2019; Mageroy, Melissa H/H-5879-2019	Nunez, Aurora Lara/0000-0003-4056-9501; Mageroy, Melissa H/0000-0001-7801-1007; Gregory, Jesse/0000-0002-9976-2085	United States (U.S.) National Science Foundation [MCB-0839926]; U.S. Dept. of Energy [FG02-07ER64498]; National Institutes of Health [R03-DE019179]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019179] Funding Source: NIH RePORTER	United States (U.S.) National Science Foundation(National Science Foundation (NSF)); U.S. Dept. of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by United States (U.S.) National Science Foundation Award MCB-0839926 (to A.D.H.), by U.S. Dept. of Energy award FG02-07ER64498 (to V. de C.L.), by National Institutes of Health Award R03-DE019179 (to K.C.R.), and by an endowment from the C.V. Griffin, Sr. Foundation.	ANDERSON CB, 1982, APPL ENVIRON MICROB, V43, P1501, DOI 10.1128/AEM.43.6.1501-1503.1982; Anguera MC, 2003, J BIOL CHEM, V278, P29856, DOI 10.1074/jbc.M302883200; Arnold RJ, 2000, ANAL BIOCHEM, V281, P45, DOI 10.1006/abio.2000.4527; Baba Tomoya, 2006, Mol Syst Biol, V2; Baggott JE, 2000, BIOCHEMISTRY-US, V39, P14647, DOI 10.1021/bi001362m; Bagley PJ, 2000, CLIN CHEM, V46, P404; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Benkovic S. J., 1984, FOLATES PTERINS, V1, P61; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bergmeyer H. U., 1974, METHOD ENZYMAT AN, V4, P2285; Biswas I, 2003, J BACTERIOL, V185, P3081, DOI 10.1128/JB.185.10.3081-3090.2003; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; BORTOLUZZI LC, 1983, CAN J BIOCHEM CELL B, V61, P248, DOI 10.1139/o83-035; Brabban AD, 1999, APPL ENVIRON MICROB, V65, P1222; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchenau B, 2004, ARCH MICROBIOL, V182, P313, DOI 10.1007/s00203-004-0714-0; CHASIN LA, 1968, J BIOL CHEM, V243, P5165; de Crecy-Lagard V., 2007, BMC GENOMICS, V8, P245; Field MS, 2007, ARCH BIOCHEM BIOPHYS, V458, P194, DOI 10.1016/j.abb.2006.12.023; FINDLAY WA, 1987, BIOCHEMISTRY-US, V26, P1948, DOI 10.1021/bi00381a024; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Goyer A, 2005, J BIOL CHEM, V280, P26137, DOI 10.1074/jbc.M503106200; GREGORY JF, 1984, J NUTR, V114, P341, DOI 10.1093/jn/114.2.341; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Holmes WB, 2002, J BIOL CHEM, V277, P20205, DOI 10.1074/jbc.M201242200; HU L, 1987, J BACTERIOL, V169, P4696, DOI 10.1128/jb.169.10.4696-4702.1987; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; KRUSCHWITZ HL, 1994, J BIOL CHEM, V269, P28757; Lee HH, 2004, J BIOL CHEM, V279, P50514, DOI 10.1074/jbc.M409672200; MATTHEWS RG, 1996, ESCHERICHIA COLI SAL, V1, P600; MIYAKE M, 1983, BIOCHIM BIOPHYS ACTA, V760, P206, DOI 10.1016/0304-4165(83)90165-4; MURLEY LL, 1995, BIOCHEMISTRY-US, V34, P10358, DOI 10.1021/bi00033a006; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NEWMAN EB, 1976, BIOCHIM BIOPHYS ACTA, V421, P97, DOI 10.1016/0304-4165(76)90173-2; OHMURA E, 1957, J BIOL CHEM, V227, P181; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pelletier JN, 1996, BIOORG CHEM, V24, P220, DOI 10.1006/bioo.1996.0020; Pfeiffer CM, 1997, J AGR FOOD CHEM, V45, P407, DOI 10.1021/jf960633q; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Roje S, 2002, J BIOL CHEM, V277, P42748, DOI 10.1074/jbc.M205632200; Sambrook J., 1989, MOL CLONING LAB MANU; SCOTT JR, 1986, J EXP MED, V164, P1641, DOI 10.1084/jem.164.5.1641; SILVERMAN M, 1957, J BIOL CHEM, V226, P83; SIMON D, 1991, FEMS MICROBIOL LETT, V82, P219, DOI 10.1016/0378-1097(91)90336-9; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Sitkiewicz I, 2006, P NATL ACAD SCI USA, V103, P16009, DOI 10.1073/pnas.0607669103; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; STOVER P, 1992, BIOCHEMISTRY-US, V31, P2155, DOI 10.1021/bi00122a037; STOVER P, 1990, J BIOL CHEM, V265, P14227; TABOR H, 1954, J BIOL CHEM, V210, P559; Tabor H., 1957, BIOCHEM PREP, V5, P100; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson HR, 2001, AM J PHYSIOL-GASTR L, V280, pG873, DOI 10.1152/ajpgi.2001.280.5.G873; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; WHITE RH, 1991, J BACTERIOL, V173, P1987, DOI 10.1128/jb.173.6.1987-1991.1991; WORRELL VE, 1988, J BACTERIOL, V170, P4420, DOI 10.1128/jb.170.9.4420-4423.1988; WRAY LV, 1994, J BACTERIOL, V176, P1894, DOI 10.1128/jb.176.7.1894-1902.1994	63	23	31	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41557	41566		10.1074/jbc.M110.190504	http://dx.doi.org/10.1074/jbc.M110.190504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20952389	Green Published, hybrid			2022-12-25	WOS:000285622600043
J	Kikani, CK; Antonysamy, SA; Bonanno, JB; Romero, R; Zhang, FF; Russell, M; Gheyi, T; Iizuka, M; Emtage, S; Sauder, JM; Turk, BE; Burley, SK; Rutter, J				Kikani, Chintan K.; Antonysamy, Stephen A.; Bonanno, Jeffrey B.; Romero, Rich; Zhang, Feiyu Fred; Russell, Marijane; Gheyi, Tarun; Iizuka, Miyo; Emtage, Spencer; Sauder, J. Michael; Turk, Benjamin E.; Burley, Stephen K.; Rutter, Jared			Structural Bases of PAS Domain-regulated Kinase (PASK) Activation in the Absence of Activation Loop Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASES; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; TRANSLATION; MTOR; ERK2; AMPK	Per-Arnt-Sim (PAS) domain-containing protein kinase (PASK) is an evolutionary conserved protein kinase that coordinates cellular metabolism with metabolic demand in yeast and mammals. The molecular mechanisms underlying PASK regulation, however, remain unknown. Herein, we describe a crystal structure of the kinase domain of human PASK, which provides insights into the regulatory mechanisms governing catalysis. We show that the kinase domain adopts an active conformation and has catalytic activity in vivo and in vitro in the absence of activation loop phosphorylation. Using site-directed mutagenesis and structural comparison with active and inactive kinases, we identified several key structural features in PASK that enable activation loop phosphorylation-independent activity. Finally, we used combinatorial peptide library screening to determine that PASK prefers basic residues at the P-3 and P-5 positions in substrate peptides. Our results describe the key features of the PASK structure and how those features are important for PASK activity and substrate selection.	[Rutter, Jared] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Antonysamy, Stephen A.; Romero, Rich; Zhang, Feiyu Fred; Russell, Marijane; Gheyi, Tarun; Iizuka, Miyo; Emtage, Spencer; Sauder, J. Michael; Burley, Stephen K.] Eli Lilly & Co, San Diego, CA 92121 USA; [Antonysamy, Stephen A.; Romero, Rich; Zhang, Feiyu Fred; Russell, Marijane; Gheyi, Tarun; Iizuka, Miyo; Emtage, Spencer; Sauder, J. Michael; Burley, Stephen K.] New York SGX Res Ctr Struct Genom NYSGXRC, San Diego, CA 92121 USA; [Bonanno, Jeffrey B.] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Utah System of Higher Education; University of Utah; Eli Lilly; Yeshiva University; Albert Einstein College of Medicine; Yale University	Rutter, J (corresponding author), Univ Utah, Sch Med, Dept Biochem, 15 N Med Dr E,Rm 5200J, Salt Lake City, UT 84112 USA.	Rutter@biochem.utah.edu		Kikani, Chintan/0000-0003-1140-0192; Sauder, J Michael/0000-0002-0254-4955; Burley, Stephen K./0000-0002-2487-9713	National Institutes of Health [U54 GM074945, DK071962, GM079498]; United States Dept. of Energy, Office of Basic Energy Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK071962, R01DK071962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079498, U54GM074945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health Grants U54 GM074945 (to New York SGX Research Center for Structural Genomics, principal investigator, S. K. Burley), DK071962 (to J. R.) and GM079498 (to B. E. T.). Use of the Advanced Photon Source was supported by the United States Dept. of Energy, Office of Basic Energy Sciences. Use of the LRL-CAT beam line facilities at Sector 31 of the APS (formerly SGX-CAT) was provided by Eli Lilly and Company, which operates the beamline (formerly SGX Pharmaceuticals).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Grose JH, 2007, EMBO J, V26, P4824, DOI 10.1038/sj.emboj.7601914; Grose JH, 2009, CELL CYCLE, V8, P1824, DOI 10.4161/cc.8.12.8799; Hao HX, 2008, IUBMB LIFE, V60, P204, DOI 10.1002/iub.32; Hao HX, 2007, P NATL ACAD SCI USA, V104, P15466, DOI 10.1073/pnas.0705407104; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Komander D, 2005, J BIOL CHEM, V280, P18797, DOI 10.1074/jbc.M500977200; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Krupa A, 2004, J MOL BIOL, V339, P1025, DOI 10.1016/j.jmb.2004.04.043; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Mazanka E, 2008, PLOS BIOL, V6, P1778, DOI 10.1371/journal.pbio.0060203; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Rutter J, 2002, CELL, V111, P17, DOI 10.1016/S0092-8674(02)00974-1; Rutter J, 2001, P NATL ACAD SCI USA, V98, P8991, DOI 10.1073/pnas.161284798; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Smith TL, 2007, MOL CELL, V26, P491, DOI 10.1016/j.molcel.2007.03.025; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; XAVIER GD, 2004, P NATL ACAD SCI USA, V101, P8319; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0	39	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41034	41043		10.1074/jbc.M110.157594	http://dx.doi.org/10.1074/jbc.M110.157594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943661	Green Published, hybrid			2022-12-25	WOS:000285414400066
J	Rani, SH; Krishna, THA; Saha, S; Negi, AS; Rajasekharan, R				Rani, Sapa Hima; Krishna, T. H. Anantha; Saha, Saikat; Negi, Arvind Singh; Rajasekharan, Ram			Defective in Cuticular Ridges (DCR) of Arabidopsis thaliana, a Gene Associated with Surface Cutin Formation, Encodes a Soluble Diacylglycerol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIACYLGLYCEROL SYNTHESIS; MICROSOMAL PREPARATIONS; BIOSYNTHESIS; EXPRESSION; SUBERIN; YEAST; ACID; IDENTIFICATION; CLONING; MONOMERS	A key step in the triacylglycerol (TAG) biosynthetic pathway is the final acylation of diacylglycerol (DAG) by DAG acyltransferase. In silico analysis has revealed that the DCR (defective in cuticular ridges) (At5g23940) gene has a typical HX4D acyltransferase motif at the N-terminal end and a lipid binding motif VX(2)GF at the middle of the sequence. To understand the biochemical function, the gene was overexpressed in Escherichia coli, and the purified recombinant protein was found to acylate DAG specifically in an acyl-CoA-dependent manner. Overexpression of At5g23940 in a Saccharomyces cerevisiae quadruple mutant deficient in DAG acyltransferases resulted in TAG accumulation. At5g23940 rescued the growth of this quadruple mutant in the oleate-containing medium, whereas empty vector control did not. Lipid particles were localized in the cytosol of At5g23940-transformed quadruple mutant cells, as observed by oil red O staining. There was an incorporation of 16-hydroxyhexadecanoic acid into TAG in At5g23940-transformed cells of quadruple mutant. Here we report a soluble acyl-CoA-dependent DAG acyltransferase from Arabidopsis thaliana. Taken together, these data suggest that a broad specific DAG acyltransferase may be involved in the cutin as well as in the TAG biosynthesis by supplying hydroxy fatty acid.	[Rani, Sapa Hima; Krishna, T. H. Anantha; Saha, Saikat; Rajasekharan, Ram] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Negi, Arvind Singh; Rajasekharan, Ram] CSIR, Cent Inst Med & Aromat Plants, Lucknow 220015, Uttar Pradesh, India	Indian Institute of Science (IISC) - Bangalore; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Rajasekharan, R (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	lipid@biochem.iisc.ernet.in	Rajasekharan, Ram/R-2257-2019; Negi, arvind singh/AAS-1530-2021; Sapa, Hima/K-1134-2019	Sapa, Hima/0000-0003-4749-7600; Rajasekharan, Ram/0000-0002-2124-6013; Ram, Rajasekharan/0000-0002-4114-0654	Department of Biotechnology (New Delhi, India); Council of Scientific and Industrial Research (New Delhi, India)	Department of Biotechnology (New Delhi, India)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (New Delhi, India)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Biotechnology (New Delhi, India) under the program "Support for Nonconventional Yeasts" and the Council of Scientific and Industrial Research (New Delhi, India).	BAFOR M, 1991, BIOCHEM J, V280, P507, DOI 10.1042/bj2800507; Beisson F, 2007, PLANT CELL, V19, P351, DOI 10.1105/tpc.106.048033; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; CROTEAU R, 1974, BIOCHEMISTRY-US, V13, P3193, DOI 10.1021/bi00712a030; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; GERARD HC, 1992, PHYTOCHEM ANALYSIS, V3, P139, DOI 10.1002/pca.2800030310; Ghosh AK, 2008, J BIOL CHEM, V283, P9768, DOI 10.1074/jbc.M708418200; Hobbs DH, 1999, FEBS LETT, V452, P145, DOI 10.1016/S0014-5793(99)00646-8; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; KENNEDY EP, 1961, FED PROC, V20, P934; Kurdyukov S, 2006, PLANT CELL, V18, P321, DOI 10.1105/tpc.105.036079; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Li RZ, 2010, LIPIDS, V45, P145, DOI 10.1007/s11745-010-3385-4; Li YH, 2007, P NATL ACAD SCI USA, V104, P18339, DOI 10.1073/pnas.0706984104; Li YH, 2007, PLANT PHYSIOL, V144, P1267, DOI 10.1104/pp.107.099432; Li YH, 2009, BIOCHIMIE, V91, P685, DOI 10.1016/j.biochi.2009.03.016; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; MARTIN BA, 1984, LIPIDS, V19, P117, DOI 10.1007/BF02534501; Mavraganis I, 2010, APPL ENVIRON MICROB, V76, P1135, DOI 10.1128/AEM.02297-09; Millar AA, 2000, TRENDS PLANT SCI, V5, P95, DOI 10.1016/S1360-1385(00)01566-1; Nykiforuk CL, 2002, BBA-MOL CELL BIOL L, V1580, P95, DOI 10.1016/S1388-1981(01)00200-1; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OHLROGGE JB, 1991, BIOCHIM BIOPHYS ACTA, V1082, P1, DOI 10.1016/0005-2760(91)90294-R; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Reddy VS, 2010, BBA-MOL CELL BIOL L, V1801, P455, DOI 10.1016/j.bbalip.2009.12.005; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Stobart K, 1997, PLANTA, V203, P58, DOI 10.1007/s004250050165; Tumaney AW, 2001, J BIOL CHEM, V276, P10847, DOI 10.1074/jbc.M100005200; Valencia-Turcotte L, 2001, BBA-MOL CELL BIOL L, V1534, P14, DOI 10.1016/S1388-1981(01)00170-6; WALTON TJ, 1972, BIOCHEMISTRY-US, V11, P1885, DOI 10.1021/bi00760a025; WALTON TJ, 1972, BIOCHEM BIOPH RES CO, V46, P16, DOI 10.1016/0006-291X(72)90623-7; WILSON RF, 1986, BIOCHIM BIOPHYS ACTA, V877, P231, DOI 10.1016/0005-2760(86)90299-7; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x	43	63	67	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38337	38347		10.1074/jbc.M110.133116	http://dx.doi.org/10.1074/jbc.M110.133116			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20921218	Green Published, hybrid			2022-12-25	WOS:000284625600040
J	Cui, JG; Li, YY; Zhao, YH; Bhattacharjee, S; Lukiw, WJ				Cui, Jian Guo; Li, Yuan Yuan; Zhao, Yuhai; Bhattacharjee, Surjyadipta; Lukiw, Walter J.			Differential Regulation of Interleukin-1 Receptor-associated Kinase-1 (IRAK-1) and IRAK-2 by MicroRNA-146a and NF-kappa B in Stressed Human Astroglial Cells and in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ON GENE-TRANSCRIPTION; EXPRESSION; CYCLOOXYGENASE-2; NEUROINFLAMMATION; DEMENTIA; FETAL	Specific microRNAs (miRNAs), small non-coding RNAs that support homeostatic gene expression, are significantly altered in abundance in human neurological disorders. In monocytes, increased expression of an NF-kappa B-regulated miRNA-146a down-regulates expression of the interleukin-1 receptor-associated kinase-1 (IRAK-1), an essential component of Toll-like/IL-1 receptor signaling. Here we extend those observations to the hippocampus and neocortex of Alzheimer disease (AD) brain and to stressed human astroglial (HAG) cells in primary culture. In 66 control and AD samples we note a significant up-regulation of miRNA-146a coupled to down-regulation of IRAK-1 and a compensatory up-regulation of IRAK-2. Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in interleukin-1 beta (IL-1 beta) and amyloid-beta-42 (A beta 42) peptide-stressed HAG cells. NF-kappa B-mediated transcriptional control of human IRAK-2 was localized to between -119 and -12 bp of the immediate IRAK-2 promoter. The NF-kappa B inhibitors curcumin, pyrrolidine dithiocarbamate or CAY10512 abrogated both IRAK-2 and miRNA-146a expression, whereas IRAK-1 was up-regulated. Incubation of a protected antisense miRNA-146a was found to inhibit miRNA-146a and restore IRAK-1, whereas IRAK-2 remained unaffected. These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in IL-1 beta+A beta 42 peptide-stressed HAG cells and that an inducible, NF-kappa B-sensitive, miRNA-146a-mediated down-regulation of IRAK-1 coupled to an NF-kappa B-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response. The interactive signaling of NF-kappa B and miRNA-146a further illustrate interplay between inducible transcription factors and pro-inflammatory miRNAs that regulate brain IRAK expression. The combinatorial use of NF-kappa B inhibitors with miRNA-146a or antisense miRNA-146a may have potential as a bi-pronged therapeutic strategy directed against IRAK-2-driven pathogenic signaling.	[Cui, Jian Guo; Li, Yuan Yuan; Bhattacharjee, Surjyadipta; Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, Louisiana State Univ Neurosci Ctr, New Orleans, LA 70112 USA; [Cui, Jian Guo; Li, Yuan Yuan; Bhattacharjee, Surjyadipta; Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; [Zhao, Yuhai; Lukiw, Walter J.] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA 15260 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, LSU Neurosci Ctr Excellence, 2020 Gravier St,Rm 904, New Orleans, LA 70112 USA.	wlukiw@lsuhsc.edu	Bhattacharjee, Surjyadipta/I-5354-2016; Bhattacharjee, Surjyadipta/AAD-7586-2021	Bhattacharjee, Surjyadipta/0000-0003-0185-553X; Bhattacharjee, Surjyadipta/0000-0003-0185-553X	National Institutes of Health [AG18031]; Louisiana State University; Alzheimer Association [IIRG-09-131729]; NIA, National Institutes of Health [P50 AG16573]; NATIONAL INSTITUTE ON AGING [R01AG018031, P50AG016573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG18031 (NIA; to W. J. L.). This work was supported in part by a Translational Research Initiative grant from Louisiana State University (to W. J. L.) and by Alzheimer Association Investigator Initiated Research Grant IIRG-09-131729 (to W. J. L.).; Thanks are extended to the many families and physicians who contributed to the human brain bank resources used in these studies and especially to Drs. P. Alexandrov, L. Carver, E. Head, H. LeBlanc, W. Poon, and T. Saing for human brain tissues. Some of the brain tissues used in this project were provided by the Institute for Memory Impairments and Neurological Disorders and the University of California at Irvine Alzheimer Disease Research Center (UCI-ADRC); funding for the UCI-ADRC was provided by NIA, National Institutes of Health Grant P50 AG16573. Thanks are also extended to Yuan Yuan Li and Darlene Guillot for expert technical assistance and statistical analysis and to Drs. K. Taganov and D. Baltimore for the use of the NF-kappa B-containing pre-miRNA-146a promoter-luciferase reporter vector (A547; Addgene, Cambridge, MA) and expression controls.	Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Bazan NG, 2002, J BIOL CHEM, V277, P30359, DOI 10.1074/jbc.M203201200; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Birdsill A. C., 2010, CELL TISSUE IN PRESS; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Cui JG, 2005, CELL MOL NEUROBIOL, V25, P789, DOI 10.1007/s10571-005-4035-x; Cui JG, 2007, NEUROREPORT, V18, P115, DOI 10.1097/WNR.0b013e32801198bc; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Forlenza OV, 2009, DEMENT GERIATR COGN, V28, P507, DOI 10.1159/000255051; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Hua X, 2010, NEUROIMAGE, V51, P63, DOI 10.1016/j.neuroimage.2010.01.104; Jellinger KA, 2006, J ALZHEIMERS DIS, V9, P61; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kuzmin I, 2005, J MOL BIOL, V346, P411, DOI 10.1016/j.jmb.2004.11.066; Lederhuber H, 2011, NEONATOLOGY, V99, P51, DOI 10.1159/000301938; Letiembre M, 2007, NEUROSCIENCE, V146, P248, DOI 10.1016/j.neuroscience.2007.01.004; Li L, 2010, SCAND J IMMUNOL, V71, P227, DOI 10.1111/j.1365-3083.2010.02383.x; Li Liwu, 2004, Curr Drug Targets Inflamm Allergy, V3, P81, DOI 10.2174/1568010043483863; Loiarro M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/674363; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lukiw WJ, 2010, NEUROREPORT, V21, P922, DOI 10.1097/WNR.0b013e32833da51a; Lukiw WJ, 2000, ALZHEIMERS REP, V3, P233; Lukiw WJ, 1998, J MOL NEUROSCI, V11, P67, DOI 10.1385/JMN:11:1:67; Lukiw WJ, 2004, NEUROCHEM RES, V29, P1287, DOI 10.1023/B:NERE.0000023615.89699.63; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Lukiw WJ, 1998, P NATL ACAD SCI USA, V95, P3914, DOI 10.1073/pnas.95.7.3914; Lukiw WJ, 1998, J NEUROSCI RES, V53, P583, DOI 10.1002/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.3.CO;2-B; Martino S, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/654346; Meylan E, 2008, NAT IMMUNOL, V9, P581, DOI 10.1038/ni0608-581; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Pogue AI, 2009, J INORG BIOCHEM, V103, P1591, DOI 10.1016/j.jinorgbio.2009.05.012; Ringwood L, 2008, CYTOKINE, V42, P1, DOI 10.1016/j.cyto.2007.12.012; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Tan LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003966; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006; Zhao YH, 2006, MOL NEUROBIOL, V34, P181, DOI 10.1385/MN:34:3:181	46	198	211	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38951	38960		10.1074/jbc.M110.178848	http://dx.doi.org/10.1074/jbc.M110.178848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937840	hybrid, Green Published			2022-12-25	WOS:000284941300025
J	Kaur, S; Martin-Manso, G; Pendrak, ML; Garfield, SH; Isenberg, JS; Roberts, DD				Kaur, Sukhbir; Martin-Manso, Gema; Pendrak, Michael L.; Garfield, Susan H.; Isenberg, Jeff S.; Roberts, David D.			Thrombospondin-1 Inhibits VEGF Receptor-2 Signaling by Disrupting Its Association with CD47	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; CELL RESPONSES; VASCULAR HOMEOSTASIS; DEPENDENT ACTIVATION; ISCHEMIC TISSUE; TYPE-1 REPEATS; IN-VITRO; ANGIOGENESIS; MIGRATION	Thrombospondin-1 (TSP1) can inhibit angiogenic responses directly by interacting with VEGF and indirectly by engaging several endothelial cell TSP1 receptors. We now describe a more potent mechanism by which TSP1 inhibits VEGF receptor-2 (VEGFR2) activation through engaging its receptor CD47. CD47 ligation is known to inhibit downstream signaling targets of VEGFR2, including endothelial nitric-oxide synthase and soluble guanylate cyclase, but direct effects on VEGFR2 have not been examined. Based on FRET and co-immunoprecipitation, CD47 constitutively associated with VEGFR2. Ligation of CD47 by TSP1 abolished resonance energy transfer with VEGFR2 and inhibited phosphorylation of VEGFR2 and its downstream target Akt without inhibiting VEGF binding to VEGFR2. The inhibitory activity of TSP1 in large vessel and microvascular endothelial cells was replicated by a recombinant domain of the protein containing its CD47-binding site and by a CD47-binding peptide derived from this domain but not by the CD36-binding domain of TSP1. Inhibition of VEGFR2 phosphorylation was lost when CD47 expression was suppressed in human endothelial cells and in murine CD47-null cells. These results reveal that anti-angiogenic signaling through CD47 is highly redundant and extends beyond inhibition of nitric oxide signaling to global inhibition of VEGFR2 signaling.	[Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Garfield, Susan H.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Isenberg, Jeff S.] Univ Pittsburgh, Vasc Med Inst, Dept Med, Pittsburgh, PA 15260 USA; [Isenberg, Jeff S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10,Rm 2A33,10 Ctr Dr,MSC1500, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008; Martin Manso, Maria Gema/D-4612-2013; Kaur, Sukhbir/ADW-6023-2022	Roberts, David D./0000-0002-2481-2981; Kaur, Sukhbir/0000-0003-0513-6225	National Institutes of Health/NCI; National Institutes of Health [CA128616]; NATIONAL CANCER INSTITUTE [K22CA128616, ZIASC009172] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health/NCI (to D. D. R.) and by National Institutes of Health Grant CA128616 (to J. S. I.).	BAGAVANDOSS P, 1990, BIOCHEM BIOPH RES CO, V170, P867, DOI 10.1016/0006-291X(90)92171-U; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Bauer E. M., 2010, CARDIOVASC IN PRESS; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Calzada MJ, 2004, CIRC RES, V94, P462, DOI 10.1161/01.RES.0000115555.05668.93; Chandrasekaran L, 2000, MOL BIOL CELL, V11, P2885, DOI 10.1091/mbc.11.9.2885; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; Curwen JO, 2008, CLIN CANCER RES, V14, P3124, DOI 10.1158/1078-0432.CCR-07-4783; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Gupta K, 1999, Angiogenesis, V3, P147, DOI 10.1023/A:1009018702832; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; Isenberg JS, 2008, CELL MOL LIFE SCI, V65, P728, DOI 10.1007/s00018-007-7488-x; Isenberg JS, 2008, ANN SURG, V247, P860, DOI 10.1097/SLA.0b013e31816c4006; Isenberg JS, 2008, ANN SURG, V247, P180, DOI 10.1097/SLA.0b013e31815685dc; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Isenberg JS, 2007, CIRC RES, V100, P712, DOI 10.1161/01.RES.0000259579.35787.4e; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Krutzsch HC, 1999, J BIOL CHEM, V274, P24080, DOI 10.1074/jbc.274.34.24080; KU DD, 1993, AM J PHYSIOL, V265, pH586, DOI 10.1152/ajpheart.1993.265.2.H586; Laklai H, 2009, P NATL ACAD SCI USA, V106, P17769, DOI 10.1073/pnas.0908674106; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Maile LA, 2003, CIRC RES, V93, P925, DOI 10.1161/01.RES.0000101754.33652.B7; Misenheimer TM, 2000, J BIOL CHEM, V275, P40938, DOI 10.1074/jbc.M007022200; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Roberts David D., 1994, Journal of Tissue Culture Methods, V16, P217, DOI 10.1007/BF01540654; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Subramanian S, 2007, J BIOL CHEM, V282, P1805, DOI 10.1074/jbc.M603923200; Sun J, 2009, AM J PHYSIOL-HEART C, V296, pH43, DOI 10.1152/ajpheart.00613.2008; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649; Zhu WF, 2005, J BIOL CHEM, V280, P29543, DOI 10.1074/jbc.M501238200	55	154	162	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38923	38932		10.1074/jbc.M110.172304	http://dx.doi.org/10.1074/jbc.M110.172304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923780	Green Published, hybrid			2022-12-25	WOS:000284941300022
J	Wen, WH; Zhu, F; Zhang, JS; Keum, YS; Zykova, T; Yao, K; Peng, C; Zheng, D; Cho, YY; Ma, WY; Bode, AM; Dong, ZG				Wen, Weihong; Zhu, Feng; Zhang, Jishuai; Keum, Young-Sam; Zykova, Tatyana; Yao, Ke; Peng, Cong; Zheng, Duo; Cho, Yong-Yeon; Ma, Wei-ya; Bode, Ann M.; Dong, Zigang			MST1 Promotes Apoptosis through Phosphorylation of Histone H2AX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-MEDIATED ACTIVATION; STE20-LIKE PROTEIN-KINASE; PROTEOLYTIC ACTIVATION; CHROMATIN CONDENSATION; DNA FRAGMENTATION; DEPENDENT MANNER; UV-IRRADIATION; CELL-DEATH; SERINE 139; C DELTA	MST1 (mammalian STE20-like kinase 1) is a serine/threonine kinase that is cleaved and activated by caspases during apoptosis. Overexpression of MST1 induces apoptotic morphological changes such as chromatin condensation, but the mechanism is not clear. Here we show that MST1 induces apoptotic chromatin condensation through its phosphorylation of histone H2AX at Ser-139. During etoposide-induced apoptosis in Jurkat cells, the cleavage of MST1 directly corresponded with strong H2AX phosphorylation. In vitro kinase assay results showed that MST1 strongly phosphorylates histone H2AX. Western blot and kinase assay results with a mutant S139A H2AX confirmed that MST1 phosphorylates H2AX at Ser-139. Direct binding of MST1 and H2AX can be detected when co-expressed in HEK293 cells and was also confirmed by an endogenous immunoprecipitation study. When overexpressed in HeLa cells, both the MST1 full-length protein and the MST1 kinase domain (MST1-NT), but not the kinase-negative mutant (MST1-NT-KN), could induce obvious endogenous histone H2AX phosphorylation. The caspase-3 inhibitor benzyloxycarbonyl-DEVD-fluoromethyl ketone (Z-DEVD-fmk) attenuates phosphorylation of H2AX by MST1 but cannot inhibit MST1-NT-induced histone H2AX phosphorylation, indicating that cleaved MST1 is responsible for H2AX phosphorylation during apoptosis. Histone H2AX phosphorylation and DNA fragmentation were suppressed in MST1 knockdown Jurkat cells after etoposide treatment. Taken together, our data indicated that H2AX is a substrate of MST1, which functions to induce apoptotic chromatin condensation and DNA fragmentation.	[Wen, Weihong; Zhu, Feng; Zhang, Jishuai; Keum, Young-Sam; Zykova, Tatyana; Yao, Ke; Peng, Cong; Zheng, Duo; Cho, Yong-Yeon; Ma, Wei-ya; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/C-1303-2010; Cho, Yong-Yeon/AAD-4263-2020; ZHU, Feng/G-3567-2010; peng, cong/A-9454-2012; 温, 家琦/GYV-3177-2022	Cho, Yong-Yeon/0000-0003-1107-2651; Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA077646, CA027502, CA111536, CA120388, R37CA081064, ES017548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA120388, R37CA081064, R01CA077646, R01CA111536, P01CA027502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, CA027502, CA111536, CA120388, R37CA081064, and ES017548 (to Z. D.) and by The Hormel Foundation.	Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Huang X, 2004, CYTOM PART A, V58A, P99, DOI 10.1002/cyto.a.20018; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kakeya H, 1998, CANCER RES, V58, P4888; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Lu ML, 1996, P NATL ACAD SCI USA, V93, P8977, DOI 10.1073/pnas.93.17.8977; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reszka AA, 1999, J BIOL CHEM, V274, P34967, DOI 10.1074/jbc.274.49.34967; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smith GCM, 1999, MOL CELL BIOL, V19, P6076; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Watabe M, 1999, ONCOGENE, V18, P5211, DOI 10.1038/sj.onc.1202901; Watabe M, 2000, J BIOL CHEM, V275, P8766, DOI 10.1074/jbc.275.12.8766; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	44	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39108	39116		10.1074/jbc.M110.151753	http://dx.doi.org/10.1074/jbc.M110.151753			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20921231	hybrid, Green Published			2022-12-25	WOS:000284941300041
J	Baggaley, RF; Burgin, J; Campbell, OMR				Baggaley, Rebecca F.; Burgin, Joanna; Campbell, Oona M. R.			The Potential of Medical Abortion to Reduce Maternal Mortality in Africa: What Benefits for Tanzania and Ethiopia?	PLOS ONE			English	Article							VAGINAL MISOPROSTOL; COST-EFFECTIVENESS; UTERINE RUPTURE; TERMINATION; PREGNANCY; MIFEPRISTONE; INTERVENTIONS; MORBIDITY; ATTITUDES; EFFICACY	Background: Unsafe abortion is estimated to account for 13% of maternal mortality globally. Medical abortion is a safe alternative. Methods: By estimating mortality risks for unsafe and medical abortion and childbirth for Tanzania and Ethiopia, we modelled changes in maternal mortality that are achievable if unsafe abortion were replaced by medical abortion. We selected Ethiopia and Tanzania because of their high maternal mortality ratios (MMRatios) and contrasting situations regarding health care provision and abortion legislation. We focused on misoprostol-only regimens due to the drug's low cost and accessibility. We included the impact of medical abortion on women who would otherwise choose unsafe abortion and on women with unwanted/mistimed pregnancies who would otherwise carry to term. Results: Thousands of lives could be saved each year in each country by implementing medical abortion using misoprostol (2122 in Tanzania and 2551 in Ethiopia assuming coverage equals family planning services levels: 56% for Tanzania, 31% for Ethiopia). Changes in MMRatios would be less pronounced because the intervention would also affect national birth rates. Conclusions: This is the first analysis of impact of medical abortion provision which takes into account additional potential users other than those currently using unsafe abortion. Thousands of women's lives could be saved, but this may not be reflected in as substantial changes in MMRatios because of medical abortion's demographic impact. Therefore policy makers must be aware of the inability of some traditional measures of maternal mortality to detect the real benefits offered by such an intervention.	[Baggaley, Rebecca F.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Burgin, Joanna] Marie Stopes Int, Med Dev Team, London, England; [Campbell, Oona M. R.] London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth, Infect Dis Epidemiol Unit, London WC1, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Baggaley, RF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	r.baggaley@imperial.ac.uk		Baggaley, Rebecca/0000-0002-4688-3924; Campbell, Oona/0000-0002-9311-0115	Wellcome Trust [GR082623MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	RFB thanks the Wellcome Trust (www.wellcome.ac.uk) for funding [GR082623MA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*A GUTM I, 1999, SHAR RESP WOM; Bankole A, 2008, J BIOSOC SCI, V40, P247, DOI 10.1017/S0021932007002283; BARBOSA RM, 1993, STUD FAMILY PLANN, V24, P236, DOI 10.2307/2939191; Bartlett LA, 2004, OBSTET GYNECOL, V103, P729, DOI 10.1097/01.AOG.0000116260.81570.60; Berer M, 2005, REPROD HEALTH MATTER, V13, P25, DOI 10.1016/S0968-8080(05)26204-3; Berer M, 2009, B WORLD HEALTH ORGAN, V87, P58, DOI 10.2471/BLT.07.050138; Bhattacharjee N, 2008, AUST NZ J OBSTET GYN, V48, P165, DOI 10.1111/j.1479-828X.2008.00831.x; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Billings DL, 2004, REPROD HEALTH MATTER, V12, P57, DOI 10.1016/S0968-8080(04)24010-1; Carbonell JLL, 2001, CONTRACEPTION, V63, P131, DOI 10.1016/S0010-7824(01)00189-5; Carbonell JLL, 1997, CONTRACEPTION, V55, P165, DOI 10.1016/S0010-7824(97)00020-6; Central Statistical Agency [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; COSTA SH, 1993, LANCET, V341, P1258, DOI 10.1016/0140-6736(93)91156-G; Coyaji K, 2002, CONTRACEPTION, V66, P33, DOI 10.1016/S0010-7824(02)00309-8; Creinin Mitchell D., 2000, American Journal of Obstetrics and Gynecology, V183, pS3; Fernandez MM, 2009, INT J GYNECOL OBSTET, V105, P180, DOI 10.1016/j.ijgo.2008.12.016; GEBRESELASSIE H, 2002, RESPONDING UNSAFE AB; Gebreselassie H, 2010, INT PERSPECT SEX R H, V36, P6, DOI 10.1363/ipsrh.36.006.10; Goyal V, 2009, OBSTET GYNECOL, V113, P1117, DOI 10.1097/AOG.0b013e31819dbfe2; Grimes DA, 2005, CONTRACEPTION, V71, P161, DOI 10.1016/j.contraception.2004.12.001; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Grossman D, 2008, REPROD HEALTH MATTER, V16, P173, DOI 10.1016/S0968-8080(08)31379-2; Hajri Selma, 2004, Afr J Reprod Health, V8, P63, DOI 10.2307/3583307; Hamoda H, 2005, CONTRACEPTION, V71, P327, DOI 10.1016/j.contraception.2004.10.015; Harper CC, 2007, INT J GYNECOL OBSTET, V98, P66, DOI 10.1016/j.ijgo.2007.03.009; Harries J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-296; Harrison A, 2000, HEALTH POLICY PLANN, V15, P424, DOI 10.1093/heapol/15.4.424; Henshaw SK, 1999, INT FAM PLAN PERSPEC, V25, pS30, DOI 10.2307/2991869; Hu D, 2009, BJOG-INT J OBSTET GY, V116, P768, DOI 10.1111/j.1471-0528.2009.02142.x; Hu D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000750; Jain JK, 2002, HUM REPROD, V17, P1477, DOI 10.1093/humrep/17.6.1477; Jowett M, 2000, HEALTH POLICY, V53, P201, DOI 10.1016/S0168-8510(00)00089-0; Kahn JG, 2000, CONTRACEPTION, V61, P29, DOI 10.1016/S0010-7824(99)00115-8; Kapp N, 2007, OBSTET GYNECOL, V110, P1304, DOI 10.1097/01.AOG.0000289577.32274.a5; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Levin C, 2009, REPROD HEALTH MATTER, V17, P120, DOI 10.1016/S0968-8080(09)33432-1; Lovold A, 2008, INT J GYNECOL OBSTET, V103, P276, DOI 10.1016/j.ijgo.2008.08.009; Majoko F, 2002, INT J GYNECOL OBSTET, V76, P77, DOI 10.1016/S0020-7292(01)00553-7; Miller S, 2005, BJOG-INT J OBSTET GY, V112, P1291, DOI 10.1111/j.1471-0528.2005.00704.x; Morhe ESK, 2007, INT J GYNECOL OBSTET, V98, P70, DOI 10.1016/j.ijgo.2007.02.023; Mundle S, 2007, CONTRACEPTION, V76, P66, DOI 10.1016/j.contraception.2007.03.010; *NBS TANZ ORC MACR, 2005, TANZ DEM HLTH SURV 2; Ngoc NTN, 1999, INT FAM PLAN PERSPEC, V25, P10, DOI 10.2307/2991896; Prata N, 2009, HEALTH POLICY, V89, P131, DOI 10.1016/j.healthpol.2008.05.007; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Turner KL, 2008, REPROD HEALTH MATTER, V16, P108, DOI 10.1016/S0968-8080(08)31389-5; *UN, 2009, STAT DEM YB; *UN, UN WEBS MILL DEV GOA; *UN, 2007, AB POL GLOB VIEW; United Nations, 2008, MILL DEV GOALS REP; von Hertzen H, 2007, LANCET, V369, P1938, DOI 10.1016/S0140-6736(07)60914-3; Warriner IK., 2006, PREVENTING UNSAFE AB; *WHO, MAT MORT 2005 EST DE; *WHO, 1994, WHOFSEMSM9411; Willmott FJ, 2008, BJOG-INT J OBSTET GY, V115, P1575, DOI 10.1111/j.1471-0528.2008.01928.x; Winikoff B, 1997, INT FAM PLAN PERSPEC, V23, P73, DOI 10.2307/2950827; *WORLD BANK, 2007, NHP DISC PAP POP ISS; World Health Organization, 2004, UNS AB GLOB REG EST	58	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13260	10.1371/journal.pone.0013260	http://dx.doi.org/10.1371/journal.pone.0013260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	661SK	20948995	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000282748100010
J	Christensen, MS; Lundbye-Jensen, J; Grey, MJ; Vejlby, AD; Belhage, B; Nielsen, JB				Christensen, Mark Schram; Lundbye-Jensen, Jesper; Grey, Michael James; Vejlby, Alexandra Damgaard; Belhage, Bo; Nielsen, Jens Bo			Illusory Sensation of Movement Induced by Repetitive Transcranial Magnetic Stimulation	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; SOMATOSENSORY CORTEX; MOTOR CORTEX; SENSE; CONSEQUENCES; CEREBELLUM; READINESS; INTENTION; VARIANCE; FEEDBACK	Human movement sense relies on both somatosensory feedback and on knowledge of the motor commands used to produce the movement. We have induced a movement illusion using repetitive transcranial magnetic stimulation over primary motor cortex and dorsal premotor cortex in the absence of limb movement and its associated somatosensory feedback. Afferent and efferent neural signalling was abolished in the arm with ischemic nerve block, and in the leg with spinal nerve block. Movement sensation was assessed following trains of high-frequency repetitive transcranial magnetic stimulation applied over primary motor cortex, dorsal premotor cortex, and a control area (posterior parietal cortex). Magnetic stimulation over primary motor cortex and dorsal premotor cortex produced a movement sensation that was significantly greater than stimulation over the control region. Movement sensation after dorsal premotor cortex stimulation was less affected by sensory and motor deprivation than was primary motor cortex stimulation. We propose that repetitive transcranial magnetic stimulation over dorsal premotor cortex produces a corollary discharge that is perceived as movement.	[Christensen, Mark Schram; Lundbye-Jensen, Jesper; Grey, Michael James; Nielsen, Jens Bo] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Christensen, Mark Schram] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, DK-2650 Hvidovre, Denmark; [Christensen, Mark Schram; Lundbye-Jensen, Jesper; Grey, Michael James; Nielsen, Jens Bo] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Vejlby, Alexandra Damgaard] Herlev Hosp, Dept Anaesthesiol, DK-2730 Herlev, Denmark; [Belhage, Bo] Bispebjerg Hosp, Dept Anaesthesiol, DK-2400 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital	Christensen, MS (corresponding author), Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark.	markc@drcmr.dk	Grey, Michael J/B-4029-2011; Lundbye-Jensen, Jesper/ABH-4025-2020; Nielsen, Jens Bo/C-7632-2015	Lundbye-Jensen, Jesper/0000-0003-3144-861X; Nielsen, Jens Bo/0000-0001-5568-2916	Danish Medical Research Council [09-062846/FSS]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Danish Medical Research Council (09-062846/FSS) (http://www.fi.dk/). The Simon Spies Foundation donated the MR-scanner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMASSIAN VE, 1989, BRAIN RES, V479, P355, DOI 10.1016/0006-8993(89)91640-5; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; BRASILNETO JP, 1992, NEUROLOGY, V42, P1302, DOI 10.1212/WNL.42.7.1302; BROMAGE PR, 1964, BRIT J ANAESTH, V36, P342, DOI 10.1093/bja/36.6.342; Christensen MS, 2007, NAT NEUROSCI, V10, P417, DOI 10.1038/nn1873; Christensen MS, 2007, CEREB CORTEX, V17, P1906, DOI 10.1093/cercor/bhl101; Cotterill RMJ, 2001, PROG NEUROBIOL, V64, P1, DOI 10.1016/S0301-0082(00)00058-7; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Ellaway PH, 2004, J PHYSIOL-LONDON, V556, P651, DOI 10.1113/jphysiol.2003.060483; FRIED I, 1991, J NEUROSCI, V11, P3656; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; Gandevia SC, 2002, ADV EXP MED BIOL, V508, P61; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Holmes G, 1917, BRAIN, V40, P461, DOI 10.1093/brain/40.4.461; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; LIBET B, 1964, J NEUROPHYSIOL, V27, P546, DOI 10.1152/jn.1964.27.4.546; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 2003, NEUROREPORT, V14, P2135, DOI 10.1097/00001756-200312020-00001; SADATO N, 1995, ANN NEUROL, V37, P74, DOI 10.1002/ana.410370114; Scarff JE, 1940, ARCH NEURO PSYCHIATR, V44, P243, DOI 10.1001/archneurpsyc.1940.02280080003001; Schwartz AB, 2004, SCIENCE, V303, P380, DOI 10.1126/science.1087788; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503	29	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13301	10.1371/journal.pone.0013301	http://dx.doi.org/10.1371/journal.pone.0013301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948962	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000282748100027
J	Hellens, RP; Moreau, C; Lin-Wang, K; Schwinn, KE; Thomson, SJ; Fiers, MWEJ; Frew, TJ; Murray, SR; Hofer, JMI; Jacobs, JME; Davies, KM; Allan, AC; Bendahmane, A; Coyne, CJ; Timmerman-Vaughan, GM; Ellis, THN				Hellens, Roger P.; Moreau, Carol; Lin-Wang, Kui; Schwinn, Kathy E.; Thomson, Susan J.; Fiers, Mark W. E. J.; Frew, Tonya J.; Murray, Sarah R.; Hofer, Julie M. I.; Jacobs, Jeanne M. E.; Davies, Kevin M.; Allan, Andrew C.; Bendahmane, Abdelhafid; Coyne, Clarice J.; Timmerman-Vaughan, Gail M.; Ellis, T. H. Noel			Identification of Mendel's White Flower Character	PLOS ONE			English	Article							SEQUENCE; PEA; ALIGNMENT; GENOME; FAMILY; GENES; EXPRESSION; EVOLUTION; GENETICS; ENCODES	Background: The genetic regulation of flower color has been widely studied, notably as a character used by Mendel and his predecessors in the study of inheritance in pea. Methodology/Principal Findings: We used the genome sequence of model legumes, together with their known synteny to the pea genome to identify candidate genes for the A and A2 loci in pea. We then used a combination of genetic mapping, fast neutron mutant analysis, allelic diversity, transcript quantification and transient expression complementation studies to confirm the identity of the candidates. Conclusions/Significance: We have identified the pea genes A and A2. A is the factor determining anthocyanin pigmentation in pea that was used by Gregor Mendel 150 years ago in his study of inheritance. The A gene encodes a bHLH transcription factor. The white flowered mutant allele most likely used by Mendel is a simple G to A transition in a splice donor site that leads to a mis-spliced mRNA with a premature stop codon, and we have identified a second rare mutant allele. The A2 gene encodes a WD40 protein that is part of an evolutionarily conserved regulatory complex.	[Hellens, Roger P.; Lin-Wang, Kui; Allan, Andrew C.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand; [Moreau, Carol; Hofer, Julie M. I.; Ellis, T. H. Noel] John Innes Ctr Plant Sci Res, Dept Crop Genet, Norwich NR4 7UH, Norfolk, England; [Schwinn, Kathy E.; Davies, Kevin M.] New Zealand Inst Plant & Food Res Ltd, Palmerston North, New Zealand; [Thomson, Susan J.; Fiers, Mark W. E. J.; Frew, Tonya J.; Murray, Sarah R.; Jacobs, Jeanne M. E.; Timmerman-Vaughan, Gail M.] New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand; [Coyne, Clarice J.] Washington State Univ, USDA ARS, Western Reg Plant Intro Stn, Pullman, WA 99164 USA; [Bendahmane, Abdelhafid] URGV, Evry, France	New Zealand Institute for Plant & Food Research Ltd; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; United States Department of Agriculture (USDA); Washington State University; UDICE-French Research Universities; Universite Paris Saclay	Hellens, RP (corresponding author), New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand.	noel.ellis@bbsrc.ac.uk	Fiers, Mark WEJ/E-6755-2010; Allan, Andrew C/L-3253-2016; Schwinn, Kathy/S-4662-2017; Timmerman-Vaughan, Gail/J-7574-2013	Fiers, Mark WEJ/0000-0001-5694-2409; Allan, Andrew C/0000-0003-1944-7067; Schwinn, Kathy/0000-0002-6337-3627; Moreau, Carol/0000-0001-5826-3928; Jacobs, Jeanne/0000-0002-1047-1039; Thomson, Susan/0000-0001-7127-9414; Hofer, Julie/0000-0002-0158-7574; Ellis, Thomas Henry Noel/0000-0001-6726-9950; Davies, Kevin/0000-0001-5652-5015; Timmerman-Vaughan, Gail/0000-0001-5538-6383; Hellens, Roger/0000-0003-2094-0887	Foundation for Research, Science and Technology, New Zealand; Biotechnology and Biological Science Research Council, United Kingdom; Department for Environment, Food and Rural Affairs [AR0711]; EU [FOOD-CT-2004-506223]	Foundation for Research, Science and Technology, New Zealand(New Zealand Foundation for Research, Science and Technology); Biotechnology and Biological Science Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); EU(European Commission)	R.P.H. and co-workers were funded by The Foundation for Research, Science and Technology, New Zealand. T.H.N.E. and co-workers were funded by the Biotechnology and Biological Science Research Council, United Kingdom and acknowledge support from the Department for Environment, Food and Rural Affairs (AR0711) and the EU FP6 project 'Grain Legumes' FOOD-CT-2004-506223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Cannon SB, 2006, P NATL ACAD SCI USA, V103, P14959, DOI 10.1073/pnas.0603228103; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Chung BYW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-120; Coyne CJ, 2007, GENOME, V50, P871, DOI 10.1139/G07-063; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DECRESCENZI P, 1805, RURALIA COMMODA COMM, P239; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; Fisher R. A., 1936, Ann Sci London, V1, P115, DOI 10.1080/00033793600200111; GOODRICH J, 1992, CELL, V68, P955, DOI 10.1016/0092-8674(92)90038-E; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; HARKER CL, 1990, PLANT CELL, V2, P185, DOI 10.1105/tpc.2.3.185; Hofer J, 2009, PLANT CELL, V21, P420, DOI 10.1105/tpc.108.064071; Jing RC, 2005, GENETICS, V171, P741, DOI 10.1534/genetics.105.045112; Jing RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-44; Kalo P, 2004, MOL GENET GENOMICS, V272, P235, DOI 10.1007/s00438-004-1055-z; Knight T.A., 1799, PHILOS T R SOC LOND, V89, P195, DOI [10.1098/rstl.1799.0013, DOI 10.1098/RSTL.1799.0013]; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Laucou V, 1998, THEOR APPL GENET, V97, P905, DOI 10.1007/s001220050971; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Marx G.A., 1989, PISUM NEWSL, V21, P35; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Olby R., 1985, ORIGINS MENDELISM; OROZCO BM, 1993, PLANT PHYSIOL, V102, P227, DOI 10.1104/pp.102.1.227; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Spelt C, 2002, PLANT CELL, V14, P2121, DOI 10.1105/tpc.003772; Uimari A, 1998, MOL GEN GENET, V257, P198, DOI 10.1007/s004380050639	36	81	88	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13230	10.1371/journal.pone.0013230	http://dx.doi.org/10.1371/journal.pone.0013230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949001	Green Submitted, gold, Green Published			2022-12-25	WOS:000282748100004
J	Liu, M; Haataja, L; Wright, J; Wickramasinghe, NP; Hua, QX; Phillips, NF; Barbetti, F; Weiss, MA; Arvan, P				Liu, Ming; Haataja, Leena; Wright, Jordan; Wickramasinghe, Nalinda P.; Hua, Qing-Xin; Phillips, Nelson F.; Barbetti, Fabrizio; Weiss, Michael A.; Arvan, Peter			Mutant INS-Gene Induced Diabetes of Youth: Proinsulin Cysteine Residues Impose Dominant-Negative Inhibition on Wild-Type Proinsulin Transport	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELLS; INSULIN-GENE; B-CHAIN; GLUCOSE-HOMEOSTASIS; SECRETORY PATHWAY; MOLECULAR-BIOLOGY; MAMMALIAN-CELLS; MUTATIONS; PROTEIN	Recently, a syndrome of Mutant INS-gene-induced Diabetes of Youth (MIDY, derived from one of 26 distinct mutations) has been identified as a cause of insulin-deficient diabetes, resulting from expression of a misfolded mutant proinsulin protein in the endoplasmic reticulum (ER) of insulin-producing pancreatic beta cells. Genetic deletion of one, two, or even three alleles encoding insulin in mice does not necessarily lead to diabetes. Yet MIDY patients are INS-gene heterozygotes; inheritance of even one MIDY allele, causes diabetes. Although a favored explanation for the onset of diabetes is that insurmountable ER stress and ER stress response from the mutant proinsulin causes a net loss of beta cells, in this report we present three surprising and interlinked discoveries. First, in the presence of MIDY mutants, an increased fraction of wild-type proinsulin becomes recruited into nonnative disulfide-linked protein complexes. Second, regardless of whether MIDY mutations result in the loss, or creation, of an extra unpaired cysteine within proinsulin, Cys residues in the mutant protein are nevertheless essential in causing intracellular entrapment of co-expressed wild-type proinsulin, blocking insulin production. Third, while each of the MIDY mutants induces ER stress and ER stress response; ER stress and ER stress response alone appear insufficient to account for blockade of wild-type proinsulin. While there is general agreement that ultimately, as diabetes progresses, a significant loss of beta cell mass occurs, the early events described herein precede cell death and loss of beta cell mass. We conclude that the molecular pathogenesis of MIDY is initiated by perturbation of the disulfide-coupled folding pathway of wild-type proinsulin.	[Liu, Ming; Haataja, Leena; Wright, Jordan; Arvan, Peter] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Wickramasinghe, Nalinda P.; Hua, Qing-Xin; Phillips, Nelson F.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Barbetti, Fabrizio] Bambino Gesu Pediat Hosp, Lab Mol Endocrinol & Metab, Sci Inst IRCCS, Rome, Italy; [Barbetti, Fabrizio] Univ Tor Vergata, Dept Internal Med, Rome, Italy	University of Michigan System; University of Michigan; Case Western Reserve University; IRCCS Bambino Gesu; University of Rome Tor Vergata	Liu, M (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	michael.weiss@case.edu; parvan@umich.edu	Wright, Jordan/AAO-4376-2021; Barbetti, Fabrizio/AAK-9106-2021; Barbetti, Fabrizio/I-7351-2018; Wickramasinghe, Nalinda P/F-9465-2010	Wright, Jordan/0000-0002-2043-0150; Barbetti, Fabrizio/0000-0003-4687-980X; Barbetti, Fabrizio/0000-0003-4687-980X; Wickramasinghe, Nalinda P./0000-0002-8700-2775	National Institutes of Health (NIH) [R01 DK48280]; Molecular Biology DNA Sequencing Core of the Michigan Diabetes Research and Training Center [P60 DK20572]; University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069764, P60DK020572, R01DK048280] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biology DNA Sequencing Core of the Michigan Diabetes Research and Training Center; University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported primarily by National Institutes of Health (NIH) R01 DK48280 (to P.A.), and also by a pilot and feasibility grant (to M.L.) and the Molecular Biology and DNA Sequencing Core of the Michigan Diabetes Research and Training Center (P60 DK20572). The authors gratefully acknowledge William and Dolores Brehm for their general support of diabetes research at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaya N, 2006, DIABETOLOGIA, V49, P1222, DOI 10.1007/s00125-006-0241-4; BARBETTI F, 1990, J CLIN ENDOCR METAB, V71, P164, DOI 10.1210/jcem-71-1-164; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Duvillie B, 2002, ENDOCRINOLOGY, V143, P1530, DOI 10.1210/en.143.4.1530; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Feng LJ, 2003, J BIOL CHEM, V278, P31486, DOI 10.1074/jbc.M305690200; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; GUPTA S, 2010, DIABETES IN PRESS; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hodish I, 2010, J BIOL CHEM, V285, P685, DOI 10.1074/jbc.M109.038042; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1993, P NATL ACAD SCI USA, V90, P582, DOI 10.1073/pnas.90.2.582; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; HUANG XF, 1994, J BIOL CHEM, V269, P20838; INOUYE K, 1979, J AM CHEM SOC, V101, P751, DOI 10.1021/ja00497a051; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Kayo T, 1998, J CLIN INVEST, V101, P2112, DOI 10.1172/JCI1842; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Leroux Loic, 2003, Int J Exp Diabesity Res, V4, P7; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; LIU M, 2010, TRENDS ENDO IN PRESS; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Marchand A, 2006, J BIOL CHEM, V281, P19124, DOI 10.1074/jbc.M602157200; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Matveyenko AV, 2009, DIABETES, V58, P906, DOI 10.2337/db08-1464; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; Polak M, 2008, DIABETES, V57, P1115, DOI 10.2337/db07-1358; Rajan S, 2010, AM J PHYSIOL-ENDOC M, V298, pE403, DOI 10.1152/ajpendo.00592.2009; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Steiner DF, 2009, DIABETES OBES METAB, V11, P189, DOI 10.1111/j.1463-1326.2009.01106.x; Steiner DF, 1997, SCIENCE, V277, P531, DOI 10.1126/science.277.5325.531; STEINER DF, 1992, DIABETOLOGIA, V35, pS41, DOI 10.1007/BF00586278; STEINER DF, 1990, DIABETES CARE, V13, P600, DOI 10.2337/diacare.13.6.600; STOY J, 2008, PEDIAT DIABETES; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; VINIK A, 1988, HORM METAB RES, V20, P1, DOI 10.1055/s-2007-1010736; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang BY, 2003, J BIOL CHEM, V278, P3687, DOI 10.1074/jbc.M209474200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	64	85	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13333	10.1371/journal.pone.0013333	http://dx.doi.org/10.1371/journal.pone.0013333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948967	Green Submitted, gold, Green Published			2022-12-25	WOS:000282748100032
J	Milhiet, PE; Yamamoto, D; Berthoumieu, O; Dosset, P; Le Grimellec, C; Verdier, JM; Marchal, S; Ando, T				Milhiet, Pierre-Emmanuel; Yamamoto, Daisuke; Berthoumieu, Olivia; Dosset, Patrice; Le Grimellec, Christian; Verdier, Jean-Michel; Marchal, Stephane; Ando, Toshio			Deciphering the Structure, Growth and Assembly of Amyloid-Like Fibrils Using High-Speed Atomic Force Microscopy	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; IN-VITRO; SUPRAMOLECULAR ASSEMBLIES; BIOMOLECULAR PROCESSES; HUMAN LITHOSTATHINE; CALCIUM-CARBONATE; CRYSTAL-STRUCTURE; PROTEIN FIBRILS; ALPHA-SYNUCLEIN	Formation of fibrillar structures of proteins that deposit into aggregates has been suggested to play a key role in various neurodegenerative diseases. However mechanisms and dynamics of fibrillization remains to be elucidated. We have previously established that lithostathine, a protein overexpressed in the pre-clinical stages of Alzheimer's disease and present in the pathognomonic lesions associated with this disease, form fibrillar aggregates after its N-terminal truncation. In this paper we visualized, using high-speed atomic force microscopy (HS-AFM), growth and assembly of lithostathine protofibrils under physiological conditions with a time resolution of one image/s. Real-time imaging highlighted a very high velocity of elongation. Formation of fibrils via protofibril lateral association and stacking was also monitored revealing a zipper-like mechanism of association. We also demonstrate that, like other amyloid beta peptides, two lithostathine protofibrils can associate to form helical fibrils. Another striking finding is the propensity of the end of a growing protofibril or fibril to associate with the edge of a second fibril, forming false branching point. Taken together this study provides new clues about fibrillization mechanism of amyloid proteins.	[Milhiet, Pierre-Emmanuel; Berthoumieu, Olivia; Dosset, Patrice; Le Grimellec, Christian] INSERM, U554, Montpellier, France; [Milhiet, Pierre-Emmanuel; Berthoumieu, Olivia; Dosset, Patrice; Le Grimellec, Christian] Univ Montpellier, CNRS, UMR 5048, Ctr Biochim Struct, F-34059 Montpellier, France; [Yamamoto, Daisuke; Ando, Toshio] Kanazawa Univ, Dept Phys, Grad Sch Sci & Technol, Kanazawa, Ishikawa 920, Japan; [Verdier, Jean-Michel; Marchal, Stephane] INSERM, U710, Montpellier, France; [Verdier, Jean-Michel; Marchal, Stephane] Univ Montpellier 2, Montpellier, France; [Verdier, Jean-Michel; Marchal, Stephane] EPHE, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Kanazawa University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Milhiet, PE (corresponding author), INSERM, U554, Montpellier, France.	pem@cbs.cnrs.fr	MARCHAL, stéphane/M-4324-2017; ANDO, Toshio/E-7054-2015	MARCHAL, stéphane/0000-0002-1101-7890; ANDO, Toshio/0000-0001-8819-154X; VERDIER, Jean-Michel/0000-0002-7252-1556; Milhiet, Pierre-Emmanuel/0000-0002-0410-5956	Agence Nationale de la Recherche (ANR); Physique et Chimie du Vivant (PCV); Core Research for Evolutional Science and Technology/Japan Science and Technology Agency)(CREST/JST);  [AFM-MB-PROT];  [HS-Bio-AFM]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Physique et Chimie du Vivant (PCV); Core Research for Evolutional Science and Technology/Japan Science and Technology Agency)(CREST/JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); ; 	This work was supported by the Agence Nationale de la Recherche (ANR), Physique et Chimie du Vivant (PCV) program, grant #AFM-MB-PROT and #HS-Bio-AFM, and by Core Research for Evolutional Science and Technology/Japan Science and Technology Agency)(CREST/JST, DY and TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CB, 2009, BIOPHYS J, V96, P1529, DOI 10.1016/j.bpj.2008.11.024; Ando T, 2008, PFLUG ARCH EUR J PHY, V456, P211, DOI 10.1007/s00424-007-0406-0; Ando T, 2007, J MOL RECOGNIT, V20, P448, DOI 10.1002/jmr.843; BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024; BERNARD JP, 1992, GASTROENTEROLOGY, V103, P1277, DOI 10.1016/0016-5085(92)91516-7; Bertrand JA, 1996, EMBO J, V15, P2678, DOI 10.1002/j.1460-2075.1996.tb00628.x; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; Cerini C, 1999, J BIOL CHEM, V274, P22266, DOI 10.1074/jbc.274.32.22266; DECARO A, 1979, BIOCHEM BIOPH RES CO, V87, P1176, DOI 10.1016/S0006-291X(79)80031-5; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; Fay N, 2003, J BIOL CHEM, V278, P30199, DOI 10.1074/jbc.M303000200; Geider S, 1996, CALCIFIED TISSUE INT, V59, P33, DOI 10.1007/s002239900082; Gerbaud V, 2000, J BIOL CHEM, V275, P1057, DOI 10.1074/jbc.275.2.1057; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Gregoire C, 2001, EMBO J, V20, P3313, DOI 10.1093/emboj/20.13.3313; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Karsai A, 2008, EUR BIOPHYS J BIOPHY, V37, P1133, DOI 10.1007/s00249-007-0253-0; Kellermayer MSZ, 2008, P NATL ACAD SCI USA, V105, P141, DOI 10.1073/pnas.0704305105; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Laurine E, 2003, J BIOL CHEM, V278, P51770, DOI 10.1074/jbc.M306767200; Lee BI, 2003, J BIOL INORG CHEM, V8, P341, DOI 10.1007/s00775-002-0421-8; Mauro V, 2008, HISTOL HISTOPATHOL, V23, P1195, DOI 10.14670/HH-23.1195; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Mesquida P, 2007, J MATER SCI-MATER M, V18, P1325, DOI 10.1007/s10856-006-0075-0; Moreno-Herrero F, 2004, BIOPHYS J, V86, P517, DOI 10.1016/S0006-3495(04)74130-2; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Paulson HL, 2000, BRAIN PATHOL, V10, P293, DOI 10.1111/j.1750-3639.2000.tb00263.x; PERFETTI R, 1994, TRANSPLANT P, V26, P733; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Pignol D, 1995, PROTEINS, V23, P604, DOI 10.1002/prot.340230418; Ranson N, 2006, PROTEIN SCI, V15, P2481, DOI 10.1110/ps.062215206; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sekikawa A, 2005, GUT, V54, P1437, DOI 10.1136/gut.2004.053587; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Walker LC, 2000, NEUROBIOL AGING, V21, P559, DOI 10.1016/S0197-4580(00)00160-3; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n	50	53	53	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13240	10.1371/journal.pone.0013240	http://dx.doi.org/10.1371/journal.pone.0013240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949034	Green Published, gold			2022-12-25	WOS:000282676700014
J	Oliveira, LJ; McClellan, S; Hansen, PJ				Oliveira, Lilian J.; McClellan, Steve; Hansen, Peter J.			Differentiation of the Endometrial Macrophage during Pregnancy in the Cow	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; HUMAN DECIDUAL MACROPHAGES; PHENOTYPIC CHARACTERIZATION; TRANSENDOTHELIAL MIGRATION; ALTERNATIVE ACTIVATION; MONONUCLEAR PHAGOCYTES; GENE-EXPRESSION; BOVINE; CELLS; PLACENTATION	Background: The presence of conceptus alloantigens necessitates changes in maternal immune function. One player in this process may be the macrophage. In the cow, there is large-scale recruitment of macrophages expressing CD68 and CD14 to the uterine endometrium during pregnancy. Methodology/Principal Findings: In the present study, the function of endometrial macrophages during pregnancy was inferred by comparison of the transcriptome of endometrial CD14(+) cells isolated from pregnant cows as compared to that of blood CD14(+) cells. The pattern of gene expression was largely similar for CD14(+) cells from both sources, suggesting that cells from both tissues are from the monocyte/macrophage lineage. A total of 1,364 unique genes were differentially expressed, with 680 genes upregulated in endometrial CD14(+) cells as compared to blood CD14(+) cells and with 674 genes downregulated in endometrial CD14(+) cells as compared to blood CD14(+) cells. Twelve genes characteristic of M2 activated macrophages (SLCO2B1, GATM, MRC1, ALDH1A1, PTGS1, RNASE6, CLEC7A, DPEP2, CD163, CCL22, CCL24, and CDH1) were upregulated in endometrial CD14(+) cells. M2 macrophages play roles in immune regulation, tissue remodeling, angiogenesis and apoptosis. Consistent with a role in tissue remodeling, there was overrepresentation of differentially expressed genes in endometrium for three ontologies related to proteolysis. A role in apoptosis is suggested by the observation that the most overrepresented gene in endometrial CD14(+) cells was GZMA. Conclusions: Results indicate that at least a subpopulation of endometrial macrophages cells differentiates along an M2 activation pathway during pregnancy and that the cells are likely to play roles in immune regulation, tissue remodeling, angiogenesis, and apoptosis.	[Oliveira, Lilian J.; Hansen, Peter J.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Oliveira, Lilian J.; Hansen, Peter J.] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [McClellan, Steve] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Flow Cytometry Core Lab, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Oliveira, LJ (corresponding author), Univ Sao Paulo, Fac Anim Sci & Food Engn, Sao Paulo, Brazil.	Hansen@animal.ufl.edu	Oliveira, Lilian/F-2898-2010; J., Oliveira L./V-9028-2017; Hansen, Peter/AAI-4693-2021	Oliveira, Lilian/0000-0003-1402-8373; J., Oliveira L./0000-0003-1402-8373; Hansen, Peter/0000-0003-3061-9333	University of Florida Foundation	University of Florida Foundation(University of Florida)	Research was supported by the University of Florida Foundation Research Opportunity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2004, AM J REPROD IMMUNOL, V51, P275, DOI 10.1111/j.1600-0897.2004.00156.x; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; AMBRUS JL, 1990, J IMMUNOL, V144, P1549; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chen L, 2009, ENDOCRINOLOGY, V150, P966, DOI 10.1210/en.2008-0571; Cupurdija K, 2004, AM J REPROD IMMUNOL, V51, P117, DOI 10.1046/j.8755-8920.2003.00128.x; Dambaeva SV, 2009, J REPROD IMMUNOL, V80, P57, DOI 10.1016/j.jri.2008.12.006; Davies CJ, 2006, AM J REPROD IMMUNOL, V55, P188, DOI 10.1111/j.1600-0897.2005.00364.x; Davies CJ, 2004, ANIM REPROD SCI, V82-3, P267, DOI 10.1016/j.anireprosci.2004.05.016; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Facciotti PR, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-25; Ferenbach D, 2008, KIDNEY INT, V74, P5, DOI 10.1038/ki.2008.189; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Gomez TM, 2004, NEURON, V42, P1, DOI 10.1016/S0896-6273(04)00188-6; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Green JA, 1998, REV REPROD, V3, P62; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hashizume K, 2007, J REPROD DEVELOP, V53, P1, DOI 10.1262/jrd.18123; Heikkinen J, 2003, CLIN EXP IMMUNOL, V131, P498, DOI 10.1046/j.1365-2249.2003.02092.x; HUNT JS, 1985, J LEUKOCYTE BIOL, V38, P255, DOI 10.1002/jlb.38.2.255; Jensen K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-224; Johnson-Leger CA, 2002, BLOOD, V100, P2479, DOI 10.1182/blood-2001-11-0098; Kim JS, 2007, PLACENTA, V28, P571, DOI 10.1016/j.placenta.2006.07.007; Kim JS, 2006, BLOOD, V108, P1821, DOI 10.1182/blood-2005-10-009191; KING A, 1993, HUM REPROD, V8, P2061, DOI 10.1093/oxfordjournals.humrep.a137982; Kzhyshkowska J, 2008, J IMMUNOL, V180, P3028, DOI 10.4049/jimmunol.180.5.3028; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; Mackler AM, 2000, BIOL REPROD, V62, P1193, DOI 10.1095/biolreprod62.5.1193; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; NODEN DM, 1990, EMBRYOLOGY DOMESTIC; Oliveira LJ, 2008, REPRODUCTION, V136, P481, DOI 10.1530/REP-08-0218; Oliveira LJ, 2009, AM J REPROD IMMUNOL, V62, P418, DOI 10.1111/j.1600-0897.2009.00761.x; Onofre Gabriela, 2009, Acta Medica (Hradec Kralove), V52, P57; Paape MJ, 1996, AM J VET RES, V57, P477; Padua MB, 2010, FASEB J, V24, P526, DOI 10.1096/fj.09-138453; Rosbottom A, 2008, INFECT IMMUN, V76, P2352, DOI 10.1128/IAI.01780-06; Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003; Tekin S, 2004, AM J REPROD IMMUNOL, V51, P56, DOI 10.1046/j.8755-8920.2003.00125.x; Thaxton JE, 2009, J IMMUNOL, V183, P1144, DOI 10.4049/jimmunol.0900788; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598; Williams PJ, 2009, J REPROD IMMUNOL, V82, P24, DOI 10.1016/j.jri.2009.08.001; Yoav B, 1995, J ROY STAT SOC, V57, P289; Young JD, 1999, NAT MED, V5, P1424; Zhang H, 2002, AM J PATHOL, V160, P2219, DOI 10.1016/S0002-9440(10)61169-8	55	53	54	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13213	10.1371/journal.pone.0013213	http://dx.doi.org/10.1371/journal.pone.0013213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949061	gold, Green Published, Green Submitted			2022-12-25	WOS:000282633700011
J	Brahmbhatt, VV; Albert, CJ; Anbukumar, DS; Cunningham, BA; Neumann, WL; Ford, DA				Brahmbhatt, Viral V.; Albert, Carolyn J.; Anbukumar, Dhanalakshmi S.; Cunningham, Bryce A.; Neumann, William L.; Ford, David A.			omega-Oxidation of alpha-Chlorinated Fatty Acids IDENTIFICATION OF alpha-CHLORINATED DICARBOXYLIC ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINYL ETHER BOND; HEREDITARY MYELOPEROXIDASE DEFICIENCY; CORONARY-ARTERY-DISEASE; DENSITY-LIPOPROTEIN; MASS-SPECTROMETRY; LIVER-MICROSOMES; LIPID-METABOLISM; PLASMALOGENS; TARGET; BIOSYNTHESIS	Myeloperoxidase-derived HOCl targets tissue-and lipoprotein-associated plasmalogens to generate alpha-chlorinated fatty aldehydes, including 2-chlorohexadecanal. Under physiological conditions, 2-chlorohexadecanal is oxidized to 2-chlorohexadecanoic acid (2-ClHA). This study demonstrates the catabolism of 2-ClHA by omega-oxidation and subsequent beta-oxidation from the omega-end. Mass spectrometric analyses revealed that 2-ClHA is omega-oxidized in the presence of liver microsomes with initial omega-hydroxylation of 2-ClHA. Subsequent oxidation steps were examined in a human hepatocellular cell line (HepG2). Three different alpha-chlorinated dicarboxylic acids, 2-chlorohexadecane-(1,16)-dioic acid, 2-chlorotetradecane-(1,14)-dioic acid, and 2-chloroadipic acid (2-ClAdA), were identified. Levels of 2-chlorohexadecane-(1,16)-dioic acid, 2-chlorotetradecane-(1,14)-dioic acid, and 2-ClAdA produced by HepG2 cells were dependent on the concentration of 2-ClHA and the incubation time. Synthetic stable isotope-labeled 2-ClHA was used to demonstrate a precursor-product relationship between 2-ClHA and the alpha-chlorinated dicarboxylic acids. We also report the identification of endogenous 2-ClAdA in human and rat urine and elevations in stable isotope-labeled urinary 2-ClAdA in rats subjected to intraperitoneal administration of stable isotope-labeled 2-ClHA. Furthermore, urinary 2-ClAdA and plasma 2-ClHA levels are increased in LPS-treated rats. Taken together, these data show that 2-ClHA is omega-oxidized to generate alpha-chlorinated dicarboxylic acids, which include alpha-chloroadipic acid that is excreted in the urine.	[Brahmbhatt, Viral V.; Albert, Carolyn J.; Anbukumar, Dhanalakshmi S.; Cunningham, Bryce A.; Ford, David A.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Albert, Carolyn J.; Anbukumar, Dhanalakshmi S.; Cunningham, Bryce A.; Ford, David A.] St Louis Univ, Cardiovasc Res Ctr, St Louis, MO 63104 USA; [Neumann, William L.] So Illinois Univ, Dept Pharmaceut Sci, Edwardsville Sch Pharm, Edwardsville, IL 62026 USA	Saint Louis University; Saint Louis University; Southern Illinois University System; Southern Illinois University Edwardsville	Ford, DA (corresponding author), Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	fordda@slu.edu	Ford, David/D-1819-2018	Ford, David/0000-0002-0029-1560	National Institutes of Health [HL074214, HL088073, HL098907, RR019232]; American Heart Association [0650044Z, 0710121Z, 0710163Z]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019232] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074214, R21HL098907, R21HL088073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL074214 (to D.A.F.), HL088073 (to D.A.F.), HL098907 (to D.A.F.), and RR019232 (to D.A.F.). This work was also supported by Grant-in-aid 0650044Z (to D.A.F.) and Predoctoral Fellowship Grants 0710121Z (to V.V.B.) and 0710163Z (to D.S.A.) from the American Heart Association.	Albert CJ, 2002, J BIOL CHEM, V277, P4694, DOI 10.1074/jbc.M110875200; Albert CJ, 2003, J BIOL CHEM, V278, P8942, DOI 10.1074/jbc.M211634200; Albert CJ, 2001, J BIOL CHEM, V276, P23733, DOI 10.1074/jbc.M101447200; Anbukumar DS, 2010, J LIPID RES, V51, P1085, DOI 10.1194/jlr.M003673; Asselbergs FW, 2004, AM J MED, V116, P429, DOI 10.1016/j.amjmed.2003.10.025; BERGSETH S, 1988, BIOCHIM BIOPHYS ACTA, V961, P103, DOI 10.1016/0005-2760(88)90135-X; Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253; BJORKHEM I, 1976, J BIOL CHEM, V251, P5259; BJORKHEM I, 1978, J LIPID RES, V19, P585; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CECH P, 1979, BLOOD, V53, P403; CHASE JFA, 1972, BIOCHEM J, V129, P55, DOI 10.1042/bj1290055; GREGERSEN N, 1983, CLIN CHIM ACTA, V132, P181, DOI 10.1016/0009-8981(83)90246-2; Grossert JS, 2005, CAN J CHEM, V83, P1878, DOI 10.1139/V05-214; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hsu FF, 1999, INT J MASS SPECTROM, V185, P795, DOI 10.1016/S1387-3806(98)14105-2; Jemal M, 1998, J CHROMATOGR B, V709, P233, DOI 10.1016/S0378-4347(98)00080-2; KAIKAUS RM, 1993, J BIOL CHEM, V268, P9593; Kakola J, 2006, J SEP SCI, V29, P1996, DOI 10.1002/jssc.200600106; Kerwin JL, 1996, ANAL BIOCHEM, V237, P56, DOI 10.1006/abio.1996.0200; KITAHARA M, 1981, BLOOD, V57, P888; Komen JC, 2004, J LIPID RES, V45, P1341, DOI 10.1194/jlr.M400064-JLR200; LAMPERT MB, 1983, BLOOD, V62, P645; LEHRER RI, 1969, J CLIN INVEST, V48, P1478, DOI 10.1172/JCI106114; LU AYH, 1968, J BIOL CHEM, V243, P1331; Marsche G, 2004, ARTERIOSCL THROM VAS, V24, P2302, DOI 10.1161/01.ATV.0000148703.43429.25; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; MORTENSEN PB, 1984, DAN MED BULL, V31, P121; MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V666, P394, DOI 10.1016/0005-2760(81)90298-8; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Nikpoor B, 2001, AM HEART J, V142, P336, DOI 10.1067/mhj.2001.116769; Okita RT, 2001, CURR DRUG METAB, V2, P265; Panneels V, 1996, J BIOL CHEM, V271, P23006, DOI 10.1074/jbc.271.38.23006; PASSI S, 1984, BIOCHEM PHARMACOL, V33, P103, DOI 10.1016/0006-2952(84)90376-9; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Skaff O, 2008, BIOCHEMISTRY-US, V47, P8237, DOI 10.1021/bi800786q; STAROSTIN EK, 1992, SYNTHESIS-STUTTGART, P917; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Thukkani AK, 2005, AM J PHYSIOL-HEART C, V288, pH2955, DOI 10.1152/ajpheart.00834.2004; Thukkani AK, 2003, CIRCULATION, V108, P3128, DOI 10.1161/01.CIR.0000104564.01539.6A; Thukkani AK, 2003, J BIOL CHEM, V278, P36365, DOI 10.1074/jbc.M305449200; Thukkani AK, 2002, J BIOL CHEM, V277, P3842, DOI 10.1074/jbc.M109489200; TONSGARD JH, 1985, J PEDIATR-US, V107, P79, DOI 10.1016/S0022-3476(85)80619-3; TONSGARD JH, 1985, J CLIN INVEST, V76, P816, DOI 10.1172/JCI112039; VAMECQ J, 1985, BIOCHEM J, V230, P683, DOI 10.1042/bj2300683; WAKABAYASHI K, 1963, BIOCHIM BIOPHYS ACTA, V70, P132, DOI 10.1016/0006-3002(63)90733-9; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wildsmith KR, 2006, CHEM PHYS LIPIDS, V139, P157, DOI 10.1016/j.chemphyslip.2005.12.003; Wildsmith KR, 2006, J BIOL CHEM, V281, P16849, DOI 10.1074/jbc.M602505200; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	51	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41255	41269		10.1074/jbc.M110.147157	http://dx.doi.org/10.1074/jbc.M110.147157			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20956542	Green Published, hybrid			2022-12-25	WOS:000285622600011
J	Ghanam, RH; Fernandez, TF; Fledderman, EL; Saad, JS				Ghanam, Ruba H.; Fernandez, Timothy F.; Fledderman, Emily L.; Saad, Jamil S.			Binding of Calmodulin to the HIV-1 Matrix Protein Triggers Myristate Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SIZE-DISTRIBUTION ANALYSIS; GAG MEMBRANE-BINDING; PLASMA-MEMBRANE; ANALYTICAL ULTRACENTRIFUGATION; INTRACELLULAR TRAFFICKING; TARGET RECOGNITION; CALCIUM-BINDING; ENVELOPE GLYCOPROTEIN; STRUCTURAL BIOLOGY	Steady progress has been made in defining both the viral and cellular determinants of retroviral assembly and release. Although it is widely accepted that targeting of the Gag polypeptide to the plasma membrane is critical for proper assembly of HIV-1, the intracellular interactions and trafficking of Gag to its assembly sites in the infected cell are poorly understood. HIV-1 Gag was shown to interact and co-localize with calmodulin (CaM), a ubiquitous and highly conserved Ca2+-binding protein expressed in all eukaryotic cells, and is implicated in a variety of cellular functions. Binding of HIV-1 Gag to CaM is dependent on calcium and is mediated by the N-terminally myristoylated matrix (myr(+)MA) domain. Herein, we demonstrate that CaM binds to myr(+) MA with a dissociation constant (K-d) of similar to 2 mu M and 1: 1 stoichiometry. Strikingly, our data revealed that CaM binding to MA induces the extrusion of the myr group. However, in contrast to all known examples of CaM-binding myristoylated proteins, our data show that the myr group is exposed to solvent and not involved in CaM binding. The interactions between CaM and myr(+) MA are endothermic and entropically driven, suggesting that hydrophobic contacts are critical for binding. As revealed by NMR data, both CaM and MA appear to engage substantial regions and/or undergo significant conformational changes upon binding. We believe that our findings will provide new insights on how Gag may interact with CaM during the HIV replication cycle.	[Ghanam, Ruba H.; Fernandez, Timothy F.; Fledderman, Emily L.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), 845 19th St S, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484	National Institutes of Health [1R01AI087101]; University of Alabama at Birmingham Center for AIDS Research and Comprehensive Cancer Center [NCI CA13148-35]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Center for AIDS Research and Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI087101. This work was also supported by intramural funding from the University of Alabama at Birmingham Center for AIDS Research and Comprehensive Cancer Center Grant NCI CA13148-35.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; Chu H, 2009, CURR TOP MICROBIOL, V339, P67, DOI 10.1007/978-3-642-02175-6_4; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; Dou J, 2009, VIROLOGY, V387, P341, DOI 10.1016/j.virol.2009.02.037; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Faurobert E, 1996, J BIOL CHEM, V271, P10256, DOI 10.1074/jbc.271.17.10256; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; FOLKERS PJM, 1993, J AM CHEM SOC, V115, P3798, DOI 10.1021/ja00062a065; FRANKE EK, 1994, J VIROL, V68, P5300, DOI 10.1128/JVI.68.8.5300-5305.1994; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Han Z, 2007, VIRUS GENES, V35, P511, DOI 10.1007/s11262-007-0125-9; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Izumi Y, 2008, BIOCHEMISTRY-US, V47, P7158, DOI 10.1021/bi702416b; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Matsubara M, 2003, J BIOL CHEM, V278, P48898, DOI 10.1074/jbc.M305488200; Matsuda S, 1998, J BIOL CHEM, V273, P20223, DOI 10.1074/jbc.273.32.20223; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MILLER MA, 1993, AIDS RES HUM RETROV, V9, P1057, DOI 10.1089/aid.1993.9.1057; Morikawa Y, 2000, J VIROL, V74, P16, DOI 10.1128/JVI.74.1.16-23.2000; Morikawa Y, 1998, J VIROL, V72, P7659, DOI 10.1128/JVI.72.9.7659-7663.1998; Nishi M, 2009, FEBS LETT, V583, P1243, DOI 10.1016/j.febslet.2009.03.041; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2010, VACCINE, V28, pB55, DOI 10.1016/j.vaccine.2009.10.021; Ono A, 2010, BIOL CELL, V102, P335, DOI 10.1042/BC20090165; Ono A, 2009, FUTURE VIROL, V4, P241, DOI 10.2217/FVL.09.4; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	94	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41911	41920		10.1074/jbc.M110.179093	http://dx.doi.org/10.1074/jbc.M110.179093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20956522	Green Published, hybrid			2022-12-25	WOS:000285622600078
J	Erez, E; Stjepanovic, G; Zelazny, AM; Brugger, B; Sinning, I; Bibi, E				Erez, Elinor; Stjepanovic, Goran; Zelazny, Adrian M.; Brugger, Britta; Sinning, Irmgard; Bibi, Eitan			Genetic Evidence for Functional Interaction of the Escherichia coli Signal Recognition Particle Receptor with Acidic Lipids in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLGLYCEROPHOSPHATE SYNTHASE; MEMBRANE ASSOCIATION; BINDING DOMAIN; SRP RECEPTOR; NULL MUTANT; NG DOMAIN; FTSY; PHOSPHOLIPIDS; CHLOROPLASTS; CARDIOLIPIN	The mechanism underlying the interaction of the Escherichia coli signal recognition particle receptor FtsY with the cytoplasmic membrane has been studied in detail. Recently, we proposed that FtsY requires functional interaction with inner membrane lipids at a late stage of the signal recognition particle pathway. In addition, an essential lipid-binding alpha-helix was identified in FtsY of various origins. Theoretical considerations and in vitro studies have suggested that it interacts with acidic lipids, but this notion is not yet fully supported by in vivo experimental evidence. Here, we present an unbiased genetic clue, obtained by serendipity, supporting the involvement of acidic lipids. Utilizing a dominant negative mutant of FtsY (termed NG), which is defective in its functional interaction with lipids, we screened for E. coli genes that suppress the negative dominant phenotype. In addition to several unrelated phenotype-suppressor genes, we identified pgsA, which encodes the enzyme phosphatidylglycerophosphate synthase (PgsA). PgsA is an integral membrane protein that catalyzes the committed step to acidic phospholipid synthesis, and we show that its overexpression increases the contents of cardiolipin and phosphatidylglycerol. Remarkably, expression of PgsA also stabilizes NG and restores its biological function. Collectively, our results strongly support the notion that FtsY functionally interacts with acidic lipids.	[Erez, Elinor; Zelazny, Adrian M.; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Stjepanovic, Goran; Brugger, Britta; Sinning, Irmgard] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Ruprecht Karls University Heidelberg	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	azelazny@mail.nih.gov; e.bibi@weizmann.ac.il	Stjepanovic, Goran/A-7902-2010	Stjepanovic, Goran/0000-0002-4841-9949; Bibi, Eitan/0000-0003-3700-2707	German-Israeli Foundation for Scientific Research and Development; Israel Science Foundation; Deutsche Forschungsgemeinschaft [GRK 1188]	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the German-Israeli Foundation for Scientific Research and Development (to I. S. and E. B.), by the Israel Science Foundation (to E. B.), and by Deutsche Forschungsgemeinschaft Collaborative Research Grant GRK 1188 (to I. S.).	Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Bahari L, 2007, J BIOL CHEM, V282, P32168, DOI 10.1074/jbc.M705429200; Bibi E, 2001, TRENDS BIOCHEM SCI, V26, P15, DOI 10.1016/S0968-0004(00)01711-4; Bohn C, 1998, J BACTERIOL, V180, P6072, DOI 10.1128/JB.180.22.6072-6075.1998; Braig D, 2009, J MOL BIOL, V390, P401, DOI 10.1016/j.jmb.2009.04.061; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; deLeeuw E, 1997, FEBS LETT, V416, P225, DOI 10.1016/S0014-5793(97)01238-6; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; GOPALAKRISHNAN AS, 1986, J BIOL CHEM, V261, P1329; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Kikuchi S, 2000, J BACTERIOL, V182, P371, DOI 10.1128/JB.182.2.371-376.2000; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Millman JS, 1999, J BIOL CHEM, V274, P33227, DOI 10.1074/jbc.274.47.33227; Mircheva M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-76; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; OHTA A, 1981, J BACTERIOL, V147, P552, DOI 10.1128/JB.147.2.552-562.1981; Parlitz R, 2007, J BIOL CHEM, V282, P32176, DOI 10.1074/jbc.M705430200; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Suzuki H, 1999, J BIOL CHEM, V274, P31020, DOI 10.1074/jbc.274.43.31020; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; USUI M, 1994, J BACTERIOL, V176, P3389, DOI 10.1128/jb.176.11.3389-3392.1994; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025	30	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40508	40514		10.1074/jbc.M110.140921	http://dx.doi.org/10.1074/jbc.M110.140921			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956528	hybrid, Green Published			2022-12-25	WOS:000285414400013
J	Borza, CM; Chen, XW; Mathew, S; Mont, S; Sanders, CR; Zent, R; Pozzi, A				Borza, Corina M.; Chen, Xiwu; Mathew, Sijo; Mont, Stacey; Sanders, Charles R.; Zent, Roy; Pozzi, Ambra			Integrin alpha 1 beta 1 Promotes Caveolin-1 Dephosphorylation by Activating T Cell Protein-tyrosine Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-STRESS; ENDOTHELIAL-CELLS; MESANGIAL CELLS; GLOMERULAR INJURY; PHOSPHORYLATION; GROWTH; KINASE; TRAFFICKING; EXPRESSION; TCPTP	Integrin alpha 1 beta 1 is a collagen receptor that down-regulates collagen and reactive oxygen species (ROS) production, and mice lacking this receptor show increased ROS levels and exacerbated glomerular sclerosis following injury. Caveolin-1 (Cav-1) is a multifunctional protein that is tyrosine-phosphorylated in response to injury and has been implicated in ROS-mediated injury. Cav-1 interacts with integrins, and integrin alpha 1 beta 1 binds/activates T cell protein-tyrosine phosphatase (TCPTP), which is homologous to the tyrosine phosphatase PTP1B known to dephosphorylate Cav-1. In this study, we analyzed whether phosphorylated Cav-1 (pCav-1) is a substrate of TCPTP and if integrin alpha 1 beta 1 is essential for promoting TCPTP-mediated Cav-1 dephosphorylation. We found that Cav-1 phosphorylation is significantly higher in cells lacking integrin alpha 1 beta 1 at base line and following oxidative stress. Overexpression of TCPTP leads to reduced pCav-1 levels only in cells expressing integrin alpha 1 beta 1. Using solid phase binding assays, we demonstrated that 1) purified Cav-1 directly interacts with TCPTP and the integrin alpha 1 subunit, 2) pCav-1 is a substrate of TCPTP, and 3) TCPTP-mediated Cav-1 dephosphorylation is highly increased by the addition of purified integrin alpha 1 beta 1 or an integrin alpha 1 cytoplasmic peptide to which TCPTP has been shown to bind. Thus, our results demonstrate that pCav-1 is a new substrate of TCPTP and that integrin alpha 1 beta 1 acts as a negative regulator of Cav-1 phosphorylation by activating TCPTP. This could explain the protective function of integrin alpha 1 beta 1 in oxidative stress-mediated damage and why integrin alpha 1-null mice are more susceptible to fibrosis following injury.	[Borza, Corina M.; Chen, Xiwu; Mathew, Sijo; Zent, Roy; Pozzi, Ambra] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37212 USA; [Mont, Stacey; Zent, Roy; Pozzi, Ambra] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37212 USA; [Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37212 USA; [Zent, Roy; Pozzi, Ambra] Vet Affairs Hosp, Dept Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Borza, CM (corresponding author), Vanderbilt Univ, Med Ctr N, Dept Med, B3115, Nashville, TN 37232 USA.	corina.borza@vanderbilt.edu; ambra.pozzi@vanderbilt.edu	Borza, Corina/AAF-5292-2020; Borza, Corina/A-1603-2013	Borza, Corina/0000-0001-9113-110X	National Institutes of Health [2P01DK065123, DK075594, DK65123, DK083187]; Department of Veterans Affairs; American Heart Association; O'Brien Center [P30DK79341-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075594, R01DK083187, P30DK079341, P01DK065123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); O'Brien Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2P01DK065123 (to A.P. and R.Z.), DK075594 and DK65123 (to R.Z.), and DK083187 (to R.Z. and C.R.S.). These studies were also supported by a Merit Review from the Department of Veterans Affairs (to A.P. and R.Z.) and an American Heart Association established investigator award (to R.Z.); and O'Brien Center Grant P30DK79341-01 (to A.P. and R.Z.).	Abair TD, 2008, BLOOD, V112, P3242, DOI 10.1182/blood-2007-12-126433; Aoki J, 1999, BIOCHEM J, V340, P365, DOI 10.1042/0264-6021:3400365; Caselli A, 2001, J BIOL CHEM, V276, P18849, DOI 10.1074/jbc.M100705200; Caselli A, 2007, BIOCHEMISTRY-US, V46, P6383, DOI 10.1021/bi0620858; Chen DB, 2005, BIOL REPROD, V73, P761, DOI 10.1095/biolreprod.105.040881; Chen XW, 2007, MOL CELL BIOL, V27, P3313, DOI 10.1128/MCB.01476-06; Chen XW, 2010, MOL CELL BIOL, V30, P3048, DOI 10.1128/MCB.00892-09; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Chretien A, 2008, FEBS LETT, V582, P1685, DOI 10.1016/j.febslet.2008.04.026; Del Galdo F, 2008, CURR OPIN RHEUMATOL, V20, P713, DOI 10.1097/BOR.0b013e3283103d27; DELAURENTIIS A, 2007, BIOCHEM J, V1, P12; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Echarri A, 2007, SEMIN CELL DEV BIOL, V18, P627, DOI 10.1016/j.semcdb.2007.08.004; Hao LN, 1997, J BIOL CHEM, V272, P29322, DOI 10.1074/jbc.272.46.29322; IVARSSON M, 1993, J INVEST DERMATOL, V101, P216, DOI 10.1111/1523-1747.ep12364810; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Kim H, 2006, NEUROSCI LETT, V402, P76, DOI 10.1016/j.neulet.2006.04.008; Krepinsky JC, 2005, J AM SOC NEPHROL, V16, P1661, DOI 10.1681/ASN.2004100897; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lam MHC, 2001, J BIOL CHEM, V276, P37700, DOI 10.1074/jbc.M105128200; Lee H, 2006, BIOCHEMISTRY-US, V45, P234, DOI 10.1021/bi051560j; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Mattila E, 2008, J CELL SCI, V121, P3570, DOI 10.1242/jcs.031898; Mattila E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-7; Nag S, 2009, NEUROPATH APPL NEURO, V35, P417, DOI 10.1111/j.1365-2990.2008.01009.x; Ostalska-Nowicka D, 2007, HISTOPATHOLOGY, V51, P611, DOI 10.1111/j.1365-2559.2007.02844.x; Parat MO, 2002, BIOCHEM J, V361, P681, DOI 10.1042/0264-6021:3610681; Park DS, 2003, BIOCHEMISTRY-US, V42, P15124, DOI 10.1021/bi0356348; Park JH, 2011, J CELL PHYSIOL, V226, P267, DOI 10.1002/jcp.22338; Percy CJ, 2008, PATHOLOGY, V40, P694, DOI 10.1080/00313020802436402; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Sanguinetti AR, 2003, CELL SIGNAL, V15, P289, DOI 10.1016/S0898-6568(02)00090-6; SETTY S, 1995, CELL ADHES COMMUN, V3, P187, DOI 10.3109/15419069509081286; Shajahan AN, 2007, J BIOL CHEM, V282, P5934, DOI 10.1074/jbc.M608857200; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Shin J, 2006, BIOCHEM BIOPH RES CO, V339, P737, DOI 10.1016/j.bbrc.2005.11.077; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Ushio-Fukai M, 2005, CIRC RES, V97, P829, DOI 10.1161/01.RES.0000185322.46009.F5; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Zent R, 2006, KIDNEY INT, V70, P460, DOI 10.1038/sj.ki.5000359; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005	51	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40114	40124		10.1074/jbc.M110.156729	http://dx.doi.org/10.1074/jbc.M110.156729			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940300	Green Published, hybrid			2022-12-25	WOS:000285185500057
J	Leal-Pinto, E; Gomez-Llorente, Y; Sundaram, S; Tang, QY; Ivanova-Nikolova, T; Mahajan, R; Baki, L; Zhang, Z; Chavez, J; Ubarretxena-Belandia, I; Logothetis, DE				Leal-Pinto, Edgar; Gomez-Llorente, Yacob; Sundaram, Shobana; Tang, Qiong-Yao; Ivanova-Nikolova, Tatyana; Mahajan, Rahul; Baki, Lia; Zhang, Zhe; Chavez, Jose; Ubarretxena-Belandia, Iban; Logothetis, Diomedes E.			Gating of a G protein-sensitive Mammalian Kir3.1 Prokaryotic Kir Channel Chimera in Planar Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; RECTIFYING K+ CHANNELS; MUSCARINIC POTASSIUM CHANNEL; HIGH-AFFINITY INHIBITOR; GTP-BINDING PROTEINS; INWARD-RECTIFIER; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; ADENYLYL-CYCLASE	Kir3 channels control heart rate and neuronal excitability through GTP-binding (G) protein and phosphoinositide signaling pathways. These channels were the first characterized effectors of the beta gamma subunits of G proteins. Because we currently lack structures of complexes between G proteins and Kir3 channels, their interactions leading to modulation of channel function are not well understood. The recent crystal structure of a chimera between the cytosolic domain of a mammalian Kir3.1 and the transmembrane region of a prokaryotic KirBac1.3 (Kir3.1 chimera) has provided invaluable structural insight. However, it was not known whether this chimera could form functional K+ channels. Here, we achieved the functional reconstitution of purified Kir3.1 chimera in planar lipid bilayers. The chimera behaved like a bona fide Kir channel displaying an absolute requirement for PIP2 and Mg2+-dependent inward rectification. The channel could also be blocked by external tertiapin Q. The three-dimensional reconstruction of the chimera by single particle electron microscopy revealed a structure consistent with the crystal structure. Channel activity could be stimulated by ethanol and activated G proteins. Remarkably, the presence of both activated G alpha and G beta gamma subunits was required for gating of the channel. These results confirm the Kir3.1 chimera as a valid structural and functional model of Kir3 channels.	[Gomez-Llorente, Yacob; Chavez, Jose; Ubarretxena-Belandia, Iban] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Leal-Pinto, Edgar; Sundaram, Shobana; Tang, Qiong-Yao; Ivanova-Nikolova, Tatyana; Mahajan, Rahul; Baki, Lia; Zhang, Zhe; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University	Ubarretxena-Belandia, I (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA.	Iban.Ubarretxena@mssm.edu; delogothetis@vcu.edu	Ubarretxena-Belandia, Iban/AAA-8939-2019; Gomez-Llorente, Yacob/E-5631-2013; Zhang, Zhe/C-2685-2011; Tang, Qiong-Yao/G-6051-2012; Mahajan, Rahul/AAS-5971-2021	Mahajan, Rahul/0000-0002-9613-2870; Chavez, Jose/0000-0003-4351-1516	National Institutes of Health [R01 HL59949, F30]; National Science Foundation [MCB-0546087]; Ministerio de Educacion y Ciencia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ministerio de Educacion y Ciencia(Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL59949 (to D. E. L.) and National Science Foundation Grant MCB-0546087 (to I. U.-B.).; Supported by a postdoctoral fellowship from the Ministerio de Educacion y Ciencia.; Supported by an National Institutes of Health F30 award.	Aleksandrov A, 1996, BIOPHYS J, V70, P2680, DOI 10.1016/S0006-3495(96)79837-5; Aryal P, 2009, NAT NEUROSCI, V12, P988, DOI 10.1038/nn.2358; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14294, DOI 10.1021/bi991206j; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LEALPINTO E, 1995, J MEMBRANE BIOL, V146, P123; LealPinto E, 1997, J BIOL CHEM, V272, P617; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P1, DOI 10.1007/s00424-007-0311-6; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Logothetis DE, 2010, PFLUG ARCH EUR J PHY, V460, P321, DOI 10.1007/s00424-010-0828-y; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mirshahi T, 2004, J BIOL CHEM, V279, P11890, DOI 10.1074/jbc.M313322200; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rubinstein JL, 2007, METHODS, V41, P409, DOI 10.1016/j.ymeth.2006.07.019; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2007, STRUCTURE, V15, P1167, DOI 10.1016/j.str.2007.09.003; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Yamada M, 1998, PHARMACOL REV, V50, P723	59	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39790	39800		10.1074/jbc.M110.151373	http://dx.doi.org/10.1074/jbc.M110.151373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937804	Green Published, hybrid			2022-12-25	WOS:000285185500023
J	Peterson, JM; Wei, ZK; Wong, GW				Peterson, Jonathan M.; Wei, Zhikui; Wong, G. William			C1q/TNF-related Protein-3 (CTRP3), a Novel Adipokine That Regulates Hepatic Glucose Output	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; GENE-EXPRESSION; ADIPONECTIN; KINASE; MICE; MUSCLE; FAMILY; ACTIVATION	Adipose tissue-derived adipokines play important roles in controlling systemic insulin sensitivity and energy balance. Our recent efforts to identify novel metabolic mediators produced by adipose tissue have led to the discovery of a highly conserved family of secreted proteins, designated as C1q/TNF-related proteins 1-10 (CTRP1 to -10). However, physiological functions regulated by CTRPs are largely unknown. Here we provide the first in vivo functional characterization of CTRP3. We show that circulating levels of CTRP3 are inversely correlated with leptin levels; CTRP3 increases with fasting, decreases in diet-induced obese mice with high leptin levels, and increases in leptin-deficient ob/ob mice. A modest 3-fold elevation of plasma CTRP3 levels by recombinant protein administration is sufficient to lower glucose levels in normal and insulin-resistant ob/ob mice, without altering insulin or adiponectin levels. The glucose-lowering effect in mice is linked to activation of the Akt signaling pathway in liver and a marked suppression of hepatic gluconeogenic gene expression. Consistent with its effects in mice, CTRP3 acts directly and independently of insulin to regulate gluconeogenesis in cultured hepatocytes. In humans, alternative splicing generates two circulating CTRP3 isoforms differing in size and glycosylation pattern. The two human proteins form hetero-oligomers, an association that does not require interdisulfide bond formation and appears to protect the longer isoform from proteolytic cleavage. Recombinant human CTRP3 also reduces glucose output in hepatocytes by suppressing gluconeogenic enzyme expression. This study provides the first functional evidence linking CTRP3 to hepatic glucose metabolism and establishes CTRP3 as a novel adipokine.	[Wong, G. William] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506; Wei, Zhikui/0000-0002-2311-9800	National Institutes of Health [DK084171]; American Heart Association [SDG2260721, PRE3790034]; Baltimore Diabetes Research and Training Center [P60DK079637]; National Institutes of Health National Research Service [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084607, R01DK084171, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baltimore Diabetes Research and Training Center; National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.). This work was also supported in part by American Heart Association Grant SDG2260721 and Baltimore Diabetes Research and Training Center Grant P60DK079637.; Supported by National Institutes of Health National Research Service Award F32DK084607.; Supported by a American Heart Association Fellowship PRE3790034.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Akiyama H, 2006, FEBS J, V273, P2257, DOI 10.1111/j.1742-4658.2006.05240.x; Akiyama H, 2007, MOL CELL BIOCHEM, V304, P243, DOI 10.1007/s11010-007-9506-6; Akiyama H, 2009, ONCOL REP, V21, P1477, DOI 10.3892/or_00000377; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Davis Kathryn E, 2008, Biochem J, V416, pe7, DOI 10.1042/BJ20082033; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Govorko D, 2007, AM J PHYSIOL-ENDOC M, V293, pE1503, DOI 10.1152/ajpendo.00420.2007; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; KLIP A, 1984, AM J PHYSIOL, V247, pE291, DOI 10.1152/ajpendo.1984.247.3.E291; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda T, 2001, J BIOL CHEM, V276, P3628, DOI 10.1074/jbc.M007898200; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Ono H, 2003, DIABETES, V52, pA301; Perrot V, 2003, J BIOL CHEM, V278, P26111, DOI 10.1074/jbc.M212750200; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Satoh H, 2005, DIABETES, V54, P1304, DOI 10.2337/diabetes.54.5.1304; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yano W, 2008, ENDOCR J, V55, P515, DOI 10.1507/endocrj.K08E-093; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zierler K, 1999, AM J PHYSIOL-ENDOC M, V276, pE409, DOI 10.1152/ajpendo.1999.276.3.E409	48	194	210	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39691	39701		10.1074/jbc.M110.180695	http://dx.doi.org/10.1074/jbc.M110.180695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20952387	hybrid, Green Published			2022-12-25	WOS:000285185500013
J	Pi, M; Parrill, AL; Quarles, LD				Pi, Min; Parrill, Abby L.; Quarles, L. Darryl			GPRC6A Mediates the Non-genomic Effects of Steroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; PROSTATE-CANCER CELLS; AMINO-ACID RECEPTOR; ANDROGEN RECEPTOR; CRYSTAL-STRUCTURE; TESTOSTERONE RECEPTORS; EXPRESSION; ESTROGEN; CLONING; GROWTH	The identity of the putative G-protein coupled receptor (GPCR) that mediates the non-genomic effects of androgens is unknown. We present in vitro and in vivo evidence that the orphan GPRC6A receptor, a widely expressed calcium and amino acid sensing GPCR, transduces the non-genomic effects of testosterone and other steroids. Overexpression of GPRC6A imparts the ability of extracellular testosterone to illicit a rapid, non-genomic signaling response in HEK-293 cells lacking the androgen receptor. Conversely, testosterone-stimulated rapid signaling and phosphorylation of ERK is attenuated in bone marrow stromal cells derived from GPRC6A(-/-) mice and in 22Rv1 prostate cancer cells after siRNA-mediated knockdown of GPRC6A. Compared with wild-type controls, GPRC6A(-/-) null mice exhibit significantly less ERK activation and Egr-1 expression in both bone marrow and testis in response to pharmacological doses of testosterone in vivo. In addition, testosterone administration results in suppression of luteinizing hormone in wild-type male mice, but paradoxically stimulates serum luteinizing hormone levels in GPRC6A(-/-) null mice. These results suggest that GPRC6A is functionally important in regulating non-genomic effects of androgens in multiple tissues.	[Pi, Min; Quarles, L. Darryl] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38103 USA; [Parrill, Abby L.] Univ Memphis, Computat Res Mat Inst, Memphis, TN 38152 USA; [Parrill, Abby L.] Univ Memphis, Dept Chem, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Memphis	Pi, M (corresponding author), 19 S Manassas St, Memphis, TN 38103 USA.	mpi@uthsc.edu; dquarles@uthsc.edu		Parrill, Abby/0000-0003-1658-8497; Pi, Min/0000-0002-0319-8003; Quarles, L. Darryl/0000-0002-5082-7896	National Institutes of Health [R01-AR37308]; Center of Biomedical Research Excellence [P20 RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Biomedical Research Excellence; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AR37308 (to L. D. Q.) and Center of Biomedical Research Excellence, Epithelial Function in Health and Disease Grant P20 RR017686 (to M. P.).	Armen TA, 2000, J CELL BIOCHEM, V79, P620, DOI 10.1002/1097-4644(20001215)79:4<620::AID-JCB110>3.3.CO;2-8; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; Benten WPM, 2004, STEROIDS, V69, P585, DOI 10.1016/j.steroids.2004.05.007; Benten WPM, 1999, MOL BIOL CELL, V10, P3113, DOI 10.1091/mbc.10.10.3113; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernauer S, 2001, DNA SEQUENCE, V12, P13, DOI 10.3109/10425170109042047; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bhasin S, 1998, J CLIN ENDOCR METAB, V83, P3435, DOI 10.1210/jc.83.10.3440; Braun AM, 2004, BIOL REPROD, V71, P146, DOI 10.1095/biolreprod.103.025825; Cato A.C., 2002, SCI STKE, V2002, pre9, DOI [10.1126/stke.2002.138.re9, DOI 10.1126/STKE.2002.138.RE9]; Chen JG, 2006, J CLIN ENDOCR METAB, V91, P4387, DOI 10.1210/jc.2006-0284; Chen Min, 2008, Zhonghua Yi Xue Za Zhi, V88, P1488; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Dong Y, 2005, MOL CANCER THER, V4, P1047, DOI 10.1158/1535-7163.MCT-05-0124; Dos Santos EG, 2002, ENDOCRINOLOGY, V143, P930; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Estrada M, 2003, ENDOCRINOLOGY, V144, P3586, DOI 10.1210/en.2002-0164; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Gerdes D, 1998, BIOL CHEM, V379, P907; GOLDSTEIN JL, 1972, J CLIN INVEST, V51, P1647, DOI 10.1172/JCI106966; Gruenewald DA, 2003, J AM GERIATR SOC, V51, P101, DOI 10.1034/j.1601-5215.2002.51018.x; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; ISWARI S, 1986, STEROIDS, V47, P189, DOI 10.1016/0039-128X(86)90088-7; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kampa M, 2002, FASEB J, V16, P1429, DOI 10.1096/fj.02-0131fje; Kang HY, 2004, J BONE MINER RES, V19, P1181, DOI 10.1359/JBMR.040306; Koeneman KS, 1999, PROSTATE, V39, P246; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; LAMBERT JJ, 1995, TRENDS PHARMACOL SCI, V16, P295, DOI 10.1016/S0165-6147(00)89058-6; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Levin ER, 2002, STEROIDS, V67, P471, DOI 10.1016/S0039-128X(01)00179-9; Liao XB, 2003, ENDOCRINOLOGY, V144, P1656, DOI 10.1210/en.2002-0157; LIEBERHERR M, 1994, J BIOL CHEM, V269, P7217; Liu DM, 2002, J BIOL CHEM, V277, P21379, DOI 10.1074/jbc.M200491200; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; MENDELSON CR, 1984, MOL CELL ENDOCRINOL, V37, P61, DOI 10.1016/0303-7207(84)90128-X; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; MOGER WH, 1974, BIOL REPROD, V11, P1, DOI 10.1095/biolreprod11.1.1; Morgentaler A, 2006, EUR UROL, V50, P935, DOI 10.1016/j.eururo.2006.06.034; Omwancha J, 2006, CURR OPIN INVEST DR, V7, P873; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2010, J BONE MINER RES, V25, P1092, DOI 10.1359/jbmr.091037; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Pike CJ, 2008, HORM BEHAV, V53, P693, DOI 10.1016/j.yhbeh.2007.11.006; Pitteloud N, 2008, J CLIN ENDOCR METAB, V93, P784, DOI 10.1210/jc.2007-2156; Raynaud JP, 2006, J STEROID BIOCHEM, V102, P261, DOI 10.1016/j.jsbmb.2006.09.032; Riedmaier I, 2009, J STEROID BIOCHEM, V114, P167, DOI 10.1016/j.jsbmb.2009.01.019; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Saidak Z, 2009, MOL PHARMACOL, V76, P1131, DOI 10.1124/mol.109.058784; Schmidt BMW, 2003, HYPERTENSION, V42, P156, DOI 10.1161/01.HYP.0000083298.23119.16; Somjen D, 2004, J ENDOCRINOL, V180, P97, DOI 10.1677/joe.0.1800097; Sutters M, 2001, KIDNEY INT, V60, P484, DOI 10.1046/j.1523-1755.2001.060002484.x; TADDEI S, 1993, HYPERTENSION, V21, P929, DOI 10.1161/01.HYP.21.6.929; Thomas P, 2006, STEROIDS, V71, P310, DOI 10.1016/j.steroids.2005.09.015; Tokumoto M, 2005, THER APHER DIAL, V9, pS27, DOI 10.1111/j.1744-9987.2005.00302.x; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Watson CS, 2002, STEROIDS, V67, P429, DOI 10.1016/S0039-128X(01)00172-6; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; WEST RE, 1985, J BIOL CHEM, V260, P4428; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006; Wunderlich F, 2002, STEROIDS, V67, P535, DOI 10.1016/S0039-128X(01)00175-1; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Yialamas MA, 2007, J CLIN ENDOCR METAB, V92, P4254, DOI 10.1210/jc.2007-0454; Zagar Y, 2004, J BIOL CHEM, V279, P2403, DOI 10.1074/jbc.M309132200; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	74	126	137	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39953	39964		10.1074/jbc.M110.158063	http://dx.doi.org/10.1074/jbc.M110.158063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947496	hybrid, Green Published			2022-12-25	WOS:000285185500040
J	Gong, P; Vetrivel, KS; Nguyen, PD; Meckler, X; Cheng, HP; Kounnas, MZ; Wagner, SL; Parent, AT; Thinakaran, G				Gong, Ping; Vetrivel, Kulandaivelu S.; Nguyen, Phuong D.; Meckler, Xavier; Cheng, Haipeng; Kounnas, Maria Z.; Wagner, Steven L.; Parent, Angeele T.; Thinakaran, Gopal			Mutation Analysis of the Presenilin 1 N-terminal Domain Reveals a Broad Spectrum of gamma-Secretase Activity toward Amyloid Precursor Protein and Other Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; BETA-SECRETASE; CELL-SURFACE; IN-VIVO; A-BETA; TRANSMEMBRANE DOMAIN-4; INTRACELLULAR DOMAIN; CATALYTIC PORE; COMPLEX; NICASTRIN	The gamma-secretase protein complex executes the intramembrane proteolysis of amyloid precursor protein (APP), which releases Alzheimer disease beta-amyloid peptide. In addition to APP, gamma-secretase also cleaves several other type I membrane protein substrates including Notch1 and N-cadherin. gamma-Secretase is made of four integral transmembrane protein subunits: presenilin (PS), nicastrin, APH1, and PEN2. Multiple lines of evidence indicate that a heteromer of PS-derived N- and C-terminal fragments functions as the catalytic subunit of gamma-secretase. Only limited information is available on the domains within each subunit involved in the recognition and recruitment of diverse substrates and the transfer of substrates to the catalytic site. Here, we performed mutagenesis of two domains of PS1, namely the first luminal loop domain (LL1) and the second transmembrane domain (TM2), and analyzed PS1 endoproteolysis as well as the catalytic activities of PS1 toward APP, Notch, and N-cadherin. Our results show that distinct residues within LL1 and TM2 domains as well as the length of the LL1 domain are critical for PS1 endoproteolysis, but not for PS1 complex formation with nicastrin, APH1, and PEN2. Furthermore, our experimental PS1 mutants formed gamma-secretase complexes with distinct catalytic properties toward the three substrates examined in this study; however, the mutations did not affect PS1 interaction with the substrates. We conclude that the N-terminal LL1 and TM2 domains are critical for PS1 endoproteolysis and the coordination between the putative substrate-docking site and the catalytic core of the gamma-secretase.	[Gong, Ping; Vetrivel, Kulandaivelu S.; Meckler, Xavier; Cheng, Haipeng; Parent, Angeele T.; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Gong, Ping; Vetrivel, Kulandaivelu S.; Meckler, Xavier; Cheng, Haipeng; Parent, Angeele T.; Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Gong, Ping; Vetrivel, Kulandaivelu S.; Meckler, Xavier; Cheng, Haipeng; Parent, Angeele T.; Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Nguyen, Phuong D.; Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA; [Kounnas, Maria Z.] Neurogenet Pharmaceut Inc, San Diego, CA 92121 USA	University of Chicago; University of Chicago; University of Chicago; University of California System; University of California San Diego	Thinakaran, G (corresponding author), Univ Chicago, Dept Neurobiol, Knapp R212,924 E 57th St, Chicago, IL 60637 USA.	gopal@uchicago.edu			National Institutes of Health [AG021495, AG019070, NS055223]; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019070, R01AG021495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021495 (to G.T.), AG019070 (to G.T.), and NS055223 (to A.T.P.). This work was also supported by grants from the Alzheimer's Association (to G.T. and K.S.V.).	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; DE SB, 1999, NATURE, V398, P518; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Iwatsubo T, 2004, MOL PSYCHIATR, V9, P8, DOI 10.1038/sj.mp.4001438; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Leem JY, 2002, NEUROBIOL DIS, V11, P64, DOI 10.1006/nbdi.2002.0546; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Wanngren J, 2010, J BIOL CHEM, V285, P8527, DOI 10.1074/jbc.M109.055590; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200; Zhao GJ, 2010, J NEUROSCI, V30, P1648, DOI 10.1523/JNEUROSCI.3826-09.2010	62	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38042	38052		10.1074/jbc.M110.132613	http://dx.doi.org/10.1074/jbc.M110.132613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20921220	Green Published, hybrid			2022-12-25	WOS:000284625600012
J	Hong, J; Cho, IH; Kwak, KI; Suh, EC; Seo, J; Min, HJ; Choi, SY; Kim, CH; Park, SH; Jo, EK; Lee, S; Lee, KE; Lee, SJ				Hong, Jinpyo; Cho, Ik-Hyun; Kwak, Kyung Il; Suh, Eun Cheng; Seo, Jinsoo; Min, Hyun Jung; Choi, Se-Young; Kim, Chong-Hyun; Park, Seung Hwa; Jo, Eun-Kyeong; Lee, Soojin; Lee, Kyung Eun; Lee, Sung Joong			Microglial Toll-like Receptor 2 Contributes to Kainic Acid-induced Glial Activation and Hippocampal Neuronal Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN-INJURY; RAT HIPPOCAMPUS; WALLERIAN DEGENERATION; STATUS EPILEPTICUS; CEREBRAL-ISCHEMIA; ENDOGENOUS LIGAND; EXPRESSION; SEIZURES; DISEASE	Recent studies indicate that Toll-like receptors (TLRs), originally identified as infectious agent receptors, also mediate sterile inflammatory responses during tissue damage. In this study, we investigated the role of TLR2 in excitotoxic hippocampal cell death using TLR2 knock-out (KO) mice. TLR2 expression was up-regulated in microglia in the ipsilateral hippocampus of kainic acid (KA)-injected mice. KA-mediated hippocampal cell death was significantly reduced in TLR2 KO mice compared with wild-type (WT) mice. Similarly, KA-induced glial activation and proinflammatory gene expression in the hippocampus were compromised in TLR2 KO mice. In addition, neurons in organotypic hippocampal slice cultures (OHSCs) from TLR2 KO mouse brains were less susceptible to KA excitotoxicity than WT OHSCs. This protection is partly attributed to decreased expression of proinflammatory genes, such as TNF-alpha and IL-1 beta in TLR2 KO mice OHSCs. These data demonstrate conclusively that TLR2 signaling in microglia contributes to KA-mediated innate immune responses and hippocampal excitotoxicity.	[Hong, Jinpyo; Kwak, Kyung Il; Seo, Jinsoo; Min, Hyun Jung; Choi, Se-Young; Lee, Sung Joong] Seoul Natl Univ, Sch Dent, BK21, Program Mol & Cellular Neurosci,DRI, Seoul 110749, South Korea; [Hong, Jinpyo; Kwak, Kyung Il; Seo, Jinsoo; Min, Hyun Jung; Choi, Se-Young; Jo, Eun-Kyeong; Lee, Sung Joong] Seoul Natl Univ, Sch Dent, Dept Oral Physiol, Seoul 110749, South Korea; [Cho, Ik-Hyun] Kyung Hee Univ, Coll Oriental Med, Dept Anat, Seoul 130701, South Korea; [Cho, Ik-Hyun] Kyung Hee Univ, Inst Oriental Med, Seoul 130701, South Korea; [Suh, Eun Cheng; Lee, Kyung Eun] Ewha Womans Univ, Sch Med, Dept Pharmacol, Seoul 158710, South Korea; [Kim, Chong-Hyun] Univ Sci & Technol, Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 130722, South Korea; [Park, Seung Hwa] Konkuk Univ, Coll Med, Dept Anat, Chungju 380701, South Korea; [Jo, Eun-Kyeong] Chungnam Natl Univ, Coll Med, Dept Microbiol, Taejon 301747, South Korea; [Jo, Eun-Kyeong] Chungnam Natl Univ, Coll Med, Infect Signaling Network Res Ctr, Taejon 301747, South Korea; [Lee, Soojin] Chungnam Natl Univ, Sch Syst Biol, Dept Microbiol, Taejon 305764, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Korea Institute of Oriental Medicine (KIOM); Kyung Hee University; Ewha Womans University; Korea Institute of Science & Technology (KIST); Konkuk University; Konkuk University Medical Center; Chungnam National University; Chungnam National University; Chungnam National University	Lee, SJ (corresponding author), 28 Yeongun Dong, Seoul 110749, South Korea.	sjlee87@snu.ac.kr	Cho, Ik-Hyun/A-9348-2014; Seo, Jinsoo/AAD-4950-2019; Min, Hyunjung/ABA-8709-2020	Seo, Jinsoo/0000-0001-6432-6964; Lee, Soojin/0000-0002-0383-5025; Choi, Se-Young/0000-0001-7534-5167; Eun-Kyeong, Jo/0000-0001-7191-0587	Ministry of Education, Science and Technology (MEST), the Republic of Korea [2009-0081467, 2009-0063285, 2009-0053167]; Korea Science and Engineering Foundation through the Infection Signaling Network Research Center at Chungnam National University [R13-2007-020-01000-0]	Ministry of Education, Science and Technology (MEST), the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation through the Infection Signaling Network Research Center at Chungnam National University(Korea Science and Engineering Foundation)	This work was supported by the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (MEST) (No. 2009-0081467, 2009-0063285, 2009-0053167), the Republic of Korea, and the Korea Science and Engineering Foundation through the Infection Signaling Network Research Center (R13-2007-020-01000-0) at Chungnam National University.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ananth C, 2003, HIPPOCAMPUS, V13, P375, DOI 10.1002/hipo.10090; ANDERSSON PB, 1991, NEUROSCIENCE, V42, P201, DOI 10.1016/0306-4522(91)90159-L; Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; Cho IH, 2006, J NEUROSCI RES, V84, P1505, DOI 10.1002/jnr.21052; COYLE JT, 1983, NEUROBEH TOXICOL TER, V5, P617; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Downen M, 1999, GLIA, V28, P114, DOI 10.1002/(SICI)1098-1136(199911)28:2<114::AID-GLIA3>3.0.CO;2-O; Dumas TC, 2000, EXP NEUROL, V166, P180, DOI 10.1006/exnr.2000.7500; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Hsieh CH, 2008, TOXICOL SCI, V101, P112, DOI 10.1093/toxsci/kfm258; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kristensen BW, 2001, BRAIN RES, V917, P21, DOI 10.1016/S0006-8993(01)02900-6; Lee H, 2006, BIOCHEM BIOPH RES CO, V350, P742, DOI 10.1016/j.bbrc.2006.09.108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MITCHELL J, 1993, EXP NEUROL, V121, P224, DOI 10.1006/exnr.1993.1089; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Park C, 2008, NEUROSCI LETT, V431, P123, DOI 10.1016/j.neulet.2007.11.057; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Song LY, 2007, J NEUROSCI RES, V85, P2186, DOI 10.1002/jnr.21367; SPERK G, 1985, BRAIN RES, V338, P289, DOI 10.1016/0006-8993(85)90159-3; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Turrin NP, 2004, NEUROBIOL DIS, V16, P321, DOI 10.1016/j.nbd.2004.03.010; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Weise J, 2005, NEUROBIOL DIS, V18, P582, DOI 10.1016/j.nbd.2004.10.025; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157	51	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39447	39457		10.1074/jbc.M110.132522	http://dx.doi.org/10.1074/jbc.M110.132522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923777	hybrid, Green Published			2022-12-25	WOS:000284941300071
J	Ziebell, A; Gracom, K; Katahira, R; Chen, F; Pu, YQ; Ragauskas, A; Dixon, RA; Davis, M				Ziebell, Angela; Gracom, Kristen; Katahira, Rui; Chen, Fang; Pu, Yunqiao; Ragauskas, Art; Dixon, Richard A.; Davis, Mark			Increase in 4-Coumaryl Alcohol Units during Lignification in Alfalfa (Medicago sativa) Alters the Extractability and Molecular Weight of Lignin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOLIGNOL BIOSYNTHESIS; DOWN-REGULATION; MAGNETIC-RESONANCE; FORAGE QUALITY; ACID BRIDGES; NMR; INTERNODES; CELLULOSE; WHEAT; CRYSTALLINITY	The lignin content of biomass can impact the ease and cost of biomass processing. Lignin reduction through breeding and genetic modification therefore has potential to reduce costs in biomass-processing industries (e. g. pulp and paper, forage, and lignocellulosic ethanol). We investigated compositional changes in two low-lignin alfalfa (Medicago sativa) lines with antisense down-regulation of p-coumarate 3-hydroxylase (C3H) or hydroxycinnamoyl-CoA:shikimate hydroxycinnamoyltransferase (HCT). We investigated whether the difference in reactivity during lignification of 4-coumaryl alcohol (H) monomers versus the naturally dominant sinapyl alcohol and coniferyl alcohol lignin monomers alters the lignin structure. Sequential base extraction readily reduced the H monomer content of the transgenic lines, leaving a residual lignin greatly enriched in H subunits; the extraction profile highlighted the difference between the control and transgenic lines. Gel permeation chromatography of isolated ball-milled lignin indicated significant changes in the weight average molecular weight distribution of the control versus transgenic lines (CTR1a, 6000; C3H4a, 5500; C3H9a, 4000; and HCT30a, 4000).	[Ziebell, Angela; Gracom, Kristen; Katahira, Rui; Davis, Mark] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Ziebell, Angela; Gracom, Kristen; Davis, Mark] Natl Renewable Energy Lab, Bioenergy Sci Ctr, Golden, CO 80401 USA; [Chen, Fang; Dixon, Richard A.] Samuel Roberts Noble Fdn Inc, Ardmore, OK 73401 USA; [Chen, Fang; Dixon, Richard A.] Bioenergy Sci Ctr, Ardmore, OK 73401 USA; [Pu, Yunqiao; Ragauskas, Art] Georgia Tech, Inst Paper Sci & Technol, Atlanta, GA 30318 USA; [Pu, Yunqiao; Ragauskas, Art] Georgia Tech, Bioenergy Sci Ctr, Atlanta, GA 30318 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Noble Research Institute; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Davis, M (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	mark.davis@nrel.gov	Ziebell, Angela/AAO-1551-2020; Ragauskas, Art/J-7486-2016; Davis, Mark/F-7341-2017; Pu, Yunqiao/H-3206-2016	Ragauskas, Art/0000-0002-3536-554X; Davis, Mark/0000-0003-4541-9852; Pu, Yunqiao/0000-0003-2554-1447; Ziebell, Angela/0000-0002-9940-2194	Bioenergy Science Center; Office of Biological and Environmental Research in the Department of Energy Office of Science	Bioenergy Science Center; Office of Biological and Environmental Research in the Department of Energy Office of Science	This work was supported by the Bioenergy Science Center, which is a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science.	Bjorkman A., 1956, SVEN PAPPERSTIDN, V59, P477, DOI DOI 10.1016/J.CHROMA.2003.08.046; Buranov AU, 2008, IND CROP PROD, V28, P237, DOI 10.1016/j.indcrop.2008.03.008; CHANG HM, 1975, HOLZFORSCHUNG, V29, P153, DOI 10.1515/hfsg.1975.29.5.153; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2006, PLANT J, V48, P113, DOI 10.1111/j.1365-313X.2006.02857.x; Chiang VL, 2006, ENVIRON CHEM LETT, V4, P143, DOI 10.1007/s10311-006-0067-9; Crestini C, 1997, J AGR FOOD CHEM, V45, P1212, DOI 10.1021/jf960568k; Freudenberg K., 1968, CONSTITUTION BIOSYNT, P95; Hult EL, 2002, CARBOHYD POLYM, V49, P231, DOI 10.1016/S0144-8617(01)00309-5; IIYAMA K, 1994, PHYTOCHEMISTRY, V35, P959, DOI 10.1016/S0031-9422(00)90647-2; IIYAMA K, 1990, PHYTOCHEMISTRY, V29, P733, DOI 10.1016/0031-9422(90)80009-6; Joseleau JP, 1997, PLANT PHYSIOL, V114, P1123, DOI 10.1104/pp.114.3.1123; LAM TBT, 1992, PHYTOCHEMISTRY, V31, P1179, DOI 10.1016/0031-9422(92)80256-E; LAPIERRE C, 1983, HOLZFORSCHUNG, V37, P189, DOI 10.1515/hfsg.1983.37.4.189; MCDOUGALL GJ, 1994, PLANTA, V194, P9, DOI 10.1007/BF00201028; Monties B., 2001, LIGNIN HUMIC SUBSTAN, P1; Nakashima J, 2008, NEW PHYTOL, V179, P738, DOI 10.1111/j.1469-8137.2008.02502.x; O'Connell A, 2002, TRANSGENIC RES, V11, P495, DOI 10.1023/A:1020362705497; Park S, 2009, CELLULOSE, V16, P641, DOI 10.1007/s10570-009-9321-1; Pu YQ, 2009, BIOENERG RES, V2, P198, DOI 10.1007/s12155-009-9056-8; Ralph J, 2006, J BIOL CHEM, V281, P8843, DOI 10.1074/jbc.M511598200; Ralph J, 1996, J NAT PROD, V59, P341, DOI 10.1021/np960143s; RALPH J, 1994, J AM CHEM SOC, V116, P9448, DOI 10.1021/ja00100a006; Ralph S. A., 2004, NMR DATABASE LIGNIN; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Robert D, 1992, METHODS LIGNIN CHEM; Russell WR, 2006, BIOMACROMOLECULES, V7, P268, DOI 10.1021/bm050636o; Russell WR, 2000, J BIOTECHNOL, V79, P73, DOI 10.1016/S0168-1656(00)00212-1; Russell WR, 1996, ARCH BIOCHEM BIOPHYS, V332, P357, DOI 10.1006/abbi.1996.0353; Sarkanen K.V., 1971, LIGNINS OCCURRENCE F; Shadle G, 2007, PHYTOCHEMISTRY, V68, P1521, DOI 10.1016/j.phytochem.2007.03.022; Sykes R, 2008, WOOD SCI TECHNOL, V42, P649, DOI 10.1007/s00226-008-0199-0; TEEAAR R, 1987, POLYM BULL, V17, P231; Wadenback J, 2004, HOLZFORSCHUNG, V58, P107, DOI 10.1515/HF.2004.015; Whetten RW, 1998, ANNU REV PLANT PHYS, V49, P585, DOI 10.1146/annurev.arplant.49.1.585; Wikberg H, 2004, CARBOHYD POLYM, V58, P461, DOI 10.1016/j.carbpol.2004.08.008	36	90	91	0	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38961	38968		10.1074/jbc.M110.137315	http://dx.doi.org/10.1074/jbc.M110.137315			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20921228	Green Published, hybrid			2022-12-25	WOS:000284941300026
J	Galardi-Castilla, M; Garciandia, A; Suarez, T; Sastre, L				Galardi-Castilla, Maria; Garciandia, Ane; Suarez, Teresa; Sastre, Leandro			The Dictyostelium discoideum acaA Gene Is Transcribed from Alternative Promoters during Aggregation and Multicellular Development	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; NUCLEOTIDE PHOSPHODIESTERASE GENE; STALK CELL-DIFFERENTIATION; ADENYLYL-CYCLASE ACA; DNA-BINDING FACTOR; SOCIAL AMEBAS; PRESPORE DIFFERENTIATION; EXTRACELLULAR CAMP; MESSENGER-RNAS; CYCLIC-AMP	Background: Extracellular cAMP is a key extracellular signaling molecule that regulates aggregation, cell differentiation and morphogenesis during multi-cellular development of the social amoeba Dictyostelium discoideum. This molecule is produced by three different adenylyl cyclases, encoded by the genes acaA, acrA and acgA, expressed at different stages of development and in different structures. Methodology/Principal Findings: This article describes the characterization of the promoter region of the acaA gene, showing that it is transcribed from three different alternative promoters. The distal promoter, promoter 1, is active during the aggregation process while the more proximal promoters are active in tip-organiser and posterior regions of the structures. A DNA fragment containing the three promoters drove expression to these same regions and similar results were obtained by in situ hybridization. Analyses of mRNA expression by quantitative RT-PCR with specific primers for each of the three transcripts also demonstrated their different temporal patterns of expression. Conclusions/Significance: The existence of an aggregation-specific promoter can be associated with the use of cAMP as chemo-attractant molecule, which is specific for some Dictyostelium species. Expression at late developmental stages indicates that adenylyl cyclase A might play a more important role in post-aggregative development than previously considered.	[Galardi-Castilla, Maria; Sastre, Leandro] Univ Autonoma Madrid, CSIC, Inst Invest Biomed, Madrid, Spain; [Garciandia, Ane; Suarez, Teresa] CSIC, Ctr Invest Biol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Galardi-Castilla, M (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed, Madrid, Spain.	lsastre@iib.uam.es	Galardi-Castilla, María/L-6439-2014; Suarez, Teresa/M-9126-2016	Galardi-Castilla, María/0000-0003-2455-6671; Suarez, Teresa/0000-0002-4553-3818; Sastre, Leandro/0000-0003-3613-5938	Spanish Secretary of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2008-02249, SAF2007-66175-C02-01]; Consejo Superior de Investigaciones Cientificas	Spanish Secretary of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas	The study was funded by the Spanish Secretary of Science and Innovation (Ministerio de Ciencia e Innovacion) through grants BFU2008-02249 and SAF2007-66175-C02-01. MG-C and AG were supported by JAE predoctoral fellowships from the Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Curto E, 2005, P NATL ACAD SCI USA, V102, P6385, DOI 10.1073/pnas.0502238102; Alvarez-Curto E, 2007, DEVELOPMENT, V134, P959, DOI 10.1242/dev.02775; Anjard C, 1998, DEVELOPMENT, V125, P4067; ANNESLEY SJ, 2009, MOL CELL BI IN PRESS; BARKLIS E, 1983, CELL, V32, P1139, DOI 10.1016/0092-8674(83)90297-0; BERKS M, 1988, DEV BIOL, V126, P108, DOI 10.1016/0012-1606(88)90244-8; BERKS M, 1990, DEVELOPMENT, V110, P977; Chisholm RL, 2004, NAT REV MOL CELL BIO, V5, P531, DOI 10.1038/nrm1427; DETTERBECK S, 1994, DEVELOPMENT, V120, P2847; Dormann D, 2000, PHILOS T R SOC B, V355, P983, DOI 10.1098/rstb.2000.0634; Escalante R, 2001, DEV BIOL, V235, P314, DOI 10.1006/dbio.2001.0303; Escalante R, 2006, DICTYOSTELIUM DISCOI, P230; ESCH RK, 1991, GENE DEV, V5, P9, DOI 10.1101/gad.5.1.9; FAURE M, 1990, MOL CELL BIOL, V10, P1921, DOI 10.1128/MCB.10.5.1921; Fukuzawa M, 2000, DEVELOPMENT, V127, P2705; Galardi-Castilla M, 2008, DEV BIOL, V316, P260, DOI 10.1016/j.ydbio.2008.01.026; HARWOOD AJ, 1992, CELL, V69, P615, DOI 10.1016/0092-8674(92)90225-2; HOPPER NA, 1993, DEVELOPMENT, V119, P147; Jin T, 2006, EUR J CELL BIOL, V85, P905, DOI 10.1016/j.ejcb.2006.04.008; Kim HJ, 1998, J BIOL CHEM, V273, P30859, DOI 10.1074/jbc.273.47.30859; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; Kriebel PW, 2004, IUBMB LIFE, V56, P541, DOI 10.1080/15216540400013887; LOUIS JM, 1993, P NATL ACAD SCI USA, V90, P5969, DOI 10.1073/pnas.90.13.5969; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; MANN SKO, 1993, DEVELOPMENT, V119, P135; MEHDY MC, 1983, CELL, V32, P763, DOI 10.1016/0092-8674(83)90062-4; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; PARENT CA, 1995, J BIOL CHEM, V270, P22693, DOI 10.1074/jbc.270.39.22693; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; PITT GS, 1993, GENE DEV, V7, P2172, DOI 10.1101/gad.7.11.2172; PODGORSKI GJ, 1989, MOL CELL BIOL, V9, P3938, DOI 10.1128/MCB.9.9.3938; RAPER KENNETH B., 1940, JOUR ELISHA MITCHELL SCI SOC, V56, P241; Ritchie AV, 2008, MOL BIOL EVOL, V25, P2109, DOI 10.1093/molbev/msn156; Saran S, 2002, J MUSCLE RES CELL M, V23, P793, DOI 10.1023/A:1024483829878; Schaap P, 2007, BIOESSAYS, V29, P635, DOI 10.1002/bies.20599; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Schilde C, 2004, DEVELOPMENT, V131, P4555, DOI 10.1242/dev.01330; SCHULKES C, 1995, FEBS LETT, V368, P381, DOI 10.1016/0014-5793(95)00676-Z; SHAULSKY G, 1993, DEV BIOL, V160, P85, DOI 10.1006/dbio.1993.1288; SIEGERT F, 1992, P NATL ACAD SCI USA, V89, P6433, DOI 10.1073/pnas.89.14.6433; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; Siol O, 2006, EUKARYOT CELL, V5, P658, DOI 10.1128/EC.5.4.658-664.2006; SMITH E, 1980, J EMBRYOL EXP MORPH, V57, P233; Soderbom F, 1999, DEVELOPMENT, V126, P5463; vanEs S, 1996, J BIOL CHEM, V271, P23623, DOI 10.1074/jbc.271.39.23623; Verkerke-van Wijk I, 2001, DEV BIOL, V234, P151, DOI 10.1006/dbio.2001.0232; Wang B, 1999, DEV BIOL, V208, P1, DOI 10.1006/dbio.1998.9193; Wang HY, 2010, INT J DEV BIOL, V54, P161, DOI 10.1387/ijdb.082723hw; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; Williams JG, 2006, EMBO REP, V7, P694, DOI 10.1038/sj.embor.7400714; Winckler T, 2004, EUKARYOT CELL, V3, P1349, DOI 10.1128/EC.3.5.1349-1358.2004	51	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13286	10.1371/journal.pone.0013286	http://dx.doi.org/10.1371/journal.pone.0013286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949015	Green Published, Green Submitted, gold			2022-12-25	WOS:000282748100020
J	Jobichen, C; Chakraborty, S; Li, M; Zheng, J; Joseph, L; Mok, YK; Leung, KY; Sivaraman, J				Jobichen, Chacko; Chakraborty, Smarajit; Li, Mo; Zheng, Jun; Joseph, Lissa; Mok, Yu-Keung; Leung, Ka Yin; Sivaraman, J.			Structural Basis for the Secretion of EvpC: A Key Type VI Secretion System Protein from Edwardsiella tarda	PLOS ONE			English	Article							VIBRIO-CHOLERAE; IDENTIFICATION; COMPLEXES; TRANSPORT; SIGNAL	The recently identified type VI secretion system (T6SS) is implicated in the virulence of many Gram-negative bacteria. Edwardsiella tarda is an important cause of hemorrhagic septicemia in fish and also gastro- and extra-intestinal infections in humans. The E. tarda virulent protein (EVP) gene cluster encodes a conserved T6SS which contains 16 open reading frames. EvpC is one of the three major EVP secreted proteins and shares high sequence similarity with Hcp1, a key T6SS virulence factor from Pseudomonas aeruginosa. EvpC contributes to the virulence of E. tarda by playing an essential role in functional T6SS. Here, we report the crystal structure of EvpC from E. tarda PPD130/91 at a 2.8 angstrom resolution, along with functional studies of the protein. EvpC has a beta-barrel domain with extended loops. The beta-barrel consists of 11 anti-parallel beta-strands with an alpha-helix located on one side. In solution, EvpC exists as a dimer at low concentration and as a hexamer at higher concentration. In the crystal, the symmetry related EvpC molecules form hexameric rings which stack together to form a tube similar to Hcp1. Structure based mutagenesis revealed that N-terminal negatively charged residues, Asp4, Glu15 and Glu26, and C-terminal positively charged residues, Lys161, Lys162 and Lys163, played crucial roles in the secretion of EvpC. Moreover, the localization study indicates the presence of wild type EvpC in cytoplasm, periplasm and secreted fractions, whereas the N-terminal and C-terminal mutants were found mostly in the periplasmic region and was completely absent in the secreted fraction. Results reported here provide insight into the structure, assembly and function of EvpC. Further, these findings can be extended to other EvpC homologs for understanding the mechanism of T6SS and targeting T6SS mediated virulence in Gram-negative pathogens.	[Jobichen, Chacko; Chakraborty, Smarajit; Li, Mo; Zheng, Jun; Joseph, Lissa; Mok, Yu-Keung; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Leung, Ka Yin] Trinity Western Univ, Fac Nat & Appl Sci, Dept Biol, Langley, BC, Canada	National University of Singapore; Trinity Western University	Jobichen, C (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsjayar@nus.edu.sg	Zheng, Jun/AAN-4698-2020; Mok, Yu Keung/H-8019-2012; Sivaraman, J/H-8028-2012; Jobichen, Chacko/D-1978-2014; Jobichen, Chacko/AAR-7637-2020	Zheng, Jun/0000-0001-6329-4518; Mok, Yu Keung/0000-0002-2829-4878; Jobichen, Chacko/0000-0001-5927-1815; J, Sivaraman/0000-0001-9781-5326	Biomedical research Council (BMRC), Agency for Science Technology and Research, Singapore [07/1/21/19/495]; National University of Singapore [R154000438112]; National University of Singapore	Biomedical research Council (BMRC), Agency for Science Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore); National University of Singapore(National University of Singapore)	This work was supported by a Biomedical research Council (BMRC) grant (07/1/21/19/495) from the Agency for Science Technology and Research (http://www.a-star.edu.sg), Singapore. J. Sivaraman thanks the funding support from Academic Research Fund (AcRF), National University of Singapore (R154000438112) (www.nus.edu.sg). Jobichen Chacko is a graduate scholar in receipt of a research scholarship from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; CAROL F, 1996, ENCYME MICROB TECHNO, V19, P332; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Das Soumita, 2003, In Silico Biology, V3, P287; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HEIJNE GV, 1988, BIOCHIM BIOPHYS ACTA, V947, P307; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hohlfeld S, 2006, MOL MICROBIOL, V59, P1624, DOI 10.1111/j.1365-2958.2006.05050.x; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; JANDA JM, 1993, CLIN INFECT DIS, V17, P742, DOI 10.1093/clinids/17.4.742; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallen MJ, 2003, CURR OPIN MICROBIOL, V6, P519, DOI 10.1016/j.mib.2003.09.005; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Plumb J. A., 1993, P61; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Tan YP, 2002, INFECT IMMUN, V70, P6475, DOI 10.1128/IAI.70.11.6475-6480.2002; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12910	10.1371/journal.pone.0012910	http://dx.doi.org/10.1371/journal.pone.0012910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886112	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100017
J	Alzogaray, V; Danquah, W; Aguirre, A; Urrutia, M; Berguer, P; Vescovi, EG; Haag, F; Koch-Nolte, F; Goldbaum, FA				Alzogaray, Vanina; Danquah, Welbeck; Aguirre, Andres; Urrutia, Mariela; Berguer, Paula; Garcia Vescovi, Eleonora; Haag, Friedrich; Koch-Nolte, Friedrich; Goldbaum, Fernando A.			Single-domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP-ribosylating toxin of Salmonella typhimurium	FASEB JOURNAL			English	Article						intrabodies; VHH; enzyme inhibition	VIRULENCE PLASMID; TUMOR-GROWTH; PROTEIN; INTRABODIES; SECRETION; ENZYME; POLYMERIZATION; IDENTIFICATION; CYTOPATHOLOGY; CYTOTOXICITY	ADP-ribosylation of host cell proteins is a common mode of cell intoxication by pathogenic bacterial toxins. Antibodies induced by immunization with inactivated ADP-ribosylating toxins provide efficient protection in case of some secreted toxins, e.g., diphtheria and pertussis toxins. However, other ADP-ribosylating toxins, such as Salmonella SpvB toxin, are secreted directly from the Salmonella-containing vacuole into the cytosol of target cells via the SPI-2 encoded bacterial type III secretion system, and thus are inaccessible to conventional antibodies. Small-molecule ADP-ribosylation inhibitors are fraught with potential side effects caused by inhibition of endogenous ADP-ribosyltransferases. Here, we report the development of a single-domain antibody from an immunized llama that blocks the capacity of SpvB to ADP-ribosylate actin at a molar ratio of 1:1. The single-domain antibody, when expressed as an intrabody, effectively protected cells from the cytotoxic activity of a translocation-competent chimeric C2IN-C/SpvB toxin. Transfected cells were also protected against cytoskeletal alterations induced by wild-type SpvB-expressing strains of Salmonella. This proof of principle paves the way for developing new antidotes against intracellular toxins.-Alzogaray, V., Danquah, W., Aguirre, A., Urrutia, M., Berguer, P., Garcia Vescovi, E., Haag, F., Koch-Nolte, F., Goldbaum, F. A. Single-domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP-ribosylating toxin of Salmonella typhimurium. FASEB J. 25, 526-534 (2011). www.fasebj.org	[Alzogaray, Vanina; Urrutia, Mariela; Berguer, Paula; Goldbaum, Fernando A.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, RA-1405 Buenos Aires, DF, Argentina; [Danquah, Welbeck; Haag, Friedrich; Koch-Nolte, Friedrich] Univ Med Ctr, Inst Immunol, Hamburg, Germany; [Aguirre, Andres; Garcia Vescovi, Eleonora] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; National University of Rosario	Goldbaum, FA (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Av Patricias Argentinas 435,C1405BWE, RA-1405 Buenos Aires, DF, Argentina.	fgoldbaum@leloir.org.ar	Berguer, Paula/AAI-6353-2020	Goldbaum, Fernando/0000-0001-6235-3002; Koch-Nolte, Friedrich/0000-0003-1730-6674; Garcia Vescovi, Eleonora/0000-0002-4431-8606; Urrutia, Mariela/0000-0002-5224-9735	Deutsche Forschungsgemeinschaft [310/4, 310/5]; Bundesministerium fur Wirtschafliche Zusammenarbeit; Fundacion YPF fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Wirtschafliche Zusammenarbeit; Fundacion YPF fellowship	This work was supported by grants 310/4 and 310/5 from the Deutsche Forschungsgemeinschaft and the Bundesministerium fur Wirtschafliche Zusammenarbeit to F.K.N. and F.G. The authors thank Fabienne Seyfried (Hamburg, Germany) for excellent technical assistance. The authors thank Drs. Bernhard Fleischer and Hans-Willi Mittrucker (Hamburg, Germany) for critical reading of the manuscript and for providing critical insight. V.A. is supported by a Fundacion YPF fellowship. The authors are grateful to Guillermo Vila Melo and Gonzalo Perez Zabala (Fundacion Biodiversidad, Buenos Aires, Argentina) for the helpful work with the immunizations of the llamas: for providing the llamas, the farm site, and veterinary care; and to Guillermo Lanuza and Hernan R. Bonomi for their help with the figures. F.H. and F.K.N. receive a share of antibody and protein sales via Analytical Services North GmbH, a wholly owned subsidiary of the University Medical Center Hamburg-Eppendorf. F.G. is cofounder of Inmunova, a wholly owned subsidiary of the Instituto Leloir, which provides molecular-assembly vaccines and llama immunizations.	AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Avignolo C, 2008, FASEB J, V22, P1237, DOI 10.1096/fj.07-8865com; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; BOERSMA WJA, 1992, RES IMMUNOL, V143, P503, DOI 10.1016/0923-2494(92)80061-O; Browne SH, 2008, FEMS IMMUNOL MED MIC, V52, P194, DOI 10.1111/j.1574-695X.2007.00364.x; Browne SH, 2002, INFECT IMMUN, V70, P7126, DOI 10.1128/IAI.70.12.7126-7135.2002; Chartier A, 2009, HUM MOL GENET, V18, P1849, DOI 10.1093/hmg/ddp101; Cohen-Saidon C, 2003, BLOOD, V102, P2506, DOI 10.1182/blood-2002-12-3921; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; da Silva FA, 2004, J MOL BIOL, V340, P525, DOI 10.1016/j.jmb.2004.04.062; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Delanote V, 2010, FASEB J, V24, P105, DOI 10.1096/fj.09-134304; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; FIERER J, 1992, J INFECT DIS, V166, P639, DOI 10.1093/infdis/166.3.639; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gotoh H, 2003, MICROB PATHOGENESIS, V34, P227, DOI 10.1016/S0882-4010(03)00034-2; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gueorguieva D, 2006, FASEB J, V20, P2636, DOI 10.1096/fj.06-6306fje; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Jendreyko N, 2005, P NATL ACAD SCI USA, V102, P8293, DOI 10.1073/pnas.0503168102; Jobling SA, 2003, NAT BIOTECHNOL, V21, P77, DOI 10.1038/nbt772; Koch-Nolte F, 2008, FRONT BIOSCI-LANDMRK, V13, P6716, DOI 10.2741/3184; Koch-Nolte F, 2007, FASEB J, V21, P3490, DOI 10.1096/fj.07-8661com; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kurita A, 2003, MICROB PATHOGENESIS, V35, P43, DOI 10.1016/S0882-4010(03)00066-4; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; Libby SJ, 2000, CELL MICROBIOL, V2, P49, DOI 10.1046/j.1462-5822.2000.00030.x; Lindgren SW, 1996, P NATL ACAD SCI USA, V93, P4197, DOI 10.1073/pnas.93.9.4197; Lo A. S. -Y., 2008, V181, P343; LOWY I, N ENGL J MED, V362, P197; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; Marquardt A, 2006, CHEM-EUR J, V12, P1915, DOI 10.1002/chem.200500785; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Otto H, 2000, MOL MICROBIOL, V37, P1106, DOI 10.1046/j.1365-2958.2000.02064.x; Paz K, 2005, MOL CANCER THER, V4, P1801, DOI 10.1158/1535-7163.MCT-05-0174; Pust S, 2007, J BIOL CHEM, V282, P10272, DOI 10.1074/jbc.M610254200; Ratier L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003524; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Serruys B, 2009, HEPATOLOGY, V49, P39, DOI 10.1002/hep.22609; Tezcan-Merdol D, 2001, MOL MICROBIOL, V39, P606, DOI 10.1046/j.1365-2958.2001.02258.x; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; Vassiloyanakopoulos AP, 1998, P NATL ACAD SCI USA, V95, P7676, DOI 10.1073/pnas.95.13.7676; VERCRUYSSE T, 2010, J BIOL CHEM; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Worley MJ, 2006, P NATL ACAD SCI USA, V103, P17915, DOI 10.1073/pnas.0604054103; Zarebski LM, 2005, J MOL BIOL, V349, P814, DOI 10.1016/j.jmb.2005.03.072	66	28	31	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					526	534		10.1096/fj.10-162958	http://dx.doi.org/10.1096/fj.10-162958			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20940265				2022-12-25	WOS:000286724800011
J	Sachdeva, M; Wu, H; Ru, P; Hwang, L; Trieu, V; Mo, YY				Sachdeva, M.; Wu, H.; Ru, P.; Hwang, L.; Trieu, V.; Mo, Y-Y			MicroRNA-101-mediated Akt activation and estrogen-independent growth	ONCOGENE			English	Article						breast cancer; estrogen receptor; miR-101; tamoxifen resistance	ALPHA MESSENGER-RNA; BREAST-CANCER; TUMOR-SUPPRESSOR; TAMOXIFEN RESISTANCE; RECEPTOR-ALPHA; PROTEIN STABILITY; PTEN; PHOSPHORYLATION; MECHANISMS; EXPRESSION	MicroRNAs are gene regulators that work through a posttranscriptional repression mechanism. Dysregulation of microRNA expression could lead to a variety of disorders, in particular, human cancer, and has also been implicated in antihormone therapy resistance. However, little is known whether microRNAs have a role in estrogen-independent growth, leading to tamoxifen resistance in estrogen receptor (ER)-positive tumors. In this study, we use an in vivo selection system against a microRNA library using the MCF-7 model and demonstrate that miR-101 promotes estrogen-independent growth and causes the upregulation of phosphorylated Akt (pAkt) without impacting the ER level or activity. Importantly, although miR-101 suppresses cell growth in normal estradiol (E2)-containing medium, it promotes cell growth in E2-free medium. Moreover, estrogen deprivation greatly enhances miR-101-mediated Akt activation. Finally, we show that MAGI-2 (membrane-associated guanylate kinase), a scaffold protein required for PTEN (phosphatase and tensin homolog) activity, is a direct target for miR-101; suppression of MAGI-2 by miR-101 reduces PTEN activity, leading to Akt activation. Taken together, these results not only establish a role for miR101 in estrogen-independent signaling but also provide a mechanistic link between miR-101 and Akt activation. Oncogene (2011) 30, 822-831; doi:10.1038/onc.2010.463; published online 18 October 2010	[Sachdeva, M.; Wu, H.; Ru, P.; Mo, Y-Y] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA; [Hwang, L.; Trieu, V.] Abraxis Biosci, Marina Del Rey, CA USA	Southern Illinois University System; Southern Illinois University	Mo, YY (corresponding author), So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, 825 N Rutledge,POB 19626, Springfield, IL 62794 USA.	ymo@siumed.edu	Mo, Yin-Yuan/R-8255-2019; Mo, Yin-Yuan/B-6141-2011		Susan G Komen for the Cure [KG100027]; Department of Defense [BC085629]; Abraxis Bioscience	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); Abraxis Bioscience	We are grateful to Andy Wilber for the preparation of the viral stock used in this study and to Dr Yutaka Hata for the MAGI2 construct. This work is supported by KG100027 from Susan G Komen for the Cure, by BC085629 from the Department of Defense and the research fund from Abraxis Bioscience.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; Lykkesfeldt AE, 1996, ACTA ONCOL, V35, P9, DOI 10.3109/02841869609083961; Maddika S, 2009, MOL CELL BIOL, V29, P1235, DOI 10.1128/MCB.00668-08; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tolkacheva T, 2001, CANCER RES, V61, P4985; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yu Y, 2002, ONCOGENE, V21, P7557, DOI 10.1038/sj.onc.1205961; Zhang YY, 2009, MOL CANCER RES, V7, P498, DOI 10.1158/1541-7786.MCR-08-0415; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	35	88	94	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	7					822	831		10.1038/onc.2010.463	http://dx.doi.org/10.1038/onc.2010.463			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	722OT	20956939				2022-12-25	WOS:000287444600006
J	Suo, J; Snider, SJ; Mills, GB; Creighton, CJ; Chen, AC; Schiff, R; Lloyd, RE; Chang, EC				Suo, J.; Snider, S. J.; Mills, G. B.; Creighton, C. J.; Chen, A. C.; Schiff, R.; Lloyd, R. E.; Chang, E. C.			Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium	ONCOGENE			English	Article						eIF3; translation; ubiquitin; proteasomes; tumor suppressor	FISSION YEAST HOMOLOG; BREAST-CANCER; TUMOR VIRUS; STEM-CELLS; PROTEIN; GENE; RESISTANCE; EXPRESSION; COMPLEXES; SUBUNIT	INT6/EIF3E has been implicated in breast tumorigenesis, but its functional activities remain poorly defined. We found that, repressing INT6 expression induced transformed properties in normal human mammary epithelium (MCF10A); in contrast, Int6 silencing induced apoptosis in HeLa cells. As in fission yeast, Int6 in human cells was required for assembly of active proteasomes. A reverse-phase protein array screen identified SRC3/AIB1 as one oncoprotein the level and stability of which increased when Int6 was silenced in MCF10A cells. Our data further show that Int6 binds SRC3 and its ubiquitin ligase Fbw7, thus perhaps mediating the interaction between SRC3-Fbw7 and proteasomes. Consistent with this, Int6 silencing did not increase SRC3 levels in HeLa cells, which have low Fbw7 levels. It is surprising that, however, polyubiquitylated proteins do not accumulate or may even decrease in Int6-silenced cells that contain defective proteasomes. Considering that decreased ubiquitin might explain this observation and that Int6 might control ubiquitin levels in its role as a subunit of eIF3 ((e) under bar ukaryote translation (i) under bar nitiation (f) under bar actor 3), we found that silencing Int6 reduced monoubiquitin protein levels, which correlated with a shift of ubiquitin mRNAs from larger polysomes to non-translating ribosomes. In contrast, levels of many housekeeping proteins did not change. This apparent reduction in the translation of ubiquitin genes correlated with a modest reduction in protein synthesis rate and formation of large polysomes. To further determine whether Int6 can selectively control translation, we analyzed translation of different 5'-untranslated region reporters and found that indeed, loss of Int6 had differential effects on these reporters. Together the data suggest that Int6 depletion blocks ubiquitin-dependent proteolysis by decreasing both ubiquitin levels and the assembly of functional proteasome machinery, leading to accumulation of oncoproteins, such as SRC3 that can transform mammary epithelium. Our data also raise the possibility that Int6 can further fine-tune protein levels by selectively controlling translation of specific mRNAs. Oncogene (2011) 30, 724-736; doi:10.1038/onc.2010.445; published online 4 October 2010	[Suo, J.; Chang, E. C.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Suo, J.; Creighton, C. J.; Chen, A. C.; Schiff, R.; Chang, E. C.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Snider, S. J.; Lloyd, R. E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Creighton, C. J.] Baylor Coll Med, Div Biostat, Houston, TX 77030 USA; [Chen, A. C.; Schiff, R.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine	Chang, EC (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	echang1@bcm.edu			NIH [CA90464, CA107187, P50CA58183, P50CA058183, AI50237, GM59803]; Susan G. Komen Foundation [PDF0402733]; Expedition Inspiration Fund for Breast Cancer Research; NATIONAL CANCER INSTITUTE [P50CA058183, R01CA090464, R01CA107187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050237, R56AI050237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059803] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Expedition Inspiration Fund for Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank John Hershey for providing eIF3 antibodies, and members of the Adrian Lee and Steffi Oesterreich labs for the help with tissue culture. We thank Carlos Rivera for technical assistance in the translation study and Steen Pedersen for assistance in the use of the fluorometer, Chris Threetor, Mike Cubbage and Xinrong Fu for the use of a flow cytometer in the Flow Cytometry core lab at Texas Children's Cancer Center, Michael Lewis for confocal microscopy, Gary Chamness for reading the manuscript, Anna Tsimelzon and Susan Hilsenbeck for database analyses, Jan Sap for assistance in Int6 expression studies, Yiling Lu for assistance in the RRPA screen, members of Robert Callahan's group for discussion and David Lonard and Bert O'Malley in the help of SRC3 study. We are particularly grateful to Sizhen Gao, Joan Brugge and Sean McGuire for sharing unpublished results and comments for the paper. ECC is supported by grants from the NIH (CA90464, CA107187 and P50CA58183), JS by fellowships from the Susan G. Komen Foundation (PDF0402733) and Expedition Inspiration Fund for Breast Cancer Research, RS by grants from NIH, P50CA058183 and SU2C (Stand Up 2 Cancer) and REL by NIH grants (AI50237 and GM59803).	Akiyoshi Y, 2001, J BIOL CHEM, V276, P10056, DOI 10.1074/jbc.M010188200; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Byrd MP, 2005, J BIOL CHEM, V280, P18610, DOI 10.1074/jbc.M414014200; Crane R, 2000, MOL BIOL CELL, V11, P3993, DOI 10.1091/mbc.11.11.3993; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Diella F, 1997, DNA CELL BIOL, V16, P839, DOI 10.1089/dna.1997.16.839; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Grzmil M, 2010, ONCOGENE, V29, P4080, DOI 10.1038/onc.2010.152; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; HOAREAU AK, 2002, FEBS LETT, V527, P15, DOI 10.1016/S0014-5793(02)03147-2; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Lonard DM, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe16; Mack DL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1742; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Marchetti A, 2001, INT J ONCOL, V18, P175; Massarweh S, 2006, CANCER RES, V66, P8266, DOI 10.1158/0008-5472.CAN-05-4045; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Mayeur GL, 2002, FEBS LETT, V514, P49, DOI 10.1016/S0014-5793(02)02307-4; Morris C, 2005, ONCOGENE, V24, P1203, DOI 10.1038/sj.onc.1208268; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; Rivera CI, 2008, VIROLOGY, V375, P59, DOI 10.1016/j.virol.2008.02.002; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Umar A, 2009, MOL CELL PROTEOMICS, V8, P1278, DOI 10.1074/mcp.M800493-MCP200; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WOODS A, 1989, J CELL SCI, V93, P491; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Yen HCS, 2000, P NATL ACAD SCI USA, V97, P14370, DOI 10.1073/pnas.97.26.14370; Yen HCS, 2003, CELL CYCLE, V2, P81, DOI 10.4161/cc.2.2.340; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	40	17	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2011	30	6					724	736		10.1038/onc.2010.445	http://dx.doi.org/10.1038/onc.2010.445			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	719GY	20890303	Green Accepted			2022-12-25	WOS:000287192000009
J	Caulfield, MJ; Dudkin, VY; Ottinger, EA; Getty, KL; Zuck, PD; Kaufhold, RM; Hepler, RW; McGaughey, GB; Citron, M; Hrin, RC; Wang, YJ; Miller, MD; Joyce, JG				Caulfield, Michael J.; Dudkin, Vadim Y.; Ottinger, Elizabeth A.; Getty, Krista L.; Zuck, Paul D.; Kaufhold, Robin M.; Hepler, Robert W.; McGaughey, Georgia B.; Citron, Michael; Hrin, Renee C.; Wang, Ying-Jie; Miller, Michael D.; Joyce, Joseph G.			Small Molecule Mimetics of an HIV-1 gp41 Fusion Intermediate as Vaccine Leads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRALIZING ANTIBODIES; DESIGN; EPITOPE; BINDING; POTENT; DIVERSITY; GP120; PEPTIDOMIMETICS; IMMUNOGENICITY; HYPERMUTATION	We describe here a novel platform technology for the discovery of small molecule mimetics of conformational epitopes on protein antigens. As a model system, we selected mimetics of a conserved hydrophobic pocket within the N-heptad repeat region of the HIV-1 envelope protein, gp41. The human monoclonal antibody, D5, binds to this target and exhibits broadly neutralizing activity against HIV-1. We exploited the antigen-binding property of D5 to select complementary small molecules using a high throughput screen of a diverse chemical collection. The resulting small molecule leads were rendered immunogenic by linking them to a carrier protein and were shown to elicit N-heptad repeat-binding antibodies in a fraction of immunized mice. Plasma from HIV-1-infected subjects shown previously to contain broadly neutralizing antibodies was found to contain antibodies capable of binding to haptens represented in the benzylpiperidine leads identified as a result of the high throughput screen, further validating these molecules as vaccine leads. Our results suggest a new paradigm for vaccine discovery using a medicinal chemistry approach to identify lead molecules that, when optimized, could become vaccine candidates for infectious diseases that have been refractory to conventional vaccine development.	[Caulfield, Michael J.; Ottinger, Elizabeth A.; Kaufhold, Robin M.; Hepler, Robert W.; Citron, Michael; Joyce, Joseph G.] Merck Res Labs, Dept Vaccine Basic Res, West Point, PA 19486 USA; [Dudkin, Vadim Y.] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA; [Getty, Krista L.; Zuck, Paul D.] Merck Res Labs, Dept Automated Biotechnol, West Point, PA 19486 USA; [McGaughey, Georgia B.] Merck Res Labs, Dept Chem Modeling & Informat, West Point, PA 19486 USA; [Hrin, Renee C.; Wang, Ying-Jie; Miller, Michael D.] Merck Res Labs, Dept Antiviral Res, West Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Joyce, JG (corresponding author), WP16-101,770 Sumneytown Pike, West Point, PA 19486 USA.	joseph_joyce@merck.com						Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; DATTA SK, 1987, J EXP MED, V165, P1252, DOI 10.1084/jem.165.5.1252; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dias RLA, 2006, J AM CHEM SOC, V128, P2726, DOI 10.1021/ja057513w; Falciani C, 2005, CHEM BIOL, V12, P417, DOI 10.1016/j.chembiol.2005.02.009; Freeman C, 2005, J BIOL CHEM, V280, P8842, DOI 10.1074/jbc.M410769200; FRENCH DL, 1989, SCIENCE, V244, P1152, DOI 10.1126/science.2658060; GIANNINI G, 1984, NUCLEIC ACIDS RES, V12, P4063, DOI 10.1093/nar/12.10.4063; Harvey AJ, 2005, BIOORG MED CHEM LETT, V15, P3193, DOI 10.1016/j.bmcl.2005.05.014; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Joyce JG, 2008, P NATL ACAD SCI USA, V105, P15684, DOI 10.1073/pnas.0807837105; Kelso MJ, 2004, J AM CHEM SOC, V126, P4828, DOI 10.1021/ja037980i; KieberEmmons T, 1997, CURR OPIN BIOTECH, V8, P435, DOI 10.1016/S0958-1669(97)80065-1; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; MILLER MD, 1994, J COMPUT AID MOL DES, V8, P153, DOI 10.1007/BF00119865; Nahas DD, 2008, BIOCONJUGATE CHEM, V19, P322, DOI 10.1021/bc700232z; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; Qiao ZS, 2005, J BIOL CHEM, V280, P23138, DOI 10.1074/jbc.M414515200; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Yang LH, 1998, J MED CHEM, V41, P2439, DOI 10.1021/jm9800191; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	34	3	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40604	40611		10.1074/jbc.M110.172197	http://dx.doi.org/10.1074/jbc.M110.172197			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943652	hybrid, Green Published			2022-12-25	WOS:000285414400023
J	Ding, PG; Huang, JA; Battiprolu, PK; Hill, JA; Kamm, KE; Stull, JT				Ding, Peiguo; Huang, Jian; Battiprolu, Pavan K.; Hill, Joseph A.; Kamm, Kristine E.; Stull, James T.			Cardiac Myosin Light Chain Kinase Is Necessary for Myosin Regulatory Light Chain Phosphorylation and Cardiac Performance in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CONTRACTION; INTERACTING PROTEIN-KINASE; HYPERTROPHIC CARDIOMYOPATHY; CA2+ SENSITIVITY; TRANSGENIC MICE; FORCE DEVELOPMENT; STRIATED-MUSCLE; THIN-FILAMENTS; KNOCKOUT MICE; HEART	In contrast to studies on skeletal and smooth muscles, the identity of kinases in the heart that are important physiologically for direct phosphorylation of myosin regulatory light chain (RLC) is not known. A Ca2+/calmodulin-activated myosin light chain kinase is expressed only in cardiac muscle (cMLCK), similar to the tissue-specific expression of skeletal muscle MLCK and in contrast to the ubiquitous expression of smooth muscle MLCK. We have ablated cMLCK expression in male mice to provide insights into its role in RLC phosphorylation in normally contracting myocardium. The extent of RLC phosphorylation was dependent on the extent of cMLCK expression in both ventricular and atrial muscles. Attenuation of RLC phosphorylation led to ventricular myocyte hypertrophy with histological evidence of necrosis and fibrosis. Echocardiography showed increases in left ventricular mass as well as end-diastolic and end-systolic dimensions. Cardiac performance measured as fractional shortening decreased proportionally with decreased cMLCK expression culminating in heart failure in the setting of no RLC phosphorylation. Hearts from female mice showed similar responses with loss of cMLCK associated with diminished RLC phosphorylation and cardiac hypertrophy. Isoproterenol infusion elicited hypertrophic cardiac responses in wild type mice. In mice lacking cMLCK, the hypertrophic hearts showed no additional increases in size with the isoproterenol treatment, suggesting a lack of RLC phosphorylation blunted the stress response. Thus, cMLCK appears to be the predominant protein kinase that maintains basal RLC phosphorylation that is required for normal physiological cardiac performance in vivo.	[Ding, Peiguo; Huang, Jian; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Battiprolu, Pavan K.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Stull, JT (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu			National Institutes of Health [HL080536, HL-075173, HL-080144, HL-090842]; American Heart Association [0640084N]; American Diabetes Association [7-08-MN-21-ADA]; American Heart Association-Jon Holden DeHaan Foundation [0970518N]; Moss Heart Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075173, R01HL080536, R01HL080144, R01HL090842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); American Heart Association-Jon Holden DeHaan Foundation(American Heart Association); Moss Heart Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080536, HL-075173, HL-080144, and HL-090842. This work was also supported by American Heart Association Grant 0640084N, American Diabetes Association Grant 7-08-MN-21-ADA, the American Heart Association-Jon Holden DeHaan Foundation Grant 0970518N, and the Moss Heart Fund.	Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chang AN, 2010, J BIOL CHEM, V285, P5122, DOI 10.1074/jbc.C109.076489; Collins JH, 2006, J MUSCLE RES CELL M, V27, P69, DOI 10.1007/s10974-006-9057-6; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Dudnakova TV, 2006, CELL MOTIL CYTOSKEL, V63, P375, DOI 10.1002/cm.20127; Ferrari MB, 2006, CELL BIOCHEM BIOPHYS, V45, P317, DOI 10.1385/CBB:45:3:317; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; Gu XH, 2010, CARDIOVASC RES, V88, P334, DOI 10.1093/cvr/cvq223; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; HERRING BP, 1986, BIOCHEM J, V240, P205, DOI 10.1042/bj2400205; HIGH CW, 1980, AM J PHYSIOL, V239, pH756, DOI 10.1152/ajpheart.1980.239.6.H756; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Huang GJ, 2006, J CELL SCI, V119, P153, DOI 10.1242/jcs.02731; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; JABBOUR A, 2010, EUR J HEART IN PRESS; Kerrick WGL, 2009, FASEB J, V23, P855, DOI 10.1096/fj.08-118182; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li HY, 2004, DEV DYNAM, V229, P231, DOI 10.1002/dvdy.10428; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; Lin PJ, 1997, J BIOL CHEM, V272, P7412, DOI 10.1074/jbc.272.11.7412; Ma XF, 2009, CIRC RES, V105, P1102, DOI 10.1161/CIRCRESAHA.109.200303; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Maillet M, 2010, J BIOL CHEM, V285, P6716, DOI 10.1074/jbc.M109.056143; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Mizutani H, 2010, CIRC J, V74, P120, DOI 10.1253/circj.CJ-09-0462; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; NUNNALLY MH, 1984, J BIOL CHEM, V259, P1776; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; Rayment I, 1996, J BIOL CHEM, V271, P15850, DOI 10.1074/jbc.271.27.15850; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Saucerman JJ, 2008, BIOPHYS J, V95, P4597, DOI 10.1529/biophysj.108.128728; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; SILVER PJ, 1986, J MOL CELL CARDIOL, V18, P31, DOI 10.1016/S0022-2828(86)80980-4; Smith L, 2000, FEBS LETT, V480, P298, DOI 10.1016/S0014-5793(00)01931-1; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Song QJ, 2008, J BIOL CHEM, V283, P31531, DOI 10.1074/jbc.M804902200; Stull JT, 1998, ACTA PHYSIOL SCAND, V164, P471, DOI 10.1111/j.1365-201X.1998.tb10699.x; STULL JT, 1986, ENZYMES, V17, P113; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Szczesna D, 2002, J APPL PHYSIOL, V92, P1661, DOI 10.1152/japplphysiol.00858.2001; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Szczesna-Cordary D, 2005, J CELL SCI, V118, P3675, DOI 10.1242/jcs.02492; van der Velden J, 2003, CARDIOVASC RES, V57, P505, DOI 10.1016/S0008-6363(02)00662-4; Wang LB, 2010, ANN INTERN MED, V152, P513, DOI 10.7326/0003-4819-152-8-201004200-00008; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102	68	89	92	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40819	40829		10.1074/jbc.M110.160499	http://dx.doi.org/10.1074/jbc.M110.160499			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943660	Green Published, hybrid			2022-12-25	WOS:000285414400047
J	Sekine, O; Love, DC; Rubenstein, DS; Hanover, JA				Sekine, Osamu; Love, Dona C.; Rubenstein, David S.; Hanover, John A.			Blocking O-Linked GlcNAc Cycling in Drosophila Insulin-producing Cells Perturbs Glucose-Insulin Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE; TETRATRICOPEPTIDE REPEATS; SIGNAL-TRANSDUCTION; SKELETAL-MUSCLE; X-CHROMOSOME; BETA-CELLS; RESISTANCE; GLYCOSYLATION; TRANSFERASE; PROTEIN	A dynamic cycle of O-linked GlcNAc (O-GlcNAc) addition and removal is catalyzed by O-GlcNAc transferase and O-GlcNAcase, respectively, in a process that serves as the final step in a nutrient-driven "hexosamine-signaling pathway." Evidence points to a role for O-GlcNAc cycling in diabetes and insulin resistance. We have used Drosophila melanogaster to determine whether O-GlcNAc metabolism plays a role in modulating Drosophila insulin-like peptide (dilp) production and insulin signaling. We employed transgenesis to either overexpress or knock down Drosophila Ogt(sxc) and Oga in insulin-producing cells (IPCs) or fat bodies using the GAL4-UAS system. Knockdown of Ogt decreased Dilp2, Dilp3, and Dilp5 production, with reduced body size and decreased phosphorylation of Akt in vivo. In contrast, knockdown of Oga increased Dilp2, Dilp3, and Dilp5 production, increased body size, and enhanced phosphorylation of Akt in vivo. However, knockdown of either Ogt(sxc) or Oga in the IPCs increased the hemolymph carbohydrate concentration. Furthermore, phosphorylation of Akt stimulated by extraneous insulin in an ex vivo cultured fat body of third instar larvae was diminished in strains subjected to IPC knockdown of Ogt or Oga. Knockdown of O-GlcNAc cycling enzymes in the fat body dramatically reduced neutral lipid stores. These results demonstrate that altered O-GlcNAc cycling in Drosophila IPCs modulates insulin production and influences the insulin responsiveness of peripheral tissues. The observed phenotypes in O-GlcNAc cycling mimic pancreatic beta-cell dysfunction and glucose toxicity related to sustained hyperglycemia in mammals.	[Sekine, Osamu] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Rubenstein, David S.] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; University of North Carolina Chapel Hill	Hanover, JA (corresponding author), NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA.	jah@helix.nih.gov			National Institutes of Health NIDDK; Cell Science Research Foundation in Japan; Manpei Suzuki Diabetes Foundation in Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060103, ZIADK060101] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cell Science Research Foundation in Japan; Manpei Suzuki Diabetes Foundation in Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health NIDDK Intramural Research Program. This work was also supported by a scholarship from the Cell Science Research Foundation in Japan and the Manpei Suzuki Diabetes Foundation in Japan.	Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; DELPRATO S, 1994, DIABETOLOGIA, V37, P1025, DOI 10.1007/BF00400466; Egawa K, 1999, J BIOL CHEM, V274, P14306, DOI 10.1074/jbc.274.20.14306; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hartweck LM, 2002, GENETICS, V161, P1279; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Konrad RJ, 2000, BIOCHEM BIOPH RES CO, V267, P26, DOI 10.1006/bbrc.1999.1895; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Lizcano JM, 2003, BIOCHEM J, V374, P297, DOI 10.1042/BJ20030577; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Lubas WA, 1997, J BIOL CHEM, V272, P9316; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Miles PDG, 1998, J CLIN INVEST, V101, P202, DOI 10.1172/JCI1256; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Tang JP, 2000, DIABETES, V49, P1492, DOI 10.2337/diabetes.49.9.1492; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Toleman CA, 2006, J BIOL CHEM, V281, P3918, DOI 10.1074/JBC.m510485200; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Zhang HF, 2009, P NATL ACAD SCI USA, V106, pE27, DOI 10.1073/pnas.0900125106; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	47	43	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38684	38691		10.1074/jbc.M110.155192	http://dx.doi.org/10.1074/jbc.M110.155192			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926386	Green Published, hybrid			2022-12-25	WOS:000284625600073
J	Higashi, K; Sakamaki, Y; Herai, E; Demizu, R; Uemura, T; Saroj, SD; Zenda, R; Terui, Y; Nishimura, K; Toida, T; Kashiwagi, K; Igarashi, K				Higashi, Kyohei; Sakamaki, Yoshiharu; Herai, Emiko; Demizu, Risa; Uemura, Takeshi; Saroj, Sunil D.; Zenda, Risa; Terui, Yusuke; Nishimura, Kazuhiro; Toida, Toshihiko; Kashiwagi, Keiko; Igarashi, Kazuei			Identification and Functions of Amino Acid Residues in PotB and PotC Involved in Spermidine Uptake Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREFERENTIAL UPTAKE SYSTEM; BINDING CASSETTE TRANSPORTER; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; POLYAMINE TRANSPORT; ABC TRANSPORTER; MALTOSE TRANSPORT; PROTEIN; ATP; MALK	Amino acid residues on PotB and PotC involved in spermidine uptake were identified by random and site-directed mutagenesis. It was found that Trp(8), Tyr(43), Trp(100), Leu(110), and Tyr(261) in PotB and Trp(46), Asp(108), Glu(169), Ser(196), Asp(198), and Asp(199) in PotC were strongly involved in spermidine uptake and that Tyr(160), Glu(172), and Leu(274) in PotB and Tyr(19), Tyr(88), Tyr(148), Glu(160), Leu(195), and Tyr(211) in PotC were moderately involved in spermidine uptake. Among 11 amino acid residues that were strongly involved in spermidine uptake, Trp(8) in PotB was important for insertion of PotB and PotC into membranes. Tyr(43), Trp(100), and Leu(110) in PotB and Trp(46), Asp(108), Ser(196), and Asp(198) in PotC were found to be involved in the interaction with PotD. Leu(110) and Tyr(261) in PotB and Asp(108), Asp(198), and Asp(199) in PotC were involved in the recognition of spermidine, and Trp(100) and Tyr(261) in PotB and Asp(108), Glu(169), and Asp(198) in PotC were involved in ATPase activity of PotA. Accordingly, Trp(100) in PotB was involved in both PotD recognition and ATPase activity, Leu(110) in PotB was involved in both PotD and spermidine recognition, and Tyr(261) in PotB was involved in both spermidine recognition and ATPase activity. Asp(108) and Asp(198) in PotC were involved in PotD and spermidine recognition as well as ATPase activity. These results suggest that spermidine passage from PotD to the cytoplasm is coupled to the ATPase activity of PotA through a structural change of PotA by its ATPase activity.	[Zenda, Risa; Nishimura, Kazuhiro; Toida, Toshihiko; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chuo Ku, Chiba 2600856, Japan; [Terui, Yusuke; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Chiba 2880025, Japan	Chiba University; Chiba University	Igarashi, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	iga16077@faculty.chiba-u.jp	Saroj, Sunil/R-8113-2019	Saroj, Sunil D/0000-0002-8071-2731; Nishimura, Kazuhiro/0000-0002-6209-5522; Higashi, Kyohei/0000-0002-2622-4825; Igarashi, Kazuei/0000-0003-3751-3187	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Eitinger T., 2010, FEMS MICROB IN PRESS; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; HOUNG HS, 1986, J BACTERIOL, V168, P1040, DOI 10.1128/jb.168.2.1040-1044.1986; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hunke S, 2000, J BACTERIOL, V182, P1432, DOI 10.1128/JB.182.5.1432-1436.2000; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; KANG CH, 1991, J BIOL CHEM, V266, P23893; KASHIWAGI K, 1990, J BIOL CHEM, V265, P20893; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; KASHIWAGI K, 1993, J BIOL CHEM, V268, P19358; Kashiwagi K, 1996, J BIOL CHEM, V271, P12205, DOI 10.1074/jbc.271.21.12205; KASHIWAGI K, 1986, J BACTERIOL, V165, P972, DOI 10.1128/jb.165.3.972-977.1986; KASHIWAGI K, 1988, J BACTERIOL, V170, P3131, DOI 10.1128/jb.170.7.3131-3135.1988; Kashiwagi K, 2002, J BIOL CHEM, V277, P24212, DOI 10.1074/jbc.M202849200; KASHIWAGI K, 1995, J BIOL CHEM, V270, P25377, DOI 10.1074/jbc.270.43.25377; Koizume S, 2006, NEUROSCIENCE, V141, P1861, DOI 10.1016/j.neuroscience.2006.05.067; KUHNAU S, 1991, J BACTERIOL, V173, P2180; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; LINDEROTH N, 1983, BIOCHEM BIOPH RES CO, V117, P616, DOI 10.1016/0006-291X(83)91245-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING LAB MANU, P250; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; PEGG AE, 1988, CANCER RES, V48, P759; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; YAMAGUCHI K, 1985, MOL GEN GENET, V200, P362, DOI 10.1007/BF00425718; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411	50	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39061	39069		10.1074/jbc.M110.186536	http://dx.doi.org/10.1074/jbc.M110.186536			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937813	hybrid, Green Published			2022-12-25	WOS:000284941300036
J	Hofman, EG; Bader, AN; Voortman, J; van den Heuvel, DJ; Sigismund, S; Verkleij, AJ; Gerritsen, HC; Henegouwen, PMPVE				Hofman, Erik G.; Bader, Arjen N.; Voortman, Jarno; van den Heuvel, Dave J.; Sigismund, Sara; Verkleij, Arie J.; Gerritsen, Hans C.; Henegouwen, Paul M. P. van Bergen En			Ligand-induced EGF Receptor Oligomerization Is Kinase-dependent and Enhances Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN CLUSTER SIZES; LIVING CELLS; ACTIVATION; DOMAIN; ENDOCYTOSIS; MICROSCOPY; SURFACE; TRAFFICKING; MECHANISM	The current activation model of the EGF receptor (EGFR) predicts that binding of EGF results in dimerization and oligomerization of the EGFR, leading to the allosteric activation of the intracellular tyrosine kinase. Little is known about the regulatory mechanism of receptor oligomerization. In this study, we have employed FRET between identical fluorophores (homo-FRET) to monitor the dimerization and oligomerization state of the EGFR before and after receptor activation. Our data show that, in the absence of ligand, similar to 40% of the EGFR molecules were present as inactive dimers or predimers. The monomer/predimer ratio was not affected by deletion of the intracellular domain. Ligand binding induced the formation of receptor oligomers, which were found in both the plasma membrane and intracellular structures. Ligand-induced oligomerization required tyrosine kinase activity and nine different tyrosine kinase substrate residues. This indicates that the binding of signaling molecules to activated EGFRs results in EGFR oligomerization. Induction of EGFR predimers or pre-oligomers using the EGFR fused to the FK506-binding protein did not affect signaling but was found to enhance EGF-induced receptor internalization. Our data show that EGFR oligomerization is the result of EGFR signaling and enhances EGFR internalization.	[Henegouwen, Paul M. P. van Bergen En] Univ Utrecht, Fac Sci, Inst Biomembranes, Dept Cellular Dynam, NL-3584 CH Utrecht, Netherlands; [Bader, Arjen N.; van den Heuvel, Dave J.; Gerritsen, Hans C.] Univ Utrecht, Fac Sci, Dept Mol Biophys, NL-3584 CH Utrecht, Netherlands; [Sigismund, Sara] FIRC Inst Mol Oncol Fdn IFOM, I-20139 Milan, Italy	Utrecht University; Utrecht University; IFOM - FIRC Institute of Molecular Oncology	Henegouwen, PMPVE (corresponding author), Univ Utrecht, Fac Sci, Inst Biomembranes, Dept Cellular Dynam, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	p.vanbergen@uu.nl	van Bergen en Henegouwen, Paul/B-8870-2011; Sigismund, Sara/H-3687-2017; Gerritsen, Hans c/B-6303-2008	van Bergen en Henegouwen, Paul/0000-0001-6050-9042; Sigismund, Sara/0000-0002-1396-4453; 	Dutch Organization for Scientific Research (NWO) [805.47.084]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Dutch Organization for Scientific Research (NWO) Grant 805.47.084 (to E. G. H. and A. N. B.).	Bader AN, 2007, OPT EXPRESS, V15, P6934, DOI 10.1364/OE.15.006934; Bader AN, 2009, BIOPHYS J, V97, P2613, DOI 10.1016/j.bpj.2009.07.059; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; de Grauw CJ, 2001, APPL SPECTROSC, V55, P670, DOI 10.1366/0003702011952587; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Rappoport JZ, 2009, J CELL SCI, V122, P1301, DOI 10.1242/jcs.040030; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Stoorvogel W, 2004, J BIOL CHEM, V279, P11562, DOI 10.1074/jbc.M308449200; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VANBELZEN N, 1988, J CELL PHYSIOL, V134, P413, DOI 10.1002/jcp.1041340312; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424	30	72	72	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39481	39489		10.1074/jbc.M110.164731	http://dx.doi.org/10.1074/jbc.M110.164731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20940297	Green Published, hybrid			2022-12-25	WOS:000284941300074
J	Islam, MR; Jimenez, T; Pelham, C; Rodova, M; Puri, S; Magenheimer, BS; Maser, RL; Widmann, C; Calvet, JP				Islam, M. Rafiq; Jimenez, Tamara; Pelham, Christopher; Rodova, Marianna; Puri, Sanjeev; Magenheimer, Brenda S.; Maser, Robin L.; Widmann, Christian; Calvet, James P.			MAP/ERK Kinase Kinase 1 (MEKK1) Mediates Transcriptional Repression by Interacting with Polycystic Kidney Disease-1 (PKD1) Promoter-bound p53 Tumor Suppressor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; N-TERMINAL KINASE; WILD-TYPE P53; C-JUN; P53-MEDIATED REPRESSION; DEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; DOWN-REGULATION; GENE; UBIQUITINATION	Mitogen-activated protein kinase (MAPK) cascades regulate a wide variety of cellular processes that ultimately depend on changes in gene expression. We have found a novel mechanism whereby one of the key MAP3 kinases, Mekk1, regulates transcriptional activity through an interaction with p53. The tumor suppressor protein p53 down-regulates a number of genes, including the gene most frequently mutated in autosomal dominant polycystic kidney disease (PKD1). We have discovered that Mekk1 translocates to the nucleus and acts as a co-repressor with p53 to down-regulate PKD1 transcriptional activity. This repression does not require Mekk1 kinase activity, excluding the need for an Mekk1 phosphorylation cascade. However, this PKD1 repression can also be induced by the stress-pathway stimuli, including TNF alpha, suggesting that Mekk1 activation induces both JNK-dependent and JNK-independent pathways that target the PKD1 gene. An Mekk1-p53 interaction at the PKD1 promoter suggests a new mechanism by which abnormally elevated stress-pathway stimuli might directly down-regulate the PKD1 gene, possibly causing haploinsufficiency and cyst formation.	[Islam, M. Rafiq; Jimenez, Tamara; Pelham, Christopher] NW Missouri State Univ, Dept Chem Phys, Maryville, MO 64468 USA; [Islam, M. Rafiq; Rodova, Marianna; Puri, Sanjeev; Magenheimer, Brenda S.; Calvet, James P.] Univ Kansas, Med Ctr, Kidney Inst, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Maser, Robin L.] Univ Kansas, Med Ctr, Kidney Inst, Dept Clin Lab Sci, Kansas City, KS 66160 USA; [Widmann, Christian] Univ Lausanne, Dept Physiol, Biol & Med Fac, CH-1005 Lausanne, Switzerland	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Lausanne	Islam, MR (corresponding author), NW Missouri State Univ, Dept Chem Phys, Maryville, MO 64468 USA.	islamr@nwmissouri.edu; jcalvet@kumc.edu	Widmann, Christian/N-9851-2013	Widmann, Christian/0000-0002-6881-0363; Puri, Sanjeev/0000-0002-3967-987X; Puri, Sanjeev/0000-0002-4314-9871	National Institutes of Health [R15 DK069897, P50 DK057301]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301, R15DK069897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R15 DK069897 (to M. R. I.) and P50 DK057301 (to J. P. C.).	Arnould T, 1998, J BIOL CHEM, V273, P6013, DOI 10.1074/jbc.273.11.6013; Banchio C, 2007, J BIOL CHEM, V282, P14827, DOI 10.1074/jbc.M700527200; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Boehme KA, 2009, CRIT REV BIOCHEM MOL, V44, P367, DOI 10.3109/10409230903401507; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Das KC, 2010, MOL CELL BIOCHEM, V337, P53, DOI 10.1007/s11010-009-0285-0; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Harris PC, 2009, J AM SOC NEPHROL, V20, P1188, DOI 10.1681/ASN.2009010014; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Im HJ, 2002, J BIOL CHEM, V277, P14612, DOI 10.1074/jbc.M109414200; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Islam MR, 2008, AM J PHYSIOL-RENAL, V295, pF1845, DOI 10.1152/ajprenal.90355.2008; Islam MR, 1999, J BIOL CHEM, V274, P23451, DOI 10.1074/jbc.274.33.23451; Kim JW, 2001, J BIOL CHEM, V276, P27064, DOI 10.1074/jbc.M009364200; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Lee CK, 2008, INT IMMUNOPHARMACOL, V8, P362, DOI 10.1016/j.intimp.2007.10.020; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Li XG, 2008, NAT MED, V14, P863, DOI 10.1038/nm1783; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Maillet M, 2009, J CLIN INVEST, V119, P3079, DOI 10.1172/JCI37694; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Marks J, 2003, J BIOL CHEM, V278, P34158, DOI 10.1074/jbc.M304543200; Maser RL, 2003, METH MOLEC MED, V86, P205; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Patel V, 2009, CURR OPIN NEPHROL HY, V18, P99, DOI 10.1097/MNH.0b013e3283262ab0; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Puri S, 2006, BIOCHEM BIOPH RES CO, V342, P1005, DOI 10.1016/j.bbrc.2006.02.045; Rodova M, 2002, J BIOL CHEM, V277, P29577, DOI 10.1074/jbc.M203570200; Sandford RN, 2009, KIDNEY INT, V75, P765, DOI 10.1038/ki.2009.17; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Shimada J, 2001, MOL ENDOCRINOL, V15, P1677, DOI 10.1210/me.15.10.1677; Takatori A, 2008, DEVELOPMENT, V135, P23, DOI 10.1242/dev.007120; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Van Bodegom D, 2006, J BIOL CHEM, V281, P31234, DOI 10.1074/jbc.M606510200; van Bodegom D, 2010, BBA-GENE REGUL MECH, V1799, P502, DOI 10.1016/j.bbagrm.2010.04.001; Wang DZ, 2001, J BIOL CHEM, V276, P3650, DOI 10.1074/jbc.M006115200; WANG Y, 1995, MOL CELL BIOL, V15, P2157; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Xia Y, 2007, MOL CELL BIOL, V27, P510, DOI 10.1128/MCB.01355-06; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Zebrowski DC, 2006, J MOL CELL CARDIOL, V40, P605, DOI 10.1016/j.yjmcc.2005.11.012; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	64	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38818	38831		10.1074/jbc.M110.145284	http://dx.doi.org/10.1074/jbc.M110.145284			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923779	Green Published, hybrid			2022-12-25	WOS:000284941300011
J	Ding, LL; Kuhne, WW; Hinton, DE; Song, JA; Dynan, WS				Ding, Lingling; Kuhne, Wendy W.; Hinton, David E.; Song, Jian; Dynan, William S.			Quantifiable Biomarkers of Normal Aging in the Japanese Medaka Fish (Oryzias latipes)	PLOS ONE			English	Article							CYSTIC DEGENERATION/SPONGIOSIS HEPATIS; GERM-CELL MUTAGENESIS; LYSOSOMAL AXIS THEORY; LIFE-SPAN; VERTEBRATE MODEL; IN-VIVO; GRADUAL SENESCENCE; ZEBRAFISH; TELEOST; ACCUMULATION	Background: Small laboratory fish share many anatomical and histological characteristics with other vertebrates, yet can be maintained in large numbers at low cost for lifetime studies. Here we characterize biomarkers associated with normal aging in the Japanese medaka (Oryzias latipes), a species that has been widely used in toxicology studies and has potential utility as a model organism for experimental aging research. Principal Findings: The median lifespan of medaka was approximately 22 months under laboratory conditions. We performed quantitative histological analysis of tissues from age-grouped individuals representing young adults (6 months old), mature adults (16 months old), and adults that had survived beyond the median lifespan (24 months). Livers of 24-month old individuals showed extensive morphologic changes, including spongiosis hepatis, steatosis, ballooning degeneration, inflammation, and nuclear pyknosis. There were also phagolysosomes, vacuoles, and residual bodies in parenchymal cells and congestion of sinusoidal vessels. Livers of aged individuals were characterized by increases in lipofuscin deposits and in the number of TUNEL-positive apoptotic cells. Some of these degenerative characteristics were seen, to a lesser extent, in the livers of 16-month old individuals, but not in 6-month old individuals. The basal layer of the dermis showed an age-dependent decline in the number of dividing cells and an increase in senescence-associated beta-galactosidase. The hearts of aged individuals were characterized by fibrosis and lipofuscin deposition. There was also a loss of pigmented cells from the retinal epithelium. By contrast, age-associated changes were not apparent in skeletal muscle, the ocular lens, or the brain. Significance: The results provide a set of markers that can be used to trace the process of normal tissue aging in medaka and to evaluate the effect of environmental stressors.	[Ding, Lingling; Kuhne, Wendy W.; Dynan, William S.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Ding, Lingling; Song, Jian] Wuhan Univ, Sch Med, Dept Anat & Embryol, Wuhan, Hubei, Peoples R China; [Kuhne, Wendy W.] Savannah River Natl Lab, Aiken, SC USA; [Hinton, David E.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	University System of Georgia; Augusta University; Wuhan University; United States Department of Energy (DOE); Savannah River National Laboratory; Duke University	Ding, LL (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.	wdynan@mcg.edu		Dynan, William/0000-0002-4045-5662; Kuhne, Wendy/0000-0002-0501-1919	U.S. Department of Energy Low Dose Radiation Research Program (DOE) [FG02-03ERG3649, DE-SC0002343]; National Research Service Award [1F32ES015663-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES015663] Funding Source: NIH RePORTER	U.S. Department of Energy Low Dose Radiation Research Program (DOE)(United States Department of Energy (DOE)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	U.S. Department of Energy Low Dose Radiation Research Program (DOE FG02-03ERG3649 and DE-SC0002343) and National Research Service Award (1F32ES015663-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au DWT, 2009, COMP BIOCHEM PHYS C, V149, P161, DOI 10.1016/j.cbpc.2008.08.005; Bannasch P, 2003, TOXICOL PATHOL, V31, P566, DOI 10.1080/01926230390224700; BANNASCH P, 2002, TOXICOL PATHOL, V30, P216; Boorman GA, 1997, TOXICOL PATHOL, V25, P202, DOI 10.1177/019262339702500210; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Cellerino A, 2009, AGING MED, P157, DOI 10.1007/978-1-60327-507-1_10; COUCH JA, 1991, TOXICOL PATHOL, V19, P237, DOI 10.1177/019262339101900306; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; EGAMI N, 1973, EXP GERONTOL, V8, P219, DOI 10.1016/0531-5565(73)90029-6; EGAMI N, 1971, EXP GERONTOL, V6, P379, DOI 10.1016/0531-5565(71)90007-6; EGAMI N, 1969, EXP GERONTOL, V4, P127, DOI 10.1016/0531-5565(69)90035-7; EGAMI NOBUO, 1962, ANNOT ZOOL JAPAN, V35, P188; Elmore LW, 2008, EXP BIOL MED, V233, P958, DOI 10.3181/0712-RM-345; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x; Gerhard GS, 2007, AGEING RES REV, V6, P64, DOI 10.1016/j.arr.2007.02.007; GOMORI G, 1950, AM J CLIN PATHOL, V20, P661, DOI 10.1093/ajcp/20.7_ts.661; Greiling TMS, 2009, MOL VIS, V15, P2313; Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006; Hawkins William E., 2003, Toxicologic Pathology, V31, P88; Hinton D E, 1984, Natl Cancer Inst Monogr, V65, P239; Hinton TG, 2004, J ENVIRON RADIOACTIV, V74, P43, DOI 10.1016/j.jenvrad.2004.01.014; Hobbie KR, 2009, COMP BIOCHEM PHYS C, V149, P141, DOI 10.1016/j.cbpc.2008.07.013; Hyodo-Taguchi Y., 1989, P185; Ijiri K, 2003, ADV SPACE B, V9, P201, DOI 10.1016/S1569-2574(03)09008-7; Karbe E, 2002, TOXICOL PATHOL, V30, P216, DOI 10.1080/019262302753559551; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kong RYC, 2008, AQUAT TOXICOL, V86, P131, DOI 10.1016/j.aquatox.2007.10.011; Kuhne WW, 2009, RADIAT RES, V172, P473, DOI 10.1667/RR1556.1; LIU RK, 1975, J GERONTOL, V30, P129, DOI 10.1093/geronj/30.2.129; Malek RL, 2004, COMP BIOCHEM PHYS C, V138, P363, DOI 10.1016/j.cca.2004.08.014; MASAHITO P, 1989, JPN J CANCER RES, V80, P1058, DOI 10.1111/j.1349-7006.1989.tb02259.x; PATNAIK BK, 1994, GERONTOLOGY, V40, P113, DOI 10.1159/000213582; Shima A, 2004, MECH DEVELOP, V121, P599, DOI 10.1016/j.mod.2004.03.011; SHIMA A, 1978, EXP GERONTOL, V13, P51, DOI 10.1016/0531-5565(78)90030-X; Shimada A, 2005, P NATL ACAD SCI USA, V102, P6063, DOI 10.1073/pnas.0500895102; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Winn RN, 2008, ENVIRON MOL MUTAGEN, V49, P173, DOI 10.1002/em.20364; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; WOODHEAD AD, 1984, EXP GERONTOL, V19, P383, DOI 10.1016/0531-5565(84)90048-2; Yen K, 2004, EXP GERONTOL, V39, P947, DOI 10.1016/j.exger.2004.03.016	47	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13287	10.1371/journal.pone.0013287	http://dx.doi.org/10.1371/journal.pone.0013287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949019	Green Published, gold, Green Submitted			2022-12-25	WOS:000282748100021
J	Ke, FY; Luu, YK; Hadjiargyrou, M; Liang, DH				Ke, Fuyou; Luu, Yen Kim; Hadjiargyrou, Michael; Liang, Dehai			Characterizing DNA Condensation and Conformational Changes in Organic Solvents	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CALF THYMUS DNA; LIGHT-SCATTERING; GENE DELIVERY; ETHANOL; ENCAPSULATION; COMPLEXES; ENTRAPMENT; THERAPY; TOROIDS	Organic solvents offer a new approach to formulate DNA into novel structures suitable for gene delivery. In this study, we examined the in situ behavior of DNA in N, N-dimethylformamide (DMF) at low concentration via laser light scattering (LLS), TEM, UV absorbance and Zeta potential analysis. Results revealed that, in DMF, a 21bp oligonucleotide remained intact, while calf thymus DNA and supercoiled plasmid DNA were condensed and denatured. During condensation and denaturation, the size was decreased by a factor of 8-10, with calf thymus DNA forming spherical globules while plasmid DNA exhibited a toroid-like conformation. In the condensed state, DNA molecules were still able to release the counterions to be negatively charged, indicating that the condensation was mainly driven by the excluded volume interactions. The condensation induced by DMF was reversible for plasmid DNA but not for calf thymus DNA. When plasmid DNA was removed from DMF and resuspended in an aqueous solution, the DNA was quickly regained a double stranded configuration. These findings provide further insight into the behavior and condensation mechanism of DNA in an organic solvent and may aid in developing more efficient non-viral gene delivery systems.	[Ke, Fuyou; Liang, Dehai] Peking Univ, Coll Chem & Mol Engn, Minist Educ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Ke, Fuyou; Liang, Dehai] Peking Univ, Coll Chem & Mol Engn, Minist Educ, Key Lab Polymer Chem & Phys, Beijing 100871, Peoples R China; [Luu, Yen Kim; Hadjiargyrou, Michael] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Peking University; Peking University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ke, FY (corresponding author), Peking Univ, Coll Chem & Mol Engn, Minist Educ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China.	michael.hadjiargyrou@sunysb.edu; dliang@pku.edu.cn	Hadjiargyrou, Michael/H-7191-2018	Hadjiargyrou, Michael/0000-0001-8927-2333	National Natural Science Foundation of China [20774004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (20774004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DNA INTERACTIONS POL; Bailey AL, 2000, BBA-BIOMEMBRANES, V1468, P239, DOI 10.1016/S0005-2736(00)00264-9; Bonner G, 2000, BIOTECHNOL BIOENG, V68, P339, DOI 10.1002/(SICI)1097-0290(20000505)68:3<339::AID-BIT12>3.0.CO;2-O; Brown MD, 2001, INT J PHARMACEUT, V229, P1, DOI 10.1016/S0378-5173(01)00861-4; Budker VG, 2002, BIOPHYS J, V82, P1570, DOI 10.1016/S0006-3495(02)75508-2; BURCHARD W, 1983, ADV POLYM SCI, V48, P1; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; Cui SX, 2007, J AM CHEM SOC, V129, P14710, DOI 10.1021/ja074776c; Ewert K, 2004, CURR MED CHEM, V11, P133, DOI 10.2174/0929867043456160; Ewert KK, 2005, EXPERT OPIN BIOL TH, V5, P33, DOI 10.1517/14712598.5.1.33; FORSTER S, 1995, ADV POLYM SCI, V120, P51; Guo CL, 2009, J PHYS CHEM B, V113, P6068, DOI 10.1021/jp810126f; HAGERMAN PJ, 1981, BIOPOLYMERS, V20, P1503, DOI 10.1002/bip.1981.360200710; Hayes ME, 2006, GENE THER, V13, P646, DOI 10.1038/sj.gt.3302699; HELMKAMP GK, 1961, J AM CHEM SOC, V83, P138, DOI 10.1021/ja01462a027; Huang H, 2009, ANGEW CHEM INT EDIT, V48, P4594, DOI 10.1002/anie.200900533; Jeffs LB, 2005, PHARM RES-DORDR, V22, P362, DOI 10.1007/s11095-004-1873-z; Kankia BI, 2001, NUCLEIC ACIDS RES, V29, P2795, DOI 10.1093/nar/29.13.2795; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; Korobko AV, 2006, J PHYS CHEM B, V110, P14550, DOI 10.1021/jp057363b; Korobko AV, 2005, LANGMUIR, V21, P34, DOI 10.1021/la047967r; LEE CH, 1981, P NATL ACAD SCI-BIOL, V78, P2838, DOI 10.1073/pnas.78.5.2838; Liang DH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni171; Lin Z, 1998, NUCLEIC ACIDS RES, V26, P3228, DOI 10.1093/nar/26.13.3228; Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X; Marty R, 2009, NUCLEIC ACIDS RES, V37, P849, DOI 10.1093/nar/gkn1003; Matzeu M, 1999, COLLOID SURFACE B, V13, P157, DOI 10.1016/S0927-7765(99)00005-3; Maurer N, 2001, BIOPHYS J, V80, P2310, DOI 10.1016/S0006-3495(01)76202-9; Maurstad G, 2003, J PHYS CHEM B, V107, P8172, DOI 10.1021/jp0271965; Mel'nikov SM, 1999, J AM CHEM SOC, V121, P1130, DOI 10.1021/ja981491e; Mikhailenko SV, 2000, BIOMACROMOLECULES, V1, P597, DOI 10.1021/bm0055403; Noguchi H, 1998, J CHEM PHYS, V109, P5070, DOI 10.1063/1.477121; Osada K, 2005, ANGEW CHEM INT EDIT, V44, P3544, DOI 10.1002/anie.200500201; Osfouri S, 2005, J PHYS CHEM B, V109, P19929, DOI 10.1021/jp053057m; Ou ZY, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1940054; PISKUR J, 1995, FEBS LETT, V375, P174, DOI 10.1016/0014-5793(95)01206-T; Ramos JEB, 2005, J PHYS CHEM B, V109, P23661, DOI 10.1021/jp0527103; Roy KB, 1999, J PHYS CHEM B, V103, P5117, DOI 10.1021/jp983306p; Sedlak M, 1996, J CHEM PHYS, V105, P10123, DOI 10.1063/1.472841; Shen MR, 2000, J AM CHEM SOC, V122, P4833, DOI 10.1021/ja000200a; Skjorringe T, 2009, J CONTROL RELEASE, V139, P140, DOI 10.1016/j.jconrel.2009.06.009; WILSON RW, 1979, BIOCHEMISTRY-US, V18, P2192, DOI 10.1021/bi00578a009; Yoshikawa Y, 1999, LANGMUIR, V15, P4085, DOI 10.1021/la981159g; Zhang C, 2008, J PHYS CHEM B, V112, P3552, DOI 10.1021/jp0776560; Zhang ZL, 2002, BIOPHYS CHEM, V97, P7, DOI 10.1016/S0301-4622(02)00006-6	45	24	27	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13308	10.1371/journal.pone.0013308	http://dx.doi.org/10.1371/journal.pone.0013308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949017	Green Published, Green Submitted, gold			2022-12-25	WOS:000282748100030
J	Kao, CS; Dietrich, R; Sommer, W				Kao, Chung-Shan; Dietrich, Rainer; Sommer, Werner			Processing Interrogative Sentence Mood at the Semantic-Syntactic Interface: An Electrophysiological Research in Chinese, German, and Polish	PLOS ONE			English	Article							WORD INTERFERENCE EXPERIMENTS; TIME-COURSE; SPEECH PRODUCTION; LATENCY DIFFERENCES; BRAIN POTENTIALS; INFORMATION; ONSET; CONTINGENT; RETRIEVAL; SPEAKING	Background: Languages differ in the marking of the sentence mood of a polar interrogative (yes/no question). For instance, the interrogative mood is marked at the beginning of the surface structure in Polish, whereas the marker appears at the end in Chinese. In order to generate the corresponding sentence frame, the syntactic specification of the interrogative mood is early in Polish and late in Chinese. In this report, German belongs to an interesting intermediate class. The yes/no question is expressed by a shift of the finite verb from its final position in the underlying structure into the utterance initial position, a move affecting, hence, both the sentence's final and the sentence's initial constituents. The present study aimed to investigate whether during generation of the semantic structure of a polar interrogative, i.e., the processing preceding the grammatical formulation, the interrogative mood is encoded according to its position in the syntactic structure at distinctive time points in Chinese, German, and Polish. Methodology/Principal Findings: In a two-choice go/nogo experimental design, native speakers of the three languages responded to pictures by pressing buttons and producing utterances in their native language while their brain potentials were recorded. The emergence and latency of lateralized readiness potentials (LRP) in nogo conditions, in which speakers asked a yes/no question, should indicate the time point of processing the interrogative mood. The results revealed that Chinese, German, and Polish native speakers did not differ from each other in the electrophysiological indicator. Conclusions/Significance: The findings suggest that the semantic encoding of the interrogative mood is temporally consistent across languages despite its disparate syntactic specification. The consistent encoding may be ascribed to economic processing of interrogative moods at various sentential positions of the syntactic structures in languages or, more generally, to the overarching status of sentence mood in the semantic structure.	[Kao, Chung-Shan] Univ Fribourg, Dept Psychol, CH-1700 Fribourg, Switzerland; [Dietrich, Rainer] Humboldt Univ, Inst Deutsch Sprache & Linguist, Berlin, Germany; [Sommer, Werner] Humboldt Univ, Inst Psychol, Berlin, Germany	University of Fribourg; Humboldt University of Berlin; Humboldt University of Berlin	Kao, CS (corresponding author), Univ Fribourg, Dept Psychol, CH-1700 Fribourg, Switzerland.	chung-shan.kao@unifr.ch	Sommer, Werner/N-1945-2019; Sommer, Werner/H-4672-2011	Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445	state government of Berlin; interdisziplinaere Zentrum fuer sprachliche Bedeutung	state government of Berlin; interdisziplinaere Zentrum fuer sprachliche Bedeutung	The research was supported by grants from the state government of Berlin (the scholarship of the Nachwuchsfoerderung) and from the interdisziplinaere Zentrum fuer sprachliche Bedeutung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Werner, 1995, DTSCH SYNTAX SPRACHE; American Electroencephalographic Society, 1994, J CLIN NEUROPHYSIOL, V11, P77, DOI 10.1097/00004691-199401000-00012; BACH E, 1962, LANGUAGE, V38, P263, DOI 10.2307/410785; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Bock J. K., 2004, INTERFACE LANGUAGE V, P249; Bock K, 2003, J MEM LANG, V48, P653, DOI 10.1016/S0749-596X(03)00007-X; Brandt Margareta., 1993, SATZ ILLOKUTION, V1, P1; BRUNIA CHM, 1980, BIOL PSYCHOL, V11, P181, DOI 10.1016/0301-0511(80)90054-X; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; De Smedt K. J. M. J., 1990, Current Research in Natural Language Generation, P167; DEJONG R, 1988, J EXP PSYCHOL HUMAN, V14, P682, DOI 10.1037/0096-1523.14.4.682; DIETRICH R, 1999, REPRESENTATIONS PROC, P57; Dietrich Rainer, 2007, PSYCHOLINGUISTIK; Ferreira VS, 1996, J MEM LANG, V35, P724, DOI 10.1006/jmla.1996.0038; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Grewendorf Gunther, 1989, SPRACHLICHES WISSEN; Griffin ZM, 2000, PSYCHOL SCI, V11, P274, DOI 10.1111/1467-9280.00255; Griffin ZM, 2001, COGNITION, V82, pB1, DOI 10.1016/S0010-0277(01)00138-X; Haider H., 1997, GERMAN SYNTACTIC PRO, P83; KEMPEN G, 1987, COGNITIVE SCI, V11, P201, DOI 10.1207/s15516709cog1102_5; KEMPEN G, 1982, P 9 INT C COMP LING, P151; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Levelt, 1993, SPEAKING INTENTION A; Lippold O. C. J., 1967, MANUAL PSYCHOPHYSIOL, P245; Low KA, 1999, PSYCHOPHYSIOLOGY, V36, P288, DOI 10.1017/S0048577299980332; Masaki H, 2004, PSYCHOPHYSIOLOGY, V41, P220, DOI 10.1111/j.1469-8986.2004.00150.x; Meyer AS, 1996, J MEM LANG, V35, P477, DOI 10.1006/jmla.1996.0026; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; MILLER J, 1992, J EXP PSYCHOL GEN, V121, P195, DOI 10.1037/0096-3445.121.2.195; Mordkoff JT, 2000, PSYCHOPHYSIOLOGY, V37, P347; OSMAN A, 1993, J EXP PSYCHOL HUMAN, V19, P1292, DOI 10.1037/0096-1523.19.6.1292; Rahman RA, 2003, J EXP PSYCHOL LEARN, V29, P850, DOI 10.1037/0278-7393.29.5.850; Rahman RA, 2003, COGNITIVE BRAIN RES, V16, P372, DOI 10.1016/S0926-6410(02)00305-1; Rodriguez-Fornells A, 2002, NEUROPSYCHOLOGIA, V40, P778, DOI 10.1016/S0028-3932(01)00188-9; Roelofs A, 1998, J EXP PSYCHOL LEARN, V24, P904, DOI 10.1037/0278-7393.24.4.904; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Schmitt BM, 2001, NEUROSCI RES, V41, P293, DOI 10.1016/S0168-0102(01)00286-3; Schmitt BM, 2001, J COGNITIVE NEUROSCI, V13, P510, DOI 10.1162/08989290152001925; Schriefers H, 1998, J MEM LANG, V39, P609, DOI 10.1006/jmla.1998.2578; Sommer W, 1996, PSYCHOL RUNDSCH, V47, P1; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1017/S0048577201000610; van Turennout M, 1999, J PSYCHOLINGUIST RES, V28, P649, DOI 10.1023/A:1023221028150; vanTurennout M, 1997, J EXP PSYCHOL LEARN, V23, P787, DOI 10.1037/0278-7393.23.4.787; VAUGHAN HG, 1968, ELECTROEN CLIN NEURO, V25, P1, DOI 10.1016/0013-4694(68)90080-1; Wheeldon L., 2003, ENCY COGNITIVE SCI, P760, DOI [10.1002/0470018860.s00252/abstract, DOI 10.1002/0470018860.S00252/ABSTRACT]	47	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13036	10.1371/journal.pone.0013036	http://dx.doi.org/10.1371/journal.pone.0013036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	655SI	20927373	Green Published, gold, Green Submitted			2022-12-25	WOS:000282269400012
J	Van Houtan, KS; Hargrove, SK; Balazs, GH				Van Houtan, Kyle S.; Hargrove, Stacy K.; Balazs, George H.			Land Use, Macroalgae, and a Tumor-Forming Disease in Marine Turtles	PLOS ONE			English	Article							CHELONIA-MYDAS; GREEN TURTLES; HAWAIIAN-ISLANDS; SOMATIC GROWTH; ARGININE; VIRUS; FIBROPAPILLOMATOSIS; REGION; TRANSMISSION; REPLICATION	Wildlife diseases are an increasing concern for endangered species conservation, but their occurrence, causes, and human influences are often unknown. We analyzed 3,939 records of stranded Hawaiian green sea turtles (Chelonia mydas) over 28 years to understand fibropapillomatosis, a tumor-forming disease linked to a herpesvirus. Turtle size is a consistent risk factor and size-standardized models revealed considerable spatial and temporal variability. The disease peaked in some areas in the 1990s, in some regions rates remained constant, and elsewhere rates increased. Land use, onshore of where the turtles feed, may play a role. Elevated disease rates were clustered in watersheds with high nitrogen-footprints; an index of natural and anthropogenic factors that affect coastal eutrophication. Further analysis shows strong epidemiological links between disease rates, nitrogen-footprints, and invasive macroalgae and points to foraging ecology. These turtles now forage on invasive macroalgae, which can dominate nutrient rich waters and sequester environmental N in the amino acid arginine. Arginine is known to regulate immune activity, promote herpesviruses, and contribute to tumor formation. Our results have implications for understanding diseases in aquatic organisms, eutrophication, herpesviruses, and tumor formation.	[Van Houtan, Kyle S.; Hargrove, Stacy K.; Balazs, George H.] Fisheries Serv, Pacific Isl Fisheries Sci Ctr, NOAA, Honolulu, HI USA; [Van Houtan, Kyle S.] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC USA	National Oceanic Atmospheric Admin (NOAA) - USA; Duke University	Van Houtan, KS (corresponding author), Fisheries Serv, Pacific Isl Fisheries Sci Ctr, NOAA, Honolulu, HI USA.	Kyle.VanHoutan@gmail.com	Van Houtan, Kyle S/GRY-0874-2022; Van Houtan, Kyle Schuyler/A-4695-2008	Van Houtan, Kyle/0000-0001-5725-1773				ABBOT IA, 1999, MARINE RED ALGAE HAW; Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; ANDERSON R M, 1991; Arthur KE, 2008, PAC SCI, V62, P205, DOI 10.2984/1534-6188(2008)62[205:ACOIGT]2.0.CO;2; BALAZS G H, 1976, Biological Conservation, V9, P125, DOI 10.1016/0006-3207(76)90045-8; Balazs GH, 2004, MAR BIOL, V145, P1043, DOI 10.1007/s00227-004-1387-6; Balazs GH, 2004, BIOL CONSERV, V117, P491, DOI 10.1016/j.biocon.2003.08.008; Bjorndal KA, 1999, CONSERV BIOL, V13, P126, DOI 10.1046/j.1523-1739.1999.97329.x; Brunsdon C, 1998, J ROY STAT SOC D-STA, V47, P431, DOI 10.1111/1467-9884.00145; Chaloupka M, 2005, MAR BIOL, V147, P1251, DOI 10.1007/s00227-005-0026-1; Chaloupka M, 2008, MAR BIOL, V154, P887, DOI 10.1007/s00227-008-0981-4; Chaloupka M, 2009, J WILDLIFE DIS, V45, P1138, DOI 10.7589/0090-3558-45.4.1138; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Dailer ML, 2010, MAR POLLUT BULL, V60, P655, DOI 10.1016/j.marpolbul.2009.12.021; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; dos Santos RG, 2010, DIS AQUAT ORGAN, V89, P87, DOI 10.3354/dao02178; Ene A, 2005, J WILDLIFE DIS, V41, P489, DOI 10.7589/0090-3558-41.3.489; *ENV SYST RES I, ARCGIS 9 3 1; Greenblatt RJ, 2004, VIROLOGY, V321, P101, DOI 10.1016/j.virol.2003.12.026; Hall SR, 2007, ECOL LETT, V10, P207, DOI 10.1111/j.1461-0248.2007.01011.x; Halley J, 2002, OIKOS, V99, P518, DOI 10.1034/j.1600-0706.2002.11962.x; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Herbst L, 2004, CURR BIOL, V14, pR697, DOI 10.1016/j.cub.2004.08.040; Herbst Lawrence H., 1994, Annual Review of Fish Diseases, V4, P389, DOI 10.1016/0959-8030(94)90037-X; HERBST LH, 1995, ENVIRON HEALTH PERSP, V103, P27, DOI 10.2307/3432408; HERBST LH, 1995, DIS AQUAT ORGAN, V22, P1, DOI 10.3354/dao022001; HIBBARD MK, 1995, J VIROL, V69, P4656, DOI 10.1128/JVI.69.8.4656-4667.1995; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; INGLIS VBM, 1968, J GEN VIROL, V3, P9, DOI 10.1099/0022-1317-3-1-9; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; KAHAN IL, 1979, A GRAEF ARCH KLIN EX, V209, P219, DOI 10.1007/BF00414614; Klyachkin YM, 2008, VIROLOGY, V374, P23, DOI 10.1016/j.virol.2007.11.014; Lackovich JK, 1999, DIS AQUAT ORGAN, V37, P89, DOI 10.3354/dao037089; Landsberg JH, 1999, J AQUAT ANIM HEALTH, V11, P199, DOI 10.1577/1548-8667(1999)011&lt;0199:TPRONT&gt;2.0.CO;2; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V298, P275, DOI 10.1016/S0022-0981(03)00363-0; LAPOINTE BE, 1992, ESTUARIES, V15, P75, DOI 10.2307/1352712; Larned ST, 1998, MAR BIOL, V132, P409, DOI 10.1007/s002270050407; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Llacer JL, 2008, CURR OPIN STRUC BIOL, V18, P673, DOI 10.1016/j.sbi.2008.11.002; Lu Y, 2000, ARCH VIROL, V145, P1885, DOI 10.1007/s007050070063; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; McDermid KJ, 2007, B MAR SCI, V81, P55; McPherson R.A., 2017, HENRYS CLIN DIAGNOSI; MIKAMI T, 1974, J GEN VIROL, V22, P115, DOI 10.1099/0022-1317-22-1-115; Mistry SK, 2001, VIRUS RES, V73, P177, DOI 10.1016/S0168-1702(00)00243-4; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; OLSHEVSKY U, 1970, NATURE, V226, P851, DOI 10.1038/226851a0; Peranzoni E, 2007, IMMUNOBIOLOGY, V212, P795, DOI 10.1016/j.imbio.2007.09.008; Russell DF, 2009, PAC SCI, V63, P181, DOI 10.2984/049.063.0202; RUSSELL DJ, 1994, AQUAT BOT, V47, P53, DOI 10.1016/0304-3770(94)90048-5; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schlesinger WH, 1997, BIOGEOCHEMISTRY; Shuman LM, 2002, J ENVIRON QUAL, V31, P1710, DOI 10.2134/jeq2002.1710; Smith Jennifer E., 2002, Pacific Science, V56, P299, DOI 10.1353/psc.2002.0030; SMITH SV, 1981, PAC SCI, V35, P279; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Van Houtan KS, 2007, CURR BIOL, V17, pR590, DOI 10.1016/j.cub.2007.06.021; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; Waller L.A., 2004, APPL SPATIAL STAT PU; WILLIAMS B. K., 2001, ANAL MANAGEMENT ANIM; Work TM, 2005, J PARASITOL, V91, P871, DOI 10.1645/GE-454R.1; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Zug GR, 2002, FISH B-NOAA, V100, P117	63	91	94	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12900	10.1371/journal.pone.0012900	http://dx.doi.org/10.1371/journal.pone.0012900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927370	Green Submitted, gold, Green Published			2022-12-25	WOS:000282269400005
J	Liu, YC; Tozeren, A				Liu, Yichuan; Tozeren, Aydin			Domain Altering SNPs in the Human Proteome and Their Impact on Signaling Pathways	PLOS ONE			English	Article							GENE-GENE INTERACTIONS; ASSOCIATION; DATABASE; SELECTION; DISCOVERY	Single nucleotide polymorphisms (n-SNPs) constitute an important mode of genetic variations observed in the human genome. A small fraction of SNPs, about four thousand out of the ten million, has been associated with genetic disorders and complex diseases. The present study focuses on SNPs that fall on protein domains, 3D structures that facilitate connectivity of proteins in cell signaling and metabolic pathways. We scanned the human proteome using the PROSITE web tool and identified proteins with SNP containing domains. We showed that SNPs that fall on protein domains are highly statistically enriched among SNPs linked to hereditary disorders and complex diseases. Proteins whose domains are dramatically altered by the presence of an SNP are even more likely to be present among proteins linked to hereditary disorders. Proteins with domain-altering SNPs comprise highly connected nodes in cellular pathways such as the focal adhesion, the axon guidance pathway and the autoimmune disease pathways. Statistical enrichment of domain/motif signatures in interacting protein pairs indicates extensive loss of connectivity of cell signaling pathways due to domain-altering SNPs, potentially leading to hereditary disorders.	[Liu, Yichuan; Tozeren, Aydin] Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA	Drexel University	Liu, YC (corresponding author), Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA.	at62@drexel.edu	Liu, Yichuan/AAF-3893-2021	LIU, YICHUAN/0000-0003-2023-072X	Drexel University; BioAdvance	Drexel University; BioAdvance	The research presented in this manuscript was funded by Drexel University Calhoun Endowment fellowship to Yichuan Liu and by BioAdvance support to Greater Philadelphia Bioinformatics Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arking DE, 2009, TRENDS GENET, V25, P387, DOI 10.1016/j.tig.2009.07.007; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bourne PE, 2004, NUCLEIC ACIDS RES, V32, pD223, DOI 10.1093/nar/gkh096; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; Clark TG, 2005, HUM HERED, V60, P97, DOI 10.1159/000088845; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Evans P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-27; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hubley RM, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-30; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelemen A, 2009, IEEE T INF TECHNOL B, V13, P841, DOI 10.1109/TITB.2009.2024144; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kronenberg F, 2008, EXP GERONTOL, V43, P39, DOI 10.1016/j.exger.2007.09.005; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Motsinger AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-39; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Ritchie MD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-28; Shastry BS, 2007, J HUM GENET, V52, P871, DOI 10.1007/s10038-007-0200-z; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Wjst M, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-92; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Zhang Y, 2010, MOL CANCER THER, V9, P279, DOI 10.1158/1535-7163.MCT-09-0508	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12890	10.1371/journal.pone.0012890	http://dx.doi.org/10.1371/journal.pone.0012890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886114	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100007
J	Choveau, FS; Rodriguez, N; Ali, FA; Labro, AJ; Rose, T; Dahimene, S; Boudin, H; Le Henaff, C; Escande, D; Snyders, DJ; Charpentier, F; Merot, J; Baro, I; Loussouarn, G				Choveau, Frank S.; Rodriguez, Nicolas; Ali, Fayal Abderemane; Labro, Alain J.; Rose, Thierry; Dahimene, Shehrazade; Boudin, Helene; Le Henaff, Carole; Escande, Denis; Snyders, Dirk J.; Charpentier, Flavien; Merot, Jean; Baro, Isabelle; Loussouarn, Gildas			KCNQ1 Channels Voltage Dependence through a Voltage-dependent Binding of the S4-S5 Linker to the Pore Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; POTASSIUM CHANNEL; ACTIVATION GATE; SENSOR; PROTEINS; CONDUCTION; MOVEMENT; K(V)LQT1; KCNE1; STATE	Voltage-dependent potassium (Kv) channels are tetramers of six transmembrane domain (S1-S6) proteins. Crystallographic data demonstrate that the tetrameric pore (S5-S6) is surrounded by four voltage sensor domains (S1-S4). One key question remains: how do voltage sensors (S4) regulate pore gating? Previous mutagenesis data obtained on the Kv channel KCNQ1 highlighted the critical role of specific residues in both the S4-S5 linker (S4S5(L)) and S6 C terminus (S6(T)). From these data, we hypothesized that S4S5(L) behaves like a ligand specifically interacting with S6(T) and stabilizing the closed state. To test this hypothesis, we designed plasmid-encoded peptides corresponding to portions of S4S5(L) and S6(T) of the voltage-gated potassium channel KCNQ1 and evaluated their effects on the channel activity in the presence and absence of the ancillary subunit KCNE1. We showed that S4S5(L) peptides inhibit KCNQ1, in a reversible and state-dependent manner. S4S5(L) peptides also inhibited a voltage-independent KCNQ1 mutant. This inhibition was competitively prevented by a peptide mimicking S6(T), consistent with S4S5(L) binding to S6(T). Val(254) in S4S5(L) is known to contact Leu(353) in S6(T) when the channel is closed, and mutations of these residues alter the coupling between the two regions. The same mutations introduced in peptides altered their effects, further confirming S4S5(L) binding to S6(T). Our results suggest a mechanistic model in which S4S5(L) acts as a voltage-dependent ligand bound to its receptor on S6 at rest. This interaction locks the channel in a closed state. Upon plasma membrane depolarization, S4 pulls S4S5(L) away from S6(T), allowing channel opening.	[Choveau, Frank S.; Rodriguez, Nicolas; Ali, Fayal Abderemane; Dahimene, Shehrazade; Le Henaff, Carole; Escande, Denis; Charpentier, Flavien; Merot, Jean; Baro, Isabelle; Loussouarn, Gildas] INSERM, U915, F-44000 Nantes, France; [Choveau, Frank S.; Rodriguez, Nicolas; Ali, Fayal Abderemane; Dahimene, Shehrazade; Le Henaff, Carole; Escande, Denis; Charpentier, Flavien; Merot, Jean; Baro, Isabelle; Loussouarn, Gildas] CNRS, ERL3147, F-44035 Nantes, France; [Choveau, Frank S.; Rodriguez, Nicolas; Ali, Fayal Abderemane; Dahimene, Shehrazade; Boudin, Helene; Le Henaff, Carole; Escande, Denis; Charpentier, Flavien; Merot, Jean; Baro, Isabelle; Loussouarn, Gildas] Univ Nantes, Fac Med, Inst Thorax, F-44000 Nantes, France; [Labro, Alain J.; Snyders, Dirk J.] Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Rose, Thierry] Inst Pasteur, F-75724 Paris 15, France; [Boudin, Helene] INSERM, U643, F-44000 Nantes, France; [Boudin, Helene] CHU Nantes, Inst Transplantat & Rech Transplantat, F-44000 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes; University of Antwerp; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Loussouarn, G (corresponding author), INSERM, U915, 8 Quai Moncousu,BP 70721, F-44007 Nantes, France.	gildas.loussouarn@inserm.fr	Loussouarn, Gildas/D-3590-2015; Baró, Isabelle/D-3604-2015; MEROT, Jean/D-5741-2015; Snyders, Dirk/A-2713-2013; Choveau, Frank/AFI-6500-2022; Charpentier, Flavien/D-3586-2015; Baró, Isabelle/ABH-5667-2020; Choveau, Frank/AAF-3858-2022; Boudin, Helene/K-2400-2015; Loussouarn, Gildas/ABH-6043-2020	Loussouarn, Gildas/0000-0001-8007-5931; Baró, Isabelle/0000-0003-4850-4171; Snyders, Dirk/0000-0001-7142-6672; Charpentier, Flavien/0000-0002-5057-0998; Baró, Isabelle/0000-0003-4850-4171; Loussouarn, Gildas/0000-0001-8007-5931; VAL, Thierry/0000-0002-5749-8570; Rodriguez, Nicolas/0000-0003-1079-6041; Boudin, Helene/0000-0002-9714-2384; ROSE, Thierry/0000-0001-8863-0207; Labro, Alain J/0000-0002-0871-7511	Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de la Recherche [ANR-05-JCJC-0160-01]; Hubert Curien Program; Association Francaise contre les Myopathies [14120]; Vaincre La Mucoviscidose; Fondation Genavie; Fondation pour la Recherche Medicale; Federation Francaise de Cardiologie; French Ministere de la Recherche	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Hubert Curien Program; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Vaincre La Mucoviscidose; Fondation Genavie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation Francaise de Cardiologie; French Ministere de la Recherche(Ministry of Research, France)	This work was supported in part by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), from the Agence Nationale de la Recherche (ANR-05-JCJC-0160-01), the Hubert Curien Program (Tournesol program), and the Association Francaise contre les Myopathies (Grant 14120 to G. L.), and from Vaincre La Mucoviscidose (to J. M.).; Supported by the Fondation Genavie, the Fondation pour la Recherche Medicale, and the Federation Francaise de Cardiologie.; Recipient of a grant from the French Ministere de la Recherche.	Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bellocq C, 2004, MOL PHARMACOL, V66, P1093, DOI 10.1124/mol.104.001065; Boulet IR, 2007, J PHYSIOL-LONDON, V585, P325, DOI 10.1113/jphysiol.2007.145813; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Gilchrist A., 2002, SCI STKE, pPL1; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; John SA, 2003, J PHYSIOL-LONDON, V552, P23, DOI 10.1113/jphysiol.2003.048843; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Le Maout S, 2001, P NATL ACAD SCI USA, V98, P10475, DOI 10.1073/pnas.181481098; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Loussouarn Gildas, 2006, V337, P167; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Rex TS, 2005, MOL VIS, V11; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Silva J, 2005, CIRCULATION, V112, P1384, DOI 10.1161/CIRCULATIONAHA.105.543306; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Zheng RJ, 2010, BIOCHEM J, V428, P75, DOI 10.1042/BJ20090977	31	42	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					707	716		10.1074/jbc.M110.146324	http://dx.doi.org/10.1074/jbc.M110.146324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20940310	Green Published, hybrid			2022-12-25	WOS:000285782800070
J	Hyvarinen, J; Parikka, M; Sormunen, R; Ramet, M; Tryggvason, K; Kivirikko, KI; Myllyharju, J; Koivunen, P				Hyvarinen, Jaana; Parikka, Mataleena; Sormunen, Raija; Ramet, Mika; Tryggvason, Karl; Kivirikko, Kari I.; Myllyharju, Johanna; Koivunen, Peppi			Deficiency of a Transmembrane Prolyl 4-Hydroxylase in the Zebrafish Leads to Basement Membrane Defects and Compromised Kidney Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; GENE-EXPRESSION; LYSYL OXIDASE; KAPPA-B; HIF-1-ALPHA; INHIBITION; HIF; OVEREXPRESSION; DIOXYGENASES; HIF-2-ALPHA	Prolyl 4-hydroxylases (P4Hs) catalyze the hydroxylation of collagens and hypoxia-inducible factor (HIF)-alpha subunits. We studied the zebrafish homologue of the recently characterized human transmembrane P4H (P4H-TM) that can hydroxylate HIF-alpha, but not collagens, in vitro and influence HIF-alpha levels in cellulo. The zebrafish P4H-TM mRNA had its highest expression in the eye and brain and lower levels in other tissues, including the kidney. Morpholino knockdown of P4H-TM in embryos resulted in a reduction in the size of the eye and head and morphological alterations in the head from 2 days postfertilization onward. In addition, pericardial edema, regarded as a sign of kidney dysfunction, developed from 3 days postfertilization onward. The phenotype was dependent on the P4H-TM catalytic activity because similar results were obtained with morpholinos targeting either translation initiation or catalytic residues of the enzyme. Structural and functional analyses of the morphant pronephric kidneys revealed fragmented glomerular basement membranes (BMs), disorganized podocyte foot processes, and severely compromised pronephric kidney function leading to proteinuria. The opacity of the eye lens was increased due to the presence of extra nuclei and deposits, and the structure of the lens capsule BM was altered.	[Hyvarinen, Jaana; Kivirikko, Kari I.; Myllyharju, Johanna; Koivunen, Peppi] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; [Hyvarinen, Jaana; Kivirikko, Kari I.; Myllyharju, Johanna; Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Hyvarinen, Jaana; Sormunen, Raija; Kivirikko, Kari I.; Myllyharju, Johanna; Koivunen, Peppi] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland; [Parikka, Mataleena; Ramet, Mika] Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland; [Parikka, Mataleena] Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, FIN-33521 Tampere, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; Tampere University; Karolinska Institutet; Tampere University; Tampere University Hospital	Koivunen, P (corresponding author), Univ Oulu, Dept Med Biochem & Mol Biol, Aapistie 7,POB 5000, FIN-90014 Oulu, Finland.	Peppi.Koivunen@oulu.fi	Parikka, Mataleena/D-4364-2014	Parikka, Mataleena/0000-0001-5555-3815	Academy of Finland [120156, 200471, 202469, 118431]; S. Juselius Foundation; FibroGen Inc.; Knut and Alice Wallenberg Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; Soderberg's Foundation; Biocenter Finland; Pirkanmaa Hospital district	Academy of Finland(Academy of Finland); S. Juselius Foundation; FibroGen Inc.; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Soderberg's Foundation; Biocenter Finland; Pirkanmaa Hospital district	This work was supported by Academy of Finland Grants 120156 (to P. K.), 200471 and 202469 (to J.M.), and 118431 (to M. R.); the S. Juselius Foundation (to P. K., J.M., and M. R.); FibroGen Inc. (to J.M.); the Knut and Alice Wallenberg Foundation; the Swedish Research Council; the Swedish Foundation for Strategic Research; and Soderberg's Foundation (to K. T.). The Tampere Zebrafish facility is supported by the Biocenter Finland. K. I. K. is a scientific founder and consultant of FibroGen Inc., which is developing HIF-P4H inhibitors as potential therapeutic agents. J.M. and K. I. K. own equity in this company, and the company itself has supported research in the laboratory headed by K. I. K. in the past and currently supports research in the laboratory of J.M. K. T. is co-founder of Nephro-Genex, Inc., and BioLamina AB Inc. but receives no research support from those companies.; Supported by the Competitive Research Funds of the Pirkanmaa Hospital district.	Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cooper ME, 2002, SEMIN NEPHROL, V22, P393, DOI 10.1053/snep.2002.34724; Corey DR, 2001, GENOME BIOL, V2; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Elamaa H, 2005, AM J PATHOL, V166, P221, DOI 10.1016/S0002-9440(10)62246-8; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Hamano Y, 2010, J AM SOC NEPHROL, V21, P1445, DOI 10.1681/ASN.2009050492; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Koivunen P, 2007, J BIOL CHEM, V282, P30544, DOI 10.1074/jbc.M704988200; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Lee J, 2007, INVEST OPHTH VIS SCI, V48, P2483, DOI 10.1167/iovs.06-1211; Majumdar A, 2000, DEV BIOL, V222, P147, DOI 10.1006/dbio.2000.9642; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Raschperger E, 2008, DEV BIOL, V313, P455, DOI 10.1016/j.ydbio.2007.10.049; Reynaud C, 2008, MATRIX BIOL, V27, P547, DOI 10.1016/j.matbio.2008.03.002; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rojas DA, 2007, GENE EXPR PATTERNS, V7, P339, DOI 10.1016/j.modgep.2006.08.002; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; van Rooijen E, 2009, BLOOD, V113, P6449, DOI 10.1182/blood-2008-07-167890; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029	47	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42023	42032		10.1074/jbc.M110.145904	http://dx.doi.org/10.1074/jbc.M110.145904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20952382	Green Published, hybrid			2022-12-25	WOS:000285622600088
J	Capp, C; Qian, YS; Sage, H; Huber, H; Hsieh, TS				Capp, Christopher; Qian, Yushen; Sage, Harvey; Huber, Harald; Hsieh, Tao-shih			Separate and Combined Biochemical Activities of the Subunits of a Naturally Split Reverse Gyrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASE-LIKE DOMAIN; NANOARCHAEUM-EQUITANS; DNA; TOPOISOMERASE; HYPERTHERMOPHILES; INSIGHTS; ASSOCIATION; EVOLUTION; TOPOLOGY; MACHINE	Reverse gyrase reanneals denatured DNA and induces positive supercoils in DNA, an activity that is critical for life at very high temperatures. Positive supercoiling occurs by a poorly understood mechanism involving the coordination of a topoisomerase domain and a helicase-like domain. In the parasitic archaeon Nanoarchaeum equitans, these domains occur as separate subunits. We express the subunits, and characterize them both in isolation and as a heterodimer. Each subunit tightly associates and interacts with the other. The topoisomerase subunit enhances the catalytic specificity of the DNA-dependent ATPase activity of the helicase-like subunit, and the helicase-like subunit inhibits the relaxation activity of the topoisomerase subunit while promoting positive supercoiling. DNA binding preference for both single-and double-stranded DNA is partitioned between the subunits. Based on a sensitive topological shift assay, the binding preference of helicase-like subunit for underwound DNA is modulated by its binding with ATP cofactor. These results provide new insight into the mechanism of positive supercoil induction by reverse gyrase.	[Capp, Christopher; Qian, Yushen; Sage, Harvey; Hsieh, Tao-shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Huber, Harald] Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany; [Huber, Harald] Univ Regensburg, Archaeal Ctr, D-93053 Regensburg, Germany	Duke University; University of Regensburg; University of Regensburg	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	hsieh@biochem.duke.edu	Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012		National Institutes of Health [GM29006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grant GM29006.	Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Brochier-Armanet Celine, 2007, Archaea, V2, P83; Capp C, 2009, J BIOL CHEM, V284, P30845, DOI 10.1074/jbc.M109.008052; CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753; Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199; Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Grogan DW, 1998, MOL MICROBIOL, V28, P1043, DOI 10.1046/j.1365-2958.1998.00853.x; Heine M, 2009, J MICROBIOL, V47, P229, DOI 10.1007/s12275-009-0019-8; Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200; Hsieh TS, 2005, J BIOL CHEM, V280, P20467, DOI 10.1074/jbc.M502739200; Jahn U, 2008, J BACTERIOL, V190, P1743, DOI 10.1128/JB.01731-07; Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683; KIKUCHI A, 1984, NATURE, V309, P677, DOI 10.1038/309677a0; KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0; Krah R, 1996, P NATL ACAD SCI USA, V93, P106, DOI 10.1073/pnas.93.1.106; Lopez-Garcia P, 1999, MOL MICROBIOL, V33, P766, DOI 10.1046/j.1365-2958.1999.01524.x; Lopez-Garcia P, 2000, J BACTERIOL, V182, P4998, DOI 10.1128/JB.182.17.4998-5000.2000; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Plank J, 2009, J BIOL CHEM, V284, P30737, DOI 10.1074/jbc.R109.051268; Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200; Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Stetter KO, 2006, EXTREMOPHILES, V10, P357, DOI 10.1007/s00792-006-0012-7; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100	26	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39637	39645		10.1074/jbc.M110.173989	http://dx.doi.org/10.1074/jbc.M110.173989			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20929866	hybrid, Green Published			2022-12-25	WOS:000285185500007
J	Dennis, EA; Deems, RA; Harkewicz, R; Quehenberger, O; Brown, HA; Milne, SB; Myers, DS; Glass, CK; Hardiman, G; Reichart, D; Merrill, AH; Sullards, MC; Wang, E; Murphy, RC; Raetz, CRH; Garrett, TA; Guan, ZQ; Ryan, AC; Russell, DW; McDonald, JG; Thompson, BM; Shaw, WA; Sud, M; Zhao, YH; Gupta, S; Maurya, MR; Fahy, E; Subramaniam, S				Dennis, Edward A.; Deems, Raymond A.; Harkewicz, Richard; Quehenberger, Oswald; Brown, H. Alex; Milne, Stephen B.; Myers, David S.; Glass, Christopher K.; Hardiman, Gary; Reichart, Donna; Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine; Murphy, Robert C.; Raetz, Christian R. H.; Garrett, Teresa A.; Guan, Ziqiang; Ryan, Andrea C.; Russell, David W.; McDonald, Jeffrey G.; Thompson, Bonne M.; Shaw, Walter A.; Sud, Manish; Zhao, Yihua; Gupta, Shakti; Maurya, Mano R.; Fahy, Eoin; Subramaniam, Shankar			A Mouse Macrophage Lipidome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITION; ENDOTOXIN; CELLS	We report the lipidomic response of the murine macrophage RAW cell line to Kdo(2)-lipid A, the active component of an inflammatory lipopolysaccharide functioning as a selective TLR4 agonist and compactin, a statin inhibitor of cholesterol biosynthesis. Analyses of lipid molecular species by dynamic quantitative mass spectrometry and concomitant transcriptomic measurements define the lipidome and demonstrate immediate responses in fatty acid metabolism represented by increases in eicosanoid synthesis and delayed responses characterized by sphingolipid and sterol biosynthesis. Lipid remodeling of glycerolipids, glycerophospholipids, and prenols also take place, indicating that activation of the innate immune system by inflammatory mediators leads to alterations in a majority of mammalian lipid categories, including unanticipated effects of a statin drug. Our studies provide a systems-level view of lipid metabolism and reveal significant connections between lipid and cell signaling and biochemical pathways that contribute to innate immune responses and to pharmacological perturbations.	[Dennis, Edward A.; Deems, Raymond A.; Subramaniam, Shankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dennis, Edward A.; Harkewicz, Richard] Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA; [Quehenberger, Oswald; Glass, Christopher K.; Hardiman, Gary] Univ Calif San Diego, Dept Med, Sch Med, La Jolla, CA 92093 USA; [Brown, H. Alex; Milne, Stephen B.; Myers, David S.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Glass, Christopher K.; Reichart, Donna; Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA; [Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine] Georgia Inst Technol, Sch Chem, Atlanta, GA 30332 USA; [Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine] Georgia Inst Technol, Sch Biochem, Atlanta, GA 30332 USA; [Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Raetz, Christian R. H.; Garrett, Teresa A.; Guan, Ziqiang; Ryan, Andrea C.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Russell, David W.; McDonald, Jeffrey G.; Thompson, Bonne M.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Shaw, Walter A.] Avanti Polar Lipids Inc, Alabaster, AL 35007 USA; [Sud, Manish; Zhao, Yihua; Gupta, Shakti; Maurya, Mano R.; Fahy, Eoin; Subramaniam, Shankar] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Vanderbilt University; University of California System; University of California San Diego; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	edennis@ucsd.edu; shankar@ucsd.edu	Guan, Ziqiang/AAE-5110-2019; Murphy, Robert/AAO-5349-2020; Dennis, Edward A./M-5554-2019; Glass, Christopher/AAI-3933-2021	Murphy, Robert/0000-0002-9430-6515; Dennis, Edward A./0000-0003-3738-3140; Glass, Christopher/0000-0003-4344-3592; Merrill, Alfred/0000-0002-6673-968X; Russell, David/0000-0002-0277-403X; Thompson, Bonne/0000-0001-7563-8330; Hardiman, Gary/0000-0003-4558-0400	National Institutes of Health through NIGMS [U54 GM069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant through the NIGMS Large Scale Collaborative "Glue" Grant U54 GM069338 (to E. A. D.).	Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Brown HA, 2007, METHOD ENZYMOL, V432, P1; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1974, J BIOL CHEM, V249, P7306; Buczynski MW, 2007, J BIOL CHEM, V282, P22834, DOI 10.1074/jbc.M701831200; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; BYRNES RW, 2007, JALA, V12, P230; Dennis E.A., 2005, FUNCTIONAL LIPIDOMIC, P1; Dennis EA, 2009, P NATL ACAD SCI USA, V106, P2089, DOI 10.1073/pnas.0812636106; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; Guan ZQ, 2007, BIOCHEMISTRY-US, V46, P14500, DOI 10.1021/bi701907g; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; Harkewicz R, 2007, J BIOL CHEM, V282, P2899, DOI 10.1074/jbc.M610067200; Ivanova PT, 2010, J LIPID RES, V51, P1581, DOI 10.1194/jlr.D003715; Ivanova PT, 2001, P NATL ACAD SCI USA, V98, P7152, DOI 10.1073/pnas.131195098; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; KANDUTSCH AA, 1974, J BIOL CHEM, V249, P6057; Kim JK, 2006, CELL METAB, V4, P417, DOI 10.1016/j.cmet.2006.11.008; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Popovic ZV, 2007, J IMMUNOL, V179, P6770, DOI 10.4049/jimmunol.179.10.6770; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wu HFM, 2005, AM J PHYSIOL-LUNG C, V288, pL585, DOI 10.1152/ajplung.00305.2004	32	203	208	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39976	39985		10.1074/jbc.M110.182915	http://dx.doi.org/10.1074/jbc.M110.182915			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20923771	hybrid, Green Published			2022-12-25	WOS:000285185500042
J	Gao, JL; Nguyen, KA; Hunter, N				Gao, Jin-Long; Nguyen, Ky-Anh; Hunter, Neil			Characterization of a Hemophore-like Protein from Porphyromonas gingivalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE-SPECIFIC GINGIPAIN; OUTER-MEMBRANE PROTEIN; HEMIN-BINDING-PROTEIN; INFLUENZAE TYPE-B; HAEMOPHILUS-INFLUENZAE; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; TRAFFICKING PROTEIN; CONTAINING PIGMENT	The porphyrin auxotrophic pathogen Porphyromonas gingivalis obtains the majority of essential iron and porphyrin from host hemoproteins. To achieve this, the organism expresses outer membrane gingipains containing cysteine proteinase domains linked to hemagglutinin domains. Heme mobilized in this way is taken up by P. gingivalis through a variety of potential portals where HmuY/HmuR of the hmu locus are best described. These receptors have relatively low binding affinities for heme. In this report, we describe a novel P. gingivalis protein, HusA, the product of PG2227, which rapidly bound heme with a high binding constant at equilibrium of 7 x 10(-10) M. HusA is both expressed on the outer membrane and released from the organism. Spectral analysis indicated an unusual pattern of binding where heme was ligated preferentially as a dimer. Further, the presence of dimeric heme induced protein dimer formation. Deletional inactivation of husA showed that expression of this moiety was essential for growth of P. gingivalis under conditions of heme limitation. This finding was in accord with the pronounced increase in gene expression levels for husA with progressive reduction of heme supplementation. Antibodies reactive against HusA were detected in patients with chronic periodontitis, suggesting that the protein is expressed during the course of infection by P. gingivalis. It is predicted that HusA efficiently sequesters heme from gingipains and fulfills the function of a high affinity hemophore-like protein to meet the heme requirement for growth of P. gingivalis during establishment of infection.	Westmead Millennium Inst, Inst Dent Res, Sydney, NSW 2145, Australia; Westmead Hosp, Ctr Oral Hlth, Sydney, NSW 2145, Australia; [Gao, Jin-Long; Nguyen, Ky-Anh] Univ Sydney, Fac Dent, Sydney, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	Nguyen, KA (corresponding author), POB 533, Wentworthville, NSW 2145, Australia.	kyanhn@gmail.com	Nguyen, Ky-Anh/A-4971-2010	Nguyen, Ky-Anh/0000-0002-1643-6576; Gao, Jinlong/0000-0002-5153-5393	Australian Research Council [LP0562660]; Ramaciotti Foundation [RN38/08]; New South Wales Dental Board; University of Sydney; Australia and Bela Schwartz Foundation	Australian Research Council(Australian Research Council); Ramaciotti Foundation; New South Wales Dental Board; University of Sydney(University of Sydney); Australia and Bela Schwartz Foundation	This work was supported by Grant LP0562660 from the Australian Research Council (to N. H.) and Establishment Grant RN38/08 from the Ramaciotti Foundation (to K.-A. N.).; Supported by Ph.D. scholarship from the New South Wales Dental Board, Australia and Bela Schwartz Foundation, and the University of Sydney.	AduseOpoku J, 1997, J BACTERIOL, V179, P4778, DOI 10.1128/jb.179.15.4778-4788.1997; Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; Anaya-Bergman C, 2010, INFECT IMMUN, V78, P688, DOI 10.1128/IAI.00108-09; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Arnoux P, 1999, NAT STRUCT BIOL, V6, P516; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Block DR, 2007, BIOCHEMISTRY-US, V46, P14391, DOI 10.1021/bi701509n; BRAMANTI TE, 1992, MICROB PATHOGENESIS, V13, P61, DOI 10.1016/0882-4010(92)90032-J; BRAMANTI TE, 1993, J PERIODONTAL RES, V28, P464, DOI 10.1111/j.1600-0765.1993.tb02103.x; Caldwell RB, 2004, APPL ENVIRON MICROB, V70, P610, DOI 10.1128/AEM.70.1.610-612.2004; Chan ACK, 2006, J MOL BIOL, V362, P1108, DOI 10.1016/j.jmb.2006.08.001; COPE LD, 1994, MOL MICROBIOL, V13, P863, DOI 10.1111/j.1365-2958.1994.tb00478.x; Crosson S, 2005, P NATL ACAD SCI USA, V102, P8018, DOI 10.1073/pnas.0503022102; Czjzek M, 2007, J MOL BIOL, V365, P1176, DOI 10.1016/j.jmb.2006.10.063; Dashper SG, 2000, J BACTERIOL, V182, P6456, DOI 10.1128/JB.182.22.6456-6462.2000; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Fujise O, 2006, J PERIODONTOL, V77, P1333, DOI 10.1902/jop.2006.050225; Ghosh K, 2005, BIOCHEMISTRY-US, V44, P16729, DOI 10.1021/bi0511585; Gibson FC, 2008, FRONT BIOSCI-LANDMRK, V13, P2041, DOI 10.2741/2822; HANSON MS, 1992, P NATL ACAD SCI USA, V89, P1973, DOI 10.1073/pnas.89.5.1973; HANSON MS, 1992, INFECT IMMUN, V60, P2257, DOI 10.1128/IAI.60.6.2257-2266.1992; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0; Lewis JP, 2010, PERIODONTOL 2000, V52, P94, DOI 10.1111/j.1600-0757.2009.00329.x; Lewis JP, 2009, MICROBIOL-SGM, V155, P3758, DOI 10.1099/mic.0.027953-0; Liu XY, 2006, INFECT IMMUN, V74, P1222, DOI 10.1128/IAI.74.2.1222-1232.2006; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; Nguyen KA, 2004, INFECT IMMUN, V72, P1374, DOI 10.1128/IAI.72.3.1374-1382.2004; Nguyen KA, 2009, MICROBIOL-SGM, V155, P328, DOI 10.1099/mic.0.024323-0; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Roper JM, 2000, J BIOL CHEM, V275, P40316, DOI 10.1074/jbc.M007146200; Rungrassamee W, 2009, J BACTERIOL, V191, P6709, DOI 10.1128/JB.00932-09; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; Shepherd M, 2007, BIOCHEMISTRY-US, V46, P5030, DOI 10.1021/bi700183u; Shibata Y, 2003, BIOCHEM BIOPH RES CO, V300, P351, DOI 10.1016/S0006-291X(02)02826-7; SHIZUKUISHI S, 1995, FEMS MICROBIOL LETT, V131, P313; Simpson W, 2000, J BACTERIOL, V182, P5737, DOI 10.1128/JB.182.20.5737-5748.2000; Smalley JW, 2006, MICROBIOL-SGM, V152, P1839, DOI 10.1099/mic.0.28835-0; Smalley JW, 2008, BIOL CHEM, V389, P1235, DOI 10.1515/BC.2008.140; Smalley JW, 2007, ARCH BIOCHEM BIOPHYS, V465, P44, DOI 10.1016/j.abb.2007.05.011; SMALLEY JW, 1993, J GEN MICROBIOL, V139, P2145, DOI 10.1099/00221287-139-9-2145; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; Smalley JW, 2004, BIOCHEM J, V379, P833, DOI 10.1042/BJ20031221; Smalley JW, 2002, BIOCHEM J, V362, P239, DOI 10.1042/0264-6021:3620239; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Tompkins GR, 1997, J BACTERIOL, V179, P620, DOI 10.1128/jb.179.3.620-626.1997; Troese MJ, 2009, INFECT IMMUN, V77, P1746, DOI 10.1128/IAI.01530-08; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wojtowicz H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000419; Wojtowicz H, 2009, BIOCHEM BIOPH RES CO, V383, P178, DOI 10.1016/j.bbrc.2009.03.148; Woodward JJ, 2007, NAT METHODS, V4, P43, DOI 10.1038/NMETH984	61	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40028	40038		10.1074/jbc.M110.163535	http://dx.doi.org/10.1074/jbc.M110.163535			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940309	Green Published, hybrid			2022-12-25	WOS:000285185500048
J	Robbins, RD; Tersey, SA; Ogihara, T; Gupta, D; Farb, TB; Ficorilli, J; Bokvist, K; Maier, B; Mirmira, RG				Robbins, Reiesha D.; Tersey, Sarah A.; Ogihara, Takeshi; Gupta, Dhananjay; Farb, Thomas B.; Ficorilli, James; Bokvist, Krister; Maier, Bernhard; Mirmira, Raghavendra G.			Inhibition of Deoxyhypusine Synthase Enhances Islet beta Cell Function and Survival in the Setting of Endoplasmic Reticulum Stress and Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 5A; UNFOLDED PROTEIN RESPONSE; INSULIN-SECRETION; NUCLEAR EXPORT; MESSENGER-RNA; TRANSLATION INITIATION; ABDOMINAL OBESITY; MICE; INFLAMMATION; EXPRESSION	Islet beta cell dysfunction resulting from inflammation, ER stress, and oxidative stress is a key determinant in the progression from insulin resistance to type 2 diabetes mellitus. It was recently shown that the enzyme deoxyhypusine synthase (DHS) promotes early cytokine-induced inflammation in the beta cell. DHS catalyzes the conversion of lysine to hypusine, an amino acid that is unique to the translational elongation factor eIF5A. Here, we sought to determine whether DHS activity contributes to beta cell dysfunction in models of type 2 diabetes in mice and beta cell lines. A 2-week treatment of obese diabetic C57BLKS/J-db/db mice with the DHS inhibitor GC7 resulted in improved glucose tolerance, increased insulin release, and enhanced beta cell mass. Thapsigargin treatment of beta cells in vitro induces a picture of ER stress and apoptosis similar to that seen in db/db mice; in this setting, DHS inhibition led to a block in CHOP (CAAT/enhancer binding protein homologous protein) production despite >30-fold activation of Chop gene transcription. Blockage of CHOP translation resulted in reduction of downstream caspase-3 cleavage and near-complete protection of cells from apoptotic death. DHS inhibition appeared to prevent the cytoplasmic co-localization of eIF5A with the ER, possibly precluding the participation of eIF5A in translational elongation at ER-based ribosomes. We conclude that hypusination by DHS is required for the ongoing production of proteins, particularly CHOP, in response to ER stress in the beta cell.	[Tersey, Sarah A.; Ogihara, Takeshi; Gupta, Dhananjay; Maier, Bernhard; Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Tersey, Sarah A.; Ogihara, Takeshi; Gupta, Dhananjay; Maier, Bernhard; Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Robbins, Reiesha D.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22904 USA; [Farb, Thomas B.; Ficorilli, James; Bokvist, Krister] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Virginia; Eli Lilly; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Maier, B (corresponding author), Indiana Univ, Sch Med, Dept Pediat, 635 Barnhill Dr,MS2021, Indianapolis, IN 46202 USA.	bfmaier@iupui.edu; rmirmira@iupui.edu	Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Tersey, Sarah/0000-0003-0667-2361	National Institutes of Health [R01 DK60581, F31 DK079420]; Ball Brothers Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK079420, R01DK060581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ball Brothers Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK60581 (to R. G. M.) and F31 DK079420 (to R. D. R.). This work was also supported by a grant from the Ball Brothers Foundation (to R.G.M.).	BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Elfgang C, 1999, P NATL ACAD SCI USA, V96, P6229, DOI 10.1073/pnas.96.11.6229; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; GOTOH M, 1990, HORM METAB RES, V25, P10; Hauber I, 2005, J CLIN INVEST, V115, P76, DOI 10.1172/JCI200521949; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Laedtke T, 2000, AM J PHYSIOL-ENDOC M, V279, pE520, DOI 10.1152/ajpendo.2000.279.3.E520; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Lebrun P, 2010, DIABETOLOGIA, V53, P1935, DOI 10.1007/s00125-010-1786-9; LEITER EH, 1981, DIABETES, V30, P30, DOI 10.2337/diabetes.30.1.30; Li CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009942; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moore CC, 2008, J INFECT DIS, V198, P1407, DOI 10.1086/592222; Ogihara T, 2010, J DIABETES INVEST, V1, P123, DOI 10.1111/j.2040-1124.2010.00021.x; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; ROE MW, 1994, J BIOL CHEM, V269, P18279; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Shao CL, 2010, J BIOL CHEM, V285, P19710, DOI 10.1074/jbc.M109.087486; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Umland TC, 2004, J BIOL CHEM, V279, P28697, DOI 10.1074/jbc.M404095200; Wolff EC, 2000, J BIOL CHEM, V275, P9170, DOI 10.1074/jbc.275.13.9170; Xu AG, 2001, J BIOL CHEM, V276, P2555, DOI 10.1074/jbc.M008982200; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	44	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39943	39952		10.1074/jbc.M110.170142	http://dx.doi.org/10.1074/jbc.M110.170142			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956533	hybrid, Green Published			2022-12-25	WOS:000285185500039
J	Noonan, J; Tanveer, R; Klompas, A; Gowran, A; McKiernan, J; Campbell, VA				Noonan, Janis; Tanveer, Riffat; Klompas, Allan; Gowran, Aoife; McKiernan, Joanne; Campbell, Veronica A.			Endocannabinoids Prevent beta-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CB1 CANNABINOID RECEPTORS; ALZHEIMERS-DISEASE; CELL-DEATH; CORTICAL-NEURONS; CATHEPSIN-D; MEMBRANE PERMEABILIZATION; MOUSE MODEL; OXIDATIVE-METABOLISM; INDUCED APOPTOSIS; NERVOUS-SYSTEM	Neuronal cell loss underlies the pathological decline in cognition and memory associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in AD has emerged as a promising new approach to treatment. Studies have identified neuroprotective roles for endocannabinoids against key pathological events in the AD brain, including cell death by apoptosis. Elucidation of the apoptotic pathway evoked by beta-amyloid (A beta) is thus important for the development of therapeutic strategies that can thwart A beta toxicity and preserve cell viability. We have previously reported that lysosomal membrane permeabilization plays a distinct role in the apoptotic pathway initiated by A beta. In the present study, we provide evidence that the endocannabinoid system can stabilize lysosomes against A beta-induced permeabilization and in turn sustain cell survival. We report that endocannabinoids stabilize lysosomes by preventing the A beta-induced up-regulation of the tumor suppressor protein, p53, and its interaction with the lysosomal membrane. We also provide evidence that intracellular cannabinoid type 1 receptors play a role in stabilizing lysosomes against A beta toxicity and thus highlight the functionality of these receptors. Given the deleterious effect of lysosomal membrane permeabilization on cell viability, stabilization of lysosomes with endocannabinoids may represent a novel mechanism by which these lipid modulators confer neuroprotection.	[Campbell, Veronica A.] Trinity Coll Dublin, Dept Physiol, Sch Med, Dublin 2, Ireland; Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Campbell, VA (corresponding author), Trinity Coll Dublin, Dept Physiol, Sch Med, Dublin 2, Ireland.	vacmpbll@tcd.ie	Gowran, Aoife/K-6671-2016	Klompas, Allan/0000-0001-8852-4666	Health Research Board Ireland	Health Research Board Ireland	This work was supported by the Health Research Board Ireland.	Ahn K, 2002, TRAFFIC, V3, P147, DOI 10.1034/j.1600-0854.2002.030207.x; Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; Benito C, 2003, J NEUROSCI, V23, P11136; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Boland B, 2003, NEUROBIOL AGING, V24, P179, DOI 10.1016/S0197-4580(02)00060-X; Boland B, 2004, NEUROBIOL AGING, V25, P83, DOI 10.1016/S0197-4580(03)00034-4; Bouaboula M, 2005, EUR J PHARMACOL, V517, P174, DOI 10.1016/j.ejphar.2005.05.032; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Campbell VA, 2007, BRIT J PHARMACOL, V152, P655, DOI 10.1038/sj.bjp.0707446; Campillo NE, 2009, MINI-REV MED CHEM, V9, P539, DOI 10.2174/138955709788167628; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Chen B, 2010, CURR ALZHEIMER RES, V7, P255, DOI 10.2174/156720510791050948; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Colak A, 2009, NEUROCIRUGIA, V20, P245; Collette J, 2004, INT REV CYTOL, V241, P1, DOI 10.1016/S0074-7696(04)41001-8; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; DEADWYLER SA, 1995, J PHARMACOL EXP THER, V273, P734; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Dodd GT, 2010, J NEUROSCI, V30, P7369, DOI 10.1523/JNEUROSCI.5455-09.2010; Downer E, 2001, NEUROREPORT, V12, P3973, DOI 10.1097/00001756-200112210-00024; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Esposito G, 2006, J MOL MED, V84, P253, DOI 10.1007/s00109-005-0025-1; Fogarty MP, 2010, NEUROBIOL AGING, V31, P1774, DOI 10.1016/j.neurobiolaging.2008.09.018; Fowler CJ, 2010, EXP NEUROL, V224, P37, DOI 10.1016/j.expneurol.2010.03.021; Galve-Roperh I, 2002, MOL PHARMACOL, V62, P1385, DOI 10.1124/mol.62.6.1385; Gomes I, 2009, FASEB J, V23, P3020, DOI 10.1096/fj.09-132142; Guzman M, 2002, PHARMACOL THERAPEUT, V95, P175, DOI 10.1016/S0163-7258(02)00256-5; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Kagedal K, 2005, INT J EXP PATHOL, V86, P309, DOI 10.1111/j.0959-9673.2005.00442.x; Karanian DA, 2005, EUR J PHARMACOL, V508, P47, DOI 10.1016/j.ejphar.2004.12.009; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Koppel J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-2; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Li N, 2007, CANCER RES, V67, P11176, DOI 10.1158/0008-5472.CAN-07-2333; Liu Q, 2009, J PHARMACOL EXP THER, V331, P1062, DOI 10.1124/jpet.109.156216; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; MACKIE K, 1995, J NEUROSCI, V15, P6552; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; MacManus A, 2000, J BIOL CHEM, V275, P4713, DOI 10.1074/jbc.275.7.4713; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Mendiguren A, 2009, BRIT J PHARMACOL, V158, P1579, DOI 10.1111/j.1476-5381.2009.00434.x; Milton NGN, 2002, NEUROSCI LETT, V332, P127, DOI 10.1016/S0304-3940(02)00936-9; Mirnikjoo B, 2009, J BIOL CHEM, V284, P6918, DOI 10.1074/jbc.M805288200; NADLER V, 1993, NEUROSCI LETT, V162, P43, DOI 10.1016/0304-3940(93)90555-Y; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Palotas A, 2002, BRAIN RES BULL, V58, P203, DOI 10.1016/S0361-9230(02)00773-6; Pertwee RG, 2007, BRIT J PHARMACOL, V152, P984, DOI 10.1038/sj.bjp.0707464; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Van der Stelt M, 2006, CELL MOL LIFE SCI, V63, P1410, DOI 10.1007/s00018-006-6037-3; WESTLAKE TM, 1994, NEUROSCIENCE, V63, P637, DOI 10.1016/0306-4522(94)90511-8; Yacoub A, 2008, MOL CANCER THER, V7, P297, DOI 10.1158/1535-7163.MCT-07-2166; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Yang HW, 2008, MOL CELL NEUROSCI, V37, P682, DOI 10.1016/j.mcn.2007.12.019; Yap YW, 2006, J NEUROCHEM, V98, P1597, DOI 10.1111/j.1471-4159.2006.03996.x; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zheng L, 2006, NEUROSCI LETT, V394, P184, DOI 10.1016/j.neulet.2005.10.035; Zhuang SY, 2005, NEUROPHARMACOLOGY, V48, P1086, DOI 10.1016/j.neuropharm.2005.01.005	88	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38543	38554		10.1074/jbc.M110.162040	http://dx.doi.org/10.1074/jbc.M110.162040			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923768	hybrid, Green Published			2022-12-25	WOS:000284625600060
J	Kazemi, Z; Chang, HN; Haserodt, S; McKen, C; Zachara, NE				Kazemi, Zahra; Chang, Hana; Haserodt, Sarah; McKen, Cathrine; Zachara, Natasha E.			O-Linked beta-N-acetylglucosamine (O-GlcNAc) Regulates Stress-induced Heat Shock Protein Expression in a GSK-3 beta-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE KINASE 3-BETA; ISCHEMIA-REPERFUSION INJURY; TARGETED GENE DISRUPTION; FACTOR-I EXPRESSION; RNA-POLYMERASE-II; NEONATAL CARDIOMYOCYTES; HEXOSAMINE BIOSYNTHESIS; MOLECULAR CHAPERONES; CYTOSOLIC PROTEINS; NUCLEOCYTOPLASMIC GLYCOSYLATION	To investigate the mechanisms by which O-linked beta-N-acetylglucosamine modification of nucleocytoplasmic proteins (O-GlcNAc) confers stress tolerance to multiple forms of cellular injury, we explored the role(s) of O-GlcNAc in the regulation of heat shock protein (HSP) expression. Using a cell line in which deletion of the O-GlcNAc transferase (OGT; the enzyme that adds O-GlcNAc) can be induced by 4-hydroxytamoxifen, we screened the expression of 84 HSPs using quantitative reverse transcriptase PCR. In OGT null cells the stress-induced expression of 18 molecular chaperones, including HSP72, were reduced. GSK-3 beta promotes apoptosis through numerous pathways, including phosphorylation of heat shock factor 1 (HSF1) at Ser(303) (Ser(P)(303) HSF1), which inactivates HSF1 and inhibits HSP expression. In OGT null cells we observed increased Ser(P)(303) HSF1; conversely, in cells in which O-GlcNAc levels had been elevated, reduced Ser(P)(303) HSF1 was detected. These data, combined with those showing that inhibition of GSK-3 beta in OGT null cells recovers HSP72 expression, suggests that O-GlcNAc regulates the activity of GSK-3 beta. In OGT null cells, stress-induced inactivation of GSK-3 beta by phosphorylation at Ser(9) was ablated providing a molecular basis for these findings. Together, these data suggest that stress-induced GlcNAcylation increases HSP expression through inhibition of GSK-3 beta	[Kazemi, Zahra; Chang, Hana; Haserodt, Sarah; McKen, Cathrine; Zachara, Natasha E.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Zachara, NE (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	nzachara@jhmi.edu			American Heart Association [SDG 0930162N]	American Heart Association(American Heart Association)	This work was supported by American Heart Association Grant SDG 0930162N (to N. E. Z.).	BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Chatham JC, 2008, SHOCK, V29, P431, DOI 10.1097/SHK.0b013e3181598bad; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dugo L, 2007, SHOCK, V27, P113, DOI 10.1097/01.shk.0000238059.23837.68; Eliasen MM, 2006, J MOL MED, V84, P147, DOI 10.1007/s00109-005-0004-6; Eom TY, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-14; Farook VS, 2002, MOL GENET METAB, V77, P189, DOI 10.1016/S1096-7192(02)00127-0; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Han I, 2000, BIOCHEM J, V350, P109, DOI 10.1042/0264-6021:3500109; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart G. W., 1995, NIH CATALYST, V3, P8; Hartigan JA, 2001, BIOCHEM BIOPH RES CO, V284, P485, DOI 10.1006/bbrc.2001.4986; Hatsell S, 2003, J BIOL CHEM, V278, P37745, DOI 10.1074/jbc.M301346200; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; Heese-Peck A, 1998, PLANT CELL, V10, P599, DOI 10.1105/tpc.10.4.599; HEESEPECK A, 1995, PLANT CELL, V7, P1459, DOI 10.1105/tpc.7.9.1459; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Huang JB, 2007, CELL IMMUNOL, V245, P1, DOI 10.1016/j.cellimm.2007.03.006; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Imahori K, 1997, J BIOCHEM, V121, P179; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kannoji A, 2008, EXPERT OPIN THER TAR, V12, P1443, DOI 10.1517/14728222.12.11.1443 ; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Konrad RJ, 2002, INT J MOL MED, V10, P535; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Lefebvre T, 2004, J CELL BIOCHEM, V93, P999, DOI 10.1002/jcb.20242; Lim KH, 2006, FEBS LETT, V580, P4645, DOI 10.1016/j.febslet.2006.07.040; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Majumdar G, 2003, AM J PHYSIOL-ENDOC M, V285, pE584, DOI 10.1152/ajpendo.00140.2003; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Miura T, 2009, CIRC J, V73, P1184, DOI 10.1253/circj.CJ-09-0284; Morrison AL, 2006, AM J PHYSIOL-CELL PH, V290, pC1625, DOI 10.1152/ajpcell.00635.2005; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Nagy T, 2006, AM J PHYSIOL-CELL PH, V290, pC57, DOI 10.1152/ajpcell.00263.2005; Ngoh GA, 2008, J PHARMACOL EXP THER, V327, P602, DOI 10.1124/jpet.108.143263; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Nollen EAA, 2002, J CELL SCI, V115, P2809; Not L. G., 2010, CRIT CARE MED, V38, P562; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Oh KH, 2004, TRANSPL IMMUNOL, V13, P273, DOI 10.1016/j.trim.2004.08.003; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Peng ZY, 2006, JPEN-PARENTER ENTER, V30, P373, DOI 10.1177/0148607106030005373; Peng ZY, 2006, JPEN-PARENTER ENTER, V30, P400, DOI 10.1177/0148607106030005400; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Santoro M G, 1996, EXS, V77, P337; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shim EH, 2002, EMBO REP, V3, P857, DOI 10.1093/embo-reports/kvf175; Singleton KD, 2008, JPEN-PARENTER ENTER, V32, P371, DOI 10.1177/0148607108320661; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2002, BBA-GEN SUBJECTS, V1573, P121, DOI 10.1016/S0304-4165(02)00369-0; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Sohn KC, 2004, BIOCHEM BIOPH RES CO, V322, P1045, DOI 10.1016/j.bbrc.2004.08.023; Tannour-Louet M, 2002, HEPATOLOGY, V35, P1072, DOI 10.1053/jhep.2002.33164; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Xi JK, 2009, EUR J PHARMACOL, V604, P111, DOI 10.1016/j.ejphar.2008.12.024; Yang SL, 2006, SHOCK, V25, P600, DOI 10.1097/01.shk.0000209563.07693.db; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	106	115	116	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39096	39107		10.1074/jbc.M110.131102	http://dx.doi.org/10.1074/jbc.M110.131102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926391	Green Published, hybrid			2022-12-25	WOS:000284941300040
J	Antonacci, D; Norscia, I; Palagi, E				Antonacci, Daniela; Norscia, Ivan; Palagi, Elisabetta			Stranger to Familiar: Wild Strepsirhines Manage Xenophobia by Playing	PLOS ONE			English	Article							MALE VERREAUXS SIFAKA; BONOBOS PAN-PANISCUS; PROPITHECUS-VERREAUXI; ADULT PLAY; KIRINDY FOREST; SOCIAL PLAY; BEHAVIOR; BENEFITS; SIGNALS; REPRODUCTION	The power of play in limiting xenophobia is a well-known phenomenon in humans. Yet, the evidence in social animals remains meager. Here, we aim to determine whether play promotes social tolerance toward strangers in one of the most basal group of primates, the strepsirhines. We observed two groups of wild lemurs (Propithecus verreauxi, Verreaux's sifaka) during the mating season. Data were also collected on nine visiting, outgroup males. We compared the distribution of play, grooming, and aggressive interactions across three conditions: OUT (resident/outgroup interactions), IN (resident/resident interactions in presence of outgroups) and BL-IN (baseline of resident/resident interactions in absence of outgroups). Play frequency between males was higher in OUT than in IN and BL-IN conditions; whereas, grooming was more frequent in IN than in OUT and BL-IN conditions. Aggression rates between resident and outgroup males were significantly higher than those between residents. However, aggressions between resident and outgroup males significantly decreased after the first play session and became comparable with resident-resident aggression levels. The presence of strangers in a well-established group implies the onset of novel social circumstances, which sifaka males cope with by two different tactics: grooming with ingroup males and playing with outgroup ones. The grooming peak, concurrently with the visit of outgroups, probably represents a social shield adopted by resident males to make their pre-existing affiliation more evident to the stranger "audience''. Being mostly restricted to unfamiliar males, adult play in sifaka appears to have a role in managing new social situations more than in maintaining old relationships. In particular, our results indicate not only that play is the interface between strangers but also that it has a specific function in reducing xenophobia. In conclusion, play appears to be an ice-breaker mechanism in the critical process that "upgrades'' an individual from stranger to familiar.	[Antonacci, Daniela; Norscia, Ivan; Palagi, Elisabetta] Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Terr, Pisa, Italy; [Palagi, Elisabetta] CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy; [Palagi, Elisabetta] CNR, Inst Cognit Sci & Technol, Ctr Primate, Rome, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Antonacci, D (corresponding author), Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Terr, Pisa, Italy.	betta.palagi@museo.unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717	Giardino Zoologico di Pistoia; Parco Zoo Punta Verde; Parco Zoo di Falconara (ITALY)	Giardino Zoologico di Pistoia; Parco Zoo Punta Verde; Parco Zoo di Falconara (ITALY)	The present study was funded by Giardino Zoologico di Pistoia, Parco Zoo Punta Verde, Parco Zoo di Falconara (ITALY). The funding covered only field and travel expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2002, SOCIOBIOLOGY NEW SYN; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Benadi G, 2008, AM J PRIMATOL, V70, P956, DOI 10.1002/ajp.20588; Brockman DK, 1999, INT J PRIMATOL, V20, P375, DOI 10.1023/A:1020500804442; Burghardt GM, 2005, GENESIS OF ANIMAL PLAY: TESTING THE LIMITS, P1; BYERS JA, 1995, AM NAT, V146, P25, DOI 10.1086/285785; Cashdan E, 2001, CURR ANTHROPOL, V42, P760, DOI 10.1086/323821; Castellan NJ, 1988, NONPARAMETRIC STAT B; Charles-Dominique P., 1977, ECOLOGY BEHAV NOCTUR; Drea CM, 1996, ANIM BEHAV, V51, P1323, DOI 10.1006/anbe.1996.0136; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Eisenberg J.F., 1976, Smithsonian Contributions to Zoology, VNo. 213, P1; Fagen Robert, 1993, P182; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gray P, 2009, AM J PLAY, V1, P476; HAYAKI H, 1985, Primates, V26, P343, DOI 10.1007/BF02382452; HERRERO S, 1977, J MAMMAL, V58, P441, DOI 10.2307/1379352; JOLLY A, 1972, FOLIA PRIMATOL, V17, P335, DOI 10.1159/000155454; Jolly A., 1966, LEMUR BEHAV MADAGASC; Jolly Alison, 2006, P32, DOI 10.1007/978-0-387-34126-2_3; KANO T, 1984, FOLIA PRIMATOL, V43, P36, DOI 10.1159/000156169; Kappeler PM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1007, DOI 10.1007/s00265-007-0528-6; Kappeler PM, 2009, AM J PHYS ANTHROPOL, V140, P487, DOI 10.1002/ajpa.21091; Kappeler PM, 1998, BEHAV ECOL SOCIOBIOL, V42, P411, DOI 10.1007/s002650050455; Kaufman AB, 2009, ANIM BEHAV, V78, P1487, DOI 10.1016/j.anbehav.2009.09.014; KLEIMAN DG, 1983, Z TIERPSYCHOL, V62, P1; Klein ZA, 2010, DEV PSYCHOBIOL, V52, P62, DOI 10.1002/dev.20413; Lawler RR, 2007, AM J PHYS ANTHROPOL, V132, P267, DOI 10.1002/ajpa.20507; Lewis R. J., 2004, THESIS DUKE U DURHAM; Lewis RJ, 2008, INT J PRIMATOL, V29, P1249, DOI 10.1007/s10764-008-9304-3; Lewis RJ, 2007, INT J PRIMATOL, V28, P159, DOI 10.1007/s10764-006-9107-3; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Mancini G, 2009, BEHAV PROCESS, V82, P286, DOI 10.1016/j.beproc.2009.07.007; Martin P., 2007, MEASURING BEHAV INTR, V3; MENDOZA SP, 1986, PHYSIOL BEHAV, V38, P795, DOI 10.1016/0031-9384(86)90045-4; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Norscia I, 2008, INT J PRIMATOL, V29, P1099, DOI 10.1007/s10764-008-9259-4; Norscia I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004679; Pages E., 1980, P97; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; Palagi E, 2004, ETHOLOGY, V110, P949, DOI 10.1111/j.1439-0310.2004.01035.x; Palagi E, 2008, ANIM BEHAV, V76, P737, DOI 10.1016/j.anbehav.2008.04.016; Palagi E, 2007, AM J PHYS ANTHROPOL, V134, P219, DOI 10.1002/ajpa.20657; Palagi E, 2007, DEV PSYCHOBIOL, V49, P433, DOI 10.1002/dev.20219; Palagi E, 2006, INT J PRIMATOL, V27, P1257, DOI 10.1007/s10764-006-9071-y; Palagi E, 2009, J COMP PSYCHOL, V123, P1, DOI 10.1037/0735-7036.123.1.1; Pellegrini AD, 1998, CHILD DEV, V69, P577, DOI 10.1111/j.1467-8624.1998.tb06226.x; Pellegrini AD., 2009, ROLE PLAY HUMAN DEV, DOI [10.1093/acprof:oso/9780195367324.001.0001, DOI 10.1093/ACPROF:OSO/9780195367324.001.0001]; Pellegrini AD, 2007, DEV REV, V27, P261, DOI 10.1016/j.dr.2006.09.001; Pellis S. M., 2009, PLAYFUL BRAIN VENTUR; Pellis SM, 1996, AGGRESS VIOLENT BEH, V1, P249, DOI 10.1016/1359-1789(95)00016-X; Pellis SM, 2002, COGNITIVE ANIMAL, P421; Pellis SM, 2000, ETHOLOGY, V106, P1083, DOI 10.1046/j.1439-0310.2000.00627.x; Pellis SM, 1999, ETHOLOGY, V105, P783, DOI 10.1046/j.1439-0310.1999.00457.x; Pereira Michael E., 1993, P285; Peterson JB, 2005, DEVELOPMENTAL ORIGINS OF AGGRESSION, P133; RICHARD AF, 2003, NATURAL HIST MADAGAS, P1345; Smith EO., 1978, SOCIAL PLAY PRIMATES, P169, DOI [10.1016/B978-0-12-652750-6.50012-2, DOI 10.1016/B978-0-12-652750-6.50012-2]; Spinka M, 2001, Q REV BIOL, V76, P141, DOI 10.1086/393866; Swaddling J., 2002, ANCIENT OLYMPIC GAME; Tanner JE, 2010, ANIM COGN, V13, P591, DOI 10.1007/s10071-009-0308-y; Tattersall I., 1982, PRIMATES MADAGASCAR, DOI 10.1002/ajpa.1330590417; Thompson KV, 1998, ANIMAL PLAY EVOLUTIO, P183; WADE TD, 1976, BEHAVIOUR, V56, P194, DOI 10.1163/156853976X00028; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1; [No title captured]	68	42	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13218	10.1371/journal.pone.0013218	http://dx.doi.org/10.1371/journal.pone.0013218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949052	gold, Green Submitted, Green Published			2022-12-25	WOS:000282633700013
J	Dynesius, M; Gibb, H; Hjalten, J				Dynesius, Mats; Gibb, Heloise; Hjalten, Joakim			Surface Covering of Downed Logs: Drivers of a Neglected Process in Dead Wood Ecology	PLOS ONE			English	Article							SAPROXYLIC BEETLES; BOREAL FORESTS; PICEA-ABIES; SUCCESSIONAL STAGE; FUNCTIONAL-GROUPS; SPRUCE FOREST; SUBSTRATE; CONSERVATION; BRYOPHYTES; DIVERSITY	Many species use coarse woody debris (CWD) and are disadvantaged by the forestry-induced loss of this resource. A neglected process affecting CWD is the covering of the surfaces of downed logs caused by sinking into the ground (increasing soil contact, mostly covering the underside of the log), and dense overgrowth by ground vegetation. Such cover is likely to profoundly influence the quality and accessibility of CWD for wood-inhabiting organisms, but the factors affecting covering are largely unknown. In a five-year experiment we determined predictors of covering rate of fresh logs in boreal forests and clear-cuts. Logs with branches were little covered because they had low longitudinal ground contact. For branchless logs, longitudinal ground contact was most strongly related to estimated peat depth (positive relation). The strongest predictor for total cover of branchless logs was longitudinal ground contact. To evaluate the effect on cover of factors other than longitudinal ground contact, we separately analyzed data from only those log sections that were in contact with the ground. Four factors were prominent predictors of percentage cover of such log sections: estimated peat depth, canopy shade (both increasing cover), potential solar radiation calculated from slope and slope aspect, and diameter of the log (both reducing cover). Peat increased cover directly through its low resistance, which allowed logs to sink and soil contact to increase. High moisture and low temperatures in pole-ward facing slopes and under a canopy favor peat formation through lowered decomposition and enhanced growth of peat-forming mosses, which also proved to rapidly overgrow logs. We found that in some boreal forests, peat and fast-growing mosses can rapidly cover logs lying on the ground. When actively introducing CWD for conservation purposes, we recommend that such rapid covering is avoided, thereby most likely improving the CWD's longevity as habitat for many species.	[Dynesius, Mats] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Gibb, Heloise] La Trobe Univ, Dept Zool, Melbourne, Vic, Australia; [Hjalten, Joakim] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	Umea University; La Trobe University; Swedish University of Agricultural Sciences	Dynesius, M (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	mats.dynesius@emg.umu.se	Dynesius, Mats/A-6219-2009; Gibb, Heloise/B-8338-2013	Dynesius, Mats/0000-0003-0628-4203; Gibb, Heloise/0000-0001-7194-0620; Hjalten, Joakim/0000-0002-8279-6633	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [2004-1521]; Kempe foundation [SMK-2443]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Kempe foundation	The study was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas # 2004-1521, URL: www.formas.se) and by the Kempe foundation (# SMK-2443, URL: www.kempe.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSSON LI, 1991, HOLARCTIC ECOL, V14, P121; [Anonymous], 2007, JMP VERS 7, P1989; Astrom M, 2007, ECOLOGY, V88, P749, DOI 10.1890/06-0613; Bisbee KE, 2001, OECOLOGIA, V129, P261, DOI 10.1007/s004420100719; Boulanger Y, 2007, ENVIRON ENTOMOL, V36, P128, DOI 10.1603/0046-225X-36.1.128; Caruso A, 2008, BIOL CONSERV, V141, P47, DOI 10.1016/j.biocon.2007.08.021; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Crites S, 1998, CAN J BOT, V76, P641, DOI 10.1139/cjb-76-4-641; Dynesius M, 2009, ECOLOGY, V90, P1042, DOI 10.1890/07-1822.1; Edman M, 2006, FOREST ECOL MANAG, V232, P12, DOI 10.1016/j.foreco.2006.05.001; Fenton NJ, 2007, CAN J BOT, V85, P43, DOI 10.1139/B06-148; Fridman J, 2000, FOREST ECOL MANAG, V131, P23, DOI 10.1016/S0378-1127(99)00208-X; Gerdol R, 1998, ARCTIC ALPINE RES, V30, P388, DOI 10.2307/1552011; Gibb H, 2006, BIOL CONSERV, V129, P437, DOI 10.1016/j.biocon.2005.11.010; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Grove SJ, 2001, FOREST ECOL MANAG, V154, P35, DOI 10.1016/S0378-1127(00)00618-6; GROVE SJ, 2000, ECOLOGICAL MANAGEMEN, V1, P62; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HARMON ME, 1989, AM MIDL NAT, V121, P112, DOI 10.2307/2425662; Hilszczanski J, 2005, BIOL CONSERV, V126, P456, DOI 10.1016/j.biocon.2005.06.026; Hjalten J, 2007, BASIC APPL ECOL, V8, P364, DOI 10.1016/j.baae.2006.08.003; Hura CE, 2004, NAT AREA J, V24, P57; Johansson T, 2007, FOREST ECOL MANAG, V242, P496, DOI 10.1016/j.foreco.2007.01.062; Jonsell M, 1998, BIODIVERS CONSERV, V7, P749, DOI 10.1023/A:1008888319031; Jonsell M, 2003, FOREST ECOL MANAG, V175, P425, DOI 10.1016/S0378-1127(02)00143-3; Jonsell M, 1999, J INSECT CONSERV, V3, P145, DOI 10.1023/A:1009665513184; Jonsson BG, 2000, J VEG SCI, V11, P51, DOI 10.2307/3236775; Kushnevskaya H, 2007, FOREST ECOL MANAG, V250, P25, DOI 10.1016/j.foreco.2007.03.006; Linder P, 1998, BIOL CONSERV, V85, P9, DOI 10.1016/S0006-3207(97)00168-7; LINDSTROM K, 2003, THESIS UMEA U UMEA; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; McAlister S, 1997, J VEG SCI, V8, P115, DOI 10.2307/3237249; MCCULLOUGH HA, 1948, ECOLOGY, V29, P508, DOI 10.2307/1932645; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Naesset E, 1999, CAN J FOREST RES, V29, P372, DOI 10.1139/cjfr-29-3-372; Odor P, 2004, J BRYOL, V26, P79, DOI 10.1179/037366804225021038; Okland B, 1996, BIODIVERS CONSERV, V5, P75, DOI 10.1007/BF00056293; OLSSON J, 2008, THESIS UMEA U UMEA; Page S, 2009, ECOSYSTEMS, V12, P888, DOI 10.1007/s10021-008-9216-2; Patterson H.D., 1974, P 8 INT BIOM C BIOM, P197; Peltonen M, 1998, FOREST ECOL MANAG, V103, P141, DOI 10.1016/S0378-1127(97)00187-4; R Core Team, 2022, R LANG ENV STAT COMP; Rambo TR, 1998, BRYOLOGIST, V101, P366, DOI 10.1639/0007-2745(1998)101[366:BSAWCW]2.0.CO;2; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Repola J, 2006, SILVA FENN, V40, P673, DOI 10.14214/sf.322; Rudolphi J, 2005, SCAND J FOREST RES, V20, P235, DOI 10.1080/02827580510036201; Searle S. R., 1992, VARIANCE COMPONENTS; Siitonen J, 2000, BIOL CONSERV, V94, P211, DOI 10.1016/S0006-3207(99)00174-3; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; SODERSTROM L, 1988, NORD J BOT, V8, P89, DOI 10.1111/j.1756-1051.1988.tb01709.x; Sverdrup-Thygeson A, 2002, BIOL CONSERV, V106, P347, DOI 10.1016/S0006-3207(01)00261-0; WALSH C, 2004, R LANGUAGE ENV STAT; WOLFINGER R, 1994, SIAM J SCI COMPUT, V15, P1294, DOI 10.1137/0915079	55	25	25	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13237	10.1371/journal.pone.0013237	http://dx.doi.org/10.1371/journal.pone.0013237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949062	Green Published, gold, Green Submitted			2022-12-25	WOS:000282633700019
J	Bilgin, CC; Lund, AW; Can, A; Plopper, GE; Yener, B				Bilgin, Cemal Cagatay; Lund, Amanda W.; Can, Ali; Plopper, George E.; Yener, Buelent			Quantification of Three-Dimensional Cell-Mediated Collagen Remodeling Using Graph Theory	PLOS ONE			English	Article							2ND-HARMONIC GENERATION; TISSUE; FIBRILLOGENESIS; ORGANIZATION; FIBRILS	Background: Cell cooperation is a critical event during tissue development. We present the first precise metrics to quantify the interaction between mesenchymal stem cells (MSCs) and extra cellular matrix (ECM). In particular, we describe cooperative collagen alignment process with respect to the spatio-temporal organization and function of mesenchymal stem cells in three dimensions. Methodology/Principal Findings: We defined two precise metrics: Collagen Alignment Index and Cell Dissatisfaction Level, for quantitatively tracking type I collagen and fibrillogenesis remodeling by mesenchymal stem cells over time. Computation of these metrics was based on graph theory and vector calculus. The cells and their three dimensional type I collagen microenvironment were modeled by three dimensional cell-graphs and collagen fiber organization was calculated from gradient vectors. With the enhancement of mesenchymal stem cell differentiation, acceleration through different phases was quantitatively demonstrated. The phases were clustered in a statistically significant manner based on collagen organization, with late phases of remodeling by untreated cells clustering strongly with early phases of remodeling by differentiating cells. The experiments were repeated three times to conclude that the metrics could successfully identify critical phases of collagen remodeling that were dependent upon cooperativity within the cell population. Conclusions/Significance: Definition of early metrics that are able to predict long-term functionality by linking engineered tissue structure to function is an important step toward optimizing biomaterials for the purposes of regenerative medicine.	[Bilgin, Cemal Cagatay; Yener, Buelent] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Lund, Amanda W.; Plopper, George E.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Can, Ali] Gen Elect Global Res Ctr, Niskayuna, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; General Electric	Bilgin, CC (corresponding author), Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA.	yener@cs.rpi.edu		Lund, Amanda/0000-0001-7389-9983	National Institutes of Health [RO1 EB008016]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by National Institutes of Health Grant RO1 EB008016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Bilgin C, 2007, P ANN INT IEEE EMBS, P5311, DOI 10.1109/IEMBS.2007.4353540; Bilgin CC, 2010, DATA MIN KNOWL DISC, V20, P416, DOI 10.1007/s10618-009-0153-2; CHAUDHURI S, 1987, IEEE T BIO-MED ENG, V34, P509, DOI 10.1109/TBME.1987.325980; CLARK JM, 1990, J ANAT, V171, P117; Dahl SLM, 2007, ANN BIOMED ENG, V35, P1749, DOI 10.1007/s10439-007-9340-8; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Elbischger PJ, 2005, ST HEAL T, V113, P97; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Grinnell F, 2003, MOL BIOL CELL, V14, P384, DOI 10.1091/mbc.E02-08-0493; GUIDRY C, 1985, J CELL SCI, V79, P67; Gunduz C, 2004, BIOINFORMATICS, V20, P145, DOI 10.1093/bioinformatics/bth933; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Ibanez L., 2005, ITK SOFTWARE GUIDE; Keenan SJ, 2000, J PATHOL, V192, P351, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH708>3.0.CO;2-I; Kim BM, 2000, LASER SURG MED, V27, P329, DOI 10.1002/1096-9101(2000)27:4<329::AID-LSM5>3.0.CO;2-C; Lazzara MJ, 2009, EXP CELL RES, V315, P717, DOI 10.1016/j.yexcr.2008.10.033; Lund AW, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/928286; Lund AW, 2009, STEM CELLS DEV, V18, P331, DOI 10.1089/scd.2008.0075; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; Rhee S, 2007, ADV DRUG DELIVER REV, V59, P1299, DOI 10.1016/j.addr.2007.08.006; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; Schroeder W, 2002, VISUALIZATION TOOLKI; Stein AM, 2008, J MICROSC-OXFORD, V232, P463, DOI 10.1111/j.1365-2818.2008.02141.x; Theodossiou T, 2002, LASER MED SCI, V17, P34, DOI 10.1007/s10103-002-8264-7; Weyn B, 1999, CYTOMETRY, V35, P23, DOI 10.1002/(SICI)1097-0320(19990101)35:1<23::AID-CYTO4>3.0.CO;2-P; Xia Y, 2001, J MICROSC-OXFORD, V204, P3, DOI 10.1046/j.1365-2818.2001.00925.x; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12783	10.1371/journal.pone.0012783	http://dx.doi.org/10.1371/journal.pone.0012783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927339	Green Published, Green Submitted, gold			2022-12-25	WOS:000282312600002
J	Freedman, AH; Buermann, W; Mitchard, ETA; DeFries, RS; Smith, TB				Freedman, Adam H.; Buermann, Wolfgang; Mitchard, Edward T. A.; DeFries, Ruth S.; Smith, Thomas B.			Human Impacts Flatten Rainforest-Savanna Gradient and Reduce Adaptive Diversity in a Rainforest Bird	PLOS ONE			English	Article							GENE FLOW; SPECIATION; DEFORESTATION; DIVERGENCE; COVER; BIODIVERSITY; DIVERSIFICATION; DISTURBANCE; EXTINCTION; EVOLUTION	Ecological gradients have long been recognized as important regions for diversification and speciation. However, little attention has been paid to the evolutionary consequences or conservation implications of human activities that fundamentally change the environmental features of such gradients. Here we show that recent deforestation in West Africa has homogenized the rainforest-savanna gradient, causing a loss of adaptive phenotypic diversity in a common rainforest bird, the little greenbul (Andropadus virens). Previously, this species was shown to exhibit morphological and song divergence along this gradient in Central Africa. Using satellite-based estimates of forest cover, recent morphological data, and historical data from museum specimens collected prior to widespread deforestation, we show that the gradient has become shallower in West Africa and that A. virens populations there have lost morphological variation in traits important to fitness. In contrast, we find no loss of morphological variation in Central Africa where there has been less deforestation and gradients have remained more intact. While rainforest deforestation is a leading cause of species extinction, the potential of deforestation to flatten gradients and inhibit rainforest diversification has not been previously recognized. More deforestation will likely lead to further flattening of the gradient and loss of diversity, and may limit the ability of species to persist under future environmental conditions.	[Freedman, Adam H.; Buermann, Wolfgang; Smith, Thomas B.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm, Los Angeles, CA 90024 USA; [Freedman, Adam H.; Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Buermann, Wolfgang] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA USA; [Mitchard, Edward T. A.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [DeFries, Ruth S.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Edinburgh; Columbia University	Freedman, AH (corresponding author), Univ Calif Los Angeles, Ctr Trop Res, Inst Environm, Los Angeles, CA 90024 USA.	afreedma@ucla.edu		Mitchard, Edward/0000-0002-5690-4055; Freedman, Adam/0000-0003-4714-3925	University of California Los Angeles; Department of Ecology and Evolutionary Biology; Environmental Protection Agency; Gatsby Plants; National Institutes of Health [EF-0430146]; National Geographic; National Science Foundation [DEB-9726425, IR-CEB9977072]; NASA [IDS/03-0169-0347]	University of California Los Angeles(University of California System); Department of Ecology and Evolutionary Biology; Environmental Protection Agency(United States Environmental Protection Agency); Gatsby Plants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Geographic(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by University of California Los Angeles, Department of Ecology and Evolutionary Biology fellowship grants and by an Environmental Protection Agency Science to Achieve Results Fellowship to AHF, a Ph.D. Studentship from Gatsby Plants to ETAM, a National Institutes of Health-funded supplement to National Science Foundation grant EF-0430146 (under the Ecology of Infectious Diseases program) to TBS, and National Geographic, National Science Foundation (DEB-9726425 and IR-CEB9977072), and NASA (IDS/03-0169-0347) grants to TBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Agbu P. A., 1994, NOAA NASA PATHFINDER; [Anonymous], 2003, DEFORESTING EARTH PR; BARNES RFW, 1990, AFR J ECOL, V28, P161, DOI 10.1111/j.1365-2028.1990.tb01150.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; BUYS P, 2006, 4097 WPS WORLD BANK; Cowling RM, 2001, P NATL ACAD SCI USA, V98, P5452, DOI 10.1073/pnas.101093498; DEBASTOS M, 2005, REV BRAS ZOOL, V22, P812; DeFries RS, 1999, J GEOPHYS RES-ATMOS, V104, P16911, DOI 10.1029/1999JD900057; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; DEFRIES RS, 1995, J GEOPHYS RES-ATMOS, V100, P20867, DOI 10.1029/95JD01536; Defries RS, 2000, GLOBAL CHANGE BIOL, V6, P247, DOI 10.1046/j.1365-2486.2000.00296.x; Desrochers A, 2010, ECOLOGY, V91, P1577, DOI 10.1890/09-2202.1; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Endler J.A., 1977, Monographs in Population Biology, pi; *ESRI INC, 2006, ARCGIS 9; Flury B, 1988, COMMON PRINCIPAL COM; Freedman AH, 2010, MOL ECOL, V19, P3773, DOI 10.1111/j.1365-294X.2010.04684.x; Freedman AH, 2009, CONSERV BIOL, V23, P81, DOI 10.1111/j.1523-1739.2008.01039.x; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Gavrilets S, 2000, P ROY SOC B-BIOL SCI, V267, P2483, DOI 10.1098/rspb.2000.1309; *GOOGL INC, 2007, GOOGL EARTH VERS 5 0; Grant P. R., 1986, ECOLOGY EVOLUTION DA, P458; Hansen MC, 2002, REMOTE SENS ENVIRON, V83, P303, DOI 10.1016/S0034-4257(02)00079-2; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Jullien M, 1996, J BIOGEOGR, V23, P7, DOI 10.1046/j.1365-2699.1996.00963.x; Keith S., 1992, BIRDS AFRICA, V4; Kirschel ANG, 2009, P NATL ACAD SCI USA, V106, P8256, DOI 10.1073/pnas.0810124106; Kitano J, 2008, CURR BIOL, V18, P769, DOI 10.1016/j.cub.2008.04.027; Kofron CP, 1995, TROP ZOOL, V8, P239, DOI 10.1080/03946975.1995.10539284; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lens L, 1999, P ROY SOC B-BIOL SCI, V266, P1241, DOI 10.1098/rspb.1999.0769; Lens L, 2002, SCIENCE, V298, P1236, DOI 10.1126/science.1075664; LETOUZEY R, 1968, ETUDE PHYTOGEOGRAPHI, V69; LONGMAN KA, 1992, NATURE AND DYNAMICS OF FOREST-SAVANNA BOUNDARIES, P3; Louette M, 1981, VERHANDELINGEN KON W, V43, P1; Mace G., 2005, ECOSYSTEMS HUMAN WEL, V1, P77; Mila B, 2009, MOL ECOL, V18, P2979, DOI 10.1111/j.1365-294X.2009.04251.x; MYERS N, 1986, TROPICAL RAIN FOREST, P9; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; Parry M., 2007, CLIMATE CHANGE 2007, P7, DOI DOI 10.2134/JEQ2008.0015BR; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; SAS Institute Inc, 2007, JMP VERS 7; Schneider CJ, 1999, P NATL ACAD SCI USA, V96, P13869, DOI 10.1073/pnas.96.24.13869; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Slabbekoorn H, 2002, EVOLUTION, V56, P1849; Smith PM, 1997, PHOTOGRAMM ENG REM S, V63, P12; Smith T.B., 1993, Biodiversity Letters, V1, P164, DOI 10.2307/2999740; Smith TB, 2005, CONSERV BIOL SER, V8, P166; Smith TB, 2005, J EVOLUTION BIOL, V18, P257, DOI 10.1111/j.1420-9101.2004.00825.x; SMITH TB, 1990, EVOLUTION, V44, P832, DOI 10.1111/j.1558-5646.1990.tb03808.x; Smith TB, 2001, GENETICA, V112, P383, DOI 10.1023/A:1013312510860; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Smith TB, 2000, MOL ECOL, V9, P1505, DOI 10.1046/j.1365-294x.2000.01032.x; SMITH TB, 2005, RAINFORESTS PAST PRE, P148; Smith TB, 2008, MOL ECOL, V17, P58, DOI 10.1111/j.1365-294X.2007.03478.x; Smith TB, 2008, MOL ECOL, V17, P1, DOI 10.1111/j.1365-294X.2007.03607.x; Smith Thomas B., 2008, P85; Smith Thomas Bates, 1993, Bird Conservation International, V3, P13; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sokal R. R., 2012, BIOMETRY; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Sumner J, 1999, BIOL CONSERV, V91, P159, DOI 10.1016/S0006-3207(99)00089-0; Thiollay JM, 1996, J TROP ECOL, V12, P535, DOI 10.1017/S0266467400009767; Thiollay JM, 1998, BIODIVERS CONSERV, V7, P1291, DOI 10.1023/A:1008898505534; White F., 1983, VEGETATION AFRICA DE; WINKLER H, 1992, IBIS, V134, P21	77	8	8	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13088	10.1371/journal.pone.0013088	http://dx.doi.org/10.1371/journal.pone.0013088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941360	Green Published, Green Submitted, gold			2022-12-25	WOS:000282312600021
J	Hughes, NK; Price, CJ; Banks, PB				Hughes, Nelika K.; Price, Catherine J.; Banks, Peter B.			Predators Are Attracted to the Olfactory Signals of Prey	PLOS ONE			English	Article							SCENT MARKS; FERAL CATS; MICE; PREFERENCE; WEASELS; RISK; BEHAVIOR; FOXES; CUES	Background: Predator attraction to prey social signals can force prey to trade-off the social imperatives to communicate against the profound effect of predation on their future fitness. These tradeoffs underlie theories on the design and evolution of conspecific signalling systems and have received much attention in visual and acoustic signalling modes. Yet while most territorial mammals communicate using olfactory signals and olfactory hunting is widespread in predators, evidence for the attraction of predators to prey olfactory signals under field conditions is lacking. Methodology/Principal Findings: To redress this fundamental issue, we examined the attraction of free-roaming predators to discrete patches of scents collected from groups of two and six adult, male house mice, Mus domesticus, which primarily communicate through olfaction. Olfactorily-hunting predators were rapidly attracted to mouse scent signals, visiting mouse scented locations sooner, and in greater number, than control locations. There were no effects of signal concentration on predator attraction to their prey's signals. Conclusions/Significance: This implies that communication will be costly if conspecific receivers and eavesdropping predators are simultaneously attracted to a signal. Significantly, our results also suggest that receivers may be at greater risk of predation when communicating than signallers, as receivers must visit risky patches of scent to perform their half of the communication equation, while signallers need not.	[Hughes, Nelika K.; Price, Catherine J.; Banks, Peter B.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	Hughes, NK (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	nelika@unsw.edu.au	Price, Catherine/AAZ-2069-2020	Price, Catherine/0000-0001-9631-2479; Banks, Peter/0000-0002-4340-6495	Australian Research Council [DP0881455]	Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council Discovery grant to PB Banks (DP0881455); see http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo L, 2004, J HERPETOL, V38, P451, DOI 10.1670/177-03N; Banks PB, 2000, P ROY SOC B-BIOL SCI, V267, P1621, DOI 10.1098/rspb.2000.1187; Brown R. E., 1985, SOCIAL ODOURS MAMMAL, V1-2; Brown RE, 1985, SOCIAL ODOURS MAMMAL, VII; Chiszar D, 1997, J CHEM ECOL, V23, P829, DOI 10.1023/B:JOEC.0000006414.01873.12; CLAPPERTON BK, 1994, WILDLIFE RES, V21, P389, DOI 10.1071/WR9940389; CUSHING BS, 1984, ANIM BEHAV, V32, P1263, DOI 10.1016/S0003-3472(84)80250-X; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Hughes NK, 2010, OIKOS, V119, P1210, DOI 10.1111/j.1600-0706.2010.18006.x; Hughes NK, 2010, J ANIM ECOL, V79, P88, DOI 10.1111/j.1365-2656.2009.01630.x; Hughes NK, 2009, OECOLOGIA, V160, P609, DOI 10.1007/s00442-009-1320-2; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Koivula M, 2001, OIKOS, V95, P275, DOI 10.1034/j.1600-0706.2001.950209.x; Mahon PS, 1998, WILDLIFE RES, V25, P11, DOI 10.1071/WR97007; NEWSOME AE, 1997, POTENTIAL IMPACTS RE; Paltridge R, 2002, WILDLIFE RES, V29, P389, DOI 10.1071/WR00010; Read J, 2001, WILDLIFE RES, V28, P195, DOI 10.1071/WR99065; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Smith TL, 2000, BEHAVIOUR, V137, P691, DOI 10.1163/156853900502295; Sundell J, 2003, OIKOS, V101, P615, DOI 10.1034/j.1600-0706.2003.12264.x; SUTHERLAND D. R., 2003, RATS MICE PEOPLE ROD, P159; Swan Michael, 2005, SNAKES LIZARDS FROGS; Triggs B., 1984, MAMMAL TRACKS SIGNS; Van Loo PLP, 2000, ANIM WELFARE, V9, P281; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; WELLS MC, 1978, BEHAV PROCESS, V3, P149, DOI 10.1016/0376-6357(78)90041-4; Whitaker PB, 2003, HERPETOL MONOGR, V17, P130, DOI 10.1655/0733-1347(2003)017[0130:ARSOMA]2.0.CO;2; Ylonen H, 2003, ECOLOGY, V84, P1447, DOI 10.1890/0012-9658(2003)084[1447:WMNNPF]2.0.CO;2	30	76	77	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13114	10.1371/journal.pone.0013114	http://dx.doi.org/10.1371/journal.pone.0013114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927352	Green Published, gold			2022-12-25	WOS:000282312600030
J	Zhang, X; Yu, CH; Wilson, K; Zhang, HY; Melton, SD; Huo, XF; Wang, DH; Genta, RM; Spechler, SJ; Souza, RF				Zhang, Xi; Yu, Chunhua; Wilson, Kathleen; Zhang, Hui Ying; Melton, Shelby D.; Huo, Xiaofang; Wang, David H.; Genta, Robert M.; Spechler, Stuart J.; Souza, Rhonda F.			Malignant Transformation of Non-Neoplastic Barrett's Epithelial Cells through Well-Defined Genetic Manipulations	PLOS ONE			English	Article							ESOPHAGEAL SQUAMOUS-CELLS; HUMAN TUMOR-CELLS; ONCOGENIC TRANSFORMATION; ADENOCARCINOMA; TELOMERASE; RAS; PROGRESSION; EXPRESSION; CANCER; ACID	Background: Human Barrett's cancer cell lines have numerous, poorly-characterized genetic abnormalities and, consequently, those lines have limited utility as models for studying the early molecular events in carcinogenesis. Cell lines with well-defined genetic lesions that recapitulate various stages of neoplastic progression in Barrett's esophagus would be most useful for such studies. Methodology/Principal Findings: To develop such model cell lines, we started with telomerase-immortalized, nonneoplastic Barrett's epithelial (BAR-T) cells, which are spontaneously deficient in p16, and proceeded to knock down p53 using RNAi, to activate Ras by introducing oncogenic H-Ras(G12V), or both. BAR-T cells infected with either p53 RNAi or oncogenic H-Ras(G12V) alone maintained cell-to-cell contact inhibition and did not exhibit anchorage-independent growth in soft agar. In contrast, the combination of p53 RNAi knockdown with expression of oncogenic H-Ras(G12V) transformed the p16-deficient BAR-T cells, as evidenced by their loss of contact inhibition, by their formation of colonies in soft agar, and by their generation of tumors in immunodeficient mice. Conclusions/Significance: Through these experiments, we have generated a number of transformed and non-transformed cell lines with well-characterized genetic abnormalities recapitulating various stages of carcinogenesis in Barrett's esophagus. These lines should be useful models for the study of carcinogenesis in Barrett's esophagus, and for testing the efficacy of chemopreventive and chemotherapeutic agents.	[Zhang, Xi; Yu, Chunhua; Zhang, Hui Ying; Huo, Xiaofang; Wang, David H.; Spechler, Stuart J.; Souza, Rhonda F.] VA N Texas Hlth Care Syst, Dept Med, Dallas, TX USA; [Zhang, Xi; Yu, Chunhua; Wilson, Kathleen; Zhang, Hui Ying; Melton, Shelby D.; Huo, Xiaofang; Wang, David H.; Genta, Robert M.; Spechler, Stuart J.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Med Sch Dallas, Dallas, TX 75390 USA; [Wilson, Kathleen; Melton, Shelby D.; Genta, Robert M.] VA N Texas Hlth Care Syst, Dept Pathol, Dallas, TX USA; [Melton, Shelby D.; Genta, Robert M.] Caris Life Sci Inc, Irving, TX USA; [Wang, David H.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, X (corresponding author), VA N Texas Hlth Care Syst, Dept Med, Dallas, TX USA.	rhonda.souza@utsouthwestern.edu			Office of Medical Research, Department of Veterans Affairs; National Institutes of Health [R01-DK63621, R01-CA134571]; Caris LifeSciences Inc; NATIONAL CANCER INSTITUTE [R01CA134571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063621] Funding Source: NIH RePORTER	Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caris LifeSciences Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Office of Medical Research, Department of Veterans Affairs (R.F.S., S.J.S.), the National Institutes of Health (R01-DK63621 to R.F.S, R01-CA134571 to R.F.S. and S.J.S.) and Caris LifeSciences Inc (R.M.G.). Caris LifeSciences Inc. provided salary support to R.M.G. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELATIF OMA, 1991, ARCH PATHOL LAB MED, V115, P880; Barch MJ, 1997, AGT CYTOGENETICS LAB; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; BLOUNT PL, 1993, P NATL ACAD SCI USA, V90, P3221, DOI 10.1073/pnas.90.8.3221; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; El-Serag HB, 1998, GUT, V43, P327, DOI 10.1136/gut.43.3.327; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Feagins LA, 2007, AM J GASTROENTEROL, V102, P10, DOI 10.1111/j.1572-0241.2006.01005.x; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harley CB, 2002, ONCOGENE, V21, P494, DOI 10.1038/sj.onc.1205076; Hormi-Carver K, 2007, AM J PHYSIOL-GASTR L, V292, pG18, DOI 10.1152/ajpgi.00237.2006; Hormi-Carver K, 2009, CANCER RES, V69, P672, DOI 10.1158/0008-5472.CAN-08-3703; Jaiswal KR, 2007, DIS ESOPHAGUS, V20, P256, DOI 10.1111/j.1442-2050.2007.00683.x; JANKOWSKI J, 1991, CLIN SCI, V81, P663, DOI 10.1042/cs0810663; Kim SH, 2006, CANCER RES, V66, P10415, DOI 10.1158/0008-5472.CAN-06-2104; Klump B, 1998, GASTROENTEROLOGY, V115, P1381, DOI 10.1016/S0016-5085(98)70016-2; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Lord RV, 2000, J GASTROEN HEPATOL, V15, P730, DOI 10.1046/j.1440-1746.2000.02163.x; Lord RVN, 2000, J GASTROINTEST SURG, V4, P135, DOI 10.1016/S1091-255X(00)80049-9; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Maley CC, 2004, CANCER RES, V64, P7629, DOI 10.1158/0008-5472.CAN-04-1738; MELTZER SJ, 1994, CANCER RES, V54, P3379; MELTZER SJ, 1990, CANCER RES, V50, P3627; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Morales CP, 1998, CANCER, V83, P652, DOI 10.1002/(SICI)1097-0142(19980815)83:4<652::AID-CNCR4>3.0.CO;2-M; Morales CP, 2003, GUT, V52, P327, DOI 10.1136/gut.52.3.327; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Sommerer F, 2004, ONCOGENE, V23, P554, DOI 10.1038/sj.onc.1207189; Takaoka M, 2004, ONCOGENE, V23, P6760, DOI 10.1038/sj.onc.1207923; Wong DJ, 1997, CANCER RES, V57, P2619; Zhang HY, 2007, CANCER RES, V67, P8580, DOI 10.1158/0008-5472.CAN-07-2023; Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13093	10.1371/journal.pone.0013093	http://dx.doi.org/10.1371/journal.pone.0013093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927195	Green Submitted, Green Published, gold			2022-12-25	WOS:000282312600024
J	De Regge, N; Van Opdenbosch, N; Nauwynck, HJ; Efstathiou, S; Favoreel, HW				De Regge, Nick; Van Opdenbosch, Nina; Nauwynck, Hans J.; Efstathiou, Stacey; Favoreel, Herman W.			Interferon Alpha Induces Establishment of Alphaherpesvirus Latency in Sensory Neurons In Vitro	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; TRIGEMINAL GANGLION NEURONS; PSEUDORABIES VIRUS; GAMMA-INTERFERON; TYPE-1 INFECTION; NERVOUS-SYSTEM; ICP0 TRANSCRIPTS; PROTECTS MICE; CELL-DEATH; REACTIVATION	Background: Several alphaherpesviruses, including herpes simplex virus 1 (HSV-1) and pseudorabies virus (PRV), establish lifelong latency in neurons of the trigeminal ganglion (TG). Although it is thought that efficient establishment of alphaherpesvirus latency is based on a subtle interplay between virus, neurons and the immune system, it is not clear which immune components are of major importance for the establishment of latency. Methodology/Principal Findings: Here, using an in vitro model that enables a natural route of infection, we show that interferon alpha (IFNalpha) has the previously uncharacterized capacity to induce a quiescent HSV-1 and PRV infection in porcine TG neurons that shows strong similarity to in vivo latency. IFNalpha induced a stably suppressed HSV-1 and PRV infection in TG neurons in vitro. Subsequent treatment of neurons containing stably suppressed virus with forskolin resulted in reactivation of both viruses. HSV and PRV latency in vivo is often accompanied by the expression of latency associated transcripts (LATs). Infection of TG neurons with an HSV-1 mutant expressing LacZ under control of the LAT promoter showed activation of the LAT promoter and RT-PCR analysis confirmed that both HSV-1 and PRV express LATs during latency in vitro. Conclusions/Significance: These data represent a unique in vitro model of alphaherpesvirus latency and indicate that IFNalpha may be a driving force in promoting efficient latency establishment.	[De Regge, Nick; Van Opdenbosch, Nina; Nauwynck, Hans J.; Favoreel, Herman W.] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Efstathiou, Stacey] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	Ghent University; University of Cambridge	De Regge, N (corresponding author), Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium.	herman.favoreel@ugent.be	Favoreel, Herman W/H-8712-2013	Favoreel, Herman W/0000-0003-4993-6857; Nauwynck, Hans/0000-0001-5470-0713	Institute for the Promotion of Innovation through Science and Technology in Flanders; Research Foundation Flanders (FWO-Vlaanderen); Research Council of Ghent University; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Institute for the Promotion of Innovation through Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO-Vlaanderen)(FWO); Research Council of Ghent University(Ghent University); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Nick De Regge was supported by a post-doctoral research grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders. Further financial support was obtained from grants from the Research Foundation Flanders (FWO-Vlaanderen) and the Research Council of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALAN P, 1994, J GEN VIROL, V75, P1245, DOI 10.1099/0022-1317-75-6-1245; CANTIN EM, 1995, J VIROL, V69, P4898, DOI 10.1128/JVI.69.8.4898-4905.1995; CARD JP, 1990, J NEUROSCI, V10, P1974; Carr DJJ, 1998, J IMMUNOL, V161, P4859; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chen SH, 2002, J VIROL, V76, P4764, DOI 10.1128/JVI.76.10.4764-4772.2002; CHEUNG AK, 1989, J VIROL, V63, P2908, DOI 10.1128/JVI.63.7.2908-2913.1989; Colgin MA, 2001, J VIROL, V75, P2912, DOI 10.1128/JVI.75.6.2912-2920.2001; CROEN KD, 1987, NEW ENGL J MED, V317, P1427, DOI 10.1056/NEJM198712033172302; Danaher RJ, 1999, J NEUROVIROL, V5, P258, DOI 10.3109/13550289909015812; Danaher RJ, 2003, J NEUROVIROL, V9, P489, DOI 10.1080/713831593; De Regge N, 2006, VET MICROBIOL, V113, P251, DOI 10.1016/j.vetmic.2005.11.004; De Regge N, 2006, J CELL BIOL, V174, P267, DOI 10.1083/jcb.200510156; Decman V, 2005, VIRAL IMMUNOL, V18, P466, DOI 10.1089/vim.2005.18.466; Derfuss T, 2009, ANN NY ACAD SCI, V1164, P300, DOI 10.1111/j.1749-6632.2009.03871.x; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; Geenen K, 2005, J GEN VIROL, V86, P1251, DOI 10.1099/vir.0.80760-0; GUTEKUNST DE, 1980, AM J VET RES, V41, P1315; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; HENDRICKS RL, 1991, J GEN VIROL, V72, P1601, DOI 10.1099/0022-1317-72-7-1601; HO DY, 1989, P NATL ACAD SCI USA, V86, P7596, DOI 10.1073/pnas.86.19.7596; Jones C, 2003, CLIN MICROBIOL REV, V16, P79, DOI 10.1128/CMR.16.1.79-95.2003; Jones CA, 2003, J VIROL, V77, P11139, DOI 10.1128/JVI.77.20.11139-11149.2003; Khanna KM, 2004, TRENDS IMMUNOL, V25, P230, DOI 10.1016/j.it.2004.02.010; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; KONDO Y, 1990, CANCER RES, V50, P7852; Lachmann RH, 1997, J VIROL, V71, P3197, DOI 10.1128/JVI.71.4.3197-3207.1997; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Maillet S, 2006, J VIROL, V80, P9310, DOI 10.1128/JVI.02615-05; Mikloska Z, 1998, J INFECT DIS, V177, P827, DOI 10.1086/515236; Mikloska Z, 2001, J VIROL, V75, P11821, DOI 10.1128/JVI.75.23.11821-11826.2001; NAUWYNCK HJ, 1995, ARCH VIROL, V140, P1137, DOI 10.1007/BF01315422; ROIZMAN B, 1987, ANNU REV MICROBIOL, V41, P543, DOI 10.1146/annurev.mi.41.100187.002551; Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002; SMITH RL, 1992, VIROLOGY, V188, P311, DOI 10.1016/0042-6822(92)90760-M; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Thompson RL, 2003, J VIROL, V77, P12319, DOI 10.1128/JVI.77.22.12319-12330.2003; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wang KN, 2005, J VIROL, V79, P14079, DOI 10.1128/JVI.79.22.14079-14087.2005; WIGDAHL B, 1984, P NATL ACAD SCI-BIOL, V81, P6217, DOI 10.1073/pnas.81.19.6217; WIGDAHL B, 1984, J VIROL, V49, P205, DOI 10.1128/JVI.49.1.205-213.1984; WIGDAHL BL, 1982, SCIENCE, V217, P1145, DOI 10.1126/science.6180477; Wilcox CL, 1997, J VIROL, V71, P6777, DOI 10.1128/JVI.71.9.6777-6785.1997; WILCOX CL, 1992, VIROLOGY, V187, P348, DOI 10.1016/0042-6822(92)90326-K; WRZOS H, 1987, VIRUS RES, V8, P301, DOI 10.1016/0168-1702(87)90002-5; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	47	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13076	10.1371/journal.pone.0013076	http://dx.doi.org/10.1371/journal.pone.0013076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927329	Green Submitted, Green Published, gold			2022-12-25	WOS:000282269400024
J	Kirkby, CA; Giudice-Granados, R; Day, B; Turner, K; Velarde-Andrade, LM; Duenas-Duenas, A; Lara-Rivas, JC; Yu, DW				Kirkby, Christopher A.; Giudice-Granados, Renzo; Day, Brett; Turner, Kerry; Velarde-Andrade, Luz Marina; Duenas-Duenas, Agusto; Lara-Rivas, Juan Carlos; Yu, Douglas W.			The Market Triumph of Ecotourism: An Economic Investigation of the Private and Social Benefits of Competing Land Uses in the Peruvian Amazon	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; OPPORTUNITY COSTS; FOREST; DEFORESTATION; DEGRADATION	Annual revenue flow to developing countries for ecotourism (or nature-based tourism) could be as large as US$ 210 x 10(12), providing an enormous financial incentive against habitat loss and exploitation. However, is ecotourism the most privately and/or socially valuable use of rainforest land? The question is rarely answered because the relevant data, estimates of profits and fixed costs, are rarely available. We present a social cost-benefit analysis of land use in an ecotourism cluster in the Tambopata region of Amazonian Peru. The net present value of ecotourism-controlled land is given by the producer surplus (profits plus fixed costs of ecotourism lodges): US$ 1,158 ha(-1), which is higher than all currently practiced alternatives, including unsustainable logging, ranching, and agriculture. To our knowledge, this is the first sector-wide study of profitability and producer surplus in a developing-country ecotourism sector and the first to compare against equivalent measures for a spectrum of alternative uses. We also find that ecotourism-controlled land sequesters between 5.3 to 8.7 million tons of above-ground carbon, which is equivalent to between 3000-5000 years of carbon emissions from the domestic component of air and surface travel between the gateway city of Cusco and the lodges, at 2005 emission rates. Ecotourism in Tambopata has successfully monetized the hedonic value of wild nature in Amazonian Peru, and justifies the maintenance of intact rainforest over all alternative uses on narrow economic grounds alone.	[Kirkby, Christopher A.; Yu, Douglas W.] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, ECEC, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Kirkby, Christopher A.; Giudice-Granados, Renzo; Yu, Douglas W.] Univ E Anglia, Sch Biol Sci, CEEC, Norwich NR4 7TJ, Norfolk, England; [Kirkby, Christopher A.; Day, Brett; Turner, Kerry] Univ E Anglia, Sch Environm Sci, CSERGE, Norwich NR4 7TJ, Norfolk, England; [Velarde-Andrade, Luz Marina] CAMDE PERU, Puerto Maldonado, Madre De Dios, Peru; [Duenas-Duenas, Agusto] Cooperaz & Sviluppo CESVI, Puerto Maldonado, Madre De Dios, Peru; [Lara-Rivas, Juan Carlos] UNSAAC, Puerto Maldonado, Madre De Dios, Peru	Chinese Academy of Sciences; Kunming Institute of Zoology; University of East Anglia; University of East Anglia; Universidad Nacional de San Antonio Abad del Cusco	Kirkby, CA (corresponding author), Chinese Acad Sci, State Key Lab Genet Resources & Evolut, ECEC, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	dougwyu@gmail.com	Yu, Douglas W./D-2536-2009	Yu, Douglas W./0000-0001-8551-5609; Giudice, Renzo/0000-0003-3802-633X; Day, Brett/0000-0001-7519-5672	United Kingdom Economic and Social Research Council/Natural Environment Research Council [PTA-036-2005-00028]; Yunnan provincial government [20080A001]; Chinese Academy of Sciences [0902281081]	United Kingdom Economic and Social Research Council/Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Economic & Social Research Council (ESRC)); Yunnan provincial government; Chinese Academy of Sciences(Chinese Academy of Sciences)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by a United Kingdom Economic and Social Research Council/Natural Environment Research Council Interdisciplinary studentship to CK (PTA-036-2005-00028). DY received support from the Yunnan provincial government (20080A001) and the Chinese Academy of Sciences (0902281081).	Alpizar F, 2006, ECOL ECON, V56, P294, DOI 10.1016/j.ecolecon.2005.02.005; ARANACARDO A, 2002, MEJORAMIENTO SISTEMA; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Barany M. E., 2001, Journal of Sustainable Tourism, V9, P95, DOI 10.1080/09669580108667392; Batagoda B., 2000, POLICY RELEVANT ECOS; Blom A., 2000, Journal of Sustainable Tourism, V8, P175, DOI 10.1080/09669580008667357; *BLS, 2009, INFL CALC; BROWN CR, 2001, VISITOR USE FEES PRO; CANCHAYATOLEDO JL, 2006, PERFIL EC COMUNIDAD; Ceballos-Lascurain H., 1987, MEX J, V1, P13; *CEPF, 2005, TROP AND HOTSP VILC; Chomitz KM, 2005, ENVIRON DEV ECON, V10, P293, DOI 10.1017/S1355770X05002081; CTAR-Madre de Dios IIAP, 2000, ZON EC EC REG MADR D; Damania R, 2005, ECOL ECON, V53, P339, DOI 10.1016/j.ecolecon.2004.09.015; Doan T. M., 2000, Journal of Sustainable Tourism, V8, P288, DOI 10.1080/09669580008667365; Drumm A., 2004, ECOTOURISM DEV MANUA; Drumm A., 1991, INTEGRATED IMPACT AS; Duellman W.E., 2005, CUSCO AMAZONICO THE; EPA, 2005, EM FACTS AV CARB DIO; Escobal J, 2003, WORLD DEV, V31, P1873, DOI 10.1016/j.worlddev.2003.08.001; ETTER A, 1994, CARACTERIZACION ECOL; Fearnside PM, 1996, FOREST ECOL MANAG, V80, P21, DOI 10.1016/0378-1127(95)03647-4; Gavin MC, 2007, ECOL ECON, V60, P752, DOI 10.1016/j.ecolecon.2006.01.010; GIUDICE R, 2010, CONSERVATION SE PERU; *GOREMAD, 2005, PLAN ESTR REG SECT A; Gossling S, 1999, ECOL ECON, V29, P303, DOI 10.1016/S0921-8009(99)00012-9; GRIFFITHS M, 1993, CONSERV BIOL, V94, P153; GROOM MJ, 1991, NEOTROPICAL WILDLIFE; Honey M., 2008, ECOTOURISM SUSTAINAB; Just RE., 2004, WELFARE EC PUBLIC PO; Kainer KA, 2007, FOREST ECOL MANAG, V250, P244, DOI 10.1016/j.foreco.2007.05.024; KARP DS, 2009, BIODIVERSITY CONSERV; KIRKBY C, ENV CONSERV IN PRESS; KIRKBY C, 2010, INTRO TROPICAL RAIN; KIRKBY CA, 2000, TOURISM DEV STATUS N; Kiss A, 2004, TRENDS ECOL EVOL, V19, P232, DOI 10.1016/j.tree.2004.03.010; Kvist L. P., 1995, Commonwealth Forestry Review, V74, P293; Mackoy R. D., 2004, Journal of Tourism Studies, V15, P13; MALKYHARB A, 2007, EFECTO CHALALAN EJER; Menkhaus S, 1996, J ENVIRON MANAGE, V47, P1, DOI 10.1006/jema.1996.0031; MIYOSHI C, 2008, PRESENT CARBON DIOXI; Muchagata M, 2003, AGR SYST, V76, P797, DOI 10.1016/S0308-521X(02)00015-X; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; NORTONGRIFFITHS M, 1995, ECOL ECON, V12, P125, DOI 10.1016/0921-8009(94)00041-S; Ohl-Schacherer J, 2008, ENVIRON CONSERV, V35, P14, DOI 10.1017/S0376892908004517; PEARCE D, 2001, VALUABLE ARE TROPICA; Pearce D, 2007, ENVIRON RESOUR ECON, V37, P313, DOI 10.1007/s10640-007-9118-3; *PRONATURALEZA, 2005, PLAN GEN EST MAN FOR; REED SE, 2008, CONSERV LETT, V1, P1; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Salafsky N, 2001, CONSERV BIOL, V15, P1585, DOI 10.1046/j.1523-1739.2001.00220.x; Sheil D, 2002, CONSERV ECOL, V6; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Soares BS, 2002, ECOL MODEL, V154, P217, DOI 10.1016/S0304-3800(02)00059-5; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; *SPDA, 2007, B INF SPDA, V3; Stronza A.L., 2000, THESIS U FLORIDA GAI; Taylor J.E., 2006, ECOTOURISM EC GROWTH; Theobald DM, 2005, ECOL APPL, V15, P1906, DOI 10.1890/03-5331; Torras M, 2000, ECOL ECON, V33, P283, DOI 10.1016/S0921-8009(99)00149-4; TORRESPADILLA J, 2006, PLAN NEGOCIOS 2006 A; van Lier HN, 1998, LANDSCAPE URBAN PLAN, V41, P83, DOI 10.1016/S0169-2046(97)00061-3; Walpole MJ, 2005, PEOPLE WILDLIFE CONF; WEARING S, 1999, ECOTOURISM IMPACTS P; Wight P., 1993, Journal of Travel Research, V31, P3, DOI 10.1177/004728759303100301; WINROCK, 2006, CARBON STORAGE LOS A; Wunder S, 2000, ECOL ECON, V32, P465, DOI 10.1016/S0921-8009(99)00119-6; WUNDER S, 1999, PROMOTING FOREST CON; WUNDER S, 2001, DEFORESTATION EC ECU; Yu DW, 1997, ENVIRON CONSERV, V24, P130, DOI 10.1017/S0376892997000192; YU DW, 2010, BIOTROPICA; YU DW, BIOTROPICA IN PRESS; [No title captured]	74	51	51	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13015	10.1371/journal.pone.0013015	http://dx.doi.org/10.1371/journal.pone.0013015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	655SI	20927377	Green Submitted, Green Published, gold			2022-12-25	WOS:000282269400010
J	Bernasconi, R; Solda, T; Galli, C; Pertel, T; Luban, J; Molinari, M				Bernasconi, Riccardo; Solda, Tatiana; Galli, Carmela; Pertel, Thomas; Luban, Jeremy; Molinari, Maurizio			Cyclosporine A-Sensitive, Cyclophilin B-Dependent Endoplasmic Reticulum-Associated Degradation	PLOS ONE			English	Article							UBIQUITIN LIGASE COMPLEX; QUALITY-CONTROL; MISFOLDED GLYCOPROTEINS; CA2+ HOMEOSTASIS; ER; RECOGNITION; PROTEASOME; SECRETION; ISOMERASE; VARIANTS	Peptidyl-prolyl cis/trans isomerases (PPIs) catalyze cis/trans isomerization of peptide bonds preceding proline residues. The involvement of PPI family members in protein refolding has been established in test tube experiments. Surprisingly, however, no data is available on the involvement of endoplasmic reticulum (ER)-resident members of the PPI family in protein folding, quality control or disposal in the living cell. Here we report that the immunosuppressive drug cyclosporine A (CsA) selectively inhibits the degradation of a subset of misfolded proteins generated in the ER. We identify cyclophilin B (CyPB) as the ER-resident target of CsA that catalytically enhances disposal from the ER of ERAD-L(S) substrates containing cis proline residues. Our manuscript presents the first evidence for enzymatic involvement of a PPI in protein quality control in the ER of living cells.	[Bernasconi, Riccardo; Solda, Tatiana; Galli, Carmela; Pertel, Thomas; Luban, Jeremy; Molinari, Maurizio] Inst Res Biomed, Bellinzona, Switzerland; [Pertel, Thomas; Luban, Jeremy] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Molinari, Maurizio] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland	Universita della Svizzera Italiana; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Bernasconi, R (corresponding author), Inst Res Biomed, Bellinzona, Switzerland.	maurizio.molinari@irb.unisi.ch	Molinari, Maurizio/N-2587-2019	Molinari, Maurizio/0000-0002-7636-5829; Luban, Jeremy/0000-0001-5650-4054; Pertel, Thomas/0000-0002-2286-6011	Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair; Swiss National Science Foundation; ONELIFE Advisors SA; NIH [AI059159]; EU; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059159] Funding Source: NIH RePORTER	Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ONELIFE Advisors SA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.M. is supported by grants from the Foundation for Research on Neurodegenerative Diseases, the Fondazione San Salvatore, the Swiss National Center of Competence in Research on Neural Plasticity and Repair, the Swiss National Science Foundation and ONELIFE Advisors SA. J.L. is supported by grants from the Swiss National Science Foundation, the NIH (AI059159) and the EU project HIV-ACE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Carpentier M, 1999, J BIOL CHEM, V274, P10990, DOI 10.1074/jbc.274.16.10990; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cohen E, 2003, EMBO J, V22, P404, DOI 10.1093/emboj/cdg045; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hebert DN, 2009, MOL CELL, V34, P635, DOI 10.1016/j.molcel.2009.06.006; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Jessop CE, 2004, BIOCHEM SOC T, V32, P655, DOI 10.1042/BST0320655; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kim J, 2008, J CELL SCI, V121, P3636, DOI 10.1242/jcs.028654; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Nagradova N, 2007, CURR PROTEIN PEPT SC, V8, P273, DOI 10.2174/138920307780831866; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SU K, 1993, J BIOL CHEM, V268, P14301; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Zohar O, 2003, MOL BRAIN RES, V115, P63, DOI 10.1016/S0169-328X(03)00182-7	36	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13008	10.1371/journal.pone.0013008	http://dx.doi.org/10.1371/journal.pone.0013008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927389	gold, Green Published, Green Submitted			2022-12-25	WOS:000282210700007
J	Held, NL; Herrera, A; Cadillo-Quiroz, H; Whitaker, RJ				Held, Nicole L.; Herrera, Alfa; Cadillo-Quiroz, Hinsby; Whitaker, Rachel J.			CRISPR Associated Diversity within a Population of Sulfolobus islandicus	PLOS ONE			English	Article							STREPTOCOCCUS-THERMOPHILUS; MICROBIAL COMMUNITIES; ACQUIRED-RESISTANCE; RESOURCE ENRICHMENT; VIRUS-RESISTANCE; BACTERIA; PHAGE; HOST; EVOLUTION; DYNAMICS	Background: Predator-prey models for virus-host interactions predict that viruses will cause oscillations of microbial host densities due to an arms race between resistance and virulence. A new form of microbial resistance, CRISPRs (clustered regularly interspaced short palindromic repeats) are a rapidly evolving, sequence-specific immunity mechanism in which a short piece of invading viral DNA is inserted into the host's chromosome, thereby rendering the host resistant to further infection. Few studies have linked this form of resistance to population dynamics in natural microbial populations. Methodology/Principal Findings: We examined sequence diversity in 39 strains of the archeaon Sulfolobus islandicus from a single, isolated hot spring from Kamchatka, Russia to determine the effects of CRISPR immunity on microbial population dynamics. First, multiple housekeeping genetic markers identify a large clonal group of identical genotypes coexisting with a diverse set of rare genotypes. Second, the sequence-specific CRISPR spacer arrays split the large group of isolates into two very different groups and reveal extensive diversity and no evidence for dominance of a single clone within the population. Conclusions/Significance: The evenness of resistance genotypes found within this population of S. islandicus is indicative of a lack of strain dominance, in contrast to the prediction for a resistant strain in a simple predator-prey interaction. Based on evidence for the independent acquisition of resistant sequences, we hypothesize that CRISPR mediated clonal interference between resistant strains promotes and maintains diversity in this natural population.	[Held, Nicole L.; Herrera, Alfa; Cadillo-Quiroz, Hinsby; Whitaker, Rachel J.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Held, NL (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	rwhitaker@life.illinois.edu		Cadillo-Quiroz, Hinsby/0000-0002-4908-4597	National Science Foundation [DEB-0816885]; Division Of Environmental Biology [0816885] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by National Science Foundation award number DEB-0816885, http://www.nsf.gov/div/index.jsp?div=DEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1997, EVOLUTION, V51, P1742, DOI 10.1111/j.1558-5646.1997.tb05098.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Banfield JF, 2009, SCIENCE, V326, P1198, DOI 10.1126/science.1181501; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bize A, 2009, P NATL ACAD SCI USA, V106, P11306, DOI 10.1073/pnas.0901238106; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Bohannan BJM, 1997, ECOLOGY, V78, P2303; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086; Brockhurst MA, 2004, P ROY SOC B-BIOL SCI, V271, P107, DOI 10.1098/rspb.2003.2556; CHAO A, 1984, SCAND J STAT, V11, P265; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Holmfeldt K, 2007, APPL ENVIRON MICROB, V73, P6730, DOI 10.1128/AEM.01399-07; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Lennon JT, 2007, ISME J, V1, P300, DOI 10.1038/ismej.2007.37; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Lythgoe KA, 2003, ECOL LETT, V6, P326, DOI 10.1046/j.1461-0248.2003.00433.x; MADDISON WP, 2005, MACCLADE ANLAYSIS PH; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Middelboe M, 2000, MICROBIAL ECOL, V40, P114; Middelboe M, 2009, ENVIRON MICROBIOL, V11, P1971, DOI 10.1111/j.1462-2920.2009.01920.x; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Prangishvili D, 2005, TRENDS MICROBIOL, V13, P535, DOI 10.1016/j.tim.2005.08.013; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schrag SJ, 1996, AM NAT, V148, P348, DOI 10.1086/285929; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Whitaker RJ, 2005, MOL BIOL EVOL, V22, P2354, DOI 10.1093/molbev/msi233; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235	50	73	74	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e12988	10.1371/journal.pone.0012988	http://dx.doi.org/10.1371/journal.pone.0012988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927396	Green Submitted, Green Published, gold			2022-12-25	WOS:000282210700006
J	Waterman, JM				Waterman, Jane M.			The Adaptive Function of Masturbation in a Promiscuous African Ground Squirrel	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; SPERM COMPETITION RISK; XERUS-INAURIS; JAPANESE MACAQUES; EJACULATE QUALITY; SIZE; ALLOCATION; CONSEQUENCES; SCIURIDAE; EVOLUTION	Background: Studies of animal mating systems increasingly emphasize female multiple mating and cryptic sexual selection, particularly sperm competition. Males under intense sperm competition may manipulate sperm quantity and quality through masturbation, which could waste sperm and decrease fertility. I examined the factors influencing masturbation by male Cape ground squirrels (Xerus inauris) in light of a number of functional hypotheses. Methodology: Observational data on a marked population of squirrels were collected in east-central Namibia using scan and all-occurrences sampling. Findings: Masturbation was far more frequent on days of female oestrus and mostly occurred after copulation. Masturbation rates were higher in dominant males, which copulate more, than in subordinates and increased with number of mates a female accepts. Conclusions: These results suggest that masturbation in this species was not a response to sperm competition nor a sexual outlet by subordinates that did not copulate. Instead masturbation could function as a form of genital grooming. Female Cape ground squirrels mate with up to 10 males in a 3-hr oestrus, and by masturbating after copulation males could reduce the chance of infection. Sexually transmitted infections (STIs) can profoundly affect fertility, and their consequences for mating strategies need to be examined more fully.	Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Waterman, JM (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	jane_waterman@umanitoba.ca			National Science Foundation [IBN0130600]	National Science Foundation(National Science Foundation (NSF))	This research was funded in part by a National Science Foundation (http://www.nsf.gov/) grant (IBN0130600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ambriz D, 2002, ARCH ANDROLOGY, V48, P389, DOI 10.1080/01485010290099255; BAGEMIHL B, 1999, BIOLOGICAL EXUBERANC; BAKER RR, 1993, ANIM BEHAV, V46, P861, DOI 10.1006/anbe.1993.1271; Birkhead TR, 1998, SPERM COMPETITION SE; CONOVER W. J, 1980, PRACTICAL NONPARAMET; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dixson AF, 2004, PHYSIOL BEHAV, V83, P361, DOI 10.1016/j.physbeh.2004.08.022; Dixson AF, 1998, PRIMATE SEXUALITY; Donovan B, 2000, SEX TRANSM INFECT, V76, P88, DOI 10.1136/sti.76.2.88; Engqvist L, 2007, P ROY SOC B-BIOL SCI, V274, P209, DOI 10.1098/rspb.2006.3722; GAGE MJG, 1991, ANIM BEHAV, V42, P1036, DOI 10.1016/S0003-3472(05)80162-9; HAIM A, 1987, S AFR J ZOOL, V22, P45; HART BL, 1988, ANN NY ACAD SCI, V525, P397, DOI 10.1111/j.1749-6632.1988.tb38624.x; HARTL P, 1987, FREQUENZ, V41, P321, DOI 10.1515/FREQ.1987.41.11-12.321; HOGLUND J, 1990, BEHAVIOUR, V114, P221, DOI 10.1163/156853990X00130; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Lehner PN, 1996, HDB ETHOLOGICAL METH; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Manjerovic MB, 2008, J ZOOL, V275, P375, DOI 10.1111/j.1469-7998.2008.00449.x; MARDH PA, 1975, SCAND J UROL NEPHROL, V9, P17, DOI 10.3109/00365597509139907; MARSH A C, 1978, Madoqua, V11, P129; MELCHIOR HERBERT R., 1965, J WILDLIFE MANAGE, V29, P671, DOI 10.2307/3798540; Nunn CL, 2003, ANIM BEHAV, V66, P37, DOI 10.1006/anbe.2003.2130; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pettitt BA, 2008, J ZOOL, V276, P291, DOI 10.1111/j.1469-7998.2008.00491.x; PIERCE JD, 1990, J REPROD FERTIL, V88, P141; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Ramm SA, 2005, P ROY SOC B-BIOL SCI, V272, P949, DOI 10.1098/rspb.2004.3048; Ramm SA, 2007, BEHAV ECOL, V18, P491, DOI 10.1093/beheco/arm003; ROOD JP, 1980, J WILDLIFE MANAGE, V44, P500, DOI 10.2307/3807988; Simmons LW, 2007, BIOL LETTERS, V3, P520, DOI 10.1098/rsbl.2007.0328; SKARPE C, 1986, J ARID ENVIRON, V11, P147, DOI 10.1016/S0140-1963(18)31226-6; Skau PA, 2003, BEHAV ECOL, V14, P40, DOI 10.1093/beheco/14.1.40; Smith C, 2009, ANIM BEHAV, V77, P1227, DOI 10.1016/j.anbehav.2009.01.027; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; STAMEY TA, 1968, NATURE, V218, P444, DOI 10.1038/218444a0; SYNNOTT AL, 1981, J REPROD FERTIL, V61, P355, DOI 10.1530/jrf.0.0610355; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007595; Thomsen R, 2004, INT J PRIMATOL, V25, P1033, DOI 10.1023/B:IJOP.0000043350.75897.89; Thomsen R, 2006, PRIMATES, V47, P272, DOI 10.1007/s10329-005-0171-7; Waterman Jane, 2007, P27; Waterman JM, 1996, J MAMMAL, V77, P134, DOI 10.2307/1382715; Waterman JM, 1998, ANIM BEHAV, V56, P459, DOI 10.1006/anbe.1998.0780; Waterman JM, 1997, ANIM BEHAV, V53, P809, DOI 10.1006/anbe.1996.0346; WATERMAN JM, 1995, ETHOLOGY, V101, P130, DOI 10.1111/j.1439-0310.1995.tb00352.x; Waterman JM, 2002, J ZOOL, V256, P113, DOI 10.1017/S0952836902000146; Zar JH, 1999, BIOSTATISTICAL ANAL	48	12	12	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13060	10.1371/journal.pone.0013060	http://dx.doi.org/10.1371/journal.pone.0013060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927404	Green Published, gold			2022-12-25	WOS:000282210700026
J	Burschowsky, D; Rudolf, F; Rabut, G; Herrmann, T; Matthias, P; Wider, G				Burschowsky, Daniel; Rudolf, Fabian; Rabut, Gwenael; Herrmann, Torsten; Matthias, Peter; Wider, Gerhard			Structural Analysis of the Conserved Ubiquitin-binding Motifs (UBMs) of the Translesion Polymerase iota in Complex with Ubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; NMR STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; DNA-DAMAGE TOLERANCE; POLYUBIQUITIN CHAINS; UBA DOMAIN; PROTEIN; RECOGNITION; REV1; DETERMINANTS	Ubiquitin-binding domains (UBDs) provide specificity to the ubiquitin system, which is also involved in translesion synthesis (TLS) in eukaryotic cells. Upon DNA damage, the UBDs (UBM domains) of polymerase iota (Pol iota) interact with ubiquitinated proliferating cell nuclear antigen to regulate the interchange between processive DNA polymerases and TLS. We report a biophysical analysis and solution structures of the two conserved UBM domains located in the C-terminal tail of murine Pol iota in complex with ubiquitin. The 35-amino acid core folds into a helix-turn-helix motif, which belongs to a novel domain fold. Similar to other UBDs, UBMs bind to ubiquitin on the hydrophobic surface delineated by Leu-8, Ile-44, and Val-70, however, slightly shifted toward the C terminus. In addition, UBMs also use electrostatic interactions to stabilize binding. NMR and fluorescence spectroscopy measurements revealed that UBMs bind monoubiquitin, and Lys-63-but not Lys-48-linked chains. Importantly, these biophysical data are supported by functional studies. Indeed, yeast cells expressing ubiquitin mutants specifically defective for UBM binding are viable but sensitive to DNA damaging conditions that require TLS for repair.	[Rudolf, Fabian; Rabut, Gwenael; Matthias, Peter] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Burschowsky, Daniel; Wider, Gerhard] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Rudolf, Fabian; Matthias, Peter] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Herrmann, Torsten] Univ Lyon, CNRS ENS Lyon UCB, Ctr Europeen RMN Tres Hauts Champs, F-69100 Villeurbanne, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ecole Normale Superieure de Lyon (ENS de LYON)	Matthias, P (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	matthias.peter@bc.biol.ethz.ch; gsw@mol.biol.ethz.ch	Rabut, Gwenaël/E-7257-2011; Herrmann, Torsten/B-9978-2008	Rabut, Gwenaël/0000-0003-2658-2769; Burschowsky, Daniel/0000-0002-7782-5508; Herrmann, Torsten/0000-0003-2115-4781; Wider, Gerhard/0000-0001-9366-7645; Peter, Matthias/0000-0002-2160-6824	Swiss National Science Foundation; Oncosuisse; INSERM; ETH Zurich [TH-42/04-2, TH-3307-3]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ETH Zurich(ETH Zurich)	This work was supported by grants from the Swiss National Science Foundation, Oncosuisse, INSERM (to G. R.), and the ETH Zurich (TH-42/04-2 and TH-3307-3).	BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Bomar MG, 2010, MOL CELL, V37, P408, DOI 10.1016/j.molcel.2009.12.038; Case D. A., 2006, AMBER9; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Groemping Y., 2005, CURR PROTOC PROTEIN, V39, P202821; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Lehmann AR, 2006, DNA REPAIR, V5, P404, DOI 10.1016/j.dnarep.2005.12.005; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Vermeulen W, 2004, PROTEIN SCI, V13, P1276, DOI 10.1110/ps.03518104; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wood A, 2007, J BIOL CHEM, V282, P20256, DOI 10.1074/jbc.M702366200; Yin LM, 2006, ISR J CHEM, V46, P159, DOI 10.1560/46F8-EDWB-6QXP-CB14; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	55	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1364	1373		10.1074/jbc.M110.135038	http://dx.doi.org/10.1074/jbc.M110.135038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20929865	Green Published, hybrid			2022-12-25	WOS:000286005000048
J	Mekler, V; Pavlova, O; Severinov, K				Mekler, Vladimir; Pavlova, Olga; Severinov, Konstantin			Interaction of Escherichia coli RNA Polymerase sigma(70) Subunit with Promoter Elements in the Context of Free sigma(70), RNA Polymerase Holoenzyme, and the beta '-sigma(70) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRANDED-DNA BUBBLE; NONTEMPLATE STRAND; BETA' SUBUNIT; TRANSCRIPTION INITIATION; STRUCTURAL ORGANIZATION; CRYSTAL-STRUCTURE; BINDING; RECOGNITION; REGION; SIGMA-70	Promoter recognition by RNA polymerase is a key point in gene expression and a target of regulation. Bacterial RNA polymerase binds promoters in the form of the holoenzyme, with the sigma specificity subunit being primarily responsible for promoter recognition. Free sigma, however, does not recognize promoter DNA, and it has been proposed that the intrinsic DNA binding ability is masked in free sigma but becomes unmasked in the holoenzyme. Here, we use a newly developed fluorescent assay to quantitatively study the interactions of free sigma 70 from Escherichia coli, the beta '-sigma complex, and the sigma(70) RNA polymerase (RNAP) holoenzyme with non-template strand of the open promoter complex transcription bubble in the context of model non-template oligonucleotides and fork junction templates. We show that sigma(70), free or in the context of the holoenzyme, recognizes the - 10 promoter element with the same efficiency and specificity. The result implies that there is no need to invoke a conformational change in sigma for recognition of the - 10 element in the single-stranded form. In the holoenzyme, weak but specific interactions of sigma are increased by contacts with DNA downstream of the - 10 element. We further show that region 1 of sigma(70) is required for stronger interaction with non-template oligonucleotides in the holoenzyme but not in free sigma. Finally, we show that binding of the beta ' RNAP subunit is sufficient to allow specific recognition of the TG motif of the extended - 10 promoter element by sigma(70). The new fluorescent assay, which we call a protein beacon assay, will be instrumental in quantitative dissection of fine details of RNAP interactions with promoters.	[Mekler, Vladimir; Pavlova, Olga; Severinov, Konstantin] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet & Gene Biol, Moscow 119334, Russia	Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Mekler, V (corresponding author), Rutgers State Univ, Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	mekler@waksman.rutgers.edu; severik@waksman.rutgers.edu	Severinov, Konstantin/C-8545-2016		National Institutes of Health [R01 GM64530]; Charles and Johanna Busch postdoctoral fellowship; Russian Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Johanna Busch postdoctoral fellowship; Russian Academy of Sciences(Russian Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM64530 (to K. S.). This work was also supported by a Charles and Johanna Busch postdoctoral fellowship (to O. P.) and Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology (to K. S.).	Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Auner H, 2003, J MOL BIOL, V331, P331, DOI 10.1016/S0022-2836(03)00727-7; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Callaci S, 1999, MOL CELL, V3, P229, DOI 10.1016/S1097-2765(00)80313-5; Callaci S, 1998, BIOCHEMISTRY-US, V37, P3312, DOI 10.1021/bi972041m; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; DeHaseth PL, 2003, METHOD ENZYMOL, V370, P553; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Doose S, 2005, CHEMPHYSCHEM, V6, P2277, DOI 10.1002/cphc.200500191; Feklistov A, 2008, P NATL ACAD SCI USA, V105, P14820, DOI 10.1073/pnas.0802822105; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; Fenton MS, 2003, J BIOL CHEM, V278, P39669, DOI 10.1074/jbc.M307412200; Figueroa-Bossi N, 1998, EMBO J, V17, P2359, DOI 10.1093/emboj/17.8.2359; Gries TJ, 2010, P NATL ACAD SCI USA, V107, P10418, DOI 10.1073/pnas.1000967107; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Kulbachinskiy A, 1999, FEBS LETT, V454, P71, DOI 10.1016/S0014-5793(99)00778-4; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Matlock DL, 2000, BIOCHEMISTRY-US, V39, P12274, DOI 10.1021/bi001433h; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Nickels BE, 2005, P NATL ACAD SCI USA, V102, P4488, DOI 10.1073/pnas.0409850102; Oh KJ, 2007, BIOCONJUGATE CHEM, V18, P607, DOI 10.1021/bc060319u; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Roberts CW, 1996, CELL, V86, P495; Rogozina A, 2009, NUCLEIC ACIDS RES, V37, P5390, DOI 10.1093/nar/gkp560; Schroeder LA, 2009, J MOL BIOL, V385, P339, DOI 10.1016/j.jmb.2008.10.023; Sun L, 2004, J MOL BIOL, V343, P1171, DOI 10.1016/j.jmb.2004.09.025; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zaychikov E, 1997, J BIOL CHEM, V272, P2259; Zenkin N, 2007, EMBO J, V26, P955, DOI 10.1038/sj.emboj.7601555	48	28	29	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					270	279		10.1074/jbc.M110.174102	http://dx.doi.org/10.1074/jbc.M110.174102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20952386	Green Published, hybrid			2022-12-25	WOS:000285782800030
J	Gohl, C; Banovic, D; Grevelhorster, A; Bogdan, S				Gohl, Christina; Banovic, Daniel; Grevelhoerster, Astrid; Bogdan, Sven			WAVE Forms Hetero- and Homo-oligomeric Complexes at Integrin Junctions in Drosophila Visualized by Bimolecular Fluorescence Complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INTERACTIONS; BIFC ANALYSIS; IN-SITU; ACTIN; KETTE; WASP; ABI; INTERACTS; SCAR/WAVE; SYSTEM	Dynamic actin polymerization drives a variety of morphogenetic events during metazoan development. Members of the WASP/WAVE protein family are central nucleation-promoting factors. They are embedded within regulatory networks of macromolecular complexes controlling Arp2/3-mediated actin nucleation in time and space. WAVE (Wiskott-Aldrich syndrome protein family verprolin-homologous protein) proteins are found in a conserved pentameric heterocomplex that contains Abi, Kette/Nap1, Sra-1/CYFIP, and HSPC300. Formation of the WAVE complex contributes to the localization, activity, and stability of the various WAVE proteins. Here, we established the Bimolecular Fluorescence Complementation (BiFC) technique in Drosophila to determine the subcellular localization of the WAVE complex in living flies. Using different split-YFP combinations, we are able to visualize the formation of the WAVE-Abi complex in vivo. We found that WAVE also forms dimers that are capable of forming higher order clusters with endogenous WAVE complex components. The N-terminal WAVE homology domain (WHD) of the WAVE protein mediates both WAVE-Abi and WAVE-WAVE interactions. Detailed localization analyses show that formation of WAVE complexes specifically takes place at basal cell compartments promoting actin polymerization. In the wing epithelium, hetero- and homooligomeric WAVE complexes co-localize with Integrin and Talin suggesting a role in integrin-mediated cell adhesion. RNAi mediated suppression of single components of the WAVE and the Arp2/3 complex in the wing further suggests that WAVE-dependent Arp2/3-mediated actin nucleation is important for the maintenance of stable integrin junctions.	[Gohl, Christina; Banovic, Daniel; Grevelhoerster, Astrid; Bogdan, Sven] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	University of Munster	Bogdan, S (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	sbogdan@uni-muenster.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants (to S.B.) from the Deutsche Forschungsgemeinschaft.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Bogdan S, 2004, DEVELOPMENT, V131, P3981, DOI 10.1242/dev.01274; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Cole KC, 2007, EUKARYOT CELL, V6, P378, DOI 10.1128/EC.00368-06; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HARTLEY JL, 2003, CURR PROTOC PROTEIN, pCH5; Hiatt SM, 2008, METHODS, V45, P185, DOI 10.1016/j.ymeth.2008.06.003; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lin TY, 2009, DEVELOPMENT, V136, P3099, DOI 10.1242/dev.033324; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Robida AM, 2009, J MOL BIOL, V394, P391, DOI 10.1016/j.jmb.2009.08.069; Saka Y, 2008, METHODS, V45, P192, DOI 10.1016/j.ymeth.2008.06.005; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Tayler TD, 2003, CURR OPIN NEUROBIOL, V13, P90, DOI 10.1016/S0959-4388(03)00004-7; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057	41	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40171	40179		10.1074/jbc.M110.139337	http://dx.doi.org/10.1074/jbc.M110.139337			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937809	Green Published, hybrid			2022-12-25	WOS:000285185500062
J	Kitazume, S; Tachida, Y; Kato, M; Yamaguchi, Y; Honda, T; Hashimoto, Y; Wada, Y; Saito, T; Iwata, N; Saido, T; Taniguchi, N				Kitazume, Shinobu; Tachida, Yuriko; Kato, Masaki; Yamaguchi, Yoshiki; Honda, Takashi; Hashimoto, Yasuhiro; Wada, Yoshinao; Saito, Takashi; Iwata, Nobuhisa; Saido, Takaomi; Taniguchi, Naoyuki			Brain Endothelial Cells Produce Amyloid beta from Amyloid Precursor Protein 770 and Preferentially Secrete the O-Glycosylated Form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INHIBITOR DOMAIN; APP; ANGIOPATHY; ACID; CLEARANCE; CLEAVAGE; NEURONS; MATRIX; DIMER	Deposition of amyloid beta(A beta) in the brain is closely associated with Alzheimer disease (AD). A beta is generated from amyloid precursor protein (APP) by the actions of beta- and gamma-secretases. In addition to A beta deposition in the brain parenchyma, deposition of A beta in cerebral vessel walls, termed cerebral amyloid angiopathy, is observed in more than 80% of AD individuals. The mechanism for how A beta accumulates in blood vessels remains largely unknown. In the present study, we show that brain endothelial cells expressed APP770, a differently spliced APP mRNA isoform from neuronal APP695, and produced A beta 40 and A beta 42. Furthermore, we found that the endothelial APP770 had sialylated core 1 type O-glycans. Interestingly, O-glycosylated APP770 was preferentially processed by both alpha- and beta-cleavage and secreted into the media, suggesting that O-glycosylation and APP processing involved related pathways. By immunostaining human brain sections with an anti-APP770 antibody, we found that APP770 was expressed in vascular endothelial cells. Because we were able to detect O-glycosylated sAPP770 beta in human cerebrospinal fluid, this unique soluble APP770 beta has the potential to serve as a marker for cortical dementias such as AD and vascular dementia.	[Kitazume, Shinobu; Tachida, Yuriko; Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Kato, Masaki; Yamaguchi, Yoshiki; Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Struct Glycobiol Team, Wako, Saitama 3510198, Japan; [Hashimoto, Yasuhiro] Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima 9601295, Japan; [Honda, Takashi] Fukushima Med Univ, Sch Nursing, Dept Human Life Sci, Fukushima 9601295, Japan; [Wada, Yoshinao] Osaka Med Ctr, Izumi 5941101, Japan; [Saito, Takashi; Iwata, Nobuhisa; Saido, Takaomi] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Taniguchi, Naoyuki] Osaka Univ, Inst Sci & Ind Res, Dept Dis Glyc, Ibaraki, Osaka 5670047, Japan; [Wada, Yoshinao] Res Inst Maternal & Child Hlth, Izumi 5941101, Japan	RIKEN; RIKEN; Fukushima Medical University; Fukushima Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; RIKEN; Osaka University	Taniguchi, N (corresponding author), RIKEN, Adv Sci Inst, Dis Glyc Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani52@wd5.so-net.ne.jp	Saido, Takaomi C/N-5472-2015; Yamaguchi, Yoshiki/N-5246-2015; Sado, Takaomi/AAN-2759-2021; Taniguchi, Naoyuki/A-7086-2016; Saito, Takashi/G-2563-2015; Taniguchi, Naoyuki/I-4182-2014	Saido, Takaomi C/0000-0003-1970-6903; Yamaguchi, Yoshiki/0000-0003-0100-5439; Sado, Takaomi/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251; Taniguchi, Naoyuki/0000-0001-5889-5968	Systems Glycobiology research project; Ministry of Education, Science, Sports, and Culture of Japan [21570154]	Systems Glycobiology research project; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Systems Glycobiology research project (to N.T.) and Grant 21570154 from the Ministry of Education, Science, Sports, and Culture of Japan (to S.K.).	AROETI B, 1994, EMBO J, V13, P2297, DOI 10.1002/j.1460-2075.1994.tb06513.x; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; DE SB, 1999, NATURE, V398, P518; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; HYNES TR, 1990, BIOCHEMISTRY-US, V29, P10018, DOI 10.1021/bi00495a002; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; Perdivara I, 2009, J PROTEOME RES, V8, P631, DOI 10.1021/pr800758g; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sato Y, 1999, BBA-GEN SUBJECTS, V1472, P344, DOI 10.1016/S0304-4165(99)00140-3; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shimizu K, 2007, BIOINFORMATICS, V23, P2337, DOI 10.1093/bioinformatics/btm330; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SMALL DH, 1992, J NEUROSCI, V12, P4143; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu F, 2005, P NATL ACAD SCI USA, V102, P18135, DOI 10.1073/pnas.0507798102; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	35	75	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40097	40103		10.1074/jbc.M110.144626	http://dx.doi.org/10.1074/jbc.M110.144626			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20952385	Green Published, hybrid			2022-12-25	WOS:000285185500055
J	Kimura, T; Fukuda, T; Sahara, N; Yamashita, S; Murayama, M; Mizoroki, T; Yoshiike, Y; Lee, B; Sotiropoulos, I; Maeda, S; Takashima, A				Kimura, Tetsuya; Fukuda, Tetsuya; Sahara, Naruhiko; Yamashita, Shunji; Murayama, Miyuki; Mizoroki, Tatsuya; Yoshiike, Yuji; Lee, Boyoung; Sotiropoulos, Ioannis; Maeda, Sumihiro; Takashima, Akihiko			Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROFIBRILLARY TANGLE FORMATION; PAIRED HELICAL FILAMENTS; TRANSGENIC ANIMAL-MODELS; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; MOUSE MODEL; MUTATIONS; TAUOPATHY; PROTEIN; MICE	Neurofibrillary tangles (NFTs), which consist of highly phosphorylated tau, are hallmarks of neurodegenerative diseases including Alzheimer disease (AD). In neurodegenerative diseases, neuronal dysfunction due to neuronal loss and synaptic loss accompanies NFT formation, suggesting that a process associated with NFT formation may be involved in neuronal dysfunction. To clarify the relationship between the tau aggregation process and synapse and neuronal loss, we compared two lines of mice expressing human tau with or without an aggregation-prone P301L mutation. P301L tau transgenic (Tg) mice exhibited neuronal loss and produced sarcosyl-insoluble tau in old age but did not exhibit synaptic loss and memory impairment. By contrast, wild-type tau Tg mice neither exhibited neuronal loss nor produced sarcosyl-insoluble tau but did exhibit synaptic loss and memory impairment. Moreover, P301L tau was less phosphorylated than wild-type tau, suggesting that the tau phosphorylation state is involved in synaptic loss, whereas the tau aggregation state is involved in neuronal loss. Finally, increasing concentrations of insoluble tau aggregates leads to the formation of fibrillar tau, which causes NFTs to form.	[Kimura, Tetsuya; Fukuda, Tetsuya; Sahara, Naruhiko; Yamashita, Shunji; Murayama, Miyuki; Mizoroki, Tatsuya; Yoshiike, Yuji; Lee, Boyoung; Sotiropoulos, Ioannis; Maeda, Sumihiro; Takashima, Akihiko] RIKEN, Lab Alzheimers Dis, Brain Sci Inst, Wako, Saitama 3510198, Japan	RIKEN	Takashima, A (corresponding author), RIKEN, Lab Alzheimers Dis, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kenneth@brain.riken.jp	Maeda, Sumihiro/W-9146-2019; Sotiropoulos, Ioannis/B-3316-2010	Sotiropoulos, Ioannis/0000-0003-0115-0038	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work supported in part by a grant-in-aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Agarwal-Mawal A, 2001, J BIOL CHEM, V276, P23712, DOI 10.1074/jbc.M010002200; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Dawson HN, 2007, J NEUROSCI, V27, P9155, DOI 10.1523/JNEUROSCI.5492-06.2007; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Gotz J, 2001, BRAIN RES REV, V35, P266, DOI 10.1016/S0165-0173(01)00055-8; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Head E, 2007, J ALZHEIMERS DIS, V11, P61; Hutton M, 2000, ANN NY ACAD SCI, V920, P63; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Kimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003540; Lee S, 2009, J ALZHEIMERS DIS, V16, P99, DOI 10.3233/JAD-2009-0954; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Miyasaka T, 2001, AM J PATHOL, V158, P373, DOI 10.1016/S0002-9440(10)63979-X; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Perez M, 2005, NEUROSCIENCE, V130, P339, DOI 10.1016/j.neuroscience.2004.09.029; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Shiarli AM, 2006, NEUROPATH APPL NEURO, V32, P374, DOI 10.1111/j.1365-2990.2006.00736.x; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Tanemura K, 2001, NEUROBIOL DIS, V8, P1036, DOI 10.1006/nbdi.2001.0439; Taniguchi T, 2005, FEBS LETT, V579, P5704, DOI 10.1016/j.febslet.2005.09.047; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200	33	72	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38692	38699		10.1074/jbc.M110.136630	http://dx.doi.org/10.1074/jbc.M110.136630			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20921222	hybrid, Green Published			2022-12-25	WOS:000284625600074
J	Kozaili, JM; Leek, D; Tobacman, LS				Kozaili, Julie Mouannes; Leek, Daniel; Tobacman, Larry S.			Dual Regulatory Functions of the Thin Filament Revealed by Replacement of the Troponin I Inhibitory Peptide with a Linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARDIAC TROPONIN; COOPERATIVE EQUILIBRIUM BINDING; AMINO-ACID-SEQUENCE; PHOTO-CROSS-LINKING; MYOSIN SUBFRAGMENT-1; SKELETAL-MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; TROPOMYOSIN COMPLEX; ACTIN-TROPOMYOSIN; CA2+ SENSITIVITY	Striated muscles are relaxed under low Ca2+ concentration conditions due to actions of the thin filament protein troponin. To investigate this regulatory mechanism, an 11-residue segment of cardiac troponin I previously termed the inhibitory peptide region was studied by mutagenesis. Several mutant troponin complexes were characterized in which specific effects of the inhibitory peptide region were abrogated by replacements of 4-10 residues with Gly-Ala linkers. The mutations greatly impaired two of troponin's actions under low Ca2+ concentration conditions: inhibition of myosin subfragment 1 (S1)-thin filament MgATPase activity and cooperative suppression of myosin S1-ADP binding to thin filaments with low myosin saturation. Inhibitory peptide replacement diminished but did not abolish the Ca2+ dependence of the ATPase rate; ATPase rates were at least 2-fold greater when Ca2+ rather than EGTA was present. This residual regulation was highly cooperative as a function of Ca2+ concentration, similar to the degree of cooperativity observed with WT troponin present. Other effects of the mutations included 2-fold or less increases in the apparent affinity of the thin filament regulatory Ca2+ sites, similar decreases in the affinity of troponin for actin-tropomyosin regardless of Ca2+, and increases in myosin S1-thin filament ATPase rates in the presence of saturating Ca2+. The overall results indicate that cooperative myosin binding to Ca2+-free thin filaments depends upon the inhibitory peptide region but that a cooperatively activating effect of Ca2+ binding does not. The findings suggest that these two processes are separable and involve different conformational changes in the thin filament.	[Leek, Daniel; Tobacman, Larry S.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Kozaili, Julie Mouannes; Tobacman, Larry S.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tobacman, LS (corresponding author), Univ Illinois, Dept Med, 1853 W Polk St,MC 784, Chicago, IL 60612 USA.	lst@uic.edu			National Institutes of Health [HL063774, HL038834]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038834, R01HL038834, R01HL063774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL063774 and HL038834.	Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; Cassell M, 1996, J BIOL CHEM, V271, P12867, DOI 10.1074/jbc.271.22.12867; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Dong WJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P135, DOI 10.1016/j.abb.2006.08.007; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; Foster DB, 2003, CIRC RES, V93, P917, DOI 10.1161/01.RES.0000099889.35340.6F; Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GREENE L, 1982, J BIOL CHEM, V257, P3993; Heeley DH, 2006, J BIOL CHEM, V281, P668, DOI 10.1074/jbc.M505549200; Heeley DH, 2002, P NATL ACAD SCI USA, V99, P16731, DOI 10.1073/pnas.252236399; Heller MJ, 2003, J BIOL CHEM, V278, P41742, DOI 10.1074/jbc.M303408200; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; HILL TL, 1983, P NATL ACAD SCI-BIOL, V80, P60, DOI 10.1073/pnas.80.1.60; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; Huynh Q, 1996, BIOPHYS J, V70, P1447, DOI 10.1016/S0006-3495(96)79704-7; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2000, BIOCHEMISTRY-US, V39, P86, DOI 10.1021/bi991903b; Kobayashi T, 2009, J BIOL CHEM, V284, P20052, DOI 10.1074/jbc.M109.001396; Kowlessur D, 2010, J BIOL CHEM, V285, P2686, DOI 10.1074/jbc.M109.062349; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Lin D, 1996, J CLIN INVEST, V97, P2842, DOI 10.1172/JCI118740; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Luo Y, 2000, J MOL BIOL, V296, P899, DOI 10.1006/jmbi.1999.3495; Mathur MC, 2009, BIOPHYS J, V96, P2237, DOI 10.1016/j.bpj.2008.12.3909; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MEHEGAN JP, 1991, J BIOL CHEM, V266, P966; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Mudalige WAKA, 2009, J MOL BIOL, V389, P575, DOI 10.1016/j.jmb.2009.04.027; NAGASHIMA H, 1982, J MOL BIOL, V155, P409, DOI 10.1016/0022-2836(82)90479-X; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; Rosol M, 2000, BIOPHYS J, V78, P908, DOI 10.1016/S0006-3495(00)76648-3; Smith DA, 2003, BIOPHYS J, V84, P3155, DOI 10.1016/S0006-3495(03)70040-X; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Strand J, 2001, J BIOL CHEM, V276, P34832, DOI 10.1074/jbc.M104750200; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TALBOT JA, 1981, J BIOL CHEM, V256, P2374; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; TOBACMAN LS, 1987, J BIOL CHEM, V262, P4059; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; VANEYK JE, 1988, J BIOL CHEM, V263, P1726; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; WILKINSON JM, 1978, NATURE, V271, P31, DOI 10.1038/271031a0; WILLIAMS DL, 1983, BIOCHEMISTRY-US, V22, P2770, DOI 10.1021/bi00280a027; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3	63	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38034	38041		10.1074/jbc.M110.165753	http://dx.doi.org/10.1074/jbc.M110.165753			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889978	Green Published, hybrid			2022-12-25	WOS:000284625600011
J	Galocha, B; de Castro, JAL				Galocha, Begona; Lopez de Castro, Jose A.			Mutational Analysis Reveals a Complex Interplay of Peptide Binding and Multiple Biological Features of HLA-B27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; CELL-SURFACE EXPRESSION; C-TERMINAL ANCHOR; ANKYLOSING-SPONDYLITIS; ENDOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODY; HEAVY-CHAINS; ANTIGENIC DETERMINANTS; SUBTYPES; POLYMORPHISM	Molecular polymorphism influences the strong association of HLA-B27 with ankylosing spondylitis through an unknown mechanism. Natural subtypes and site-directed mutants were used to analyze the effect of altering the peptide-binding site of this molecule on its stability, interaction with tapasin, folding, and export. The disease-associated subtypes B*2705, B*2702, and B*2704 showed higher thermostability at 50 degrees C than all other subtypes and mutants, except some mimicking B*2702 polymorphism. The lowest values were found among pocket B mutants, most of which interacted strongly with tapasin, but otherwise there was no correlation between thermostability and tapasin interaction. Mutants resulting in increased hydrophobicity frequently acquired their maximal thermostability faster than those with increased polarity, suggesting that this process is largely driven by the thermodynamics of peptide binding. Folding, export, and tendency to misfold were influenced by polymorphism all along the peptide-binding site and were not specifically dependent on any particular region or structural feature. Frequent uncoupling of thermostability, folding/misfolding, and export can be explained by the distinct effect of mutations on the acquisition of a folded conformation, the optimization rate of B27-peptide complexes, and their quality control in the endoplasmic reticulum, all of which largely depend on the ways in which mutations alter peptide binding, without excluding additional effects on interactions with tapasin or other proteins involved in folding and export. The similarity of the generally disease-associated B*2707 to nondisease-associated subtypes in all the features analyzed suggests that molecular properties other than antigen presentation may not currently explain the relationship between HLA-B27 polymorphism and ankylosing spondylitis.	[Lopez de Castro, Jose A.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; [Galocha, Begona] Inst Salud Carlos III, Madrid 28007, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Instituto de Salud Carlos III	de Castro, JAL (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	aldecastro@cbm.uam.es			Ministry of Science and Innovation of Spain [SAF2008/00461]; Fundacion Ramon Areces to the Centro de Biolog a Molecular Severo Ochoa	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces to the Centro de Biolog a Molecular Severo Ochoa	This work was supported by Grant SAF2008/00461 from the Ministry of Science and Innovation of Spain and an institutional grant of the Fundacion Ramon Areces to the Centro de Biolog a Molecular Severo Ochoa.	Allen RL, 1999, J IMMUNOL, V162, P5045; Barnden MJ, 2000, J IMMUNOL, V165, P322, DOI 10.4049/jimmunol.165.1.322; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; Bird LA, 2003, EUR J IMMUNOL, V33, P748, DOI 10.1002/eji.200323678; Blanco-Gelaz MA, 2009, MOL IMMUNOL, V46, P1304, DOI 10.1016/j.molimm.2008.11.023; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; Bowness P, 2002, RHEUMATOLOGY, V41, P857, DOI 10.1093/rheumatology/41.8.857; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; CALVO V, 1990, J IMMUNOL, V144, P4038; Chapman DC, 2010, SEMIN CELL DEV BIOL, V21, P512, DOI 10.1016/j.semcdb.2009.12.013; Colbert RA, 2000, MOL MED TODAY, V6, P224, DOI 10.1016/S1357-4310(00)01699-3; Cragnolini JJ, 2008, MOL CELL PROTEOMICS, V7, P170, DOI 10.1074/mcp.M700386-MCP200; Dangoria NS, 2002, J BIOL CHEM, V277, P23459, DOI 10.1074/jbc.M110336200; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Edwards JCW, 2000, IMMUNOL TODAY, V21, P256, DOI 10.1016/S0167-5699(00)01625-X; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; FIORILLO MT, 1995, IMMUNOGENETICS, V41, P38, DOI 10.1007/BF00188430; Galocha B, 2008, ARTHRITIS RHEUM-US, V58, P401, DOI 10.1002/art.23164; Garstka M, 2007, J BIOL CHEM, V282, P30680, DOI 10.1074/jbc.M701721200; Gomez P, 2006, EUR J IMMUNOL, V36, P1867, DOI 10.1002/eji.200635896; Goodall JC, 2006, ARTHRITIS RHEUM, V54, P138, DOI 10.1002/art.21552; Hildebrand WH, 2002, HUM IMMUNOL, V63, P248, DOI 10.1016/S0198-8859(02)00364-6; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Marcilla M, 2008, TISSUE ANTIGENS, V71, P495, DOI 10.1111/j.1399-0039.2008.01051.x; Mear JP, 1999, J IMMUNOL, V163, P6665; Merino E, 2008, ARTHRITIS RHEUM-US, V58, P3693, DOI 10.1002/art.24045; Neisig A, 1996, J IMMUNOL, V156, P3196; Paulsson KM, 2006, J IMMUNOL, V176, P7482, DOI 10.4049/jimmunol.176.12.7482; Paulsson KM, 2002, J BIOL CHEM, V277, P18266, DOI 10.1074/jbc.M201388200; Raine T, 2006, RHEUMATOLOGY, V45, P1338, DOI 10.1093/rheumatology/kel305; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Ramos M, 2002, J BIOL CHEM, V277, P37573, DOI 10.1074/jbc.M205470200; ROTZSCHKE O, 1994, IMMUNOGENETICS, V39, P74; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Sesma L, 2002, J BIOL CHEM, V277, P16744, DOI 10.1074/jbc.M200371200; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; STAM NJ, 1986, J IMMUNOL, V137, P2299; Thammavongsa V, 2009, IMMUNOGENETICS, V61, P703, DOI 10.1007/s00251-009-0399-2; Thammavongsa V, 2006, J IMMUNOL, V177, P3150, DOI 10.4049/jimmunol.177.5.3150; Tran TM, 2006, ARTHRITIS RHEUM-US, V54, P1317, DOI 10.1002/art.21740; Tran TM, 2001, IMMUNOGENETICS, V53, P440, DOI 10.1007/s002510100353; Tran TM, 2000, HUM IMMUNOL, V61, P1197, DOI 10.1016/S0198-8859(00)00220-2; Turnquist HR, 2000, EUR J IMMUNOL, V30, P3021, DOI 10.1002/1521-4141(200010)30:10<3021::AID-IMMU3021>3.0.CO;2-U; Uchanska-Ziegler B, 2003, TRENDS IMMUNOL, V24, P73, DOI 10.1016/S1471-4906(02)00028-5; Varnavidou-Nicolaidou A, 2004, HUM IMMUNOL, V65, P1451, DOI 10.1016/j.humimm.2004.08.177; Vazquez MN, 2005, ARTHRITIS RHEUM-US, V52, P3290, DOI 10.1002/art.21284; VILLADANGOS JA, 1994, J IMMUNOL, V152, P2317; VILLADANGOS JA, 1995, EUR J IMMUNOL, V25, P2370, DOI 10.1002/eji.1830250837; VILLADANGOS JA, 1992, J IMMUNOL, V149, P505; VILLADANGOS JA, 1994, EUR J IMMUNOL, V24, P2548, DOI 10.1002/eji.1830241043; WANG J, 1994, J IMMUNOL, V152, P1197; WEN J, 1994, IMMUNOGENETICS, V39, P444; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680; Ziegler A, 2009, ADV EXP MED BIOL, V649, P177	64	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39180	39190		10.1074/jbc.M110.149906	http://dx.doi.org/10.1074/jbc.M110.149906			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889980	Green Published, hybrid			2022-12-25	WOS:000284941300048
J	Ohshima, K; Inoue, K; Fujiwara, A; Hatakeyama, K; Kanto, K; Watanabe, Y; Muramatsu, K; Fukuda, Y; Ogura, S; Yamaguchi, K; Mochizuki, T				Ohshima, Keiichi; Inoue, Kanako; Fujiwara, Akemi; Hatakeyama, Keiichi; Kanto, Kaori; Watanabe, Yuko; Muramatsu, Koji; Fukuda, Yorikane; Ogura, Shun-ichiro; Yamaguchi, Ken; Mochizuki, Tohru			Let-7 MicroRNA Family Is Selectively Secreted into the Extracellular Environment via Exosomes in a Metastatic Gastric Cancer Cell Line	PLOS ONE			English	Article							PERITONEAL DISSEMINATION; INTERCELLULAR TRANSFER; CIRCULATING MICRORNAS; MEMBRANE-VESICLES; TUMOR; SERUM; MICROVESICLES; BIOMARKERS; MARKER; EXPRESSION	Background: Exosomes play a major role in cell-to-cell communication, targeting cells to transfer exosomal molecules including proteins, mRNAs, and microRNAs (miRNAs) by an endocytosis-like pathway. miRNAs are small noncoding RNA molecules on average 22 nucleotides in length that regulate numerous biological processes including cancer pathogenesis and mediate gene down-regulation by targeting mRNAs to induce RNA degradation and/or interfering with translation. Recent reports imply that miRNAs can be stably detected in circulating plasma and serum since miRNAs are packaged by exosomes to be protected from RNA degradation. Thus, profiling exosomal miRNAs are in need to clarify intercellular signaling and discover a novel disease marker as well. Methodology/Principal Findings: Exosomes were isolated from cultured cancer cell lines and their quality was validated by analyses of transmission electron microscopy and western blotting. One of the cell lines tested, a metastatic gastric cancer cell line, AZ-P7a, showed the highest RNA yield in the released exosomes and distinctive shape in morphology. In addition, RNAs were isolated from cells and culture media, and profiles of these three miRNA fractions were obtained using microarray analysis. By comparing signal intensities of microarray data and the following validation using RT-PCR analysis, we found that let-7 miRNA family was abundant in both the intracellular and extracellular fractions from AZ-P7a cells, while low metastatic AZ-521, the parental cell line of AZ-P7a, as well as other cancer cell lines showed no such propensity. Conclusions/Significance: The enrichment of let-7 miRNA family in the extracellular fractions, particularly, in the exosomes from AZ-P7a cells may reflect their oncogenic characteristics including tumorigenesis and metastasis. Since let-7 miRNAs generally play a tumor-suppressive role as targeting oncogenes such as RAS and HMGA2, our results suggest that AZ-P7a cells release let-7 miRNAs via exosomes into the extracellular environment to maintain their oncogenesis.	[Ohshima, Keiichi; Inoue, Kanako; Fujiwara, Akemi; Hatakeyama, Keiichi; Kanto, Kaori; Watanabe, Yuko; Ogura, Shun-ichiro; Mochizuki, Tohru] Shizuoka Canc Ctr Res Inst, Div Med Genet, Shizuoka, Japan; [Muramatsu, Koji] Shizuoka Canc Ctr Hosp, Div Pathol, Shizuoka, Japan; [Fukuda, Yorikane] Tokyo Univ Agr & Technol, Grad Sch Engn, Div Biotechnol & Life Sci, Tokyo, Japan; [Yamaguchi, Ken] Shizuoka Canc Ctr Hosp & Res Inst, Shizuoka, Japan	Shizuoka Cancer Center; Shizuoka Cancer Center; Tokyo University of Agriculture & Technology; Shizuoka Cancer Center	Ohshima, K (corresponding author), Shizuoka Canc Ctr Res Inst, Div Med Genet, Shizuoka, Japan.	k.ohshima@scchr.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by a grant in cooperation with Innovative Technology and Advanced Research in Evolutional Area (CITY AREA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2007, EXPERT REV MOL DIAGN, V7, P569, DOI 10.1586/14737159.7.5.569; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Fukui R, 2005, J SURG RES, V129, P94, DOI 10.1016/j.jss.2005.04.030; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hanke M, UROL ONCOL IN PRESS; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ichim TE, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-37; Iinuma H, 2002, INT J CANCER, V99, P130, DOI 10.1002/ijc.10242; Ji H, 2008, ELECTROPHORESIS, V29, P2660, DOI 10.1002/elps.200800015; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nishimori H, 2000, JPN J CANCER RES, V91, P715, DOI 10.1111/j.1349-7006.2000.tb01004.x; Ogura S, 2008, PROTEOM CLIN APPL, V2, P1620, DOI 10.1002/prca.200800039; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; POUTSIAKA DD, 1985, J IMMUNOL, V134, P138; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sasaki K, 2002, CANCER RES, V62, P4894; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Xiao WH, 2010, WORLD J GASTROENTERO, V16, P2371, DOI 10.3748/wjg.v16.i19.2371	43	446	487	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13247	10.1371/journal.pone.0013247	http://dx.doi.org/10.1371/journal.pone.0013247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949044	Green Published, gold, Green Submitted			2022-12-25	WOS:000282676700018
J	Duquette, PM; Zhou, X; Yap, NL; MacLaren, EJ; Lu, JJ; Wallace, VA; Chen, HH				Duquette, Philippe M.; Zhou, Xun; Yap, Nida Lerma; MacLaren, Erik J.; Lu, Jesse J.; Wallace, Valerie A.; Chen, Hsiao-Huei			Loss of LMO4 in the Retina Leads to Reduction of GABAergic Amacrine Cells and Functional Deficits	PLOS ONE			English	Article							NEURAL-TUBE CLOSURE; LIM DOMAIN; NEGATIVE REGULATION; FATE SPECIFICATION; PROGENITOR CELLS; CEREBRAL-CORTEX; MOTOR-NEURON; PROTEIN LMO4; INNER-EAR; TRANSCRIPTION	Background: LMO4 is a transcription cofactor expressed during retinal development and in amacrine neurons at birth. A previous study in zebrafish reported that morpholino RNA ablation of one of two related genes, LMO4b, increases the size of eyes in embryos. However, the significance of LMO4 in mammalian eye development and function remained unknown since LMO4 null mice die prior to birth. Methodology/Principal Findings: We observed the presence of a smaller eye and/or coloboma in similar to 40% LMO4 null mouse embryos. To investigate the postnatal role of LMO4 in retinal development and function, LMO4 was conditionally ablated in retinal progenitor cells using the Pax6 alpha-enhancer Cre/LMO4flox mice. We found that these mice have fewer Bhlhb5-positive GABAergic amacrine and OFF-cone bipolar cells. The deficit appears to affect the postnatal wave of Bhlhb5+ neurons, suggesting a temporal requirement for LMO4 in retinal neuron development. In contrast, cholinergic and dopaminergic amacrine, rod bipolar and photoreceptor cell numbers were not affected. The selective reduction in these interneurons was accompanied by a functional deficit revealed by electroretinography, with reduced amplitude of b-waves, indicating deficits in the inner nuclear layer of the retina. Conclusions/Significance: Inhibitory GABAergic interneurons play a critical function in controlling retinal image processing, and are important for neural networks in the central nervous system. Our finding of an essential postnatal function of LMO4 in the differentiation of Bhlhb5-expressing inhibitory interneurons in the retina may be a general mechanism whereby LMO4 controls the production of inhibitory interneurons in the nervous system.	[Duquette, Philippe M.; Zhou, Xun; Yap, Nida Lerma; MacLaren, Erik J.; Lu, Jesse J.; Chen, Hsiao-Huei] Ottawa Hosp Res Inst, Ctr Stroke Recovery, Ottawa, ON, Canada; [Wallace, Valerie A.] Ottawa Hosp Res Inst, Program Mol Med, Ottawa, ON, Canada; [Wallace, Valerie A.; Chen, Hsiao-Huei] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Chen, Hsiao-Huei] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Wallace, Valerie A.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Wallace, Valerie A.] Univ Ottawa, Inst Eye, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Duquette, PM (corresponding author), Ottawa Hosp Res Inst, Ctr Stroke Recovery, Ottawa, ON, Canada.	hchen@uottawa.ca		Chen, Hsiao-Huei/0000-0003-2914-6057	Ontario Ministry of Research and Innovation; Canada Foundation for Innovation; CIHR [MOP-179197, RMF92100]; Heart and Stroke Foundation of Canada; Foundation Fighting Blindness and Stem Cell Network of Canada; Ontario Graduate Scholarship	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Foundation Fighting Blindness and Stem Cell Network of Canada; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by an Early Researcher Award from the Ontario Ministry of Research and Innovation (HHC), by infrastructure support from the Ontario Research Fund (HHC) and the Canada Foundation for Innovation (HHC), and by CIHR grants (MOP-179197). HHC is a recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada. VAW is supported by CIHR (RMF92100), Foundation Fighting Blindness and Stem Cell Network of Canada. PMD is a recipient of an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado DM, 2009, DEV DYNAM, V238, P3093, DOI 10.1002/dvdy.22149; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bramblett DE, 2004, NEURON, V43, P779, DOI 10.1016/j.neuron.2004.08.032; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Chen HH, 2002, DEVELOPMENT, V129, P4879; de la Calle-Mustienes E, 2003, DEV BIOL, V264, P564, DOI 10.1016/j.ydbio.2003.09.002; Deng M, 2010, DEV BIOL, V338, P38, DOI 10.1016/j.ydbio.2009.11.003; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Gomez-Smith M, 2010, CELL MOL LIFE SCI, V67, P949, DOI 10.1007/s00018-009-0223-z; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Inoue T, 2002, DEVELOPMENT, V129, P831; Joshi K, 2009, NEURON, V61, P839, DOI 10.1016/j.neuron.2009.02.011; Joshi PS, 2008, NEURON, V60, P258, DOI 10.1016/j.neuron.2008.08.006; Kashani AH, 2006, J NEUROSCI, V26, P8398, DOI 10.1523/JNEUROSCI.0618-06.2006; Kubo F, 2009, DEVELOPMENT, V136, P1823, DOI 10.1242/dev.029272; Lee SK, 2005, MOL CELL NEUROSCI, V28, P205, DOI 10.1016/j.mcn.2004.04.010; Leonard KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000314; Liu H, 2007, DEV BIOL, V308, P54, DOI 10.1016/j.ydbio.2007.04.052; Manetopoulos C, 2003, BIOCHEM BIOPH RES CO, V307, P891, DOI 10.1016/S0006-291X(03)01298-1; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; McCollum CW, 2007, DEV BIOL, V309, P373, DOI 10.1016/j.ydbio.2007.07.004; Medina CF, 2009, HUM MOL GENET, V18, P966, DOI 10.1093/hmg/ddn424; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; Morrow EM, 1999, DEVELOPMENT, V126, P23; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Schock SC, 2008, J NEUROSCI, V28, P12433, DOI 10.1523/JNEUROSCI.2897-08.2008; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Song MR, 2009, DEVELOPMENT, V136, P2923, DOI 10.1242/dev.037986; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Tse E, 2004, MOL CELL BIOL, V24, P2063, DOI 10.1128/MCB.24.5.2063-2073.2004; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wallace VA, 2008, BRAIN RES, V1192, P61, DOI 10.1016/j.brainres.2007.06.018; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465	39	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13232	10.1371/journal.pone.0013232	http://dx.doi.org/10.1371/journal.pone.0013232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949055	gold, Green Submitted, Green Published			2022-12-25	WOS:000282633700018
J	Berentzen, TL; Jakobsen, MU; Halkjaer, J; Tjonneland, A; Overvad, K; Sorensen, TIA				Berentzen, Tina Landsvig; Jakobsen, Marianne Uhre; Halkjaer, Jytte; Tjonneland, Anne; Overvad, Kim; Sorensen, Thorkild I. A.			Changes in Waist Circumference and Mortality in Middle-Aged Men and Women	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; FAT-FREE MASS; FOOD FREQUENCY QUESTIONNAIRE; INTENTIONAL WEIGHT-LOSS; 2ND NATIONAL-HEALTH; FOLLOW-UP; PROSPECTIVE COHORT; HIP CIRCUMFERENCE; VISCERAL FAT	Background: Waist circumference (WC) adjusted for body mass index (BMI) is positively associated with mortality, but the association with changes in WC is less clear. We investigated the association between changes in WC and mortality in middle-aged men and women, and evaluated the influence from concurrent changes in BMI. Methodology/Principal Findings: Data on 26,625 healthy men and women from the Danish Diet, Cancer and Health study was analyzed. WC and BMI were assessed in 1993-97 and in 1999-02. Information on mortality was obtained by linkage to the Danish central Person Register. Hazard ratios (HR) were estimated with Cox regression models. During 6.7 years of follow-up, 568 and 361 deaths occurred among men and women, respectively. Changes in WC were positively associated with mortality (HR per 5 cm for the sexes combined = 1.09 (1.02:1.16) with adjustment for covariates, baseline WC, BMI and changes in BMI), whereas changes in BMI were inversely associated with mortality (HR per kg/m2 for the sexes combined = 0.91 (0.86, 0.97) with adjustment for covariates, baseline WC, BMI and changes in WC). Associations between changes in WC and mortality were not notably different in sub-groups stratified according to changes in BMI, baseline WC or when smokers or deaths occurring within the first years of follow-up were excluded. Conclusions/Significance: Changes in WC were positively associated with mortality in healthy middle-aged men and women throughout the range of concurrent changes in BMI. These findings suggest a need for development of prevention and treatment strategies targeted against redistribution of fat mass towards the abdominal region.	[Berentzen, Tina Landsvig; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Ctr Hlth & Soc, Copenhagen, Denmark; [Jakobsen, Marianne Uhre; Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg, Denmark; [Jakobsen, Marianne Uhre; Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark	University of Copenhagen; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Danish Cancer Society	Berentzen, TL (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Ctr Hlth & Soc, Copenhagen, Denmark.	tb@ipm.regionh.dk	Jakobsen, Marianne Uhre/I-8550-2018	Jakobsen, Marianne Uhre/0000-0001-6518-4136; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097	European Commission [LSHM-CT-2005-018734]; Danish Council for Strategic Research [2101-06-0005]; Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen	This work is part of the project Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP; www.hepadip.org), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme (contract LSHM-CT-2005-018734), and part of the research program of the Danish Obesity Research Centre (DanORC; www.danorc.dk), which is supported by the Danish Council for Strategic Research (contract 2101-06-0005). Funding was also obtained from The Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; Andersen TF, 1999, DAN MED BULL, V46, P263; Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502507, 10.1111/j.1753-4887.2006.tb00183.x]; Bigaard J, 2005, J NUTR, V135, P2263; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Coffey CS, 2005, STAT MED, V24, P941, DOI 10.1002/sim.1964; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Fontaine K R, 2001, Eat Behav, V2, P87, DOI 10.1016/S1471-0153(01)00024-1; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gupta AK, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-36; Harrel jF, 2002, APPL LINEAR MODELS L; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Heitmann BL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3292; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; Kristensen JK, 2001, DAN MED BULL, V48, P33; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Mikkelsen KL, 1999, EPIDEMIOLOGY, V10, P671, DOI 10.1097/00001648-199911000-00005; Myrskyla M, 2009, EPIDEMIOLOGY, V20, P840, DOI 10.1097/EDE.0b013e3181b5f520; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pischon T, 2010, INT J EPIDEMIOL, V39, P528, DOI 10.1093/ije/dyp388; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Simonsen MK, 2008, NUTR REV, V66, P375, DOI 10.1111/j.1753-4887.2008.00047.x; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhu SK, 2003, ANN EPIDEMIOL, V13, P286, DOI 10.1016/S1047-2797(02)00417-9	41	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13097	10.1371/journal.pone.0013097	http://dx.doi.org/10.1371/journal.pone.0013097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927346	gold, Green Published, Green Submitted			2022-12-25	WOS:000282312600025
J	Hsu, CT; Patton, DF; Mistlberger, RE; Steele, AD				Hsu, Cynthia T.; Patton, Danica F.; Mistlberger, Ralph E.; Steele, Andrew D.			Palatable Meal Anticipation in Mice	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; ACCUMBENS SHELL; C57BL/6J MICE; FOOD; RATS; DOPAMINE; REWARD; ENTRAINMENT; MECHANISMS; ZEITGEBER	The ability to sense time and anticipate events is a critical skill in nature. Most efforts to understand the neural and molecular mechanisms of anticipatory behavior in rodents rely on daily restricted food access, which induces a robust increase of locomotor activity in anticipation of daily meal time. Interestingly, rats also show increased activity in anticipation of a daily palatable meal even when they have an ample food supply, suggesting a role for brain reward systems in anticipatory behavior, and providing an alternate model by which to study the neurobiology of anticipation in species, such as mice, that are less well adapted to "stuff and starve'' feeding schedules. To extend this model to mice, and exploit molecular genetic resources available for that species, we tested the ability of wild-type mice to anticipate a daily palatable meal. We observed that mice with free access to regular chow and limited access to highly palatable snacks of chocolate or "Fruit Crunchies'' avidly consumed the snack but did not show anticipatory locomotor activity as measured by running wheels or video-based behavioral analysis. However, male mice receiving a snack of high fat chow did show increased food bin entry prior to access time and a modest increase in activity in the two hours preceding the scheduled meal. Interestingly, female mice did not show anticipation of a daily high fat meal but did show increased activity at scheduled mealtime when that meal was withdrawn. These results indicate that anticipation of a scheduled food reward in mice is behavior, diet, and gender specific.	[Hsu, Cynthia T.; Steele, Andrew D.] CALTECH, Div Biol, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Patton, Danica F.; Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	California Institute of Technology; Simon Fraser University	Hsu, CT (corresponding author), CALTECH, Div Biol, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA.	mistlber@sfu.ca; steelea@caltech.edu			Ellison Medical Foundation; Eating Disorders Research Klarman Family Foundation; Natural Sciences and Engineering Research Council of Canada	Ellison Medical Foundation(Lawrence Ellison Foundation); Eating Disorders Research Klarman Family Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Broad Fellows in Brain Circuitry Program at Caltech (ADS), an Ellison Medical Foundation New Scholar Award (ADS), a Grants Program in Eating Disorders Research Klarman Family Foundation (ADS), and an operating grant (REM) and Postgraduate Scholarship (DFP) from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1989, PHYSIOL BEHAV, V45, P397, DOI 10.1016/0031-9384(89)90146-7; Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Antle MC, 2009, EUR J NEUROSCI, V30, P1643, DOI 10.1111/j.1460-9568.2009.06959.x; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; Caba M, 2009, EUR J NEUROSCI, V30, P1697, DOI 10.1111/j.1460-9568.2009.06964.x; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Hsu JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011802; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Mendoza J, 2005, NEUROSCIENCE, V133, P293, DOI 10.1016/j.neuroscience.2005.01.064; Mendoza J, 2005, BEHAV BRAIN RES, V158, P133, DOI 10.1016/j.bbr.2004.08.016; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1988, J BIOL RHYTHM, V3, P277, DOI 10.1177/074873048800300306; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; SAHR AE, 2008, AM J PHYSIOL-REG I, V463, pR463; SHIBATA S, 1995, J PHARMACOL EXP THER, V274, P688; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Stephan FK, 1998, PHYSIOL BEHAV, V65, P277, DOI 10.1016/S0031-9384(98)00166-8; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Webb IC, 2009, EUR J NEUROSCI, V30, P1739, DOI 10.1111/j.1460-9568.2009.06966.x	30	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12903	10.1371/journal.pone.0012903	http://dx.doi.org/10.1371/journal.pone.0012903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941366	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000282312600009
J	Coelho, PMBM; Salvador, A; Savageau, MA				Coelho, Pedro M. B. M.; Salvador, Armindo; Savageau, Michael A.			Relating Mutant Genotype to Phenotype via Quantitative Behavior of the NADPH Redox Cycle in Human Erythrocytes	PLOS ONE			English	Article							HEXOSE-MONOPHOSPHATE SHUNT; G6PD DEFICIENCY; GLUCOSE-6-PHOSPHATE DEHYDROGENASE; PLASMODIUM-FALCIPARUM; OXIDATIVE STRESS; SEVERE MALARIA; BLOOD-CELLS; RESISTANCE; ENZYME; SUSCEPTIBILITY	Background: The NADPH redox cycle plays a key role in antioxidant protection of human erythrocytes. It consists of two enzymes: glucose-6-phosphate dehydrogenase (G6PD) and glutathione reductase. Over 160 G6PD variants have been characterized and associated with several distinct clinical manifestations. However, the mechanistic link between the genotype and the phenotype remains poorly understood. Methodology/Principal Findings: We address this issue through a novel framework (design space) that integrates information at the genetic, biochemical and clinical levels. Our analysis predicts three qualitatively-distinct phenotypic regions that can be ranked according to fitness. When G6PD variants are analyzed in design space, a correlation is revealed between the phenotypic region and the clinical manifestation: the best region with normal physiology, the second best region with a pathology, and the worst region with a potential lethality. We also show that Plasmodium falciparum, by induction of its own G6PD gene in G6PD-deficient erythrocytes, moves the operation of the cycle to a region of the design space that yields robust performance. Conclusions/Significance: In conclusion, the design space for the NADPH redox cycle, which includes relationships among genotype, phenotype and environment, illuminates the function, design and fitness of the cycle, and its phenotypic regions correlate with the organism's clinical status.	[Coelho, Pedro M. B. M.] Univ Coimbra, Dept Chem, Biol Chem Grp, Coimbra, Portugal; [Coelho, Pedro M. B. M.; Savageau, Michael A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Salvador, Armindo] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal	Universidade de Coimbra; University of California System; University of California Davis; Universidade de Coimbra	Coelho, PMBM (corresponding author), Univ Coimbra, Dept Chem, Biol Chem Grp, Coimbra, Portugal.	masavageau@ucdavis.edu	Salvador, Armindo/I-3469-2012; Coelho, Paulo Marcos Zech/ABE-6169-2021	Salvador, Armindo/0000-0002-4442-4900; Coelho, Paulo Marcos Zech/0000-0002-2443-8897; Coelho, Pedro/0000-0002-8192-4621	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/8304/2002, PTDC/QUI/70523/2006]; US Public Health Service [RO1- GM30054]; Center for Non-Linear Studies of the Los Alamos National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030054] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Center for Non-Linear Studies of the Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a fellowship to PMBMC (SFRH/BD/8304/2002) from Fundacao para a Ciencia e Tecnologia, Portugal, and by grants to AS (PTDC/QUI/70523/2006) from Fundacao para a Ciencia e Tecnologia (http://alfa.fct.mctes.pt), Portugal, and to MAS (RO1- GM30054) from the US Public Health Service (http://www.nigms.nih.gov) and a Stanislaw Ulam Distinguished Scholar Award from the Center for Non-Linear Studies of the Los Alamos National Laboratory (http://cnls.lanl.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell M.L.L., 1999, STAT MATH; ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; ATAMNA H, 1994, MOL BIOCHEM PARASIT, V67, P79, DOI 10.1016/0166-6851(94)90098-1; BERKOWITZ FE, 1991, REV INFECT DIS, V13, P1151; BEUTLER E, 1990, SEMIN HEMATOL, V27, P137; Beutler E., 1984, GLUTATHIONE RED CELL; BIENZLE U, 1972, LANCET, V1, P107; BIENZLE U, 1979, AM J TROP MED HYG, V28, P619, DOI 10.4269/ajtmh.1979.28.619; BUCKWITZ D, 1986, BIOMED BIOCHIM ACTA, V45, P429; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cheng YS, 1999, J BIOMED SCI, V6, P106, DOI 10.1159/000025377; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Coelho PMBM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000319; Cook GC., 2009, DISEASES-BASEL, DOI [10.1016/B978-1-4160-4470-3.50014-8, DOI 10.1016/B978-1-4160-4470-3.50014-8]; Fiorelli G, 2000, BEST PRACT RES CL HA, V13, P39, DOI 10.1053/beha.1999.0056; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Johnson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007246; KIRKMAN HN, 1980, J LAB CLIN MED, V95, P877; Lell B, 1999, CLIN INFECT DIS, V28, P794, DOI 10.1086/515193; Mason PJ, 2007, BLOOD REV, V21, P267, DOI 10.1016/j.blre.2007.05.002; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; Mulquiney PJ, 1999, BIOCHEM J, V342, P581, DOI 10.1042/0264-6021:3420581; Murray CK, 2006, MIL MED, V171, P905, DOI 10.7205/MILMED.171.9.905; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Parikh S, 2004, AM J TROP MED HYG, V71, P750, DOI 10.4269/ajtmh.2004.71.750; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Salvador A, 2006, P NATL ACAD SCI USA, V103, P2226, DOI 10.1073/pnas.0510776103; Salvador A, 2003, P NATL ACAD SCI USA, V100, P14463, DOI 10.1073/pnas.2335687100; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Savageau MA, 2009, FEBS LETT, V583, P3914, DOI 10.1016/j.febslet.2009.10.073; Savageau MA, 2009, P NATL ACAD SCI USA, V106, P6435, DOI 10.1073/pnas.0809869106; THORBURN DR, 1985, EUR J BIOCHEM, V150, P371, DOI 10.1111/j.1432-1033.1985.tb09030.x; USANGA EA, 1985, NATURE, V313, P793, DOI 10.1038/313793a0; WORTHINGTON DJ, 1976, EUR J BIOCHEM, V67, P231, DOI 10.1111/j.1432-1033.1976.tb10654.x; YOSHIDA A, 1987, BLOOD, V69, P1528; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	43	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13031	10.1371/journal.pone.0013031	http://dx.doi.org/10.1371/journal.pone.0013031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927393	Green Published, gold, Green Submitted			2022-12-25	WOS:000282210700012
J	Khau, T; Langenbach, SY; Schuliga, M; Harris, T; Johnstone, CN; Anderson, RL; Stewart, AG				Khau, Thippadey; Langenbach, Shenna Y.; Schuliga, Michael; Harris, Trudi; Johnstone, Cameron N.; Anderson, Robin L.; Stewart, Alastair G.			Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2	FASEB JOURNAL			English	Article						MCF-7; cell cycle; cyclin D; apoptosis; estradiol; lipoxin A(4)	A1 DOWN-REGULATION; CYCLE PROGRESSION; GROWTH ARREST; GLIOMA-CELLS; IN-VIVO; EXPRESSION; CANCER; DIFFERENTIATION; ESTROGEN; LIGAND	The role of the calcium-and phospholipid-binding protein annexin I (ANXA1) in cell cycle regulation has been investigated in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast tumor cell lines. In MCF-7 cells, ANXA1-targeting small interfering RNA (siRNA) reduced ANXA1 mRNA and protein levels and attenuated cell proliferation induced by FCS, estradiol, or epidermal growth factor. Well-characterized agonists for the known ANXA1 receptor, FPR2, including the ANXA1 N-terminal proteolytic product ANXA1(2-26), lipoxin A(4) (LXA(4)), and the synthetic peptide, Trp-Lys-Tyr-Met-Val-D-Met (WKYMVm), stimulated proliferation of MCF-7 and MDA-MB-231 cells that was attenuated by incubation with FPR2 antagonists WRW4 (1 mu M) or Boc2 (100 nM) or by siRNA against FPR2. FCS-induced mitogenic responses were attenuated by each of the FPR antagonists and by siRNA against FPR2 and, to a lesser extent, FPR1. LXA(4) increased phosphorylation of Akt, p70(S6K) but not ERK1/2. Increases in cyclin D1 protein induced by FCS or LXA(4) were blocked by the PI3 kinase inhibitor, LY294002, and attenuated by FPR2 antagonism using Boc2. In invasive breast cancer, immunohistochemistry revealed the presence of ANXA1 and its receptor, FPR2, in both tumor epithelium and stromal cells. These observations suggest a novel signaling role for ANXA1 in mitogen-activated proliferation of breast tumor epithelial cells that is mediated via activation of FPR1 and FPR2.-Khau, T., Langenbach, S. Y., Schuliga, M., Harris, T., Johnstone, C. N., Anderson, R. L., Stewart, A. G. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2. FASEB J. 25, 483-496 (2011). www.fasebj.org	[Khau, Thippadey; Langenbach, Shenna Y.; Schuliga, Michael; Harris, Trudi; Stewart, Alastair G.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia; [Anderson, Robin L.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Johnstone, Cameron N.; Anderson, Robin L.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Peter Maccallum Cancer Center	Stewart, AG (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville Campus,Level 8 Med Bldg,Grattan St, Parkville, Vic 3010, Australia.	astew@unimelb.edu.au	Schuliga, Michael/ABC-4802-2021; Anderson, Robin/I-2306-2013; Anderson, Robin/K-6966-2019; Anderson, Robin/S-1005-2017	Schuliga, Michael/0000-0001-6742-5028; stewart, alastair/0000-0002-2271-5942; Anderson, Robin/0000-0002-6841-7422	Australia National Health and Medical Research Council [566776]; National Breast Cancer Foundation	Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This work was supported a grant from the Australia National Health and Medical Research Council (566776) and by a fellowship from the National Breast Cancer Foundation to R.L.A.	Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620; Ang EZF, 2009, MOL CANCER RES, V7, P266, DOI 10.1158/1541-7786.MCR-08-0147; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bae YS, 2004, J IMMUNOL, V173, P607, DOI 10.4049/jimmunol.173.1.607; Bae YS, 2003, MOL PHARMACOL, V64, P721, DOI 10.1124/mol.64.3.721; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; BLACKWELL GJ, 1980, NATURE, V287, P147, DOI 10.1038/287147a0; Byford JR, 2002, J STEROID BIOCHEM, V80, P49, DOI 10.1016/S0960-0760(01)00174-1; Cao Y, 2008, APPL IMMUNOHISTO M M, V16, P530, DOI 10.1097/PAI.0b013e31817432c3; Castro-Caldas M, 2001, MEDIAT INFLAMM, V10, P245, DOI 10.1080/09629350120093713; Chang HL, 2009, ANTICANCER RES, V29, P3195; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; CROXTALL JD, 1992, P NATL ACAD SCI USA, V89, P3571, DOI 10.1073/pnas.89.8.3571; de Coupade C, 2000, HEPATOLOGY, V31, P371, DOI 10.1002/hep.510310217; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; DICKER P, 1980, NATURE, V287, P607, DOI 10.1038/287607a0; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; Frey BM, 1999, FASEB J, V13, P2235, DOI 10.1096/fasebj.13.15.2235; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Gavins FNE, 2005, PROSTAG LEUKOTR ESS, V73, P211, DOI 10.1016/j.plefa.2005.05.008; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Horman S, 2000, CELL PROLIFERAT, V33, P331, DOI 10.1046/j.1365-2184.2000.00188.x; Huang J, 2008, CANCER LETT, V267, P254, DOI 10.1016/j.canlet.2008.03.014; Huo XF, 2005, BIOCHEM BIOPH RES CO, V331, P1346, DOI 10.1016/j.bbrc.2005.04.049; Khau T, 2008, EJC SUPPL, V6, P118, DOI 10.1016/S1359-6349(08)72309-7; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Maggiolini M, 2002, J STEROID BIOCHEM, V82, P315, DOI 10.1016/S0960-0760(02)00230-3; MCLEOD JD, 1995, BIOCHEM PHARMACOL, V50, P1103, DOI 10.1016/0006-2952(95)00234-Q; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Minghetti L, 1999, BRIT J PHARMACOL, V126, P1307, DOI 10.1038/sj.bjp.0702423; Mitchell D, 2004, AM J PATHOL, V164, P937, DOI 10.1016/S0002-9440(10)63181-1; Mulla A, 2004, CLIN ENDOCRINOL, V60, P107, DOI 10.1111/j.1365-2265.2004.01936.x; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paweletz CP, 2000, CANCER RES, V60, P6293; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; PEERS SH, 1993, BRIT J PHARMACOL, V108, P66, DOI 10.1111/j.1476-5381.1993.tb13441.x; Pencil SD, 1998, CLIN EXP METASTAS, V16, P113, DOI 10.1023/A:1021917017109; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Perretti M, 2001, AM J PATHOL, V158, P1969, DOI 10.1016/S0002-9440(10)64667-6; PERRETTI M, 1993, J IMMUNOL, V151, P4306; Roviezzo F, 2002, J PHYSIOL PHARMACOL, V53, P541; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; SCHLAEPFER DD, 1990, J CELL BIOL, V111, P229, DOI 10.1083/jcb.111.1.229; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Solito E, 2001, BRIT J PHARMACOL, V133, P217, DOI 10.1038/sj.bjp.0704054; SOTO AM, 1985, J STEROID BIOCHEM, V23, P87, DOI 10.1016/0022-4731(85)90265-1; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Sutherland TE, 2005, CLIN CANCER RES, V11, P1722, DOI 10.1158/1078-0432.CCR-04-1789; Vishwanatha JK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-8; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wang YA, 2008, INT J CANCER, V123, P1536, DOI 10.1002/ijc.23671; Yang D, 2001, J IMMUNOL, V166, P4092, DOI 10.4049/jimmunol.166.6.4092	63	80	87	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					483	496		10.1096/fj.09-154096	http://dx.doi.org/10.1096/fj.09-154096			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20930115				2022-12-25	WOS:000286724800007
J	Recchiuti, A; Krishnamoorthy, S; Fredman, G; Chiang, N; Serhan, CN				Recchiuti, Antonio; Krishnamoorthy, Sriram; Fredman, Gabrielle; Chiang, Nan; Serhan, Charles N.			MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits	FASEB JOURNAL			English	Article						GPCR; resolution indices; lipid mediators; 5-lipoxygenase; cytokines; transcription factors	ANTIINFLAMMATORY PROPERTIES; LIPID MEDIATORS; ASPIRIN; 5-LIPOXYGENASE; LEUKOTRIENES; EXPRESSION; LIPOXINS; TARGETS; D1	Mechanisms controlling resolution of acute inflammation are of wide interest. Here, we investigated microRNAs (miRNAs) in self-limited acute inflammatory exudates and their regulation by resolvin D1 (RvD1). Using real-time PCR analysis, we found in resolving exudates that miR-21, miR-146b, miR-208a, miR-203, miR-142, miR-302d, and miR-219 were selectively regulated (P<0.05) in self-limited murine peritonitis. RvD1 (300 ng/mouse or 15 mu g kg(-1)) reduced zymosan-elicited neutrophil infiltration into the peritoneum 25-50% and shortened the resolution interval (R-i) by similar to 4 h. In peritonitis at 12 h, RvD1 up-regulated miR-21, miR-146b, and miR-219 and down-regulated miR-208a in vivo. In human macrophages overexpressing recombinant RvD1 receptors ALX/FPR2 or GPR32, these same miRNAs were significantly regulated (P<0.05) by RvD1 at concentrations as low as 10 nM, recapitulating the in vivo circuit. In addition, RvD1-miRNAs identified herein target cytokines and proteins involved in the immune system, e. g., miR-146b targeted NF-kappa B signaling, and miR-219 targeted 5-lipoxygenase and reduced leukotriene production. RvD1 also reduced nuclear translocation of NF-kappa B and SMAD and down-regulated phospho-I kappa B. Taken together, these results indicate that resolvin-regulated specific miRNAs target genes involved in resolution and establish a novel resolution circuit involving RvD1 receptor-dependent regulation of specific miRNAs.-Recchiuti, A., Krishnamoorthy, S., Fredman, G., Chiang, N., and Serhan, C. N. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J. 25, 544-560 (2011). www.fasebj.org	[Serhan, Charles N.] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 77 Ave Louis Pasteur,Harvard Inst Med 829, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Chiang, Nan/ABA-4924-2021; Recchiuti, Antonio/K-7670-2016	Chiang, Nan/0000-0003-1963-1585; Recchiuti, Antonio/0000-0002-1409-5261	U.S. National Institutes of Health (NIH) [R37GM38765, R01DK074448, R01DE019938]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038765, R01GM038765] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Thad Vickery for LC-MS-MS lipidomics, Dr. Sungwhan F. Oh for generating the transcription factor heat map, Padmini S. Pillai for helping with animal experiments, and Mary H Small for assistance with manuscript preparation. The authors also acknowledge the Institute of Chemistry and Cell Biology (ICCB)-Longwood for the use of their real-time PCR equipment and IPA software license. This work was supported by U.S. National Institutes of Health (NIH) grants R37GM38765, R01DK074448, and R01DE019938. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Science, the National Institute of Diabetes and Digestive and Kidney Diseases, or the NIH. C.N.S. is the inventor on patents assigned to Brigham and Women's Hospital and Partners HealthCare on the composition of matter, uses, and clinical development of anti-inflammatory and proresolving lipid mediators. These are licensed for clinical development. C.N.S. retains founder stock in Resolvyx Pharmaceuticals.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bannenberg G, 2004, BRIT J PHARMACOL, V143, P43, DOI 10.1038/sj.bjp.0705912; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chiang N, 2004, P NATL ACAD SCI USA, V101, P15178, DOI 10.1073/pnas.0405445101; Clish CB, 1999, P NATL ACAD SCI USA, V96, P8247, DOI 10.1073/pnas.96.14.8247; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Dincbas-Renqvist V, 2009, BBA-GENE REGUL MECH, V1789, P99, DOI 10.1016/j.bbagrm.2008.10.002; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; MAJNO G, 1982, CURRENT TOPICS INFLA, P1; MAJNO G, 1982, CURRENT TOPICS INFLA, V23; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Prasad SVN, 2009, J BIOL CHEM, V284, P27487, DOI 10.1074/jbc.M109.036541; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Randolph GJ, 2009, J THROMB HAEMOST, V7, P28, DOI 10.1111/j.1538-7836.2009.03423.x; Rossi A, 2008, RESOLUTION INFLAMMAT; RYAN GB, 1977, AM J PATHOL, V86, P183; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2009, J THROMB HAEMOST, V7, P44, DOI 10.1111/j.1538-7836.2009.03396.x; Serhan CN, 2007, METHOD ENZYMOL, V432, P275, DOI 10.1016/S0076-6879(07)32012-0; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Winyard P. G., 2003, INFLAMMATION PROTOCO; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003	50	226	231	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					544	560		10.1096/fj.10-169599	http://dx.doi.org/10.1096/fj.10-169599			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20956612	Green Published			2022-12-25	WOS:000286724800013
J	Ozga, M; Dolot, R; Janicka, M; Kaczmarek, R; Krakowiak, A				Ozga, Magdalena; Dolot, Rafal; Janicka, Magdalena; Kaczmarek, Renata; Krakowiak, Agnieszka			Histidine Triad Nucleotide-binding Protein 1 (HINT-1) Phosphoramidase Transforms Nucleoside 5 '-O-Phosphorothioates to Nucleoside 5 '-O-Phosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-GROWTH; PHOSPHOROTHIOATE; OLIGONUCLEOTIDES; METABOLISM; BIODISTRIBUTION; PHOSPHODIESTER; PRONUCLEOTIDES; STABILITY; HYDROLASE; MECHANISM	Nucleoside 5'-O-phosphorothioates are formed in vivo as primary products of hydrolysis of oligo(nucleoside phosphorothioate)s (PS-oligos) that are applied as antisense therapeutic molecules. The biodistribution of PS-oligos and their pharmacokinetics have been widely reported, but little is known about their subsequent decay inside the organism. We suggest that the enzyme responsible for nucleoside 5'-O-monophosphorothioate ((d)NMPS) metabolism could be histidine triad nucleotide-binding protein 1 (Hint-1), a phosphoramidase belonging to the histidine triad (HIT) superfamily that is present in all forms of life. An additional, but usually ignored, activity of Hint-1 is its ability to catalyze the conversion of adenosine 5'-O-monophosphorothioate (AMPS) to 5'-O-monophosphate (AMP). By mutagenetic and biochemical studies, we defined the active site of Hint-1 and the kinetic parameters of the desulfuration reaction (P-S bond cleavage). Additionally, crystallographic analysis (resolution from 1.08 to 1.37 angstrom) of three engineered cysteine mutants showed the high similarity of their structures, which were not very different from the structure of WT Hint-1. Moreover, we found that not only AMPS but also other ribonucleoside and 2'-deoxyribonucleoside phosphorothioates are desulfurated by Hint-1 at the following relative rates: GMPS > AMPS > dGMPS >= CMPS > UMPS > dAMPS >> dCMPS > TMPS, and during the reaction, hydrogen sulfide, which is thought to be the third gaseous mediator, was released.	[Ozga, Magdalena; Dolot, Rafal; Janicka, Magdalena; Kaczmarek, Renata; Krakowiak, Agnieszka] Polish Acad Sci, Ctr Mol & Macromol Studies, Dept Bioorgan Chem, PL-90363 Lodz, Poland	Polish Academy of Sciences; Centre of Molecular & Macromolecular Studies of the Polish Academy of Sciences	Krakowiak, A (corresponding author), Sienkiewicza 112, PL-90363 Lodz, Poland.	akrakow@bio.cbmm.lodz.pl	Krakowiak, Agnieszka/ABC-8848-2020	Krakowiak, Agnieszka/0000-0002-0273-2972; Dolot, Rafal/0000-0002-2300-5264	Polish Ministry of Science and Higher Education [NN204130137, PBZ-MNiSW-07/I/2007]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Polish Ministry of Science and Higher Education Grants NN204130137 (to A.K.) and PBZ-MNiSW-07/I/2007 (2008-2010).	Abraham TW, 1996, J MED CHEM, V39, P4569, DOI 10.1021/jm9603680; AGRAWAL S, 1991, P NATL ACAD SCI USA, V88, P7595, DOI 10.1073/pnas.88.17.7595; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baraniak J, 2002, J ORG CHEM, V67, P7267, DOI 10.1021/jo026027d; Beltowski Jerzy, 2004, Postepy Hig Med Dosw (Online), V58, P285; Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1997, NAT STRUCT BIOL, V4, P231, DOI 10.1038/nsb0397-231; BRESLOW R, 1968, J AM CHEM SOC, V90, P7376, DOI 10.1021/ja01028a054; Cahard D, 2004, MINI-REV MED CHEM, V4, P371; CHLEBOWSKI JF, 1974, J BIOL CHEM, V249, P7192; Chou TF, 2007, MOL PHARMACEUT, V4, P208, DOI 10.1021/mp060070y; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dias N, 2002, MOL CANCER THER, V1, P347; ECKSTEIN F, 1989, TRENDS BIOCHEM SCI, V14, P97, DOI 10.1016/0968-0004(89)90130-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gilar M, 1997, NUCLEIC ACIDS RES, V25, P3615, DOI 10.1093/nar/25.18.3615; Guranowski A, 2010, NEW J CHEM, V34, P888, DOI 10.1039/b9nj00660e; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Koziolkiewicz M, 1997, ANTISENSE NUCLEIC A, V7, P43, DOI 10.1089/oli.1.1997.7.43; Koziolkiewicz M, 2001, BLOOD, V98, P995, DOI 10.1182/blood.V98.4.995; Krakowiak A, 2004, J BIOL CHEM, V279, P18711, DOI 10.1074/jbc.M314271200; Krakowiak A, 2007, CHEM COMMUN, P2163, DOI 10.1039/b615160d; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li H, 2006, ONCOGENE, V25, P713, DOI 10.1038/sj.onc.1209111; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; Lowicka E, 2007, PHARMACOL REP, V59, P4; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mirandola P, 2007, J CELL PHYSIOL, V213, P826, DOI 10.1002/jcp.21151; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SANDS H, 1994, MOL PHARMACOL, V45, P932; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; Temsamani J, 1997, ANTISENSE NUCLEIC A, V7, P159, DOI 10.1089/oli.1.1997.7.159; Vaerman JL, 1997, BLOOD, V90, P331; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wagner CR, 2000, MED RES REV, V20, P417, DOI 10.1002/1098-1128(200011)20:6<417::AID-MED1>3.0.CO;2-Z; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Wojcik M, 2007, OLIGONUCLEOTIDES, V17, P134, DOI 10.1089/oli.2007.0021; Yuan BZ, 2004, NEOPLASIA, V6, P412, DOI 10.1593/neo.03490; Zemlicka J, 2002, BBA-MOL BASIS DIS, V1587, P276, DOI 10.1016/S0925-4439(02)00090-X; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; ZON G, 1988, PHARM RES-DORDR, V5, P539, DOI 10.1023/A:1015985728434	50	30	35	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40809	40818		10.1074/jbc.M110.162065	http://dx.doi.org/10.1074/jbc.M110.162065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20940308	hybrid, Green Published			2022-12-25	WOS:000285414400046
J	Prasad, R; Shock, DD; Beard, WA; Wilson, SH				Prasad, Rajendra; Shock, David D.; Beard, William A.; Wilson, Samuel H.			Substrate Channeling in Mammalian Base Excision Repair Pathways: Passing the Baton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; DEOXYRIBOSE PHOSPHATE LYASE; LIGASE-I; BOVINE TESTIS; IDENTIFICATION; MECHANISM; CELLS; RECONSTITUTION; BINDING; PROTEIN	The current model for base excision repair (BER) involves two general sub-pathways termed single-nucleotide BER and long patch BER that are distinguished by their repair patch sizes and the enzymes/co-factors involved. Both sub-pathways involve a series of sequential steps from initiation to completion of repair. The BER sub-pathways are designed to sequester the various intermediates, passing them along from one step to the next without allowing these toxic molecules to trigger cell cycle arrest, necrotic cell death, or apoptosis. Although a variety of DNA-protein and protein-protein interactions are known for the BER intermediates and enzymes/co-factors, the molecular mechanisms accounting for step-to-step coordination are not well understood. In the present study we designed an in vitro assay to explore the question of whether there is a channeling or "hand-off" of the repair intermediates during BER in vitro. The results show that when BER enzymes are pre-bound to the initial single-nucleotide BER intermediate, the DNA is channeled from apurinic/apyrimidinic endonuclease 1 to DNA polymerase beta and then to DNA ligase. In the long patch BER subpathway, where the 5'-end of the incised strand is blocked, the intermediate after DNA polymerase beta gap filling is not channeled to the subsequent enzyme, flap endonuclease 1. Instead, flap endonuclease 1 must recognize and bind to the intermediate in competition with other molecules.	[Prasad, Rajendra; Shock, David D.; Beard, William A.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	National Institutes of Health Research [Z01-ES050158, Z01-ES050159]; NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050159, ZIAES050158, Z01ES050158, Z01ES050159] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Research Projects Z01-ES050158 and Z01-ES050159 in the Intramural Research Program of the NIEHS.	Asagoshi K, 2010, DNA REPAIR, V9, P109, DOI 10.1016/j.dnarep.2009.11.002; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; CASASFINET JR, 1991, J BIOL CHEM, V266, P19618; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; DOETSCH PW, 1986, BIOCHEMISTRY-US, V25, P2212, DOI 10.1021/bi00356a054; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; Donny W, 2004, J BIOL CHEM, V279, P25268, DOI 10.1074/jbc.M400804200; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; KUMAR A, 1990, J BIOL CHEM, V265, P2124; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Parikh Sudip S., 1999, Current Opinion in Structural Biology, V9, P37, DOI 10.1016/S0959-440X(99)80006-2; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 2005, DNA REPAIR, V4, P1347, DOI 10.1016/j.dnarep.2005.08.009; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Tomkinson AE, 2001, PROG NUCLEIC ACID RE, V68, P151; WANG YCJ, 1994, J BIOL CHEM, V269, P31923; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	44	110	110	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40479	40488		10.1074/jbc.M110.155267	http://dx.doi.org/10.1074/jbc.M110.155267			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952393	Green Published, hybrid			2022-12-25	WOS:000285414400010
J	Zhou, J; Liu, Y; Zhang, W; Popov, VM; Wang, M; Pattabiraman, N; Sune, C; Cvekl, A; Wu, KM; Jiang, J; Wang, CG; Pestell, RG				Zhou, Jie; Liu, Yang; Zhang, Wei; Popov, Vladimir M.; Wang, Min; Pattabiraman, Nagarajan; Sune, Carlos; Cvekl, Ales; Wu, Kongming; Jiang, Jie; Wang, Chenguang; Pestell, Richard G.			Transcription Elongation Regulator 1 Is a Co-integrator of the Cell Fate Determination Factor Dachshund Homolog 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; DETERMINATION FACTOR DACH1; ECTOPIC EYE DEVELOPMENT; CYCLIN D1; ALTERED EXPRESSION; BREAST-CANCER; PROTEIN; CA150; DROSOPHILA; GROWTH	DACH1 (Dachshund homolog 1) is a key component of the retinal determination gene network and regulates gene expression either indirectly as a co-integrator or through direct DNA binding. The current studies were conducted to understand, at a higher level of resolution, the mechanisms governing DACH1-mediated transcriptional repression via DNA sequence- specific binding. DACH1 repressed gene transcription driven by the DACH1-responsive element (DRE). Recent genome- wide ChIP-Seq analysis demonstrated DACH1 binding sites co-localized with Forkhead protein (FOX) binding sites. Herein, DACH1 repressed, whereas FOX proteins enhanced, both DRE and FOXA-responsive element-driven gene expression. Reduced DACH1 expression using a shRNA approach enhanced FOX protein activity. As DACH1 antagonized FOX target gene expression and attenuated FOX signaling, we sought to identify limiting co-integrator proteins governing DACH1 signaling. Proteomic analysis identified transcription elongation regulator 1 (TCERG1) as the transcriptional coregulator of DACH1 activity. The FF2 domain of TCERG1 was required for DACH1 binding, and the deletion of FF2 abolished DACH1 trans-repression function. The carboxyl terminus of DACH1 was necessary and sufficient for TCERG1 binding. Thus, DACH1 represses gene transcription through direct DNA binding to the promoter region of target genes by recruiting the transcriptional co-regulator, TCERG1.	[Zhou, Jie; Liu, Yang; Zhang, Wei; Popov, Vladimir M.; Wang, Min; Pattabiraman, Nagarajan; Wu, Kongming; Wang, Chenguang; Pestell, Richard G.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Wu, Kongming; Pestell, Richard G.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Wang, Chenguang] Thomas Jefferson Univ, Dept Stem Cell Biol & Regenerat Med, Philadelphia, PA 19107 USA; [Sune, Carlos] CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Mol Biol, Granada 18100, Spain; [Cvekl, Ales] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Liu, Yang; Jiang, Jie] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250012, Shandong, Peoples R China	Jefferson University; Jefferson University; Jefferson University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Yeshiva University; Albert Einstein College of Medicine; Shandong University	Wang, CG (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, 233 S 10th St, Philadelphia, PA 19107 USA.	chenguang.wang@jefferson.edu; richard.pestell@jefferson.edu	Suñé, Carlos/AAA-8198-2019; Pattabiraman, Nagarjan/A-9347-2011; Cvekl, Ales/B-2427-2013	Suñé, Carlos/0000-0002-7991-0458; 	National Institutes of Health [R01CA70896, R01CA75503, R01CA86072]; National Institutes of Health Cancer Center [P30CA56036]; Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; Spanish Ministry of Science and Innovation [BFU2008-01599]; NATIONAL CANCER INSTITUTE [R01CA070896, R01CA075503, P30CA056036, R01CA086072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA70896, R01CA75503, and R01CA86072 (to R. G. P.). Work conducted at the Kimmel Cancer Center was supported by National Institutes of Health Cancer Center Core Grant P30CA56036 (to R. G. P.). This work was also supported by the Dr. Ralph and Marian C. Falk Medical Research Trust and a grant from Pennsylvania Department of Health (to R. G. P. and C. W.) and Spanish Ministry of Science and Innovation Grant BFU2008-01599 (C.S.).	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Dalgin GS, 2008, J UROLOGY, V180, P1126, DOI 10.1016/j.juro.2008.04.137; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Kim SS, 2002, STRUCTURE, V10, P787, DOI 10.1016/S0969-2126(02)00769-4; Li X, 2002, SCIENCE, V297, P1180; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; MARDON G, 1994, DEVELOPMENT, V120, P3473; Nan FF, 2009, CANCER BIOL THER, V8, P1534, DOI 10.4161/cbt.8.16.8963; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Pearson JL, 2008, J BIOL CHEM, V283, P7949, DOI 10.1074/jbc.M709402200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Shen WP, 1997, DEVELOPMENT, V124, P45; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Sune C, 1999, MOL CELL BIOL, V19, P4719; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang CG, 2001, MOL CELL BIOL, V21, P3057, DOI 10.1128/MCB.21.9.3057-3070.2001; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917; Wu KM, 2003, J BIOL CHEM, V278, P51673, DOI 10.1074/jbc.M310021200; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Wu KM, 2007, MOL BIOL CELL, V18, P755, DOI 10.1091/mbc.E06-09-0793; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x; Zhou J, 2010, P NATL ACAD SCI USA, V107, P6864, DOI 10.1073/pnas.1002746107	29	20	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40342	40350		10.1074/jbc.M110.156141	http://dx.doi.org/10.1074/jbc.M110.156141			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956529	Green Published, hybrid			2022-12-25	WOS:000285185500077
J	Eltit, JM; Feng, W; Lopez, JR; Padilla, IT; Pessah, IN; Molinski, TF; Fruen, BR; Allen, PD; Perez, CF				Eltit, Jose M.; Feng, Wei; Lopez, Jose R.; Padilla, Isela T.; Pessah, Isaac N.; Molinski, Tadeusz F.; Fruen, Bradley R.; Allen, Paul D.; Perez, Claudio F.			Ablation of Skeletal Muscle Triadin Impairs FKBP12/RyR1 Channel Interactions Essential for Maintaining Resting Cytoplasmic Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC RYANODINE RECEPTOR; JUNCTIONAL FOOT PROTEIN; CALCIUM-RELEASE CHANNEL; FK506-BINDING PROTEIN; DIHYDROPYRIDINE RECEPTOR; INTRACELLULAR CA2+; BINDING; MYOTUBES; CALSEQUESTRIN; RYR1	Previously, we have shown that lack of expression of triadins in skeletal muscle cells results in significant increase of myoplasmic resting free Ca2+ ([Ca2+](rest)), suggesting a role for triadins in modulating global intracellular Ca2+ homeostasis. To understand this mechanism, we study here how triadin alters [Ca2+](rest), Ca2+ release, and Ca2+ entry pathways using a combination of Ca2+ microelectrodes, channels reconstituted in bilayer lipid membranes (BLM), Ca2+, and Mn2+ imaging analyses of myotubes and RyR1 channels obtained from triadin-null mice. Unlike WT cells, triadin-null myotubes had chronically elevated [Ca2+](rest) that was sensitive to inhibition with ryanodine, suggesting that triadin-null cells have increased basal RyR1 activity. Consistently, BLM studies indicate that, unlike WT-RyR1, triadin-null channels more frequently display atypical gating behavior with multiple and stable subconductance states. Accordingly, pulldown analysis and fluorescent FKBP12 binding studies in triadin-null muscles revealed a significant impairment of the FKBP12/RyR1 interaction. Mn2+ quench rates under resting conditions indicate that triadin-null cells also have higher Ca2+ entry rates and lower sarcoplasmic reticulum Ca2+ load than WT cells. Overexpression of FKBP12.6 reverted the null phenotype, reducing resting Ca2+ entry, recovering sarcoplasmic reticulum Ca2+ content levels, and restoring near normal [Ca2+](rest). Exogenous FKBP12.6 also reduced the RyR1 channel P-o but did not rescue subconductance behavior. In contrast, FKBP12 neither reduced P-o nor recovered multiple subconductance gating. These data suggest that elevated [Ca2+](rest) in triadin-null myotubes is primarily driven by dysregulated RyR1 channel activity that results in part from impaired FKBP12/RyR1 functional interactions and a secondary increased Ca2+ entry at rest.	[Eltit, Jose M.; Lopez, Jose R.; Allen, Paul D.; Perez, Claudio F.] Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Feng, Wei; Padilla, Isela T.; Pessah, Isaac N.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Molinski, Tadeusz F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Molinski, Tadeusz F.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Fruen, Bradley R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Harvard University; Brigham & Women's Hospital; University of California System; University of California Davis; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities	Perez, CF (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol, 75 Francis St, Boston, MA 02115 USA.	cperez@zeus.bwh.harvard.edu	Pessah, Isaac N/K-7985-2017; Molinski, Tadeusz F/P-2125-2018	Pessah, Isaac N/0000-0002-8149-588X; 	National Institute of Health [5K01AR054818, P01AR47605, R01HL076433]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054818, P01AR052354, R03AR047605] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institute of Health Grants 5K01AR054818 (to C. F. P.), P01AR47605 (to P. D. A. and I. N. P.), and R01HL076433 (to B. R. F.).	Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; BRANDT NR, 1990, J MEMBRANE BIOL, V113, P237, DOI 10.1007/BF01870075; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Buck ED, 1997, J BIOL CHEM, V272, P7360, DOI 10.1074/jbc.272.11.7360; Chen L, 1999, J BIOL CHEM, V274, P32603, DOI 10.1074/jbc.274.46.32603; Cornea RL, 2010, J BIOL CHEM, V285, P19219, DOI 10.1074/jbc.M109.066944; Eltit JM, 2010, BIOPHYS J, V98, p509A, DOI 10.1016/j.bpj.2009.12.2774; Eltit JM, 2010, J BIOL CHEM, V285, P13781, DOI 10.1074/jbc.M110.107300; Fodor J, 2008, J PHYSIOL-LONDON, V586, P5803, DOI 10.1113/jphysiol.2008.160457; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Goonasekera SA, 2007, J GEN PHYSIOL, V130, P365, DOI 10.1085/jgp.200709790; Groh S, 1999, J BIOL CHEM, V274, P12278, DOI 10.1074/jbc.274.18.12278; Gu W, 1996, SOC GEN PHY, V51, P19; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Jeyakumar LH, 2001, BIOCHEM BIOPH RES CO, V281, P979, DOI 10.1006/bbrc.2001.4444; KIM KC, 1990, BIOCHEMISTRY-US, V29, P9281, DOI 10.1021/bi00491a025; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb GD, 1996, J PHYSIOL-LONDON, V494, P569, DOI 10.1113/jphysiol.1996.sp021514; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Lee EH, 2004, J BIOL CHEM, V279, P26481, DOI 10.1074/jbc.M309574200; LOPEZ JR, 1986, MUSCLE NERVE, V9, P85; MACK MM, 1994, J BIOL CHEM, V269, P23236; Marty I, 2009, J PHYSIOL-LONDON, V587, P3117, DOI 10.1113/jphysiol.2009.171892; Masuno MN, 2006, J MED CHEM, V49, P4497, DOI 10.1021/jm050708u; MAYRLEITNER M, 1994, CELL CALCIUM, V15, P99, DOI 10.1016/0143-4160(94)90048-5; MOTOIKE HK, 1994, J MUSCLE RES CELL M, V15, P493, DOI 10.1007/BF00121156; Ohkura M, 1998, BIOCHEMISTRY-US, V37, P12987, DOI 10.1021/bi972803d; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Pessah IN, 1997, AM J PHYSIOL-CELL PH, V272, pC601, DOI 10.1152/ajpcell.1997.272.2.C601; Qin J, 2009, BIOPHYS J, V97, P1961, DOI 10.1016/j.bpj.2009.07.030; Rezgui SS, 2005, J BIOL CHEM, V280, P39302, DOI 10.1074/jbc.M506566200; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Tang W, 2004, FASEB J, V18, P1597, DOI 10.1096/fj.04-1587fje; Wang Y, 2009, CELL CALCIUM, V45, P29, DOI 10.1016/j.ceca.2008.05.006; Westerman KA, 2010, EXP CELL RES, V316, P1966, DOI 10.1016/j.yexcr.2010.03.022; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006	40	16	16	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38453	38462		10.1074/jbc.M110.164525	http://dx.doi.org/10.1074/jbc.M110.164525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926377	hybrid, Green Published			2022-12-25	WOS:000284625600051
J	Sheu, JJC; Guan, B; Choi, JH; Lin, A; Lee, CH; Hsiao, YT; Wang, TL; Tsai, FJ; Shih, IM				Sheu, Jim Jinn-Chyuan; Guan, Bin; Choi, Jung-Hye; Lin, Athena; Lee, Chia-Huei; Hsiao, Yi-Ting; Wang, Tian-Li; Tsai, Fuu-Jen; Shih, Ie-Ming			Rsf-1, a Chromatin Remodeling Protein, Induces DNA Damage and Promotes Genomic Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAK REPAIR PATHWAYS; FUNCTIONAL-ANALYSIS; DOWNSTREAM TARGET; CELL-GROWTH; C-MYC; EXPRESSION; ONCOGENES; CANCER; GENE; AMPLIFICATION	Rsf-1 (HBXAP) has been reported as an amplified gene in human cancer, including the highly aggressive ovarian serous carcinoma. Rsf-1 protein interacts with SNF2H to form an ISWI chromatin remodeling complex, RSF. In this study, we investigated the functional role of Rsf-1 by observing phenotypes after expressing it in nontransformed cells. Acute expression of Rsf-1 resulted in DNA damage as evidenced by DNA strand breaks, nuclear gamma H2AX foci, and activation of the ATM-CHK2-p53-p21 pathway, leading to growth arrest and apoptosis. Deletion mutation and gene knockdown assays revealed that formation of a functional RSF complex with SNF2H was required for Rsf-1 to trigger DNA damage response (DDR). Gene knock-out of TP53 alleles, TP53 mutation, or treatment with an ATM inhibitor abolished up-regulation of p53 and p21 and prevented Rsf-1-induced growth arrest. Chronic induction of Rsf-1 expression resulted in chromosomal aberration and clonal selection for cells with c-myc amplification and CDKN2A/B deletion. Co-culture assays indicated Rsf-1-induced DDR as a selecting barrier that favored outgrowth of cell clones with a TP53 mutation. The above findings suggest that increased Rsf-1 expression and thus excessive RSF activity, which occurs in tumors harboring Rsf-1 amplification, can induce chromosomal instability likely through DDR.	[Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Pathol & Oncol, Baltimore, MD 21231 USA; [Sheu, Jim Jinn-Chyuan; Hsiao, Yi-Ting; Tsai, Fuu-Jen] China Med Univ Hosp, Ctr Human Genet, Taichung 40447, Taiwan; [Sheu, Jim Jinn-Chyuan; Hsiao, Yi-Ting; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung 40447, Taiwan; [Choi, Jung-Hye] Kyung Hee Univ, Dept Oriental Pharm, Seoul 130701, South Korea; [Lin, Athena] Touro Univ, Dept Basic Sci & Int Hlth, Vallejo, CA 94592 USA; [Lee, Chia-Huei] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan 35053, Taiwan	Johns Hopkins University; Johns Hopkins Medicine; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Kyung Hee University; Touro University California; National Health Research Institutes - Taiwan	Sheu, JJC (corresponding author), 2 Yuh Der Rd, Taichung 40447, Taiwan.	jimsheu@mail.cmu.edu.tw; ishih@jhmi.edu	Choi, Jung-Hye/AAI-9922-2020; sdsd, shihieih/ABE-6190-2020; Tsai, Fuu-Jen/J-4140-2015; Lee, Chia-Huei/B-1063-2010	Guan, Bin/0000-0001-5986-5189; Lee, Chia-Huei/0000-0002-8847-3288; Choi, Jung-Hye/0000-0001-5178-6814	NCI, National Institutes of Health [RO1CA129080, RO1CA103937]; Johns Hopkins-China Medical University [DMR-98-104]; National Science Council (Taiwan) [NSC 98-2320-B-039-033-MY3]; NATIONAL CANCER INSTITUTE [R01CA129080, R01CA103937] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Johns Hopkins-China Medical University; National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants RO1CA129080 and RO1CA103937. This work was also supported by Johns Hopkins-China Medical University Research Collaboration Fund (DMR-98-104) and National Science Council Grant NSC 98-2320-B-039-033-MY3 (Taiwan).	Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bommer GT, 2005, J BIOL CHEM, V280, P7962, DOI 10.1074/jbc.M412593200; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Choi JH, 2005, J CLIN ENDOCR METAB, V90, P207, DOI 10.1210/jc.2004-0297; Choi JH, 2009, CANCER RES, V69, P1407, DOI 10.1158/0008-5472.CAN-08-3602; Davidson B, 2006, GYNECOL ONCOL, V103, P814, DOI 10.1016/j.ygyno.2006.05.042; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Di Micco R, 2007, TRENDS CELL BIOL, V17, P529, DOI 10.1016/j.tcb.2007.07.012; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Downey M, 2006, NAT CELL BIOL, V8, P9, DOI 10.1038/ncb0106-9; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Francis R, 2007, GENE DEV, V21, P1064, DOI 10.1101/gad.1522807; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Komiya T, 2006, ONCOGENE, V25, P6128, DOI 10.1038/sj.onc.1209627; Lafon-Hughes L, 2008, MUTAT RES-REV MUTAT, V658, P191, DOI 10.1016/j.mrrev.2008.01.008; Leitao MM, 2004, GYNECOL ONCOL, V93, P301, DOI 10.1016/j.ygyno.2004.01.043; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Loyola A, 2003, MOL CELL BIOL, V23, P6759, DOI 10.1128/MCB.23.19.6759-6768.2003; Loyola A, 2001, GENE DEV, V15, P2837; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Salani R, 2008, INT J GYNECOL CANCER, V18, P487, DOI 10.1111/j.1525-1438.2007.01039.x; Schwab M, 1998, BIOESSAYS, V20, P473, DOI 10.1002/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.3.CO;2-N; Sehdev AES, 2010, MODERN PATHOL, V23, p264A; Shen JJC, 2008, CANCER RES, V68, P4050, DOI 10.1158/0008-5472.CAN-07-3240; Shih LM, 2005, P NATL ACAD SCI USA, V102, P14004, DOI 10.1073/pnas.0504195102; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang GG, 2007, TRENDS MOL MED, V13, P373, DOI 10.1016/j.molmed.2007.07.004; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wolffe AP, 2001, ONCOGENE, V20, P2988, DOI 10.1038/sj.onc.1204322; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Ye Y, 2009, MOL CANCER RES, V7, P1984, DOI 10.1158/1541-7786.MCR-09-0119; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	49	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38260	38269		10.1074/jbc.M110.138735	http://dx.doi.org/10.1074/jbc.M110.138735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923775	Green Published, hybrid			2022-12-25	WOS:000284625600034
J	Carlucci, A; Porpora, M; Garbi, C; Galgani, M; Santoriello, M; Mascolo, M; di Lorenzo, D; Altieri, V; Quarto, M; Terracciano, L; Gottesman, ME; Insabato, L; Feliciello, A				Carlucci, Annalisa; Porpora, Monia; Garbi, Corrado; Galgani, Mario; Santoriello, Margherita; Mascolo, Massimo; di Lorenzo, Domenico; Altieri, Vincenzo; Quarto, Maria; Terracciano, Luigi; Gottesman, Max E.; Insabato, Luigi; Feliciello, Antonio			PTPD1 Supports Receptor Stability and Mitogenic Signaling in Bladder Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GENE-EXPRESSION; OXIDATIVE-METABOLISM; ENDOCYTOSIS; KINESIN; TARGETS; KINASE; CLASSIFICATION; TRAFFICKING; REGULATOR	PTPD1, a cytosolic non-receptor protein-tyrosine phosphatase, stimulates the Src-EGF transduction pathway. Localization of PTPD1 at actin cytoskeleton and adhesion sites is required for cell scattering and migration. Here, we show that during EGF stimulation, PTPD1 is rapidly recruited to endocytic vesicles containing the EGF receptor. Endosomal localization of PTPD1 is mediated by interaction with KIF16B, an endosomal kinesin that modulates receptor recycling at the plasma membrane. Silencing of PTPD1 promotes degradation of EGF receptor and inhibits downstream ERK signaling. We also found that PTPD1 is markedly increased in bladder cancer tissue samples. PTPD1 levels positively correlated with the grading and invasiveness potential of these tumors. Transgenic expression of an inactive PTPD1 mutant or genetic knockdown of the endogenous PTPD1 severely inhibited both growth and motility of human bladder cancer cells. These findings identify PTPD1 as a novel component of the endocytic machinery that impacts on EGF receptor stability and on growth and motility of bladder cancer cells.	[Quarto, Maria] Univ Naples Federico II, Dipartimento Biol & Patol Mol & Cellulare, Naples, Italy; [Mascolo, Massimo; Insabato, Luigi] Univ Naples Federico II, Dipartimento Sci Biomorfol & Funz, Naples, Italy; [di Lorenzo, Domenico; Altieri, Vincenzo] Univ Naples Federico II, Dipartimento Urol, Naples, Italy; [Terracciano, Luigi] Univ Hosp, Inst Pathol, Basel, Switzerland; [Gottesman, Max E.] Columbia Univ, Inst Canc Res, New York, NY 10032 USA	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Columbia University		feliciel@unina.it	Mascolo, Massimo/AAE-3547-2021; Galgani, Mario/AAC-3298-2022; Terracciano, Luigi M./AAB-5335-2022	Mascolo, Massimo/0000-0002-2576-220X; Terracciano, Luigi M./0000-0002-9393-9660; Quarto, Maria/0000-0003-0119-2393; Feliciello, Antonio/0000-0002-7932-2170; Galgani, Mario/0000-0001-8414-1676	Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of University and Research MIUR [2007KS47FW_002]; Union for International Cancer Control [YY1/09/012]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research MIUR(Ministry of Education, Universities and Research (MIUR)); Union for International Cancer Control	This work was supported by a grant from Associazione Italiana per la Ricerca sul Cancro and Italian Ministry of University and Research MIUR 2008-2009 Grant 2007KS47FW_002, and Union for International Cancer Control Study Grant YY1/09/012 (to A. F.).	Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Baffa R, 2006, J EXP CLIN CANC RES, V25, P145; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Black Peter C, 2008, Curr Urol Rep, V9, P55, DOI 10.1007/s11934-008-0011-6; Blanchet P, 2001, EUR UROL, V40, P169, DOI 10.1159/000049768; Blatner NR, 2007, EMBO J, V26, P3709, DOI 10.1038/sj.emboj.7601800; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Carlucci A, 2008, J BIOL CHEM, V283, P10919, DOI 10.1074/jbc.M707248200; Carlucci A, 2008, TRENDS CELL BIOL, V18, P604, DOI 10.1016/j.tcb.2008.09.006; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dorner C, 1998, J BIOL CHEM, V273, P20267, DOI 10.1074/jbc.273.32.20267; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jui HY, 2000, J BIOL CHEM, V275, P41124, DOI 10.1074/jbc.M007772200; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Liedberg F, 2008, UROL ONCOL-SEMIN ORI, V26, P17, DOI 10.1016/j.urolonc.2006.08.021; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; MOLLER NPH, 1994, P NATL ACAD SCI USA, V91, P7477, DOI 10.1073/pnas.91.16.7477; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Sanchez-Carbayo M, 2006, AM J PATHOL, V168, P93, DOI 10.2353/ajpath.2006.050601; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Wallerand H, 2008, CURR OPIN UROL, V18, P524, DOI 10.1097/MOU.0b013e3283097889; Zwang Yaara, 2009, Traffic, V10, P349, DOI 10.1111/j.1600-0854.2008.00870.x	38	38	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39260	39270		10.1074/jbc.M110.174706	http://dx.doi.org/10.1074/jbc.M110.174706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923765	Green Published, hybrid			2022-12-25	WOS:000284941300055
J	Wang, YL; Kuo, JH; Lee, SC; Liu, JS; Hsieh, YC; Shih, YT; Chen, CJ; Chiu, JJ; Wu, WG				Wang, Yu-Ling; Kuo, Je-Hung; Lee, Shao-Chen; Liu, Jai-Shin; Hsieh, Yin-Cheng; Shih, Yu-Tsung; Chen, Chun-Jung; Chiu, Jeng-Jiann; Wu, Wen-guey			Cobra CRISP Functions as an Inflammatory Modulator via a Novel Zn2+- and Heparan Sulfate-dependent Transcriptional Regulation of Endothelial Cell Adhesion Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH SECRETORY PROTEIN-3; GATED ION CHANNELS; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CRYSTAL-STRUCTURE; HUMAN NEUTROPHILS; NATRIN TOXIN; SNAKE-VENOM; E-SELECTIN; FAMILY	Cysteine-rich secretory proteins (CRISPs) have been identified as a toxin family in most animal venoms with biological functions mainly associated with the ion channel activity of cysteine-rich domain (CRD). CRISPs also bind to Zn2+ at their N-terminal pathogenesis-related (PR-1) domain, but their function remains unknown. Interestingly, similar the Zn2+-binding site exists in all CRISP family, including those identified in a wide range of organisms. Here, we report that the CRISP from Naja atra (natrin) could induce expression of vascular endothelial cell adhesion molecules, i.e. intercellular adhesion molecule-1, vascular adhesion molecule-1, and E-selectin, to promote monocytic cell adhesion in a heparan sulfate (HS)- and Zn2+-dependent manner. Using specific inhibitors and small interfering RNAs, the activation mechanisms are shown to involve both mitogen-activated protein kinases and nuclear factor-kappa B. Biophysical characterization of natrin by using fluorescence, circular dichroism, and x-ray crystallographic methods further reveals the presence of two Zn2+-binding sites for natrin. The strong binding site is located near the putative Ser-His-Glucatalytic triad of the N-terminal domain. The weak binding site remains to be characterized, but it may modulate HS binding by enhancing its interaction with long chain HS. Our results strongly suggest that natrin may serve as an inflammatory modulator that could perturb the wound-healing process of the bitten victim by regulating adhesion molecule expression in endothelial cells. Our finding uncovers a new aspect of the biological role of CRISP family in immune response and is expected to facilitate future development of new therapeutic strategy for the envenomed victims.	[Wang, Yu-Ling; Shih, Yu-Tsung; Chiu, Jeng-Jiann] Natl Hlth Res Inst, Div Med Engn Res, Miaoli 35053, Taiwan; [Wang, Yu-Ling; Kuo, Je-Hung; Liu, Jai-Shin; Hsieh, Yin-Cheng; Wu, Wen-guey] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Lee, Shao-Chen] FuJen Catholic Univ, Sch Med, Hsinchuang 24205, Taiwan; [Hsieh, Yin-Cheng; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; Fu Jen Catholic University; National Synchrotron Radiation Research Center	Chiu, JJ (corresponding author), Natl Hlth Res Inst, Div Med Engn Res, Miaoli 35053, Taiwan.	jjchiu@nhri.org.tw; wgwu@life.nthu.edu.tw	Chen, Chun-Jung/A-6880-2011; Chiu, Jeng-Jiann/E-3980-2010	Chen, Chun-Jung/0000-0002-5157-4288; Kuo, Je-Hung/0000-0002-5499-8027	Ministry of Economic Affairs [98_EC_17_A_17_S2_0101]; National Science Council [99-3112-B-400-008, 99-2321-B-400-002]	Ministry of Economic Affairs; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Economic Affairs Grant 98_EC_17_A_17_S2_0101 (to W.-g. W.) and National Science Council Grants 99-3112-B-400-008 and 99-2321-B-400-002 (to J.-J. C.).	ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Asmann YW, 2002, CANCER RES, V62, P3308; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; Brown RL, 1999, P NATL ACAD SCI USA, V96, P754, DOI 10.1073/pnas.96.2.754; Brunger AT, 1998, CURR OPIN STRUC BIOL, V8, P606, DOI 10.1016/S0959-440X(98)80152-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CHEN CC, 1995, AGENT ACTION SUPPL, V47, P135; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Coombe DR, 2008, IMMUNOL CELL BIOL, V86, P598, DOI 10.1038/icb.2008.49; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gibbs GM, 2006, J BIOL CHEM, V281, P4156, DOI 10.1074/jbc.M506849200; Giese A, 2002, GENE, V299, P101, DOI 10.1016/S0378-1119(02)01018-1; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; HAENDLER B, 1993, ENDOCRINOLOGY, V133, P192, DOI 10.1210/en.133.1.192; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9; Horne AW, 2009, MOL HUM REPROD, V15, P287, DOI 10.1093/molehr/gap019; Hung DZ, 2003, TOXICON, V41, P409, DOI 10.1016/S0041-0101(02)00336-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kjeldsen L, 1996, FEBS LETT, V380, P246, DOI 10.1016/0014-5793(96)00030-0; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kuvibidila SR, 2006, J NATL MED ASSOC, V98, P1263; Laine M, 2007, ARTHRITIS RHEUM, V56, P2575, DOI 10.1002/art.22828; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Liao Q, 2003, HISTOL HISTOPATHOL, V18, P425, DOI 10.14670/HH-18.425; Lin YH, 1999, FEBS LETT, V453, P395, DOI 10.1016/S0014-5793(99)00760-7; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; O'Bryan MK, 1998, MOL REPROD DEV, V50, P313, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;313::AID-MRD7&gt;3.0.CO;2-M; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Patel HV, 1997, J BIOL CHEM, V272, P1484, DOI 10.1074/jbc.272.32.20185; PECK EJ, 1971, J BIOL CHEM, V246, P1160; Pfisterer P, 1996, MOL CELL BIOL, V16, P6160; SCHULTZ RM, 1982, INT J PEPT PROT RES, V19, P454; Serrano RL, 2004, J MOL BIOL, V339, P173, DOI 10.1016/j.jmb.2004.03.015; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; SIMONS TJB, 1991, J MEMBRANE BIOL, V123, P63, DOI 10.1007/BF01993964; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Suzuki N, 2008, ACTA CRYSTALLOGR D, V64, P1034, DOI 10.1107/S0907444908023512; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Udby L, 2004, BIOCHEMISTRY-US, V43, P12877, DOI 10.1021/bi048823e; Udby L, 2002, J IMMUNOL METHODS, V263, P43, DOI 10.1016/S0022-1759(02)00033-9; Udby L, 2002, J LEUKOCYTE BIOL, V72, P462; VandenBerg E, 2004, J CELL BIOCHEM, V91, P926, DOI 10.1002/jcb.20011; Vinay DS, 2009, CELL BIOL INT, V33, P453, DOI 10.1016/j.cellbi.2009.02.001; Wang F, 2006, BIOCHEM BIOPH RES CO, V351, P443, DOI 10.1016/j.bbrc.2006.10.067; Wang J, 2005, BIOCHEMISTRY-US, V44, P10145, DOI 10.1021/bi050614m; Wang YQ, 2004, ACTA CRYSTALLOGR E, V60, pM876, DOI 10.1107/S1600536804012565; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Yamazaki Y, 2002, BIOCHEMISTRY-US, V41, P11331, DOI 10.1021/bi026132h; Zhou Q, 2008, BIOPHYS J, V95, P4289, DOI 10.1529/biophysj.108.137224	64	69	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37872	37883		10.1074/jbc.M110.146290	http://dx.doi.org/10.1074/jbc.M110.146290			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20889969	Green Published, hybrid			2022-12-25	WOS:000284424000077
J	Pradhan, RK; Qi, F; Beard, DA; Dash, RK				Pradhan, Ranjan K.; Qi, Feng; Beard, Daniel A.; Dash, Ranjan K.			Characterization of Membrane Potential Dependency of Mitochondrial Ca2+ Uptake by an Improved Biophysical Model of Mitochondrial Ca2+ Uniporter	PLOS ONE			English	Article							CALCIUM-UPTAKE; TRANSPORT; KINETICS; HEART; PHYSIOLOGY	Mitochondrial Ca2+ uniporter is the primary influx pathway for Ca2+ into respiring mitochondria, and hence plays a key role in mitochondrial Ca2+ homeostasis. Though the mechanism of extra-matrix Ca2+ dependency of mitochondrial Ca2+ uptake has been well characterized both experimentally and mathematically, the mechanism of membrane potential (DY) dependency of mitochondrial Ca2+ uptake has not been completely characterized. In this paper, we perform a quantitative reevaluation of a previous biophysical model of mitochondrial Ca2+ uniporter that characterized the possible mechanism of DY dependency of mitochondrial Ca2+ uptake. Based on a model simulation analysis, we show that model predictions with a variant assumption (Case 2: external and internal Ca2+ binding constants for the uniporter are distinct), that provides the best possible description of the DY dependency, are highly sensitive to variation in matrix [Ca2+], indicating limitations in the variant assumption (Case 2) in providing physiologically plausible description of the observed DY dependency. This sensitivity is attributed to negative estimate of a biophysical parameter that characterizes binding of internal Ca2+ to the uniporter. Reparameterization of the model with additional nonnengativity constraints on the biophysical parameters showed that the two variant assumptions (Case 1 and Case 2) are indistinguishable, indicating that the external and internal Ca2+ binding constants for the uniporter may be equal (Case 1). The model predictions in this case are insensitive to variation in matrix [Ca2+] but do not match the DY dependent data in the domain Delta Psi <= 120 mV. To effectively characterize this DY dependency, we reformulate the DY dependencies of the rate constants of Ca2+ translocation via the uniporter by exclusively redefining the biophysical parameters associated with the free-energy barrier of Ca2+ translocation based on a generalized, non-linear Goldman-Hodgkin-Katz formulation. This alternate uniporter model has all the characteristics of the previous uniporter model and is also able to characterize the possible mechanisms of both the extra-matrix Ca2+ and DY dependencies of mitochondrial Ca2+ uptake. In addition, the model is insensitive to variation in matrix [Ca2+], predicting relatively stable physiological operation. The model is critical in developing mechanistic, integrated models of mitochondrial bioenergetics and Ca2+ handling.	[Pradhan, Ranjan K.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Pradhan, RK (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	rdash@mcw.edu			National Institutes of Health [R01-HL072011, R01-HL095122]; American Heart Association [SDG-0735093N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072011, R01HL095122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants R01-HL072011 (DAB) and R01-HL095122 (RKD) and American Heart Association grant SDG-0735093N (RKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Brini M, 2003, CELL CALCIUM, V34, P399, DOI 10.1016/S0143-4160(03)00145-3; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; CROMPTON M, 1976, EUR J BIOCHEM, V69, P429, DOI 10.1111/j.1432-1033.1976.tb10927.x; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; Dash RK, 2009, BIOPHYS J, V96, P1318, DOI 10.1016/j.bpj.2008.11.005; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; FALL CP, COMPUTATIONAL CELL B, P468; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Keener J. P., 1998, MATH PHYSL, P766; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; LAUGER P, 1973, BIOCHIM BIOPHYS ACTA, V311, P423, DOI 10.1016/0005-2736(73)90323-4; Lauger P, 1973, Membranes, V2, P1; Magnus G, 1997, AM J PHYSIOL-CELL PH, V273, pC717, DOI 10.1152/ajpcell.1997.273.2.C717; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Marhl M, 1998, BIOPHYS CHEM, V71, P125, DOI 10.1016/S0301-4622(97)00139-7; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MCCORMACK JG, 1989, BIOCHIM BIOPHYS ACTA, V973, P420, DOI 10.1016/S0005-2728(89)80384-6; Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151; Nguyen MHT, 2007, AM J PHYSIOL-CELL PH, V292, pC2004, DOI 10.1152/ajpcell.00271.2006; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Pradhan RK, 2010, BIOPHYS J, V98, P218, DOI 10.1016/j.bpj.2009.10.005; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; SCARPA A, 1973, J GEN PHYSIOL, V62, P756, DOI 10.1085/jgp.62.6.756; VINOGRADOV A, 1973, J BIOL CHEM, V248, P5527; WINGROVE DE, 1984, J BIOL CHEM, V259, P9390; WOODBURY JW, 1971, CHEM DYNAMICS PAPERS	35	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13278	10.1371/journal.pone.0013278	http://dx.doi.org/10.1371/journal.pone.0013278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949039	Green Published, gold, Green Submitted			2022-12-25	WOS:000282676700020
J	Garcia-Prieto, E; Gonzalez-Lopez, A; Cabrera, S; Astudillo, A; Gutierrez-Fernandez, A; Fanjul-Fernandez, M; Batalla-Solis, E; Puente, XS; Fueyo, A; Lopez-Otin, C; Albaiceta, GM				Garcia-Prieto, Emilio; Gonzalez-Lopez, Adrian; Cabrera, Sandra; Astudillo, Aurora; Gutierrez-Fernandez, Ana; Fanjul-Fernandez, Miriam; Batalla-Solis, Estefania; Puente, Xose S.; Fueyo, Antonio; Lopez-Otin, Carlos; Albaiceta, Guillermo M.			Resistance to Bleomycin-Induced Lung Fibrosis in MMP-8 Deficient Mice Is Mediated by Interleukin-10	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; MATRIX METALLOPROTEINASES; INFLAMMATION; GENE; BRONCHIOLIZATION; OVEREXPRESSION; SUSCEPTIBILITY; EXPRESSION; MULTIPLE; CANCER	Background: Matrix metalloproteinases (MMPs) may have pro and antifibrotic roles within the lungs, due to its ability to modulate collagen turnover and immune mediators. MMP-8 is a collagenase that also cleaves a number of cytokines and chemokines. Methodology and Principal Findings: To evaluate its relevance in lung fibrosis, wildtype and Mmp8(-/-) mice were treated with either intratracheal bleomycin or saline, and lungs were harvested at different time points. Fibrosis, collagen, collagenases, gelatinases, TGF beta and IL-10 were measured in lung tissue. Mmp8(-/-) mice developed less fibrosis than their wildtype counterparts. This was related to an increase in lung inflammatory cells, MMP-9 and IL-10 levels in these mutant animals. In vitro experiments showed that MMP-8 cleaves murine and human IL-10, and tissue from knockout animals showed decreased IL-10 processing. Additionally, lung fibroblasts from these mice were cultured in the presence of bleomycin and collagen, IL-10 and STAT3 activation (downstream signal in response to IL-10) measured by western blotting. In cell cultures, bleomycin increased collagen synthesis only in wildtype mice. Fibroblasts from knockout mice did not show increased collagen synthesis, but increased levels of unprocessed IL-10 and STAT3 phosphorylation. Blockade of IL-10 reverted this phenotype, increasing collagen in cultures. Conclusions: According to these results, we conclude that the absence of MMP-8 has an antifibrotic effect by increasing IL-10 and propose that this metalloprotease could be a relevant modulator of IL-10 metabolism in vivo.	[Garcia-Prieto, Emilio; Gonzalez-Lopez, Adrian; Fueyo, Antonio; Albaiceta, Guillermo M.] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Biol Func, Oviedo, Spain; [Cabrera, Sandra; Gutierrez-Fernandez, Ana; Fanjul-Fernandez, Miriam; Puente, Xose S.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain; [Astudillo, Aurora] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Cirugia & Especialidades Medicoquirurg, Oviedo, Spain; [Garcia-Prieto, Emilio; Albaiceta, Guillermo M.] Inst Salud Carlos III, CIBER Enfermedades Resp, Hosp Univ Cent Asturias, Unidad Cuidados Intens, Oviedo, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Albaiceta, GM (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Dept Biol Func, Oviedo, Spain.	Guillermo.muniz@sespa.princast.es	López-Otín, Carlos/AAB-2106-2020; García-Prieto, Emilio/AAR-7946-2021; Fueyo, Antonio/ABH-3243-2020; Gutierrez-Fernandez, Ana/ABG-6678-2020; Gonzalez, Adrian/AAD-2269-2021; Puente, Xosé S./ADB-0672-2022; Gutierrez-Fernandez, Ana/AAS-9954-2021; Garcia-Prieto, Emilio/ABG-6744-2020; Albaiceta, Guillermo/AAU-5069-2020	López-Otín, Carlos/0000-0001-6964-1904; García-Prieto, Emilio/0000-0002-2011-3059; Fueyo, Antonio/0000-0002-7121-9398; Puente, Xosé S./0000-0001-9525-1483; Gutierrez-Fernandez, Ana/0000-0002-9287-8843; Albaiceta, Guillermo/0000-0002-9276-3253; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809; Cabrera Benitez, Sandra/0000-0003-3700-3371; Miriam, Fanjul Fernandez/0000-0002-0074-2325; Gonzalez-Lopez, Adrian/0000-0001-5347-278X	Fondo de Investigacion Sanitaria [PI07/0597]; Ministerio de Ciencia e Innovacion; Fundacion M. Botin; European Union (FP7 MicroEnviMet); FICYT [COF-08-20]; Universidad de Oviedo [UNOV-09-BECDOC]; CONACYT; Obra Social Cajastur-Asturias, Spain	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion M. Botin; European Union (FP7 MicroEnviMet); FICYT; Universidad de Oviedo; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Obra Social Cajastur-Asturias, Spain	Supported by grants from Fondo de Investigacion Sanitaria (PI07/0597), Ministerio de Ciencia e Innovacion, Fundacion M. Botin and European Union (FP7 MicroEnviMet). AGL is the recipient of a grant from FICYT (COF-08-20) and Universidad de Oviedo (UNOV-09-BECDOC). EBS is the recipient of a grant from FICYT (COF-08-20). SC is the recipient of a grant from CONACYT. Instituto Universitario de Oncologia is supported by Obra Social Cajastur-Asturias, Spain. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albaiceta GM, 2009, AM J RESP CELL  0603; Arai T, 2000, AM J PHYSIOL-LUNG C, V278, pL914, DOI 10.1152/ajplung.2000.278.5.L914; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Barbarin V, 2005, AM J PHYSIOL-LUNG C, V288, pL841, DOI 10.1152/ajplung.00329.2004; Betsuyaku T, 2000, AM J PATHOL, V157, P525, DOI 10.1016/S0002-9440(10)64563-4; Cabrera S, 2007, INT J BIOCHEM CELL B, V39, P2324, DOI 10.1016/j.biocel.2007.06.022; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; Garantziotis S, 2006, AM J RESP CELL MOL, V35, P662, DOI 10.1165/rcmb.2006-0055OC; Giambartolomei GH, 2002, INFECT IMMUN, V70, P1881, DOI 10.1128/IAI.70.4.1881-1888.2002; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Jensen-Taubman SM, 1998, INT J CANCER, V75, P489, DOI 10.1002/(SICI)1097-0215(19980209)75:4<489::AID-IJC1>3.0.CO;2-P; Kradin RL, 2004, EXP MOL PATHOL, V76, P205, DOI 10.1016/j.yexmp.2003.12.010; Krein PM, 2002, CHEST, V122, p289S, DOI 10.1378/chest.122.6_suppl.289S; Kunugi S, 2001, LAB INVEST, V81, P1309, DOI 10.1038/labinvest.3780344; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; McKeown S, 2009, EUR RESPIR J, V33, P77, DOI 10.1183/09031936.00060708; Miriam F-F, 2010, BIOCHIM BIOPHYS ACTA, V1803, P3, DOI DOI 10.1016/J.BBAMCR.2009.07.004; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakagome K, 2006, THORAX, V61, P886, DOI 10.1136/thx.2005.056317; O'Reilly PJ, 2008, CURR OPIN PHARMACOL, V8, P242, DOI 10.1016/j.coph.2008.02.003; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Strieter Robert M, 2008, Proc Am Thorac Soc, V5, P305, DOI 10.1513/pats.200710-160DR; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Walter Nicholas, 2006, Proc Am Thorac Soc, V3, P330, DOI 10.1513/pats.200602-016TK; Zhou Xiaoxia, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P465, DOI 10.2174/156800805774912926; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	38	71	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13242	10.1371/journal.pone.0013242	http://dx.doi.org/10.1371/journal.pone.0013242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V32LH	20949050	Green Published, Green Submitted, gold			2022-12-25	WOS:000208952200005
J	Song, AX; Zhou, CJ; Peng, Y; Gao, XC; Zhou, ZR; Fu, QS; Hong, J; Lin, DH; Hu, HY				Song, Ai-Xin; Zhou, Chen-Jie; Peng, Yu; Gao, Xue-Chao; Zhou, Zi-Ren; Fu, Qing-Shan; Hong, Jing; Lin, Dong-Hai; Hu, Hong-Yu			Structural Transformation of the Tandem Ubiquitin-Interacting Motifs in Ataxin-3 and Their Cooperative Interactions with Ubiquitin Chains	PLOS ONE			English	Article							POLYGLUTAMINE DISEASE PROTEIN; DEUBIQUITINATING ENZYME ATAXIN-3; MACHADO-JOSEPH-DISEASE; NMR SOLUTION STRUCTURE; BINDING DOMAINS; CRYSTAL-STRUCTURE; CHEMICAL-SHIFT; RECOGNITION; SYSTEM; PROTEASOME	The ubiquitin-interacting motif (UIM) is a short peptide with dual function of binding ubiquitin (Ub) and promoting ubiquitination. We elucidated the structures and dynamics of the tandem UIMs of ataxin-3 (AT3-UIM12) both in free and Ub-bound forms. The solution structure of free AT3-UIM12 consists of two alpha-helices and a flexible linker, whereas that of the Ub-bound form is much more compact with hydrophobic contacts between the two helices. NMR dynamics indicates that the flexible linker becomes rigid when AT3-UIM12 binds with Ub. Isothermal titration calorimetry and NMR titration demonstrate that AT3-UIM12 binds diUb with two distinct affinities, and the linker plays a critical role in association of the two helices in diUb binding. These results provide an implication that the tandem UIM12 interacts with Ub or diUb in a cooperative manner through an allosteric effect and dynamics change of the linker region, which might be related to its recognitions with various Ub chains and ubiquitinated substrates.	[Song, Ai-Xin; Zhou, Chen-Jie; Gao, Xue-Chao; Zhou, Zi-Ren; Fu, Qing-Shan; Hu, Hong-Yu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Peng, Yu; Hong, Jing; Lin, Dong-Hai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS	Song, AX (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	dhlin@mail.shcnc.ac.cn; hyhu@sibs.ac.cn	Fu, Qingshan/E-8083-2015; Hu, Hong-Yu/AAQ-2633-2020; Fu, Qingshan/E-1405-2015; Chou, Steven Ziren/M-1995-2014	Fu, Qingshan/0000-0002-7445-2355; Peng, Yu/0000-0003-2039-9015	National Natural Science Foundation of China [30600103, 30670431, 30870485]; Shanghai Institutes for Biological Sciences [2008KIP201]; National Basic Research Program of China [2006CB806508, 2006CB910305, 2007CB914304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the grants from the National Natural Science Foundation of China (30600103, 30670431 and 30870485), the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences (2008KIP201, CAS), and the National Basic Research Program of China (2006CB806508, 2006CB910305 and 2007CB914304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chang YG, 2008, J BIOL CHEM, V283, P13370, DOI 10.1074/jbc.M800162200; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Choi JY, 2007, MOL CELL NEUROSCI, V34, P69, DOI 10.1016/j.mcn.2006.10.002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Flick K, 2006, NAT CELL BIOL, V8, P509, DOI 10.1038/ncb1402; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Gao YG, 2006, STRUCTURE, V14, P1755, DOI 10.1016/j.str.2006.09.014; Goto J, 1997, NEUROSCI RES, V28, P373, DOI 10.1016/S0168-0102(97)00056-4; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hu HY, 2004, J BIOL CHEM, V279, P39736, DOI 10.1074/jbc.M402842200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Miller SLH, 2007, J BIOL CHEM, V282, P10096, DOI 10.1074/jbc.M611151200; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; Ogura K, 2006, J BIOL CHEM, V281, P3660, DOI 10.1074/jbc.M505193200; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Raasi Shahri, 2005, V301, P47; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; ROSENBERG RN, 1992, MOVEMENT DISORD, V7, P193, DOI 10.1002/mds.870070302; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Shekhtman A, 2002, BIOCHEM BIOPH RES CO, V296, P1222, DOI 10.1016/S0006-291X(02)02006-5; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tarlac V, 2003, J NEUROSCI RES, V74, P406, DOI 10.1002/jnr.10746; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; WANG AC, 1995, J BIOMOL NMR, V5, P376; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010	61	35	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13202	10.1371/journal.pone.0013202	http://dx.doi.org/10.1371/journal.pone.0013202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949063	Green Published, gold, Green Submitted			2022-12-25	WOS:000282633700009
J	Jiroutova, K; Koreny, L; Bowler, C; Obornik, M				Jiroutova, Katerina; Koreny, Ludek; Bowler, Chris; Obornik, Miroslav			A Gene in the Process of Endosymbiotic Transfer	PLOS ONE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; NUCLEOTIDE-SEQUENCE; CHLOROPLAST GENOMES; EVOLUTION; PROTEIN; REVEALS; DNA; TRANSFORMATION; PLASTIDS; NUCLEUS	ackground: The endosymbiotic birth of organelles is accompanied by massive transfer of endosymbiont genes to the eukaryotic host nucleus. In the centric diatom Thalassiosira pseudonana the Psb28 protein is encoded in the plastid genome while a second version is nuclear-encoded and possesses a bipartite N-terminal presequence necessary to target the protein into the diatom complex plastid. Thus it can represent a gene captured during endosymbiotic gene transfer. Methodology/Principal Findings: To specify the origin of nuclear-and plastid-encoded Psb28 in T. pseudonana we have performed extensive phylogenetic analyses of both mentioned genes. We have also experimentally tested the intracellular location of the nuclear-encoded Psb28 protein (nuPsb28) through transformation of the diatom Phaeodactylum tricornutum with the gene in question fused to EYFP. Conclusions/Significance: We show here that both versions of the psb28 gene in T. pseudonana are transcribed. We also provide experimental evidence for successful targeting of the nuPsb28 fused with EYFP to the diatom complex plastid. Extensive phylogenetic analyses demonstrate that nucleotide composition of the analyzed genes deeply influences the tree topology and that appropriate methods designed to deal with a compositional bias of the sequences and the long branch attraction artefact (LBA) need to be used to overcome this obstacle. We propose that nuclear psb28 in T. pseudonana is a duplicate of a plastid localized version, and that it has been transferred from its endosymbiont.	[Jiroutova, Katerina; Koreny, Ludek; Obornik, Miroslav] Acad Sci Czech Republ, Inst Parasitol, CR-37005 Ceske Budejovice, Czech Republic; [Jiroutova, Katerina; Koreny, Ludek; Obornik, Miroslav] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Bowler, Chris] Ecole Normale Super, CNRS, UMR8197, Inst Biol, Paris, France	Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Jiroutova, K (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	obornik@paru.cas.cz	Koreny, Ludek/G-9766-2014; Obornik, Miroslav/G-9350-2014; Bowler, Chris/AAC-6256-2019	Bowler, Chris/0000-0003-3835-6187; Koreny, Ludek/0000-0002-9979-3172	Ministry of Education of the Czech Republic [MSMT 6007665801]; Academy of Sciences of the Czech Republic [z60220518]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA601410907]; Agence Nationale de la Recherche (ANR)	Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the Ministry of Education of the Czech Republic (MSMT 6007665801), Research Plan of the Academy of Sciences of the Czech Republic (z60220518) and the Grant Agency of the Academy of Sciences of the Czech Republic to M.O. (IAA601410907), and the Agence Nationale de la Recherche (ANR) to C. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cattolico RA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-211; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Huang CY, 2004, P NATL ACAD SCI USA, V101, P9710, DOI 10.1073/pnas.0400853101; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kroth PG, 2002, INT REV CYTOL, V221, P191; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Maheswari U, 2009, NUCLEIC ACIDS RES, V37, pD1001, DOI 10.1093/nar/gkn905; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Nassoury N, 2005, BBA-MOL CELL RES, V1743, P5, DOI 10.1016/j.bbamcr.2004.09.017; Nisbet RER, 2004, CURR BIOL, V14, pR1048, DOI 10.1016/j.cub.2004.11.043; Obornik M, 2009, INT J PARASITOL, V39, P1, DOI 10.1016/j.ijpara.2008.07.010; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Sheppard AE, 2008, PLANT PHYSIOL, V148, P328, DOI 10.1104/pp.108.119107; Shi LX, 2004, BBA-BIOENERGETICS, V1608, P75, DOI 10.1016/j.bbabio.2003.12.004; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Stirewalt VL, 1995, PLANT MOL BIOL REP, V13, P327, DOI 10.1007/BF02669186; SWOFFORD D.L., 2000, PHYLOGENETIC ANAL US; Van de Peer Y, 2002, GENE, V295, P205, DOI 10.1016/S0378-1119(02)00689-3	38	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13234	10.1371/journal.pone.0013234	http://dx.doi.org/10.1371/journal.pone.0013234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949086	Green Submitted, gold, Green Published			2022-12-25	WOS:000282568400020
J	Breitling, LP; Arndt, V; Drath, C; Rothenbacher, D; Brenner, H				Breitling, Lutz P.; Arndt, Volker; Drath, Christoph; Rothenbacher, Dietrich; Brenner, Hermann			Smoking and gamma-Glutamyltransferase: Opposite Interactions with Alcohol Consumption and Body Mass Index	PLOS ONE			English	Article							CONSTRUCTION WORKERS; CIGARETTE-SMOKING; OXIDATIVE STRESS; LIVER-ENZYMES; RISK; COHORT; MEN; MORTALITY; DETERMINANTS; ASSOCIATION	Background: Smoking has recently been suggested to synergistically interact with alcohol intake as a determinant of serum gamma-glutamyltransferase (gamma-GT), an emergent powerful predictor of disease and mortality. This study investigated whether this also applies to higher smoking and alcohol exposure ranges and to body mass index (BMI), which likewise is strongly associated with gamma-GT. Methodology/Principal Findings: Analyses were based on occupational health examinations of more than 15,000 German male workers aged 16-64 years, predominantly from the construction industry. Sociodemographics and other health-related information were collected during the exam. Joint associations of smoking and alcohol consumption or BMI with elevated or log-transformed gamma-GT were examined by tabulation and multiple adjusted regression models. Cigarette smoking exerted no effect on gamma-GT in teetotalers, but there was a statistically significant effect of smoking among participants with higher alcohol consumption intensity, odds of elevated gamma-GT being increased by 24% and 27% per additional 10 cigarettes smoked per day in subjects drinking 61-90 and > 90 gram alcohol per day, respectively (P for interaction = 0.039). The interaction was opposite for BMI, where no association was seen in obese subjects, whereas odds of elevated gamma-GT were increased by 24% per 10 cigarettes below 25 kg/m(2) (P for interaction = 0.040). This novel interaction was replicable in an independent cohort. Conclusion: The evidence for opposite interactions of smoking with alcohol and BMI as determinants of serum gamma-GT suggests that different physiological pathways are responsible for the associations between these factors.	[Breitling, Lutz P.; Arndt, Volker; Rothenbacher, Dietrich; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany; [Drath, Christoph] Workmens Compensat Board Construct Workers, Occupat Hlth Serv, Boblingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Breitling, LP (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany.	L.Breitling@dkfz-heidelberg.de	Brenner, Hermann/ABE-6383-2020; /AAM-5330-2020; Brenner, Hermann/B-4627-2017; Arndt, Volker/AAI-7282-2020; Breitling, Lutz/C-7377-2008; Arndt, Volker/B-4999-2014	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Arndt, Volker/0000-0001-9320-8684; Arndt, Volker/0000-0001-9320-8684; Rothenbacher, Dietrich/0000-0002-3563-2791	Association of the Workmen's Compensation Board for Construction Workers, Germany; German Research Foundation (DFG) [Br1704/11-1, SPP1226]	Association of the Workmen's Compensation Board for Construction Workers, Germany; German Research Foundation (DFG)(German Research Foundation (DFG))	Funding from the Association of the Workmen's Compensation Board for Construction Workers, Germany, is gratefully acknowledged. LPB was supported by grant Br1704/11-1 within the German Research Foundation (DFG) priority programme SPP1226 "Nicotine''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo PI, 2008, AM J CLIN NUTR, V88, P1097, DOI 10.1093/ajcn/88.4.1097; Arndt V, 1998, INT ARCH OCC ENV HEA, V71, P405, DOI 10.1007/s004200050299; Bidel S, 2008, EUR J CLIN NUTR, V62, P178, DOI 10.1038/sj.ejcn.1602712; Breitling LP, 2010, J EPIDEMIOL COMMUN H, V64, P300, DOI 10.1136/jech.2009.089458; Breitling LP, 2009, HEPATOLOGY, V49, P802, DOI 10.1002/hep.22727; BRENNER H, 1992, EPIDEMIOLOGY, V3, P420, DOI 10.1097/00001648-199209000-00007; Brenner H, 1997, PREV MED, V26, P305, DOI 10.1006/pmed.1997.0144; Burke A, 2003, PROG CARDIOVASC DIS, V46, P79, DOI 10.1016/S0033-0620(03)00076-8; Claessen H, 2009, OCCUP ENVIRON MED, V66, P402, DOI 10.1136/oem.2008.042440; Claessen H, 2010, HEPATOLOGY, V51, P482, DOI 10.1002/hep.23324; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Husain K, 2001, ALCOHOL, V25, P89, DOI 10.1016/S0741-8329(01)00176-8; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Lee DH, 2008, ARTERIOSCL THROM VAS, V28, pE26, DOI 10.1161/ATVBAHA.107.159376; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Low M, 2004, DEUT MED WOCHENSCHR, V129, P2643, DOI 10.1055/s-2004-836089; Meisinger C, 2006, ATHEROSCLEROSIS, V189, P297, DOI 10.1016/j.atherosclerosis.2006.01.010; Meisinger C, 2005, J INTERN MED, V258, P527, DOI 10.1111/j.1365-2796.2005.01572.x; POIKOLAINEN K, 1985, BRIT J ADDICT, V80, P215; Poikolainen K, 1997, AM J EPIDEMIOL, V146, P1019, DOI 10.1093/oxfordjournals.aje.a009230; Rebagliato M, 2002, J EPIDEMIOL COMMUN H, V56, P163, DOI 10.1136/jech.56.3.163; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Sillanaukee P, 2000, AM J EPIDEMIOL, V152, P747, DOI 10.1093/aje/152.8.747; Steffensen FH, 1997, INT J EPIDEMIOL, V26, P92, DOI 10.1093/ije/26.1.92; Strasak AM, 2008, CANCER RES, V68, P3970, DOI 10.1158/0008-5472.CAN-07-6686; THORNTON RJ, 1989, J LABOR RES, V10, P443, DOI 10.1007/BF02685335; Wannamethee SG, 2010, ANN CLIN BIOCHEM, V47, P321, DOI 10.1258/acb.2010.009303; Whitehead TP, 1996, ANN CLIN BIOCHEM, V33, P530, DOI 10.1177/000456329603300607; WHO, 1995, 854 WHO TRS; Yamada Y, 2003, J OCCUP HEALTH, V45, P293, DOI 10.1539/joh.45.293	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13116	10.1371/journal.pone.0013116	http://dx.doi.org/10.1371/journal.pone.0013116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927196	Green Published, gold, Green Submitted			2022-12-25	WOS:000282312600031
J	Cauda, F; Geminiani, G; D'Agata, F; Sacco, K; Duca, S; Bagshaw, AP; Cavanna, AE				Cauda, Franco; Geminiani, Giuliano; D'Agata, Federico; Sacco, Katiuscia; Duca, Sergio; Bagshaw, Andrew P.; Cavanna, Andrea E.			Functional Connectivity of the Posteromedial Cortex	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; POSTERIOR PARIETAL CORTEX; RESTING-STATE NETWORKS; ANTERIOR CINGULATE CORTEX; BOLD SIGNAL FLUCTUATIONS; DEFAULT-MODE NETWORK; FMRI TIME-SERIES; HUMAN BRAIN; STRUCTURAL CONNECTIVITY; CLUSTERING-ALGORITHM	As different areas within the PMC have different connectivity patterns with various cortical and subcortical regions, we hypothesized that distinct functional modules may be present within the PMC. Because the PMC appears to be the most active region during resting state, it has been postulated to play a fundamental role in the control of baseline brain functioning within the default mode network (DMN). Therefore one goal of this study was to explore which components of the PMC are specifically involved in the DMN. In a sample of seventeen healthy volunteers, we performed an unsupervised voxelwise ROI-based clustering based on resting state functional connectivity. Our results showed four clusters with different network connectivity. Each cluster showed positive and negative correlations with cortical regions involved in the DMN. Progressive shifts in PMC functional connectivity emerged from anterior to posterior and from dorsal to ventral ROIs. Ventral posterior portions of PMC were found to be part of a network implicated in the visuo-spatial guidance of movements, whereas dorsal anterior portions of PMC were interlinked with areas involved in attentional control. Ventral retrosplenial PMC selectively correlated with a network showing considerable overlap with the DMN, indicating that it makes essential contributions in self-referential processing, including autobiographical memory processing. Finally, ventral posterior PMC was shown to be functionally connected with a visual network. The paper represents the first attempt to provide a systematic, unsupervised, voxelwise clustering of the human posteromedial cortex (PMC), using resting-state functional connectivity data. Moreover, a ROI-based parcellation was used to confirm the results.	[Cauda, Franco; Geminiani, Giuliano; D'Agata, Federico; Sacco, Katiuscia; Duca, Sergio] Koelliker Hosp, CCS fMRI, Turin, Italy; [Cauda, Franco; Geminiani, Giuliano; D'Agata, Federico; Sacco, Katiuscia] Univ Turin, Dept Psychol, Turin, Italy; [D'Agata, Federico] AOU S Giovanni Battista, Dept Neurosci, Turin, Italy; [Bagshaw, Andrew P.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Cavanna, Andrea E.] Univ Birmingham, Dept Neuropsychiat, Birmingham, W Midlands, England; [Cavanna, Andrea E.] Birmingham & Solihull Mental Hlth NHS Fdn Trust B, Birmingham, W Midlands, England; [Cavanna, Andrea E.] UCL, Inst Neurol, London, England	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Birmingham; University of Birmingham; University of London; University College London	Cauda, F (corresponding author), Koelliker Hosp, CCS fMRI, Turin, Italy.	franco.cauda@unito.it	Sacco, Katiuscia/J-2133-2012; Cauda, Franco/G-5021-2010; D'Agata, Federico/ABG-8839-2021	Sacco, Katiuscia/0000-0002-9660-5236; Cauda, Franco/0000-0003-1526-8475; D'Agata, Federico/0000-0001-9432-0248; Bagshaw, Andrew/0000-0001-6217-1292	Regione Piemonte, bando Scienze Umane e Sociali	Regione Piemonte, bando Scienze Umane e Sociali(Regione Piemonte)	This study has been supported by Regione Piemonte, bando Scienze Umane e Sociali 2008, L. R. n. 4/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bandettini PA, 2008, HUM BRAIN MAPP, V29, P737, DOI 10.1002/hbm.20607; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BLUM JS, 1950, J COMP NEUROL, V93, P53, DOI 10.1002/cne.900930105; Brodmann, 1909, VERGLEICHENDE LOKALI; Brown W, 1910, BRIT J PSYCHOL, V3, P296, DOI 10.1111/j.2044-8295.1910.tb00207.x; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; CAMINITI R, 1996, VISION MOVEMENT MECH, P42; Canavero S, 2009, J NEUROL, V256, P834, DOI 10.1007/s00415-009-5019-4; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; de Munck JC, 2009, NEUROIMAGE, V47, P69, DOI 10.1016/j.neuroimage.2009.04.029; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fadili MJ, 2001, MED IMAGE ANAL, V5, P55, DOI 10.1016/S1361-8415(00)00035-9; Fadili MJ, 2000, HUM BRAIN MAPP, V10, P160, DOI 10.1002/1097-0193(200008)10:4<160::AID-HBM20>3.0.CO;2-U; Ferandez-Miranda JC, 2008, J NEUROSURG, V108, P764, DOI 10.3171/JNS/2008/108/4/0764; Fiset P, 1999, J NEUROSCI, V19, P5506; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Golay X, 1998, MAGNET RESON MED, V40, P249, DOI 10.1002/mrm.1910400211; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; JOHNSON PB, 1993, EXP BRAIN RES, V97, P361; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Maquet P, 1997, J NEUROSCI, V17, P2807; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller KJ, 2009, P NATL ACAD SCI USA, V106, P12174, DOI 10.1073/pnas.0902071106; Moller U, 2002, NEUROIMAGE, V17, P431, DOI 10.1006/nimg.2002.1166; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Nioche C, 2009, AM J NEURORADIOL, V30, P396, DOI 10.3174/ajnr.A1375; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Petrella JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001104; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sacco K, 2006, NEUROIMAGE, V32, P1441, DOI 10.1016/j.neuroimage.2006.05.018; Smolders A, 2007, MAGN RESON IMAGING, V25, P860, DOI 10.1016/j.mri.2007.02.018; Sorensen T, 1948, K DAN VIDENSK SELSK, V5, P1, DOI DOI 10.1234/12345678; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; von Economo C, 1925, CYTOARCHITEKTONIK HI; WEISSENBACHER A, 2009, NEUROIMAGE; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; ZADEH LA, 1977, CLASSFICATION CLUSTE, P355; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; ZHANG N, IN PRESS J NEUROSCI; Zilles Karl, 2003, Adv Neurol, V93, P1	80	97	97	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13107	10.1371/journal.pone.0013107	http://dx.doi.org/10.1371/journal.pone.0013107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927345	Green Published, Green Submitted, gold			2022-12-25	WOS:000282312600029
J	Poat, B; Hazari, S; Chandra, PK; Gunduz, F; Balart, LA; Alvarez, X; Dash, S				Poat, Bret; Hazari, Sidhartha; Chandra, Partha K.; Gunduz, Feyza; Balart, Luis A.; Alvarez, Xavier; Dash, Srikanta			SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-gamma Signaling in IFN-alpha Resistant HCV Replicon Cells (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							HEPATITIS-C VIRUS; INTERFERON-ALPHA; GENE-EXPRESSION; PLUS RIBAVIRIN; MESSENGER-RNA; RECEPTOR; LIVER; GENOTYPE; THERAPY; PROTEIN	Background: We have developed multiple stable cell lines containing subgenomic HCV RNA that are resistant to treatment with interferon alpha (IFN-alpha Characterization of these IFN-alpha resistant replicon cells showed defects in the phosphorylation and nuclear translocation of STAT1 and STAT2 proteins due to a defective Jak-STAT pathway. Methodology/Principal Findings: In this study, we have developed an alternative strategy to overcome interferon resistance in a cell culture model by improving intracellular STAT1 signaling. An engineered STAT1-CC molecule with double cysteine substitutions in the Src-homology 2 (SH2) domains of STAT1 (at Ala-656 and Asn-658) efficiently phosphorylates and translocates to the nucleus of IFN-resistant cells in an IFN-gamma dependent manner. Transfection of a plasmid clone containing STAT1-CC significantly activated the GAS promoter compared to wild type STAT1 and STAT3. The activity of the engineered STAT1-CC is dependent upon the phosphorylation of tyrosine residue 701, since the construct with a substituted phenylalanine residue at position 701 (STAT1-CC-Y701F) failed to activate GAS promoter in the replicon cells. Intracellular expression of STAT1-CC protein showed phosphorylation and nuclear translocation in the resistant cell line after IFN-gamma treatment. Transient transfection of STAT1-CC plasmid clone into an interferon resistant cell line resulted in inhibition of viral replication and viral clearance in an IFN-gamma dependent manner. Furthermore, the resistant replicon cells transfected with STAT1-CC constructs significantly up regulated surface HLA-1 expression when compared to the wild type and Y to F mutant controls. Conclusions: These results suggest that modification of the SH2 domain of the STAT1 molecule allows for improved IFN-gamma signaling through increased STAT1 phosphorylation, nuclear translocation, HLA-1 surface expression, and prolonged interferon antiviral gene activation.	[Poat, Bret; Hazari, Sidhartha; Chandra, Partha K.; Gunduz, Feyza; Dash, Srikanta] Dept Pathol & Lab Med, New Orleans, LA USA; [Gunduz, Feyza; Balart, Luis A.; Dash, Srikanta] Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Alvarez, Xavier] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA	Tulane University; Tulane University	Poat, B (corresponding author), Dept Pathol & Lab Med, New Orleans, LA USA.	sdash@tulane.edu			National Cancer Institute [CA127481, CA129776]; Louisiana Cancer Research Consortium; Tulane Cancer Center; Louisiana Board of Regents; National Institutes of Health [RR000164]; NATIONAL CANCER INSTITUTE [R21CA129776, R01CA127481] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Louisiana Cancer Research Consortium; Tulane Cancer Center; Louisiana Board of Regents; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funds received from the National Cancer Institute (CA127481, CA129776), Louisiana Cancer Research Consortium, and Tulane Cancer Center. Louisiana Board of Regents provided a graduate fellowship to BP. This work was also supported partially by National Institutes of Health Grant RR000164 (XAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2009, MOL THER, V17, P872, DOI 10.1038/mt.2009.36; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brown RS, 2003, LIVER TRANSPLANT, V9, pS10, DOI 10.1053/jlts.2003.50244; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Cheney IW, 2002, J VIROL, V76, P11148, DOI 10.1128/JVI.76.21.11148-11154.2002; Dash S, 2005, LIVER INT, V25, P580, DOI 10.1111/j.1478-3231.2005.01082.x; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Frese M, 2002, HEPATOLOGY, V35, P694, DOI 10.1053/jhep.2002.31770; Fujiwara D, 2004, J VIRAL HEPATITIS, V11, P136, DOI 10.1046/j.1365-2893.2003.00477.x; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Hazari S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-36; Hazari S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-89; He YP, 2002, VIRAL IMMUNOL, V15, P95, DOI 10.1089/088282402317340260; Kim SI, 2007, MOL THER, V15, P1145, DOI 10.1038/sj.mt.6300168; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Kumashiro R, 2002, HEPATOL RES, V22, P20, DOI 10.1016/S1386-6346(01)00113-9; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Liddle FJ, 2006, BIOCHEMISTRY-US, V45, P5599, DOI 10.1021/bi0525674; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Melen K, 2000, J HEPATOL, V33, P764, DOI 10.1016/S0168-8278(00)80308-6; Meng XW, 2005, WORLD J GASTROENTERO, V11, P3962; Morita K, 1998, J CLIN GASTROENTEROL, V26, P135, DOI 10.1097/00004836-199803000-00010; Pestka S, 2000, BIOPOLYMERS, V55, P254, DOI 10.1002/1097-0282(2000)55:4<254::AID-BIP1001>3.0.CO;2-1; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; SAEZROYUELA F, 1991, HEPATOLOGY, V13, P327, DOI 10.1002/hep.1840130220; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Soza A, 2005, J HEPATOL, V43, P67, DOI 10.1016/j.jhep.2005.02.023; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sy Theodore, 2006, Int J Med Sci, V3, P41; Taniguchi H, 2007, INTERVIROLOGY, V50, P32, DOI 10.1159/000096310; Taylor DR, 2000, MICROBES INFECT, V2, P1743, DOI 10.1016/S1286-4579(00)01329-0; Trepo C, 2000, J VIRAL HEPATITIS, V7, P250; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Welzel TM, 2009, HEPATOLOGY, V49, P1847, DOI 10.1002/hep.22877; Zhang Y, 2005, J BIOL CHEM, V280, P34306, DOI 10.1074/jbc.M503263200; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	42	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13117	10.1371/journal.pone.0013117	http://dx.doi.org/10.1371/journal.pone.0013117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20949125	gold, Green Published, Green Submitted			2022-12-25	WOS:000282312600032
J	DeCicco-Skinner, KL; Trovato, EL; Simmons, JK; Lepage, PK; Wiest, JS				DeCicco-Skinner, K. L.; Trovato, E. L.; Simmons, J. K.; Lepage, P. K.; Wiest, J. S.			Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis	ONCOGENE			English	Article						Tpl2; skin cancer; inflammation; MAP3K8; NF-kappa B	NF-KAPPA-B; PROTEIN-KINASE-C; NF-KAPPA-B1 P105; MOUSE SKIN; SIGNALING PATHWAYS; CANCER DEVELOPMENT; TRANSGENIC MICE; T-CELLS; IN-VIVO; ACTIVATION	Tumor progression locus 2 (Tpl2) is a serine/threonine kinase in the mitogen-activated protein kinase signal transduction cascade known to regulate inflammatory pathways. Previously identified as an oncogene, its mutation or overexpression is reported in a variety of human cancers. To address its role in skin carcinogenesis, Tpl2(-/-) or wild-type (WT) C57BL/6 mice were subjected to a two-stage dimethylbenzanthracene/12-O-tetradecanoylphorbol- 13-acetate (TPA) mouse skin carcinogenesis model. Tpl2(-/-) mice developed a significantly higher incidence of tumors (80%) than WT mice (17%), as well as a reduced tumor latency and a significantly higher number of total tumors (113 vs 6). Moreover, Tpl2(-/-) mice treated with TPA experienced significantly higher nuclear factor kappaB (NF-kappa B) activation, edema, infiltrating neutrophils and production of proinflammatory cytokines than did WT mice. We investigated the role of the p38, JNK, MEK and NF-kappa B signaling pathways both in vitro and in vivo in WT and Tpl2(-/-) mice by using inhibitors for each of these pathways. We confirmed that the proinflammatory effect in Tpl2(-/-) mice was due to heightened activity of the NF-kappa B pathway. These studies indicate that Tpl2 may serve more as a tumor suppressor than as an oncogene in chemically induced skin carcinogenesis, with its absence contributing to both tumorigenesis and inflammation. Oncogene (2011) 30, 389-397; doi: 10.1038/onc.2010.447; published online 11 October 2010	[DeCicco-Skinner, K. L.; Trovato, E. L.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Trovato, E. L.; Simmons, J. K.; Lepage, P. K.; Wiest, J. S.] American Univ, Dept Biol, Washington, DC 20016 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American University	Wiest, JS (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, 37 Convent Dr, Bethesda, MD 20892 USA.	wiestj@mail.nih.gov		DeCicco-Skinner, Kathleen/0000-0002-0256-5609	NCI/NIH; NATIONAL CANCER INSTITUTE [ZIABC011108] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Jyotsna Pandey for her assistance with confocal microscopy. This work was supported by the NCI/NIH Intramural Research Program.	AOKI M, 1991, ONCOGENE, V6, P1515; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Cataisson C, 2005, J IMMUNOL, V174, P1686, DOI 10.4049/jimmunol.174.3.1686; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Clark AM, 2004, GENE CHROMOSOME CANC, V41, P99, DOI 10.1002/gcc.20069; Colombo MP, 1996, CANCER RES, V56, P2531; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DIGIOVANNI J, 1984, CARCINOGENESIS, V5, P1493, DOI 10.1093/carcin/5.11.1493; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Glick A, 2007, MOL CARCINOGEN, V46, P605, DOI 10.1002/mc.20345; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hu YH, 2006, BIOORG MED CHEM LETT, V16, P6067, DOI 10.1016/j.bmcl.2006.08.102; Jansen AP, 2001, CANCER RES, V61, P808; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Reddig PJ, 1999, CANCER RES, V59, P5710; RIJZEWIJK JJ, 1989, ACTA DERM-VENEREOL, V69, P512; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Sharma SD, 2009, CARCINOGENESIS, V30, P1970, DOI 10.1093/carcin/bgp228; Sourvinos G, 1999, ONCOGENE, V18, P4968, DOI 10.1038/sj.onc.1202891; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; Sur I, 2008, INT REV IMMUNOL, V27, P205, DOI 10.1080/08830180802130319; TAHARA H, 1994, CANCER RES, V54, P182; Tomczak MF, 2006, J IMMUNOL, V176, P1244, DOI 10.4049/jimmunol.176.2.1244; Tsatsanis C, 2000, INT J MOL MED, V5, P583; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Tsatsanis C, 2008, P NATL ACAD SCI USA, V105, P2987, DOI 10.1073/pnas.0708381104; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Velasco-Sampayo A, 2001, J IMMUNOL, V166, P6084, DOI 10.4049/jimmunol.166.10.6084; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6	44	25	25	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	4					389	397		10.1038/onc.2010.447	http://dx.doi.org/10.1038/onc.2010.447			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	711WH	20935675	Green Accepted			2022-12-25	WOS:000286621600002
J	Moller, C; Melaun, C; Castillo, C; Diaz, ME; Renzelman, CM; Estrada, O; Kuch, U; Lokey, S; Mari, F				Moeller, Carolina; Melaun, Christian; Castillo, Cecilia; Diaz, Mary E.; Renzelman, Chad M.; Estrada, Omar; Kuch, Ulrich; Lokey, Scott; Mari, Frank			Functional Hypervariability and Gene Diversity of Cardioactive Neuropeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAB CARCINUS-MAENAS; D-AMINO-ACID; PEPTIDE CCAP; MANDUCA-SEXTA; SHORE CRAB; CARDIOACCELERATORY PEPTIDE; GAMMA-CARBOXYGLUTAMATE; DECAPOD CRUSTACEANS; LOCUSTA-MIGRATORIA; ALPHA-AMYLASE	Crustacean cardioactive peptide (CCAP) and related peptides are multifunctional regulatory neurohormones found in invertebrates. We isolated a CCAP-related peptide (conoCAP-a, for cone snail CardioActive Peptide) and cloned the cDNA of its precursor from venom of Conus villepinii. The precursor of conoCAP-a encodes for two additional CCAP-like peptides: conoCAP-b and conoCAP-c. This multi-peptide precursor organization is analogous to recently predicted molluscan CCAP-like preprohormones, and suggests a mechanism for the generation of biological diversification without gene amplification. While arthropod CCAP is a cardio-accelerator, we found that conoCAP-a decreases the heart frequency in Drosophila larvae, demonstrating that conoCAP-a and CCAP have opposite effects. Intravenous injection of conoCAP-a in rats caused decreased heart frequency and blood pressure in contrast to the injection of CCAP, which did not elicit any cardiac effect. Perfusion of rat ventricular cardiac myocytes with conoCAP-a decreased systolic calcium, indicating that conoCAP-a cardiac negative inotropic effects might be mediated via impairment of intracellular calcium trafficking. The contrasting cardiac effects of conoCAP-a and CCAP indicate that molluscan CCAP-like peptides have functions that differ from those of their arthropod counterparts. Molluscan CCAP-like peptides sequences, while homologous, differ between taxa and have unique sequences within a species. This relates to the functional hypervariability of these peptides as structure activity relationship studies demonstrate that single amino acids variations strongly affect cardiac activity. The discovery of conoCAPs in cone snail venom emphasizes the significance of their gene plasticity to have mutations as an adaptive evolution in terms of structure, cellular site of expression, and physiological functions.	[Mari, Frank] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; [Melaun, Christian; Kuch, Ulrich] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Castillo, Cecilia] Inst Estudios Avanzados IDEA, Ctr Biociencias & Med Mol, Caracas 1015A, Venezuela; [Diaz, Mary E.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Renzelman, Chad M.; Lokey, Scott] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; Inst Venezolano Invest Cient, Biophys & Biochem Ctr, Caracas 1020A, Venezuela	State University System of Florida; Florida Atlantic University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Edinburgh; University of California System; University of California Santa Cruz; Venezuelan Institute Science Research	Mari, F (corresponding author), Florida Atlantic Univ, Dept Chem & Biochem, 777 Glades Rd, Boca Raton, FL 33431 USA.	mari@fau.edu	Castillo, Cecilia/AAH-1903-2020; Kuch, Ulrich/C-6656-2013; Estrada, Omar/G-9953-2018	Castillo, Cecilia/0000-0003-3978-2866; Kuch, Ulrich/0000-0002-5091-7752; Diaz, Mary/0000-0001-8946-8563; Estrada, Omar/0000-0001-9214-5183	National Institutes of Health [1R21NS066371-01]; Florida Seagrant program [R/LR-MB-28]; Hesse's Ministry of Higher Education, Research, and the Arts (UK); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Seagrant program; Hesse's Ministry of Higher Education, Research, and the Arts (UK); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21NS066371-01 (to F.M.), Florida Seagrant program Grant R/LR-MB-28 (to F.M.), LOEWE-Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of Hesse's Ministry of Higher Education, Research, and the Arts (UK).	Aguilar MB, 2008, PEPTIDES, V29, P186, DOI 10.1016/j.peptides.2007.09.022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; CARPINO LA, 1986, J ORG CHEM, V51, P3732, DOI 10.1021/jo00369a042; Cazzamali G, 2003, BIOCHEM BIOPH RES CO, V303, P146, DOI 10.1016/S0006-291X(03)00302-4; Chung JS, 2006, J EXP BIOL, V209, P3862, DOI 10.1242/jeb.02425; Chung JS, 2004, DEVELOPMENT, V131, P4751, DOI 10.1242/dev.01312; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; Dasari S, 2006, J COMP PHYSIOL B, V176, P349, DOI 10.1007/s00360-005-0058-3; Dewey EM, 2004, CURR BIOL, V14, P1208, DOI 10.1016/j.cub.2004.06.051; Diaz ME, 2002, CIRC RES, V91, P585, DOI 10.1161/01.RES.0000035527.53514.C2; Donini A, 2002, PEPTIDES, V23, P1915, DOI 10.1016/S0196-9781(02)00174-2; Donini A, 2002, PEPTIDES, V23, P683, DOI 10.1016/S0196-9781(01)00662-3; Ducancel F, 2002, TOXICON, V40, P1541, DOI 10.1016/S0041-0101(02)00159-9; Dulcis D, 2005, J NEUROBIOL, V64, P259, DOI 10.1002/neu.20136; Dulcis D, 2001, J COMP PHYSIOL A, V187, P837, DOI 10.1007/s00359-001-0254-x; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; EIPPER BA, 1985, ENDOCRINOLOGY, V116, P2497, DOI 10.1210/endo-116-6-2497; Fort TJ, 2007, J NEUROPHYSIOL, V97, P3407, DOI 10.1152/jn.00939.2006; Franco A, 2006, PROG MOLEC, V43, P83, DOI 10.1007/978-3-540-30880-5_4; FURUYA K, 1993, BIOL CHEM H-S, V374, P1065, DOI 10.1515/bchm3.1993.374.7-12.1065; Gammie SC, 1997, J NEUROSCI, V17, P4389; Honegger HW, 2002, J COMP NEUROL, V452, P163, DOI 10.1002/cne.10357; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; LEHMAN HK, 1993, PEPTIDES, V14, P735, DOI 10.1016/0196-9781(93)90106-Q; Lirazan M, 2002, TOXICON, V40, P901, DOI 10.1016/S0041-0101(02)00079-X; Maillo M, 2002, TOXICON, V40, P401, DOI 10.1016/S0041-0101(01)00176-3; Minakata H., 1992, PEPTIDE CHEM; Moller C, 2007, BIOCHEM J, V404, P413, DOI 10.1042/BJ20061480; Moller C, 2005, BIOCHEMISTRY-US, V44, P15986, DOI 10.1021/bi0511181; Muneoka Y., 1994, PERSPECTIVES COMP EN; Nagata K., 2005, PEPTIDE SCI, V44, P441; Nichols R, 1999, PEPTIDES, V20, P1153, DOI 10.1016/S0196-9781(99)00118-7; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; OLIVERA BM, 1995, TRENDS BIOTECHNOL, V13, P422, DOI 10.1016/S0167-7799(00)88996-9; Phlippen MK, 2000, J EXP BIOL, V203, P521; Pimenta AMC, 2005, J PEPT SCI, V11, P670, DOI 10.1002/psc.701; Sakai T, 2004, ENDOCRINOLOGY, V145, P5671, DOI 10.1210/en.2004-0722; Sakai T, 2006, PEPTIDES, V27, P2157, DOI 10.1016/j.peptides.2006.04.009; SCHWARTZ TW, 1986, FEBS LETT, V200, P1, DOI 10.1016/0014-5793(86)80500-2; STANGIER J, 1987, P NATL ACAD SCI USA, V84, P575, DOI 10.1073/pnas.84.2.575; STANGIER J, 1989, GEN COMP ENDOCR, V74, P271; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; THORNDYKE MC, 1988, BIOL J LINN SOC, V34, P249, DOI 10.1111/j.1095-8312.1988.tb01962.x; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; Torres AM, 2002, FEBS LETT, V524, P172, DOI 10.1016/S0014-5793(02)03050-8; TUBLITZ NJ, 1986, J NEUROSCI, V6, P2451; Veelaert D, 1997, ENDOCRINOLOGY, V138, P138, DOI 10.1210/en.138.1.138; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; WILKENS JL, 1993, PHYSIOL ZOOL, V66, P237, DOI 10.1086/physzool.66.2.30163688	57	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40673	40680		10.1074/jbc.M110.171397	http://dx.doi.org/10.1074/jbc.M110.171397			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20923766	Green Published, hybrid			2022-12-25	WOS:000285414400030
J	Su, SC; Maxwell, SA; Bayless, KJ				Su, Shih-Chi; Maxwell, Steve A.; Bayless, Kayla J.			Annexin 2 Regulates Endothelial Morphogenesis by Controlling AKT Activation and Junctional Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL COLLAGEN MATRICES; SPHINGOSINE 1-PHOSPHATE; LUMEN FORMATION; IN-VIVO; TYROSINE PHOSPHORYLATION; VASCULAR MATURATION; SIGNAL-TRANSDUCTION; ADHERENS JUNCTIONS; BARRIER INTEGRITY; CAPILLARY LUMEN	Sprouting angiogenesis is a multistep process that involves endothelial cell activation, basement membrane degradation, proliferation, lumen formation, and stabilization. In this study, we identified annexin 2 as a regulator of endothelial morphogenesis using a three-dimensional in vitro model where sprouting angiogenesis was driven by sphingosine 1-phosphate and angiogenic growth factors. We observed that sphingosine 1-phosphate triggered annexin 2 translocation from the cytosol to the plasma membrane and its association with vascular endothelial (VE)-cadherin. In addition, annexin 2 depletion attenuated Akt activation, which was associated with increased phosphorylation of VE-cadherin and endothelial barrier leakage. Disrupting homotypic VE-cadherin interactions with EGTA, antibodies to the extracellular domain of VE-cadherin, or gene silencing all resulted in decreased Akt (but not Erk1/2) activation. Furthermore, expression of constitutively active Akt restored reduced endothelial sprouting responses observed with annexin 2 and VE-cadherin knockdown. Collectively, we report that annexin 2 regulates endothelial morphogenesis through an adherens junction-mediated pathway upstream of Akt.	[Su, Shih-Chi; Maxwell, Steve A.; Bayless, Kayla J.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bayless, KJ (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, 440 Reynolds Med Bldg, College Stn, TX 77843 USA.	kbayless@medicine.tamhsc.edu			National Institutes of Health from the NHLBI [RO1HL095786]; Texas A&M Health Science Center [134403-20605]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095786] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Texas A&M Health Science Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HL095786 from the NHLBI (to K. J. B.). This work was also supported by Texas A&M Health Science Center Research Development Grant 134403-20605 to (K. J. B. and S. A. M.).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Babiychuk EB, 2002, FASEB J, V16, DOI 10.1096/fj.02-0070com; Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bayless KJ, 2003, BIOCHEM BIOPH RES CO, V312, P903, DOI 10.1016/j.bbrc.2003.11.017; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Donati C, 2006, BBA-BIOMEMBRANES, V1758, P2037, DOI 10.1016/j.bbamem.2006.06.015; Dossumbekova A, 2008, AM J PHYSIOL-HEART C, V295, pH2417, DOI 10.1152/ajpheart.00501.2008; Egginton S, 2003, MICROCIRCULATION, V10, P45, DOI 10.1038/sj.mn.7800174; Endo A, 2002, J BIOL CHEM, V277, P23747, DOI 10.1074/jbc.M111794200; English D, 2002, BBA-MOL CELL BIOL L, V1582, P228, DOI 10.1016/S1388-1981(02)00176-2; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Heyraud S, 2008, MOL CELL BIOL, V28, P1657, DOI 10.1128/MCB.00695-07; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kang HJ, 2008, AM J PHYSIOL-HEART C, V295, pH2087, DOI 10.1152/ajpheart.00281.2008; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Krump-Konvalinkova V, 2005, ARTERIOSCL THROM VAS, V25, P546, DOI 10.1161/01.ATV.0000154360.36106.d9; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Montesano R, 1992, EXS, V61, P129; Muraki K, 2001, J PHYSIOL-LONDON, V537, P431, DOI 10.1111/j.1469-7793.2001.00431.x; Nicosia RF, 1999, INT REV CYTOL, V185, P1; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohsugi M, 1997, DEV BIOL, V185, P261, DOI 10.1006/dbio.1997.8560; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Somanath PR, 2008, ANGIOGENESIS, V11, P277, DOI 10.1007/s10456-008-9111-7; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Su SC, 2008, AM J PHYSIOL-CELL PH, V295, pC1215, DOI 10.1152/ajpcell.00336.2008; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Tsunezumi J, 2008, FEBS J, V275, P4810, DOI 10.1111/j.1742-4658.2008.06620.x; VERNON RB, 1995, AM J PATHOL, V147, P873; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002	74	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52								10.1074/jbc.M110.157271	http://dx.doi.org/10.1074/jbc.M110.157271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20947498	Green Published, hybrid			2022-12-25	WOS:000285414400025
J	Mayer, PR; Huang, NA; Dewey, CM; Dries, DR; Zhang, H; Yu, G				Mayer, Paul R.; Huang, Nian; Dewey, Colleen M.; Dries, Daniel R.; Zhang, Hong; Yu, Gang			Expression, Localization, and Biochemical Characterization of Nicotinamide Mononucleotide Adenylyltransferase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEINS; DELAYS AXONAL DEGENERATION; GTP-BINDING PROTEINS; SYNAPTIC VESICLES; BETA-COP; NMN/NAMN ADENYLYLTRANSFERASE; NAD BIOSYNTHESIS; TRITON X-114; IN-VIVO; BRAIN	Nicotinamide mononucleotide (NMN) adenylyltransferase 2 (Nmnat2) catalyzes the synthesis of NAD from NMN and ATP. The Nmnat2 transcript is expressed predominately in the brain; we report here that Nmnat2 is a low abundance protein expressed in neurons. Previous studies indicate that Nmnat2 localizes to Golgi. As Nmnat2 is not predicted to contain a signal sequence, lipid-binding domain, or transmembrane domain, we investigated the nature of this interaction. These experiments reveal that Nmnat2 is palmitoylated in vitro, and this modification is required for membrane association. Surprisingly, exogenous Nmnat2 is toxic to neurons, indicating that protein levels must be tightly regulated. To analyze Nmnat2 localization in neurons (previous experiments relied on exogenous expression in HeLa cells), mouse brains were fractionated, showing that Nmnat2 is enriched in numerous membrane compartments including synaptic terminals. In HeLa cells, in addition to Golgi, Nmnat2 localizes to Rab7-containing late endosomes. These studies show that Nmnat2 is a neuronal protein peripherally attached to membranes via palmitoylation and suggest that Nmnat2 is transported to synaptic terminals via an endosomal pathway.	[Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Huang, Nian; Zhang, Hong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Gang.Yu@UTSouthwestern.edu		DRIES, DANIEL/0000-0002-0530-5212	National Institutes of Health [R01 AG029547]; Ruth K. Broad Biomedical Research Foundation; Ted Nash Long Life Foundation; NATIONAL INSTITUTE ON AGING [R01AG029547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth K. Broad Biomedical Research Foundation; Ted Nash Long Life Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG029547. This work was also supported by the Ruth K. Broad Biomedical Research Foundation and the Ted Nash Long Life Foundation.	Abuin A, 2007, Handb Exp Pharmacol, P129; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Conforti L, 2009, J CELL BIOL, V184, P491, DOI 10.1083/jcb.200807175; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; El-Husseini AE, 2001, J BIOL CHEM, V276, P44984, DOI 10.1074/jbc.M103049200; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; GRIFFITHS G, 1995, J CELL SCI, V108, P2839; Hegyi J, 2004, INT J DERMATOL, V43, P1, DOI 10.1111/j.1365-4632.2004.01959.x; HOGEBOOM GH, 1952, J BIOL CHEM, V197, P611; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; KINSELLA BT, 1991, J BIOL CHEM, V266, P8540; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; KNAUS P, 1986, J NEUROCHEM, V47, P1302; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kurnasov OV, 2002, J BACTERIOL, V184, P6906, DOI 10.1128/JB.184.24.6906-6917.2002; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; OPRINS A, 1993, J CELL BIOL, V121, P49, DOI 10.1083/jcb.121.1.49; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Ponnambalam S, 1996, J CELL SCI, V109, P675; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; SALMON P, 2006, CURR PROTOC NEUROSCI, V37; Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; SHAW G, 1982, NATURE, V298, P277, DOI 10.1038/298277a0; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sood R, 2001, GENOMICS, V73, P211, DOI 10.1006/geno.2001.6500; Spies TD, 1939, ANN INTERN MED, V12, P1830, DOI 10.7326/0003-4819-12-11-1830; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Voss AK, 1998, DEV DYNAM, V212, P258; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; WHITTAKER VP, 1993, J NEUROCYTOL, V22, P735, DOI 10.1007/BF01181319; WHITTAKER VP, 1964, BIOCHEM J, V90, P293, DOI 10.1042/bj0900293; Yalowitz JA, 2004, BIOCHEM J, V377, P317, DOI 10.1042/BJ20030518; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	67	51	51	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40387	40396		10.1074/jbc.M110.178913	http://dx.doi.org/10.1074/jbc.M110.178913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20943658	hybrid, Green Published			2022-12-25	WOS:000285185500081
J	Smith-Pearson, PS; Greuber, EK; Yogalingam, G; Pendergast, AM				Smith-Pearson, Pameeka S.; Greuber, Emileigh K.; Yogalingam, Gouri; Pendergast, Ann Marie			Abl Kinases Are Required for Invadopodia Formation and Chemokine-induced Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; EXTRACELLULAR-MATRIX DEGRADATION; SRC-DEPENDENT PHOSPHORYLATION; ALDRICH-SYNDROME PROTEIN; ROUS-SARCOMA-VIRUS; TYROSINE-KINASE; C-ABL; TRANSFORMING ACTIVITY; FAMILY KINASES; N-WASP	The Abl tyrosine kinases, Abl and Arg, play a role in the regulation of the actin cytoskeleton by modulating cell-cell adhesion and cell motility. Deregulation of both the actin cytoskeleton and Abl kinases have been implicated in cancers. Abl kinase activity is elevated in a number of metastatic cancers and these kinases are activated downstream of several oncogenic growth factor receptor signaling pathways. However, the role of Abl kinases in regulation of the actin cytoskeleton during tumor progression and invasion remains elusive. Here we identify the Abl kinases as essential regulators of invadopodia assembly and function. We show that Abl kinases are activated downstream of the chemokine receptor, CXCR4, and are required for cancer cell invasion and matrix degradation induced by SDF1 alpha, serum growth factors, and activated Src kinase. Moreover, Abl kinases are readily detected at invadopodia assembly sites and their inhibition prevents the assembly of actin and cortactin into organized invadopodia structures. We show that active Abl kinases form complexes with membrane type-1 matrix metalloproteinase (MT1-MMP), a critical invadopodia component required for matrix degradation. Further, loss of Abl kinase signaling induces internalization of MT1-MMP from the cell surface, promotes its accumulation in the perinuclear compartment and inhibits MT1-MMP tyrosine phosphorylation. Our findings reveal that Abl kinase signaling plays a critical role in invadopodia formation and function, and have far-reaching implications for the treatment of metastatic carcinomas.	[Smith-Pearson, Pameeka S.; Greuber, Emileigh K.; Yogalingam, Gouri; Pendergast, Ann Marie] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Pendergast, AM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, 308 Res Dr,DUMC Box 3813, Durham, NC 27710 USA.	pende014@mc.duke.edu		Pendergast, Ann Marie/0000-0002-1250-6880	National Institutes of Health [CA 70940, HL 084102]; American Cancer Society New England Division-Spin Odyssey Postdoctoral Fellowship; Molecular Cancer Biology Postdoctoral Fellowship; PhRMA Predoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA070940] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society New England Division-Spin Odyssey Postdoctoral Fellowship(American Cancer Society); Molecular Cancer Biology Postdoctoral Fellowship; PhRMA Predoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 70940 and HL 084102 (to A.M.P.).; Supported by the American Cancer Society New England Division-Spin Odyssey Postdoctoral Fellowship and by the Molecular Cancer Biology Postdoctoral Fellowship Training Grant.; Supported by a PhRMA Predoctoral Fellowship.	Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Bartolome RA, 2009, AM J PATHOL, V174, P602, DOI 10.2353/ajpath.2009.080636; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Burton EA, 2005, MOL CELL BIOL, V25, P8834, DOI 10.1128/MCB.25.20.8834-8843.2005; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; CHEN WT, 1985, NATURE, V316, P156, DOI 10.1038/316156a0; Cho JA, 2008, J BIOL CHEM, V283, P17391, DOI 10.1074/jbc.M708943200; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; DAVIDPFEUTY T, 1980, P NATL ACAD SCI-BIOL, V77, P6687, DOI 10.1073/pnas.77.11.6687; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Koreckij T, 2009, BRIT J CANCER, V101, P263, DOI 10.1038/sj.bjc.6605178; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Li YS, 2001, CANCER RES, V61, P6906; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Miller MM, 2010, BIOCHEMISTRY-US, V49, P2227, DOI 10.1021/bi901721u; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mizutani K, 2002, CANCER RES, V62, P669; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Osiak AE, 2005, EXP CELL RES, V307, P342, DOI 10.1016/j.yexcr.2005.03.035; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Ptasznik A, 2002, J EXP MED, V196, P667, DOI 10.1084/jem.20020519; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Schade B, 2007, CANCER RES, V67, P7579, DOI 10.1158/0008-5472.CAN-06-4724; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Sun XL, 2009, CARCINOGENESIS, V30, P2109, DOI 10.1093/carcin/bgp251; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Yamazaki D, 2009, ONCOGENE, V28, P1570, DOI 10.1038/onc.2009.2; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zou DH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2332	68	63	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40201	40211		10.1074/jbc.M110.147330	http://dx.doi.org/10.1074/jbc.M110.147330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937825	Green Published, hybrid			2022-12-25	WOS:000285185500065
J	Soundararajan, R; Wang, JA; Melters, D; Pearce, D				Soundararajan, Rama; Wang, Jian; Melters, Daniel; Pearce, David			Glucocorticoid-induced Leucine Zipper 1 Stimulates the Epithelial Sodium Channel by Regulating Serum- and Glucocorticoid-induced Kinase 1 Stability and Subcellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; DEGRADATION; ALDOSTERONE; PROTEIN; TRANSPORT; SGK-1; UBIQUITYLATION; EXPRESSION; ISOFORMS; NEDD4-2	Serum-and glucocorticoid-induced kinase 1 (SGK1) is a multifunctional protein kinase that markedly influences various cellular processes such as proliferation, apoptosis, glucose metabolism, and sodium (Na+) transport via the epithelial Na+ channel, ENaC. SGK1 is a short-lived protein, which is predominantly targeted to the endoplasmic reticulum (ER) to undergo rapid proteasome-mediated degradation through the ER-associated degradation (ERAD) system. We show here that the aldosterone-induced chaperone, GILZ1 (glucocorticoid-induced leucine zipper protein-1) selectively decreases SGK1 localization to ER as well as its interaction with ER-associated E3 ubiquitin ligases, HRD1 and CHIP. GILZ1 inhibits SGK1 ubiquitinylation and subsequent proteasome-mediated degradation, thereby prolonging its half-life and increasing its steady-state expression. Furthermore, comparison of the effect of GILZ1 with that of proteasome inhibition (by MG-132) supports the idea that these effects of GILZ1 are secondary to physical interaction of GILZ1 with SGK1 and enhanced recruitment of SGK1 to targets within an "ENaC regulatory complex," thus making less SGK1 available to the ERAD machinery. Finally, effects of GILZ1 knockdown and overexpression strongly support the idea that these effects of GILZ1 are functionally important for ENaC regulation. These data provide new insight into how the manifold activities of SGK1 are selectively deployed and strengthened through modulation of its molecular interactions, subcellular localization, and stability.	[Soundararajan, Rama; Wang, Jian; Pearce, David] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Melters, Daniel] Univ Calif Davis, Cell & Dev Biol Grad Grp, Dept Plant Biol, Davis, CA 95616 USA; [Melters, Daniel] Univ Calif Davis, Cell & Dev Biol Grad Grp, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Pearce, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco	Pearce, D (corresponding author), Univ Calif San Francisco, Dept Med, Div Nephrol, 600 16th St,N274H,Box 2140,Genentech Hall, San Francisco, CA 94143 USA.	dpearce@medsfgh.ucsf.edu	wang, jian/GVS-0711-2022	Melters, Daniel/0000-0003-4809-0562	National Institutes of Health [K01-DK078679, R01-DK56695, R01-DK85101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078679, R01DK085101, R01DK056695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants K01-DK078679 (to R. S.), R01-DK56695 (to D. P.), and R01-DK85101 (to D. P.).	Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Bhargava A, 2004, MOL CELL ENDOCRINOL, V217, P189, DOI 10.1016/j.mce.2003.10.020; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; Feng L, 2007, P NATL ACAD SCI USA, V104, P14348, DOI 10.1073/pnas.0701298104; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; KENDALL JM, 1994, ANAL BIOCHEM, V221, P173, DOI 10.1006/abio.1994.1394; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; Lee EJ, 2009, EXP MOL MED, V41, P555, DOI 10.3858/emm.2009.41.8.061; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; LU M, J AM SOC NEPHROL, V21, P811; McCormick JA, 2005, PHYSIOLOGY, V20, P134, DOI 10.1152/physiol.00053.2004; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morice C, 1999, EUR J NEUROSCI, V11, P1995, DOI 10.1046/j.1460-9568.1999.00609.x; Muller OG, 2003, J AM SOC NEPHROL, V14, P1107, DOI 10.1097/01.ASN.0000061777.67332.77; Pao AC, 2007, AM J PHYSIOL-RENAL, V292, pF1741, DOI 10.1152/ajprenal.00027.2007; Paolino M, 2009, EUR J IMMUNOL, V39, P2337, DOI 10.1002/eji.200939662; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Vallon V, 2005, AM J PHYSIOL-REG I, V288, pR4, DOI 10.1152/ajpregu.00369.2004; Verrey F, 2008, KIDNEY INT, V73, P691, DOI 10.1038/sj.ki.5002737; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200	30	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39905	39913		10.1074/jbc.M110.161133	http://dx.doi.org/10.1074/jbc.M110.161133			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947508	Green Published, hybrid			2022-12-25	WOS:000285185500035
J	Spoerner, M; Hozsa, C; Poetzl, JA; Reiss, K; Ganser, P; Geyer, M; Kalbitzer, HR				Spoerner, Michael; Hozsa, Constantin; Poetzl, Johann A.; Reiss, Kerstin; Ganser, Petra; Geyer, Matthias; Kalbitzer, Hans Robert			Conformational States of Human Rat Sarcoma (Ras) Protein Complexed with Its Natural Ligand GTP and Their Role for Effector Interaction and GTP Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-31 NMR-SPECTROSCOPY; BINDING DOMAIN; H-RAS; EXCHANGE PROCESSES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; P21(RAS); P21; MOLECULES; MECHANISM	The guanine nucleotide-binding protein Ras exists in solution in two different conformational states when complexed with different GTP analogs such as GppNHp or GppCH(2)p. State 1 has only a very low affinity to effectors and seems to be recognized by guanine nucleotide exchange factors, whereas state 2 represents the high affinity effector binding state. In this work we investigate Ras in complex with the physiological nucleoside triphosphate GTP. By polarization transfer P-31 NMR experiments and effector binding studies we show that Ras(wt)center dot Mg2+center dot GTP also exists in a dynamical equilibrium between the weakly populated conformational state 1 and the dominant state 2.At 278 K the equilibrium constant between state 1 and state 2 of C-terminal truncated wild-type Ras(1166) K-12 is 11.3. K-12 of full-length Ras is > 20, suggesting that the C terminus may also have a regulatory effect on the conformational equilibrium. The exchange rate (k(ex)) for Ras(wt)center dot Mg2+center dot GTP is 7 s(-1) and thus 18-fold lower compared with that found for the Ras. GppNHp complex. The intrinsic GTPase activity substantially increases after effector binding for the switch I mutants Ras(Y32F), (Y32R), (Y32W), (Y32C/C118S), (T35S), and the switch II mutant Ras(G60A) by stabilizing state 2, with the largest effect on Ras(Y32R) with a 13-fold increase compared with wild-type. In contrast, no acceleration was observed in Ras(T35A). Thus Ras in conformational state 2 has a higher affinity to effectors as well as a higher GTPase activity. These observations can be used to explain why many mutants have a low GTPase activity but are not oncogenic.	[Spoerner, Michael; Hozsa, Constantin; Poetzl, Johann A.; Reiss, Kerstin; Ganser, Petra; Kalbitzer, Hans Robert] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Geyer, Matthias] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44227 Dortmund, Germany	University of Regensburg; Max Planck Society	Kalbitzer, HR (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93053 Regensburg, Germany.	hans-robert.kalbitzer@biologie.uni-regensburg.de	Spörner, Michael/B-9018-2012; Spoerner, Michael/C-9035-2012	Hozsa, Constantin/0000-0001-7766-3644; Kalbitzer, Hans Robert/0000-0002-6514-2355; Geyer, Matthias/0000-0002-7718-5002	Deutsche Forschungsgemeinschaft; Volkswagenstiftung; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagenstiftung(Volkswagen); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft, the Volkswagenstiftung, and the Fonds der Chemischen Industrie.	Buhrman G, 2007, STRUCTURE, V15, P1618, DOI 10.1016/j.str.2007.10.011; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Geyer M, 1999, BIOCHEMISTRY-US, V38, P11250, DOI 10.1021/bi9904306; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Gronwald W, 2001, STRUCTURE, V9, P1029, DOI 10.1016/S0969-2126(01)00671-2; HAUSSER KH, 1991, NMR MED BIOL STRUCTU; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Iuga A, 2004, J MOL BIOL, V342, P1033, DOI 10.1016/j.jmb.2004.07.077; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1993, J BIOL CHEM, V268, P923; Kalbitzer HR, 2009, J AM CHEM SOC, V131, P16714, DOI 10.1021/ja904314q; Kotting C, 2007, CHEMBIOCHEM, V8, P781, DOI 10.1002/cbic.200600552; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Maurer T, 1996, J MAGN RESON SER B, V113, P177, DOI 10.1006/jmrb.1996.0172; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; RAIFORD DS, 1979, ANAL CHEM, V51, P2050, DOI 10.1021/ac50048a040; ROSCH P, 1986, BIOCHEM BIOPH RES CO, V135, P549, DOI 10.1016/0006-291X(86)90029-X; Rosnizeck IC, 2010, ANGEW CHEM INT EDIT, V49, P3830, DOI 10.1002/anie.200907002; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14225, DOI 10.1021/bi961118o; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Shima F, 2010, J BIOL CHEM, V285, P22696, DOI 10.1074/jbc.M110.125161; Spangler C, 2009, ANAL BIOANAL CHEM, V394, P989, DOI 10.1007/s00216-008-2517-7; Spoerner M, 2005, BIOCHEM BIOPH RES CO, V334, P709, DOI 10.1016/j.bbrc.2005.06.144; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Stumber M, 2002, J MOL BIOL, V323, P899, DOI 10.1016/S0022-2836(02)01010-0; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	42	93	93	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39768	39778		10.1074/jbc.M110.145235	http://dx.doi.org/10.1074/jbc.M110.145235			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937837	Green Published, hybrid			2022-12-25	WOS:000285185500021
J	Durr, KL; Seuffert, I; Friedrich, T				Duerr, Katharina L.; Seuffert, Ina; Friedrich, Thomas			Deceleration of the E1P-E2P Transition and Ion Transport by Mutation of Potentially Salt Bridge-forming Residues Lys-791 and Glu-820 in Gastric H+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-CLAMP FLUOROMETRY; K+-COMPETITIVE INHIBITOR; SWISS-MODEL WORKSPACE; RAT DISTAL COLON; ADENOSINE-TRIPHOSPHATE; ESCHERICHIA-COLI; LACTOSE PERMEASE; INORGANIC-PHOSPHATE; STATE STABILIZATION; CRYSTAL-STRUCTURE	A lysine residue within the highly conserved center of the fifth transmembrane segment in P-IIC-type ATPase alpha-subunits is uniquely found in H,K-ATPases instead of a serine in all Na,K-ATPase isoforms. Because previous studies suggested a prominent role of this residue in determining the electrogenicity of non-gastric H,K-ATPase and in pK(a) modulation of the proton-translocating residues in the gastric H,K-ATPases as well, we investigated its functional significance for ion transport by expressing several Lys-791 variants of the gastric H,K-ATPase in Xenopus oocytes. Although the mutant proteins were all detected at the cell surface, none of the investigated mutants displayed any measurable K+-induced stationary currents. In Rb+ uptake measurements, replacement of Lys-791 by Arg, Ala, Ser, and Glu substantially impaired transport activity and reduced the sensitivity toward the E-2-specific inhibitor SCH28080. Furthermore, voltage clamp fluorometry using a reporter site in the TM5/TM6 loop for labeling with tetramethylrhodamine-6-maleimide revealed markedly changed fluorescence signals. All four investigated mutants exhibited a strong shift toward the E1P state, in agreement with their reduced SCH28080 sensitivity, and an about 5-10-fold decreased forward rate constant of the E1P <-> E2P conformational transition, thus explaining the E1P shift and the reduced Rb+ transport activity. When Glu-820 in TM6 adjacent to Lys-791 was replaced by non-charged or positively charged amino acids, severe effects on fluorescence signals and Rb+ transport were also observed, whereas substitution by aspartate was less disturbing. These results suggest that formation of an E2P-stabilizing interhelical salt bridge is essential to prevent futile proton exchange cycles of H+ pumping P-type ATPases.	[Duerr, Katharina L.; Seuffert, Ina; Friedrich, Thomas] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany	Technical University of Berlin	Durr, KL (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	duerr@ohsu.edu	Friedrich, Thomas/AAA-3418-2022; Duerr, Katharina/A-6975-2015	Duerr, Katharina/0000-0002-3245-4088	Deutsche Forschungsgemeinschaft [SFB 740]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 740 and Cluster of Excellence Unifying Concepts in Catalysis).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asano S, 1997, J BIOL CHEM, V272, P17668, DOI 10.1074/jbc.272.28.17668; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BuffinMeyer B, 1997, AM J PHYSIOL-RENAL, V272, pF124, DOI 10.1152/ajprenal.1997.272.1.F124; Burnay M, 2003, J BIOL CHEM, V278, P19237, DOI 10.1074/jbc.M300946200; Burnay M, 2001, AM J PHYSIOL-RENAL, V281, pF869, DOI 10.1152/ajprenal.2001.281.5.F869; CHIESI M, 1984, BIOCHEMISTRY-US, V23, P2595, DOI 10.1021/bi00307a009; CHMOULIO.M, 1974, PFLUG ARCH EUR J PHY, V350, P309, DOI 10.1007/BF00592639; Cougnon M, 1998, P NATL ACAD SCI USA, V95, P6516, DOI 10.1073/pnas.95.11.6516; Cougnon M, 1996, J BIOL CHEM, V271, P7277, DOI 10.1074/jbc.271.13.7277; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142, DOI 10.1021/bi00243a015; de Meis L, 1977, Biochemistry, V16, P4455, DOI 10.1021/bi00639a020; De Pont JJHHM, 2003, ANN NY ACAD SCI, V986, P175; DEWEER P, 1984, NATURE, V309, P450, DOI 10.1038/309450a0; Durr KL, 2009, J BIOL CHEM, V284, P20147, DOI 10.1074/jbc.M109.005769; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; DUNTEN RL, 1993, BIOCHEMISTRY-US, V32, P3139, DOI 10.1021/bi00063a028; Durr KL, 2008, BIOCHEMISTRY-US, V47, P4288, DOI 10.1021/bi800092k; EFTHYMIADIS A, 1991, BIOCHIM BIOPHYS ACTA, V1068, P73, DOI 10.1016/0005-2736(91)90062-D; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P237, DOI 10.1113/jphysiol.1967.sp008298; GARRAHAN PJ, 1966, NATURE, V211, P1414, DOI 10.1038/2111414a0; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Geibel S, 2003, ANN NY ACAD SCI, V986, P31, DOI 10.1111/j.1749-6632.2003.tb07136.x; Geibel S, 2003, P NATL ACAD SCI USA, V100, P964, DOI 10.1073/pnas.0337336100; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; HELMICHDEJONG ML, 1985, BIOCHIM BIOPHYS ACTA, V821, P377, DOI 10.1016/0005-2736(85)90041-0; Hermsen HPH, 2001, BIOCHEMISTRY-US, V40, P6527, DOI 10.1021/bi002456z; Hermsen HPH, 1999, BBA-BIOMEMBRANES, V1416, P251, DOI 10.1016/S0005-2736(98)00227-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAISSER F, 1993, J CELL BIOL, V123, P1421, DOI 10.1083/jcb.123.6.1421; KING SC, 1991, BIOCHIM BIOPHYS ACTA, V1062, P177, DOI 10.1016/0005-2736(91)90390-T; KNOWLES AF, 1975, J BIOL CHEM, V250, P1949; Koenderink JB, 2004, J BIOL CHEM, V279, P16417, DOI 10.1074/jbc.M400020200; Lew V L, 1970, Nature, V225, P865, DOI 10.1038/225865a0; LORENTZON P, 1988, J BIOL CHEM, V263, P10705; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; MENDLEIN J, 1990, J BIOL CHEM, V265, P5030; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Munson K, 2005, BIOCHEMISTRY-US, V44, P5267, DOI 10.1021/bi047761p; Nissen P, 2009, EMBO J, V28, P1535, DOI 10.1038/emboj.2009.137; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Rajendran VM, 2000, J BIOL CHEM, V275, P13035, DOI 10.1074/jbc.275.17.13035; SACHS G, 1976, J BIOL CHEM, V251, P7690; SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547; Shin JM, 2009, PFLUG ARCH EUR J PHY, V457, P609, DOI 10.1007/s00424-008-0495-4; STEKHOVEN FMAHS, 1986, BIOCHIM BIOPHYS ACTA, V854, P21; STENGELIN M, 1993, J MEMBRANE BIOL, V132, P211; Swarts HGP, 1998, EMBO J, V17, P3029, DOI 10.1093/emboj/17.11.3029; Swarts HGP, 1999, MOL PHARMACOL, V55, P541; Swarts HGP, 2001, J BIOL CHEM, V276, P36909, DOI 10.1074/jbc.M103945200; TANIGUCHI K, 1975, J BIOL CHEM, V250, P3010; THOMAS RC, 1969, J PHYSIOL-LONDON, V201, P495, DOI 10.1113/jphysiol.1969.sp008769; Vagin O, 2001, BIOCHEMISTRY-US, V40, P7480, DOI 10.1021/bi0105328; VANDERHIJDEN HTWM, 1990, J MEMBRANE BIOL, V114, P245, DOI 10.1007/BF01869218; WALLMARK B, 1983, BIOCHIM BIOPHYS ACTA, V728, P31, DOI 10.1016/0005-2736(83)90433-9; WUTHRICH A, 1979, EXPERIENTIA, V35, P1589	60	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39366	39379		10.1074/jbc.M110.133470	http://dx.doi.org/10.1074/jbc.M110.133470			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20921224	Green Published, hybrid			2022-12-25	WOS:000284941300064
J	Lee, GT; Kwon, SJ; Lee, JH; Jeon, SS; Jang, KT; Choi, HY; Lee, HM; Kim, WJ; Kim, SJ; Kim, IY				Lee, Geun Taek; Kwon, Seok Joo; Lee, Jae-Ho; Jeon, Seong Soo; Jang, Kee Taek; Choi, Han Yong; Lee, Hyun Moo; Kim, Wun-Jae; Kim, Seong Jin; Kim, Isaac Yi			Induction of Interleukin-6 Expression by Bone Morphogenetic Protein-6 in Macrophages Requires Both SMAD and p38 Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RECEPTOR; REGULATORS; KINASE; ACTS	Unlike the prototype transforming growth factor-beta (TGF-beta), bone morphogenetic protein-6 (BMP-6) activates macrophages. Here, we report that BMP-6 induces the expression of IL-6 in macrophages. Using overexpression and knockdown experiments, we demonstrate that BMP receptor type II and activin-like kinase-2 are necessary for IL-6 induction by BMP-6. At the intracellular level, both Smad and p38 signaling pathways are required for the induction of IL-6. The cross-talk between the two pathways occurs at the level of transcription factor GATA4 and Smad 1/4. These results, taken together, demonstrate a novel BMP-6 signaling mechanism in which both the Smad and non-Smad pathways directly interact to activate the transcription of a target gene.	[Kim, Isaac Yi] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dean & Betty Gallo Prostate Canc Ctr, Sect Urol Oncol,Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Lee, Geun Taek; Kwon, Seok Joo; Lee, Jae-Ho; Jeon, Seong Soo; Kim, Isaac Yi] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Urol, Sect Urol Oncol,Canc Inst New Jersey,Dept Surg, New Brunswick, NJ 08903 USA; [Jeon, Seong Soo; Choi, Han Yong; Lee, Hyun Moo] Sungkyunkwan Univ, Coll Med, Samsung Med Ctr, Dept Urol, Seoul 135710, South Korea; [Jang, Kee Taek] Sungkyunkwan Univ, Coll Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea; [Kim, Wun-Jae] Chungbuk Natl Univ, Coll Med, Dept Urol, Chonju 361711, South Korea; [Kim, Seong Jin] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 401840, South Korea	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Chungbuk National University; Gachon University	Kim, IY (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dean & Betty Gallo Prostate Canc Ctr, Sect Urol Oncol,Canc Inst New Jersey, 195 Little Albany St,4560, New Brunswick, NJ 08903 USA.	kimiy@umdnj.edu			Ruth Estrin Goldberg Memorial Foundation; Tanzman Foundation; Jon Runyan Score for the Cure; Korean government Ministry of Education, Science, and Technology [09-1975-CCR-EO, PC 080209, R11-2008-014-00001-0]	Ruth Estrin Goldberg Memorial Foundation; Tanzman Foundation; Jon Runyan Score for the Cure; Korean government Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work has been supported in part by grants from the Ruth Estrin Goldberg Memorial Foundation, the Tanzman Foundation, and the Jon Runyan Score for the Cure, and by New Jersey Commission on Cancer Research Grant 09-1975-CCR-EO, Department of Defense Grant PC 080209, and Korea Science and Engineering Foundation Grant R11-2008-014-00001-0 funded by the Korean government Ministry of Education, Science, and Technology.	Belaguli NS, 2007, AM J PHYSIOL-GASTR L, V292, pG1520, DOI 10.1152/ajpgi.00236.2006; Brewer Alison, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000093; Dawes LJ, 2009, INVEST OPHTH VIS SCI, V50, P5318, DOI 10.1167/iovs.08-3223; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hong JH, 2009, IMMUNOLOGY, V128, pe442, DOI 10.1111/j.1365-2567.2008.02998.x; Hsu MY, 2005, CANCER METAST REV, V24, P251, DOI 10.1007/s10555-005-1575-y; Hu MC, 2004, J BIOL CHEM, V279, P12051, DOI 10.1074/jbc.M310526200; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Kwon SJ, 2009, IMMUNOLOGY, V128, pe758, DOI 10.1111/j.1365-2567.2009.03079.x; LIU F, 1995, MOL CELL BIOL, V15, P3479; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sivertsen EA, 2007, EUR J IMMUNOL, V37, P2937, DOI 10.1002/eji.200636759; Tokuda H, 2003, AM J PHYSIOL-ENDOC M, V284, pE1202, DOI 10.1152/ajpendo.00300.2002; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	23	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39401	39408		10.1074/jbc.M110.103705	http://dx.doi.org/10.1074/jbc.M110.103705			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889504	hybrid, Green Published			2022-12-25	WOS:000284941300067
J	Weidenmaier, C; McLoughlin, RM; Lee, JC				Weidenmaier, Christopher; McLoughlin, Rachel M.; Lee, Jean C.			The Zwitterionic Cell Wall Teichoic Acid of Staphylococcus aureus Provokes Skin Abscesses in Mice by a Novel CD4+T-Cell-Dependent Mechanism	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; CAPSULAR POLYSACCHARIDES; NASAL COLONIZATION; ANTIMICROBIAL PEPTIDES; ENDOTHELIAL-CELLS; T-CELLS; EXPRESSION; VIRULENCE; INFECTIONS; RESISTANCE	Zwitterionic polysaccharide (ZPS) components of the bacterial cell envelope have been shown to exert a major histocompatibility complex (MHC) II-dependent activation of CD4+ T cells, which in turn can modulate the outcome and progression of infections in animal models. We investigated the impact of zwitterionic cell wall teichoic acid (WTA) produced by Staphylococcus aureus on the development of skin abscesses in a mouse model. We also compared the relative biological activities of WTA and capsular polysaccharide (CP), important S. aureus pathogenicity factors, in abscess formation. Expression of both WTA and CP markedly affected the ability of S. aureus to induce skin abscess formation in mice. Purified wild-type zwitterionic WTA was more active in inducing abscess formation than negatively charged mutant WTA or purified CP8. To assess the ability of purified native WTA to stimulate T cell proliferation in vitro, we co-cultivated WTA with human T-cells and antigen presenting cells in the presence and absence of various inhibitors of MHC-II presentation. Wild-type WTA induced T cell proliferation to a significantly greater extent than negatively charged WTA. T cell activation was dependent on the presentation of WTA on MHC II, since inhibitors of MHC II-dependent presentation and antibodies to MHC II significantly reduced T cell proliferation. T cells activated in vitro with wild-type WTA, but not negatively charged WTA, induced abscess formation when injected subcutaneously into wild-type mice. CD4-/- mice similarly injected with WTA failed to develop abscesses. Our results demonstrate that the zwitterionic WTA of S. aureus induces CD4+ T-cell proliferation in an MHCII-dependent manner, which in turn modulates abscess formation in a mouse skin infection model. An understanding of this novel T cell-dependent host response to staphylococcal abscess formation may lead to the development of new strategies to combat S. aureus skin and soft tissue infections.	[Weidenmaier, Christopher] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Weidenmaier, C (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	jclee@rics.bwh.harvard.edu		Lee, Jean/0000-0002-8094-5180; McLoughlin, Rachel/0000-0003-4553-018X; Weidenmaier, Christopher/0000-0003-4107-739X	Deutsche Forschungsgesellschaft	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	CW was supported by a fellowship from the Deutsche Forschungsgesellschaft (http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddiley J, 1972, Essays Biochem, V8, P35; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Burian M, 2010, J INFECT DIS, V201, P1414, DOI 10.1086/651619; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cobb BA, 2005, CELL MICROBIOL, V7, P1398, DOI 10.1111/j.1462-5822.2005.00591.x; Cobb BA, 2008, GLYCOBIOLOGY, V18, P707, DOI 10.1093/glycob/cwn050; Cocchiaro JL, 2006, MOL MICROBIOL, V59, P948, DOI 10.1111/j.1365-2958.2005.04978.x; Doss M, J LEUKOC BIOL, V87, P79; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; Herbert S, 2001, J BACTERIOL, V183, P4609, DOI 10.1128/JB.183.15.4609-4613.2001; HUGHES AH, 1973, BIOCHEM J, V132, P83, DOI 10.1042/bj1320083; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Kalka-Moll WM, 2002, J IMMUNOL, V169, P6149, DOI 10.4049/jimmunol.169.11.6149; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Koprivnjak T, 2008, INFECT IMMUN, V76, P2169, DOI 10.1128/IAI.01705-07; Kraus D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-85; LEE JC, 1993, INFECT IMMUN, V61, P1853, DOI 10.1128/IAI.61.5.1853-1858.1993; Luong T, 2002, INFECT IMMUN, V70, P444, DOI 10.1128/IAI.70.2.444-450.2002; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; McLoughlin RM, 2006, P NATL ACAD SCI USA, V103, P10408, DOI 10.1073/pnas.0508961103; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Moreillon P, 2003, SCAND J INFECT DIS, V35, P632, DOI 10.1080/00365540310016259; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nilsson IM, 1997, INFECT IMMUN, V65, P4216, DOI 10.1128/IAI.65.10.4216-4221.1997; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pohlmann-Dietze P, 2000, INFECT IMMUN, V68, P4865, DOI 10.1128/IAI.68.9.4865-4871.2000; Portoles M, 2001, INFECT IMMUN, V69, P917, DOI 10.1128/IAI.69.2.917-923.2001; SAXENA S, 1997, EMERG INFECT DIS, V16, P530; SCHLAG M, MOL MICROBIOL; Stevens DL, 2009, J INFECTION, V59, pS32, DOI 10.1016/S0163-4453(09)60006-2; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; TOMASZ A, 1975, J SUPRAMOL STR CELL, V3, P1, DOI 10.1002/jss.400030102; Tzianabos AO, 2001, P NATL ACAD SCI USA, V98, P9365, DOI 10.1073/pnas.161175598; Tzianabos AO, 2000, INFECT IMMUN, V68, P6650, DOI 10.1128/IAI.68.12.6650-6655.2000; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, INT J MED MICROBIOL, V298, P505, DOI 10.1016/j.ijmm.2007.11.006	49	32	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13227	10.1371/journal.pone.0013227	http://dx.doi.org/10.1371/journal.pone.0013227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949105	Green Published, Green Submitted, gold			2022-12-25	WOS:000282633700016
J	Zach, S; Felk, S; Gillardon, F				Zach, Susanne; Felk, Sandra; Gillardon, Frank			Signal Transduction Protein Array Analysis Links LRRK2 to Ste20 Kinases and PKC Zeta That Modulate Neuronal Plasticity	PLOS ONE			English	Article								Background: Dominant mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease, however, the underlying pathogenic mechanisms are poorly understood. Several in vitro studies have shown that the most frequent mutation, LRRK2(G2019S), increases kinase activity and impairs neuronal survival. LRRK2 has been linked to the mitogen-activated protein kinase kinase kinase family and the receptor-interacting protein kinases based on sequence similarity within the kinase domain and in vitro substrate phosphorylation. Methodology/Principal Findings: We used an unbiased proteomic approach to identify the kinase signaling pathways wherein LRRK2 may be active. By incubation of protein microarrays containing 260 signal transduction proteins we detected four arrayed Ste20 serine/threonine kinase family members (TAOK3, STK3, STK24, STK25) as novel LRRK2 substrates and LRRK2 interacting proteins, respectively. Moreover, we found that protein kinase C (PKC) zeta binds and phosphorylates LRRK2 both in vitro and in vivo. Conclusions/Significance: Ste20 kinases and PKC zeta contribute to neuronal Tau phosphorylation, neurite outgrowth and synaptic plasticity under physiological conditions. Our data suggest that these kinases may also be involved in synaptic dysfunction and neurite fragmentation in transgenic mice and in human PD patients carrying toxic gain-of-function LRRK2 mutations.	[Zach, Susanne; Felk, Sandra; Gillardon, Frank] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Biberach, Germany	Boehringer Ingelheim	Gillardon, F (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Biberach, Germany.	Frank.Gillardon@boehringer-ingelheim.com						Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Chen C, 2009, ENVIRON SCI ENG TECH, P29; Chen LJ, 2001, J BIOL CHEM, V276, P21737, DOI 10.1074/jbc.M008069200; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Liu XF, 2009, J NEUROSCI, V29, P12229, DOI 10.1523/JNEUROSCI.2842-09.2009; Lorber B, 2009, NAT NEUROSCI, V12, P1407, DOI 10.1038/nn.2414; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Melrose H, 2008, FUTUR NEUROL, V3, P669, DOI 10.2217/14796708.3.6.669; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Strange K, 2006, PHYSIOLOGY, V21, P61, DOI 10.1152/physiol.00139.2005; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Taymans JM, 2010, BIOESSAYS, V32, P227, DOI 10.1002/bies.200900163; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008	31	33	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13191	10.1371/journal.pone.0013191	http://dx.doi.org/10.1371/journal.pone.0013191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V32LH	20949042	Green Published, gold, Green Submitted			2022-12-25	WOS:000208952200003
J	Wang, B; Hasan, MK; Alvarado, E; Yuan, H; Wu, H; Chen, WY				Wang, B.; Hasan, M. K.; Alvarado, E.; Yuan, H.; Wu, H.; Chen, W. Y.			NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response	ONCOGENE			English	Article						prostate cancer; NAMPT; SIRT1; NAD; nicotinamide; Foxo3a	COLONY-ENHANCING FACTOR; TRANSCRIPTION FACTOR FOXO3A; LIFE-SPAN EXTENSION; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; CALORIE RESTRICTION; COLORECTAL-CANCER; SACCHAROMYCES-CEREVISIAE; P53-DEFICIENT MICE; ANDROGEN RECEPTOR; NAD BIOSYNTHESIS	Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme in regenerating nicotinamide adenine dinucleotide (NAD(+)) from nicotinamide in mammals. NAMPT has crucial roles for many cellular functions by regulating NAD(+)-dependent SIRT1 deacetylase. However, roles of NAMPT in cancer are poorly defined. In this study, we show that NAMPT is prominently over-expressed in human prostate cancer cells along with SIRT1. Elevation of NAMPT expression occurs early for the prostate neoplasia. Inhibition of NAMPT significantly suppresses cell growth in culture, soft agar colony formation, cell invasion and growth of xenografted prostate cancer cells in mice. NAMPT knockdown sensitizes prostate cancer cells to oxidative stress caused by H2O2 or chemotherapeutic treatment. Overexpression of NAMPT increases prostate cancer cell resistance to oxidative stress, which is partially blocked by SIRT1 knockdown. We demonstrate that in addition to modulating SIRT1 functions, the NAMPT inhibition reduces forkhead box, class 'O' (FOXO)3a protein expression and its downstream anti-oxidant genes catalase and manganese superoxide dismutase. Our results suggest important roles of concomitant upregulation of NAMPT and SIRT1 along with increased FOXO3a protein level for prostate carcinogenesis and their contribution to oxidative stress resistance of prostate cancer cells. These findings may have implications for exploring the NAMPT pathway for prostate cancer prevention and treatment. Oncogene (2011) 30, 907-921; doi:10.1038/onc.2010.468; published online 18 October 2010	[Chen, W. Y.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Alvarado, E.] Calif State Univ Long Beach, Dept Biol, Long Beach, CA 90840 USA; [Wu, H.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Pathol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; California State University System; California State University Long Beach; City of Hope; Beckman Research Institute of City of Hope	Chen, WY (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	wechen@coh.org	Chen, WenYong/D-6748-2012; yuan, hongfeng/A-3633-2012	Chen, WenYong/0000-0001-6913-5729	City of Hope; STOPCANCER foundation; American Cancer Society; California Institute of Regenerative Medicine	City of Hope; STOPCANCER foundation; American Cancer Society(American Cancer Society); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	This study is supported by the start-up fund from City of Hope, career development award from STOPCANCER foundation and research scholar award from American Cancer Society (WYC). EA was supported by a training grant awarded to CSULB from California Institute of Regenerative Medicine.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Charvet C, 2003, ONCOGENE, V22, P4557, DOI 10.1038/sj.onc.1206778; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-17; Cressman VL, 1999, CELL GROWTH DIFFER, V10, P1; Dai Y, 2007, MOL ENDOCRINOL, V21, P1807, DOI 10.1210/me.2006-0467; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Drevs J, 2003, ANTICANCER RES, V23, P4853; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gartner EM, 2010, CANCER J, V16, P83, DOI 10.1097/PPO.0b013e3181d78223; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; Hasmann M, 2003, CANCER RES, V63, P7436; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Hufton SE, 1999, FEBS LETT, V463, P77, DOI 10.1016/S0014-5793(99)01578-1; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Jang KY, 2009, PATHOLOGY, V41, P366, DOI 10.1080/00313020902884451; Jung-Hynes B, 2009, J BIOL CHEM, V284, P3823, DOI 10.1074/jbc.M807869200; Karger S, 2009, ENDOCR-RELAT CANCER, V16, P189, DOI 10.1677/ERC-07-0283; Kikuno N, 2008, INT J CANCER, V123, P552, DOI 10.1002/ijc.23590; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Nosho K, 2009, MODERN PATHOL, V22, P922, DOI 10.1038/modpathol.2009.49; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ognjanovic S, 2001, J MOL ENDOCRINOL, V26, P107, DOI 10.1677/jme.0.0260107; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shukla S, 2009, INT J ONCOL, V34, P1613, DOI 10.3892/ijo_00000291; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Turkbey B, 2009, NAT REV UROL, V6, P191, DOI 10.1038/nrurol.2009.27; van Beijnum JR, 2002, INT J CANCER, V101, P118, DOI 10.1002/ijc.10584; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Warburg O., 1931, METABOLISM TUMORS; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Williams AC, 2005, J CLIN NEUROSCI, V12, P6, DOI 10.1016/j.jocn.2004.10.002; Xiao D, 2006, CARCINOGENESIS, V27, P2223, DOI 10.1093/carcin/bgl087; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103	79	183	196	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	8					907	921		10.1038/onc.2010.468	http://dx.doi.org/10.1038/onc.2010.468			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	726CJ	20956937				2022-12-25	WOS:000287695900003
J	Benjannet, S; Saavedra, YGL; Hamelin, J; Asselin, MC; Essalmani, R; Pasquato, A; Lemaire, P; Duke, G; Miao, B; Duclos, F; Parker, R; Mayer, G; Seidah, NG				Benjannet, Suzanne; Saavedra, Yascara Grisel Luna; Hamelin, Josee; Asselin, Marie-Claude; Essalmani, Rachid; Pasquato, Antonella; Lemaire, Peter; Duke, Gerald; Miao, Bowman; Duclos, Franck; Parker, Rex; Mayer, Gaetan; Seidah, Nabil G.			Effects of the Prosegment and pH on the Activity of PCSK9 EVIDENCE FOR ADDITIONAL PROCESSING EVENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PROPROTEIN CONVERTASE PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; SECRETED PCSK9; LDL-RECEPTOR; HEPG2 CELLS; DEGRADATION; CHOLESTEROL; BINDING	PCSK9, a target for the treatment of dyslipidemia, enhances the degradation of the LDL receptor (LDLR) in endosomes/lysosomes, up-regulating LDL-cholesterol levels. Whereas the targeting and degradation of the PCSK9-LDLR complex are under scrutiny, the roles of the N- and C-terminal domains of PCSK9 are unknown. Although autocatalytic zymogen processing of PCSK9 occurs at Gln(152)down arrow, here we show that human PCSK9 can be further cleaved in its N-terminal prosegment at Arg(46)down arrow by an endogenous enzyme of insect High Five cells and by a cellular mammalian protease, yielding an similar to 4-fold enhanced activity. Removal of the prosegment acidic stretch resulted in similar to 3-fold higher binding to LDLR in vitro, in >= 4-fold increased activity on cellular LDLR, and faster cellular internalization in endosome/lysosome-like compartments. Finally, swapping the acidic stretch of PCSK9 with a similar one found in the glycosylphosphatidylinositol-anchored hepa-rin-binding protein 1 does not impair PCSK9 autoprocessing, secretion, or activity and confirmed that the acidic stretch acts as an inhibitor of PCSK9 function. We also show that upon short exposure to pH values 6.5 to 5.5, an similar to 2.5-fold increase in PCSK9 activity on total and cell surface LDLR occurs, and PCSK9 undergoes a second cleavage at Arg(248), generating a two-chain PCSK9-Delta N-248. At pH values below 5.5, PCSK9 dissociates from its prosegment and loses its activity. This pH-dependent activation of PCSK9 represents a novel pathway to further activate PCSK9 in acidic endosomes. These data enhance our understanding of the functional role of the acidic prosegment and on the effect of pH in the regulation of PCSK9 activity.	[Benjannet, Suzanne; Saavedra, Yascara Grisel Luna; Hamelin, Josee; Asselin, Marie-Claude; Essalmani, Rachid; Pasquato, Antonella; Mayer, Gaetan; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Lemaire, Peter; Duke, Gerald; Miao, Bowman; Duclos, Franck; Parker, Rex] Bristol Myers Squibb Co, Princeton, NJ 08543 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Bristol-Myers Squibb	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; Pasquato, Antonella/0000-0002-9428-0722	Canadian Institutes of Health Research [MOP-102741, CTP-82946]; Strauss Foundation; Bristol-Myers Squibb; Canada Chair [216684]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Canada Chair	This work was supported by Canadian Institutes of Health Research Grants MOP-102741 and CTP-82946 (to N. G. S.), Strauss Foundation grant (to N. G. S.), Bristol-Myers Squibb collaborative research grant, and Canada Chair 216684 (to N. G. S.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, J LIPID RES, V50, pS57, DOI 10.1194/jlr.R800030-JLR200; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; Dewpura T, 2008, FEBS J, V275, P3480, DOI 10.1111/j.1742-4658.2008.06495.x; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Fan D, 2008, BIOCHEMISTRY-US, V47, P1631, DOI 10.1021/bi7016359; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; LLOYDJONES D, 2009, Y Circulation, V119, pE21; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Miao B, 2002, METHOD ENZYMOL, V357, P180; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Noguchi T, 2010, ATHEROSCLEROSIS, V210, P166, DOI 10.1016/j.atherosclerosis.2009.11.018; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1999, BRAIN RES, V848, pA14; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Teupser D, 1996, BBA-LIPID LIPID MET, V1303, P193, DOI 10.1016/0005-2760(96)00094-X; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	50	53	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40965	40978		10.1074/jbc.M110.154815	http://dx.doi.org/10.1074/jbc.M110.154815			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20937814	hybrid, Green Published			2022-12-25	WOS:000285414400060
J	Glantschnig, H; Hampton, RA; Lu, P; Zhao, JZ; Vitelli, S; Huang, LY; Haytko, P; Cusick, T; Ireland, C; Jarantow, SW; Ernst, R; Wei, N; Nantermet, P; Scott, KR; Fisher, JE; Talamo, F; Orsatti, L; Reszka, AA; Sandhu, P; Kimmel, D; Flores, O; Strohl, W; An, ZQ; Wang, FB				Glantschnig, Helmut; Hampton, Richard A.; Lu, Ping; Zhao, Jing Z.; Vitelli, Salvatore; Huang, Lingyi; Haytko, Peter; Cusick, Tara; Ireland, Cheryl; Jarantow, Stephen W.; Ernst, Robin; Wei, Nan; Nantermet, Pascale; Scott, Kevin R.; Fisher, John E.; Talamo, Fabio; Orsatti, Laura; Reszka, Alfred A.; Sandhu, Punam; Kimmel, Donald; Flores, Osvaldo; Strohl, William; An, Zhiqiang; Wang, Fubao			Generation and Selection of Novel Fully Human Monoclonal Antibodies That Neutralize Dickkopf-1 (DKK1) Inhibitory Function in Vitro and Increase Bone Mass in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC TARGETS; MISSENSE MUTATIONS; CELL-LINE; LRP5; RECEPTOR; EXPRESSION; DISEASE; MECHANISM; REGULATOR; DENSITY	Wnt/LRP5 signaling is a central regulatory component of bone formative and resorptive activities, and the pathway inhibitor DKK1 is a suppressor of bone formation and bone mass accrual in mice. In addition, augmented DKK1 levels are associated with high bone turnover in diverse low bone mass states in rodent models and disease etiologies in human. However, examination of the precise role of DKK1 in the normal skeleton and in higher species requires the development of refined DKK1-specific pharmacological tools. Here, we report the strategy resulting in isolation of a panel of fully human anti-DKK1 antibodies applicable to studies interrogating the roles of mouse, rhesus, and human DKK1. Selected anti-DKK1 antibodies bind primate and human DKK-1 with picomolar affinities yet do not appreciably bind to DKK2 or DKK4. Epitopes mapped within the DKK1 C-terminal domain necessary for interaction with LRP5/6 and consequently effectively neutralized DKK1 function in vitro. When introduced into naive normal growing female mice, IgGs significantly improved trabecular bone volume and structure and increased both trabecular and cortical bone mineral densities in a dose-related fashion. Furthermore, fully human DKK1-IgG displayed favorable pharmacokinetic parameters in non-human primates. In summary, we demonstrate here a rate-limiting function of physiologic DKK1 levels in the regulation of bone mass in intact female mice, amendable to specific pharmacologic neutralization by newly identified DKK1-IgGs. Importantly the fully human IgGs display a profile of attributes that recommends their testing in higher species and their use in evaluating DKK1 function in relevant disease models.	[Glantschnig, Helmut; Cusick, Tara; Wei, Nan; Nantermet, Pascale; Scott, Kevin R.; Fisher, John E.; Reszka, Alfred A.; Kimmel, Donald; Flores, Osvaldo] Merck Res Labs, Mol Endocrinol & Bone Biol, West Point, PA 19486 USA; [Hampton, Richard A.; Lu, Ping; Zhao, Jing Z.; Vitelli, Salvatore; Huang, Lingyi; Haytko, Peter; Ireland, Cheryl; Jarantow, Stephen W.; Ernst, Robin; Strohl, William; An, Zhiqiang; Wang, Fubao] Merck Res Labs, Biol Res, West Point, PA 19486 USA; [Sandhu, Punam] Merck Res Labs, Preclin DMPK, West Point, PA 19486 USA; [Talamo, Fabio; Orsatti, Laura] Merck Res Labs, Ist Ric Biol Mol P Angeletti, Dept Biochem, I-00040 Rome, Italy	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Wang, FB (corresponding author), 700 Sumneytownpike, West Point, PA 19486 USA.	fubao_wang@merck.com		Strohl, William/0000-0002-8271-6875; An, Zhiqiang/0000-0001-9309-2335				Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; An ZQ, 2009, MABS-AUSTIN, V1, P572, DOI 10.4161/mabs.1.6.10185; [Anonymous], 2001, PHAGE DISPLAY LAB MA; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bajada S, 2009, BONE, V45, P726, DOI 10.1016/j.bone.2009.06.015; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Chen LJ, 2008, J BIOL CHEM, V283, P23364, DOI 10.1074/jbc.M802375200; Choi Y, 2009, NAT REV RHEUMATOL, V5, P543, DOI 10.1038/nrrheum.2009.175; Darling RJ, 2002, BIOCHEMISTRY-US, V41, P14524, DOI 10.1021/bi0265022; Deal C, 2009, CURR OPIN RHEUMATOL, V21, P380, DOI 10.1097/BOR.0b013e32832cbc2a; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Fleury D, 2010, PROTEIN EXPRES PURIF, V70, P39, DOI 10.1016/j.pep.2009.08.012; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Gavriatopoulou M, 2009, EXPERT OPIN THER TAR, V13, P839, DOI 10.1517/14728220903025770; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hager-Braun C, 2005, EXPERT REV PROTEOMIC, V2, P745, DOI 10.1586/14789450.2.5.745; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Johnson ML, 2004, J BONE MINER RES, V19, P1749, DOI 10.1359/JBMR.040816; Kaiser M, 2008, EUR J HAEMATOL, V80, P490, DOI 10.1111/j.1600-0609.2008.01065.x; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Komatsu DE, 2010, J ORTHOP RES, V28, P928, DOI 10.1002/jor.21078; Leucht P, 2008, SEMIN CELL DEV BIOL, V19, P434, DOI 10.1016/j.semcdb.2008.09.002; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; McCarthy HS, 2010, EXPERT OPIN THER TAR, V14, P221, DOI 10.1517/14728220903525720; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rodan G, 2002, PRINCIPLES BONE BIOL, P1275; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; van Tilbeurgh H, 1999, BBA-MOL CELL BIOL L, V1441, P173, DOI 10.1016/S1388-1981(99)00149-3; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Wang K, 2008, J BIOL CHEM, V283, P23371, DOI 10.1074/jbc.M802376200; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712	59	69	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40135	40147		10.1074/jbc.M110.166892	http://dx.doi.org/10.1074/jbc.M110.166892			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20929859	Green Published, hybrid			2022-12-25	WOS:000285185500059
J	Jayapal, S; Lee, KL; Ji, P; Kaldis, P; Lim, B; Lodish, HF				Jayapal, Senthil; Lee, Kian Leong; Ji, Peng; Kaldis, Philipp; Lim, Bing; Lodish, Harvey F.			Down-regulation of Myc Is Essential for Terminal Erythroid Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; C-MYC; CELL-CYCLE; MICE LACKING; DIFFERENTIATION; ERYTHROPOIETIN; ERYTHROBLASTS; KINASE; P27(KIP1); APOPTOSIS	Terminal differentiation of mammalian erythroid progenitors involves 4-5 cell divisions and induction of many erythroid important genes followed by chromatin and nuclear condensation and enucleation. The protein levels of c-Myc (Myc) are reduced dramatically during late stage erythroid maturation, coinciding with cell cycle arrest in G(1) phase and enucleation, suggesting possible roles for c-Myc in either or both of these processes. Here we demonstrate that ectopic Myc expression affects terminal erythroid maturation in a dose-dependent manner. Expression of Myc at physiological levels did not affect erythroid differentiation or cell cycle shutdown but specifically blocked erythroid nuclear condensation and enucleation. Continued Myc expression prevented deacetylation of several lysine residues in histones H3 and H4 that are normally deacetylated during erythroid maturation. The histone acetyltransferase Gcn5 was up-regulated by Myc, and ectopic Gcn5 expression partially blocked enucleation and inhibited the late stage erythroid nuclear condensation and histone deacetylation. When overexpressed at levels higher than the physiological range, Myc blocked erythroid differentiation, and the cells continued to proliferate in cytokine-free, serum-containing culture medium with an early erythroblast morphology. Gene expression analysis demonstrated the dysregulation of erythropoietin signaling pathway and the up-regulation of several positive regulators of G(1)-S cell cycle checkpoint by supraphysiological levels of Myc. These results reveal an important dose-dependent function of Myc in regulating terminal maturation in mammalian erythroid cells.	[Jayapal, Senthil; Lim, Bing] Genome Inst Singapore, Singapore 138672, Singapore; [Jayapal, Senthil; Lim, Bing; Lodish, Harvey F.] Singapore Massachusetts Inst Technol Alliance, Singapore 117576, Singapore; [Lee, Kian Leong] Natl Univ Singapore, Ctr Life Sci, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Ji, Peng; Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Ji, Peng; Lodish, Harvey F.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kaldis, Philipp] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lim, B (corresponding author), Genome Inst Singapore, 60 Biopolis St, Singapore 138672, Singapore.	limb1@gis.a-star.edu.sg; lodish@wi.mit.edu	Kaldis, Philipp/G-2714-2010; LEE, Kian Leong/E-3584-2013	Kaldis, Philipp/0000-0002-7247-7591; LEE, Kian Leong/0000-0002-0443-2746; Jayapal, Senthil Raja/0000-0002-0670-7766	National Institutes of Health [DK047636, AI54973, P01 HL32262]; Singapore-MIT alliance [C-382-641-001-091]; A*STAR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); A*STAR(Agency for Science Technology & Research (A*STAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK047636 and AI54973 (to B.L.) and P01 HL32262 (to H.F.L.). This study was also supported by Singapore-MIT alliance Grant C-382-641-001-091 (to B.L. and H.F.L.).; Supported by a Singapore-MIT Alliance graduate fellowship.; Supported by A*STAR funds in Genome Institute of Singapore.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; CORY S, 1991, CELL GROWTH DIFFER, V2, P165; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dolznig H, 2002, CURR BIOL, V12, P1076, DOI 10.1016/S0960-9822(02)00930-2; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Ghaffari S, 2006, BLOOD, V107, P1888, DOI 10.1182/blood-2005-06-2304; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Hsieh FF, 2000, BLOOD, V96, P2746, DOI 10.1182/blood.V96.8.2746.h8002746_2746_2754; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Janz S, 2005, ONCOGENE, V24, P3541, DOI 10.1038/sj.onc.1208473; Ji P, 2010, HAEMATOL-HEMATOL J, V95, P2013, DOI 10.3324/haematol.2010.029827; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; KOURY ST, 1988, EXP HEMATOL, V16, P758; Krauss SW, 2005, BLOOD, V106, P2200, DOI 10.1182/blood-2005-04-1357; LENG L, 1993, CANCER RES, V53, P5554; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Popova EY, 2009, CHROMOSOME RES, V17, P47, DOI 10.1007/s10577-008-9005-y; Ray D, 2007, CELL CYCLE, V6, P3039, DOI 10.4161/cc.6.24.5104; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; SIMPSON CF, 1967, J CELL BIOL, V35, P237, DOI 10.1083/jcb.35.1.237; SKUTELSKY E, 1967, J CELL BIOL, V33, P625, DOI 10.1083/jcb.33.3.625; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; SPANGLER R, 1992, BLOOD, V79, P52; SPOTTS GD, 1990, MOL CELL BIOL, V10, P3952, DOI 10.1128/MCB.10.8.3952; VENNSTROM B, 1982, J VIROL, V42, P773, DOI 10.1128/JVI.42.3.773-779.1982; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xu WT, 1998, MOL CELL BIOL, V18, P5659, DOI 10.1128/MCB.18.10.5659; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhang YX, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-69; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	52	49	61	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40252	40265		10.1074/jbc.M110.181073	http://dx.doi.org/10.1074/jbc.M110.181073			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940306	Green Published, hybrid			2022-12-25	WOS:000285185500069
J	Lokareddy, RK; Lunelli, M; Eilers, B; Wolter, V; Kolbe, M				Lokareddy, Ravi Kumar; Lunelli, Michele; Eilers, Bjoern; Wolter, Vivien; Kolbe, Michael			Combination of Two Separate Binding Domains Defines Stoichiometry between Type III Secretion System Chaperone IpgC and Translocator Protein IpaB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHIGELLA-FLEXNERI; YERSINIA-ENTEROCOLITICA; EPITHELIAL-CELLS; SALMONELLA-TYPHIMURIUM; BACTERIAL PATHOGENS; VIRULENCE GENES; HOST-CELLS; YOPE; PLASMID; INVASINS	Type III secretion systems (TTSSs) utilized by enteropathogenic bacteria require the presence of small, acidic virulence-associated chaperones for effective host cell infection. We adopted a combination of biochemical and cellular techniques to define the chaperone binding domains (CBDs) in the translocators IpaB and IpaC associated with the chaperone IpgC from Shigella flexneri. We identified a novel CBD in IpaB and furthermore precisely mapped the boundaries of the CBDs in both translocator proteins. In IpaC a single binding domain associates with IpgC. In IpaB, we show that the binding of the newly characterized CBD is essential in maintaining the ternary arrangement of chaperone-translocator complex. This hitherto unknown function is reflected in the co-crystal structure as well, with an IpgC dimer bound to an IpaB fragment comprising both CBDs. Moreover, in the absence of this novel CBD the IpaB/IpgC complex aggregates. This dual-recognition of a domain in the protein by the chaperone in facilitating the correct chaperone-substrate organization describes a new function for the TTSS associated chaperone-substrate complexes.	[Lokareddy, Ravi Kumar; Lunelli, Michele; Eilers, Bjoern; Wolter, Vivien; Kolbe, Michael] Max Planck Inst Infect Biol, Dept Cellular Microbiol, D-10117 Berlin, Germany; [Lokareddy, Ravi Kumar] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Eilers, Bjoern] Inst Lab Med, D-10627 Berlin, Germany	Max Planck Society; Jefferson University	Kolbe, M (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Charite Pl 1, D-10117 Berlin, Germany.	kolbe@mpiib-berlin.mpg.de						Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buttner CR, 2008, J MOL BIOL, V375, P997, DOI 10.1016/j.jmb.2007.11.009; Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Cornelis GR, 2003, MOL MICROBIOL, V50, P1091, DOI 10.1046/j.1365-2958.2003.03812.x; Darwin KH, 2000, MOL MICROBIOL, V35, P949, DOI 10.1046/j.1365-2958.2000.01772.x; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2003, NAT STRUCT BIOL, V10, P789, DOI 10.1038/nsb982; FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x; Harrington AT, 2003, INFECT IMMUN, V71, P1255, DOI 10.1128/IAI.71.3.1255-1264.2003; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; MAURELLI AT, 1985, INFECT IMMUN, V49, P164, DOI 10.1128/IAI.49.1.164-171.1985; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Page AL, 2001, MOL MICROBIOL, V42, P1133, DOI 10.1046/j.1365-2958.2001.02715.x; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Penno C, 2005, MOL MICROBIOL, V56, P204, DOI 10.1111/j.1365-2958.2004.04530.x; Picking WL, 1996, PROTEIN EXPRES PURIF, V8, P401, DOI 10.1006/prep.1996.0117; Russmann H, 2000, EUR J IMMUNOL, V30, P1375; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; SASAKAWA C, 1989, MOL MICROBIOL, V3, P1191, DOI 10.1111/j.1365-2958.1989.tb00269.x; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WATARAI M, 1995, EMBO J, V14, P2461, DOI 10.1002/j.1460-2075.1995.tb07243.x; WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x; ZYCHLINSKY A, 1994, MOL MICROBIOL, V11, P619, DOI 10.1111/j.1365-2958.1994.tb00341.x	42	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39965	39975		10.1074/jbc.M110.135616	http://dx.doi.org/10.1074/jbc.M110.135616			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937829	Green Published, hybrid			2022-12-25	WOS:000285185500041
J	Paris, LL; Hu, JJ; Galan, J; Ong, SS; Martin, VA; Ma, HY; Tao, WA; Harrison, ML; Geahlen, RL				Paris, Leela L.; Hu, Jianjie; Galan, Jacob; Ong, Su Sien; Martin, Victoria A.; Ma, Haiyan; Tao, W. Andy; Harrison, Marietta L.; Geahlen, Robert L.			Regulation of Syk by Phosphorylation on Serine in the Linker Insert	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; GREEN FLUORESCENT PROTEIN; B-CELL DEVELOPMENT; ANTIGEN RECEPTOR; STRUCTURAL BASIS; PHORBOL ESTER; ACTIVATION; LYMPHOCYTES; PROHIBITIN; ZAP-70	The Syk protein-tyrosine kinase is phosphorylated on multiple tyrosines after the aggregation of the B cell antigen receptor. However, metabolic labeling experiments indicate that Syk is inducibly phosphorylated to an even greater extent on serine after receptor ligation. A combination of phosphopeptide mapping and mass spectrometric analyses indicates that serine 291 is a major site of phosphorylation. Serine 291 lies within a 23-amino acid insert located within the linker B region that distinguishes Syk from SykB and Zap-70. The phosphorylation of serine-291 by protein kinase C enhances the ability of Syk to couple the antigen receptor to the activation of the transcription factors NFAT and Elk-1. Protein interaction studies indicate a role for the phosphorylated linker insert in promoting an interaction between Syk and the chaperone protein, prohibitin.	[Harrison, Marietta L.; Geahlen, Robert L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Galan, Jacob; Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Tao, W. Andy; Harrison, Marietta L.; Geahlen, Robert L.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Geahlen, RL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Hansen Life Sci Res Bldg,201 S Univ St, W Lafayette, IN 47907 USA.	geahlen@purdue.edu	Tao, Andy/N-1290-2019; ma, haiyan/GWQ-7425-2022; Tao, Weiguo/AAL-2777-2020; Ong, Su Sien/I-2245-2012	Tao, Weiguo/0000-0002-5535-5517; Geahlen, Robert/0000-0001-8400-2924; Galan, Jacob/0000-0003-3304-0474	National Institutes of Health [CA037372]; National Science Foundation;  [CA115465]; NATIONAL CANCER INSTITUTE [R01CA037372, R01CA115465] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA037372 (NCI; to R. L. G. and M. L. H.). This work was also supported by a National Science Foundation Career Award (to W. A. T.).; Supported by a Research Supplement to Promote Diversity in Health-related Research to National Institutes of Health CA115465 (to R. L. G. and W. A. T.).	CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Couture C, 1997, EUR J BIOCHEM, V246, P447, DOI 10.1111/j.1432-1033.1997.00447.x; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; GEAHLEN RL, 2009, L BIOCHIM BIOPHYS AC, V1793, P1115; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; Hitomi T, 2001, GENES CELLS, V6, P475, DOI 10.1046/j.1365-2443.2001.00434.x; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Keshvara LM, 1998, J IMMUNOL, V161, P5276; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Latour S, 1998, EMBO J, V17, P2584, DOI 10.1093/emboj/17.9.2584; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Papp E, 2007, BIOCHEMISTRY-US, V46, P15103, DOI 10.1021/bi701596u; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rasmussen RK, 1997, ELECTROPHORESIS, V18, P588, DOI 10.1002/elps.1150180342; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; ROWLEY RB, 1995, J BIOL CHEM, V270, P12659, DOI 10.1074/jbc.270.21.12659; SEVERSON CD, 1987, IMMUNOL LETT, V15, P291, DOI 10.1016/0165-2478(87)90130-1; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; SloanLancaster J, 1997, J EXP MED, V186, P1713, DOI 10.1084/jem.186.10.1713; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Wang L, 2003, CANCER RES, V63, P4724; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang Sheng, 2008, Transl Oncogenomics, V3, P23; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Xia K, 1999, MOL CELL BIOL, V19, P4819; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; YAGI S, 1994, BIOCHEM BIOPH RES CO, V200, P28, DOI 10.1006/bbrc.1994.1409; Zhang J, 1998, J IMMUNOL, V161, P4366; Zhou F, 2006, MOL CELL BIOL, V26, P3478, DOI 10.1128/MCB.26.9.3478-3491.2006	38	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39844	39854		10.1074/jbc.M110.164509	http://dx.doi.org/10.1074/jbc.M110.164509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956537	Green Published, hybrid			2022-12-25	WOS:000285185500029
J	Donald, JE; Zhu, H; Litvinov, RI; DeGrado, WF; Bennett, JS				Donald, Jason E.; Zhu, Hua; Litvinov, Rustem I.; DeGrado, William F.; Bennett, Joel S.			Identification of Interacting Hot Spots in the beta 3 Integrin Stalk Using Comprehensive Interface Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSIDE-OUT ACTIVATION; CYTOPLASMIC FACE; STRUCTURAL BASIS; BINDING-ENERGY; FIBRINOGEN; DOMAIN; ALPHA-IIB-BETA-3; ALPHA(V)BETA(3); MECHANISM; AFFINITY	Protein-protein interfaces are usually large and complementary surfaces, but specific side chains, representing energetic "hot spots," often contribute disproportionately to binding free energy. We used a computational method, comprehensive interface design, to identify hot spots in the interface between the stalk regions of the beta 3 and the complementary alpha IIb and alpha v integrin subunits. Using the Rosetta alanine-scanning and design algorithms to predict destabilizing, stabilizing, and neutral mutations in the beta 3 region extending from residues Lys(532) through Gly(690), we predicted eight alanine mutations that would destabilize the alpha IIb beta 3 interface as well as nine predicted to destabilize the alpha v beta 3 interface, by at least 0.3 kcal/mol. The mutations were widely and unevenly distributed, with four between residues 552 and 563 and five between 590 and 610, but none between 565 and 589, and 611 and 655. Further, mutations destabilizing the alpha v beta 3 and alpha IIb beta 3 interfaces were not identical. The predictions were then tested by introducing selected mutations into the full-length integrins expressed in Chinese hamster ovary cells. Five mutations predicted to destabilize alpha IIb and beta 3 caused fibrinogen binding to alpha IIb beta 3, whereas three of four predicted to be neutral or stabilizing did not. Conversely, a mutation predicted to destabilize alpha v beta 3, but not alpha IIb beta 3 (D552A), caused osteopontin binding to alpha v beta 3, but not fibrinogen binding to alpha IIb beta 3. These results indicate that stability of the distal stalk interface is involved in constraining integrins in stable, inactive conformations. Further, they demonstrate the ability of comprehensive interface design to identify functionally significant integrin mutations.	[Zhu, Hua; Bennett, Joel S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Litvinov, Rustem I.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bennett, JS (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	bennetts@mail.med.upenn.edu	Litvinov, Rustem/E-5291-2011	Litvinov, Rustem/0000-0003-0643-1496	National Institutes of Health [HL40387, HL81012, T32 HL107971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P50HL081012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL40387 and HL81012.; Supported in part by the National Institutes of Health Training Grant T32 HL107971.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Dantas G, 2007, J MOL BIOL, V366, P1209, DOI 10.1016/j.jmb.2006.11.080; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kashiwagi H, 1999, BLOOD, V93, P2559, DOI 10.1182/blood.V93.8.2559.408k12_2559_2568; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Litvinov RI, 2006, BIOCHEMISTRY-US, V45, P4957, DOI 10.1021/bi0526581; Litvinov RI, 2003, J BIOL CHEM, V278, P51285, DOI 10.1074/jbc.M304581200; Litvinov RI, 2005, BIOPHYS J, V89, P2824, DOI 10.1529/biophysj.105.061887; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhu H, 2010, J MOL BIOL, V401, P882, DOI 10.1016/j.jmb.2010.06.062; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200	35	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38658	38665		10.1074/jbc.M110.170670	http://dx.doi.org/10.1074/jbc.M110.170670			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20929856	Green Published, hybrid			2022-12-25	WOS:000284625600070
J	Gakh, O; Bedekovics, T; Duncan, SF; Smith, DY; Berkholz, DS; Isaya, G				Gakh, Oleksandr; Bedekovics, Tibor; Duncan, Samantha F.; Smith, Douglas Y.; Berkholz, Donald S.; Isaya, Grazia			Normal and Friedreich Ataxia Cells Express Different Isoforms of Frataxin with Complementary Roles in Iron-Sulfur Cluster Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST FRATAXIN; MITOCHONDRIAL LOCALIZATION; BINDING PROPERTIES; DEFICIENCY; MECHANISM; PROTEINS; CYAY; DETOXIFICATION; BIOGENESIS; MATURATION	Friedreich ataxia (FRDA) is an autosomal recessive degenerative disease caused by insufficient expression of frataxin (FXN), a mitochondrial iron-binding protein required for Fe-S cluster assembly. The development of treatments to increase FXN levels in FRDA requires elucidation of the steps involved in the biogenesis of functional FXN. The FXN mRNA is translated to a precursor polypeptide that is transported to the mitochondrial matrix and processed to at least two forms, FXN42-210 and FXN81-210. Previous reports suggested that FXN42-210 is a transient processing intermediate, whereas FXN81-210 represents the mature protein. However, we find that both FXN42-210 and FXN81-210 are present in control cell lines and tissues at steady-state, and that FXN42-210 is consistently more depleted than FXN81-210 in samples from FRDA patients. Moreover, FXN42-210 and FXN81-210 have strikingly different biochemical properties. A shorter N terminus correlates with monomeric configuration, labile iron binding, and dynamic contacts with components of the Fe-S cluster biosynthetic machinery, i.e. the sulfur donor complex NFS1 center dot ISD11 and the scaffold ISCU. Conversely, a longer N terminus correlates with the ability to oligomerize, store iron, and form stable contacts with NFS1 center dot ISD11 and ISCU. Monomeric FXN81-210 donates Fe2+ for Fe-S cluster assembly on ISCU, whereas oligomeric FXN42-210 donates either Fe2+ or Fe3+. These functionally distinct FXN isoforms seem capable to ensure incremental rates of Fe-S cluster synthesis from different mitochondrial iron pools. We suggest that the levels of both isoforms are relevant to FRDA pathophysiology and that the FXN81-210/FXN42-210 molar ratio should provide a useful parameter to optimize FXN augmentation and replacement therapies.	Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health [AG15709]; Friedreich Ataxia Research Alliance, Muscular Dystrophy Association; Mayo Clinic Department of Pediatric & Adolescent Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich Ataxia Research Alliance, Muscular Dystrophy Association(Muscular Dystrophy Association); Mayo Clinic Department of Pediatric & Adolescent Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15709, and grants from the Friedreich Ataxia Research Alliance, Muscular Dystrophy Association (to G. I.), and the Mayo Clinic Department of Pediatric & Adolescent Medicine (to T. B. and D. S. B.). Mayo Clinic has a financial interest associated with technology used in this research (rec-FXN<SUP>56-210</SUP>), which has been licensed to MitoSciences, Inc. Mayo Clinic, but not the investigators, has received royalties of less than the federal threshold for significant financial interest.	Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Babady NE, 2007, P NATL ACAD SCI USA, V104, P6158, DOI 10.1073/pnas.0610618104; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Kearney M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007791.pub2; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Long S, 2008, P NATL ACAD SCI USA, V105, P13468, DOI 10.1073/pnas.0806762105; Lu CY, 2009, BBA-MOL BASIS DIS, V1792, P1052, DOI 10.1016/j.bbadis.2009.07.011; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Pianese L, 2002, HUM MOL GENET, V11, P2989, DOI 10.1093/hmg/11.23.2989; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Sparaco M, 2009, J NEUROL SCI, V287, P111, DOI 10.1016/j.jns.2009.08.052; Tan G, 2001, HUM MOL GENET, V10, P2099, DOI 10.1093/hmg/10.19.2099; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Whitnall M, 2008, P NATL ACAD SCI USA, V105, P9757, DOI 10.1073/pnas.0804261105; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Yoon T, 2007, J BIOL INORG CHEM, V12, P535, DOI 10.1007/s00775-007-0205-2	52	61	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38486	38501		10.1074/jbc.M110.145144	http://dx.doi.org/10.1074/jbc.M110.145144			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889968	Green Published, hybrid			2022-12-25	WOS:000284625600054
J	Wang, YN; Yamaguchi, H; Huo, LF; Du, Y; Lee, HJ; Lee, HH; Wang, HM; Hsu, JM; Hung, MC				Wang, Ying-Nai; Yamaguchi, Hirohito; Huo, Longfei; Du, Yi; Lee, Hong-Jen; Lee, Heng-Huan; Wang, Hongmei; Hsu, Jung-Mao; Hung, Mien-Chie			The Translocon Sec61 beta Localized in the Inner Nuclear Membrane Transports Membrane-embedded EGF Receptor to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CELL-SURFACE RECEPTORS; PROTEIN TRANSLOCATION; ENDOPLASMIC-RETICULUM; PROGNOSTIC VALUE; BREAST-CANCER; EXPRESSION; IMPORTIN; BIOLOGY; PATHWAY	Accumulating evidence indicates that endocytosis plays an essential role in the nuclear transport of the ErbB family members, such as epidermal growth factor receptor (EGFR) and ErbB-2. Nevertheless, how full-length receptors embedded in the endosomal membrane pass through the nuclear pore complexes and function as non-membrane-bound receptors in the nucleus remains unclear. Here we show that upon EGF treatment, the biotinylated cell surface EGFR is trafficked to the inner nuclear membrane (INM) through the nuclear pore complexes, remaining in a membrane-bound environment. We further find that importin beta regulates EGFR nuclear transport to the INM in addition to the nucleus/nucleoplasm. Unexpectedly, the well known endoplasmic reticulum associated translocon Sec61 beta is found to reside in the INM and associate with EGFR. Knocking down Sec61 beta expression reduces EGFR level in the nucleoplasm portion and accumulates it in the INM portion. Thus, the Sec61 beta translocon plays an unrecognized role in the release of the membrane- anchored EGFR from the lipid bilayer of the INM to the nucleus. The newly identified Sec61 beta function provides an alternative pathway for nuclear transport that can be utilized by membrane- embedded proteins such as full-length EGFR.	[Wang, Ying-Nai; Yamaguchi, Hirohito; Huo, Longfei; Du, Yi; Lee, Hong-Jen; Lee, Heng-Huan; Wang, Hongmei; Hsu, Jung-Mao; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Du, Yi; Lee, Hong-Jen; Lee, Heng-Huan; Hsu, Jung-Mao; Hung, Mien-Chie] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan	University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Hung, MC (corresponding author), 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Huo, Longfei/F-9233-2010; Hsu, Jung-Mao/AAC-9527-2019; Hsu, Jung-Mao/AAP-8045-2020	Hung, Mien-Chie/0000-0003-4317-4740; Du, Yi/0000-0002-3969-2652; Wang, Ying-Nai/0000-0002-5275-6729; Wang, Hongmei/0000-0002-5881-2488	National Institutes of Health [RO1 109311, PO1 099031]; National Breast Cancer Foundation, Inc.; China Medical University Hospital; MD Anderson Cancer Center; Taiwan Cancer Research Center of Excellence Grant [DOH99-TD-C-111-005]; High Resolution Electron Microscopy Facility [CA 16672]; National Science Council Taiwan [TMS-94-2B-001]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA109311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation, Inc.; China Medical University Hospital; MD Anderson Cancer Center; Taiwan Cancer Research Center of Excellence Grant; High Resolution Electron Microscopy Facility; National Science Council Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 109311 and PO1 099031 (to M.-C. H.). This work was also supported by the National Breast Cancer Foundation, Inc. and the Sister Institutional fund from China Medical University Hospital and MD Anderson Cancer Center (to M.-C. H.); the Taiwan Cancer Research Center of Excellence Grant DOH99-TD-C-111-005; the Institutional Core Grant CA 16672 High Resolution Electron Microscopy Facility; and the National Science Council Taiwan Merit Postdoctoral Scholarship TMS-94-2B-001 (to Y.-N. W.).	Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Edwards J, 2006, CLIN CANCER RES, V12, P123, DOI 10.1158/1078-0432.CCR-05-1445; Feng YY, 1999, BIOCHEM BIOPH RES CO, V256, P192, DOI 10.1006/bbrc.1998.9790; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Greenfield JJA, 1999, J CELL SCI, V112, P1477; Hadzisejdic I, 2010, MODERN PATHOL, V23, P392, DOI 10.1038/modpathol.2009.166; Hoelz A, 2004, NATURE, V432, P815, DOI 10.1038/432815a; Hoshino M, 2007, PATHOBIOLOGY, V74, P15, DOI 10.1159/000101047; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Humbert JP, 1996, J BIOL CHEM, V271, P478, DOI 10.1074/jbc.271.1.478; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Klein C, 2004, BIOCHEMISTRY-US, V43, P15873, DOI 10.1021/bi048604t; Kutay U, 2006, NATURE, V442, P991, DOI 10.1038/nature05173; Liao HJ, 2007, MOL BIOL CELL, V18; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lo HW, 2005, CANCER RES, V65, P338; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Rexach MF, 2006, NAT STRUCT MOL BIOL, V13, P476, DOI 10.1038/nsmb0606-476; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Romisch K, 1999, J CELL SCI, V112, P4185; Saksena S, 2006, NAT STRUCT MOL BIOL, V13, P500, DOI 10.1038/nsmb1098; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504	52	87	92	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38720	38729		10.1074/jbc.M110.158659	http://dx.doi.org/10.1074/jbc.M110.158659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20937808	Green Published, hybrid			2022-12-25	WOS:000284625600077
J	Nishitani, Y; Yoshida, S; Fujihashi, M; Kitagawa, K; Doi, T; Atomi, H; Imanaka, T; Miki, K				Nishitani, Yuichi; Yoshida, Shosuke; Fujihashi, Masahiro; Kitagawa, Kazuya; Doi, Takashi; Atomi, Haruyuki; Imanaka, Tadayuki; Miki, Kunio			Structure-based Catalytic Optimization of a Type III Rubisco from a Hyperthermophile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; RHODOSPIRILLUM-RUBRUM; CRYSTAL-STRUCTURE; ACTIVE-SITE; RIBULOSEBISPHOSPHATE CARBOXYLASE; CO2/O2 SPECIFICITY; ARCHAEAL RUBISCO; PROTEIN	The Calvin-Benson-Bassham cycle is responsible for carbon dioxide fixation in all plants, algae, and cyanobacteria. The enzyme that catalyzes the carbon dioxide-fixing reaction is ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco). Rubisco from a hyperthermophilic archaeon Thermococcus kodakarensis (Tk-Rubisco) belongs to the type III group, and shows high activity at high temperatures. We have previously found that replacement of the entire alpha-helix 6 of Tk-Rubisco with the corresponding region of the spinach enzyme (SP6 mutant) results in an improvement of catalytic performance at mesophilic temperatures, both in vivo and in vitro, whereas the former and latter half-replacements of the alpha-helix 6 (SP4 and SP5 mutants) do not yield such improvement. We report here the crystal structures of the wild-type Tk-Rubisco and the mutants SP4 and SP6, and discuss the relationships between their structures and enzymatic activities. A comparison among these structures shows the movement and the increase of temperature factors of alpha-helix 6 induced by four essential factors. We thus supposed that an increase in the flexibility of the alpha-helix 6 and loop 6 regions was important to increase the catalytic activity of Tk-Rubisco at ambient temperatures. Based on this structural information, we constructed a new mutant, SP5-V330T, which was designed to have significantly greater flexibility in the above region, and it proved to exhibit the highest activity among all mutants examined to date. The thermostability of the SP5-V330T mutant was lower than that of wild-type Tk-Rubisco, providing further support on the relationship between flexibility and activity at ambient temperatures.	[Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Yoshida, Shosuke; Atomi, Haruyuki; Imanaka, Tadayuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan	Kyoto University; Kyoto University	Miki, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	miki@kuchem.kyoto-u.ac.jp		Atomi, Haruyuki/0000-0001-9687-6426	Ministry of Education, Culture, Sports, Science and Technology, Japan [B-29]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Targeted Proteins Research Program (B-29) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The synchrotron radiation experiments were performed at the Photon Factory and SPring-8 with the approval of the Photon Factory Advisory Committee (proposals 2008S2-001 and 2008G149) and the Japan Synchrotron Radiation Research Institute (JASRI) (proposals 2008A1511, 2008A1973, 2008A2001, 2008A2048, 2009A1012, and 2009A1013).	Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHEN ZX, 1991, BIOCHEMISTRY-US, V30, P8846, DOI 10.1021/bi00100a017; CHEN ZX, 1989, J BIOL CHEM, V264, P3051; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; FUJII T, 1983, AGR BIOL CHEM TOKYO, V47, P2747; GATENBY AA, 1988, PHOTOSYNTH RES, V17, P145, DOI 10.1007/BF00047686; GATENBY AA, 1985, NATURE, V314, P617, DOI 10.1038/314617a0; GUTTERIDGE S, 1984, EMBO J, V3, P2737, DOI 10.1002/j.1460-2075.1984.tb02204.x; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; HARPEL MR, 1995, TECH PROT CHEM, V6, P357, DOI 10.1016/S1080-8914(06)80044-X; HARTMAN FC, 1994, ANNU REV BIOCHEM, V63, P197, DOI 10.1146/annurev.biochem.63.1.197; Karkehabadi S, 2007, BIOCHEMISTRY-US, V46, P11080, DOI 10.1021/bi701063f; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LORIMER GH, 1980, BIOCHEMISTRY-US, V19, P5321, DOI 10.1021/bi00564a027; Maeda N, 1999, J MOL BIOL, V293, P57, DOI 10.1006/jmbi.1999.3145; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; READ BA, 1994, ARCH BIOCHEM BIOPHYS, V312, P210, DOI 10.1006/abbi.1994.1301; Sambrook J, 2001, MOL CLONING LAB MANU; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; SCHNEIDER G, 1992, ANNU REV BIOPH BIOM, V21, P119, DOI 10.1146/annurev.bb.21.060192.001003; SCHNEIDER G, 1986, EMBO J, V5, P3409, DOI 10.1002/j.1460-2075.1986.tb04662.x; SCHNEIDER G, 1990, J MOL BIOL, V211, P989, DOI 10.1016/0022-2836(90)90088-4; SCHREUDER HA, 1993, P NATL ACAD SCI USA, V90, P9968, DOI 10.1073/pnas.90.21.9968; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; SOMERVILLE CR, 1984, MOL GEN GENET, V193, P214, DOI 10.1007/BF00330670; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDERVIES SM, 1986, EMBO J, V5, P2439, DOI 10.1002/j.1460-2075.1986.tb04519.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999; Yoshida S, 2007, APPL ENVIRON MICROB, V73, P6254, DOI 10.1128/AEM.00044-07; Yoshida S, 2006, J BIOTECHNOL, V124, P532, DOI 10.1016/j.jbiotec.2006.02.001	48	17	18	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39339	39347		10.1074/jbc.M110.147587	http://dx.doi.org/10.1074/jbc.M110.147587			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926376	Green Published, hybrid			2022-12-25	WOS:000284941300061
J	Larkin, EA; Stiles, BG; Ulrich, RG				Larkin, Eileen A.; Stiles, Bradley G.; Ulrich, Robert G.			Inhibition of Toxic Shock by Human Monoclonal Antibodies against Staphylococcal Enterotoxin B	PLOS ONE			English	Article							OF-THE-LITERATURE; INTRAVENOUS IMMUNOGLOBULIN; CROSS-REACTIVITY; MURINE MODEL; DOUBLE-BLIND; IN-VITRO; AUREUS; SUPERANTIGENS; INFECTIONS; RESISTANT	Background: Staphylococcus aureus is implicated in many opportunistic bacterial infections around the world. Rising antibiotic resistance and few alternative methods of treatment are just two looming problems associated with clinical management of S. aureus. Among numerous virulence factors produced by S. aureus, staphylococcal enterotoxin (SE) B is a secreted protein that binds T-cell receptor and major histocompatibility complex class II, potentially causing toxic shock mediated by pathological activation of T cells. Recombinant monoclonal antibodies that target SEB and block receptor interactions can be of therapeutic value. Methodology/Principal Findings: The inhibitory and biophysical properties of ten human monoclonal antibodies, isolated from a recombinant library by panning against SEB vaccine (STEBVax), were examined as bivalent Fabs and native full-length IgG (Mab). The best performing Fabs had binding affinities equal to polyclonal IgG, low nanomolar IC(50)s against SEB in cell culture assays, and protected mice from SEB-induced toxic shock. The orthologous staphylococcal proteins, SEC1 and SEC2, as well as streptococcal pyrogenic exotoxin C were recognized by several Fabs. Four Fabs against SEB, with the lowest IC(50)s, were converted into native full-length Mabs. Although SEB-binding kinetics were identical between each Fab and respective Mab, a 250-fold greater inhibition of SEB-induced T-cell activation was observed with two Mabs. Conclusions/Significance: Results suggest that these human monoclonal antibodies possess high affinity, target specificity, and toxin neutralization qualities essential for any therapeutic agent.	[Larkin, Eileen A.; Stiles, Bradley G.; Ulrich, Robert G.] USA, Med Res Inst Infect Dis, Dept Immunol, Frederick, MD USA; [Larkin, Eileen A.; Ulrich, Robert G.] Hood Coll, Dept Biomed Sci, Frederick, MD 21701 USA; [Stiles, Bradley G.] Wilson Coll, Dept Biol, Chambersburg, PA USA		Larkin, EA (corresponding author), USA, Med Res Inst Infect Dis, Dept Immunol, Frederick, MD USA.	bstiles@wilson.edu; rulrich@bioanalysis.org			Joint Science and Technology Office [3.1003 07 RD B]	Joint Science and Technology Office	Funding was provided by The Joint Science and Technology Office 3.1003 07 RD B. This research was supported in part by an appointment of EAL to the Postgraduate Research Participation Program at the Medical Research Institute of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MM, 2001, CLIN INFECT DIS, V32, P1470, DOI 10.1086/320170; BAKER T, 2006, COMPREHENSIVE SOURCE, P872; Balbir-Gurman A, 2007, CLIN EXP RHEUMATOL, V25, pS28; Bavari S, 1999, J INFECT DIS, V180, P1365, DOI 10.1086/314977; BAVARI S, 1995, INFECT IMMUN, V63, P423, DOI 10.1128/IAI.63.2.423-429.1995; BOHACH GA, 1988, INFECT IMMUN, V56, P400, DOI 10.1128/IAI.56.2.400-404.1988; Boles JW, 2003, CLIN IMMUNOL, V108, P51, DOI 10.1016/S1521-6616(03)00066-4; BONVENTRE PF, 1988, INFECT IMMUN, V56, P135, DOI 10.1128/IAI.56.1.135-141.1988; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; DELONGE M, 2007, J PEDIAT, V151, P260; Descloux E, 2008, EUR J CLIN MICROBIOL, V27, P37, DOI 10.1007/s10096-007-0405-2; Glowalla E, 2009, INFECT IMMUN, V77, P2719, DOI 10.1128/IAI.00617-08; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Hassoun Ali, 2007, Am J Geriatr Pharmacother, V5, P48, DOI 10.1016/j.amjopharm.2007.03.001; Hot A, 2008, AM J HEMATOL, V83, P159, DOI 10.1002/ajh.21008; Hu DL, 2008, J MED MICROBIOL, V57, P1106, DOI 10.1099/jmm.0.2008/002790-0; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; Kakita M, 2006, INFECT IMMUN, V74, P3682, DOI 10.1128/IAI.01731-05; Kansal R, 2007, J CLIN IMMUNOL, V27, P327, DOI 10.1007/s10875-007-9072-4; Kato Kumiko, 2007, Allergol Int, V56, P439, DOI 10.2332/allergolint.O-06-462; KIENLE E, 1989, MED MICROBIOL IMMUN, V178, P127, DOI 10.1007/BF00198011; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Lamothe F, 1995, CLIN INFECT DIS, V21, P1469, DOI 10.1093/clinids/21.6.1469; LANG AB, 1993, J IMMUNOL, V151, P466; LeClaire RD, 2002, INFECT IMMUN, V70, P2278, DOI 10.1128/IAI.70.5.2278-2281.2002; LEE ACM, 1980, INFECT IMMUN, V27, P431, DOI 10.1128/IAI.27.2.431-434.1980; Maragakis LL, 2008, EXPERT REV ANTI-INFE, V6, P751, DOI 10.1586/14787210.6.5.751; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; MARR JC, 1993, INFECT IMMUN, V61, P4254, DOI 10.1128/IAI.61.10.4254-4262.1993; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Marton JP, 2008, CURR MED RES OPIN, V24, P2821, DOI [10.1185/03007990802365169, 10.1185/03007990802365169 ]; Mata S, 2007, EUR J NEUROL, V14, P1147, DOI 10.1111/j.1468-1331.2007.01929.x; NORRBYTEGLUND A, 2007, SUPERANTIGENS MOL BA, P197; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Pai Jennifer C, 2009, Recent Pat Antiinfect Drug Discov, V4, P1; Parsonnet J, 2005, J CLIN MICROBIOL, V43, P4628, DOI 10.1128/JCM.43.9.4628-4634.2005; Patel R, 2000, J INFECT DIS, V181, P230, DOI 10.1086/315198; Perez CM, 1997, AM J MED, V102, P111, DOI 10.1016/S0002-9343(96)00304-X; Poivell C, 2007, PEDIATR INFECT DIS J, V26, P759, DOI 10.1097/INF.0b013e3180618c15; Sakata K, 2007, EUR J PEDIATR, V166, P565, DOI 10.1007/s00431-006-0280-3; Schaffer AC, 2008, INT J ANTIMICROB AG, V32, pS71, DOI 10.1016/j.ijantimicag.2008.06.009; Schlievert PM, 2001, J ALLERGY CLIN IMMUN, V108, pS107, DOI 10.1067/mai.2001.117820; SPERO L, 1978, J IMMUNOL, V120, P86; Stiles B. G., 2005, Clinical Microbiology Newsletter, V27, P179, DOI 10.1016/j.clinmicnews.2005.11.001; STILES BG, 1995, INFECT IMMUN, V63, P1229, DOI 10.1128/IAI.63.4.1229-1234.1995; Stiles BG, 1999, INFECT IMMUN, V67, P1521, DOI 10.1128/IAI.67.3.1521-1525.1999; Stiles BG, 2001, INFECT IMMUN, V69, P2031, DOI 10.1128/IAI.69.4.2031-2036.2001; TAKEI S, 1993, J CLIN INVEST, V91, P602, DOI 10.1172/JCI116240; THOMPSON NE, 1984, INFECT IMMUN, V45, P281, DOI 10.1128/IAI.45.1.281-285.1984; Tilahun ME, 2010, INFECT IMMUN, V78, P2801, DOI 10.1128/IAI.01121-09; Uchiyama T., 2006, COMPREHENSIVE SOURCE, V3rd, P830, DOI [10.1016/B978-012088445-2/50055-X, DOI 10.1016/B978-012088445-2/50055-X]; ULRICH RG, 1995, NAT STRUCT BIOL, V2, P554, DOI 10.1038/nsb0795-554; Ulrich RG, 2000, FEMS IMMUNOL MED MIC, V27, P1; Ulrich RG, 1998, VACCINE, V16, P1857, DOI 10.1016/S0264-410X(98)00176-5; Vernachio JH, 2006, ANTIMICROB AGENTS CH, V50, P511, DOI 10.1128/AAC.50.2.511-518.2006; Vucic S, 2007, CLIN NEUROPHYSIOL, V118, P1980, DOI 10.1016/j.clinph.2007.05.001; Weems JJ, 2006, ANTIMICROB AGENTS CH, V50, P2751, DOI 10.1128/AAC.00096-06; Weisman LE, 2007, ARCH PEDIATRIE, V14, pS31, DOI 10.1016/S0929-693X(07)80008-X; Woody MA, 1997, VACCINE, V15, P133, DOI 10.1016/S0264-410X(96)00166-1; Wu H, 2008, CURR TOP MICROBIOL, V317, P103; Yanagisawa Chie, 2007, Journal of Infection and Chemotherapy, V13, P368, DOI 10.1007/s10156-007-0551-6	65	45	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13253	10.1371/journal.pone.0013253	http://dx.doi.org/10.1371/journal.pone.0013253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949003	gold, Green Submitted, Green Published			2022-12-25	WOS:000282748100006
J	Roquilly, A; Gautreau, L; Segain, JP; de Coppet, P; Sebille, V; Jacqueline, C; Caillon, J; Potel, G; Lejus, C; Josien, R; Asehnoune, K				Roquilly, Antoine; Gautreau, Laetitia; Segain, Jean Pierre; de Coppet, Pierre; Sebille, Veronique; Jacqueline, Cedric; Caillon, Jocelyne; Potel, Gilles; Lejus, Corinne; Josien, Regis; Asehnoune, Karim			CpG-ODN and MPLA Prevent Mortality in a Murine Model of Post-Hemorrhage-Staphyloccocus aureus Pneumonia	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; DENDRITIC CELL SUBSETS; DR ANTIGEN EXPRESSION; HEAD-TRAUMA PATIENTS; ACUTE LUNG INJURY; POLYMICROBIAL SEPSIS; RISK-FACTORS; MONONUCLEAR-CELLS; INNATE IMMUNITY; TNF PRODUCTION	Infections are the most frequent cause of complications in trauma patients. Post-traumatic immune suppression (IS) exposes patients to pneumonia (PN). The main pathogen involved in PN is Methicillin Susceptible Staphylococcus aureus (MSSA). Dendritic cells () may be centrally involved in the IS. We assessed the consequences of hemorrhage on pneumonia outcomes and investigated its consequences on DCs functions. A murine model of hemorrhagic shock with a subsequent MSSA pneumonia was used. Hemorrhage decreased the survival rate of infected mice, increased systemic dissemination of sepsis and worsened inflammatory lung lesions. The mRNA expression of Tumor Necrosis Factor-alpha (TNF-alpha), Interferon-beta (IFN-beta) and Interleukin (IL)-12p40 were mitigated for hemorrhaged-mice. The effects of hemorrhage on subsequent PN were apparent on the pDCs phenotype (reduced MHC class II, CD80, and CD86 molecule membrane expression). In addition, hemorrhage dramatically decreased CD8(+) cDCs- and CD8(-) cDCs- induced allogeneic T-cell proliferation during PN compared with mice that did not undergo hemorrhage. In conclusion, hemorrhage increased morbidity and mortality associated with PN; induced severe phenotypic disturbances of the pDCs subset and functional alterations of the cDCs subset. After hemorrhage, a preventive treatment with CpG-ODN or Monophosphoryl Lipid A increased transcriptional activity in DCs (TNF-alpha, IFN-beta and IL-12p40) and decreased mortality of post-hemorrhage MSSA pneumonia.	[Roquilly, Antoine; Jacqueline, Cedric; Caillon, Jocelyne; Potel, Gilles; Asehnoune, Karim] Univ Nantes, Fac Med, Lab UPRES EA Therapeut Clin & Expt Infect 3826, Nantes, France; [Roquilly, Antoine; Lejus, Corinne; Asehnoune, Karim] Ctr Hosp Univ Nantes, Hotel Dieu HME, Serv Anesthesie Reanimat Chirurg, Nantes, France; [Gautreau, Laetitia; Josien, Regis] INSERM, Unite Mixte Rech 643, Nantes, France; [Segain, Jean Pierre; de Coppet, Pierre] Univ Nantes, Inst Natl Rech Agron, Unite Mixte Rech Physiol Adaptat Nutr 1280, Nantes, France; [Sebille, Veronique] Univ Nantes, Fac Pharm, Cellule Biostat Cellule Promot Rech Clin, Nantes, France; [Sebille, Veronique] Univ Nantes, Fac Pharm, EA 4275, Nantes, France; [Josien, Regis] Ctr Hosp Univ Nantes, Immunol Lab, Nantes, France; [Josien, Regis] ITUN, Nantes, France	Nantes Universite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Nantes Universite; Nantes Universite; Nantes Universite; Nantes Universite; CHU de Nantes	Roquilly, A (corresponding author), Univ Nantes, Fac Med, Lab UPRES EA Therapeut Clin & Expt Infect 3826, Nantes, France.	karim.asehnoune@chu-nantes.fr	Josien, Regis/U-4405-2019; Sébille, Véronique/L-8761-2015; Rolland, Laetitia Gautreau/L-3081-2015; Josien, Regis/L-7468-2015; CAILLON, Jocelyne/AAF-8179-2020; Roquilly, Antoine/P-9826-2017; Sebille, Veronique/I-3309-2015; Jacqueline, Cédric/G-5650-2010; Gautreau-Rolland, Laetitia/AAC-8059-2019	Josien, Regis/0000-0001-7900-7413; Jacqueline, Cédric/0000-0001-9606-5930; Gautreau-Rolland, Laetitia/0000-0003-0113-488X; Sebille, Veronique/0000-0002-0780-7742	Societe Francaise d'Anesthesie Reanimation (SFAR); Centaure Foundation; Fondation pour la Recherche Medicale; Progreffe Foundation	Societe Francaise d'Anesthesie Reanimation (SFAR); Centaure Foundation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Progreffe Foundation	This work was supported by a grant from the Societe Francaise d'Anesthesie Reanimation (SFAR) and institutional sources. K Asehnoune was a recipient of funding from SFAR. L. Gautreau was recipient of funding from the Centaure Foundation, Fondation pour la Recherche Medicale and Progreffe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Adib-Conquy M, 2003, AM J RESP CRIT CARE, V168, P158, DOI 10.1164/rccm.200209-1077OC; Adib-Conquy M, 2001, J LEUKOCYTE BIOL, V70, P30; Agbaht K, 2007, INTENS CARE MED, V33, P1387, DOI 10.1007/s00134-007-0729-5; Asehnoune K, 2006, RESUSCITATION, V68, P127, DOI 10.1016/j.resuscitation.2005.05.015; Asehnoune K, 2006, CYTOKINE, V34, P212, DOI 10.1016/j.cyto.2006.05.003; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bandiera GW, 1999, J TRAUMA, V47, P932, DOI 10.1097/00005373-199911000-00020; Boutoille D, 2009, EXP LUNG RES, V35, P263, DOI 10.1080/01902140802632290; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; CHEADLE WG, 1991, AM J SURG, V161, P639, DOI 10.1016/0002-9610(91)91247-G; Czaja AS, 2009, J TRAUMA, V67, P805, DOI 10.1097/TA.0b013e318185e1fb; Damsgaard CT, 2009, J IMMUNOL METHODS, V340, P95, DOI 10.1016/j.jim.2008.10.005; Ditschkowski M, 1999, ANN SURG, V229, P246, DOI 10.1097/00000658-199902000-00013; ESRIG BC, 1977, SURG GYNECOL OBSTET, V144, P915; Fitzgerald KA, 2007, SCIENCE, V316, P1574, DOI 10.1126/science.1144483; Flohe SB, 2006, J LEUKOCYTE BIOL, V79, P473, DOI 10.1189/jlb.0705413; Henrich D, 2009, J SURG RES, V154, P239, DOI 10.1016/j.jss.2008.06.038; HERSHMAN MJ, 1990, BRIT J SURG, V77, P204, DOI 10.1002/bjs.1800770225; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawasaki T, 2006, J IMMUNOL, V177, P4514, DOI 10.4049/jimmunol.177.7.4514; Keel M, 1996, J TRAUMA, V40, P907, DOI 10.1097/00005373-199606000-00008; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnotti Louis J, 2004, Surg Infect (Larchmt), V5, P237, DOI 10.1089/sur.2004.5.237; Marie C, 1998, BLOOD, V91, P3439, DOI 10.1182/blood.V91.9.3439.3439_3439_3446; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MEGJUGORAC NJ, 2009, J LEUKOC BIOL; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Muehlstedt SG, 2002, CRIT CARE MED, V30, P1322, DOI 10.1097/00003246-200206000-00029; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Ouabed A, 2008, J IMMUNOL, V180, P5862, DOI 10.4049/jimmunol.180.9.5862; Papia G, 1999, J TRAUMA, V47, P923, DOI 10.1097/00005373-199911000-00018; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Pene F, 2008, J IMMUNOL, V181, P8513, DOI 10.4049/jimmunol.181.12.8513; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Poehlmann H, 2009, CRIT CARE, V13, DOI 10.1186/cc7969; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; ROBINSON A, 1991, CRIT CARE MED, V19, P1285, DOI 10.1097/00003246-199110000-00011; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; STEPHAN RN, 1987, ARCH SURG-CHICAGO, V122, P62; Thibault R, 2007, GASTROENTEROLOGY, V133, P1916, DOI 10.1053/j.gastro.2007.08.041; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Weighardt H, 2000, J IMMUNOL, V165, P4537, DOI 10.4049/jimmunol.165.8.4537	52	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13228	10.1371/journal.pone.0013228	http://dx.doi.org/10.1371/journal.pone.0013228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949109	Green Published, gold, Green Submitted			2022-12-25	WOS:000282633700017
J	Wen, Y; Li, J; Xiong, MQ; Peng, Y; Yao, WM; Hong, J; Lin, DH				Wen, Yi; Li, Jun; Xiong, Minqian; Peng, Yu; Yao, Wenming; Hong, Jing; Lin, Donghai			Solution Structure and Dynamics of the I214V Mutant of the Rabbit Prion Protein	PLOS ONE			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; NMR STRUCTURE; ORDER PARAMETERS; AMYLOID FIBRILS; HEAT-CAPACITY; SCRAPIE; BINDING; SHEEP; RESIDUES	Background: The conformational conversion of the host-derived cellular prion protein (PrPC) into the disease-associated scrapie isoform (PrPSc) is responsible for the pathogenesis of transmissible spongiform encephalopathies (TSEs). Various single-point mutations in PrP(C)s could cause structural changes and thereby distinctly influence the conformational conversion. Elucidation of the differences between the wild-type rabbit PrPC (RaPrPC) and various mutants would be of great help to understand the ability of RaPrPC to be resistant to TSE agents. Methodology/Principal Findings: We determined the solution structure of the I214V mutant of RaPrPC (91-228) and detected the backbone dynamics of its structured C-terminal domain (121-228). The I214V mutant displays a visible shift of surface charge distribution that may have a potential effect on the binding specificity and affinity with other chaperones. The number of hydrogen bonds declines dramatically. Urea-induced transition experiments reveal an obvious decrease in the conformational stability. Furthermore, the NMR dynamics analysis discloses a significant increase in the backbone flexibility on the pico- to nanosecond time scale, indicative of lower energy barrier for structural rearrangement. Conclusions/Significance: Our results suggest that both the surface charge distribution and the intrinsic backbone flexibility greatly contribute to species barriers for the transmission of TSEs, and thereby provide valuable hints for understanding the inability of the conformational conversion for RaPrPC	[Wen, Yi; Li, Jun; Xiong, Minqian; Peng, Yu; Yao, Wenming; Hong, Jing; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, NMR Lab, Shanghai 200031, Peoples R China; [Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Xiamen University	Wen, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, NMR Lab, Shanghai 200031, Peoples R China.	dhlin@mail.shcnc.ac.cn	li, jun/A-1197-2011; Lin, Donghai/A-1482-2011	Peng, Yu/0000-0003-2039-9015	National Natural Science Foundation of China [30730026, 30570352]; National Science & Technology, China [2009ZX09301-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology, China	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30730026, 30570352) and National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program,'' China (No. 2009ZX09301-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; ALONSO DOV, 1991, BIOCHEMISTRY-US, V30, P5974, DOI 10.1021/bi00238a023; Bae SH, 2009, BIOCHEMISTRY-US, V48, P8120, DOI 10.1021/bi900923b; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Blinov N, 2009, BIOCHEMISTRY-US, V48, P1488, DOI 10.1021/bi802043h; Calzolai L, 2000, P NATL ACAD SCI USA, V97, P8340, DOI 10.1073/pnas.97.15.8340; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; CLOUSCARD C, 1995, J GEN VIROL, V76, P2097, DOI 10.1099/0022-1317-76-8-2097; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hornemann S, 2004, EMBO REP, V5, P1159, DOI 10.1038/sj.embor.7400297; Hunter N, 1997, TRENDS MICROBIOL, V5, P331, DOI 10.1016/S0966-842X(97)01081-0; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Kay LE, 1998, NAT STRUCT BIOL, V5, P156, DOI 10.1038/nsb0298-156; Kirby L, 2010, BIOCHEMISTRY-US, V49, P1448, DOI 10.1021/bi901855z; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu H, 1999, BIOCHEMISTRY-US, V38, P5362, DOI 10.1021/bi982878x; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; PRIVALOV PL, 1992, J MOL BIOL, V224, P715, DOI 10.1016/0022-2836(92)90555-X; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WEN Y, 2010, J BIOL CHEM IN PRESS; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Yin SM, 2003, PROTEIN EXPRES PURIF, V32, P104, DOI 10.1016/S1046-5928(03)00195-5; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang JP, 2010, J THEOR BIOL, V264, P119, DOI 10.1016/j.jtbi.2010.01.024; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	64	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13273	10.1371/journal.pone.0013273	http://dx.doi.org/10.1371/journal.pone.0013273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949107	Green Published, gold			2022-12-25	WOS:000282633700023
J	Mattiuzzo, G; Takeuchi, Y				Mattiuzzo, Giada; Takeuchi, Yasuhiro			Suboptimal Porcine Endogenous Retrovirus Infection in Non-Human Primate Cells: Implication for Preclinical Xenotransplantation	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; LIVING PIG-TISSUE; LARGE WHITE-PIG; IN-VITRO; HOST-RANGE; MINIATURE SWINE; NO EVIDENCE; SUBGROUP-A; PERV; IDENTIFICATION	Background: Porcine endogenous retrovirus (PERV) poses a potential risk of zoonotic infection in xenotransplantation. Preclinical transplantation trials using non-human primates (NHP) as recipients of porcine xenografts present the opportunity to assess the zoonosis risk in vivo. However, PERV poorly infects NHP cells for unclear reasons and therefore NHP may represent a suboptimal animal model to assess the risk of PERV zoonoses. We investigated the mechanism responsible for the low efficiency of PERV-A infection in NHP cells. Principal Findings: Two steps, cell entry and exit, were inefficient for the replication of high-titer, human-tropic A/C recombinant PERV. A restriction factor, tetherin, is likely to be responsible for the block to matured virion release, supported by the correlation between the levels of inhibition and tetherin expression. In rhesus macaque, cynomolgus macaque and baboon the main receptor for PERV entry, PERV-A receptor 1 (PAR-1), was found to be genetically deficient: PAR-1 genes in these species encode serine at amino acid 109 in place of the leucine in human PAR-1. This genetic defect inevitably impacts in vivo sensitivity to PERV infection of these species. In contrast, African green monkey (AGM) PAR-1 is functional, but PERV infection is still poor. Although the mechanism is unclear, tunicamycin treatment, which removes N-glycosylated sugar chains, increases PERV infection, suggesting a possible role for the glycosylation of the receptors. Conclusions: Since cynomolgus macaque and baboon, species often used in pig-to-NHP xenotransplantation experiments, have a defective PAR-1, they hardly represent an ideal animal model to assess the risk of PERV transmission in xenotransplantation. Alternatively, NHP species, like AGM, whose both PARs are functional may represent a better model than baboon and cynomolgus macaque for PERV zoonosis in vivo studies.	[Mattiuzzo, Giada; Takeuchi, Yasuhiro] UCL, Div Infect & Immun, Wohl Virion Ctr, London, England	University of London; University College London	Mattiuzzo, G (corresponding author), UCL, Div Infect & Immun, Wohl Virion Ctr, London, England.	y.takeuchi@ucl.ac.uk			European Sixth Framework Programme (Life Science, Genomics and Biotechnology for Health) [LSHB-CT-2006-037377]	European Sixth Framework Programme (Life Science, Genomics and Biotechnology for Health)	This work was supported by the European Sixth Framework Programme (Life Science, Genomics and Biotechnology for Health) funded project LSHB-CT-2006-037377. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 1998, J VIROL, V72, P4503, DOI 10.1128/JVI.72.5.4503-4507.1998; Bartosch B, 2004, J VIROL, V78, P13880, DOI 10.1128/JVI.78.24.13880-13890.2004; Bartosch B, 2002, J GEN VIROL, V83, P2231, DOI 10.1099/0022-1317-83-9-2231; Blusch JH, 2000, J VIROL, V74, P7687, DOI 10.1128/JVI.74.16.7687-7690.2000; Bosch S, 2000, J VIROL, V74, P8575, DOI 10.1128/JVI.74.18.8575-8581.2000; Clemenceau B, 2001, DIABETOLOGIA, V44, P2044, DOI 10.1007/s001250100010; Cunningham DA, 2001, TRENDS CARDIOVAS MED, V11, P190, DOI 10.1016/S1050-1738(01)00104-9; Denner J, 2003, Ann Transplant, V8, P39; Denner J, 2008, ARCH VIROL, V153, P1421, DOI 10.1007/s00705-008-0141-7; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Edamura K, 2004, J VET MED SCI, V66, P129, DOI 10.1292/jvms.66.129; Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005; Elliott RB, 2000, CELL TRANSPLANT, V9, P895, DOI 10.1177/096368970000900616; Ericsson TA, 2003, P NATL ACAD SCI USA, V100, P6759, DOI 10.1073/pnas.1138025100; Gemeniano M, 2006, VIROLOGY, V346, P108, DOI 10.1016/j.virol.2005.10.021; Heneine W, 1998, LANCET, V352, P695, DOI 10.1016/S0140-6736(98)07145-1; Herring C, 2001, J VIROL, V75, P12252, DOI 10.1128/JVI.75.24.12252-12265.2001; Lavillette D, 2002, J VIROL, V76, P6442, DOI 10.1128/JVI.76.13.6442-6452.2002; Lee JH, 2002, J VIROL, V76, P5548, DOI 10.1128/JVI.76.11.5548-5556.2002; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; Li Z, 2004, VIRUS RES, V105, P167, DOI 10.1016/j.virusres.2004.05.007; Marcucci KT, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-3; Marin M, 2003, J VIROL, V77, P2936, DOI 10.1128/JVI.77.5.2936-2945.2003; Martin U, 1999, TRANSPLANT P, V31, P913, DOI 10.1016/S0041-1345(98)01832-6; Mattiuzzo G, 2008, CURR OPIN ORGAN TRAN, V13, P184, DOI 10.1097/MOT.0b013e3282f7961e; Mattiuzzo G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-93; Mattiuzzo G, 2010, J VIROL, V84, P2618, DOI 10.1128/JVI.01928-09; Moscoso I, 2005, TRANSPLANTATION, V79, P777, DOI 10.1097/01.TP.0000152662.55720.83; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Niebert M, 2002, J VIROL, V76, P2714, DOI 10.1128/JVI.76.6.2714-2720.2002; Nishitai R, 2005, J SURG RES, V124, P45, DOI 10.1016/j.jss.2004.09.006; Oldmixon BA, 2002, J VIROL, V76, P3045, DOI 10.1128/JVI.76.6.3045-3048.2002; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patience C, 1998, LANCET, V352, P699, DOI 10.1016/S0140-6736(98)04369-4; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Patience C, 2001, J VIROL, V75, P2771, DOI 10.1128/JVI.75.6.2771-2775.2001; Ritzhaupt A, 2002, J VIROL, V76, P11312, DOI 10.1128/JVI.76.22.11312-11320.2002; Rogel-Gaillard C, 1999, CYTOGENET CELL GENET, V85, P205, DOI 10.1159/000015294; Scobie L, 2009, CURR OPIN ORGAN TRAN, V14, P175, DOI 10.1097/MOT.0b013e328327984d; Simon A R, 2003, Ann Transplant, V8, P24; Specke V, 2001, J GEN VIROL, V82, P837, DOI 10.1099/0022-1317-82-4-837; Specke V, 2009, XENOTRANSPLANTATION, V16, P34, DOI 10.1111/j.1399-3089.2009.00508.x; Switzer WM, 2001, TRANSPLANTATION, V71, P959, DOI 10.1097/00007890-200104150-00022; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; Templin C, 2000, TRANSPLANT P, V32, P1163, DOI 10.1016/S0041-1345(00)01167-2; Wilson CA, 2008, CELL MOL LIFE SCI, V65, P3399, DOI 10.1007/s00018-008-8498-z; Wilson CA, 2000, J VIROL, V74, P49, DOI 10.1128/JVI.74.1.49-56.2000; Wilson CA, 1998, J VIROL, V72, P3082, DOI 10.1128/JVI.72.4.3082-3087.1998; Wood A, 2009, J GEN VIROL, V90, P702, DOI 10.1099/vir.0.007377-0; Wood JC, 2004, J VIROL, V78, P2494, DOI 10.1128/JVI.78.5.2494-2501.2004; Yan Y, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-2	51	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13203	10.1371/journal.pone.0013203	http://dx.doi.org/10.1371/journal.pone.0013203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949092	Green Published, Green Submitted, gold			2022-12-25	WOS:000282568400014
J	Freedman, BS; Miller, KE; Heald, R				Freedman, Benjamin S.; Miller, Kelly E.; Heald, Rebecca			Xenopus Egg Extracts Increase Dynamics of Histone H1 on Sperm Chromatin	PLOS ONE			English	Article							LINKER HISTONES; NUCLEAR IMPORT; IN-VIVO; DOMAINS; BINDING; DNA; NUCLEOSOME; LOCATION; CELLS; PHOSPHORYLATION	Background: Linker histone H1 has been studied in vivo and using reconstituted chromatin, but there have been few systematic studies of the effects of the cellular environment on its function. Due to the presence of many other chromatin factors and specific chaperones such as RanBP7/importin beta that regulate histone H1, linker histones likely function differently in vivo than in purified systems. Methodology/Principal Findings: We have directly compared H1 binding to sperm nuclei in buffer versus Xenopus egg extract cytoplasm, and monitored the effects of adding nuclear import chaperones. In buffer, RanBP7 decondenses sperm nuclei, while H1 binds tightly to the chromatin and rescues RanBP7-mediated decondensation. H1 binding is reduced in cytoplasm, and H1 exhibits rapid FRAP dynamics in cytoplasm but not in buffer. RanBP7 decreases H1 binding to chromatin in both buffer and extract but does not significantly affect H1 dynamics in either condition. Importin beta has a lesser effect than RanBP7 on sperm chromatin decondensation and H1 binding, while a combination of RanBP7/importin beta is no more effective than RanBP7 alone. In extracts supplemented with RanBP7, H1 localizes to chromosomal foci, which increase after DNA damage. Unlike somatic H1, the embryonic linker histone H1M binds equally well to chromatin in cytoplasm compared to buffer. Amino-globular and carboxyl terminal domains of H1M bind chromatin comparably to the full-length protein in buffer, but are inhibited similar to 10-fold in cytoplasm. High levels of H1 or its truncations distort mitotic chromosomes and block their segregation during anaphase. Conclusion/Significance: RanBP7 can decondense sperm nuclei and decrease H1 binding, but the rapid dynamics of H1 on chromatin depend on other cytoplasmic factors. Cytoplasm greatly impairs the activity of individual H1 domains, and only the full-length protein can condense chromatin properly. Our findings begin to bridge the gap between purified and in vivo chromatin systems.	[Freedman, Benjamin S.; Miller, Kelly E.; Heald, Rebecca] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freedman, BS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	bheald@berkeley.edu		Heald, Rebecca/0000-0001-6671-6528; Miller, Kelly/0000-0002-2273-2064	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Baatout S, 2006, CELL BIOCHEM FUNCT, V24, P93, DOI 10.1002/cbf.1293; Becker M, 2005, MOL BIOL CELL, V16, P3887, DOI 10.1091/mbc.E05-04-0350; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Dou YL, 2002, J CELL BIOL, V158, P1161, DOI 10.1083/jcb.200202131; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Freedman BS, 2010, CURR BIOL, V20, P1048, DOI 10.1016/j.cub.2010.04.025; Grandi P, 2001, J CELL SCI, V114, P3345; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Maresca Thomas J., 2006, V322, P459; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; RAGHURAM N, BIOCHEMISTRY, V49, P4420; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rosidi B, 2008, NUCLEIC ACIDS RES, V36, P1610, DOI 10.1093/nar/gkn013; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; STAYNOV DZ, 1988, EMBO J, V7, P3685, DOI 10.1002/j.1460-2075.1988.tb03250.x; Tamada H, 2006, MOL CELL BIOL, V26, P1259, DOI 10.1128/MCB.26.4.1259-1271.2006; Tashker JS, 2002, MOL BIOL CELL, V13, P393, DOI 10.1091/mbc.01-06-0291; THOMA F, 1977, CELL, V12, P101, DOI 10.1016/0092-8674(77)90188-X; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMA F, 1983, J MOL BIOL, V167, P619, DOI 10.1016/S0022-2836(83)80102-8; THOMAS JO, 1992, NUCLEIC ACIDS RES, V20, P187, DOI 10.1093/nar/20.2.187; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; VARSHAVSKY AJ, 1976, NUCLEIC ACIDS RES, V3, P477, DOI 10.1093/nar/3.2.477; WHITLOCK JP, 1976, BIOCHEMISTRY-US, V15, P3307, DOI 10.1021/bi00660a022	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13111	10.1371/journal.pone.0013111	http://dx.doi.org/10.1371/journal.pone.0013111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927327	Green Published, Green Submitted, gold			2022-12-25	WOS:000282269400033
J	Ward, JBJ; Lawler, K; Amu, S; Taylor, CT; Fallon, PG; Keely, SJ				Ward, Joseph B. J.; Lawler, Karen; Amu, Sylvie; Taylor, Cormac T.; Fallon, Padraic G.; Keely, Stephen J.			Hydroxylase inhibition attenuates colonic epithelial secretory function and ameliorates experimental diarrhea	FASEB JOURNAL			English	Article						chloride secretion; dimethyloxallyl glycine; Na+/K+-ATPase	TRANSMEMBRANE CONDUCTANCE REGULATOR; INDUCIBLE FACTOR-I; CYSTIC-FIBROSIS; ION-TRANSPORT; INTESTINAL EPITHELIUM; CHLORIDE SECRETION; OXYGEN SENSORS; CL-SECRETION; MAST-CELLS; BLOOD-FLOW	Hydroxylases are oxygen-sensing enzymes that regulate cellular responses to hypoxia. Transepithelial Cl- secretion, the driving force for fluid secretion, is dependent on O-2 availability for generation of cellular energy. Here, we investigated the role of hydroxylases in regulating epithelial secretion and the potential for targeting these enzymes in treatment of diarrheal disorders. Ion transport was measured as short-circuit current changes across voltage-clamped monolayers of T-84 cells and mouse colon. The antidiarrheal efficacy of dimethyloxallyl glycine (DMOG) was tested in a mouse model of allergic disease. Hydroxylase inhibition with DMOG attenuated Ca2+ - and cAMP-dependent secretory responses in voltage-clamped T-84 cells to 20.2 +/- 2.6 and 38.8 +/- 6.7% (n=16; P <= 0.001) of those in control cells, respectively. Antisecretory actions of DMOG were time and concentration dependent, being maximal after 18 h of DMOG (1 mM) treatment. DMOG specifically inhibited Na+/K+-ATPase pump activity without altering its expression or membrane localization. In mice, DMOG inhibited agonist-induced secretory responses ex vivo and prevented allergic diarrhea in vivo. In conclusion, hydroxylases are important regulators of epithelial Cl- and fluid secretion and present a promising target for development of new drugs to treat transport disorders.-Ward, J. B. J., Lawler, K., Amu, S., Taylor, C. T., Fallon, P. G., Keely, S. J. Hydroxylase inhibition attenuates colonic epithelial secretory function and ameliorates experimental diarrhea. FASEB J. 25, 535-543 (2011). www.fasebj.org	[Keely, Stephen J.] Beaumont Hosp, RCSI Educ & Res Ctr, Mol Med Labs, Royal Coll Surg Ireland, Dublin 9, Ireland; [Amu, Sylvie; Fallon, Padraic G.] Trinity Coll Dublin, Inst Mol Med, Sch Med, Dublin, Ireland; [Taylor, Cormac T.] Univ Coll Dublin, Conway Inst, Sch Med & Life Sci, Coll Life Sci, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Trinity College Dublin; University College Dublin	Keely, SJ (corresponding author), Beaumont Hosp, RCSI Educ & Res Ctr, Mol Med Labs, Royal Coll Surg Ireland, Smurfit Bldg, Dublin 9, Ireland.	skeely@rcsi.ie	Fallon, Padraic/Y-2711-2019; Tuluc, Petronel/C-2527-2011	Fallon, Padraic/0000-0002-8401-7293; Keely, Stephen/0000-0002-6315-3587; Amu, Sylvie/0000-0001-9593-7952; Taylor, Cormac/0000-0002-0946-1247	Science Foundation Ireland; National Biophotonics Imaging Platform Ireland; Irish government's Programme for Research in Third Level Institutions	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Biophotonics Imaging Platform Ireland; Irish government's Programme for Research in Third Level Institutions	This work was supported by Science Foundation Ireland Principal Investigator and Research Frontiers Programme awards to S.J.K. and by National Biophotonics Imaging Platform Ireland, and funded by the Irish government's Programme for Research in Third Level Institutions, Cycle 4, National Development Plan 2007-2013.	Asikainen TM, 2005, FREE RADICAL BIO MED, V38, P1002, DOI 10.1016/j.freeradbiomed.2004.12.004; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Bijvelds MJC, 2009, GASTROENTEROLOGY, V137, P976, DOI 10.1053/j.gastro.2009.05.037; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bystriansky JS, 2007, J BIOENERG BIOMEMBR, V39, P373, DOI 10.1007/s10863-007-9100-3; CARTWRIGHT CA, 1985, J CLIN INVEST, V76, P1837, DOI 10.1172/JCI112176; CHOW DC, 1995, J EXP BIOL, V198, P1; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; CUTHBERT AW, 1994, PFLUG ARCH EUR J PHY, V428, P508, DOI 10.1007/BF00374572; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Dada LA, 2007, ADV EXP MED BIOL, V618, P159; DEJONGE HR, 2006, PED PULMONOL S, V29, P148; Del Castillo IC, 2005, AM J PHYSIOL-CELL PH, V289, pC1332, DOI 10.1152/ajpcell.00580.2004; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Floyd ZE, 2007, J CELL BIOCHEM, V101, P1545, DOI 10.1002/jcb.21266; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Genetos DC, 2009, J CELL BIOCHEM, V107, P233, DOI 10.1002/jcb.22119; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Ibla JC, 2006, AM J PHYSIOL-CELL PH, V291, pC282, DOI 10.1152/ajpcell.00564.2005; KIRK KL, 1983, J GEN PHYSIOL, V82, P297, DOI 10.1085/jgp.82.3.297; Lam RS, 2003, J PHYSIOL-LONDON, V548, P475, DOI 10.1113/jphysiol.2002.036806; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Liu J, 2002, KIDNEY INT, V62, P2118, DOI 10.1046/j.1523-1755.2002.00672.x; Lomb DJ, 2007, J NEUROCHEM, V103, P1897, DOI 10.1111/j.1471-4159.2007.04873.x; Matheson PJ, 2000, J SURG RES, V93, P182, DOI 10.1006/jsre.2000.5862; Metzen E, 2004, BIOL CHEM, V385, P223, DOI 10.1515/BC.2004.016; MUSCH TI, 1987, J APPL PHYSIOL, V63, P2269, DOI 10.1152/jappl.1987.63.6.2269; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PERDUE MH, 1991, J CLIN INVEST, V87, P687, DOI 10.1172/JCI115047; Ratcliffe PJ, 2006, CLIN MED, V6, P573, DOI 10.7861/clinmedicine.6-6-573; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; ROCHWERGER L, 1994, J CELL SCI, V107, P2439; Schodel J, 2009, AM J PATHOL, V174, P1663, DOI 10.2353/ajpath.2009.080687; Schoots VG, 2006, SURGERY, V139, P244, DOI 10.1016/j.surg.2005.07.032; Schultz K, 2009, AM J PHYSIOL-LUNG C, V296, pL921, DOI 10.1152/ajplung.90393.2008; Takeda K, 2009, ARTERIOSCL THROM VAS, V29, P2132, DOI 10.1161/ATVBAHA.109.196071; Taylor CT, 1998, J PHARMACOL EXP THER, V284, P568; Yoon T, 2006, FEBS LETT, V580, P3558, DOI 10.1016/j.febslet.2006.05.042; Zheng W, 2009, FASEB J, V23, P204, DOI 10.1096/fj.08-110221	42	9	9	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					535	543		10.1096/fj.10-166983	http://dx.doi.org/10.1096/fj.10-166983			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20944011				2022-12-25	WOS:000286724800012
J	Nagle, MA; Truong, DM; Dnyanmote, AV; Ahn, SY; Eraly, SA; Wu, W; Nigam, SK				Nagle, Megha A.; Truong, David M.; Dnyanmote, Ankur V.; Ahn, Sun-Young; Eraly, Satish A.; Wu, Wei; Nigam, Sanjay K.			Analysis of Three-dimensional Systems for Developing and Mature Kidneys Clarifies the Role of OAT1 and OAT3 in Antiviral Handling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTERS; SLC22A FAMILY-MEMBERS; MOLECULAR-CLONING; ION TRANSPORTERS; NEPHROTOXICITY; EXPRESSION; TENOFOVIR; DRUG; RAT; IMMUNOLOCALIZATION	The organic anion transporters OAT1 (SLC22A6, originally identified by us as NKT) and OAT3 (SLC22A8) are critical for handling many toxins, metabolites, and drugs, including antivirals (Truong, D. M., Kaler, G., Khandelwal, A., Swaan, P. W., and Nigam, S. K. (2008) J. Biol. Chem. 283, 8654-8663). Although microinjected Xenopus oocytes and/or transfected cells indicate overlapping specificities, the individual contributions of these transporters in the three-dimensional context of the tissues in which they normally function remain unclear. Here, handling of HIV antivirals (stavudine, tenofovir, lamivudine, acyclovir, and zidovudine) was analyzed with three-dimensional ex vivo functional assays using knock-out tissue. To investigate the contribution of OAT1 and OAT3 in various nephron segments, the OAT-selective fluorescent tracer substrates 5-carboxyfluorescein and 6-carboxyfluorescein were used. Although OAT1 function (uptake in oat3(-/-) tissue) was confined to portions of the cortex, consistent with a proximal tubular localization, OAT3 function (uptake in oat1(-/-) tissue) was apparent throughout the cortex, indicating localization in the distal as well as proximal nephron. This functional localization indicates a complex three-dimensional context, which needs to be considered for metabolites, toxins, and drugs (e. g. antivirals) handled by both transporters. These results also raise the possibility of functional differences in the relative importance of OAT1 and OAT3 in antiviral handling in developing and mature tissue. Because the HIV antivirals are used in pregnant women, the results may also help in understanding how these drugs are handled by developing organs.	[Eraly, Satish A.; Wu, Wei; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, La Jolla, CA 92093 USA; [Nagle, Megha A.; Dnyanmote, Ankur V.; Ahn, Sun-Young; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Truong, David M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Austin	Nigam, SK (corresponding author), Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@ucsd.edu		Ahn, Sun-Young/0000-0001-5571-6901; Truong, David/0000-0002-5121-5111	National Institutes of Health [AI057695, DK079784, GM88824, HL094728]; Society of Toxicology and Colgate Palmolive; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Toxicology and Colgate Palmolive; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057695, DK079784, and GM88824 (to S. K. N.) and HL094728 (to S. A. E.). This work was also supported by a postdoctoral fellowship from the Society of Toxicology and Colgate Palmolive (to A. V. D.).	Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Cihlar T, 2001, NUCLEOS NUCLEOT NUCL, V20, P641, DOI 10.1081/NCN-100002341; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2003, CURR OPIN NEPHROL HY, V12, P551, DOI 10.1097/00041552-200309000-00011; Hasegawa M, 2003, J PHARMACOL EXP THER, V305, P1087, DOI 10.1124/jpet.102.046847; Hussain S, 2006, PEDIATR NEPHROL, V21, P1034, DOI 10.1007/s00467-006-0109-3; Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kojima R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134848; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; Nigam SK, 2007, NAT CLIN PRACT NEPHR, V3, P443, DOI 10.1038/ncpneph0558; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Servais Aude, 2005, Nephrol Ther, V1, P296, DOI 10.1016/j.nephro.2005.06.011; Servais A, 2006, EUR J PHARMACOL, V540, P168, DOI 10.1016/j.ejphar.2006.04.047; Sweet DH, 2005, TOXICOL APPL PHARM, V204, P198, DOI 10.1016/j.taap.2004.10.016; Sweet DH, 2006, KIDNEY INT, V69, P837, DOI 10.1038/sj.ki.5000170; Sweet DH, 2003, AM J PHYSIOL-RENAL, V284, pF763, DOI 10.1152/ajprenal.00405.2002; Sykes D, 2004, AM J PHYSIOL-RENAL, V286, pF972, DOI 10.1152/ajprenal.00356.2003; Tahara H, 2005, PHARM RES-DORDR, V22, P647, DOI 10.1007/s11095-005-2503-0; Takeda M, 2002, J PHARMACOL EXP THER, V300, P918, DOI 10.1124/jpet.300.3.918; Trifillis AL, 1999, EXP NEPHROL, V7, P353; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Uwai Y, 2007, PHARM RES, V24, P811, DOI 10.1007/s11095-006-9196-x; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Wada S, 2000, J PHARMACOL EXP THER, V294, P844	29	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					243	251		10.1074/jbc.M110.139949	http://dx.doi.org/10.1074/jbc.M110.139949			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20921221	Green Published, hybrid			2022-12-25	WOS:000285782800027
J	Chen, W; Dong, QH; Shin, KH; Kim, RH; Oh, JE; Park, NH; Kang, MK				Chen, Wei; Dong, Qinghua; Shin, Ki-Hyuk; Kim, Reuben H.; Oh, Ju-Eun; Park, No-Hee; Kang, Mo K.			Grainyhead-like 2 Enhances the Human Telomerase Reverse Transcriptase Gene Expression by Inhibiting DNA Methylation at the 5 '-CpG Island in Normal Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ORAL KERATINOCYTES; PROMOTER ACTIVITY; IMMORTAL CELLS; DROSOPHILA; HTERT; DIFFERENTIATION; SENESCENCE; MECHANISM; BINDING; HEAD	We recently identified Grainyhead-like 2 (GRHL2) as a novel transcription factor that binds to and regulates the activity of the human telomerase reverse transcriptase (hTERT) gene promoter. In this study, we investigated the biological functions of GRHL2 and the molecular mechanism underlying hTERT gene regulation by GRHL2. Retroviral transduction of GRHL2 in normal human keratinocytes (NHK) led to a significant extension of replicative life span, whereas GRHL2 knockdown notably repressed telomerase activity and cell proliferation. Using promoter magnetic precipitation coupled with Western blotting, we confirmed the binding of GRHL2 to the hTERT promoter and mapped the minimal binding region at -53 to -13 of the promoter. Furthermore, mutation analysis revealed the three nucleotides from -21 to -19 to be critical for GRHL2 binding. Because hTERT expression is regulated in part by DNA methylation, we determined the effects of GRHL2 on the methylation status of the hTERT promoter. Senescent NHK exhibited hypermethylation of the CpG island, which occurred with the loss of hTERT expression. On the contrary, the promoter remained hypomethylated in GRHL2-transduced NHK, irrespective of cell proliferation status. Also, knockdown of endogenous GRHL2 led to hypermethylation of the promoter. These results indicate that GRHL2 regulates the hTERT expression through an epigenetic mechanism and controls the cellular life span.	[Kang, Mo K.] Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Los Angeles, CA 90095 USA; [Shin, Ki-Hyuk; Kim, Reuben H.; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90095 USA; [Shin, Ki-Hyuk; Kim, Reuben H.; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Park, No-Hee] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kang, MK (corresponding author), Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Rm 43-009,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	mkang@dentistry.ucla.edu			National Institutes of Health, NIDCR [R01DE18295, K02DE18959]; Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K02DE018959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018295] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE18295 and K02DE18959 from NIDCR.; Supported by the Jack A. Weichman Endowed Fund.	Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Boldrini L, 2006, INT J ONCOL, V28, P1555; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Cann JR, 1998, ELECTROPHORESIS, V19, P127, DOI 10.1002/elps.1150190202; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Dessain SK, 2000, CANCER RES, V60, P537; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hayashi Y, 1999, J BIOL CHEM, V274, P35080, DOI 10.1074/jbc.274.49.35080; Horikawa I, 2004, CYTOTECHNOLOGY, V45, P23, DOI 10.1007/s10616-004-5122-4; Horikawa I, 1999, CANCER RES, V59, P826; Huang JD, 1995, GENE DEV, V9, P3177, DOI 10.1101/gad.9.24.3177; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Kang MK, 2000, EXP CELL RES, V258, P288, DOI 10.1006/excr.2000.4943; Kang MK, 2004, J CELL PHYSIOL, V199, P364, DOI 10.1002/jcp.10410; Kang MK, 1998, CELL GROWTH DIFFER, V9, P85; Kang Mo K, 2007, Methods Mol Biol, V371, P151; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim RH, 2007, EXP CELL RES, V313, P462, DOI 10.1016/j.yexcr.2006.10.025; Kristensen LS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-453; Kyo S, 1999, INT J CANCER, V80, P60, DOI 10.1002/(SICI)1097-0215(19990105)80:1<60::AID-IJC12>3.3.CO;2-5; Lo YMD, 1999, CANCER RES, V59, P3899; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Shin KH, 2003, BRIT J CANCER, V89, P1473, DOI 10.1038/sj.bjc.6601291; Stramer B, 2005, CURR BIOL, V15, pR425, DOI 10.1016/j.cub.2005.05.034; Svedruzic ZM, 2008, CURR MED CHEM, V15, P92, DOI 10.2174/092986708783330700; Tanaka Y, 2008, J HEPATOL, V49, P746, DOI 10.1016/j.jhep.2008.06.019; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting SB, 2003, BIOCHEM J, V370, P953, DOI 10.1042/BJ20021476; UV AE, 1994, MOL CELL BIOL, V14, P4020, DOI 10.1128/MCB.14.6.4020; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Wilanowski T, 2008, EMBO J, V27, P886, DOI 10.1038/emboj.2008.24; Wooten LG, 2005, J BIOL CHEM, V280, P28867, DOI 10.1074/jbc.M413444200; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015	41	40	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40852	40863		10.1074/jbc.M110.103812	http://dx.doi.org/10.1074/jbc.M110.103812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20938050	Green Published, hybrid			2022-12-25	WOS:000285414400050
J	Lee, KP; Yuan, JP; So, I; Worley, PF; Muallem, S				Lee, Kyu Pil; Yuan, Joseph P.; So, Insuk; Worley, Paul F.; Muallem, Shmuel			STIM1-dependent and STIM1-independent Function of Transient Receptor Potential Canonical (TRPC) Channels Tunes Their Store-operated Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST CA2+-DEPENDENT INACTIVATION; STROMAL INTERACTION MOLECULE-1; PLASMA-MEMBRANE; CRAC CHANNELS; CA2+ ENTRY; ORAI CHANNELS; STIM1; DOMAIN; DEPLETION; OLIGOMERIZATION	Ca(2+)influx by store-operated Ca2+ channels is a key component of the receptor-evoked Ca2+ signal. In all cells examined, transient receptor potential canonical (TRPC) channels mediate a significant portion of the receptor-stimulated Ca2+ influx. Recent studies have revealed how STIM1 activates TRPC1 in response to store depletion; however, the role of STIM1 in TRPC channel activation by receptor stimulation is not fully understood. Here, we established mutants of TRPC channels that could not be activated by STIM1 but were activated by the "charge-swap" mutant STIM1(K684E,K685E). Significantly, WT but not mutant TRPC channels were inhibited by scavenging STIM1 with Orai1(R91W), indicating the STIM1 dependence and independence of WT and mutant TRPC channels, respectively. Importantly, mutant TRPC channels were robustly activated by receptor stimulation. Moreover, STIM1 and STIM1(K684E, K685E) reciprocally affected receptor-activated WT and mutant TRPC channels. Together, these findings indicate that TRPC channels can function as STIM1-dependent and STIM1-independent channels, which increases the versatility of TRPC channel function and their role in receptor-stimulated Ca2+ influx.	[Lee, Kyu Pil; Yuan, Joseph P.; Muallem, Shmuel] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Lee, Kyu Pil; Muallem, Shmuel] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [So, Insuk] Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Seoul 110799, South Korea; [Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci & Neurol, Baltimore, MD 21205 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Seoul National University (SNU); Johns Hopkins University	Muallem, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	shmuel.muallem@nih.gov	So, Insuk/J-2762-2012	lee, kyu pil/0000-0002-7192-4791	National Institutes of Health [DE12302, DK38938]; NIDCR/DIR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR/DIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DE12302 and DK38938 and by NIDCR/DIR.	DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020	26	57	57	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38666	38673		10.1074/jbc.M110.155036	http://dx.doi.org/10.1074/jbc.M110.155036			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926378	Green Published, hybrid			2022-12-25	WOS:000284625600071
J	Habib, LK; Lee, MTC; Yang, J				Habib, Lila K.; Lee, Michelle T. C.; Yang, Jerry			Inhibitors of Catalase-Amyloid Interactions Protect Cells from beta-Amyloid-Induced Oxidative Stress and Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-RADICAL GENERATION; ANTIOXIDANT ENZYME-ACTIVITY; ALZHEIMERS-DISEASE BRAIN; A-BETA; HYDROGEN-PEROXIDE; PRECURSOR PROTEIN; THIOFLAVIN-T; COLORIMETRIC ASSAY; SURFACE-AREA; PEPTIDE	Compelling evidence shows a strong correlation between accumulation of neurotoxic beta-amyloid (A beta) peptides and oxidative stress in the brains of patients afflicted with Alzheimer disease (AD). One hypothesis for this correlation involves the direct and harmful interaction of aggregated A beta peptides with enzymes responsible for maintaining normal, cellular levels of reactive oxygen species (ROS). Identification of specific, destructive interactions of A beta peptides with cellular anti-oxidant enzymes would represent an important step toward understanding the pathogenicity of A beta peptides in AD. This report demonstrates that exposure of human neuroblastoma cells to cytotoxic preparations of aggregated A beta peptides results in significant intracellular co-localization of A beta with catalase, an anti-oxidant enzyme responsible for catalyzing the degradation of the ROS intermediate hydrogen peroxide (H2O2). These catalase-A beta interactions deactivate catalase, resulting in increased cellular levels of H2O2. Furthermore, small molecule inhibitors of catalase-amyloid interactions protect the hydrogen peroxide-degrading activity of catalase in A beta-rich environments, leading to reduction of the co-localization of catalase and A beta in cells, inhibition of A beta-induced increases in cellular levels of H2O2, and reduction of the toxicity of A beta peptides. These studies, thus, provide evidence for the important role of intracellular catalase-amyloid interactions in A beta-induced oxidative stress and propose a novel molecular strategy to inhibit such harmful interactions in AD.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lee, Michelle T. C.; Yang, Jerry] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Yang, J (corresponding author), 9500 Gilman Dr,MC 0358, La Jolla, CA 92093 USA.	jerryyang@ucsd.edu			Hellman Foundation; Alzheimer Disease Research Center [3P50 AG005131]; Alzheimer Association [NIRG-08-91651]; National Science Foundation [CHE-0847530, CHE-0116662]; Kuwait University; UCSD Cancer Center Microscopy Shared Facility [P30 CA23100]; UCSD Neuroscience Microscopy Shared Facility [P30 NS047101]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	Hellman Foundation; Alzheimer Disease Research Center; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); National Science Foundation(National Science Foundation (NSF)); Kuwait University; UCSD Cancer Center Microscopy Shared Facility; UCSD Neuroscience Microscopy Shared Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Hellman Foundation, the Alzheimer Disease Research Center (3P50 AG005131), the Alzheimer Association (NIRG-08-91651), and the National Science Foundation (CAREER Award CHE-0847530, to J. Y.).; Supported by a Kuwait University fellowship.; We thank Jennifer Meerloo and Dr. Kersi Pestonjamasp for technical assistance. We thank Neal Sekiya of the UCSD Flow Cytometry Research Core for acquiring the flow cytometry data and Valentina Matlachova for preliminary work in developing the catalase activity assay. We acknowledge the UCSD Cancer Center Microscopy Shared Facility supported by Grant P30 CA23100 and the UCSD Neuroscience Microscopy Shared Facility supported by Grant P30 NS047101. We also acknowledge the National Science Foundation for support of the mass spectrometry facility at UCSD (CHE-0116662).	Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Behl C, 1997, CELL TISSUE RES, V290, P471, DOI 10.1007/s004410050955; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bhatia R, 2000, FASEB J, V14, P1233, DOI 10.1096/fasebj.14.9.1233; Bieschke J, 2008, BIOCHEMISTRY-US, V47, P50, DOI 10.1021/bi701757v; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Clark DE, 1999, J PHARM SCI, V88, P815, DOI 10.1021/js980402t; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; FOSSATI P, 1980, CLIN CHEM, V26, P227; GAUNT GL, 1976, J NEUROCHEM, V26, P749, DOI 10.1111/j.1471-4159.1976.tb04448.x; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; GSELL W, 1995, J NEUROCHEM, V64, P1216; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Halliwell B.G.J.M.C., 2007, FREE RADICALS BIOL M; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Hensley K, 1996, ANN NY ACAD SCI, V786, P120, DOI 10.1111/j.1749-6632.1996.tb39057.x; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Huang XD, 2004, ANN NY ACAD SCI, V1012, P153, DOI 10.1196/annals.1306.012; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Inbar P, 2006, BIOORG MED CHEM LETT, V16, P1076, DOI 10.1016/j.bmcl.2005.10.067; Inbar P, 2008, ANAL CHEM, V80, P3502, DOI 10.1021/ac702592f; Inbar P, 2006, CHEMBIOCHEM, V7, P1563, DOI 10.1002/cbic.200600119; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kaminsky YG, 2008, FREE RADICAL RES, V42, P564, DOI 10.1080/10715760802159057; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Lomakin A, 1999, METHOD ENZYMOL, V309, P429; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; LOVELL MA, 1995, NEUROLOGY, V45, P1594, DOI 10.1212/WNL.45.8.1594; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; MARGOLIASH E, 1960, BIOCHEM J, V74, P339, DOI 10.1042/bj0740339; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; MARTTILA RJ, 1988, J NEURAL TRANSM, V74, P87, DOI 10.1007/BF01245142; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Milton NGN, 1999, BIOCHEM J, V344, P293, DOI 10.1042/0264-6021:3440293; Milton NGN, 2004, DRUG AGING, V21, P81, DOI 10.2165/00002512-200421020-00002; Milton NGN, 2001, NEUROTOXICOLOGY, V22, P767, DOI 10.1016/S0161-813X(01)00064-X; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; PAPPOLLA MA, 1992, AM J PATHOL, V140, P621; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Rensink AAM, 2002, BRAIN RES, V952, P111, DOI 10.1016/S0006-8993(02)03218-3; Rottkamp CA, 2001, FREE RADICAL BIO MED, V30, P447, DOI 10.1016/S0891-5849(00)00494-9; Sagara Y, 1996, J NEUROSCI, V16, P497; SCHUBERT D, 1995, BIOCHEM BIOPH RES CO, V216, P702, DOI 10.1006/bbrc.1995.2678; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Slaughter MR, 2000, CLIN BIOCHEM, V33, P525, DOI 10.1016/S0009-9120(00)00158-2; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; SUBBARAO KV, 1990, J NEUROCHEM, V55, P342, DOI 10.1111/j.1471-4159.1990.tb08858.x; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; TOMSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P630, DOI 10.1016/0003-9861(92)90735-F; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Walters WP, 1999, CURR OPIN CHEM BIOL, V3, P384, DOI 10.1016/S1367-5931(99)80058-1; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V76, P541, DOI 10.1007/BF00689591; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yan SD, 1997, NATURE, V389, P689; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Zhang ZY, 1996, J NEUROCHEM, V67, P1595	100	65	69	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38933	38943		10.1074/jbc.M110.132860	http://dx.doi.org/10.1074/jbc.M110.132860			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923778	Green Published, hybrid			2022-12-25	WOS:000284941300023
J	Nagy, K; Pilbat, AM; Groma, G; Szalontai, B; Cuisinier, FJG				Nagy, Krisztina; Pilbat, Ana-Maria; Groma, Geza; Szalontai, Balazs; Cuisinier, Frederic J. G.			Casein Aggregates Built Step-by-Step on Charged Polyelectrolyte Film Surfaces Are Calcium Phosphate-cemented	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; INTRINSICALLY UNSTRUCTURED PROTEINS; MULTILAYERS; MICELLES; BOVINE	The possible mechanism of casein aggregation and micelle buildup was studied in a new approach by letting alpha-casein adsorb from low concentration (0.1 mg.ml(-1)) solutions onto the charged surfaces of polyelectrolyte films. It was found that alpha-casein could adsorb onto both positively and negatively charged surfaces. However, only when its negative phosphoseryl clusters remained free, i.e. when it adsorbed onto a negative surface, could calcium phosphate (CaP) nanoclusters bind to the casein molecules. Once the CaP clusters were in place, step-by-step building of multilayered casein architectures became possible. The presence of CaP was essential; neither Ca2+ nor phosphate could alone facilitate casein aggregation. Thus, it seems that CaP is the organizing motive in the casein micelle formation. Atomic force microscopy revealed that even a single adsorbed casein layer was composed of very small (in the range of tens of nanometers) spherical forms. The stiffness of the adsorbed casein layer largely increased in the presence of CaP. On this basis, we can imagine that casein micelles emerge according to the following scheme. The amphipathic casein monomers aggregate into oligomers via hydrophobic interactions even in the absence of CaP. Full scale, CaP-carrying micelles could materialize by interlocking these casein oligomers with CaP nanoclusters. Such a mechanism would not contradict former experimental results and could offer a synthesis between the submicelle and the block copolymer models of casein micelles.	Hungarian Acad Sci, Inst Biophys, Biol Res Ctr, H-6071 Szeged, Hungary; [Cuisinier, Frederic J. G.] Univ Montpellier 1, Fac Chirurg Dent, Montpellier 5, France	Hungarian Academy of Sciences; Hungarian Biological Research Center; Universite de Montpellier		balazs@brc.hu	Cuisinier, Frédéric/ABD-4152-2020	Cuisinier, Frédéric/0000-0001-6870-0490	Hungarian Research Foundation [75818]; ECO-NET program (France) [16203RK]	Hungarian Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ECO-NET program (France)	This work was supported by Grant 75818 from Hungarian Research Foundation and by Grant 16203RK from ECO-NET program (France).	Balint Z, 2007, EUR BIOPHYS J BIOPHY, V36, P113, DOI 10.1007/s00249-006-0112-4; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Coifman R. R., 1995, WAVELETS STAT, P125; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Farrell H.M., 2006, ACS S SERIES AM CHEM, VVolume 935, P52; Farrell HM, 2006, CURR OPIN COLLOID IN, V11, P135, DOI 10.1016/j.cocis.2005.11.005; Farrell HM, 2003, J PROTEIN CHEM, V22, P259, DOI 10.1023/A:1025020503769; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; HERTZ M, 1982, J REINE ANGEWANDTE M, V92, P156; Heuvingh J, 2005, LANGMUIR, V21, P3165, DOI 10.1021/la047388m; Horne D. S., 2006, Current Opinion in Colloid and Interface Science, V11, P148, DOI 10.1016/j.cocis.2005.11.004; Horne DS, 2002, CURR OPIN COLLOID IN, V7, P456, DOI 10.1016/S1359-0294(02)00082-1; Horne DS, 1998, INT DAIRY J, V8, P171, DOI 10.1016/S0958-6946(98)00040-5; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k; MALLAT S, 1998, WAVELET TOUR SIGNAL, P248; Martin P., 2003, ADV DAIRY CHEM, V1, P277; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; MORAGUTIERREZ A, 1993, J AGR FOOD CHEM, V41, P372, DOI 10.1021/jf00027a007; Muller-Buschbaum P, 2007, BIOPHYS J, V93, P960, DOI 10.1529/biophysj.107.106385; Saab MB, 2009, LANGMUIR, V25, P5159, DOI 10.1021/la9002274; Schwinte P, 2002, BIOMACROMOLECULES, V3, P1135, DOI 10.1021/bm025547f; Schwinte P, 2001, J PHYS CHEM B, V105, P11906, DOI 10.1021/jp0123031; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4; Walstra P, 1999, INT DAIRY J, V9, P189, DOI 10.1016/S0958-6946(99)00059-X	28	10	10	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38811	38817		10.1074/jbc.M110.151167	http://dx.doi.org/10.1074/jbc.M110.151167			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20921229	Green Published, hybrid			2022-12-25	WOS:000284941300010
J	McGillivary, G; Bakaletz, LO				McGillivary, Glen; Bakaletz, Lauren O.			The Multifunctional Host Defense Peptide SPLUNC1 Is Critical for Homeostasis of the Mammalian Upper Airway	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; RESPIRATORY SYNCYTIAL VIRUS; ACUTE OTITIS-MEDIA; NASAL LAVAGE FLUID; ANTIMICROBIAL PEPTIDE; EUSTACHIAN-TUBE; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; SURFACTANT PROTEIN; PLUNC GENE	Otitis media (OM) is a highly prevalent pediatric disease caused by normal flora of the nasopharynx that ascend the Eustachian tube and enter the middle ear. As OM is a disease of opportunity, it is critical to gain an increased understanding of immune system components that are operational in the upper airway and aid in prevention of this disease. SPLUNC1 is an antimicrobial host defense peptide that is hypothesized to contribute to the health of the airway both through bactericidal and non-bactericidal mechanisms. We used small interfering RNA (siRNA) technology to knock down expression of the chinchilla ortholog of human SPLUNC1 (cSPLUNC1) to begin to determine the role that this protein played in prevention of OM. We showed that knock down of cSPLUNC1 expression did not impact survival of nontypeable Haemophilus influenzae, a predominant causative agent of OM, in the chinchilla middle ear under the conditions tested. In contrast, expression of cSPLUNC1 was essential for maintenance of middle ear pressure and efficient mucociliary clearance, key defense mechanisms of the tubotympanum. Collectively, our data have provided the first in vivo evidence that cSPLUNC1 functions to maintain homeostasis of the upper airway and, thereby, is critical for protection of the middle ear.	[McGillivary, Glen; Bakaletz, Lauren O.] Ohio State Univ, Coll Med, Ctr Microbial Pathogenesis, Res Inst Nationwide Childrens Hosp, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	McGillivary, G (corresponding author), Ohio State Univ, Coll Med, Ctr Microbial Pathogenesis, Res Inst Nationwide Childrens Hosp, Columbus, OH 43210 USA.	Lauren.Bakaletz@nationwidechildrens.org	Bakaletz, Lauren/GMW-8490-2022		NIDCD/NIH [K99 DC008966, R01 DC005847]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC008966, R01DC005847] Funding Source: NIH RePORTER	NIDCD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grant K99 DC008966 to G. M. and R01 DC005847 to L.O.B from the NIDCD/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKALETZ LO, 1989, ANN OTO RHINOL LARYN, V98, P278, DOI 10.1177/000348948909800408; BAKALETZ LO, 2002, OTITIS MEDIA, P259; Bartlett JA, 2008, J LEUKOCYTE BIOL, V83, P1201, DOI 10.1189/jlb.0507302; Bingle CD, 2000, BBA-GENE STRUCT EXPR, V1493, P363, DOI 10.1016/S0167-4781(00)00196-2; Bingle CD, 2004, PROTEIN SCI, V13, P422, DOI 10.1110/ps.03332704; Bingle L, 2005, J PATHOL, V205, P491, DOI 10.1002/path.1726; Bingle L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-79; Bondy J, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e72; Caye-Thomasen P, 2004, OTOL NEUROTOL, V25, P14; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Di YP, 2003, J BIOL CHEM, V278, P1165, DOI 10.1074/jbc.M210523200; GAKHAR L, PLOS ONE, V5, pE9098; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; GAZZANOSANTORO H, 1992, INFECT IMMUN, V60, P4754, DOI 10.1128/IAI.60.11.4754-4761.1992; Ghafouri B, 2004, BBA-PROTEINS PROTEOM, V1699, P57, DOI 10.1016/j.bbapap.2004.01.001; Ghafouri B, 2003, BIOCHEM SOC T, V31, P810, DOI 10.1042/BST0310810; Glasser SW, 2008, J IMMUNOL, V181, P621, DOI 10.4049/jimmunol.181.1.621; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Harris RH, 2004, J BIOL CHEM, V279, P20250, DOI 10.1074/jbc.M400499200; Heikkinen T, 2003, CLIN MICROBIOL REV, V16, P230, DOI 10.1128/CMR.16.2.230-241.2003; Herr C, 2007, EXPERT OPIN BIOL TH, V7, P1449, DOI 10.1517/14712598.7.9.1449; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Jiang ZL, 1999, INFECT IMMUN, V67, P187, DOI 10.1128/IAI.67.1.187-192.1999; Jung HH, 2003, LARYNGOSCOPE, V113, P432, DOI 10.1097/00005537-200303000-00008; Kaplan B, 1997, PEDIATR INFECT DIS J, V16, pS9, DOI 10.1097/00006454-199702001-00003; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; Lee HY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-12; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lim DJ, 2000, VACCINE, V19, pS17, DOI 10.1016/S0264-410X(00)00273-5; MARGOLIS RH, 1994, ANN OTOL RHINOL LA S, V163, P34; Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005; McDonald RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005726; McGillivary G, 2007, MOL IMMUNOL, V44, P2446, DOI 10.1016/j.molimm.2006.10.008; McGillivary G, 2009, CELL MICROBIOL, V11, P1399, DOI 10.1111/j.1462-5822.2009.01339.x; McGuire JF, 2002, INT J PEDIATR OTORHI, V66, P1, DOI 10.1016/S0165-5876(02)00203-3; MONTO AS, 1974, JAMA-J AM MED ASSOC, V227, P164, DOI 10.1001/jama.227.2.164; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Novotny LA, 2006, VACCINE, V24, P4804, DOI 10.1016/j.vaccine.2006.03.021; PATEL J, 1992, INT J PEDIATR OTORHI, V23, P15, DOI 10.1016/0165-5876(92)90075-Z; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; Schuerman L, 2009, VACCINE, V27, P5748, DOI 10.1016/j.vaccine.2009.07.070; SEILLY DJ, 1982, MED LAB SCI, V39, P71; Shimada J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-134; Zhou FJ, 2008, PEDIATRICS, V121, P253, DOI 10.1542/peds.2007-0619; Zhou HD, 2008, MOL CELL BIOCHEM, V309, P191, DOI 10.1007/s11010-007-9659-3	46	44	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13224	10.1371/journal.pone.0013224	http://dx.doi.org/10.1371/journal.pone.0013224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949060	Green Submitted, gold, Green Published			2022-12-25	WOS:000282633700015
J	Park, J; Kim, Y; Choi, S; Koh, H; Lee, SH; Kim, JM; Chung, J				Park, Jeehye; Kim, Yongsung; Choi, Sekyu; Koh, Hyongjong; Lee, Sang-Hee; Kim, Jin-Man; Chung, Jongkyeong			Drosophila Porin/VDAC Affects Mitochondrial Morphology	PLOS ONE			English	Article								Voltage-dependent anion channel (VDAC) has been suggested to be a mediator of mitochondrial-dependent cell death induced by Ca2+ overload, oxidative stress and Bax-Bid activation. To confirm this hypothesis in vivo, we generated and characterized Drosophila VDAC (porin) mutants and found that Porin is not required for mitochondrial apoptosis, which is consistent with the previous mouse studies. We also reported a novel physiological role of Porin. Loss of porin resulted in locomotive defects and male sterility. Intriguingly, porin mutants exhibited elongated mitochondria in indirect flight muscle, whereas Porin overexpression produced fragmented mitochondria. Through genetic analysis with the components of mitochondrial fission and fusion, we found that the elongated mitochondria phenotype in porin mutants were suppressed by increased mitochondrial fission, but enhanced by increased mitochondrial fusion. Furthermore, increased mitochondrial fission by Drp1 expression suppressed the flight defects in the porin mutants. Collectively, our study showed that loss of Drosophila Porin results in mitochondrial morphological defects and suggested that the defective mitochondrial function by Porin deficiency affects the mitochondrial remodeling process.	[Park, Jeehye; Kim, Yongsung; Choi, Sekyu; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul, South Korea; [Kim, Yongsung; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Choi, Sekyu] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Koh, Hyongjong] Dong A Univ, Dept Pharmacol, Coll Med, Pusan, South Korea; [Lee, Sang-Hee; Kim, Jin-Man] Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon, South Korea; [Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Dong A University; Chungnam National University; Seoul National University (SNU)	Chung, J (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul, South Korea.	jkc@snu.ac.kr		Choi, Sekyu/0000-0003-2928-0942; KIM, JIN MAN/0000-0003-0905-9730; Koh, Hyongjong/0000-0003-2594-4799	Korean National Creative Research Initiatives Program - Ministry of Education, Science and Technology [2010-0018291]; World Class Institute Program of National Research Foundation of Korea - Ministry of Education, Science and Technology of Korea	Korean National Creative Research Initiatives Program - Ministry of Education, Science and Technology; World Class Institute Program of National Research Foundation of Korea - Ministry of Education, Science and Technology of Korea	This research was supported by a grant from the Korean National Creative Research Initiatives Program (2010-0018291), funded by the Ministry of Education, Science and Technology. Y. Kim is supported by World Class Institute Program of National Research Foundation of Korea funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Colussi PA, 2000, J CELL BIOL, V148, P703, DOI 10.1083/jcb.148.4.703; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; FULLER MT, 1993, DEV DROSOPHILA MELAN, V1, P71; Gazaryan IG, 2007, NEUROCHEM RES, V32, P917, DOI 10.1007/s11064-006-9252-2; Graham BH, 2005, MOL GENET METAB, V85, P308, DOI 10.1016/j.ymgme.2005.03.009; Graham BH, 2010, J BIOL CHEM, V285, P11143, DOI 10.1074/jbc.M109.080317; Guarino F, 2006, BIOCHEM BIOPH RES CO, V346, P665, DOI 10.1016/j.bbrc.2006.05.172; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Jang C, 2008, J CELL BIOL, V183, P11, DOI 10.1083/jcb.200807052; Komarov AG, 2004, BIOPHYS J, V86, P152, DOI 10.1016/S0006-3495(04)74093-X; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Lee S, 2007, DEV NEUROBIOL, V67, P1533, DOI 10.1002/dneu.20526; McQuibban GA, 2006, CURR BIOL, V16, P982, DOI 10.1016/j.cub.2006.03.062; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Oliva M, 1998, FEBS LETT, V430, P327, DOI 10.1016/S0014-5793(98)00693-0; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	25	44	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13151	10.1371/journal.pone.0013151	http://dx.doi.org/10.1371/journal.pone.0013151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V32LH	20949033	Green Published, gold, Green Submitted			2022-12-25	WOS:000208952200001
J	Styrkarsdottir, U; Halldorsson, BV; Gudbjartsson, DF; Tang, NLS; Koh, JM; Xiao, SM; Kwok, TCY; Kim, GS; Chan, JCN; Cherny, S; Lee, SH; Kwok, A; Ho, S; Gretarsdottir, S; Kostic, JP; Palsson, ST; Sigurdsson, G; Sham, PC; Kim, BJ; Kung, AWC; Kim, SY; Woo, J; Leung, PC; Kong, A; Thorsteinsdottir, U; Stefansson, K				Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Gudbjartsson, Daniel F.; Tang, Nelson L. S.; Koh, Jung-Min; Xiao, Su-mei; Kwok, Timothy C. Y.; Kim, Ghi Su; Chan, Juliana C. N.; Cherny, Stacey; Lee, Seung Hun; Kwok, Anthony; Ho, Suzanne; Gretarsdottir, Solveig; Kostic, Jelena Pop; Palsson, Stefan Th.; Sigurdsson, Gunnar; Sham, Pak C.; Kim, Beom-Jun; Kung, Annie W. C.; Kim, Shin-Yoon; Woo, Jean; Leung, Ping-C.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			European Bone Mineral Density Loci Are Also Associated with BMD in East-Asian Populations	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; GENOME-WIDE ASSOCIATION; HONG-KONG CHINESE; OSTEOPOROTIC FRACTURES; GENETIC-LOCI; WOMEN; VARIANTS; POLYMORPHISM; MASS; LRP5	Most genome-wide association (GWA) studies have focused on populations of European ancestry with limited assessment of the influence of the sequence variants on populations of other ethnicities. To determine whether markers that we have recently shown to associate with Bone Mineral Density (BMD) in Europeans also associate with BMD in East-Asians we analysed 50 markers from 23 genomic loci in samples from Korea (n = 1,397) and two Chinese Hong Kong sample sets (n = 3,869 and n = 785). Through this effort we identified fourteen loci that associated with BMD in East-Asian samples using a false discovery rate (FDR) of 0.05; 1p36 (ZBTB40, P = 4.3x10(-9)), 1p31 (GPR177, P = 0.00012), 3p22 (CTNNB1, P = 0.00013), 4q22 (MEPE, P = 0.0026), 5q14 (MEF2C, P = 1.3x10(-5)), 6q25 (ESR1, P = 0.0011), 7p14 (STARD3NL, P = 0.00025), 7q21 (FLJ42280, P = 0.00017), 8q24 (TNFRSF11B, P = 3.4x10(-5)), 11p15 (SOX6, P = 0.00033), 11q13 (LRP5, P = 0.0033), 13q14 (TNFSF11, P = 7.5x10(-5)), 16q24 (FOXL1, P = 0.0010) and 17q21 (SOST, P = 0.015). Our study marks an early effort towards the challenge of cataloguing bone density variants shared by many ethnicities by testing BMD variants that have been established in Europeans, in East-Asians.	[Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Gudbjartsson, Daniel F.; Gretarsdottir, Solveig; Kostic, Jelena Pop; Palsson, Stefan Th.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Halldorsson, Bjarni V.] Reykjavik Univ, Reykjavik, Iceland; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Fac Med, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Fac Med, Lab Genet Dis Susceptibil, Hong Kong, Hong Kong, Peoples R China; [Koh, Jung-Min; Kim, Ghi Su; Lee, Seung Hun; Kim, Beom-Jun] Univ Ulsan, Coll Med, Asan Med Ctr, Div Endocrinol & Metab, Seoul, South Korea; [Koh, Jung-Min; Kim, Ghi Su; Lee, Seung Hun; Kim, Beom-Jun; Kim, Shin-Yoon] Kyungpook Natl Univ Hosp, Skeletal Dis Genome Res Ctr, Taegu, South Korea; [Xiao, Su-mei; Kung, Annie W. C.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Xiao, Su-mei; Kung, Annie W. C.] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Kwok, Timothy C. Y.; Chan, Juliana C. N.; Woo, Jean] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Cherny, Stacey; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ho, Suzanne] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Sigurdsson, Gunnar] Univ Hosp, Dept Endocrinol & Metab, Reykjavik, Iceland; [Sigurdsson, Gunnar; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Kim, Shin-Yoon] Kyungpook Natl Univ Sch Med, Dept Orthoped Surg, Taegu, South Korea	Reykjavik University; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Ulsan; Asan Medical Center; Kyungpook National University; Kyungpook National University Hospital; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Landspitali National University Hospital; University of Iceland; Kyungpook National University	Styrkarsdottir, U (corresponding author), DeCODE Genet, Reykjavik, Iceland.	unnur.styrkarsdottir@decode.is; kari.stefansson@decode.is	Kwok, Timothy/C-3725-2008; Stefansson, Kari/AAE-7187-2019; Tang, Nelson L/P-5018-2017; Woo, Jean/K-2625-2014; Kwok, Anthony/AAL-4289-2020; Cherny, Stacey S/B-3315-2008; Chan, Juliana/B-7918-2016	Kwok, Timothy/0000-0001-9253-3549; Tang, Nelson L/0000-0002-3607-5819; Woo, Jean/0000-0001-7593-3081; Kwok, Anthony/0000-0002-3918-9205; Cherny, Stacey S/0000-0002-0269-3352; Chan, Juliana/0000-0003-1325-1194; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Styrkarsdottir, Unnur/0000-0001-8146-8278; Halldorsson, Bjarni/0000-0003-0756-0767	European Community [FP7/2007-2013, HEALTH-F2-2008-201865-GEFOS]; Korea Healthcare Technology; Ministry for Health, Welfare & Family Affairs, Republic of Korea [A010252]; Research Grants Council of Hong Kong [CUHK 4101/02M]; Chinese University of Hong Kong; Centre for Nutritional Studies; School of Public Health and Primary Care; Hong Kong Jockey Club Charities Foundation; Hong Kong Research Grant Council; HKU Foundation; University of Hong Kong; deCODE Genetics	European Community(European Commission); Korea Healthcare Technology; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong); Centre for Nutritional Studies; School of Public Health and Primary Care; Hong Kong Jockey Club Charities Foundation; Hong Kong Research Grant Council(Hong Kong Research Grants Council); HKU Foundation(University of Hong Kong); University of Hong Kong(University of Hong Kong); deCODE Genetics	This work was supported by deCODE Genetics and funded in part by the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS. The Korean study was supported by a grant from the Korea Healthcare Technology R& D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Project No.: A010252). The Chinese Hong Kong-I study was supported in part by grants from Research Grants Council of Hong Kong, (CUHK 4101/02M), Direct Grant from the Chinese University of Hong Kong, the Centre for Nutritional Studies, School of Public Health and Primary Care, and the Hong Kong Jockey Club Charities Foundation. The Hong Kong-II study was supported by Hong Kong Research Grant Council; The Bone Health fund of HKU Foundation; Matching Grant, CRCG Grant and The Osteoporosis Research Fund of The University of Hong Kong. The study design, data generation (in part), overall analysis of data, decision to publish and preparation of the manuscript was lead by employees of deCODE Genetics, a funder of this study.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Ezura Y, 2007, BONE, V40, P997, DOI 10.1016/j.bone.2005.06.025; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Kim GS, 2005, J BONE MINER RES, V20, P1342, DOI 10.1359/JBMR.050320; Kung AWC, 2006, BONE, V39, P1097, DOI 10.1016/j.bone.2006.04.029; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Kung AWC, 1998, BONE, V22, P389, DOI 10.1016/S8756-3282(97)00301-3; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lau EMC, 1996, J BONE MINER RES, V11, P1364; Lau HHL, 2006, J BONE MINER METAB, V24, P226, DOI 10.1007/s00774-005-0676-6; Lynn HS, 2005, OSTEOPOROSIS INT, V16, P1663, DOI 10.1007/s00198-005-1899-z; Mizuguchi T, 2004, J HUM GENET, V49, P80, DOI 10.1007/s10038-003-0111-6; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Sigurdsson G, 2008, J BONE MINER RES, V23, P1584, DOI 10.1359/JBMR.080507; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; THORLEIFSSON G, 2010, NAT GENET IN PRESS; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Urano T, 2004, J BONE MINER METAB, V22, P341, DOI 10.1007/s00774-003-0492-9; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Zhang ZL, 2005, ACTA PHARMACOL SIN, V26, P1111, DOI 10.1111/j.1745-7254.2005.00173.x	31	69	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13217	10.1371/journal.pone.0013217	http://dx.doi.org/10.1371/journal.pone.0013217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949110	Green Published, Green Submitted, gold			2022-12-25	WOS:000282633700012
J	Zang-Edou, ES; Bisvigou, U; Taoufiq, Z; Lekoulou, F; Lekana-Douki, JB; Traore, Y; Mazier, D; Toure-Ndouo, FS				Zang-Edou, Estelle S.; Bisvigou, Ulrick; Taoufiq, Zacharie; Lekoulou, Faustin; Lekana-Douki, Jean Bernard; Traore, Yves; Mazier, Dominique; Toure-Ndouo, Fousseyni S.			Inhibition of Plasmodium falciparum Field Isolates-Mediated Endothelial Cell Apoptosis by Fasudil: Therapeutic Implications for Severe Malaria	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; CEREBRAL MALARIA; NITRIC-OXIDE; MICROVASCULAR SEQUESTRATION; CYTOCHROME-C; BRAIN; EXPRESSION; ADHESION; CYTOADHERENCE; PATHOGENESIS	Plasmodium falciparum infection can abruptly progress to severe malaria, a life-threatening complication resulting from sequestration of parasitized red blood cells (PRBC) in the microvasculature of various organs such as the brain and lungs. PRBC adhesion can induce endothelial cell (EC) activation and apoptosis, thereby disrupting the blood-brain barrier. Moreover, hemozoin, the malarial pigment, induces the erythroid precursor apoptosis. Despite the current efficiency of antimalarial drugs in killing parasites, severe malaria still causes up to one million deaths every year. A new strategy targeting both parasite elimination and EC protection is urgently needed in the field. Recently, a rho-kinase inhibitior Fasudil, a drug already in clinical use in humans for cardio- and neuro-vascular diseases, was successfully tested on laboratory strains of P. falciparum to protect and to reverse damages of the endothelium. We therefore assessed herein whether Fasudil would have a similar efficiency on P. falciparum taken directly from malaria patients using contact and non-contact experiments. Seven (23.3%) of 30 PRBC preparations from different patients were apoptogenic, four (13.3%) acting by cytoadherence and three (10%) via soluble factors. None of the apoptogenic PRBC preparations used both mechanisms indicating a possible mutual exclusion of signal transduction ligand. Three PRBC preparations (42.9%) induced EC apoptosis by cytoadherence after 4 h of coculture ("rapid transducers''), and four (57.1%) after a minimum of 24 h ("slow transducers''). The intensity of apoptosis increased with time. Interestingly, Fasudil inhibited EC apoptosis mediated both by cell-cell contact and by soluble factors but did not affect PRBC cytoadherence. Fasudil was found to be able to prevent endothelium apoptosis from all the P. falciparum isolates tested. Our data provide evidence of the strong anti-apoptogenic effect of Fasudil and show that endothelial cell-P. falciparum interactions are more complicated than previously thought. These findings may warrant clinical trials of Fasudil in severe malaria management.	[Zang-Edou, Estelle S.; Bisvigou, Ulrick; Lekoulou, Faustin; Lekana-Douki, Jean Bernard; Toure-Ndouo, Fousseyni S.] CIRMF, Franceville, Gabon; [Taoufiq, Zacharie; Mazier, Dominique] INSERM, U511, Paris, France; [Traore, Yves] Univ Ouagadougou, Ouagadougou, Burkina Faso; [Mazier, Dominique] Univ Paris 06, UMR S511, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Zang-Edou, ES (corresponding author), CIRMF, Franceville, Gabon.	fousseyni@yahoo.fr	Bisvigou, Ulrick/GXA-0039-2022	Taoufiq, Zacharie/0000-0003-4893-0322	Total Gabon; Gabonese government; Ministere Francais des Affaires Etrangeres	Total Gabon(Total SA); Gabonese government; Ministere Francais des Affaires Etrangeres	This work has been supported by Total Gabon, the Gabonese government and Ministere Francais des Affaires Etrangeres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Brown H, 2001, AM J TROP MED HYG, V64, P207, DOI 10.4269/ajtmh.2001.64.207; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Combes V, 2006, INT J PARASITOL, V36, P541, DOI 10.1016/j.ijpara.2006.02.005; DAVID PH, 1988, AM J TROP MED HYG, V38, P289, DOI 10.4269/ajtmh.1988.38.289; Dimmeler S, 1997, CIRC RES, V81, P970; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Girard M, 2003, INT J PARASITOL, V33, P713, DOI 10.1016/S0020-7519(03)00033-X; GOODYER ID, 1994, ANN TROP MED PARASIT, V88, P209, DOI 10.1080/00034983.1994.11812859; Hirooka Yoshitaka, 2005, Am J Cardiovasc Drugs, V5, P31, DOI 10.2165/00129784-200505010-00005; HO M, 1991, INFECT IMMUN, V59, P2135, DOI 10.1128/IAI.59.6.2135-2139.1991; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200; Kim YM, 1997, BIOCHEM BIOPH RES CO, V236, P655, DOI 10.1006/bbrc.1997.7031; KREMSNER PG, 1988, J INFECT DIS, V158, P1368, DOI 10.1093/infdis/158.6.1368; Lamikanra AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008446; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARIANNA M, 2009, MALARIA J, V8, P12; MARSH K, 1987, T ROY SOC TROP MED H, V81, P514, DOI 10.1016/0035-9203(87)90184-2; MARSH K, 1988, EXP PARASITOL, V65, P202, DOI 10.1016/0014-4894(88)90123-3; Mazier D, 2000, PARASITE IMMUNOL, V22, P613, DOI 10.1046/j.1365-3024.2000.00342.x; Muanza K, 1996, RES IMMUNOL, V147, P149, DOI 10.1016/0923-2494(96)83167-1; Nakakuki T, 2005, ARTERIOSCL THROM VAS, V25, P2088, DOI 10.1161/01.ATV.0000183607.50230.9f; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Ridley RG, 2002, P NATL ACAD SCI USA, V99, P13362, DOI 10.1073/pnas.232483699; RINGWALD P, 1993, INFECT IMMUN, V61, P5198, DOI 10.1128/IAI.61.12.5198-5204.1993; Rouzine IM, 2003, P NATL ACAD SCI USA, V100, P3473, DOI 10.1073/pnas.262796299; Saavedra JE, 1997, J MED CHEM, V40, P1947, DOI 10.1021/jm9701031; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Siau A, 2007, J INFECT DIS, V196, P1603, DOI 10.1086/522012; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Stiles JK, 2004, MOL BIOCHEM PARASIT, V133, P229, DOI 10.1016/j.molbiopara.2003.10.011; Taoufiq Z, 2008, J INFECT DIS, V197, P1062, DOI 10.1086/528988; Taoufiq Z, 2006, MOL BIOCHEM PARASIT, V150, P166, DOI 10.1016/j.molbiopara.2006.07.008; TAYLOR TE, 2004, NAT MED, V187, P1283; Toure FS, 2008, PARASITE IMMUNOL, V30, P47; Toure FS, 2007, CLIN MED RES, V5, P106, DOI 10.3121/cmr.2007.696; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tripathi AK, 2007, J INFECT DIS, V195, P942, DOI 10.1086/512083; *UNICEF WHO, 2005, WORLD MAL REP; vanHensbroek MB, 1996, NEW ENGL J MED, V335, P69, DOI 10.1056/NEJM199607113350201; Wassmer SC, 2005, PLOS MED, V2, P885, DOI 10.1371/journal.pmed.0020245; Wilson NO, 2008, MOL BIOCHEM PARASIT, V162, P172, DOI 10.1016/j.molbiopara.2008.09.003; WILSON PD, 2005, BIOCH J IMMEDIATE PU, V237; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	54	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13221	10.1371/journal.pone.0013221	http://dx.doi.org/10.1371/journal.pone.0013221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949056	gold, Green Published, Green Submitted			2022-12-25	WOS:000282633700014
J	Moore, DJ; Zienkiewicz, J; Kendall, PL; Liu, DY; Liu, XY; Veach, RA; Collins, RD; Hawiger, J				Moore, Daniel J.; Zienkiewicz, Jozef; Kendall, Peggy L.; Liu, Danya; Liu, Xueyan; Veach, Ruth Ann; Collins, Robert D.; Hawiger, Jacek			In Vivo Islet Protection by a Nuclear Import Inhibitor in a Mouse Model of Type 1 Diabetes	PLOS ONE			English	Article							NF-KAPPA-B; ANTI-CD3 MONOCLONAL-ANTIBODY; PANCREATIC LYMPH-NODES; BETA-CELL APOPTOSIS; T-CELLS; LOCALIZATION SEQUENCE; INTERFERON-GAMMA; DENDRITIC CELLS; INNATE IMMUNITY; APC FUNCTION	In Background: Insulin-dependent Type 1 diabetes (T1D) is a devastating autoimmune disease that destroys beta cells within the pancreatic islets and afflicts over 10 million people worldwide. These patients face life-long risks for blindness, cardiovascular and renal diseases, and complications of insulin treatment. New therapies that protect islets from autoimmune destruction and allow continuing insulin production are needed. Increasing evidence regarding the pathomechanism of T1D indicates that islets are destroyed by the relentless attack by autoreactive immune cells evolving from an aberrant action of the innate, in addition to adaptive, immune system that produces islet-toxic cytokines, chemokines, and other effectors of islet inflammation. We tested the hypothesis that targeting nuclear import of stress-responsive transcription factors evoked by agonist-stimulated innate and adaptive immunity receptors would protect islets from autoimmune destruction. Principal Findings: Here we show that a first-in-class inhibitor of nuclear import, cSN50 peptide, affords in vivo islet protection following a 2-day course of intense treatment in NOD mice, which resulted in a diabetes-free state for one year without apparent toxicity. This nuclear import inhibitor precipitously reduces the accumulation of islet-destructive autoreactive lymphocytes while enhancing activation-induced cell death of T and B lymphocytes derived from autoimmune diabetes-prone, non-obese diabetic (NOD) mice that develop T1D. Moreover, in this widely used model of human T1D we noted attenuation of pro-inflammatory cytokine and chemokine production in immune cells. Conclusions: These results indicate that a novel form of immunotherapy that targets nuclear import can arrest inflammation-driven destruction of insulin-producing beta cells at the site of autoimmune attack within pancreatic islets during the progression of T1D.	[Moore, Daniel J.; Zienkiewicz, Jozef; Liu, Danya; Liu, Xueyan; Veach, Ruth Ann; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37235 USA; [Moore, Daniel J.] Vanderbilt Univ, Med Ctr, Dept Pediat, Ian Burr Div Endocrinol & Diabet, Nashville, TN 37232 USA; [Kendall, Peggy L.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Collins, Robert D.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Liu, Danya] Emory Univ, Dept Surg, Atlanta, GA 30322 USA; [Liu, Danya] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University; Emory University	Moore, DJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37235 USA.	jacek.hawiger@vanderbilt.edu	Moore, Daniel J/A-4924-2008; Moore, Daniel/V-6145-2019	Moore, Daniel J/0000-0002-6889-9345; Moore, Daniel/0000-0002-6889-9345; Kendall, Peggy/0000-0002-0516-654X; Veach, Ruth Ann/0000-0003-0038-8802	US National Institutes of Health [5PO1HL068744]; Department of Microbiology and Immunology; Price Family Discovery Fund; NRSA Fellowship [1F32DK083161-01]; Endocrine Fellows Foundation; NIH [5K08DK070924-05]; NIH for the Vanderbilt Ingram Cancer Center [2P30 CA 68485, P30DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK070924, P30DK058404, F32DK083161] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology and Immunology; Price Family Discovery Fund; NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Fellows Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH for the Vanderbilt Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by US National Institutes of Health grant 5PO1HL068744, by Department of Microbiology and Immunology funds, and by the Price Family Discovery Fund, the generous gift of the Price family to the Ian Burr Division of Endocrinology and Diabetes. DJM was supported by the Ruth Kirschstein NRSA Fellowship 1F32DK083161-01 and by a research grant from the Endocrine Fellows Foundation. PLK was supported by NIH Career Development Award 5K08DK070924-05. The Cell Imaging Core Services were supported by NIH grant 2P30 CA 68485 for the Vanderbilt Ingram Cancer Center and by NIH grant P30DK058404 to the Digestive Disease Research Center at Vanderbilt University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablamunits V, 1999, J AUTOIMMUN, V13, P383, DOI 10.1006/jaut.1999.0331; Arreaza G, 2003, CLIN IMMUNOL, V107, P103, DOI 10.1016/S1521-6616(03)00049-4; BAXTER AG, 1991, CLIN EXP IMMUNOL, V85, P464; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; FOULIS AK, 1991, J PATHOL, V165, P97, DOI 10.1002/path.1711650203; Greeley SAW, 2001, J IMMUNOL, V167, P4351, DOI 10.4049/jimmunol.167.8.4351; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Huang XL, 2008, ENDOCR REV, V29, P603, DOI 10.1210/er.2008-0006; Hussain S, 2005, J IMMUNOL, V174, P680, DOI 10.4049/jimmunol.174.2.680; Hussain S, 2004, DIABETES, V53, P2003, DOI 10.2337/diabetes.53.8.2003; JensenUrstad KJ, 1996, DIABETES, V45, P1253, DOI 10.2337/diabetes.45.9.1253; Kendall PL, 2004, EUR J IMMUNOL, V34, P2387, DOI 10.1002/eji.200324744; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Koulmanda M, 2007, P NATL ACAD SCI USA, V104, P13074, DOI 10.1073/pnas.0705863104; LEE KU, 1988, DIABETES, V37, P989, DOI 10.2337/diabetes.37.7.989; Li FX, 2003, P NATL ACAD SCI USA, V100, P12935, DOI 10.1073/pnas.2231861100; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu DY, 2009, MOL THER, V17, P796, DOI 10.1038/mt.2009.18; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu DY, 2004, J BIOL CHEM, V279, P19239, DOI 10.1074/jbc.M313442200; Liu XY, 2000, J BIOL CHEM, V275, P16774; Liuwantara D, 2006, DIABETES, V55, P2491, DOI 10.2337/db06-0142; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Mangge H, 2004, EXP CLIN ENDOCR DIAB, V112, P378, DOI 10.1055/s-2004-821023; Matos M, 2004, DIABETES, V53, P2310, DOI 10.2337/diabetes.53.9.2310; Noorchashm H, 2000, J IMMUNOL, V165, P4685, DOI 10.4049/jimmunol.165.8.4685; Noorchashm H, 1999, CELL IMMUNOL, V195, P75, DOI 10.1006/cimm.1999.1522; Papaccio G, 2005, J CELL PHYSIOL, V204, P124, DOI 10.1002/jcp.20276; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Poligone B, 2002, J IMMUNOL, V168, P188, DOI 10.4049/jimmunol.168.1.188; Ramamoorthy A, 2007, BIOCHEMISTRY-US, V46, P965, DOI 10.1021/bi061895g; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Salojin KV, 1998, IMMUNOL TODAY, V19, P468, DOI 10.1016/S0167-5699(98)01326-7; Sen P, 2003, J IMMUNOL, V170, P1770, DOI 10.4049/jimmunol.170.4.1770; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; SIGNORE A, 1994, HISTOCHEMISTRY, V101, P263, DOI 10.1007/BF00315913; Skyler JS, 2008, ANN NY ACAD SCI, V1150, P190, DOI 10.1196/annals.1447.055; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Thornley TB, 2006, J IMMUNOL, V176, P1561, DOI 10.4049/jimmunol.176.3.1561; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200; WEBB SR, 1994, J IMMUNOL, V152, P586; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wheat W, 2004, EUR J IMMUNOL, V34, P1395, DOI 10.1002/eji.200324490; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Yang ZD, 2002, DIABETOLOGIA, V45, P1307, DOI 10.1007/s00125-002-0901-y; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	57	14	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13235	10.1371/journal.pone.0013235	http://dx.doi.org/10.1371/journal.pone.0013235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949090	Green Published, gold, Green Submitted			2022-12-25	WOS:000282568400021
J	Xue, G; Mei, LL; Chen, CS; Lu, ZL; Poldrack, RA; Dong, Q				Xue, Gui; Mei, Leilei; Chen, Chuansheng; Lu, Zhong-Lin; Poldrack, Russell A.; Dong, Qi			Facilitating Memory for Novel Characters by Reducing Neural Repetition Suppression in the Left Fusiform Cortex	PLOS ONE			English	Article							WORD FORM AREA; NEUROFUNCTIONAL PREDICTORS; DEVELOPMENTAL DYSLEXIA; FUNCTIONAL-PROPERTIES; RECOGNITION MEMORY; WRITING SYSTEM; BRAIN ACTIVITY; TASKS; FMRI; EXPERIENCE	Background: The left midfusiform and adjacent regions have been implicated in processing and memorizing familiar words, yet its role in memorizing novel characters has not been well understood. Methodology/Principal Findings: Using functional MRI, the present study examined the hypothesis that the left midfusiform is also involved in memorizing novel characters and spaced learning could enhance the memory by enhancing the left midfusiform activity during learning. Nineteen native Chinese readers were scanned while memorizing the visual form of 120 Korean characters that were novel to the subjects. Each character was repeated four times during learning. Repetition suppression was manipulated by using two different repetition schedules: massed learning and spaced learning, pseudo-randomly mixed within the same scanning session. Under the massed learning condition, the four repetitions were consecutive (with a jittered inter-repetition interval to improve the design efficiency). Under the spaced learning condition, the four repetitions were interleaved with a minimal inter-repetition lag of 6 stimuli. Spaced learning significantly improved participants' performance during the recognition memory test administered one hour after the scan. Stronger left midfusiform and inferior temporal gyrus activities during learning (summed across four repetitions) were associated with better memory of the characters, based on both within-and cross-subjects analyses. Compared to massed learning, spaced learning significantly reduced neural repetition suppression and increased the overall activities in these regions, which were associated with better memory for novel characters. Conclusions/Significance: These results demonstrated a strong link between cortical activity in the left midfusiform and memory for novel characters, and thus challenge the visual word form area (VWFA) hypothesis. Our results also shed light on the neural mechanisms of the spacing effect in memorizing novel characters.	[Xue, Gui; Mei, Leilei; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Xue, Gui; Lu, Zhong-Lin] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Mei, Leilei; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Poldrack, Russell A.] Univ Texas Austin, Imaging Res Ctr, Austin, TX 78712 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Neurobiol, Austin, TX 78712 USA	Beijing Normal University; University of Southern California; University of California System; University of California Irvine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Xue, G (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	guixue@gmail.com	Xue, Gui/A-1762-2009	Xue, Gui/0000-0001-7891-8151; Lu, Zhong-Lin/0000-0002-7295-727X; Poldrack, Russell/0000-0001-6755-0259; Chen, Chuansheng/0000-0002-8224-1005	Program for New Century Excellent Talents in University; National Science Foundation [BCS 0823624, BCS 0823495]; National Institute of Health [HD057884-01A2]; 111 Project of China [B07008]; Direct For Social, Behav & Economic Scie [0823624] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [0823495] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057884] Funding Source: NIH RePORTER	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project of China(Ministry of Education, China - 111 Project); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Program for New Century Excellent Talents in University, the National Science Foundation (grant numbers BCS 0823624 and BCS 0823495), the National Institute of Health (grant number HD057884-01A2), and the 111 Project of China (B07008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Arthur W, 1998, HUM PERFORM, V11, P57, DOI 10.1207/s15327043hup1101_3; Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Barton JJS, 2010, J COGNITIVE NEUROSCI, V22, P1649, DOI 10.1162/jocn.2009.21286; Brem S, 2006, NEUROIMAGE, V29, P822, DOI 10.1016/j.neuroimage.2005.09.023; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brozinsky CJ, 2005, HIPPOCAMPUS, V15, P557, DOI 10.1002/hipo.20087; Bruno JL, 2008, NEUROIMAGE, V39, P1988, DOI 10.1016/j.neuroimage.2007.10.044; Callan DE, 2010, HUM BRAIN MAPP, V31, P645, DOI 10.1002/hbm.20894; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Chen CS, 2007, NEUROPSYCHOLOGIA, V45, P741, DOI 10.1016/j.neuropsychologia.2006.08.018; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Cohen L, 2004, NEUROPSYCHOLOGIA, V42, P1768, DOI 10.1016/j.neuropsychologia.2004.04.018; Cornoldi C., 1977, ITALIAN J PSYCHOL, V4, P65; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dempster FN, 1989, EDUC PSYCHOL REV, V1, P309, DOI 10.1007/BF01320097; Dong Q, 2008, NEUROSCI LETT, V430, P87, DOI 10.1016/j.neulet.2007.09.078; Donovan JJ, 1999, J APPL PSYCHOL, V84, P795, DOI 10.1037/0021-9010.84.5.795; Epelbaum S, 2008, CORTEX, V44, P962, DOI 10.1016/j.cortex.2008.05.003; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; GREENE RL, 1989, J EXP PSYCHOL LEARN, V15, P371, DOI 10.1037/0278-7393.15.3.371; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Hintzman D. L., 1974, THEORIES COGNITIVE P, P77; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Liu C, 2008, NEUROIMAGE, V40, P1350, DOI 10.1016/j.neuroimage.2007.10.014; Mammarella N, 2004, EUR J COGN PSYCHOL, V16, P387, DOI 10.1080/09541440340000042; Mammarella N, 2002, MEM COGNITION, V30, P1238, DOI 10.3758/BF03213406; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McCrory EJ, 2005, BRAIN, V128, P261, DOI 10.1093/brain/awh340; Mei LL, 2010, NEUROIMAGE, V52, P371, DOI 10.1016/j.neuroimage.2010.03.067; Mumford J., 2007, GUIDE CALCULATING PE; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Proverbio AM, 2006, COGN NEUROPSYCHOL, V23, P355, DOI 10.1080/02643290442000536; Reinke K, 2008, BRAIN LANG, V104, P180, DOI 10.1016/j.bandl.2007.04.006; Russo R, 1998, J EXP PSYCHOL LEARN, V24, P161, DOI 10.1037/0278-7393.24.1.161; Russo R, 2002, J EXP PSYCHOL LEARN, V28, P819, DOI 10.1037//0278-7393.28.5.819; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; SNYDER PJ, 1993, CORTEX, V29, P115, DOI 10.1016/S0010-9452(13)80216-X; STARK S, 2008, MEMORY, P1; Turk-Browne NB, 2006, NEURON, V49, P917, DOI 10.1016/j.neuron.2006.01.030; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Van der Mark S, 2009, NEUROIMAGE, V47, P1940, DOI 10.1016/j.neuroimage.2009.05.021; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wagner AD, 2000, J COGNITIVE NEUROSCI, V12, P52, DOI 10.1162/089892900564064; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wong YK, 2010, J COGNITIVE NEUROSCI, V22, P695, DOI 10.1162/jocn.2009.21229; XUE G, 2010, J COGNITIVE NEUROSCI; Xue G, 2008, NEUROIMAGE, V39, P2025, DOI 10.1016/j.neuroimage.2007.10.021; Xue G, 2007, J COGNITIVE NEUROSCI, V19, P1643, DOI 10.1162/jocn.2007.19.10.1643; Xue G, 2006, NEUROIMAGE, V31, P1315, DOI 10.1016/j.neuroimage.2005.11.055; Xue G, 2006, J COGNITIVE NEUROSCI, V18, P923, DOI 10.1162/jocn.2006.18.6.923; YONELINAS AP, 1994, J EXP PSYCHOL LEARN, V20, P1341, DOI 10.1037/0278-7393.20.6.1341	65	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13204	10.1371/journal.pone.0013204	http://dx.doi.org/10.1371/journal.pone.0013204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	659LQ	20949093	Green Published, gold			2022-12-25	WOS:000282568400015
J	Liu, Y; Wu, N; Dong, J; Gao, YP; Zhang, X; Mu, CH; Shao, NS; Yang, GA				Liu, Yu; Wu, Na; Dong, Jie; Gao, Yaping; Zhang, Xin; Mu, Chunhua; Shao, Ningsheng; Yang, Guang			Hfq Is a Global Regulator That Controls the Pathogenicity of Staphylococcus aureus	PLOS ONE			English	Article							SM-LIKE PROTEIN; MESSENGER-RNA TARGETS; VIRULENCE FACTORS; AGR; BINDING; GENE; SARA; MUTANTS; CLONING; GROWTH	The Hfq protein is reported to be an RNA chaperone, which is involved in the stress response and the virulence of several pathogens. In E. coli, Hfq can mediate the interaction between some sRNAs and their target mRNAs. But it is controversial whether Hfq plays an important role in S. aureus. In this study, we found that the deletion of hfq gene in S. aureus 8325-4 can increase the surface carotenoid pigments. The hfq mutant was more resistant to oxidative stress but the pathogenicity of the mutant was reduced. We reveal that the Hfq protein can be detected only in some S. aureus strains. Using microarray and qRT-PCR, we identified 116 genes in the hfq mutant which had differential expression from the wild type, most of which are related to the phenotype and virulence of S. aureus. Among the 116 genes, 49 mRNAs can specifically bind Hfq protein, which indicates that Hfq also acts as an RNA binding protein in S. aureus. Our data suggest that Hfq protein of S. aureus is a multifunctional regulator involved in stress and virulence.	[Liu, Yu; Wu, Na; Dong, Jie; Gao, Yaping; Zhang, Xin; Mu, Chunhua; Shao, Ningsheng; Yang, Guang] Beijing Inst Basic Med Sci, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Liu, Y (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	shaonsh@hotmail.com; yanggg@hotmail.com			China National Key Program on Basic Research [2005CB724600]; National Natural Science Foundation of China [30700007, 30870093]; National High-Tech Research and Development Program [2006AA02Z132, 2006AA02Z323]	China National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by grants from China National Key Program on Basic Research (2005CB724600, http://www.973.gov.cn/English/), National Natural Science Foundation of China (30700007, 30870093, http://www.nsfc.gov.cn/Portal0/default106.htm) and National High-Tech Research and Development Program (2006AA02Z132, 2006AA02Z323, http://www.most.gov.cn/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Arluison V, 2007, PROTEIN SCI, V16, P1830, DOI 10.1110/ps.072883707; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fantappie L, 2009, INFECT IMMUN, V77, P1842, DOI 10.1128/IAI.01216-08; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Franze de Fernandez M T, 1972, J Biol Chem, V247, P824; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; ISENBERG HD, 1976, INFECT IMMUN, V14, P483, DOI 10.1128/IAI.14.2.483-489.1976; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Korem M, 2005, INFECT IMMUN, V73, P6220, DOI 10.1128/IAI.73.10.6220-6228.2005; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mohanty BK, 2004, MOL MICROBIOL, V54, P905, DOI 10.1111/j.1365-2958.2004.04337.x; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; SCHWESINGER MD, 1975, J BACTERIOL, V123, P724, DOI 10.1128/JB.123.2.724-738.1975; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vassilieva IM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1293, DOI 10.1023/A:1021365808520; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x	44	44	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13069	10.1371/journal.pone.0013069	http://dx.doi.org/10.1371/journal.pone.0013069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927372	gold, Green Submitted, Green Published			2022-12-25	WOS:000282269400020
J	Kumar, M; Lu, Z; Takwi, AAL; Chen, W; Callander, NS; Ramos, KS; Young, KH; Li, Y				Kumar, M.; Lu, Z.; Takwi, A. A. L.; Chen, W.; Callander, N. S.; Ramos, K. S.; Young, K. H.; Li, Y.			Negative regulation of the tumor suppressor p53 gene by microRNAs	ONCOGENE			English	Article						microRNA; p53; senescence; apoptosis; cell cycle arrest; multiple myeloma	MIR-34A; TARGET; IDENTIFICATION; RESTORATION; ACTIVATION; APOPTOSIS; PATHWAY; ARREST; TP53	The tumor suppressor p53, encoded by the TP53 gene, is recognized as the guardian of the human genome because it regulates many downstream genes to exercise its function in cell cycle and cell death. Recent studies have revealed that several microRNAs (miRNAs) are important components of the p53 tumor suppressor network with miR-125b and miR-504 directly targeting TP53. In this study, we use a screening method to identify that two miRNAs (miR-25 and miR-30d) directly target the 3'UTR of TP53 to downregulate p53 protein levels and reduce the expression of genes that are transcriptionally activated by p53. Correspondingly, both miR-25 and miR-30d adversely affect apoptotic cell death, cell cycle arrest and cellular senescence. Inhibition of either miR-25 or miR-30d expression increases endogenous p53 expression and elevates cellular apoptosis in several cell lines, including one from multiple myeloma that has little TP53 mutations. Thus, beyond miR-125b and miR-504, the human TP53 gene is negatively regulated by two more miRNAs: miR-25 and miR-30d. Oncogene (2011) 30, 843-853; doi:10.1038/onc.2010.457; published online 11 October 2010	[Kumar, M.; Lu, Z.; Takwi, A. A. L.; Chen, W.; Ramos, K. S.; Li, Y.] Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Callander, N. S.; Young, K. H.] Univ Wisconsin, Sch Med & Publ Hlth, Paul P Carbone Comprehens Canc Ctr, Dept Pathol & Lab Med Oncol, Madison, WI USA	University of Louisville; University of Wisconsin System; University of Wisconsin Madison	Li, Y (corresponding author), Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Biochem & Mol Biol, 319 Abraham Flexner Way,Room 513-A Bldg, Louisville, KY 40202 USA.	yong.li@louisville.edu	Kumar, Munish/Z-4106-2019; Xie, Huangming/B-2260-2012	Callander, Natalie/0000-0002-6975-1086	NIEHS/NIH [P30ES014443]; NCI/NIH [R01CA138688, P20CA103697, 1RC1CA146299]; NCRR/NIH [P20 RR024489]; University of Wisconsin Paul Carbone Comprehensive Cancer Center; Gundersen Medical Foundation; University of Wisconsin; NATIONAL CANCER INSTITUTE [RC1CA146299, P20CA103697, R01CA138688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Wisconsin Paul Carbone Comprehensive Cancer Center; Gundersen Medical Foundation; University of Wisconsin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Y L is supported by the Director's Biomarker Award from the Center for Environmental Genomics and Integrative Biology, funded by NIEHS/NIH (P30ES014443), Kentucky Lung Cancer Research Program, NCI/NIH (R01CA138688) and NCRR/NIH (P20 RR024489). K H Y is supported by the University of Wisconsin Paul Carbone Comprehensive Cancer Center Award, the Gundersen Medical Foundation Award, the University of Wisconsin Pathology R & D Fund and by NCI/NIH (P20CA103697 and 1RC1CA146299). We are grateful to the critical reviews from Drs Korise E Rasmusson and Nancy C Martin.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chng WJ, 2007, LEUKEMIA, V21, P582, DOI 10.1038/sj.leu.2404524; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hu WW, 2010, MOL CELL, V38, P689, DOI 10.1016/j.molcel.2010.05.027; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mayer B, 2003, NEWS PHYSIOL SCI, V18, P89, DOI 10.1152/nips.01433.2002; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Prendergast NJ, 1996, J UROLOGY, V155, P1685, DOI 10.1016/S0022-5347(01)66165-2; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; VOELLER HJ, 1994, J UROLOGY, V151, P492; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Xiong W, 2008, BLOOD, V112, P4235, DOI 10.1182/blood-2007-10-119123; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	39	209	219	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	7					843	853		10.1038/onc.2010.457	http://dx.doi.org/10.1038/onc.2010.457			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	722OT	20935678	Green Accepted			2022-12-25	WOS:000287444600008
J	Louboutin, JP; Chekmasova, A; Marusich, E; Agrawal, L; Strayer, DS				Louboutin, Jean-Pierre; Chekmasova, Alena; Marusich, Elena; Agrawal, Lokesh; Strayer, David S.			Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage	FASEB JOURNAL			English	Article						chemokine receptors; neuroregeneration; bone marrow	BLOOD-BRAIN-BARRIER; TEMPORAL-LOBE EPILEPSY; FOCAL CEREBRAL-ISCHEMIA; CHEMOKINE RECEPTOR CCR5; CENTRAL-NERVOUS-SYSTEM; MONOCYTE CHEMOATTRACTANT PROTEIN-1; SECRETORY PHOSPHOLIPASE A(2); INDUCED STATUS EPILEPTICUS; VIVO GENE-TRANSFER; ENDOTHELIAL-CELLS	Chemokines may play a role in leukocyte migration across the blood-brain barrier (BBB) during neuroinflammation and other neuropathological processes, such as epilepsy. We investigated the role of the chemokine receptor CCR5 in seizures. We used a rat model based on intraperitoneal kainic acid (KA) administration. Four months before KA injection, adult rats were given femoral intramarrow inoculations of SV (RNAiR5-RevM10.AU1), which carries an interfering RNA (RNAi) against CCR5, plus a marker epitope (AU1), or its monofunctional RNAi-carrying homologue, SV(RNAiR5). This treatment lowered expression of CCR5 in circulating cells. In control rats, seizures induced elevated expression of CCR5 ligands MIP-1 alpha and RANTES in the microvasculature, increased BBB leakage and CCR5(+) cells, as well as neuronal loss, inflammation, and gliosis in the hippocampi. Animals given either the bifunctional or the monofunctional vector were largely protected from KA-induced seizures, neuroinflammation, BBB damage, and neuron loss. Brain CCR5 mRNA was reduced. Rats receiving RNAiR5-bearing vectors showed far greater repair responses: increased neuronal proliferation, and decreased production of MIP-1 alpha and RANTES. Controls received unrelated SV(BUGT) vectors. Decrease in CCR5 in circulating cells strongly protected from excitotoxin-induced seizures, BBB leakage, CNS injury, and inflammation, and facilitated neurogenic repair.-Louboutin, J.-P., Chekmasova, A., Marusich, E., Agrawal, L., Strayer, D. S. Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage. FASEB J. 25, 737-753 (2011). www.fasebj.org	[Louboutin, Jean-Pierre; Chekmasova, Alena; Marusich, Elena; Agrawal, Lokesh; Strayer, David S.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol, Philadelphia, PA 19107 USA	Jefferson University	Louboutin, JP (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol, 1020 Locust St,Rm 251, Philadelphia, PA 19107 USA.	jplouboutin@hotmail.com		MARUSICH, ELENA/0000-0003-1943-6245	National Institutes of Health [MH70287]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The anti-alpha 4 integrin antibody was a kind gift from Dr. A. Aplin (Thomas Jefferson University). This work was supported by grant MH70287 from the National Institutes of Health.	Agrawal L, 2006, GENE THER, V13, P1645, DOI 10.1038/sj.gt.3302821; Agrawal L, 2009, J GEN VIROL, V90, P710, DOI 10.1099/vir.0.006205-0; Andjelkovic AV, 2000, J NEUROCHEM, V75, P1898, DOI 10.1046/j.1471-4159.2000.0751898.x; Andjelkovic AV, 1999, J CELL BIOL, V145, P403, DOI 10.1083/jcb.145.2.403; Arganaraz GA, 2004, BRAIN RES, V1013, P30, DOI 10.1016/j.brainres.2004.03.046; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Balistreri CR, 2006, ANN NY ACAD SCI, V1089, P454, DOI 10.1196/annals.1386.012; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bigini P, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-71; Bolton SJ, 1998, EXP NEUROL, V154, P231, DOI 10.1006/exnr.1998.6927; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Bregola G, 1999, NEUROSCIENCE, V92, P1043, DOI 10.1016/S0306-4522(99)00075-5; Briones MA, 2001, CORONARY ARTERY DIS, V12, P179, DOI 10.1097/00019501-200105000-00004; Chen ZG, 2003, J NEUROCHEM, V86, P61, DOI 10.1046/j.1471-4159.2003.01807.x; Chui R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-1; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; Combarros O, 2004, NEUROSCI LETT, V366, P312, DOI 10.1016/j.neulet.2004.05.058; Cordelier P, 2004, GENE THER, V11, P1627, DOI 10.1038/sj.gt.3302329; Couture R, 2001, EUR J PHARMACOL, V429, P161, DOI 10.1016/S0014-2999(01)01318-8; Cowell RM, 2002, STROKE, V33, P795, DOI 10.1161/hs0302.103740; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dos Santos AC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-49; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Ekdahl CT, 2001, EUR J NEUROSCI, V14, P937, DOI 10.1046/j.0953-816x.2001.01713.x; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Farooqui AA, 2010, MOL NEUROBIOL, V41, P267, DOI 10.1007/s12035-009-8091-y; Frank S, 2000, BIOCHEM J, V347, P265, DOI 10.1042/0264-6021:3470265; Galasso JM, 1998, AM J PATHOL, V153, P1631, DOI 10.1016/S0002-9440(10)65752-5; Galimberti D, 2004, J NEUROL SCI, V225, P79, DOI 10.1016/j.jns.2004.07.005; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Gourmala NG, 1999, NEUROSCIENCE, V88, P1255, DOI 10.1016/S0306-4522(98)00295-4; Greenwood J, 2002, VASC PHARMACOL, V38, P315, DOI 10.1016/S1537-1891(02)00199-4; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; Kleen JK, 2008, NAT MED, V14, P1309, DOI 10.1038/nm1208-1309; Kotani A, 2002, IMMUNOL LETT, V84, P1, DOI 10.1016/S0165-2478(02)00082-2; Kremlev SG, 2004, J NEUROIMMUNOL, V149, P1, DOI 10.1016/j.jneuroim.2003.11.012; Lee TS, 2007, MOL MED, V13, P1, DOI 10.2119/2006-00079.Lee; Li M, 2009, J IMMUNOL, V182, P5778, DOI 10.4049/jimmunol.0803013; Liu BL, 2005, BLOOD, V106, P2655, DOI 10.1182/blood-2005-01-0028; Liu JL, 1998, J NEUROSCI, V18, P7768; Louboutin JP, 2007, GENE THER, V14, P1650, DOI 10.1038/sj.gt.3303030; Louboutin JP, 2007, GENE THER, V14, P939, DOI 10.1038/sj.gt.3302939; Louboutin JP, 2007, J GENE MED, V9, P843, DOI 10.1002/jgm.1084; Louboutin JP, 2006, STEM CELLS, V24, P2801, DOI 10.1634/stemcells.2006-0124; Louboutin JP, 2010, NEUROBIOL DIS, V38, P313, DOI 10.1016/j.nbd.2010.02.007; Louboutin JP, 2009, NEUROBIOL DIS, V34, P462, DOI 10.1016/j.nbd.2009.03.003; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; Mandel RJ, 1998, J NEUROSCI, V18, P4271; Manley NC, 2007, BRAIN RES, V1182, P138, DOI 10.1016/j.brainres.2007.08.092; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Mazzuferi M, 2005, NEUROSCIENCE, V135, P979, DOI 10.1016/j.neuroscience.2005.06.070; Mennicken F, 2002, GLIA, V37, P124, DOI 10.1002/glia.10021; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mohapel P, 2004, NEUROBIOL DIS, V15, P196, DOI 10.1016/j.nbd.2003.11.010; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morinville A, 2004, J NEUROSCI, V24, P5549, DOI 10.1523/JNEUROSCI.2719-03.2004; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; Nikonov AA, 2005, P NATL ACAD SCI USA, V102, P18688, DOI 10.1073/pnas.0505241102; Parathath SR, 2006, J CELL SCI, V119, P339, DOI 10.1242/jcs.02734; Perosa SR, 2007, HIPPOCAMPUS, V17, P26, DOI 10.1002/hipo.20239; Pocock J M, 2001, Prog Brain Res, V132, P555; Quandt J, 2004, J NEUROPATH EXP NEUR, V63, P350, DOI 10.1093/jnen/63.4.350; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Rosell DR, 2003, NEUROSCIENCE, V122, P329, DOI 10.1016/S0306-4522(03)00593-1; Rouger K, 2001, AM J PATHOL, V158, P355, DOI 10.1016/S0002-9440(10)63976-4; Sandhya TL, 1998, BRAIN RES, V788, P223, DOI 10.1016/S0006-8993(97)01552-7; Sauter BV, 2000, GASTROENTEROLOGY, V119, P1348, DOI 10.1053/gast.2000.19577; Sawa Y, 2008, CELL TISSUE RES, V333, P237, DOI 10.1007/s00441-008-0625-5; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Schreiber TH, 2007, BLOOD, V109, P1381, DOI 10.1182/blood-2006-07-032995; Seguin R, 2003, J NEUROPATH EXP NEUR, V62, P412, DOI 10.1093/jnen/62.4.412; Shukaliak JA, 2000, J NEUROPATH EXP NEUR, V59, P339, DOI 10.1093/jnen/59.5.339; Signoret N, 1998, J CELL SCI, V111, P2819; Strayer DA, 1999, J CELL PHYSIOL, V181, P375, DOI 10.1002/(SICI)1097-4652(199912)181:3<375::AID-JCP1>3.0.CO;2-8; Strayer DS, 1997, GENE THER, V4, P219, DOI 10.1038/sj.gt.3300368; Strayer DS, 2001, METH MOL B, V165, P103; Subileau EA, 2009, J NEUROPATH EXP NEUR, V68, P227, DOI 10.1097/NEN.0b013e318197eca7; Takami S, 2002, J CEREBR BLOOD F MET, V22, P780, DOI 10.1097/00004647-200207000-00003; THEELE DP, 1993, GLIA, V7, P5, DOI 10.1002/glia.440070104; Thwin MM, 2003, EXP BRAIN RES, V150, P427, DOI 10.1007/s00221-003-1476-7; Tripathy D, 2007, J ALZHEIMERS DIS, V11, P447; Ubogu EE, 2006, CELL IMMUNOL, V243, P19, DOI 10.1016/j.cellimm.2006.12.001; Ubogu EE, 2006, J NEUROIMMUNOL, V179, P132, DOI 10.1016/j.jneuroim.2006.06.004; van Gassen KLI, 2008, EPILEPSIA, V49, P1055, DOI 10.1111/j.1528-1167.2007.01470.x; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 1999, J NEUROSCI, V19, P5054; Wang HK, 2008, J NEUROSCI, V28, P1721, DOI 10.1523/JNEUROSCI.4973-07.2008; Won SJ, 1999, NEUROSCIENCE, V94, P83, DOI 10.1016/S0306-4522(99)00196-7; Xia MQ, 1998, AM J PATHOL, V153, P31, DOI 10.1016/S0002-9440(10)65542-3; Xu JH, 2009, NEUROPATH APPL NEURO, V35, P496, DOI 10.1111/j.1365-2990.2009.01022.x; YABUUCHI K, 1993, MOL BRAIN RES, V20, P153, DOI 10.1016/0169-328X(93)90121-5; Yegin A, 2002, ACTA NEUROL SCAND, V106, P258, DOI 10.1034/j.1600-0404.2002.01238.x; Yeligar SM, 2009, J IMMUNOL, V183, P5964, DOI 10.4049/jimmunol.0901564; Youssef S, 1999, J AUTOIMMUN, V13, P21, DOI 10.1006/jaut.1999.0306; Zozulya AL, 2007, J IMMUNOL, V178, P520, DOI 10.4049/jimmunol.178.1.520	101	57	59	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2011	25	2					737	753		10.1096/fj.10-161851	http://dx.doi.org/10.1096/fj.10-161851			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20940264	Green Published			2022-12-25	WOS:000286724800031
J	Savelyeva, I; Dobbelstein, M				Savelyeva, I.; Dobbelstein, M.			Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A	ONCOGENE			English	Article						adenovirus; E1A; E1B; p53; Sp1; p300	TUMOR-SUPPRESSOR P53; CELL-CYCLE; PROTEIN; ONYX-015; TYPE-5; TRANSCRIPTION; REPLICATION; PROMOTER; P300/CBP; BINDING	Wild-type adenovirus type 5 eliminates p53 through the E1B-55 kDa and E4-34 kDa gene products. Deletion or mutation of E1B-55 kDa has long been thought to confer p53-selective replication of oncolytic viruses. We show here that infection with E1B-defective adenovirus mutants induces massive accumulation of p53, without obvious defects in p53 localization, phosphorylation, conformation and oligomerization. Nonetheless, p53 completely failed to induce its target genes in this scenario, for example, p21/CDKN1A, Mdm2 and PUMA. Two regions of the E1A gene products independently contributed to the suppression of p21 transcription. Depending on the E1A conserved region 3, E1B-defective adenovirus impaired the ability of the transcription factor Sp1 to bind the p21 promoter. Moreover, the amino terminal region of E1A, binding the acetyl transferases p300 and CREB-binding protein, blocked p53 K382 acetylation in infected cells. Mutating either of these E1A regions, in addition to E1B, partially restored p21 mRNA levels. Our findings argue that adenovirus attenuates p53-mediated p21 induction, through at least two E1B-independent mechanisms. Other virus species and cancer cells may employ analogous strategies to impair p53 activity. Oncogene (2011) 30, 865-875; doi:10.1038/onc.2010.461; published online 11 October 2010	[Savelyeva, I.; Dobbelstein, M.] Univ Gottingen, Gottingen Ctr Mol Biosci, Dept Mol Oncol, D-37077 Gottingen, Lower Saxony, Germany; [Savelyeva, I.; Dobbelstein, M.] Univ So Denmark, Inst Med Biol, Ctr Med Biotechnol, Odense C, Denmark	University of Gottingen; University of Southern Denmark	Dobbelstein, M (corresponding author), Univ Gottingen, Gottingen Ctr Mol Biosci, Dept Mol Oncol, Ernst Caspari Haus,Justus von Liebig Weg 11, D-37077 Gottingen, Lower Saxony, Germany.	mdobbel@uni-goettingen.de		Dobbelstein, Matthias/0000-0001-5052-3967	German Cancer Aid/Dr Mildred Scheel Stiftung; EU; German Research Foundation (DFG); Wilhelm Sander Stiftung; Statens Sundhedsvidenskabelige Forskningsrad of Denmark; Danish Cancer Society; Novonordisk fonden	German Cancer Aid/Dr Mildred Scheel Stiftung(Deutsche Krebshilfe); EU(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); Wilhelm Sander Stiftung; Statens Sundhedsvidenskabelige Forskningsrad of Denmark; Danish Cancer Society(Danish Cancer Society); Novonordisk fonden(Novo Nordisk Foundation)	We thank JS Mymryk, RJA Grand, X Zhang and G Ketner for viruses, K Roemer for plasmids, AJ Levine for antibodies, OG Opitz for cells, C Hippel and A Dickmanns for excellent technical assistance, and S Johnsen for the help with ChIP experiments. The work was supported by the German Cancer Aid/Dr Mildred Scheel Stiftung, the EU 6th Framework Program (Integrated Project Active p53), the German Research Foundation (DFG), the Wilhelm Sander Stiftung, the Statens Sundhedsvidenskabelige Forskningsrad of Denmark, the Danish Cancer Society, and the Novonordisk fonden.	Atz J, 2000, J CELL BIOCHEM, V76, P572, DOI 10.1002/(SICI)1097-4644(20000315)76:4<572::AID-JCB6>3.0.CO;2-6; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709; Bernat A, 2003, ONCOGENE, V22, P7871, DOI 10.1038/sj.onc.1206896; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; BRIDGE E, 1990, VIROLOGY, V174, P345, DOI 10.1016/0042-6822(90)90088-9; CARLOCK LR, 1981, J VIROL, V40, P657, DOI 10.1128/JVI.40.3.657-664.1981; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Goodrum FD, 1998, J VIROL, V72, P9479, DOI 10.1128/JVI.72.12.9479-9490.1998; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Harada H, 2003, MOL CANCER RES, V1, P729; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; Harrod R, 2003, J BIOL CHEM, V278, P12310, DOI 10.1074/jbc.M211167200; Heise C, 1997, NAT MED, V3, P639, DOI 10.1038/nm0697-639; Hobom U, 2004, J VIROL, V78, P7685, DOI 10.1128/JVI.78.14.7685-7697.2004; Hsu CH, 2004, EMBO J, V23, P2269, DOI 10.1038/sj.emboj.7600239; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; Koch P, 2001, CANCER RES, V61, P5941; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; O'Shea CC, 2005, CANCER CELL, V8, P61, DOI 10.1016/j.ccr.2005.06.009; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; PILDER S, 1986, MOL CELL BIOL, V6, P470, DOI 10.1128/MCB.6.2.470; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Rothmann T, 1998, J VIROL, V72, P9470, DOI 10.1128/JVI.72.12.9470-9478.1998; Shen YQ, 2001, J VIROL, V75, P4297, DOI 10.1128/JVI.75.9.4297-4307.2001; SHEPHERD SE, 1993, J VIROL, V67, P2944, DOI 10.1128/JVI.67.5.2944-2949.1993; Steegenga WT, 1996, MOL CELL BIOL, V16, P2101; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Turnell AS, 2000, EMBO J, V19, P4759, DOI 10.1093/emboj/19.17.4759; Turnell AS, 1999, J VIROL, V73, P2074, DOI 10.1128/JVI.73.3.2074-2083.1999; Wang XY, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-44; Weigel S, 2000, J VIROL, V74, P764, DOI 10.1128/JVI.74.2.764-772.2000; Wong KS, 2005, J BIOL CHEM, V280, P9390, DOI 10.1074/jbc.M408643200; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	49	15	18	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	7					865	875		10.1038/onc.2010.461	http://dx.doi.org/10.1038/onc.2010.461			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	722OT	20935676				2022-12-25	WOS:000287444600010
J	Zhan, Y; Modi, N; Stewart, AM; Hieronimus, RI; Liu, J; Gutmann, DH; Chadee, DN				Zhan, Y.; Modi, N.; Stewart, A. M.; Hieronimus, R. I.; Liu, J.; Gutmann, D. H.; Chadee, D. N.			Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer	ONCOGENE			English	Article						MLK3; NF2; MAPK; B-Raf; Cdc42	NF2 TUMOR-SUPPRESSOR; MEDIATES CONTACT INHIBITION; TYPE-2 GENE-PRODUCT; N-TERMINAL KINASE; CELL-PROLIFERATION; B-RAF; ACTIVATION LOOP; NIH 3T3-CELLS; SCHWANN-CELLS; MERLIN	The Neurofibromatosis-2 (NF2) tumor suppressor merlin negatively regulates cell proliferation in numerous cell types. We have previously shown that the NF2 protein (merlin/schwannomin) associates with mixed lineage kinase 3 (MLK3), a mitogen-activated protein kinase (MAPK) kinase kinase that is required for the proliferation of normal and neoplastic cells. In this study, we show that merlin inhibits MLK3 activity, as well as the activation of its downstream effectors, B-Raf, extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK). The ability of merlin to regulate MLK3 activity requires a direct association between MLK3 and residues in the C-terminal region of merlin. Merlin integrates Rho GTPase family signaling with MAPK activity by inhibiting the binding between MLK3 and its upstream activator, Cdc42. Furthermore, we demonstrate that MLK3 is required for merlin-mediated suppression of cell proliferation and invasion. Collectively, these results establish merlin as a potent inhibitor of MLK3, ERK and JNK activation in cancer, and provide a mechanistic link between deregulated MAPK and Rho GTPase signaling in NF2 growth control. Oncogene (2011) 30, 781-789; doi:10.1038/onc.2010.453; published online 4 October 2010	[Zhan, Y.; Modi, N.; Stewart, A. M.; Hieronimus, R. I.; Chadee, D. N.] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Liu, J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Gutmann, D. H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	University System of Ohio; University of Toledo; University of Texas System; UTMD Anderson Cancer Center; Washington University (WUSTL)	Chadee, DN (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	deborah.chadee@utoledo.edu	ZHAN, YU/P-4025-2014	Gutmann, David/0000-0002-3127-5045	National Institutes of Health [1 R15 CA132006-01]; American Cancer Society (Ohio Division); NATIONAL CANCER INSTITUTE [R15CA132006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (Ohio Division)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr J Kyriakis for the FLAG-Cdc42 constructs and Dr D Lim for HEI193 cells. This work was supported by National Institutes of Health Grant 1 R15 CA132006-01 and by an American Cancer Society (Ohio Division) grant (to D.N.C.).	Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Chadee DN, 2004, CELL CYCLE, V3, P1227, DOI 10.4161/cc.3.10.1187; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chadee DN, 2002, MOL CELL BIOL, V22, P737, DOI 10.1128/MCB.22.3.737-749.2002; Cho YY, 2004, CANCER RES, V64, P3855, DOI 10.1158/0008-5472.CAN-04-0201; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Fernandez-Valle C, 2002, NAT GENET, V31, P354, DOI 10.1038/ng930; Fraenzer JT, 2003, INT J ONCOL, V23, P1493; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Gonzalez-Agosti C, 1999, J BIOL CHEM, V274, P34438, DOI 10.1074/jbc.274.48.34438; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; Gutmann DH, 2001, HUM MOL GENET, V10, P825, DOI 10.1093/hmg/10.8.825; Hartkamp J, 1999, CANCER RES, V59, P2195; Hung G, 2002, INT J ONCOL, V20, P475; Ikeda K, 1999, J NEUROSURG, V91, P85, DOI 10.3171/jns.1999.91.1.0085; Jannatipour M, 2001, J BIOL CHEM, V276, P33093, DOI 10.1074/jbc.M105792200; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Khatlani TS, 2007, ONCOGENE, V26, P2658, DOI 10.1038/sj.onc.1210050; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee JY, 2006, ONCOGENE, V25, P1143, DOI 10.1038/sj.onc.1209150; Leung IWL, 2001, J BIOL CHEM, V276, P1961, DOI 10.1074/jbc.M004092200; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; LUTCHMAN M, 1995, CANCER RES, V55, P2270; McClatchey AI, 1997, GENE DEV, V11, P1253, DOI 10.1101/gad.11.10.1253; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Obremski VJ, 1998, J NEUROBIOL, V37, P487, DOI 10.1002/(SICI)1097-4695(199812)37:4<487::AID-NEU1>3.3.CO;2-2; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Poulikakos PI, 2006, ONCOGENE, V25, P5960, DOI 10.1038/sj.onc.1209587; Ramesh V, 2004, NAT REV NEUROSCI, V5, P462, DOI 10.1038/nrn1407; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Reed N, 2001, TRENDS MOL MED, V7, P157, DOI 10.1016/S1471-4914(01)01955-4; Rennefahrt U, 2004, CANCER LETT, V215, P113, DOI 10.1016/j.canlet.2004.05.015; Rennefahrt UEE, 2002, J BIOL CHEM, V277, P29510, DOI 10.1074/jbc.M203010200; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; Scoles DR, 2000, HUM MOL GENET, V9, P1567, DOI 10.1093/hmg/9.11.1567; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Sun CX, 2002, J CELL SCI, V115, P3991, DOI 10.1242/jcs.00094; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Vacratsis PO, 2000, J BIOL CHEM, V275, P27893; Velho S, 2010, HUM MOL GENET, V19, P697, DOI 10.1093/hmg/ddp536; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Zhang H, 2001, J BIOL CHEM, V276, P45598, DOI 10.1074/jbc.M107176200	46	21	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	7					781	789		10.1038/onc.2010.453	http://dx.doi.org/10.1038/onc.2010.453			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	722OT	20890305	Green Accepted			2022-12-25	WOS:000287444600003
J	Eissa, A; Amodeo, V; Smith, CR; Diamandis, EP				Eissa, Azza; Amodeo, Vanessa; Smith, Christopher R.; Diamandis, Eleftherios P.			Kallikrein-related Peptidase-8 (KLK8) Is an Active Serine Protease in Human Epidermis and Sweat and Is Involved in a Skin Barrier Proteolytic Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TISSUE KALLIKREINS; HUMAN STRATUM-CORNEUM; NEUROPSIN MESSENGER-RNA; NETHERTON-SYNDROME; TRYPSIN-LIKE; ENZYMATIC CHARACTERIZATION; MOLECULAR-CLONING; SEMINAL PLASMA; GENE FAMILY; EXPRESSION	Kallikrein-related peptidase-8 (KLK8) is a relatively uncharacterized epidermal protease. Although proposed to regulate skin-barrier desquamation and recovery, the catalytic activity of KLK8 was never demonstrated in human epidermis, and its regulators and targets remain unknown. Herein, we elucidated for the first time KLK8 activity in human non-palmoplantar stratum corneum and sweat ex vivo. The majority of stratum corneum and sweat KLK8 was catalytically active, displaying optimal activity at pH 8.5 and considerable activity at pH 5. We also showed that KLK8 is a keratinocyte-specific protease, not secreted by human melanocytes or dermal fibroblasts. KLK8 secretion increased significantly upon calcium induction of terminal keratinocyte differentiation, suggesting an active role for this protease in upper epidermis. Potential activators, regulators, and targets of KLK8 activity were identified by in vitro kinetic assays using pro-KLK8 and mature KLK8 recombinant proteins produced in Pichia pastoris. Mature KLK8 activity was enhanced by calcium and magnesium ions and attenuated by zinc ions and by autocleavage after Arg(164). Upon screening KLK8 cleavage of a library of FRET-quenched peptides, trypsin-like specificity was observed with the highest preference for (R/K)(S/T)(A/V) at P1-P1'-P2'. We also demonstrated that KLK5 and lysyl endopeptidase activate latent pro-KLK8, whereas active KLK8 targets pro-KLK11, pro-KLK1, and LL-37 antimicrobial peptide activation in vitro. Together, our data identify KLK8 as a new active serine protease in human stratum corneum and sweat, and we propose regulators and targets that augment its involvement in a skin barrier proteolytic cascade. The implications of KLK8 elevation and hyperactivity in desquamatory and inflammatory skin disease conditions remain to be studied.	[Diamandis, Eleftherios P.] Mt Sinai Hosp, Joseph & Wolf Lebov Ctr, Dept Pathol & Lab Med, Toronto, ON M5T 3L9, Canada; [Eissa, Azza; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Smith, Christopher R.; Diamandis, Eleftherios P.] Univ Hlth Network, Dept Clin Biochem, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Diamandis, EP (corresponding author), Mt Sinai Hosp, Joseph & Wolf Lebov Ctr, Dept Pathol & Lab Med, 6th Fl,Rm 6-201,60 Murray St, Toronto, ON M5T 3L9, Canada.	ediamandis@mtsinai.on.ca		Diamandis, Eleftherios/0000-0002-1589-820X				Bernard D, 2003, J INVEST DERMATOL, V120, P592, DOI 10.1046/j.1523-1747.2003.12086.x; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Borgono CA, 2007, J BIOL CHEM, V282, P2405, DOI 10.1074/jbc.M608348200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Brattsand M, 2009, J INVEST DERMATOL, V129, P1656, DOI 10.1038/jid.2008.448; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Crew A, 2008, TALANTA, V75, P1221, DOI 10.1016/j.talanta.2008.01.043; Denda M, 1999, ARCH DERMATOL RES, V291, P560, DOI 10.1007/s004030050454; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; EGELRUD T, 1991, ARCH DERMATOL RES, V283, P108, DOI 10.1007/BF00371618; EGELRUD T, 1988, ACTA DERM-VENEREOL, V68, P93; Eissa A, 2008, BIOL CHEM, V389, P669, DOI 10.1515/BC.2008.079; Emami N, 2008, J BIOL CHEM, V283, P3031, DOI 10.1074/jbc.M707253200; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; Hachem JP, 2010, J INVEST DERMATOL, V130, P500, DOI 10.1038/jid.2009.249; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; HIBINO T, 1994, J INVEST DERMATOL, V102, P214, DOI 10.1111/1523-1747.ep12371765; Inoue N, 1998, J INVEST DERMATOL, V110, P923, DOI 10.1046/j.1523-1747.1998.00212.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Jayakumar A, 2005, ARCH BIOCHEM BIOPHYS, V435, P89, DOI 10.1016/j.abb.2004.12.012; Jayakumar A, 2004, PROTEIN EXPRES PURIF, V35, P93, DOI 10.1016/j.pep.2003.12.004; Kirihara T, 2003, BRIT J DERMATOL, V149, P700, DOI 10.1046/j.1365-2133.2003.05484.x; Kishi T, 2006, BIOL CHEM, V387, P723, DOI 10.1515/BC.2006.091; Kishibe M, 2007, J BIOL CHEM, V282, P5834, DOI 10.1074/jbc.M607998200; Kitayoshi H, 1999, ARCH DERMATOL RES, V291, P333, DOI 10.1007/s004030050418; Komatsu N, 2007, BRIT J DERMATOL, V156, P875, DOI 10.1111/j.1365-2133.2006.07743.x; Komatsu N, 2005, J INVEST DERMATOL, V125, P1182, DOI 10.1111/j.0022-202X.2005.23933.x; Komatsu N, 2005, BRIT J DERMATOL, V153, P274, DOI 10.1111/j.1365-2133.2005.06754.x; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Komatsu N, 2006, J INVEST DERMATOL, V126, P925, DOI 10.1038/sj.jid.5700146; Komatsu N, 2006, J INVEST DERMATOL, V126, P2338, DOI 10.1038/sj.jid.5700379; Kuwae K, 2002, J CLIN PATHOL-MOL PA, V55, P235, DOI 10.1136/mp.55.4.235; Lee PHA, 2005, P NATL ACAD SCI USA, V102, P3750, DOI 10.1073/pnas.0500268102; LUNDSTROM A, 1991, ACTA DERM-VENEREOL, V71, P471; LUNDSTROM A, 1994, ARCH DERMATOL RES, V286, P369, DOI 10.1007/BF00371795; Luo LY, 2006, BIOL CHEM, V387, P813, DOI 10.1515/BC.2006.103; Luo LY, 2006, CLIN CANCER RES, V12, P742, DOI 10.1158/1078-0432.CCR-05-1696; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; MENON GK, 1994, BRIT J DERMATOL, V130, P139, DOI 10.1111/j.1365-2133.1994.tb02892.x; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Milstone LM, 2004, J DERMATOL SCI, V36, P131, DOI 10.1016/j.jdermsci.2004.05.004; Murakami M, 2002, J INVEST DERMATOL, V119, P1090, DOI 10.1046/j.1523-1747.2002.19507.x; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; Nitzan YB, 2004, J HISTOCHEM CYTOCHEM, V52, P529, DOI 10.1177/002215540405200411; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Okabe A, 1996, BRAIN RES, V728, P116, DOI 10.1016/S0006-8993(96)00473-8; Stefansson K, 2006, BIOL CHEM, V387, P761, DOI 10.1515/BC.2006.095; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; Yoshida S, 1998, GENE, V213, P9, DOI 10.1016/S0378-1119(98)00232-7; Yousef GM, 2000, GENOMICS, V65, P184, DOI 10.1006/geno.2000.6159; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184	61	79	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					687	706		10.1074/jbc.M110.125310	http://dx.doi.org/10.1074/jbc.M110.125310			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20940292	Green Published, hybrid			2022-12-25	WOS:000285782800069
J	Wu, BH; Song, J; Beitz, E				Wu, Binghua; Song, Jie; Beitz, Eric			Novel Channel Enzyme Fusion Proteins Confer Arsenate Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; PLASMODIUM-FALCIPARUM; ARSENITE TRANSPORT; GENE ENCODES; REDUCTASE; DETOXIFICATION; BACTERIA; GLYCEROL; AQUAGLYCEROPORINS	Steady exposure to environmental arsenic has led to the evolution of vital cellular detoxification mechanisms. Under aerobic conditions, a two-step process appears most common among microorganisms involving reduction of predominant, oxidized arsenate ((H2AsO4-)-O-V/(HAsO42-)-O-V) to arsenite (As-III(OH)(3)) by a cytosolic enzyme (ArsC; Escherichia coli type arsenate reductase) and subsequent extrusion via ArsB (E. coli type arsenite transporter)/ACR3 (yeast type arsenite transporter). Here, we describe novel fusion proteins consisting of an aquaglyceroporin-derived arsenite channel with a C-terminal arsenate reductase domain of phosphotyrosine-phosphatase origin, providing transposable, single gene-encoded arsenate resistance. The fusion occurred in actinobacteria from soil, Frankia alni, and marine environments, Salinispora tropica; Mycobacterium tuberculosis encodes an analogous ACR3-ArsC fusion. Mutations rendered the aquaglyceroporin channel more polar resulting in lower glycerol permeability and enhanced arsenite selectivity. The arsenate reductase domain couples to thioredoxin and can complement arsenate-sensitive yeast strains. A second isoform with a nonfunctional channel may use the mycothiol/mycoredoxin cofactor pool. These channel enzymes constitute prototypes of a novel concept in metabolism in which a substrate is generated and compartmentalized by the same molecule. Immediate diffusion maintains the dynamic equilibrium and prevents toxic accumulation of metabolites in an energy-saving fashion.	[Beitz, Eric] Univ Kiel, Inst Pharmaceut, Dept Pharmaceut & Med Chem, D-24118 Kiel, Germany	University of Kiel	Beitz, E (corresponding author), Univ Kiel, Inst Pharmaceut, Dept Pharmaceut & Med Chem, Gutenbergstr 76, D-24118 Kiel, Germany.	ebeitz@pharmazie.uni-kiel.de			Deutsche Forschungsgemeinschaft [Be2253/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Be2253/3 (to E. B.).	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; ADAMSON SR, 1981, BIOCHEMISTRY-US, V20, P3418, DOI 10.1021/bi00515a018; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; Brachmann CB, 1998, YEAST, V14, P115; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Martin P, 2001, STRUCTURE, V9, P1071, DOI 10.1016/S0969-2126(01)00672-4; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; MOORE SA, 1983, J BIOL CHEM, V258, P6266; Mukhopadhyay R, 1998, FEMS MICROBIOL LETT, V168, P127, DOI 10.1016/S0378-1097(98)00430-3; Newby ZER, 2008, NAT STRUCT MOL BIOL, V15, P619, DOI 10.1038/nsmb.1431; Newton GL, 2008, ARCH MICROBIOL, V190, P547, DOI 10.1007/s00203-008-0405-3; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SCHAFER A, 1990, J BACTERIOL, V172, P1663, DOI 10.1128/jb.172.3.1663-1666.1990; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; TURNER AW, 1949, NATURE, V164, P76, DOI 10.1038/164076a0; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; Weber JH, 2004, CELL SIGNAL, V16, P115, DOI 10.1016/S0898-6568(03)00129-3; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x; Yang HC, 2005, J BACTERIOL, V187, P6991, DOI 10.1128/JB.187.20.6991-6997.2005; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	39	36	37	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40081	40087		10.1074/jbc.M110.184457	http://dx.doi.org/10.1074/jbc.M110.184457			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947511	Green Published, hybrid			2022-12-25	WOS:000285185500053
J	Zheng, YX; Brash, AR				Zheng, Yuxiang; Brash, Alan R.			Dioxygenase Activity of Epidermal Lipoxygenase-3 Unveiled TYPICAL AND ATYPICAL FEATURES OF ITS CATALYTIC ACTIVITY WITH NATURAL AND SYNTHETIC POLYUNSATURATED FATTY ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLENE OXIDE SYNTHASE; SOYBEAN LIPOXYGENASE-1; LINOLEIC-ACID; FATTY-ACIDS; RETICULOCYTE LIPOXYGENASE; HYDROPEROXIDE ISOMERASE; MANGANESE LIPOXYGENASE; PERMEABILITY BARRIER; MINI-LIPOXYGENASE; INDUCTION PERIOD	Epidermal lipoxygenase-3 (eLOX3) exhibits hydroperoxide isomerase activity implicated in epidermal barrier formation, but its potential dioxygenase activity has remained elusive. We identified herein a synthetic fatty acid, 9E,11Z,14Z-20:3 omega 6, that was oxygenated by eLOX3 specifically to the 9S-hydroperoxide. Reaction showed a pronounced lag phase, which suggested that eLOX3 is deficient in its activation step. Indeed, we found that high concentrations of hydroperoxide activator (e. g. 65 mu M) overcame a prolonged lag phase (> 1 h) and unveiled a dioxygenase activity with arachidonic acid; the main products were the 5-, 9-, and 7-hydroperoxyeicosatetraenoic acids (HPETEs). These were R/S mixtures (ranging from similar to 50:50 to 73:27), and as the bis-allylic 7-HPETE can be formed only inside the enzyme active site, the results indicate there is oxygen availability along either face of the reacting fatty acid radical. That the active site oxygen supply is limited is implied from the need for continuous re-activation, as carbon radical leakage leaves the enzyme in the unactivated ferrous state. An Ala-to-Gly mutation, known to affect the positioning of O-2 in the active site of other lipoxygenase enzymes, led to more readily activated reaction and a significant increase in the 9R-over the 5-HPETE. Activation and cycling of the ferric enzyme are thus promoted using the 9E,11Z,14Z-20:3 omega 6 substrate, by continuous hydroperoxide activation, or by the Ala-to-Gly mutation. We suggest that eLOX3 represents one end of a spectrum among lipoxygenases where activation is inefficient, favoring hydroperoxide isomerase cycling, with the opposite end represented by readily activated enzymes in which dioxygenase activity is prominent.	[Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, 23rd Ave S Pierce, Nashville, TN 37232 USA.	brash@vanderbilt.edu			National Institutes of Health [AR-051968]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR-051968 (to A. R. B.).	Andreou A, 2010, J BIOL CHEM, V285, P14178, DOI 10.1074/jbc.M109.094771; Andreou AZ, 2008, PHYTOCHEMISTRY, V69, P1832, DOI 10.1016/j.phytochem.2008.03.002; Axelrod B., 1981, METH ENZYMOL, V441, P451, DOI [10.1016/0076-6879(81)71055-3, DOI 10.1016/0076-6879(81)71055-3]; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; BRASH AR, 1989, ARCH BIOCHEM BIOPHYS, V273, P414, DOI 10.1016/0003-9861(89)90500-6; BRASH AR, 1995, ARCH BIOCHEM BIOPHYS, V321, P485, DOI 10.1006/abbi.1995.1421; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; BRASH AR, 1987, BIOCHEMISTRY-US, V26, P5465, DOI 10.1021/bi00391a038; Brash AR, 2000, LIPIDS, V35, P947, DOI 10.1007/s11745-000-0604-0; Butovich IA, 2001, BBA-PROTEIN STRUCT M, V1546, P379, DOI 10.1016/S0167-4838(01)00162-5; Clapp CH, 2006, BIOCHEMISTRY-US, V45, P15884, DOI 10.1021/bi0619425; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Cristea N, 2007, J LIPID RES, V48, P890, DOI 10.1194/jlr.M600505-JLR200; Cristea M, 2006, J BIOL CHEM, V281, P17612, DOI 10.1074/jbc.M510311200; DEGROOT JJM, 1975, BIOCHIM BIOPHYS ACTA, V377, P71, DOI 10.1016/0005-2744(75)90287-9; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; Furstenberger G, 2007, PROSTAG OTH LIPID M, V82, P128, DOI 10.1016/j.prostaglandins.2006.05.006; Fukushige H, 2005, J AGR FOOD CHEM, V53, P5691, DOI 10.1021/jf047958o; Gao XQ, 2008, PLANTA, V227, P491, DOI 10.1007/s00425-007-0634-8; GARSSEN GJ, 1971, BIOCHEM J, V122, P327, DOI 10.1042/bj1220327; Glickman MH, 1996, BIOCHEMISTRY-US, V35, P12882, DOI 10.1021/bi960985q; HAINING JL, 1958, J BIOL CHEM, V232, P193; Huang LS, 2006, ARCH BIOCHEM BIOPHYS, V455, P119, DOI 10.1016/j.abb.2006.09.015; Ivanov I, 2005, FEBS J, V272, P2523, DOI 10.1111/j.1742-4658.2005.04673.x; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; KEMAL C, 1987, BIOCHEMISTRY-US, V26, P7064, DOI 10.1021/bi00396a031; Kinzig A, 1999, GENOMICS, V58, P158, DOI 10.1006/geno.1999.5816; KRIEG P, 2010, 12 INT WINT EIC C MA; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; KUHN H, 1986, FEBS LETT, V203, P247, DOI 10.1016/0014-5793(86)80752-9; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Moran JL, 2007, J INVEST DERMATOL, V127, P1893, DOI 10.1038/sj.jid.5700825; NELSON MJ, 1988, BIOCHEMISTRY-US, V27, P4273, DOI 10.1021/bi00412a011; NUGTEREN DH, 1987, PROSTAGLANDINS, V33, P403, DOI 10.1016/0090-6980(87)90022-0; Perez-Gilabert M, 2005, J AGR FOOD CHEM, V53, P6140, DOI 10.1021/jf050521b; PISTORIUS EK, 1974, THESIS PURDUE U; Pratt DA, 2003, J AM CHEM SOC, V125, P5801, DOI 10.1021/ja034182j; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; SALZMANN U, 1984, BIOCHIM BIOPHYS ACTA, V795, P535, DOI 10.1016/0005-2760(84)90183-8; SCHILSTRA MJ, 1994, BIOCHEMISTRY-US, V33, P3974, DOI 10.1021/bi00179a025; SCHILSTRA MJ, 1993, BIOCHEMISTRY-US, V32, P7686, DOI 10.1021/bi00081a012; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Tallman KA, 2001, J AM CHEM SOC, V123, P11827, DOI 10.1021/ja0169724; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200; Zheng YX, 2010, J BIOL CHEM, V285, P39876, DOI 10.1074/jbc.M110.180794	52	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39866	39875		10.1074/jbc.M110.155374	http://dx.doi.org/10.1074/jbc.M110.155374			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20921226	Green Published, hybrid			2022-12-25	WOS:000285185500031
J	Chen, D; Gao, F; Li, B; Wang, HF; Xu, YX; Zhu, CQ; Wang, GH				Chen, Dong; Gao, Feng; Li, Bin; Wang, Hongfeng; Xu, Yuxia; Zhu, Cuiqing; Wang, Guanghui			Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE JUVENILE PARKINSONISM; DOPAMINE-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; DISEASE GENE-PRODUCT; LEWY-BODY FORMATION; PROTEIN LIGASE; CELL-DEATH; INDEPENDENT UBIQUITINATION; PC12 CELLS; MUTATIONS	Parkin is an E3 ubiquitin ligase that mediates the ubiquitination of protein substrates. The mutations in the parkin gene can lead to a loss of function of parkin and cause autosomal recessive juvenile onset parkinsonism. Recently, parkin was reported to be involved in the regulation of mitophagy. Here, we identify the Bcl-2, an anti-apoptotic and autophagy inhibitory protein, as a substrate for parkin. Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2. Overexpression of parkin, but not its ligase-deficient forms, decreases autophagy marker LC3 conversion, whereas knockdown of parkin increases LC3 II levels. In HeLa cells, a parkin-deficient cell line, knockdown of parkin does not change LC3 conversion. Moreover, overexpression of parkin enhances the interactions between Bcl-2 and Beclin 1. Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2.	[Chen, Dong; Gao, Feng; Li, Bin; Wang, Hongfeng; Wang, Guanghui] Chinese Acad Sci, Univ Sci & Technol China, Sch Life Sci, Lab Mol Neuropathol, Hefei 230027, Anhui, Peoples R China; [Chen, Dong; Gao, Feng; Li, Bin; Wang, Hongfeng; Wang, Guanghui] Chinese Acad Sci, Univ Sci & Technol China, Sch Life Sci, Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China; [Xu, Yuxia; Zhu, Cuiqing] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Fudan University	Wang, GH (corresponding author), Chinese Acad Sci, Univ Sci & Technol China, Sch Life Sci, Lab Mol Neuropathol, Hefei 230027, Anhui, Peoples R China.	wghui@ustc.edu.cn	Wang, Guanghui/U-3979-2017	Wang, Guanghui/0000-0001-8551-6468; Li, Bin/0000-0001-9341-4672	National Natural Sciences Foundation of China [30770664, 30970921]; National High-Tech Research and Development Program of China Project 973 [2006CB500703]; National High-Tech Research and Development Program of China Project 863 [2006AA02A408]; Chinese Academy of Sciences [KSCX2-YW-R138]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China Project 973(National Basic Research Program of China); National High-Tech Research and Development Program of China Project 863(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by National Natural Sciences Foundation of China Grants 30770664 and 30970921, National High-Tech Research and Development Program of China Project 973 Grant 2006CB500703 and Project 863 Grant 2006AA02A408, and Chinese Academy of Sciences Knowledge Innovation Project Grant KSCX2-YW-R138.	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Berger AK, 2009, HUM MOL GENET, V18, P4317, DOI 10.1093/hmg/ddp384; Casarejos MJ, 2009, J NEUROCHEM, V110, P1523, DOI 10.1111/j.1471-4159.2009.06248.x; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Huang Y, 2004, BRAIN RES REV, V46, P44, DOI 10.1016/j.brainresrev.2004.04.007; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Maruyama M, 2000, ANN NEUROL, V48, P245, DOI 10.1002/1531-8249(200008)48:2<245::AID-ANA15>3.0.CO;2-2; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nichols WC, 2002, J MED GENET, V39, P489, DOI 10.1136/jmg.39.7.489; Offen D, 1997, CELL MOL NEUROBIOL, V17, P289, DOI 10.1023/A:1026390201168; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pawlyk AC, 2003, J BIOL CHEM, V278, P48120, DOI 10.1074/jbc.M306889200; Periquet M, 2003, BRAIN, V126, P1271, DOI 10.1093/brain/awg136; Periquet M, 2001, AM J HUM GENET, V68, P617, DOI 10.1086/318791; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Ren Y, 2003, J NEUROSCI, V23, P3316; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Takai N, 1998, J NEUROSCI RES, V54, P214, DOI 10.1002/(SICI)1097-4547(19981015)54:2<214::AID-JNR9>3.0.CO;2-H; Um JW, 2006, J BIOL CHEM, V281, P3595, DOI 10.1074/jbc.M504994200; West A, 2002, AM J MED GENET, V114, P584, DOI 10.1002/ajmg.10525; West AB, 2004, HUM GENET, V114, P327, DOI 10.1007/s00439-003-1074-6; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	51	127	135	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38214	38223		10.1074/jbc.M110.101469	http://dx.doi.org/10.1074/jbc.M110.101469			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889974	Green Published, hybrid			2022-12-25	WOS:000284625600029
J	Kanu, N; Penicud, K; Hristova, M; Wong, B; Irvine, E; Plattner, F; Raivich, G; Behrens, A				Kanu, Nnennaya; Penicud, Kay; Hristova, Mariya; Wong, Barnaby; Irvine, Elaine; Plattner, Florian; Raivich, Gennadij; Behrens, Axel			The ATM Cofactor ATMIN Protects against Oxidative Stress and Accumulation of DNA Damage in the Aging Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELANGIECTASIA-LIKE DISORDER; CLASS-SWITCH RECOMBINATION; ATAXIA-TELANGIECTASIA; DEFICIENT MICE; SENESCENCE; FIBROBLASTS; ACTIVATION; OXYGEN; CELLS; GENE	Progressive accumulation of DNA damage is causally involved in cellular senescence and organismal aging. The DNA damage kinase ATM plays a central role in maintaining genomic stability. ATM mutations cause the genetic disorder ataxia telangiectasia, which is primarily characterized by progressive neurodegeneration and cancer susceptibility. Although the importance of ATM function to protect against oxidative DNA damage and during aging is well described, the mechanism of ATM activation by these stimuli is not known. Here we identify ATM interactor (ATMIN) as an essential component of the ATM signaling pathway in response to oxidative stress and aging. Embryos lacking ATMIN (atmin(Delta/Delta)) died in utero and showed increased numbers of cells positive for phosphorylated histone H2aX, indicative of increased DNA damage. atmin(Delta/Delta) mouse embryonic fibroblasts accumulated DNA damage and prematurely entered senescence when cultured at atmospheric oxygen levels (20%), but this defect was rescued by addition of an antioxidant and also by culturing cells at physiological oxygen levels (3%). In response to acute oxidative stress, atmin(Delta/Delta) mouse embryonic fibroblasts showed slightly lower levels of ATM phosphorylation and reduced ATM substrate phosphorylation. Conditional deletion of ATMIN in the murine nervous system (atmin(Delta N)) resulted in reduced numbers of dopaminergic neurons, as does ATM deficiency. ATM activity was observed in old, but not in young, control mice, but aging-induced ATM signaling was impaired by ATMIN deficiency. Consequently, old atmin(Delta N) mice showed accumulation of DNA damage in the cortex accompanied by gliosis, resulting in increased mortality of aging mutant mice. These results suggest that ATMIN mediates ATM activation by oxidative stress, and thereby ATMIN protects the aging brain by preventing accumulation of DNA damage.	[Behrens, Axel] Canc Res UK, Mammalian Genet Lab, London Res Inst, London WC2A 3Y, England; [Hristova, Mariya; Wong, Barnaby; Raivich, Gennadij] UCL, Perinatal Brain Repair Grp, Dept Obstet & Gynaecol, London WC1E 6HX, England; [Hristova, Mariya; Wong, Barnaby; Raivich, Gennadij] UCL, Dept Anat, London WC1E 6HX, England; [Irvine, Elaine] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Plattner, Florian] UCL, Inst Neurol, London WC1N 3BG, England	Cancer Research UK; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Behrens, A (corresponding author), Canc Res UK, Mammalian Genet Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3Y, England.	axel.behrens@cancer.org.uk	Raivich, Gennadij/A-6770-2011; Raivich, Gennadij/AAL-7229-2021	Irvine, Elaine/0000-0001-5508-8140; Plattner, Florian/0000-0002-3150-1866; Behrens, Axel/0000-0002-1557-1143	London Research Institute from Cancer Research UK	London Research Institute from Cancer Research UK	This work was supported by a grant from The London Research Institute from Cancer Research UK.	Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Boder E, 1985, Kroc Found Ser, V19, P1; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dulic V, 2000, MOL CELL BIOL, V20, P6741, DOI 10.1128/MCB.20.18.6741-6754.2000; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Eilam R, 1998, P NATL ACAD SCI USA, V95, P12653, DOI 10.1073/pnas.95.21.12653; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; FARAGHER RGA, 1993, P NATL ACAD SCI USA, V90, P12030, DOI 10.1073/pnas.90.24.12030; FARRINGTON JA, 1973, BIOCHIM BIOPHYS ACTA, V314, P372, DOI 10.1016/0005-2728(73)90121-7; Frappart PO, 2006, NEUROMOL MED, V8, P495, DOI 10.1385/NMM:8:4:495; Grimes A, 2009, CANCER RES TREAT, V41, P187, DOI 10.4143/crt.2009.41.4.187; Kamsler A, 2001, CANCER RES, V61, P1849; Kanu N, 2008, CELL CYCLE, V7, P3483, DOI 10.4161/cc.7.22.7044; Kanu N, 2007, EMBO J, V26, P2933, DOI 10.1038/sj.emboj.7601733; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Liu N, 2005, LAB INVEST, V85, P1471, DOI 10.1038/labinvest.3700354; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Panda S, 2008, MECH AGEING DEV, V129, P332, DOI 10.1016/j.mad.2008.02.014; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Peng J, 2009, FREE RADICAL BIO MED, V46, P312, DOI 10.1016/j.freeradbiomed.2008.10.045; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reliene R, 2007, J NUTR, V137, p229S, DOI 10.1093/jn/137.1.229S; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SHILOH Y, 1982, EXP CELL RES, V140, P191, DOI 10.1016/0014-4827(82)90169-0; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	49	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38534	38542		10.1074/jbc.M110.145896	http://dx.doi.org/10.1074/jbc.M110.145896			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889973	hybrid, Green Published			2022-12-25	WOS:000284625600059
J	Kumar, B; Kim, YC; DeMartino, GN				Kumar, Brajesh; Kim, Young-Chan; DeMartino, George N.			The C Terminus of Rpt3, an ATPase Subunit of PA700 (19 S) Regulatory Complex, Is Essential for 26 S Proteasome Assembly but Not for Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; SUBSTRATE ENTRY; CORE PARTICLE; AAA SUBUNITS; DEGRADATION; PATHWAY; BINDING; ROLES; GATE; POLYUBIQUITIN	PA700, the 19 S regulatory subcomplex of the 26 S proteasome, contains a heterohexameric ring of AAA subunits (Rpt1 to -6) that forms the binding interface with a heteroheptameric ring of alpha subunits (alpha 1 to -7) of the 20 S proteasome. Binding of these subcomplexes is mediated by interactions of C termini of certain Rpt subunits with cognate binding sites on the 20 S proteasome. Binding of two Rpt subunits (Rpt2 and Rpt5) depends on their last three residues, which share an HbYX motif (where Hb is a hydrophobic amino acid) and open substrate access gates in the center of the alpha ring. The relative roles of other Rpt subunits for proteasome binding and activation remain poorly understood. Here we demonstrate that the C-terminal HbYX motif of Rpt3 binds to the 20 S proteasome but does not promote proteasome gating. Binding requires the last three residues and occurs at a dedicated site on the proteasome. A C-terminal peptide of Rpt3 blocked ATP-dependent in vitro assembly of 26 S proteasome from PA700 and 20 S proteasome. In HEK293 cells, wild-type Rpt3, but not Rpt3 lacking the HbYX motif was incorporated into 26 S proteasome. These results indicate that the C terminus of Rpt3 was required for cellular assembly of this subunit into 26 S proteasome. Mutant Rpt3 was assembled into intact PA700. This result indicates that intact PA700 can be assembled independently of association with 20 S proteasome and thus may be a direct precursor for 26 S proteasome assembly under normal conditions. These results provide new insights to the non-equivalent roles of Rpt subunits in 26 S proteasome function and identify specific roles for Rpt3.	[Kumar, Brajesh; Kim, Young-Chan; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	george.demartino@utsouthwestern.edu			National Institutes of Health [R01 DK46181]; Welch Foundation [I-500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK46181. This work was also supported by Welch Foundation Grant I-500 (to G. N. D.).	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foerster F, 2010, MOL CELL PROTEOMICS, V9, P1666, DOI 10.1074/mcp.R000002-MCP201; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Groll M, 2003, CURR OPIN STRUC BIOL, V13, P665, DOI 10.1016/j.sbi.2003.10.005; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hendil KB, 2009, J MOL BIOL, V394, P320, DOI 10.1016/j.jmb.2009.09.038; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Nickell S, 2007, BIOCHEM BIOPH RES CO, V353, P115, DOI 10.1016/j.bbrc.2006.11.141; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; PUHLER G, 1992, EMBO J, V11, P1607, DOI 10.1002/j.1460-2075.1992.tb05206.x; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	51	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39523	39535		10.1074/jbc.M110.153627	http://dx.doi.org/10.1074/jbc.M110.153627			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937828	hybrid, Green Published			2022-12-25	WOS:000284941300078
J	Sun, YM; Fei, T; Yang, T; Zhang, F; Chen, YG; Li, HS; Xu, ZH				Sun, Yiming; Fei, Teng; Yang, Tao; Zhang, Feng; Chen, Ye-Guang; Li, Huashun; Xu, Zhiheng			The Suppression of CRMP2 Expression by Bone Morphogenetic Protein (BMP)-SMAD Gradient Signaling Controls Multiple Stages of Neuronal Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; CELL-MIGRATION; GENE-TRANSFER; BRAIN; PHOSPHORYLATION; DPYSL2; GROWTH; ELECTROPORATION; SCHIZOPHRENIA	The formation of the functional mammalian cerebral cortex requires a concerted control of neurogenesis, neuronal migration, and neuronal morphogenesis. However, molecular mechanisms that control these processes are not well understood. We have found that the BMP signaling downstream transcription factor SMAD1 and CRMP2 (collapsin response mediator protein-2) are inversely and complementarily expressed in the developing neocortex. BMPs can suppress CRMP2 expression in cortical cells. Our ChIP assay demonstrates that both SMAD1 and -4 bind to CRMP2 promoter in the neocortex, and overexpression of SMAD1 and 4 in vivo suppresses CRMP2 expression. RNA interference of CRMP2 and overexpression of dominant negative forms of CRMP2 in utero cause accumulation of multipolar cells in the ventricular, subventricular, and intermediate zones and suppresses neurite outgrowth, suggesting that CRMP2 is required for multipolar to bipolar transition for directional neuronal migration and neurite outgrowth. Thus, our study reveals a novel mechanism that the BMP-SMAD signaling pathway controls neuronal migration and neurite outgrowth by suppressing the transcription of CRMP2.	[Sun, Yiming; Yang, Tao; Zhang, Feng; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Fei, Teng; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Li, Huashun] Sichuan Univ, W China Womens & Childrens Hosp, Dev & Stem Cell Inst, Chengdu 610041, Sichuan, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Tsinghua University; Sichuan University	Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, 1 W Beichen Rd, Beijing 100101, Peoples R China.	zhxu@genetics.ac.cn	Yang, T/AFR-6763-2022; Chen, Ye-Guang/L-6998-2019; Fei, Teng/G-5324-2015; Fei, Teng/A-5963-2010	Fei, Teng/0000-0001-5707-0673; Xu, Zhiheng/0000-0002-4809-2851; Zhang, Feng/0000-0003-2887-8184; FEI, TENG/0000-0001-9620-0450	MOST (Ministry of Science and Technology) of China [2007CB947202, 2006CB500701, 2006AA02Z173, 2009DFA32450, 2009R0002]; NSF (China) [30725007, 30670663]; Chinese Academy of Sciences [KSCX1-YW-R-62/84]; National Natural Science Foundation of China [30725007, 30670663, 30921004]	MOST (Ministry of Science and Technology) of China(Ministry of Science and Technology, China); NSF (China)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from MOST of China, "973" program (2007CB947202 and 2006CB500701), "863" program (2006AA02Z173, 2009DFA32450, and 2009R0002); NSF (China) (30725007 and 30670663); and the Chinese Academy of Sciences (Bairen plan and KSCX1-YW-R-62/84). This work also was supported in part by grants from MOST (Ministry of Science and Technology) of China, "973" program (2007CB947202 and 2006CBS00701), "863" program (2006AA02Z173, 2009DFA32450, and 2009R0002); National Natural Science Foundation of China (30725007, 30670663 and 30921004); and the Chinese Academy of Sciences (Bairen plan and KSCX1-YW-R-62/84).	Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Indraswari F, 2009, NEUROCHEM INT, V55, P235, DOI 10.1016/j.neuint.2009.03.005; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Koide T, 2010, J HUM GENET, V55, P469, DOI 10.1038/jhg.2010.38; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Soutar MPM, 2009, CURR ALZHEIMER RES, V6, P269, DOI 10.2174/156720509788486572; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takata K, 2009, AM J PATHOL, V175, P17, DOI 10.2353/ajpath.2009.080908; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yoshimura T, 2006, ANN NY ACAD SCI, V1086, P116, DOI 10.1196/annals.1377.013; Zhao XZ, 2006, INT J NEUROPSYCHOPH, V9, P705, DOI 10.1017/S1461145705006267	34	43	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39039	39050		10.1074/jbc.M110.168351	http://dx.doi.org/10.1074/jbc.M110.168351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926379	Green Published, hybrid			2022-12-25	WOS:000284941300034
J	Helmerhorst, EJ; Zamakhchari, M; Schuppan, D; Oppenheim, FG				Helmerhorst, Eva J.; Zamakhchari, Maram; Schuppan, Detlef; Oppenheim, Frank G.			Discovery of a Novel and Rich Source of Gluten-Degrading Microbial Enzymes in the Oral Cavity	PLOS ONE			English	Article							CELIAC-DISEASE; PROLYL ENDOPEPTIDASES; GLIADIN PEPTIDES; SPRUE; TRANSGLUTAMINASE; IDENTIFICATION; DIVERSITY; PROTEASES; EPITOPES; THERAPY	Background: Celiac disease is a T cell mediated-inflammatory enteropathy caused by the ingestion of gluten in genetically predisposed individuals carrying HLA-DQ2 or HLA-DQ8. The immunogenic gliadin epitopes, containing multiple glutamine and proline residues, are largely resistant to degradation by gastric and intestinal proteases. Salivary microorganisms however exhibit glutamine endoprotease activity, discovered towards glutamine-and proline-rich salivary proteins. The aim was to explore if gliadins can serve as substrates for oral microbial enzymes. Methodology/Principal Findings: Proteolytic activity in suspended dental plaque was studied towards a) gliadin-derived paranitroanilide(pNA)-linked synthetic enzyme substrates b) a mixture of natural gliadins and c) synthetic highly immunogenic gliadin peptides (33-mer of alpha 2-gliadin and 26-mer of gamma-gliadin). In addition, gliadin zymography was conducted to obtain the approximate molecular weights and pH activity profiles of the gliadin-degrading oral enzymes and liquid iso-electric focusing was performed to establish overall enzyme iso-electric points. Plaque bacteria efficiently hydrolyzed Z-YPQ-pNA, Z-QQP-pNA, Z-PPF-pNA and Z-PFP-pNA, with Z-YPQ-pNA being most rapidly cleaved. Gliadin immunogenic domains were extensively degraded in the presence of oral bacteria. Gliadin zymography revealed that prominent enzymes exhibit molecular weights > 70 kD and are active over a broad pH range from 3 to 10. Liquid iso-electric focusing indicated that most gliadin-degrading enzymes are acidic in nature with iso-electric points between 2.5 and 4.0. Conclusions/Significance: This is the first reported evidence for gluten-degrading microorganisms associated with the upper gastro-intestinal tract. Such microorganisms may play a hitherto unappreciated role in the digestion of dietary gluten and thus protection from celiac disease in subjects at risk.	[Helmerhorst, Eva J.; Zamakhchari, Maram; Oppenheim, Frank G.] Boston Univ, Henry M Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA; [Schuppan, Detlef] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Helmerhorst, EJ (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA.	helmer@bu.edu		Helmerhorst, Eva/0000-0002-4803-3018	National Institutes of Health [AI087803, DE18132, DK073254, AI078385, DE05672, DE7652]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078385, R01AI087803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005672, R01DE005672, F31DE005672, R21DE018132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health: AI087803 (EJH), DE18132 (EJH), DK073254 (DS), AI078385 (DS) DE05672 (FO) and DE7652 (FO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; ABE T, 1977, BIOCHEMISTRY-US, V16, P5495, DOI 10.1021/bi00644a016; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Biagi F, 2001, EUR J GASTROEN HEPAT, V13, P561, DOI 10.1097/00042737-200105000-00016; Camp JG, 2009, GASTROENTEROLOGY, V136, P1989, DOI 10.1053/j.gastro.2009.02.075; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; DeSesso JM, 2001, FOOD CHEM TOXICOL, V39, P209, DOI 10.1016/S0278-6915(00)00136-8; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fleckenstein B, 2004, J BIOL CHEM, V279, P17607, DOI 10.1074/jbc.M310198200; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gass J, 2007, CELL MOL LIFE SCI, V64, P345, DOI 10.1007/s00018-006-6317-y; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Hausch F, 2002, AM J PHYSIOL-GASTR L, V283, pG996, DOI 10.1152/ajpgi.00136.2002; Helmerhorst EJ, 2008, J BIOL CHEM, V283, P19957, DOI 10.1074/jbc.M708282200; Jabri B, 2006, NAT CLIN PRACT GASTR, V3, P516, DOI 10.1038/ncpgasthep0582; Koning F, 2005, BEST PRACT RES CL GA, V19, P373, DOI 10.1016/j.bpg.2005.02.003; Koning F, 2003, J MOL RECOGNIT, V16, P333, DOI 10.1002/jmr.641; Koning F, 2003, SCIENCE, V299, P513, DOI 10.1126/science.299.5606.513; LAMKIN MS, 1993, CRIT REV ORAL BIOL M, V4, P251, DOI 10.1177/10454411930040030101; MAEDA N, 1985, J BIOL CHEM, V260, P1123; Messana I, 2008, MOL CELL PROTEOMICS, V7, P911, DOI 10.1074/mcp.M700501-MCP200; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Shan L, 2005, J PROTEOME RES, V4, P1732, DOI 10.1021/pr050173t; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2006, CHEM BIOL, V13, P649, DOI 10.1016/j.chembiol.2006.04.009; Stenman SM, 2009, ANN MED, V41, P390, DOI 10.1080/07853890902878138; Stepniak D, 2006, AM J PHYSIOL-GASTR L, V291, pG621, DOI 10.1152/ajpgi.00034.2006; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Troncone R, 2008, CURR OPIN CLIN NUTR, V11, P329, DOI 10.1097/MCO.0b013e3282f795f8; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	35	65	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13264	10.1371/journal.pone.0013264	http://dx.doi.org/10.1371/journal.pone.0013264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948997	Green Published, gold			2022-12-25	WOS:000282748100013
J	Pan, J; Zhang, Q; Wang, YA; You, M				Pan, Jing; Zhang, Qi; Wang, Yian; You, Ming			26S Proteasome Activity Is Down-Regulated in Lung Cancer Stem-Like Cells Propagated In Vitro	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; SIDE POPULATION CELLS; BETA-CATENIN; PROSPECTIVE IDENTIFICATION; VIVO; DIFFERENTIATION; TUMORS; EXPRESSION; RESISTANCE; PHENOTYPE	Cancer stem cells (CSCs) are a small subset of cancer cells capable of self-renewal and tumor maintenance. Eradicating cancer stem cells, the root of tumor origin and recurrence, has emerged as one promising approach to improve lung cancer survival. Cancer stem cells are reported to reside in the side population (SP) of cultured lung cancer cells. We report here the coexistence of a distinct population of non-SP (NSP) cells that have equivalent self-renewal capacity compared to SP cells in a lung tumor sphere assay. Compared with the corresponding cells in monolayer cultures, lung tumor spheres, formed from human non-small cell lung carcinoma cell lines A549 or H1299, showed marked morphologic differences and increased expression of the stem cell markers CD133 and OCT3/4. Lung tumor spheres also exhibited increased tumorigenic potential as only 10,000 lung tumor sphere cells were required to produce xenografts tumors in nude mice, whereas the same number of monolayer cells failed to induce tumors. We also demonstrate that lung tumor spheres showed decreased 26S proteasome activity compared to monolayer. By using the ZsGreen-cODC (C-terminal sequence that directs degradation of Ornithine Decarboxylase) reporter assay in NSCLC cell lines, only less than 1% monolayer cultures were ZsGreen positive indicating low 26S proteasome, whereas lung tumor sphere showed increased numbers of ZsGreen-positive cells, suggesting the enrichment of CSCs in sphere cultures.	[Pan, Jing; Zhang, Qi; Wang, Yian; You, Ming] Washington Univ, Sch Med, Dept Surg, Siteman Canc Ctr, St Louis, MO 63110 USA	Siteman Cancer Center; Washington University (WUSTL)	Pan, J (corresponding author), Washington Univ, Sch Med, Dept Surg, Siteman Canc Ctr, St Louis, MO 63110 USA.	youm@wudosis.wustl.edu			NIH [R01CA134682]; NATIONAL CANCER INSTITUTE [R01CA134682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by NIH grant R01CA134682. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Eaker Shannon S, 2004, Methods Mol Biol, V263, P161; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Fekete MR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-114; Ferrandina G, 2008, INT J GYNECOL CANCER, V18, P506, DOI 10.1111/j.1525-1438.2007.01056.x; Gebb SA, 2000, DEV DYNAM, V217, P159, DOI 10.1002/(SICI)1097-0177(200002)217:2<159::AID-DVDY3>3.0.CO;2-9; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hosford GE, 2003, AM J PHYSIOL-LUNG C, V285, pL161, DOI 10.1152/ajplung.00285.2002; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kraft HJ, 1996, J BIOL CHEM, V271, P12873, DOI 10.1074/jbc.271.22.12873; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Morita Y, 2006, BLOOD, V108, P2850, DOI 10.1182/blood-2006-03-010207; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Platet N, 2007, FEBS LETT, V581, P1435, DOI 10.1016/j.febslet.2007.02.071; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prasad A, 2008, J BIOL CHEM, V283, P26624, DOI 10.1074/jbc.M800679200; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Semba S, 2000, ENDOCR PATHOL, V11, P243, DOI 10.1385/EP:11:3:243; Singh SK, 2003, CANCER RES, V63, P5821; Srivastava VK, 2008, CYTOM PART A, V73A, P940, DOI 10.1002/cyto.a.20633; Tilignac T, 2002, CANCER RES, V62, P2771; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; White MJ, 1996, J NEUROSCI METH, V70, P195, DOI 10.1016/S0165-0270(96)00118-5; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999	39	54	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13298	10.1371/journal.pone.0013298	http://dx.doi.org/10.1371/journal.pone.0013298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949018	Green Published, Green Submitted, gold			2022-12-25	WOS:000282748100024
J	Dessing, JC; Craig, CM				Dessing, Joost C.; Craig, Cathy M.			Bending It Like Beckham: How to Visually Fool the Goalkeeper	PLOS ONE			English	Article							TARGET MOTION; MANUAL INTERCEPTIONS; ARM MOVEMENTS; AREA MT; ACCELERATION; MODEL; SPEED; BALL; PERCEPTION; OCCLUSION	Background: As bending free-kicks becomes the norm in modern day soccer, implications for goalkeepers have largely been ignored. Although it has been reported that poor sensitivity to visual acceleration makes it harder for expert goalkeepers to perceptually judge where the curved free-kicks will cross the goal line, it is unknown how this affects the goalkeeper's actual movements. Methodology/Principal Findings: Here, an in-depth analysis of goalkeepers' hand movements in immersive, interactive virtual reality shows that they do not fully account for spin-induced lateral ball acceleration. Hand movements were found to be biased in the direction of initial ball heading, and for curved free-kicks this resulted in biases in a direction opposite to those necessary to save the free-kick. These movement errors result in less time to cover a now greater distance to stop the ball entering the goal. These and other details of the interceptive behaviour are explained using a simple mathematical model which shows how the goalkeeper controls his movements online with respect to the ball's current heading direction. Furthermore our results and model suggest how visual landmarks, such as the goalposts in this instance, may constrain the extent of the movement biases. Conclusions: While it has previously been shown that humans can internalize the effects of gravitational acceleration, these results show that it is much more difficult for goalkeepers to account for spin-induced visual acceleration, which varies from situation to situation. The limited sensitivity of the human visual system for detecting acceleration, suggests that curved free-kicks are an important goal-scoring opportunity in the game of soccer.	[Dessing, Joost C.] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Dessing, Joost C.] Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, Amsterdam, Netherlands; [Dessing, Joost C.] York Univ, Canadian Act & Percept Network CAPnet, Toronto, ON M3J 2R7, Canada; [Craig, Cathy M.] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	York University - Canada; Vrije Universiteit Amsterdam; York University - Canada; Queens University Belfast	Dessing, JC (corresponding author), York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada.	joost@yorku.ca	Craig, Cathy/D-9833-2014	Craig, Cathy/0000-0001-5509-1120	Netherlands Organization for Scientific Research (NWO) [451-05-016]; Starting Independent Researchers [210007-TEMPUS_G]; European Research Council	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Starting Independent Researchers; European Research Council(European Research Council (ERC)European Commission)	Research supported by grant 451-05-016 (Veni) of the Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl), awarded to Joost C. Dessing, and a Starting Independent Researchers grant 210007-TEMPUS_G awarded to Cathy M. Craig by the European Research Council (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABLER TG, 1993, J EXP PSYCHOL HUMAN, V19, P15, DOI 10.1037/0096-1523.19.1.15; Bennett SJ, 2007, J NEUROPHYSIOL, V98, P1405, DOI 10.1152/jn.00132.2007; Bray Y, 2003, J SPORT SCI, V21, P75, DOI 10.1080/0264041031000070994; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; Bullock D, 1998, CEREB CORTEX, V8, P48, DOI 10.1093/cercor/8.1.48; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Craig CM, 2009, ATTEN PERCEPT PSYCHO, V71, P515, DOI 10.3758/APP.71.3.515; Craig CM, 2006, NATURWISSENSCHAFTEN, V93, P97, DOI 10.1007/s00114-005-0071-0; Dessing JC, 2005, J COGNITIVE NEUROSCI, V17, P668, DOI 10.1162/0898929053467604; Dessing JC, 2004, BIOL CYBERN, V91, P377, DOI 10.1007/s00422-004-0520-4; Dessing JC, 2002, NEURAL NETWORKS, V15, P163, DOI 10.1016/S0893-6080(01)00136-8; Dessing JC, 2009, EXP BRAIN RES, V192, P669, DOI 10.1007/s00221-008-1588-1; GOTTSDANKER RM, 1956, PSYCHOL BULL, V53, P477, DOI 10.1037/h0045160; Lisberger SG, 1999, J NEUROSCI, V19, P2224; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MCBEATH MK, 1990, PERCEPTION, V19, P545, DOI 10.1068/p190545; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Montagne G, 1999, EXP BRAIN RES, V129, P87, DOI 10.1007/s002210050939; Mrotek LA, 2007, EXP BRAIN RES, V178, P99, DOI 10.1007/s00221-006-0717-y; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; Price NSC, 2005, J NEUROPHYSIOL, V94, P3451, DOI 10.1152/jn.00564.2005; ROSENBAUM DA, 1975, J EXP PSYCHOL HUMAN, V1, P395, DOI 10.1037/0096-1523.1.4.395; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; SAVELSBERGH GJP, 1991, J EXP PSYCHOL HUMAN, V17, P315, DOI 10.1037/0096-1523.17.2.315; Schlack A, 2007, J NEUROSCI, V27, P11009, DOI 10.1523/JNEUROSCI.3165-07.2007; SCHMERLER J, 1976, PERCEPTION, V5, P167, DOI 10.1068/p050167; SMITH J, 2010, 11 INT WORKSH EC PSY; Tarr MJ, 2002, NAT NEUROSCI, V5, P1089, DOI 10.1038/nn948; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003	30	50	50	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13161	10.1371/journal.pone.0013161	http://dx.doi.org/10.1371/journal.pone.0013161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	659LQ	20949130	gold, Green Published, Green Submitted			2022-12-25	WOS:000282568400006
J	Wang, D; Qiu, CX; Zhang, HJ; Wang, JA; Cui, QH; Yin, YX				Wang, Dong; Qiu, Chengxiang; Zhang, Haijun; Wang, Juan; Cui, Qinghua; Yin, Yuxin			Human MicroRNA Oncogenes and Tumor Suppressors Show Significantly Different Biological Patterns: From Functions to Targets	PLOS ONE			English	Article							CELL-DEATH; C-ELEGANS; EVOLUTION; CANCER; DATABASE; SITES; APOPTOSIS; MIRNAS; LIN-14; GENES	MicroRNAs (miRNAs) are small noncoding RNAs which play essential roles in many important biological processes. Therefore, their dysfunction is associated with a variety of human diseases, including cancer. Increasing evidence shows that miRNAs can act as oncogenes or tumor suppressors, and although there is great interest in research into these cancer-associated miRNAs, little is known about them. In this study, we performed a comprehensive analysis of putative human miRNA oncogenes and tumor suppressors. We found that miRNA oncogenes and tumor suppressors clearly show different patterns in function, evolutionary rate, expression, chromosome distribution, molecule size, free energy, transcription factors, and targets. For example, miRNA oncogenes are located mainly in the amplified regions in human cancers, whereas miRNA tumor suppressors are located mainly in the deleted regions. miRNA oncogenes tend to cleave target mRNAs more frequently than miRNA tumor suppressors. These results indicate that these two types of cancer-associated miRNAs play different roles in cancer formation and development. Moreover, the patterns identified here can discriminate novel miRNA oncogenes and tumor suppressors with a high degree of accuracy. This study represents the first large-scale bioinformatic analysis of human miRNA oncogenes and tumor suppressors. Our findings provide help for not only understanding of miRNAs in cancer but also for the specific identification of novel miRNAs as miRNA oncogenes and tumor suppressors. In addition, the data presented in this study will be valuable for the study of both miRNAs and cancer.	[Wang, Dong; Qiu, Chengxiang; Zhang, Haijun; Wang, Juan; Cui, Qinghua] Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China; [Wang, Dong; Qiu, Chengxiang; Zhang, Haijun; Wang, Juan; Cui, Qinghua; Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Beijing 100871, Peoples R China; [Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Wang, D (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yinyuxin@hsc.pku.edu.cn	Qiu, Chengxiang/X-5040-2019	Qiu, Chengxiang/0000-0002-6346-8669	Natural Science Foundation of China [30900829]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant No. 30900829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babbitt CC, 2007, CELL, V131, P225, DOI 10.1016/j.cell.2007.10.001; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Davis JC, 2004, PLOS BIOL, V2, P318, DOI 10.1371/journal.pbio.0020055; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Taccioli C, 2009, NUCLEIC ACIDS RES, V37, pD41, DOI 10.1093/nar/gkn702; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; ZHANG Q, 2008, NATURE P, P1; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhou T, 2008, J MOL EVOL, V66, P395, DOI 10.1007/s00239-008-9094-4	49	119	126	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13067	10.1371/journal.pone.0013067	http://dx.doi.org/10.1371/journal.pone.0013067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927335	Green Published, Green Submitted, gold			2022-12-25	WOS:000282312600016
J	Bottley, A; Phillips, NM; Webb, TE; Willis, AE; Spriggs, KA				Bottley, Andrew; Phillips, Nicola M.; Webb, Thomas E.; Willis, Anne E.; Spriggs, Keith A.			eIF4A Inhibition Allows Translational Regulation of mRNAs Encoding Proteins Involved in Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MILD COGNITIVE IMPAIRMENT; RIBOSOMAL ENTRY SITE; OXIDATIVE STRESS; A-BETA; DIFFERENTIAL-DISPLAY; GENE-EXPRESSION; TRANSGENIC MICE; CELL-CYCLE; INITIATION	Alzheimer's disease (AD) is the main cause of dementia in our increasingly aging population. The debilitating cognitive and behavioral symptoms characteristic of AD make it an extremely distressing illness for patients and carers. Although drugs have been developed to treat AD symptoms and to slow disease progression, there is currently no cure. The incidence of AD is predicted to increase to over one hundred million by 2050, placing a heavy burden on communities and economies, and making the development of effective therapies an urgent priority. Two proteins are thought to have major contributory roles in AD: the microtubule associated protein tau, also known as MAPT; and the amyloid-beta peptide (A-beta), a cleavage product of amyloid precursor protein (APP). Oxidative stress is also implicated in AD pathology from an early stage. By targeting eIF4A, an RNA helicase involved in translation initiation, the synthesis of APP and tau, but not neuroprotective proteins, can be simultaneously and specifically reduced, representing a novel avenue for AD intervention. We also show that protection from oxidative stress is increased upon eIF4A inhibition. We demonstrate that the reduction of these proteins is not due to changes in mRNA levels or increased protein degradation, but is a consequence of translational repression conferred by inhibition of the helicase activity of eIF4A. Inhibition of eIF4A selectively and simultaneously modulates the synthesis of proteins involved in Alzheimer's disease: reducing A-beta and tau synthesis, while increasing proteins predicted to be neuroprotective.	[Bottley, Andrew; Phillips, Nicola M.; Webb, Thomas E.; Willis, Anne E.; Spriggs, Keith A.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England	University of Nottingham	Bottley, A (corresponding author), Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.	keith.spriggs@nottingham.ac.uk		Willis, Anne/0000-0002-1470-8531; Webb, Thomas/0000-0003-4660-2341	Biotechnology and Biological Sciences Research Council, UK [BB/F006926/1]; School of Pharmacy, University of Nottingham, UK; BBSRC [BB/F006926/1, BB/F02326X/2] Funding Source: UKRI; MRC [MC_UP_A600_1023] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F006926/1, BB/F02326X/2] Funding Source: researchfish; Medical Research Council [MC_UP_A600_1023] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); School of Pharmacy, University of Nottingham, UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biotechnology and Biological Sciences Research Council, UK (BB/F006926/1) and the School of Pharmacy, University of Nottingham, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Akterin S, 2006, CELL DEATH DIFFER, V13, P1454, DOI 10.1038/sj.cdd.4401818; An J, 2005, PROTEOMICS, V5, P1656, DOI 10.1002/pmic.200401049; Beaudoin ME, 2008, NUCLEIC ACIDS RES, V36, P6835, DOI 10.1093/nar/gkn792; Biran Y, 2009, J CELL MOL MED, V13, P61, DOI 10.1111/j.1582-4934.2008.00595.x; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Brink TC, 2009, BIOGERONTOLOGY, V10, P549, DOI 10.1007/s10522-008-9197-8; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Butterfield DA, 2002, J ALZHEIMERS DIS, V4, P193, DOI 10.3233/JAD-2002-4309; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Celsi F, 2004, NEUROCHEM INT, V44, P25, DOI 10.1016/S0197-0186(03)00101-3; Daga RR, 1999, J CELL SCI, V112, P3137; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; Fukao A, 2009, MOL CELL, V36, P1007, DOI 10.1016/j.molcel.2009.11.013; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Harris SE, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-43; Haugabook SJ, 2001, FASEB J, V15, P16; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jin H, 2006, MOL CANCER THER, V5, P1041, DOI 10.1158/1535-7163.MCT-05-0433; Lahiri DK, 2005, FASEB J, V19, P653, DOI 10.1096/fj.04-2900fje; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li QY, 1999, MOL CELL BIOL, V19, P7336; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lovell MA, 2007, J NEUROSCI RES, V85, P3036, DOI 10.1002/jnr.21346; Masutani H, 2004, MOL NEUROBIOL, V29, P229, DOI 10.1385/MN:29:3:229; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Morel M, 2009, J CELL MOL MED, V13, P1476, DOI 10.1111/j.1582-4934.2009.00849.x; Morgan R, 1997, DEVELOPMENT, V124, P2751; Morse LJ, 2004, J MOL NEUROSCI, V24, P129, DOI 10.1385/JMN:24:1:129; Mus E, 2007, P NATL ACAD SCI USA, V104, P10679, DOI 10.1073/pnas.0701532104; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Payton S, 2003, J MOL NEUROSCI, V20, P267, DOI 10.1385/JMN:20:3:267; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Resende R, 2008, J NEUROSCI RES, V86, P2091, DOI 10.1002/jnr.21648; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rogers JT, 2002, J MOL NEUROSCI, V19, P77, DOI 10.1007/s12031-002-0014-6; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Svitkin YV, 2001, RNA, V7, P1743; Turner BJ, 2004, NEUROCHEM RES, V29, P2281, DOI 10.1007/s11064-004-7037-z; van Marum RJ, 2008, FUND CLIN PHARMACOL, V22, P265, DOI 10.1111/j.1472-8206.2008.00578.x; Veo BL, 2009, J ALZHEIMERS DIS, V16, P271, DOI 10.3233/JAD-2009-0978; Wang HD, 2002, J NEUROSCI, V22, P10232; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009; Yeh CH, 2004, CHEST, V125, P228, DOI 10.1378/chest.125.1.228	53	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13030	10.1371/journal.pone.0013030	http://dx.doi.org/10.1371/journal.pone.0013030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927385	Green Submitted, Green Published, gold			2022-12-25	WOS:000282210700011
J	Narayan, V; Pion, E; Landre, V; Muller, P; Ball, KL				Narayan, Vikram; Pion, Emmanuelle; Landre, Vivien; Mueller, Petr; Ball, Kathryn L.			Docking-dependent Ubiquitination of the Interferon Regulatory Factor-1 Tumor Suppressor Protein by the Ubiquitin Ligase CHIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR IRF-1; HEAT-SHOCK PROTEINS; CHAPERONE FUNCTIONS; PROTEASOME PATHWAY; DNA-DAMAGE; E3 LIGASE; DEGRADATION; P53; COMPLEX; REPAIR	Characteristically for a regulatory protein, the IRF-1 tumor suppressor turns over rapidly with a half-life of between 20-40 min. This allows IRF-1 to reach new steady state protein levels swiftly in response to changing environmental conditions. Whereas CHIP ( C terminus of Hsc70-interacting protein), appears to chaperone IRF-1 in unstressed cells, formation of a stable IRF-1.CHIP complex is seen under specific stress conditions. Complex formation, in heat- or heavy metal-treated cells, is accompanied by a decrease in IRF-1 steady state levels and an increase in IRF-1 ubiquitination. CHIP binds directly to an intrinsically disordered domain in the central region of IRF-1 ( residues 106-140), and this site is sufficient to form a stable complex with CHIP in cells and to compete in trans with full-length IRF-1, leading to a reduction in its ubiquitination. The study reveals a complex relationship between CHIP and IRF-1 and highlights the role that direct binding or "docking" of CHIP to its substrate(s) can play in its mechanism of action as an E3 ligase.	[Narayan, Vikram; Pion, Emmanuelle; Landre, Vivien; Ball, Kathryn L.] Univ Edinburgh, Inst Genet & Mol Med, Cell Signalling Unit, CRUK Interferon & Cell Signalling Grp, Edinburgh EH4 2XR, Midlothian, Scotland; [Mueller, Petr] Masaryk Mem Canc Inst, Dept Expt Oncol, Brno 65653, Czech Republic	University of Edinburgh; Masaryk Memorial Cancer Institute	Ball, KL (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Cell Signalling Unit, CRUK Interferon & Cell Signalling Grp, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	kathryn.ball@ed.ac.uk	Muller, Petr/F-7762-2015; Muller, Petr/AAK-5014-2021; Narayan, Vikram/AAF-3964-2020	Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Narayan, Vikram/0000-0002-6128-7944	Cancer Research UK [C377/A6355]; Scottish University; Internal Grant Agency of the Ministry of Health [MZ CR NS/9812-4]; Grantova Agentura Ceske Republiky [301/08/1468]	Cancer Research UK(Cancer Research UK); Scottish University; Internal Grant Agency of the Ministry of Health; Grantova Agentura Ceske Republiky(Grant Agency of the Czech Republic)	This work is funded by Cancer Research UK Programme Grant C377/A6355 (to K. L. B.).; Recipient of a Scottish Universities Life Sciences Alliance Ph.D. studentship.; Supported by Internal Grant Agency of the Ministry of Health Grant MZ CR NS/9812-4 and Grantova Agentura Ceske Republiky Grant 301/08/1468.	Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Flodstrom M, 1997, ENDOCRINOLOGY, V138, P2747, DOI 10.1210/en.138.7.2747; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; Graf C, 2010, BIOCHEMISTRY-US, V49, P2121, DOI 10.1021/bi901829f; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; McDonough H, 2009, J BIOL CHEM, V284, P20649, DOI 10.1074/jbc.M109.011767; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Nozawa H, 1998, INT J CANCER, V77, P522, DOI 10.1002/(SICI)1097-0215(19980812)77:4<522::AID-IJC8>3.0.CO;2-W; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pion E, 2009, CELL SIGNAL, V21, P1479, DOI 10.1016/j.cellsig.2009.05.004; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Schaper F, 1998, BIOCHEM J, V335, P147, DOI 10.1042/bj3350147; Shang Y, 2009, BIOCHEM BIOPH RES CO, V386, P242, DOI 10.1016/j.bbrc.2009.06.043; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Tamura G, 1996, J PATHOL, V180, P371, DOI 10.1002/(SICI)1096-9896(199612)180:4<371::AID-PATH704>3.0.CO;2-2; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	38	41	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					607	619		10.1074/jbc.M110.153122	http://dx.doi.org/10.1074/jbc.M110.153122			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20947504	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000285782800063
J	Krause, C; Korchynskyi, O; de Rooij, K; Weidauer, SE; de Gorter, DJJ; van Bezooijen, RL; Hatsell, S; Economides, AN; Mueller, TD; Lowik, CWGM; ten Dijke, P				Krause, Carola; Korchynskyi, Olexandr; de Rooij, Karien; Weidauer, Stella E.; de Gorter, David J. J.; van Bezooijen, Rutger L.; Hatsell, Sarah; Economides, Aris N.; Mueller, Thomas D.; Loewik, Clemens W. G. M.; ten Dijke, Peter			Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; VAN-BUCHEM-DISEASE; TGF-BETA; PARATHYROID-HORMONE; BMP ANTAGONIST; SOST GENE; OSTEOCYTES; EXPRESSION; DENSITY; CELLS	Sclerostin is expressed by osteocytes and has catabolic effects on bone. It has been shown to antagonize bone morphogenetic protein (BMP) and/or Wnt activity, although at present the underlying mechanisms are unclear. Consistent with previous findings, Sclerostin opposed direct Wnt3a-induced but not direct BMP7-induced responses when both ligand and antagonist were provided exogenously to cells. However, we found that when both proteins are expressed in the same cell, sclerostin can antagonize BMP signaling directly by inhibiting BMP7 secretion. Sclerostin interacts with both the BMP7 mature domain and pro-domain, leading to intracellular retention and proteasomal degradation of BMP7. Analysis of sclerostin knock-out mice revealed an inhibitory action of sclerostin on Wnt signaling in both osteoblasts and osteocytes in cortical and cancellous bones. BMP7 signaling was predominantly inhibited by sclerostin in osteocytes of the calcaneus and the cortical bone of the tibia. Our results suggest that sclerostin exerts its potent bone catabolic effects by antagonizing Wnt signaling in a paracrine and autocrine manner and antagonizing BMP signaling selectively in the osteocytes that synthesize simultaneously both sclerostin and BMP7 proteins.	[Krause, Carola; Korchynskyi, Olexandr; de Gorter, David J. J.; van Bezooijen, Rutger L.; ten Dijke, Peter] Univ Wurzburg, Dept Mol Cell Biol, D-97074 Wurzburg, Germany; [Krause, Carola; Korchynskyi, Olexandr; de Gorter, David J. J.; van Bezooijen, Rutger L.; ten Dijke, Peter] Univ Wurzburg, Ctr Biomed Genet, D-97074 Wurzburg, Germany; [de Rooij, Karien; Loewik, Clemens W. G. M.] Univ Wurzburg, Dept Endocrinol, D-97074 Wurzburg, Germany; [Weidauer, Stella E.; Mueller, Thomas D.] Univ Wurzburg, Lehrstuhl Bot Mol Pflanzenphysiol & Biophys 1, Julius von Sachs Inst Biowissensch, D-97074 Wurzburg, Germany; [Hatsell, Sarah; Economides, Aris N.] Regeneron Pharmaceut Inc, Genome Engn Technol, Tarrytown, NY 10591 USA	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Regeneron	ten Dijke, P (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Postzone S-1-P,Postbus 9600, NL-2300 RC Leiden, Netherlands.	P.ten_Dijke@lumc.nl	Dijke, Peter ten/AAG-4660-2021; Korchynskyi, Olexandr/ADA-6398-2022	Dijke, Peter ten/0000-0002-7234-342X; Hatsell, Sarah/0000-0003-1103-6087; de Rooij, Karien/0000-0001-7950-089X; Mueller, Thomas/0000-0003-1862-7357; Economides, Aris/0000-0002-6508-8942; Korchynskyi, Olexandr/0000-0002-4557-4003	Dutch Organization for Scientific Research [NWO 918.66.606]; Centre for Biomedical Genetics; European Union	Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Biomedical Genetics; European Union(European Commission)	This work was supported by Dutch Organization for Scientific Research Grant NWO 918.66.606 and the Centre for Biomedical Genetics and European Union FP7 Program TALOS.	Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balemans W, 2007, J BONE MINER RES, V22, P708, DOI 10.1359/JBMR.070211; BEIGHTON P, 1984, CLIN GENET, V25, P175; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; BIEWENER AA, 1983, J EXP BIOL, V103, P131; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; BURGER EH, 1995, J NUTR, V125, pS2020, DOI 10.1093/jn/125.suppl_7.2020S; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FROST HM, 1960, J BONE JOINT SURG AM, V42, P138, DOI 10.2106/00004623-196042010-00011; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; REYNOLDS TR, 1985, AM J PHYS ANTHROPOL, V67, P335, DOI 10.1002/ajpa.1330670406; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; Silvestrini G, 2007, J MOL HISTOL, V38, P261, DOI 10.1007/s10735-007-9096-3; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Sun JP, 2006, J BIOL CHEM, V281, P29349, DOI 10.1074/jbc.M603833200; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Van Der Horst G, 2002, BONE, V31, P661, DOI 10.1016/S8756-3282(02)00903-1; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Wei AQ, 2008, SPINE J, V8, P466, DOI 10.1016/j.spinee.2007.04.021; Weidauer SE, 2009, BIOCHEM BIOPH RES CO, V380, P160, DOI 10.1016/j.bbrc.2009.01.062; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yamashita T, 1996, BONE, V19, P429, DOI 10.1016/S8756-3282(96)00255-4; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Zaman G, 2010, BONE, V46, P628, DOI 10.1016/j.bone.2009.10.021; Zhou FF, 2008, J BIOL CHEM, V283, P14506, DOI 10.1074/jbc.M706136200; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41	74	125	146	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41614	41626		10.1074/jbc.M110.153890	http://dx.doi.org/10.1074/jbc.M110.153890			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20952383	Green Published, hybrid			2022-12-25	WOS:000285622600049
J	Mendoza-Cozatl, DG; Zhai, ZY; Jobe, TO; Akmakjian, GZ; Song, WY; Limbo, O; Russell, MR; Kozlovskyy, VI; Martinoia, E; Vatamaniuk, OK; Russell, P; Schroeder, JI				Mendoza-Cozatl, David G.; Zhai, Zhiyang; Jobe, Timothy O.; Akmakjian, Garo Z.; Song, Won-Yong; Limbo, Oliver; Russell, Matthew R.; Kozlovskyy, Volodymyr I.; Martinoia, Enrico; Vatamaniuk, Olena K.; Russell, Paul; Schroeder, Julian I.			Tonoplast-localized Abc2 Transporter Mediates Phytochelatin Accumulation in Vacuoles and Confers Cadmium Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTERS; HEAVY-METAL DETOXIFICATION; FISSION YEAST REQUIRES; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS-THALIANA; PEPTIDES; GLUTATHIONE; SYNTHASE; GENES; IDENTIFICATION	Phytochelatins mediate tolerance to heavy metals in plants and some fungi by sequestering phytochelatin-metal complexes into vacuoles. To date, only Schizosaccharomyces pombe Hmt1 has been described as a phytochelatin transporter and attempts to identify orthologous phytochelatin transporters in plants and other organisms have failed. Furthermore, recent data indicate that the hmt1 mutant accumulates significant phytochelatin levels in vacuoles, suggesting that unidentified phytochelatin transporters exist in fungi. Here, we show that deletion of all vacuolar ABC transporters abolishes phytochelatin accumulation in S. pombe vacuoles and abrogates 35S-PC2 uptake into S. pombe microsomal vesicles. Systematic analysis of the entire S. pombe ABC transporter family identified Abc2 as a full-size ABC transporter (ABCC-type) that mediates phytochelatin transport into vacuoles. The S. pombe abc1 abc2 abc3 abc4 hmt1 quintuple and abc2 hmt1 double mutant show no detectable phytochelatins in vacuoles. Abc2 expression restores phytochelatin accumulation into vacuoles and suppresses the cadmium sensitivity of the abc quintuple mutant. A novel, unexpected, function of Hmt1 in GS-conjugate transport is also shown. In contrast to Hmt1, Abc2 orthologs are widely distributed among kingdoms and are proposed as the long-sought vacuolar phytochelatin transporters in plants and other organisms.	[Mendoza-Cozatl, David G.; Jobe, Timothy O.; Akmakjian, Garo Z.; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Zhai, Zhiyang; Kozlovskyy, Volodymyr I.; Vatamaniuk, Olena K.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Song, Won-Yong; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Limbo, Oliver; Russell, Matthew R.; Russell, Paul] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Cornell University; University of Zurich; Scripps Research Institute	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jischroeder@ucsd.edu	Zhai, Zhiyang/AAY-5475-2020; Jobe, Timothy O/A-7087-2012; Martinoia, Enrico/AAH-8712-2021	Jobe, Timothy O/0000-0002-5729-4981; Schroeder, Julian/0000-0002-3283-5972; Russell, Matthew/0000-0002-0291-7379; Mendoza Cozatl, David/0000-0002-9616-0791; Kozlovskyy, Volodymyr/0000-0002-2401-3178; Limbo, Oliver/0000-0003-1686-1414; Zhai, Zhiyang/0000-0003-3181-1773	NIEHS, National Institutes of Health [P42 ES010337]; Energy Biosciences Office of the Department of Energy [DE-FG0203ER15449]; EU [FOOD-CT-20060016253]; National Science Foundation [MCB-0923731]; Cornell University Agricultural Experiment Station CUAES Hatch [NYC-125433]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Energy Biosciences Office of the Department of Energy(United States Department of Energy (DOE)); EU(European Commission); National Science Foundation(National Science Foundation (NSF)); Cornell University Agricultural Experiment Station CUAES Hatch; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by grants from the NIEHS, National Institutes of Health (P42 ES010337, to J. I. S. and P. R.), the Energy Biosciences Office of the Department of Energy (DE-FG0203ER15449, to J. I. S.), the EU Project PHIME (Contract no. FOOD-CT-20060016253, to E. M.), National Science Foundation (MCB-0923731, to O. K. V.), and Cornell University Agricultural Experiment Station CUAES Hatch (NYC-125433, to O. K. V.).	Broderick JB, 2007, NAT CHEM BIOL, V3, P243, DOI 10.1038/nchembio0507-243; Chen A, 2006, PLANT PHYSIOL, V141, P108, DOI 10.1104/pp.105.072637; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen S, 2007, J BIOL CHEM, V282, P21561, DOI 10.1074/jbc.M702383200; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Clemens S, 2001, EUR J BIOCHEM, V268, P3640, DOI 10.1046/j.1432-1327.2001.02293.x; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Gong JM, 2003, P NATL ACAD SCI USA, V100, P10118, DOI 10.1073/pnas.1734072100; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; Guo YY, 2010, SCI TOTAL ENVIRON, V408, P3113, DOI 10.1016/j.scitotenv.2010.04.018; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; HAYASHI Y, 1991, METHOD ENZYMOL, V205, P348; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Iwaki T, 2006, MICROBIOL-SGM, V152, P2309, DOI 10.1099/mic.0.28952-0; Iwema T, 2009, BIOCHEMISTRY-US, V48, P6041, DOI 10.1021/bi900440m; Kennedy PJ, 2008, TOXICOL SCI, V106, P124, DOI 10.1093/toxsci/kfn153; Kim DY, 2006, PLANT PHYSIOL, V140, P922, DOI 10.1104/pp.105.074146; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Mendoza-Cozatl DG, 2008, PLANT J, V54, P249, DOI 10.1111/j.1365-313X.2008.03410.x; Mo W, 2009, EXPERT OPIN DRUG MET, V5, P1049, DOI 10.1517/17425250903124371; MUTOH N, 1988, BIOCHEM BIOPH RES CO, V151, P32, DOI 10.1016/0006-291X(88)90555-4; Nagy R, 2009, J BIOL CHEM, V284, P33614, DOI 10.1074/jbc.M109.030247; Ogunseitan OA, 2009, SCIENCE, V326, P670, DOI 10.1126/science.1176929; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; PLOCKE DJ, 1992, EUR J BIOCHEM, V207, P201, DOI 10.1111/j.1432-1033.1992.tb17038.x; Preveral S, 2009, J BIOL CHEM, V284, P4936, DOI 10.1074/jbc.M808130200; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; REESE RN, 1988, J BIOL CHEM, V263, P12832; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Ryan JA, 2004, ENVIRON SCI TECHNOL, V38, p18A, DOI 10.1021/es040337r; SALT DE, 1993, J BIOL CHEM, V268, P12297; SALT DE, 1995, PLANT PHYSIOL, V107, P1293, DOI 10.1104/pp.107.4.1293; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Schwartz MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009564; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; SPEISER DM, 1992, MOL CELL BIOL, V12, P5301, DOI 10.1128/MCB.12.12.5301; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Trompier D, 2006, J BIOL CHEM, V281, P20283, DOI 10.1074/jbc.M601072200; Van Belleghem F, 2007, NEW PHYTOL, V173, P495, DOI 10.1111/j.1469-8137.2006.01940.x; Vande Weghe JG, 2001, MOL MICROBIOL, V42, P29, DOI 10.1046/j.1365-2958.2001.02624.x; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; Vatamaniuk OK, 2000, J BIOL CHEM, V275, P31451, DOI 10.1074/jbc.M002997200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; VOGELILANGE R, 1990, PLANT PHYSIOL, V92, P1086, DOI 10.1104/pp.92.4.1086; Wu JS, 1995, BIOCHEM MOL BIOL INT, V36, P1169; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200; Zenk MH, 1996, GENE, V179, P21, DOI 10.1016/S0378-1119(96)00422-2	60	66	71	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40416	40426		10.1074/jbc.M110.155408	http://dx.doi.org/10.1074/jbc.M110.155408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20937798	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000285414400004
J	Xuan, SH; Szabolcs, M; Cinti, F; Perincheri, S; Accili, D; Efstratiadis, A				Xuan, Shouhong; Szabolcs, Matthias; Cinti, Francesca; Perincheri, Suhdir; Accili, Domenico; Efstratiadis, Argiris			Genetic Analysis of Type-1 Insulin-like Growth Factor Receptor Signaling through Insulin Receptor Substrate-1 and -2 in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DIABETES-MELLITUS; TRANSCRIPTION FACTOR FOXO1; FORKHEAD PROTEIN FOXO1; GLYCEMIC CONTROL; RESISTANCE; MICE; SECRETION; IRS-2; DYSFUNCTION; DISRUPTION	Signaling by receptor tyrosine kinases regulates pancreatic beta cell function. Inactivation of insulin receptor (InsR), IGF1 receptor (Igf1r), or Irs1 in beta cells impairs insulin secretion. Conversely, Irs2 ablation impairs beta cell replication. In this study, we examined aspects of the Igf1r regulatory signaling cascade in beta cells. To examine genetically the involvement of Irs1 and Irs2 in Igf1r signaling, we generated double mutant mice lacking Igf1r specifically in pancreatic beta cells in an Irs1-or Irs2-null background. We show that Igf1r/Irs1 double mutants do not differ phenotypically from Irs1 single mutants and exhibit hyperinsulinemia, while maintaining normal beta cell mass and glucose tolerance. In contrast, lack of Igf1r function in beta cells aggravates the consequences of Irs2 ablation in double mutants and results in lethal diabetes by 6 weeks of age. This additivity of phenotypic manifestations indicates that Irs2 serves a pathway that is largely independent of Igf1r signaling. Consistent with the view that the latter is the InsR pathway, we show that combined beta cell-specific knock-out of both Insr and Igf1r results in a phenocopy of double mutants lacking Igf1r and Irs2. We conclude that Igf1r signals primarily through Irs1 and affects insulin secretion, whereas beta cell proliferation is mainly regulated by InsR using Irs2 as a downstream signaling effector. The insulin and IGF pathways appear to control beta cell functions independently and selectively.	[Xuan, Shouhong; Cinti, Francesca; Perincheri, Suhdir; Efstratiadis, Argiris] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Szabolcs, Matthias] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; [Accili, Domenico] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Efstratiadis, Argiris] Acad Athens, Biomed Res Fdn, Athens 11527, Greece	Columbia University; Columbia University; Columbia University; Academy of Athens	Accili, D (corresponding author), 1150 St Nicholas Av,Rm 238, New York, NY 10032 USA.	da230@columbia.edu	Cinti, Francesca/AAY-5534-2021	Cinti, Francesca/0000-0001-5170-7055	National Institutes of Health [DK58282, DK63608]; Russell Berrie Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058282, R01DK058282, P30DK063608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russell Berrie Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK58282 and DK63608 (Columbia University Diabetes & Endocrinology Research Center) and a research grant from the Russell Berrie Foundation (to A. E. and D. A.).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Ferrannini E, 1998, ENDOCR REV, V19, P477, DOI 10.1210/edrv.19.4.0336; FRATTALI AL, 1993, J BIOL CHEM, V268, P7393; GREENWOOD RH, 1976, LANCET, V1, P444; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kido Y, 2002, J BIOL CHEM, V277, P36740, DOI 10.1074/jbc.M206314200; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim JJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1694, DOI 10.1152/ajpendo.00430.2006; Kitamura T, 2004, J CLIN INVEST, V113, P209, DOI 10.1172/JCI200417810; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Kushner JA, 2002, J CLIN INVEST, V109, P1193, DOI 10.1172/JCI200214439; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; Levy J, 1998, DIABETIC MED, V15, P290, DOI 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Monnier L, 2007, DIABETES CARE, V30, P263, DOI 10.2337/dc06-1612; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Terauchi Y, 2003, J BIOL CHEM, V278, P14284, DOI 10.1074/jbc.M211045200; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276	48	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41044	41050		10.1074/jbc.M110.144790	http://dx.doi.org/10.1074/jbc.M110.144790			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20947509	Green Published, hybrid			2022-12-25	WOS:000285414400067
J	Garcia, J; Han, D; Sancheti, H; Yap, LP; Kaplowitz, N; Cadenas, E				Garcia, Jerome; Han, Derick; Sancheti, Harsh; Yap, Li-Peng; Kaplowitz, Neil; Cadenas, Enrique			Regulation of Mitochondrial Glutathione Redox Status and Protein Glutathionylation by Respiratory Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE ANION; IDENTIFICATION; MODULATION; MECHANISMS; RELEASE; SITES	Brain and liver mitochondria isolated by a discontinuous Percoll gradient show an oxidized redox environment, which is reflected by low GSH levels and high GSSG levels and significant glutathionylation of mitochondrial proteins as well as by low NAD(P) H/NAD(P) values. The redox potential of brain mitochondria isolated by a discontinuous Percoll gradient method was calculated to be -171 mV based on GSH and GSSG concentrations. Immunoblotting and LC/MS/MS analysis revealed that succinyl-CoA transferase and ATP synthase (F-1 complex, alpha-subunit) were extensively glutathionylated; S-glutathionylation of these proteins resulted in a substantial decrease of activity. Supplementation of mitochondria with complex I or complex II respiratory substrates (malate/glutamate or succinate, respectively) increased NADH and NADPH levels, resulting in the restoration of GSH levels through reduction of GSSG and deglutathionylation of mitochondrial proteins. Under these conditions, the redox potential of brain mitochondria was calculated to be -291 mV. Supplementation of mitochondria with respiratory substrates prevented GSSG formation and, consequently, ATP synthase glutathionylation in response to H2O2 challenges. ATP synthase appears to be the major mitochondrial protein that becomes glutathionylated under oxidative stress conditions. Glutathionylation of mitochondrial proteins is a major consequence of oxidative stress, and respiratory substrates are key regulators of mitochondrial redox status (as reflected by thiol/disulfide exchange) by maintaining mitochondrial NADPH levels.	[Garcia, Jerome; Sancheti, Harsh; Yap, Li-Peng; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Han, Derick; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Cadenas, E (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave, Los Angeles, CA 90089 USA.	cadenas@usc.edu		Sancheti, Harsh/0000-0001-8084-4550	National Institutes of Health [AA016911, AG016718, DK067215]; Tobacco-Related Disease Research Program [16RT-0186]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA016911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA016911 (to D. H.), AG016718 (to E. C.), and DK067215 (to N. K.). This work was also supported by Tobacco-Related Disease Research Program Grant 16RT-0186 (to E. C.).	Anderson MF, 2000, BRAIN RES PROTOC, V5, P95, DOI 10.1016/S1385-299X(99)00060-4; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fernandez-Checa JC, 1998, SEMIN LIVER DIS, V18, P389, DOI 10.1055/s-2007-1007172; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Han D, 2005, BIOCHEMISTRY-US, V44, P11986, DOI 10.1021/bi0509393; Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136; Han D, 2002, METHOD ENZYMOL, V349, P271, DOI 10.1016/S0076-6879(02)49341-X; Han D, 2006, AM J PHYSIOL-GASTR L, V291, pG1, DOI 10.1152/ajpgi.00001.2006; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Lam PY, 2009, FREE RADICAL RES, V43, P431, DOI 10.1080/10715760902849813; MEISTER A, 1995, BBA-MOL BASIS DIS, V1271, P35, DOI 10.1016/0925-4439(95)00007-Q; Odin JA, 2001, J CLIN INVEST, V108, P223, DOI 10.1172/JCI200110716; OLAFSDOTTIR K, 1988, BIOCHIM BIOPHYS ACTA, V964, P377, DOI 10.1016/0304-4165(88)90038-4; REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131; RYDSTROM J, 2006, J BIOCHIM BIOPHYS AC, V1757, P721; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; SIES H, 1985, PHILOS T ROY SOC B, V311, P617, DOI 10.1098/rstb.1985.0168; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; Yap LP, 2010, METHOD ENZYMOL, V473, P137, DOI 10.1016/S0076-6879(10)73006-8; Yap LP, 2010, BIOCHEM J, V428, P85, DOI 10.1042/BJ20100164; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015	33	151	150	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39646	39654		10.1074/jbc.M110.164160	http://dx.doi.org/10.1074/jbc.M110.164160			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937819	Green Published, hybrid			2022-12-25	WOS:000285185500008
J	Mondin, M; Carta, M; Normand, E; Mulle, C; Coussen, F				Mondin, Magali; Carta, Mario; Normand, Elisabeth; Mulle, Christophe; Coussen, Francoise			Profilin II Regulates the Exocytosis of Kainate Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICE VARIANTS; SUBUNIT; TRAFFICKING; ENDOCYTOSIS; PATHWAY; COMPLEX; BINDING	The trafficking of ionotropic glutamate receptors to and from synaptic sites is regulated by proteins that interact with their cytoplasmic C-terminal domain. Profilin IIa (PfnIIa), an actin-binding protein expressed in the brain and recruited to synapses in an activity-dependent manner, was shown previously to interact with the C-terminal domain of the GluK2b subunit splice variant of kainate receptors (KARs). Here, we characterize this interaction and examine the role of PfnIIa in the regulation of KAR trafficking. PfnIIa directly and specifically binds to the C-terminal domain of GluK2b through a diproline motif. Expression of PfnIIa in transfected COS-7 cells and in cultured hippocampal neurons from PfnII-deficient mice decreases the level of extracellular of homomeric GluK2b as well as heteromeric GluK2a/GluK2b KARs. Our data suggest a novel mechanism by which PfnIIa exerts a dual role on the trafficking of KARs, by a generic inhibition of clathrin-mediated endocytosis through its interaction with dynamin-1, and by controlling KARs exocytosis through a direct and specific interaction with GluK2b.	[Mondin, Magali; Carta, Mario; Normand, Elisabeth; Mulle, Christophe; Coussen, Francoise] Univ Bordeaux, CNRS, Lab Physiol Cellulaire Synapse, UMR 5091, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Coussen, F (corresponding author), Univ Bordeaux, CNRS, Lab Physiol Cellulaire Synapse, UMR 5091, 146 Rue Leo Saignat, F-33077 Bordeaux, France.	fcoussen@pcs.u-bordeaux2.fr		Mondin, Magali/0000-0001-5802-007X; Mulle, Christophe/0000-0003-2709-6615; Carta, Mario/0000-0003-1225-2742	Centre National de la Recherche Scientifique; Conseil Regional d'Aquitaine; European Commission [LSHM-CT-2005-019055]; Agence Nationale de la Recherche; European community [KAR TRAF/PIEF-GA-2009-235073]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); European community(European Commission)	This work was supported by grants from the Centre National de la Recherche Scientifique, the Conseil Regional d'Aquitaine, the European Commission (EUSynapse Project, Contract LSHM-CT-2005-019055), and the Agence Nationale de la Recherche (PresynGlu Project) (to C.M.). The European community's Seventh frame work, program (FP7) through an EIF fellowship (KAR TRAF/PIEF-GA-2009-235073) to M.C.	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Coussen F, 2009, NEUROSCIENCE, V158, P25, DOI 10.1016/j.neuroscience.2007.12.052; Di Nardo A, 2000, J CELL SCI, V113, P3795; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; Giesemann T, 2003, J NEUROSCI, V23, P8330; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Jaskolski F, 2005, J BIOL CHEM, V280, P22968, DOI 10.1074/jbc.M413166200; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Laezza F, 2007, MOL CELL NEUROSCI, V34, P539, DOI 10.1016/j.mcn.2006.12.003; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Ren Z, 2003, J BIOL CHEM, V278, P52700, DOI 10.1074/jbc.M309585200; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Winkler A, 1999, BRAIN RES PROTOC, V4, P69, DOI 10.1016/S1385-299X(99)00005-7; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yan S, 2004, J NEUROSCI, V24, P679, DOI 10.1523/JNEUROSCI.4985-03.2004; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	28	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40060	40071		10.1074/jbc.M110.140442	http://dx.doi.org/10.1074/jbc.M110.140442			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937818	Green Published, hybrid			2022-12-25	WOS:000285185500051
J	Zhang, XYZ; Lloubes, R; Duche, D				Zhang, Xiang Y. -Z.; Lloubes, Roland; Duche, Denis			Channel Domain of Colicin A Modifies the Dimeric Organization of Its Immunity Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING DOMAIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CROSS-LINKING; OUTER-MEMBRANE; ION-CHANNEL; LOCALIZATION; INHIBITION; FRAGMENT; HELICES	Proteins conferring immunity against pore-forming colicins are localized in the Escherichia coli inner membrane. Their protective effects are mediated by direct interaction with the C-terminal domain of their cognate colicins. Cai, the immunity protein protecting E. coli against colicin A, contains four cysteine residues. We report cysteine cross-linking experiments showing that Cai forms homodimers. Cai contains four transmembrane segments (TMSs), and dimerization occurs via the third TMS. Furthermore, we observe the formation of intramolecular disulfide bonds that connect TMS2 with either TMS1 or TMS3. Co-expression of Cai with its target, the colicin A pore-forming domain (pfColA), in the inner membrane prevents the formation of intermolecular and intramolecular disulfide bonds, indicating that pfColA interacts with the dimer of Cai and modifies its conformation. Finally, we show that when Cai is locked by disulfide bonds, it is no longer able to protect cells against exogenous added colicin A.	[Duche, Denis] CNRS, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UPR 9027, F-13402 Marseille 20, France; [Zhang, Xiang Y. -Z.; Lloubes, Roland; Duche, Denis] Univ Mediterranee Aix Marseille, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Duche, D (corresponding author), CNRS, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UPR 9027, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	duche@ibsm.cnrs-mrs.fr		LLOUBES, Roland/0000-0002-9520-1053; Duche, Denis/0000-0002-4208-6661	Agence Nationale de la Recherche [ANR-07-BLANC-67]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Agence Nationale de la Recherche, SODATOL Project ANR-07-BLANC-67.	Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; DUCHE D, 1995, J BACTERIOL, V177, P4935, DOI 10.1128/jb.177.17.4935-4939.1995; Duche D, 2002, BIOCHIMIE, V84, P455, DOI 10.1016/S0300-9084(02)01424-4; Duche D, 1999, J MOL BIOL, V285, P1965, DOI 10.1006/jmbi.1998.2423; Elkins P, 1997, STRUCTURE, V5, P443, DOI 10.1016/S0969-2126(97)00200-1; ESPESSET D, 1994, MOL MICROBIOL, V13, P1111, DOI 10.1111/j.1365-2958.1994.tb00502.x; GELI V, 1989, MOL MICROBIOL, V3, P679, DOI 10.1111/j.1365-2958.1989.tb00216.x; GELI V, 1988, P NATL ACAD SCI USA, V85, P689, DOI 10.1073/pnas.85.3.689; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; JI TH, 1980, BIOCHIM BIOPHYS ACTA, V603, P371, DOI 10.1016/0005-2736(80)90382-X; Journet L, 2001, MOL MICROBIOL, V42, P331, DOI 10.1046/j.1365-2958.2001.02592.x; LEE GF, 1994, J BIOL CHEM, V269, P29920; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Nardi A, 2001, J BACTERIOL, V183, P6721, DOI 10.1128/JB.183.22.6721-6725.2001; Nardi A, 2001, J MOL BIOL, V307, P1293, DOI 10.1006/jmbi.2001.4524; PARKER MW, 1989, NATURE, V337, P93, DOI 10.1038/337093a0; PILSL H, 1995, J BACTERIOL, V177, P6966, DOI 10.1128/jb.177.23.6966-6972.1995; Ren XY, 2008, BIOCHEMISTRY-US, V47, P6081, DOI 10.1021/bi800177t; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; SCHRAMM E, 1988, MOL GEN GENET, V211, P176, DOI 10.1007/BF00338410; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Slatin SL, 2002, P NATL ACAD SCI USA, V99, P1286, DOI 10.1073/pnas.022480199; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Smajs D, 2006, FEMS MICROBIOL LETT, V258, P108, DOI 10.1111/j.1574-6968.2006.00201.x; Smajs D, 2008, FEBS J, V275, P5325, DOI 10.1111/j.1742-4658.2008.06662.x; SONG HY, 1991, J BACTERIOL, V173, P2935, DOI 10.1128/JB.173.9.2935-2943.1991; Vetter IR, 1998, STRUCTURE, V6, P863, DOI 10.1016/S0969-2126(98)00088-4; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; ZHANG YL, 1993, J BIOL CHEM, V268, P10176	30	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38053	38061		10.1074/jbc.M110.144071	http://dx.doi.org/10.1074/jbc.M110.144071			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923759	Green Published, hybrid			2022-12-25	WOS:000284625600013
J	Okwan-Duodu, D; Datta, V; Shen, XZ; Goodridge, HS; Bernstein, EA; Fuchs, S; Liu, GY; Bernstein, KE				Okwan-Duodu, Derick; Datta, Vivekanand; Shen, Xiao Z.; Goodridge, Helen S.; Bernstein, Ellen A.; Fuchs, Sebastien; Liu, George Y.; Bernstein, Kenneth E.			Angiotensin-converting Enzyme Overexpression in Mouse Myelomonocytic Cells Augments Resistance to Listeria and Methicillin-resistant Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; MACROPHAGE POLARIZATION; IMMUNE EVASION; MICE; INNATE; SYSTEM; INFLAMMATION; INFECTION; RESPONSES; BACTERIA	Gene targeting in ES cells was used to substitute control of angiotensin converting enzyme (ACE) expression from the endogenous promoter to the mouse c-fms promoter. The result is an animal model called ACE 10/10 in which ACE is overexpressed by monocytes, macrophages, and other myelomonocytic lineage cells. To study the immune response of these mice to bacterial infection, we challenged them with Listeria monocytogenes or methicillin-resistant Staphylococcus aureus (MRSA). ACE 10/10 mice have a significantly enhanced immune response to both bacteria in vivo and in vitro. For example, 5 days after Listeria infection, the spleen and liver of ACE 10/10 mice had 8.0- and 5.2-fold less bacteria than wild type mice (WT). In a model of MRSA skin infection, ACE 10/10 mice had 50-fold less bacteria than WT mice. Histologic examination showed a prominent infiltrate of ACE-positive mononuclear cells in the skin lesions from ACE 10/10. Increased bacterial resistance in ACE 10/10 is directly due to overexpression of ACE, as it is eliminated by an ACE inhibitor. Critical to increased immunity in ACE 10/10 is the overexpression of iNOS and reactive nitrogen intermediates, as inhibition of iNOS by the inhibitor 1400W eliminated all in vitro and in vivo differences in innate bacterial resistance between ACE 10/10 and WT mice. Increased resistance to MRSA was transferable by bone marrow transplantation. The overexpression of ACE and iNOS by myelomonocytic cells substantially boosts innate immunity and may represent a new means to address serious bacterial infections.	[Okwan-Duodu, Derick; Shen, Xiao Z.; Goodridge, Helen S.; Bernstein, Ellen A.; Fuchs, Sebastien; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Datta, Vivekanand; Shen, Xiao Z.; Fuchs, Sebastien; Liu, George Y.; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Liu, George Y.] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Bernstein, KE (corresponding author), 110 N George Burns Rd,Davis 2021, Los Angeles, CA 90048 USA.	kbernst@cshs.org		Bernstein, Kenneth/0000-0001-8097-3272	National Institutes of Health [R01 K039777, R01 DK051445, R01 AI074832, R00 HL088000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL088000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported, in whole or in part, by National Institutes of Health Grants R01 K039777 (to K. E. B.), R01 DK051445 (to K. E. B.), R01 AI074832 (to G. Y. L.), and R00 HL088000 (to S. F.).	[Anonymous], 1999, JAMA, V282, P1123; Babu BR, 1998, CURR OPIN CHEM BIOL, V2, P491, DOI 10.1016/S1367-5931(98)80125-7; BECKERMAN KP, 1993, J IMMUNOL, V150, pA53; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bernstein KE, 2006, HYPERTENSION, V47, P509, DOI 10.1161/01.HYP.0000196266.23639.c6; Bernstein KE, 2005, CIRC RES, V96, P1135, DOI 10.1161/01.RES.0000169536.73576.66; BOOCKVAR KS, 1994, INFECT IMMUN, V62, P1089, DOI 10.1128/IAI.62.3.1089-1100.1994; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cole J, 2002, CIRC RES, V90, P87, DOI 10.1161/hh0102.102360; CORVOL P, 1995, METHOD ENZYMOL, V248, P283; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Graves SF, 2010, J MOL MED, V88, P109, DOI 10.1007/s00109-009-0573-x; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Han G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007804; Hoch NE, 2009, AM J PHYSIOL-REG I, V296, pR208, DOI 10.1152/ajpregu.90521.2008; Houghton AM, 2009, NATURE, V460, P637, DOI 10.1038/nature08181; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; LANGFORD KG, 1991, J BIOL CHEM, V266, P15559; Leehey DJ, 2000, KIDNEY INT, V58, pS93, DOI 10.1046/j.1523-1755.2000.07715.x; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martinez LR, 2009, J INVEST DERMATOL, V129, P2463, DOI 10.1038/jid.2009.95; Metzger R, 2000, ATHEROSCLEROSIS, V150, P21, DOI 10.1016/S0021-9150(99)00354-8; Montecucco F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/752406; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; Sakiniene E, 1997, CLIN EXP IMMUNOL, V110, P370, DOI 10.1046/j.1365-2249.1997.4431456.x; Sasaki S, 1998, INFECT IMMUN, V66, P1017, DOI 10.1128/IAI.66.3.1017-1022.1998; Scharfstein J, 2008, BIOL CHEM, V389, P1015, DOI 10.1515/BC.2008.126; Shen XZ, 2008, J BIOL CHEM, V283, P9957, DOI 10.1074/jbc.M709574200; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	49	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39051	39060		10.1074/jbc.M110.163782	http://dx.doi.org/10.1074/jbc.M110.163782			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937811	Green Published, hybrid			2022-12-25	WOS:000284941300035
J	Umanah, GKE; Huang, LY; Ding, FX; Arshava, B; Farley, AR; Link, AJ; Naider, F; Becker, JM				Umanah, George K. E.; Huang, Liyin; Ding, Fa-xiang; Arshava, Boris; Farley, Adam R.; Link, Andrew J.; Naider, Fred; Becker, Jeffrey M.			Identification of Residue-to-residue Contact between a Peptide Ligand and Its G Protein-coupled Receptor Using Periodate-mediated Dihydroxyphenylalanine Cross-linking and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MATING PHEROMONE; ALPHA-FACTOR RECEPTOR; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE DOMAIN; AMINO-ACIDS; BINDING; ANALOGS; PURIFICATION; STE2P; FRAGMENTS	Fundamental knowledge about how G protein-coupled receptors and their ligands interact is important for understanding receptor-ligand binding and the development of new drug discovery strategies. We have used cross-linking and tandem mass spectrometry analyses to investigate the interaction of the N terminus of the Saccharomyces cerevisiae tridecapeptide pheromone, alpha-factor (WHWLQLKPGQPMY), and Ste2p, its cognate G protein-coupled receptor. The Trp(1) residue of alpha-factor was replaced by 3,4-dihydroxyphenylalanine (DOPA) for periodate-mediated chemical cross-linking, and biotin was conjugated to Lys(7) for detection purposes to create the peptide [DOPA(1),Lys(7)(BioACA),Nle(12)]alpha-factor, called Bio-DOPA(1)-alpha-factor. This ligand analog was a potent agonist and bound to Ste2p with similar to 65 nanomolar affinity. Immunoblot analysis of purified Ste2p samples that were treated with Bio-DOPA(1)-alpha-factor showed that the peptide analog cross-linked efficiently to Ste2p. The cross-linking was inhibited by the presence of either native alpha-factor or an alpha-factor antagonist. MALDI-TOF and immunoblot analyses revealed that Bio-DOPA(1)-alpha-factor cross-linked to a fragment of Ste2p encompassing residues Ser(251)-Met(294). Fragmentation of the cross-linked fragment and Ste2p using tandem mass spectrometry pinpointed the cross-link point of the DOPA(1) of the alpha-factor analog to the Ste2p Lys(269) side chain near the extracellular surface of the TM6-TM7 bundle. This conclusion was confirmed by a greatly diminished cross-linking of Bio-DOPA(1)-alpha-factor into a Ste2p(K269A) mutant. Based on these and previously obtained binding contact data, a mechanism of alpha-factor binding to Ste2p is proposed. The model for bound alpha-factor shows how ligand binding leads to conformational changes resulting in receptor activation of the signal transduction pathway.	[Umanah, George K. E.; Huang, Liyin; Becker, Jeffrey M.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Ding, Fa-xiang; Arshava, Boris; Naider, Fred] CUNY Coll Staten Isl, Dept Chem, New York, NY 10314 USA; [Ding, Fa-xiang; Arshava, Boris; Naider, Fred] CUNY Coll Staten Isl, Macromol Assemblies Inst, New York, NY 10314 USA; [Naider, Fred] CUNY Grad Sch & Univ Ctr, New York, NY 10314 USA; [Farley, Adam R.; Link, Andrew J.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	University of Tennessee System; University of Tennessee Knoxville; City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; Vanderbilt University	Becker, JM (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	jbecker@utk.edu			National Institutes of Health, NIGMS [GM22087]; National Institutes of Health [GM064779]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM022087, R01GM022087, R01GM064779] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant GM22087.; Supported by National Institutes of Health Grant GM064779.	Abel MG, 1998, J PEPT RES, V52, P95; Bajaj A, 2007, BBA-MOL CELL RES, V1773, P707, DOI 10.1016/j.bbamcr.2007.02.002; Bauer A, 2003, EUR J BIOCHEM, V270, P570, DOI 10.1046/j.1432-1033.2003.03428.x; Beavis R, 2004, CURR PROTOC BIOINFOR; Blake AD, 1996, CHEM BIOL, V3, P967, DOI 10.1016/S1074-5521(96)90163-5; Burdine L, 2004, J AM CHEM SOC, V126, P11442, DOI 10.1021/ja045982c; Chapter MC, 2010, PHARMACOL THERAPEUT, V125, P39, DOI 10.1016/j.pharmthera.2009.07.006; David NE, 1997, J BIOL CHEM, V272, P15553, DOI 10.1074/jbc.272.24.15553; De Amici M, 2010, MED RES REV, V30, P463, DOI 10.1002/med.20166; Ding FX, 2002, J PEPT RES, V60, P65, DOI 10.1034/j.1399-3011.2002.21004.x; Ding FX, 2001, BIOCHEMISTRY-US, V40, P1102, DOI 10.1021/bi0021535; Dinger MC, 2003, J BIOL CHEM, V278, P10562, DOI 10.1074/jbc.M205747200; Eglen RM, 2009, METHODS MOL BIOL, V552, P1, DOI 10.1007/978-1-60327-317-6_1; ERIOTOUBARGIOTA E, 1992, BIOCHEMISTRY-US, V31, P551, DOI 10.1021/bi00117a036; Graumann J, 2004, MOL CELL PROTEOMICS, V3, P226, DOI 10.1074/mcp.M300099-MCP200; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Gurrath M, 2001, CURR MED CHEM, V8, P1605, DOI 10.2174/0929867013371798; Hauser M, 2007, J BIOL CHEM, V282, P10387, DOI 10.1074/jbc.M608903200; Henry LK, 2002, BIOCHEMISTRY-US, V41, P6128, DOI 10.1021/bi015863z; Hornak V, 2010, J MOL BIOL, V396, P510, DOI 10.1016/j.jmb.2009.12.003; Huang LY, 2008, BIOCHEMISTRY-US, V47, P5638, DOI 10.1021/bi701866e; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; Kraft P, 2001, ANAL BIOCHEM, V292, P76, DOI 10.1006/abio.2001.5072; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Lee BK, 2002, BIOCHEMISTRY-US, V41, P13681, DOI 10.1021/bi026100u; Lee BK, 2001, J BIOL CHEM, V276, P37950; Lee YH, 2006, J BIOL CHEM, V281, P2263, DOI 10.1074/jbc.M509987200; Link AJ, 2005, METHODS, V35, P274, DOI 10.1016/j.ymeth.2004.08.019; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Lundgren Deborah H, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1303s28; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Naider F, 2004, PEPTIDES, V25, P1441, DOI 10.1016/j.peptides.2003.11.028; Naider F, 2007, BIOCHEMISTRY-US, V46, P3476, DOI 10.1021/bi602415u; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; RATHS SK, 1988, J BIOL CHEM, V263, P17333; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sommers CM, 1997, J MOL BIOL, V266, P559, DOI 10.1006/jmbi.1996.0816; Son CD, 2005, J PEPT RES, V65, P418, DOI 10.1111/j.1399-3011.2005.00248.X; Son CD, 2004, BIOCHEMISTRY-US, V43, P13193, DOI 10.1021/bi0496889; Tantry S, 2010, BIOCHEMISTRY-US, V49, P5007, DOI 10.1021/bi100280f; Turcatti G, 1996, J BIOL CHEM, V271, P19991, DOI 10.1074/jbc.271.33.19991; Umanah GKE, 2009, BIOCHEMISTRY-US, V48, P2033, DOI 10.1021/bi802061z; Williams C, 2009, METHODS MOL BIOL, V552, P39, DOI 10.1007/978-1-60327-317-6_3; Wilm M, 2000, ADV PROTEIN CHEM, V54, P1, DOI 10.1016/S0065-3233(00)54001-7; Zhang YL, 1998, BIOCHEMISTRY-US, V37, P12465, DOI 10.1021/bi980787u; Zhang YL, 1997, J PEPT RES, V50, P319	48	24	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39425	39436		10.1074/jbc.M110.149500	http://dx.doi.org/10.1074/jbc.M110.149500			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923758	Green Published, hybrid			2022-12-25	WOS:000284941300069
J	Verduci, L; Simili, M; Rizzo, M; Mercatanti, A; Evangelista, M; Mariani, L; Rainaldi, G; Pitto, L				Verduci, Lorena; Simili, Marcella; Rizzo, Milena; Mercatanti, Alberto; Evangelista, Monica; Mariani, Laura; Rainaldi, Giuseppe; Pitto, Letizia			MicroRNA (miRNA)-mediated Interaction between Leukemia/Lymphoma-related Factor (LRF) and Alternative Splicing Factor/Splicing Factor 2 (ASF/SF2) Affects Mouse Embryonic Fibroblast Senescence and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; TUMOR-SUPPRESSOR; SR PROTEINS; REPRESSES TRANSCRIPTION; FACTOR SF2/ASF; DNA-BINDING; GENE; PROTOONCOGENE; EXPRESSION; POKEMON	Leukemia/lymphoma-related factor (LRF) is a transcriptional repressor, which by recruiting histone deacetylases specifically represses p19/ARF expression, thus behaving as an oncogene. Conversely, in mouse embryonic fibroblasts (MEF), LRF inhibition causes aberrant p19ARF up-regulation resulting in proliferative defects and premature senescence. We have recently shown that LRF is controlled by microRNAs. Here we show that LRF acts on MEF proliferation and senescence/apoptosis by repressing miR-28 and miR-505, revealing a regulatory circuit where microRNAs (miRNAs) work both upstream and downstream of LRF. By analyzing miRNA expression profiles of MEF transfected with LRF-specific short interfering RNAs, we found that miR-28 and miR-505 are modulated by LRF. Both miRNAs are predicted to target alternative splicing factor/splicing factor 2 (ASF/SF2), a serine/arginine protein essential for cell viability. In vertebrates, loss or inactivation of ASF/SF2 may result in genomic instability and induce G2 cell cycle arrest and apoptosis. We showed that miR-28 and miR-505 modulate ASF/SF2 by directly binding ASF/SF2 3'-UTR. Decrease in LRF causes a decrease in ASF/SF2, which depends on up-regulation of miR-28 and miR-505. Alteration of each of the members of the LRF/miR-28/miR-505/ASF/SF2 axis affects MEF proliferation and the number of senescent and apoptotic cells. Consistently, the axis is coordinately modulated as cell senescence increases with passages in MEF culture. In conclusion, we show that LRF-dependent miRNAs miR-28 and miR-505 control MEF proliferation and survival by targeting ASF/SF2 and suggest a central role of LRF-related miRNAs, in addition to the role of LRF-dependent p53 control, in cellular homeostasis.	[Verduci, Lorena; Simili, Marcella; Rizzo, Milena; Mercatanti, Alberto; Evangelista, Monica; Mariani, Laura; Rainaldi, Giuseppe; Pitto, Letizia] CNR, Inst Clin Physiol, Lab Gene & Mol Therapy, I-56124 Pisa, Italy; [Verduci, Lorena] Scuola Super Sant Anna, I-56127 Pisa, Italy; [Rainaldi, Giuseppe] Ist Toscano Tumori, I-50139 Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Pitto, L (corresponding author), CNR, Inst Clin Physiol, Lab Gene & Mol Therapy, I-56124 Pisa, Italy.	l.pitto@ifc.cnr.it	Rizzo, Milena/L-1481-2016; Pitto, Letizia/A-3070-2014	Rizzo, Milena/0000-0001-5924-8615; Pitto, Letizia/0000-0002-8660-9516; EVANGELISTA, MONICA/0000-0002-5674-8523; Mercatanti, Alberto/0000-0001-5110-9688	Associazione Italiana per la Ricerca sul Cancro (AIRC) [4753]; Istituto Superiore di Sanita (ISS) [527/A/3A/4]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Istituto Superiore di Sanita (ISS)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC) (Project 4753) and Istituto Superiore di Sanita (ISS) (Project 527/A/3A/4).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Apostolopoulou K, 2007, J PATHOL, V213, P294, DOI 10.1002/path.2222; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; FU XD, 1993, NATURE, V365, P82, DOI 10.1038/365082a0; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hanamura A, 1998, RNA, V4, P430; Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kumar A, 2003, MOL CELL BIOL, V23, P6631, DOI 10.1128/MCB.23.18.6631-6645.2003; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maeda T, 2009, DEV CELL, V17, P527, DOI 10.1016/j.devcel.2009.09.005; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Pendergrast PS, 2002, MOL BIOL CELL, V13, P915, DOI 10.1091/mbc.01-08-0383; Pessler F, 2003, J BIOL CHEM, V278, P29327, DOI 10.1074/jbc.M302980200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitto L, 2009, PHYSIOL GENOMICS, V39, P210, DOI 10.1152/physiolgenomics.00085.2009; Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; TACKE R, 1992, NUCLEIC ACIDS RES, V20, P5482, DOI 10.1093/nar/20.20.5482; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712; Zerbe LK, 2004, MOL CARCINOGEN, V41, P187, DOI 10.1002/mc.20053; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	59	42	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39551	39563		10.1074/jbc.M110.114736	http://dx.doi.org/10.1074/jbc.M110.114736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923760	Green Published, hybrid			2022-12-25	WOS:000284941300081
J	A, JY; Qian, SX; Wang, GJ; Yan, B; Zhang, SJ; Huang, Q; Ni, LN; Zha, WB; Liu, LS; Cao, B; Hong, M; Wu, HX; Lu, H; Shi, JA; Li, MJ; Li, J				A, Jiye; Qian, Sixuan; Wang, Guangji; Yan, Bei; Zhang, Sujiang; Huang, Qing; Ni, Lingna; Zha, Weibin; Liu, Linsheng; Cao, Bei; Hong, Ming; Wu, Hanxin; Lu, Hua; Shi, Jian; Li, Mengjie; Li, Jianyong			Chronic Myeloid Leukemia Patients Sensitive and Resistant to Imatinib Treatment Show Different Metabolic Responses	PLOS ONE			English	Article							CHROMOSOME-POSITIVE LEUKEMIAS; TYROSINE KINASE INHIBITORS; MOLECULAR RESPONSES; CD34(+) CELLS; CHRONIC-PHASE; METABONOMICS; EXPRESSION; MECHANISMS; SIGNATURE; PATHWAYS	The BCR-ABL tyrosine kinase inhibitor imatinib is highly effective for chronic myeloid leukemia (CML). However, some patients gradually develop resistance to imatinib, resulting in therapeutic failure. Metabonomic and genomic profiling of patients' responses to drug interventions can provide novel information about the in vivo metabolism of low-molecular-weight compounds and extend our insight into the mechanism of drug resistance. Based on a multi-platform of high-throughput metabonomics, SNP array analysis, karyotype and mutation, the metabolic phenotypes and genomic polymorphisms of CML patients and their diverse responses to imatinib were characterized. The untreated CML patients (UCML) showed different metabolic patterns from those of healthy controls, and the discriminatory metabolites suggested the perturbed metabolism of the urea cycle, tricarboxylic acid cycle, lipid metabolism, and amino acid turnover in UCML. After imatinib treatment, patients sensitive to imatinib (SCML) and patients resistant to imatinib (RCML) had similar metabolic phenotypes to those of healthy controls and UCML, respectively. SCML showed a significant metabolic response to imatinib, with marked restoration of the perturbed metabolism. Most of the metabolites characterizing CML were adjusted to normal levels, including the intermediates of the urea cycle and tricarboxylic acid cycle (TCA). In contrast, neither cytogenetic nor metabonomic analysis indicated any positive response to imatinib in RCML. We report for the first time the associated genetic and metabonomic responses of CML patients to imatinib and show that the perturbed in vivo metabolism of UCML is independent of imatinib treatment in resistant patients. Thus, metabonomics can potentially characterize patients' sensitivity or resistance to drug intervention.	[A, Jiye; Wang, Guangji; Yan, Bei; Huang, Qing; Zha, Weibin; Liu, Linsheng; Cao, Bei; Shi, Jian; Li, Mengjie] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China; [Qian, Sixuan; Zhang, Sujiang; Ni, Lingna; Hong, Ming; Wu, Hanxin; Lu, Hua; Li, Jianyong] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Peoples R China	China Pharmaceutical University; Nanjing Medical University	A, JY (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China.	lijianyonglm@medmail.com.cn	li, mengjie/GRS-3931-2022; Shi, Jian/Y-9055-2019; Shi, Jian/Q-1667-2018; liu, linsheng/AGF-5590-2022	Shi, Jian/0000-0003-2609-0094; Shi, Jian/0000-0003-2609-0094; liu, linsheng/0000-0001-5371-3109; Huang, Qing/0000-0001-6803-8038	National Natural Science Foundation of the People's Republic of China [81070437, 30700461]; National Key New Drug Creation Special Programs [2009ZX09304-001, 2009ZX09502-004]; Jiangsu Province Social Development Foundation [BE2008673]; Jiangsu Province's Outstanding Medical Academic Leader Program [LJ200623]; National Science & Technology Pillar Program of China [2008BAI61B01]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); National Key New Drug Creation Special Programs; Jiangsu Province Social Development Foundation; Jiangsu Province's Outstanding Medical Academic Leader Program; National Science & Technology Pillar Program of China	This work was supported by the National Natural Science Foundation of the People's Republic of China (No. 81070437,30700461), the National Key New Drug Creation Special Programs (2009ZX09304-001 and 2009ZX09502-004), Jiangsu Province Social Development Foundation (BE2008673), Jiangsu Province's Outstanding Medical Academic Leader Program (LJ200623), and the National Science & Technology Pillar Program of China (Grant No. 2008BAI61B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Batetta B, 2006, EUR J LIPID SCI TECH, V108, P687, DOI 10.1002/ejlt.200600015; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; Branford S, 2003, LEUKEMIA, V17, P2401, DOI 10.1038/sj.leu.2403158; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ellis DI, 2007, PHARMACOGENOMICS, V8, P1243, DOI 10.2217/14622416.8.9.1243; Eriksson L., 2001, MULTI MEGAVARIATE DA; Fan TWM, 2006, DRUG METAB REV, V38, P707, DOI 10.1080/03602530600959599; Franceschino A, 2008, HAEMATOLOGICA, V93, P317, DOI 10.3324/haematol.11680; Gottardi M, 2005, NEW ENGL J MED, V353, P2722, DOI 10.1056/NEJMc052500; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Johansson B, 2002, ACTA HAEMATOL-BASEL, V107, P76, DOI 10.1159/000046636; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kantarjian H, 2008, BLOOD, V111, P1774, DOI 10.1182/blood-2007-09-110189; Kantarjian HM, 2003, CANCER-AM CANCER SOC, V97, P1033, DOI 10.1002/cncr.11223; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Kominsky DJ, 2009, CLIN CANCER RES, V15, P3442, DOI 10.1158/1078-0432.CCR-08-3291; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; McWeeney SK, 2010, BLOOD, V115, P315, DOI 10.1182/blood-2009-03-210732; Mitelman F., 1995, ISCN INT SYSTEM HUMA; Morvan D, 2007, CANCER RES, V67, P2150, DOI 10.1158/0008-5472.CAN-06-2346; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nowak D, 2010, BLOOD, V115, P1049, DOI 10.1182/blood-2009-03-210377; Oksman-Caldentey KM, 2005, CURR OPIN BIOTECH, V16, P174, DOI 10.1016/j.copbio.2005.02.007; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rowley JD, 2008, SCIENCE, V321, P1302, DOI 10.1126/science.1163791; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sviridov D, 2002, ATHEROSCLEROSIS, V161, P245, DOI 10.1016/S0021-9150(01)00677-3; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Xu GW, 2001, METH MOL B, V162, P459; Yong ASM, 2006, BLOOD, V107, P205, DOI 10.1182/blood-2005-05-2155; Zheng C, 2006, LEUKEMIA, V20, P1028, DOI 10.1038/sj.leu.2404227	44	14	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13186	10.1371/journal.pone.0013186	http://dx.doi.org/10.1371/journal.pone.0013186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949032	Green Published, gold, Green Submitted			2022-12-25	WOS:000282676700005
J	Lambard, S; Reichman, S; Berlinicke, C; Niepon, ML; Goureau, O; Sahel, JA; Leveillard, T; Zack, DJ				Lambard, Sophie; Reichman, Sacha; Berlinicke, Cynthia; Niepon, Marie-Laure; Goureau, Olivier; Sahel, Jose-Alain; Leveillard, Thierry; Zack, Donald J.			Expression of Rod-Derived Cone Viability Factor: Dual Role of CRX in Regulating Promoter Activity and Cell-Type Specificity	PLOS ONE			English	Article							THIOREDOXIN-LIKE PROTEIN; HOMEOBOX GENE; IDENTIFICATION; MUTATIONS; LINE; NRL; DYSTROPHY; THERAPY	Background: RdCVF and RdCVF2, encoded by the nucleoredoxin-like genes NXNL1 and NXNL2, are trophic factors with therapeutic potential that are involved in cone photoreceptor survival. Studying how their expression is regulated in the retina has implications for understanding both their activity and the mechanisms determining cell-type specificity within the retina. Methodology/Principal Findings: In order to define and characterize their promoters, a series of luciferase/GFP reporter constructs that contain various fragments of the 5'-upstream region of each gene, both murine and human, were tested in photoreceptor-like and non-photoreceptor cell lines and also in a biologically more relevant mouse retinal explant system. For NXNL1, 5'-deletion analysis identified the human -205/+57 bp and murine -351/+51 bp regions as having promoter activity. Moreover, in the retinal explants these constructs drove expression specifically to photoreceptor cells. For NXNL2, the human -393/+27 bp and murine -195/+70 bp regions were found to be sufficient for promoter activity. However, despite the fact that endogenous NXNL2 expression is photoreceptor-specific within the retina, neither of these DNA sequences nor larger upstream regions demonstrated photoreceptor-specific expression. Further analysis showed that a 79 bp NXNL2 positive regulatory sequence (-393 to 315 bp) combined with a 134 bp inactive minimal NXNL1 promoter fragment (-77 to +57 bp) was able to drive photoreceptor-specific expression, suggesting that the minimal NXNL1 fragment contains latent elements that encode cell-type specificity. Finally, based on bioinformatic analysis that suggested the importance of a CRX binding site within the minimal NXNL1 fragment, we found by mutation analysis that, depending on the context, the CRX site can play a dual role. Conclusions/Significance: The regulation of the Nucleoredoxin-like genes involves a CRX responsive element that can act as both as a positive regulator of promoter activity and as a modulator of cell-type specificity.	[Lambard, Sophie; Reichman, Sacha; Niepon, Marie-Laure; Goureau, Olivier; Sahel, Jose-Alain; Leveillard, Thierry; Zack, Donald J.] INSERM, Dept Genet, U968, Paris, France; [Lambard, Sophie; Reichman, Sacha; Niepon, Marie-Laure; Goureau, Olivier; Sahel, Jose-Alain; Leveillard, Thierry; Zack, Donald J.] UPMC Univ Paris 06, INSERM, UMR S 968, Inst Vis, Paris, France; [Lambard, Sophie; Reichman, Sacha; Niepon, Marie-Laure; Goureau, Olivier; Sahel, Jose-Alain; Leveillard, Thierry; Zack, Donald J.] CNRS, UMR 7210, Paris, France; [Berlinicke, Cynthia; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Lambard, S (corresponding author), INSERM, Dept Genet, U968, Paris, France.	thierry.leveillard@inserm.fr	GOUREAU, Olivier/ABH-9547-2020; Léveillard, Thierry/AAR-1804-2020; Reichman, Sacha/R-7581-2017; GOUREAU, Olivier/F-2752-2017; Sahel, Jose-Alain/F-3172-2017	GOUREAU, Olivier/0000-0001-7730-9143; Léveillard, Thierry/0000-0001-5692-8770; Reichman, Sacha/0000-0003-1776-6339; GOUREAU, Olivier/0000-0001-7730-9143; Sahel, Jose-Alain/0000-0002-4831-1153; Zack, Don/0000-0002-7966-1973	Agence Nationale de la Recherche (ANR); Inserm; Conventions Industrielles de Formation par la Recherche (CIFRE); National Institutes of Health (NIH); Foundation Fighting Blindness; European Vision Institute; NATIONAL EYE INSTITUTE [R01EY009769] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Conventions Industrielles de Formation par la Recherche (CIFRE); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); European Vision Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by funds from Agence Nationale de la Recherche (ANR, Chaire d'excellence), Inserm, Conventions Industrielles de Formation par la Recherche (CIFRE), National Institutes of Health (NIH), Foundation Fighting Blindness, and European Vision Institute FP6 programme acronym GENORET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameixa C, 2000, BIOCHEM J, V347, P485, DOI 10.1042/0264-6021:3470485; Chalmel F, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-74; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; Cronin T, 2007, CURR GENE THER, V7, P121, DOI 10.2174/156652307780363143; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Fridlich R, 2009, MOL CELL PROTEOMICS, V8, P1206, DOI 10.1074/mcp.M800406-MCP200; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Goodwin P, 2008, CURR OPIN OPHTHALMOL, V19, P255, DOI 10.1097/ICU.0b013e3282fc27fc; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Ikeda T, 2007, BIOCHEM BIOPH RES CO, V357, P383, DOI 10.1016/j.bbrc.2007.03.133; Kennan A, 2005, TRENDS GENET, V21, P103, DOI 10.1016/j.tig.2004.12.001; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Leveillard T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000866; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Pittler SJ, 2004, J BIOL CHEM, V279, P19800, DOI 10.1074/jbc.M401864200; Reichman S, 2010, HUM MOL GENET, V19, P250, DOI 10.1093/hmg/ddp484; Roger J, 2006, DEV BIOL, V298, P527, DOI 10.1016/j.ydbio.2006.07.003; Sahel JA, 2005, CR BIOL, V328, P163, DOI 10.1016/j.crvi.2004.12.007; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang J, 2007, BIOCHEM BIOPH RES CO, V357, P8, DOI 10.1016/j.bbrc.2007.02.153; Wang QL, 2004, HUM MOL GENET, V13, P1025, DOI 10.1093/hmg/ddh117; Wang XW, 2008, FREE RADICAL BIO MED, V45, P336, DOI 10.1016/j.freeradbiomed.2008.04.028; Wang XW, 2007, FREE RADICAL BIO MED, V42, P247, DOI 10.1016/j.freeradbiomed.2006.10.040; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Yoshida T, 2005, NUCLEIC ACIDS RES, V33, P3465, DOI 10.1093/nar/gki653; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4	40	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13075	10.1371/journal.pone.0013075	http://dx.doi.org/10.1371/journal.pone.0013075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949100	Green Submitted, Green Published, gold			2022-12-25	WOS:000282633700004
J	Feng, J; Wang, QS; Chiang, A; Chen, BY				Feng, Jing; Wang, Qing-shan; Chiang, Ambrose; Chen, Bao-yuan			The Effects of Sleep Hypoxia on Coagulant Factors and Hepatic Inflammation in Emphysematous Rats	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; FACTOR-KAPPA-B; COPD PATIENTS; NOCTURNAL DESATURATION; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; ALVEOLAR HYPOXIA; OXYGEN; HYPERTENSION	Objectives: To develop a sleep hypoxia (SH) in emphysema (SHE) rat model and to explore whether SHE results in more severe hepatic inflammation than emphysema alone and whether the inflammation changes levels of coagulant/anticoagulant factors synthesized in the liver. Methods: Seventy-five rats were put into 5 groups: SH control (SHCtrl), treated with sham smoke exposure (16 weeks) and SH exposure (12.5% O-2, 3 h/d, latter 8 weeks); emphysema control (ECtrl), smoke exposure and sham SH exposure (21% O-2); short SHE (SHEShort), smoke exposure and short SH exposure (1.5 h/d); mild SHE (SHEMild), smoke exposure and mild SH exposure (15% O-2); standard SHE (SHEStand), smoke exposure and SH exposure. Therefore, ECtrl, SHEShort, SHEMild and SHEStand group were among emphysematous groups. Arterial blood gas (ABG) data was obtained during preliminary tests. After exposure, hepatic inflammation (interleukin -6 [IL-6] mRNA and protein, tumor necrosis factor alpha [TNF alpha] mRNA and protein) and liver coagulant/anticoagulant factors (antithrombin [AT], fibrinogen [FIB] and Factor VIII [F VIII]) were evaluated. SPSS 11.5 software was used for statistical analysis. Results: Characteristics of emphysema were obvious in emphysematous groups and ABGs reached SH criteria on hypoxia exposure. Hepatic inflammation parameters and coagulant factors are the lowest in SHCtrl and the highest in SHEStand while AT is the highest in SHCtrl and the lowest in SHEStand. Inflammatory cytokines of liver correlate well with coagulant factors positively and with AT negatively. Conclusions: When SH is combined with emphysema, hepatic inflammation and coagulability enhance each other synergistically and produce a more significant liver-derivative inflammatory and prothrombotic status.	[Feng, Jing; Chen, Bao-yuan] Tianjin Med Univ, Gen Hosp, Resp Dept, Tianjin, Peoples R China; [Feng, Jing; Chiang, Ambrose] Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC USA; [Wang, Qing-shan] Shandong Univ, Inst Toxicol, Jinan 250100, Shandong, Peoples R China	Tianjin Medical University; Duke University; Shandong University	Feng, J (corresponding author), Tianjin Med Univ, Gen Hosp, Resp Dept, Tianjin, Peoples R China.	zyyhxkcby@yahoo.com.cn	Wang, Qingshan/P-4861-2014	Wang, Qingshan/0000-0002-8724-7465	National Natural Science Foundation of China [30800507, 30770934]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from National Natural Science Foundation of China (No. 30800507, 30770934). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, P165; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barnes PJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000220; Becker HF, 1999, AM J RESP CRIT CARE, V159, P112, DOI 10.1164/ajrccm.159.1.9803037; Bendz B, 2000, LANCET, V356, P1657, DOI 10.1016/S0140-6736(00)03165-2; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P74, DOI 10.1164/rccm.200409-1257OC; Brijker F, 2001, CHEST, V119, P1820, DOI 10.1378/chest.119.6.1820; Casey KR, 2007, CHEST, V131, P1936, DOI 10.1378/chest.06-2334; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Chao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-54; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Feng J, 2009, SLEEP BREATH, V13, P277, DOI 10.1007/s11325-009-0246-6; Feng Jing, 2007, Zhonghua Yi Xue Za Zhi, V87, P774; Feng Jing, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P202; FLETCHER EC, 1992, CHEST, V101, P649, DOI 10.1378/chest.101.3.649; FLETCHER EC, 1987, CHEST, V92, P604, DOI 10.1378/chest.92.4.604; Fuhrmann V, 2009, INTENS CARE MED, V35, P1397, DOI 10.1007/s00134-009-1508-2; GERTLER JP, 1993, J VASC SURG, V18, P939, DOI 10.1016/0741-5214(93)90548-Z; GERTLER JP, 1991, J VASC SURG, V13, P428, DOI 10.1067/mva.1991.25767; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Gonzalez NC, 2010, ADV EXP MED BIOL, V662, P27, DOI 10.1007/978-1-4419-1241-1_3; Horner RL, 1997, J NEUROSCI, V17, P7541; Kardos Peter, 2006, MedGenMed, V8, P54; Kim Victor, 2008, Proc Am Thorac Soc, V5, P513, DOI 10.1513/pats.200708-124ET; KOO KW, 1975, AM J MED, V58, P663, DOI 10.1016/0002-9343(75)90502-1; Krachman Samuel, 2008, Proc Am Thorac Soc, V5, P536, DOI 10.1513/pats.200708-134ET; Krachman SL, 2005, CHEST, V128, P3221, DOI 10.1378/chest.128.5.3221; Lee LH, 2005, AM J RESP CRIT CARE, V172, P987, DOI 10.1164/rccm.200501-041OC; Lewis CA, 2009, THORAX, V64, P133, DOI 10.1136/thx.2007.088930; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Nunes DM, 2009, LUNG, V187, P159, DOI 10.1007/s00408-009-9147-5; O'Donoghue FJ, 2004, J PHYSIOL-LONDON, V559, P663, DOI 10.1113/jphysiol.2004.066084; O'Reilly P, 2007, CURR OPIN PULM MED, V13, P120, DOI 10.1097/MCP.0b013e32802c7cfe; OLDS RJ, 1994, SEMIN THROMB HEMOST, V20, P353, DOI 10.1055/s-2007-1001927; Orem JM, 2005, SLEEP, V28, P801, DOI 10.1093/sleep/28.7.801; Papaioannou AI, 2010, RESP MED, V104, P275, DOI 10.1016/j.rmed.2009.09.016; PDE TM, 2008, J BRAS PNEUMOL, V34, P567; Plywaczewski R, 2000, CHEST, V117, P679, DOI 10.1378/chest.117.3.679; Rota S, 1998, BLOOD, V91, P508, DOI 10.1182/blood.V91.2.508.508_508_515; Sabit R, 2010, CHEST, V138, P47, DOI 10.1378/chest.09-2764; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sergi M, 2002, RESPIRATION, V69, P117, DOI 10.1159/000056313; Tapson Victor F, 2005, Proc Am Thorac Soc, V2, P71, DOI 10.1513/pats.200407-038MS; Ten Vadim S, 2002, Curr Opin Crit Care, V8, P242, DOI 10.1097/00075198-200206000-00008; THURLBEC.WM, 1967, THORAX, V22, P483, DOI 10.1136/thx.22.6.483; Tillie-Leblond I, 2006, ANN INTERN MED, V144, P390, DOI 10.7326/0003-4819-144-6-200603210-00005; Undas A, 2009, THROMB HAEMOSTASIS, V102, P1176, DOI 10.1160/TH09-02-0118; Vaidyula VR, 2009, THROMB RES, V124, P259, DOI 10.1016/j.thromres.2008.12.030; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820; Viegi G, 2001, RESPIRATION, V68, P4, DOI 10.1159/000050456; Wagner U, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-12	55	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13201	10.1371/journal.pone.0013201	http://dx.doi.org/10.1371/journal.pone.0013201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949089	Green Published, gold			2022-12-25	WOS:000282568400013
J	Syngkon, A; Elluri, S; Koley, H; Rompikuntal, PK; Saha, DR; Chakrabarti, MK; Bhadra, RK; Wai, SN; Pal, A				Syngkon, Aurelia; Elluri, Sridhar; Koley, Hemanta; Rompikuntal, Pramod K.; Saha, Dhira Rani; Chakrabarti, Manoj K.; Bhadra, Rupak K.; Wai, Sun Nyunt; Pal, Amit			Studies on a Novel Serine Protease of a Delta hapA Delta prtV Vibrio cholerae O1 Strain and Its Role in Hemorrhagic Response in the Rabbit Ileal Loop Model	PLOS ONE			English	Article							HEMAGGLUTININ PROTEASE; EXTRACELLULAR PROTEASES; VACCINE STRAINS; EL-TOR; GENE; VIRULENCE; TOXIN; METALLOPROTEASE; PURIFICATION; CLONING	Background: Two well-characterized proteases secreted by Vibrio cholerae O1 strains are hemagglutinin protease (HAP) and V. cholerae protease (PrtV). The hapA and prtV knock out mutant, V. cholerae O1 strain CHA6.8 Delta prtV, still retains residual protease activity. We initiated this study to characterize the protease present in CHA6.8 Delta prtV strain and study its role in pathogenesis in rabbit ileal loop model (RIL). Methodology/Principal Findings: We partially purified the residual protease secreted by strain CHA6.8DprtV from culture supernatant by anion-exchange chromatography. The major protein band in native PAGE was identified by MS peptide mapping and sequence analysis showed homology with a 59-kDa trypsin-like serine protease encoded by VC1649. The protease activity was partially inhibited by 25 mM PMSF and 10 mM EDTA and completely inhibited by EDTA and PMSF together. RIL assay with culture supernatants of strains C6709 (FA ratio 1.1+/-0.3 n = 3), CHA6.8 (FA ratio 1.08+/-0.2 n = 3), CHA6.8 Delta prtV (FA ratio 1.02+/-0.2 n = 3) and partially purified serine protease from CHA6.8 Delta prtV (FA ratio 1.2+/-0.3 n = 3) induced fluid accumulation and histopathological studies on rabbit ileum showed destruction of the villus structure with hemorrhage in all layers of the mucosa. RIL assay with culture supernatant of CHA6.8 Delta prtV Delta VC1649 strain (FA ratio 0.11+/-0.005 n = 3) and with protease incubated with PMSF and EDTA (FA ratio 0.3+/-0.05 n = 3) induced a significantly reduced FA ratio with almost complete normal villus structure. Conclusion: Our results show the presence of a novel 59-kDa serine protease in a Delta hapA Delta prtV V. cholerae O1 strain and its role in hemorrhagic response in RIL model.	[Syngkon, Aurelia; Elluri, Sridhar; Chakrabarti, Manoj K.; Pal, Amit] Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata, West Bengal, India; [Koley, Hemanta] Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, West Bengal, India; [Saha, Dhira Rani] Natl Inst Cholera & Enter Dis, Div Histol & Electron Microscopy, Kolkata, West Bengal, India; [Elluri, Sridhar; Rompikuntal, Pramod K.; Wai, Sun Nyunt] Umea Univ, Dept Mol Biol, UCMR, Umea, Sweden; [Bhadra, Rupak K.] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, West Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Umea University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Syngkon, A (corresponding author), Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata, West Bengal, India.	apal7364@rediffmail.com	rompikuntal, pramod/C-6917-2015	rompikuntal, pramod/0000-0002-4754-4676; Wai, Sun Nyunt/0000-0003-4793-4671	Swedish Foundation for International Cooperation in Research and Higher Education (STINT), Sweden [IG2008 2049]; Department of Biotechnology, India; Indian Council of Medical Research, New Delhi, India; STINT	Swedish Foundation for International Cooperation in Research and Higher Education (STINT), Sweden; Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); STINT	This work was supported by grants from the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), Sweden (Institutional Grants IG2008 2049). The awards of Senior Research Fellowship to A. S. is from the Department of Biotechnology, India and to S. E. from the Indian Council of Medical Research, New Delhi, India and also from STINT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIOSCA EG, 1991, J FISH DIS, V14, P103, DOI 10.1111/j.1365-2761.1991.tb00581.x; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; BOOTH BA, 1984, INFECT IMMUN, V45, P558, DOI 10.1128/IAI.45.3.558-560.1984; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P427; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; FIELDS PI, 1992, J CLIN MICROBIOL, V30, P2118, DOI 10.1128/JCM.30.8.2118-2121.1992; FINKELSTEIN RA, 1992, INFECT IMMUN, V60, P472, DOI 10.1128/IAI.60.2.472-478.1992; FINKELSTEIN RA, 1982, INFECT IMMUN, V36, P1199, DOI 10.1128/IAI.36.3.1199-1208.1982; FINKELSTEINRR, 1983, P NATL ACAD SCI USA, V80, P1092; Fullner KJ, 2002, J EXP MED, V195, P1455, DOI 10.1084/jem.20020318; Ghosh A, 2006, INFECT IMMUN, V74, P2937, DOI 10.1128/IAI.74.5.2937-2946.2006; GILL DM, 1979, J INFECT DIS, V139, P674, DOI 10.1093/infdis/139.6.674; Haralalka S, 2003, J BACTERIOL, V185, P4672, DOI 10.1128/JB.185.16.4672-4682.2003; Harrington DJ, 1996, INFECT IMMUN, V64, P1885, DOI 10.1128/IAI.64.6.1885-1891.1996; HASE CC, 1991, J BACTERIOL, V173, P3311; HASE CC, 1993, MICROBIOL REV, V57, P823; HASE CC, 1990, INFECT IMMUN, V58, P4011; Ishihara M, 2002, MICROBIOL IMMUNOL, V46, P299, DOI 10.1111/j.1348-0421.2002.tb02699.x; Lee CY, 2002, FEMS MICROBIOL LETT, V209, P31, DOI 10.1111/j.1574-6968.2002.tb11105.x; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Mel SF, 2000, INFECT IMMUN, V68, P6487, DOI 10.1128/IAI.68.11.6487-6492.2000; MILTON DL, 1992, J BACTERIOL, V174, P7235, DOI 10.1128/jb.174.22.7235-7244.1992; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Miyoshi S, 2006, J DERMATOL, V33, P589, DOI 10.1111/j.1346-8138.2006.00139.x; Ogierman MA, 1997, J BACTERIOL, V179, P7072, DOI 10.1128/jb.179.22.7072-7080.1997; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Rodriguez BL, 2001, INFECT IMMUN, V69, P613, DOI 10.1128/IAI.69.1.613-616.2001; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; SRIMINOVA NI, 2004, MICROB PATHOG, V36, P131; Toma C, 1996, INFECT IMMUN, V64, P4495, DOI 10.1128/IAI.64.11.4495-4500.1996; Toma C, 1996, FEMS MICROBIOL LETT, V135, P143, DOI 10.1016/0378-1097(95)00463-7; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Wang J, 2008, MICROB PATHOGENESIS, V44, P494, DOI 10.1016/j.micpath.2008.01.001; Wu ZY, 2000, CELL MICROBIOL, V2, P11, DOI 10.1046/j.1462-5822.2000.00025.x; YOUNG DB, 1982, INFECT IMMUN, V37, P875, DOI 10.1128/IAI.37.3.875-883.1982; Zhou X, 2004, INFECT IMMUN, V72, P389, DOI 10.1128/IAI.72.1.389-397.2004; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	38	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13122	10.1371/journal.pone.0013122	http://dx.doi.org/10.1371/journal.pone.0013122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927349	gold, Green Published, Green Submitted			2022-12-25	WOS:000282312600035
J	Salim, NN; Feig, AL				Salim, Nilshad N.; Feig, Andrew L.			An Upstream Hfq Binding Site in the fhlA mRNA Leader Region Facilitates the OxyS-fhlA Interaction	PLOS ONE			English	Article							ESCHERICHIA-COLI-HFQ; SM-LIKE PROTEIN; SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; RIBOSOME-BINDING; REGULATORY RNA; VIRULENCE; DSRA; SALMONELLA	Background: To survive, bacteria must be able to adapt to environmental stresses. Small regulatory RNAs have been implicated as intermediates in a variety of stress-response pathways allowing dynamic gene regulation. The RNA binding protein Hfq facilitates this process in many cases, helping sRNAs base pair with their target mRNAs and initiate gene regulation. Although Hfq has been identified as a critical component in many RNPs, the manner by which Hfq controls these interactions is not known. Methodology/Principal Findings: To test the requirement of Hfq in these mRNA-sRNA complexes, the OxyS-fhlA system was used as a model. OxyS is induced in response to oxidative stress and down regulates the translation of fhlA, a gene encoding a transcriptional activator for formate metabolism. Biophysical characterization of this system previously used a minimal construct of the fhlA mRNA which inadvertently removed a critical element within the leader sequence of this mRNA that effected thermodynamics and kinetics for the interaction with Hfq. Conclusions/Significance: Herein, we report thermodynamic, kinetic and structural mapping studies during binary and ternary complex formation between Hfq, OxyS and fhlA mRNA. Hfq binds fhlA mRNA using both the proximal and distal surfaces and stimulates association kinetics between the sRNA and mRNA but remains bound to fhlA forming a ternary complex. The upstream Hfq binding element within fhlA is similar to (ARN) x elements recently identified in other mRNAs regulated by Hfq. This work leads to a kinetic model for the dynamics of these complexes and the regulation of gene expression by bacterial sRNAs.	[Salim, Nilshad N.; Feig, Andrew L.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Wayne State University	Salim, NN (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	afeig@chem.wayne.edu	Feig, Andrew/B-7414-2011	Feig, Andrew/0000-0002-5783-1097	National Institutes of Health [R01-GM075068]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Institutes of Health R01-GM075068 (to A.L.F.). Purchase of the Biacore was generously supported by Wayne State University, Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Argaman L, 2000, J MOL BIOL, V300, P1101, DOI 10.1006/jmbi.2000.3942; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Brescia CC, 2003, RNA, V9, P33, DOI 10.1261/rna.2570803; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Franze de Fernandez M T, 1972, J Biol Chem, V247, P824; Lease RA, 2004, J MOL BIOL, V344, P1211, DOI 10.1016/j.jmb.2004.10.006; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; MATHEWS DH, 2006, CURR PROTOC BIOINFOR, pCH12, DOI DOI 10.1002/0471250953.BI1206S13; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mikulecky PJ, 2004, NAT STRUCT MOL BIOL, V11, P1206, DOI 10.1038/nsmb858; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Sun XG, 2006, BIOCHEMISTRY-US, V45, P4875, DOI 10.1021/bi0523613; Takada A, 1999, BIOCHEM BIOPH RES CO, V266, P579, DOI 10.1006/bbrc.1999.1863; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Updegrove T, 2008, BIOCHEMISTRY-US, V47, P11184, DOI 10.1021/bi800479p; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Windbichler N, 2008, RNA BIOL, V5, P30, DOI 10.4161/rna.5.1.5694; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zhang CX, 2009, CURR OPIN MOL THER, V11, P641	43	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13028	10.1371/journal.pone.0013028	http://dx.doi.org/10.1371/journal.pone.0013028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927406	Green Submitted, Green Published, gold			2022-12-25	WOS:000282210700009
J	Tommasi, S; Besaratinia, A; Wilczynski, SP; Pfeifer, GP				Tommasi, S.; Besaratinia, A.; Wilczynski, S. P.; Pfeifer, G. P.			Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy	ONCOGENE			English	Article						aneuploidy; chromosomal abnormalities; cytokinesis; tetraploidy; tumor suppressor gene	DOMAIN FAMILY PROTEIN; SUPPRESSOR RASSF1A; EPIGENETIC INACTIVATION; MICROTUBULE STABILITY; GENOMIC INSTABILITY; P53; ASSOCIATION; CHECKPOINT; GENE; TETRAPLOIDY	Loss of RASSF1A leads to several mitotic abnormalities, including cytokinesis failure and tetraploidization. Uncontrolled proliferation of tetraploid cells is known to trigger genomic instability and tumor development and is normally prevented through activation of a p53-dependent tetraploidy checkpoint. RASSF1A is the most commonly silenced and p53 is the most frequently mutated tumor suppressor gene in human cancer. However, their mutual contribution to tumorigenesis has never been investigated in animal models. Here, we explore whether concomitant loss of RASSF1A and p53 will result in increased levels of aneuploidy, genomic instability and tumorigenesis. We have intercrossed Rassf1a-knockout mice with mice lacking the p53 gene and generated a combination of single-and compound-mutant animals. Rassf1a(-/-) p53(-/-) mice were viable and fertile and developed normally. However, these mice were remarkably tumor prone and succumbed to malignancies significantly faster than single-mutant littermates, with a median survival time of 136 days (versus 158 days in p53(-/-) mice, P = 0.0207, and > 600 days in Rassf1a(-/-) animals, P<0.0001). Rassf1a-null mice with one functional p53 allele displayed a more moderate, yet tumor-prone phenotype, characterized by increased tumor multiplicity as compared with single knockouts. On cell-cycle profiling and cytogenetic analysis, cells derived from Rassf1a(-/-) p53(-/-) mice exhibited several mitotic defects associated with high levels of tetraploidy/ aneuploidy. Conversely, cells with a proficient p53 allele could better cope with the mitotic failures imposed by Rassf1a loss. Altogether, we provide the first experimental evidence for a pivotal role of Rassf1a as an early 'gatekeeper' gene, whose loss of function deteriorates cellular fitness by enhancing tetraploidization. Concomitant loss of p53, which causes unrestrained propagation of tetraploids into aneuploid cells, further undermines genomic stability and accelerates tumorigenesis. Oncogene (2011) 30, 690-700; doi:10.1038/onc.2010.440; published online 4 October 2010	[Tommasi, S.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Ctr Canc, Duarte, CA 91010 USA; [Wilczynski, S. P.] City Hope Natl Med Ctr, Ctr Canc, Dept Pathol Anat, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope	Tommasi, S (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Ctr Canc, Duarte, CA 91010 USA.	stommasi@coh.org	Tommasi, Stefania/J-6732-2012	Tommasi, Stefania/0000-0002-2157-2978; Besaratinia, Ahmad/0000-0001-7231-228X; Tommasi, Stella/0000-0001-6897-4985	University of California [17RT-0116]	University of California(University of California System)	We would like to thank Donna Isbell, Stefanie Wright-Golightly and Armando Amaya for mouse colony management; Lucy Brown and Claudio Spalla for FACS analysis; Dr Marilyn Slovak, Dr Joyce Collins and Victoria Bedell for cytogenetics on mouse cell lines and tumor PET sections. This work was supported by a grant from the University of California Tobacco related Disease Research Program (TRDRP grant 17RT-0116 to GPP).	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Chi YH, 2009, INT J CANCER, V124, P1483, DOI 10.1002/ijc.24094; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2003, HISTOL HISTOPATHOL, V18, P665, DOI 10.14670/HH-18.665; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Duensing A, 2005, BIOCHEM BIOPH RES CO, V331, P694, DOI 10.1016/j.bbrc.2005.03.157; Foley CJ, 2008, MOL CELL BIOL, V28, P4520, DOI 10.1128/MCB.02011-07; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Fukasawa K, 1997, ONCOGENE, V15, P1295, DOI 10.1038/sj.onc.1201482; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; GIARETTI W, 1994, LAB INVEST, V71, P904; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; PURDIE CA, 1994, ONCOGENE, V9, P603; Rabizadeh S, 2004, J BIOL CHEM, V279, P29247, DOI 10.1074/jbc.M401699200; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; SEGERS P, 1994, CANCER GENET CYTOGEN, V75, P120, DOI 10.1016/0165-4608(94)90163-5; Senovilla L, 2009, CELL CYCLE, V8, P1380, DOI 10.4161/cc.8.9.8305; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Song MS, 2005, J BIOL CHEM, V280, P3920, DOI 10.1074/jbc.M409115200; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Tommasi S, 2005, CANCER RES, V65, P92; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; VERDOODT B, 1994, CANCER GENET CYTOGEN, V78, P53, DOI 10.1016/0165-4608(94)90046-9; Vogel C, 2004, ONCOGENE, V23, P6845, DOI 10.1038/sj.onc.1207860; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	50	26	26	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	6					690	700		10.1038/onc.2010.440	http://dx.doi.org/10.1038/onc.2010.440			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	719GY	20890300	Bronze			2022-12-25	WOS:000287192000006
J	Kuettner, EB; Kettner, K; Keim, A; Svergun, DI; Volke, D; Singer, D; Hoffmann, R; Muller, EC; Otto, A; Kriegel, TM; Strater, N				Kuettner, E. Bartholomeus; Kettner, Karina; Keim, Antje; Svergun, Dmitri I.; Volke, Daniela; Singer, David; Hoffmann, Ralf; Mueller, Eva-Christina; Otto, Albrecht; Kriegel, Thomas M.; Straeter, Norbert			Crystal Structure of Hexokinase KlHxk1 of Kluyveromyces lactis A MOLECULAR BASIS FOR UNDERSTANDING THE CONTROL OF YEAST HEXOKINASE FUNCTIONS VIA COVALENT MODIFICATION AND OLIGOMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CRYSTALLOGRAPHY; CONFORMATIONAL-CHANGE; DOMAIN MOTIONS; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS INTERACTION; GLUCOKINASE ACTIVATORS; GLUCOSE REPRESSION; DIFFRACTION DATA; HIGH-RESOLUTION	Crystal structures of the unique hexokinase KlHxk1 of the yeast Kluyveromyces lactis were determined using eight independent crystal forms. In five crystal forms, a symmetrical ring-shaped homodimer was observed, corresponding to the physiological dimer existing in solution as shown by small-angle x-ray scattering. The dimer has a head-to-tail arrangement such that the small domain of one subunit interacts with the large domain of the other subunit. Dimer formation requires favorable interactions of the 15 N-terminal amino acids that are part of the large domain with amino acids of the small domain of the opposite subunit, respectively. The head-to-tail arrangement involving both domains of the two KlHxk1 subunits is appropriate to explain the reduced activity of the homodimer as compared with the monomeric enzyme and the influence of substrates and products on dimer formation and dissociation. In particular, the structure of the symmetrical KlHxk1 dimer serves to explain why phosphorylation of conserved residue Ser-15 may cause electrostatic repulsions with nearby negatively charged residues of the adjacent subunit, thereby inducing a dissociation of the homologous dimeric hexokinases KlHxk1 and ScHxk2. Two complex structures of KlHxk1 with bound glucose provide a molecular model of substrate binding to the open conformation and the subsequent classical domain closure motion of yeast hexokinases. The entirety of the novel data extends the current concept of glucose signaling in yeast and complements the induced-fit model by integrating the events of N-terminal phosphorylation and dissociation of homodimeric yeast hexokinases.	[Kettner, Karina; Kriegel, Thomas M.] Tech Univ Dresden, Carl Gustav Carus Med Fac, Inst Physiol Chem, D-01307 Dresden, Germany; [Kuettner, E. Bartholomeus; Keim, Antje; Volke, Daniela; Singer, David; Hoffmann, Ralf; Straeter, Norbert] Univ Leipzig, Fac Chem & Mineral, Ctr Biotechnol & Biomed, Inst Bioanalyt Chem, D-04103 Leipzig, Germany; [Svergun, Dmitri I.] DESY, Hamburg Outstn, European Mol Biol Lab, D-22603 Hamburg, Germany; [Mueller, Eva-Christina; Otto, Albrecht] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Technische Universitat Dresden; Leipzig University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kriegel, TM (corresponding author), Tech Univ Dresden, Carl Gustav Carus Med Fac, Inst Physiol Chem, Fetscherstr 74, D-01307 Dresden, Germany.	kriegel@mail.zih.tu-dresden.de; strater@bbz.uni-leipzig.de	Hoffmann, Ralf/ABD-8779-2020; Strater, Norbert/P-4856-2018	Svergun, Dmitri/0000-0003-0830-5696; Strater, Norbert/0000-0002-2001-0500				Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; ANDERSON CM, 1978, J MOL BIOL, V123, P1, DOI 10.1016/0022-2836(78)90373-X; ANDERSON CM, 1978, J MOL BIOL, V123, P15, DOI 10.1016/0022-2836(78)90374-1; ANDERSON WF, 1974, J MOL BIOL, V86, P261, DOI 10.1016/0022-2836(74)90017-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar D, 2003, J BIOL CHEM, V278, P39280, DOI 10.1074/jbc.M305706200; Behlke J, 1998, BIOCHEMISTRY-US, V37, P11989, DOI 10.1021/bi980914m; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; BENNETT WS, 1980, J MOL BIOL, V140, P211, DOI 10.1016/0022-2836(80)90103-5; Blume A, 2009, CARBOHYD RES, V344, P1567, DOI 10.1016/j.carres.2009.01.002; Bolotin-Fukuhara M, 2000, FEBS LETT, V487, P66, DOI 10.1016/S0014-5793(00)02282-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; CASSART JP, 1995, FEBS LETT, V371, P191, DOI 10.1016/0014-5793(95)00909-S; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Golbik R, 2001, BIOCHEMISTRY-US, V40, P1083, DOI 10.1021/bi001745k; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hayward S, 1999, PROTEINS, V36, P425, DOI 10.1002/(SICI)1097-0134(19990901)36:4<425::AID-PROT6>3.3.CO;2-J; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HOGGETT JG, 1992, BIOCHEM J, V287, P567, DOI 10.1042/bj2870567; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kettner K, 2007, FEMS YEAST RES, V7, P683, DOI 10.1111/j.1567-1364.2007.00259.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KRIEGEL TM, 1994, BIOCHEMISTRY-US, V33, P148, DOI 10.1021/bi00167a019; Kuettner EB, 2007, ACTA CRYSTALLOGR F, V63, P430, DOI 10.1107/S1744309107018271; Kuser P, 2008, PROTEINS, V72, P731, DOI 10.1002/prot.21956; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Matschinsky FM, 2006, DIABETES, V55, P1; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; MCDONALD RC, 1979, J BIOL CHEM, V254, P2942; MCDONALD RC, 1979, BIOCHEMISTRY-US, V18, P338, DOI 10.1021/bi00569a017; Milkowski C, 2001, J BACTERIOL, V183, P5223, DOI 10.1128/JB.183.18.5223-5229.2001; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; PRIOR C, 1993, MOL CELL BIOL, V13, P3882, DOI 10.1128/MCB.13.7.3882; Riboldi-Tunnicliffe A, 1999, J APPL CRYSTALLOGR, V32, P1003, DOI 10.1107/S0021889899008584; Riera A, 2008, BIOCHEM J, V415, P233, DOI 10.1042/BJ20080797; Rolland F, 2005, BIOCHEM SOC T, V33, P269, DOI 10.1042/BST0330269; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Schaffrath R, 2000, FUNGAL GENET BIOL, V30, P173, DOI 10.1006/fgbi.2000.1221; SCHMIDT JJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P471, DOI 10.1016/0003-9861(73)90538-9; STEITZ TA, 1973, J MOL BIOL, V78, P551, DOI 10.1016/0022-2836(73)90475-0; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TIELENS AGM, 1994, J BIOL CHEM, V269, P24736; VOJTEK AB, 1990, EUR J BIOCHEM, V190, P371, DOI 10.1111/j.1432-1033.1990.tb15585.x; Weirich J, 1997, EUR J BIOCHEM, V249, P248, DOI 10.1111/j.1432-1033.1997.t01-1-00248.x; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	64	20	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41019	41033		10.1074/jbc.M110.185850	http://dx.doi.org/10.1074/jbc.M110.185850			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943665	Green Published, hybrid			2022-12-25	WOS:000285414400065
J	Kim, KS; Choi, HW; Yoon, HE; Kim, IY				Kim, Ki Soon; Choi, Hae Woong; Yoon, Hee Eun; Kim, Ick Young			Reactive Oxygen Species Generated by NADPH Oxidase 2 and 4 Are Required for Chondrogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; NOX-FAMILY; ENDOCHONDRAL OSSIFICATION; CELL-PROLIFERATION; GROWTH-FACTOR; IN-VITRO; EXPRESSION; INSULIN; CARTILAGE; SURVIVAL	Although generation of reactive oxygen species (ROS) by NADPH oxidases (Nox) is thought to be important for signal transduction in nonphagocytic cells, little is known of the role ROS plays in chondrogenesis. We therefore examined the possible contribution of ROS generation to chondrogenesis using both ATDC5 cells and primary chondrocytes derived from mouse embryos. The intracellular level of ROS was increased during the differentiation process, which was then blocked by treatment with the ROS scavenger N-acetylcysteine. Expression of Nox1 and Nox2 was increased upon differentiation of ATDC5 cells and primary mouse chondrocytes, whereas that of Nox4, which was relatively high initially, was decreased gradually during chondrogenesis. In developing limb, Nox1 and Nox2 were highly expressed in prehypertrophic and hypertrophic chondrocytes. However, Nox4 was highly expressed in proliferating chondrocytes and prehypertrophic chondrocytes. Depletion of Nox2 or Nox4 expression by RNA interference blocked both ROS generation and differentiation of ATDC5 cells, whereas depletion of Nox1 had no such effect. We also found that ATDC5 cells depleted of Nox2 or Nox4 underwent apoptosis. Further, inhibition of Akt phosphorylation along with subsequent activation of ERK was observed in the cells. Finally, depletion of Nox2 or Nox4 inhibited the accumulation of proteoglycan in primary chondrocytes. Taken together, our data suggest that ROS generated by Nox2 or Nox4 are essential for survival and differentiation in the early stage of chondrogenesis.	[Kim, Ki Soon; Choi, Hae Woong; Yoon, Hee Eun; Kim, Ick Young] Korea Univ, Sch Life Sci & Biotechnol, Lab Cellular & Mol Biochem, Seoul 136701, South Korea	Korea University	Kim, IY (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Lab Cellular & Mol Biochem, 1,5 Ka, Seoul 136701, South Korea.	ickkim@korea.ac.kr		Choi, Hae Woong/0000-0001-9372-1875	Korean Government [2007-0053186]; Korea University	Korean Government(Korean Government); Korea University	This work was supported by Grant 2007-0053186 from the National Research Foundation of Korea funded by the Korean Government. This work was also supported in part by a Korea University grant.	ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beier F, 2010, J CELL BIOCHEM, V110, P573, DOI 10.1002/jcb.22604; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Goldstein BJ, 2005, ANTIOXID REDOX SIGN, V7, P1021, DOI 10.1089/ars.2005.7.1021; Grange L, 2006, ANTIOXID REDOX SIGN, V8, P1485, DOI 10.1089/ars.2006.8.1485; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Hidaka K, 2003, EXP CELL RES, V290, P254, DOI 10.1016/S0014-4827(03)00337-9; Kawakami Y, 2006, CURR OPIN CELL BIOL, V18, P723, DOI 10.1016/j.ceb.2006.10.007; Koh JM, 2006, J BONE MINER RES, V21, P1003, DOI [10.1359/jbmr.060406, 10.1359/JBMR.060406]; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lawlor MA, 2001, J CELL SCI, V114, P2903; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; Mouche S, 2007, BBA-MOL CELL RES, V1773, P1015, DOI 10.1016/j.bbamcr.2007.03.003; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; Nakajima A, 2003, ENDOCRINOLOGY, V144, P4659, DOI 10.1210/en.2003-0158; Panda DK, 2001, J BIOL CHEM, V276, P41229, DOI 10.1074/jbc.M104231200; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0; Phornphutkul C, 2006, MOL CELL ENDOCRINOL, V249, P107, DOI 10.1016/j.mce.2006.02.002; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Sasaki H, 2009, J MED INVESTIG, V56, P33, DOI 10.2152/jmi.56.33; Schroeder K, 2009, ARTERIOSCL THROM VAS, V29, P239, DOI 10.1161/ATVBAHA.108.174219; Shi DY, 2003, FEBS LETT, V542, P60, DOI 10.1016/S0014-5793(03)00338-7; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838	48	91	91	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40294	40302		10.1074/jbc.M110.126821	http://dx.doi.org/10.1074/jbc.M110.126821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20952384	Green Published, hybrid			2022-12-25	WOS:000285185500072
J	Landgraf, KE; Santell, L; Billeci, KL; Quan, C; Young, JC; Maun, HR; Kirchhofer, D; Lazarus, RA				Landgraf, Kyle E.; Santell, Lydia; Billeci, Karen L.; Quan, Clifford; Young, Judy C.; Maun, Henry R.; Kirchhofer, Daniel; Lazarus, Robert A.			Allosteric Peptide Activators of Pro-Hepatocyte Growth Factor Stimulate Met Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; AMINO-TERMINAL SEQUENCE; STRONG LIGAND-BINDING; FACTOR SCATTER FACTOR; C-MET; BOVINE TRYPSINOGEN; CRYSTAL-STRUCTURE; FACTOR/SCATTER FACTOR; ZYMOGEN ACTIVATION; STRUCTURAL BASIS	Hepatocyte growth factor (HGF) binds to its target receptor tyrosine kinase, Met, as a single-chain form (pro-HGF) or as a cleaved two-chain disulfide-linked alpha/beta-heterodimer. However, only two-chain HGF stimulates Met signaling. Proteolytic cleavage of the Arg(494)-Val(495) peptide bond in the zymogen- like pro-HGF results in allosteric activation of the serine protease-like beta-chain (HGF beta) which binds Met to initiate signaling. We use insights from the canonical trypsin-like serine protease activation mechanism to show that isolated peptides corresponding to the first 7-10 residues of the cleaved N terminus of the beta-chain stimulate Met phosphorylation by pro-HGF to levels that are similar to 25% of those stimulated by two-chain HGF. Biolayer interferometry data demonstrate that peptide VVNGIPTR (peptide V8) allosterically enhances proHGF beta binding to Met, resulting in a K-D(app) of 1.6 mu M, only 8-fold weaker than the Met/HGF beta-chain affinity. Most notably, in vitro cell stimulation with peptide V8 in the presence of pro-HGF leads to Akt phosphorylation, enhances cell survival, and facilitates cell migration between 75 and 100% of that found with two-chain HGF, thus revealing a novel approach for activation of Met signaling that bypasses proteolytic processing of pro-HGF. Peptide V8 is unable to enhance Met binding or signaling with HGF proteins having a mutated activation pocket (D672N). Furthermore, Gly substitution of the N-terminal Val residue in peptide V8 results in loss of all activity. Overall, these findings identify the activation pocket of the serine protease-like beta-chain as a "hot spot" for allosteric regulation of pro-HGF and have broad implications for developing selective allosteric activators of serine proteases and pseudoproteases.	[Kirchhofer, Daniel; Lazarus, Robert A.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Billeci, Karen L.; Young, Judy C.] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Quan, Clifford] Genentech Inc, Dept Small Mol Drug Discovery, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Lazarus, RA (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	lazarus.bob@gene.com						ANTONINI E, 1984, MOL CELL BIOCHEM, V60, P163; Ascenzi P, 1988, J Mol Recognit, V1, P130, DOI 10.1002/jmr.300010306; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BODE W, 1984, EUR J BIOCHEM, V144, P185, DOI 10.1111/j.1432-1033.1984.tb08447.x; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; BODE W, 1979, J MOL BIOL, V127, P357, DOI 10.1016/0022-2836(79)90227-4; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; Botkjaer KA, 2009, BIOCHEMISTRY-US, V48, P9606, DOI 10.1021/bi900510f; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Buchstein N, 2009, AM J PATHOL, V174, P2116, DOI 10.2353/ajpath.2009.080597; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72; Chirgadze DY, 1998, FEBS LETT, V430, P126, DOI 10.1016/S0014-5793(98)00558-4; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Conway K, 2006, WOUND REPAIR REGEN, V14, P2, DOI 10.1111/j.1743-6109.2005.00081.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DERMAN MP, 1995, AM J PHYSIOL-RENAL, V268, pF1211, DOI 10.1152/ajprenal.1995.268.6.F1211; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; JACKSON KW, 1978, THROMB RES, V13, P693, DOI 10.1016/0049-3848(78)90159-7; Kataoka H, 2003, CANCER METAST REV, V22, P223, DOI 10.1023/A:1023051500010; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Khan AR, 1998, PROTEIN SCI, V7, P815; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Kirchhofer D, 2004, J BIOL CHEM, V279, P39915, DOI 10.1074/jbc.M404795200; Kirchhofer D, 2007, P NATL ACAD SCI USA, V104, P5306, DOI 10.1073/pnas.0700184104; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; Lowman HB, 1998, BIOCHEMISTRY-US, V37, P8870, DOI 10.1021/bi980426e; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; Nayeri F, 2006, J DERMATOL SCI, V43, P49, DOI 10.1016/j.jdermsci.2006.03.004; Olsen OH, 2008, CELL MOL LIFE SCI, V65, P953, DOI 10.1007/s00018-007-7480-5; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Parr C, 2010, ANTI-CANCER AGENT ME, V10, P47, DOI 10.2174/1871520611009010047; Pasternak A, 1998, BIOCHEMISTRY-US, V37, P16201, DOI 10.1021/bi980951d; Peek M, 2002, J BIOL CHEM, V277, P47804, DOI 10.1074/jbc.M209778200; SHIMOMURA T, 1995, EUR J BIOCHEM, V229, P257, DOI 10.1111/j.1432-1033.1995.0257l.x; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Tolbert WD, 2007, P NATL ACAD SCI USA, V104, P14592, DOI 10.1073/pnas.0704290104; Tolbert WD, 2010, P NATL ACAD SCI USA, V107, P13264, DOI 10.1073/pnas.1005183107; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Ultsch M, 1998, STRUCT FOLD DES, V6, P1383, DOI 10.1016/S0969-2126(98)00138-5; VINCENT JP, 1976, FEBS LETT, V63, P240, DOI 10.1016/0014-5793(76)80103-2; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; WATANABE S, 1994, BIOCHEM BIOPH RES CO, V199, P1453, DOI 10.1006/bbrc.1994.1394; Webb CP, 1998, ONCOGENE, V17, P2019, DOI 10.1038/sj.onc.1202135; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	72	16	17	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40362	40372		10.1074/jbc.M110.179721	http://dx.doi.org/10.1074/jbc.M110.179721			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937841	hybrid, Green Published			2022-12-25	WOS:000285185500079
J	Wang, QA; Pless, SA; Lynch, JW				Wang, Qian; Pless, Stephan A.; Lynch, Joseph W.			Ligand- and Subunit-specific Conformational Changes in the Ligand-binding Domain and the TM2-TM3 Linker of alpha 1 beta 2 gamma 2 GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; DISTINCT STRUCTURAL-CHANGES; GATED ION-CHANNEL; CRYSTAL-STRUCTURE; LOOP F; BENZODIAZEPINE MODULATION; SIGNAL-TRANSDUCTION; GATING MECHANISM; PROTEIN MOBILITY; GLYCINE	Cys-loop receptor ligand binding sites are located at subunit interfaces where they are lined by loops A-C from one subunit and loops D-F from the adjacent subunit. Agonist binding induces large conformational changes in loops C and F. However, it is controversial as to whether these conformational changes are essential for gating. Here we used voltage clamp fluorometry to investigate the roles of loops C and F in gating the alpha 1 beta 2 gamma 2 GABA(A) receptor. Voltage clamp fluorometry involves labeling introduced cysteines with environmentally sensitive fluorophores and inferring structural rearrangements from ligand-induced fluorescence changes. Previous attempts to define the roles of loops C and F using this technique have focused on homomeric Cys-loop receptors. However, the problem with studying homomeric receptors is that it is difficult to eliminate the possibility of bound ligands interacting directly with attached fluorophores at the same site. Here we show that ligands binding to the beta 2-alpha 1 interface GABA binding site produce conformational changes at the adjacent subunit interface. This is most likely due to agonist-induced loop C closure directly altering loop F conformation at the adjacent alpha 1-beta 2 subunit interface. However, as antagonists and agonists produce identical alpha 1 subunit loop F conformational changes, these conformational changes appear unimportant for gating. Finally, we demonstrate that TM2-TM3 loops from adjacent beta 2 subunits in alpha 1 beta 2 receptors can dimerize via K24'C disulfides in the closed state. This result implies unexpected conformational mobility in this crucial part of the gating machinery. Together, this information provides new insights into the activation mechanisms of Cys-loop receptors.	[Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009	Pless, Stephan/0000-0001-6654-114X	Australian Research Council; National Health and Medical Research Council of Australia (NHMRC); University of Queensland	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland)	This work was supported in part by the Australian Research Council and the National Health and Medical Research Council of Australia (NHMRC).; Supported by a University of Queensland confirmation scholarship.	Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1997, MOL PHARMACOL, V52, P676, DOI 10.1124/mol.52.4.676; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Casula MA, 2001, J NEUROCHEM, V77, P445, DOI 10.1046/j.1471-4159.2001.00289.x; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Davies M, 1998, J NEUROCHEM, V70, P2188; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein J, 2005, J BIOL CHEM, V280, P1573, DOI 10.1074/jbc.M410881200; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Jones MV, 1998, J NEUROSCI, V18, P8590; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Khatri A, 2010, J PHYSIOL-LONDON, V588, P59, DOI 10.1113/jphysiol.2009.179705; Khatri A, 2009, BIOPHYS J, V96, P45, DOI 10.1016/j.bpj.2008.09.011; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Meera P, 2010, MOL PHARMACOL, V78, P918, DOI 10.1124/mol.109.062687; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mourot A, 2008, J NEUROCHEM, V105, P413, DOI 10.1111/j.1471-4159.2007.05151.x; Muroi Y, 2006, BIOCHEMISTRY-US, V45, P7013, DOI 10.1021/bi060222v; Muroi Y, 2009, BIOPHYS J, V96, P499, DOI 10.1016/j.bpj.2008.09.037; Padgett CL, 2008, J BIOL CHEM, V283, P2702, DOI 10.1074/jbc.M705699200; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Pless SA, 2009, J NEUROCHEM, V108, P1585, DOI 10.1111/j.1471-4159.2009.05930.x; Sedelnikova A, 2005, J BIOL CHEM, V280, P1535, DOI 10.1074/jbc.M409908200; Shan Q, 2002, J BIOL CHEM, V277, P44845, DOI 10.1074/jbc.M208647200; SIEGHART W, 2002, G Curr Top Med Chem, V2, P795; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Ueno S, 1997, J NEUROSCI, V17, P625; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; Wiltfong RE, 2009, J NEUROSCI, V29, P1626, DOI 10.1523/JNEUROSCI.4121-08.2009; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x; Yang Z, 2007, J BIOL CHEM, V282, P16803, DOI 10.1074/jbc.M611555200; Zhang JL, 2009, J PHYSIOL-LONDON, V587, P139, DOI 10.1113/jphysiol.2008.160093	54	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40373	40386		10.1074/jbc.M110.161513	http://dx.doi.org/10.1074/jbc.M110.161513			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937799	Green Published, hybrid			2022-12-25	WOS:000285185500080
J	Xu, ZJ; Vagnarelli, P; Ogawa, H; Samejima, K; Earnshaw, WC				Xu, Zhenjie; Vagnarelli, Paola; Ogawa, Hiromi; Samejima, Kumiko; Earnshaw, William C.			Gradient of Increasing Aurora B Kinase Activity Is Required for Cells to Execute Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; CENTROMERE PROTEIN INCENP; INNER CENTROMERE; MITOTIC SPINDLE; SURVIVIN; PHOSPHORYLATION; ACTIVATION; INHIBITION; MECHANISM; BOREALIN	INCENP, Borealin, Survivin, and Aurora B kinase comprise the chromosomal passenger complex, an essential regulator of mitotic events. INCENP (inner centromere protein) binds and activates Aurora B through a feedback loop involving phosphorylation of a Thr-Ser-Ser (TSS) motif near the INCENP C terminus. Here, we have examined the role of the TSS motif in vertebrate cells using an DT40 INCENPON/OFF conditional knock-out cell line in which mutants are expressed in the absence of wild-type INCENP. Our analysis confirms that regulated phosphorylation of the two serine residues (presumably by Aurora B) is critical for full activation of the kinase and is essential for cell viability. Cells expressing INCENP mutants bearing either phospho-null (TAA) or phospho-mimetic (TEE) mutations exhibit significant levels of Aurora B kinase activity but fail to undergo normal spindle elongation or complete cytokinesis. This work confirms previous suggestions that INCENP can act as a rheostat, with different INCENP mutants promoting differing degrees of kinase activation. Our results also reveal that mitotic progression is accompanied by a requirement for progressively higher levels of Aurora B kinase activity.	[Xu, Zhenjie; Vagnarelli, Paola; Ogawa, Hiromi; Samejima, Kumiko; Earnshaw, William C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Samejima, K (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	kumiko.samejima@ed.ac.uk; bill.earnshaw@ed.ac.uk	Xu, Zhenjie/A-6443-2014; Earnshaw, William/AAY-7438-2020; Vagnarelli, Paola/AAI-1996-2020	Vagnarelli, Paola/0000-0002-0000-2271; Earnshaw, William/0000-0002-7191-0621	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (to the W. C. E. laboratory).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Ahonen LJ, 2009, CHROMOSOMA, V118, P71, DOI 10.1007/s00412-008-0178-0; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Civelekoglu-Scholey G, 2006, BIOPHYS J, V90, P3966, DOI 10.1529/biophysj.105.078691; COOKE CA, 1987, J CELL BIOL, V105, P2053, DOI 10.1083/jcb.105.5.2053; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Mirchenko L, 2010, CURR BIOL, V20, P1396, DOI 10.1016/j.cub.2010.06.023; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vazquez-Novelle MD, 2010, CURR BIOL, V20, P1402, DOI 10.1016/j.cub.2010.06.036; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Xu ZJ, 2009, J CELL BIOL, V187, P637, DOI 10.1083/jcb.200906053	30	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40163	40170		10.1074/jbc.M110.181545	http://dx.doi.org/10.1074/jbc.M110.181545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956539	Green Published, hybrid			2022-12-25	WOS:000285185500061
J	Soprova, Z; Sauri, A; van Ulsen, P; Tame, JRH; den Blaauwen, T; Jong, WSP; Luirink, J				Soprova, Zora; Sauri, Ana; van Ulsen, Peter; Tame, Jeremy R. H.; den Blaauwen, Tanneke; Jong, Wouter S. P.; Luirink, Joen			A Conserved Aromatic Residue in the Autochaperone Domain of the Autotransporter Hbp Is Critical for Initiation of Outer Membrane Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENIC ESCHERICHIA-COLI; PARALLEL BETA-HELICES; HEMOGLOBIN PROTEASE; PASSENGER DOMAIN; SERINE-PROTEASE; BACTERIAL AUTOTRANSPORTER; CRYSTAL-STRUCTURE; COMMON THEMES; SECRETION; PROTEINS	Autotransporters are bacterial virulence factors that share a common mechanism by which they are transported to the cell surface. They consist of an N-terminal passenger domain and a C-terminal beta-barrel, which has been implicated in translocation of the passenger across the outer membrane (OM). The mechanism of passenger translocation and folding is still unclear but involves a conserved region at the C terminus of the passenger domain, the so-called autochaperone domain. This domain functions in the stepwise translocation process and in the folding of the passenger domain after translocation. In the autotransporter hemoglobin protease (Hbp), the autochaperone domain consists of the last rung of the beta-helix and a capping domain. To examine the role of this region, we have mutated several conserved aromatic residues that are oriented toward the core of the beta-helix. We found that non-conservative mutations affected secretion with Trp(1015) in the cap region as the most critical residue. Substitution at this position yielded a DegP-sensitive intermediate that is located at the periplasmic side of the OM. Further analysis revealed that Trp(1015) is most likely required for initiation of processive folding of the beta-helix at the cell surface, which drives sequential translocation of the Hbp passenger across the OM.	[Soprova, Zora; Sauri, Ana; van Ulsen, Peter; Jong, Wouter S. P.; Luirink, Joen] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Tame, Jeremy R. H.] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; [den Blaauwen, Tanneke] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Dept Mol Cytol, NL-1098 XH Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Yokohama City University; University of Amsterdam	Luirink, J (corresponding author), Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands.	joen.luirink@falw.vu.nl	Luirink, Joen/AAB-8658-2021	den Blaauwen, Tanneke/0000-0002-5403-5597; Jong, W.S.P./0000-0002-8907-6954; Luirink, J./0000-0001-8431-0804; Jong, Wouter/0000-0002-4132-4605; van Ulsen, Peter/0000-0002-2164-1611	Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by an "Aard en Levens Wetenschappen Open Program" grant from the Netherlands Organization for Scientific Research (NWO) (to A.S. and W.S.P.J.). and a Mosaic Grant from NWO (to Z.S.).	Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Bernstein HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/j.tim.2007.09.007; Brandon LD, 2001, J BACTERIOL, V183, P951, DOI 10.1128/JB.183.3.951-958.2001; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; den Blaauwen T, 2003, MOL MICROBIOL, V47, P539, DOI 10.1046/j.1365-2958.2003.03316.x; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Fink DL, 2003, J BACTERIOL, V185, P1608, DOI 10.1128/JB.185.5.1608-1615.2003; Gangwer KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/pnas.0707447104; Hashemzadeh-Bonehi L, 1998, MOL MICROBIOL, V30, P676, DOI 10.1046/j.1365-2958.1998.01116.x; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hodak H, 2007, RES MICROBIOL, V158, P631, DOI 10.1016/j.resmic.2007.08.001; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Johnson TA, 2009, J MOL BIOL, V389, P559, DOI 10.1016/j.jmb.2009.04.041; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kajava AV, 2006, J STRUCT BIOL, V155, P306, DOI 10.1016/j.jsb.2006.01.015; Kamen DE, 2000, BIOCHEMISTRY-US, V39, P15932, DOI 10.1021/bi001900v; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Konieczny MPJ, 2001, ANTON LEEUW INT J G, V80, P19, DOI 10.1023/A:1012084325728; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; Miller J.H., 1992, SHORT COURSE BACTERI, P150; OHNISHI Y, 1994, J BIOL CHEM, V269, P32800; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oliver DC, 2003, J BACTERIOL, V185, P489, DOI 10.1128/JB.185.2.489-495.2003; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Otto BR, 1998, J EXP MED, V188, P1091, DOI 10.1084/jem.188.6.1091; Otto BR, 2002, INFECT IMMUN, V70, P5, DOI 10.1128/IAI.70.1.5-10.2002; Purdy GE, 2007, J BACTERIOL, V189, P5566, DOI 10.1128/JB.00483-07; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Tajima N, 2010, J MOL BIOL, V402, P645, DOI 10.1016/j.jmb.2010.06.068; Tsai HH, 2006, STRUCTURE, V14, P1059, DOI 10.1016/j.str.2006.03.015; van Dooren SJM, 2001, FEMS MICROBIOL LETT, V205, P147, DOI 10.1016/S0378-1097(01)00454-2; Velarde JJ, 2004, J BIOL CHEM, V279, P31495, DOI 10.1074/jbc.M404424200; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Yen YT, 2008, TRENDS MICROBIOL, V16, P370, DOI 10.1016/j.tim.2008.05.003	49	47	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38224	38233		10.1074/jbc.M110.180505	http://dx.doi.org/10.1074/jbc.M110.180505			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923769	hybrid, Green Published			2022-12-25	WOS:000284625600030
J	Bebeacua, C; Bron, P; Lai, L; Vegge, CS; Brondsted, L; Spinelli, S; Campanacci, V; Veesler, D; van Heel, M; Cambillau, C				Bebeacua, Cecilia; Bron, Patrick; Lai, Livia; Vegge, Christina Skovgaard; Brondsted, Lone; Spinelli, Silvia; Campanacci, Valerie; Veesler, David; van Heel, Marin; Cambillau, Christian			Structure and Molecular Assignment of Lactococcal Phage TP901-1 Baseplate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING PROTEIN; CRYSTAL-STRUCTURE; STRUCTURE REVEALS; TAIL STRUCTURE; LACTIS PHAGES; IDENTIFICATION; BACTERIOPHAGE-TP901-1; COMPLEXES; MECHANISM; EVOLUTION	P335 lactococcal phages infect the Gram(+) bacterium Lactococcus lactis using a large multiprotein complex located at the distal part of the tail and termed baseplate (BP). The BP harbors the receptor-binding proteins (RBPs), which allow the specific recognition of saccharidic receptors localized on the host cell surface. We report here the electron microscopic structure of the phage TP901-1 wild-type BP as well as those of two mutants bppL(-) and bppU(-), lacking BppL (the RBPs) or both peripheral BP components (BppL and BppU), respectively. We also achieved an electron microscopic reconstruction of a partial BP complex, formed by BppU and BppL. This complex exhibits a tripod shape and is composed of nine BppLs and three BppUs. These structures, combined with light-scattering measurements, led us to propose that the TP901-1 BP harbors six tripods at its periphery, located around the central tube formed by ORF46 (Dit) hexamers, at its proximal end, and a ORF47 (Tal) trimer at its distal extremity. A total of 54 BppLs (18 RBPs) are thus available to mediate host anchoring with a large apparent avidity. TP901-1 BP exhibits an infection-ready conformation and differs strikingly from the lactococcal phage p2 BP, bearing only 6 RBPs, and which needs a conformational change to reach its activated state. The comparison of several Siphoviridae structures uncovers a close organization of their central BP core whereas striking differences occur at the periphery, leading to diverse mechanisms of host recognition.	[Spinelli, Silvia; Campanacci, Valerie; Veesler, David; Cambillau, Christian] CNRS, UMR 6098, F-13288 Marseille 09, France; [Spinelli, Silvia; Campanacci, Valerie; Veesler, David; Cambillau, Christian] Univ Aix Marseille 1, F-13288 Marseille 09, France; [Spinelli, Silvia; Campanacci, Valerie; Veesler, David; Cambillau, Christian] Univ Aix Marseille 2, F-13288 Marseille 09, France; [van Heel, Marin] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; [Bron, Patrick] CNRS, INSERM, Ctr Biochim Struct, U554,UMR 5048, F-34090 Montpellier, France; [Vegge, Christina Skovgaard; Brondsted, Lone] Univ Copenhagen, Dept Vet Dis Biol, DK-1870 Frederiksberg C, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Copenhagen	Cambillau, C (corresponding author), CNRS, UMR 6098, Campus Luminy,Case 932, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr	Veesler, David/HCH-3986-2022	Brondsted, Lone/0000-0002-7930-5725; bron, patrick/0000-0002-3354-9513; Campanacci, Valerie/0000-0001-6407-6395	Marseille-Nice Geno-pole; CNRS; Agence Nationale de la Recherche [ANR-07-BLAN-0095]; Ministere francais de l'enseignement superieur et de la recherche [22976-2006]; National Institutes of Health [P41 RR-01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	Marseille-Nice Geno-pole; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere francais de l'enseignement superieur et de la recherche; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in part, by grants from the Marseille-Nice Geno-pole and the CNRS and by Agence Nationale de la Recherche Grant ANR-07-BLAN-0095, "siphophages." This work was also supported by "ministere francais de l'enseignement superieur et de la recherche" Ph.D. Grant 22976-2006 (to D. V.). Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, supported by National Institutes of Health Grant P41 RR-01081.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brondsted L, 2001, VIROLOGY, V283, P93, DOI 10.1006/viro.2001.0871; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; De Haard HJW, 2005, J BACTERIOL, V187, P4531, DOI 10.1128/JB.187.13.4531-4541.2005; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; Effantin G, 2006, J MOL BIOL, V361, P993, DOI 10.1016/j.jmb.2006.06.081; HARAUZ G, 1986, OPTIK, V73, P146; HARAUZ G, 1984, ULTRAMICROSCOPY, V12, P309, DOI 10.1016/0304-3991(83)90245-0; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Kostyuchenko VA, 2003, NAT STRUCT BIOL, V10, P688, DOI 10.1038/nsb970; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Ricagno S, 2006, J VIROL, V80, P9331, DOI 10.1128/JVI.01160-06; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Siponen M, 2009, J BACTERIOL, V191, P3220, DOI 10.1128/JB.01637-08; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; Tremblay DM, 2006, J BACTERIOL, V188, P2400, DOI 10.1128/JB.188.7.2400-2410.2006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Veesler D, 2010, J BIOL CHEM, V285, P36666, DOI 10.1074/jbc.M110.157529; Veesler D, 2009, J BIOL CHEM, V284, P30718, DOI 10.1074/jbc.M109.037812; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Vincentelli R, 2003, ACCOUNTS CHEM RES, V36, P165, DOI 10.1021/ar010130s; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004	40	48	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39079	39086		10.1074/jbc.M110.175646	http://dx.doi.org/10.1074/jbc.M110.175646			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937834	Green Published, hybrid			2022-12-25	WOS:000284941300038
J	Li, HL; Ding, XD; Lopez, JR; Takeshima, H; Ma, JJ; Allen, PD; Eltit, JM				Li, Hongli; Ding, Xudong; Lopez, Jose R.; Takeshima, Hiroshi; Ma, Jianjie; Allen, Paul D.; Eltit, Jose M.			Impaired Orai1-mediated Resting Ca2+ Entry Reduces the Cytosolic [Ca2+] and Sarcoplasmic Reticulum Ca2+ Loading in Quiescent Junctophilin 1 Knock-out Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; OPERATED CALCIUM-CHANNEL; TRPC CHANNELS; CRAC CHANNEL; ORAI1; STIM1; DEFICIENCY; RELEASE; ACTIVATION; DEPLETION	In the absence of store depletion, plasmalemmal Ca2+ permeability in resting muscle is very low, and its contribution in the maintenance of Ca2+ homeostasis at rest has not been studied in detail. Junctophilin 1 knock-out myotubes (JP1 KO) have a severe reduction in store-operated Ca2+ entry, presumably caused by physical alteration of the sarcoplasmic reticulum (SR) and T-tubule junction, leading to disruption of the SR signal sent by Stim1 to activate Orai1. Using JP1 KO myotubes as a model, we assessed the contribution of the Orai1-mediated Ca2+ entry pathway on overall Ca2+ homeostasis at rest with no store depletion. JP1 KO myotubes have decreased Ca2+ entry, [Ca2+](rest), and intracellular Ca2+ content compared with WT myotubes and unlike WT myotubes, are refractory to BTP2, a Ca2+ entry blocker. JP1 KO myotubes show down-regulation of Orai1 and Stim1 proteins, suggesting that this pathway may be important in the control of resting Ca2+ homeostasis. WT myotubes stably transduced with Orai1(E190Q) had similar alterations in their resting Ca2+ homeostasis as JP1 KO myotubes and were also unresponsive to BTP2. JP1 KO cells show decreased expression of TRPC1 and -3 but overexpress TRPC4 and -6; on the other hand, the TRPC expression profile in Orai1(E190Q) myotubes was comparable with WT. These data suggest that an important fraction of resting plasmalemmal Ca2+ permeability is mediated by the Orai1 pathway, which contributes to the control of [Ca2+] rest and resting Ca2+ stores and that this pathway is defective in JP1 KO myotubes.	[Li, Hongli; Ding, Xudong; Lopez, Jose R.; Allen, Paul D.; Eltit, Jose M.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; [Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Harvard University; Brigham & Women's Hospital; Kyoto University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Eltit, JM (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	jmeltit@zeus.bwh.harvard.edu		Takeshima, Hiroshi/0000-0003-4525-3725	National Institutes of Health/NIAMS [2R01AR43140, RO1AG28856, RO1HL69000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052354, R01AR043140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028856] Funding Source: NIH RePORTER	National Institutes of Health/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health/NIAMS Grants 2R01AR43140 (to P. D. A.), RO1AG28856 (to J. M. and H. T.), and RO1HL69000 (to J. M.).	Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Eltit JM, 2010, J BIOL CHEM, V285, P13781, DOI 10.1074/jbc.M110.107300; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Komazaki S, 2002, FEBS LETT, V524, P225, DOI 10.1016/S0014-5793(02)03042-9; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; LOPEZ JR, 1983, BIOPHYS J, V43, P1, DOI 10.1016/S0006-3495(83)84316-1; Lopez JR, 2000, ANESTHESIOLOGY, V92, P1799, DOI 10.1097/00000542-200006000-00040; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Mery L, 2001, FEBS LETT, V487, P377, DOI 10.1016/S0014-5793(00)02362-0; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shin DM, 2008, NAT CELL BIOL, V10, P639, DOI 10.1038/ncb0608-639; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	31	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39171	39179		10.1074/jbc.M110.149690	http://dx.doi.org/10.1074/jbc.M110.149690			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937810	Green Published, hybrid			2022-12-25	WOS:000284941300047
J	Krammer, F; Pontiller, J; Tauer, C; Palmberger, D; Maccani, A; Baumann, M; Grabherr, R				Krammer, Florian; Pontiller, Jens; Tauer, Christopher; Palmberger, Dieter; Maccani, Andreas; Baumann, Martina; Grabherr, Reingard			Evaluation of the Influenza A Replicon for Transient Expression of Recombinant Proteins in Mammalian Cells	PLOS ONE			English	Article							RNA-POLYMERASE-I; MUTATIONAL ANALYSIS; REVERSE GENETICS; VIRUS; GENERATION; PROMOTER; VECTORS; VRNA; DNA; CLONING	Recombinant protein expression in mammalian cells has become a very important technique over the last twenty years. It is mainly used for production of complex proteins for biopharmaceutical applications. Transient recombinant protein expression is a possible strategy to produce high quality material for preclinical trials within days. Viral replicon based expression systems have been established over the years and are ideal for transient protein expression. In this study we describe the evaluation of an influenza A replicon for the expression of recombinant proteins. We investigated transfection and expression levels in HEK-293 cells with EGFP and firefly luciferase as reporter proteins. Furthermore, we studied the influence of different influenza non-coding regions and temperature optima for protein expression as well. Additionally, we exploited the viral replication machinery for the expression of an antiviral protein, the human monoclonal anti-HIV-gp41 antibody 3D6. Finally we could demonstrate that the expression of a single secreted protein, an antibody light chain, by the influenza replicon, resulted in fivefold higher expression levels compared to the usually used CMV promoter based expression. We emphasize that the influenza A replicon system is feasible for high level expression of complex proteins in mammalian cells.	[Krammer, Florian; Pontiller, Jens; Tauer, Christopher; Palmberger, Dieter; Maccani, Andreas; Baumann, Martina; Grabherr, Reingard] Univ Nat Resources & Appl Life Sci, Vienna Inst BioTechnol, Dept Biotechnol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Krammer, F (corresponding author), Univ Nat Resources & Appl Life Sci, Vienna Inst BioTechnol, Dept Biotechnol, Vienna, Austria.	Reingard.grabherr@boku.ac.at	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X; Grabherr, Reingard/0000-0002-4501-927X; Maccani, Andreas/0000-0002-7564-7410; Palmberger, Dieter/0000-0002-2086-0396	FWF (Austrian Science Fund) [P17361-B13]	FWF (Austrian Science Fund)(Austrian Science Fund (FWF))	This work was funded by the FWF (Austrian Science Fund, http://www.fwf.ac.at/) project P17361-B13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Baldi L, 2007, BIOTECHNOL LETT, V29, P677, DOI 10.1007/s10529-006-9297-y; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Frolov I, 1996, P NATL ACAD SCI USA, V93, P11371, DOI 10.1073/pnas.93.21.11371; HEIX J, 1995, CURR OPIN GENET DEV, V5, P652, DOI 10.1016/0959-437X(95)80035-2; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2000, VIROLOGY, V267, P310, DOI 10.1006/viro.1999.0140; HOSSAIN M, 2010, J CLIN MICROBIOL; Kittel C, 2005, J VIROL, V79, P10672, DOI 10.1128/JVI.79.16.10672-10677.2005; Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035; LUYTJES W, 1989, CELL, V59, P1107, DOI 10.1016/0092-8674(89)90766-6; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Molnar MJ, 2004, MOL THER, V10, P447, DOI 10.1016/j.ymthe.2004.06.642; Nakowitsch S, 2006, MOL BIOTECHNOL, V34, P157, DOI 10.1385/MB:34:2:157; NEUMANN G, 1995, J GEN VIROL, V76, P1709, DOI 10.1099/0022-1317-76-7-1709; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ng SSF, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-2; Nishimura K, 2007, J BIOL CHEM, V282, P27383, DOI 10.1074/jbc.M702028200; Ozaki H, 2004, J VIROL, V78, P1851, DOI 10.1128/JVI.78.4.1851-1857.2004; PICCONE ME, 1993, VIRUS RES, V28, P99, DOI 10.1016/0168-1702(93)90129-B; Pontiller J, 2010, MOL BIOTECHNOL, V45, P235, DOI 10.1007/s12033-010-9278-1; Rice Charles M., 1992, Current Opinion in Biotechnology, V3, P523, DOI 10.1016/0958-1669(92)90081-S; RUKER F, 1991, ANN NY ACAD SCI, V646, P212; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Sereinig S, 2006, CLIN VACCINE IMMUNOL, V13, P898, DOI 10.1128/CVI.00056-06; Spadaccini A, 2010, VACCINE, V28, P1181, DOI 10.1016/j.vaccine.2009.11.037; Varnavski AN, 2000, J VIROL, V74, P4394, DOI 10.1128/JVI.74.9.4394-4403.2000; Wang LY, 2009, VET MICROBIOL, V135, P239, DOI 10.1016/j.vetmic.2008.09.067; Wang ZT, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-102	30	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13265	10.1371/journal.pone.0013265	http://dx.doi.org/10.1371/journal.pone.0013265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949004	gold, Green Published, Green Submitted			2022-12-25	WOS:000282748100014
J	Bryksin, AV; Matsumura, I				Bryksin, Anton V.; Matsumura, Ichiro			Rational Design of a Plasmid Origin That Replicates Efficiently in Both Gram-Positive and Gram-Negative Bacteria	PLOS ONE			English	Article							CLONING VECTORS; DNA; CONSTRUCTION; PROKARYOTES; PERSISTENCE; EVOLUTION; PROTEINS; SEQUENCE; GROWTH; GENES	Background: Most plasmids replicate only within a particular genus or family. Methodology/Principal Findings: Here we describe an engineered high copy number expression vector, pBAV1K-T5, that produces varying quantities of active reporter proteins in Escherichia coli, Acinetobacter baylyi ADP1, Agrobacterium tumefaciens, (all Gram-negative), Streptococcus pneumoniae, Leifsonia shinshuensis, Peanibacillus sp. S18-36 and Bacillus subtilis (Gram-positive). Conclusions/Significance: Our results demonstrate the efficiency of pBAV1K-T5 replication in different bacterial species, thereby facilitating the study of proteins that don't fold well in E. coli and pathogens not amenable to existing genetic tools.	[Bryksin, Anton V.; Matsumura, Ichiro] Emory Univ, Dept Biochem, Ctr Fundamental & Appl Mol Evolut, Atlanta, GA 30322 USA	Emory University	Bryksin, AV (corresponding author), Emory Univ, Dept Biochem, Ctr Fundamental & Appl Mol Evolut, Atlanta, GA 30322 USA.	imatsum@emory.edu	Matsumura, Ichiro/E-1985-2011		National Institutes of Health [1 R01 GM074264, 1 R01 GM086824]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086824, R01GM074264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Institutes of Health grants 1 R01 GM074264 and 1 R01 GM086824 to IM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakvik T, 2009, FEMS MICROBIOL LETT, V296, P149, DOI 10.1111/j.1574-6968.2009.01639.x; Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Bosse JT, 2009, APPL ENVIRON MICROB, V75, P6124, DOI 10.1128/AEM.00809-09; BREHM SP, 1973, J BACTERIOL, V115, P1063, DOI 10.1128/JB.115.3.1063-1070.1973; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Bugrysheva JV, 2005, INFECT IMMUN, V73, P4972, DOI 10.1128/IAI.73.8.4972-4981.2005; BUJARD H, 1987, METHOD ENZYMOL, V155, P416; CANGELOSI GA, 1991, METHOD ENZYMOL, V204, P384; Cheng CH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-102; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Dennis JJ, 2005, CURR OPIN BIOTECH, V16, P291, DOI 10.1016/j.copbio.2005.04.002; GRUSS A, 1989, MICROBIOL REV, V53, P231, DOI 10.1128/MMBR.53.2.231-241.1989; HAMILTON RH, 1971, EXPERIENTIA, V27, P229, DOI 10.1007/BF02145913; HARWOOD CR, 1990, MOL BIOL METHODS BAC, pR35; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; Khan SA, 2005, PLASMID, V53, P126, DOI 10.1016/j.plasmid.2004.12.008; KOK J, 1984, APPL ENVIRON MICROB, V48, P726, DOI 10.1128/AEM.48.4.726-731.1984; LEENHOUTS KJ, 1991, PLASMID, V26, P55, DOI 10.1016/0147-619X(91)90036-V; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Moreno C, 2002, MICROBIOL-SGM, V148, P1233, DOI 10.1099/00221287-148-4-1233; OTTOLENGHI E, 1962, J EXP MED, V116, P491, DOI 10.1084/jem.116.4.491; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Boer DR, 2009, EMBO J, V28, P1666, DOI 10.1038/emboj.2009.125; ROMANOWSKI G, 1993, APPL ENVIRON MICROB, V59, P3438, DOI 10.1128/AEM.59.10.3438-3446.1993; Sambrook J., 2001, MOL CLONING LAB MANU; SATOH K, 2009, PLASMID; SEEGERS JFML, 1995, MOL GEN GENET, V249, P43, DOI 10.1007/BF00290234; Shareck J, 2004, CRIT REV BIOTECHNOL, V24, P155, DOI 10.1080/07388550490904288; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; SHEVCHUK NA, 2007, METHODS EXPRESS SERI, P197; Trevors JT, 1996, ANTON LEEUW INT J G, V70, P1, DOI 10.1007/BF00393564; Vaneechoutte M, 2006, APPL ENVIRON MICROB, V72, P932, DOI 10.1128/AEM.72.1.932-936.2006	39	63	71	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13244	10.1371/journal.pone.0013244	http://dx.doi.org/10.1371/journal.pone.0013244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949038	Green Submitted, gold, Green Published			2022-12-25	WOS:000282676700016
J	Shen, Y; Winkler, IG; Barbier, V; Sims, NA; Hendy, J; Levesque, JP				Shen, Yi; Winkler, Ingrid G.; Barbier, Valerie; Sims, Natalie A.; Hendy, Jean; Levesque, Jean-Pierre			Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Regulates Hematopoiesis and Bone Formation In Vivo	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; GROWTH-PROMOTING ACTIVITY; STEM-CELL MOBILIZATION; PROGENITOR CELLS; MATRIX-METALLOPROTEINASE; G-CSF; OSTEOBLASTIC METALLOPROTEINASES; TUMOR-GROWTH; C-KIT	Background: Tissue inhibitor of metalloproteinases-3 (TIMP-3) inhibits matrix metalloproteinases and membrane-bound sheddases. TIMP-3 is associated with the extracellular matrix and is expressed in highly remodeling tissues. TIMP-3 function in the hematopoietic system is unknown. Methodology/Principal Findings: We now report that TIMP-3 is highly expressed in the endosteal region of the bone marrow (BM), particularly by osteoblasts, endothelial and multipotent mesenchymal stromal cells which are all important cellular components of hematopoietic stem cell (HSC) niches, whereas its expression is very low in mature leukocytes and hematopoietic stem and progenitor cells. A possible role of TIMP-3 as an important niche component was further suggested by its down-regulation during granulocyte colony-stimulating factor-induced mobilization. To further investigate TIMP-3 function, mouse HSC were retrovirally transduced with human TIMP-3 and transplanted into lethally irradiated recipients. TIMP-3 overexpression resulted in decreased frequency of B and T lymphocytes and increased frequency of myeloid cells in blood and BM, increased Lineage-negative Sca-1(+)KIT(+) cell proliferation in vivo and in vitro and increased colony-forming cell trafficking to blood and spleen. Finally, over-expression of human TIMP-3 caused a late onset fatal osteosclerosis. Conclusions/Significance: Our results suggest that TIMP-3 regulates HSC proliferation, differentiation and trafficking in vivo, as well as bone and bone turn-over, and that TIMP-3 is expressed by stromal cells forming HSC niches within the BM. Thus, TIMP-3 may be an important HSC niche component regulating both hematopoiesis and bone remodeling.	[Shen, Yi; Winkler, Ingrid G.; Barbier, Valerie; Levesque, Jean-Pierre] Mater Med Res Inst, Hematopoiet Stem Cell Lab, Brisbane, Qld, Australia; [Shen, Yi; Levesque, Jean-Pierre] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Sims, Natalie A.; Hendy, Jean] St Vincents Inst, Fitzroy, Vic, Australia	Mater Research; University of Queensland; St. Vincent's Institute of Medical Research	Shen, Y (corresponding author), Mater Med Res Inst, Hematopoiet Stem Cell Lab, Brisbane, Qld, Australia.	jplevesque@mmri.mater.org.au	Heazlewood, Shen Y/I-7370-2013; Levesque, Jean-Pierre/C-5426-2011; Sims, Natalie Ann/A-7192-2012; Winkler, Ingrid G/F-3263-2011; Heazlewood, Shen/C-9238-2015	Heazlewood, Shen Y/0000-0003-1541-0224; Levesque, Jean-Pierre/0000-0002-7299-6025; Sims, Natalie Ann/0000-0003-1421-8468; Winkler, Ingrid G/0000-0001-6026-3572; 	National Health and Medical Research Council of Australia [288701, 434515, 488817]; Australian Postgraduate Award; Mater Medical Research Institute; Cancer Council of Queensland	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Mater Medical Research Institute; Cancer Council of Queensland(Cancer Council Queensland)	This work was supported by project grants (#288701 and #434515 to JPL) and a research fellowship (#488817 to IGW) from the National Health and Medical Research Council of Australia, an Australian Postgraduate Award and Mater Medical Research Institute top-up scholarship (YS), and a senior research fellowship from the Cancer Council of Queensland (JPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817; AnandApte B, 1996, BIOCHEM CELL BIOL, V74, P853, DOI 10.1139/o96-090; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Askmyr M, 2009, TRENDS ENDOCRIN MET, V20, P303, DOI 10.1016/j.tem.2009.03.004; Bian JH, 1996, CARCINOGENESIS, V17, P1805, DOI 10.1093/carcin/17.9.1805; BLAVIER L, 1995, J CELL SCI, V108, P3649; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cruz AC, 2004, J BIOL CHEM, V279, P5612, DOI 10.1074/jbc.M312323200; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; GASSON JC, 1985, NATURE, V315, P768, DOI 10.1038/315768a0; Geoffroy V, 2004, J BONE MINER RES, V19, P811, DOI 10.1359/JBMR.040119; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Haviernik P, 2008, BLOOD CELL MOL DIS, V41, P179, DOI 10.1016/j.bcmd.2008.03.005; Hawkes SP, 2000, METH MOL B, V151, P399, DOI 10.1385/1-59259-046-2:399; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Horiuchi K, 2009, J IMMUNOL, V182, P7408, DOI 10.4049/jimmunol.0801931; Horiuchi K, 2009, J IMMUNOL, V182, P2093, DOI 10.4049/jimmunol.0802491; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Kamei M, 1999, INVEST OPHTH VIS SCI, V40, pS919; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kuiperij HB, 2009, EXP HEMATOL, V37, P641, DOI 10.1016/j.exphem.2009.02.004; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; Levesque JP, 2002, EXP HEMATOL, V30, P440, DOI 10.1016/S0301-472X(02)00788-9; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Levesque JP, 2003, EXP HEMATOL, V31, P109, DOI 10.1016/S0301-472X(02)01028-7; LEVESQUE JP, 2010, LEUKEMIA IN PRESS; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Mahmoodi M, 2005, AM J PATHOL, V166, P1733, DOI 10.1016/S0002-9440(10)62483-2; Marquez-Curtis LA, 2001, BRIT J HAEMATOL, V115, P595, DOI 10.1046/j.1365-2141.2001.03160.x; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; NAKAJIMA H, 2010, BLOOD, DOI DOI 10.1182/BL00D-2010-2001-266528; NAKAMURA Y, 2010, BLOOD; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; Pelus LM, 2004, BLOOD, V103, P110, DOI 10.1182/blood-2003-04-1115; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pruijt JFM, 1999, P NATL ACAD SCI USA, V96, P10863, DOI 10.1073/pnas.96.19.10863; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Robbins PB, 1997, J VIROL, V71, P9466, DOI 10.1128/JVI.71.12.9466-9474.1997; Rovida E, 2001, J IMMUNOL, V166, P1583, DOI 10.4049/jimmunol.166.3.1583; Sato T, 1998, J BONE MINER RES, V13, P59, DOI 10.1359/jbmr.1998.13.1.59; Schiltz C, 2008, J CELL BIOCHEM, V104, P1803, DOI 10.1002/jcb.21747; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Short Brenton J., 2009, V482, P259, DOI 10.1007/978-1-59745-060-7_16; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; van Pel M, 2006, P NATL ACAD SCI USA, V103, P1469, DOI 10.1073/pnas.0510192103; Villeneuve J, 2009, EXP HEMATOL, V37, P849, DOI 10.1016/j.exphem.2009.03.009; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Winkler I. G., 2010, BLOOD; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; WINKLER IG, 2010, BLOOD, DOI DOI 10.1182/BL00D-2009-2011-253534; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zeng Y, 1998, DEV DYNAM, V211, P228	78	54	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13086	10.1371/journal.pone.0013086	http://dx.doi.org/10.1371/journal.pone.0013086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941363	Green Published, gold			2022-12-25	WOS:000282312600019
J	Bare, LA; Ruiz-Narvaez, EA; Tong, CH; Arellano, AR; Rowland, CM; Catanese, JJ; Sacks, FM; Devlin, JJ; Campos, H				Bare, Lance A.; Ruiz-Narvaez, Edward A.; Tong, Carmen H.; Arellano, Andre R.; Rowland, Charles M.; Catanese, Joseph J.; Sacks, Frank M.; Devlin, James J.; Campos, Hannia			Investigation of KIF6 Trp719Arg in a Case-Control Study of Myocardial Infarction: A Costa Rican Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENE VARIANTS; ADMIXTURE; RISK; ASSOCIATION; VALLEY	Background and Methodology: The 719Arg allele of KIF6 (rs20455) was associated with coronary events in Caucasian participants of five prospective studies. We investigated whether this KIF6 variant was associated with non-fatal myocardial infarction (MI) in a case-control study of an admixed population from the Central Valley of Costa Rica. Genotypes of the KIF6 variant were determined for 4,134 men and women. Cases (1,987) had survived a first MI; controls (2,147) had no history of MI and were matched to cases by age, sex, and area of residence. We tested the association between the KIF6 719Arg allele and non-fatal MI by conditional logistic regression and adjusted for admixture of founder populations. Principal Findings: Compared with the reference Trp/Trp homozygotes, KIF6 719Arg carriers were not at significantly higher risk for non-fatal MI in this study after adjustment for traditional risk factors or admixture (OR = 1.12; 95% CI, 0.98-1.28). Heterozygotes of the KIF6 Trp719Arg variant were at increased risk of non-fatal MI: the adjusted odds ratio was 1.16 (95% confidence interval, 1.01-1.34), but this association would not be significant after a multiple testing correction. Conclusions/Significance: We found that carriers of the KIF6 719Arg allele were not at increased risk of non-fatal MI in a case-control study of Costa Ricans living in the Central Valley of Costa Rica.	[Bare, Lance A.; Tong, Carmen H.; Arellano, Andre R.; Rowland, Charles M.; Catanese, Joseph J.; Devlin, James J.] Celera, Alameda, CA USA; [Ruiz-Narvaez, Edward A.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Sacks, Frank M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Campos, Hannia] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Bare, LA (corresponding author), Celera, Alameda, CA USA.	lance.bare@celera.com		Ruiz-Narvaez, Edward/0000-0002-0339-5824	National Institutes of Health [HL49086, HL60692]; American Heart Association [0625819T]; Celera; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060692, R01HL049086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Celera; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Recruitment and sample collection for the case-control study was supported by grants HL49086 and HL60692 from the National Institutes of Health. Edward A. Ruiz-Narvaez was supported by post-doctoral fellowship 0625819T from the American Heart Association. National Institutes of Health and the American Heart Association had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Statistical analysis was funded by Celera. Celera conducted the genotyping and had a role in study design, analysis, decision to publish and preparation of the manuscript.	Arnal I, 1998, STRUCTURE, V6, P33, DOI 10.1016/S0969-2126(98)00005-7; Bare LA, 2007, GENET MED, V9, P682, DOI 10.1097/GIM.0b013e318156fb62; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campos H, 2000, INT J EPIDEMIOL, V29, P429, DOI 10.1093/ije/29.3.429; Campos-Sanchez R, 2006, HUM BIOL, V78, P551, DOI 10.1353/hub.2007.0002; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Iakoubova OA, 2008, J AM COLL CARDIOL, V51, P435, DOI 10.1016/j.jacc.2007.05.057; Kabagambe EK, 2007, CIRCULATION, V115, P1075, DOI 10.1161/CIRCULATIONAHA.106.643544; Morera B, 2004, REV BIOL TROP, V52, P629; Morera B, 2004, REV BIOL TROP, V52, P713; Morera B, 2003, ANN HUM GENET, V67, P71, DOI 10.1046/j.1469-1809.2003.00010.x; RUIZNARVAEZ EA, 2010, HUM GENET; Shiffman D, 2008, J AM COLL CARDIOL, V51, P444, DOI 10.1016/j.jacc.2007.09.044; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Stewart AFR, 2009, J AM COLL CARDIOL, V53, P1471, DOI 10.1016/j.jacc.2008.12.051	17	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13081	10.1371/journal.pone.0013081	http://dx.doi.org/10.1371/journal.pone.0013081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927332	Green Published, gold			2022-12-25	WOS:000282269400027
J	Loewen, CA; Feany, MB				Loewen, Carin A.; Feany, Mel B.			The Unfolded Protein Response Protects from Tau Neurotoxicity In Vivo	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-CYCLE REENTRY; ALZHEIMERS-DISEASE; RETINAL DEGENERATION; NEUROFIBRILLARY TANGLES; DROSOPHILA; NEURODEGENERATION; PHOSPHORYLATION; TAUOPATHY; TOXICITY	The unfolded protein response is a critical system by which the cell handles excess misfolded protein in the secretory pathway. The role of the system in modulating the effects of aggregation prone cytosolic proteins has received less attention. We use genetic reporters to demonstrate activation of the unfolded protein response in a transgenic Drosophila model of Alzheimer's disease and related tauopathies. We then use loss of function genetic reagents to support a role for the unfolded protein response in protecting from tau neurotoxicity. Our findings suggest that the unfolded protein response can ameliorate the toxicity of tau in vivo.	[Loewen, Carin A.; Feany, Mel B.] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Loewen, CA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA.	mel_feany@hms.harvard.edu		Feany, Mel/0000-0003-0315-7970	National Institutes of Health (NIH) [R01 AG019790]; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R01AG019790] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health (NIH) R01 AG019790 and The Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Busser J, 1998, J NEUROSCI, V18, P2801; Chafekar SM, 2008, CURR ALZHEIMER RES, V5, P469, DOI 10.2174/156720508785908883; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; Naidoo N, 2009, REV NEUROSCIENCE, V20, P23; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Oakes SA, 2006, CURR MOL MED, V6, P99, DOI 10.2174/156652406775574587; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shulman JM, 2003, GENETICS, V165, P1233; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Steinhilb ML, 2007, J NEUROSCI RES, V85, P1271, DOI 10.1002/jnr.21232; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	35	68	69	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13084	10.1371/journal.pone.0013084	http://dx.doi.org/10.1371/journal.pone.0013084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927324	Green Published, Green Submitted, gold			2022-12-25	WOS:000282269400029
J	Torres-Arancivia, C; Ross, CM; Chavez, J; Assur, Z; Dolios, G; Mancia, F; Ubarretxena-Belandia, I				Torres-Arancivia, Celia; Ross, Carolyn M.; Chavez, Jose; Assur, Zahra; Dolios, Georgia; Mancia, Filippo; Ubarretxena-Belandia, Iban			Identification of an Archaeal Presenilin-Like Intramembrane Protease	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; GAMMA-SECRETASE ACTIVITY; AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEASE; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; CLEAVAGE; PROTEOLYSIS; FAMILY; SUBSTRATE	Background: The GXGD-type diaspartyl intramembrane protease, presenilin, constitutes the catalytic core of the gamma-secretase multi-protein complex responsible for activating critical signaling cascades during development and for the production of beta-amyloid peptides (A beta) implicated in Alzheimer's disease. The only other known GXGD-type diaspartyl intramembrane proteases are the eukaryotic signal peptide peptidases (SPPs). The presence of presenilin-like enzymes outside eukaryots has not been demonstrated. Here we report the existence of presenilin-like GXGD-type diaspartyl intramembrane proteases in archaea. Methodology and Principal Findings: We have employed in vitro activity assays to show that MCMJR1, a polytopic membrane protein from the archaeon Methanoculleus marisnigri JR1, is an intramembrane protease bearing the signature YD and GXGD catalytic motifs of presenilin-like enzymes. Mass spectrometry analysis showed MCMJR1 could cleave model intramembrane protease substrates at several sites within their transmembrane region. Remarkably, MCMJR1 could also cleave substrates derived from the beta-amyloid precursor protein (APP) without the need of protein co-factors, as required by presenilin. Two distinct cleavage sites within the transmembrane domain of APP could be identified, one of which coincided with A beta 40, the predominant site processed by gamma-secretase. Finally, an established presenilin and SPP transition-state analog inhibitor could inhibit MCMJR1. Conclusions and Significance: Our findings suggest that a primitive GXGD-type diaspartyl intramembrane protease from archaea can recapitulate key biochemical properties of eukaryotic presenilins and SPPs. MCMJR1 promises to be a more tractable, simpler system for in depth structural and mechanistic studies of GXGD-type diaspartyl intramembrane proteases.	[Torres-Arancivia, Celia; Chavez, Jose; Ubarretxena-Belandia, Iban] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Torres-Arancivia, Celia; Chavez, Jose] CUNY, Grad Ctr, New York, NY USA; [Ross, Carolyn M.; Assur, Zahra] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Dolios, Georgia] Mt Sinai Sch Med, Dept Human Genet, New York, NY USA; [Mancia, Filippo] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA	Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Columbia University; Icahn School of Medicine at Mount Sinai; Columbia University	Torres-Arancivia, C (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA.	fm123@columbia.edu; iban.ubarretxena@mssm.edu	Ubarretxena-Belandia, Iban/AAA-8939-2019	Chavez, Jose/0000-0003-4351-1516; Mancia, Filippo/0000-0003-3293-2200	National Science Foundation [MCB-0546087]	National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by grant MCB-0546087 (to I.U.-B.) from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fluhrer R, 2008, J BIOL CHEM, V283, P30121, DOI 10.1074/jbc.M806092200; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Mirza SP, 2007, PHYSIOL GENOMICS, V30, P89, DOI 10.1152/physiolgenomics.00279.2006; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Szabo Z, 2006, J BACTERIOL, V188, P1437, DOI 10.1128/JB.188.4.1437-1443.2006; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	49	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13072	10.1371/journal.pone.0013072	http://dx.doi.org/10.1371/journal.pone.0013072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927381	Green Published, gold			2022-12-25	WOS:000282269400022
J	Harth, S; Kotzsch, A; Hu, JL; Sebald, W; Mueller, TD				Harth, Stefan; Kotzsch, Alexander; Hu, Junli; Sebald, Walter; Mueller, Thomas D.			A Selection Fit Mechanism in BMP Receptor IA as a Possible Source for BMP Ligand-Receptor Promiscuity	PLOS ONE			English	Article							STRUCTURE ANALYSIS REVEALS; FACTOR-BETA SUPERFAMILY; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; HIGH-AFFINITY; MORPHOGENETIC PROTEINS; MOLECULAR RECOGNITION; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; SPECIFICITY	Background: Members of the TGF-beta superfamily are characterized by a highly promiscuous ligand-receptor interaction as is readily apparent from the numeral discrepancy of only seven type I and five type II receptors available for more than 40 ligands. Structural and functional studies have been used to address the question of how specific signals can be deduced from a limited number of receptor combinations and to unravel the molecular mechanisms underlying the protein-protein recognition that allow such limited specificity. Principal Findings: In this study we have investigated how an antigen binding antibody fragment (Fab) raised against the extracellular domain of the BMP receptor type IA (BMPR-IA) recognizes the receptor's BMP-2 binding epitope and thereby neutralizes BMP-2 receptor activation. The crystal structure of the complex of the BMPR-IA ectodomain bound to the Fab AbD1556 revealed that the contact surface of BMPR-IA overlaps extensively with the contact surface for BMP-2 interaction. Although the structural epitopes of BMPR-IA to both binding partners coincides, the structures of BMPR-IA in the two complexes differ significantly. In contrast to the structural differences, alanine-scanning mutagenesis of BMPR-IA showed that the functional determinants for binding to the antibody and BMP-2 are almost identical. Conclusions: Comparing the structures of BMPR-IA bound to BMP-2 or bound to the Fab AbD1556 with the structure of unbound BMPR-IA shows that binding of BMPR-IA to its interaction partners follows a selection fit mechanism, possibly indicating that the ligand promiscuity of BMPR-IA is inherently encoded by structural adaptability. The functional and structural analysis of the BMPR-IA binding antibody AbD1556 mimicking the BMP-2 binding epitope may thus pave the way for the design of low-molecular weight synthetic receptor binders/inhibitors.	[Harth, Stefan; Hu, Junli; Sebald, Walter] Univ Wurzburg, Lehrstuhl Physiol Chem 2, Theodor Boveri Inst Biowissensch, Wurzburg, Germany; [Kotzsch, Alexander; Mueller, Thomas D.] Univ Wurzburg, Lehrstuhl Mol Pflanzenphysiol & Biophys, Julius von Sachs Inst, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Harth, S (corresponding author), Univ Wurzburg, Lehrstuhl Physiol Chem 2, Theodor Boveri Inst Biowissensch, Wurzburg, Germany.	mueller@biozentrum.uni-wuerzburg.de		Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft (DFG) [SFB 487 TP B1 and B2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This project was supported by the Deutsche Forschungsgemeinschaft (DFG), SFB 487 TP B1 and B2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Faber C, 1998, IMMUNOTECHNOLOGY, V3, P253, DOI 10.1016/S1380-2933(97)10003-3; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gavin AC, 2003, CURR OPIN CHEM BIOL, V7, P21, DOI 10.1016/S1367-5931(02)00007-8; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Harth S, 2010, ACTA CRYSTALLOGR F, V66, P964, DOI 10.1107/S1744309110024681; Hein G, 2009, CENT EUR J MATH, V7, P59, DOI 10.2478/s11533-008-0058-0; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hodivala-Dilke KM, 2003, CELL TISSUE RES, V314, P131, DOI 10.1007/s00441-003-0774-5; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kirsch T, 2000, FEBS LETT, V468, P215, DOI 10.1016/S0014-5793(00)01214-X; Klages J, 2008, BIOCHEMISTRY-US, V47, P11930, DOI 10.1021/bi801059j; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kotzsch A, 2008, J BIOL CHEM, V283, P5876, DOI 10.1074/jbc.M706029200; Kotzsch A, 2009, EMBO J, V28, P937, DOI 10.1038/emboj.2009.37; Kraich M, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-13; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Steidl S, 2008, MOL IMMUNOL, V46, P135, DOI 10.1016/j.molimm.2008.07.013; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Sundberg EJ, 2009, METHODS MOL BIOL, V524, P23, DOI 10.1007/978-1-59745-450-6_2; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13049	10.1371/journal.pone.0013049	http://dx.doi.org/10.1371/journal.pone.0013049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927405	gold, Green Published, Green Submitted			2022-12-25	WOS:000282210700020
J	Somda, ZC; Perry, HN; Messonnier, NR; Djingarey, MH; Ki, SO; Meltzer, MI				Somda, Zana C.; Perry, Helen N.; Messonnier, Nancy R.; Djingarey, Mamadou H.; Ki, Salimata Ouedraogo; Meltzer, Martin I.			Modeling the Cost-Effectiveness of the Integrated Disease Surveillance and Response (IDSR) System: Meningitis in Burkina Faso	PLOS ONE			English	Article							MENINGOCOCCAL MENINGITIS; IMMUNIZATION CAMPAIGNS; DEVELOPING-COUNTRIES; EPIDEMICS; MALARIA; BURDEN; AFRICA; INTERVENTIONS; VACCINATION; LEVEL	Background: Effective surveillance for infectious diseases is an essential component of public health. There are few studies estimating the cost-effectiveness of starting or improving disease surveillance. We present a cost-effectiveness analysis the Integrated Disease Surveillance and Response (IDSR) strategy in Africa. Methodology/Principal Findings: To assess the impact of the IDSR in Africa, we used pre- and post-IDSR meningococcal meningitis surveillance data from Burkina Faso (1996-2002 and 2003-2007). IDSR implementation was correlated with a median reduction of 2 weeks to peak of outbreaks (25(th) percentile 1 week; 75(th) percentile 4 weeks). IDSR was also correlated with a reduction of 43 meningitis cases per 100,000 (25(th)-40: 75(th)-129). Assuming the correlations between reductions in time to peak of outbreaks and cases are related, the cost-effectiveness of IDSR was $23 per case averted (25(th)-$30; 75(th)-cost saving), and $98 per meningitis-related death averted (25(th)-$140: 75(th)-cost saving). Conclusions/Significance: We cannot absolutely claim that the measured differences were due to IDSR. We believe, however, that it is reasonable to claim that IDSR can improve the cost-effectiveness of public health surveillance.	[Somda, Zana C.; Perry, Helen N.; Messonnier, Nancy R.; Meltzer, Martin I.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Djingarey, Mamadou H.] WHO IST W Africa, Ouagadougou, Burkina Faso; [Ki, Salimata Ouedraogo] Minist Sante, Ouagadougou, Burkina Faso	Centers for Disease Control & Prevention - USA	Somda, ZC (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	qzm4@cdc.gov	Meltzer, Martin/AAT-3235-2021	Meltzer, Martin/0000-0002-7250-0472	U.S. Centers for Disease Control and Prevention (CDC); USAID Global Surveillance and Africa Bureaus	U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID Global Surveillance and Africa Bureaus(United States Agency for International Development (USAID))	This research was supported by the U.S. Centers for Disease Control and Prevention (CDC) with funding from USAID Global Surveillance and Africa Bureaus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bovier PA, 1999, SOC SCI MED, V48, P1205, DOI 10.1016/S0277-9536(98)00419-5; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; du Chatelet IP, 2001, VACCINE, V19, P3420, DOI 10.1016/S0264-410X(01)00066-4; Elbasha EH, 2000, EMERG INFECT DIS, V6, P293, DOI 10.3201/eid0603.000310; Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235; Hutubessy RCW, 2001, ACTA TROP, V78, P191, DOI 10.1016/S0001-706X(00)00176-5; International Monetary Fund, WORLD EC FIN SURV WO; John TJ, 1998, LANCET, V352, P58, DOI 10.1016/S0140-6736(97)10494-9; Kaninda AV, 2000, INT J EPIDEMIOL, V29, P933, DOI 10.1093/ije/29.5.933; Khan MM, 2004, J HEALTH POPUL NUTR, V22, P404; Lapeyssonnie L., 1963, B WHO              S, V28, P3; Lewis R, 2001, LANCET, V358, P287, DOI 10.1016/S0140-6736(01)05484-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Miller MA, 2005, PHARMACOECONOMICS, V23, P333, DOI 10.2165/00019053-200523040-00004; Mohammed I, 2000, T ROY SOC TROP MED H, V94, P265, DOI 10.1016/S0035-9203(00)90316-X; MONATH TP, 1993, AM J TROP MED HYG, V48, P274, DOI 10.4269/ajtmh.1993.48.274; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Nicolas P, 2001, EMERG INFECT DIS, V7, P849; Perry HN, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-24; Robbins JB, 1997, LANCET, V350, P880, DOI 10.1016/S0140-6736(97)03227-3; ROBERTSON RL, 1985, J TROP MED HYG, V88, P343; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SMITH AW, 1988, T ROY SOC TROP MED H, V82, P312, DOI 10.1016/0035-9203(88)90459-2; Somda Zana C, 2009, Cost Eff Resour Alloc, V7, P1, DOI 10.1186/1478-7547-7-1; Taha MK, 2002, J CLIN MICROBIOL, V40, P1083, DOI 10.1128/JCM.40.3.1083-1084.2002; Uzicanin A, 2004, VACCINE, V22, P3419, DOI 10.1016/j.vaccine.2004.02.042; Walker D, 2000, HEALTH ECON, V9, P681, DOI 10.1002/1099-1050(200012)9:8<681::AID-HEC545>3.0.CO;2-X; *WHO, 2002, TECHN GUID INT DIS S; *WHO, 1999, INT DIS SURV RESP RE; Wilkins JJ, 2002, T ROY SOC TROP MED H, V96, P85, DOI 10.1016/S0035-9203(02)90251-8; World Health Organisation, 2000, WKLY EPIDEMIOL REC, V75, P306; Worrall E, 2004, AM J TROP MED HYG, V71, P136, DOI 10.4269/ajtmh.2004.71.136	35	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13044	10.1371/journal.pone.0013044	http://dx.doi.org/10.1371/journal.pone.0013044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	654ZQ	20927386	gold, Green Published, Green Submitted			2022-12-25	WOS:000282210700019
J	Tilghman, RW; Cowan, CR; Mih, JD; Koryakina, Y; Gioeli, D; Slack-Davis, JK; Blackman, BR; Tschumperlin, DJ; Parsons, JT				Tilghman, Robert W.; Cowan, Catharine R.; Mih, Justin D.; Koryakina, Yulia; Gioeli, Daniel; Slack-Davis, Jill K.; Blackman, Brett R.; Tschumperlin, Daniel J.; Parsons, J. Thomas			Matrix Rigidity Regulates Cancer Cell Growth and Cellular Phenotype	PLOS ONE			English	Article							E-CADHERIN; MYOCARDIAL-INFARCTION; GENE-EXPRESSION; ADHESION KINASE; TISSUE; PROLIFERATION; TRANSITIONS; TENSION; DIRECTS; DIFFERENTIATION	Background: The mechanical properties of the extracellular matrix have an important role in cell growth and differentiation. However, it is unclear as to what extent cancer cells respond to changes in the mechanical properties (rigidity/stiffness) of the microenvironment and how this response varies among cancer cell lines. Methodology/Principal Findings: In this study we used a recently developed 96-well plate system that arrays extracellular matrix-conjugated polyacrylamide gels that increase in stiffness by at least 50-fold across the plate. This plate was used to determine how changes in the rigidity of the extracellular matrix modulate the biological properties of tumor cells. The cell lines tested fall into one of two categories based on their proliferation on substrates of differing stiffness: "rigidity dependent" (those which show an increase in cell growth as extracellular rigidity is increased), and "rigidity independent" (those which grow equally on both soft and stiff substrates). Cells which grew poorly on soft gels also showed decreased spreading and migration under these conditions. More importantly, seeding the cell lines into the lungs of nude mice revealed that the ability of cells to grow on soft gels in vitro correlated with their ability to grow in a soft tissue environment in vivo. The lung carcinoma line A549 responded to culture on soft gels by expressing the differentiated epithelial marker E-cadherin and decreasing the expression of the mesenchymal transcription factor Slug. Conclusions/Significance: These observations suggest that the mechanical properties of the matrix environment play a significant role in regulating the proliferation and the morphological properties of cancer cells. Further, the multiwell format of the soft-plate assay is a useful and effective adjunct to established 3-dimensional cell culture models.	[Tilghman, Robert W.; Cowan, Catharine R.; Koryakina, Yulia; Gioeli, Daniel; Slack-Davis, Jill K.; Parsons, J. Thomas] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Tilghman, Robert W.; Cowan, Catharine R.; Koryakina, Yulia; Gioeli, Daniel; Slack-Davis, Jill K.; Parsons, J. Thomas] Univ Virginia, Ctr Canc, Sch Med, Charlottesville, VA 22908 USA; [Mih, Justin D.; Tschumperlin, Daniel J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blackman, Brett R.] Univ Virginia, Sch Med, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; Harvard University; Harvard T.H. Chan School of Public Health; University of Virginia	Tilghman, RW (corresponding author), Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA.	jtp@virginia.edu			NIH-NCI (National Institutes of Health-National Cancer Institute) [CA40042]; Coulter Foundation [NIH HL092961, NIH CA124706]; NATIONAL CANCER INSTITUTE [R01CA124706] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092961] Funding Source: NIH RePORTER	NIH-NCI (National Institutes of Health-National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Coulter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants NIH-NCI CA40042 (National Institutes of Health-National Cancer Institute) (www.nih.gov) and funding from the Coulter Foundation Translational Partners Award (www.whcf.org) (JTP), NIH HL092961 (DJT), and NIH CA124706 (DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Fre S, 2008, ADV CANCER RES, V100, P85, DOI 10.1016/S0065-230X(08)00003-1; Gagne D, 2010, J CELL PHYSIOL, V222, P387, DOI 10.1002/jcp.21963; Hayashida Y, 2006, J BIOL CHEM, V281, P32469, DOI 10.1074/jbc.M607240200; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010	33	238	246	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12905	10.1371/journal.pone.0012905	http://dx.doi.org/10.1371/journal.pone.0012905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886123	Green Published, gold, Green Submitted			2022-12-25	WOS:000282091100014
J	Kremerskothen, J; Stolting, M; Wiesner, C; Korb-Pap, A; van Vliet, V; Linder, S; Huber, TB; Rottiers, P; Reuzeau, E; Genot, E; Pavenstadt, H				Kremerskothen, Joachim; Stoelting, Miriam; Wiesner, Christiane; Korb-Pap, Adelheid; van Vliet, Vanessa; Linder, Stefan; Huber, Tobias B.; Rottiers, Patricia; Reuzeau, Edith; Genot, Elisabeth; Pavenstaedt, Hermann			Zona occludens proteins modulate podosome formation and function	FASEB JOURNAL			English	Article						podosomes; ZO-1; cortactin; actin assembly	SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX DEGRADATION; TIGHT JUNCTIONS; ACTIN CYTOSKELETON; DISCRETE MICRODOMAINS; EPITHELIAL-CELLS; DORSAL RUFFLES; DIRECT BINDING; ZO-1; CORTACTIN	Podosomes are highly dynamic structures that are involved in cell adhesion and extracellular matrix remodeling. They present as intracellular columns composed of an actin-rich core region and a surrounding ring-like structure containing focal adhesion proteins, actin binders as well as cell signaling molecules. A key player in podosome biogenesis is the scaffolding protein cortactin, which is thought to control actin assembly at the core region. We show that the zona occludens protein 1 (ZO-1), a pivotal tight junction protein and known binding partner of cortactin, is a component of podosomes. In the smooth muscle cell line A7r5, phorbol ester treatment induced a rapid relocation of ZO-1 from the cell cortex and cytosolic pools toward newly formed podosomes. Podosomal localization was also observed for the known ZO-1-binding proteins l-afadin, alpha-catenin, and phospho-connexin 43. Truncation studies revealed that the actin-binding domain but not the association with cortactin is necessary for ZO-1 recruitment to podosomes. Moreover, impaired ZO-1 expression leads to significantly reduced podosome formation and concomitant decreased matrix degradation at podosomes. Our findings demonstrate that besides their known function in tight junction assembly and intercellular communication, zona occludens proteins and their binding partners may play a novel role in podosome formation and associated function, thus regulating cell adhesion and matrix remodeling.-Kremerskothen, J., Stolting, M., Wiesner, C., Korb-Pap, A., van Vliet, V., Linder, S., Huber, T. B., Rottiers, P., Reuzeau, E., Genot, E., Pavenstadt, H. Zona occludens proteins modulate podosome formation and function. FASEB J. 25, 505-514 (2011). www.fasebj.org	[Kremerskothen, Joachim; Stoelting, Miriam; Korb-Pap, Adelheid; Pavenstaedt, Hermann] Univ Clin Munster, Dept Mol Nephrol, D-48149 Munster, Germany; [Wiesner, Christiane; van Vliet, Vanessa; Linder, Stefan] Univ Clin Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Huber, Tobias B.] Univ Med Ctr Freiburg, Dept Nephrol, Freiburg, Germany; [Rottiers, Patricia; Reuzeau, Edith; Genot, Elisabeth] European Inst Biol & Chem, Dept Mol & Cellular Biol, INSERM, U889, Pessac, France	University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kremerskothen, J (corresponding author), Univ Clin Munster, Dept Mol Nephrol, Domagkstr 3A, D-48149 Munster, Germany.	joachim.kremerskothen@uni-muenster.de	Genot, Elisabeth/G-8031-2014	Huber, Tobias B./0000-0001-7175-5062	 [IMF KR-110904];  [ARC3549];  [ANR-06-BLAN-0362]	; ; 	The authors thank Alan Fanning (University of North Carolina, Chapel Hill, NC, USA) and Alan Mak (Queen's University, Kingston, ON, Canada) for ZO-1 and cortactin constructs, respectively. The authors gratefully acknowledge Angelika Barnekow (University of Muenster, Muenster, Germany) for the LA90-RSV cells and Guido Bose (Nanospot, Muenster, Germany) for use of the TIRF microscope. The authors thank Christine Varon and Fabien Guegan (INSERM, Pessac, France) for help with preliminary experiments. The authors are grateful to Jens Cornils (University Clinic Hamburg, Hamburg, Germany) for excellent technical assistance. This research was funded by grants IMF KR-110904 to J.K. and ARC3549 and ANR-06-BLAN-0362 to E.G.	Adamopoulos IE, 2006, HUM PATHOL, V37, P1176, DOI 10.1016/j.humpath.2006.04.007; Akoyev V, 2007, CELL SIGNAL, V19, P958, DOI 10.1016/j.cellsig.2006.11.007; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Balda MS, 2000, SEMIN CELL DEV BIOL, V11, P281, DOI 10.1006/scdb.2000.0177; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; BALDA MS, 1993, AM J PHYSIOL, V264, pC918, DOI 10.1152/ajpcell.1993.264.4.C918; Beatch M, 1996, J BIOL CHEM, V271, P25723, DOI 10.1074/jbc.271.42.25723; Benezra M, 2007, INVEST OPHTH VIS SCI, V48, P2043, DOI 10.1167/iovs.06-0754; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Ebnet K, 2008, HISTOCHEM CELL BIOL, V130, P1, DOI 10.1007/s00418-008-0418-7; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fultz ME, 2000, J MUSCLE RES CELL M, V21, P775, DOI 10.1023/A:1010396429297; Gaidos G, 2007, J CELL SCI, V120, P2366, DOI 10.1242/jcs.004333; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gimona M, 2003, MOL BIOL CELL, V14, P2482, DOI 10.1091/mbc.E02-11-0743; Gimona M, 2008, SEMIN CANCER BIOL, V18, P23, DOI 10.1016/j.semcancer.2007.08.005; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; GRAY GM, 1989, ONCOGENE, V4, P1213; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Katsube T, 1998, J BIOL CHEM, V273, P29672, DOI 10.1074/jbc.273.45.29672; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Taliana L, 2005, INVEST OPHTH VIS SCI, V46, P96, DOI 10.1167/iovs.04-0145; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wiesner C, 2010, BLOOD, V116, P1559, DOI 10.1182/blood-2009-12-257089; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Xu JL, 2008, MOL CELL BIOL, V28, P1669, DOI 10.1128/MCB.00891-07; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595; Zhou ST, 2006, AM J PHYSIOL-CELL PH, V290, pC463, DOI 10.1152/ajpcell.00350.2005	56	18	18	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2011	25	2					505	514		10.1096/fj.10-155598	http://dx.doi.org/10.1096/fj.10-155598			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	20930113				2022-12-25	WOS:000286724800009
J	Li, J; Cheng, Y; Tai, D; Martinka, M; Welch, DR; Li, G				Li, J.; Cheng, Y.; Tai, D.; Martinka, M.; Welch, D. R.; Li, G.			Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis	ONCOGENE			English	Article						BRMS1; melanoma; tumor progression; prognosis; angiogenesis	BREAST-CANCER METASTASIS; SUPPRESSOR GENE; CARCINOMA METASTASIS; MICROVESSEL DENSITY; OVARIAN-CARCINOMA; CHROMOSOME 11Q13; HIGH-RISK; OSTEOPONTIN; GROWTH; MECHANISMS	Breast cancer metastasis suppressor 1 (BRMS1) has been reported to suppress metastasis without significantly affecting tumorigenicity in breast cancer and ovarian cancer. To investigate the role of BRMS1 in human melanoma progression and prognosis, we established tissue microarray and BRMS1 expression was evaluated by immunohistochemistry in 41 dysplastic nevi, 90 primary melanomas and 47 melanoma metastases. We found that BRMS1 expression was significantly decreased in metastatic melanoma compared with primary melanoma or dysplastic nevi (P = 0.021 and 0.001, respectively, chi(2) test). In addition, reduced BRMS1 staining was significantly correlated with American Joint Committee on Cancer stages (P = 0.011, chi(2) test), but not associated with tumor thickness, tumor ulceration and other clinicopathological parameters. Furthermore, BRMS1 expression was significantly correlated with disease-specific 5-year survival of melanoma patients (P = 0.007, log-rank test). Multivariate Cox regression analysis revealed that BRMS1 staining was an independent prognostic factor for melanoma patients (relative risk 0.51; confidence interval = 0.29-0.91; P = 0.022). Moreover, we demonstrated that BRMS1 overexpression inhibited endothelial cell growth and tube formation ability by suppressing NF-kappa B activity and IL-6 expression in vitro. We also showed that knockdown of BRMS1 increased IL-6 expression and promoted endothelial cell growth and tube formation. In addition, our data revealed that the BRMS1-mediated IL-6 expression is dependent on NF-kappa B. Strikingly, our in vivo studies using nude mice confirmed that BRMS1 inhibited blood vessel formation and the recruitment of CD31-positive cells in matrigel plugs. Taken together, BRMS1 expression was decreased in metastatic melanomas, which resulted in deficient suppression of angiogenesis and contributed to melanoma progression. BRMS1 may serve an important prognostic marker and therapeutic target for melanoma patients. Oncogene (2011) 30, 896-906; doi: 10.1038/onc.2010.470; published online 11 October 2010	[Li, G.] Univ British Columbia, Dept Dermatol & Skin Sci, Jack Bell Res Ctr, Vancouver Coastal Hlth Res Inst, Vancouver, BC V6H 3Z6, Canada; [Martinka, M.] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Dept Pathol, Vancouver, BC V6H 3Z6, Canada; [Welch, D. R.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health Research Institute; University of Alabama System; University of Alabama Birmingham	Li, G (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Jack Bell Res Ctr, Vancouver Coastal Hlth Res Inst, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	gangli@interchange.ubc.ca	Cheng, Yabin/AAY-2178-2020; Welch, Danny R/B-7310-2009; Li, Gang/A-8257-2011; Cheng, Yabin/P-7071-2015	Cheng, Yabin/0000-0002-6205-3648; Welch, Danny R/0000-0002-1951-4947; Cheng, Yabin/0000-0002-6205-3648	Canadian Institutes of Health Research [MOP-84559, MOP-93810]; Canadian Dermatology Foundation; Natural Sciences and Engineering Research Council of Canada; University of British Columbia; CIHR Skin Research Training Centre; NATIONAL CANCER INSTITUTE [R01CA087728, R01CA134981] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Dermatology Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of British Columbia; CIHR Skin Research Training Centre(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Steve Hendy for technical assistance with EMSA. This work was supported by the Canadian Institutes of Health Research (MOP-84559 and MOP-93810) and Canadian Dermatology Foundation to GL. JL is a recipient of Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and University of British Columbia Graduate Fellowship. Both JL and YC are recipients of CIHR Skin Research Training Centre Trainee Award.	Angeletti CA, 1996, CANCER-AM CANCER SOC, V78, P409, DOI 10.1002/(SICI)1097-0142(19960801)78:3<409::AID-CNCR5>3.0.CO;2-E; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Ballo MT, 2003, SURG CLIN N AM, V83, P323, DOI 10.1016/S0039-6109(02)00096-8; Brawer MK, 1996, EUR UROL, V29, P19; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; Cicek M, 2009, CLIN EXP METASTAS, V26, P229, DOI 10.1007/s10585-009-9235-1; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; Dauda M M, 2005, Niger Postgrad Med J, V12, P125; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Garate M, 2007, FASEB J, V21, P3705, DOI 10.1096/fj.07-8069com; GASPARINI G, 1993, INT J CANCER, V55, P739, DOI 10.1002/ijc.2910550507; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Hedley BD, 2008, INT J CANCER, V123, P526, DOI 10.1002/ijc.23542; Hersey P, 2003, INTERN MED J, V33, P33, DOI 10.1046/j.1445-5994.2002.00289.x; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; HOLLINGSWORTH HC, 1995, AM J PATHOL, V147, P33; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Karst AM, 2009, INT J CANCER, V124, P494, DOI 10.1002/ijc.23973; Kauffman EC, 2003, J UROLOGY, V169, P1122, DOI 10.1097/01.ju.0000051580.89109.4b; Li G, 1998, MELANOMA RES, V8, P17, DOI 10.1097/00008390-199802000-00004; MAEDA K, 1995, BRIT J CANCER, V72, P319, DOI 10.1038/bjc.1995.331; Maffey AH, 2007, MOL CELL ENDOCRINOL, V268, P10, DOI 10.1016/j.mce.2007.01.009; MANSFIELD PF, 1994, CURR PROB SURG, V31, P257; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Meehan WJ, 2003, CLIN EXP METASTAS, V20, P45, DOI 10.1023/A:1022542519586; Metge BJ, 2008, CLIN EXP METASTAS, V25, P753, DOI 10.1007/s10585-008-9187-x; Ostmeier H, 1999, CANCER-AM CANCER SOC, V85, P2391, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2391::AID-CNCR14>3.0.CO;2-I; Phadke PA, 2008, AM J PATHOL, V172, P809, DOI 10.2353/ajpath.2008.070772; REMMELE W, 1987, PATHOLOGE, V8, P138; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Samant RS, 2001, CLIN EXP METASTAS, V18, P683, DOI 10.1023/A:1013124725690; Seraj MJ, 2000, CANCER RES, V60, P2764; Seraj MJ, 2001, CLIN EXP METASTAS, V18, P519, DOI 10.1023/A:1011819621859; Shevde LA, 2002, EXP CELL RES, V273, P229, DOI 10.1006/excr.2001.5452; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Standal T, 2004, EXP ONCOL, V26, P179; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; Tsao H, 2005, DERMATOL CLIN, V23, P323, DOI 10.1016/j.det.2004.09.005; Vaidya KS, 2008, J BIOL CHEM, V283, P28354, DOI 10.1074/jbc.M710068200; WEIDNER N, 1995, AM J PATHOL, V147, P9; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WEIDNER N, 1993, AM J PATHOL, V143, P401; Welch DR, 1997, PATHOBIOLOGY, V65, P311, DOI 10.1159/000164143; WIGGINS DL, 1995, GYNECOL ONCOL, V56, P353, DOI 10.1006/gyno.1995.1062; YAMAZAKI K, 1994, CANCER, V74, P2245, DOI 10.1002/1097-0142(19941015)74:8<2245::AID-CNCR2820740807>3.0.CO;2-X; Yang JY, 2008, CANCER LETT, V269, P46, DOI 10.1016/j.canlet.2008.04.016; Zainabadi K, 2005, GENOMICS, V85, P704, DOI 10.1016/j.ygeno.2005.02.014; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x	52	39	43	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	8					896	906		10.1038/onc.2010.470	http://dx.doi.org/10.1038/onc.2010.470			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	726CJ	20935672	Green Accepted			2022-12-25	WOS:000287695900002
J	Ishii, T; Shiomi, Y; Takami, T; Murakami, Y; Ohnishi, N; Nishitani, H				Ishii, Takashi; Shiomi, Yasushi; Takami, Toshihiro; Murakami, Yusuke; Ohnishi, Naho; Nishitani, Hideo			Proliferating Cell Nuclear Antigen-dependent Rapid Recruitment of Cdt1 and CRL4(Cdt2) at DNA-damaged Sites after UV Irradiation in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; UBIQUITIN LIGASE; S-PHASE; H2AX PHOSPHORYLATION; EUKARYOTIC CELLS; CHROMOSOMAL DNA; RE-REPLICATION; PCNA; DEGRADATION; CHROMATIN	The licensing factor Cdt1 is degraded by CRL4(Cdt2) ubiquitin ligase dependent on proliferating cell nuclear antigen (PCNA) during S phase and when DNA damage is induced in G(1) phase. Association of both Cdt2 and PCNA with chromatin was observed in S phase and after UV irradiation. Here we used a micropore UV irradiation assay to examine Cdt2 accumulation at cyclobutane pyrimidine dimer-containing DNA-damaged sites in the process of Cdt1 degradation in HeLa cells. Cdt2, present in the nucleus throughout the cell cycle, accumulated rapidly at damaged DNA sites during G1 phase. The recruitment of Cdt2 is dependent on prior PCNA chromatin binding because Cdt2 association was prevented when PCNA was silenced. Cdt1 was also recruited to damaged sites soon after UV irradiation through its PIP-box. As Cdt1 was degraded, the Cdt2 signal at damaged sites was reduced, but PCNA, cyclobutane pyrimidine dimer, and XPA (xeroderma pigmentosum, complementation group A) signals remained at the same levels. These findings suggest that Cdt1 degradation following UV irradiation occurs rapidly at damaged sites due to PCNA chromatin loading and the recruitment of Cdt1 and CRL4Cdt2, before DNA damage repair is completed.	[Ishii, Takashi; Shiomi, Yasushi; Takami, Toshihiro; Murakami, Yusuke; Ohnishi, Naho; Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan	University of Hyogo	Nishitani, H (corresponding author), Univ Hyogo, Grad Sch Life Sci, Kouto 3-2-1, Kamigori, Hyogo 6781297, Japan.	hideon@sci.u-hyogo.ac.jp		Nishitani, Hideo/0000-0001-5907-9380	Ministry of Education, Culture, Sport, Science, and Technology of Japan; Naito Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-aid for Scientific Research (B), Scientific Research on Priority Areas, and the Global Center of Excellence Program from the Ministry of Education, Culture, Sport, Science, and Technology of Japan and the Naito Foundation (to H.N.); and Grants-in-aid for Scientific Research and the Uehara Memorial Foundation (to Y.S.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Xouri G, 2007, CELL CYCLE, V6, P1549, DOI 10.4161/cc.6.13.4455; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200	40	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41993	42000		10.1074/jbc.M110.161661	http://dx.doi.org/10.1074/jbc.M110.161661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20929861	hybrid, Green Published			2022-12-25	WOS:000285622600085
J	Schmid, S; Mordstein, M; Kochs, G; Garcia-Sastre, A; tenOever, BR				Schmid, Sonja; Mordstein, Markus; Kochs, Georg; Garcia-Sastre, Adolfo; tenOever, Benjamin R.			Transcription Factor Redundancy Ensures Induction of the Antiviral State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERFERON-INDUCED TRANSCRIPTION; NECROSIS-FACTOR-ALPHA; REGULATORY FACTOR-I; CRYSTAL-STRUCTURE; GENE-EXPRESSION; NUCLEAR FACTORS; BETA ENHANCER; DNA-BINDING; POSITIVE FEEDBACK	The transcriptional response to virus infection is thought to be predominantly induced by interferon (IFN) signaling. Here we demonstrate that, in the absence of IFN signaling, an IFN-like transcriptome is still maintained. This transcriptional activity is mediated from IFN-stimulated response elements (ISREs) that bind to both the IFN-stimulated gene factor 3 (ISGF3) as well as to IFN response factor 7 (IRF7). Through a combination of both in vitro biochemistry and in vivo transcriptional profiling, we have dissected what constitutes IRF-specific, ISGF3-specific, or universal ISREs. Taken together, the data presented here suggest that IRF7 can induce an IFN-like transcriptome in the absence of type-I or -III signaling and therefore provides a level of redundancy to cells to ensure the induction of the antiviral state.	[tenOever, Benjamin R.] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo; tenOever, Benjamin R.] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Mordstein, Markus; Kochs, Georg] Univ Freiburg, Dept Virol, D-79104 Freiburg, Germany	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Freiburg	tenOever, BR (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,Box 1124, New York, NY 10029 USA.	Benjamin.tenOever@mssm.edu		Garcia-Sastre, Adolfo/0000-0002-6551-1827; Schmid, Sonja/0000-0002-1946-5970	National Institutes of Health NIAID [R01AI080624, R01AI046954, U19AI083025, U01AI082970]; CRIP (Center for Research in Influenza Pathogenesis) [HHSN266200700010C]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046954, U01AI082970, R01AI080624, U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CRIP (Center for Research in Influenza Pathogenesis); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health NIAID Grants R01AI080624 (to B. R. t. O.) and R01AI046954, U19AI083025, and U01AI082970 and by CRIP (Center for Research in Influenza Pathogenesis, HHSN266200700010C), a NIAID-funded Center of Excellence for Influenza Research and Surveillance (CEIRS) (to A.G.-S.).	Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Asano A, 2003, GENE, V306, P105, DOI 10.1016/S0378-1119(03)00428-1; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Baum A, 2010, AMINO ACIDS, V38, P1283, DOI 10.1007/s00726-009-0374-0; Brierley MM, 2005, J BIOL CHEM, V280, P13029, DOI 10.1074/jbc.M500426200; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; COHEN B, 1988, EMBO J, V7, P1411, DOI 10.1002/j.1460-2075.1988.tb02958.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kochs G, 2007, J GEN VIROL, V88, P1403, DOI 10.1099/vir.0.82764-0; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lu RQ, 2002, J BIOL CHEM, V277, P16592, DOI 10.1074/jbc.M111440200; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; LUSTER AD, 1987, MOL CELL BIOL, V7, P3723, DOI 10.1128/MCB.7.10.3723; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Martensen PM, 2001, EUR J BIOCHEM, V268, P5947, DOI 10.1046/j.0014-2956.2001.02545.x; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Morin P, 2002, J MOL BIOL, V316, P1009, DOI 10.1006/jmbi.2001.5401; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; RUTHERFORD MN, 1988, EMBO J, V7, P751, DOI 10.1002/j.1460-2075.1988.tb02872.x; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; SHIRAYOSHI Y, 1988, P NATL ACAD SCI USA, V85, P5884, DOI 10.1073/pnas.85.16.5884; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; VEALS SA, 1993, MOL CELL BIOL, V13, P196, DOI 10.1128/MCB.13.1.196; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wolff T, 2009, J INTERF CYTOK RES, V29, P549, DOI 10.1089/jir.2009.0066; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	60	85	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42013	42022		10.1074/jbc.M110.165936	http://dx.doi.org/10.1074/jbc.M110.165936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20943654	Green Published, hybrid			2022-12-25	WOS:000285622600087
J	Maurer, LM; Tomasini-Johansson, BR; Ma, WJ; Annis, DS; Eickstaedt, NL; Ensenberger, MG; Satyshur, KA; Mosher, DF				Maurer, Lisa M.; Tomasini-Johansson, Bianca R.; Ma, Wenjiang; Annis, Douglas S.; Eickstaedt, Nathan L.; Ensenberger, Martin G.; Satyshur, Kenneth A.; Mosher, Deane F.			Extended Binding Site on Fibronectin for the Functional Upstream Domain of Protein F1 of Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM BETA-ZIPPER; STAPHYLOCOCCUS-AUREUS FNBPA; N-TERMINAL MODULES; EXTRACELLULAR-MATRIX; CIRCULAR-DICHROISM; GELATIN-BINDING; (6)F1(1)F2(2)F2 FRAGMENT; CONFORMATIONAL-CHANGE; BORRELIA-BURGDORFERI; CRYSTAL-STRUCTURES	The 49-residue functional upstream domain (FUD) of Streptococcus pyogenes F1 adhesin interacts with fibronectin (FN) in a heretofore unknown manner that prevents assembly of a FN matrix. Biotinylated FUD (b-FUD) bound to adsorbed FN or its recombinant N-terminal 70-kDa fibrin-and gelatin-binding fragment (70K). Binding was blocked by FN or 70K, but not by fibrin-or gelatin-binding subfragments of 70K. Isothermal titration calorimetry showed that FUD binds with K-d values of 5.2 and 59 nM to soluble 70K and FN, respectively. We tested sets of FUD mutants and epitope-mapped monoclonal antibodies (mAbs) for ability to compete with b-FUD for binding to FN or to block FN assembly by cultured fibroblasts. Deletions or alanine substitutions throughout FUD caused loss of both activities. mAb 4D1 to the (FNI)-F-2 module had little effect, whereas mAb 7D5 to the (FNI)-F-4 module in the fibrin-binding region, 5C3 to the (FNI)-F-9 module in the gelatin-binding region, or L8 to the G-strand of (FNIII)-F-1 module adjacent to 9FNI caused loss of binding of b-FUD to FN and decreased FN assembly. Conversely, FUD blocked binding of 7D5, 5C3, or L8, but not of 4D1, to FN. Circular dichroism indicated that FUD binds to 70K by beta-strand addition, a possibility supported by modeling based on crystal structures of peptides bound to (FNI)-F-2-(FNI)-F-5 of the fibrin-binding domain and (FNI)-F-8-(FNI)-F-9 of the gelatin-binding domain. Thus, the interaction likely involves an extensive anti-parallel beta-zipper in which FUD interacts with the E-strands of (FNI)-F-2-(FNI)-F-5 and (FNI)-F-8-(FNI)-F-9.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), 1300 Univ Ave,Rm 4285, Madison, WI 53706 USA.	dfm1@medicine.wisc.edu		Satyshur, Kenneth/0000-0001-9371-2493	National Institutes of Health [HL021644]; American Heart Association [0815362G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL021644 (to D. F. M.).; Supported by American Heart Association Grant 0815362G.	Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; BARON M, 1990, NATURE, V345, P642, DOI 10.1038/345642a0; BEYCHOK S, 1966, SCIENCE, V154, P1288, DOI 10.1126/science.154.3754.1288; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Cho J, 2006, J THROMB HAEMOST, V4, P1461, DOI 10.1111/j.1538-7836.2006.01943.x; Cho J, 2006, J THROMB HAEMOST, V4, P943, DOI 10.1111/j.1538-7836.2006.01862.x; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; DZAMBA BJ, 1994, J BIOL CHEM, V269, P19646; Ellis IR, 2010, EXP CELL RES, V316, P2465, DOI 10.1016/j.yexcr.2010.04.003; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Ensenberger MG, 2001, J BIOL CHEM, V276, P35606, DOI 10.1074/jbc.M105417200; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Karuri NW, 2009, J BIOL CHEM, V284, P3445, DOI 10.1074/jbc.M805025200; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Maas C, 2008, AMYLOID, V15, P166, DOI 10.1080/13506120802193498; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Maurer LM, 2010, THROMB RES, V125, P287, DOI 10.1016/j.thromres.2009.12.017; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; MOSHER DF, 1993, CURR OPIN STRUC BIOL, V3, P214, DOI 10.1016/S0959-440X(05)80155-1; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; ODERMATT E, 1989, BIOL EXTRACELLULAR M, P29; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pagett A, 2005, BIOCHEMISTRY-US, V44, P14682, DOI 10.1021/bi050937i; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Schor SL, 1999, J CELL SCI, V112, P3879; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Sottile J, 1990, Protein Expr Purif, V1, P104, DOI 10.1016/1046-5928(90)90002-G; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; WILLIAMS MJ, 1994, J MOL BIOL, V235, P1302, DOI 10.1006/jmbi.1994.1083; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu JL, 2010, J BIOL CHEM, V285, P8563, DOI 10.1074/jbc.M109.062646; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; Zhang QH, 1996, J BIOL CHEM, V271, P33284, DOI 10.1074/jbc.271.52.33284; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	73	49	50	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41087	41099		10.1074/jbc.M110.153692	http://dx.doi.org/10.1074/jbc.M110.153692			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20947497	hybrid, Green Published			2022-12-25	WOS:000285414400071
J	Moore, SA; Ferhatoglu, Y; Jia, YH; Al-Jiab, RA; Scott, MJ				Moore, Stanley A.; Ferhatoglu, Yurdagul; Jia, Yunhua; Al-Jiab, Rami A.; Scott, Maxwell J.			Structural and Biochemical Studies on the Chromo-barrel Domain of Male Specific Lethal 3 (MSL3) Reveal a Binding Preference for Mono- or Dimethyllysine 20 on Histone H4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DOSAGE COMPENSATION; X-CHROMOSOME; FUNCTIONAL-INTEGRATION; LYSINE METHYLATION; ACTIVE GENES; COMPLEX; DNA; ACETYLATION; ACETYLTRANSFERASE; MOF	We have determined the human male specific lethal 3 (hMSL3) chromo-barrel domain structure by x-ray crystallography to a resolution of 2.5 angstrom (r = 0.226, R-free = 0.270). hMSL3 contains a canonical methyllysine binding pocket made up of residues Tyr-31, Phe-56, Trp-59, and Trp-63. A six-residue insertion between strands beta(1) and beta(2) of the hMSL3 chromo-barrel domain directs the side chain of Glu-21 into the methyllysine binding pocket where it hydrogen bonds to the NH group of a bound cyclohexylamino ethanesulfonate buffer molecule, likely mimicking interactions with a histone tail dimethyllysine residue. In vitro binding studies revealed that both the human and Drosophila MSL3 chromo-barrel domains bind preferentially to peptides representing the mono or dimethyl isoform of lysine 20 on the histone H4 N-terminal tail (H4K20Me(1) or H4K20Me(2)). Mutation of Tyr-31 to Ala in the hMSL3 methyllysine-binding cage resulted in weaker in vitro binding to H4K20Me(1). The same mutation in the msl3 gene compromised male survival in Drosophila. Combined mutation of Glu-21 and Pro-22 to Ala in hMSL3 resulted in slightly weaker in vitro binding to H4K20Me(1), but the corresponding msl3 mutation had no effect on male survival in Drosophila. We propose MSL3 plays an important role in targeting the male specific lethal complex to chromatin in both humans and flies by binding to H4K20Me(1). Binding studies on the related dMRG15 chromo-barrel domain revealed that MRG15 prefers binding to H4K20Me(3).	[Moore, Stanley A.; Ferhatoglu, Yurdagul; Jia, Yunhua] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Al-Jiab, Rami A.; Scott, Maxwell J.] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand	University of Saskatchewan; Massey University	Moore, SA (corresponding author), A3 Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	stan.moore@usask.ca	Scott, Maxwell J/J-1935-2015	Scott, Maxwell J/0000-0001-6536-4735	Saskatchewan Health Research Foundation; University of Saskatchewan College of Medicine; Canadian Institutes for Health Research (CIHR) [MOP 79377]; National Science and Engineering Council of Canada (NSERC); Canadian foundation for innovation (CFI); University of Saskatchewan	Saskatchewan Health Research Foundation; University of Saskatchewan College of Medicine; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian foundation for innovation (CFI)(Canada Foundation for Innovation); University of Saskatchewan	This work was supported by Canadian Institutes for Health Research Grant MOP 79377 (to S. M.), the Saskatchewan Health Research Foundation regional partnership program, and bridge funding from the University of Saskatchewan College of Medicine.; We thank Bradley McLellan, Massey University, New Zealand, for cloning the dMSL3 chromo-barrel domain fragment; George Wong for purification conditions for the dMSL3 chromo-barrel domain; and Andrew Welham who carried out the initial characterization of the dMSL3 and hMSL3 chromo-barrel domains. Ewa Kerc contributed to the cloning of the hMSL3 chromo-barrel domain. Robert Shearer cloned the D. melanogaster MRG15 chromo-barrel domain and conducted the initial purification studies. We thank Edwin Smith for generously providing cDNAs for the hMSL proteins, and Prof. Mitzi Kuroda, Harvard Medical School, for providing the msl3-TAP construct for Drosophila transgenic studies. David Sanders (Dept of Chemistry, University of Saskatchewan) provided access to the Nanodrop device. Jeremy Lee graciously conducted the ethidium bromide fluorescence assays. SPR data were collected at the Saskatchewan Structural Sciences Centre, University of Saskatchewan. We thank Pawel Grochulski and James Gorin of the Canadian Light Source CMCF small-gap undulator beamline for timely access and expert assistance with data collection. The Canadian Light Source is funded by the Canadian Institutes for Health Research (CIHR), the National Science and Engineering Council of Canada (NSERC), the Canadian foundation for innovation (CFI) and the University of Saskatchewan.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bertram MJ, 2001, GENE, V266, P111, DOI 10.1016/S0378-1119(01)00372-9; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buscaino A, 2006, EMBO REP, V7, P531, DOI 10.1038/sj.embor.7400658; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Demakova OV, 2003, CHROMOSOMA, V112, P103, DOI 10.1007/s00412-003-0249-1; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; GORMAN M, 1995, DEVELOPMENT, V121, P463; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gu WG, 2000, EMBO J, V19, P5202, DOI 10.1093/emboj/19.19.5202; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Lucchesi JC, 2009, CURR OPIN GENET DEV, V19, P550, DOI 10.1016/j.gde.2009.10.004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morales V, 2005, MOL CELL BIOL, V25, P5947, DOI 10.1128/MCB.25.14.5947-5954.2005; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; MORGAN AR, 1979, NUCLEIC ACIDS RES, V7, P547, DOI 10.1093/nar/7.3.547; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Prakash SK, 1999, GENOMICS, V59, P77, DOI 10.1006/geno.1999.5844; Qi D, 2006, GENETICS, V174, P241, DOI 10.1534/genetics.106.059980; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Sakaguchi A, 2008, GENETICS, V179, P317, DOI 10.1534/genetics.108.087650; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Scott MJ, 2008, RNA BIOL, V5, P13, DOI 10.4161/rna.5.1.5943; Scott MJ, 2000, EMBO J, V19, P144, DOI 10.1093/emboj/19.1.144; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sural TH, 2008, NAT STRUCT MOL BIOL, V15, P1318, DOI 10.1038/nsmb.1520; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Yang HB, 2009, BIOCHEM CELL BIOL, V87, P151, DOI 10.1139/O08-131; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	71	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40879	40890		10.1074/jbc.M110.134312	http://dx.doi.org/10.1074/jbc.M110.134312			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943666	hybrid, Green Published			2022-12-25	WOS:000285414400052
J	Xu, DZ; Yao, YX; Jiang, XJ; Lu, L; Dai, W				Xu, Dazhong; Yao, Yixin; Jiang, Xuejun; Lu, Luo; Dai, Wei			Regulation of PTEN Stability and Activity by Plk3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; POLO-LIKE KINASES; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; SIGNALING PATHWAY; PROTEIN STABILITY; CANCER CELLS; LUNG-CANCER; PHOSPHORYLATION; POLO-LIKE-KINASE-3	By studying primary isogenic murine embryonic fibroblasts (MEFs), we have shown that PLK3 null MEFs contain a reduced level of phosphatase and tensin homolog (PTEN) and increased Akt1 activation coupled with decreased GSK3 beta activation under normoxia and hypoxia. Purified recombinant Plk3, but not a kinase-defective mutant, efficiently phosphorylates PTEN in vitro. Mass spectrometry identifies threonine 366 and serine 370 as two putative residues that are phosphorylated by Plk3. Immunoblotting using a phosphospecific antibody confirms these sites as Plk3 phosphorylation sites. Moreover, treatment of MEFs with LiC1, an inhibitor of GSK3 beta and CK2, only partially suppresses the phosphorylation, suggesting Plk3 as an additional kinase that phosphorylates these sites in vivo. Plk3-targeting mutants of PTEN are expressed at a reduced level in comparison with the wild-type counterpart, which is associated with an enhanced activity of PDK1, an upstream activator of Akt1. Furthermore, the reduced level of PTEN in PLK3 null MEFs is stabilized by treatment with MG132, a proteosome inhibitor. Combined, our study identifies Plk3 as a new player in the regulation of the PI3K/PDK1/Akt signaling axis by phosphorylation and stabilization of PTEN.	[Xu, Dazhong; Yao, Yixin; Dai, Wei] NYU, Langone Med Ctr, Dept Environm Med & Pharmacol, Sch Med, Tuxedo Pk, NY 10987 USA; [Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10024 USA; [Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA	New York University; NYU Langone Medical Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dai, W (corresponding author), NYU, Langone Med Ctr, Dept Environm Med & Pharmacol, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@med.nyu.edu		Xu, Dazhong/0000-0001-9264-3342; Dai, Wei/0000-0003-0169-8327; Yao, Yixin/0000-0003-1891-7186	National Institutes of Health, USPHS [CA074229, CA113349, AG009953]; NATIONAL CANCER INSTITUTE [R01CA074229, R01CA113349] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018343, R01EY015281] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA074229 and CA113349 from USPHS (to W. D.) and AG009953 (to D. X.).	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Bardos JI, 2004, BIOESSAYS, V26, P262, DOI 10.1002/bies.20002; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Brauer PM, 2009, CELL CYCLE, V8, P2728, DOI 10.4161/cc.8.17.9389; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chizhikov V, 2001, MOL CARCINOGEN, V30, P151, DOI 10.1002/mc.1023; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Perotti D, 1999, HAEMATOLOGICA, V84, P110; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schnitzer SE, 2005, FEBS LETT, V579, P529, DOI 10.1016/j.febslet.2004.12.023; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Yang G, 2008, DEVELOPMENT, V135, P3587, DOI 10.1242/dev.028118; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zhong H, 2000, CANCER RES, V60, P1541	44	51	56	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39935	39942		10.1074/jbc.M110.166462	http://dx.doi.org/10.1074/jbc.M110.166462			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940307	hybrid, Green Published			2022-12-25	WOS:000285185500038
J	Balakrishnan, L; Polaczek, P; Pokharel, S; Campbell, JL; Bambara, RA				Balakrishnan, Lata; Polaczek, Piotr; Pokharel, Subhash; Campbell, Judith L.; Bambara, Robert A.			Dna2 Exhibits a Unique Strand End-dependent Helicase Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; ENZYMATIC-PROPERTIES; XENOPUS DNA2; YEAST; CLEAVAGE; HELICASE/NUCLEASE; ENDONUCLEASE; SUBSTRATE	Dna2 endonuclease/helicase participates in eukaryotic DNA transactions including cleavage of long flaps generated during Okazaki fragment processing. Its unusual substrate interaction consists of recognition and binding of the flap base, then threading over the 5'-end of the flap, and cleaving periodically to produce a terminal product similar to 5 nt in length. Blocking the 5'-end prevents cleavage. The Dna2 ATP-driven 5' to 3' DNA helicase function promotes motion of Dna2 on the flap, presumably aiding its nuclease function. Here we demonstrate using two different nuclease-dead Dna2 mutants that on substrates simulating Okazaki fragments, Dna2 must thread onto an unblocked 5' flap to display helicase activity. This requirement is maintained on substrates with single-stranded regions thousands of nucleotides in length. To our knowledge this is the first description of a eukaryotic helicase that cannot load onto its tracking strand internally but instead must enter from the end. Biologically, the loading requirement likely helps the helicase to coordinate with the Dna2 nuclease function to prevent creation of undesirably long flaps during DNA transactions.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Polaczek, Piotr; Pokharel, Subhash; Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology		robert_bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM087666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM024441 (to R. A. B.) and GM087666 (to J. L. C.).	Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; Formosa T, 1999, GENETICS, V151, P1459; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kim DH, 2005, NUCLEIC ACIDS RES, V33, P1372, DOI 10.1093/nar/gki255; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; LOHMAN TM, 1992, MOL MICROBIOL, V6, P5, DOI 10.1111/j.1365-2958.1992.tb00831.x; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pokharel S, 2009, J AM CHEM SOC, V131, P11882, DOI 10.1021/ja9034076; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Wawrousek KE, 2010, CELL CYCLE, V9, P1156, DOI 10.4161/cc.9.6.11049; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	41	25	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38861	38868		10.1074/jbc.M110.165191	http://dx.doi.org/10.1074/jbc.M110.165191			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20929864	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000284941300015
J	Devaiah, BN; Lu, HX; Gegonne, A; Sercan, Z; Zhang, HE; Clifford, RJ; Lee, MP; Singer, DS				Devaiah, Ballachanda N.; Lu, Hanxin; Gegonne, Anne; Sercan, Zeynep; Zhang, Hongen; Clifford, Robert J.; Lee, Maxwell P.; Singer, Dinah S.			Novel Functions for TAF7, a Regulator of TAF1-independent Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II TRANSACTIVATOR; MHC CLASS-I; ACETYLTRANSFERASE ACTIVITY; GENE-TRANSCRIPTION; BASAL PROMOTER; COMPLEX; CIITA; EXPRESSION; TAF(II)250; TAT	The transcription factor TFIID components TAF7 and TAF1 regulate eukaryotic transcription initiation. TAF7 regulates transcription initiation of TAF1-dependent genes by binding to the acetyltransferase (AT) domain of TAF1 and inhibiting the enzymatic activity that is essential for transcription. TAF7 is released from the TAF1-TFIID complex upon completion of preinitiation complex assembly, allowing transcription to initiate. However, not all transcription is TAF1-dependent, and the role of TAF7 in regulating TAF1-independent transcription has not been defined. The IFN gamma-induced transcriptional co-activator CIITA activates MHC class I and II genes, which are vital for immune responses, in a TAF1-independent manner. Activation by CIITA depends on its intrinsic AT activity. We now show that TAF7 binds to CIITA and inhibits its AT activity, thereby repressing activated transcription. Consistent with this TAF7 function, siRNA-mediated depletion of TAF7 resulted in increased CIITA-dependent transcription. A more global role for TAF7 as a regulator of transcription was revealed by expression profiling analysis: expression of 30-40% of genes affected by TAF7 depletion was independent of either TAF1 or CIITA. Surprisingly, although TAF1-dependent transcripts were largely down-regulated by TAF7 depletion, TAF1-independent transcripts were predominantly up-regulated. We conclude that TAF7, until now considered only a TFIID component and regulator of TAF1-dependent transcription, also regulates TAF1-independent transcription.	[Singer, Dinah S.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Zhang, Hongen; Clifford, Robert J.; Lee, Maxwell P.] NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Singer, DS (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	dinah.singer@nih.gov			NATIONAL CANCER INSTITUTE [ZIASC010375, ZIABC009285, ZIABC011250] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen Z, 2003, J BIOL CHEM, V278, P35172, DOI 10.1074/jbc.M304241200; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Fontes JD, 1999, MICROBES INFECT, V1, P863, DOI 10.1016/S1286-4579(99)80529-2; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Gegonne A, 2006, P NATL ACAD SCI USA, V103, P602, DOI 10.1073/pnas.0510031103; Gegonne A, 2001, P NATL ACAD SCI USA, V98, P12432, DOI 10.1073/pnas.211444798; Gegonne A, 2008, P NATL ACAD SCI USA, V105, P5367, DOI 10.1073/pnas.0801637105; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; HAYASHIDA T, 1994, GENE, V141, P267; Howcroft TK, 2003, MOL CELL BIOL, V23, P3377, DOI 10.1128/MCB.23.10.3377-3391.2003; HOWCROFT TK, 1995, IMMUNITY, V3, P127; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; Kirshner S, 2000, MOL ENDOCRINOL, V14, P82, DOI 10.1210/me.14.1.82; Lee MP, 2005, GENOME RES, V15, P1189, DOI 10.1101/gr.3873705; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; Masternak K, 2000, GENE DEV, V14, P1156; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Mozes E, 2005, LUPUS, V14, P308, DOI 10.1191/0961203305lu2079oa; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Raval A, 2001, MOL CELL, V7, P105, DOI 10.1016/S1097-2765(01)00159-9; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; Tavassoli P, 2010, MOL ENDOCRINOL, V24, P696, DOI 10.1210/me.2009-0229; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; van den Elsen PJ, 1999, MICROBES INFECT, V1, P887, DOI 10.1016/S1286-4579(99)80532-2; Vora AR, 1997, BRIT J CANCER, V76, P836, DOI 10.1038/bjc.1997.472; Weissman JD, 1998, P NATL ACAD SCI USA, V95, P11601, DOI 10.1073/pnas.95.20.11601; Weissman JDJ, 2000, J BIOL CHEM, V275, P10160, DOI 10.1074/jbc.275.14.10160; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	34	17	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38772	38780		10.1074/jbc.M110.173864	http://dx.doi.org/10.1074/jbc.M110.173864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937824	hybrid, Green Published			2022-12-25	WOS:000284941300006
J	McLuskey, K; Paterson, NG; Bland, ND; Isaacs, NW; Mottram, JC				McLuskey, Karen; Paterson, Neil G.; Bland, Nicholas D.; Isaacs, Neil W.; Mottram, Jeremy C.			Crystal Structure of Leishmania major Oligopeptidase B Gives Insight into the Enzymatic Properties of a Trypanosomatid Virulence Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-FACTOR; PROLYL OLIGOPEPTIDASE; ACTIVE-SITE; BRUCEI; CRUZI; ENDOPEPTIDASE; PEPTIDASE; PURIFICATION; REPLACEMENT; REFINEMENT	Oligopeptidase B (OPB) is a serine peptidase with dibasic substrate specificity. It is found in bacteria, plants, and trypanosomatid pathogens, where it has been identified as a virulence factor and potential drug target. In this study we expressed active recombinant Leishmania major OPB and provide the first structure of an oligopeptidase B at high resolution. The crystallographic study reveals that OPB comprises two domains, a catalytic and a propeller domain, linked together by a hinge region. The structure has been determined in complex with the oligopeptide, protease-inhibitor antipain, giving detailed information on the enzyme active site and extended substrate binding pockets. It shows that Glu-621 plays a critical role in the S1 binding pocket and, along with Phe-603, is largely responsible for the enzyme substrate specificity in P1. In the S2 binding pocket, Tyr-499 was shown to be important for substrate stability. The structure also allowed an investigation into the function of residues highlighted in other studies including Glu-623, which was predicted to be involved in the S1 binding pocket but is found forming an inter-domain hydrogen bond. Additional important salt bridges/hydrogen bonds between the two domains were observed, highlighting the significance of the domain interface in OPB. This work provides a foundation for the study of the role of OPBs as virulence factors in trypanosomatids. It could facilitate the development of specific OPB inhibitors with therapeutic potential by exploiting its unique substrate recognition properties as well as providing a model for OPBs in general.	[McLuskey, Karen; Paterson, Neil G.; Isaacs, Neil W.] Univ Glasgow, Westchem Sch Chem, Glasgow G12 8TA, Lanark, Scotland; [Bland, Nicholas D.; Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow; University of Glasgow	McLuskey, K (corresponding author), Glasgow Biomed Res Ctr, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	Karen.McLuskey@glasgow.ac.uk	Bland, Nicholas/A-8038-2008	Bland, Nicholas/0000-0002-7692-5689; Mottram, Jeremy/0000-0001-5574-3766; McLuskey, Karen/0000-0002-9841-4943; Paterson, Neil/0000-0003-4292-6971	MRC [G9722968, G0000508]; Wellcome Trust; Medical Research Council [G0000508, G9722968] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the MRC (Grant Numbers G9722968 and G0000508) and by a Wellcome Trust Value in People Award (to K. McL.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker SC, 1997, J MOL BIOL, V269, P440, DOI 10.1006/jmbi.1997.1070; BARRETT AJ, 1992, BIOL CHEM H-S, V373, P353, DOI 10.1515/bchm3.1992.373.2.353; BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; BURLEIGH BA, 1995, ANNU REV MICROBIOL, V49, P175, DOI 10.1146/annurev.mi.49.100195.001135; Burleigh BA, 1997, J CELL BIOL, V136, P609, DOI 10.1083/jcb.136.3.609; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coetzer THT, 2008, BIOCHIMIE, V90, P336, DOI 10.1016/j.biochi.2007.10.011; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Fuxreiter M, 2005, PROTEINS, V60, P504, DOI 10.1002/prot.20508; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hemerly JP, 2003, BIOCHEM J, V373, P933, DOI 10.1042/BJ20030342; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Juhasz T, 2005, J MOL BIOL, V346, P907, DOI 10.1016/j.jmb.2004.12.014; KANATANI A, 1991, J BIOCHEM-TOKYO, V110, P315, DOI 10.1093/oxfordjournals.jbchem.a123577; KORNBLATT MJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P25, DOI 10.1016/0003-9861(92)90360-9; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morty RE, 1999, J BIOL CHEM, V274, P26149, DOI 10.1074/jbc.274.37.26149; Morty RE, 1999, MOL BIOCHEM PARASIT, V102, P145, DOI 10.1016/S0166-6851(99)00097-3; Morty RE, 2000, BIOCHEM PHARMACOL, V60, P1497, DOI 10.1016/S0006-2952(00)00459-7; Morty RE, 2005, J BIOL CHEM, V280, P10925, DOI 10.1074/jbc.M410066200; Morty RE, 1998, FEBS LETT, V433, P251, DOI 10.1016/S0014-5793(98)00914-4; Morty RE, 2002, J BACTERIOL, V184, P3329, DOI 10.1128/JB.184.12.3329-3337.2002; Morty RE, 2001, INFECT IMMUN, V69, P2757, DOI 10.1128/IAI.69.4.2757-2761.2001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NDUNGU JM, 1992, PARASITOL RES, V78, P553, DOI 10.1007/BF00936451; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Troeberg L, 1996, EUR J BIOCHEM, V238, P728, DOI 10.1111/j.1432-1033.1996.0728w.x; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Usuki H, 2009, BBA-PROTEINS PROTEOM, V1794, P1673, DOI 10.1016/j.bbapap.2009.07.024; Velankar S, 2011, NUCLEIC ACIDS RES, V39, pD402, DOI [10.1093/nar/gkq985, 10.1093/nar/gkp916]; Venalainen JI, 2004, EUR J BIOCHEM, V271, P2705, DOI 10.1111/j.1432-1033.2004.04199.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WELCHES WR, 1993, LIFE SCI, V52, P1461, DOI 10.1016/0024-3205(93)90108-F	56	46	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39249	39259		10.1074/jbc.M110.156679	http://dx.doi.org/10.1074/jbc.M110.156679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926390	hybrid, Green Published			2022-12-25	WOS:000284941300054
J	Vozzolo, L; Loh, B; Gane, PJ; Tribak, M; Zhou, LH; Anderson, I; Nyakatura, E; Jenner, RG; Selwood, D; Fassati, A				Vozzolo, Luciano; Loh, Belinda; Gane, Paul J.; Tribak, Maryame; Zhou, Lihong; Anderson, Ian; Nyakatura, Elisabeth; Jenner, Richard G.; Selwood, David; Fassati, Ariberto			Gyrase B Inhibitor Impairs HIV-1 Replication by Targeting Hsp90 and the Capsid Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHROMATIN-REMODELING COMPLEX; NONDIVIDING CELLS; GENE-EXPRESSION; DNA GYRASE; TERMINAL DIMERIZATION; MOLECULAR CHAPERONE; QUANTITATIVE ASSAY; CRYSTAL-STRUCTURE; CYCLOPHILIN-A	Chemical genetics is an emerging approach to investigate the biology of host-pathogen interactions. We screened several inhibitors of ATP-dependent DNA motors and detected the gyrase B inhibitor coumermycin A1 (C-A1) as a potent antiretroviral. C-A1 inhibited HIV-1 integration and gene expression from acutely infected cell, but the two activities mapped to distinct targets. Target discovery identified Hsp90 as the C-A1 target affecting viral gene expression. Chromatin immunoprecipitation revealed that Hsp90 associates with the viral promoter and may directly regulate gene expression. Molecular docking suggested that C-A1 binds to two novel pockets at the C terminal domain of Hsp90. C-A1 inhibited Hsp90 dimer formation, suggesting that it impairs viral gene expression by preventing Hsp90 dimerization at the C terminus. The inhibition of HIV-1 integration imposed by C-A1 was independent of Hsp90 and mapped to the capsid protein, and a point mutation at residue 105 made the virus resistant to this block. HIV-1 susceptibility to the integration block mediated by C-A1 was influenced by cyclophilin A. Our chemical genetic approach revealed an unexpected function of capsid in HIV-1 integration and provided evidence for a role of Hsp90 in regulating gene expression in mammalian cells. Both activities were amenable to inhibition by small molecules and represent novel antiretroviral drug targets.	[Nyakatura, Elisabeth; Fassati, Ariberto] UCL, Wohl Vir Ctr, London W1T 4JF, England; [Vozzolo, Luciano; Loh, Belinda; Tribak, Maryame; Zhou, Lihong; Anderson, Ian; Nyakatura, Elisabeth; Jenner, Richard G.; Fassati, Ariberto] UCL, Med Res Council Ctr Med Mol Virol, Div Infect & Immun, London W1T 4JF, England; [Gane, Paul J.; Selwood, David] UCL, Wolfson Inst Biomed Res, Med Chem Grp, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Fassati, A (corresponding author), UCL, Wohl Vir Ctr, 46 Cleveland St, London W1T 4JF, England.	a.fassati@ucl.ac.uk	Jenner, Richard/J-8683-2012; Loh, Belinda/AAT-1236-2021	Jenner, Richard/0000-0002-2946-6811; Loh, Belinda/0000-0003-1364-6911; Fassati, Ariberto/0000-0003-1934-5327; Gane, Paul/0000-0002-9153-5240; Selwood, David/0000-0002-6817-5064	Wellcome Trust; University College London Hospital Charities Clinical Research and Development Committee [F144]; Medical Research Council; MRC [G0600081, G9721629, G0900950] Funding Source: UKRI; Medical Research Council [G0900950, G9721629B, G9721629, G0600081, G0900950B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); University College London Hospital Charities Clinical Research and Development Committee; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust and University College London Hospital Charities Clinical Research and Development Committee Grant F144 (to A. F.).; Supported by Medical Research Council Ph.D. studentship.	Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; [Anonymous], 2008, AIDS EP UPD 2009; Arfi V, 2009, J VIROL, V83, P7524, DOI 10.1128/JVI.00429-09; BABA M, 1989, International Journal of Experimental and Clinical Chemotherapy, V2, P15; BACHUR NR, 1993, MOL PHARMACOL, V44, P1064; Bonnet F, 2008, CURR OPIN ONCOL, V20, P534, DOI 10.1097/CCO.0b013e32830a5080; Bower M, 2008, BLOOD, V111, P3986, DOI 10.1182/blood-2007-10-115659; Bruce JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000207; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Burlison JA, 2006, ORG LETT, V8, P4855, DOI 10.1021/ol061918j; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chiosis G, 2006, CURR TOP MED CHEM, V6, P1183, DOI 10.2174/156802606777812013; Ciuffi A, 2008, CURR GENE THER, V8, P419, DOI 10.2174/156652308786848021; Cutino-Moguel T, 2006, TRAFFIC, V7, P978, DOI 10.1111/j.1600-0854.2006.00449.x; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fassati A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-74; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Gadelle D, 2003, BIOESSAYS, V25, P232, DOI 10.1002/bies.10245; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Grattinger M, 1999, VIROLOGY, V257, P247, DOI 10.1006/viro.1999.9668; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hartkoorn RC, 2010, PHARMACOGENET GENOM, V20, P112, DOI 10.1097/FPC.0b013e328335b02d; Hazuda D, 2009, ANNU REV PHARMACOL, V49, P377, DOI 10.1146/annurev.pharmtox.011008.145553; Homme MB, 2005, BIOPHYS J, V88, P2078, DOI 10.1529/biophysj.104.053298; Hue S, 2009, J VIROL, V83, P2645, DOI 10.1128/JVI.01556-08; Inoue N, 1999, HUM MOL GENET, V8, P1201, DOI 10.1093/hmg/8.7.1201; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; KAPLAN SA, 1970, J PHARM SCI, V59, P1569, DOI 10.1002/jps.2600591105; Kellam P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-201; Kim RH, 2008, CARCINOGENESIS, V29, P2425, DOI 10.1093/carcin/bgn225; Lewis RJ, 1996, EMBO J, V15, P1412, DOI 10.1002/j.1460-2075.1996.tb00483.x; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; Loh B, 2010, CHEM BIOL DRUG DES, V75, P461, DOI 10.1111/j.1747-0285.2010.00956.x; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Martin CJ, 2008, J MED CHEM, V51, P2853, DOI 10.1021/jm701558c; Matheson EC, 2003, CARCINOGENESIS, V24, P31, DOI 10.1093/carcin/24.1.31; Mbisa Jean L., 2009, V485, P55, DOI 10.1007/978-1-59745-170-3_5; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; NEWMARK HL, 1970, J PHARM SCI, V59, P1246, DOI 10.1002/jps.2600590905; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pannecouque C, 2002, CURR BIOL, V12, P1169, DOI 10.1016/S0960-9822(02)00952-1; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Qi ML, 2008, J VIROL, V82, P12001, DOI 10.1128/JVI.01518-08; Ratzke C, 2010, P NATL ACAD SCI USA, V107, P16101, DOI 10.1073/pnas.1000916107; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Shafer RW, 2008, AIDS REV, V10, P67; SMITH CL, 1978, NATURE, V275, P420, DOI 10.1038/275420a0; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; TACHEDJIAN G, 1992, ANTIVIR CHEM CHEMOTH, V3, P183, DOI 10.1177/095632029200300309; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Uetrecht J. P., 2007, DRUG METABOLISM CHEM, P120; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09; YANG HL, 1979, P NATL ACAD SCI USA, V76, P3304, DOI 10.1073/pnas.76.7.3304; Yin L, 1998, J VIROL, V72, P6430, DOI 10.1128/JVI.72.8.6430-6436.1998; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158	74	64	66	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39314	39328		10.1074/jbc.M110.155275	http://dx.doi.org/10.1074/jbc.M110.155275			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937817	hybrid, Green Published			2022-12-25	WOS:000284941300059
J	Veliz, LA; Toro, CA; Vivar, JP; Arias, LA; Villegas, J; Castro, MA; Brauchi, S				Veliz, Luis A.; Toro, Carlos A.; Vivar, Juan P.; Arias, Luis A.; Villegas, Jenifer; Castro, Maite A.; Brauchi, Sebastian			Near-Membrane Dynamics and Capture of TRPM8 Channels within Transient Confinement Domains	PLOS ONE			English	Article							INTERNAL-REFLECTION FLUORESCENCE; KISS-AND-RUN; PLASMA-MEMBRANE; CATION CHANNEL; RECEPTOR TRPM8; CELL-SURFACE; ION CHANNELS; TRAFFICKING; TRANSLOCATION; CHOLESTEROL	Background: The cold and menthol receptor, TRPM8, is a non-selective cation channel expressed in a subset of peripheral neurons that is responsible for neuronal detection of environmental cold stimuli. It was previously shown that members of the transient receptor potential (TRP) family of ion channels are translocated toward the plasma membrane (PM) in response to agonist stimulation. Because the spatial and temporal dynamics of cold receptor cell-surface residence may determine neuronal activity, we hypothesized that the movement of TRPM8 to and from the PM might be a regulated process. Single particle tracking (SPT) is a useful tool for probing the organization and dynamics of protein constituents in the plasma membrane. Methodology/Principal Findings: We used SPT to study the receptor dynamics and describe membrane/near-membrane behavior of particles containing TRPM8-EGFP in transfected HEK-293T and F-11 cells. Cells were imaged using total internal reflection fluorescence (TIRF) microscopy and the 2D and 3D trajectories of TRPM8 molecules were calculated by analyzing mean-square particle displacement against time. Four characteristic types of motion were observed: stationary mode, simple Brownian diffusion, directed motion, and confined diffusion. In the absence of cold or menthol to activate the channel, most TRPM8 particles move in network covering the PM, periodically lingering for 2-8 s in confined microdomains of about 800 nm radius. Removing cholesterol with methyl-beta-cyclodextrin (M beta CD) stabilizes TRPM8 motion in the PM and is correlated with larger TRPM8 current amplitude that results from an increase in the number of available channels without a change in open probability. Conclusions/Significance: These results reveal a novel mechanism for regulating TRPM8 channel activity, and suggest that PM dynamics may play an important role in controlling electrical activity in cold-sensitive neurons.	[Veliz, Luis A.; Toro, Carlos A.; Vivar, Juan P.; Arias, Luis A.; Villegas, Jenifer; Brauchi, Sebastian] Univ Austral Chile, Fac Med, Inst Fisiol, Valdivia, Chile; [Castro, Maite A.] Univ Austral Chile, Fac Ciencias, Inst Bioquim, Valdivia, Chile; [Veliz, Luis A.] Univ Austral Chile, Fac Ciencias Ingn, Inst Ingn Informat, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Austral de Chile	Veliz, LA (corresponding author), Univ Austral Chile, Fac Med, Inst Fisiol, Campus Isla Teja, Valdivia, Chile.	sbrauchi@docentes.uach.cl	Toro, Carlos A/K-6642-2019; Soriano, Vicente/O-5730-2018; Brauchi, Sebastian E/A-2395-2008	Toro, Carlos A/0000-0002-7355-7534; Soriano, Vicente/0000-0002-4624-5199; Brauchi, Sebastian E/0000-0002-8494-9912	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11070190, 11070065]; SeedingLabs, MA; PEW Program in Biomedical Sciences	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); SeedingLabs, MA; PEW Program in Biomedical Sciences	This work was funded by the PEW Program in Biomedical Sciences, Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grants #11070190 and #11070065, and SeedingLabs, MA. C.T. is a Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2008, P NATL ACAD SCI USA, V105, P8304, DOI 10.1073/pnas.0800881105; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Chang YP, 2008, J BIOPHOTONICS, V1, P287, DOI 10.1002/jbio.200810029; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lambers TT, 2007, MOL CELL BIOL, V27, P1486, DOI 10.1128/MCB.01468-06; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Mattheyses AL, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2161018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Peters KW, 2001, PFLUG ARCH EUR J PHY, V443, pS65, DOI 10.1007/s004240100647; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Ryan TA, 2003, P NATL ACAD SCI USA, V100, P2171, DOI 10.1073/pnas.0530260100; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Stewart AP, 2010, BIOCHEM BIOPH RES CO, V394, P383, DOI 10.1016/j.bbrc.2010.03.027; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Triller A, 2003, BIOL CELL, V95, P465, DOI 10.1016/j.biolcel.2003.07.001; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; ZHANG X, 2005, EMBO J, P2424	41	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13290	10.1371/journal.pone.0013290	http://dx.doi.org/10.1371/journal.pone.0013290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948964	Green Submitted, gold, Green Published			2022-12-25	WOS:000282748100022
J	Mohd-Padil, H; Tajul-Arifin, K; Mohd-Adnan, A				Mohd-Padil, Hirzahida; Tajul-Arifin, Khairina; Mohd-Adnan, Adura			Characterization of the Functional Domain of beta 2-Microglobulin from the Asian Seabass, Lates calcarifer	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; BETA(2)-MICROGLOBULIN GENE; EXPRESSION; IDENTIFICATION; CHICKEN; CLONING; FISH	Background: beta 2-Microglobulin (beta M-2) is the light chain of major histocompatibility class I (MHC I) that binds non-covalently with the a heavy chain. Both proteins attach to the antigen peptide, presenting a complex to the T cell to be destroyed via the immune mechanism. Methodology/Principal Findings: In this study, a cDNA sequence encoding beta M-2 in the Asian seabass (Lates calcarifer) was identified and analyzed using in silico approaches to predict and characterize its functional domain. The beta M-2 cDNA contains an open reading frame (ORF) of 351 bases with a coding capacity of 116 amino acids. A large portion of the protein consists of the IG constant domain (IGc1), similar to beta M-2 sequences from other species studied thus far. Alignment of the IGc1 domains of beta M-2 from L. calcarifer and other species shows a high degree of overall conservation. Seven amino acids were found to be conserved across taxa whereas conservation between L. calcarifer and other fish species was restricted to 14 amino acids at identical conserved positions. Conclusion/Significance: As the L. calcarifer beta M-2 protein analyzed in this study contains a functional domain similar to that of beta M-2 proteins in other species, it can be postulated that the beta M-2 proteins from L. calcarifer and other organisms are derived from a common ancestor and thus have a similar immune function. Interestingly, fish beta M-2 genes could also be classified according to the ecological habitat of the species, i.e. whether it is from a freshwater, marine or euryhaline environment.	[Mohd-Padil, Hirzahida; Tajul-Arifin, Khairina; Mohd-Adnan, Adura] Univ Kebangsaan Malaysia, Sch Biosci & Biotechnol, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Mohd-Padil, H (corresponding author), Univ Kebangsaan Malaysia, Sch Biosci & Biotechnol, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia.	kay.tarifin@gmail.com	Mohd-Padil, Hirzahida/AAK-8082-2020		Ministry of Science, Technology and Innovation (MOSTI), Malaysia [05-02-02-T002]	Ministry of Science, Technology and Innovation (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	Ministry of Science, Technology and Innovation (MOSTI), Malaysia under the Top-Down program (Project no. 05-02-02-T002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER JW, 1985, P NATL ACAD SCI USA, V82, P4225, DOI 10.1073/pnas.82.12.4225; Benyamini H, 2003, J MOL BIOL, V330, P159, DOI 10.1016/S0022-2836(03)00557-6; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Canavez FC, 1999, AM J PRIMATOL, V48, P225, DOI 10.1002/(SICI)1098-2345(1999)48:3<225::AID-AJP4>3.0.CO;2-4; Canavez FC, 1998, IMMUNOGENETICS, V48, P133, DOI 10.1007/s002510050413; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; Choi WB, 2006, MOL IMMUNOL, V43, P1565, DOI 10.1016/j.molimm.2005.09.021; Coico R., 2003, IMMUNOLOGY SHORT COU; COLE T, 1989, EUR J BIOCHEM, V186, P35, DOI 10.1111/j.1432-1033.1989.tb15174.x; Collins RWM, 2004, EUR J IMMUNOGENET, V31, P105, DOI 10.1111/j.1365-2370.2004.00457.x; Criscitiello MF, 1998, IMMUNOGENETICS, V48, P339, DOI 10.1007/s002510050441; DANIEL F, 1983, EMBO J, V2, P1061, DOI 10.1002/j.1460-2075.1983.tb01546.x; DIXON B, 1995, DEV COMP IMMUNOL, V19, P109, DOI 10.1016/0145-305X(94)00056-L; Dixon B, 1996, IMMUNOGENETICS, V44, P419, DOI 10.1007/s002510050148; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ELLIS SA, 1993, IMMUNOGENETICS, V38, P383, DOI 10.1007/BF00210486; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; GATES FT, 1979, BIOCHEMISTRY-US, V18, P2267, DOI 10.1021/bi00578a021; GROVES ML, 1982, J BIOL CHEM, V257, P2619; GUSSOW D, 1987, J IMMUNOL, V139, P3132; Hansen TH, 1997, ADV IMMUNOL, V64, P105, DOI 10.1016/S0065-2776(08)60888-3; HUI FH, 2006, FISH SHELLFISH IMMMU, V20, P118; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Lundqvist ML, 1999, IMMUNOGENETICS, V50, P79, DOI 10.1007/s002510050690; MILLAND J, 1993, IMMUNOGENETICS, V38, P464, DOI 10.1007/BF00184532; Miska KB, 2003, DEV COMP IMMUNOL, V27, P247, DOI 10.1016/S0145-305X(02)00095-2; Naruse K, 2000, GENETICS, V154, P1773; ONO H, 1993, IMMUNOGENETICS, V38, P1, DOI 10.1007/BF00216384; Riegert P, 1996, P NATL ACAD SCI USA, V93, P1243, DOI 10.1073/pnas.93.3.1243; ROBERT DF, 2006, NUCLEIC ACIDS RES, V34, P247; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shum BP, 1996, P NATL ACAD SCI USA, V93, P2779, DOI 10.1073/pnas.93.7.2779; Stewart R, 2005, DEV COMP IMMUNOL, V29, P723, DOI 10.1016/j.dci.2004.12.004; Tallmadge RL, 2003, IMMUNOGENETICS, V54, P725, DOI 10.1007/s00251-002-0514-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan SL, 2008, GENE, V411, P77, DOI 10.1016/j.gene.2008.01.008; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vihtelic TS, 2005, MOL VIS, V11, P1083; WELINDER KG, 1991, MOL IMMUNOL, V28, P177, DOI 10.1016/0161-5890(91)90102-P; Western AH, 2003, MOL IMMUNOL, V39, P707, DOI 10.1016/S0161-5890(02)00260-2; WOLFE PB, 1980, MOL IMMUNOL, V17, P1493, DOI 10.1016/0161-5890(80)90175-3; York IA, 2005, J IMMUNOL, V174, P6839, DOI 10.4049/jimmunol.174.11.6839; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13159	10.1371/journal.pone.0013159	http://dx.doi.org/10.1371/journal.pone.0013159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949082	Green Published, Green Submitted, gold			2022-12-25	WOS:000282568400005
J	Holliday, CM; Ridgely, RC; Sedlmayr, JC; Witmer, LM				Holliday, Casey M.; Ridgely, Ryan C.; Sedlmayr, Jayc C.; Witmer, Lawrence M.			Cartilaginous Epiphyses in Extant Archosaurs and Their Implications for Reconstructing Limb Function in Dinosaurs	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; GROWTH-PATTERNS; PRIMITIVE FORM; LONG BONES; EVOLUTION; FORELIMB; THEROPODA; THICKNESS; MAMMALS; POSTURE	Extinct archosaurs, including many non-avian dinosaurs, exhibit relatively simply shaped condylar regions in their appendicular bones, suggesting potentially large amounts of unpreserved epiphyseal ( articular) cartilage. This "lost anatomy'' is often underappreciated such that the ends of bones are typically considered to be the joint surfaces, potentially having a major impact on functional interpretation. Extant alligators and birds were used to establish an objective basis for inferences about cartilaginous articular structures in such extinct archosaur clades as non-avian dinosaurs. Limb elements of alligators, ostriches, and other birds were dissected, disarticulated, and defleshed. Lengths and condylar shapes of elements with intact epiphyses were measured. Limbs were subsequently completely skeletonized and the measurements repeated. Removal of cartilaginous condylar regions resulted in statistically significant changes in element length and condylar breadth. Moreover, there was marked loss of those cartilaginous structures responsible for joint architecture and congruence. Compared to alligators, birds showed less dramatic, but still significant changes. Condylar morphologies of dinosaur limb bones suggest that most non-coelurosaurian clades possessed large cartilaginous epiphyses that relied on the maintenance of vascular channels that are otherwise eliminated early in ontogeny in smaller-bodied tetrapods. A sensitivity analysis using cartilage correction factors (CCFs) obtained from extant taxa indicates that whereas the presence of cartilaginous epiphyses only moderately increases estimates of dinosaur height and speed, it has important implications for our ability to infer joint morphology, posture, and the complicated functional movements in the limbs of many extinct archosaurs. Evidence suggests that the sizes of sauropod epiphyseal cartilages surpassed those of alligators, which account for at least 10% of hindlimb length. These data suggest that large cartilaginous epiphyses were widely distributed among non-avian archosaurs and must be considered when making inferences about locomotor functional morphology in fossil taxa.	[Holliday, Casey M.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Ridgely, Ryan C.; Witmer, Lawrence M.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Sedlmayr, Jayc C.] Louisiana State Univ New Orleans, Sch Med, Dept Cell Biol & Anat, New Orleans, LA 70112 USA	University of Missouri System; University of Missouri Columbia; University System of Ohio; Ohio University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Holliday, CM (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	hollidayca@missouri.edu		Holliday, Casey/0000-0001-8210-8434; Witmer, Lawrence/0000-0002-7610-0118	National Science Foundation (NSF) [DDIG 0407735, IBN-9601174, IBN-0343744, IOB-0517257]; Ohio University Department of Biological; Ohio University Department of Biomedical Sciences; Ohio University College of Osteopathic Medicine; University of Missouri Department of Pathology and Anatomical Sciences	National Science Foundation (NSF)(National Science Foundation (NSF)); Ohio University Department of Biological; Ohio University Department of Biomedical Sciences; Ohio University College of Osteopathic Medicine; University of Missouri Department of Pathology and Anatomical Sciences	Funding was provided by National Science Foundation (NSF) DDIG 0407735 (to L. M. W and C. M. H.) and NSF IBN-9601174, IBN-0343744, IOB-0517257 (to L.M.W.) as well as Ohio University Departments of Biological and Biomedical Sciences, Ohio University College of Osteopathic Medicine, and University of Missouri Department of Pathology and Anatomical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1991, SCI AM, V264, P130, DOI 10.1038/scientificamerican0491-130; ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; BAKKER RT, 1971, NATURE, V229, P172, DOI 10.1038/229172a0; Bakker RT., 1986, DINOSAUR HERESIES; BARRETO C, 1993, SCIENCE, V262, P2020, DOI 10.1126/science.262.5142.2020; BAUMEL JJ, 1993, HDB AVIAN ANATOMY NO, P00133; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; BIKNEVICIUS AR, 1992, ANAT RECORD, V232, P157, DOI 10.1002/ar.1092320118; Biknevicius AR, 1999, J ZOOL, V248, P179, DOI 10.1111/j.1469-7998.1999.tb01194.x; Blob RW, 2000, J ZOOL, V250, P507, DOI 10.1111/j.1469-7998.2000.tb00793.x; BONNAN M, IN PRESS ANAT REC; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P139; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Brochu CA, 2001, J PALEONTOL, V75, P1185, DOI 10.1666/0022-3360(2001)075<1185:PAFDIA>2.0.CO;2; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; CARPENTER K, 1999, EGGS NESTS BABY DINO, P352; Carpenter Kenneth, 1997, P150; Carrano MT, 1998, PALEOBIOLOGY, V24, P450, DOI 10.1017/S0094837300020108; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Carter DR, 2003, PHILOS T ROY SOC B, V358, P1461, DOI 10.1098/rstb.2003.1346; Carter DR, 1998, ZOOL J LINN SOC-LOND, V123, P163, DOI 10.1006/zjls.1997.0108; Carter DR, 2001, SKELETAL FUNCTION FO; Charig A.J., 1972, P121; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; Chrtstiansen P, 1999, J VERTEBR PALEONTOL, V19, P666, DOI 10.1080/02724634.1999.10011180; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Colbert Edwin H., 1947, BULL AMER MUS NAT HIST, V88, P53; COOMBS WP, 1975, PALAEOGEOGR PALAEOCL, V17, P1, DOI 10.1016/0031-0182(75)90027-9; COPE E, 1884, AM NAT, V18, P526; Cope ED, 1878, AM NAT, V12, P71, DOI [10.1086/272033., DOI 10.1086/272033]; CURREY JD, 1985, J ZOOL, V206, P453; Dodson P., 1996, HORNED DINOSAURS NAT; Eckstein F, 1997, J BIOMECH, V30, P285, DOI 10.1016/S0021-9290(97)81146-3; Egger GF, 2008, J MORPHOL, V269, P118, DOI 10.1002/jmor.10600; Enlow D. H., 1969, pUnpaginated; Enlow DH, 1980, SCI F ORTHOPAEDICS T, P185; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Farlow JO, 2004, LETHAIA, V37, P401, DOI 10.1080/00241160410002117; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Faux CM, 2007, PALEOBIOLOGY, V33, P201, DOI 10.1666/06015.1; FREY E, 1988, STUTTGARTER BEITRAGE, V426, P1; Fujiwara S, 2010, J MORPHOL, V271, P883, DOI 10.1002/jmor.10846; GALTON P M, 1970, Journal of Paleontology, V44, P464; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Gatesy SM, 1997, J VERTEBR PALEONTOL, V17, P308, DOI 10.1080/02724634.1997.10010977; Gatesy SM, 2009, J VERTEBR PALEONTOL, V29, P535, DOI 10.1671/039.029.0213; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Gishlick AD, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P301; Haine RW, 1942, BIOL REV, V17, P262; Haines R. W, 1969, EPIPHYSES SESAMOIDS, P81; Haines RW, 1941, J ANAT, V75, P282; Haines RW, 1938, J ANAT, V72, P323; Haines RW, 1939, J ANAT, V74, P80; Hall B.K., 2015, BONES CARTILAGE DEV; HALLETT M, 1987, DINOSAURS PAST PRESE, V1, P96; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Hay OP, 1908, AM NAT, V42, P672, DOI 10.1086/278992; HEINRICH RE, 1993, ZOOL J LINN SOC-LOND, V108, P179, DOI 10.1111/j.1096-3642.1993.tb00294.x; Heinrich RE, 1998, J MORPHOL, V235, P121, DOI 10.1002/(SICI)1097-4687(199802)235:2<121::AID-JMOR3>3.0.CO;2-C; Holliday Casey M., 2001, Journal of Vertebrate Paleontology, V21, p62A; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Hutchinson JR, 2006, NATURE, V440, P292, DOI 10.1038/440292a; Hutchinson JR, 2005, PALEOBIOLOGY, V31, P676; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Jaramillo D, 2004, AM J ROENTGENOL, V182, P353, DOI 10.2214/ajr.182.2.1820353; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Long R.A., 1995, NEW MEXICO MUSEUM NA, V4, P1; LUBOSCH W, 1924, MORPH JB, V53, P49; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Madsen JH., 1976, UTAH GEOLOGICAL SURV, V109, P163; Marsh O., 1883, AM J SCI, V26, P81; MARSH OC, 1896, 16 US GEOL SURV, P133; MARSH OC, 1883, AM J SCI, V3, P81; MAZZETTA G, 2004, BODY SIZE SOME SO S, P1; MCCUTCHEN CW, 1983, CARTILAGE BIOMEDICAL, P87; Moodie RL, 1908, AM J ANAT, V7, P443, DOI 10.1002/aja.1000070403; NICHOLLS EL, 1985, PALAEONTOLOGY, V28, P643; NORMAN DB, 1980, I ROYAL SCI NATURELL, V178, P1; Osborn H. F., 1898, Bulletin of the American Museum of Natural History, Vx, P219; Ostrom J. A., 1966, MARSHS DINOSAURS COL; Ostrom J.H., 1976, BREVIORA, V439, P1; OWEN R, 1875, MONOGRAPHS BRIT FO 2, P875; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Parrish J.M., 1986, P35; Parrish J.M., 1986, Hunteria, V1, P1; Parsons T.S., 1969, BIOL REPTILIA, VI, P81, DOI DOI 10.1093/ICB/ICP063; PAUL G, 1998, SIMON SCHUSTER, P464; PAUL G, 2002, JOHNS HOPKINS U PRES; Paul GS, 2000, PALEOBIOLOGY, V26, P450, DOI 10.1666/0094-8373(2000)026<0450:FPINDI>2.0.CO;2; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; REID REH, 1984, S ZOOLOGICAL SOC LON, V52, P629; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P303; Royo-Torres R, 2006, SCIENCE, V314, P1925, DOI 10.1126/science.1132885; Ruff C., 1990, P119; Schmidt-Nielson K., 1984, SCALING WHY IS ANIMA; Schwarz D, 2007, J GEOL SOC LONDON, V164, P61, DOI 10.1144/0016-76492006-019; Senter P, 2005, PALEOBIOLOGY, V31, P373, DOI 10.1666/0094-8373(2005)031[0373:FITSFO]2.0.CO;2; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; Senter P, 2007, J ZOOL, V273, P305, DOI 10.1111/j.1469-7998.2007.00329.x; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P385; SIMON WH, 1970, ARTHRITIS RHEUM, V13, P244, DOI 10.1002/art.1780130305; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Thulborn R.A., 1989, DINOSAUR TRACKS TRAC, P39; THULBORN RA, 1982, PALAEOGEOGR PALAEOCL, V38, P227, DOI 10.1016/0031-0182(82)90005-0; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; [No title captured]	119	85	85	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13120	10.1371/journal.pone.0013120	http://dx.doi.org/10.1371/journal.pone.0013120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927347	Green Submitted, gold, Green Published			2022-12-25	WOS:000282312600033
J	Fenstad, MH; Johnson, MP; Roten, LT; Aas, PA; Forsmo, S; Klepper, K; East, CE; Abraham, LJ; Blangero, J; Brennecke, SP; Austgulen, R; Moses, EK				Fenstad, Mona H.; Johnson, Matthew P.; Roten, Linda T.; Aas, Per A.; Forsmo, Siri; Klepper, Kjetil; East, Christine E.; Abraham, Lawrence J.; Blangero, John; Brennecke, Shaun P.; Austgulen, Rigmor; Moses, Eric K.			Genetic and Molecular Functional Characterization of Variants within TNFSF13B, a Positional Candidate Preeclampsia Susceptibility Gene on 13q	PLOS ONE			English	Article							B-LYMPHOCYTE STIMULATOR; NECROSIS-FACTOR FAMILY; TRAIT LINKAGE ANALYSIS; NK CELLS; TRANSMISSION DISEQUILIBRIUM; SUPERFAMILY LIGANDS; RISK; LOCUS; FETAL; BLYS	Background: Preeclampsia is a serious pregnancy complication, demonstrating a complex pattern of inheritance. The elucidation of genetic liability to preeclampsia remains a major challenge in obstetric medicine. We have adopted a positional cloning approach to identify maternal genetic components, with linkages previously demonstrated to chromosomes 2q, 5q and 13q in an Australian/New Zealand familial cohort. The current study aimed to identify potential functional and structural variants in the positional candidate gene TNFSF13B under the 13q linkage peak and assess their association status with maternal preeclampsia genetic susceptibility. Methodology/Principal Findings: The proximal promoter and coding regions of the positional candidate gene TNFSF13B residing within the 13q linkage region was sequenced using 48 proband or founder individuals from Australian/New Zealand families. Ten sequence variants (nine SNPs and one single base insertion) were identified and seven SNPs were successfully genotyped in the total Australian/New Zealand family cohort (74 families/480 individuals). Borderline association to preeclampsia (p = 0.0153) was observed for three rare SNPs (rs16972194, rs16972197 and rs56124946) in strong linkage disequilibrium with each other. Functional evaluation by electrophoretic mobility shift assays showed differential nuclear factor binding to the minor allele of the rs16972194 SNP, residing upstream of the translation start site, making this a putative functional variant. The observed genetic associations were not replicated in a Norwegian case/control cohort (The Nord-Trondelag Health Study (HUNT2), 851 preeclamptic and 1,440 non-preeclamptic women). Conclusion/Significance: TNFSF13B has previously been suggested to contribute to the normal immunological adaption crucial for a successful pregnancy. Our observations support TNFSF13B as a potential novel preeclampsia susceptibility gene. We discuss a possible role for TNFSF13B in preeclampsia pathogenesis, and propose the rs16972194 variant as a candidate for further functional evaluation.	[Fenstad, Mona H.; Roten, Linda T.; Aas, Per A.; Klepper, Kjetil; Austgulen, Rigmor] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Johnson, Matthew P.; Blangero, John; Moses, Eric K.] SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; [Forsmo, Siri] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [East, Christine E.; Brennecke, Shaun P.] Univ Melbourne, Parkville, Vic 3052, Australia; [East, Christine E.; Brennecke, Shaun P.] Royal Womens Hosp, Dept Obstet & Gynaecol, Dept Perinatal Med, Parkville, Vic, Australia; [Abraham, Lawrence J.] Univ Western Australia Crawley, Sch Biomed Biomol & Chem Sci, Perth, WA, Australia	Norwegian University of Science & Technology (NTNU); Texas Biomedical Research Institute; Norwegian University of Science & Technology (NTNU); University of Melbourne; University of Western Australia	Fenstad, MH (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	mona.n.fenstad@ntnu.no	East, Christine/H-4938-2013; Blangero, John/ABA-7175-2021; Brennecke, Shaun/AFV-3919-2022	East, Christine/0000-0002-1196-8426; Brennecke, Shaun/0000-0003-3070-6971; Moses, Eric/0000-0001-7781-4465; Fenstad, Mona Hoysaeter/0000-0002-9102-8409	National Institutes of Health [HD049847, MH059490]; Norwegian University of Science and Technology (NTNU); Liaison Committee of NTNU; Central Norway Regional Health Authority; Research Council of Norway; Fulbright Foundation for Educational Exchange; National Center for Research Resources, National Institutes of Health [RR13556, RR017515]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049847] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556, C06RR017515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian University of Science and Technology (NTNU); Liaison Committee of NTNU; Central Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Fulbright Foundation for Educational Exchange; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants HD049847 (to E. K. M, S. P. B. and J.B.) and MH059490 (to J.B.); The Norwegian University of Science and Technology (NTNU) (M. H. F, L. T. R., R. A.); the Liaison Committee of NTNU and Central Norway Regional Health Authority (M. H. F. and L. T. R.); the Research Council of Norway (M. H. F., travel grant) and the Fulbright Foundation for Educational Exchange (M. H. F., travel grant). This investigation was conducted in facilities constructed with support from Research Facilities Improvement Program grants RR13556 and RR017515 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2009, DNA REPAIR, V8, P822, DOI 10.1016/j.dnarep.2009.03.008; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Blangero J, 2005, HUM BIOL, V77, P541, DOI 10.1353/hub.2006.0003; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P133, DOI 10.1111/j.1479-828X.2000.tb01136.x; BROWN MA, 1993, MED J AUSTRALIA, V158, P700; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chang SK, 2006, BLOOD, V108, P2687, DOI 10.1182/blood-2005-12-017319; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; COSTARODRIGUEZ EV, 2007, EUR J IMMUNOL, V37, P990; Dekker G, 2007, J REPROD IMMUNOL, V76, P8, DOI 10.1016/j.jri.2007.03.015; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Esplin MS, 2001, NEW ENGL J MED, V344, P867, DOI 10.1056/NEJM200103223441201; Fenstad MH, 2010, MOL HUM REPROD, V16, P960, DOI 10.1093/molehr/gaq064; Fitzpatrick E, 2004, HUM BIOL, V76, P849, DOI 10.1353/hub.2005.0017; Fitzpatrick E, 2009, MOL HUM REPROD, V15, P195, DOI 10.1093/molehr/gap001; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Guo WJ, 2008, CHINESE MED J-PEKING, V121, P309, DOI 10.1097/00029330-200802020-00006; Harrison GA, 1997, AM J HUM GENET, V60, P1158; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Havill LM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S91; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Johnson MP, 2007, MOL HUM REPROD, V13, P61, DOI 10.1093/molehr/gal095; Johnson MP, 2009, HUM GENET, V126, P655, DOI 10.1007/s00439-009-0714-x; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Lachmeijer AMA, 2001, EUR J HUM GENET, V9, P758, DOI 10.1038/sj.ejhg.5200706; Laivuori H, 2003, AM J HUM GENET, V72, P168, DOI 10.1086/345311; Laivuori H, 2007, FRONT BIOSCI-LANDMRK, V12, P2372, DOI 10.2741/2239; Li DK, 2000, AM J EPIDEMIOL, V151, P57, DOI 10.1093/oxfordjournals.aje.a010122; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay Fabienne, 2005, V8, P243; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Moses EK, 2006, MOL HUM REPROD, V12, P505, DOI 10.1093/molehr/gal056; Moses EK, 2000, AM J HUM GENET, V67, P1581, DOI 10.1086/316888; Moses EK, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.024; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Muetze S, 2008, J PERINAT MED, V36, P38, DOI 10.1515/JPM.2008.004; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Novak AJ, 2006, J CLIN ONCOL, V24, P983, DOI 10.1200/JCO.2005.02.7938; Novak AJ, 2009, CANCER RES, V69, P4217, DOI 10.1158/0008-5472.CAN-08-4915; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Phillips TA, 2003, J LEUKOCYTE BIOL, V74, P81, DOI 10.1189/jlb.0103033; Phillips TA, 2001, PLACENTA, V22, P663, DOI 10.1053/plac.2001.0703; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Pu J, 2009, EUR J HAEMATOL, V82, P267, DOI 10.1111/j.1600-0609.2008.01203.x; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Riley JK, 2010, CLIN REV ALLERG IMMU, V39, P185, DOI 10.1007/s12016-009-8178-2; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Roten LT, 2009, EUR J HUM GENET, V17, P250, DOI 10.1038/ejhg.2008.158; ROTEN LT, 2009, THESIS NORWEGIAN U S; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Santoni A, 2007, AM J REPROD IMMUNOL, V58, P280, DOI 10.1111/j.1600-0897.2007.00513.x; Sargent IL, 2006, REPROD BIOMED ONLINE, V13, P680, DOI 10.1016/S1472-6483(10)60659-1; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Shan X, 2006, PHYSIOL RES, V55, P301, DOI 10.33549/physiolres.930816; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Sobel E, 1996, AM J HUM GENET, V58, P1323; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Zhang W, 2008, IMMUNOL LETT, V120, P96, DOI 10.1016/j.imlet.2008.07.005	85	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12993	10.1371/journal.pone.0012993	http://dx.doi.org/10.1371/journal.pone.0012993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927378	Green Submitted, Green Published, gold			2022-12-25	WOS:000282269400007
J	Kullo, IJ; Ding, KY; Jouni, H; Smith, CY; Chute, CG				Kullo, Iftikhar J.; Ding, Keyue; Jouni, Hayan; Smith, Carin Y.; Chute, Christopher G.			A Genome-Wide Association Study of Red Blood Cell Traits Using the Electronic Medical Record	PLOS ONE			English	Article							HEMOGLOBIN LEVELS; DISEASE; TMPRSS6; CONSORTIUM; VISCOSITY; VARIANTS; PRESSURE; LINKAGE; ANEMIA; VOLUME	Background: The Electronic Medical Record (EMR) is a potential source for high throughput phenotyping to conduct genome-wide association studies (GWAS), including those of medically relevant quantitative traits. We describe use of the Mayo Clinic EMR to conduct a GWAS of red blood cell (RBC) traits in a cohort of patients with peripheral arterial disease (PAD) and controls without PAD. Methodology and Principal Findings: Results for hemoglobin level, hematocrit, RBC count, mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration were extracted from the EMR from January 1994 to September 2009. Out of 35,159 RBC trait values in 3,411 patients, we excluded 12,864 values in 1,165 patients that had been measured during hospitalization or in the setting of hematological disease, malignancy, or use of drugs that affect RBC traits, leaving a final genotyped sample of 3,012, 80% of whom had >= 2 measurements. The median of each RBC trait was used in the genetic analyses, which were conducted using an additive model that adjusted for age, sex, and PAD status. We identified four genomic loci that were associated (P<5 x 10(-8)) with one or more of the RBC traits (HBLS1/MYB on 6q23.3, TMPRSS6 on 22q12.3, HFE on 6p22.1, and SLC17A1 on 6p22.2). Three of these loci (HBLS1/MYB, TMPRSS6, and HFE) had been identified in recent GWAS and the allele frequencies, effect sizes, and the directions of effects of the replicated SNPs were similar to the prior studies. Conclusions: Our results demonstrate feasibility of using the EMR to conduct high throughput genomic studies of medically relevant quantitative traits.	[Kullo, Iftikhar J.; Ding, Keyue; Jouni, Hayan] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Kullo, IJ (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.	kullo.iftikhar@mayo.edu	Chute, Christopher/AAT-8540-2021	Smith, Carin/0000-0002-3610-6945; Ding, Keyue/0000-0002-3496-6415	National Human Genome Research Institute [HG05499]	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was funded as part of the National Human Genome Research Institute-supported eMERGE (Electronic Records and Genomics) Network (HG05499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NC, 2009, NAT GENET, V41, P1161, DOI 10.1038/ng1109-1161; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; CARPENTER PC, 1994, INT J BIOMED COMPUT, V34, P159, DOI 10.1016/0020-7101(94)90019-1; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Chernecky C.C., 2001, LAB TESTS DIAGNOSTIC, V3rd; Chute CG, 2010, J AM MED INFORM ASSN, V17, P131, DOI 10.1136/jamia.2009.002691; de Lusignan Simon, 2006, Inform Prim Care, V14, P203; de Simone G, 2005, HYPERTENSION, V45, P625, DOI 10.1161/01.HYP.0000157526.07977.ec; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Giannetti AM, 2004, J BIOL CHEM, V279, P25866, DOI 10.1074/jbc.M401467200; Kullo IJ, 2010, J AM MED INFORM ASSN, V17, P568, DOI 10.1136/jamia.2010.004366; LETCHER RL, 1983, HYPERTENSION, V5, P757, DOI 10.1161/01.HYP.5.5.757; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Lin JP, 2007, AM J HEMATOL, V82, P605, DOI 10.1002/ajh.20868; Louie B, 2007, J BIOMED INFORM, V40, P5, DOI 10.1016/j.jbi.2006.02.007; Manolio TA, 2009, PHARMACOGENOMICS, V10, P235, DOI 10.2217/14622416.10.2.235; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; Sharp DS, 1996, CIRCULATION, V93, P1677, DOI 10.1161/01.CIR.93.9.1677; Silva-Brandao KL, 2008, MOL ECOL RESOUR, V8, P502, DOI 10.1111/j.1471-8286.2007.02022.x; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Timmer RT, 2000, J GEN PHYSIOL, V116, P363, DOI 10.1085/jgp.116.3.363; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200	27	86	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13011	10.1371/journal.pone.0013011	http://dx.doi.org/10.1371/journal.pone.0013011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927387	gold, Green Published, Green Submitted			2022-12-25	WOS:000282210700008
J	Schaub, M; Martinez, N; Tagmann-Ioset, A; Weisshaupt, N; Maurer, ML; Reichlin, TS; Abadi, F; Zbinden, N; Jenni, L; Arlettaz, R				Schaub, Michael; Martinez, Nicolas; Tagmann-Ioset, Aline; Weisshaupt, Nadja; Maurer, Melanie L.; Reichlin, Thomas S.; Abadi, Fitsum; Zbinden, Niklaus; Jenni, Lukas; Arlettaz, Raphael			Patches of Bare Ground as a Staple Commodity for Declining Ground-Foraging Insectivorous Farmland Birds	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; AGRICULTURAL INTENSIFICATION; TERRESTRIAL ECOSYSTEMS; PROMOTING BIODIVERSITY; HABITAT STRUCTURE; PREDATION RISK; FOOD RESOURCES; GRASSLAND; MANAGEMENT; LANDSCAPES	Conceived to combat widescale biodiversity erosion in farmland, agri-environment schemes have largely failed to deliver their promises despite massive financial support. While several common species have shown to react positively to existing measures, rare species have continued to decline in most European countries. Of particular concern is the status of insectivorous farmland birds that forage on the ground. We modelled the foraging habitat preferences of four declining insectivorous bird species (hoopoe, wryneck, woodlark, common redstart) inhabiting fruit tree plantations, orchards and vineyards. All species preferred foraging in habitat mosaics consisting of patches of grass and bare ground, with an optimal, species-specific bare ground coverage of 30-70% at the foraging patch scale. In the study areas, birds thrived in intensively cultivated farmland where such ground vegetation mosaics existed. Not promoted by conventional agri-environment schemes until now, patches of bare ground should be implemented throughout grassland in order to prevent further decline of insectivorous farmland birds.	[Schaub, Michael; Tagmann-Ioset, Aline; Weisshaupt, Nadja; Maurer, Melanie L.; Reichlin, Thomas S.; Abadi, Fitsum; Arlettaz, Raphael] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Schaub, Michael; Martinez, Nicolas; Reichlin, Thomas S.; Zbinden, Niklaus; Jenni, Lukas; Arlettaz, Raphael] Swiss Ornithol Inst, Sempach, Switzerland	University of Bern; Swiss Ornithological Institute	Schaub, M (corresponding author), Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland.	raphael.arlettaz@iee.unibe.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339; Walter, Jens/0000-0003-1754-172X; Schaub, Michael/0000-0003-2745-0557	University of Bern; Swiss Ornithological Institute; Ignace Marietan Foundation (Societe Valaisanne de Sciences Naturelles)	University of Bern; Swiss Ornithological Institute; Ignace Marietan Foundation (Societe Valaisanne de Sciences Naturelles)	Most funding was provided by the University of Bern and the Swiss Ornithological Institute. Reduced additional funding was provided by the Ignace Marietan Foundation (Societe Valaisanne de Sciences Naturelles) in the form of an MSc grant to Melanie Maurer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PW, 2005, J APPL ECOL, V42, P932, DOI 10.1111/j.1365-2664.2005.01070.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Birrer S, 2007, J ORNITHOL, V148, pS295, DOI 10.1007/s10336-007-0237-y; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Britschgi A, 2006, BIOL CONSERV, V130, P193, DOI 10.1016/j.biocon.2005.12.013; Buckingham DL, 2006, AGR ECOSYST ENVIRON, V112, P21, DOI 10.1016/j.agee.2005.06.019; Buckingham DL, 2004, IBIS, V146, P163, DOI 10.1111/j.1474-919X.2004.00350.x; Butler SJ, 2004, IBIS, V146, P123, DOI 10.1111/j.1474-919X.2004.00352.x; COUDRAIN V, 2010, J ORNITHOL EARLY; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Davey CM, 2010, IBIS, V152, P459, DOI 10.1111/j.1474-919X.2009.01001.x; Devereux CL, 2006, BEHAV ECOL, V17, P303, DOI 10.1093/beheco/arj032; Devereux CL, 2006, AGR ECOSYST ENVIRON, V117, P57, DOI 10.1016/j.agee.2006.03.007; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Douglas DJT, 2009, J APPL ECOL, V46, P353, DOI 10.1111/j.1365-2664.2009.01613.x; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Knop E, 2006, J APPL ECOL, V43, P120, DOI 10.1111/j.1365-2664.2005.01113.x; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Martinez N, 2010, J ORNITHOL, V151, P297, DOI 10.1007/s10336-009-0455-6; Mermod M, 2009, IBIS, V151, P731, DOI 10.1111/j.1474-919X.2009.00956.x; Moorcroft D, 2002, J APPL ECOL, V39, P535, DOI 10.1046/j.1365-2664.2002.00730.x; Morris MG, 2000, BIOL CONSERV, V95, P129, DOI 10.1016/S0006-3207(00)00028-8; Perkins AJ, 2000, BIOL CONSERV, V95, P279, DOI 10.1016/S0006-3207(00)00042-2; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Royle J. A., 2008, HIERARCHICAL MODELIN; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Sierro Antoine, 2009, Nos Oiseaux, V56, P129; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Taylor ME, 2009, AGR ECOSYST ENVIRON, V130, P9, DOI 10.1016/j.agee.2008.11.004; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Whittingham MJ, 2007, J APPL ECOL, V44, P1, DOI 10.1111/j.1365-2664.2006.01263.x; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x	41	301	309	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13115	10.1371/journal.pone.0013115	http://dx.doi.org/10.1371/journal.pone.0013115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949083	Green Published, gold			2022-12-25	WOS:000282568400002
